Citrus Sinensis ID: 027675

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220
Protein Sequence
MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEAVNLASPKRPAFVVRRGSSSSASTSNKPESNNELTHSLEGR
Secondary Structure (PSIPRED)
cccccHHHHHHHHHHHHHcccccccEEEcccccccccccccccccccccccccccccccccccccEEEEEcccccHHHHcccccccccccccHHHEEEEHcccccccccccccccccHHHHHHHHcccccccccccccccccccHHHHHHHHHHHHHcccccccccccHHHHHHHHccccccccccccccEEEEccccccccccccccccccEEEEEEcc
Secondary Structure Prediction (SSPRO)
cccHHHHHHHHHHHHHHHHHccHccEEcccccHHHEEEcccccEEEccccccHEcccccccccccEEEEEccHccHHHHHHccccHHHHHHHHHHHHHHHEccccccccccccccccHHHHHHHHHHccccEEEEcccccccccHHHHHHHHHHEEEEEcccHcccccHHHEEEEEcccccccccccccEEEEEEccccccccccccccccEEEEEEEcc
Coil and Loop (DISEMBL)
MEMLFNIILGVSRRLLYLHQDSKLRIIHRdfktsnilldhemnpkisdfgltrifegkqtdgttnrvvgtygymspeyalggffsvksdVFSFGVVVLEIISgkrntgfynSELALSLLGYAWKLWQEgkaldmmdqkpgaisKANEILKCINVGLlcvqedpndrptmSDVVIMLGSeavnlaspkrpafvvrrgssssastsnkpesnnelthslegr
Flexible Loop (DISEMBL)
MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKtsnilldhemnpkISDFGLTRifegkqtdgttnrVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEavnlaspkrpAFVVRRgssssastsnkpesnnelthslegr
Low Complexity Region (SEG)
MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEAVNLASPKRPAFVVRRGssssastsNKPESNNELTHSLEGR
Disordered region (IsUnstruct)
***LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE*********DVVIMLGSE*****************************************
Disordered Region (DISOPRED)
MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEAVNLASPKRPAF*********************LTHSLEGR
Disordered Region (DISEMBL)
MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEAVNLASPKRPAF*****************************
Disordered Region (DISPRO)
*EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEAVNLASPKRPAFVVRRGS************NNELTHSLEGR
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEAVNLASPKRPAFVVRRGSSSSASTSNKPESNNELTHSLEGR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	220	2.2.26 [Sep-21-2011]
Q9ZR08	852	G-type lectin S-receptor-	no	no	0.986	0.254	0.692	1e-78
Q39086	843	Receptor-like serine/thre	no	no	0.959	0.250	0.569	4e-67
Q9SXB8	842	G-type lectin S-receptor-	no	no	0.972	0.254	0.570	1e-66
Q9S972	847	Receptor-like serine/thre	no	no	0.868	0.225	0.620	1e-66
O81905	850	Receptor-like serine/thre	no	no	0.968	0.250	0.560	9e-66
P0DH86	853	G-type lectin S-receptor-	no	no	0.945	0.243	0.565	1e-65
Q9LPZ9	830	G-type lectin S-receptor-	no	no	0.981	0.260	0.547	5e-65
Q09092	857	Putative serine/threonine	N/A	no	0.968	0.248	0.548	3e-64
Q9LPZ3	845	G-type lectin S-receptor-	no	no	0.863	0.224	0.584	3e-63
Q8L7G3	659	Cysteine-rich receptor-li	no	no	0.981	0.327	0.509	5e-63

>sp|Q9ZR08|Y4230_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g03230 OS=Arabidopsis thaliana GN=At4g03230 PE=3 SV=3

 Score =  292 bits (747), Expect = 1e-78,   Method: Compositional matrix adjust.
 Identities = 153/221 (69%), Positives = 176/221 (79%), Gaps = 4/221 (1%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           +M  NIILG++R LLYLHQDS+LRIIHRD KTSNILLD EMNPKISDFGL RIF G +T 
Sbjct: 629 KMRCNIILGIARGLLYLHQDSRLRIIHRDLKTSNILLDEEMNPKISDFGLARIFGGSETS 688

Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGY 121
             TNRVVGTYGYMSPEYAL G FS KSDVFSFGVVV+E ISGKRNTGF+  E +LSLLG+
Sbjct: 689 ANTNRVVGTYGYMSPEYALEGLFSFKSDVFSFGVVVIETISGKRNTGFHEPEKSLSLLGH 748

Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLG-SEA 180
           AW LW+  + ++++DQ      +    LKC+NVGLLCVQEDPNDRPTMS+VV MLG SEA
Sbjct: 749 AWDLWKAERGIELLDQALQESCETEGFLKCLNVGLLCVQEDPNDRPTMSNVVFMLGSSEA 808

Query: 181 VNLASPKRPAFVVRRG-SSSSASTSNKPE--SNNELTHSLE 218
             L +PK+PAFV+RR  SSS AS+S KPE  S NELT +LE
Sbjct: 809 ATLPTPKQPAFVLRRCPSSSKASSSTKPETCSENELTITLE 849

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1

 Score =  254 bits (648), Expect = 4e-67,   Method: Compositional matrix adjust.
 Identities = 127/223 (56%), Positives = 159/223 (71%), Gaps = 12/223 (5%)

Query: 5   FNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTT 64
           F+II G++R LLYLHQDS+ RIIHRD K SN+LLD  M PKISDFG+ RIF  ++T+  T
Sbjct: 619 FDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANT 678

Query: 65  NRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWK 124
            RVVGTYGYMSPEYA+ G FS+KSDVFSFGV++LEIISGKRN GFYNS   L+LLG+ W+
Sbjct: 679 RRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWR 738

Query: 125 LWQEGKALDMMDQKPGAISK------ANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGS 178
            W+EG  L+++D  P  I         +EIL+CI +GLLCVQE   DRP MS V++MLGS
Sbjct: 739 HWKEGNELEIVD--PINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGS 796

Query: 179 EAVNLASPKRPAFVVRRG---SSSSASTSNKPESN-NELTHSL 217
           E   +  PKRP F + R    + SS+ST    E   N++T S+
Sbjct: 797 ETTAIPQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQITLSV 839

Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3

 Score =  253 bits (645), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 126/221 (57%), Positives = 159/221 (71%), Gaps = 7/221 (3%)

Query: 5   FNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTT 64
           FNI+ G+ R LLYLH+DS+L+IIHRD K SNILLD  +NPKISDFGL RIF   + +  T
Sbjct: 624 FNIMEGICRGLLYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFRANEDEANT 683

Query: 65  NRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWK 124
            RVVGTYGYMSPEYA+ GFFS KSDVFS GV+ LEIISG+RN+  +  E  L+LL YAWK
Sbjct: 684 RRVVGTYGYMSPEYAMEGFFSEKSDVFSLGVIFLEIISGRRNSSSHKEENNLNLLAYAWK 743

Query: 125 LWQEGKALDMMDQKPGAISKA--NEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEAVN 182
           LW +G+A  + D  P    K    EI KC+++GLLCVQE  NDRP +S+V+ ML +E ++
Sbjct: 744 LWNDGEAASLAD--PAVFDKCFEKEIEKCVHIGLLCVQEVANDRPNVSNVIWMLTTENMS 801

Query: 183 LASPKRPAFVVRRGSS---SSASTSNKPESNNELTHSLEGR 220
           LA PK+PAF+VRRG+S   SS  +S K   N+    ++ GR
Sbjct: 802 LADPKQPAFIVRRGASEAESSDQSSQKVSINDVSLTAVTGR 842

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2

 Score =  253 bits (645), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 121/195 (62%), Positives = 148/195 (75%), Gaps = 4/195 (2%)

Query: 5   FNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTT 64
           F+II G++R LLYLHQDS+ RIIHRD K SN+LLD  M PKISDFG+ RIF  ++T+  T
Sbjct: 623 FDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANT 682

Query: 65  NRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWK 124
            RVVGTYGYMSPEYA+ G FS+KSDVFSFGV++LEIISGKRN GFYNS   L+LLG+ W+
Sbjct: 683 RRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWR 742

Query: 125 LWQEGKALDMMDQ-KPGAISK---ANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEA 180
            W+EGK L+++D     A+S     +EIL+CI +GLLCVQE   DRP MS V++MLGSE 
Sbjct: 743 HWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSET 802

Query: 181 VNLASPKRPAFVVRR 195
             +  PKRP F V R
Sbjct: 803 TAIPQPKRPGFCVGR 817

Involved in the regulation of cellular expansion and differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1

 Score =  249 bits (637), Expect = 9e-66,   Method: Compositional matrix adjust.
 Identities = 121/216 (56%), Positives = 156/216 (72%), Gaps = 3/216 (1%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           +M F+II G++R LLYLHQDS+ RIIHRD K SNILLD  M PKISDFG+ RIF   +T+
Sbjct: 623 QMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETE 682

Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGY 121
             T +VVGTYGYMSPEYA+ G FS+KSDVFSFGV++LEIIS KRN GFYNS+  L+LLG 
Sbjct: 683 ANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLLGC 742

Query: 122 AWKLWQEGKALDMMD---QKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGS 178
            W+ W+EGK L+++D       +  + +EIL+CI +GLLCVQE   DRPTMS V++MLGS
Sbjct: 743 VWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVILMLGS 802

Query: 179 EAVNLASPKRPAFVVRRGSSSSASTSNKPESNNELT 214
           E+  +  PK P + + R    + S+S+K   +   T
Sbjct: 803 ESTTIPQPKAPGYCLERSLLDTDSSSSKQRDDESWT 838

Involved in the regulation of cellular expansion and differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P0DH86|SRK_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SRK OS=Arabidopsis thaliana GN=SRK PE=2 SV=1

 Score =  249 bits (635), Expect = 1e-65,   Method: Compositional matrix adjust.
 Identities = 121/214 (56%), Positives = 157/214 (73%), Gaps = 6/214 (2%)

Query: 5   FNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTT 64
           F+II G++R LLYLHQDS+ +IIHRD K SN+LLD  M PKISDFG+ RIFE  +T+  T
Sbjct: 625 FSIINGIARGLLYLHQDSRFKIIHRDLKASNVLLDKNMTPKISDFGMARIFERDETEANT 684

Query: 65  NRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWK 124
            +VVGTYGYMSPEYA+ G FSVKSDVFSFGV+VLEI+SGKRN GF+NS    +LLGY W+
Sbjct: 685 RKVVGTYGYMSPEYAMEGIFSVKSDVFSFGVLVLEIVSGKRNRGFHNSGQDNNLLGYTWE 744

Query: 125 LWQEGKALDMMDQKPG------AISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGS 178
            W+EGK L+++D          ++ + +E+L+CI +GLLCVQE   DRP MS VV+MLGS
Sbjct: 745 NWKEGKGLEIVDSIIVDSSSSMSLFQPHEVLRCIQIGLLCVQERAEDRPKMSSVVLMLGS 804

Query: 179 EAVNLASPKRPAFVVRRGSSSSASTSNKPESNNE 212
           E   +  PKRP + V R S  +A +S+  + ++E
Sbjct: 805 EKGEIPQPKRPGYCVGRSSLDTADSSSSTKRDSE 838

Female specificity determinant of self-incompatibility.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LPZ9|SD113_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-13 OS=Arabidopsis thaliana GN=SD113 PE=1 SV=2

 Score =  247 bits (630), Expect = 5e-65,   Method: Compositional matrix adjust.
 Identities = 120/219 (54%), Positives = 156/219 (71%), Gaps = 3/219 (1%)

Query: 5   FNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTT 64
           FNII G+ R L+YLH+DS+L+IIHRD K SNILLD  +NPKISDFGL RIF+G + + +T
Sbjct: 612 FNIIDGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFQGNEDEVST 671

Query: 65  NRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWK 124
            RVVGTYGYM+PEYA+GG FS KSDVFS GV++LEI+SG+RN+ FYN     +L  YAWK
Sbjct: 672 VRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIVSGRRNSSFYNDGQNPNLSAYAWK 731

Query: 125 LWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEAVNLA 184
           LW  G+ + ++D         NEI +C++VGLLCVQ+  NDRP+++ V+ ML SE  NL 
Sbjct: 732 LWNTGEDIALVDPVIFEECFENEIRRCVHVGLLCVQDHANDRPSVATVIWMLSSENSNLP 791

Query: 185 SPKRPAFVVRRGSS---SSASTSNKPESNNELTHSLEGR 220
            PK+PAF+ RRG+S   SS  +  +   NN     + GR
Sbjct: 792 EPKQPAFIPRRGTSEVESSGQSDPRASINNVSLTKITGR 830

Receptor-like serine/threonine-protein kinase that represses the disease resistance signaling pathway triggered in response to bacterial pathogen such as Pseudomonas syringae pv. tomato.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2

 Score =  244 bits (624), Expect = 3e-64,   Method: Compositional matrix adjust.
 Identities = 124/226 (54%), Positives = 151/226 (66%), Gaps = 13/226 (5%)

Query: 5   FNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTT 64
           F+I  GV+R LLYLHQDS+ RIIHRD K SNILLD  M PKISDFG+ RIFE  +T+  T
Sbjct: 628 FDITNGVARGLLYLHQDSRFRIIHRDLKVSNILLDKNMIPKISDFGMARIFERDETEANT 687

Query: 65  NRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWK 124
            +VVGTYGYMSPEYA+ G FS KSDVFSFGV+VLEI+SGK+N GFYN +    LL Y W 
Sbjct: 688 MKVVGTYGYMSPEYAMYGIFSEKSDVFSFGVIVLEIVSGKKNRGFYNLDYENDLLSYVWS 747

Query: 125 LWQEGKALDMMD-------QKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLG 177
            W+EG+AL+++D           +I +  E+LKCI +GLLCVQE    RP MS VV M G
Sbjct: 748 RWKEGRALEIVDPVIVDSLSSQPSIFQPQEVLKCIQIGLLCVQELAEHRPAMSSVVWMFG 807

Query: 178 SEAVNLASPKRPAFVVRRG------SSSSASTSNKPESNNELTHSL 217
           SEA  +  PK P + VRR       SSS     N+  + N+ T S+
Sbjct: 808 SEATEIPQPKPPGYCVRRSPYELDPSSSWQCDENESWTVNQYTCSV 853

Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain.

Brassica oleracea var. acephala (taxid: 3713)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3

 Score =  241 bits (615), Expect = 3e-63,   Method: Compositional matrix adjust.
 Identities = 114/195 (58%), Positives = 151/195 (77%), Gaps = 5/195 (2%)

Query: 16  LYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMS 75
           LYLHQDS+LRIIHRD K SN+LLD+EM PKI+DFGL RIF G Q +G+TNRVVGTYGYMS
Sbjct: 634 LYLHQDSRLRIIHRDLKASNVLLDNEMIPKIADFGLARIFGGNQIEGSTNRVVGTYGYMS 693

Query: 76  PEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMM 135
           PEYA+ G FS+KSDV+SFGV++LEII+GKRN+ FY  E +L+L+ + W  W+ G+A++++
Sbjct: 694 PEYAMDGQFSIKSDVYSFGVLILEIITGKRNSAFY--EESLNLVKHIWDRWENGEAIEII 751

Query: 136 DQKPGAIS-KANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEAVNLASPKRPAFVV- 193
           D+  G  +    E++KC+++GLLCVQE+ +DRP MS VV MLG  A++L SPK PAF   
Sbjct: 752 DKLMGEETYDEGEVMKCLHIGLLCVQENSSDRPDMSSVVFMLGHNAIDLPSPKHPAFTAG 811

Query: 194 -RRGSSSSASTSNKP 207
            RR + +  S+ N P
Sbjct: 812 RRRNTKTGGSSDNWP 826

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8L7G3|CRK7_ARATH Cysteine-rich receptor-like protein kinase 7 OS=Arabidopsis thaliana GN=CRK7 PE=2 SV=1

 Score =  240 bits (613), Expect = 5e-63,   Method: Compositional matrix adjust.
 Identities = 110/216 (50%), Positives = 157/216 (72%)

Query: 5   FNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTT 64
           ++II G++R +LYLHQDS+L IIHRD K SNILLD +MNPKI+DFG+ RIF   QT   T
Sbjct: 436 YHIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGMDQTQQNT 495

Query: 65  NRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWK 124
           +R+VGTYGYMSPEYA+ G FS+KSDV+SFGV+VLEIISG++N  F  ++ A  L+ +AW+
Sbjct: 496 SRIVGTYGYMSPEYAMRGQFSMKSDVYSFGVLVLEIISGRKNNSFIETDDAQDLVTHAWR 555

Query: 125 LWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEAVNLA 184
           LW+ G ALD++D       + +E+++C ++GLLCVQEDP  RP MS + +ML S  + L 
Sbjct: 556 LWRNGTALDLVDPFIADSCRKSEVVRCTHIGLLCVQEDPVKRPAMSTISVMLTSNTMALP 615

Query: 185 SPKRPAFVVRRGSSSSASTSNKPESNNELTHSLEGR 220
           +P++P F VR    ++   S++  +N  +T S++ +
Sbjct: 616 APQQPGFFVRSRPGTNRLDSDQSTTNKSVTVSIDDK 651

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	220
296081240	1004	unnamed protein product [Vitis vinifera]	0.995	0.218	0.740	6e-91
449453474	1030	PREDICTED: G-type lectin S-receptor-like	0.986	0.210	0.726	2e-85
224146691	865	predicted protein [Populus trichocarpa]	0.931	0.236	0.731	4e-85
356544860	991	PREDICTED: G-type lectin S-receptor-like	0.986	0.218	0.716	4e-83
449493195	1010	PREDICTED: G-type lectin S-receptor-like	0.918	0.2	0.737	4e-81
296081242	459	unnamed protein product [Vitis vinifera]	0.995	0.477	0.657	1e-80
296081245	679	unnamed protein product [Vitis vinifera]	0.986	0.319	0.689	3e-80
296081241	663	unnamed protein product [Vitis vinifera]	0.986	0.327	0.689	7e-80
296081243	810	unnamed protein product [Vitis vinifera]	0.986	0.267	0.657	1e-79
359485737	1379	PREDICTED: G-type lectin S-receptor-like	0.986	0.157	0.689	1e-79

>gi|296081240|emb|CBI17984.3| unnamed protein product [Vitis vinifera]

 Score =  339 bits (869), Expect = 6e-91,   Method: Compositional matrix adjust.
 Identities = 163/220 (74%), Positives = 186/220 (84%), Gaps = 1/220 (0%)

Query: 2    EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
            E  F+IILG++R LLYLHQDS+LRIIHRD KTSNILLD EMNPKISDFGL RIF GKQT+
Sbjct: 785  EKRFDIILGIARGLLYLHQDSRLRIIHRDLKTSNILLDEEMNPKISDFGLARIFGGKQTE 844

Query: 62   GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGY 121
             +TNRVVGTYGYMSPEYAL GFFS+KSDVFSFGVVVLEIISGKRNTGFY S+ ALSLLGY
Sbjct: 845  ASTNRVVGTYGYMSPEYALDGFFSIKSDVFSFGVVVLEIISGKRNTGFYQSQQALSLLGY 904

Query: 122  AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEAV 181
            AW+LWQE KALD+MDQ         E L+C+NVGLLCVQEDP+DRP MS+VV +LGSE  
Sbjct: 905  AWRLWQENKALDLMDQSLHETCDVAEFLRCVNVGLLCVQEDPSDRPVMSNVVFLLGSETA 964

Query: 182  NLASPKRPAFVVRRGSSSSASTSNKPES-NNELTHSLEGR 220
             L +PK+PAF VRRG  S+AS+S+KPE+  NELT S++GR
Sbjct: 965  TLPTPKQPAFTVRRGVFSTASSSSKPETCTNELTVSVDGR 1004

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449453474|ref|XP_004144482.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g03230-like [Cucumis sativus]

 Score =  320 bits (821), Expect = 2e-85,   Method: Compositional matrix adjust.
 Identities = 159/219 (72%), Positives = 179/219 (81%), Gaps = 2/219 (0%)

Query: 2    EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
            +M FN+ILG++R LLYLHQDS+LRIIHRD KTSNILLD EMNPKISDFGL RIF GK+T 
Sbjct: 809  DMRFNVILGIARGLLYLHQDSRLRIIHRDLKTSNILLDEEMNPKISDFGLARIFGGKETA 868

Query: 62   GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGY 121
              T RVVGTYGYMSPEYAL G FSVKSDVFSFGVVV+EIISGKRNTGF++SE ALSLLGY
Sbjct: 869  TNTKRVVGTYGYMSPEYALDGIFSVKSDVFSFGVVVIEIISGKRNTGFFHSEKALSLLGY 928

Query: 122  AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEAV 181
            AW LW + + LD+M+Q      K +E LKC+NVGLLCVQEDP DRPTM +VV MLGSE  
Sbjct: 929  AWDLWMKDEGLDLMEQTLSGNCKRDEYLKCLNVGLLCVQEDPWDRPTMLNVVFMLGSETA 988

Query: 182  NLASPKRPAFVVRRGSSSSASTSNKPE--SNNELTHSLE 218
             L SPK PAFVVRR  SS AS+S KPE  S+NELT +L+
Sbjct: 989  TLPSPKPPAFVVRRCPSSRASSSTKPETFSHNELTVTLQ 1027

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224146691|ref|XP_002326100.1| predicted protein [Populus trichocarpa] gi|222862975|gb|EEF00482.1| predicted protein [Populus trichocarpa]

 Score =  319 bits (818), Expect = 4e-85,   Method: Compositional matrix adjust.
 Identities = 150/205 (73%), Positives = 173/205 (84%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           EM F+IILGV+R LLYLHQDS+LRIIHRD KTSNILLD EMNPKISDFGL R+FEGKQT+
Sbjct: 632 EMRFDIILGVARGLLYLHQDSRLRIIHRDMKTSNILLDAEMNPKISDFGLARMFEGKQTE 691

Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGY 121
           G+TNRVVGTYGYMSPEYAL G FSVKSDVFSFGVVVLEI+SGKRNTG++NS+ A SLL Y
Sbjct: 692 GSTNRVVGTYGYMSPEYALDGLFSVKSDVFSFGVVVLEILSGKRNTGYFNSDEAQSLLAY 751

Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEAV 181
           AW+LW+E K LD+MD+    I   NE L+C+N  LLCVQ+DP+DRPTMS+VV+ML SE  
Sbjct: 752 AWRLWREDKVLDLMDETLREICNTNEFLRCVNAALLCVQDDPSDRPTMSNVVVMLSSETA 811

Query: 182 NLASPKRPAFVVRRGSSSSASTSNK 206
           NL  PK PAF +RRG S +AS S+K
Sbjct: 812 NLPVPKNPAFFIRRGLSGTASCSSK 836

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356544860|ref|XP_003540865.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g03230-like [Glycine max]

 Score =  313 bits (801), Expect = 4e-83,   Method: Compositional matrix adjust.
 Identities = 157/219 (71%), Positives = 177/219 (80%), Gaps = 2/219 (0%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           ++ F IILG++R LLYLH+DS+LRIIHRD KTSNILLD E NPKISDFGL RIF GK+T 
Sbjct: 770 DVRFKIILGIARGLLYLHEDSRLRIIHRDLKTSNILLDEEKNPKISDFGLARIFGGKETV 829

Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGY 121
             T RVVGTYGYMSPEYAL G FSVKSDVFSFGVVVLEIISGKRNTGFY ++  LSLLGY
Sbjct: 830 ANTERVVGTYGYMSPEYALDGHFSVKSDVFSFGVVVLEIISGKRNTGFYQADHELSLLGY 889

Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEAV 181
           AW LW+EGKAL+ MDQ       A+E LKC+ VGLLC+QEDPN+RPTMS+VV MLGSE  
Sbjct: 890 AWLLWKEGKALEFMDQTLCQTCNADECLKCVIVGLLCLQEDPNERPTMSNVVFMLGSEFN 949

Query: 182 NLASPKRPAFVVRRGSSSSASTSNKPE--SNNELTHSLE 218
            L SPK PAFV+RR  SS ASTS+K E  S NELT ++E
Sbjct: 950 TLPSPKEPAFVIRRCPSSRASTSSKLETFSRNELTVTIE 988

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449493195|ref|XP_004159218.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g03230-like, partial [Cucumis sativus]

 Score =  306 bits (784), Expect = 4e-81,   Method: Compositional matrix adjust.
 Identities = 149/202 (73%), Positives = 166/202 (82%)

Query: 2    EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
            +M FN+ILG++R LLYLHQDS+LRIIHRD KTSNILLD EMNPKISDFGL RIF GK+T 
Sbjct: 809  DMRFNVILGIARGLLYLHQDSRLRIIHRDLKTSNILLDEEMNPKISDFGLARIFGGKETA 868

Query: 62   GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGY 121
              T RVVGTYGYMSPEYAL G FSVKSDVFSFGVVV+EIISGKRNTGF++SE ALSLLGY
Sbjct: 869  TNTKRVVGTYGYMSPEYALDGIFSVKSDVFSFGVVVIEIISGKRNTGFFHSEKALSLLGY 928

Query: 122  AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEAV 181
            AW LW + + LD+M+Q      K +E LKC+NVGLLCVQEDP DRPTM +VV MLGSE  
Sbjct: 929  AWDLWMKDEGLDLMEQTLSGNCKRDEYLKCLNVGLLCVQEDPWDRPTMLNVVFMLGSETA 988

Query: 182  NLASPKRPAFVVRRGSSSSAST 203
             L SPK PAFVVRR  SS AS+
Sbjct: 989  TLPSPKPPAFVVRRCPSSRASS 1010

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296081242|emb|CBI17986.3| unnamed protein product [Vitis vinifera]

 Score =  304 bits (779), Expect = 1e-80,   Method: Compositional matrix adjust.
 Identities = 146/222 (65%), Positives = 178/222 (80%), Gaps = 3/222 (1%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           E  F+II+G++R LLYLHQDS+L+IIHRD KTSNILLD EMNPKISDFGL RIF+ KQ +
Sbjct: 238 EKRFDIIMGIARGLLYLHQDSRLKIIHRDLKTSNILLDDEMNPKISDFGLARIFDSKQVE 297

Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGY 121
            +TNRVVGTYGYMSPEYAL GFFS KSDVFSFGV+VLEIISGKRNTGFY S+  LSLLG 
Sbjct: 298 ASTNRVVGTYGYMSPEYALDGFFSEKSDVFSFGVMVLEIISGKRNTGFYQSDQTLSLLGQ 357

Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEAV 181
           AWKL +E K L++MDQ         E L+C+NVGLLCVQEDP+DRPTM+  V+ML S+  
Sbjct: 358 AWKLLKEDKVLELMDQTLCETCNTKEFLRCVNVGLLCVQEDPSDRPTMAVAVVMLSSDIA 417

Query: 182 NLASPKRPAFVVRRGSSSSASTSNKPES--NNELTHSL-EGR 220
            +  PK+PAFV++R  S +AS+S+KPE+  N+E+  ++ EGR
Sbjct: 418 TMPVPKQPAFVLKRDLSRTASSSSKPEASWNSEILATIEEGR 459

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296081245|emb|CBI17989.3| unnamed protein product [Vitis vinifera]

 Score =  303 bits (776), Expect = 3e-80,   Method: Compositional matrix adjust.
 Identities = 151/219 (68%), Positives = 177/219 (80%), Gaps = 2/219 (0%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           E  F+IILG++R LLYLHQDS+L+IIHRD KTSNILLD EMNPKISDFGL RIFE KQ +
Sbjct: 458 EKRFDIILGIARGLLYLHQDSRLKIIHRDLKTSNILLDDEMNPKISDFGLARIFESKQVE 517

Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGY 121
            +TNRVVGTYGYMSPEYAL GFFS KSDVFSFGVVVLEIISGKRNT  Y S+  LSLL +
Sbjct: 518 ASTNRVVGTYGYMSPEYALDGFFSEKSDVFSFGVVVLEIISGKRNTRSYQSDRNLSLLAH 577

Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEAV 181
           AWKLW+E + L++MDQ      K NE L+C+NVGLLCVQEDP+DRPTM+  V+ML S+  
Sbjct: 578 AWKLWKEDRVLELMDQTLSETCKTNEFLRCVNVGLLCVQEDPSDRPTMAVAVVMLSSDTA 637

Query: 182 NLASPKRPAFVVRRGSSSSASTSNKPES--NNELTHSLE 218
            L  PK+PAFVVRR  SSSAS+S+KPE+  N+E   ++E
Sbjct: 638 TLPVPKQPAFVVRRDLSSSASSSSKPEASLNSEFLATIE 676

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296081241|emb|CBI17985.3| unnamed protein product [Vitis vinifera]

 Score =  302 bits (773), Expect = 7e-80,   Method: Compositional matrix adjust.
 Identities = 151/219 (68%), Positives = 178/219 (81%), Gaps = 2/219 (0%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           E  F+IILG++R LLYLHQDS+L+IIHRD KTSNILLD EMNPKISDFGL RIFE KQ +
Sbjct: 442 EKRFDIILGIARGLLYLHQDSRLKIIHRDLKTSNILLDDEMNPKISDFGLARIFESKQVE 501

Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGY 121
            +TNRVVGTYGYMSPEYAL GFFS KSDVFSFGVVVLEIISGKRNT  Y S+L LSLL +
Sbjct: 502 ASTNRVVGTYGYMSPEYALDGFFSEKSDVFSFGVVVLEIISGKRNTRSYQSDLNLSLLAH 561

Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEAV 181
           AWKLW+E + L++MDQ        NE L+C+NVGLLCVQEDP+DRPTM+  V+ML S+  
Sbjct: 562 AWKLWKEDRVLELMDQTLSQTCNTNEFLRCVNVGLLCVQEDPSDRPTMAVAVVMLSSDTA 621

Query: 182 NLASPKRPAFVVRRGSSSSASTSNKPES--NNELTHSLE 218
            L  PK+PAFVVRR  SSSAS+S+KPE+  N+E+  ++E
Sbjct: 622 TLPVPKQPAFVVRRDLSSSASSSSKPEASLNSEILATIE 660

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296081243|emb|CBI17987.3| unnamed protein product [Vitis vinifera]

 Score =  301 bits (772), Expect = 1e-79,   Method: Compositional matrix adjust.
 Identities = 144/219 (65%), Positives = 175/219 (79%), Gaps = 2/219 (0%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           E  F+II+G++R LLYLHQDS+L+IIHRD KTSNILLD EMNPKISDFGL RIF+ KQ +
Sbjct: 589 EKRFDIIMGIARGLLYLHQDSRLKIIHRDLKTSNILLDDEMNPKISDFGLARIFDSKQVE 648

Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGY 121
            +TNRVVGTYGYMSPEYAL GFFS KSDVFSFGV+VLEIISGKRNTGFY S+  LSLLG 
Sbjct: 649 ASTNRVVGTYGYMSPEYALDGFFSEKSDVFSFGVMVLEIISGKRNTGFYQSDQTLSLLGQ 708

Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEAV 181
           AWKL +E K L++MDQ         E L+C+NVGLLCVQEDP+DRPTM+  V+ML S+  
Sbjct: 709 AWKLLKEDKVLELMDQTLCETCNTKEFLRCVNVGLLCVQEDPSDRPTMAVAVVMLSSDIA 768

Query: 182 NLASPKRPAFVVRRGSSSSASTSNKPES--NNELTHSLE 218
            +  PK+PAFV++R  S +AS+S+KPE   N+E+  ++E
Sbjct: 769 TMPVPKQPAFVLKRDLSRTASSSSKPEVSWNSEILATIE 807

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485737|ref|XP_003633326.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g03230-like [Vitis vinifera]

 Score =  301 bits (770), Expect = 1e-79,   Method: Compositional matrix adjust.
 Identities = 151/219 (68%), Positives = 178/219 (81%), Gaps = 2/219 (0%)

Query: 2    EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
            E  F+IILG++R LLYLHQDS+L+IIHRD KTSNILLD EMNPKISDFGL RIFE KQ +
Sbjct: 1158 EKRFDIILGIARGLLYLHQDSRLKIIHRDLKTSNILLDDEMNPKISDFGLARIFESKQVE 1217

Query: 62   GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGY 121
             +TNRVVGTYGYMSPEYAL GFFS KSDVFSFGVVVLEIISGKRNT  Y S+L LSLL +
Sbjct: 1218 ASTNRVVGTYGYMSPEYALDGFFSEKSDVFSFGVVVLEIISGKRNTRSYQSDLNLSLLAH 1277

Query: 122  AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEAV 181
            AWKLW+E + L++MDQ        NE L+C+NVGLLCVQEDP+DRPTM+  V+ML S+  
Sbjct: 1278 AWKLWKEDRVLELMDQTLSQTCNTNEFLRCVNVGLLCVQEDPSDRPTMAVAVVMLSSDTA 1337

Query: 182  NLASPKRPAFVVRRGSSSSASTSNKPES--NNELTHSLE 218
             L  PK+PAFVVRR  SSSAS+S+KPE+  N+E+  ++E
Sbjct: 1338 TLPVPKQPAFVVRRDLSSSASSSSKPEASLNSEILATIE 1376

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	220
TAIR|locus:2018506	847	RK2 "receptor kinase 2" [Arabi	0.868	0.225	0.620	3.4e-61
TAIR|locus:2141181	850	RK3 "receptor kinase 3" [Arabi	0.968	0.250	0.550	2.4e-60
TAIR|locus:2018546	843	RK1 "receptor kinase 1" [Arabi	0.868	0.226	0.605	3.1e-60
TAIR|locus:2200151	830	SD1-13 "S-domain-1 13" [Arabid	0.981	0.260	0.538	1.9e-58
TAIR|locus:2131694	815	AT4G27300 [Arabidopsis thalian	0.968	0.261	0.539	1.7e-57
TAIR|locus:2121676	669	CRK10 "cysteine-rich RLK (RECE	0.840	0.276	0.578	2e-56
TAIR|locus:2141176	849	B120 [Arabidopsis thaliana (ta	0.977	0.253	0.520	2.8e-56
TAIR|locus:2121636	659	CRK7 "cysteine-rich RLK (RECEP	0.981	0.327	0.504	4.2e-56
TAIR|locus:2131684	783	AT4G27290 [Arabidopsis thalian	0.954	0.268	0.542	5.3e-56
TAIR|locus:2115728	675	CRK25 "cysteine-rich RLK (RECE	0.863	0.281	0.542	4.8e-55

TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 626 (225.4 bits), Expect = 3.4e-61, P = 3.4e-61
 Identities = 121/195 (62%), Positives = 148/195 (75%)

Query:     5 FNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTT 64
             F+II G++R LLYLHQDS+ RIIHRD K SN+LLD  M PKISDFG+ RIF  ++T+  T
Sbjct:   623 FDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANT 682

Query:    65 NRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWK 124
              RVVGTYGYMSPEYA+ G FS+KSDVFSFGV++LEIISGKRN GFYNS   L+LLG+ W+
Sbjct:   683 RRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWR 742

Query:   125 LWQEGKALDMMDQ-KPGAISK---ANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEA 180
              W+EGK L+++D     A+S     +EIL+CI +GLLCVQE   DRP MS V++MLGSE 
Sbjct:   743 HWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSET 802

Query:   181 VNLASPKRPAFVVRR 195
               +  PKRP F V R
Sbjct:   803 TAIPQPKRPGFCVGR 817

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0034613 "cellular protein localization" evidence=IGI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 618 (222.6 bits), Expect = 2.4e-60, P = 2.4e-60
 Identities = 119/216 (55%), Positives = 152/216 (70%)

Query:     2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
             +M F+II G++R LLYLHQDS+ RIIHRD K SNILLD  M PKISDFG+ RIF   +T+
Sbjct:   623 QMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETE 682

Query:    62 GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGY 121
               T +VVGTYGYMSPEYA+ G FS+KSDVFSFGV++LEIIS KRN GFYNS+  L+LLG 
Sbjct:   683 ANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLLGC 742

Query:   122 AWKLWQEGKALDMMDQ---KPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGS 178
              W+ W+EGK L+++D       +  + +EIL+CI +GLLCVQE   DRPTMS V++MLGS
Sbjct:   743 VWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVILMLGS 802

Query:   179 EAVNLASPKRPAFVVRRGXXXXXXXXNKPESNNELT 214
             E+  +  PK P + + R         +K   +   T
Sbjct:   803 ESTTIPQPKAPGYCLERSLLDTDSSSSKQRDDESWT 838

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0005773 "vacuole" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 617 (222.3 bits), Expect = 3.1e-60, P = 3.1e-60
 Identities = 118/195 (60%), Positives = 147/195 (75%)

Query:     5 FNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTT 64
             F+II G++R LLYLHQDS+ RIIHRD K SN+LLD  M PKISDFG+ RIF  ++T+  T
Sbjct:   619 FDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANT 678

Query:    65 NRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWK 124
              RVVGTYGYMSPEYA+ G FS+KSDVFSFGV++LEIISGKRN GFYNS   L+LLG+ W+
Sbjct:   679 RRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWR 738

Query:   125 LWQEGKALDMMDQ-KPGAISK---ANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEA 180
              W+EG  L+++D     ++S     +EIL+CI +GLLCVQE   DRP MS V++MLGSE 
Sbjct:   739 HWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSET 798

Query:   181 VNLASPKRPAFVVRR 195
               +  PKRP F + R
Sbjct:   799 TAIPQPKRPGFCIGR 813

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0009875 "pollen-pistil interaction" evidence=TAS

GO:0016020 "membrane" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 600 (216.3 bits), Expect = 1.9e-58, P = 1.9e-58
 Identities = 118/219 (53%), Positives = 152/219 (69%)

Query:     5 FNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTT 64
             FNII G+ R L+YLH+DS+L+IIHRD K SNILLD  +NPKISDFGL RIF+G + + +T
Sbjct:   612 FNIIDGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFQGNEDEVST 671

Query:    65 NRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWK 124
              RVVGTYGYM+PEYA+GG FS KSDVFS GV++LEI+SG+RN+ FYN     +L  YAWK
Sbjct:   672 VRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIVSGRRNSSFYNDGQNPNLSAYAWK 731

Query:   125 LWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEAVNLA 184
             LW  G+ + ++D         NEI +C++VGLLCVQ+  NDRP+++ V+ ML SE  NL 
Sbjct:   732 LWNTGEDIALVDPVIFEECFENEIRRCVHVGLLCVQDHANDRPSVATVIWMLSSENSNLP 791

Query:   185 SPKRPAFVVRRGXXXXXXXXNK-PES--NNELTHSLEGR 220
              PK+PAF+ RRG           P +  NN     + GR
Sbjct:   792 EPKQPAFIPRRGTSEVESSGQSDPRASINNVSLTKITGR 830

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

GO:0009637 "response to blue light" evidence=RCA

GO:0010155 "regulation of proton transport" evidence=RCA

GO:0016556 "mRNA modification" evidence=RCA

TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)]

 Score = 591 (213.1 bits), Expect = 1.7e-57, P = 1.7e-57
 Identities = 117/217 (53%), Positives = 158/217 (72%)

Query:     6 NIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTN 65
             NII GV+R +LYLHQDS+LRIIHRD K  N+LLD++MNPKISDFGL + F G Q++ +TN
Sbjct:   601 NIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSESSTN 660

Query:    66 RVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKL 125
             RVVGTYGYM PEYA+ G FSVKSDVFSFGV+VLEII+GK N GF +++  L+LLG+ WK+
Sbjct:   661 RVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRHADHDLNLLGHVWKM 720

Query:   126 WQEGKALDMMDQK-PGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEAVNLA 184
             W E + +++ +++     S   E+L+CI+V LLCVQ+ P DRPTM+ VV+M GS++ +L 
Sbjct:   721 WVEDREIEVPEEEWLEETSVIPEVLRCIHVALLCVQQKPEDRPTMASVVLMFGSDS-SLP 779

Query:   185 SPKRPAFVVRRGXXXXXXXXNKPESNNELTHS-LEGR 220
              P +P F   R         +   S NE++ + L+GR
Sbjct:   780 HPTQPGFFTNRNVPDISSSLSL-RSQNEVSITMLQGR 815

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 581 (209.6 bits), Expect = 2.0e-56, P = 2.0e-56
 Identities = 107/185 (57%), Positives = 144/185 (77%)

Query:     5 FNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTT 64
             + II GV+R +LYLHQDS+L IIHRD K SNILLD +MNPKI+DFG+ RIF   QT+  T
Sbjct:   448 YKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGLDQTEENT 507

Query:    65 NRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWK 124
             +R+VGTYGYMSPEYA+ G +S+KSDV+SFGV+VLEIISGK+N+ FY ++ A  L+ YAW 
Sbjct:   508 SRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDGAHDLVSYAWG 567

Query:   125 LWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEAVNLA 184
             LW  G+ L+++D       + NE+++C+++GLLCVQEDP +RPT+S +V+ML S  V L 
Sbjct:   568 LWSNGRPLELVDPAIVENCQRNEVVRCVHIGLLCVQEDPAERPTLSTIVLMLTSNTVTLP 627

Query:   185 SPKRP 189
              P++P
Sbjct:   628 VPRQP 632

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)]

 Score = 582 (209.9 bits), Expect = 2.8e-56, P = 2.8e-56
 Identities = 115/221 (52%), Positives = 156/221 (70%)

Query:     2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
             ++ F+II G++R LLYLH+DS+LRIIHRD K SN+LLD EMNPKISDFG+ RIF G Q +
Sbjct:   626 KLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNE 685

Query:    62 GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGY 121
               T RVVGTYGYMSPEYA+ G FSVKSDV+SFGV++LEI+SGKRNT   +SE   SL+GY
Sbjct:   686 ANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHG-SLIGY 744

Query:   122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEAV 181
             AW L+  G++ +++D K        E L+CI+V +LCVQ+   +RP M+ V++ML S+  
Sbjct:   745 AWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESDTA 804

Query:   182 NLASPKRPAFV-VRRGXXXXXXXXNKPE----SNNELTHSL 217
              LA+P++P F   RR         +  +    S+NE+T ++
Sbjct:   805 TLAAPRQPTFTSTRRNSIDVNFALDSSQQYIVSSNEITSTV 845

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0006979 "response to oxidative stress" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2121636 CRK7 "cysteine-rich RLK (RECEPTOR-like protein kinase) 7" [Arabidopsis thaliana (taxid:3702)]

 Score = 578 (208.5 bits), Expect = 4.2e-56, P = 4.2e-56
 Identities = 109/216 (50%), Positives = 154/216 (71%)

Query:     5 FNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTT 64
             ++II G++R +LYLHQDS+L IIHRD K SNILLD +MNPKI+DFG+ RIF   QT   T
Sbjct:   436 YHIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGMDQTQQNT 495

Query:    65 NRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWK 124
             +R+VGTYGYMSPEYA+ G FS+KSDV+SFGV+VLEIISG++N  F  ++ A  L+ +AW+
Sbjct:   496 SRIVGTYGYMSPEYAMRGQFSMKSDVYSFGVLVLEIISGRKNNSFIETDDAQDLVTHAWR 555

Query:   125 LWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEAVNLA 184
             LW+ G ALD++D       + +E+++C ++GLLCVQEDP  RP MS + +ML S  + L 
Sbjct:   556 LWRNGTALDLVDPFIADSCRKSEVVRCTHIGLLCVQEDPVKRPAMSTISVMLTSNTMALP 615

Query:   185 SPKRPAFVVRRGXXXXXXXXNKPESNNELTHSLEGR 220
             +P++P F VR          ++  +N  +T S++ +
Sbjct:   616 APQQPGFFVRSRPGTNRLDSDQSTTNKSVTVSIDDK 651

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0034976 "response to endoplasmic reticulum stress" evidence=RCA

TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)]

 Score = 577 (208.2 bits), Expect = 5.3e-56, P = 5.3e-56
 Identities = 116/214 (54%), Positives = 152/214 (71%)

Query:     7 IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
             II G++R +LYLH+DS+LRIIHRD K SN+LLD +MN KISDFGL R   G +T+  T R
Sbjct:   567 IIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLARTLGGDETEANTTR 626

Query:    67 VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLW 126
             VVGTYGYMSPEY + G+FS+KSDVFSFGV+VLEI+SG+RN GF N E  L+LLG+AW+ +
Sbjct:   627 VVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFRNEEHKLNLLGHAWRQF 686

Query:   127 QEGKALDMMDQKPG-AISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEAVNLAS 185
              E KA +++D+    + +  +E+L+ I++GLLCVQ+DP DRP MS VV+ML SE + L  
Sbjct:   687 LEDKAYEIIDEAVNESCTDISEVLRVIHIGLLCVQQDPKDRPNMSVVVLMLSSEML-LLD 745

Query:   186 PKRPAFVVRRGXXXXXXXXNKPE--SNNELTHSL 217
             P++P F   R            E  SNN  T S+
Sbjct:   746 PRQPGFFNERNLLFSDTVSINLEIPSNNFQTMSV 779

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0048765 "root hair cell differentiation" evidence=RCA

TAIR|locus:2115728 CRK25 "cysteine-rich RLK (RECEPTOR-like protein kinase) 25" [Arabidopsis thaliana (taxid:3702)]

 Score = 568 (205.0 bits), Expect = 4.8e-55, P = 4.8e-55
 Identities = 103/190 (54%), Positives = 142/190 (74%)

Query:     5 FNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTT 64
             + II G++R +LYLH+DS+L IIHRD K SNILLD +M+PKISDFG+ RIF   QT   T
Sbjct:   447 YKIIEGIARGILYLHRDSRLTIIHRDLKASNILLDADMHPKISDFGMARIFGVDQTQANT 506

Query:    65 NRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWK 124
              R+VGTYGYMSPEYA+ G +SVKSDV+SFGV+VLE+I+GK+N+ FY  +    L+ Y WK
Sbjct:   507 KRIVGTYGYMSPEYAIHGKYSVKSDVYSFGVLVLELITGKKNSSFYEEDGLGDLVTYVWK 566

Query:   125 LWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEAVNLA 184
             LW E   L+++D+      + NE+++CI++ LLCVQED ++RP+M D+++M+ S  V L 
Sbjct:   567 LWVENSPLELVDEAMRGNFQTNEVIRCIHIALLCVQEDSSERPSMDDILVMMNSFTVTLP 626

Query:   185 SPKRPAFVVR 194
              PKR  F++R
Sbjct:   627 IPKRSGFLLR 636

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000041 "transition metal ion transport" evidence=RCA

GO:0006826 "iron ion transport" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00026123001 SubName- Full=Chromosome chr12 scaffold_36, whole genome shotgun sequence; (826 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	220
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-26
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-26
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	4e-26
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	9e-26
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	9e-26
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-25
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-25
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	8e-23
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-22
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-21
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-20
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-20
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-19
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-19
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	9e-19
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	9e-18
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-17
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	9e-17
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-16
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-16
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-16
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-16
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-16
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-16
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	6e-16
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	7e-16
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	9e-16
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-15
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-15
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	7e-15
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	8e-15
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	9e-15
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	9e-15
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-14
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-14
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-14
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-14
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-14
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	6e-14
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	6e-14
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	8e-14
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-13
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-13
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-13
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	6e-13
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	7e-13
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	7e-13
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	8e-13
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	9e-13
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-12
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-12
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-12
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-12
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-12
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-12
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-12
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-12
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-12
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-12
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-12
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-12
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-12
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-12
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-12
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-12
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-12
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-12
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	5e-12
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	5e-12
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	6e-12
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	9e-12
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	9e-12
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	9e-12
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-11
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-11
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-11
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-11
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-11
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-11
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-11
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-11
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-11
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-11
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	4e-11
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	5e-11
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	5e-11
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	5e-11
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	5e-11
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	6e-11
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	7e-11
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	7e-11
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	7e-11
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	8e-11
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	8e-11
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	9e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-10
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-10
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-10
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-10
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-10
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-10
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-10
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-10
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-10
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-10
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-10
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-10
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-10
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-10
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-10
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-10
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-10
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-10
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-10
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	4e-10
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	4e-10
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	5e-10
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-10
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	7e-10
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	7e-10
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	8e-10
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	8e-10
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	9e-10
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	9e-10
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	9e-10
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-09
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-09
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-09
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-09
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-09
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-09
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-09
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-09
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-09
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-09
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-09
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-09
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-09
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-09
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-09
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-09
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-09
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-09
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-09
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-09
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-09
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-09
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-09
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-09
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-09
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-09
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-09
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-09
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-09
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-09
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-09
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	5e-09
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	5e-09
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	5e-09
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	5e-09
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	6e-09
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	6e-09
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	6e-09
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	6e-09
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	7e-09
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	8e-09
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	8e-09
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	8e-09
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	9e-09
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-08
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-08
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-08
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-08
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-08
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-08
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-08
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-08
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-08
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-08
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-08
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-08
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-08
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-08
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-08
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-08
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-08
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-08
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-08
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-08
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-08
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-08
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-08
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-08
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	4e-08
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-08
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-08
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-08
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-08
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	5e-08
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	5e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	5e-08
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	6e-08
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	6e-08
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	8e-08
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	9e-08
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	9e-08
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-07
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-07
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-07
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-07
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-07
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-07
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-07
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-07
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-07
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-07
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-07
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-07
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-07
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-07
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-07
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-07
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-07
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-07
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	4e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-07
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-07
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	5e-07
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	5e-07
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-07
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	5e-07
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	6e-07
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	6e-07
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	6e-07
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	7e-07
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	7e-07
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	7e-07
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	8e-07
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-06
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-06
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-06
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-06
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-06
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-06
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-06
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-06
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-06
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-06
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-06
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-06
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-06
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-06
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-06
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	5e-06
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-06
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	5e-06
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	6e-06
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	7e-06
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	7e-06
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	8e-06
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-05
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-05
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-05
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-05
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	4e-05
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	5e-05
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	5e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	8e-05
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	1e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-04
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	4e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	4e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	5e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	6e-04
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	6e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.002
pfam11883	48	pfam11883, DUF3403, Domain of unknown function (DU	0.003
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	0.003

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  102 bits (257), Expect = 1e-26
 Identities = 53/180 (29%), Positives = 74/180 (41%), Gaps = 38/180 (21%)

Query: 6   NIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTN 65
            I L + R L YLH      IIHRD K  NILLD     KI+DFGL +      +  TT 
Sbjct: 102 KIALQILRGLEYLH---SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT- 157

Query: 66  RVVGTYGYMSPE-YALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWK 124
             VGT  YM+PE    G  +  K DV+S GV++ E+++GK                    
Sbjct: 158 -FVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGK-------------------P 197

Query: 125 LWQEGKALDMM---DQKPGAISKANEILKCINV--------GLLCVQEDPNDRPTMSDVV 173
            +     LD +    +  G   + +E                 L    DP+ RPT  +++
Sbjct: 198 PFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNK--DPSKRPTAEEIL 255

Length = 260

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  102 bits (257), Expect = 1e-26
 Identities = 48/160 (30%), Positives = 72/160 (45%), Gaps = 28/160 (17%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH   K  IIHRD K SN+L++ +   KI+DFG++++ E   T    N  VGT  YM
Sbjct: 112 LDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLE--NTLDQCNTFVGTVTYM 167

Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGK------RNTGFYNSELALSLLGYAWKLWQE 128
           SPE   G  +S  +D++S G+ +LE   GK          F+  EL  ++          
Sbjct: 168 SPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFF--ELMQAICDGPPPSLPA 225

Query: 129 GKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPT 168
            +                + +        C+Q+DP  RP+
Sbjct: 226 EEFSPEFR----------DFISA------CLQKDPKKRPS 249

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  101 bits (253), Expect = 4e-26
 Identities = 50/159 (31%), Positives = 71/159 (44%), Gaps = 21/159 (13%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH      I+HRD K  NILLD + + K++DFGL R              VGT  YM
Sbjct: 110 LEYLH---SKGIVHRDLKPENILLDEDGHVKLADFGLARQL---DPGEKLTTFVGTPEYM 163

Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDM 134
           +PE  LG  +    D++S GV++ E+++GK    F   +  L L     K   + K    
Sbjct: 164 APEVLLGKGYGKAVDIWSLGVILYELLTGK--PPFPGDDQLLELF----KKIGKPK--PP 215

Query: 135 MDQKPGAISK-ANEILKCINVGLLCVQEDPNDRPTMSDV 172
                  IS  A ++++     LL    DP  R T  + 
Sbjct: 216 FPPPEWDISPEAKDLIR----KLLVK--DPEKRLTAEEA 248

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  100 bits (251), Expect = 9e-26
 Identities = 58/181 (32%), Positives = 84/181 (46%), Gaps = 29/181 (16%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           +  L +  L ++R + YL        IHRD    N L+   +  KISDFGL+R       
Sbjct: 102 LSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSR----DLY 154

Query: 61  DGTTNRVVGT---YGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKR-NTGFYNSELA 115
           D    +V G      +M+PE    G F+ KSDV+SFGV++ EI + G+    G  N+E+ 
Sbjct: 155 DDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEV- 213

Query: 116 LSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIM 175
           L  L       ++G  L      P  +           + L C  EDP DRPT S++V +
Sbjct: 214 LEYL-------KKGYRLPKPPNCPPEL---------YKLMLQCWAEDPEDRPTFSELVEI 257

Query: 176 L 176
           L
Sbjct: 258 L 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  100 bits (251), Expect = 9e-26
 Identities = 58/181 (32%), Positives = 83/181 (45%), Gaps = 29/181 (16%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           +  L +  L ++R + YL        IHRD    N L+   +  KISDFGL+R       
Sbjct: 101 LSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSR----DLY 153

Query: 61  DGTTNRVVGT---YGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKR-NTGFYNSELA 115
           D    R  G      +M+PE    G F+ KSDV+SFGV++ EI + G++   G  N E+ 
Sbjct: 154 DDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEV- 212

Query: 116 LSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIM 175
           L  L       + G  L      P  +          ++ L C  EDP DRPT S++V +
Sbjct: 213 LEYL-------KNGYRLPQPPNCPPEL---------YDLMLQCWAEDPEDRPTFSELVEI 256

Query: 176 L 176
           L
Sbjct: 257 L 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 98.8 bits (247), Expect = 3e-25
 Identities = 51/179 (28%), Positives = 85/179 (47%), Gaps = 24/179 (13%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQ 59
           ++ L +  + +++ + YL      + +HRD    N L+  ++  KISDFGL+R +++   
Sbjct: 104 LKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY 160

Query: 60  TDGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALS 117
               T   +    +M+PE    G F+ KSDV+SFGV++ EI +       G  N E+   
Sbjct: 161 YRKKTGGKLPIR-WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEY 219

Query: 118 LLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
           L        ++G  L   +  P  +    E++        C Q DP DRPT S++V  L
Sbjct: 220 L--------RKGYRLPKPEYCPDELY---ELMLS------CWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score = 97.3 bits (243), Expect = 4e-25
 Identities = 40/101 (39%), Positives = 58/101 (57%), Gaps = 7/101 (6%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDH-EMNPKISDFGLTRIFEGKQT 60
           + +  I+L +   L YLH      IIHRD K  NILLD      K++DFGL+++      
Sbjct: 92  DEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD-- 146

Query: 61  DGTTNRVVGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEI 100
                 +VGT  YM+PE  LG G++S KSD++S GV++ E+
Sbjct: 147 KSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 92.6 bits (231), Expect = 8e-23
 Identities = 45/159 (28%), Positives = 73/159 (45%), Gaps = 27/159 (16%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH      I+HRD K +NIL+D +   K++DFG  +     +T   T  V GT  +M
Sbjct: 114 LAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWM 170

Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDM 134
           +PE   G  +   +D++S G  V+E+ +GK    +      ++ L   +K+         
Sbjct: 171 APEVIRGEEYGRAADIWSLGCTVIEMATGKPP--WSELGNPMAAL---YKI--------G 217

Query: 135 MDQKPGAI-----SKANEILKCINVGLLCVQEDPNDRPT 168
              +P  I      +A + L+       C++ DP  RPT
Sbjct: 218 SSGEPPEIPEHLSEEAKDFLRK------CLRRDPKKRPT 250

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 91.4 bits (228), Expect = 2e-22
 Identities = 53/183 (28%), Positives = 79/183 (43%), Gaps = 32/183 (17%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           ++ L  + L +++ + YL   SK   +HRD    N L+   +  KISDFGL+R       
Sbjct: 101 LKDLLQMALQIAKGMEYLE--SK-NFVHRDLAARNCLVTENLVVKISDFGLSR-----DI 152

Query: 61  DGTTNRVVGTYGY-----MSPEYALGGFFSVKSDVFSFGVVVLEIISGKRN--TGFYNSE 113
                      G      M+PE    G F+ KSDV+SFGV++ EI +       G  N E
Sbjct: 153 YEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE 212

Query: 114 LALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
           +   L        ++G  L   +  P  +    E++        C   DP DRPT S++V
Sbjct: 213 VLELL--------EDGYRLPRPENCPDEL---YELML------QCWAYDPEDRPTFSELV 255

Query: 174 IML 176
             L
Sbjct: 256 EDL 258

Length = 258

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 88.9 bits (221), Expect = 2e-21
 Identities = 39/98 (39%), Positives = 59/98 (60%), Gaps = 6/98 (6%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           I + V + L YLH   K +IIHRD K SNIL++     K+ DFG++    G+  +     
Sbjct: 105 IAVAVLKGLTYLH--EKHKIIHRDVKPSNILVNSRGQIKLCDFGVS----GQLVNSLAKT 158

Query: 67  VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
            VGT  YM+PE   G  +SVKSD++S G+ ++E+ +G+
Sbjct: 159 FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 85.2 bits (212), Expect = 4e-20
 Identities = 48/173 (27%), Positives = 81/173 (46%), Gaps = 27/173 (15%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           ++    + L +     YLH     +I+HRD K  NI L      K+ DFG++++      
Sbjct: 106 LDWFVQLCLALK----YLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD 158

Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLG 120
              T  VVGT  Y+SPE      ++ KSD++S G V+ E+ + K    F       +LL 
Sbjct: 159 LAKT--VVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKH--PFE----GENLLE 210

Query: 121 YAWKLWQEGKALDMMDQKPGAI-SKANEILKCINVGLLCVQEDPNDRPTMSDV 172
            A K+         +  +   I S+ +  L+ +   LL  Q+DP +RP+++ +
Sbjct: 211 LALKI---------LKGQYPPIPSQYSSELRNLVSSLL--QKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 85.0 bits (211), Expect = 5e-20
 Identities = 34/98 (34%), Positives = 52/98 (53%), Gaps = 6/98 (6%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +   + + L YLH      IIHRD K +NILL  +   K+ DFGL+      +     N 
Sbjct: 103 VCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK---ARNT 156

Query: 67  VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           +VGT  +M+PE   G  +  K+D++S G+  +E+  GK
Sbjct: 157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 83.7 bits (208), Expect = 1e-19
 Identities = 39/102 (38%), Positives = 55/102 (53%), Gaps = 7/102 (6%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH    L II+RD K  NILLD + + K++DFGL +  E       TN   GT  Y+
Sbjct: 106 LEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAK--ELSSEGSRTNTFCGTPEYL 160

Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELAL 116
           +PE  LG  +    D +S GV++ E+++GK    FY  +   
Sbjct: 161 APEVLLGKGYGKAVDWWSLGVLLYEMLTGK--PPFYAEDRKE 200

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 84.1 bits (208), Expect = 2e-19
 Identities = 42/103 (40%), Positives = 62/103 (60%), Gaps = 6/103 (5%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           E+L  I + V   L YL+  +  RI+HRD K SNIL++     K+ DFG++    G+  +
Sbjct: 103 EILGKIAVAVVEGLTYLY--NVHRIMHRDIKPSNILVNSRGQIKLCDFGVS----GELIN 156

Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
              +  VGT  YMSPE   GG ++VKSDV+S G+ ++E+  GK
Sbjct: 157 SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 81.6 bits (202), Expect = 9e-19
 Identities = 49/162 (30%), Positives = 71/162 (43%), Gaps = 21/162 (12%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLT-RIFEGKQTDGTT-NRVVGTYG 72
           L YLH      I+HRD K +NI LDH    K+ DFG   ++     T G     + GT  
Sbjct: 112 LAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPA 168

Query: 73  YMSPEYALGGFFSVK---SDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEG 129
           YM+PE   GG        +D++S G VVLE+ +GKR     ++E  +        ++  G
Sbjct: 169 YMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI--------MFHVG 220

Query: 130 KALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSD 171
                   KP          +  +    C++ DP  RPT S+
Sbjct: 221 -----AGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASE 257

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 79.1 bits (196), Expect = 9e-18
 Identities = 34/89 (38%), Positives = 53/89 (59%), Gaps = 5/89 (5%)

Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH +    I+HRD K SNIL++++   K++DFGL R +  + +   TNRV+ T  Y  P
Sbjct: 115 YLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPP 170

Query: 77  EYALGGF-FSVKSDVFSFGVVVLEIISGK 104
           E  LG   +  + D++S G ++ E+  GK
Sbjct: 171 ELLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 79.0 bits (193), Expect = 3e-17
 Identities = 47/177 (26%), Positives = 73/177 (41%), Gaps = 15/177 (8%)

Query: 5   FNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMN-PKISDFGLTRIFEGKQTDGT 63
             I+  +   L YLH      IIHRD K  NILLD +    K+ DFGL ++     +  +
Sbjct: 104 LFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSS 160

Query: 64  ----TNRVVGTYGYMSPEYALGGFF---SVKSDVFSFGVVVLEIISGKRNTGFYNSELAL 116
                +  VGT GYM+PE  LG      S  SD++S G+ + E+++G        +  A 
Sbjct: 161 IPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSAT 220

Query: 117 SLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
           S       + +           P      ++    +   LL    DP +R + S  +
Sbjct: 221 SQTLK--IILELPTPSLASPLSPSNPELISKAASDLLKKLLAK--DPKNRLSSSSDL 273

Length = 384

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 76.2 bits (188), Expect = 9e-17
 Identities = 35/101 (34%), Positives = 54/101 (53%), Gaps = 9/101 (8%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L+  + G    L YLH     + IHRD K  NILL+ E   K++DFG++       T   
Sbjct: 105 LYQTLKG----LEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD--TMAK 155

Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
            N V+GT  +M+PE      ++ K+D++S G+  +E+  GK
Sbjct: 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 76.0 bits (187), Expect = 1e-16
 Identities = 43/92 (46%), Positives = 56/92 (60%), Gaps = 4/92 (4%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLD-HEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGY 73
           LL LH      I+HRD KT NILLD H+M  KI DFG+++I   K    T   VVGT  Y
Sbjct: 111 LLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT---VVGTPCY 167

Query: 74  MSPEYALGGFFSVKSDVFSFGVVVLEIISGKR 105
           +SPE   G  ++ KSD+++ G V+ E+ S KR
Sbjct: 168 ISPELCEGKPYNQKSDIWALGCVLYELASLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 75.2 bits (185), Expect = 2e-16
 Identities = 50/175 (28%), Positives = 82/175 (46%), Gaps = 27/175 (15%)

Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
            LF I+  VS    Y+H+     I+HRD KT NI L      K+ DFG+++I   + +  
Sbjct: 106 YLFQIVSAVS----YIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA 158

Query: 63  TTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYN-SELALSLLGY 121
            T  VVGT  YMSPE   G  ++ KSD+++ G V+ E+++ KR     N   L + ++  
Sbjct: 159 ET--VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG 216

Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
            +       + ++                 I++    +Q+DP  RPT  +V+   
Sbjct: 217 NYTPVVSVYSSEL-----------------ISLVHSLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 75.7 bits (187), Expect = 2e-16
 Identities = 33/91 (36%), Positives = 50/91 (54%), Gaps = 9/91 (9%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR--VVGTYG 72
           L YLH      +IHRD K+ NILL  + + K++DFG    F  + T   + R  VVGT  
Sbjct: 129 LEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFG----FAAQLTKEKSKRNSVVGTPY 181

Query: 73  YMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           +M+PE      +  K D++S G++ +E+  G
Sbjct: 182 WMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 75.0 bits (185), Expect = 2e-16
 Identities = 35/105 (33%), Positives = 50/105 (47%), Gaps = 8/105 (7%)

Query: 6   NIILGVSRRLL----YLH--QDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQ 59
             I  +  +LL      H   D    ++HRD K +NI LD   N K+ DFGL +I     
Sbjct: 105 EFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS 164

Query: 60  TDGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           +   T   VGT  YMSPE      +  KSD++S G ++ E+ +  
Sbjct: 165 SFAKT--YVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 75.2 bits (185), Expect = 3e-16
 Identities = 37/98 (37%), Positives = 51/98 (52%), Gaps = 10/98 (10%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           II G    L +LHQ    RI++RD K  N+LLD   N +ISD GL    +G +       
Sbjct: 104 IICG----LEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKG 153

Query: 67  VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
             GT GYM+PE   G  +    D F+ G  + E+I+G+
Sbjct: 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 75.2 bits (185), Expect = 3e-16
 Identities = 37/95 (38%), Positives = 51/95 (53%), Gaps = 7/95 (7%)

Query: 10  GVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVG 69
            V + L YLH     +IIHRD K SNILL  +   K+ DFG++         GT     G
Sbjct: 113 SVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL-AGT---FTG 165

Query: 70  TYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           T  YM+PE   G  +S+ SDV+S G+ +LE+   +
Sbjct: 166 TSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 73.9 bits (182), Expect = 6e-16
 Identities = 39/91 (42%), Positives = 47/91 (51%), Gaps = 6/91 (6%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH  SK  IIHRD K  NILLD + +  I+DF +         D  T    GT GYM
Sbjct: 113 LEYLH--SK-GIIHRDIKPDNILLDEQGHVHITDFNIATKVT---PDTLTTSTSGTPGYM 166

Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGKR 105
           +PE      +SV  D +S GV   E + GKR
Sbjct: 167 APEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 74.9 bits (184), Expect = 7e-16
 Identities = 52/167 (31%), Positives = 76/167 (45%), Gaps = 27/167 (16%)

Query: 11  VSRRLL----YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           V+R++L    YLH   +  I+HRD K SN+L++   N KI+DFG++RI    QT    N 
Sbjct: 173 VARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL--AQTMDPCNS 227

Query: 67  VVGTYGYMSPE-----YALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGY 121
            VGT  YMSPE        G +     D++S GV +LE   G+           +   G 
Sbjct: 228 SVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR-------FPFGVGRQGD 280

Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPT 168
               W        M Q P A + A+   +  +    C+Q +P  R +
Sbjct: 281 ----WASLMCAICMSQPPEAPATASREFR--HFISCCLQREPAKRWS 321

Length = 353

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 74.0 bits (182), Expect = 9e-16
 Identities = 40/103 (38%), Positives = 61/103 (59%), Gaps = 6/103 (5%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
            +L  I + V R L YL +  K +I+HRD K SNIL++     K+ DFG++    G+  D
Sbjct: 99  NILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLID 152

Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
              N  VGT  YMSPE   G  ++V+SD++S G+ ++E+  G+
Sbjct: 153 SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 73.1 bits (180), Expect = 1e-15
 Identities = 49/166 (29%), Positives = 79/166 (47%), Gaps = 27/166 (16%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGL-TRIFEGKQTDG 62
           ++ ++ G    L YLH+     +IHRD K +NIL   +   K++DFG+ T++ +      
Sbjct: 105 VYQVLQG----LAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLND---VSK 154

Query: 63  TTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA 122
               VVGT  +M+PE       S  SD++S G  V+E+++G  N  +Y+       L   
Sbjct: 155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTG--NPPYYD-------LNPM 205

Query: 123 WKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPT 168
             L++  +  D     P  IS         +  + C Q+DPN RPT
Sbjct: 206 AALFRIVQ--DDHPPLPEGISPE-----LKDFLMQCFQKDPNLRPT 244

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 73.2 bits (179), Expect = 2e-15
 Identities = 41/103 (39%), Positives = 62/103 (60%), Gaps = 6/103 (5%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           E+L  + + V R L YL +  K +I+HRD K SNIL++     K+ DFG++    G+  D
Sbjct: 103 EILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLID 156

Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
              N  VGT  YMSPE   G  +SV+SD++S G+ ++E+  G+
Sbjct: 157 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 71.1 bits (175), Expect = 7e-15
 Identities = 32/106 (30%), Positives = 50/106 (47%), Gaps = 21/106 (19%)

Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIF------------------EGK 58
           YLH      IIHRD K  NILLD +M+ KI+DFG  ++                   + +
Sbjct: 117 YLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173

Query: 59  QTDGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           +        VGT  Y+SPE          SD+++ G ++ ++++GK
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 71.0 bits (174), Expect = 8e-15
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 16/160 (10%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH      I+HRD K  N+L+D +   KISDFG+++  +    +     + G+  +M
Sbjct: 121 LAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177

Query: 75  SPE--YALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKAL 132
           +PE  ++    +S K D++S G VVLE+ +G+R             +   +KL  +  A 
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS------DEEAIAAMFKLGNKRSAP 231

Query: 133 DMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
            +       +S        ++    C   +P++RPT  ++
Sbjct: 232 PIPPDVSMNLSPV-----ALDFLNACFTINPDNRPTAREL 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 70.7 bits (173), Expect = 9e-15
 Identities = 45/146 (30%), Positives = 71/146 (48%), Gaps = 24/146 (16%)

Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTY--GYMSPEYALGGFF 84
           IHRD + +NIL+   +  KI+DFGL R+ E  +    T R    +   + +PE    G F
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTF 180

Query: 85  SVKSDVFSFGVVVLEIISGKR--NTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           ++KSDV+SFG+++ EI++  R    G  N E+  +L        + G  +   D  P  +
Sbjct: 181 TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL--------ERGYRMPRPDNCPEEL 232

Query: 143 SKANEILKCINVGLLCVQEDPNDRPT 168
                      +  LC +E P +RPT
Sbjct: 233 ---------YELMRLCWKEKPEERPT 249

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 70.4 bits (173), Expect = 9e-15
 Identities = 47/149 (31%), Positives = 71/149 (47%), Gaps = 26/149 (17%)

Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTY--GYMSPEYALGG 82
             IHRD    NIL+   +  KI+DFGL R+ E    D  T R    +   + +PE A  G
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLARLIE---DDEYTAREGAKFPIKWTAPEAANYG 179

Query: 83  FFSVKSDVFSFGVVVLEIISGKR--NTGFYNSELALSL-LGYAWKLWQEGKALDMMDQKP 139
            F++KSDV+SFG+++ EI++  R    G  N E+   +  GY             M + P
Sbjct: 180 RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY------------RMPRPP 227

Query: 140 GAISKANEILKCINVGLLCVQEDPNDRPT 168
               +  +++      L C  +DP +RPT
Sbjct: 228 NCPEELYDLM------LQCWDKDPEERPT 250

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 70.9 bits (174), Expect = 1e-14
 Identities = 37/108 (34%), Positives = 59/108 (54%), Gaps = 11/108 (10%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           ++L  I + + + L YLH  SKL +IHRD K SN+L++     K+ DFG++    G   D
Sbjct: 103 DILGKIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS----GYLVD 156

Query: 62  GTTNRV-VGTYGYMSPEYALGGF----FSVKSDVFSFGVVVLEIISGK 104
                +  G   YM+PE          + VKSDV+S G+ ++E+ +G+
Sbjct: 157 SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 70.4 bits (172), Expect = 2e-14
 Identities = 39/103 (37%), Positives = 62/103 (60%), Gaps = 6/103 (5%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           ++L  + + V + L YL +  K +I+HRD K SNIL++     K+ DFG++    G+  D
Sbjct: 103 QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLID 156

Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
              N  VGT  YMSPE   G  +SV+SD++S G+ ++E+  G+
Sbjct: 157 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 69.7 bits (171), Expect = 2e-14
 Identities = 47/172 (27%), Positives = 73/172 (42%), Gaps = 29/172 (16%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTN--RVVGTYG 72
           + YL      R IHRD    NIL++ E   KISDFGL ++    +             + 
Sbjct: 122 MDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFW 178

Query: 73  YMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWK-------- 124
           Y +PE      FS  SDV+SFGV + E+ +    +    S  A  L              
Sbjct: 179 Y-APECLRTSKFSSASDVWSFGVTLYELFTYGDPS---QSPPAEFLRMIGIAQGQMIVTR 234

Query: 125 ---LWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
              L +EG+ L    + P    +  +++K      LC + +P DRP+ +D++
Sbjct: 235 LLELLKEGERL---PRPPSCPDEVYDLMK------LCWEAEPQDRPSFADLI 277

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 69.8 bits (172), Expect = 2e-14
 Identities = 37/103 (35%), Positives = 58/103 (56%), Gaps = 10/103 (9%)

Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +++ ++ G++    Y H     RI+HRD K  NIL++ +   K++DFGL R F G     
Sbjct: 103 IMYQLLRGLA----YCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRT 154

Query: 63  TTNRVVGTYGYMSPEYALGG-FFSVKSDVFSFGVVVLEIISGK 104
            T+ VV T  Y +PE  LG   +S   D++S G +  E+I+GK
Sbjct: 155 YTHEVV-TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 69.2 bits (170), Expect = 3e-14
 Identities = 35/95 (36%), Positives = 51/95 (53%), Gaps = 9/95 (9%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRI-FEGKQTDGT-----TNRVV 68
           L YLH      IIHRD K  NIL+D   + K++DFGL+++    +Q +         R+V
Sbjct: 106 LEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV 162

Query: 69  GTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           GT  Y++PE  LG   S   D +S G ++ E + G
Sbjct: 163 GTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 68.7 bits (168), Expect = 6e-14
 Identities = 35/91 (38%), Positives = 53/91 (58%), Gaps = 4/91 (4%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR-VVGTYGY 73
           + YLH +    I+HRD K +NIL D   N K+ DFG ++  +   + GT  + V GT  +
Sbjct: 117 VEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYW 173

Query: 74  MSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           MSPE   G  +  K+DV+S G  V+E+++ K
Sbjct: 174 MSPEVISGEGYGRKADVWSVGCTVVEMLTEK 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 68.5 bits (168), Expect = 6e-14
 Identities = 47/168 (27%), Positives = 74/168 (44%), Gaps = 34/168 (20%)

Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQTDGTTNRVVGTYGYMS 75
           YL      + +HRD    N ++  ++  KI DFG+TR I+E          ++    +M+
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-WMA 189

Query: 76  PEYALGGFFSVKSDVFSFGVVVLEIIS-------GKRNTGFYNSELALSLLGYAWKLWQE 128
           PE    G F+ KSDV+SFGVV+ E+ +       G  N      E  L  +        +
Sbjct: 190 PESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN------EEVLKFVI-------D 236

Query: 129 GKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
           G  LD+ +  P          K + +  +C Q +P  RPT  ++V  L
Sbjct: 237 GGHLDLPENCPD---------KLLELMRMCWQYNPKMRPTFLEIVSSL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 68.6 bits (168), Expect = 8e-14
 Identities = 35/98 (35%), Positives = 56/98 (57%), Gaps = 9/98 (9%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           I+LG    L +LH+     II+RD K  N+LLD E + KI+DFG+ +  EG     TT+ 
Sbjct: 105 IVLG----LQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTST 155

Query: 67  VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
             GT  Y++PE      +    D ++ GV++ E+++G+
Sbjct: 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 66.8 bits (163), Expect = 2e-13
 Identities = 37/98 (37%), Positives = 57/98 (58%), Gaps = 9/98 (9%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           I+LG++    +LH     +I+HRD K+ N+ LD   N KI D G+ ++     T+   N 
Sbjct: 110 ILLGLA----HLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL-SDNTN-FANT 160

Query: 67  VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           +VGT  Y+SPE      ++ KSDV++ GVV+ E  +GK
Sbjct: 161 IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGK 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 67.2 bits (164), Expect = 2e-13
 Identities = 38/98 (38%), Positives = 54/98 (55%), Gaps = 9/98 (9%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           II G    L +LHQ    RII+RD K  N+LLD++ N +ISD GL    +  Q+   T  
Sbjct: 106 IISG----LEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTKG 156

Query: 67  VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
             GT G+M+PE   G  +    D F+ GV + E+I+ +
Sbjct: 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 65.8 bits (160), Expect = 5e-13
 Identities = 47/150 (31%), Positives = 79/150 (52%), Gaps = 24/150 (16%)

Query: 23  KLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTY--GYMSPEYAL 80
           ++  IHRD + +NIL+   +  KI+DFGL R+ E  +    T R    +   + +PE AL
Sbjct: 120 RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE---YTARQGAKFPIKWTAPEAAL 176

Query: 81  GGFFSVKSDVFSFGVVVLEIISGKR--NTGFYNSELALSLLGYAWKLWQEGKALDMMDQK 138
            G F++KSDV+SFG+++ E+++  R    G  N E+ L  +   ++          M   
Sbjct: 177 YGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV-LEQVERGYR----------MPCP 225

Query: 139 PGAISKANEILKCINVGLLCVQEDPNDRPT 168
            G     +E++K      LC ++DP++RPT
Sbjct: 226 QGCPESLHELMK------LCWKKDPDERPT 249

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 65.5 bits (160), Expect = 6e-13
 Identities = 47/169 (27%), Positives = 80/169 (47%), Gaps = 18/169 (10%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           ++   + +   L ++H     RI+HRD K +N+ +      K+ D GL R F  K T   
Sbjct: 108 IWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH 164

Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAW 123
           +  +VGT  YMSPE      ++ KSD++S G ++ E+ + +  + FY  ++ L  L    
Sbjct: 165 S--LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ--SPFYGDKMNLYSL---- 216

Query: 124 KLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
                 K ++  D  P      +E L+  ++   C+  DP  RP +S V
Sbjct: 217 -----CKKIEKCDYPPLPADHYSEELR--DLVSRCINPDPEKRPDISYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 65.6 bits (160), Expect = 7e-13
 Identities = 36/103 (34%), Positives = 60/103 (58%), Gaps = 7/103 (6%)

Query: 6   NIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTN 65
           N +  + + L YLH      IIHRD K +NIL+D++   KISDFG+++  E       TN
Sbjct: 110 NFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTN 166

Query: 66  R----VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
                + G+  +M+PE      ++ K+D++S G +V+E+++GK
Sbjct: 167 GARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 65.5 bits (160), Expect = 7e-13
 Identities = 33/102 (32%), Positives = 56/102 (54%), Gaps = 5/102 (4%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           +  L ++   V+  + YL +      IHRD    NIL+  ++  K++DFGL R+   K+ 
Sbjct: 103 VASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLI--KED 157

Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS 102
              ++     Y + +PE A  G FS KSDV+SFG+++ E+ +
Sbjct: 158 VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 65.4 bits (159), Expect = 8e-13
 Identities = 46/146 (31%), Positives = 75/146 (51%), Gaps = 24/146 (16%)

Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTY--GYMSPEYALGGFF 84
           IHRD + +N+L+   +  KI+DFGL R+ E  +    T R    +   + +PE    G F
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGSF 181

Query: 85  SVKSDVFSFGVVVLEIIS-GK-RNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           ++KSDV+SFG+++ EI++ GK    G  NS++  +L        Q G  +  M+  P  +
Sbjct: 182 TIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL--------QRGYRMPRMENCPDEL 233

Query: 143 SKANEILKCINVGLLCVQEDPNDRPT 168
               +I+K       C +E   +RPT
Sbjct: 234 Y---DIMK------TCWKEKAEERPT 250

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 65.4 bits (159), Expect = 9e-13
 Identities = 49/177 (27%), Positives = 86/177 (48%), Gaps = 28/177 (15%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQ 59
           M  L +    +SR + YL   ++++++HRD    N+L+      KISDFGL+R ++E   
Sbjct: 126 MGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE--- 179

Query: 60  TDGTTNRVVG--TYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELA 115
            D    R  G     +M+ E      ++ +SDV+SFGV++ EI++  G    G     L 
Sbjct: 180 EDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL- 238

Query: 116 LSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
                  + L + G  ++    +P   S+        N+ L C +++P+ RPT +D+
Sbjct: 239 -------FNLLKTGYRME----RPENCSEE-----MYNLMLTCWKQEPDKRPTFADI 279

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 64.8 bits (158), Expect = 1e-12
 Identities = 49/148 (33%), Positives = 71/148 (47%), Gaps = 28/148 (18%)

Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIF---EGKQTDGTTNRVVGTYGYMSPEYALGGF 83
           IHRD    N+L+      K++DFGL R+      +  +G    +  T    +PE AL   
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWT----APEAALYNR 180

Query: 84  FSVKSDVFSFGVVVLEIISGKR--NTGFYNSE-LALSLLGYAWKLWQEGKALDMMDQKPG 140
           FS+KSDV+SFG+++ EI++  R    G  N+E L     GY             M   PG
Sbjct: 181 FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGY------------RMPCPPG 228

Query: 141 AISKANEILKCINVGLLCVQEDPNDRPT 168
              +  +I+      L C +EDP+DRPT
Sbjct: 229 CPKELYDIM------LDCWKEDPDDRPT 250

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 64.8 bits (158), Expect = 2e-12
 Identities = 30/90 (33%), Positives = 51/90 (56%), Gaps = 6/90 (6%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L Y+H+     +IHRD K +NIL+ +  N K+ DFG+  +    Q     +  VGT  +M
Sbjct: 114 LKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLN--QNSSKRSTFVGTPYWM 168

Query: 75  SPEYALGG-FFSVKSDVFSFGVVVLEIISG 103
           +PE    G ++  K+D++S G+ + E+ +G
Sbjct: 169 APEVITEGKYYDTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 64.3 bits (156), Expect = 2e-12
 Identities = 43/150 (28%), Positives = 70/150 (46%), Gaps = 32/150 (21%)

Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYG------YMSPEYAL 80
           IHRD + +NIL+   +  KI+DFGL R+ E        N      G      + +PE   
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVIE-------DNEYTAREGAKFPIKWTAPEAIN 176

Query: 81  GGFFSVKSDVFSFGVVVLEIISGKRN--TGFYNSELALSLLGYAWKLWQEGKALDMMDQK 138
            G F++KSDV+SFG++++EI++  R    G  N E+  +L        + G  +   +  
Sbjct: 177 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL--------ERGYRMPRPENC 228

Query: 139 PGAISKANEILKCINVGLLCVQEDPNDRPT 168
           P  +          N+ + C +  P +RPT
Sbjct: 229 PEEL---------YNIMMRCWKNRPEERPT 249

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 64.4 bits (157), Expect = 2e-12
 Identities = 36/99 (36%), Positives = 51/99 (51%), Gaps = 13/99 (13%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           ++LGV      LHQ     IIHRD K  N+L+D   + K++DFGL+R     +      +
Sbjct: 106 VVLGVE----DLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK------K 152

Query: 67  VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKR 105
            VGT  Y++PE  LG      SD +S G V+ E + G  
Sbjct: 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYP 191

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 64.3 bits (157), Expect = 2e-12
 Identities = 54/194 (27%), Positives = 82/194 (42%), Gaps = 58/194 (29%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           + ML  I  G+     YL   S++  +HRD    NIL++  +  K+SDFGL+R  E  + 
Sbjct: 109 VGMLRGIASGMK----YL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA 161

Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLL 119
             TT        + +PE      F+  SDV+SFG+V+ E++S G+R              
Sbjct: 162 TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGER-------------- 207

Query: 120 GYAWKLWQEGKALDMMDQKPGAISKANEILKCINVG-----------------LLCVQED 162
                 W      DM +Q         +++K +  G                 L C Q+D
Sbjct: 208 ----PYW------DMSNQ---------DVIKAVEDGYRLPPPMDCPSALYQLMLDCWQKD 248

Query: 163 PNDRPTMSDVVIML 176
            N+RPT S +V  L
Sbjct: 249 RNERPTFSQIVSTL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 64.3 bits (157), Expect = 2e-12
 Identities = 41/107 (38%), Positives = 59/107 (55%), Gaps = 10/107 (9%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           E+L  I +   + L YL ++  L+IIHRD K SNILLD   N K+ DFG++    G+  D
Sbjct: 107 EILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGIS----GQLVD 160

Query: 62  GTT-NRVVGTYGYMSPEYALGGF---FSVKSDVFSFGVVVLEIISGK 104
                R  G   YM+PE         + V+SDV+S G+ + E+ +GK
Sbjct: 161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 64.4 bits (157), Expect = 2e-12
 Identities = 34/100 (34%), Positives = 53/100 (53%), Gaps = 5/100 (5%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQTDG 62
             +I + ++  + YL   S    +HRD    N L+   +  KISDFGL+R I+       
Sbjct: 126 FLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRV 182

Query: 63  TTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS 102
            +  ++    +M PE  L G F+ +SD++SFGVV+ EI S
Sbjct: 183 QSKSLLPVR-WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 64.2 bits (157), Expect = 2e-12
 Identities = 36/100 (36%), Positives = 57/100 (57%), Gaps = 9/100 (9%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           I+  V   L YLH++ K   IHRD K +NILL  E + K++DFG++    G+ T   + R
Sbjct: 103 ILREVLLGLEYLHEEGK---IHRDIKAANILLSEEGDVKLADFGVS----GQLTSTMSKR 155

Query: 67  --VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
              VGT  +M+PE      +  K+D++S G+  +E+  G+
Sbjct: 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGE 195

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 64.2 bits (157), Expect = 2e-12
 Identities = 35/103 (33%), Positives = 53/103 (51%), Gaps = 10/103 (9%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           I+    R L YLH++   ++IHRD K  NILL      K+ DFG++   +   T G  N 
Sbjct: 118 ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA--QLDSTLGRRNT 172

Query: 67  VVGTYGYMSPE-----YALGGFFSVKSDVFSFGVVVLEIISGK 104
            +GT  +M+PE           +  +SDV+S G+  +E+  GK
Sbjct: 173 FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 64.3 bits (157), Expect = 2e-12
 Identities = 35/102 (34%), Positives = 56/102 (54%), Gaps = 10/102 (9%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L+ ++ G++    Y H     R++HRD K  N+L+D E   K++DFGL R F G      
Sbjct: 105 LYQLLQGIA----YCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTY 156

Query: 64  TNRVVGTYGYMSPEYALGG-FFSVKSDVFSFGVVVLEIISGK 104
           T+ VV T  Y +PE  LG   +S   D++S G +  E+++ +
Sbjct: 157 THEVV-TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 63.9 bits (155), Expect = 2e-12
 Identities = 47/150 (31%), Positives = 77/150 (51%), Gaps = 24/150 (16%)

Query: 23  KLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTY--GYMSPEYAL 80
           ++  IHRD +++NIL+   +  KI+DFGL R+ E  +    T R    +   + +PE AL
Sbjct: 120 RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY---TARQGAKFPIKWTAPEAAL 176

Query: 81  GGFFSVKSDVFSFGVVVLEIISGKR--NTGFYNSELALSLLGYAWKLWQEGKALDMMDQK 138
            G F++KSDV+SFG+++ E+++  R    G  N E+          L Q  +   M   +
Sbjct: 177 YGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREV----------LEQVERGYRMPCPQ 226

Query: 139 PGAISKANEILKCINVGLLCVQEDPNDRPT 168
              IS    +L+C        ++DP +RPT
Sbjct: 227 DCPISLHELMLQCW-------KKDPEERPT 249

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 64.1 bits (156), Expect = 3e-12
 Identities = 34/102 (33%), Positives = 55/102 (53%), Gaps = 7/102 (6%)

Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L  I + V + L YL     L+I+HRD K SN+L++     K+ DFG++     +  + 
Sbjct: 96  VLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVST----QLVNS 148

Query: 63  TTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
                VGT  YM+PE   G  + + SDV+S G+  +E+  G+
Sbjct: 149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 63.6 bits (155), Expect = 3e-12
 Identities = 51/175 (29%), Positives = 69/175 (39%), Gaps = 29/175 (16%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQ- 59
            E L ++   V   + YL  +     IHRD    N L+  +   K+SDFGL R     Q 
Sbjct: 99  TEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155

Query: 60  --TDGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRN--TGFYNSELA 115
             + GT   V     +  PE      FS KSDV+SFGV++ E+ S  +     F NSE+ 
Sbjct: 156 TSSQGTKFPV----KWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV 211

Query: 116 LSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMS 170
            S+          G  L      P  +     I+        C  E P DRP   
Sbjct: 212 ESV--------SAGYRLYRPKLAPTEVY---TIMY------SCWHEKPEDRPAFK 249

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 63.5 bits (154), Expect = 3e-12
 Identities = 44/158 (27%), Positives = 77/158 (48%), Gaps = 18/158 (11%)

Query: 19  HQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEY 78
           H  S+ R++HRD K +N+ +      K+ D GL R F  K T    + +VGT  YMSPE 
Sbjct: 121 HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPER 177

Query: 79  ALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQK 138
                ++ KSD++S G ++ E+ +    + FY  ++          L+   K ++  D  
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAA--LQSPFYGDKM---------NLYSLCKKIEQCDYP 226

Query: 139 P-GAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIM 175
           P  +   + E+ + +N   +C+  DP  RP ++ V  +
Sbjct: 227 PLPSDHYSEELRQLVN---MCINPDPEKRPDITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 64.0 bits (156), Expect = 3e-12
 Identities = 35/98 (35%), Positives = 56/98 (57%), Gaps = 9/98 (9%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           II G    L +LH+     II+RD K  N+LLD + + KI+DFG+ +  E    +G  + 
Sbjct: 105 IICG----LQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCK--ENMNGEGKAST 155

Query: 67  VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
             GT  Y++PE   G  ++   D +SFGV++ E++ G+
Sbjct: 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 63.1 bits (154), Expect = 4e-12
 Identities = 50/177 (28%), Positives = 78/177 (44%), Gaps = 25/177 (14%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L  +   V+  + YL  +SK   +HRD    N+LL +    KISDFG++R   G  +D  
Sbjct: 97  LKELAHQVAMGMAYL--ESK-HFVHRDLAARNVLLVNRHQAKISDFGMSRAL-GAGSDYY 152

Query: 64  TNRVVGTY--GYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLL 119
                G +   + +PE    G FS KSDV+S+GV + E  S   K       +E+     
Sbjct: 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVI---- 208

Query: 120 GYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
                + + G+ L   ++ P  I          ++ L C +  P DRPT S++    
Sbjct: 209 ----AMLESGERLPRPEECPQEI---------YSIMLSCWKYRPEDRPTFSELESTF 252

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 63.0 bits (154), Expect = 4e-12
 Identities = 29/88 (32%), Positives = 45/88 (51%), Gaps = 6/88 (6%)

Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH      II+RD K  N+LLD     K+ DFG  +  +  Q    T    GT  Y++P
Sbjct: 108 YLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAP 161

Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISGK 104
           E  L   +    D +S G+++ E+++G+
Sbjct: 162 EIILNKGYDFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 63.2 bits (154), Expect = 5e-12
 Identities = 46/186 (24%), Positives = 77/186 (41%), Gaps = 38/186 (20%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           + ++ I + + R L  LH+    +I+HRD K++NILL      KI D G++++       
Sbjct: 103 QEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVL----KK 155

Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGY 121
                 +GT  YM+PE   G  +S KSD++S G ++ E+ +      F            
Sbjct: 156 NMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA--PPF------------ 201

Query: 122 AWKLWQEGKALDMMDQK------PGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIM 175
                 E +++  +  K      P      ++ L   N     +Q  P  RP    +   
Sbjct: 202 ------EARSMQDLRYKVQRGKYPPIPPIYSQDL--QNFIRSMLQVKPKLRPNCDKI--- 250

Query: 176 LGSEAV 181
           L S AV
Sbjct: 251 LASPAV 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 63.1 bits (154), Expect = 5e-12
 Identities = 32/91 (35%), Positives = 48/91 (52%), Gaps = 6/91 (6%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L + H      I+HRD K  N+L++ E   K++DFGL R F        T+ VV T  Y 
Sbjct: 111 LAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVV-TRWYR 165

Query: 75  SPEYALG-GFFSVKSDVFSFGVVVLEIISGK 104
           +PE  LG   +S   D++S G +  E++S +
Sbjct: 166 APELLLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 63.2 bits (154), Expect = 5e-12
 Identities = 55/172 (31%), Positives = 83/172 (48%), Gaps = 36/172 (20%)

Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILL--DHEMNPKISDFGLTR-----IFEGKQTDGT 63
           V+R + +L   SK + IHRD    N+L+  DH M  KI+DFGL R      +  K T+G 
Sbjct: 141 VARGMEFL--ASK-KCIHRDLAARNVLVTEDHVM--KIADFGLARDIHHIDYYRKTTNG- 194

Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLGY 121
             R+     +M+PE      ++ +SDV+SFGV++ EI +  G    G    EL       
Sbjct: 195 --RL--PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL------- 243

Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
            +KL +EG  ++    KP      N   +  ++   C  E P+ RPT   +V
Sbjct: 244 -FKLLKEGYRME----KP-----QNCTQELYHLMRDCWHEVPSQRPTFKQLV 285

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 62.9 bits (153), Expect = 6e-12
 Identities = 53/187 (28%), Positives = 76/187 (40%), Gaps = 44/187 (23%)

Query: 12  SRRLLYLHQDSK-------LRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTT 64
            + LLY  Q  K        R +HRD  T NIL++ E   KI DFGLT++   +  +   
Sbjct: 108 RKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP-QDKEYYK 166

Query: 65  NRVVG---TYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS----------------GKR 105
            R  G    + Y +PE      FSV SDV+SFGVV+ E+ +                G  
Sbjct: 167 VREPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGND 225

Query: 106 NTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPND 165
             G       + LL    +L             PG  ++   I+K       C   DP+ 
Sbjct: 226 KQGQMIVYHLIELLKNNGRL----------PAPPGCPAEIYAIMK------ECWNNDPSQ 269

Query: 166 RPTMSDV 172
           RP+ S++
Sbjct: 270 RPSFSEL 276

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 62.7 bits (153), Expect = 9e-12
 Identities = 34/101 (33%), Positives = 53/101 (52%), Gaps = 15/101 (14%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT----------T 64
           + YLH++    I+HRD K +NIL+D++   KI+DFGL R ++G   +            T
Sbjct: 128 INYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYT 184

Query: 65  NRVVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
           N VV T  Y  PE  LG   ++   D++  G V  E+ + +
Sbjct: 185 NLVV-TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 62.5 bits (152), Expect = 9e-12
 Identities = 35/91 (38%), Positives = 51/91 (56%), Gaps = 6/91 (6%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L +LHQ   L II+RD K  NILLD E +  ++DFGL++ F  ++ +       GT  YM
Sbjct: 118 LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYM 173

Query: 75  SPEYALGGF--FSVKSDVFSFGVVVLEIISG 103
           +PE   GG        D +S GV+  E+++G
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 62.7 bits (152), Expect = 9e-12
 Identities = 37/98 (37%), Positives = 55/98 (56%), Gaps = 9/98 (9%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           II G    L +LH      I++RD K  NILLD + + KI+DFG+ +  E    D  T  
Sbjct: 105 IICG----LQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCT 155

Query: 67  VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
             GT  Y++PE  LG  ++   D +SFGV++ E++ G+
Sbjct: 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 62.2 bits (152), Expect = 1e-11
 Identities = 34/89 (38%), Positives = 49/89 (55%), Gaps = 6/89 (6%)

Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           +LH +    I+HRD KTSN+LL++    KI DFGL R +       T   VV T  Y +P
Sbjct: 121 HLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQL-VV-TLWYRAP 175

Query: 77  EYALG-GFFSVKSDVFSFGVVVLEIISGK 104
           E  LG   +S   D++S G +  E+++ K
Sbjct: 176 ELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 61.8 bits (150), Expect = 2e-11
 Identities = 48/174 (27%), Positives = 79/174 (45%), Gaps = 34/174 (19%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR------IFEGKQT 60
           I   V+  + YL   S+ + +HRD  T N L+   M  KI+DFGL+R       ++  + 
Sbjct: 135 IAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASEN 191

Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNT--GFYNSELALSL 118
           D    R      +M PE      ++ +SDV+++GVV+ EI S       G  + E    +
Sbjct: 192 DAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE----V 241

Query: 119 LGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
           + Y     ++G  L   D  P         L+  N+  LC  + P+DRP+ + +
Sbjct: 242 IYYV----RDGNVLSCPDNCP---------LELYNLMRLCWSKLPSDRPSFASI 282

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 62.2 bits (151), Expect = 2e-11
 Identities = 32/91 (35%), Positives = 52/91 (57%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           LL +H      +IHRD K++NILL      K+ DFG ++++    +D       GT  Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212

Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGKR 105
           +PE      +S K+D+FS GV++ E+++ KR
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKR 243

Length = 496

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 61.6 bits (150), Expect = 2e-11
 Identities = 34/95 (35%), Positives = 52/95 (54%), Gaps = 11/95 (11%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTN-RVVGTYGY 73
           L YL +  K  +IHRD K SNILLD   N K+ DFG++    G+  D     R  G   Y
Sbjct: 127 LHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGIS----GRLVDSKAKTRSAGCAAY 180

Query: 74  MSPEY----ALGGFFSVKSDVFSFGVVVLEIISGK 104
           M+PE          + +++DV+S G+ ++E+ +G+
Sbjct: 181 MAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 61.2 bits (148), Expect = 2e-11
 Identities = 36/89 (40%), Positives = 51/89 (57%), Gaps = 4/89 (4%)

Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR-VVGTYGYMS 75
           YLH +    I+HRD K +NIL D   N K+ DFG ++  +     GT  R V GT  +MS
Sbjct: 121 YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMS 177

Query: 76  PEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           PE   G  +  K+DV+S G  V+E+++ K
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 61.7 bits (150), Expect = 3e-11
 Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 5/93 (5%)

Query: 13  RRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYG 72
           R L YLH      I+HRD K  N+L++     KI DFGL R+ E  ++   T  VV  Y 
Sbjct: 114 RGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169

Query: 73  YMSPEYALGG-FFSVKSDVFSFGVVVLEIISGK 104
           Y +PE  +G   ++   D++S G +  E++  +
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 61.3 bits (149), Expect = 3e-11
 Identities = 37/112 (33%), Positives = 58/112 (51%), Gaps = 18/112 (16%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
             L  I + ++  ++YL   +    +HRD  T N L+ +++  KI DFG++R       D
Sbjct: 122 SQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR-------D 171

Query: 62  GTTN---RVVGT----YGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKR 105
             T    RV G       +M PE  +   F+ +SDV+SFGVV+ EI + GK+
Sbjct: 172 VYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQ 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 61.5 bits (149), Expect = 3e-11
 Identities = 34/95 (35%), Positives = 55/95 (57%), Gaps = 9/95 (9%)

Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR--IFEGKQTDGTTNRVV 68
           ++  L++LH      II+RD K  N+LLDHE + K++DFG+ +  IF GK    TT+   
Sbjct: 105 ITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK----TTSTFC 157

Query: 69  GTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           GT  Y++PE      +    D ++ GV++ E++ G
Sbjct: 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 60.8 bits (148), Expect = 3e-11
 Identities = 37/107 (34%), Positives = 57/107 (53%), Gaps = 12/107 (11%)

Query: 6   NIILGVSRRLL----YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFE--GKQ 59
            II  V + +L    YLH +     IHRD K  NILL  + + KI+DFG++      G +
Sbjct: 102 AIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158

Query: 60  TDGTTNRVVGTYGYMSPE--YALGGFFSVKSDVFSFGVVVLEIISGK 104
           T       VGT  +M+PE    + G +  K+D++SFG+  +E+ +G 
Sbjct: 159 TRKVRKTFVGTPCWMAPEVMEQVHG-YDFKADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 60.8 bits (147), Expect = 4e-11
 Identities = 30/85 (35%), Positives = 52/85 (61%), Gaps = 5/85 (5%)

Query: 23  KLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTY--GYMSPEYAL 80
           ++  +HRD + +NIL+   +  K++DFGL R+ E  +    T R    +   + +PE AL
Sbjct: 120 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAAL 176

Query: 81  GGFFSVKSDVFSFGVVVLEIISGKR 105
            G F++KSDV+SFG+++ E+ +  R
Sbjct: 177 YGRFTIKSDVWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 60.9 bits (148), Expect = 4e-11
 Identities = 34/92 (36%), Positives = 53/92 (57%), Gaps = 9/92 (9%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR--IFEGKQTDGTTNRVVGTYG 72
           L +LH      II+RD K  N++LD E + KI+DFG+ +  IF GK    TT    GT  
Sbjct: 114 LFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK----TTRTFCGTPD 166

Query: 73  YMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           Y++PE      +    D ++FGV++ E+++G+
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 60.3 bits (146), Expect = 4e-11
 Identities = 38/100 (38%), Positives = 53/100 (53%), Gaps = 10/100 (10%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
            E    ++LGV     Y+HQ    RI+HRD K  NI L + +  KI DFG++R+  G   
Sbjct: 109 CEWFIQLLLGVH----YMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCD 160

Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEI 100
             TT    GT  YMSPE      +  KSD++S G ++ E+
Sbjct: 161 LATT--FTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 60.4 bits (146), Expect = 5e-11
 Identities = 34/88 (38%), Positives = 51/88 (57%), Gaps = 8/88 (9%)

Query: 18  LHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLT-RIFEGKQTDGTTNRVVGTYGYMSP 76
           LHQ+   RI++RD K  NILLD   + +ISD GL   + EG+   G     VGT GYM+P
Sbjct: 118 LHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAP 170

Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISGK 104
           E      ++   D ++ G ++ E+I+G+
Sbjct: 171 EVVKNERYTFSPDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 60.2 bits (146), Expect = 5e-11
 Identities = 39/117 (33%), Positives = 64/117 (54%), Gaps = 8/117 (6%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           E ++NI + +   L YLH++   RI+HRD   +NI+L  +    I+DFGL +    KQ +
Sbjct: 113 ERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPE 167

Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSL 118
                VVGT  Y  PE      +  K+DV++FG ++ ++ +      FY++ + LSL
Sbjct: 168 SKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT--LQPPFYSTNM-LSL 221

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 60.6 bits (147), Expect = 5e-11
 Identities = 36/91 (39%), Positives = 50/91 (54%), Gaps = 8/91 (8%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGL-TRIFEGKQTDGTTNRVVGTYGY 73
           L  LH++   RI++RD K  NILLD   + +ISD GL   I EG+   G     VGT GY
Sbjct: 115 LEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR----VGTVGY 167

Query: 74  MSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           M+PE      ++   D +  G ++ E+I GK
Sbjct: 168 MAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 60.1 bits (146), Expect = 5e-11
 Identities = 45/164 (27%), Positives = 75/164 (45%), Gaps = 28/164 (17%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           I+LG    L YLH       +HRD K +NIL+D     K++DFG+ +             
Sbjct: 111 ILLG----LEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV---EFSFAKS 160

Query: 67  VVGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKL 125
             G+  +M+PE     G + + +D++S G  VLE+ +GK           L  +   +K+
Sbjct: 161 FKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWS------QLEGVAAVFKI 214

Query: 126 WQEGKALDMMDQKPGAIS-KANEILKCINVGLLCVQEDPNDRPT 168
            +  +   +    P  +S +A + +      L C+Q DP+ RPT
Sbjct: 215 GRSKELPPI----PDHLSDEAKDFI------LKCLQRDPSLRPT 248

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 60.0 bits (145), Expect = 6e-11
 Identities = 45/154 (29%), Positives = 76/154 (49%), Gaps = 16/154 (10%)

Query: 19  HQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEY 78
           H  S+ R++HRD K +N+ +      K+ D GL R F  K T    + +VGT  YMSPE 
Sbjct: 121 HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPER 177

Query: 79  ALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQK 138
                ++ KSD++S G ++ E+ +    + FY  ++ L      + L Q+   ++  D  
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAA--LQSPFYGDKMNL------FSLCQK---IEQCDYP 226

Query: 139 PGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
           P      +E L+   +  +C+  DP+ RP +  V
Sbjct: 227 PLPTEHYSEKLR--ELVSMCIYPDPDQRPDIGYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 59.9 bits (145), Expect = 7e-11
 Identities = 47/175 (26%), Positives = 81/175 (46%), Gaps = 18/175 (10%)

Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHE-MNPKISDFGLTRIFEGKQT- 60
           ++ N    + R L YLH++   +IIHRD K +N+L+D      +I+DFG       K T 
Sbjct: 104 VIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160

Query: 61  -DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLL 119
                 +++GT  +M+PE   G  +    DV+S G V++E+ + K           L+L+
Sbjct: 161 AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI 220

Query: 120 GYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVI 174
              +K+     A  +    P  +S         +V L C++  P DRP   +++ 
Sbjct: 221 ---FKIASATTAPSI----PEHLSPGLR-----DVTLRCLELQPEDRPPSRELLK 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 60.0 bits (146), Expect = 7e-11
 Identities = 32/104 (30%), Positives = 55/104 (52%), Gaps = 12/104 (11%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           M ML     GV+    Y+H      I+HRD K +N+L+  +   KI+DFGL R+F  ++ 
Sbjct: 105 MRMLLK---GVA----YMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154

Query: 61  DGTTNRVVGTYGYMSPEYALGG-FFSVKSDVFSFGVVVLEIISG 103
              +++ V T  Y +PE   G   +    D+++ G +  E+++G
Sbjct: 155 RLYSHQ-VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 60.1 bits (146), Expect = 7e-11
 Identities = 35/99 (35%), Positives = 54/99 (54%), Gaps = 6/99 (6%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           ++L + R L YLH++    IIHRD K SN+LL  +   KI+DFGL R +       T   
Sbjct: 113 LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKV 169

Query: 67  VVGTYGYMSPEYALGGFFSVKS-DVFSFGVVVLEIISGK 104
           V  T  Y +PE  LG      + D+++ G ++ E+++ K
Sbjct: 170 V--TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 60.1 bits (145), Expect = 8e-11
 Identities = 33/94 (35%), Positives = 56/94 (59%), Gaps = 5/94 (5%)

Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGT 70
           +S  L YLH+     II+RD K  N+LLD E + K++D+G+ +  EG +   TT+   GT
Sbjct: 105 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGT 159

Query: 71  YGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
             Y++PE   G  +    D ++ GV++ E+++G+
Sbjct: 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 60.0 bits (145), Expect = 8e-11
 Identities = 47/157 (29%), Positives = 75/157 (47%), Gaps = 25/157 (15%)

Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQTDGTTNRVVGTY--GYMSPEYALG 81
           + +HRD    N ++ H+   KI DFG+TR I+E   TD       G     +M+PE    
Sbjct: 139 KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE---TDYYRKGGKGLLPVRWMAPESLKD 195

Query: 82  GFFSVKSDVFSFGVVVLEI--ISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKP 139
           G F+  SD++SFGVV+ EI  ++ +   G  N ++         K   +G  LD  D  P
Sbjct: 196 GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL--------KFVMDGGYLDQPDNCP 247

Query: 140 GAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
             ++         ++  +C Q +P  RPT  ++V +L
Sbjct: 248 ERVT---------DLMRMCWQFNPKMRPTFLEIVNLL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 59.7 bits (144), Expect = 9e-11
 Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 4/91 (4%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT-TNRVVGTYGY 73
           + YLH +    I+HRD K +NIL D   N K+ DFG ++  +     GT    V GT  +
Sbjct: 119 VSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYW 175

Query: 74  MSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           MSPE   G  +  K+D++S G  V+E+++ K
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 59.2 bits (143), Expect = 1e-10
 Identities = 33/94 (35%), Positives = 51/94 (54%), Gaps = 5/94 (5%)

Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGT 70
           ++  L YLH+     I+HRD KT N+ L      K+ D G+ R+ E +    +T  ++GT
Sbjct: 111 IAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGT 165

Query: 71  YGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
             YMSPE      ++ KSDV++ G  V E+ + K
Sbjct: 166 PYYMSPELFSNKPYNYKSDVWALGCCVYEMATLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 59.4 bits (144), Expect = 1e-10
 Identities = 32/100 (32%), Positives = 55/100 (55%), Gaps = 9/100 (9%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           + L V + L +LH      +IHRD K+ +ILL  +   K+SDFG    F  + +     R
Sbjct: 120 VCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFG----FCAQVSKEVPRR 172

Query: 67  --VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
             +VGT  +M+PE      +  + D++S G++V+E++ G+
Sbjct: 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 59.2 bits (143), Expect = 1e-10
 Identities = 36/104 (34%), Positives = 52/104 (50%), Gaps = 8/104 (7%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           + L    L V   + YL  ++    +HRD    N+L+  +   K+SDFGLT+  E   T 
Sbjct: 102 DCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQ 156

Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKR 105
            T    V    + +PE      FS KSDV+SFG+++ EI S  R
Sbjct: 157 DTGKLPV---KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 59.2 bits (143), Expect = 1e-10
 Identities = 32/91 (35%), Positives = 52/91 (57%), Gaps = 8/91 (8%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLT-RIFEGKQTDGTTNRVVGTYGY 73
           +L+LH    + I++RD K  N+LLD + N ++SD GL   + +GK    T  +  GT GY
Sbjct: 108 ILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK----TITQRAGTNGY 160

Query: 74  MSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           M+PE      +S   D F+ G  + E+++G+
Sbjct: 161 MAPEILKEEPYSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 59.3 bits (143), Expect = 1e-10
 Identities = 38/99 (38%), Positives = 54/99 (54%), Gaps = 8/99 (8%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT-TN 65
           I+ GVS    YLH +    I+HRD K +NIL D   N K+ DFG ++  +     GT   
Sbjct: 115 ILQGVS----YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIK 167

Query: 66  RVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
            V GT  +MSPE   G  +  K+DV+S    V+E+++ K
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 59.3 bits (144), Expect = 1e-10
 Identities = 50/164 (30%), Positives = 70/164 (42%), Gaps = 24/164 (14%)

Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQTDGTT-NRVVGTYGYM 74
           YL      R IHRD    NILL  +   KI DFGL R + + +       +  V  + + 
Sbjct: 112 YLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWC 167

Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSE--LALSLLGYAWKLWQEGKAL 132
           +PE      FS  SDV+ FGV + E+ +       Y  E    LS      K+ +EG+ L
Sbjct: 168 APESLRTRTFSHASDVWMFGVTLWEMFT-------YGEEPWAGLSGSQILKKIDKEGERL 220

Query: 133 DMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
               ++P A           NV L C   +P DRPT + +   L
Sbjct: 221 ----ERPEACP-----QDIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 59.5 bits (144), Expect = 1e-10
 Identities = 34/93 (36%), Positives = 50/93 (53%), Gaps = 9/93 (9%)

Query: 13  RRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYG 72
           R L Y+H      ++HRD K SNIL++   + KI DFGL RI + + T       V T  
Sbjct: 119 RGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTG-----YVSTRY 170

Query: 73  YMSPEYALG-GFFSVKSDVFSFGVVVLEIISGK 104
           Y +PE  L    + V+ D++S G +  E++ GK
Sbjct: 171 YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 59.0 bits (143), Expect = 1e-10
 Identities = 28/81 (34%), Positives = 41/81 (50%), Gaps = 5/81 (6%)

Query: 26  IIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFFS 85
            +HRD    N+L+  ++  K+SDFGL +     Q  G          + +PE      FS
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKL-----PVKWTAPEALREKKFS 177

Query: 86  VKSDVFSFGVVVLEIISGKRN 106
            KSDV+SFG+++ EI S  R 
Sbjct: 178 TKSDVWSFGILLWEIYSFGRV 198

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 58.8 bits (142), Expect = 1e-10
 Identities = 47/153 (30%), Positives = 65/153 (42%), Gaps = 31/153 (20%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           E L  + L V   + YL   +   +IHRD    N L+      K+SDFG+TR     Q  
Sbjct: 100 ETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156

Query: 62  GTTNRVVGT---YGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKR------------- 105
            +T    GT     + SPE      +S KSDV+SFGV++ E+ S  +             
Sbjct: 157 SST----GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVE 212

Query: 106 --NTGF--YNSELA----LSLLGYAWKLWQEGK 130
             N GF  Y   LA      L+ + WK   E +
Sbjct: 213 TINAGFRLYKPRLASQSVYELMQHCWKERPEDR 245

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 58.9 bits (142), Expect = 2e-10
 Identities = 34/100 (34%), Positives = 56/100 (56%), Gaps = 9/100 (9%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           I+  + + L YLH + K   IHRD K +N+LL  + + K++DFG+     G+ TD    R
Sbjct: 106 ILREILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVA----GQLTDTQIKR 158

Query: 67  --VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
              VGT  +M+PE      +  K+D++S G+  +E+  G+
Sbjct: 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 58.4 bits (141), Expect = 2e-10
 Identities = 50/181 (27%), Positives = 85/181 (46%), Gaps = 33/181 (18%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L  ++ G++  + YL   S +  +HRD    NIL++  +  K+SDFGL+R+ E       
Sbjct: 108 LVGMLRGIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAY 164

Query: 64  TNRVVGTYG------YMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNT-GFYNSELA 115
           T R     G      + +PE      F+  SDV+S+G+V+ E++S G+R      N ++ 
Sbjct: 165 TTR-----GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVI 219

Query: 116 LSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIM 175
            ++        +EG  L      P A+ +         + L C Q+D N+RP    +V +
Sbjct: 220 KAI--------EEGYRLPAPMDCPAALHQ---------LMLDCWQKDRNERPKFEQIVSI 262

Query: 176 L 176
           L
Sbjct: 263 L 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 58.5 bits (141), Expect = 2e-10
 Identities = 32/81 (39%), Positives = 46/81 (56%), Gaps = 5/81 (6%)

Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGL-TRIFEGKQTDGTTNRVVGTYGYMSPEYALGGF 83
           RI++RD K  NILLD   + +ISD GL  +I EG+   G     VGT GYM+PE      
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR----VGTVGYMAPEVINNEK 177

Query: 84  FSVKSDVFSFGVVVLEIISGK 104
           ++   D +  G ++ E+I G+
Sbjct: 178 YTFSPDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 58.5 bits (141), Expect = 2e-10
 Identities = 36/104 (34%), Positives = 57/104 (54%), Gaps = 13/104 (12%)

Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           ML  I+ G+     YLH + K   IHRD K +N+LL  + + K++DFG+     G+ TD 
Sbjct: 106 MLKEILKGLD----YLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVA----GQLTDT 154

Query: 63  TTNR--VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
              R   VGT  +M+PE      +  K+D++S G+  +E+  G+
Sbjct: 155 QIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 58.8 bits (142), Expect = 2e-10
 Identities = 31/89 (34%), Positives = 51/89 (57%), Gaps = 2/89 (2%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L  L    K  +I+RD K  NILLD++ +  + DFGL ++    + D  TN   GT  Y+
Sbjct: 103 LCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKL--NMKDDDKTNTFCGTPEYL 160

Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           +PE  LG  ++   D ++ GV++ E+++G
Sbjct: 161 APELLLGHGYTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 58.8 bits (143), Expect = 2e-10
 Identities = 35/127 (27%), Positives = 56/127 (44%), Gaps = 32/127 (25%)

Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGL-TRIFEGKQTDGTTNR--------- 66
            +H   KL  IHRD K  NIL+D + + K++DFGL  ++ + K  +   N          
Sbjct: 116 SVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172

Query: 67  -----------------VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGF 109
                             VGT  Y++PE   G  + ++ D +S GV++ E++ G     F
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF--PPF 230

Query: 110 YNSELAL 116
           Y+  L  
Sbjct: 231 YSDTLQE 237

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 58.5 bits (142), Expect = 2e-10
 Identities = 33/84 (39%), Positives = 47/84 (55%), Gaps = 14/84 (16%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIF---EG 57
           M+ML N        L Y+H++   +I+HRD K +NIL+  +   K++DFGL R F   + 
Sbjct: 125 MKMLLN-------GLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKN 174

Query: 58  KQTDGTTNRVVGTYGYMSPEYALG 81
            + +  TNRVV T  Y  PE  LG
Sbjct: 175 SKPNRYTNRVV-TLWYRPPELLLG 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 58.6 bits (142), Expect = 3e-10
 Identities = 32/87 (36%), Positives = 47/87 (54%), Gaps = 5/87 (5%)

Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L II+RD K  NILLD + +  ++DFGL +  EG +   TT+   GT  Y++P
Sbjct: 111 YLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAP 165

Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E      +    D +  G V+ E++ G
Sbjct: 166 EVLRKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 58.4 bits (142), Expect = 3e-10
 Identities = 34/96 (35%), Positives = 49/96 (51%), Gaps = 7/96 (7%)

Query: 13  RRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIF---EGKQTDGTTNRVVG 69
           + L Y+H      +IHRD K SNILL+ +   K++DFGL R     E    +      V 
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174

Query: 70  TYGYMSPEYALGGFFSVKS-DVFSFGVVVLEIISGK 104
           T  Y +PE  LG     K  D++S G ++ E++ GK
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 58.0 bits (140), Expect = 3e-10
 Identities = 33/102 (32%), Positives = 57/102 (55%), Gaps = 9/102 (8%)

Query: 7   IILGVSRRLL----YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
            I  V R  L    +LH +   ++IHRD K+ NILL  + + K++DFG       +Q+  
Sbjct: 116 QIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172

Query: 63  TTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           +T  +VGT  +M+PE      +  K D++S G++ +E++ G+
Sbjct: 173 ST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 57.9 bits (140), Expect = 4e-10
 Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 5/94 (5%)

Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGT 70
           V+  L++LH+     +I+RD K  NILLD E + K++DFG+ +  EG     TT    GT
Sbjct: 105 VTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGT 159

Query: 71  YGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
             Y++PE      +    D ++ GV++ E+++G+
Sbjct: 160 PDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 58.3 bits (141), Expect = 4e-10
 Identities = 34/89 (38%), Positives = 51/89 (57%), Gaps = 5/89 (5%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L +LH    L II+RD K  NILLD E + K++DFGL++  E    +       GT  YM
Sbjct: 111 LDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYM 165

Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           +PE       +  +D +SFGV++ E+++G
Sbjct: 166 APEVVNRRGHTQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 58.3 bits (141), Expect = 4e-10
 Identities = 32/94 (34%), Positives = 56/94 (59%), Gaps = 5/94 (5%)

Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGT 70
           +S  L +LH+     II+RD K  N+LLD E + K++D+G+ +  EG +   TT+   GT
Sbjct: 105 ISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGT 159

Query: 71  YGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
             Y++PE   G  +    D ++ GV++ E+++G+
Sbjct: 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 58.7 bits (142), Expect = 4e-10
 Identities = 28/88 (31%), Positives = 47/88 (53%), Gaps = 8/88 (9%)

Query: 26  IIHRDFKTSNILL---DHEMNPKISDFGLTRIFEG-----KQTDGTTNRVVGTYGYMSPE 77
           I+HRD K  NI++       + K+ DFG+  +  G       T   T  V+GT  Y +PE
Sbjct: 100 IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE 159

Query: 78  YALGGFFSVKSDVFSFGVVVLEIISGKR 105
              G   +  SD++++G++ LE ++G+R
Sbjct: 160 QLRGEPVTPNSDLYAWGLIFLECLTGQR 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 57.6 bits (139), Expect = 5e-10
 Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 15/106 (14%)

Query: 2   EMLF---NIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGK 58
           EM F    IILG    L ++H      +++RD K +NILLD   + +ISD GL   F  K
Sbjct: 98  EMRFYAAEIILG----LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK 150

Query: 59  QTDGTTNRVVGTYGYMSPE-YALGGFFSVKSDVFSFGVVVLEIISG 103
           +   +    VGT+GYM+PE    G  +   +D FS G ++ +++ G
Sbjct: 151 KPHAS----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 57.5 bits (139), Expect = 5e-10
 Identities = 34/102 (33%), Positives = 57/102 (55%), Gaps = 10/102 (9%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           LF ++ G++    + H     R++HRD K  N+L++ E   K++DFGL R F G      
Sbjct: 106 LFQLLQGLA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTY 157

Query: 64  TNRVVGTYGYMSPEYALGG-FFSVKSDVFSFGVVVLEIISGK 104
           T+ VV T  Y +PE  LG  ++S   D++S G +  E+++ +
Sbjct: 158 THEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 57.4 bits (139), Expect = 7e-10
 Identities = 34/83 (40%), Positives = 44/83 (53%), Gaps = 11/83 (13%)

Query: 26  IIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT----TNRVVGTYGYMSPEYALG 81
           IIHRD K SNI++  +   KI DFGL R      T GT    T  VV  Y Y +PE  LG
Sbjct: 139 IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAGTSFMMTPYVVTRY-YRAPEVILG 191

Query: 82  GFFSVKSDVFSFGVVVLEIISGK 104
             +    D++S G ++ E+I G 
Sbjct: 192 MGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 56.9 bits (137), Expect = 7e-10
 Identities = 33/103 (32%), Positives = 53/103 (51%), Gaps = 4/103 (3%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           +  I   ++  ++YL   + L  +HRD  T N L+   +  KI DFG++R          
Sbjct: 124 MLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV 180

Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKR 105
             R +    +M PE  L   F+ +SD++SFGVV+ EI + GK+
Sbjct: 181 GGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 56.9 bits (137), Expect = 8e-10
 Identities = 51/177 (28%), Positives = 84/177 (47%), Gaps = 25/177 (14%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L  ++ G++  + YL   S +  +HRD    NIL++  +  K+SDFGL+R+ E    +GT
Sbjct: 109 LVGMLRGIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE-DDPEGT 164

Query: 64  TNRVVGTYG--YMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNT-GFYNSELALSLL 119
                G     + +PE      F+  SDV+SFG+V+ E++S G+R      N E+  ++ 
Sbjct: 165 YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI- 223

Query: 120 GYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
                   +G  L      P A+ +         + L C Q+D   RP   D+V +L
Sbjct: 224 -------NDGFRLPAPMDCPSAVYQ---------LMLQCWQQDRARRPRFVDIVNLL 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 56.9 bits (137), Expect = 8e-10
 Identities = 33/91 (36%), Positives = 51/91 (56%), Gaps = 8/91 (8%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLT-RIFEGKQTDGTTNRVVGTYGY 73
           L  LH+++    ++RD K  NILLD   + +ISD GL  +I EG+   G     VGT GY
Sbjct: 115 LEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VGTVGY 167

Query: 74  MSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           M+PE      +++  D +  G ++ E+I G+
Sbjct: 168 MAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 57.0 bits (137), Expect = 9e-10
 Identities = 34/100 (34%), Positives = 54/100 (54%), Gaps = 9/100 (9%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           I+  + + L YLH + K   IHRD K +N+LL      K++DFG+     G+ TD    R
Sbjct: 106 ILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQIKR 158

Query: 67  --VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
              VGT  +M+PE      +  K+D++S G+  +E+  G+
Sbjct: 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 56.7 bits (137), Expect = 9e-10
 Identities = 51/179 (28%), Positives = 74/179 (41%), Gaps = 27/179 (15%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP----KISDFGLTRIFE 56
           M+ L      V++   YL ++     IHRD    N LL  +  P    KI+DFG+ R   
Sbjct: 115 MKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIY 170

Query: 57  GKQTDGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRN--TGFYNSEL 114
                    R +    +M PE  L G F+ K+DV+SFGV++ EI S       G  N E+
Sbjct: 171 RASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV 230

Query: 115 ALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
              + G        G  LD     PG + +         +   C Q  P DRP  + ++
Sbjct: 231 MEFVTG--------GGRLDPPKGCPGPVYR---------IMTDCWQHTPEDRPNFATIL 272

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 56.8 bits (137), Expect = 9e-10
 Identities = 35/106 (33%), Positives = 60/106 (56%), Gaps = 7/106 (6%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L  ++ G++  + YL   S++  +HRD    NIL++  +  K+SDFGL+R  E   +D T
Sbjct: 108 LVGMLRGIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 164

Query: 64  TNRVVG---TYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKR 105
               +G      + +PE      F+  SDV+S+G+V+ E++S G+R
Sbjct: 165 YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 56.5 bits (136), Expect = 1e-09
 Identities = 32/87 (36%), Positives = 48/87 (55%), Gaps = 6/87 (6%)

Query: 19  HQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEY 78
           + +SK +++HRD    NIL+  +   K+SDFGL R+      D +   V  T    +PE 
Sbjct: 115 YLESK-KLVHRDLAARNILVSEDGVAKVSDFGLARV-GSMGVDNSKLPVKWT----APEA 168

Query: 79  ALGGFFSVKSDVFSFGVVVLEIISGKR 105
                FS KSDV+S+GV++ E+ S  R
Sbjct: 169 LKHKKFSSKSDVWSYGVLLWEVFSYGR 195

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 57.0 bits (137), Expect = 1e-09
 Identities = 33/115 (28%), Positives = 63/115 (54%), Gaps = 5/115 (4%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           ++L N  + +++ ++YL +    R++HRD    N+L+    + KI+DFGL R+ EG + +
Sbjct: 109 QLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE 165

Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSEL 114
              +       +M+ E      F+ +SDV+S+GV + E+++  GK   G    E+
Sbjct: 166 YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI 220

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 56.6 bits (136), Expect = 1e-09
 Identities = 32/100 (32%), Positives = 57/100 (57%), Gaps = 5/100 (5%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQTDG 62
             +I+  ++  + +L   S   ++H+D  T N+L+  ++N KISD GL R ++       
Sbjct: 126 FVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKL 182

Query: 63  TTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS 102
             N ++    +MSPE  + G FS+ SD++S+GVV+ E+ S
Sbjct: 183 MGNSLLPIR-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 56.6 bits (137), Expect = 1e-09
 Identities = 33/97 (34%), Positives = 54/97 (55%), Gaps = 9/97 (9%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           ++LG    L YLH++   +I++RD K  N+LLD E   KI+DFGL +  EG      T+ 
Sbjct: 110 VVLG----LQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTST 160

Query: 67  VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
             GT  +++PE      ++   D +  GV++ E++ G
Sbjct: 161 FCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 56.6 bits (136), Expect = 1e-09
 Identities = 51/172 (29%), Positives = 75/172 (43%), Gaps = 30/172 (17%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +  G  + L YLH  +   +IHRD K  NILL      K+ DFG   I          N 
Sbjct: 120 VTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANX 170

Query: 67  VVGTYGYMSPEYALG---GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAW 123
            VGT  +M+PE  L    G +  K DV+S G+  +E+   +R    +N   A+S      
Sbjct: 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMN-AMS------ 221

Query: 124 KLWQEGKALDMMDQKPGAISKANEILKCI-NVGLLCVQEDPNDRPTMSDVVI 174
                  AL  + Q      ++    +   N    C+Q+ P DRPT S+V++
Sbjct: 222 -------ALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPT-SEVLL 265

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 56.7 bits (136), Expect = 1e-09
 Identities = 29/90 (32%), Positives = 54/90 (60%), Gaps = 5/90 (5%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L +LH +   ++IHRD K+ N+LL  + + K++DFG       +Q+  +T  +VGT  +M
Sbjct: 128 LEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWM 182

Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           +PE      +  K D++S G++ +E++ G+
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 56.3 bits (136), Expect = 1e-09
 Identities = 36/102 (35%), Positives = 56/102 (54%), Gaps = 10/102 (9%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L+ I+ G+    L+ H     R++HRD K  N+L+D++   K++DFGL R F G      
Sbjct: 107 LYQILQGI----LFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVY 158

Query: 64  TNRVVGTYGYMSPEYALGG-FFSVKSDVFSFGVVVLEIISGK 104
           T+ VV T  Y +PE  LG   +S   D++S G +  E+ + K
Sbjct: 159 THEVV-TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 56.3 bits (136), Expect = 1e-09
 Identities = 49/159 (30%), Positives = 71/159 (44%), Gaps = 24/159 (15%)

Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVG-----TYGYMSPEYALG 81
           IHRD    N+LL H    KI DFGL R          +N VV         +M+PE    
Sbjct: 163 IHRDLAARNVLLTHGKIVKICDFGLAR-----DIMNDSNYVVKGNARLPVKWMAPESIFN 217

Query: 82  GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGA 141
             ++ +SDV+S+G+++ EI S   N   Y      S     +KL +EG     M Q   A
Sbjct: 218 CVYTFESDVWSYGILLWEIFSLGSNP--YPGMPVDSKF---YKLIKEGY---RMAQPEHA 269

Query: 142 ISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEA 180
            ++  +I+K       C   DP  RPT   +V ++G + 
Sbjct: 270 PAEIYDIMKT------CWDADPLKRPTFKQIVQLIGKQL 302

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 56.3 bits (136), Expect = 1e-09
 Identities = 34/91 (37%), Positives = 53/91 (58%), Gaps = 5/91 (5%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L Y H   K   +HRD K SNILL+++   K++DFGL R++  +++   TN+V+ T  Y 
Sbjct: 129 LNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-TLWYR 184

Query: 75  SPEYALGG-FFSVKSDVFSFGVVVLEIISGK 104
            PE  LG   +    DV+S G ++ E+ + K
Sbjct: 185 PPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 56.4 bits (136), Expect = 2e-09
 Identities = 37/103 (35%), Positives = 56/103 (54%), Gaps = 11/103 (10%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP-KISDFGLTRIFEGKQTDG 62
           L+ I+ G++    Y H     R++HRD K  N+L+D   N  K++DFGL R F G     
Sbjct: 108 LYQILRGIA----YCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRT 159

Query: 63  TTNRVVGTYGYMSPEYALGG-FFSVKSDVFSFGVVVLEIISGK 104
            T+ VV T  Y +PE  LG   +S   D++S G +  E+++ K
Sbjct: 160 FTHEVV-TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 55.9 bits (135), Expect = 2e-09
 Identities = 31/98 (31%), Positives = 53/98 (54%), Gaps = 11/98 (11%)

Query: 9   LGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQT---DGTT 64
           + ++  + YLH   K  +IH+D    N ++D E+  KI+D  L+R +F        D   
Sbjct: 124 IQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDN-E 179

Query: 65  NRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS 102
           NR V    +M+ E  +   +S  SDV+SFGV++ E+++
Sbjct: 180 NRPV---KWMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 56.4 bits (137), Expect = 2e-09
 Identities = 36/104 (34%), Positives = 55/104 (52%), Gaps = 11/104 (10%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L+ I+ G    L YLH  +   +IHRD K SNIL++   + KI DFGL R  +  + +  
Sbjct: 109 LYQILRG----LKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKG 161

Query: 64  --TNRVVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
             T  VV T  Y +PE  L    ++   D++S G +  E+++ K
Sbjct: 162 FLTEYVV-TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 56.2 bits (135), Expect = 2e-09
 Identities = 30/90 (33%), Positives = 53/90 (58%), Gaps = 5/90 (5%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L +LH+     II+RD K  N+LLD + + K++D+G+ +  EG     TT+   GT  Y+
Sbjct: 109 LNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYI 163

Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           +PE   G  +    D ++ GV++ E+++G+
Sbjct: 164 APEILRGEEYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 55.8 bits (134), Expect = 2e-09
 Identities = 41/151 (27%), Positives = 69/151 (45%), Gaps = 19/151 (12%)

Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFF 84
           + +HRD    N ++  +   KI DFG+TR            + +    +MSPE    G F
Sbjct: 139 KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF 198

Query: 85  SVKSDVFSFGVVVLEI--ISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           +  SDV+SFGVV+ EI  ++ +   G  N ++         +   EG  LD  D  P  +
Sbjct: 199 TTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL--------RFVMEGGLLDKPDNCPDML 250

Query: 143 SKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
               E+++      +C Q +P  RP+  +++
Sbjct: 251 F---ELMR------MCWQYNPKMRPSFLEII 272

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 56.1 bits (135), Expect = 2e-09
 Identities = 31/90 (34%), Positives = 51/90 (56%), Gaps = 5/90 (5%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L +LH      II+RD K  N++LD + + KI+DFG+ +  E    D   +   GT  Y+
Sbjct: 109 LQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCK--ENVFGDNRASTFCGTPDYI 163

Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           +PE   G  ++   D +SFGV++ E++ G+
Sbjct: 164 APEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 55.6 bits (134), Expect = 2e-09
 Identities = 52/176 (29%), Positives = 82/176 (46%), Gaps = 35/176 (19%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILL-----DHEMNPKISDFGLTR-IFEG 57
           L +I L V++  +YL Q   +  IHRD    N L+     D +   KI DFGL R I++ 
Sbjct: 108 LLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKS 164

Query: 58  ----KQTDGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNS 112
               K+ +G          +M+PE  L G F+ +SDV+SFGV++ EI++ G++    Y +
Sbjct: 165 DYYRKEGEGLLP-----VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP---YPA 216

Query: 113 ELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPT 168
                +L +       G  L   +  P  I           +   C  +DP++RPT
Sbjct: 217 LNNQEVLQHV----TAGGRLQKPENCPDKIY---------QLMTNCWAQDPSERPT 259

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 56.0 bits (135), Expect = 2e-09
 Identities = 54/183 (29%), Positives = 78/183 (42%), Gaps = 29/183 (15%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQ 59
           +E L +    V+R + +L   +  + IHRD    NILL      KI DFGL R I+  K 
Sbjct: 172 LEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIY--KD 226

Query: 60  TDGTTN---RVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSEL 114
            D       R+     +M+PE      ++ +SDV+SFGV++ EI S       G    E 
Sbjct: 227 PDYVRKGDARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE 284

Query: 115 ALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVI 174
               L       +EG  +   +     I             L C   +P DRPT S++V 
Sbjct: 285 FCRRL-------KEGTRMRAPEYATPEIYSIM---------LDCWHNNPEDRPTFSELVE 328

Query: 175 MLG 177
           +LG
Sbjct: 329 ILG 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 55.9 bits (135), Expect = 2e-09
 Identities = 26/87 (29%), Positives = 46/87 (52%), Gaps = 11/87 (12%)

Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYG-----YMSPEYA 79
           R++HRD    N+L+    + KI+DFGL ++ +  +            G     +M+ E  
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE-----KEYHAEGGKVPIKWMALESI 183

Query: 80  LGGFFSVKSDVFSFGVVVLEIIS-GKR 105
           L   ++ KSDV+S+GV V E+++ G +
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAK 210

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 55.6 bits (134), Expect = 2e-09
 Identities = 43/178 (24%), Positives = 81/178 (45%), Gaps = 23/178 (12%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQT 60
           +ML ++   V   + YL ++S    IHRD    N L+      K+SDFG+TR + + + T
Sbjct: 100 DMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156

Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLL 119
             +  +      +  PE      +S KSDV+SFGV++ E+ + GK      ++   + ++
Sbjct: 157 SSSGAKF--PVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI 214

Query: 120 GYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLG 177
              ++L++   A             +  + +   V   C  E P  RPT ++++  + 
Sbjct: 215 SRGFRLYRPKLA-------------SMTVYE---VMYSCWHEKPEGRPTFAELLRAIT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 55.8 bits (134), Expect = 2e-09
 Identities = 37/106 (34%), Positives = 57/106 (53%), Gaps = 15/106 (14%)

Query: 2   EMLF---NIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGK 58
           EM F    IILG+       H  ++  +++RD K +NILLD   + +ISD GL   F  K
Sbjct: 98  EMRFYATEIILGLE------HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKK 150

Query: 59  QTDGTTNRVVGTYGYMSPE-YALGGFFSVKSDVFSFGVVVLEIISG 103
           +   +    VGT+GYM+PE    G  +   +D FS G ++ +++ G
Sbjct: 151 KPHAS----VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 55.7 bits (135), Expect = 2e-09
 Identities = 37/101 (36%), Positives = 51/101 (50%), Gaps = 14/101 (13%)

Query: 6   NIILGVSRRLL----YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRI--FEGKQ 59
             I  + R+LL    +LH     RI+HRD K  NIL+  +   KI+DFGL RI  FE   
Sbjct: 107 ETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL 163

Query: 60  TDGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEI 100
           T      VV T  Y +PE  L   ++   D++S G +  E+
Sbjct: 164 TS-----VVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 55.5 bits (133), Expect = 2e-09
 Identities = 30/90 (33%), Positives = 54/90 (60%), Gaps = 5/90 (5%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L +LH +   ++IHRD K+ NILL  + + K++DFG       +Q+  +T  +VGT  +M
Sbjct: 128 LDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWM 182

Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           +PE      +  K D++S G++ +E++ G+
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 55.7 bits (134), Expect = 3e-09
 Identities = 33/93 (35%), Positives = 51/93 (54%), Gaps = 5/93 (5%)

Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGT 70
           V+  + YLH    L II+RD K  NILLD + +  ++DFGL +  EG + + TT+   GT
Sbjct: 105 VASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGT 159

Query: 71  YGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
             Y++PE      +    D +  G V+ E++ G
Sbjct: 160 PEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 55.5 bits (134), Expect = 3e-09
 Identities = 45/163 (27%), Positives = 81/163 (49%), Gaps = 24/163 (14%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L +LH     ++IHRD K  NILL  + + K++DFG++   + K T    +  +GT  +M
Sbjct: 116 LNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSA--KNKSTLQKRDTFIGTPYWM 170

Query: 75  SPEYALGGFFS-----VKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEG 129
           +PE      F       K+D++S G+ ++E+   +      + E  L+ +    K+  + 
Sbjct: 171 APEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP----HHE--LNPMRVLLKI-LKS 223

Query: 130 KALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
           +    +DQ     S  N+ LK       C+ +DP+DRPT +++
Sbjct: 224 EP-PTLDQPSKWSSSFNDFLK------SCLVKDPDDRPTAAEL 259

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 55.3 bits (133), Expect = 3e-09
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 3/101 (2%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
             L ++ L ++  + YL   S L  +HRD  T N L+   +  KI+DFG++R        
Sbjct: 138 SSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYY 194

Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS 102
               R V    +M+ E  L G F+  SDV++FGV + EI+ 
Sbjct: 195 RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 55.6 bits (134), Expect = 3e-09
 Identities = 47/163 (28%), Positives = 70/163 (42%), Gaps = 40/163 (24%)

Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYG-----YMSPEYALG 81
           IHRD    N+LL      KI DFGL R          +N VV         +M+PE    
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMND-----SNYVVKGNARLPVKWMAPESIFD 288

Query: 82  GFFSVKSDVFSFGVVVLEIIS-GKR-------NTGFYNSELALSLLGYAWKLWQEGKALD 133
             ++V+SDV+S+G+++ EI S GK        N+ FY             K+ + G  + 
Sbjct: 289 CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFY-------------KMVKRGYQMS 335

Query: 134 MMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
             D  P  I     I+K      +C   +P +RPT S +  ++
Sbjct: 336 RPDFAPPEIYS---IMK------MCWNLEPTERPTFSQISQLI 369

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 55.0 bits (132), Expect = 3e-09
 Identities = 32/90 (35%), Positives = 48/90 (53%), Gaps = 2/90 (2%)

Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFFSV 86
           +H+D    NIL+  +++ KISD GL+R            + +    +M PE  + G FS 
Sbjct: 146 VHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSS 205

Query: 87  KSDVFSFGVVVLEIISG--KRNTGFYNSEL 114
            SD++SFGVV+ EI S   +   GF N E+
Sbjct: 206 DSDIWSFGVVLWEIFSFGLQPYYGFSNQEV 235

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 55.0 bits (132), Expect = 4e-09
 Identities = 36/105 (34%), Positives = 57/105 (54%), Gaps = 9/105 (8%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           E +  + L V R L YLH      +IHRD K+ +ILL  +   K+SDFG    F  + + 
Sbjct: 118 EQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFG----FCAQVSK 170

Query: 62  GTTNR--VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
               R  +VGT  +M+PE      +  + D++S G++V+E+I G+
Sbjct: 171 EVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 55.0 bits (133), Expect = 4e-09
 Identities = 34/105 (32%), Positives = 53/105 (50%), Gaps = 13/105 (12%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP----KISDFGLTRIFEGK- 58
           L+ I+ GV     YLH +    ++HRD K +NIL+  E       KI D GL R+F    
Sbjct: 114 LWQILNGVH----YLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL 166

Query: 59  QTDGTTNRVVGTYGYMSPEYALGGFFSVKS-DVFSFGVVVLEIIS 102
           +     + VV T  Y +PE  LG     K+ D+++ G +  E+++
Sbjct: 167 KPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 55.0 bits (132), Expect = 4e-09
 Identities = 52/186 (27%), Positives = 81/186 (43%), Gaps = 41/186 (22%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           + L +    V+R + YL Q    + IHRD    NIL+      KI+DFGL+R        
Sbjct: 124 QQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-------- 172

Query: 62  GTTNRVVGTYG-----YMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSEL 114
           G    V  T G     +M+ E      ++  SDV+S+GV++ EI+S  G    G   +EL
Sbjct: 173 GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 232

Query: 115 ALSL-LGYAWK--LWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSD 171
              L  GY  +  L  + +  D+M Q                    C +E P +RP+ + 
Sbjct: 233 YEKLPQGYRLEKPLNCDDEVYDLMRQ--------------------CWREKPYERPSFAQ 272

Query: 172 VVIMLG 177
           +++ L 
Sbjct: 273 ILVSLN 278

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 54.8 bits (132), Expect = 4e-09
 Identities = 47/165 (28%), Positives = 68/165 (41%), Gaps = 27/165 (16%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           I  G  + L YLH       IHRD K  NILL      K++DFG   +          N 
Sbjct: 120 ICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVS------PANS 170

Query: 67  VVGTYGYMSPEYALG---GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAW 123
            VGT  +M+PE  L    G +  K DV+S G+  +E+   +R    +N   A+S L +  
Sbjct: 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMN-AMSALYH-- 225

Query: 124 KLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPT 168
                     +       +S  +      N    C+Q+ P DRP+
Sbjct: 226 ----------IAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPS 260

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 54.8 bits (132), Expect = 5e-09
 Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 19/158 (12%)

Query: 22  SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG 81
           S  R +HRD    N L+  +   K+S   L++     +     N ++    +++PE    
Sbjct: 134 SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLAPEAVQE 192

Query: 82  GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKA-LDMMDQKP 139
             FS KSDV+SFGV++ E+ + G+      + E  L+ L       Q GK  L + +  P
Sbjct: 193 DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL-------QAGKLELPVPEGCP 245

Query: 140 GAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLG 177
             + K   + +C  V        P DRP+ S++V  LG
Sbjct: 246 SRLYKL--MTRCWAVN-------PKDRPSFSELVSALG 274

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 54.7 bits (132), Expect = 5e-09
 Identities = 31/89 (34%), Positives = 47/89 (52%), Gaps = 9/89 (10%)

Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGK--QTDGTTNRVVGTYGY 73
           YL     L  +HRD  T N L+      KI+DFG++R ++     +  G   R      +
Sbjct: 145 YL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQG---RAPLPIRW 198

Query: 74  MSPEYALGGFFSVKSDVFSFGVVVLEIIS 102
           M+ E  L G F+ KSDV++FGV + EI++
Sbjct: 199 MAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 54.7 bits (131), Expect = 5e-09
 Identities = 30/90 (33%), Positives = 53/90 (58%), Gaps = 5/90 (5%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L +LH +   ++IHRD K+ NILL  + + K++DFG       +Q+    + +VGT  +M
Sbjct: 129 LEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWM 183

Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           +PE      +  K D++S G++ +E+I G+
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 54.6 bits (131), Expect = 5e-09
 Identities = 34/99 (34%), Positives = 54/99 (54%), Gaps = 6/99 (6%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH  S+  +++RD K  N++LD + + KI+DFGL +  EG +   T     GT  Y+
Sbjct: 108 LDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYL 163

Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSE 113
           +PE      +    D +  GVV+ E++ G+    FYN +
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 200

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 54.4 bits (131), Expect = 6e-09
 Identities = 44/182 (24%), Positives = 79/182 (43%), Gaps = 30/182 (16%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEG-- 57
           ++ L   ++ ++  + YL   S    IHRD    N +L  +M   ++DFGL++ I+ G  
Sbjct: 112 LQTLLKFMVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDY 168

Query: 58  -KQTDGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRN--TGFYNSEL 114
            +Q       V     +++ E      ++ KSDV++FGV + EI +  +    G  N E+
Sbjct: 169 YRQGRIAKMPV----KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI 224

Query: 115 ALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVI 174
              L          G  L    Q    + +  +++        C + DP DRPT + +  
Sbjct: 225 YDYLRH--------GNRL---KQPEDCLDELYDLM------YSCWRADPKDRPTFTKLRE 267

Query: 175 ML 176
           +L
Sbjct: 268 VL 269

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 54.3 bits (130), Expect = 6e-09
 Identities = 47/182 (25%), Positives = 80/182 (43%), Gaps = 42/182 (23%)

Query: 12  SRRLLYLHQD--------SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           S++LL+   D        S+ + IHRD    NIL+      KI+DFGL+R        G 
Sbjct: 111 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--------GQ 162

Query: 64  TNRVVGTYG-----YMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELAL 116
              V  T G     +M+ E      ++  SDV+S+GV++ EI+S  G    G   +EL  
Sbjct: 163 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 222

Query: 117 SL-LGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIM 175
            L  GY             +++      +  ++++       C +E P +RP+ + +++ 
Sbjct: 223 KLPQGY------------RLEKPLNCDDEVYDLMR------QCWREKPYERPSFAQILVS 264

Query: 176 LG 177
           L 
Sbjct: 265 LN 266

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 54.5 bits (132), Expect = 6e-09
 Identities = 29/87 (33%), Positives = 49/87 (56%), Gaps = 8/87 (9%)

Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L I++RD K  N+LLD +   KI+DFG  +  +G+     T  + GT  Y++P
Sbjct: 116 YLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAP 167

Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   +    D ++ G+++ E+++G
Sbjct: 168 EIILSKGYGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 54.1 bits (130), Expect = 6e-09
 Identities = 46/165 (27%), Positives = 77/165 (46%), Gaps = 28/165 (16%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLD-HEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGY 73
           L YLH     +I+HRD K  N+L++ +    KISDFG ++   G   +  T    GT  Y
Sbjct: 121 LKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTETFTGTLQY 175

Query: 74  MSPEYALGGF--FSVKSDVFSFGVVVLEIISGKRNTGFY---NSELALSLLGYAWKLWQE 128
           M+PE    G   +   +D++S G  ++E+ +GK    F      + A+  +G  +K+  E
Sbjct: 176 MAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK--PPFIELGEPQAAMFKVGM-FKIHPE 232

Query: 129 GKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
                     P ++S      +  N  L C + DP+ R +  D++
Sbjct: 233 ---------IPESLS-----AEAKNFILRCFEPDPDKRASAHDLL 263

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 54.3 bits (130), Expect = 7e-09
 Identities = 44/172 (25%), Positives = 79/172 (45%), Gaps = 22/172 (12%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L N  + +++ + YL +   +R++HRD    N+L+    + KI+DFGL R+ +  +T+  
Sbjct: 111 LLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYH 167

Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLGY 121
            +       +M+ E  L   F+ +SDV+S+GV V E+++   K   G    E+       
Sbjct: 168 ADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP------ 221

Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
              L ++G+ L    Q P        I+      + C   D   RP   ++V
Sbjct: 222 --DLLEKGERL---PQPPICTIDVYMIM------VKCWMIDSECRPRFRELV 262

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 54.0 bits (130), Expect = 8e-09
 Identities = 30/81 (37%), Positives = 49/81 (60%), Gaps = 3/81 (3%)

Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG-F 83
           R++HRD K  N+L++     K++DFGL R F G   +  +N VV T  Y +P+  LG   
Sbjct: 120 RVLHRDLKPQNLLINKRGELKLADFGLARAF-GIPVNTFSNEVV-TLWYRAPDVLLGSRT 177

Query: 84  FSVKSDVFSFGVVVLEIISGK 104
           +S   D++S G ++ E+I+G+
Sbjct: 178 YSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 54.3 bits (130), Expect = 8e-09
 Identities = 34/106 (32%), Positives = 55/106 (51%), Gaps = 11/106 (10%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           E +  + L V + L  LH      +IHRD K+ +ILL H+   K+SDFG        Q  
Sbjct: 116 EQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFC-----AQVS 167

Query: 62  GTTNR---VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
               R   +VGT  +M+PE      +  + D++S G++V+E++ G+
Sbjct: 168 KEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 54.5 bits (131), Expect = 8e-09
 Identities = 48/163 (29%), Positives = 72/163 (44%), Gaps = 40/163 (24%)

Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYG-----YMSPEYALG 81
           IHRD    NILL H    KI DFGL R     + D  +N VV         +M+PE    
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDI---RND--SNYVVKGNARLPVKWMAPESIFN 290

Query: 82  GFFSVKSDVFSFGVVVLEIIS-GKR-------NTGFYNSELALSLLGYAWKLWQEGKALD 133
             ++ +SDV+S+G+++ EI S G         ++ FY             K+ +EG  + 
Sbjct: 291 CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFY-------------KMIKEGYRML 337

Query: 134 MMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
             +  P   S+  +I+K       C   DP  RPT   +V ++
Sbjct: 338 SPECAP---SEMYDIMKS------CWDADPLKRPTFKQIVQLI 371

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 54.3 bits (130), Expect = 9e-09
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 125 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 176

Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 177 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 53.9 bits (130), Expect = 1e-08
 Identities = 31/86 (36%), Positives = 44/86 (51%), Gaps = 8/86 (9%)

Query: 18  LHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPE 77
           LH+   L  IHRD K  N L+D   + K++DFGL+     K      N VVG+  YM+PE
Sbjct: 117 LHE---LGYIHRDLKPENFLIDASGHIKLTDFGLS-----KGIVTYANSVVGSPDYMAPE 168

Query: 78  YALGGFFSVKSDVFSFGVVVLEIISG 103
              G  +    D +S G ++ E + G
Sbjct: 169 VLRGKGYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 53.9 bits (129), Expect = 1e-08
 Identities = 49/172 (28%), Positives = 74/172 (43%), Gaps = 31/172 (18%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           I  G  + L YLH  +    IHRD K  NILL      K++DFG              N 
Sbjct: 126 ITHGALQGLAYLHSHNM---IHRDIKAGNILLTEPGQVKLADFGSASK------SSPANS 176

Query: 67  VVGTYGYMSPEYALG---GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAW 123
            VGT  +M+PE  L    G +  K DV+S G+  +E+   +R    +N   A+S      
Sbjct: 177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMN-AMS------ 227

Query: 124 KLWQEGKALDMMDQKPGAISKANEILKCINVGLL--CVQEDPNDRPTMSDVV 173
                  AL  + Q      ++NE       G +  C+Q+ P +RP  ++++
Sbjct: 228 -------ALYHIAQNDSPTLQSNEWTDSFR-GFVDYCLQKIPQERPASAELL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 53.7 bits (129), Expect = 1e-08
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 7/99 (7%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH      +++RD K  N++LD + + KI+DFGL +  EG     T     GT  Y+
Sbjct: 108 LGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYL 162

Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSE 113
           +PE      +    D +  GVV+ E++ G+    FYN +
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 199

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 53.9 bits (129), Expect = 1e-08
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 7/99 (7%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH      +++RD K  N++LD + + KI+DFGL +  EG     T     GT  Y+
Sbjct: 108 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYL 162

Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSE 113
           +PE      +    D +  GVV+ E++ G+    FYN +
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 199

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 53.9 bits (129), Expect = 1e-08
 Identities = 52/166 (31%), Positives = 78/166 (46%), Gaps = 24/166 (14%)

Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQTDGTTNRVVG 69
           V+R + YL   +  + IHRD    N+L+  +   KI+DFGL R I        TTN  + 
Sbjct: 149 VARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 205

Query: 70  TYGYMSPEYALGGFFSVKSDVFSFGVVVLEI--ISGKRNTGFYNSELALSLLGYAWKLWQ 127
              +M+PE      ++ +SDV+SFGV++ EI  + G    G    EL        +KL +
Sbjct: 206 V-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL--------FKLLK 256

Query: 128 EGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
           EG  +D    KP   +  NE+   +     C    P+ RPT   +V
Sbjct: 257 EGHRMD----KPSNCT--NELYMMMRD---CWHAVPSQRPTFKQLV 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 53.5 bits (128), Expect = 1e-08
 Identities = 45/168 (26%), Positives = 74/168 (44%), Gaps = 34/168 (20%)

Query: 18  LHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYG----- 72
           +   S+ + IHRD    N+L+   +  KI+DFGL+R        G    V  T G     
Sbjct: 132 MQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR--------GEEVYVKKTMGRLPVR 183

Query: 73  YMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSL-LGYAWKLWQEG 129
           +M+ E      ++ KSDV+SFGV++ EI+S  G    G   +EL   L  GY        
Sbjct: 184 WMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-------- 235

Query: 130 KALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLG 177
                M++      +  E+++       C ++ P +RP  + + + L 
Sbjct: 236 ----RMEKPRNCDDEVYELMR------QCWRDRPYERPPFAQISVQLS 273

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 53.5 bits (128), Expect = 1e-08
 Identities = 32/95 (33%), Positives = 54/95 (56%), Gaps = 7/95 (7%)

Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRV-VG 69
           +S  L +LH+     II+RD K  N++LD E + KI+DFG+ +       DG T R   G
Sbjct: 110 ISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCG 163

Query: 70  TYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           T  Y++PE      +    D +++GV++ E+++G+
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 53.4 bits (128), Expect = 1e-08
 Identities = 27/81 (33%), Positives = 42/81 (51%)

Query: 22  SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG 81
           + L  +HRD  T N L+ +    KI+DFG++R            R V    +M+ E  L 
Sbjct: 146 ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL 205

Query: 82  GFFSVKSDVFSFGVVVLEIIS 102
           G F+  SDV++FGV + E+ +
Sbjct: 206 GKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 53.2 bits (127), Expect = 1e-08
 Identities = 32/98 (32%), Positives = 51/98 (52%), Gaps = 10/98 (10%)

Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGT 70
           + R L +LHQ    ++IHRD K  N+LL      K+ DFG++   +  +T G  N  +GT
Sbjct: 120 ILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD--RTVGRRNTFIGT 174

Query: 71  YGYMSPEYAL-----GGFFSVKSDVFSFGVVVLEIISG 103
             +M+PE           +  KSD++S G+  +E+  G
Sbjct: 175 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 53.5 bits (128), Expect = 2e-08
 Identities = 53/181 (29%), Positives = 79/181 (43%), Gaps = 25/181 (13%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQ 59
           ME L      V+R + +L   +  + IHRD    NILL      KI DFGL R I++   
Sbjct: 173 MEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD 229

Query: 60  TDGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGF-YNSELAL 116
                +  +    +M+PE      ++ +SDV+SFGV++ EI S       G   N E   
Sbjct: 230 YVRKGSARL-PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQ 288

Query: 117 SLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
            L        ++G  +   +     I +         + L C Q DP +RPT S +V +L
Sbjct: 289 RL--------KDGTRMRAPENATPEIYR---------IMLACWQGDPKERPTFSALVEIL 331

Query: 177 G 177
           G
Sbjct: 332 G 332

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 53.1 bits (127), Expect = 2e-08
 Identities = 32/103 (31%), Positives = 52/103 (50%), Gaps = 6/103 (5%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           E + +++  + R L +LH     R++HRD K  NIL+      K++DFGL RI+  +   
Sbjct: 110 ETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM-- 164

Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
                VV T  Y +PE  L   ++   D++S G +  E+   K
Sbjct: 165 -ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 53.4 bits (128), Expect = 2e-08
 Identities = 33/90 (36%), Positives = 54/90 (60%), Gaps = 2/90 (2%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           +L L    KL I++RD K  NILLD E +  ++DFGL++ F  ++ + T +   GT  YM
Sbjct: 115 ILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIEYM 173

Query: 75  SPEYALGGFFSVKS-DVFSFGVVVLEIISG 103
           +PE   G     K+ D +S G+++ E+++G
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 53.2 bits (127), Expect = 2e-08
 Identities = 52/171 (30%), Positives = 75/171 (43%), Gaps = 29/171 (16%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           I  G  + L YLH  +   +IHRD K  NILL      K++DFG   I          N 
Sbjct: 130 ITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIAS------PANS 180

Query: 67  VVGTYGYMSPEYALG---GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAW 123
            VGT  +M+PE  L    G +  K DV+S G+  +E+   +R    +N   A+S      
Sbjct: 181 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMN-AMS------ 231

Query: 124 KLWQEGKALDMMDQKPGAISKANEILKCI-NVGLLCVQEDPNDRPTMSDVV 173
                  AL  + Q      ++NE      N    C+Q+ P DRPT  +++
Sbjct: 232 -------ALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELL 275

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 53.2 bits (127), Expect = 2e-08
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 7/99 (7%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH     +I++RD K  N++LD + + KI+DFGL +  EG     T     GT  Y+
Sbjct: 108 LDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYL 162

Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSE 113
           +PE      +    D +  GVV+ E++ G+    FYN +
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 199

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 53.1 bits (127), Expect = 2e-08
 Identities = 32/91 (35%), Positives = 50/91 (54%), Gaps = 3/91 (3%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           +L L    KL II+RD K  NILLD   +  ++DFGL++ F   + +   +   GT  YM
Sbjct: 115 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCGTIEYM 173

Query: 75  SPEYALGG--FFSVKSDVFSFGVVVLEIISG 103
           +P+   GG        D +S GV++ E+++G
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 52.9 bits (127), Expect = 2e-08
 Identities = 42/148 (28%), Positives = 71/148 (47%), Gaps = 20/148 (13%)

Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTY--GYMSPEYALGGFF 84
           IHRD    N L+      K++DFGL+R+  G   D  T      +   + +PE      F
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNKF 182

Query: 85  SVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISK 144
           S+KSDV++FGV++ EI +      +  S      L   ++L ++G     M++  G   K
Sbjct: 183 SIKSDVWAFGVLLWEIAT------YGMSPYPGIDLSQVYELLEKGY---RMERPEGCPPK 233

Query: 145 ANEILKCINVGLLCVQEDPNDRPTMSDV 172
             E++        C Q +P+DRP+ +++
Sbjct: 234 VYELM------RACWQWNPSDRPSFAEI 255

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 53.1 bits (127), Expect = 2e-08
 Identities = 33/105 (31%), Positives = 56/105 (53%), Gaps = 9/105 (8%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           E +  +   V + L YLH      +IHRD K+ +ILL  +   K+SDFG    F  + + 
Sbjct: 117 EQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFG----FCAQISK 169

Query: 62  GTTNR--VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
               R  +VGT  +M+PE      +  + D++S G++V+E++ G+
Sbjct: 170 DVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGE 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 53.1 bits (128), Expect = 2e-08
 Identities = 35/95 (36%), Positives = 51/95 (53%), Gaps = 7/95 (7%)

Query: 13  RRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIF--EGKQTDGTTNRVVGT 70
           R L Y+H  +   ++HRD K SN+LL+   + KI DFGL RI   E   T G     V T
Sbjct: 117 RGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHT-GFLTEYVAT 172

Query: 71  YGYMSPEYALGGFFSVKS-DVFSFGVVVLEIISGK 104
             Y +PE  L      K+ D++S G ++ E++S +
Sbjct: 173 RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 53.1 bits (127), Expect = 2e-08
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 9/92 (9%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR--IFEGKQTDGTTNRVVGTYG 72
           L +LH      II+RD K  N++LD E + KI+DFG+ +  +++G     TT    GT  
Sbjct: 114 LFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV----TTKTFCGTPD 166

Query: 73  YMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           Y++PE      +    D ++FGV++ E+++G+
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 52.2 bits (125), Expect = 3e-08
 Identities = 48/177 (27%), Positives = 75/177 (42%), Gaps = 27/177 (15%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
              L  +   V   + YL  +SK + IHRD    N L+D +   K+SDFGL+R       
Sbjct: 99  PSQLLEMCKDVCEGMAYL--ESK-QFIHRDLAARNCLVDDQGCVKVSDFGLSRYV----L 151

Query: 61  DGTTNRVVGT---YGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELAL 116
           D      VG+     +  PE  L   FS KSDV++FGV++ E+ S GK     +N+   +
Sbjct: 152 DDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETV 211

Query: 117 SLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
             +    +L++   A +                K   +   C  E   +RPT   ++
Sbjct: 212 EKVSQGLRLYRPHLASE----------------KVYAIMYSCWHEKAEERPTFQQLL 252

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 52.7 bits (126), Expect = 3e-08
 Identities = 35/103 (33%), Positives = 54/103 (52%), Gaps = 10/103 (9%)

Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGT 70
           ++  L YLH    L I++RD K  NILLD + +  ++DFGL +  E  + +GTT+   GT
Sbjct: 105 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGT 159

Query: 71  YGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG-----KRNTG 108
             Y++PE      +    D +  G V+ E++ G      RNT 
Sbjct: 160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA 202

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 52.5 bits (126), Expect = 3e-08
 Identities = 45/152 (29%), Positives = 72/152 (47%), Gaps = 25/152 (16%)

Query: 18  LHQDSKLRIIHRDFKTSNILLDHEMNPKISDFG-LTRIFEGKQTDGT--TNRVVGTYGYM 74
           +HQ   L  +HRD K  N+LLD   + +++DFG   R+      DGT  +N  VGT  Y+
Sbjct: 118 VHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRL----LADGTVQSNVAVGTPDYI 170

Query: 75  SPEY--ALG---GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEG 129
           SPE   A+    G +  + D +S GV + E++ G+  T FY    A SL+    K+    
Sbjct: 171 SPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE--TPFY----AESLVETYGKIMNHK 224

Query: 130 KALDMMDQKPGAISKANEILKCINVGLLCVQE 161
           +             +A ++++     L+C  E
Sbjct: 225 EHFQFPPDVTDVSEEAKDLIR----RLICSPE 252

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 52.2 bits (125), Expect = 3e-08
 Identities = 30/81 (37%), Positives = 42/81 (51%)

Query: 22  SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG 81
           S L  +HRD  T N L+      KI+DFG++R            R V    +MS E  L 
Sbjct: 147 SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL 206

Query: 82  GFFSVKSDVFSFGVVVLEIIS 102
           G F+  SDV++FGV + EI++
Sbjct: 207 GKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 52.3 bits (126), Expect = 3e-08
 Identities = 29/88 (32%), Positives = 41/88 (46%), Gaps = 5/88 (5%)

Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           Y H      IIHRD K  NIL+      K+ DFG  R    +     T+ V  T  Y +P
Sbjct: 115 YCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAP 170

Query: 77  EYALGGFFSVKS-DVFSFGVVVLEIISG 103
           E  +G     K  DV++ G ++ E++ G
Sbjct: 171 ELLVGDTNYGKPVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 52.4 bits (125), Expect = 4e-08
 Identities = 33/99 (33%), Positives = 50/99 (50%), Gaps = 9/99 (9%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   +I DFGL R     Q D     
Sbjct: 123 LIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTG 174

Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E++ GK
Sbjct: 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 51.8 bits (124), Expect = 4e-08
 Identities = 27/80 (33%), Positives = 44/80 (55%), Gaps = 2/80 (2%)

Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFF 84
           +I+HRD K+ NI L  +   K+ DFG+ R+         T   +GT  Y+SPE      +
Sbjct: 121 KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART--CIGTPYYLSPEICENRPY 178

Query: 85  SVKSDVFSFGVVVLEIISGK 104
           + KSD+++ G V+ E+ + K
Sbjct: 179 NNKSDIWALGCVLYEMCTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 52.3 bits (126), Expect = 4e-08
 Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 9/93 (9%)

Query: 13  RRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYG 72
           R L Y+H      IIHRD K SNI ++ +   KI DFGL R  + + T       V T  
Sbjct: 129 RGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTG-----YVATRW 180

Query: 73  YMSPEYALG-GFFSVKSDVFSFGVVVLEIISGK 104
           Y +PE  L    ++   D++S G ++ E+++GK
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 52.2 bits (125), Expect = 4e-08
 Identities = 30/108 (27%), Positives = 48/108 (44%), Gaps = 18/108 (16%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRI------ 54
           ++    I   +   L YLH     RIIHRD KT NI ++      I D G  +       
Sbjct: 156 IDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA 212

Query: 55  FEGKQTDGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS 102
           F G         + GT    +PE      ++ K+D++S G+V+ E+++
Sbjct: 213 FLG---------LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 52.3 bits (125), Expect = 4e-08
 Identities = 48/166 (28%), Positives = 78/166 (46%), Gaps = 24/166 (14%)

Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQTDGTTNRVVG 69
           V+R + YL  +S+ R IHRD    N+L+  +   KI+DFGL R + +      T+N  + 
Sbjct: 143 VARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLP 199

Query: 70  TYGYMSPEYALGGFFSVKSDVFSFGVVVLEI--ISGKRNTGFYNSELALSLLGYAWKLWQ 127
              +M+PE      ++ +SDV+SFG+++ EI  + G    G    EL        +KL +
Sbjct: 200 V-KWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL--------FKLLR 250

Query: 128 EGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
           EG     MD+      +   +++       C    P  RPT   +V
Sbjct: 251 EGH---RMDKPSNCTHELYMLMR------ECWHAVPTQRPTFKQLV 287

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 51.9 bits (124), Expect = 5e-08
 Identities = 31/92 (33%), Positives = 46/92 (50%), Gaps = 6/92 (6%)

Query: 13  RRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYG 72
           R L +LH +    I+HRD K  NIL+      K++DFGL RI+  +        VV T  
Sbjct: 119 RGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQM---ALTPVVVTLW 172

Query: 73  YMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           Y +PE  L   ++   D++S G +  E+   K
Sbjct: 173 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 51.5 bits (124), Expect = 5e-08
 Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 16/92 (17%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFG----LTRIFEGKQTDGTTNRVVGT 70
           L YLH+  K   IHRD K +NILL  + + K++DFG    LT     +++       +GT
Sbjct: 114 LAYLHETGK---IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS------FIGT 164

Query: 71  YGYMSPEYA---LGGFFSVKSDVFSFGVVVLE 99
             +M+PE A     G +  K D+++ G+  +E
Sbjct: 165 PYWMAPEVAAVERKGGYDGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 51.8 bits (124), Expect = 5e-08
 Identities = 30/87 (34%), Positives = 43/87 (49%), Gaps = 4/87 (4%)

Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQTDGTTNRVVGTYGYMS 75
           YLH       IHRD    N+LLD++   KI DFGL + + EG +             + +
Sbjct: 122 YLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 178

Query: 76  PEYALGGFFSVKSDVFSFGVVVLEIIS 102
            E      FS  SDV+SFGV + E+++
Sbjct: 179 VECLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 51.9 bits (124), Expect = 5e-08
 Identities = 51/166 (30%), Positives = 77/166 (46%), Gaps = 24/166 (14%)

Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQTDGTTNRVVG 69
           V+R + YL   +  + IHRD    N+L+  +   KI+DFGL R +        TTN  + 
Sbjct: 143 VARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLP 199

Query: 70  TYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLGYAWKLWQ 127
              +M+PE      ++ +SDV+SFGV++ EI +  G    G    EL        +KL +
Sbjct: 200 V-KWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL--------FKLLK 250

Query: 128 EGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
           EG  +D    KP     AN   +   +   C    P+ RPT   +V
Sbjct: 251 EGHRMD----KP-----ANCTHELYMIMRECWHAVPSQRPTFKQLV 287

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 51.9 bits (124), Expect = 5e-08
 Identities = 32/93 (34%), Positives = 48/93 (51%), Gaps = 9/93 (9%)

Query: 13  RRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYG 72
           + L Y+H      IIHRD K  N+ ++ +   KI DFGL R     QTD      V T  
Sbjct: 129 KGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRW 180

Query: 73  YMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
           Y +PE  L    ++   D++S G ++ E+++GK
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 51.6 bits (123), Expect = 6e-08
 Identities = 49/165 (29%), Positives = 73/165 (44%), Gaps = 22/165 (13%)

Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGT 70
           V+R + YL   +  + IHRD    N+L+      KI+DFGL R          T      
Sbjct: 146 VARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLP 202

Query: 71  YGYMSPEYALGGFFSVKSDVFSFGVVVLEI--ISGKRNTGFYNSELALSLLGYAWKLWQE 128
             +M+PE      ++ +SDV+SFGV++ EI  + G    G    EL        +KL +E
Sbjct: 203 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL--------FKLLKE 254

Query: 129 GKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
           G  +D    KP   +  NE+   +     C    P+ RPT   +V
Sbjct: 255 GHRMD----KPANCT--NELYMMMRD---CWHAIPSHRPTFKQLV 290

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 51.7 bits (124), Expect = 6e-08
 Identities = 31/89 (34%), Positives = 48/89 (53%), Gaps = 5/89 (5%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L +LHQ     II+RD K  NILLD + + K++DFGL +  E       T+   GT  YM
Sbjct: 113 LEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFCGTIEYM 167

Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           +PE  +        D +S G ++ ++++G
Sbjct: 168 APEILMRSGHGKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 51.1 bits (122), Expect = 8e-08
 Identities = 42/180 (23%), Positives = 78/180 (43%), Gaps = 26/180 (14%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGK- 58
           ++ L   ++ ++  + YL   S    IHRD    N +L+  M   ++DFGL++ I+ G  
Sbjct: 112 LQTLVRFMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDY 168

Query: 59  QTDGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRN--TGFYNSELAL 116
              G  +++     +++ E      ++  SDV++FGV + EI++  +    G  NSE+  
Sbjct: 169 YRQGCASKL--PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYN 226

Query: 117 SLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
            L+         G  L    Q P  +    E++        C   +P  RP+   +   L
Sbjct: 227 YLIK--------GNRL---KQPPDCLEDVYELM------CQCWSPEPKCRPSFQHLRDQL 269

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 50.8 bits (121), Expect = 9e-08
 Identities = 44/175 (25%), Positives = 77/175 (44%), Gaps = 26/175 (14%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLT-RIFEGK-Q 59
           +ML   +  ++  + YL   S    IHRD    N +L+  MN  ++DFGL+ +I+ G   
Sbjct: 112 QMLVKFMTDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYY 168

Query: 60  TDGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRN--TGFYNSELALS 117
             G   ++     +++ E      ++ KSDV+SFGV + EI +  +    G  NSE+   
Sbjct: 169 RQGRIAKM--PVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI--- 223

Query: 118 LLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
                +   ++G  L    Q P  +     ++        C   +P DRP+   +
Sbjct: 224 -----YDYLRQGNRL---KQPPDCLDGLYSLMSS------CWLLNPKDRPSFETL 264

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 51.2 bits (122), Expect = 9e-08
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 10/101 (9%)

Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L+ ++ G+     +LH      IIHRD K SNI++  +   KI DFGL R      T+ 
Sbjct: 128 LLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART---ACTNF 177

Query: 63  TTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
                V T  Y +PE  LG  +    D++S G ++ E++ G
Sbjct: 178 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 50.9 bits (122), Expect = 1e-07
 Identities = 35/96 (36%), Positives = 49/96 (51%), Gaps = 8/96 (8%)

Query: 13  RRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRI-FEGKQTDGTTNRVVGTY 71
           R L Y+H  +   + HRD K  NIL + +   KI DFGL R+ F    T       V T 
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 72  GYMSPEYALGGFFSVKS---DVFSFGVVVLEIISGK 104
            Y +PE   G FFS  +   D++S G +  E+++GK
Sbjct: 171 WYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 51.0 bits (122), Expect = 1e-07
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 10/88 (11%)

Query: 23  KLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG 82
           +  IIHRD K +N+L++     K+ DFG++    G          +G   YM+PE    G
Sbjct: 121 EHNIIHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTNIGCQSYMAPERIKSG 176

Query: 83  ------FFSVKSDVFSFGVVVLEIISGK 104
                  ++V+SDV+S G+ +LE+  G+
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 51.1 bits (122), Expect = 1e-07
 Identities = 33/90 (36%), Positives = 48/90 (53%), Gaps = 6/90 (6%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L +LH   K  I++RD K  NILLD   +  + DFGL++       + TTN   GT  Y+
Sbjct: 109 LEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYL 163

Query: 75  SPEYALG-GFFSVKSDVFSFGVVVLEIISG 103
           +PE  L    ++   D +S GV+V E+  G
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 50.7 bits (122), Expect = 1e-07
 Identities = 33/93 (35%), Positives = 50/93 (53%), Gaps = 6/93 (6%)

Query: 13  RRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYG 72
           R L YLH +    I+HRD K +N+L+  +   K++DFGL R F G      T++VV T  
Sbjct: 113 RGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSF-GSPNRKMTHQVV-TRW 167

Query: 73  YMSPEYALGG-FFSVKSDVFSFGVVVLEIISGK 104
           Y +PE   G   + V  D++S G +  E++   
Sbjct: 168 YRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 51.2 bits (122), Expect = 1e-07
 Identities = 38/106 (35%), Positives = 54/106 (50%), Gaps = 18/106 (16%)

Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L+ ++ G+     +LH      IIHRD K SNI++  +   KI DFGL R      T G
Sbjct: 131 LLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAG 177

Query: 63  T----TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           T    T  VV  Y Y +PE  LG  +    D++S G ++ E+I G 
Sbjct: 178 TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 50.5 bits (121), Expect = 1e-07
 Identities = 44/171 (25%), Positives = 74/171 (43%), Gaps = 23/171 (13%)

Query: 8   ILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRV 67
              +S  L YL   SK R +HRD    N+L+      K+ DFGL+R  E  ++    ++ 
Sbjct: 113 SYQLSTALAYLE--SK-RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKG 168

Query: 68  VGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRN-TGFYNSELALSLLGYAWKL 125
                +M+PE      F+  SDV+ FGV + EI+  G +   G  N+++   +       
Sbjct: 169 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI------- 221

Query: 126 WQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
            + G+ L M    P  +          ++   C   DP+ RP  +++   L
Sbjct: 222 -ENGERLPMPPNCPPTL---------YSLMTKCWAYDPSKRPRFTELKAQL 262

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 50.8 bits (121), Expect = 1e-07
 Identities = 29/91 (31%), Positives = 52/91 (57%), Gaps = 10/91 (10%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH++   +IIHRD K  NIL   + + K++DFG++   +  +T    +  +GT  +M
Sbjct: 116 LNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWM 170

Query: 75  SPEYALGGF-----FSVKSDVFSFGVVVLEI 100
           +PE  +        +  K+DV+S G+ ++E+
Sbjct: 171 APEVVMCETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 51.0 bits (122), Expect = 1e-07
 Identities = 55/207 (26%), Positives = 77/207 (37%), Gaps = 56/207 (27%)

Query: 3   MLFNIILGVSRRLL----YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGK 58
           +     + + RRLL    YLH      IIHRD KT NI LD   N  + DFG        
Sbjct: 182 LPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFG-----AAC 233

Query: 59  QTDGTTNRV-----VGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSE 113
           + D   +        GT    SPE      +  K+D++S G+V+ E +S K  T F    
Sbjct: 234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFE-MSVKNVTLF---- 288

Query: 114 LALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
                          GK      Q   + S+   I++C+ V  L   E P +  T     
Sbjct: 289 ---------------GK------QVKSSSSQLRSIIRCMQVHPL---EFPQNGST----- 319

Query: 174 IMLGSEAVNLASPKRPAF----VVRRG 196
             L       A   RP +    V+R+ 
Sbjct: 320 -NLCKHFKQYAIVLRPPYTIPPVIRKY 345

Length = 392

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 50.8 bits (121), Expect = 1e-07
 Identities = 30/88 (34%), Positives = 45/88 (51%), Gaps = 3/88 (3%)

Query: 18  LHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQTDGTTNRVVGTYGYMSP 76
           +H   K  I+HRD K  N+L+ H    K+ DFG  R + EG  ++      V T  Y SP
Sbjct: 113 IHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG--SNANYTEYVATRWYRSP 170

Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISGK 104
           E  LG  +    D++S G ++ E+  G+
Sbjct: 171 ELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 50.6 bits (121), Expect = 1e-07
 Identities = 31/102 (30%), Positives = 51/102 (50%), Gaps = 11/102 (10%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP-KISDFGLTRIFEGKQTDG 62
           ++ ++ GV+    + H   K  ++HRD K  N+L+D +    KI+D GL R F       
Sbjct: 116 MYQLLKGVA----HCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS-IPVKS 167

Query: 63  TTNRVVGTYGYMSPEYALGG-FFSVKSDVFSFGVVVLEIISG 103
            T+ +V T  Y +PE  LG   +S   D++S G +  E+   
Sbjct: 168 YTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 50.0 bits (119), Expect = 2e-07
 Identities = 43/186 (23%), Positives = 85/186 (45%), Gaps = 20/186 (10%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           +  + +I   ++  ++YL   +    +HRD  T N L+   +  KI DFG++R       
Sbjct: 122 LSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 178

Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLG 120
                  +    +M PE  +   F+ +SDV+SFGV++ EI +  +   F   +L+ + + 
Sbjct: 179 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF---QLSNTEV- 234

Query: 121 YAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEA 180
              +   +G+ L    ++P    K     +  ++ L C Q +P  R  + ++  +L   A
Sbjct: 235 --IECITQGRVL----ERPRVCPK-----EVYDIMLGCWQREPQQRLNIKEIYKIL--HA 281

Query: 181 VNLASP 186
           +  A+P
Sbjct: 282 LGKATP 287

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 50.0 bits (119), Expect = 2e-07
 Identities = 28/91 (30%), Positives = 52/91 (57%), Gaps = 10/91 (10%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH    ++IIHRD K  N+LL  + + K++DFG++   +  +T    +  +GT  +M
Sbjct: 123 LQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSA--KNVKTLQRRDSFIGTPYWM 177

Query: 75  SPEYAL-----GGFFSVKSDVFSFGVVVLEI 100
           +PE  +        +  K+D++S G+ ++E+
Sbjct: 178 APEVVMCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 50.0 bits (119), Expect = 2e-07
 Identities = 27/82 (32%), Positives = 42/82 (51%), Gaps = 2/82 (2%)

Query: 23  KLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG 82
           + R++HRD K+ NI L      K+ DFG  R+         T   VGT  Y+ PE     
Sbjct: 118 EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWENM 175

Query: 83  FFSVKSDVFSFGVVVLEIISGK 104
            ++ KSD++S G ++ E+ + K
Sbjct: 176 PYNNKSDIWSLGCILYELCTLK 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 50.0 bits (119), Expect = 2e-07
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 5/93 (5%)

Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGT 70
           ++  L YLH    + I++RD K  NILLD + +  ++DFGL +  EG     TT    GT
Sbjct: 105 IASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGT 159

Query: 71  YGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
             Y++PE      +    D +  G V+ E++ G
Sbjct: 160 PEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 49.7 bits (119), Expect = 2e-07
 Identities = 33/99 (33%), Positives = 47/99 (47%), Gaps = 6/99 (6%)

Query: 6   NIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTN 65
            II    + + + H   K   IHRD K  NIL+  +   K+ DFG  RI  G   D T  
Sbjct: 104 KIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD- 159

Query: 66  RVVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISG 103
             V T  Y +PE  +G   +    DV++ G V  E+++G
Sbjct: 160 -YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 49.6 bits (118), Expect = 3e-07
 Identities = 30/98 (30%), Positives = 50/98 (51%), Gaps = 10/98 (10%)

Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGT 70
           + R L +LH     ++IHRD K  N+LL      K+ DFG++   +  +T G  N  +GT
Sbjct: 130 ILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD--RTVGRRNTFIGT 184

Query: 71  YGYMSPEYAL-----GGFFSVKSDVFSFGVVVLEIISG 103
             +M+PE           +  +SD++S G+  +E+  G
Sbjct: 185 PYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 49.4 bits (118), Expect = 3e-07
 Identities = 25/77 (32%), Positives = 39/77 (50%)

Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFFSV 86
           IHRD    N L+      KISDFG++R  EG     +         + +PE    G ++ 
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174

Query: 87  KSDVFSFGVVVLEIISG 103
           +SDV+S+G+++ E  S 
Sbjct: 175 ESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 49.6 bits (118), Expect = 3e-07
 Identities = 45/160 (28%), Positives = 75/160 (46%), Gaps = 24/160 (15%)

Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT--TNRVV 68
           ++  +L +H   +L  +HRD K  N+LLD   + +++DFG          DGT  ++  V
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKM---NQDGTVQSSVAV 164

Query: 69  GTYGYMSPEYALG-----GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAW 123
           GT  Y+SPE         G +  + D +S GV + E++ G+  T FY   L  +      
Sbjct: 165 GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE--TPFYAESLVETY----- 217

Query: 124 KLWQEGKALDMMD--QKPGAISKANEILKCINVGLLCVQE 161
                GK ++  +  Q P  I+  +E  K +   L+C +E
Sbjct: 218 -----GKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRE 252

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 49.0 bits (117), Expect = 4e-07
 Identities = 30/96 (31%), Positives = 48/96 (50%), Gaps = 5/96 (5%)

Query: 9   LGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVV 68
           L V++ + YL      + +HRD    N +LD     K++DFGL R    K+     N   
Sbjct: 105 LQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTG 161

Query: 69  GTY--GYMSPEYALGGFFSVKSDVFSFGVVVLEIIS 102
                 +M+ E      F+ KSDV+SFGV++ E+++
Sbjct: 162 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 48.8 bits (116), Expect = 4e-07
 Identities = 31/94 (32%), Positives = 47/94 (50%), Gaps = 6/94 (6%)

Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGT 70
           VS  + YL   +    +HRD    N+LL ++   KISDFGL++   G        R  G 
Sbjct: 104 VSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKAL-GADDSYYKARSAGK 159

Query: 71  Y--GYMSPEYALGGFFSVKSDVFSFGVVVLEIIS 102
           +   + +PE      FS +SDV+S+G+ + E  S
Sbjct: 160 WPLKWYAPECINFRKFSSRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 49.3 bits (117), Expect = 4e-07
 Identities = 37/106 (34%), Positives = 54/106 (50%), Gaps = 18/106 (16%)

Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L+ ++ G+     +LH      IIHRD K SNI++  +   KI DFGL R      T G
Sbjct: 124 LLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAG 170

Query: 63  T----TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           T    T  VV  Y Y +PE  LG  +    D++S G ++ E++  K
Sbjct: 171 TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 49.1 bits (117), Expect = 4e-07
 Identities = 29/96 (30%), Positives = 48/96 (50%), Gaps = 7/96 (7%)

Query: 8   ILGVSRRLL----YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           +  V+R+LL    Y+H +    IIHRD KT N+L++   +  + DFG      G  +   
Sbjct: 262 VTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318

Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLE 99
              + GT    +PE   G  ++   D++S G+V+ E
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 48.8 bits (116), Expect = 5e-07
 Identities = 29/81 (35%), Positives = 43/81 (53%), Gaps = 3/81 (3%)

Query: 25  RIIHRDFKTSNILLDHE-MNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGF 83
           +I+HRD K+ NI L    M  K+ DFG+ R          T   VGT  Y+SPE      
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGTPYYLSPEICQNRP 178

Query: 84  FSVKSDVFSFGVVVLEIISGK 104
           ++ K+D++S G V+ E+ + K
Sbjct: 179 YNNKTDIWSLGCVLYELCTLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 49.0 bits (117), Expect = 5e-07
 Identities = 31/87 (35%), Positives = 46/87 (52%), Gaps = 8/87 (9%)

Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH      II+RD K  N+LLD++ + K++DFG    F  K  D T   + GT  Y++P
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFG----FAKKVPDRTFT-LCGTPEYLAP 184

Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E           D ++ GV++ E I+G
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 48.8 bits (116), Expect = 5e-07
 Identities = 36/106 (33%), Positives = 54/106 (50%), Gaps = 14/106 (13%)

Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L+  +LG    L +LH +   RIIHRD K +NILL  E   K+ DFG++   +   T  
Sbjct: 133 ILYGALLG----LQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSA--QLTSTRL 183

Query: 63  TTNRVVGTYGYMSPEY-----ALGGFFSVKSDVFSFGVVVLEIISG 103
             N  VGT  +M+PE           +  + DV+S G+  +E+  G
Sbjct: 184 RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 49.0 bits (117), Expect = 5e-07
 Identities = 34/118 (28%), Positives = 59/118 (50%), Gaps = 26/118 (22%)

Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIF------- 55
           +L  I+ G++     LH   K   +HRD   +NI ++ +   KI+DFGL R +       
Sbjct: 124 ILLQILNGLNV----LH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSD 176

Query: 56  ------EGKQTDGTTNRVVGTYGYMSPEYALGG---FFSVKSDVFSFGVVVLEIISGK 104
                   ++ +  T++VV T  Y +PE  +G     F+V  D++S G +  E+++GK
Sbjct: 177 TLSKDETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAV--DMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 48.9 bits (116), Expect = 5e-07
 Identities = 45/156 (28%), Positives = 65/156 (41%), Gaps = 18/156 (11%)

Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFF 84
           + IHRD    NILL      KI DFGL R                   +M+PE      +
Sbjct: 199 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 258

Query: 85  SVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           +++SDV+SFGV++ EI S       G    E     L       +EG  +   D      
Sbjct: 259 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-------KEGTRMRAPDY----- 306

Query: 143 SKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGS 178
               E+ + +   L C   +P+ RPT S++V  LG+
Sbjct: 307 -TTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGN 338

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 48.8 bits (116), Expect = 6e-07
 Identities = 27/78 (34%), Positives = 43/78 (55%), Gaps = 3/78 (3%)

Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTT--NRVVGTYGYMSPEYALGGFF 84
           +HRD    N+L++ E   KI DFGLT+  E  +   T   +     + Y +PE  +   F
Sbjct: 131 VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECLIQSKF 189

Query: 85  SVKSDVFSFGVVVLEIIS 102
            + SDV+SFGV + E+++
Sbjct: 190 YIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 48.4 bits (115), Expect = 6e-07
 Identities = 33/102 (32%), Positives = 54/102 (52%), Gaps = 10/102 (9%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L+ I+ G    L Y H   + +++HRD K  N+L++     K++DFGL R  +   T   
Sbjct: 110 LYQILRG----LAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARA-KSVPTKTY 161

Query: 64  TNRVVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
           +N VV T  Y  P+  LG   +S + D++  G +  E+ SG+
Sbjct: 162 SNEVV-TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 48.5 bits (116), Expect = 6e-07
 Identities = 35/93 (37%), Positives = 49/93 (52%), Gaps = 6/93 (6%)

Query: 13  RRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYG 72
           R L Y+H  +   ++HRD K SN+LL+   + KI DFGL R    K  D  T  VV T  
Sbjct: 119 RGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG-DFMTEYVV-TRW 173

Query: 73  YMSPEYALG-GFFSVKSDVFSFGVVVLEIISGK 104
           Y +PE  L    ++   DV+S G +  E++  K
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 48.4 bits (115), Expect = 7e-07
 Identities = 35/112 (31%), Positives = 55/112 (49%), Gaps = 16/112 (14%)

Query: 2   EMLF-----NIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFE 56
           E +F      I+ GV+    YLH +    ++HRD K +N++L      K+ DFG  R   
Sbjct: 101 EPVFCKYTKQILDGVA----YLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153

Query: 57  GKQTDGTTNRVV----GTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
                GT + ++    GT  +M+PE      +  KSD++S G  V E+ +GK
Sbjct: 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 48.4 bits (115), Expect = 7e-07
 Identities = 28/101 (27%), Positives = 53/101 (52%), Gaps = 3/101 (2%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           + L N  + +++ + YL +    R++HR+    NILL  +   +I+DFG+  +       
Sbjct: 109 QRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK 165

Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS 102
              +       +M+ E  L G ++ +SDV+S+GV V E++S
Sbjct: 166 YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 48.5 bits (115), Expect = 7e-07
 Identities = 44/129 (34%), Positives = 64/129 (49%), Gaps = 13/129 (10%)

Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG----G 82
           IHRD K  N+LLD   + K++DFG T +   K+     +  VGT  Y+SPE        G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFG-TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDG 222

Query: 83  FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           ++  + D +S GV + E++ G  +T FY    A SL+G   K+     +L   D     I
Sbjct: 223 YYGRECDWWSVGVFLYEMLVG--DTPFY----ADSLVGTYSKIMNHKNSLTFPDDND--I 274

Query: 143 SKANEILKC 151
           SK  + L C
Sbjct: 275 SKEAKNLIC 283

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 48.3 bits (116), Expect = 8e-07
 Identities = 50/195 (25%), Positives = 79/195 (40%), Gaps = 46/195 (23%)

Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQ--T 60
           +++ I+ G    L ++H   K    HRD K  N+L+      KI+DFGL R    +   T
Sbjct: 104 IIYQILQG----LAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYT 156

Query: 61  DGTTNRVVGTYGYMSPEYAL-GGFFSVKSDVFSFGVVVLEIIS------GKRNTGFYNSE 113
           D      V T  Y +PE  L    +S   D+++ G ++ E+ +      G       +SE
Sbjct: 157 D-----YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPG-------SSE 204

Query: 114 L-----ALSLLGY-AWKLWQEGKALD-----MMDQKPGA-----ISKANEILKCINVGLL 157
           +       S+LG    + W EG  L         Q         I  A+   + I++   
Sbjct: 205 IDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASP--EAIDLIKD 262

Query: 158 CVQEDPNDRPTMSDV 172
            ++ DP  RPT S  
Sbjct: 263 MLRWDPKKRPTASQA 277

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 48.1 bits (114), Expect = 1e-06
 Identities = 25/80 (31%), Positives = 44/80 (55%), Gaps = 5/80 (6%)

Query: 24  LRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGF 83
           L I++RD K  N+LLD +   K++DFG  ++ + +     T  + GT  Y++PE  L   
Sbjct: 150 LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNVG 204

Query: 84  FSVKSDVFSFGVVVLEIISG 103
               +D ++ G+ + EI+ G
Sbjct: 205 HGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 47.7 bits (114), Expect = 1e-06
 Identities = 29/103 (28%), Positives = 51/103 (49%), Gaps = 16/103 (15%)

Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQ--T 60
            ++ ++  +     ++H++    I HRD K  NIL+  +   K++DFG  R    K   T
Sbjct: 105 YMYQLLKSLD----HMHRNG---IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYT 156

Query: 61  DGTTNRVVGTYGYMSPEYAL-GGFFSVKSDVFSFGVVVLEIIS 102
           +      + T  Y +PE  L  G++  K D+++ G V  EI+S
Sbjct: 157 E-----YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 47.7 bits (113), Expect = 1e-06
 Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 6/93 (6%)

Query: 13  RRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYG 72
           R L Y H   K +I+HRD K  N+L++ +   K++DFGL R  +   T   +N VV T  
Sbjct: 114 RGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARA-KSVPTKTYSNEVV-TLW 168

Query: 73  YMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
           Y  P+  LG   +S   D++  G ++ E+ +G+
Sbjct: 169 YRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 48.1 bits (114), Expect = 1e-06
 Identities = 29/97 (29%), Positives = 45/97 (46%), Gaps = 10/97 (10%)

Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRV--- 67
           V R + YLH++   RIIHRD K  NI ++H  +  + DFG          D   N+    
Sbjct: 191 VLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACF----PVDINANKYYGW 243

Query: 68  VGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
            GT    +PE      +    D++S G+V+ E+ +  
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 47.8 bits (114), Expect = 1e-06
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 6/93 (6%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEG--KQTDGTTNRVVGTYG 72
           L Y+H  +   ++HRD K  N+L++ +   KI DFGL R F     +  G     V T  
Sbjct: 118 LKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRW 174

Query: 73  YMSPEYALGGFFSVKS-DVFSFGVVVLEIISGK 104
           Y +PE  L      K+ DV+S G ++ E++  K
Sbjct: 175 YRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 47.5 bits (113), Expect = 1e-06
 Identities = 32/92 (34%), Positives = 47/92 (51%), Gaps = 7/92 (7%)

Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG----G 82
           IHRD K  N+LLD   + K++DFG T +          +  VGT  Y+SPE        G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFG-TCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDG 222

Query: 83  FFSVKSDVFSFGVVVLEIISGKRNTGFYNSEL 114
           ++  + D +S GV + E++ G  +T FY   L
Sbjct: 223 YYGRECDWWSVGVFLYEMLVG--DTPFYADSL 252

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 47.3 bits (112), Expect = 1e-06
 Identities = 30/93 (32%), Positives = 50/93 (53%), Gaps = 6/93 (6%)

Query: 13  RRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYG 72
           R L Y H   + +++HRD K  N+L++     K++DFGL R  +   T   +N VV T  
Sbjct: 115 RGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARA-KSIPTKTYSNEVV-TLW 169

Query: 73  YMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
           Y  P+  LG   +S + D++  G +  E+ +G+
Sbjct: 170 YRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 47.3 bits (112), Expect = 2e-06
 Identities = 27/99 (27%), Positives = 53/99 (53%), Gaps = 3/99 (3%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L N  + +++ + YL +    R++HRD    N+L+    + KI+DFGL ++    + +  
Sbjct: 111 LLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYH 167

Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS 102
                    +M+ E  L   ++ +SDV+S+GV V E+++
Sbjct: 168 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 47.5 bits (113), Expect = 2e-06
 Identities = 33/126 (26%), Positives = 48/126 (38%), Gaps = 45/126 (35%)

Query: 23  KLRIIHRDFKTSNILLDHEMNPKISDFGL-------------TRIFEGKQ-TDGTTNR-- 66
           KL  IHRD K  NIL+D   + K+SDFGL              ++ +GK   +   NR  
Sbjct: 119 KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNS 178

Query: 67  -----------------------------VVGTYGYMSPEYALGGFFSVKSDVFSFGVVV 97
                                         VGT  Y++PE  L   +  + D +S G ++
Sbjct: 179 VAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238

Query: 98  LEIISG 103
            E + G
Sbjct: 239 FECLIG 244

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 47.8 bits (114), Expect = 2e-06
 Identities = 30/102 (29%), Positives = 50/102 (49%), Gaps = 19/102 (18%)

Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD------GTTN----- 65
           Y+H  SK  ++HRD K  NILL       I D+G     + ++ D         N     
Sbjct: 128 YVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184

Query: 66  -----RVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS 102
                ++VGT  YM+PE  LG   S  +D+++ GV++ ++++
Sbjct: 185 MTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 47.0 bits (112), Expect = 2e-06
 Identities = 33/94 (35%), Positives = 46/94 (48%), Gaps = 10/94 (10%)

Query: 13  RRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTT--NRVVGT 70
           R L Y HQ    R++HRD K  N+L+      K++DFGL R    K     T  N VV T
Sbjct: 114 RGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR---AKSVPSKTYSNEVV-T 166

Query: 71  YGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISG 103
             Y  P+  LG   +S   D++  G +  E+ +G
Sbjct: 167 LWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 46.9 bits (111), Expect = 2e-06
 Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 8/94 (8%)

Query: 13  RRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTT-NRVVGTY 71
           R L Y+H      I+HRD K  N+L+ +    K++DFGL R    K     T +  V T 
Sbjct: 114 RGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLAR---AKSIPSQTYSSEVVTL 167

Query: 72  GYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            Y  P+  LG   +S   D++  G + +E++ G+
Sbjct: 168 WYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 47.2 bits (112), Expect = 2e-06
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 9/91 (9%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L Y+H      IIHRD K  N+ ++ +   KI DFGL R       D      V T  Y 
Sbjct: 130 LKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYR 181

Query: 75  SPEYALGGFFSVKS-DVFSFGVVVLEIISGK 104
           +PE  L      ++ D++S G ++ E+++GK
Sbjct: 182 APEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 47.0 bits (111), Expect = 2e-06
 Identities = 43/149 (28%), Positives = 72/149 (48%), Gaps = 26/149 (17%)

Query: 23  KLRIIHRDFKTSNILLDHEMNPKISDFG-LTRIFEGKQTDGT--TNRVVGTYGYMSPEYA 79
           +L  +HRD K  NIL+D   + +++DFG   ++ E    DGT  ++  VGT  Y+SPE  
Sbjct: 120 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME----DGTVQSSVAVGTPDYISPEIL 175

Query: 80  LG-----GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDM 134
                  G +  + D +S GV + E++ G+  T FY   L  +           GK ++ 
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYGE--TPFYAESLVETY----------GKIMNH 223

Query: 135 MD--QKPGAISKANEILKCINVGLLCVQE 161
            +  Q P  ++  +E  K +   L+C +E
Sbjct: 224 KERFQFPAQVTDVSEDAKDLIRRLICSRE 252

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 46.9 bits (111), Expect = 2e-06
 Identities = 24/76 (31%), Positives = 36/76 (47%)

Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFFSV 86
           +HRD    N+LL      KI DFGL R         +         +M+PE      ++ 
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTT 318

Query: 87  KSDVFSFGVVVLEIIS 102
            SDV+S+G+++ EI S
Sbjct: 319 LSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 46.9 bits (111), Expect = 3e-06
 Identities = 26/91 (28%), Positives = 50/91 (54%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           +L L +    +++HRD K++NI L      K+ DFG ++ +    +    +   GT  Y+
Sbjct: 179 VLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYL 238

Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGKR 105
           +PE      +S K+D++S GV++ E+++  R
Sbjct: 239 APELWERKRYSKKADMWSLGVILYELLTLHR 269

Length = 478

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 46.4 bits (111), Expect = 3e-06
 Identities = 33/101 (32%), Positives = 47/101 (46%), Gaps = 12/101 (11%)

Query: 6   NIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP-KISDFGLTRIFEGKQT-DGT 63
            II  +   L  LH   K  IIH D K  N+L D   +   + D+GL +I       DGT
Sbjct: 113 KIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGT 169

Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
            +       Y SPE   G  + V  D ++ GV+  E+++GK
Sbjct: 170 LD-------YFSPEKIKGHNYDVSFDWWAVGVLTYELLTGK 203

Length = 267

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 46.6 bits (110), Expect = 3e-06
 Identities = 34/102 (33%), Positives = 53/102 (51%), Gaps = 10/102 (9%)

Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
            LF ++ G+S    Y+HQ     I+HRD K  N+L+      K++DFGL R  +   +  
Sbjct: 108 FLFQLLRGLS----YIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARA-KSVPSHT 159

Query: 63  TTNRVVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISG 103
            +N VV T  Y  P+  LG   +S   D++  G + +E+I G
Sbjct: 160 YSNEVV-TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 46.3 bits (110), Expect = 3e-06
 Identities = 30/88 (34%), Positives = 46/88 (52%), Gaps = 8/88 (9%)

Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH      I++RD K  NILLD E + K++DFG    F  K  D T   + GT  Y++P
Sbjct: 116 YLHS---KEIVYRDLKPENILLDKEGHIKLTDFG----FAKKLRDRTWT-LCGTPEYLAP 167

Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISGK 104
           E       +   D ++ G+++ E++ G 
Sbjct: 168 EVIQSKGHNKAVDWWALGILIYEMLVGY 195

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 46.6 bits (111), Expect = 3e-06
 Identities = 30/96 (31%), Positives = 49/96 (51%), Gaps = 7/96 (7%)

Query: 13  RRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTT--NRVVGT 70
           R L Y+H  +   +IHRD K SN+L++ +   +I DFG+ R      T+        V T
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174

Query: 71  YGYMSPEYALG-GFFSVKSDVFSFGVVVLEIISGKR 105
             Y +PE  L    ++   D++S G +  E++ G+R
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRR 209

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 45.9 bits (109), Expect = 4e-06
 Identities = 31/100 (31%), Positives = 51/100 (51%), Gaps = 16/100 (16%)

Query: 13  RRLLYLHQDSKLRIIHRDFKTSNILLDHE-MNPKISDFGLTRIFE------GKQTDGTTN 65
           R L Y+H  +   ++HRD K +N+ ++ E +  KI DFGL RI +      G  ++G   
Sbjct: 125 RGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV- 180

Query: 66  RVVGTYGYMSPEYALGGFFSVKS-DVFSFGVVVLEIISGK 104
               T  Y SP   L      K+ D+++ G +  E+++GK
Sbjct: 181 ----TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 45.8 bits (108), Expect = 5e-06
 Identities = 28/80 (35%), Positives = 42/80 (52%), Gaps = 8/80 (10%)

Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGT----YGYMSPEYALGG 82
           IHRD    N L+  +   KISDFG++R    ++ DG      G       + +PE    G
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR----EEEDGVYASTGGMKQIPVKWTAPEALNYG 171

Query: 83  FFSVKSDVFSFGVVVLEIIS 102
            +S +SDV+SFG+++ E  S
Sbjct: 172 RYSSESDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 46.4 bits (110), Expect = 5e-06
 Identities = 41/175 (23%), Positives = 82/175 (46%), Gaps = 12/175 (6%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           I +G+++ L +LH      ++  +     I++D +  P +    L  +        T  +
Sbjct: 785 IAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL------CTDTK 837

Query: 67  VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLW 126
              +  Y++PE       + KSD++ FG++++E+++GK         +  S++ +A   +
Sbjct: 838 CFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA-EFGVHGSIVEWARYCY 896

Query: 127 QEGKALDM-MDQ--KPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGS 178
            +   LDM +D   +       NEI++ +N+ L C   DP  RP  +DV+  L S
Sbjct: 897 SDCH-LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLES 950

Length = 968

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 45.8 bits (108), Expect = 5e-06
 Identities = 30/103 (29%), Positives = 51/103 (49%), Gaps = 4/103 (3%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           + +I   ++  ++YL   +    +HRD  T N L+   +  KI DFG++R          
Sbjct: 122 MLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRV 178

Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKR 105
               +    +M PE  +   F+ +SDV+S GVV+ EI + GK+
Sbjct: 179 GGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 221

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 45.8 bits (108), Expect = 6e-06
 Identities = 40/126 (31%), Positives = 61/126 (48%), Gaps = 19/126 (15%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT----TNRVVGT 70
           +L L     + +IHRD K  N+LLD   + K++DFG        + D T     +  VGT
Sbjct: 152 VLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC-----MKMDETGMVRCDTAVGT 206

Query: 71  YGYMSPEYALG----GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLW 126
             Y+SPE        G++  + D +S GV + E++ G  +T FY    A SL+G   K+ 
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG--DTPFY----ADSLVGTYSKIM 260

Query: 127 QEGKAL 132
               +L
Sbjct: 261 DHKNSL 266

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 45.3 bits (107), Expect = 7e-06
 Identities = 33/96 (34%), Positives = 46/96 (47%), Gaps = 10/96 (10%)

Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGK----QTDGTTNR 66
           VS  + YL + +    +HRD    N+LL  +   KISDFGL++         +       
Sbjct: 104 VSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW 160

Query: 67  VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS 102
            V  Y   +PE      FS KSDV+SFGV++ E  S
Sbjct: 161 PVKWY---APECMNYYKFSSKSDVWSFGVLMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 45.4 bits (107), Expect = 7e-06
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 10/94 (10%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L +LH +   + IHRD K +NILL  E   K+ DFG++   +   T    N  VGT  +M
Sbjct: 137 LQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSA--QLTSTRLRRNTSVGTPFWM 191

Query: 75  SPEY-----ALGGFFSVKSDVFSFGVVVLEIISG 103
           +PE       L   +  + DV+S G+  +E+  G
Sbjct: 192 APEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 45.2 bits (107), Expect = 8e-06
 Identities = 31/101 (30%), Positives = 49/101 (48%), Gaps = 19/101 (18%)

Query: 16  LYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFG----LTRIFEGKQTDGTTNRV--VG 69
           L +H   ++  +HRD K  N+L+D   + K++DFG    LT        +   N    VG
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA-------NKMVNSKLPVG 165

Query: 70  TYGYMSPEY------ALGGFFSVKSDVFSFGVVVLEIISGK 104
           T  Y++PE          G + V+ D +S GV+  E+I G+
Sbjct: 166 TPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 44.7 bits (105), Expect = 1e-05
 Identities = 41/147 (27%), Positives = 73/147 (49%), Gaps = 29/147 (19%)

Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP-----KISDFGLTRIFEG 57
           +L+ I+ G+     YLH +    ++HRD K +NIL+  E  P     KI+D G  R+F  
Sbjct: 113 LLYQILDGIH----YLHAN---WVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNS 164

Query: 58  K-QTDGTTNRVVGTYGYMSPEYALGGFFSVKS-DVFSFGVVVLEIISG-----------K 104
             +     + VV T+ Y +PE  LG     K+ D+++ G +  E+++            K
Sbjct: 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 224

Query: 105 RNTGFYNSEL--ALSLLGY-AWKLWQE 128
            +  F++ +L    S++G+ A K W++
Sbjct: 225 TSNPFHHDQLDRIFSVMGFPADKDWED 251

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 44.7 bits (105), Expect = 1e-05
 Identities = 29/86 (33%), Positives = 46/86 (53%), Gaps = 4/86 (4%)

Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           Y+H   K  +IHRD K  NI L+ +    + DFG    FE K+ +      VGT    SP
Sbjct: 282 YIH--DKK-LIHRDIKLENIFLNCDGKIVLGDFGTAMPFE-KEREAFDYGWVGTVATNSP 337

Query: 77  EYALGGFFSVKSDVFSFGVVVLEIIS 102
           E   G  +   +D++S G+++L+++S
Sbjct: 338 EILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 44.7 bits (105), Expect = 1e-05
 Identities = 33/109 (30%), Positives = 57/109 (52%), Gaps = 15/109 (13%)

Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP-----KISDFGLTRIFEG 57
           +L+ I+ G+     YLH +    ++HRD K +NIL+  E  P     KI+D G  R+F  
Sbjct: 113 LLYQILDGIH----YLHAN---WVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNS 164

Query: 58  K-QTDGTTNRVVGTYGYMSPEYALGGFFSVKS-DVFSFGVVVLEIISGK 104
             +     + VV T+ Y +PE  LG     K+ D+++ G +  E+++ +
Sbjct: 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 44.3 bits (104), Expect = 2e-05
 Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 12/91 (13%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR--VVGTYG 72
           L YLH   K+   HRD K +NILL    + K++DFG+      K T     R   +GT  
Sbjct: 119 LAYLHSKGKM---HRDIKGANILLTDNGDVKLADFGVA----AKITATIAKRKSFIGTPY 171

Query: 73  YMSPEYAL---GGFFSVKSDVFSFGVVVLEI 100
           +M+PE A     G ++   D+++ G+  +E+
Sbjct: 172 WMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 44.4 bits (105), Expect = 2e-05
 Identities = 31/102 (30%), Positives = 49/102 (48%), Gaps = 16/102 (15%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGL---------TRIFEGKQTDGTTN 65
           L YLH      I+HRD K  N+L+    + K++DFGL         T ++EG     T  
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170

Query: 66  ----RVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
               +V GT  Y++PE  L   +    D ++ G+++ E + G
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 44.5 bits (105), Expect = 2e-05
 Identities = 22/53 (41%), Positives = 33/53 (62%), Gaps = 3/53 (5%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRI 54
           EM    I  V+  L YLH+     IIHRD K  N+L+ +E + K++DFGL+++
Sbjct: 104 EMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 43.5 bits (103), Expect = 3e-05
 Identities = 31/101 (30%), Positives = 48/101 (47%), Gaps = 10/101 (9%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           LF I+ G+     + H  +   IIHRD K  NIL+      K+ DFG  R         T
Sbjct: 106 LFQILRGIE----FCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYT 158

Query: 64  TNRVVGTYGYMSPEYALGGFFSVKS-DVFSFGVVVLEIISG 103
               V T  Y +PE  +G     ++ D+++ G +V E+++G
Sbjct: 159 D--YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 43.5 bits (102), Expect = 3e-05
 Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 10/90 (11%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH   K   +HRD K +NILL    + K++DFG++   +   T       +GT  +M
Sbjct: 119 LYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSA--QITATIAKRKSFIGTPYWM 173

Query: 75  SPEYAL----GGFFSVKSDVFSFGVVVLEI 100
           +PE A     GG+  +  D+++ G+  +E+
Sbjct: 174 APEVAAVERKGGYNQL-CDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 43.5 bits (103), Expect = 4e-05
 Identities = 35/129 (27%), Positives = 53/129 (41%), Gaps = 36/129 (27%)

Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGL------------------- 51
           ++  +L +    KL  IHRD K  N+LLD + + K+SDFGL                   
Sbjct: 107 IAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHA 166

Query: 52  ----TRIFEGKQTDGT-------TNR------VVGTYGYMSPEYALGGFFSVKSDVFSFG 94
                  F  K             NR       VGT  Y++PE  L   ++ + D +S G
Sbjct: 167 LPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226

Query: 95  VVVLEIISG 103
           V++ E++ G
Sbjct: 227 VIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 42.7 bits (100), Expect = 5e-05
 Identities = 27/80 (33%), Positives = 39/80 (48%), Gaps = 9/80 (11%)

Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVG----TYGYMSPEYALGG 82
           IHRD    N L+      KISDFG++R     Q D       G       + +PE    G
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR-----QEDDGIYSSSGLKQIPIKWTAPEALNYG 169

Query: 83  FFSVKSDVFSFGVVVLEIIS 102
            +S +SDV+S+G+++ E  S
Sbjct: 170 RYSSESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 42.8 bits (101), Expect = 5e-05
 Identities = 28/94 (29%), Positives = 45/94 (47%), Gaps = 6/94 (6%)

Query: 13  RRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYG 72
           + L + H      ++HRD K  N+L++     K++DFGL R F G      +  VV T  
Sbjct: 110 KGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAF-GIPVRCYSAEVV-TLW 164

Query: 73  YMSPEYALGG-FFSVKSDVFSFGVVVLEIISGKR 105
           Y  P+   G   +S   D++S G +  E+ +  R
Sbjct: 165 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 42.3 bits (99), Expect = 8e-05
 Identities = 36/153 (23%), Positives = 63/153 (41%), Gaps = 18/153 (11%)

Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFFSV 86
           +HRD    N+L+      KI DFGL R         +         +M+PE      ++ 
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT 320

Query: 87  KSDVFSFGVVVLEI--ISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISK 144
            SDV+SFG+++ EI  + G        +E   + +   +++ +   A D          +
Sbjct: 321 LSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASD----------E 370

Query: 145 ANEILKCINVGLLCVQEDPNDRPTMSDVVIMLG 177
             EI++       C +E    RP  S +V ++G
Sbjct: 371 IYEIMQ------KCWEEKFEIRPDFSQLVHLVG 397

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 41.9 bits (98), Expect = 1e-04
 Identities = 35/112 (31%), Positives = 54/112 (48%), Gaps = 13/112 (11%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILL---DHEMNPKIS-----DFGLTRIF 55
           L  II      L Y H  ++L ++H D K  NIL+   D  ++P  +     D    RI 
Sbjct: 233 LAQIIFQTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRIC 290

Query: 56  E-GKQTDGTTNR--VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           + G   D   +R  +V T  Y SPE  LG  +   +D++S G ++ E+ +GK
Sbjct: 291 DLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342

Length = 467

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 41.9 bits (98), Expect = 1e-04
 Identities = 35/110 (31%), Positives = 59/110 (53%), Gaps = 18/110 (16%)

Query: 6   NIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTN 65
           NI+ G  R L YLHQ+     IHR+ K S+IL+  +    +S  GL+ ++   + +G   
Sbjct: 105 NILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLS--GLSHLYSLVR-NGQKA 158

Query: 66  RVVGTYG--------YMSPEYA---LGGFFSVKSDVFSFGVVVLEIISGK 104
           +VV  +         ++SPE     L G+ +VKSD++S G+   E+ +G+
Sbjct: 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGY-NVKSDIYSVGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 41.4 bits (97), Expect = 1e-04
 Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 7/104 (6%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGK-QTDG 62
           L  ++ G++  + YL   S++  +H+      +L++ ++  KIS F   R+ E K +   
Sbjct: 109 LMGMLPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIY 163

Query: 63  TTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKR 105
           TT        + +PE      FS  SDV+SFG+V+ E++S G+R
Sbjct: 164 TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGER 207

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 40.9 bits (95), Expect = 4e-04
 Identities = 37/124 (29%), Positives = 57/124 (45%), Gaps = 30/124 (24%)

Query: 8   ILGVSRRLL----YLHQ----DSKLRIIHRDFKTSNILLD-------------HEMN--- 43
           I+ ++R+LL    Y H      +  R++HRD K  NI L              + +N   
Sbjct: 120 IVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRP 179

Query: 44  -PKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL--GGFFSVKSDVFSFGVVVLEI 100
             KI DFGL++       +   +  VGT  Y SPE  L     +  KSD+++ G ++ E+
Sbjct: 180 IAKIGDFGLSK---NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL 236

Query: 101 ISGK 104
            SGK
Sbjct: 237 CSGK 240

Length = 1021

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 40.2 bits (94), Expect = 4e-04
 Identities = 30/123 (24%), Positives = 50/123 (40%), Gaps = 41/123 (33%)

Query: 23  KLRIIHRDFKTSNILLDHEMNPKISDFGLTRIF----------EG--------------- 57
           K+  IHRD K  NIL+D + + K++DFGL   F          +G               
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178

Query: 58  ----------------KQTDGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEII 101
                           +      + +VGT  Y++PE  L   ++   D +S GV++ E++
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238

Query: 102 SGK 104
            G+
Sbjct: 239 VGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 40.0 bits (93), Expect = 5e-04
 Identities = 32/126 (25%), Positives = 55/126 (43%), Gaps = 33/126 (26%)

Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGL-TRIFEGKQTDGTTN---- 65
           ++  +L +    +L  IHRD K  N+LLD + + K+SDFGL T + +  +T+   N    
Sbjct: 107 IAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHN 166

Query: 66  ----------------------------RVVGTYGYMSPEYALGGFFSVKSDVFSFGVVV 97
                                         VGT  Y++PE  +   ++   D +S GV++
Sbjct: 167 PPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226

Query: 98  LEIISG 103
            E++ G
Sbjct: 227 YEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 39.6 bits (92), Expect = 6e-04
 Identities = 32/126 (25%), Positives = 55/126 (43%), Gaps = 33/126 (26%)

Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGL-TRIFEGKQTDGTTN---- 65
           ++  +L +    +L  IHRD K  N+LLD + + K+SDFGL T + +  +T+   N    
Sbjct: 107 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHS 166

Query: 66  ----------------------------RVVGTYGYMSPEYALGGFFSVKSDVFSFGVVV 97
                                         VGT  Y++PE  +   ++   D +S GV++
Sbjct: 167 LPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226

Query: 98  LEIISG 103
            E++ G
Sbjct: 227 YEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 39.6 bits (92), Expect = 6e-04
 Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 8/93 (8%)

Query: 13  RRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP-KISDFGLTRIFEGKQTDGTTNRVVGTY 71
           R L Y+H  SK  I HRD K  N+L+D   +  K+ DFG  +     Q   +    + + 
Sbjct: 181 RALAYIH--SKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVS---YICSR 234

Query: 72  GYMSPEYALGGF-FSVKSDVFSFGVVVLEIISG 103
            Y +PE  LG   ++   D++S G ++ E+I G
Sbjct: 235 FYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 38.4 bits (89), Expect = 0.002
 Identities = 31/127 (24%), Positives = 50/127 (39%), Gaps = 45/127 (35%)

Query: 23  KLRIIHRDFKTSNILLDHEMNPKISDFGL----------------------TRIFEGKQT 60
           K+  IHRD K  NIL+D + + K++DFGL                      +  F  +  
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178

Query: 61  DGTTNR-----------------------VVGTYGYMSPEYALGGFFSVKSDVFSFGVVV 97
           D    R                       +VGT  Y++PE  L   ++   D +S GV++
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238

Query: 98  LEIISGK 104
            E++ G+
Sbjct: 239 YEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403)

 Score = 34.6 bits (80), Expect = 0.003
 Identities = 15/48 (31%), Positives = 26/48 (54%), Gaps = 5/48 (10%)

Query: 178 SEAVNLASPKRPAFVVRRG----SSSSASTSNKPESNNELTHS-LEGR 220
           SE   +  PK+P F V R      SSS++  ++  + N++T S ++ R
Sbjct: 1   SETTEIPQPKQPGFCVGRSPYETDSSSSTQRDESWTVNQVTVSVIDAR 48

This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 37.7 bits (87), Expect = 0.003
 Identities = 31/127 (24%), Positives = 49/127 (38%), Gaps = 45/127 (35%)

Query: 23  KLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT---------------------D 61
           K+  IHRD K  NIL+D + + K++DFGL   F                          D
Sbjct: 119 KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178

Query: 62  GTTN------------------------RVVGTYGYMSPEYALGGFFSVKSDVFSFGVVV 97
             +N                         +VGT  Y++PE  L   ++   D +S GV++
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238

Query: 98  LEIISGK 104
            E++ G+
Sbjct: 239 FEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	220
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	99.97
KOG0192	362	consensus Tyrosine kinase specific for activated (	99.97
KOG1187	361	consensus Serine/threonine protein kinase [Signal	99.97
KOG0575	592	consensus Polo-like serine/threonine protein kinas	99.97
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.97
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	99.97
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	99.97
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	99.97
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	99.97
KOG0578	550	consensus p21-activated serine/threonine protein k	99.97
KOG0198	313	consensus MEKK and related serine/threonine protei	99.97
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.97
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.96
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.96
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.96
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.96
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.96
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	99.96
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.96
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.96
KOG0583	370	consensus Serine/threonine protein kinase [Signal	99.96
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.96
KOG0598	357	consensus Ribosomal protein S6 kinase and related	99.96
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.96
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.96
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.96
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.96
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.96
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.96
PHA02882	294	putative serine/threonine kinase; Provisional	99.96
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.96
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.96
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.96
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.96
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.96
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.96
PHA03207	392	serine/threonine kinase US3; Provisional	99.96
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.96
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.96
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.96
PTZ00284	467	protein kinase; Provisional	99.96
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.95
PHA02988	283	hypothetical protein; Provisional	99.95
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.95
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.95
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.95
PHA03212	391	serine/threonine kinase US3; Provisional	99.95
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.95
PTZ00283	496	serine/threonine protein kinase; Provisional	99.95
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.95
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.95
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.95
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.95
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.95
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.95
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.95
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.95
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.95
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.95
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.95
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.95
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.95
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.95
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.95
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.95
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.95
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.95
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.95
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.95
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.95
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.95
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.95
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.95
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.95
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.95
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.95
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.95
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.95
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.95
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.95
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.95
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.95
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.95
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.95
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.95
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.95
PTZ00267	478	NIMA-related protein kinase; Provisional	99.95
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.95
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.95
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.95
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.95
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.95
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.95
PTZ00036	440	glycogen synthase kinase; Provisional	99.95
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.95
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.95
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.95
PHA03211	461	serine/threonine kinase US3; Provisional	99.95
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.95
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.95
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.95
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.95
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.95
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.95
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.95
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.95
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.95
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.95
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.95
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.95
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.95
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.95
KOG0589	426	consensus Serine/threonine protein kinase [General	99.95
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.95
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.95
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.95
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.95
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.95
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.95
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.95
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.95
PHA03210	501	serine/threonine kinase US3; Provisional	99.95
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.95
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.95
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.95
KOG0605	550	consensus NDR and related serine/threonine kinases	99.95
PHA03209	357	serine/threonine kinase US3; Provisional	99.95
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.95
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.95
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.95
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.95
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.95
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.95
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.94
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.94
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.94
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.94
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.94
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.94
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.94
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.94
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.94
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.94
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.94
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.94
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.94
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.94
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.94
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.94
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.94
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.94
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.94
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.94
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.94
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	99.94
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.94
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.94
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.94
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.94
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.94
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.94
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.94
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.94
KOG0595	429	consensus Serine/threonine-protein kinase involved	99.94
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.94
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.94
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.94
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.94
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.94
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.94
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.94
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.94
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.94
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.94
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.94
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.94
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.94
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.94
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.94
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.94
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.94
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.94
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.94
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.94
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.94
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.94
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.94
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.94
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.94
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.94
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.94
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.94
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.94
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.94
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.94
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.94
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.94
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.94
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.94
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.94
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.94
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.94
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.94
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.94
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.94
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.94
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.94
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.94
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.94
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.94
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.94
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.94
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.94
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.94
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.94
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.94
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.93
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.93
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.93
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.93
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.93
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.93
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.93
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.93
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.93
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.93
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.93
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.93
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.93
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.93
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.93
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.93
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.93
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.93
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.93
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.93
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.93
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.93
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.93
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.93
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.93
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.93
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.93
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.93
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.93
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.93
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.93
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.93
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.93
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.93
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.93
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.93
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.93
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.93
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.93
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.93
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.93
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.93
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.93
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.93
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.93
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.93
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.93
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.93
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.93
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.93
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.93
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.93
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.93
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.93
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.93
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.93
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.93
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.93
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.93
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.93
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.93
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.93
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.93
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.93
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.93
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.93
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.93
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.93
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.92
PLN00181	793	protein SPA1-RELATED; Provisional	99.92
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.92
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.92
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.92
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.92
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.92
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.92
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.92
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.92
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.92
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.92
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.92
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.92
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.92
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.92
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.92
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.92
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.92
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.92
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.92
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.92
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.92
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.92
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.92
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.92
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.92
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.92
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.92
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.92
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.92
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.92
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.92
KOG0610	459	consensus Putative serine/threonine protein kinase	99.92
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.92
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.92
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.92
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.92
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.92
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.92
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.92
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.92
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.92
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.92
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.92
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.92
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.92
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.92
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.92
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.92
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.92
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.92
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.92
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.92
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.91
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.91
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.91
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.91
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.91
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.91
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.91
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.91
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.91
KOG0584	632	consensus Serine/threonine protein kinase [General	99.91
PLN00009	294	cyclin-dependent kinase A; Provisional	99.91
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.91
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.91
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.91
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.91
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.91
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.91
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.91
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.91
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.91
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.91
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.91
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.91
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.91
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.91
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.91
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.9
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.9
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.9
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.9
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.9
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.9
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.9
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.9
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.89
KOG0586	596	consensus Serine/threonine protein kinase [General	99.89
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.89
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.89
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.89
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.88
KOG3653	534	consensus Transforming growth factor beta/activin	99.88
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.88
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.88
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.87
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.87
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.87
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.87
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.86
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.86
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.85
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.85
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.85
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.85
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.85
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.85
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.84
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.84
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.83
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.82
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.82
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.82
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.8
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.79
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.76
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.73
KOG1152	772	consensus Signal transduction serine/threonine kin	99.7
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.7
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.68
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.67
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.67
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.67
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.63
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.59
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.59
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.58
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.54
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.52
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.49
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.46
PRK09188	365	serine/threonine protein kinase; Provisional	99.3
PRK12274	218	serine/threonine protein kinase; Provisional	99.25
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.22
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.17
COG4248	637	Uncharacterized protein with protein kinase and he	99.16
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.14
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.07
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.07
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.02
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.89
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.87
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	98.77
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	98.76
smart00090	237	RIO RIO-like kinase.	98.75
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	98.69
PRK10345	210	hypothetical protein; Provisional	98.62
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.6
PRK14879	211	serine/threonine protein kinase; Provisional	98.58
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	98.53
PRK09605	535	bifunctional UGMP family protein/serine/threonine	98.51
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.28
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	98.23
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.23
KOG1243	690	consensus Protein kinase [General function predict	98.2
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	98.14
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.03
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	97.98
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	97.96
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	97.92
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	97.83
KOG3087	229	consensus Serine/threonine protein kinase [General	97.76
PRK09902	216	hypothetical protein; Provisional	97.55
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.34
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	97.23
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.08
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	96.89
COG0478	304	RIO-like serine/threonine protein kinase fused to	96.71
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	96.0
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.91
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	95.91
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	95.49
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	95.25
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	95.12
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	94.93
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	94.77
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	94.55
PF01636	239	APH: Phosphotransferase enzyme family This family	94.47
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	94.46
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	94.33
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	94.3
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	94.24
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	94.15
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	93.92
PRK10271	188	thiK thiamine kinase; Provisional	93.75
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	93.63
COG0661	517	AarF Predicted unusual protein kinase [General fun	93.53
PRK05231	319	homoserine kinase; Provisional	93.47
PLN02236	344	choline kinase	92.96
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	92.53
COG2334	331	Putative homoserine kinase type II (protein kinase	92.53
KOG2268	465	consensus Serine/threonine protein kinase [Signal	92.36
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	92.3
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	92.03
KOG1093	725	consensus Predicted protein kinase (contains TBC a	91.93
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	91.83
PRK09550	401	mtnK methylthioribose kinase; Reviewed	91.48
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	91.36
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	90.67
PRK06148	1013	hypothetical protein; Provisional	90.23
PHA03111	444	Ser/Thr kinase; Provisional	89.56
PRK12396	409	5-methylribose kinase; Reviewed	88.81
PF11883	48	DUF3403: Domain of unknown function (DUF3403); Int	88.79
PRK11768	325	serine/threonine protein kinase; Provisional	88.7
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	88.39
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	88.09
KOG0576	829	consensus Mitogen-activated protein kinase kinase	87.83
PLN02756	418	S-methyl-5-thioribose kinase	87.79
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	86.3
PRK06149	972	hypothetical protein; Provisional	82.64
PRK10593	297	hypothetical protein; Provisional	80.36
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	80.2

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-34  Score=223.13  Aligned_cols=160  Identities=33%  Similarity=0.486  Sum_probs=125.0

Q ss_pred             hHHHHHHHHHHHHHHhhh-CCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            3 MLFNIILGVSRRLLYLHQ-DSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~-~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+-+|+.+|++||.|||. .+   |+||||||+|||++.+|.|||||||++....+.    .-+.++||..|+|||.+.+
T Consensus       179 ~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a~tfvGT~~YMsPERi~g  251 (364)
T KOG0581|consen  179 VLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IANTFVGTSAYMSPERISG  251 (364)
T ss_pred             HHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh----hcccccccccccChhhhcC
Confidence            345799999999999996 77   999999999999999999999999998765543    2233689999999999999


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..|+.++||||||+.++|+..|+.||.... .......+...         .+.+..+........+.++..||..||+.
T Consensus       252 ~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~-~~~~~~~~Ll~---------~Iv~~ppP~lP~~~fS~ef~~FV~~CL~K  321 (364)
T KOG0581|consen  252 ESYSVKSDIWSLGLSLLELAIGRFPYPPPN-PPYLDIFELLC---------AIVDEPPPRLPEGEFSPEFRSFVSCCLRK  321 (364)
T ss_pred             CcCCcccceecccHHHHHHhhCCCCCCCcC-CCCCCHHHHHH---------HHhcCCCCCCCcccCCHHHHHHHHHHhcC
Confidence            999999999999999999999999986531 11111221111         12232333222225667899999999999


Q ss_pred             CCCCCCCHHHHHHHhcCc
Q 027675          162 DPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~~~  179 (220)
                      ||.+||++.|+++|=+-.
T Consensus       322 dp~~R~s~~qLl~Hpfi~  339 (364)
T KOG0581|consen  322 DPSERPSAKQLLQHPFIK  339 (364)
T ss_pred             CcccCCCHHHHhcCHHHh
Confidence            999999999999876444

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=99.97  E-value=3.9e-32  Score=207.39  Aligned_cols=168  Identities=20%  Similarity=0.329  Sum_probs=127.4

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc-
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG-   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~-   81 (220)
                      .+.++++|+++|+.|+|+++   ++||||||+||+++.+|.+||||||+++....  .....+.++.|.+|.|||++.| 
T Consensus       102 ~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pgd~YTDYVATRWYRaPELLvGD  176 (396)
T KOG0593|consen  102 LVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA--PGDNYTDYVATRWYRAPELLVGD  176 (396)
T ss_pred             HHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC--CcchhhhhhhhhhccChhhhccc
Confidence            46789999999999999999   99999999999999999999999999987553  3344556778999999999998 


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHH--------HHHHHhcccccccc-CCCCCcCc-----HHH
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA--------WKLWQEGKALDMMD-QKPGAISK-----ANE  147 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~-~~~~~~~~-----~~~  147 (220)
                      ..|....|||++||++.||++|.+.|.+..+.++.-.+...        +.++.......-+. +.+....+     +..
T Consensus       177 tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~  256 (396)
T KOG0593|consen  177 TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKI  256 (396)
T ss_pred             CcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccc
Confidence            57899999999999999999999999766554443322111        23333332221111 11111111     223


Q ss_pred             HHHHHHHhccccCCCCCCCCCHHHHHHH
Q 027675          148 ILKCINVGLLCVQEDPNDRPTMSDVVIM  175 (220)
Q Consensus       148 ~~~~~~li~~cl~~~p~~Rps~~~~l~~  175 (220)
                      +.-+++++..||+.||++|++-++++.+
T Consensus       257 s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  257 SNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             hHHHHHHHHHHhcCCccccccHHHHhcC
Confidence            4468999999999999999999999844

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=217.03  Aligned_cols=164  Identities=30%  Similarity=0.439  Sum_probs=128.7

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCC-CceecCccceeeecCCCCCcccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEM-NPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~   80 (220)
                      ..+++|+.+|+.|++|||+++.  |+|||||++|||++.++ .+||+|||+++......  ...+...||+.|+|||++.
T Consensus       142 ~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~  217 (362)
T KOG0192|consen  142 KVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLR  217 (362)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc--ccccCCCCCccccChhhhc
Confidence            4678999999999999999973  89999999999999997 99999999998654321  2222357899999999999


Q ss_pred             --cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           81 --GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        81 --~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                        +..++.++||||||+++|||++|+.||........      .......+.+..+...         ....+..+|.+|
T Consensus       218 ~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~------~~~v~~~~~Rp~~p~~---------~~~~l~~l~~~C  282 (362)
T KOG0192|consen  218 GEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV------ASAVVVGGLRPPIPKE---------CPPHLSSLMERC  282 (362)
T ss_pred             CCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH------HHHHHhcCCCCCCCcc---------CCHHHHHHHHHh
Confidence              56899999999999999999999999986554221      1222223333333222         334678888889


Q ss_pred             cCCCCCCCCCHHHHHHHhcCccccCC
Q 027675          159 VQEDPNDRPTMSDVVIMLGSEAVNLA  184 (220)
Q Consensus       159 l~~~p~~Rps~~~~l~~l~~~~~~~~  184 (220)
                      |..||+.||++.+++..|+.......
T Consensus       283 W~~dp~~RP~f~ei~~~l~~~~~~~~  308 (362)
T KOG0192|consen  283 WLVDPSRRPSFLEIVSRLESIMSHIS  308 (362)
T ss_pred             CCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence            99999999999999999976655444

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=218.12  Aligned_cols=176  Identities=41%  Similarity=0.667  Sum_probs=147.7

Q ss_pred             CchHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecC-CCCCccccee-ecccCccChhh
Q 027675            1 MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEG-KQTDGTTNRV-VGTYGYMSPEY   78 (220)
Q Consensus         1 ~~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~-~~~~~y~aPe~   78 (220)
                      |+++++|+.++++||+|||....++|+|||||++|||++.+..+||+|||++..... ....   ... .|+..|++||+
T Consensus       173 W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~---~~~~~gt~gY~~PEy  249 (361)
T KOG1187|consen  173 WETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSV---STTVMGTFGYLAPEY  249 (361)
T ss_pred             HHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccce---eeecCCCCccCChhh
Confidence            688999999999999999998877899999999999999999999999999965432 1111   111 67899999999


Q ss_pred             hhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCC-CcCcH-HHHHHHHHHhc
Q 027675           79 ALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPG-AISKA-NEILKCINVGL  156 (220)
Q Consensus        79 ~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~li~  156 (220)
                      ......+.++||||||++++|+++|+.+.+............|.+..+.++...+++|+... ..+.. .+...+..+..
T Consensus       250 ~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~  329 (361)
T KOG1187|consen  250 ASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELAL  329 (361)
T ss_pred             hccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHH
Confidence            98888899999999999999999999887754433444467777888888899999998866 44443 67788999999


Q ss_pred             cccCCCCCCCCCHHHHHHHhcCc
Q 027675          157 LCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       157 ~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      +|++.+|+.||+|.+|++.|...
T Consensus       330 ~C~~~~~~~RP~m~~Vv~~L~~~  352 (361)
T KOG1187|consen  330 RCLRPDPKERPTMSQVVKELEGI  352 (361)
T ss_pred             HHcCcCCCcCcCHHHHHHHHHhh
Confidence            99999999999999999999444

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=3.8e-32  Score=223.66  Aligned_cols=153  Identities=24%  Similarity=0.343  Sum_probs=123.2

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      +++.+++||+.||.|||+++   |+|||||..|+|++.+..|||+|||++.......  ......-||+.|.|||++.+.
T Consensus       119 Eary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~--Erk~TlCGTPNYIAPEVl~k~  193 (592)
T KOG0575|consen  119 EARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG--ERKKTLCGTPNYIAPEVLNKS  193 (592)
T ss_pred             HHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCcc--cccceecCCCcccChhHhccC
Confidence            57889999999999999999   9999999999999999999999999998765321  223346799999999999988


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      +.+..+||||+||++|-|+.|++||+..+-.+....+      .       ..+.    ..+...+....++|..+|+.|
T Consensus       194 gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~I------k-------~~~Y----~~P~~ls~~A~dLI~~lL~~~  256 (592)
T KOG0575|consen  194 GHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKI------K-------LNEY----SMPSHLSAEAKDLIRKLLRPN  256 (592)
T ss_pred             CCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHH------H-------hcCc----ccccccCHHHHHHHHHHhcCC
Confidence            8999999999999999999999999865444433222      1       0011    111133446788999999999


Q ss_pred             CCCCCCHHHHHHHhc
Q 027675          163 PNDRPTMSDVVIMLG  177 (220)
Q Consensus       163 p~~Rps~~~~l~~l~  177 (220)
                      |.+|||+++|+.+=.
T Consensus       257 P~~Rpsl~~vL~h~F  271 (592)
T KOG0575|consen  257 PSERPSLDEVLDHPF  271 (592)
T ss_pred             cccCCCHHHHhcCHh
Confidence            999999999996643

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.1e-31  Score=213.77  Aligned_cols=169  Identities=25%  Similarity=0.315  Sum_probs=128.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +.+.+|+.||++||+|+|++|   ++|||+||+|||+..+..+||+|||+++.......   .+.++.|.+|+|||++..
T Consensus       110 ~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP---YTeYVSTRWYRAPEvLLr  183 (538)
T KOG0661|consen  110 SDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRSKPP---YTEYVSTRWYRAPEVLLR  183 (538)
T ss_pred             HHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccccCCC---cchhhhcccccchHHhhh
Confidence            468999999999999999999   99999999999999888999999999997654433   445788999999998754


Q ss_pred             -CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHH-----HHHHHhcc------cccc--ccCCCCCcCcHHH
Q 027675           82 -GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA-----WKLWQEGK------ALDM--MDQKPGAISKANE  147 (220)
Q Consensus        82 -~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~------~~~~--~~~~~~~~~~~~~  147 (220)
                       ..|+.+.|||++|||++|+++-++.|.+.++.+....+-.+     +..+.++.      ....  ..+.+-....++.
T Consensus       184 s~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~  263 (538)
T KOG0661|consen  184 SGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNA  263 (538)
T ss_pred             ccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCccc
Confidence             56899999999999999999999999877665544332111     11111111      1111  1111111122335


Q ss_pred             HHHHHHHhccccCCCCCCCCCHHHHHHHh
Q 027675          148 ILKCINVGLLCVQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       148 ~~~~~~li~~cl~~~p~~Rps~~~~l~~l  176 (220)
                      ...+.++|.+|+.+||++||||.+++++-
T Consensus       264 s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  264 SSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             CHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence            67889999999999999999999999875

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=5.7e-31  Score=214.07  Aligned_cols=158  Identities=31%  Similarity=0.472  Sum_probs=129.6

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+++.|+.||++|++||++++   ++||||.+.|||++++..+|++|||+++............ ..-+..|.|||.+..
T Consensus       303 ~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~-~kfPIkWtAPEa~~~  378 (468)
T KOG0197|consen  303 PQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEG-GKFPIKWTAPEALNY  378 (468)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceeecCC-CCCCceecCHHHHhh
Confidence            467899999999999999999   9999999999999999999999999999544332222221 122568999999999


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++||||||+++||++| |+.||..+......       .....|.++..+..+|.         .++++|..||.
T Consensus       379 ~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~-------~~le~GyRlp~P~~CP~---------~vY~lM~~CW~  442 (468)
T KOG0197|consen  379 GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVL-------ELLERGYRLPRPEGCPD---------EVYELMKSCWH  442 (468)
T ss_pred             CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHH-------HHHhccCcCCCCCCCCH---------HHHHHHHHHhh
Confidence            999999999999999999997 88887766554433       34456777766666554         78899999999


Q ss_pred             CCCCCCCCHHHHHHHhcCc
Q 027675          161 EDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~  179 (220)
                      .+|++|||++.+...++..
T Consensus       443 ~~P~~RPtF~~L~~~l~~~  461 (468)
T KOG0197|consen  443 EDPEDRPTFETLREVLEDF  461 (468)
T ss_pred             CCcccCCCHHHHHHHHHHh
Confidence            9999999999999888665

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=4.9e-31  Score=199.64  Aligned_cols=157  Identities=25%  Similarity=0.337  Sum_probs=123.7

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCC--eEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLR--IIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYA   79 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~--i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~   79 (220)
                      +++|+++-|++.||..+|.+ .++  +.||||||.|||++.+|.|||+|||+++......  ......+|||-|++||.+
T Consensus       124 ~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~--tfA~S~VGTPyYMSPE~i  200 (375)
T KOG0591|consen  124 KTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKT--TFAHSLVGTPYYMSPERI  200 (375)
T ss_pred             HHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCceeeccchhHhHhcchh--HHHHhhcCCCcccCHHHH
Confidence            47899999999999999984 233  9999999999999999999999999998765432  233447899999999999


Q ss_pred             hcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           80 LGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        80 ~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      .+.+++.++||||+||++|||..-..||...+-......               +-.+.........++..+..+|..|+
T Consensus       201 ~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~K---------------I~qgd~~~~p~~~YS~~l~~li~~ci  265 (375)
T KOG0591|consen  201 HESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKK---------------IEQGDYPPLPDEHYSTDLRELINMCI  265 (375)
T ss_pred             hcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHH---------------HHcCCCCCCcHHHhhhHHHHHHHHHc
Confidence            999999999999999999999999999975532222211               11111222233567778888899999


Q ss_pred             CCCCCCCCCHHHHHHHh
Q 027675          160 QEDPNDRPTMSDVVIML  176 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l  176 (220)
                      ..||+.||+.-.++..+
T Consensus       266 ~vd~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  266 AVDPEQRPDTVPYVQDI  282 (375)
T ss_pred             cCCcccCCCcchHHHHH
Confidence            99999999965555544

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=99.97  E-value=3e-31  Score=215.81  Aligned_cols=153  Identities=27%  Similarity=0.349  Sum_probs=122.8

Q ss_pred             HHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCC---------ccc--ceeecccC
Q 027675            4 LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD---------GTT--NRVVGTYG   72 (220)
Q Consensus         4 ~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~---------~~~--~~~~~~~~   72 (220)
                      .+.++.+|+.||+|||++|   |+||||||+|||++.++.++|+|||.+.........         ...  ..++||-.
T Consensus       176 aR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAe  252 (604)
T KOG0592|consen  176 ARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAE  252 (604)
T ss_pred             HHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeec
Confidence            4568899999999999999   999999999999999999999999999876532211         111  33789999


Q ss_pred             ccChhhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHH
Q 027675           73 YMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCI  152 (220)
Q Consensus        73 y~aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (220)
                      |.+||++.....+..+|+|+|||++|+|+.|.+||...++......+..            + +......+    .....
T Consensus       253 YVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~------------l-~y~fp~~f----p~~a~  315 (604)
T KOG0592|consen  253 YVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQA------------L-DYEFPEGF----PEDAR  315 (604)
T ss_pred             ccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHH------------h-cccCCCCC----CHHHH
Confidence            9999999999999999999999999999999999987776655433211            0 11111111    14678


Q ss_pred             HHhccccCCCCCCCCCHHHHHHHh
Q 027675          153 NVGLLCVQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       153 ~li~~cl~~~p~~Rps~~~~l~~l  176 (220)
                      ++|.++|..||.+|+|..+|.+|-
T Consensus       316 dLv~KLLv~dp~~Rlt~~qIk~Hp  339 (604)
T KOG0592|consen  316 DLIKKLLVRDPSDRLTSQQIKAHP  339 (604)
T ss_pred             HHHHHHHccCccccccHHHHhhCc
Confidence            899999999999999999999876

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2.5e-31  Score=210.09  Aligned_cols=160  Identities=23%  Similarity=0.299  Sum_probs=119.8

Q ss_pred             HHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCC---CCceecCccceeeecCCCCCcccceeecccCccChhhhh
Q 027675            4 LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHE---MNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         4 ~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~   80 (220)
                      ..-+++||+.|+.|||++|   |+||||||+|||+..+   ..+|++|||++......   ......-||+.|.|||++.
T Consensus       278 ~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~---sfm~TlCGTpsYvAPEVl~  351 (475)
T KOG0615|consen  278 GKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEG---SFMKTLCGTPSYVAPEVLA  351 (475)
T ss_pred             hHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchhhccccc---eehhhhcCCccccChhhee
Confidence            3568899999999999999   9999999999999776   66899999999865421   2233367899999999998


Q ss_pred             cCCC---cccCceeehhHHHHHHHhcCccCcccchhH-HHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhc
Q 027675           81 GGFF---SVKSDVFSFGVVVLEIISGKRNTGFYNSEL-ALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGL  156 (220)
Q Consensus        81 ~~~~---~~~~DiwslG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  156 (220)
                      +.++   ..+.|+||+||++|-+++|.+||....... ..       ++...|+-      ......-.....+..++|.
T Consensus       352 ~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~-------eQI~~G~y------~f~p~~w~~Iseea~dlI~  418 (475)
T KOG0615|consen  352 SKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLK-------EQILKGRY------AFGPLQWDRISEEALDLIN  418 (475)
T ss_pred             cCCeecccchheeeeccceEEEEeccCCCcccccCCccHH-------HHHhcCcc------cccChhhhhhhHHHHHHHH
Confidence            7643   347799999999999999999996432221 11       11111111      1111122344568899999


Q ss_pred             cccCCCCCCCCCHHHHHHHhcCcccc
Q 027675          157 LCVQEDPNDRPTMSDVVIMLGSEAVN  182 (220)
Q Consensus       157 ~cl~~~p~~Rps~~~~l~~l~~~~~~  182 (220)
                      +||..||++|||+.++|.|=|.....
T Consensus       419 ~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  419 WMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             HhhEeCcccCcCHHHHhcChhhhccc
Confidence            99999999999999999887766443

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.8e-30  Score=211.13  Aligned_cols=155  Identities=25%  Similarity=0.363  Sum_probs=125.6

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      +|..|++++++||+|||.+|   |+|||||.+||++..+|.+||+|||++..+.....  .-...+||+.|+|||+....
T Consensus       370 qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR~TmVGTPYWMAPEVvtrk  444 (550)
T KOG0578|consen  370 QIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KRSTMVGTPYWMAPEVVTRK  444 (550)
T ss_pred             HHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC--ccccccCCCCccchhhhhhc
Confidence            67889999999999999999   99999999999999999999999999877655443  23336899999999999999


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      .|..+.||||||+++.||+.|++||-..+.-.....+       ..       ...+........+..+.+|+.+||+.|
T Consensus       445 ~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI-------a~-------ng~P~lk~~~klS~~~kdFL~~cL~~d  510 (550)
T KOG0578|consen  445 PYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------AT-------NGTPKLKNPEKLSPELKDFLDRCLVVD  510 (550)
T ss_pred             ccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH-------hh-------cCCCCcCCccccCHHHHHHHHHHhhcc
Confidence            9999999999999999999999998543322222111       11       122333333445568899999999999


Q ss_pred             CCCCCCHHHHHHHh
Q 027675          163 PNDRPTMSDVVIML  176 (220)
Q Consensus       163 p~~Rps~~~~l~~l  176 (220)
                      +++|+++.++|+|=
T Consensus       511 v~~RasA~eLL~Hp  524 (550)
T KOG0578|consen  511 VEQRASAKELLEHP  524 (550)
T ss_pred             hhcCCCHHHHhcCh
Confidence            99999999999774

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=8.1e-31  Score=206.71  Aligned_cols=160  Identities=28%  Similarity=0.393  Sum_probs=118.7

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCC-CCCceecCccceeeecC-CCCCcccceeecccCccChhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDH-EMNPKISDFGLTRIFEG-KQTDGTTNRVVGTYGYMSPEYA   79 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~-~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~~y~aPe~~   79 (220)
                      +.+..+.+|+++||+|||++|   |+|+|||++|||++. ++.+||+|||.+..... ...........|++.|+|||++
T Consensus       117 ~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi  193 (313)
T KOG0198|consen  117 PLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVI  193 (313)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhh
Confidence            357889999999999999999   999999999999999 79999999998875442 1111222236789999999999


Q ss_pred             hcC-CCcccCceeehhHHHHHHHhcCccCccc-chhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcc
Q 027675           80 LGG-FFSVKSDVFSFGVVVLEIISGKRNTGFY-NSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLL  157 (220)
Q Consensus        80 ~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  157 (220)
                      ... .....+|||||||++.||+||..||... ......      ..........         ...........+|+..
T Consensus       194 ~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~------~~ig~~~~~P---------~ip~~ls~~a~~Fl~~  258 (313)
T KOG0198|consen  194 RNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEAL------LLIGREDSLP---------EIPDSLSDEAKDFLRK  258 (313)
T ss_pred             cCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHH------HHHhccCCCC---------CCCcccCHHHHHHHHH
Confidence            853 2345999999999999999999998753 111111      1111111111         1111133467889999


Q ss_pred             ccCCCCCCCCCHHHHHHHhcCc
Q 027675          158 CVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       158 cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      |++.||++||||+++|.+....
T Consensus       259 C~~~~p~~Rpta~eLL~hpf~~  280 (313)
T KOG0198|consen  259 CFKRDPEKRPTAEELLEHPFLK  280 (313)
T ss_pred             HhhcCcccCcCHHHHhhChhhh
Confidence            9999999999999999987554

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.97  E-value=9.8e-30  Score=211.16  Aligned_cols=170  Identities=21%  Similarity=0.213  Sum_probs=126.1

Q ss_pred             CchHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCC--CCceecCccceeeecCCCCCcccceeecccCccChhh
Q 027675            1 MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHE--MNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEY   78 (220)
Q Consensus         1 ~~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~--~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~   78 (220)
                      +..++.|++||+.||.+||+.+   |+|+||||+|||+.+.  ..+|++|||.++.......     .+..+.-|.|||+
T Consensus       288 l~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy-----tYiQSRfYRAPEV  359 (586)
T KOG0667|consen  288 LPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY-----TYIQSRFYRAPEV  359 (586)
T ss_pred             HHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccccCCcce-----eeeeccccccchh
Confidence            3568899999999999999999   9999999999999654  3589999999987654433     3566788999999


Q ss_pred             hhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHH---------------HHHHHh-ccccc---------
Q 027675           79 ALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA---------------WKLWQE-GKALD---------  133 (220)
Q Consensus        79 ~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~---------------~~~~~~-~~~~~---------  133 (220)
                      +.|.+|+.+.||||||||++||++|.+.|.+.+..++...+..+               .+.+.. .....         
T Consensus       360 ILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~  439 (586)
T KOG0667|consen  360 ILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPR  439 (586)
T ss_pred             hccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccc
Confidence            99999999999999999999999999999877666555443222               001111 00000         


Q ss_pred             -------------------cc-cCCCCC-cCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcC
Q 027675          134 -------------------MM-DQKPGA-ISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       134 -------------------~~-~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~  178 (220)
                                         .+ +..... .....+...+++++++||++||.+|+|+.++++|-+-
T Consensus       440 ~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl  505 (586)
T KOG0667|consen  440 GTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFL  505 (586)
T ss_pred             cccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCccc
Confidence                               00 000000 1112344578999999999999999999999977643

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.96  E-value=2.8e-30  Score=209.70  Aligned_cols=160  Identities=30%  Similarity=0.427  Sum_probs=119.5

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +++..++.|+++||.|||+++   |+||||||+||+++.++.++|+|||++................++..|+|||.+.+
T Consensus       174 ~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  250 (338)
T cd05102         174 EDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFD  250 (338)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhc
Confidence            356789999999999999999   99999999999999999999999999875432211111222334568999999988


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++||||||+++|+|++ |..||.........      ......+.....         .......+.+++.+||+
T Consensus       251 ~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~------~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~  315 (338)
T cd05102         251 KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF------CQRLKDGTRMRA---------PENATPEIYRIMLACWQ  315 (338)
T ss_pred             CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHH------HHHHhcCCCCCC---------CCCCCHHHHHHHHHHcc
Confidence            888999999999999999997 99998654322111      111111111111         11123467899999999


Q ss_pred             CCCCCCCCHHHHHHHhcCc
Q 027675          161 EDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~  179 (220)
                      .||++|||+.++++.|+..
T Consensus       316 ~dp~~RPs~~el~~~l~~~  334 (338)
T cd05102         316 GDPKERPTFSALVEILGDL  334 (338)
T ss_pred             CChhhCcCHHHHHHHHHHH
Confidence            9999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.96  E-value=6.1e-30  Score=192.10  Aligned_cols=188  Identities=22%  Similarity=0.262  Sum_probs=134.0

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+.+++.++++|++|||.+.   |+||||||.|++++.+|.+|++|||+++.+..........  +-+.+|.|||++.|.
T Consensus       102 ~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~--V~TRWYRAPELLfGs  176 (318)
T KOG0659|consen  102 DIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQ--VVTRWYRAPELLFGS  176 (318)
T ss_pred             HHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCcccccc--eeeeeccChHHhccc
Confidence            47789999999999999999   9999999999999999999999999999877654443332  457899999999886


Q ss_pred             -CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHH-----HHHHHhccc------cccccCCCCCcCcHHHHHH
Q 027675           83 -FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA-----WKLWQEGKA------LDMMDQKPGAISKANEILK  150 (220)
Q Consensus        83 -~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~------~~~~~~~~~~~~~~~~~~~  150 (220)
                       .|+...||||.|||+.||+-+.+.|.+.++.++...+-..     ...+.+-..      .......+....-......
T Consensus       177 r~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d  256 (318)
T KOG0659|consen  177 RQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSD  256 (318)
T ss_pred             hhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHH
Confidence             5788999999999999999999888776666655443221     001110000      0000001111122233445


Q ss_pred             HHHHhccccCCCCCCCCCHHHHHHHhcCccccCCCCCCchhhhccCC
Q 027675          151 CINVGLLCVQEDPNDRPTMSDVVIMLGSEAVNLASPKRPAFVVRRGS  197 (220)
Q Consensus       151 ~~~li~~cl~~~p~~Rps~~~~l~~l~~~~~~~~~~~~~~~~~~~~~  197 (220)
                      .++++..||.+||.+|+++.|++++=....  .+.|..+...+.+++
T Consensus       257 ~ldLl~~m~~ynP~~Rita~qaL~~~yf~~--~P~pt~~~~lp~p~~  301 (318)
T KOG0659|consen  257 ALDLLSKMLTYNPKKRITASQALKHPYFKS--LPLPTPPSKLPIPST  301 (318)
T ss_pred             HHHHHHhhhccCchhcccHHHHhcchhhhc--CCCCCChhhCcCCcc
Confidence            689999999999999999999998864443  444444444444444

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=6.4e-30  Score=203.94  Aligned_cols=164  Identities=29%  Similarity=0.410  Sum_probs=121.6

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCc-cc-ceeecccCccChhhhh
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG-TT-NRVVGTYGYMSPEYAL   80 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~-~~-~~~~~~~~y~aPe~~~   80 (220)
                      .|..|++++++||.|||++|   .+|||||+.||||+.+|.|+|+|||+.-.......+. .. +.+.+++.|+|||++.
T Consensus       127 ~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~  203 (516)
T KOG0582|consen  127 SIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLM  203 (516)
T ss_pred             HHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhh
Confidence            46678999999999999999   9999999999999999999999999876433221111 11 4568899999999964


Q ss_pred             c--CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           81 G--GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        81 ~--~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                      .  .+|+.|+||||||+...||.+|..||+.+......-.     ++...-....  ...............+.+++..|
T Consensus       204 q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~-----tLqn~pp~~~--t~~~~~d~~k~~~ksf~e~i~~C  276 (516)
T KOG0582|consen  204 QQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLL-----TLQNDPPTLL--TSGLDKDEDKKFSKSFREMIALC  276 (516)
T ss_pred             hcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHH-----HhcCCCCCcc--cccCChHHhhhhcHHHHHHHHHH
Confidence            3  4799999999999999999999999987776543211     1111111111  11111222233345788999999


Q ss_pred             cCCCCCCCCCHHHHHHHh
Q 027675          159 VQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       159 l~~~p~~Rps~~~~l~~l  176 (220)
                      |..||.+|||+++++++-
T Consensus       277 L~kDP~kRptAskLlkh~  294 (516)
T KOG0582|consen  277 LVKDPSKRPTASKLLKHA  294 (516)
T ss_pred             hhcCcccCCCHHHHhccH
Confidence            999999999999999653

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.4e-30  Score=201.63  Aligned_cols=171  Identities=26%  Similarity=0.318  Sum_probs=124.8

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc-
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG-   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~-   81 (220)
                      .+.-+++|++.||+|+|+.+   ++||||||.|++++.++.+|++|||+++...........+.++-|.+|.|||++.. 
T Consensus       126 H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~  202 (359)
T KOG0660|consen  126 HAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNS  202 (359)
T ss_pred             HHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhcc
Confidence            45668899999999999999   99999999999999999999999999997654322333345677899999999854 


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHH---------HHHH---Hhccccccc--cCCCCCcCcHHH
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA---------WKLW---QEGKALDMM--DQKPGAISKANE  147 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~---------~~~~---~~~~~~~~~--~~~~~~~~~~~~  147 (220)
                      ..++...||||+|||+.||++|++.|.+.+.-.+...+...         ..+.   ...-+....  .+.+....-++.
T Consensus       203 ~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a  282 (359)
T KOG0660|consen  203 SEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNA  282 (359)
T ss_pred             ccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCC
Confidence            57899999999999999999999999766554444333221         0000   000000000  011111111233


Q ss_pred             HHHHHHHhccccCCCCCCCCCHHHHHHHh
Q 027675          148 ILKCINVGLLCVQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       148 ~~~~~~li~~cl~~~p~~Rps~~~~l~~l  176 (220)
                      ....++++.+||..||.+|+|++++|+|-
T Consensus       283 ~p~AidLlekmL~fdP~kRita~eAL~hP  311 (359)
T KOG0660|consen  283 NPLAIDLLEKMLVFDPKKRITAEEALAHP  311 (359)
T ss_pred             CHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence            45678999999999999999999999875

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.96  E-value=3e-30  Score=212.39  Aligned_cols=173  Identities=27%  Similarity=0.397  Sum_probs=126.5

Q ss_pred             CchHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhh
Q 027675            1 MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         1 ~~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~   80 (220)
                      |.+.+.|++|+++|+.|||.++   |+|+|||..|||+.++++|+|+|||++.....-....-.....+...|+|||++.
T Consensus       487 m~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIR  563 (678)
T KOG0193|consen  487 MNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIR  563 (678)
T ss_pred             HHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHh
Confidence            3578899999999999999999   9999999999999999999999999986432111111111235677999999997


Q ss_pred             c---CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcc
Q 027675           81 G---GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLL  157 (220)
Q Consensus        81 ~---~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  157 (220)
                      .   .+|+.++||||||+++|||++|..||...+.+...-      .   .|+---..+.   .....+....+.+++..
T Consensus       564 mqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIif------m---VGrG~l~pd~---s~~~s~~pk~mk~Ll~~  631 (678)
T KOG0193|consen  564 MQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIF------M---VGRGYLMPDL---SKIRSNCPKAMKRLLSD  631 (678)
T ss_pred             hcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEE------E---ecccccCccc---hhhhccCHHHHHHHHHH
Confidence            4   478999999999999999999999998444333211      0   0111000111   11112334467888888


Q ss_pred             ccCCCCCCCCCHHHHHHHhcCccccCCCCCC
Q 027675          158 CVQEDPNDRPTMSDVVIMLGSEAVNLASPKR  188 (220)
Q Consensus       158 cl~~~p~~Rps~~~~l~~l~~~~~~~~~~~~  188 (220)
                      ||++++++||.+.+|+..|+......+...+
T Consensus       632 C~~~~~~eRP~F~~il~~l~~l~~~~pki~R  662 (678)
T KOG0193|consen  632 CWKFDREERPLFPQLLSKLEELLPSLPKINR  662 (678)
T ss_pred             HHhcCcccCccHHHHHHHHHHhhhccccccc
Confidence            9999999999999999988777665555544

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=3.6e-29  Score=202.21  Aligned_cols=172  Identities=25%  Similarity=0.306  Sum_probs=127.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+|..+++||+.||+|+|.+|   ++|||||.+||||+++|.+||+|||+++.+.........+. +-|.+|.|||++.|
T Consensus       218 ~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~r-VvTLWYRpPELLLG  293 (560)
T KOG0600|consen  218 PQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSR-VVTLWYRPPELLLG  293 (560)
T ss_pred             HHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCCCCcccccc-eEEeeccChHHhcC
Confidence            468899999999999999999   99999999999999999999999999997766554444443 44889999999998


Q ss_pred             C-CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHH-----HHHHHhcccc--ccccCCCCCcCcHHH-----H
Q 027675           82 G-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA-----WKLWQEGKAL--DMMDQKPGAISKANE-----I  148 (220)
Q Consensus        82 ~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~--~~~~~~~~~~~~~~~-----~  148 (220)
                      . .|+...|+||+|||+.||+.|++.|...++..+...+...     ...|......  ..+.+.........+     .
T Consensus       294 ~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~  373 (560)
T KOG0600|consen  294 ATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFP  373 (560)
T ss_pred             CcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCC
Confidence            6 6899999999999999999999999877666554433221     0011111111  111111111111111     2


Q ss_pred             HHHHHHhccccCCCCCCCCCHHHHHHHhc
Q 027675          149 LKCINVGLLCVQEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       149 ~~~~~li~~cl~~~p~~Rps~~~~l~~l~  177 (220)
                      ...++++..+|..||.+|.|+.++|..=.
T Consensus       374 ~~~l~Ll~~lL~ldP~kR~tA~~aL~sey  402 (560)
T KOG0600|consen  374 ASALDLLEKLLSLDPDKRGTASSALQSEY  402 (560)
T ss_pred             HHHHHHHHHHhccCccccccHHHHhcCcc
Confidence            35678888999999999999999996643

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-29  Score=216.20  Aligned_cols=160  Identities=23%  Similarity=0.249  Sum_probs=130.9

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCc-----ccc--eeecccCcc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG-----TTN--RVVGTYGYM   74 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~-----~~~--~~~~~~~y~   74 (220)
                      .++++|++++++|+.+||.. +++|+|||||.+||||+.+|..||||||.+..........     ...  ...-|+.|+
T Consensus       144 ~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YR  222 (738)
T KOG1989|consen  144 DEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYR  222 (738)
T ss_pred             HHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCcccc
Confidence            47899999999999999998 6789999999999999999999999999987433211000     000  123478999


Q ss_pred             Chhhh---hcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHH
Q 027675           75 SPEYA---LGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKC  151 (220)
Q Consensus        75 aPe~~---~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (220)
                      +||.+   .+.+.++|+|||+|||+||.|+....||+.                   +....++...-.......+...+
T Consensus       223 sPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~-------------------sg~laIlng~Y~~P~~p~ys~~l  283 (738)
T KOG1989|consen  223 SPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEE-------------------SGKLAILNGNYSFPPFPNYSDRL  283 (738)
T ss_pred             ChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCc-------------------CcceeEEeccccCCCCccHHHHH
Confidence            99976   567889999999999999999999999973                   22445666666666667889999


Q ss_pred             HHHhccccCCCCCCCCCHHHHHHHhcCccc
Q 027675          152 INVGLLCVQEDPNDRPTMSDVVIMLGSEAV  181 (220)
Q Consensus       152 ~~li~~cl~~~p~~Rps~~~~l~~l~~~~~  181 (220)
                      .+||+.||+.||++||++-+++..+-.+..
T Consensus       284 ~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  284 KDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             HHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence            999999999999999999999988866544

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.96  E-value=6.7e-30  Score=203.06  Aligned_cols=168  Identities=23%  Similarity=0.299  Sum_probs=119.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++......   .......++..|+|||.+.+
T Consensus       110 ~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~  183 (290)
T cd07862         110 ETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQ  183 (290)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccceEeccCC---cccccccccccccChHHHhC
Confidence            357889999999999999999   999999999999999999999999998754322   11223457889999999988


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHH-----HHHHhccc--cccccCCCCCc---CcHHHHHHH
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAW-----KLWQEGKA--LDMMDQKPGAI---SKANEILKC  151 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~--~~~~~~~~~~~---~~~~~~~~~  151 (220)
                      ..++.++|+|||||++|+|++|.+||...+............     ..+.....  ...........   ........+
T Consensus       184 ~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (290)
T cd07862         184 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELG  263 (290)
T ss_pred             CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHH
Confidence            888999999999999999999999997655433222111000     00000000  00000000000   001123456


Q ss_pred             HHHhccccCCCCCCCCCHHHHHHH
Q 027675          152 INVGLLCVQEDPNDRPTMSDVVIM  175 (220)
Q Consensus       152 ~~li~~cl~~~p~~Rps~~~~l~~  175 (220)
                      .+++.+||+.||++|||+.+++++
T Consensus       264 ~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         264 KDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             HHHHHHHhccCchhcCCHHHHhcC
Confidence            799999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.9e-29  Score=205.52  Aligned_cols=157  Identities=26%  Similarity=0.345  Sum_probs=121.9

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCC-CCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHE-MNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ++.++++|++.|++|||++|   |+||||||+||+++.+ +.+||+|||++....  ..........|++.|+|||++.+
T Consensus       121 ~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~  195 (370)
T KOG0583|consen  121 EARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSG  195 (370)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCC
Confidence            56789999999999999999   9999999999999999 999999999998653  11223344678999999999998


Q ss_pred             CC-C-cccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           82 GF-F-SVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        82 ~~-~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      .. | ..++|+||+|+++|-|++|+.||...+......      + +..+..     ..+...   . +..+..++.+||
T Consensus       196 ~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~------k-i~~~~~-----~~p~~~---~-S~~~~~Li~~mL  259 (370)
T KOG0583|consen  196 KGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYR------K-IRKGEF-----KIPSYL---L-SPEARSLIEKML  259 (370)
T ss_pred             CCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHH------H-HhcCCc-----cCCCCc---C-CHHHHHHHHHHc
Confidence            77 7 488999999999999999999998633322221      1 111110     111111   1 557889999999


Q ss_pred             CCCCCCCCCHHHHHHHhcCcc
Q 027675          160 QEDPNDRPTMSDVVIMLGSEA  180 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l~~~~  180 (220)
                      ..||.+|+++.+++.+=|...
T Consensus       260 ~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  260 VPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             CCCcccCCCHHHHhhChhhcc
Confidence            999999999999997665553

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.96  E-value=1.9e-29  Score=199.74  Aligned_cols=157  Identities=27%  Similarity=0.423  Sum_probs=120.0

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      +++.++.|+++||.|||+.+   ++|+||||+||++++++.++|+|||++................++..|+|||.+.+.
T Consensus       125 ~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  201 (283)
T cd05048         125 DFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG  201 (283)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccC
Confidence            46789999999999999999   999999999999999999999999998754322211112223446789999999888


Q ss_pred             CCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           83 FFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      .++.++|+|||||++|+|++ |..||..........       ....+....         ........+.+++.+||+.
T Consensus       202 ~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~-------~i~~~~~~~---------~~~~~~~~~~~l~~~c~~~  265 (283)
T cd05048         202 KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE-------MIRSRQLLP---------CPEDCPARVYALMIECWNE  265 (283)
T ss_pred             cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-------HHHcCCcCC---------CcccCCHHHHHHHHHHccC
Confidence            88999999999999999997 998986544432211       111111111         1122345788999999999


Q ss_pred             CCCCCCCHHHHHHHhcC
Q 027675          162 DPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~~  178 (220)
                      ||++||++.+++++|..
T Consensus       266 ~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         266 IPARRPRFKDIHTRLRS  282 (283)
T ss_pred             ChhhCcCHHHHHHHHhc
Confidence            99999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-29  Score=198.58  Aligned_cols=152  Identities=26%  Similarity=0.333  Sum_probs=117.9

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+.-++..|+.||.|||+.|   |+||||||+|||++.+|.++|+|||++......  ......+.||+.|+|||++.+.
T Consensus       126 ~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~--~~~t~tfcGT~eYmAPEil~~~  200 (357)
T KOG0598|consen  126 RARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD--GDATRTFCGTPEYMAPEILLGK  200 (357)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccC--CCccccccCCccccChHHHhcC
Confidence            35668899999999999999   999999999999999999999999998743322  2233447899999999999999


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      +++..+|.||||+++|+|++|.+||...+.......+.       .++.     ..+.    .-......+++..+|+.|
T Consensus       201 gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~-------~~k~-----~~~p----~~ls~~ardll~~LL~rd  264 (357)
T KOG0598|consen  201 GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKIL-------KGKL-----PLPP----GYLSEEARDLLKKLLKRD  264 (357)
T ss_pred             CCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHh-------cCcC-----CCCC----ccCCHHHHHHHHHHhccC
Confidence            99999999999999999999999997666544432221       1110     1111    112336788899999999


Q ss_pred             CCCCC----CHHHHHHH
Q 027675          163 PNDRP----TMSDVVIM  175 (220)
Q Consensus       163 p~~Rp----s~~~~l~~  175 (220)
                      |++|.    ++++|..|
T Consensus       265 p~~RLg~~~d~~~ik~H  281 (357)
T KOG0598|consen  265 PRQRLGGPGDAEEIKRH  281 (357)
T ss_pred             HHHhcCCCCChHHhhcC
Confidence            99995    56666544

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.96  E-value=4e-29  Score=200.07  Aligned_cols=163  Identities=26%  Similarity=0.398  Sum_probs=117.0

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      ++++++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++................++..|+|||.+.+.
T Consensus       139 ~~~~i~~~i~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  215 (304)
T cd05096         139 SLLHVALQIASGMKYLSSLN---FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG  215 (304)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC
Confidence            56789999999999999999   999999999999999999999999998754322211122223346689999999888


Q ss_pred             CCcccCceeehhHHHHHHHh--cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           83 FFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      .++.++|+||||+++|+|++  +..||..........   ................. +     ......+.++|.+||+
T Consensus       216 ~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~-~-----~~~~~~~~~li~~cl~  286 (304)
T cd05096         216 KFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIE---NAGEFFRDQGRQVYLFR-P-----PPCPQGLYELMLQCWS  286 (304)
T ss_pred             CCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHH---HHHHHhhhccccccccC-C-----CCCCHHHHHHHHHHcc
Confidence            88999999999999999986  556665443332211   11111111111000000 1     1122467899999999


Q ss_pred             CCCCCCCCHHHHHHHhc
Q 027675          161 EDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~  177 (220)
                      .+|++|||+.+|.+.|+
T Consensus       287 ~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         287 RDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCchhCcCHHHHHHHHh
Confidence            99999999999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.96  E-value=5e-29  Score=200.61  Aligned_cols=161  Identities=23%  Similarity=0.425  Sum_probs=120.0

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .++.++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++.................+..|++||.+.+.
T Consensus       110 ~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~  186 (316)
T cd05108         110 YLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHR  186 (316)
T ss_pred             HHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccC
Confidence            56789999999999999999   999999999999999999999999998765432211111112234579999999988


Q ss_pred             CCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           83 FFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      .++.++|+||||+++|+|++ |..||..........       ....+.....    +     ......+.+++.+||..
T Consensus       187 ~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~-------~~~~~~~~~~----~-----~~~~~~~~~li~~cl~~  250 (316)
T cd05108         187 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-------ILEKGERLPQ----P-----PICTIDVYMIMVKCWMI  250 (316)
T ss_pred             CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH-------HHhCCCCCCC----C-----CCCCHHHHHHHHHHccC
Confidence            89999999999999999997 999986544332211       1111111110    0     11224678899999999


Q ss_pred             CCCCCCCHHHHHHHhcCcccc
Q 027675          162 DPNDRPTMSDVVIMLGSEAVN  182 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~~~~~~  182 (220)
                      +|++||++.+++..+.....+
T Consensus       251 ~p~~Rps~~~l~~~l~~~~~~  271 (316)
T cd05108         251 DADSRPKFRELIIEFSKMARD  271 (316)
T ss_pred             ChhhCcCHHHHHHHHHHHHcC
Confidence            999999999999998666443

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.96  E-value=3.5e-29  Score=202.19  Aligned_cols=153  Identities=22%  Similarity=0.254  Sum_probs=117.5

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      ++..++.|++.||+|||+.|   |+||||||+||+++.++.++|+|||++.......  .......|++.|+|||.+.+.
T Consensus        96 ~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~  170 (323)
T cd05571          96 RARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDN  170 (323)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--CcccceecCccccChhhhcCC
Confidence            56778999999999999999   9999999999999999999999999876432111  112234678999999999988


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      .++.++|+|||||++|+|++|..||...+........      . .+. .   .      ........+.++|.+||..|
T Consensus       171 ~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~------~-~~~-~---~------~p~~~~~~~~~li~~~L~~d  233 (323)
T cd05571         171 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------L-MEE-I---R------FPRTLSPEAKSLLAGLLKKD  233 (323)
T ss_pred             CCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHH------H-cCC-C---C------CCCCCCHHHHHHHHHHccCC
Confidence            8999999999999999999999999654433221111      0 000 0   0      01112346788999999999


Q ss_pred             CCCCC-----CHHHHHHHhc
Q 027675          163 PNDRP-----TMSDVVIMLG  177 (220)
Q Consensus       163 p~~Rp-----s~~~~l~~l~  177 (220)
                      |++||     ++.+++++-+
T Consensus       234 P~~R~~~~~~~~~~ll~h~~  253 (323)
T cd05571         234 PKQRLGGGPEDAKEIMEHRF  253 (323)
T ss_pred             HHHcCCCCCCCHHHHHcCCC
Confidence            99999     8999997643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.96  E-value=5.2e-29  Score=202.28  Aligned_cols=160  Identities=30%  Similarity=0.439  Sum_probs=120.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +.+.+++.|++.||.|||+++   |+||||||.||+++.++.++|+|||++................++..|+|||.+.+
T Consensus       173 ~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  249 (337)
T cd05054         173 EDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFD  249 (337)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcC
Confidence            457889999999999999999   99999999999999999999999999875432221111222334567999999999


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+|||||++|+|++ |..||........      .......+.....    +     ......+.+++.+||+
T Consensus       250 ~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~------~~~~~~~~~~~~~----~-----~~~~~~~~~l~~~cl~  314 (337)
T cd05054         250 KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE------FCRRLKEGTRMRA----P-----EYATPEIYSIMLDCWH  314 (337)
T ss_pred             CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH------HHHHHhccCCCCC----C-----ccCCHHHHHHHHHHcc
Confidence            889999999999999999998 9999864322211      1111112111111    1     1123468899999999


Q ss_pred             CCCCCCCCHHHHHHHhcCc
Q 027675          161 EDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~  179 (220)
                      .+|++||++.+++++|...
T Consensus       315 ~~p~~RPs~~ell~~l~~~  333 (337)
T cd05054         315 NNPEDRPTFSELVEILGDL  333 (337)
T ss_pred             CChhhCcCHHHHHHHHHHH
Confidence            9999999999999999654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-29  Score=198.73  Aligned_cols=167  Identities=22%  Similarity=0.298  Sum_probs=124.2

Q ss_pred             CchHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCC--------------------CCCceecCccceeeecCCCC
Q 027675            1 MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDH--------------------EMNPKISDFGLTRIFEGKQT   60 (220)
Q Consensus         1 ~~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~--------------------~~~~~l~d~~~~~~~~~~~~   60 (220)
                      ++++..|++|+++++++||+.+   ++|.||||+||++.+                    +..++++|||.+....... 
T Consensus       191 i~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-  266 (415)
T KOG0671|consen  191 IDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-  266 (415)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-
Confidence            3578999999999999999999   999999999999942                    3347899999988654433 


Q ss_pred             CcccceeecccCccChhhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHH--------------HHHH
Q 027675           61 DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA--------------WKLW  126 (220)
Q Consensus        61 ~~~~~~~~~~~~y~aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------------~~~~  126 (220)
                          ..++.|..|.|||++.+.+++..+|+||+|||+.|+++|...|+..+..+-....+-+              .+.+
T Consensus       267 ----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf  342 (415)
T KOG0671|consen  267 ----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYF  342 (415)
T ss_pred             ----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhh
Confidence                3356788999999999999999999999999999999999999876643322222111              1111


Q ss_pred             Hhcccccc---------------ccCCC-CCcCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHh
Q 027675          127 QEGKALDM---------------MDQKP-GAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       127 ~~~~~~~~---------------~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l  176 (220)
                      ..+ .++.               +.+.. .......+...+++++..||.+||.+|+|+.|++.+-
T Consensus       343 ~~~-rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~Hp  407 (415)
T KOG0671|consen  343 RRG-RLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHP  407 (415)
T ss_pred             hcc-cccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCH
Confidence            111 1110               00000 0122345567899999999999999999999999763

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.96  E-value=4.6e-29  Score=197.58  Aligned_cols=156  Identities=26%  Similarity=0.398  Sum_probs=117.0

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .++.++.|++.||.|||+.+   ++||||||.||++++++.++|+|||++................+++.|+|||.+.+.
T Consensus       125 ~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  201 (283)
T cd05091         125 DFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG  201 (283)
T ss_pred             HHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcC
Confidence            46789999999999999999   999999999999999999999999987654322211111223345689999999888


Q ss_pred             CCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           83 FFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      .++.++|+||||+++|+|++ |..||...........       ...+.....         .......+.+++.+||+.
T Consensus       202 ~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~-------i~~~~~~~~---------~~~~~~~~~~li~~cl~~  265 (283)
T cd05091         202 KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM-------IRNRQVLPC---------PDDCPAWVYTLMLECWNE  265 (283)
T ss_pred             CCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-------HHcCCcCCC---------CCCCCHHHHHHHHHHhCC
Confidence            88999999999999999998 7778765433222111       111111111         112334678999999999


Q ss_pred             CCCCCCCHHHHHHHhc
Q 027675          162 DPNDRPTMSDVVIMLG  177 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~  177 (220)
                      +|++||++++++..|+
T Consensus       266 ~p~~RP~~~~i~~~l~  281 (283)
T cd05091         266 FPSRRPRFKDIHSRLR  281 (283)
T ss_pred             CcccCCCHHHHHHHhh
Confidence            9999999999999885

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.96  E-value=1.2e-28  Score=196.49  Aligned_cols=159  Identities=20%  Similarity=0.243  Sum_probs=118.2

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCC-----CcccceeecccCccChh
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT-----DGTTNRVVGTYGYMSPE   77 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~-----~~~~~~~~~~~~y~aPe   77 (220)
                      .+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||+++.......     ........+++.|+|||
T Consensus       127 ~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape  203 (294)
T PHA02882        127 LIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLD  203 (294)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHH
Confidence            46789999999999999999   99999999999999999999999999876532110     11112245789999999


Q ss_pred             hhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhh---HHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHH
Q 027675           78 YALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSL---LGYAWKLWQEGKALDMMDQKPGAISKANEILKCINV  154 (220)
Q Consensus        78 ~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  154 (220)
                      .+.+..++.++|+|||||++++|++|..||...........   ..+.... ..+..    .. .      .....+.++
T Consensus       204 ~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~~----~~-~------~~~~~~~~~  271 (294)
T PHA02882        204 AHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRL-HEGKI----KI-K------NANKFIYDF  271 (294)
T ss_pred             HhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHh-hhhhh----cc-C------CCCHHHHHH
Confidence            99998899999999999999999999999975532211110   1111111 11111    00 0      112467888


Q ss_pred             hccccCCCCCCCCCHHHHHHHh
Q 027675          155 GLLCVQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       155 i~~cl~~~p~~Rps~~~~l~~l  176 (220)
                      +..||+.+|++||++.++++.+
T Consensus       272 ~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        272 IECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHHHHhCCCCCCCCHHHHHHhh
Confidence            9999999999999999999876

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.96  E-value=1.9e-28  Score=189.46  Aligned_cols=184  Identities=27%  Similarity=0.282  Sum_probs=130.9

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      ++.-+..|+++|++|||.+.   |+|||||++|+|++..|.+|++|||+++.++.....  .+..+-|.+|.|||++.|.
T Consensus       178 evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~--~T~lVVTLWYRaPELLLG~  252 (419)
T KOG0663|consen  178 EVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKP--YTPLVVTLWYRAPELLLGA  252 (419)
T ss_pred             HHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCCccc--CcceEEEeeecCHHHhcCC
Confidence            46678899999999999999   999999999999999999999999999987755333  3335568899999999986


Q ss_pred             -CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHH--------HHHHHhccccccccC------CCCCcCcH-H
Q 027675           83 -FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA--------WKLWQEGKALDMMDQ------KPGAISKA-N  146 (220)
Q Consensus        83 -~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~------~~~~~~~~-~  146 (220)
                       .|+...||||+|||+.|++.+++.|.+.....+...+...        |....+-........      .....+.. .
T Consensus       253 ~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~  332 (419)
T KOG0663|consen  253 KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALS  332 (419)
T ss_pred             cccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccc
Confidence             5799999999999999999999999876665554433221        111111111100000      00000000 0


Q ss_pred             HHHHHHHHhccccCCCCCCCCCHHHHHHHhcCccccCCCCCCchhhh
Q 027675          147 EILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEAVNLASPKRPAFVV  193 (220)
Q Consensus       147 ~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~~~~~~~~~~~~~~~  193 (220)
                      .....++++..+|.+||++|.|+++.|++=+..  ..+.|..+.+.+
T Consensus       333 lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~--e~P~p~~P~~~P  377 (419)
T KOG0663|consen  333 LSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFR--ETPLPIDPSMFP  377 (419)
T ss_pred             cchhHHHHHHHHhccCccccccHHHhhcccccc--cCCCCCChhhcC
Confidence            225678899999999999999999999885443  333343444333

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.4e-29  Score=200.18  Aligned_cols=150  Identities=24%  Similarity=0.374  Sum_probs=122.5

Q ss_pred             HHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcCCC
Q 027675            5 FNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFF   84 (220)
Q Consensus         5 ~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~~~   84 (220)
                      .-++++++.|+.|||.++   .+|||||+.||++..+|.++|+|||++..........  ..++||+.|+|||++++..|
T Consensus       114 ~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr--~tfvGTPfwMAPEVI~~~~Y  188 (467)
T KOG0201|consen  114 AVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR--KTFVGTPFWMAPEVIKQSGY  188 (467)
T ss_pred             eeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhcc--ccccccccccchhhhccccc
Confidence            347899999999999999   9999999999999999999999999987655433332  44789999999999999899


Q ss_pred             cccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCCCC
Q 027675           85 SVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPN  164 (220)
Q Consensus        85 ~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~  164 (220)
                      +.++||||||+..+||.+|.+|+.........                -.+........+......+.+||..||+.||+
T Consensus       189 ~~KADIWSLGITaiEla~GePP~s~~hPmrvl----------------flIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~  252 (467)
T KOG0201|consen  189 DTKADIWSLGITAIELAKGEPPHSKLHPMRVL----------------FLIPKSAPPRLDGDFSPPFKEFVEACLDKNPE  252 (467)
T ss_pred             cchhhhhhhhHHHHHHhcCCCCCcccCcceEE----------------EeccCCCCCccccccCHHHHHHHHHHhhcCcc
Confidence            99999999999999999999998755543221                11222222233336667789999999999999


Q ss_pred             CCCCHHHHHHH
Q 027675          165 DRPTMSDVVIM  175 (220)
Q Consensus       165 ~Rps~~~~l~~  175 (220)
                      .||+|.+++++
T Consensus       253 ~RpsA~~LLKh  263 (467)
T KOG0201|consen  253 FRPSAKELLKH  263 (467)
T ss_pred             cCcCHHHHhhh
Confidence            99999999965

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.96  E-value=1.5e-28  Score=194.56  Aligned_cols=161  Identities=25%  Similarity=0.368  Sum_probs=121.1

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++................++..|++||.+.+
T Consensus       109 ~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~  185 (279)
T cd05111         109 QRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF  185 (279)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhcc
Confidence            357889999999999999999   99999999999999999999999999875432221111222345568999999988


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++|++++ |..||.........       +....+.......     .    ....+.+++.+||.
T Consensus       186 ~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~-------~~~~~~~~~~~~~-----~----~~~~~~~li~~c~~  249 (279)
T cd05111         186 GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP-------DLLEKGERLAQPQ-----I----CTIDVYMVMVKCWM  249 (279)
T ss_pred             CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------HHHHCCCcCCCCC-----C----CCHHHHHHHHHHcC
Confidence            889999999999999999998 99898654332221       1122222211111     1    12356788899999


Q ss_pred             CCCCCCCCHHHHHHHhcCccc
Q 027675          161 EDPNDRPTMSDVVIMLGSEAV  181 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~~~  181 (220)
                      .||++|||+.++++.|....+
T Consensus       250 ~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         250 IDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             CCcccCcCHHHHHHHHHHHHh
Confidence            999999999999999876644

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.96  E-value=8.8e-29  Score=196.89  Aligned_cols=158  Identities=28%  Similarity=0.377  Sum_probs=118.6

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+++++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++................++..|+|||.+.+.
T Consensus       133 ~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  209 (293)
T cd05053         133 DLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR  209 (293)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccC
Confidence            56789999999999999999   999999999999999999999999998754332211111112234579999999888


Q ss_pred             CCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           83 FFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      .++.++|+|||||++|++++ |..||..........       ....+....         ........+.+++.+||..
T Consensus       210 ~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~-------~~~~~~~~~---------~~~~~~~~~~~li~~~l~~  273 (293)
T cd05053         210 VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK-------LLKEGYRME---------KPQNCTQELYHLMRDCWHE  273 (293)
T ss_pred             CcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH-------HHHcCCcCC---------CCCCCCHHHHHHHHHHccc
Confidence            88999999999999999997 888886544332221       111111111         1112234688999999999


Q ss_pred             CCCCCCCHHHHHHHhcCc
Q 027675          162 DPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~~~  179 (220)
                      +|++|||+.++++.|...
T Consensus       274 ~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         274 VPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             CcccCcCHHHHHHHHHHh
Confidence            999999999999998654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=7.9e-29  Score=205.85  Aligned_cols=154  Identities=25%  Similarity=0.324  Sum_probs=123.6

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      +..++++|++.|+.|+|..+   |+|||+||+|++++..+.+||+|||++........   .....|.+.|++||+..|.
T Consensus       113 eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl---LeTSCGSPHYA~PEIV~G~  186 (786)
T KOG0588|consen  113 EAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL---LETSCGSPHYAAPEIVSGR  186 (786)
T ss_pred             HHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCCcc---ccccCCCcccCCchhhcCC
Confidence            56789999999999999999   99999999999999999999999999976554332   2235689999999999999


Q ss_pred             CC-cccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           83 FF-SVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        83 ~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      +| ..++||||+|+|+|-|++|..||+..+........      . .| ..+++         .+...+..+++.+||..
T Consensus       187 pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV------~-~G-~f~MP---------s~Is~eaQdLLr~ml~V  249 (786)
T KOG0588|consen  187 PYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKV------Q-RG-VFEMP---------SNISSEAQDLLRRMLDV  249 (786)
T ss_pred             CCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHH------H-cC-cccCC---------CcCCHHHHHHHHHHhcc
Confidence            87 68899999999999999999999855544443221      1 11 11121         12233678899999999


Q ss_pred             CCCCCCCHHHHHHHhcCc
Q 027675          162 DPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~~~  179 (220)
                      ||+.|.|+++|++|-+..
T Consensus       250 Dp~~RiT~~eI~kHP~l~  267 (786)
T KOG0588|consen  250 DPSTRITTEEILKHPFLS  267 (786)
T ss_pred             CccccccHHHHhhCchhh
Confidence            999999999999997554

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=2.6e-29  Score=204.96  Aligned_cols=156  Identities=27%  Similarity=0.348  Sum_probs=118.4

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+..+++||+.|+.++|++|   |+|.||||.|+++.+ |.+||+|||.+.........-....+.||+.|++||.+...
T Consensus       461 ~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~  536 (677)
T KOG0596|consen  461 FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDM  536 (677)
T ss_pred             HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCccccceeeccccCcccccCHHHHhhc
Confidence            46778999999999999999   999999999999875 67999999999876655444455567899999999998532


Q ss_pred             -----------CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcC-cHHHHHH
Q 027675           83 -----------FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAIS-KANEILK  150 (220)
Q Consensus        83 -----------~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  150 (220)
                                 ..+.++||||||||+|+|+.|++||+.+....              .+...+.++.....+ .......
T Consensus       537 ~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~--------------aKl~aI~~P~~~Iefp~~~~~~~  602 (677)
T KOG0596|consen  537 SSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQI--------------AKLHAITDPNHEIEFPDIPENDE  602 (677)
T ss_pred             cccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHH--------------HHHHhhcCCCccccccCCCCchH
Confidence                       25688999999999999999999997322111              112223333221111 1111223


Q ss_pred             HHHHhccccCCCCCCCCCHHHHHHHh
Q 027675          151 CINVGLLCVQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       151 ~~~li~~cl~~~p~~Rps~~~~l~~l  176 (220)
                      ++++|+.||++||++||+..++|++-
T Consensus       603 li~~mK~CL~rdPkkR~si~eLLqhp  628 (677)
T KOG0596|consen  603 LIDVMKCCLARDPKKRWSIPELLQHP  628 (677)
T ss_pred             HHHHHHHHHhcCcccCCCcHHHhcCc
Confidence            88999999999999999999999774

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=5.4e-29  Score=206.04  Aligned_cols=174  Identities=24%  Similarity=0.216  Sum_probs=121.6

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+++.++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++................++..|+|||.+.+
T Consensus       185 ~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  261 (392)
T PHA03207        185 EQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLAL  261 (392)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcC
Confidence            467889999999999999999   99999999999999999999999999875443322222223568899999999998


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhc-------------------cccccc-cCCCCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEG-------------------KALDMM-DQKPGA  141 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~-~~~~~~  141 (220)
                      ..++.++|+|||||++|+|++|+.||..............+.+.....                   ...... ...+..
T Consensus       262 ~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (392)
T PHA03207        262 DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPV  341 (392)
T ss_pred             CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccch
Confidence            889999999999999999999999985433221111111111100000                   000000 000000


Q ss_pred             cCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcC
Q 027675          142 ISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       142 ~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~  178 (220)
                      .........+.++|.+||..||++||++.+++.+-+.
T Consensus       342 ~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f  378 (392)
T PHA03207        342 IRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLF  378 (392)
T ss_pred             hhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchh
Confidence            0001123467789999999999999999999988544

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.96  E-value=7.8e-29  Score=197.22  Aligned_cols=161  Identities=24%  Similarity=0.377  Sum_probs=121.7

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..+++++.|++.||.|||+++   ++||||||.||+++.++.++|+|||++................++..|+|||.+.+
T Consensus       123 ~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  199 (291)
T cd05094         123 SQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY  199 (291)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc
Confidence            357889999999999999999   99999999999999999999999999864332211111222344678999999988


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++|+|++ |..||.........       +....+......         ......+.+++.+||+
T Consensus       200 ~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~-------~~~~~~~~~~~~---------~~~~~~~~~li~~~l~  263 (291)
T cd05094         200 RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI-------ECITQGRVLERP---------RVCPKEVYDIMLGCWQ  263 (291)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHhCCCCCCCC---------ccCCHHHHHHHHHHcc
Confidence            888999999999999999998 99998654433221       111111111111         1123467899999999


Q ss_pred             CCCCCCCCHHHHHHHhcCccc
Q 027675          161 EDPNDRPTMSDVVIMLGSEAV  181 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~~~  181 (220)
                      .+|++||++.++++.|.....
T Consensus       264 ~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         264 REPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             cChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999977643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.96  E-value=2.1e-28  Score=194.18  Aligned_cols=170  Identities=21%  Similarity=0.239  Sum_probs=119.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +.++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++......... ......++..|+|||.+.+
T Consensus       100 ~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~  175 (287)
T cd07848         100 EKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA-NYTEYVATRWYRSPELLLG  175 (287)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccccc-cccccccccccCCcHHHcC
Confidence            356789999999999999999   999999999999999999999999998754322111 1122457889999999988


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHH--------HHHHHhccccccccCCCC-CcC------cHH
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA--------WKLWQEGKALDMMDQKPG-AIS------KAN  146 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~-~~~------~~~  146 (220)
                      ..++.++|+|||||++|+|++|+.||...+...........        .+................ ...      ...
T Consensus       176 ~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (287)
T cd07848         176 APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGI  255 (287)
T ss_pred             CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcc
Confidence            88899999999999999999999999754432221111000        000000000000000000 000      011


Q ss_pred             HHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 027675          147 EILKCINVGLLCVQEDPNDRPTMSDVVIM  175 (220)
Q Consensus       147 ~~~~~~~li~~cl~~~p~~Rps~~~~l~~  175 (220)
                      ....+.++|.+||+.||++|||++++++|
T Consensus       256 ~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         256 LSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             cCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            23468999999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.96  E-value=1.6e-28  Score=191.40  Aligned_cols=169  Identities=22%  Similarity=0.252  Sum_probs=122.3

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+.++++|++.||+|||+++   |+||||||.||+|+++|.+||+|||+++...-....  ....+.|..|.|||++.|.
T Consensus       121 ~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~--yt~evvTlWYRaPEvLlGs  195 (323)
T KOG0594|consen  121 LIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRT--YTPEVVTLWYRAPEVLLGS  195 (323)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchHHHhcCCccc--ccccEEEeeccCHHHhcCC
Confidence            57899999999999999999   999999999999999999999999999865422221  2334668899999999887


Q ss_pred             -CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHH-----HHHhccccccccCCCCCcC---c-----HHHH
Q 027675           83 -FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWK-----LWQEGKALDMMDQKPGAIS---K-----ANEI  148 (220)
Q Consensus        83 -~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~---~-----~~~~  148 (220)
                       .|+...||||+|||++||+++++.|.+..+..+...+.....     .++.-......+.......   .     ....
T Consensus       196 ~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~  275 (323)
T KOG0594|consen  196 TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLD  275 (323)
T ss_pred             CcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccC
Confidence             689999999999999999999999987666444332221100     0000000000000000000   0     1111


Q ss_pred             HHHHHHhccccCCCCCCCCCHHHHHHHh
Q 027675          149 LKCINVGLLCVQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       149 ~~~~~li~~cl~~~p~~Rps~~~~l~~l  176 (220)
                      ....+++.+||+++|.+|.|++.++.|-
T Consensus       276 ~~~~dll~~~L~y~p~~R~Sa~~al~h~  303 (323)
T KOG0594|consen  276 PDGIELLSKLLQYDPAKRISAKGALTHP  303 (323)
T ss_pred             ccHHHHHHHHhccCcccCcCHHHHhcCh
Confidence            4678999999999999999999999883

>PTZ00284 protein kinase; Provisional

Probab=99.96  E-value=9.3e-29  Score=208.95  Aligned_cols=169  Identities=21%  Similarity=0.226  Sum_probs=117.8

Q ss_pred             hHHHHHHHHHHHHHHhhh-CCCCCeEeccCCCCceeeCCCC----------------CceecCccceeeecCCCCCcccc
Q 027675            3 MLFNIILGVSRRLLYLHQ-DSKLRIIHRDFKTSNILLDHEM----------------NPKISDFGLTRIFEGKQTDGTTN   65 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~-~~~~~i~H~dlk~~nili~~~~----------------~~~l~d~~~~~~~~~~~~~~~~~   65 (220)
                      .+..++.|++.||+|||+ .+   |+||||||+||+++.++                .+||+|||.+.....     ...
T Consensus       232 ~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~  303 (467)
T PTZ00284        232 HLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRT  303 (467)
T ss_pred             HHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc-----ccc
Confidence            567899999999999997 48   99999999999998765                489999998653221     122


Q ss_pred             eeecccCccChhhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHH-----------------HHHHh
Q 027675           66 RVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAW-----------------KLWQE  128 (220)
Q Consensus        66 ~~~~~~~y~aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-----------------~~~~~  128 (220)
                      ...+++.|+|||++.+..++.++|||||||++|+|++|+.||...+............                 .....
T Consensus       304 ~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~  383 (467)
T PTZ00284        304 AIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNS  383 (467)
T ss_pred             cccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhh
Confidence            3567899999999999999999999999999999999999997655433222111100                 00000


Q ss_pred             ccc-cccccCC-------CCCcCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          129 GKA-LDMMDQK-------PGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       129 ~~~-~~~~~~~-------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      ... ....+..       ............+++||.+||.+||++|||++|+++|=+..
T Consensus       384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~  442 (467)
T PTZ00284        384 AGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVL  442 (467)
T ss_pred             cccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcccc
Confidence            000 0000000       00000111234678999999999999999999999876544

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.95  E-value=1.3e-28  Score=194.60  Aligned_cols=163  Identities=24%  Similarity=0.365  Sum_probs=120.9

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+++   ++||||||+||++++++.++|+|||++................++..|++||...+
T Consensus       109 ~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~  185 (279)
T cd05109         109 QDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILH  185 (279)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhcc
Confidence            357889999999999999999   99999999999999999999999999876542221111111123467999999988


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+|||||++|++++ |..||..........       ....+.....         .......+.+++.+||.
T Consensus       186 ~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-------~~~~~~~~~~---------~~~~~~~~~~li~~~l~  249 (279)
T cd05109         186 RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD-------LLEKGERLPQ---------PPICTIDVYMIMVKCWM  249 (279)
T ss_pred             CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-------HHHCCCcCCC---------CccCCHHHHHHHHHHcC
Confidence            888999999999999999998 888886443322211       1111111111         11223467889999999


Q ss_pred             CCCCCCCCHHHHHHHhcCccccC
Q 027675          161 EDPNDRPTMSDVVIMLGSEAVNL  183 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~~~~~  183 (220)
                      .||++||++.+++..+....+..
T Consensus       250 ~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         250 IDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             CChhhCcCHHHHHHHHHHhhcCC
Confidence            99999999999999886665443

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>PHA02988 hypothetical protein; Provisional

Probab=99.95  E-value=1.6e-28  Score=194.92  Aligned_cols=155  Identities=18%  Similarity=0.274  Sum_probs=118.3

Q ss_pred             chHHHHHHHHHHHHHHhhhC-CCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQD-SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~-~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~   80 (220)
                      .+.++++.+++.||.|||+. +   ++||||||+||++++++.++++|||++........     ...++..|+|||.+.
T Consensus       122 ~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~y~aPE~~~  193 (283)
T PHA02988        122 KTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPF-----KNVNFMVYFSYKMLN  193 (283)
T ss_pred             hHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhccccc-----cccCcccccCHHHhh
Confidence            45688999999999999985 7   88999999999999999999999999764332111     134577899999997


Q ss_pred             c--CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           81 G--GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        81 ~--~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                      +  ..++.++||||||+++|+|++|..||...+......      .....+....         .+......+.+++.+|
T Consensus       194 ~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~------~i~~~~~~~~---------~~~~~~~~l~~li~~c  258 (283)
T PHA02988        194 DIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYD------LIINKNNSLK---------LPLDCPLEIKCIVEAC  258 (283)
T ss_pred             hccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHH------HHHhcCCCCC---------CCCcCcHHHHHHHHHH
Confidence            6  578999999999999999999999997654332211      1111111111         1112234688999999


Q ss_pred             cCCCCCCCCCHHHHHHHhcCc
Q 027675          159 VQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       159 l~~~p~~Rps~~~~l~~l~~~  179 (220)
                      |+.||++|||+.++++.|+..
T Consensus       259 l~~dp~~Rps~~ell~~l~~~  279 (283)
T PHA02988        259 TSHDSIKRPNIKEILYNLSLY  279 (283)
T ss_pred             hcCCcccCcCHHHHHHHHHHH
Confidence            999999999999999998654

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.95  E-value=2e-28  Score=192.61  Aligned_cols=158  Identities=22%  Similarity=0.369  Sum_probs=119.0

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .++.++.|++.||.|||+++   ++|+||||+||++++++.++|+|||+++................+..|.+||.+.+.
T Consensus       114 ~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~  190 (273)
T cd05035         114 TLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR  190 (273)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccC
Confidence            46789999999999999999   999999999999999999999999998754432221111112335679999999888


Q ss_pred             CCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           83 FFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      .++.++|+||||+++|+|++ |..||..........       ....+.....         .......+.+++.+||+.
T Consensus       191 ~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~-------~~~~~~~~~~---------~~~~~~~~~~li~~~l~~  254 (273)
T cd05035         191 VYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYD-------YLRHGNRLKQ---------PEDCLDELYDLMYSCWRA  254 (273)
T ss_pred             CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHH-------HHHcCCCCCC---------CcCCCHHHHHHHHHHcCC
Confidence            88999999999999999999 888886543322211       1111111111         112334788999999999


Q ss_pred             CCCCCCCHHHHHHHhcCc
Q 027675          162 DPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~~~  179 (220)
                      ||++||++.++++.|...
T Consensus       255 ~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         255 DPKDRPTFTKLREVLENI  272 (273)
T ss_pred             ChhhCcCHHHHHHHHHhh
Confidence            999999999999998653

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.95  E-value=9.9e-29  Score=203.26  Aligned_cols=160  Identities=25%  Similarity=0.398  Sum_probs=118.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +++++++.|++.||.|||+++   ++||||||+||++++++.++|+|||++................++..|+|||.+.+
T Consensus       212 ~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  288 (374)
T cd05106         212 DDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFD  288 (374)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcC
Confidence            457899999999999999999   99999999999999999999999999875432221111112233457999999988


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++|+|++ |..||........      ..+....+.....    +.     .....+.+++.+||+
T Consensus       289 ~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~------~~~~~~~~~~~~~----~~-----~~~~~l~~li~~cl~  353 (374)
T cd05106         289 CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK------FYKMVKRGYQMSR----PD-----FAPPEIYSIMKMCWN  353 (374)
T ss_pred             CCCCccccHHHHHHHHHHHHhCCCCCCccccccHH------HHHHHHcccCccC----CC-----CCCHHHHHHHHHHcC
Confidence            889999999999999999997 9999864332211      0111111111100    11     112467889999999


Q ss_pred             CCCCCCCCHHHHHHHhcCc
Q 027675          161 EDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~  179 (220)
                      .||++||++.++++.|+..
T Consensus       354 ~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         354 LEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             CChhhCcCHHHHHHHHHHH
Confidence            9999999999999998653

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.95  E-value=5.9e-29  Score=197.72  Aligned_cols=169  Identities=20%  Similarity=0.235  Sum_probs=116.7

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc-
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG-   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~-   81 (220)
                      .+..++.|++.||.|||+++   |+||||||+||+++.++.++|+|||++.........  .....++..|+|||.+.+ 
T Consensus       104 ~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~  178 (288)
T cd07871         104 NVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT--YSNEVVTLWYRPPDVLLGS  178 (288)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc--ccCceecccccChHHhcCC
Confidence            56788999999999999999   999999999999999999999999998754322111  122356789999999876 


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHH--------HHHHHhcc-ccccccCCCCC----cCcHHHH
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA--------WKLWQEGK-ALDMMDQKPGA----ISKANEI  148 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~-~~~~~~~~~~~----~~~~~~~  148 (220)
                      ..++.++|+||+||++|+|++|+.||...+...........        +....... ......+....    .......
T Consensus       179 ~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (288)
T cd07871         179 TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLD  258 (288)
T ss_pred             cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCC
Confidence            45789999999999999999999999754433222111000        00000000 00000000000    0001123


Q ss_pred             HHHHHHhccccCCCCCCCCCHHHHHHHh
Q 027675          149 LKCINVGLLCVQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       149 ~~~~~li~~cl~~~p~~Rps~~~~l~~l  176 (220)
                      ....+++.+||+.||.+|||++++++|-
T Consensus       259 ~~~~dll~~mL~~dp~~R~t~~~~l~hp  286 (288)
T cd07871         259 TDGIDLLSSLLLYETKSRISAEAALRHS  286 (288)
T ss_pred             HHHHHHHHHhcCcCcccCCCHHHHhcCC
Confidence            4678999999999999999999999763

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.95  E-value=1.2e-28  Score=203.74  Aligned_cols=173  Identities=18%  Similarity=0.190  Sum_probs=117.6

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+++   |+||||||+||+++.++.++|+|||++....... ........|++.|+|||++.+
T Consensus       182 ~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~  257 (391)
T PHA03212        182 CDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-ANKYYGWAGTIATNAPELLAR  257 (391)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-ccccccccCccCCCChhhhcC
Confidence            356789999999999999999   9999999999999999999999999986422111 111222467899999999998


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchh-----HHHhhHHHHH------------------HH---HHhccccccc
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSE-----LALSLLGYAW------------------KL---WQEGKALDMM  135 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~-----~~~~~~~~~~------------------~~---~~~~~~~~~~  135 (220)
                      ..++.++|+|||||++|+|++|..||-.....     ..........                  ..   ....... ..
T Consensus       258 ~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~  336 (391)
T PHA03212        258 DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSR-KP  336 (391)
T ss_pred             CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCC-CC
Confidence            88999999999999999999999775321100     0000000000                  00   0000000 00


Q ss_pred             cCCCCCcCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          136 DQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       136 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      ...+...........+.++|.+||+.||++|||+++++++-+..
T Consensus       337 ~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~  380 (391)
T PHA03212        337 GSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQ  380 (391)
T ss_pred             CCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhc
Confidence            00000001112244688999999999999999999999776543

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.95  E-value=2.2e-28  Score=201.31  Aligned_cols=159  Identities=27%  Similarity=0.434  Sum_probs=118.5

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +.+++++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++................++..|+|||.+.+
T Consensus       214 ~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  290 (375)
T cd05104         214 EDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFN  290 (375)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcC
Confidence            457889999999999999999   99999999999999999999999999875443222111222234557999999998


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++|+|++ |..||.........      .+....+.....    +.     .....+.+++.+||+
T Consensus       291 ~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~------~~~~~~~~~~~~----~~-----~~~~~l~~li~~cl~  355 (375)
T cd05104         291 CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF------YKMIKEGYRMLS----PE-----CAPSEMYDIMKSCWD  355 (375)
T ss_pred             CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHH------HHHHHhCccCCC----CC-----CCCHHHHHHHHHHcc
Confidence            889999999999999999997 88888643322111      111112111111    11     112367899999999


Q ss_pred             CCCCCCCCHHHHHHHhcC
Q 027675          161 EDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~  178 (220)
                      .||++||++.++++.|+.
T Consensus       356 ~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         356 ADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             CChhHCcCHHHHHHHHHh
Confidence            999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=8.4e-29  Score=210.12  Aligned_cols=154  Identities=28%  Similarity=0.391  Sum_probs=119.4

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .++.++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++................|++.|+|||.+.+.
T Consensus       144 ~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~  220 (496)
T PTZ00283        144 EAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK  220 (496)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCC
Confidence            46778999999999999999   999999999999999999999999998765433222233345678899999999998


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      .++.++||||||+++|+|++|..||...+......      +.. .+..    ...+     ......+.+++.+||..|
T Consensus       221 ~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~------~~~-~~~~----~~~~-----~~~~~~l~~li~~~L~~d  284 (496)
T PTZ00283        221 PYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMH------KTL-AGRY----DPLP-----PSISPEMQEIVTALLSSD  284 (496)
T ss_pred             CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH------HHh-cCCC----CCCC-----CCCCHHHHHHHHHHcccC
Confidence            89999999999999999999999997544322211      111 1111    1111     112346788999999999


Q ss_pred             CCCCCCHHHHHHH
Q 027675          163 PNDRPTMSDVVIM  175 (220)
Q Consensus       163 p~~Rps~~~~l~~  175 (220)
                      |++||++.+++.+
T Consensus       285 P~~RPs~~ell~~  297 (496)
T PTZ00283        285 PKRRPSSSKLLNM  297 (496)
T ss_pred             hhhCcCHHHHHhC
Confidence            9999999999875

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.95  E-value=2e-28  Score=193.43  Aligned_cols=156  Identities=28%  Similarity=0.422  Sum_probs=118.4

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      ++..++.+++.|+.+||+++   ++|+||||+||+++.++.++|+|||++................++..|+|||.+.+.
T Consensus       123 ~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  199 (280)
T cd05049         123 QLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR  199 (280)
T ss_pred             HHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccC
Confidence            56789999999999999999   999999999999999999999999998653222111112223345789999999988


Q ss_pred             CCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           83 FFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      .++.++|+||||+++|+|++ |..||...+.......       ...+.....    +     ......+.+++.+||+.
T Consensus       200 ~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~-------~~~~~~~~~----~-----~~~~~~~~~li~~~l~~  263 (280)
T cd05049         200 KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC-------ITQGRLLQR----P-----RTCPSEVYDIMLGCWKR  263 (280)
T ss_pred             CcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-------HHcCCcCCC----C-----CCCCHHHHHHHHHHcCC
Confidence            89999999999999999998 9999865443332111       111111111    1     11234678999999999


Q ss_pred             CCCCCCCHHHHHHHhc
Q 027675          162 DPNDRPTMSDVVIMLG  177 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~  177 (220)
                      ||++||++.++++.|.
T Consensus       264 ~p~~Rp~~~eil~~l~  279 (280)
T cd05049         264 DPQQRINIKDIHERLQ  279 (280)
T ss_pred             CcccCCCHHHHHHHhh
Confidence            9999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.95  E-value=1.6e-28  Score=194.83  Aligned_cols=168  Identities=23%  Similarity=0.278  Sum_probs=117.9

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +.+..++.|++.||.|||+.|   ++|+||||+||+++.++.++|+|||++........   .....++..|+|||.+.+
T Consensus       108 ~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~  181 (288)
T cd07863         108 ETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA---LTPVVVTLWYRAPEVLLQ  181 (288)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccccccCccc---CCCccccccccCchHhhC
Confidence            357889999999999999999   99999999999999999999999999875432211   122356788999999988


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHH-----HHHHhcccc--ccccCCCCC---cCcHHHHHHH
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAW-----KLWQEGKAL--DMMDQKPGA---ISKANEILKC  151 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~--~~~~~~~~~---~~~~~~~~~~  151 (220)
                      ..++.++|+|||||++|+|++|.+||................     ..+......  .........   .........+
T Consensus       182 ~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (288)
T cd07863         182 STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESG  261 (288)
T ss_pred             CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHH
Confidence            889999999999999999999999986544332221111000     000000000  000000000   0001123467


Q ss_pred             HHHhccccCCCCCCCCCHHHHHHH
Q 027675          152 INVGLLCVQEDPNDRPTMSDVVIM  175 (220)
Q Consensus       152 ~~li~~cl~~~p~~Rps~~~~l~~  175 (220)
                      .+++.+||+.||++|||+.+++.+
T Consensus       262 ~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         262 AQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             HHHHHHHhccCcccCCCHHHHhcC
Confidence            899999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.95  E-value=3.6e-28  Score=199.25  Aligned_cols=171  Identities=20%  Similarity=0.162  Sum_probs=120.3

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+..++.|++.||.|||+++   |+||||||+||+++.++.++|+|||++.......   ......++..|+|||.+.+.
T Consensus       127 ~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~  200 (364)
T cd07875         127 RMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGM  200 (364)
T ss_pred             HHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCccccCCCC---cccCCcccCCcCCHHHHhCC
Confidence            56789999999999999999   9999999999999999999999999987543221   11224568899999999998


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHH--------HHH--------HHHhcccccc-----ccC----
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGY--------AWK--------LWQEGKALDM-----MDQ----  137 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~--------~~~--------~~~~~~~~~~-----~~~----  137 (220)
                      .++.++|+|||||++|+|++|+.||...+..........        ..+        ..........     ...    
T Consensus       201 ~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (364)
T cd07875         201 GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLF  280 (364)
T ss_pred             CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccc
Confidence            899999999999999999999999975543322111100        000        0000000000     000    


Q ss_pred             CCCCcCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          138 KPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       138 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      .............+.++|.+||..||++|||+.+++++-+..
T Consensus       281 ~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~  322 (364)
T cd07875         281 PADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN  322 (364)
T ss_pred             cccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence            000000111234678999999999999999999999886543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.95  E-value=1.6e-28  Score=199.02  Aligned_cols=171  Identities=26%  Similarity=0.387  Sum_probs=120.2

Q ss_pred             hHHHHHHHHHHHHHHhhhC-CCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            3 MLFNIILGVSRRLLYLHQD-SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~-~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+..++.+++.||.|||+. +   ++||||||+||+++.++.++|+|||++......    ......++..|+|||.+.+
T Consensus       104 ~~~~~~~~i~~~l~~lH~~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~g~~~y~aPE~~~~  176 (331)
T cd06649         104 ILGKVSIAVLRGLAYLREKHQ---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQG  176 (331)
T ss_pred             HHHHHHHHHHHHHHHHhhcCC---EEcCCCChhhEEEcCCCcEEEccCccccccccc----ccccCCCCcCcCCHhHhcC
Confidence            4678999999999999985 5   999999999999999999999999987654321    1222457889999999998


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccc------------------------------
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKA------------------------------  131 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------------------------  131 (220)
                      ..++.++|+|||||++|+|++|+.||...+.................+..                              
T Consensus       177 ~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (331)
T cd06649         177 THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFEL  256 (331)
T ss_pred             CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHH
Confidence            88999999999999999999999999654433222111000000000000                              


Q ss_pred             -cccccCCCCCcCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcCcc
Q 027675          132 -LDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEA  180 (220)
Q Consensus       132 -~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~~  180 (220)
                       ..+................+.++|.+||+.||++|||+++++++-+...
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~  306 (331)
T cd06649         257 LDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKR  306 (331)
T ss_pred             HHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhh
Confidence             0000000000011123457899999999999999999999998875543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.95  E-value=5.9e-29  Score=187.96  Aligned_cols=156  Identities=28%  Similarity=0.362  Sum_probs=119.0

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhh--
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL--   80 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~--   80 (220)
                      ...+|++|+.+|++|||.++   |+||||||+||+++++..++|+|||+++......   ......||++|+|||.++  
T Consensus       124 ~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~~l~~Ge---kLrelCGTPgYLAPEtikC~  197 (411)
T KOG0599|consen  124 ETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFACQLEPGE---KLRELCGTPGYLAPETIKCS  197 (411)
T ss_pred             HHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceeeccCCch---hHHHhcCCCcccChhheeee
Confidence            46789999999999999999   9999999999999999999999999998755432   234467899999999985  


Q ss_pred             ----cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhc
Q 027675           81 ----GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGL  156 (220)
Q Consensus        81 ----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  156 (220)
                          ..+|+...|+|++|+|+|.|+.|.+||-  ..+...     +...+.+|+-.  +....+    .+.+....++|.
T Consensus       198 m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw--HRkQml-----MLR~ImeGkyq--F~speW----adis~~~KdLIs  264 (411)
T KOG0599|consen  198 MYENHPGYSKEVDEWACGVIMYTLLAGCPPFW--HRKQML-----MLRMIMEGKYQ--FRSPEW----ADISATVKDLIS  264 (411)
T ss_pred             cccCCCCccchhhHHHHHHHHHHHHcCCCchh--HHHHHH-----HHHHHHhcccc--cCCcch----hhccccHHHHHH
Confidence                2468899999999999999999999973  222111     12222222221  111111    223446789999


Q ss_pred             cccCCCCCCCCCHHHHHHHhc
Q 027675          157 LCVQEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       157 ~cl~~~p~~Rps~~~~l~~l~  177 (220)
                      +||+.||.+|.|++++|.|-.
T Consensus       265 rlLqVdp~~Ritake~LaHpf  285 (411)
T KOG0599|consen  265 RLLQVDPTKRITAKEALAHPF  285 (411)
T ss_pred             HHHeeCchhcccHHHHhcChH
Confidence            999999999999999996643

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.95  E-value=2.8e-28  Score=197.35  Aligned_cols=150  Identities=24%  Similarity=0.254  Sum_probs=115.9

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+..++.|++.||+|||+++   ++||||||+||+++.++.++|+|||++.......     ....|++.|+|||.+.+.
T Consensus       119 ~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~  190 (329)
T PTZ00263        119 VAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-----FTLCGTPEYLAPEVIQSK  190 (329)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-----ceecCChhhcCHHHHcCC
Confidence            45678899999999999999   9999999999999999999999999987543221     224578899999999988


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      .++.++|+|||||++|+|++|..||...+......      .. ..+. ..    .+.     .....+.++|.+||+.|
T Consensus       191 ~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~------~i-~~~~-~~----~p~-----~~~~~~~~li~~~L~~d  253 (329)
T PTZ00263        191 GHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYE------KI-LAGR-LK----FPN-----WFDGRARDLVKGLLQTD  253 (329)
T ss_pred             CCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHH------HH-hcCC-cC----CCC-----CCCHHHHHHHHHHhhcC
Confidence            88999999999999999999999986443322111      11 1111 00    011     12236789999999999


Q ss_pred             CCCCCC-----HHHHHHHhc
Q 027675          163 PNDRPT-----MSDVVIMLG  177 (220)
Q Consensus       163 p~~Rps-----~~~~l~~l~  177 (220)
                      |.+||+     +++++.|-+
T Consensus       254 P~~R~~~~~~~~~~ll~hp~  273 (329)
T PTZ00263        254 HTKRLGTLKGGVADVKNHPY  273 (329)
T ss_pred             HHHcCCCCCCCHHHHhcCCc
Confidence            999997     799997754

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.95  E-value=9.1e-29  Score=200.57  Aligned_cols=173  Identities=25%  Similarity=0.272  Sum_probs=117.9

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCC-CcccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT-DGTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~y~aPe~~~   80 (220)
                      +.+..++.|+++||.|||+++   ++||||||+||+++.++.++|+|||++........ ........++..|+|||.+.
T Consensus       103 ~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~  179 (338)
T cd07859         103 EHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG  179 (338)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHh
Confidence            356789999999999999999   99999999999999999999999999875322111 11112346788999999987


Q ss_pred             c--CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHH--------HHHHHhcc---ccccccCCCCCcC---c
Q 027675           81 G--GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA--------WKLWQEGK---ALDMMDQKPGAIS---K  144 (220)
Q Consensus        81 ~--~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~---~~~~~~~~~~~~~---~  144 (220)
                      +  ..++.++|+|||||++|+|++|+.||...+...........        ........   .............   .
T Consensus       180 ~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  259 (338)
T cd07859         180 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKF  259 (338)
T ss_pred             ccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhc
Confidence            6  56788999999999999999999999654432221111000        00000000   0000000000000   0


Q ss_pred             HHHHHHHHHHhccccCCCCCCCCCHHHHHHHhc
Q 027675          145 ANEILKCINVGLLCVQEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       145 ~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~  177 (220)
                      ......+.+++.+||..||++||++++++++-+
T Consensus       260 ~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~  292 (338)
T cd07859         260 PNADPLALRLLERLLAFDPKDRPTAEEALADPY  292 (338)
T ss_pred             CCCChHHHHHHHHHcCcCcccCCCHHHHhcCch
Confidence            012245689999999999999999999997743

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.95  E-value=3.9e-28  Score=195.53  Aligned_cols=151  Identities=24%  Similarity=0.326  Sum_probs=115.1

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++.......  .......|+..|+|||.+.+.
T Consensus        97 ~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~  171 (316)
T cd05592          97 RARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKASTFCGTPDYIAPEILKGQ  171 (316)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--CccccccCCccccCHHHHcCC
Confidence            56778999999999999999   9999999999999999999999999987533221  122234678899999999988


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      .++.++|+|||||++|+|++|..||...+.......      .. . ...    ..+     ......+.+++.+||..|
T Consensus       172 ~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~------i~-~-~~~----~~~-----~~~~~~~~~ll~~~l~~~  234 (316)
T cd05592         172 KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDS------IL-N-DRP----HFP-----RWISKEAKDCLSKLFERD  234 (316)
T ss_pred             CCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHH------HH-c-CCC----CCC-----CCCCHHHHHHHHHHccCC
Confidence            889999999999999999999999976544322211      11 0 000    001     112335678999999999


Q ss_pred             CCCCCCHH-HHHHH
Q 027675          163 PNDRPTMS-DVVIM  175 (220)
Q Consensus       163 p~~Rps~~-~~l~~  175 (220)
                      |++||++. +++.+
T Consensus       235 P~~R~~~~~~l~~h  248 (316)
T cd05592         235 PTKRLGVDGDIRQH  248 (316)
T ss_pred             HHHcCCChHHHHcC
Confidence            99999875 66654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.95  E-value=1.6e-28  Score=193.29  Aligned_cols=158  Identities=23%  Similarity=0.360  Sum_probs=118.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++................++..|++||...+
T Consensus       112 ~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~  188 (272)
T cd05075         112 QMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLAD  188 (272)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccC
Confidence            346789999999999999999   99999999999999999999999999875432221111122234568999999988


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++|++++ |..||.........       +....+.....         .......+.++|.+||+
T Consensus       189 ~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-------~~~~~~~~~~~---------~~~~~~~~~~li~~~l~  252 (272)
T cd05075         189 RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIY-------DYLRQGNRLKQ---------PPDCLDGLYSLMSSCWL  252 (272)
T ss_pred             CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------HHHHcCCCCCC---------CCCCCHHHHHHHHHHcC
Confidence            888999999999999999998 78888643322211       11112211110         01123357899999999


Q ss_pred             CCCCCCCCHHHHHHHhcC
Q 027675          161 EDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~  178 (220)
                      .+|++|||+.++++.|..
T Consensus       253 ~~p~~Rps~~~l~~~l~~  270 (272)
T cd05075         253 LNPKDRPSFETLRCELEK  270 (272)
T ss_pred             CCcccCcCHHHHHHHHHh
Confidence            999999999999999865

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.95  E-value=1.5e-28  Score=198.89  Aligned_cols=154  Identities=23%  Similarity=0.282  Sum_probs=117.5

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .++..++.||+.||+|||+++   |+||||||+||+++.++.++|+|||++.......  .......+++.|+|||.+.+
T Consensus        95 ~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~  169 (328)
T cd05593          95 DRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKTFCGTPEYLAPEVLED  169 (328)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--cccccccCCcCccChhhhcC
Confidence            356789999999999999999   9999999999999999999999999876432111  11122457889999999998


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+|||||++|+|++|..||...+........      . ...    . ..+     ......+.+++.+||..
T Consensus       170 ~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~------~-~~~----~-~~p-----~~~~~~~~~li~~~L~~  232 (328)
T cd05593         170 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------L-MED----I-KFP-----RTLSADAKSLLSGLLIK  232 (328)
T ss_pred             CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHh------c-cCC----c-cCC-----CCCCHHHHHHHHHHcCC
Confidence            88899999999999999999999999654433221110      0 000    0 001     11234678899999999


Q ss_pred             CCCCCC-----CHHHHHHHhc
Q 027675          162 DPNDRP-----TMSDVVIMLG  177 (220)
Q Consensus       162 ~p~~Rp-----s~~~~l~~l~  177 (220)
                      ||++|+     ++.+++++-+
T Consensus       233 dP~~R~~~~~~~~~~il~h~~  253 (328)
T cd05593         233 DPNKRLGGGPDDAKEIMRHSF  253 (328)
T ss_pred             CHHHcCCCCCCCHHHHhcCCC
Confidence            999997     8999998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.95  E-value=1.7e-28  Score=197.21  Aligned_cols=160  Identities=25%  Similarity=0.319  Sum_probs=124.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCC---CCCcccceeecccCccChhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGK---QTDGTTNRVVGTYGYMSPEY   78 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~~y~aPe~   78 (220)
                      .+.++++++++.||+|||.+|   |+||||||+|+|++.+|.+||+|||++..+...   ..........||+.|.|||.
T Consensus       210 ~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~  286 (576)
T KOG0585|consen  210 QQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPEL  286 (576)
T ss_pred             HHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHh
Confidence            468899999999999999999   999999999999999999999999999866322   11122233689999999999


Q ss_pred             hhcCC----CcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHH
Q 027675           79 ALGGF----FSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINV  154 (220)
Q Consensus        79 ~~~~~----~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  154 (220)
                      +.+..    .+.+.||||+|+.+|-|+.|+.||-.........               ++...........+....+.++
T Consensus       287 c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~---------------KIvn~pL~fP~~pe~~e~~kDl  351 (576)
T KOG0585|consen  287 CSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFD---------------KIVNDPLEFPENPEINEDLKDL  351 (576)
T ss_pred             hcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHH---------------HHhcCcccCCCcccccHHHHHH
Confidence            87632    3678999999999999999999985322222211               1222233333334556688999


Q ss_pred             hccccCCCCCCCCCHHHHHHHhcCc
Q 027675          155 GLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       155 i~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      |.+||+.||++|.+..+|..|.|.-
T Consensus       352 i~~lL~KdP~~Ri~l~~ik~Hpwvt  376 (576)
T KOG0585|consen  352 IKRLLEKDPEQRITLPDIKLHPWVT  376 (576)
T ss_pred             HHHHhhcChhheeehhhheecceec
Confidence            9999999999999999999998654

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.95  E-value=2.1e-28  Score=199.86  Aligned_cols=159  Identities=28%  Similarity=0.390  Sum_probs=116.1

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc-
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG-   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~-   81 (220)
                      .+..++.||+.||.|||+++   ++|||||++||+++.++.++|+|||++........  ......++..|+|||.+.. 
T Consensus       169 ~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~  243 (353)
T PLN00034        169 FLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--PCNSSVGTIAYMSPERINTD  243 (353)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc--cccccccCccccCccccccc
Confidence            45789999999999999999   99999999999999999999999999875432211  1122467889999998743 


Q ss_pred             ----CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcc
Q 027675           82 ----GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLL  157 (220)
Q Consensus        82 ----~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  157 (220)
                          ...+.++|||||||++|+|++|+.||............   .... ....         ..........+.++|.+
T Consensus       244 ~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~---~~~~-~~~~---------~~~~~~~~~~l~~li~~  310 (353)
T PLN00034        244 LNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLM---CAIC-MSQP---------PEAPATASREFRHFISC  310 (353)
T ss_pred             cccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHH---HHHh-ccCC---------CCCCCccCHHHHHHHHH
Confidence                22356899999999999999999999743322211111   0110 0000         00111233468899999


Q ss_pred             ccCCCCCCCCCHHHHHHHhcCc
Q 027675          158 CVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       158 cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      ||+.||++||++.+++++-+..
T Consensus       311 ~l~~~P~~Rpt~~ell~hp~~~  332 (353)
T PLN00034        311 CLQREPAKRWSAMQLLQHPFIL  332 (353)
T ss_pred             HccCChhhCcCHHHHhcCcccc
Confidence            9999999999999999986544

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.95  E-value=2.7e-28  Score=193.84  Aligned_cols=160  Identities=25%  Similarity=0.392  Sum_probs=119.5

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      ++++++.|++.||+|||+++   ++||||||+||++++++.++|+|||++................++..|+|||.+.+.
T Consensus       121 ~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  197 (288)
T cd05093         121 QMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR  197 (288)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccC
Confidence            57889999999999999999   999999999999999999999999998644322111111112335679999999888


Q ss_pred             CCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           83 FFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      .++.++|+||||+++|+|++ |..||.........       .....+.....    +.     .....+.+++.+||+.
T Consensus       198 ~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~-------~~i~~~~~~~~----~~-----~~~~~l~~li~~~l~~  261 (288)
T cd05093         198 KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI-------ECITQGRVLQR----PR-----TCPKEVYDLMLGCWQR  261 (288)
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCCcCCC----CC-----CCCHHHHHHHHHHccC
Confidence            88999999999999999998 88888644432211       11111111111    11     1223688999999999


Q ss_pred             CCCCCCCHHHHHHHhcCccc
Q 027675          162 DPNDRPTMSDVVIMLGSEAV  181 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~~~~~  181 (220)
                      ||.+|||+.++++.|+....
T Consensus       262 ~p~~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         262 EPHMRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             ChhhCCCHHHHHHHHHHHHH
Confidence            99999999999999876643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.95  E-value=1e-28  Score=198.68  Aligned_cols=104  Identities=27%  Similarity=0.514  Sum_probs=85.5

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceee----CCCCCceecCccceeeecCCCC-CcccceeecccCccChh
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILL----DHEMNPKISDFGLTRIFEGKQT-DGTTNRVVGTYGYMSPE   77 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili----~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~y~aPe   77 (220)
                      .+..++.|++.||.|||+++   ++||||||+||++    ..++.++|+|||++........ ........+++.|+|||
T Consensus       109 ~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE  185 (317)
T cd07868         109 MVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE  185 (317)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCH
Confidence            46789999999999999999   9999999999999    4567899999999876432211 11122346688999999


Q ss_pred             hhhcC-CCcccCceeehhHHHHHHHhcCccCcc
Q 027675           78 YALGG-FFSVKSDVFSFGVVVLEIISGKRNTGF  109 (220)
Q Consensus        78 ~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~  109 (220)
                      .+.+. .++.++|+||+||++|+|++|.+||..
T Consensus       186 ~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         186 LLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             HHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence            98774 578899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.95  E-value=1.5e-28  Score=195.03  Aligned_cols=155  Identities=22%  Similarity=0.271  Sum_probs=117.0

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .++.++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++........   .....++..|+|||.+.+.
T Consensus       103 ~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~  176 (285)
T cd05631         103 RAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET---VRGRVGTVGYMAPEVINNE  176 (285)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe---ecCCCCCCCccCHhhhcCC
Confidence            56788999999999999999   99999999999999999999999999875432211   1224578899999999988


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      .++.++|+|||||++|+|++|+.||............   .......          ...........+.+++.+||+.|
T Consensus       177 ~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~---~~~~~~~----------~~~~~~~~s~~~~~li~~~l~~~  243 (285)
T cd05631         177 KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV---DRRVKED----------QEEYSEKFSEDAKSICRMLLTKN  243 (285)
T ss_pred             CCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHH---HHHhhcc----------cccCCccCCHHHHHHHHHHhhcC
Confidence            8999999999999999999999999754332111110   0000000          00111122346788999999999


Q ss_pred             CCCCCC-----HHHHHHHh
Q 027675          163 PNDRPT-----MSDVVIML  176 (220)
Q Consensus       163 p~~Rps-----~~~~l~~l  176 (220)
                      |++||+     +++++++-
T Consensus       244 P~~R~~~~~~~~~~~~~h~  262 (285)
T cd05631         244 PKERLGCRGNGAAGVKQHP  262 (285)
T ss_pred             HHHhcCCCCCCHHHHhcCH
Confidence            999997     89999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.95  E-value=4.1e-29  Score=204.79  Aligned_cols=160  Identities=29%  Similarity=0.434  Sum_probs=123.1

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      ....|.++|+.|+.|||.+.   |+|||||.-||||+-+..|||+|||.++......   ..-.+.||..|+|||.+++.
T Consensus       213 llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S---TkMSFaGTVaWMAPEvIrne  286 (904)
T KOG4721|consen  213 LLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKS---TKMSFAGTVAWMAPEVIRNE  286 (904)
T ss_pred             HHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhh---hhhhhhhhHhhhCHHHhhcC
Confidence            35789999999999999998   9999999999999999999999999987654331   12236789999999999999


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      +.++|.|||||||+||||+||+.||...+....      +|.+-.....+..+         ..+..-+.-+|++||+-.
T Consensus       287 PcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI------IwGVGsNsL~LpvP---------stcP~GfklL~Kqcw~sK  351 (904)
T KOG4721|consen  287 PCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI------IWGVGSNSLHLPVP---------STCPDGFKLLLKQCWNSK  351 (904)
T ss_pred             CcccccceehhHHHHHHHHhcCCCccccchhee------EEeccCCcccccCc---------ccCchHHHHHHHHHHhcC
Confidence            999999999999999999999999864332211      11111111111111         122235566788899999


Q ss_pred             CCCCCCHHHHHHHhcCccccC
Q 027675          163 PNDRPTMSDVVIMLGSEAVNL  183 (220)
Q Consensus       163 p~~Rps~~~~l~~l~~~~~~~  183 (220)
                      |.+||++.+++.||....-++
T Consensus       352 pRNRPSFrqil~HldIa~pel  372 (904)
T KOG4721|consen  352 PRNRPSFRQILLHLDIASPEL  372 (904)
T ss_pred             CCCCccHHHHHHHHhhcCHHH
Confidence            999999999999997664433

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.2e-28  Score=196.25  Aligned_cols=152  Identities=25%  Similarity=0.267  Sum_probs=118.2

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+..++.|++.||+|||+++   ++||||||+||+++.++.++|+|||++......     .....+++.|+|||.+.+.
T Consensus       102 ~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~  173 (291)
T cd05612         102 TGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----TWTLCGTPEYLAPEVIQSK  173 (291)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC-----cccccCChhhcCHHHHcCC
Confidence            46788999999999999999   999999999999999999999999998654321     1124578899999999988


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      .++.++|||||||++|+|++|..||...+......      ... .+..    . .+     ......+.++|.+||+.|
T Consensus       174 ~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~------~i~-~~~~----~-~~-----~~~~~~~~~li~~~l~~d  236 (291)
T cd05612         174 GHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYE------KIL-AGKL----E-FP-----RHLDLYAKDLIKKLLVVD  236 (291)
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHH-hCCc----C-CC-----ccCCHHHHHHHHHHcCCC
Confidence            88999999999999999999999997544332211      111 1110    0 00     112346789999999999


Q ss_pred             CCCCCC-----HHHHHHHhcCc
Q 027675          163 PNDRPT-----MSDVVIMLGSE  179 (220)
Q Consensus       163 p~~Rps-----~~~~l~~l~~~  179 (220)
                      |.+||+     +++++.+-+..
T Consensus       237 p~~R~~~~~~~~~~~l~h~~~~  258 (291)
T cd05612         237 RTRRLGNMKNGADDVKNHRWFK  258 (291)
T ss_pred             HHHccCCccCCHHHHhcCcccc
Confidence            999995     99999886554

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.95  E-value=2.7e-28  Score=190.52  Aligned_cols=166  Identities=20%  Similarity=0.236  Sum_probs=122.5

Q ss_pred             HHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCC-CCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            4 LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHE-MNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         4 ~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      +.-+.+||.+||.|||+.|   |+||||||.|+|++.+ |.+||||||.+........   +..+..+.-|+|||++.|.
T Consensus       127 iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep---niSYicSRyYRaPELifga  200 (364)
T KOG0658|consen  127 IKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP---NISYICSRYYRAPELIFGA  200 (364)
T ss_pred             eHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeeccCCC---ceeEEEeccccCHHHHcCc
Confidence            4557899999999999999   9999999999999866 8899999999987654332   2335668899999999885


Q ss_pred             -CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHH-----HHHHhcccc------ccccCCCCC-cCcHHHHH
Q 027675           83 -FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAW-----KLWQEGKAL------DMMDQKPGA-ISKANEIL  149 (220)
Q Consensus        83 -~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~------~~~~~~~~~-~~~~~~~~  149 (220)
                       .|+.+.||||.||++.||+-|++.|.+.+...+...+..+.     +........      ..+...+.. ........
T Consensus       201 ~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~  280 (364)
T KOG0658|consen  201 TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPP  280 (364)
T ss_pred             cccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCH
Confidence             68999999999999999999999998765555444332221     111111100      111111111 12233445


Q ss_pred             HHHHHhccccCCCCCCCCCHHHHHHH
Q 027675          150 KCINVGLLCVQEDPNDRPTMSDVVIM  175 (220)
Q Consensus       150 ~~~~li~~cl~~~p~~Rps~~~~l~~  175 (220)
                      ..++++.++|+++|.+|.++.+++.+
T Consensus       281 d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  281 DALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             HHHHHHHHHhccChhhcCCHHHHhcc
Confidence            78899999999999999999999955

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.95  E-value=3e-28  Score=199.08  Aligned_cols=170  Identities=20%  Similarity=0.184  Sum_probs=119.3

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+..++.|+++||.|||++|   ++||||||+||+++.++.++|+|||++........   .....++..|+|||.+.+.
T Consensus       120 ~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~  193 (355)
T cd07874         120 RMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGM  193 (355)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccccCCCccc---cCCccccCCccCHHHHcCC
Confidence            46779999999999999999   99999999999999999999999999875432211   1224568899999999988


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhH-HH---------------HHHHHHhccccc---cccCCCC---
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLL-GY---------------AWKLWQEGKALD---MMDQKPG---  140 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~-~~---------------~~~~~~~~~~~~---~~~~~~~---  140 (220)
                      .++.++|+|||||++|+|++|..||...+........ ..               ............   .....+.   
T Consensus       194 ~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (355)
T cd07874         194 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLF  273 (355)
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhcccccc
Confidence            8999999999999999999999999654422211100 00               000000000000   0000000   


Q ss_pred             ---CcCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcC
Q 027675          141 ---AISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       141 ---~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~  178 (220)
                         ..........+.++|.+||..||++|||+.+++++-+.
T Consensus       274 ~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~  314 (355)
T cd07874         274 PADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYI  314 (355)
T ss_pred             ccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcch
Confidence               00111123467899999999999999999999988543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.95  E-value=3e-28  Score=192.42  Aligned_cols=156  Identities=27%  Similarity=0.425  Sum_probs=116.4

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      +++.++.|+++||.|||+.+   ++|+||||+||+++.++.++|+|||++................++..|+|||.+.+.
T Consensus       120 ~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  196 (277)
T cd05062         120 KMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG  196 (277)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcC
Confidence            46788999999999999999   999999999999999999999999987643322111111112335679999999888


Q ss_pred             CCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           83 FFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      .++.++|+||||+++|+|++ |..||..........       ....+.....    +.     .....+.+++.+||+.
T Consensus       197 ~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~-------~~~~~~~~~~----~~-----~~~~~~~~li~~~l~~  260 (277)
T cd05062         197 VFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR-------FVMEGGLLDK----PD-----NCPDMLFELMRMCWQY  260 (277)
T ss_pred             CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-------HHHcCCcCCC----CC-----CCCHHHHHHHHHHcCC
Confidence            88999999999999999998 688886544332211       1111111111    11     1223678999999999


Q ss_pred             CCCCCCCHHHHHHHhc
Q 027675          162 DPNDRPTMSDVVIMLG  177 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~  177 (220)
                      +|++||++.++++.|+
T Consensus       261 ~p~~Rps~~e~l~~l~  276 (277)
T cd05062         261 NPKMRPSFLEIISSIK  276 (277)
T ss_pred             ChhhCcCHHHHHHHhh
Confidence            9999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.95  E-value=5e-28  Score=190.95  Aligned_cols=156  Identities=27%  Similarity=0.431  Sum_probs=118.5

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++...............++..|.|||.+.+.
T Consensus       120 ~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  196 (277)
T cd05032         120 KFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG  196 (277)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcC
Confidence            57789999999999999999   999999999999999999999999987654322211111222345689999999888


Q ss_pred             CCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           83 FFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      .++.++|+||||+++|++++ |..||...+......       ....+........         ....+.+++.+||+.
T Consensus       197 ~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~-------~~~~~~~~~~~~~---------~~~~~~~li~~~l~~  260 (277)
T cd05032         197 VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLK-------FVIDGGHLDLPEN---------CPDKLLELMRMCWQY  260 (277)
T ss_pred             CCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHH-------HHhcCCCCCCCCC---------CCHHHHHHHHHHcCC
Confidence            88999999999999999998 888886544333221       1112211111111         134788999999999


Q ss_pred             CCCCCCCHHHHHHHhc
Q 027675          162 DPNDRPTMSDVVIMLG  177 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~  177 (220)
                      +|++|||+.+++..|+
T Consensus       261 ~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         261 NPKMRPTFLEIVSSLK  276 (277)
T ss_pred             ChhhCCCHHHHHHHhc
Confidence            9999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.95  E-value=4.2e-28  Score=195.30  Aligned_cols=152  Identities=22%  Similarity=0.276  Sum_probs=114.9

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+..++.|++.||+|||+++   ++||||||+||+++.++.++|+|||++......  ........|+..|+|||.+.+.
T Consensus        97 ~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~  171 (316)
T cd05620          97 RATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNRASTFCGTPDYIAPEILQGL  171 (316)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCceeccCCCcCccCHHHHcCC
Confidence            56778999999999999999   999999999999999999999999987642211  1112234678899999999988


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      .++.++|+|||||++|+|++|..||...+.......       ....    .. ..+.     .....+.+++.+||..|
T Consensus       172 ~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~-------~~~~----~~-~~~~-----~~~~~~~~li~~~l~~d  234 (316)
T cd05620         172 KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFES-------IRVD----TP-HYPR-----WITKESKDILEKLFERD  234 (316)
T ss_pred             CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH-------HHhC----CC-CCCC-----CCCHHHHHHHHHHccCC
Confidence            899999999999999999999999975443322111       1110    00 0011     12346788999999999


Q ss_pred             CCCCCCHH-HHHHHh
Q 027675          163 PNDRPTMS-DVVIML  176 (220)
Q Consensus       163 p~~Rps~~-~~l~~l  176 (220)
                      |++||++. +++.+-
T Consensus       235 P~~R~~~~~~~~~h~  249 (316)
T cd05620         235 PTRRLGVVGNIRGHP  249 (316)
T ss_pred             HHHcCCChHHHHcCC
Confidence            99999984 676554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.95  E-value=5.6e-28  Score=195.95  Aligned_cols=161  Identities=29%  Similarity=0.374  Sum_probs=119.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .++++++.|++.||.|||+++   ++||||||+||+++.++.++|+|||+++...............++..|+|||.+.+
T Consensus       134 ~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  210 (334)
T cd05100         134 KDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD  210 (334)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc
Confidence            356778999999999999999   99999999999999999999999999875433221111111223457999999988


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++|+|++ |..||...+......       ....+.....         .......+.+++.+||.
T Consensus       211 ~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~-------~~~~~~~~~~---------~~~~~~~l~~li~~cl~  274 (334)
T cd05100         211 RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK-------LLKEGHRMDK---------PANCTHELYMIMRECWH  274 (334)
T ss_pred             CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH-------HHHcCCCCCC---------CCCCCHHHHHHHHHHcc
Confidence            888999999999999999998 888876443322211       1111111111         11123467899999999


Q ss_pred             CCCCCCCCHHHHHHHhcCccc
Q 027675          161 EDPNDRPTMSDVVIMLGSEAV  181 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~~~  181 (220)
                      .+|++||++.+++..|.....
T Consensus       275 ~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         275 AVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             cChhhCcCHHHHHHHHHHHhh
Confidence            999999999999999976643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.95  E-value=4.3e-28  Score=193.15  Aligned_cols=164  Identities=24%  Similarity=0.373  Sum_probs=118.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++................++..|+|||.+.+
T Consensus       130 ~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  206 (296)
T cd05051         130 STLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL  206 (296)
T ss_pred             HHHHHHHHHHHHHHHHHHHcC---ccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc
Confidence            357889999999999999999   99999999999999999999999999865432222222222344568999999988


Q ss_pred             CCCcccCceeehhHHHHHHHh--cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      ..++.++|+||||+++|+|++  +..||.........   ................      .........+.+++.+||
T Consensus       207 ~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl  277 (296)
T cd05051         207 GKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVI---ENAGHFFRDDGRQIYL------PRPPNCPKDIYELMLECW  277 (296)
T ss_pred             CCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHH---HHHHhccccccccccC------CCccCCCHHHHHHHHHHh
Confidence            788999999999999999998  66777543322221   1111111111111000      011122347899999999


Q ss_pred             CCCCCCCCCHHHHHHHhc
Q 027675          160 QEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l~  177 (220)
                      +.||++|||+.++++.|.
T Consensus       278 ~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         278 RRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             ccChhcCCCHHHHHHHhc
Confidence            999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=2.8e-28  Score=197.68  Aligned_cols=160  Identities=21%  Similarity=0.196  Sum_probs=120.7

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.....     ......+++.|+|||.+.+.
T Consensus       102 ~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~  173 (333)
T cd05600         102 HARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGK  173 (333)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-----ccCCcccCccccChhHhcCC
Confidence            56778999999999999999   99999999999999999999999999865432     12234678899999999988


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      .++.++|+|||||++|+|++|..||...+........      .......   ...............+.+++.+||..+
T Consensus       174 ~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i------~~~~~~~---~~~~~~~~~~~~s~~~~~li~~~l~~~  244 (333)
T cd05600         174 GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENL------KYWKETL---QRPVYDDPRFNLSDEAWDLITKLINDP  244 (333)
T ss_pred             CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHH------Hhccccc---cCCCCCccccccCHHHHHHHHHHhhCh
Confidence            8999999999999999999999999755443322111      0000001   111111111223457788999999999


Q ss_pred             CCCCCCHHHHHHHhcCc
Q 027675          163 PNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       163 p~~Rps~~~~l~~l~~~  179 (220)
                      |++||++++++++-+..
T Consensus       245 ~~rr~s~~~ll~h~~~~  261 (333)
T cd05600         245 SRRFGSLEDIKNHPFFK  261 (333)
T ss_pred             hhhcCCHHHHHhCcccC
Confidence            99999999999885443

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.95  E-value=6.6e-28  Score=188.14  Aligned_cols=157  Identities=31%  Similarity=0.435  Sum_probs=120.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||++||+++   ++|+||+|+||+++.++.++|+|||.+................++..|.|||.+.+
T Consensus       105 ~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  181 (262)
T cd00192         105 KDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKD  181 (262)
T ss_pred             HHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhcc
Confidence            467899999999999999999   99999999999999999999999999876543321122223345678999999988


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++|+|++ |..||...........       ...+.....         .......+.+++.+||+
T Consensus       182 ~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-------~~~~~~~~~---------~~~~~~~~~~li~~~l~  245 (262)
T cd00192         182 GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEY-------LRKGYRLPK---------PEYCPDELYELMLSCWQ  245 (262)
T ss_pred             CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-------HHcCCCCCC---------CccCChHHHHHHHHHcc
Confidence            888999999999999999998 5888875533322111       111111111         11124578899999999


Q ss_pred             CCCCCCCCHHHHHHHhc
Q 027675          161 EDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~  177 (220)
                      .+|++||++.+++.+|+
T Consensus       246 ~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         246 LDPEDRPTFSELVERLE  262 (262)
T ss_pred             CCcccCcCHHHHHHhhC
Confidence            99999999999999873

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.95  E-value=2.6e-28  Score=196.84  Aligned_cols=154  Identities=22%  Similarity=0.289  Sum_probs=117.7

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.......  .......|++.|+|||.+.+.
T Consensus        97 ~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~  171 (320)
T cd05590          97 RARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTSTFCGTPDYIAPEILQEM  171 (320)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--CcccccccCccccCHHHHcCC
Confidence            46778999999999999999   9999999999999999999999999976432111  112234678899999999988


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      .++.++|+|||||++|+|++|+.||...+.......      . ..+..    . .+     ......+.+++.+||+.|
T Consensus       172 ~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~------i-~~~~~----~-~~-----~~~~~~~~~li~~~L~~d  234 (320)
T cd05590         172 LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA------I-LNDEV----V-YP-----TWLSQDAVDILKAFMTKN  234 (320)
T ss_pred             CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHH------H-hcCCC----C-CC-----CCCCHHHHHHHHHHcccC
Confidence            889999999999999999999999976554332211      1 11110    0 01     112346788999999999


Q ss_pred             CCCCCCH------HHHHHHhcC
Q 027675          163 PNDRPTM------SDVVIMLGS  178 (220)
Q Consensus       163 p~~Rps~------~~~l~~l~~  178 (220)
                      |++||++      ++++.+-+.
T Consensus       235 P~~R~~~~~~~~~~~~~~h~~f  256 (320)
T cd05590         235 PTMRLGSLTLGGEEAILRHPFF  256 (320)
T ss_pred             HHHCCCCCCCCCHHHHHcCCCc
Confidence            9999998      788876543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=3.4e-28  Score=195.48  Aligned_cols=154  Identities=23%  Similarity=0.235  Sum_probs=116.0

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++.......  .......|++.|+|||.+.+
T Consensus        93 ~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~  167 (312)
T cd05585          93 SRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFCGTPEYLAPELLLG  167 (312)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--CccccccCCcccCCHHHHcC
Confidence            356778999999999999999   9999999999999999999999999986432211  11223467889999999999


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+|||||++|+|++|..||...+.....      ..... +.        ..  ........+.+++.+||+.
T Consensus       168 ~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~------~~~~~-~~--------~~--~~~~~~~~~~~li~~~L~~  230 (312)
T cd05585         168 HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMY------RKILQ-EP--------LR--FPDGFDRDAKDLLIGLLSR  230 (312)
T ss_pred             CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHH------HHHHc-CC--------CC--CCCcCCHHHHHHHHHHcCC
Confidence            88999999999999999999999999654332211      11111 00        00  0111234678899999999


Q ss_pred             CCCCCCC---HHHHHHHhc
Q 027675          162 DPNDRPT---MSDVVIMLG  177 (220)
Q Consensus       162 ~p~~Rps---~~~~l~~l~  177 (220)
                      ||++||+   +.+++.+-+
T Consensus       231 dp~~R~~~~~~~e~l~hp~  249 (312)
T cd05585         231 DPTRRLGYNGAQEIKNHPF  249 (312)
T ss_pred             CHHHcCCCCCHHHHHcCCC
Confidence            9999975   677776643

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.95  E-value=4.5e-28  Score=195.48  Aligned_cols=152  Identities=22%  Similarity=0.278  Sum_probs=114.0

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+..++.|+++||.|||+.+   ++||||||+||+++.++.++|+|||++.......  .......+++.|+|||.+.+.
T Consensus        97 ~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~  171 (321)
T cd05603          97 RARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTSTFCGTPEYLAPEVLRKE  171 (321)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--CccccccCCcccCCHHHhcCC
Confidence            46678999999999999999   9999999999999999999999999876422111  112234578899999999988


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      .++.++|+|||||++|+|++|..||...+......      ... ...    . ..+     ......+.+++.+||+.+
T Consensus       172 ~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~------~i~-~~~----~-~~~-----~~~~~~~~~li~~~l~~~  234 (321)
T cd05603         172 PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYD------NIL-HKP----L-QLP-----GGKTVAACDLLVGLLHKD  234 (321)
T ss_pred             CCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHH------HHh-cCC----C-CCC-----CCCCHHHHHHHHHHccCC
Confidence            88999999999999999999999996544322211      111 110    0 011     112346789999999999


Q ss_pred             CCCCCCHH----HHHHHh
Q 027675          163 PNDRPTMS----DVVIML  176 (220)
Q Consensus       163 p~~Rps~~----~~l~~l  176 (220)
                      |.+||++.    +++++.
T Consensus       235 p~~R~~~~~~~~~~~~~~  252 (321)
T cd05603         235 QRRRLGAKADFLEIKNHV  252 (321)
T ss_pred             HhhcCCCCCCHHHHhCCC
Confidence            99999764    655543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.95  E-value=4.5e-28  Score=195.74  Aligned_cols=154  Identities=25%  Similarity=0.293  Sum_probs=117.6

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.......  .......+++.|+|||.+.+
T Consensus       101 ~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~  175 (324)
T cd05589         101 PRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG--DRTSTFCGTPEFLAPEVLTE  175 (324)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCCC--CcccccccCccccCHhHhcC
Confidence            357789999999999999999   9999999999999999999999999876432211  11223467889999999998


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+|||||++|+|++|..||...+.......      .. .+..     ..+     ......+.++|.+||..
T Consensus       176 ~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~------i~-~~~~-----~~p-----~~~~~~~~~li~~~L~~  238 (324)
T cd05589         176 TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDS------IV-NDEV-----RYP-----RFLSREAISIMRRLLRR  238 (324)
T ss_pred             CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHH------HH-hCCC-----CCC-----CCCCHHHHHHHHHHhhc
Confidence            8889999999999999999999999975543332211      11 1110     001     11234678899999999


Q ss_pred             CCCCCC-----CHHHHHHHhc
Q 027675          162 DPNDRP-----TMSDVVIMLG  177 (220)
Q Consensus       162 ~p~~Rp-----s~~~~l~~l~  177 (220)
                      ||++||     ++.+++++-+
T Consensus       239 dP~~R~~~~~~~~~~l~~~~~  259 (324)
T cd05589         239 NPERRLGSGEKDAEDVKKQPF  259 (324)
T ss_pred             CHhHcCCCCCCCHHHHhhCCC
Confidence            999999     6888887653

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.95  E-value=1.6e-28  Score=198.45  Aligned_cols=154  Identities=22%  Similarity=0.280  Sum_probs=117.4

Q ss_pred             chHHHHHHHHHHHHHHhhh-CCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQ-DSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~-~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~   80 (220)
                      +.+..++.|++.||.|||+ .+   ++||||||+||+++.++.++|+|||++........  ......+++.|+|||.+.
T Consensus        95 ~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~  169 (325)
T cd05594          95 DRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLE  169 (325)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--ccccccCCcccCCHHHHc
Confidence            3567889999999999997 78   99999999999999999999999998764322111  112245788999999999


Q ss_pred             cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           81 GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      +..++.++|+|||||++|+|++|..||...+........      . ... ..    .+.     .....+.+++.+||+
T Consensus       170 ~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i------~-~~~-~~----~p~-----~~~~~~~~li~~~L~  232 (325)
T cd05594         170 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------L-MEE-IR----FPR-----TLSPEAKSLLSGLLK  232 (325)
T ss_pred             cCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH------h-cCC-CC----CCC-----CCCHHHHHHHHHHhh
Confidence            888999999999999999999999999754433222111      0 000 00    011     123467889999999


Q ss_pred             CCCCCCC-----CHHHHHHHhc
Q 027675          161 EDPNDRP-----TMSDVVIMLG  177 (220)
Q Consensus       161 ~~p~~Rp-----s~~~~l~~l~  177 (220)
                      .||++|+     ++.+++++-+
T Consensus       233 ~dP~~R~~~~~~~~~~il~h~~  254 (325)
T cd05594         233 KDPKQRLGGGPDDAKEIMQHKF  254 (325)
T ss_pred             cCHHHhCCCCCCCHHHHhcCCC
Confidence            9999997     8999998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.95  E-value=3.4e-28  Score=196.24  Aligned_cols=153  Identities=23%  Similarity=0.273  Sum_probs=117.7

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++........  ......++..|+|||.+.+.
T Consensus        97 ~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~  171 (321)
T cd05591          97 RSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTFCGTPDYIAPEILQEL  171 (321)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc--cccccccCccccCHHHHcCC
Confidence            46778999999999999999   99999999999999999999999998865322111  12224578899999999988


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      .++.++|+||||+++|+|++|..||...+......      ..... ..    . .+.     .....+.+++..||..|
T Consensus       172 ~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~------~i~~~-~~----~-~p~-----~~~~~~~~ll~~~L~~d  234 (321)
T cd05591         172 EYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFE------SILHD-DV----L-YPV-----WLSKEAVSILKAFMTKN  234 (321)
T ss_pred             CCCCccceechhHHHHHHhcCCCCCCCCCHHHHHH------HHHcC-CC----C-CCC-----CCCHHHHHHHHHHhccC
Confidence            89999999999999999999999997655433221      11111 10    0 000     12236788999999999


Q ss_pred             CCCCC-------CHHHHHHHhc
Q 027675          163 PNDRP-------TMSDVVIMLG  177 (220)
Q Consensus       163 p~~Rp-------s~~~~l~~l~  177 (220)
                      |++||       ++.+++++-+
T Consensus       235 p~~R~~~~~~~~~~~~~~~hp~  256 (321)
T cd05591         235 PNKRLGCVASQGGEDAIKQHPF  256 (321)
T ss_pred             HHHcCCCCCCCCCHHHHhcCCc
Confidence            99999       8899997754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.95  E-value=5.7e-28  Score=189.46  Aligned_cols=156  Identities=26%  Similarity=0.412  Sum_probs=117.3

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .++.++.|+++||+|||+++   ++||||||+||++++++.++|+|||++.......... ......+..|+|||.+.+.
T Consensus       105 ~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~  180 (263)
T cd05052         105 VLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYN  180 (263)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceeec-cCCCCCccccCCHHHhccC
Confidence            56789999999999999999   9999999999999999999999999987543321111 1111224579999999888


Q ss_pred             CCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           83 FFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      .++.++|+||||+++|+|++ |..||...+.....       .....+.....         .......+.+++.+||+.
T Consensus       181 ~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~-------~~~~~~~~~~~---------~~~~~~~~~~li~~cl~~  244 (263)
T cd05052         181 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-------ELLEKGYRMER---------PEGCPPKVYELMRACWQW  244 (263)
T ss_pred             CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------HHHHCCCCCCC---------CCCCCHHHHHHHHHHccC
Confidence            88999999999999999998 88888654433221       11111111111         011234688899999999


Q ss_pred             CCCCCCCHHHHHHHhcC
Q 027675          162 DPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~~  178 (220)
                      +|++||++.++++.|+.
T Consensus       245 ~p~~Rp~~~~l~~~l~~  261 (263)
T cd05052         245 NPSDRPSFAEIHQAFET  261 (263)
T ss_pred             CcccCCCHHHHHHHHHh
Confidence            99999999999999864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.95  E-value=2.8e-28  Score=195.08  Aligned_cols=171  Identities=22%  Similarity=0.246  Sum_probs=116.5

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +.+..++.|++.||+|||+++   ++||||||+||+++.++.++|+|||++........  ......++..|+|||.+.+
T Consensus       103 ~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~  177 (303)
T cd07869         103 ENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH--TYSNEVVTLWYRPPDVLLG  177 (303)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCCc--cCCCCcccCCCCChHHHcC
Confidence            357789999999999999999   99999999999999999999999999864332111  1122356788999999876


Q ss_pred             C-CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhc--------cccccccC--CC-CCcCcH----
Q 027675           82 G-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEG--------KALDMMDQ--KP-GAISKA----  145 (220)
Q Consensus        82 ~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~--~~-~~~~~~----  145 (220)
                      . .++.++|+|||||++|+|++|..||.........  ...........        ........  .. ......    
T Consensus       178 ~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (303)
T cd07869         178 STEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ--LERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAW  255 (303)
T ss_pred             CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH--HHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHh
Confidence            4 4688899999999999999999999754332111  00000000000        00000000  00 000000    


Q ss_pred             ---HHHHHHHHHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          146 ---NEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       146 ---~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                         .....+.+++.+||+.||++|||++++++|-+..
T Consensus       256 ~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~  292 (303)
T cd07869         256 NKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFS  292 (303)
T ss_pred             hccCCChHHHHHHHHHhccCchhccCHHHHhcCcccc
Confidence               0123567899999999999999999999876543

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.95  E-value=4e-28  Score=192.11  Aligned_cols=157  Identities=26%  Similarity=0.379  Sum_probs=116.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+++.++.|++.|++|||+.+   ++|+||||+||++++++.++|+|||++................++..|+|||.+.+
T Consensus       122 ~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  198 (280)
T cd05092         122 GQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY  198 (280)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc
Confidence            457889999999999999999   99999999999999999999999999865432221111122233567999999988


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+|||||++|+|++ |..||...........       ...+......    .     .....+.+++.+||+
T Consensus       199 ~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-------~~~~~~~~~~----~-----~~~~~~~~li~~cl~  262 (280)
T cd05092         199 RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC-------ITQGRELERP----R-----TCPPEVYAIMQGCWQ  262 (280)
T ss_pred             CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH-------HHcCccCCCC----C-----CCCHHHHHHHHHHcc
Confidence            888999999999999999998 8888854333222111       1111111111    1     122367899999999


Q ss_pred             CCCCCCCCHHHHHHHhc
Q 027675          161 EDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~  177 (220)
                      .||.+||++.++++.|+
T Consensus       263 ~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         263 REPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             CChhhCCCHHHHHHHHh
Confidence            99999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.95  E-value=7.9e-28  Score=196.92  Aligned_cols=171  Identities=19%  Similarity=0.189  Sum_probs=119.4

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+..++.|++.||.|||+++   |+||||||+||+++.++.++|+|||++.......   ......++..|+|||.+.+.
T Consensus       124 ~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~  197 (359)
T cd07876         124 RMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGM  197 (359)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCccccccCc---cCCCCcccCCCCCchhccCC
Confidence            46778999999999999999   9999999999999999999999999986432211   11224567889999999998


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhH-H---------------HHHHHHHhcccccc------ccC---
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLL-G---------------YAWKLWQEGKALDM------MDQ---  137 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~-~---------------~~~~~~~~~~~~~~------~~~---  137 (220)
                      .++.++|+||||+++|+|++|..||...+........ .               ..............      ...   
T Consensus       198 ~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (359)
T cd07876         198 GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIF  277 (359)
T ss_pred             CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhcccccc
Confidence            8999999999999999999999999754432211100 0               00000000000000      000   


Q ss_pred             CCCCcCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          138 KPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       138 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      .............+.+++.+||..||++|||+.+++.+-+..
T Consensus       278 ~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~  319 (359)
T cd07876         278 PSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT  319 (359)
T ss_pred             ccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhh
Confidence            000000111234678999999999999999999999886543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.95  E-value=3.7e-28  Score=191.94  Aligned_cols=157  Identities=28%  Similarity=0.386  Sum_probs=115.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCC---CceecCccceeeecCCCCCcccceeecccCccChhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEM---NPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEY   78 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~   78 (220)
                      ..++.++.|++.||.|||+++   ++|+||||+||+++.++   .++|+|||++.................+..|+|||.
T Consensus       116 ~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  192 (277)
T cd05036         116 KDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEA  192 (277)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHH
Confidence            356789999999999999999   99999999999998765   489999999875432211111111223457999999


Q ss_pred             hhcCCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcc
Q 027675           79 ALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLL  157 (220)
Q Consensus        79 ~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  157 (220)
                      +.+..++.++|+|||||++|+|++ |..||...........       ........         ........+.+++.+
T Consensus       193 ~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~-------~~~~~~~~---------~~~~~~~~~~~~i~~  256 (277)
T cd05036         193 FLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF-------VTGGGRLD---------PPKGCPGPVYRIMTD  256 (277)
T ss_pred             HhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-------HHcCCcCC---------CCCCCCHHHHHHHHH
Confidence            988889999999999999999996 9999865443322111       11111110         011123467889999


Q ss_pred             ccCCCCCCCCCHHHHHHHhc
Q 027675          158 CVQEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       158 cl~~~p~~Rps~~~~l~~l~  177 (220)
                      ||+.+|++||++.+++++|.
T Consensus       257 cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         257 CWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HcCCCcccCcCHHHHHHHhh
Confidence            99999999999999999985

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.95  E-value=3.6e-28  Score=205.77  Aligned_cols=154  Identities=21%  Similarity=0.268  Sum_probs=118.3

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++................|++.|+|||.+.+.
T Consensus       170 ~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  246 (478)
T PTZ00267        170 EVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERK  246 (478)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCC
Confidence            46678999999999999999   999999999999999999999999998765433222223335678899999999988


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      .++.++|+|||||++|+|++|..||...+......      ... .+...    ..+     ......+.++|.+||..+
T Consensus       247 ~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~------~~~-~~~~~----~~~-----~~~s~~~~~li~~~L~~d  310 (478)
T PTZ00267        247 RYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQ------QVL-YGKYD----PFP-----CPVSSGMKALLDPLLSKN  310 (478)
T ss_pred             CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHH-hCCCC----CCC-----ccCCHHHHHHHHHHhccC
Confidence            89999999999999999999999986544322111      111 11110    111     112346789999999999


Q ss_pred             CCCCCCHHHHHHH
Q 027675          163 PNDRPTMSDVVIM  175 (220)
Q Consensus       163 p~~Rps~~~~l~~  175 (220)
                      |++||++++++.+
T Consensus       311 P~~Rps~~~~l~~  323 (478)
T PTZ00267        311 PALRPTTQQLLHT  323 (478)
T ss_pred             hhhCcCHHHHHhC
Confidence            9999999999753

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.95  E-value=3e-28  Score=193.71  Aligned_cols=159  Identities=27%  Similarity=0.411  Sum_probs=119.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+++.++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++................++..|+|||.+.+
T Consensus       127 ~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~  203 (290)
T cd05045         127 GDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD  203 (290)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc
Confidence            356889999999999999999   99999999999999999999999999865432221111111234568999999988


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++++|++ |..||.........       .....+.....         .......+.+++.+||+
T Consensus       204 ~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-------~~~~~~~~~~~---------~~~~~~~~~~~i~~cl~  267 (290)
T cd05045         204 HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF-------NLLKTGYRMER---------PENCSEEMYNLMLTCWK  267 (290)
T ss_pred             CCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH-------HHHhCCCCCCC---------CCCCCHHHHHHHHHHcc
Confidence            888999999999999999998 99888654433221       11111111110         11123467899999999


Q ss_pred             CCCCCCCCHHHHHHHhcCc
Q 027675          161 EDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~  179 (220)
                      .+|++||++.++++.|+..
T Consensus       268 ~~P~~Rp~~~~i~~~l~~~  286 (290)
T cd05045         268 QEPDKRPTFADISKELEKM  286 (290)
T ss_pred             CCcccCCCHHHHHHHHHHH
Confidence            9999999999999998654

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.95  E-value=5.8e-28  Score=191.35  Aligned_cols=157  Identities=27%  Similarity=0.427  Sum_probs=117.1

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      +++.++.+++.||.|||+++   ++|+||||+||+++.++.++|+|||++................++..|+|||.+.+.
T Consensus       125 ~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  201 (283)
T cd05090         125 DFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG  201 (283)
T ss_pred             HHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccC
Confidence            45779999999999999999   999999999999999999999999998754322211112223345679999999888


Q ss_pred             CCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           83 FFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      .++.++|+||||+++|+|++ |..||............       .......    .+     ......+.+++.+||+.
T Consensus       202 ~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~-------~~~~~~~----~~-----~~~~~~~~~li~~cl~~  265 (283)
T cd05090         202 KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV-------RKRQLLP----CS-----EDCPPRMYSLMTECWQE  265 (283)
T ss_pred             CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-------HcCCcCC----CC-----CCCCHHHHHHHHHHccc
Confidence            88999999999999999998 88888644332221111       1111111    11     11224678899999999


Q ss_pred             CCCCCCCHHHHHHHhcC
Q 027675          162 DPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~~  178 (220)
                      ||++||++.++++.|..
T Consensus       266 ~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         266 GPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             CcccCcCHHHHHHHhhc
Confidence            99999999999998854

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.95  E-value=4.6e-28  Score=195.62  Aligned_cols=152  Identities=23%  Similarity=0.314  Sum_probs=116.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.......  .......|++.|+|||.+.+
T Consensus       101 ~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~  175 (323)
T cd05616         101 PHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG--VTTKTFCGTPDYIAPEIIAY  175 (323)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCC--CccccCCCChhhcCHHHhcC
Confidence            357789999999999999999   9999999999999999999999999986432111  11223457889999999999


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+|||||++|+|++|..||...+.......      .. ....     ..+     ......+.+++.+||+.
T Consensus       176 ~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~------i~-~~~~-----~~p-----~~~s~~~~~li~~~l~~  238 (323)
T cd05616         176 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS------IM-EHNV-----AYP-----KSMSKEAVAICKGLMTK  238 (323)
T ss_pred             CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHH------HH-hCCC-----CCC-----CcCCHHHHHHHHHHccc
Confidence            8899999999999999999999999976554332211      11 1110     001     11234678899999999


Q ss_pred             CCCCCCCH-----HHHHHH
Q 027675          162 DPNDRPTM-----SDVVIM  175 (220)
Q Consensus       162 ~p~~Rps~-----~~~l~~  175 (220)
                      +|++|++.     .+++.+
T Consensus       239 ~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         239 HPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             CHHhcCCCCCCCHHHHhcC
Confidence            99999984     677655

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.95  E-value=2.7e-28  Score=196.99  Aligned_cols=155  Identities=23%  Similarity=0.277  Sum_probs=117.7

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++........  ......+++.|+|||.+.+
T Consensus        95 ~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~  169 (323)
T cd05595          95 ERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLED  169 (323)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--ccccccCCcCcCCcccccC
Confidence            357789999999999999999   99999999999999999999999998764221111  1122457889999999988


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+|||||++|+|++|..||...+........      . ... .   . .+     ......+.++|.+||..
T Consensus       170 ~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~------~-~~~-~---~-~p-----~~~~~~~~~li~~~L~~  232 (323)
T cd05595         170 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI------L-MEE-I---R-FP-----RTLSPEAKSLLAGLLKK  232 (323)
T ss_pred             CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH------h-cCC-C---C-CC-----CCCCHHHHHHHHHHccC
Confidence            88899999999999999999999999654433221111      0 000 0   0 01     11234678899999999


Q ss_pred             CCCCCC-----CHHHHHHHhcC
Q 027675          162 DPNDRP-----TMSDVVIMLGS  178 (220)
Q Consensus       162 ~p~~Rp-----s~~~~l~~l~~  178 (220)
                      ||++|+     ++.+++++-+.
T Consensus       233 dP~~R~~~~~~~~~~~l~h~~~  254 (323)
T cd05595         233 DPKQRLGGGPSDAKEVMEHRFF  254 (323)
T ss_pred             CHHHhCCCCCCCHHHHHcCCCc
Confidence            999998     89999976533

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.95  E-value=1.5e-27  Score=190.17  Aligned_cols=163  Identities=25%  Similarity=0.357  Sum_probs=116.9

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      +++.++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++.................+..|++||...+.
T Consensus       131 ~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~  207 (296)
T cd05095         131 TLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG  207 (296)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---eecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC
Confidence            57899999999999999999   999999999999999999999999998654322211112222335679999988888


Q ss_pred             CCcccCceeehhHHHHHHHh--cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           83 FFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      .++.++|+|||||++|+|++  |..||...+......   ............... ..+     ......+.+++.+||+
T Consensus       208 ~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~-~~~-----~~~~~~~~~li~~cl~  278 (296)
T cd05095         208 KFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIE---NTGEFFRDQGRQVYL-PKP-----ALCPDSLYKLMLSCWR  278 (296)
T ss_pred             CccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHH---HHHHHHhhccccccC-CCC-----CCCCHHHHHHHHHHcC
Confidence            88999999999999999998  667775443322211   111111111000000 111     1122477899999999


Q ss_pred             CCCCCCCCHHHHHHHhc
Q 027675          161 EDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~  177 (220)
                      .||++||++.++++.|+
T Consensus       279 ~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         279 RNAKERPSFQEIHATLL  295 (296)
T ss_pred             CCcccCCCHHHHHHHHh
Confidence            99999999999999885

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.95  E-value=4.2e-28  Score=196.35  Aligned_cols=157  Identities=21%  Similarity=0.284  Sum_probs=115.0

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhh--
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL--   80 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~--   80 (220)
                      .+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++......... ......+++.|+|||.+.  
T Consensus       103 ~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~  178 (330)
T cd05601         103 MAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTM  178 (330)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCce-eeecccCCccccCHHHhccc
Confidence            46678899999999999999   999999999999999999999999998764432211 122235788999999986  


Q ss_pred             ----cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhc
Q 027675           81 ----GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGL  156 (220)
Q Consensus        81 ----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  156 (220)
                          +..++.++|+|||||++|+|++|..||..........      +..........    +   ........+.+++.
T Consensus       179 ~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~------~i~~~~~~~~~----~---~~~~~~~~~~~li~  245 (330)
T cd05601         179 NGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYN------NIMNFQRFLKF----P---EDPKVSSDFLDLIQ  245 (330)
T ss_pred             cccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHH------HHHcCCCccCC----C---CCCCCCHHHHHHHH
Confidence                3456789999999999999999999996544332211      11111111110    1   11112346778888


Q ss_pred             cccCCCCCCCCCHHHHHHHhc
Q 027675          157 LCVQEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       157 ~cl~~~p~~Rps~~~~l~~l~  177 (220)
                      .||. +|++||++++++.+-+
T Consensus       246 ~ll~-~p~~R~t~~~l~~h~~  265 (330)
T cd05601         246 SLLC-GQKERLGYEGLCCHPF  265 (330)
T ss_pred             HHcc-ChhhCCCHHHHhCCCC
Confidence            8997 9999999999997743

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.95  E-value=1.8e-28  Score=205.48  Aligned_cols=170  Identities=21%  Similarity=0.194  Sum_probs=116.1

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCC-CceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEM-NPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .++.++.|++.||.|||+.+   |+||||||+||+++.++ .++|+|||++........   .....+++.|+|||.+.+
T Consensus       171 ~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~  244 (440)
T PTZ00036        171 LVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLG  244 (440)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccccchhccCCCC---cccCCCCcCccCHHHhcC
Confidence            46778899999999999999   99999999999998665 699999999875432211   112456888999999876


Q ss_pred             C-CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHH-----HHHHHhc-cccccccCCCCCc------CcHHHH
Q 027675           82 G-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA-----WKLWQEG-KALDMMDQKPGAI------SKANEI  148 (220)
Q Consensus        82 ~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~-~~~~~~~~~~~~~------~~~~~~  148 (220)
                      . .++.++|+|||||++|+|++|.+||...............     ....... .............      ......
T Consensus       245 ~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~  324 (440)
T PTZ00036        245 ATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTP  324 (440)
T ss_pred             CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCC
Confidence            4 6889999999999999999999999754433221111000     0000000 0000000000000      001123


Q ss_pred             HHHHHHhccccCCCCCCCCCHHHHHHHhcC
Q 027675          149 LKCINVGLLCVQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       149 ~~~~~li~~cl~~~p~~Rps~~~~l~~l~~  178 (220)
                      ..+.++|.+||..||.+|||+.+++.+-+.
T Consensus       325 ~~~~~li~~~L~~dP~~R~ta~e~l~hp~f  354 (440)
T PTZ00036        325 DDAINFISQFLKYEPLKRLNPIEALADPFF  354 (440)
T ss_pred             HHHHHHHHHHCCCChhHCcCHHHHhCChhH
Confidence            468899999999999999999999977543

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.95  E-value=4.9e-28  Score=193.76  Aligned_cols=158  Identities=29%  Similarity=0.366  Sum_probs=118.4

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      +++.++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++................++..|+|||.+.+.
T Consensus       138 ~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  214 (304)
T cd05101         138 DLVSCTYQVARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR  214 (304)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---eeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC
Confidence            56788999999999999999   999999999999999999999999998765432222112222345679999999888


Q ss_pred             CCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           83 FFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      .++.++|+||||+++|++++ |..||...+......       ....+.....         .......+.+++.+||..
T Consensus       215 ~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-------~~~~~~~~~~---------~~~~~~~~~~li~~cl~~  278 (304)
T cd05101         215 VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK-------LLKEGHRMDK---------PANCTNELYMMMRDCWHA  278 (304)
T ss_pred             CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH-------HHHcCCcCCC---------CCCCCHHHHHHHHHHccc
Confidence            88999999999999999998 777775443322211       1111111111         112334678899999999


Q ss_pred             CCCCCCCHHHHHHHhcCc
Q 027675          162 DPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~~~  179 (220)
                      +|++||++.++++.|...
T Consensus       279 ~p~~Rps~~e~l~~l~~~  296 (304)
T cd05101         279 IPSHRPTFKQLVEDLDRI  296 (304)
T ss_pred             ChhhCCCHHHHHHHHHHH
Confidence            999999999999998654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.95  E-value=5.5e-28  Score=195.20  Aligned_cols=153  Identities=27%  Similarity=0.353  Sum_probs=116.9

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++........  ......+++.|+|||.+.+.
T Consensus       101 ~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~  175 (323)
T cd05584         101 TACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--VTHTFCGTIEYMAPEILMRS  175 (323)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--cccccCCCccccChhhccCC
Confidence            45678899999999999999   99999999999999999999999999764322111  12224578899999999888


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      .++.++|+||||+++|+|++|..||...+......      ... .+. ...    +.     .....+.++|.+||+.+
T Consensus       176 ~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~------~~~-~~~-~~~----~~-----~~~~~~~~li~~~l~~~  238 (323)
T cd05584         176 GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTID------KIL-KGK-LNL----PP-----YLTPEARDLLKKLLKRN  238 (323)
T ss_pred             CCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHH------HHH-cCC-CCC----CC-----CCCHHHHHHHHHHcccC
Confidence            88999999999999999999999997544332211      111 111 000    11     12236789999999999


Q ss_pred             CCCCC-----CHHHHHHHhc
Q 027675          163 PNDRP-----TMSDVVIMLG  177 (220)
Q Consensus       163 p~~Rp-----s~~~~l~~l~  177 (220)
                      |++||     ++.+++.+-+
T Consensus       239 p~~R~~~~~~~~~~l~~h~~  258 (323)
T cd05584         239 PSSRLGAGPGDAAEVQSHPF  258 (323)
T ss_pred             HhHcCCCCCCCHHHHhcCCC
Confidence            99999     8999987653

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.95  E-value=6.1e-28  Score=194.14  Aligned_cols=160  Identities=28%  Similarity=0.370  Sum_probs=118.7

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      ++.+++.|++.||.|||++|   ++|+||||+||+++.++.++|+|||++................++..|+|||.+.+.
T Consensus       135 ~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  211 (314)
T cd05099         135 DLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR  211 (314)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccC
Confidence            46788999999999999999   999999999999999999999999998654322111111111234579999999888


Q ss_pred             CCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           83 FFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      .++.++|+||||+++|++++ |..||...........       ...+.....         .......+.+++.+||..
T Consensus       212 ~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~-------~~~~~~~~~---------~~~~~~~l~~li~~cl~~  275 (314)
T cd05099         212 VYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL-------LREGHRMDK---------PSNCTHELYMLMRECWHA  275 (314)
T ss_pred             CcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HHcCCCCCC---------CCCCCHHHHHHHHHHcCC
Confidence            88999999999999999998 8888865443322211       111111111         111233677899999999


Q ss_pred             CCCCCCCHHHHHHHhcCccc
Q 027675          162 DPNDRPTMSDVVIMLGSEAV  181 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~~~~~  181 (220)
                      +|++||++.++++.|.....
T Consensus       276 ~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         276 VPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             CcccCcCHHHHHHHHHHHHH
Confidence            99999999999999976643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.95  E-value=7.5e-28  Score=201.97  Aligned_cols=173  Identities=18%  Similarity=0.257  Sum_probs=116.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+++.|+.|++.||.|||+++   |+||||||+||+++.++.++|+|||+++...............|+..|+|||++.+
T Consensus       260 ~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~  336 (461)
T PHA03211        260 AQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAG  336 (461)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcC
Confidence            467889999999999999999   99999999999999999999999999875433222222223467899999999999


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccC-cccchhHHHhhHHHHHHHHHhcccc-ccc------------------cCCCC-
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNT-GFYNSELALSLLGYAWKLWQEGKAL-DMM------------------DQKPG-  140 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~-~~~------------------~~~~~-  140 (220)
                      ..++.++|||||||++|||++|..++ ................+........ ...                  ...+. 
T Consensus       337 ~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  416 (461)
T PHA03211        337 DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAY  416 (461)
T ss_pred             CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCcc
Confidence            88999999999999999999887653 2111100000000000111100000 000                  00000 


Q ss_pred             CcCc----HHHHHHHHHHhccccCCCCCCCCCHHHHHHHhc
Q 027675          141 AISK----ANEILKCINVGLLCVQEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       141 ~~~~----~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~  177 (220)
                      ....    ......+.++|.+||+.||.+|||+.|+|++-+
T Consensus       417 ~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~  457 (461)
T PHA03211        417 TRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPL  457 (461)
T ss_pred             CCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcc
Confidence            0000    011235788999999999999999999998854

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.95  E-value=3.9e-28  Score=196.03  Aligned_cols=152  Identities=23%  Similarity=0.246  Sum_probs=115.2

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+..++.|+++||.|||++|   ++||||||+||+++.++.++|+|||++.......  .......|++.|+|||.+.+.
T Consensus        97 ~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~  171 (323)
T cd05575          97 RARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTTSTFCGTPEYLAPEVLRKQ  171 (323)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--CccccccCChhhcChhhhcCC
Confidence            46778999999999999999   9999999999999999999999999876432211  112234578899999999988


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      .++.++|+|||||++|+|++|..||...+......      ... .+.    ....      ......+.+++.+||+.|
T Consensus       172 ~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~------~i~-~~~----~~~~------~~~~~~~~~li~~~l~~~  234 (323)
T cd05575         172 PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD------NIL-NKP----LRLK------PNISVSARHLLEGLLQKD  234 (323)
T ss_pred             CCCccccccccchhhhhhhcCCCCCCCCCHHHHHH------HHH-cCC----CCCC------CCCCHHHHHHHHHHhhcC
Confidence            89999999999999999999999997544332211      111 110    0000      112346788999999999


Q ss_pred             CCCCCCH----HHHHHHh
Q 027675          163 PNDRPTM----SDVVIML  176 (220)
Q Consensus       163 p~~Rps~----~~~l~~l  176 (220)
                      |++||++    .+++.+-
T Consensus       235 p~~R~~~~~~~~~il~~~  252 (323)
T cd05575         235 RTKRLGAKDDFLEIKNHV  252 (323)
T ss_pred             HHhCCCCCCCHHHHHcCC
Confidence            9999998    4777553

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.95  E-value=6.4e-28  Score=187.88  Aligned_cols=157  Identities=26%  Similarity=0.312  Sum_probs=115.6

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+++.++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++.................+..|+|||.+.+
T Consensus        94 ~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  170 (252)
T cd05084          94 KELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNY  170 (252)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcC
Confidence            357889999999999999999   99999999999999999999999999764332111111111122346999999988


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++|++++ |..||..........       ........         .........+.+++.+||.
T Consensus       171 ~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~-------~~~~~~~~---------~~~~~~~~~~~~li~~~l~  234 (252)
T cd05084         171 GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE-------AIEQGVRL---------PCPELCPDAVYRLMERCWE  234 (252)
T ss_pred             CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHH-------HHHcCCCC---------CCcccCCHHHHHHHHHHcC
Confidence            888999999999999999997 888886443322211       11111111         0111223478899999999


Q ss_pred             CCCCCCCCHHHHHHHhc
Q 027675          161 EDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~  177 (220)
                      .+|++||++.++++.|.
T Consensus       235 ~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         235 YDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CChhhCcCHHHHHHHHh
Confidence            99999999999999874

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.95  E-value=7.1e-28  Score=190.48  Aligned_cols=160  Identities=24%  Similarity=0.339  Sum_probs=119.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+++.++.+++.||+|||+++   ++|+||||+||++++++.++++|||+++...............++..|+|||.+.+
T Consensus       117 ~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~  193 (280)
T cd05043         117 QQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN  193 (280)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhc
Confidence            357789999999999999999   99999999999999999999999999865432211111112234567999999988


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++||||||+++|++++ |..||...+.....       .....+.....         .......+.+++.+||.
T Consensus       194 ~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~~~~~~---------~~~~~~~~~~li~~~l~  257 (280)
T cd05043         194 KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA-------AYLKDGYRLAQ---------PINCPDELFAVMACCWA  257 (280)
T ss_pred             CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHH-------HHHHcCCCCCC---------CCcCCHHHHHHHHHHcC
Confidence            888999999999999999998 99998654432221       11111111100         11123467899999999


Q ss_pred             CCCCCCCCHHHHHHHhcCcc
Q 027675          161 EDPNDRPTMSDVVIMLGSEA  180 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~~  180 (220)
                      .+|++|||+.++++.|....
T Consensus       258 ~~p~~Rps~~~~~~~l~~~~  277 (280)
T cd05043         258 LDPEERPSFSQLVQCLTDFH  277 (280)
T ss_pred             CChhhCCCHHHHHHHHHHHH
Confidence            99999999999999987653

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.95  E-value=6.2e-28  Score=194.49  Aligned_cols=154  Identities=22%  Similarity=0.224  Sum_probs=117.9

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.......  .......++..|+|||.+.+
T Consensus        96 ~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~  170 (318)
T cd05570          96 PRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTTSTFCGTPDYIAPEILSY  170 (318)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--CcccceecCccccCHHHhcC
Confidence            356788999999999999999   9999999999999999999999999876422111  11222457889999999999


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+|||||++|+|++|..||...+.......      .. .... .         ........+.++|.+||..
T Consensus       171 ~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~------i~-~~~~-~---------~~~~~~~~~~~li~~~l~~  233 (318)
T cd05570         171 QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQS------IL-EDEV-R---------YPRWLSKEAKSILKSFLTK  233 (318)
T ss_pred             CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHH------HH-cCCC-C---------CCCcCCHHHHHHHHHHccC
Confidence            8899999999999999999999999975443322111      11 1100 0         0011234678999999999


Q ss_pred             CCCCCCCH-----HHHHHHhc
Q 027675          162 DPNDRPTM-----SDVVIMLG  177 (220)
Q Consensus       162 ~p~~Rps~-----~~~l~~l~  177 (220)
                      ||++||++     .+++.+-+
T Consensus       234 dP~~R~s~~~~~~~~ll~~~~  254 (318)
T cd05570         234 NPEKRLGCLPTGEQDIKGHPF  254 (318)
T ss_pred             CHHHcCCCCCCCHHHHhcCCC
Confidence            99999999     99987643

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.95  E-value=5.1e-28  Score=195.45  Aligned_cols=152  Identities=23%  Similarity=0.311  Sum_probs=115.6

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .++.++.|++.||.|||+++   |+||||||+||+++.++.++|+|||++.......  .......|+..|+|||.+.+.
T Consensus       102 ~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~  176 (324)
T cd05587         102 HAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG--KTTRTFCGTPDYIAPEIIAYQ  176 (324)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCC--CceeeecCCccccChhhhcCC
Confidence            56778999999999999999   9999999999999999999999999876422111  112234678899999999988


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      .++.++|+|||||++|+|++|+.||...+.......      .. ... .    ..+.     .....+.+++.+||..|
T Consensus       177 ~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~------i~-~~~-~----~~~~-----~~~~~~~~li~~~l~~~  239 (324)
T cd05587         177 PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQS------IM-EHN-V----SYPK-----SLSKEAVSICKGLLTKH  239 (324)
T ss_pred             CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH------HH-cCC-C----CCCC-----CCCHHHHHHHHHHhhcC
Confidence            889999999999999999999999975543322211      11 100 0    0011     12336788999999999


Q ss_pred             CCCCCCH-----HHHHHHh
Q 027675          163 PNDRPTM-----SDVVIML  176 (220)
Q Consensus       163 p~~Rps~-----~~~l~~l  176 (220)
                      |.+|++.     ++++++-
T Consensus       240 P~~R~~~~~~~~~~~~~hp  258 (324)
T cd05587         240 PAKRLGCGPTGERDIREHA  258 (324)
T ss_pred             HHHcCCCCCCCHHHHhcCC
Confidence            9999986     6777663

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.95  E-value=8.9e-28  Score=197.52  Aligned_cols=172  Identities=22%  Similarity=0.273  Sum_probs=118.7

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.......... .....++..|+|||.+.+
T Consensus       103 ~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~  178 (372)
T cd07853         103 DHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKH-MTQEVVTQYYRAPEILMG  178 (372)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecccCcccc-CCCCCcCCCcCCHHHHcC
Confidence            357789999999999999999   9999999999999999999999999987543222111 112345778999999887


Q ss_pred             C-CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHH----------------HHHHHhccccccccCCCCCcCc
Q 027675           82 G-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA----------------WKLWQEGKALDMMDQKPGAISK  144 (220)
Q Consensus        82 ~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~  144 (220)
                      . .++.++|+|||||++|+|++|+.||...+.......+...                .......... ...........
T Consensus       179 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  257 (372)
T cd07853         179 SRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHK-PPSLPVLYTLS  257 (372)
T ss_pred             CCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCC-CCchHHhcccC
Confidence            5 4688999999999999999999999755433222111100                0000000000 00000000000


Q ss_pred             HHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcC
Q 027675          145 ANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       145 ~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~  178 (220)
                      ......+.++|.+||+.||++|||+.+++.+-+-
T Consensus       258 ~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~  291 (372)
T cd07853         258 SQATHEAVHLLCRMLVFDPDKRISAADALAHPYL  291 (372)
T ss_pred             CCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhh
Confidence            1123467899999999999999999999987543

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.95  E-value=1.2e-27  Score=187.28  Aligned_cols=157  Identities=27%  Similarity=0.445  Sum_probs=118.0

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+++.++.+++.||+|||+.+   ++|+||||+||+++.++.++|+|||++......... ......++..|+|||.+.+
T Consensus       103 ~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~  178 (261)
T cd05072         103 PKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINF  178 (261)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee-ccCCCccceecCCHHHhcc
Confidence            456789999999999999999   999999999999999999999999998764432211 1111234567999999988


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++|+|++ |..||...........       ...+...      +..   ......+.+++.+||.
T Consensus       179 ~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~-------~~~~~~~------~~~---~~~~~~~~~li~~~l~  242 (261)
T cd05072         179 GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA-------LQRGYRM------PRM---ENCPDELYDIMKTCWK  242 (261)
T ss_pred             CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHH-------HHcCCCC------CCC---CCCCHHHHHHHHHHcc
Confidence            888999999999999999998 8999864333222111       1111110      000   1123467889999999


Q ss_pred             CCCCCCCCHHHHHHHhcC
Q 027675          161 EDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~  178 (220)
                      .+|++||+++++++.|+.
T Consensus       243 ~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         243 EKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             CCcccCcCHHHHHHHHhc
Confidence            999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=7.9e-28  Score=196.09  Aligned_cols=161  Identities=25%  Similarity=0.312  Sum_probs=119.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCC----------------------
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQ----------------------   59 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~----------------------   59 (220)
                      ..++.++.|++.||+|||+.|   ++||||||+||+++.++.++|+|||++.......                      
T Consensus       101 ~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (350)
T cd05573         101 ETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR  177 (350)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccc
Confidence            356789999999999999999   9999999999999999999999999987543221                      


Q ss_pred             -----CCcccceeecccCccChhhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhcccccc
Q 027675           60 -----TDGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDM  134 (220)
Q Consensus        60 -----~~~~~~~~~~~~~y~aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  134 (220)
                           .........+++.|+|||.+.+..++.++|||||||++|+|++|..||...+......      +..........
T Consensus       178 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~------~i~~~~~~~~~  251 (350)
T cd05573         178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYN------KIINWKESLRF  251 (350)
T ss_pred             cccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHH------HHhccCCcccC
Confidence                 0011223467889999999999889999999999999999999999997554322211      11110000000


Q ss_pred             ccCCCCCcCcHHHHHHHHHHhccccCCCCCCCCC-HHHHHHHhcCc
Q 027675          135 MDQKPGAISKANEILKCINVGLLCVQEDPNDRPT-MSDVVIMLGSE  179 (220)
Q Consensus       135 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps-~~~~l~~l~~~  179 (220)
                          +.   .......+.++|.+||. +|.+||+ +++++++-+..
T Consensus       252 ----p~---~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~  289 (350)
T cd05573         252 ----PP---DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFK  289 (350)
T ss_pred             ----CC---CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcC
Confidence                00   01133467888899997 9999999 99999886443

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.95  E-value=1.7e-27  Score=189.83  Aligned_cols=163  Identities=23%  Similarity=0.351  Sum_probs=116.3

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .++.++.+++.||.|||+.+   ++|+||||+||+++.++.++|+|||++................++..|.|||.+.+.
T Consensus       130 ~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  206 (295)
T cd05097         130 NLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG  206 (295)
T ss_pred             HHHHHHHHHHHHHHHHHhcC---eeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccC
Confidence            46789999999999999999   999999999999999999999999988653322111112222345689999999888


Q ss_pred             CCcccCceeehhHHHHHHHh--cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           83 FFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      .++.++|+||||+++|+|++  +..||...........   ..+............. +     ......+.+++.+||+
T Consensus       207 ~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~-~-----~~~~~~l~~li~~~l~  277 (295)
T cd05097         207 KFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIEN---TGEFFRNQGRQIYLSQ-T-----PLCPSPVFKLMMRCWS  277 (295)
T ss_pred             CcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHH---HHHhhhhccccccCCC-C-----CCCCHHHHHHHHHHcC
Confidence            88999999999999999988  5567654333222111   1111111000000000 0     1123478999999999


Q ss_pred             CCCCCCCCHHHHHHHhc
Q 027675          161 EDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~  177 (220)
                      .+|++||+++++++.|.
T Consensus       278 ~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         278 RDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             CCchhCcCHHHHHHHHh
Confidence            99999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.95  E-value=1.4e-27  Score=186.96  Aligned_cols=157  Identities=28%  Similarity=0.435  Sum_probs=118.1

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..+.+++.+++.||.+||+.+   ++|+||||+||+++.++.++|+|||++......... .......+..|+|||...+
T Consensus       103 ~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~  178 (261)
T cd05068         103 PQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE-AREGAKFPIKWTAPEAALY  178 (261)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc-ccCCCcCceeccCcccccc
Confidence            467889999999999999999   999999999999999999999999998765422111 1111122347999999988


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++|+|++ |+.||..........       ........         .........+.+++.+||+
T Consensus       179 ~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-------~~~~~~~~---------~~~~~~~~~~~~li~~~l~  242 (261)
T cd05068         179 NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQ-------QVDQGYRM---------PCPPGCPKELYDIMLDCWK  242 (261)
T ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH-------HHHcCCCC---------CCCCcCCHHHHHHHHHHhh
Confidence            888999999999999999999 998886443322111       11111110         0111223478899999999


Q ss_pred             CCCCCCCCHHHHHHHhcC
Q 027675          161 EDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~  178 (220)
                      .+|++||++.++++.|+.
T Consensus       243 ~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         243 EDPDDRPTFETLQWKLED  260 (261)
T ss_pred             cCcccCCCHHHHHHHHhc
Confidence            999999999999999865

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.95  E-value=4.3e-28  Score=198.63  Aligned_cols=153  Identities=25%  Similarity=0.363  Sum_probs=123.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +.+..++.+++.||.|||+++   |+|||+||.||++...|.+|+||||+++.....  ....+.+.|++-|+|||+..+
T Consensus       100 e~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~--t~vltsikGtPlYmAPElv~e  174 (808)
T KOG0597|consen  100 EQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN--TSVLTSIKGTPLYMAPELVEE  174 (808)
T ss_pred             HHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC--ceeeeeccCcccccCHHHHcC
Confidence            467889999999999999998   999999999999999999999999999865543  344556789999999999999


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      .+++..+|+||||||+||+++|++||-...      ....+..+..+           ...........+.+++...|..
T Consensus       175 ~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I~~d-----------~v~~p~~~S~~f~nfl~gLL~k  237 (808)
T KOG0597|consen  175 QPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSILKD-----------PVKPPSTASSSFVNFLQGLLIK  237 (808)
T ss_pred             CCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHHhcC-----------CCCCcccccHHHHHHHHHHhhc
Confidence            999999999999999999999999984211      11112222111           1111225566889999999999


Q ss_pred             CCCCCCCHHHHHHHh
Q 027675          162 DPNDRPTMSDVVIML  176 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l  176 (220)
                      ||.+|.+..+++.|-
T Consensus       238 dP~~RltW~~Ll~Hp  252 (808)
T KOG0597|consen  238 DPAQRLTWTDLLGHP  252 (808)
T ss_pred             ChhhcccHHHHhcCh
Confidence            999999999999653

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.95  E-value=4.4e-28  Score=192.05  Aligned_cols=174  Identities=21%  Similarity=0.261  Sum_probs=118.5

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCc-ccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG-TTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~y~aPe~~~   80 (220)
                      ..++.++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++.......... ......++..|++||.+.
T Consensus       107 ~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~  183 (283)
T cd05080         107 AQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK  183 (283)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhc
Confidence            467889999999999999999   9999999999999999999999999987543221110 011122345689999998


Q ss_pred             cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           81 GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      +..++.++|+||||+++|+|++|..|+.......... ................................+.+++..||+
T Consensus       184 ~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  262 (283)
T cd05080         184 ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEM-IGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWE  262 (283)
T ss_pred             ccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhh-hcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhc
Confidence            8888999999999999999999999975433211100 000000000000000000000001111223478899999999


Q ss_pred             CCCCCCCCHHHHHHHhcCc
Q 027675          161 EDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~  179 (220)
                      .+|++|||+++++..|+..
T Consensus       263 ~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         263 TEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             cChhhCCCHHHHHHHHHHh
Confidence            9999999999999998654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.95  E-value=1.1e-27  Score=188.05  Aligned_cols=159  Identities=30%  Similarity=0.441  Sum_probs=118.9

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..+++++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++................++..|+|||.+.+
T Consensus       106 ~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~  182 (266)
T cd05033         106 GQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY  182 (266)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhcc
Confidence            457889999999999999999   99999999999999999999999999876542211111111223467999999988


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++|++++ |..||..........       ....+....    .+     ......+.+++.+||+
T Consensus       183 ~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~-------~~~~~~~~~----~~-----~~~~~~l~~li~~cl~  246 (266)
T cd05033         183 RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIK-------AVEDGYRLP----PP-----MDCPSALYQLMLDCWQ  246 (266)
T ss_pred             CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHH-------HHHcCCCCC----CC-----CCCCHHHHHHHHHHcC
Confidence            888999999999999999997 998886444332211       111111110    01     1123467899999999


Q ss_pred             CCCCCCCCHHHHHHHhcCc
Q 027675          161 EDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~  179 (220)
                      .+|++||++++++++|...
T Consensus       247 ~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         247 KDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             CCcccCcCHHHHHHHHHhh
Confidence            9999999999999998653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.95  E-value=2e-27  Score=185.71  Aligned_cols=158  Identities=25%  Similarity=0.369  Sum_probs=118.2

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCc-ccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG-TTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~y~aPe~~~   80 (220)
                      +.+..++.|++.||.|||+++   ++||||||.||+++.++.++|+|||++.......... ......++..|+|||.+.
T Consensus        95 ~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  171 (257)
T cd05116          95 KNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMN  171 (257)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhc
Confidence            457889999999999999999   9999999999999999999999999987543222111 011112246899999998


Q ss_pred             cCCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           81 GGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      +..++.++|+||||+++|++++ |..||..........       ....+.....    +.     .....+.++|.+||
T Consensus       172 ~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-------~i~~~~~~~~----~~-----~~~~~l~~li~~~~  235 (257)
T cd05116         172 YYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQ-------MIESGERMEC----PQ-----RCPPEMYDLMKLCW  235 (257)
T ss_pred             cCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-------HHHCCCCCCC----CC-----CCCHHHHHHHHHHh
Confidence            8788899999999999999998 999987544332211       1112211111    11     12346789999999


Q ss_pred             CCCCCCCCCHHHHHHHhcC
Q 027675          160 QEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l~~  178 (220)
                      +.||++||++.+|.+.|..
T Consensus       236 ~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         236 TYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             ccCchhCcCHHHHHHHHhc
Confidence            9999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.95  E-value=5.6e-28  Score=195.77  Aligned_cols=153  Identities=24%  Similarity=0.366  Sum_probs=125.2

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +++++|+-|++.|+.|||++.   |+|||||..|||++.++.|+|+|||++.......  .....+.||+.|++||++.+
T Consensus       106 ~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~--~~a~tvvGTp~YmcPEil~d  180 (426)
T KOG0589|consen  106 ERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED--SLASTVVGTPYYMCPEILSD  180 (426)
T ss_pred             HHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCch--hhhheecCCCcccCHHHhCC
Confidence            468899999999999999888   9999999999999999999999999998765443  13344789999999999999


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      .+|..++|||||||++|||++-+++|...+-.....      +....     .     .......++..+..+|..|+..
T Consensus       181 ~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~------ki~~~-----~-----~~Plp~~ys~el~~lv~~~l~~  244 (426)
T KOG0589|consen  181 IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELIL------KINRG-----L-----YSPLPSMYSSELRSLVKSMLRK  244 (426)
T ss_pred             CCCCccCcchhhcchHHHHHhcccccCccchHHHHH------HHhhc-----c-----CCCCCccccHHHHHHHHHHhhc
Confidence            999999999999999999999999997555443321      11111     1     1222334556888999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 027675          162 DPNDRPTMSDVVIM  175 (220)
Q Consensus       162 ~p~~Rps~~~~l~~  175 (220)
                      +|+.||++.++|..
T Consensus       245 ~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  245 NPEHRPSALELLRR  258 (426)
T ss_pred             CCccCCCHHHHhhC
Confidence            99999999999965

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.95  E-value=7.9e-28  Score=193.72  Aligned_cols=152  Identities=24%  Similarity=0.294  Sum_probs=115.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .++..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++.......  .......++..|+|||.+.+
T Consensus        96 ~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~  170 (316)
T cd05619          96 PRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKTCTFCGTPDYIAPEILLG  170 (316)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--CceeeecCCccccCHHHHcC
Confidence            356789999999999999999   9999999999999999999999999876432111  11223457889999999998


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+|||||++|+|++|..||...+........       ....      ....    ......+.+++.+||..
T Consensus       171 ~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i-------~~~~------~~~~----~~~~~~~~~li~~~l~~  233 (316)
T cd05619         171 QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI-------RMDN------PCYP----RWLTREAKDILVKLFVR  233 (316)
T ss_pred             CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHH-------HhCC------CCCC----ccCCHHHHHHHHHHhcc
Confidence            88999999999999999999999999755433222111       1100      0000    11233678899999999


Q ss_pred             CCCCCCCHH-HHHHH
Q 027675          162 DPNDRPTMS-DVVIM  175 (220)
Q Consensus       162 ~p~~Rps~~-~~l~~  175 (220)
                      ||++||++. +++.+
T Consensus       234 ~P~~R~~~~~~l~~h  248 (316)
T cd05619         234 EPERRLGVKGDIRQH  248 (316)
T ss_pred             CHhhcCCChHHHHcC
Confidence            999999997 77654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.95  E-value=4.5e-28  Score=189.85  Aligned_cols=156  Identities=33%  Similarity=0.535  Sum_probs=114.6

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .++++|+.|++.||.|||+++   ++|++|+++||+++.++.+||+|||+.....................|.|||.+.+
T Consensus       103 ~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  179 (259)
T PF07714_consen  103 QQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKD  179 (259)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHH
T ss_pred             ccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            467899999999999999999   99999999999999999999999999876532222222222345678999999998


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++||||||+++||+++ |..||..........      +. .++.......         .....+.++|..||.
T Consensus       180 ~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~------~~-~~~~~~~~~~---------~~~~~~~~li~~C~~  243 (259)
T PF07714_consen  180 GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIE------KL-KQGQRLPIPD---------NCPKDIYSLIQQCWS  243 (259)
T ss_dssp             SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHH------HH-HTTEETTSBT---------TSBHHHHHHHHHHT-
T ss_pred             ccccccccccccccccccccccccccccccccccccc------cc-cccccceecc---------chhHHHHHHHHHHcC
Confidence            889999999999999999999 678886554433221      11 2222222111         123367889999999


Q ss_pred             CCCCCCCCHHHHHHHh
Q 027675          161 EDPNDRPTMSDVVIML  176 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l  176 (220)
                      .+|++||++.++++.|
T Consensus       244 ~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  244 HDPEKRPSFQEILQEL  259 (259)
T ss_dssp             SSGGGS--HHHHHHHH
T ss_pred             CChhhCcCHHHHHhcC
Confidence            9999999999999875

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.95  E-value=2.2e-27  Score=186.49  Aligned_cols=157  Identities=31%  Similarity=0.449  Sum_probs=116.7

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCC-----CceecCccceeeecCCCCCcccceeecccCccCh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEM-----NPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP   76 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~-----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aP   76 (220)
                      .+++.++.|++.||.|||+.+   ++|+||+|+||+++.++     .++++|||++.................+..|+||
T Consensus       106 ~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  182 (269)
T cd05044         106 KELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAP  182 (269)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCH
Confidence            457789999999999999999   99999999999999877     7999999998654322111111122345689999


Q ss_pred             hhhhcCCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHh
Q 027675           77 EYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVG  155 (220)
Q Consensus        77 e~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  155 (220)
                      |.+.+..++.++|+||||+++|+|++ |..||...+.......       ...+....         ........+.+++
T Consensus       183 E~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~-------~~~~~~~~---------~~~~~~~~~~~li  246 (269)
T cd05044         183 ESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQH-------VTAGGRLQ---------KPENCPDKIYQLM  246 (269)
T ss_pred             HHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHH-------HhcCCccC---------CcccchHHHHHHH
Confidence            99998888999999999999999998 9999864433222111       11111110         1112234678999


Q ss_pred             ccccCCCCCCCCCHHHHHHHhc
Q 027675          156 LLCVQEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       156 ~~cl~~~p~~Rps~~~~l~~l~  177 (220)
                      .+||..+|++||+++++++.|.
T Consensus       247 ~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         247 TNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             HHHcCCCcccCCCHHHHHHHHh
Confidence            9999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.95  E-value=5.6e-28  Score=195.29  Aligned_cols=147  Identities=25%  Similarity=0.284  Sum_probs=111.9

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+..++.|+++||.|||++|   ++||||||+||+++.++.++|+|||++.......  .......|++.|+|||.+.+.
T Consensus        97 ~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~  171 (325)
T cd05602          97 RARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTTSTFCGTPEYLAPEVLHKQ  171 (325)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CCcccccCCccccCHHHHcCC
Confidence            45678999999999999999   9999999999999999999999999986432211  112234678899999999998


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      .++.++|+|||||++|+|++|..||...+......      ... ...    ...      .......+.+++.+||+.+
T Consensus       172 ~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~------~i~-~~~----~~~------~~~~~~~~~~li~~~l~~~  234 (325)
T cd05602         172 PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD------NIL-NKP----LQL------KPNITNSARHLLEGLLQKD  234 (325)
T ss_pred             CCCCccccccccHHHHHHhcCCCCCCCCCHHHHHH------HHH-hCC----cCC------CCCCCHHHHHHHHHHcccC
Confidence            89999999999999999999999996544332211      111 100    000      0112336788999999999


Q ss_pred             CCCCCCHHH
Q 027675          163 PNDRPTMSD  171 (220)
Q Consensus       163 p~~Rps~~~  171 (220)
                      |.+||++.+
T Consensus       235 p~~R~~~~~  243 (325)
T cd05602         235 RTKRLGAKD  243 (325)
T ss_pred             HHHCCCCCC
Confidence            999999873

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.95  E-value=4.7e-28  Score=200.69  Aligned_cols=153  Identities=19%  Similarity=0.174  Sum_probs=120.0

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceee-CCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILL-DHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili-~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+..|+.+|+.|+.|||.+|   ++||||||+|||+ +..++++|+|||.+......   ....  .-+..|.|||.+..
T Consensus       416 e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---~~tp--~~t~~y~APEvl~~  487 (612)
T KOG0603|consen  416 EASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---CDTP--ALTLQYVAPEVLAI  487 (612)
T ss_pred             HHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh---hccc--chhhcccChhhhcc
Confidence            34569999999999999999   9999999999999 69999999999998754433   1111  22568999999999


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchh-HHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSE-LALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      .+++++||+||||+++|+|++|+.||...... ....                   ......+....+....+++.+||+
T Consensus       488 ~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~-------------------~i~~~~~s~~vS~~AKdLl~~LL~  548 (612)
T KOG0603|consen  488 QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHT-------------------RIQMPKFSECVSDEAKDLLQQLLQ  548 (612)
T ss_pred             CCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHH-------------------hhcCCccccccCHHHHHHHHHhcc
Confidence            89999999999999999999999999765544 1110                   001111113345577899999999


Q ss_pred             CCCCCCCCHHHHHHHhcCcccc
Q 027675          161 EDPNDRPTMSDVVIMLGSEAVN  182 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~~~~  182 (220)
                      .||.+|+++.+++.+-+.....
T Consensus       549 ~dP~~Rl~~~~i~~h~w~~~~~  570 (612)
T KOG0603|consen  549 VDPALRLGADEIGAHPWFLSHP  570 (612)
T ss_pred             CChhhCcChhhhccCcchhcCC
Confidence            9999999999999887763333

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.95  E-value=1.8e-27  Score=185.83  Aligned_cols=153  Identities=27%  Similarity=0.368  Sum_probs=116.6

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +.++.++.+++.||.|||+++   ++|+||||+||++++++.++|+|||++.......     .....+..|+|||.+.+
T Consensus       102 ~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~  173 (256)
T cd05082         102 DCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALRE  173 (256)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC-----CCCccceeecCHHHHcc
Confidence            456889999999999999999   9999999999999999999999999876533221     11223457999999988


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++|+|++ |+.||...+.......       ...+.....         .......+.+++.+||.
T Consensus       174 ~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~-------~~~~~~~~~---------~~~~~~~~~~li~~~l~  237 (256)
T cd05082         174 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-------VEKGYKMDA---------PDGCPPVVYDVMKQCWH  237 (256)
T ss_pred             CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HhcCCCCCC---------CCCCCHHHHHHHHHHhc
Confidence            888999999999999999997 8888864433222111       111111110         11123467899999999


Q ss_pred             CCCCCCCCHHHHHHHhcC
Q 027675          161 EDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~  178 (220)
                      .+|++|||+.++++.|..
T Consensus       238 ~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         238 LDAATRPSFLQLREQLEH  255 (256)
T ss_pred             CChhhCcCHHHHHHHHhc
Confidence            999999999999998864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.95  E-value=1.6e-27  Score=177.64  Aligned_cols=157  Identities=22%  Similarity=0.270  Sum_probs=118.2

Q ss_pred             HHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCC---CCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            5 FNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDH---EMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         5 ~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      -+.++|++++|.|+|.++   |+|||+||.|+++..   ...+||+|||++...... ..+  ....|++.|+|||+++.
T Consensus       113 SH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g-~~~--~G~~GtP~fmaPEvvrk  186 (355)
T KOG0033|consen  113 SHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG-EAW--HGFAGTPGYLSPEVLKK  186 (355)
T ss_pred             HHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeCCc-ccc--ccccCCCcccCHHHhhc
Confidence            357899999999999999   999999999999953   334899999999866522 222  22578999999999999


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      .+++...|||+.|+++|-|+.|++||-..+.......+       ..+    ..+-.++..  .+......+++++||..
T Consensus       187 dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I-------~~g----~yd~~~~~w--~~is~~Ak~LvrrML~~  253 (355)
T KOG0033|consen  187 DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQI-------KAG----AYDYPSPEW--DTVTPEAKSLIRRMLTV  253 (355)
T ss_pred             CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHH-------hcc----ccCCCCccc--CcCCHHHHHHHHHHhcc
Confidence            99999999999999999999999999653333322111       111    111112111  12334667899999999


Q ss_pred             CCCCCCCHHHHHHHhcCcc
Q 027675          162 DPNDRPTMSDVVIMLGSEA  180 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~~~~  180 (220)
                      ||.+|.|+.+.|.|-|.-.
T Consensus       254 dP~kRIta~EAL~HpWi~~  272 (355)
T KOG0033|consen  254 NPKKRITADEALKHPWICN  272 (355)
T ss_pred             ChhhhccHHHHhCCchhcc
Confidence            9999999999997765443

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.95  E-value=9.3e-28  Score=194.46  Aligned_cols=160  Identities=23%  Similarity=0.261  Sum_probs=116.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +.+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++......... ......|+..|+|||.+.+
T Consensus       105 ~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~  180 (332)
T cd05614         105 DEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRG  180 (332)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccccccCCC-ccccccCCccccCHHHhcC
Confidence            356788999999999999999   999999999999999999999999998654322111 1223467889999999986


Q ss_pred             C-CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 G-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      . .++.++|||||||++|+|++|..||...........  .......      . +....    ......+.+++.+||+
T Consensus       181 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~--~~~~~~~------~-~~~~~----~~~~~~~~~li~~~l~  247 (332)
T cd05614         181 KGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSE--VSRRILK------C-DPPFP----SFIGPEAQDLLHKLLR  247 (332)
T ss_pred             CCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHH--HHHHHhc------C-CCCCC----CCCCHHHHHHHHHHcC
Confidence            5 468899999999999999999999964322211110  0011110      0 01000    1123467889999999


Q ss_pred             CCCCCCC-----CHHHHHHHhcC
Q 027675          161 EDPNDRP-----TMSDVVIMLGS  178 (220)
Q Consensus       161 ~~p~~Rp-----s~~~~l~~l~~  178 (220)
                      .||++||     ++++++++-+.
T Consensus       248 ~dp~~R~~~~~~~~~~~l~h~~~  270 (332)
T cd05614         248 KDPKKRLGAGPQGASEIKEHPFF  270 (332)
T ss_pred             CCHHHcCCCCCCCHHHHHcCCCc
Confidence            9999999     78899977543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.95  E-value=6.6e-28  Score=205.06  Aligned_cols=172  Identities=21%  Similarity=0.212  Sum_probs=115.7

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+..++.||+.||.|||+++   |+||||||+||+++.++.++|+|||++......... ......|+..|+|||.+.+.
T Consensus       268 ~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~  343 (501)
T PHA03210        268 QTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGD  343 (501)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCC
Confidence            46679999999999999999   999999999999999999999999998765432211 11224678999999999998


Q ss_pred             CCcccCceeehhHHHHHHHhcCcc-CcccchhHHHhhHHHHH-----------------HHHHhccccccccCCCCCcCc
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRN-TGFYNSELALSLLGYAW-----------------KLWQEGKALDMMDQKPGAISK  144 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p-~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~  144 (220)
                      .++.++|||||||++|+|++|..+ +................                 ...............+.....
T Consensus       344 ~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~  423 (501)
T PHA03210        344 GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRN  423 (501)
T ss_pred             CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHh
Confidence            899999999999999999998754 43222111111111100                 000000000000000000000


Q ss_pred             HHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcC
Q 027675          145 ANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       145 ~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~  178 (220)
                      ......+.+++.+||+.||++|||+.+++.+-+.
T Consensus       424 ~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f  457 (501)
T PHA03210        424 LGLPADFEYPLVKMLTFDWHLRPGAAELLALPLF  457 (501)
T ss_pred             cCCChHHHHHHHHHhccCcccCcCHHHHhhChhh
Confidence            0112346778899999999999999999987543

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.95  E-value=1.7e-27  Score=185.25  Aligned_cols=157  Identities=25%  Similarity=0.344  Sum_probs=116.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.++++||.|||+++   ++|+||+|+||+++.++.++|+|||++.................+..|+|||.+.+
T Consensus        93 ~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~  169 (251)
T cd05041          93 KKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNY  169 (251)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhcc
Confidence            356789999999999999999   99999999999999999999999999865432111111111122456999999988


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++|+|++ |..||............       ......         .........+.+++.+||.
T Consensus       170 ~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~-------~~~~~~---------~~~~~~~~~~~~li~~~l~  233 (251)
T cd05041         170 GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI-------ESGYRM---------PAPQLCPEEIYRLMLQCWA  233 (251)
T ss_pred             CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH-------hcCCCC---------CCCccCCHHHHHHHHHHhc
Confidence            888999999999999999998 88888655433222111       111000         0111223478899999999


Q ss_pred             CCCCCCCCHHHHHHHhc
Q 027675          161 EDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~  177 (220)
                      .+|++||++.++++.|.
T Consensus       234 ~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         234 YDPENRPSFSEIYNELQ  250 (251)
T ss_pred             cChhhCcCHHHHHHHhh
Confidence            99999999999999875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.95  E-value=4.8e-28  Score=194.69  Aligned_cols=104  Identities=27%  Similarity=0.524  Sum_probs=85.5

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceee----CCCCCceecCccceeeecCCCCC-cccceeecccCccChh
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILL----DHEMNPKISDFGLTRIFEGKQTD-GTTNRVVGTYGYMSPE   77 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili----~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~y~aPe   77 (220)
                      .++.++.|++.||.|||+.+   ++||||||+||++    +.++.++|+|||+++........ .......++..|+|||
T Consensus       109 ~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE  185 (317)
T cd07867         109 MVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE  185 (317)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcH
Confidence            46789999999999999999   9999999999999    45678999999998765432211 1122345678999999


Q ss_pred             hhhcC-CCcccCceeehhHHHHHHHhcCccCcc
Q 027675           78 YALGG-FFSVKSDVFSFGVVVLEIISGKRNTGF  109 (220)
Q Consensus        78 ~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~  109 (220)
                      .+.+. .++.++|+|||||++|+|++|.+||..
T Consensus       186 ~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         186 LLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             HhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            98764 478899999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.95  E-value=7.6e-28  Score=192.95  Aligned_cols=159  Identities=28%  Similarity=0.367  Sum_probs=118.0

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .++++++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++................++..|+|||.+.+
T Consensus       140 ~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  216 (307)
T cd05098         140 KDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD  216 (307)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc
Confidence            457789999999999999999   99999999999999999999999998865432111111111123457999999988


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++|+|++ |..||...+......       ....+.....         .......+.+++.+||.
T Consensus       217 ~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~-------~~~~~~~~~~---------~~~~~~~~~~li~~~l~  280 (307)
T cd05098         217 RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK-------LLKEGHRMDK---------PSNCTNELYMMMRDCWH  280 (307)
T ss_pred             CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH-------HHHcCCCCCC---------CCcCCHHHHHHHHHHcc
Confidence            888999999999999999998 888886443322211       1111111111         11123477889999999


Q ss_pred             CCCCCCCCHHHHHHHhcCc
Q 027675          161 EDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~  179 (220)
                      .+|++||++.++++.|...
T Consensus       281 ~~p~~Rps~~evl~~l~~~  299 (307)
T cd05098         281 AVPSQRPTFKQLVEDLDRI  299 (307)
T ss_pred             cChhhCcCHHHHHHHHHHH
Confidence            9999999999999998664

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.95  E-value=9.4e-28  Score=195.29  Aligned_cols=176  Identities=22%  Similarity=0.255  Sum_probs=123.8

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCC----------------------CC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGK----------------------QT   60 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~----------------------~~   60 (220)
                      .+.-++.+++-|++.||+.|   ++||||||+|+||+.+|++||+|||++......                      ..
T Consensus       242 ~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (550)
T KOG0605|consen  242 WARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDF  318 (550)
T ss_pred             HHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccc
Confidence            45668899999999999999   999999999999999999999999998532210                      00


Q ss_pred             C-----ccc------------------ceeecccCccChhhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHH-
Q 027675           61 D-----GTT------------------NRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELAL-  116 (220)
Q Consensus        61 ~-----~~~------------------~~~~~~~~y~aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-  116 (220)
                      .     ...                  ...+|||.|+|||++.+.++...+|.||||||+||||.|.+||...+....- 
T Consensus       319 ~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~r  398 (550)
T KOG0605|consen  319 PKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYR  398 (550)
T ss_pred             cccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            0     000                  1247899999999999999999999999999999999999999754443322 


Q ss_pred             hhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCCCCCCCC---HHHHHHHhc--CccccCCCCCCchh
Q 027675          117 SLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPT---MSDVVIMLG--SEAVNLASPKRPAF  191 (220)
Q Consensus       117 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps---~~~~l~~l~--~~~~~~~~~~~~~~  191 (220)
                      ....|  +.     .+       ..+.......+..++|.+|+. ||++|..   ++||.+|=+  ...++.--...++|
T Consensus       399 kI~nw--r~-----~l-------~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~~apf  463 (550)
T KOG0605|consen  399 KIVNW--RE-----TL-------KFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHLREMPAPF  463 (550)
T ss_pred             HHHHH--hh-----hc-------cCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcchhhcCCCCC
Confidence            22222  11     11       111111222577899999998 9999965   888887653  33333333333455


Q ss_pred             hhccC
Q 027675          192 VVRRG  196 (220)
Q Consensus       192 ~~~~~  196 (220)
                      ++.-.
T Consensus       464 vP~v~  468 (550)
T KOG0605|consen  464 VPQVN  468 (550)
T ss_pred             CCCCC
Confidence            55433

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.95  E-value=1.5e-27  Score=195.09  Aligned_cols=100  Identities=27%  Similarity=0.371  Sum_probs=84.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.|+.||+.||.|||+.+   |+||||||+||+++.++.++|+|||++.......   ......++..|+|||.+.+
T Consensus       157 ~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~  230 (357)
T PHA03209        157 DQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP---AFLGLAGTVETNAPEVLAR  230 (357)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCc---ccccccccccccCCeecCC
Confidence            467889999999999999999   9999999999999999999999999986422111   1122457889999999998


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNT  107 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~  107 (220)
                      ..++.++|+|||||++|+|+++..++
T Consensus       231 ~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        231 DKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             CCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            88999999999999999999865543

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.95  E-value=1.4e-27  Score=191.14  Aligned_cols=159  Identities=24%  Similarity=0.418  Sum_probs=118.9

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .++.++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++................++..|++||.+.+.
T Consensus       110 ~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~  186 (303)
T cd05110         110 LLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR  186 (303)
T ss_pred             HHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccC
Confidence            56889999999999999999   999999999999999999999999998754422211111112335689999999888


Q ss_pred             CCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           83 FFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      .++.++|+||||+++|++++ |..||.........       .....+.....     .    ......+.+++..||..
T Consensus       187 ~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~-------~~~~~~~~~~~-----~----~~~~~~~~~li~~c~~~  250 (303)
T cd05110         187 KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP-------DLLEKGERLPQ-----P----PICTIDVYMVMVKCWMI  250 (303)
T ss_pred             CCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHCCCCCCC-----C----CCCCHHHHHHHHHHcCC
Confidence            88999999999999999997 88888644322221       11111111110     0    11234678899999999


Q ss_pred             CCCCCCCHHHHHHHhcCcc
Q 027675          162 DPNDRPTMSDVVIMLGSEA  180 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~~~~  180 (220)
                      +|++||+++++++.+....
T Consensus       251 ~p~~Rp~~~~l~~~l~~~~  269 (303)
T cd05110         251 DADSRPKFKELAAEFSRMA  269 (303)
T ss_pred             ChhhCcCHHHHHHHHHHHH
Confidence            9999999999999987653

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.95  E-value=2e-27  Score=192.21  Aligned_cols=160  Identities=25%  Similarity=0.372  Sum_probs=116.6

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||+|||+++   ++||||||+||+++.++.++|+|||++.......  .......|++.|+|||.+.+
T Consensus        96 ~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~  170 (327)
T cd05617          96 EHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTTSTFCGTPNYIAPEILRG  170 (327)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--CceecccCCcccCCHHHHCC
Confidence            356789999999999999999   9999999999999999999999999876422111  11223467889999999998


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+||||+++|+|++|..||........................     ..+.     .....+.+++.+||..
T Consensus       171 ~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----~~p~-----~~~~~~~~li~~~L~~  240 (327)
T cd05617         171 EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI-----RIPR-----FLSVKASHVLKGFLNK  240 (327)
T ss_pred             CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC-----CCCC-----CCCHHHHHHHHHHhcc
Confidence            88999999999999999999999999643222111111111121111110     1111     1223567899999999


Q ss_pred             CCCCCCC------HHHHHHHh
Q 027675          162 DPNDRPT------MSDVVIML  176 (220)
Q Consensus       162 ~p~~Rps------~~~~l~~l  176 (220)
                      ||++|++      +++++.+-
T Consensus       241 dP~~R~~~~~~~~~~~i~~h~  261 (327)
T cd05617         241 DPKERLGCQPQTGFSDIKSHT  261 (327)
T ss_pred             CHHHcCCCCCCCCHHHHHcCC
Confidence            9999998      46888764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.95  E-value=2.1e-27  Score=185.43  Aligned_cols=158  Identities=28%  Similarity=0.435  Sum_probs=117.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhh-
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL-   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~-   80 (220)
                      ..++.++.|+++||++||+++   ++|+||||+||+++.++.++|+|||.+.....  .........++..|.|||.+. 
T Consensus        98 ~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~  172 (260)
T PF00069_consen   98 EEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NNENFNPFVGTPEYMAPEVLQQ  172 (260)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS--TTSEBSSSSSSGGGSCHHHHTT
T ss_pred             ccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--cccccccccccccccccccccc
Confidence            467899999999999999999   99999999999999999999999999865311  112222345678899999998 


Q ss_pred             cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHH-HHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           81 GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGY-AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      +...+.++|+||||+++++|++|..||.............. .......        ......   .....+.+++.+||
T Consensus       173 ~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~---~~~~~l~~li~~~l  241 (260)
T PF00069_consen  173 GKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPS--------SSQQSR---EKSEELRDLIKKML  241 (260)
T ss_dssp             TSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHH--------HTTSHT---TSHHHHHHHHHHHS
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhhcccccccc--------cccccc---hhHHHHHHHHHHHc
Confidence            77889999999999999999999999876522222211111 1000000        000000   00157889999999


Q ss_pred             CCCCCCCCCHHHHHHH
Q 027675          160 QEDPNDRPTMSDVVIM  175 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~  175 (220)
                      +.||++||++.+++++
T Consensus       242 ~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  242 SKDPEQRPSAEELLKH  257 (260)
T ss_dssp             SSSGGGSTTHHHHHTS
T ss_pred             cCChhHCcCHHHHhcC
Confidence            9999999999999976

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.95  E-value=9.1e-28  Score=178.87  Aligned_cols=161  Identities=23%  Similarity=0.285  Sum_probs=121.7

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCC--CCc-----ccceeecccCccC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQ--TDG-----TTNRVVGTYGYMS   75 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~--~~~-----~~~~~~~~~~y~a   75 (220)
                      +++.|+.++++||++||+.. .++.||||||.||++.+++.+++.|||.+....-..  ...     .-.....+..|.|
T Consensus       128 ~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRA  206 (302)
T KOG2345|consen  128 QILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRA  206 (302)
T ss_pred             HHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccC
Confidence            57899999999999999985 469999999999999999999999999986432110  000     0011245789999


Q ss_pred             hhhhh---cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhcccc--ccccCCCCCcCcHHHHHH
Q 027675           76 PEYAL---GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKAL--DMMDQKPGAISKANEILK  150 (220)
Q Consensus        76 Pe~~~---~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  150 (220)
                      ||++.   +.-.++++|||||||++|.|+.|.-||+..-               ..|...  .........+.....+..
T Consensus       207 PELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~---------------~~GgSlaLAv~n~q~s~P~~~~yse~  271 (302)
T KOG2345|consen  207 PELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY---------------QQGGSLALAVQNAQISIPNSSRYSEA  271 (302)
T ss_pred             chheecccCcccccccchhhhhHHHHHHHHcCCcchHHh---------------hcCCeEEEeeeccccccCCCCCccHH
Confidence            99985   3356899999999999999999999986321               122222  222222333344447788


Q ss_pred             HHHHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          151 CINVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       151 ~~~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      +.++|.+||+.||.+||++.+++..+..+
T Consensus       272 l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  272 LHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             HHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence            99999999999999999999999887654

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.95  E-value=1.3e-27  Score=194.26  Aligned_cols=151  Identities=23%  Similarity=0.266  Sum_probs=117.4

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++......     .....|++.|+|||.+.+.
T Consensus       132 ~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~  203 (340)
T PTZ00426        132 VGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNV  203 (340)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCC-----cceecCChhhcCHHHHhCC
Confidence            46788999999999999999   999999999999999999999999998754321     1234678899999999988


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      .++.++|+|||||++|+|++|..||...+......      ... .+..     ..+..     ....+.++|.+||+.|
T Consensus       204 ~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~------~i~-~~~~-----~~p~~-----~~~~~~~li~~~l~~d  266 (340)
T PTZ00426        204 GHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQ------KIL-EGII-----YFPKF-----LDNNCKHLMKKLLSHD  266 (340)
T ss_pred             CCCccccccchhhHHHHHhcCCCCCCCCCHHHHHH------HHh-cCCC-----CCCCC-----CCHHHHHHHHHHcccC
Confidence            88999999999999999999999997544322211      111 1110     01111     1235678999999999


Q ss_pred             CCCCC-----CHHHHHHHhcC
Q 027675          163 PNDRP-----TMSDVVIMLGS  178 (220)
Q Consensus       163 p~~Rp-----s~~~~l~~l~~  178 (220)
                      |++|+     ++++++++-+.
T Consensus       267 p~~R~~~~~~~~~~~~~hp~f  287 (340)
T PTZ00426        267 LTKRYGNLKKGAQNVKEHPWF  287 (340)
T ss_pred             HHHcCCCCCCCHHHHHcCCCc
Confidence            99995     89999988544

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.95  E-value=8.9e-28  Score=195.40  Aligned_cols=170  Identities=24%  Similarity=0.276  Sum_probs=117.2

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +.+..++.|++.||.|||+++   |+||||||+||+++.++.++|+|||++......     .....++..|+|||.+.+
T Consensus       118 ~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~  189 (343)
T cd07878         118 EHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRWYRAPEIMLN  189 (343)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccceecCCC-----cCCccccccccCchHhcC
Confidence            357789999999999999999   999999999999999999999999998754322     122457889999999877


Q ss_pred             -CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHH--------HHHHHhccccccccCCCCCcC-c-----HH
Q 027675           82 -GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA--------WKLWQEGKALDMMDQKPGAIS-K-----AN  146 (220)
Q Consensus        82 -~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~-~-----~~  146 (220)
                       ..++.++|||||||++|+|++|..||...+...........        ................+.... .     ..
T Consensus       190 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (343)
T cd07878         190 WMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRG  269 (343)
T ss_pred             CccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccC
Confidence             46788999999999999999999998654332211110000        000000000000000000000 0     00


Q ss_pred             HHHHHHHHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          147 EILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       147 ~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      ....+.+++.+||..||++|||+.+++.+-+..
T Consensus       270 ~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~  302 (343)
T cd07878         270 ANPLAIDLLEKMLVLDSDKRISASEALAHPYFS  302 (343)
T ss_pred             CCHHHHHHHHHHcCCChhhCCCHHHHhcCcchh
Confidence            123467999999999999999999999875443

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.94  E-value=1.9e-27  Score=186.01  Aligned_cols=156  Identities=28%  Similarity=0.439  Sum_probs=117.9

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+++.++.+++.||.|||+++   ++|+||+|+||+++.++.++|+|||++..........  ....++..|++||.+.+
T Consensus       104 ~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~--~~~~~~~~~~~PE~~~~  178 (261)
T cd05148         104 ASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLS--SDKKIPYKWTAPEAASH  178 (261)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccccc--cCCCCceEecCHHHHcc
Confidence            457889999999999999999   9999999999999999999999999886543221111  11234567999999988


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++|+|++ |..||...+.......       ...+....         ........+.++|.+||+
T Consensus       179 ~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~-------~~~~~~~~---------~~~~~~~~~~~~i~~~l~  242 (261)
T cd05148         179 GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQ-------ITAGYRMP---------CPAKCPQEIYKIMLECWA  242 (261)
T ss_pred             CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH-------HHhCCcCC---------CCCCCCHHHHHHHHHHcC
Confidence            888999999999999999998 8899865442221111       11111110         011223467899999999


Q ss_pred             CCCCCCCCHHHHHHHhcC
Q 027675          161 EDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~  178 (220)
                      .||++|||+.++++.|+.
T Consensus       243 ~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         243 AEPEDRPSFKALREELDN  260 (261)
T ss_pred             CCchhCcCHHHHHHHHhc
Confidence            999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.94  E-value=2.9e-27  Score=185.10  Aligned_cols=157  Identities=28%  Similarity=0.465  Sum_probs=117.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+++.++.+++.||.|||+++   ++|+||||+||++++++.++|+|||++.......... .....++..|+|||...+
T Consensus       102 ~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~  177 (260)
T cd05070         102 PNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALY  177 (260)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccccc-ccCCCCCccccChHHHhc
Confidence            357899999999999999999   9999999999999999999999999987543221111 111223457999999988


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++|++++ |..||...+.......       ...+...         .........+.+++.+||.
T Consensus       178 ~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~-------~~~~~~~---------~~~~~~~~~~~~li~~~l~  241 (260)
T cd05070         178 GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQ-------VERGYRM---------PCPQDCPISLHELMLQCWK  241 (260)
T ss_pred             CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-------HHcCCCC---------CCCCcCCHHHHHHHHHHcc
Confidence            888999999999999999999 8888865433222111       1111110         0111223468899999999


Q ss_pred             CCCCCCCCHHHHHHHhcC
Q 027675          161 EDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~  178 (220)
                      .+|++|||+.++.+.|+.
T Consensus       242 ~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         242 KDPEERPTFEYLQSFLED  259 (260)
T ss_pred             cCcccCcCHHHHHHHHhc
Confidence            999999999999998854

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.94  E-value=2.5e-27  Score=185.15  Aligned_cols=159  Identities=28%  Similarity=0.420  Sum_probs=118.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcc-cceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT-TNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~-~~~~~~~~~y~aPe~~~   80 (220)
                      ..++.++.|++.||+|||..+   ++|+||||+||+++.++.++|+|||++........... .....++..|.|||.+.
T Consensus        95 ~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  171 (257)
T cd05060          95 SDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECIN  171 (257)
T ss_pred             HHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhc
Confidence            457889999999999999999   99999999999999999999999999875433221111 11112235799999998


Q ss_pred             cCCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           81 GGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      +..++.++|+||||+++|++++ |..||...+.....       +..........    +     ......+.++|.+||
T Consensus       172 ~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~-------~~~~~~~~~~~----~-----~~~~~~l~~li~~cl  235 (257)
T cd05060         172 YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVI-------AMLESGERLPR----P-----EECPQEIYSIMLSCW  235 (257)
T ss_pred             CCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHH-------HHHHcCCcCCC----C-----CCCCHHHHHHHHHHh
Confidence            8889999999999999999997 99998654432211       11111111111    1     112246789999999


Q ss_pred             CCCCCCCCCHHHHHHHhcCc
Q 027675          160 QEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l~~~  179 (220)
                      +.+|++||++.++++.|+..
T Consensus       236 ~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         236 KYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             cCChhhCcCHHHHHHHHHhc
Confidence            99999999999999998654

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.94  E-value=2.7e-27  Score=185.18  Aligned_cols=158  Identities=25%  Similarity=0.340  Sum_probs=117.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcc-cceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT-TNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~-~~~~~~~~~y~aPe~~~   80 (220)
                      .++++++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++........... .....++..|+|||.+.
T Consensus        95 ~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  171 (257)
T cd05115          95 SNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECIN  171 (257)
T ss_pred             HHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHc
Confidence            467889999999999999999   99999999999999999999999998864332211111 11112245799999998


Q ss_pred             cCCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           81 GGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      +..++.++|+||||+++|++++ |..||.........       .....+.....         +......+.+++.+||
T Consensus       172 ~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~~~~~~---------~~~~~~~l~~li~~c~  235 (257)
T cd05115         172 FRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM-------SFIEQGKRLDC---------PAECPPEMYALMKDCW  235 (257)
T ss_pred             cCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH-------HHHHCCCCCCC---------CCCCCHHHHHHHHHHc
Confidence            8888999999999999999996 99998654433221       11112211111         1122347788999999


Q ss_pred             CCCCCCCCCHHHHHHHhcC
Q 027675          160 QEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l~~  178 (220)
                      ..+|++||++.++.+.|+.
T Consensus       236 ~~~~~~Rp~~~~i~~~l~~  254 (257)
T cd05115         236 IYKWEDRPNFAKVEERMRT  254 (257)
T ss_pred             CCChhhCcCHHHHHHHHhh
Confidence            9999999999999998864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.94  E-value=4e-27  Score=184.37  Aligned_cols=157  Identities=27%  Similarity=0.445  Sum_probs=117.9

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.+++.||.|||+.+   ++|+||||+||++++++.++|+|||++......... ......++..|++||...+
T Consensus       102 ~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~  177 (260)
T cd05069         102 PQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALY  177 (260)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc-ccCCCccchhhCCHHHhcc
Confidence            357889999999999999999   999999999999999999999999998754322111 1111234567999999988


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ...+.++|+||||+++|++++ |..||..........       ....+...         .........+.+++.+||.
T Consensus       178 ~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-------~~~~~~~~---------~~~~~~~~~~~~li~~~l~  241 (260)
T cd05069         178 GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLE-------QVERGYRM---------PCPQGCPESLHELMKLCWK  241 (260)
T ss_pred             CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-------HHHcCCCC---------CCCcccCHHHHHHHHHHcc
Confidence            888999999999999999999 888886443322111       11111110         0011223468899999999


Q ss_pred             CCCCCCCCHHHHHHHhcC
Q 027675          161 EDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~  178 (220)
                      .||++||+++++++.|+.
T Consensus       242 ~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         242 KDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCcccCcCHHHHHHHHhc
Confidence            999999999999999864

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.94  E-value=3.6e-27  Score=184.13  Aligned_cols=158  Identities=28%  Similarity=0.415  Sum_probs=118.1

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCC-CcccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT-DGTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~y~aPe~~~   80 (220)
                      ..++.++.|+++||.|||+++   ++|+||+|+||+++.++.++|+|||++........ ........++..|+|||.+.
T Consensus        97 ~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~  173 (257)
T cd05040          97 STLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR  173 (257)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhc
Confidence            457889999999999999999   99999999999999999999999999876543211 11111234566899999998


Q ss_pred             cCCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           81 GGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      +..++.++|+||||+++|+|++ |..||...+.......      ..........         .......+.+++.+||
T Consensus       174 ~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~------~~~~~~~~~~---------~~~~~~~~~~li~~~l  238 (257)
T cd05040         174 TRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKK------IDKEGERLER---------PEACPQDIYNVMLQCW  238 (257)
T ss_pred             ccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH------HHhcCCcCCC---------CccCCHHHHHHHHHHC
Confidence            8888999999999999999998 9999864433321111      1111111100         0112346888999999


Q ss_pred             CCCCCCCCCHHHHHHHhc
Q 027675          160 QEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l~  177 (220)
                      +.+|++||++.+++..|.
T Consensus       239 ~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         239 AHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCCcccCCCHHHHHHHhc
Confidence            999999999999999874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.94  E-value=2.7e-27  Score=187.92  Aligned_cols=156  Identities=29%  Similarity=0.417  Sum_probs=116.5

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .++.++.|++.||+|||.++   ++||||||.||+++.++.++|+|||++.................+..|.|||.+.+.
T Consensus       131 ~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  207 (288)
T cd05050         131 EQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN  207 (288)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC
Confidence            46789999999999999999   999999999999999999999999987654322211111122335579999999888


Q ss_pred             CCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           83 FFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      .++.++|+||||+++|+|++ |..||...+.....       .....+....    .+     ......+.+++.+||+.
T Consensus       208 ~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~-------~~~~~~~~~~----~~-----~~~~~~l~~li~~~l~~  271 (288)
T cd05050         208 RYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVI-------YYVRDGNVLS----CP-----DNCPLELYNLMRLCWSK  271 (288)
T ss_pred             CCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHhcCCCCC----CC-----CCCCHHHHHHHHHHccc
Confidence            88999999999999999997 77787543332211       1111111111    01     11234788999999999


Q ss_pred             CCCCCCCHHHHHHHhc
Q 027675          162 DPNDRPTMSDVVIMLG  177 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~  177 (220)
                      +|++||++.++++.|+
T Consensus       272 ~p~~Rpt~~el~~~l~  287 (288)
T cd05050         272 LPSDRPSFASINRILQ  287 (288)
T ss_pred             CcccCCCHHHHHHHhh
Confidence            9999999999999885

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.94  E-value=2.9e-27  Score=184.86  Aligned_cols=156  Identities=28%  Similarity=0.426  Sum_probs=117.1

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+.+   ++|+||||.||+++.++.++|+|||.+......... ......++..|.+||...+
T Consensus       100 ~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~  175 (256)
T cd05113         100 SQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLLY  175 (256)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-ecCCCccChhhCCHHHHhc
Confidence            467899999999999999999   999999999999999999999999987654322111 1111223457999999988


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++|+|++ |..||...+.......      . ..+...    ..+.     .....+.+++.+||.
T Consensus       176 ~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~------~-~~~~~~----~~~~-----~~~~~~~~li~~cl~  239 (256)
T cd05113         176 SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEK------V-SQGLRL----YRPH-----LASEKVYAIMYSCWH  239 (256)
T ss_pred             CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH------H-hcCCCC----CCCC-----CCCHHHHHHHHHHcC
Confidence            888999999999999999998 9999875543322111      1 111111    0011     123578899999999


Q ss_pred             CCCCCCCCHHHHHHHhc
Q 027675          161 EDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~  177 (220)
                      .+|++||++.+++..++
T Consensus       240 ~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         240 EKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCcccCCCHHHHHHhhC
Confidence            99999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.94  E-value=2.7e-27  Score=186.34  Aligned_cols=158  Identities=20%  Similarity=0.331  Sum_probs=118.0

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+++++.|++.||+|||+++   ++|+||||+||+++.++.++++|||+++...............++..|.+||.+.+.
T Consensus       114 ~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~  190 (273)
T cd05074         114 TLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADN  190 (273)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcC
Confidence            46889999999999999999   999999999999999999999999988754322211111122345679999999888


Q ss_pred             CCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           83 FFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      .++.++|+||||+++|+|++ |..||...+.....       .....+.....         .......+.+++.+||+.
T Consensus       191 ~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~-------~~~~~~~~~~~---------~~~~~~~~~~l~~~~l~~  254 (273)
T cd05074         191 VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIY-------NYLIKGNRLKQ---------PPDCLEDVYELMCQCWSP  254 (273)
T ss_pred             ccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHH-------HHHHcCCcCCC---------CCCCCHHHHHHHHHHcCC
Confidence            88999999999999999998 88887644332211       11111111100         011234788999999999


Q ss_pred             CCCCCCCHHHHHHHhcCc
Q 027675          162 DPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~~~  179 (220)
                      +|++||++.++++.|+..
T Consensus       255 ~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         255 EPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             ChhhCcCHHHHHHHHHhh
Confidence            999999999999998654

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.94  E-value=5.3e-27  Score=182.87  Aligned_cols=153  Identities=27%  Similarity=0.395  Sum_probs=118.2

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .++++++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........  ......++..|+|||...+
T Consensus       101 ~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~  175 (256)
T cd08529         101 DQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN--FANTIVGTPYYLSPELCED  175 (256)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc--hhhccccCccccCHHHhcC
Confidence            356789999999999999999   99999999999999999999999998875443221  1222456788999999998


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+||||+++++|++|..||...+.....      .+.. .+...    .     ........+.+++.+||+.
T Consensus       176 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~-~~~~~----~-----~~~~~~~~~~~~i~~~l~~  239 (256)
T cd08529         176 KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALI------LKII-RGVFP----P-----VSQMYSQQLAQLIDQCLTK  239 (256)
T ss_pred             CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHH-cCCCC----C-----CccccCHHHHHHHHHHccC
Confidence            88899999999999999999999999754432211      1111 11110    1     1112345788999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 027675          162 DPNDRPTMSDVVIM  175 (220)
Q Consensus       162 ~p~~Rps~~~~l~~  175 (220)
                      +|++||++.+++++
T Consensus       240 ~p~~Rp~~~~ll~~  253 (256)
T cd08529         240 DYRQRPDTFQLLRN  253 (256)
T ss_pred             CcccCcCHHHHhhC
Confidence            99999999999976

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.94  E-value=2.6e-27  Score=185.89  Aligned_cols=159  Identities=23%  Similarity=0.361  Sum_probs=119.1

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .++.++.+++.||.|||+++   ++|+||+|+||+++.++.++|+|||++........  ......++..|+|||.+.+.
T Consensus       107 ~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~  181 (267)
T cd08228         107 TVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHEN  181 (267)
T ss_pred             HHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccchhH--HHhcCCCCccccChhhhccC
Confidence            56789999999999999999   99999999999999999999999998875443221  11123567789999999888


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      .++.++|+||||+++|+|++|+.||.........    ..... .....        ...........+.+++.+||+.+
T Consensus       182 ~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~----~~~~~-~~~~~--------~~~~~~~~~~~~~~li~~cl~~~  248 (267)
T cd08228         182 GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFS----LCQKI-EQCDY--------PPLPTEHYSEKLRELVSMCIYPD  248 (267)
T ss_pred             CCCchhhHHHHHHHHHHHhcCCCCCccccccHHH----HHHHH-hcCCC--------CCCChhhcCHHHHHHHHHHCCCC
Confidence            8899999999999999999999998532211111    11111 11110        01111223457889999999999


Q ss_pred             CCCCCCHHHHHHHhcCc
Q 027675          163 PNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       163 p~~Rps~~~~l~~l~~~  179 (220)
                      |++||++.++++.++..
T Consensus       249 p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         249 PDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             cccCcCHHHHHHHHHHh
Confidence            99999999999998654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.94  E-value=2.9e-27  Score=191.47  Aligned_cols=160  Identities=26%  Similarity=0.343  Sum_probs=115.9

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++.......  .......|+..|+|||.+.+.
T Consensus        97 ~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~  171 (329)
T cd05618          97 HARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGE  171 (329)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--CccccccCCccccCHHHHcCC
Confidence            56789999999999999999   9999999999999999999999999876422111  112234678899999999998


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhH--HHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSEL--ALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      .++.++|+|||||++|+|++|..||.......  ......+..+....... .    .+     ......+.+++.+||.
T Consensus       172 ~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~----~p-----~~~~~~~~~ll~~~L~  241 (329)
T cd05618         172 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-R----IP-----RSLSVKAASVLKSFLN  241 (329)
T ss_pred             CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-C----CC-----CCCCHHHHHHHHHHhc
Confidence            88999999999999999999999985321110  00111111111111111 0    11     1123467899999999


Q ss_pred             CCCCCCCC------HHHHHHHhc
Q 027675          161 EDPNDRPT------MSDVVIMLG  177 (220)
Q Consensus       161 ~~p~~Rps------~~~~l~~l~  177 (220)
                      .||++||+      +.+++.+-+
T Consensus       242 ~dP~~R~~~~~~~~~~~i~~hp~  264 (329)
T cd05618         242 KDPKERLGCHPQTGFADIQGHPF  264 (329)
T ss_pred             CCHHHcCCCCCCCCHHHHhcCCC
Confidence            99999998      578887643

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=2.3e-27  Score=185.76  Aligned_cols=157  Identities=26%  Similarity=0.353  Sum_probs=116.6

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcc-cceeecccCccChhhhhc
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT-TNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~-~~~~~~~~~y~aPe~~~~   81 (220)
                      .+..++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........... .....++..|+|||.+.+
T Consensus       105 ~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  181 (263)
T cd06625         105 VTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG  181 (263)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceecc
Confidence            45788999999999999999   99999999999999999999999999865432211111 012345678999999998


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+||||+++|++++|+.||...+.....      .........         ..........+.+++.+||..
T Consensus       182 ~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~  246 (263)
T cd06625         182 EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI------FKIATQPTN---------PQLPSHVSPDARNFLRRTFVE  246 (263)
T ss_pred             CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH------HHHhccCCC---------CCCCccCCHHHHHHHHHHhhc
Confidence            88899999999999999999999998643222111      111111000         011112334678899999999


Q ss_pred             CCCCCCCHHHHHHHhc
Q 027675          162 DPNDRPTMSDVVIMLG  177 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~  177 (220)
                      +|++||++.+++.+.+
T Consensus       247 ~p~~Rpt~~~ll~~~~  262 (263)
T cd06625         247 NAKKRPSAEELLRHFF  262 (263)
T ss_pred             CcccCCCHHHHhhCCC
Confidence            9999999999998753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.94  E-value=2.3e-27  Score=185.34  Aligned_cols=155  Identities=29%  Similarity=0.420  Sum_probs=116.2

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++........ ......++..|.|||.+.+
T Consensus       100 ~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~  175 (256)
T cd05059         100 EWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SSQGTKFPVKWAPPEVFDY  175 (256)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc-ccCCCCCCccccCHHHhcc
Confidence            357889999999999999999   999999999999999999999999988654322111 1111122347999999988


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++|++++ |..||..........       ....+.....    +     ......+.+++.+||.
T Consensus       176 ~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-------~~~~~~~~~~----~-----~~~~~~~~~li~~cl~  239 (256)
T cd05059         176 SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVE-------SVSAGYRLYR----P-----KLAPTEVYTIMYSCWH  239 (256)
T ss_pred             CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHH-------HHHcCCcCCC----C-----CCCCHHHHHHHHHHhc
Confidence            888999999999999999998 788886544332211       1111111100    0     1134478899999999


Q ss_pred             CCCCCCCCHHHHHHHh
Q 027675          161 EDPNDRPTMSDVVIML  176 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l  176 (220)
                      .+|++|||+.++++.|
T Consensus       240 ~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         240 EKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CChhhCcCHHHHHHHh
Confidence            9999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.94  E-value=7.8e-28  Score=193.84  Aligned_cols=152  Identities=24%  Similarity=0.304  Sum_probs=115.1

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +.++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++........  ......++..|+|||.+.+
T Consensus        98 ~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~  172 (318)
T cd05582          98 EDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNR  172 (318)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--ceecccCChhhcCHHHHcC
Confidence            357889999999999999999   99999999999999999999999999865432211  1222457889999999998


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+||||+++|+|++|..||...+......      ... ....     ..+.     .....+.+++.+||+.
T Consensus       173 ~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~------~i~-~~~~-----~~p~-----~~~~~~~~li~~~l~~  235 (318)
T cd05582         173 RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMT------MIL-KAKL-----GMPQ-----FLSPEAQSLLRALFKR  235 (318)
T ss_pred             CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHH------HHH-cCCC-----CCCC-----CCCHHHHHHHHHHhhc
Confidence            888999999999999999999999997544332211      111 1110     0011     1233677899999999


Q ss_pred             CCCCCCC-----HHHHHHH
Q 027675          162 DPNDRPT-----MSDVVIM  175 (220)
Q Consensus       162 ~p~~Rps-----~~~~l~~  175 (220)
                      ||++||+     +.+++.+
T Consensus       236 ~P~~R~~a~~~~~~~~~~~  254 (318)
T cd05582         236 NPANRLGAGPDGVEEIKRH  254 (318)
T ss_pred             CHhHcCCCCCCCHHHHhCC
Confidence            9999999     5556654

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.94  E-value=2.7e-27  Score=186.00  Aligned_cols=157  Identities=24%  Similarity=0.318  Sum_probs=116.7

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..+++++.|++.||+|||+.+   ++||||||+||+++.++.++++|||........... ......++..|+|||.+.+
T Consensus       107 ~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~  182 (266)
T cd05064         107 GQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY-TTMSGKSPVLWAAPEAIQY  182 (266)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccccchh-cccCCCCceeecCHHHHhh
Confidence            467899999999999999999   999999999999999999999999976543211111 1111223467999999998


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+|||||++|++++ |..||..........       ...++....    .     .......+.+++..||+
T Consensus       183 ~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~-------~~~~~~~~~----~-----~~~~~~~~~~li~~c~~  246 (266)
T cd05064         183 HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIK-------AVEDGFRLP----A-----PRNCPNLLHQLMLDCWQ  246 (266)
T ss_pred             CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHH-------HHHCCCCCC----C-----CCCCCHHHHHHHHHHcC
Confidence            889999999999999999775 999986544332211       111111110    0     11233467889999999


Q ss_pred             CCCCCCCCHHHHHHHhcC
Q 027675          161 EDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~  178 (220)
                      .+|++||+++++++.|..
T Consensus       247 ~~p~~RP~~~~i~~~l~~  264 (266)
T cd05064         247 KERGERPRFSQIHSILSK  264 (266)
T ss_pred             CCchhCCCHHHHHHHHHh
Confidence            999999999999998754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.94  E-value=2.6e-27  Score=191.37  Aligned_cols=151  Identities=22%  Similarity=0.268  Sum_probs=114.2

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+..++.||+.||+|||+.|   ++||||||+||+++.++.++|+|||++.......  .......++..|+|||.+.+.
T Consensus        97 ~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~  171 (325)
T cd05604          97 RARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DTTTTFCGTPEYLAPEVIRKQ  171 (325)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CCcccccCChhhCCHHHHcCC
Confidence            56789999999999999999   9999999999999999999999999876432111  112234678899999999998


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      .++.++|+|||||++|+|++|..||...+......      ... ...    ....+      .....+.+++.+||..+
T Consensus       172 ~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~------~~~-~~~----~~~~~------~~~~~~~~ll~~ll~~~  234 (325)
T cd05604         172 PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYD------NIL-HKP----LVLRP------GASLTAWSILEELLEKD  234 (325)
T ss_pred             CCCCcCccccccceehhhhcCCCCCCCCCHHHHHH------HHH-cCC----ccCCC------CCCHHHHHHHHHHhccC
Confidence            89999999999999999999999996544322211      111 110    00111      12346778999999999


Q ss_pred             CCCCCCHH----HHHHH
Q 027675          163 PNDRPTMS----DVVIM  175 (220)
Q Consensus       163 p~~Rps~~----~~l~~  175 (220)
                      |.+||++.    +++++
T Consensus       235 p~~R~~~~~~~~~i~~h  251 (325)
T cd05604         235 RQRRLGAKEDFLEIQEH  251 (325)
T ss_pred             HHhcCCCCCCHHHHhcC
Confidence            99999875    56654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.94  E-value=1.9e-27  Score=189.77  Aligned_cols=157  Identities=25%  Similarity=0.353  Sum_probs=116.6

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .++.++.|++.||+|||+++   ++||||||+||+++.++.++|+|||++.......   .......+..|+|||...+.
T Consensus       120 ~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~  193 (297)
T cd05089         120 QLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYS  193 (297)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeEEECCcCCCcccccee---ccCCCCcCccccCchhhccC
Confidence            56889999999999999999   9999999999999999999999999875322110   01111223469999999888


Q ss_pred             CCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           83 FFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      .++.++|+||||+++|+|++ |..||...........       ...+....    .     .......+.+++.+||+.
T Consensus       194 ~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~-------~~~~~~~~----~-----~~~~~~~~~~li~~~l~~  257 (297)
T cd05089         194 VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK-------LPQGYRME----K-----PRNCDDEVYELMRQCWRD  257 (297)
T ss_pred             CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-------HhcCCCCC----C-----CCCCCHHHHHHHHHHcCC
Confidence            88999999999999999997 9999865443322111       11111110    0     111234678999999999


Q ss_pred             CCCCCCCHHHHHHHhcCccc
Q 027675          162 DPNDRPTMSDVVIMLGSEAV  181 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~~~~~  181 (220)
                      +|.+||+++++++.|.....
T Consensus       258 ~p~~Rp~~~~i~~~l~~~~~  277 (297)
T cd05089         258 RPYERPPFAQISVQLSRMLE  277 (297)
T ss_pred             ChhhCcCHHHHHHHHHHHHH
Confidence            99999999999998866544

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.94  E-value=1.9e-27  Score=188.32  Aligned_cols=158  Identities=23%  Similarity=0.287  Sum_probs=117.7

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++........  ......+++.|+|||.+.+
T Consensus        97 ~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~  171 (280)
T cd05608          97 PRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTKGYAGTPGFMAPELLQG  171 (280)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--cccccCCCcCccCHHHhcC
Confidence            356789999999999999999   99999999999999999999999999875433221  1222457889999999999


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+||||+++|+|++|+.||...........  .....     .    ...  ..........+.+++.+||+.
T Consensus       172 ~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~--~~~~~-----~----~~~--~~~~~~~~~~~~~li~~~l~~  238 (280)
T cd05608         172 EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE--LKQRI-----L----NDS--VTYPDKFSPASKSFCEALLAK  238 (280)
T ss_pred             CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHH--HHHhh-----c----ccC--CCCcccCCHHHHHHHHHHhcC
Confidence            8899999999999999999999999964332211100  00000     0    000  011112344678899999999


Q ss_pred             CCCCCC-----CHHHHHHHhc
Q 027675          162 DPNDRP-----TMSDVVIMLG  177 (220)
Q Consensus       162 ~p~~Rp-----s~~~~l~~l~  177 (220)
                      ||++||     ++++++.+-+
T Consensus       239 ~P~~R~~~~~~~~~~~l~h~~  259 (280)
T cd05608         239 DPEKRLGFRDGNCDGLRTHPL  259 (280)
T ss_pred             CHHHhcCCCCCCHHHHhcChh
Confidence            999999     7788987643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.94  E-value=2.7e-27  Score=191.67  Aligned_cols=162  Identities=25%  Similarity=0.323  Sum_probs=117.5

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++......  ........|+..|+|||.+.+
T Consensus        96 ~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~  170 (329)
T cd05588          96 EHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDTTSTFCGTPNYIAPEILRG  170 (329)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CCccccccCCccccCHHHHcC
Confidence            356789999999999999999   999999999999999999999999987642211  111223467889999999999


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhH--HHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSEL--ALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      ..++.++|+|||||++|+|++|..||.......  ......+..+....... .    .+.     .....+.+++.+||
T Consensus       171 ~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~----~p~-----~~~~~~~~li~~~L  240 (329)
T cd05588         171 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI-R----IPR-----SLSVKASSVLKGFL  240 (329)
T ss_pred             CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC-C----CCC-----CCCHHHHHHHHHHh
Confidence            888999999999999999999999996322111  00111111111111111 1    111     12336788999999


Q ss_pred             CCCCCCCCC------HHHHHHHhcC
Q 027675          160 QEDPNDRPT------MSDVVIMLGS  178 (220)
Q Consensus       160 ~~~p~~Rps------~~~~l~~l~~  178 (220)
                      +.||.+|++      +++++++-+.
T Consensus       241 ~~dP~~R~~~~~~~~~~~i~~hp~~  265 (329)
T cd05588         241 NKDPKERLGCHPQTGFRDIKSHPFF  265 (329)
T ss_pred             ccCHHHcCCCCCCCCHHHHhcCCCC
Confidence            999999997      7888876443

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=1.1e-27  Score=193.92  Aligned_cols=155  Identities=25%  Similarity=0.235  Sum_probs=114.9

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..+..++.|++.||+|||+++   |+||||||+||+++.++.++|+|||++.......  .......|+..|+|||.+.+
T Consensus        96 ~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~  170 (330)
T cd05586          96 DRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTNTFCGTTEYLAPEVLLD  170 (330)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCccCccCCccccCHHHHcC
Confidence            356789999999999999999   9999999999999999999999999976432211  11223457889999999876


Q ss_pred             C-CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 G-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      . .++.++|+|||||++|+|++|..||...+......       ....+.. .    .+..    .....+.+++.+||.
T Consensus       171 ~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~-------~i~~~~~-~----~~~~----~~~~~~~~li~~~L~  234 (330)
T cd05586         171 EKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYR-------NIAFGKV-R----FPKN----VLSDEGRQFVKGLLN  234 (330)
T ss_pred             CCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHH-------HHHcCCC-C----CCCc----cCCHHHHHHHHHHcC
Confidence            4 47899999999999999999999986544322211       1111110 0    0111    123366789999999


Q ss_pred             CCCCCCC----CHHHHHHHhc
Q 027675          161 EDPNDRP----TMSDVVIMLG  177 (220)
Q Consensus       161 ~~p~~Rp----s~~~~l~~l~  177 (220)
                      .||++||    ++.+++++-+
T Consensus       235 ~~P~~R~~~~~~~~~ll~h~~  255 (330)
T cd05586         235 RNPQHRLGAHRDAVELKEHPF  255 (330)
T ss_pred             CCHHHCCCCCCCHHHHhcCcc
Confidence            9999998    6888887644

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=99.94  E-value=1.5e-27  Score=181.71  Aligned_cols=149  Identities=25%  Similarity=0.276  Sum_probs=115.7

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .++-++.+|+.||+|||+.+   |++|||||+|||++++|.+|++|||++.....+     .-...||+.|+|||++...
T Consensus       145 ~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-----T~TlCGTPeYLAPEii~sk  216 (355)
T KOG0616|consen  145 HARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-----TWTLCGTPEYLAPEIIQSK  216 (355)
T ss_pred             hHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc-----EEEecCCccccChHHhhcC
Confidence            45668999999999999999   999999999999999999999999999875543     2336789999999999999


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      ++..++|.|+||+++|||+.|.+||...+......      ++.         .....  .+.-....+.+++..+|+.|
T Consensus       217 ~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~------KI~---------~~~v~--fP~~fs~~~kdLl~~LL~vD  279 (355)
T KOG0616|consen  217 GYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYE------KIL---------EGKVK--FPSYFSSDAKDLLKKLLQVD  279 (355)
T ss_pred             CCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHH------HHH---------hCccc--CCcccCHHHHHHHHHHHhhh
Confidence            99999999999999999999999997666533322      111         11111  11122336778888899999


Q ss_pred             CCCC-----CCHHHHHHHh
Q 027675          163 PNDR-----PTMSDVVIML  176 (220)
Q Consensus       163 p~~R-----ps~~~~l~~l  176 (220)
                      -.+|     ....+|..|-
T Consensus       280 ~t~R~gnlknG~~dIk~H~  298 (355)
T KOG0616|consen  280 LTKRFGNLKNGVEDIKNHP  298 (355)
T ss_pred             hHhhhcCcCCCccccccCc
Confidence            9888     3444555443

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.94  E-value=6e-27  Score=183.66  Aligned_cols=157  Identities=24%  Similarity=0.419  Sum_probs=118.5

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +.++.++.++++||.|||+.+   ++|+||||+||++++++.++|+|||.+......... ......++..|++||...+
T Consensus       102 ~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~  177 (262)
T cd05071         102 PQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALY  177 (262)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc-cccCCcccceecCHhHhcc
Confidence            467889999999999999999   999999999999999999999999998754432211 1111234567999999988


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++|++++ |..||...........       ...+...         .........+.+++.+||+
T Consensus       178 ~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~-------~~~~~~~---------~~~~~~~~~l~~li~~~l~  241 (262)
T cd05071         178 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-------VERGYRM---------PCPPECPESLHDLMCQCWR  241 (262)
T ss_pred             CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHH-------HhcCCCC---------CCccccCHHHHHHHHHHcc
Confidence            888999999999999999999 8888864433222111       1111000         0112234467899999999


Q ss_pred             CCCCCCCCHHHHHHHhcC
Q 027675          161 EDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~  178 (220)
                      .+|++||++.++++.|+.
T Consensus       242 ~~p~~Rp~~~~~~~~l~~  259 (262)
T cd05071         242 KEPEERPTFEYLQAFLED  259 (262)
T ss_pred             CCcccCCCHHHHHHHHHH
Confidence            999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.94  E-value=3.3e-27  Score=188.96  Aligned_cols=159  Identities=28%  Similarity=0.469  Sum_probs=118.5

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .++..++.+++.||.|||+++   ++|+||||+||+++.++.++++|||++................++..|.|||.+.+
T Consensus       141 ~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  217 (302)
T cd05055         141 EDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFN  217 (302)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhcc
Confidence            457889999999999999999   99999999999999999999999999865433221111222344568999999988


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++|++++ |..||.........      .+....+....    .+     ......+.+++.+||.
T Consensus       218 ~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~------~~~~~~~~~~~----~~-----~~~~~~~~~li~~cl~  282 (302)
T cd05055         218 CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF------YKLIKEGYRMA----QP-----EHAPAEIYDIMKTCWD  282 (302)
T ss_pred             CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH------HHHHHcCCcCC----CC-----CCCCHHHHHHHHHHcC
Confidence            888999999999999999998 89988643322111      01111111100    00     1123468899999999


Q ss_pred             CCCCCCCCHHHHHHHhcC
Q 027675          161 EDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~  178 (220)
                      .+|++||++.++++.|..
T Consensus       283 ~~p~~Rpt~~ell~~l~~  300 (302)
T cd05055         283 ADPLKRPTFKQIVQLIGK  300 (302)
T ss_pred             CCchhCcCHHHHHHHHHh
Confidence            999999999999999865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.94  E-value=4e-27  Score=183.89  Aligned_cols=155  Identities=28%  Similarity=0.411  Sum_probs=115.6

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +.++.++.+++.||+|||+++   ++|+||+|+||+++.++.++++|||.+......... ......++..|.|||.+.+
T Consensus       100 ~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~  175 (256)
T cd05114         100 DMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-SSSGAKFPVKWSPPEVFNF  175 (256)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-ccCCCCCchhhCChhhccc
Confidence            457889999999999999999   999999999999999999999999987653321111 1111223457999999988


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++|++++ |+.||...+......      .. ..+.....    +.     .....+.+++.+||+
T Consensus       176 ~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~------~i-~~~~~~~~----~~-----~~~~~~~~li~~c~~  239 (256)
T cd05114         176 SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVE------MI-SRGFRLYR----PK-----LASMTVYEVMYSCWH  239 (256)
T ss_pred             CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH------HH-HCCCCCCC----CC-----CCCHHHHHHHHHHcc
Confidence            888999999999999999999 888886543322211      11 11111100    11     122467899999999


Q ss_pred             CCCCCCCCHHHHHHHh
Q 027675          161 EDPNDRPTMSDVVIML  176 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l  176 (220)
                      .+|++||+++++++.|
T Consensus       240 ~~p~~Rps~~~l~~~l  255 (256)
T cd05114         240 EKPEGRPTFAELLRAI  255 (256)
T ss_pred             CCcccCcCHHHHHHhh
Confidence            9999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.94  E-value=7.7e-27  Score=182.16  Aligned_cols=153  Identities=25%  Similarity=0.398  Sum_probs=118.0

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+++.++.+++.|+.+||+.+   ++|+||+|+||+++.++.++|+|||++........  ......+++.|+|||...+
T Consensus       102 ~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~  176 (257)
T cd08223         102 NQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMSPELFSN  176 (257)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccCC--ccccccCCcCccChhHhcC
Confidence            357889999999999999999   99999999999999999999999999875532211  1223456788999999998


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+||||++++++++|+.||...+......      .. ..+...    .     ........+.+++.+||+.
T Consensus       177 ~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~------~~-~~~~~~----~-----~~~~~~~~~~~li~~~l~~  240 (257)
T cd08223         177 KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY------RI-IEGKLP----P-----MPKDYSPELGELIATMLSK  240 (257)
T ss_pred             CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHH------HH-HhcCCC----C-----CccccCHHHHHHHHHHhcc
Confidence            888999999999999999999999986443222110      11 111110    0     1122345788999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 027675          162 DPNDRPTMSDVVIM  175 (220)
Q Consensus       162 ~p~~Rps~~~~l~~  175 (220)
                      +|++||++.+++++
T Consensus       241 ~p~~Rp~~~~~l~~  254 (257)
T cd08223         241 RPEKRPSVKSILRQ  254 (257)
T ss_pred             CcccCCCHHHHhcC
Confidence            99999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.94  E-value=1.7e-27  Score=191.03  Aligned_cols=172  Identities=20%  Similarity=0.243  Sum_probs=118.2

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++.........  .....++..|+|||.+.+.
T Consensus       105 ~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~  179 (309)
T cd07872         105 NVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT--YSNEVVTLWYRPPDVLLGS  179 (309)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCccc--cccccccccccCCHHHhCC
Confidence            46778999999999999999   999999999999999999999999998654322111  1123457889999998754


Q ss_pred             -CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHH--------HHHHHhccccccccCCCC-----CcCcHHHH
Q 027675           83 -FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA--------WKLWQEGKALDMMDQKPG-----AISKANEI  148 (220)
Q Consensus        83 -~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~-----~~~~~~~~  148 (220)
                       .++.++|+||||+++|+|++|..||...+...........        +............+....     ........
T Consensus       180 ~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (309)
T cd07872         180 SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLD  259 (309)
T ss_pred             CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCC
Confidence             5788999999999999999999999755443222111100        000000000000000000     00001123


Q ss_pred             HHHHHHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          149 LKCINVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       149 ~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      ..+.++|.+||..||++|||+.+++.+-+..
T Consensus       260 ~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~  290 (309)
T cd07872         260 TEGIELLTKFLQYESKKRISAEEAMKHAYFR  290 (309)
T ss_pred             HHHHHHHHHhccCChhhCCCHHHHhcChhhh
Confidence            4678999999999999999999999876544

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.94  E-value=5.9e-27  Score=186.63  Aligned_cols=159  Identities=25%  Similarity=0.349  Sum_probs=118.7

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ++++.++.+++.||.|||+++   ++||||||+||+++.++.++|+|||++........  ......++..|+|||.+.+
T Consensus       118 ~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~  192 (292)
T cd06658         118 EQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRKSLVGTPYWMAPEVISR  192 (292)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCceeecCccccCHHHHcc
Confidence            467889999999999999999   99999999999999999999999998764332211  1223456789999999988


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+||||+++|++++|..||..........      .. ..     .......  ........+.+++.+||..
T Consensus       193 ~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~------~~-~~-----~~~~~~~--~~~~~~~~~~~li~~~l~~  258 (292)
T cd06658         193 LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMR------RI-RD-----NLPPRVK--DSHKVSSVLRGFLDLMLVR  258 (292)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HH-Hh-----cCCCccc--cccccCHHHHHHHHHHccC
Confidence            888999999999999999999999986433322111      00 00     0001000  1112234677889999999


Q ss_pred             CCCCCCCHHHHHHHhcCc
Q 027675          162 DPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~~~  179 (220)
                      ||++|||+++++++-+..
T Consensus       259 ~P~~Rpt~~~il~~~~~~  276 (292)
T cd06658         259 EPSQRATAQELLQHPFLK  276 (292)
T ss_pred             ChhHCcCHHHHhhChhhh
Confidence            999999999999875444

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.94  E-value=5.5e-27  Score=185.40  Aligned_cols=161  Identities=24%  Similarity=0.415  Sum_probs=120.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++.................+..|++||.+..
T Consensus       109 ~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~  185 (279)
T cd05057         109 QYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH  185 (279)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhc
Confidence            357889999999999999999   99999999999999999999999999876443222111111122457999999988


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++|++++ |..||...........       ...+...    ..+     ......+.+++.+||.
T Consensus       186 ~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-------~~~~~~~----~~~-----~~~~~~~~~~~~~~l~  249 (279)
T cd05057         186 RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDL-------LEKGERL----PQP-----PICTIDVYMVLVKCWM  249 (279)
T ss_pred             CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH-------HhCCCCC----CCC-----CCCCHHHHHHHHHHcC
Confidence            888999999999999999998 9999875543322211       1111111    001     1122467889999999


Q ss_pred             CCCCCCCCHHHHHHHhcCccc
Q 027675          161 EDPNDRPTMSDVVIMLGSEAV  181 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~~~  181 (220)
                      .+|+.||++.++++.|....+
T Consensus       250 ~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         250 IDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             CChhhCCCHHHHHHHHHHHHh
Confidence            999999999999999977644

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.94  E-value=3.5e-27  Score=195.33  Aligned_cols=160  Identities=22%  Similarity=0.370  Sum_probs=119.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..+++++.|+++||+|||+.+   ++|+||||+||+++.++.++|+|||++................++..|+|||.+.+
T Consensus       237 ~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  313 (400)
T cd05105         237 LDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD  313 (400)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC
Confidence            356789999999999999999   99999999999999999999999999875433222112222345668999999988


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++||||||+++|+|++ |..||.........      ......+....         ........+.+++.+||+
T Consensus       314 ~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~------~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~  378 (400)
T cd05105         314 NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF------YNKIKSGYRMA---------KPDHATQEVYDIMVKCWN  378 (400)
T ss_pred             CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH------HHHHhcCCCCC---------CCccCCHHHHHHHHHHCc
Confidence            888999999999999999997 88888643222111      11111111111         011223467899999999


Q ss_pred             CCCCCCCCHHHHHHHhcCc
Q 027675          161 EDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~  179 (220)
                      .||++||++.++.+.|...
T Consensus       379 ~dP~~RPt~~~l~~~l~~l  397 (400)
T cd05105         379 SEPEKRPSFLHLSDIVESL  397 (400)
T ss_pred             cCHhHCcCHHHHHHHHHHH
Confidence            9999999999999998754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.94  E-value=5.7e-27  Score=185.30  Aligned_cols=154  Identities=24%  Similarity=0.403  Sum_probs=113.5

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCC------CCceecCccceeeecCCCCCcccceeecccCccC
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHE------MNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMS   75 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~------~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~a   75 (220)
                      +++..++.||+.||++||+++   |+||||||+|||++..      ..+||+|||+++.....   .......|++.|+|
T Consensus       109 ~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~---~~a~tlcGSplYMA  182 (429)
T KOG0595|consen  109 ATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG---SMAETLCGSPLYMA  182 (429)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch---hHHHHhhCCccccC
Confidence            357889999999999999999   9999999999999764      45799999999876533   22334678999999


Q ss_pred             hhhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHh
Q 027675           76 PEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVG  155 (220)
Q Consensus        76 Pe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  155 (220)
                      ||++....|+.|+|+||+|+|+|++++|+.||...+..+.......         ........+...     ...+.+++
T Consensus       183 PEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k---------~~~~~~~~~~~~-----s~~~~~Ll  248 (429)
T KOG0595|consen  183 PEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKK---------GNEIVPVLPAEL-----SNPLRELL  248 (429)
T ss_pred             HHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc---------cccccCchhhhc-----cCchhhhh
Confidence            9999999999999999999999999999999986655554432111         111111111111     11334555


Q ss_pred             ccccCCCCCCCCCHHHHHHH
Q 027675          156 LLCVQEDPNDRPTMSDVVIM  175 (220)
Q Consensus       156 ~~cl~~~p~~Rps~~~~l~~  175 (220)
                      ...++.++.+|.++.+-..+
T Consensus       249 ~~ll~~~~~~~~~~~~~~~~  268 (429)
T KOG0595|consen  249 ISLLQRNPKDRISFEDFFDH  268 (429)
T ss_pred             hHHHhcCccccCchHHhhhh
Confidence            66677788888777766644

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.94  E-value=8.4e-27  Score=183.01  Aligned_cols=160  Identities=24%  Similarity=0.368  Sum_probs=119.0

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+++.++.++++||.|||+++   ++|+||+|+||+++.++.++++|||++.........  .....++..|+|||.+.+
T Consensus       106 ~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~ape~~~~  180 (267)
T cd08229         106 KTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHE  180 (267)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccCCcc--cccccCCcCccCHHHhcC
Confidence            356789999999999999999   999999999999999999999999987654322211  122356778999999988


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+||||+++|+|++|..||......... ..   ... ...      ..  ...........+.+++.+||..
T Consensus       181 ~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~---~~~-~~~------~~--~~~~~~~~~~~~~~li~~~l~~  247 (267)
T cd08229         181 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-LC---KKI-EQC------DY--PPLPSDHYSEELRQLVNMCINP  247 (267)
T ss_pred             CCccchhhHHHHHHHHHHHHhCCCCcccccchHHH-Hh---hhh-hcC------CC--CCCCcccccHHHHHHHHHhcCC
Confidence            88899999999999999999999998533221111 00   000 000      00  0011112345788999999999


Q ss_pred             CCCCCCCHHHHHHHhcCc
Q 027675          162 DPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~~~  179 (220)
                      +|++|||+.+|++.++..
T Consensus       248 ~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         248 DPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             CcccCCCHHHHHHHHhhh
Confidence            999999999999888653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.94  E-value=5.5e-27  Score=187.72  Aligned_cols=155  Identities=27%  Similarity=0.366  Sum_probs=115.1

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      +++.++.|++.||+|||+++   ++||||||+||+++.++.++|+|||++.......   .......+..|+|||.+.+.
T Consensus       125 ~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~  198 (303)
T cd05088         125 QLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYS  198 (303)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcEEeCccccCcccchhh---hcccCCCcccccCHHHHhcc
Confidence            57889999999999999999   9999999999999999999999999875321111   11111224579999999888


Q ss_pred             CCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           83 FFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      .++.++|+||||+++|+|++ |..||...+......       ....+.....         .......+.+++.+||+.
T Consensus       199 ~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~-------~~~~~~~~~~---------~~~~~~~~~~li~~~l~~  262 (303)
T cd05088         199 VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE-------KLPQGYRLEK---------PLNCDDEVYDLMRQCWRE  262 (303)
T ss_pred             CCcccccchhhhhHHHHHHhcCCCCcccCChHHHHH-------HHhcCCcCCC---------CCCCCHHHHHHHHHHcCC
Confidence            88999999999999999998 999986443322111       1111111100         011233678999999999


Q ss_pred             CCCCCCCHHHHHHHhcCc
Q 027675          162 DPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~~~  179 (220)
                      +|++||++.+++..+...
T Consensus       263 ~p~~Rp~~~~il~~l~~~  280 (303)
T cd05088         263 KPYERPSFAQILVSLNRM  280 (303)
T ss_pred             ChhhCcCHHHHHHHHHHH
Confidence            999999999999988544

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.94  E-value=3.3e-27  Score=186.66  Aligned_cols=154  Identities=24%  Similarity=0.343  Sum_probs=113.9

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++........   .....++..|+|||.+.+
T Consensus        95 ~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~  168 (277)
T cd05607          95 ERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEILKE  168 (277)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eeccCCCCCccCHHHHcc
Confidence            346778999999999999999   99999999999999999999999999875433211   122356789999999988


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+|||||++|+|++|..||.........  ......... .    .....     .......+.+++..||+.
T Consensus       169 ~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~-~----~~~~~-----~~~~~~~~~~li~~~L~~  236 (277)
T cd05607         169 EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EELKRRTLE-D----EVKFE-----HQNFTEESKDICRLFLAK  236 (277)
T ss_pred             CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HHHHHHhhc-c----ccccc-----cccCCHHHHHHHHHHhcc
Confidence            88999999999999999999999998654332211  111111110 0    00000     012234678999999999


Q ss_pred             CCCCCCCHHHHH
Q 027675          162 DPNDRPTMSDVV  173 (220)
Q Consensus       162 ~p~~Rps~~~~l  173 (220)
                      ||++||++++++
T Consensus       237 ~P~~R~~~~~~~  248 (277)
T cd05607         237 KPEDRLGSREKN  248 (277)
T ss_pred             CHhhCCCCccch
Confidence            999999995544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.94  E-value=8.1e-27  Score=182.55  Aligned_cols=157  Identities=26%  Similarity=0.457  Sum_probs=118.5

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+++.++.+++.||+|||+.+   ++|+||||+||++++++.++|+|||++......... ......++..|+|||.+.+
T Consensus       102 ~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~  177 (260)
T cd05067         102 NKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINY  177 (260)
T ss_pred             HHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc-cccCCcccccccCHHHhcc
Confidence            356789999999999999999   999999999999999999999999998754422111 1112234568999999988


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++|++++ |+.||...+.......       ...+.....    +     ......+.+++.+||.
T Consensus       178 ~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-------~~~~~~~~~----~-----~~~~~~~~~li~~~l~  241 (260)
T cd05067         178 GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN-------LERGYRMPR----P-----DNCPEELYELMRLCWK  241 (260)
T ss_pred             CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHH-------HHcCCCCCC----C-----CCCCHHHHHHHHHHcc
Confidence            888999999999999999998 9999865443222111       111111111    1     1123468899999999


Q ss_pred             CCCCCCCCHHHHHHHhcC
Q 027675          161 EDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~  178 (220)
                      .+|++||++++++..|+.
T Consensus       242 ~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         242 EKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CChhhCCCHHHHHHHhhc
Confidence            999999999999998864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.94  E-value=6.7e-27  Score=192.17  Aligned_cols=159  Identities=20%  Similarity=0.205  Sum_probs=117.0

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+..++.|++.||+|||+++   |+||||||+||+++.++.++|+|||++........ .......|++.|+|||.+.+.
T Consensus       143 ~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~  218 (370)
T cd05596         143 WARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQ  218 (370)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc-ccCCCCCCCcCeECHHHhccC
Confidence            45678899999999999999   99999999999999999999999999875432211 111224578899999998653


Q ss_pred             ----CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           83 ----FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        83 ----~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                          .++.++|+|||||++|+|++|..||...+.....      .+.........       ..........+.++|.+|
T Consensus       219 ~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~------~~i~~~~~~~~-------~~~~~~~s~~~~~li~~~  285 (370)
T cd05596         219 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY------SKIMDHKNSLT-------FPDDIEISKQAKDLICAF  285 (370)
T ss_pred             CCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHH------HHHHcCCCcCC-------CCCcCCCCHHHHHHHHHH
Confidence                3688999999999999999999999754432211      11111111111       111112345778899999


Q ss_pred             cCCCCCC--CCCHHHHHHHhcC
Q 027675          159 VQEDPND--RPTMSDVVIMLGS  178 (220)
Q Consensus       159 l~~~p~~--Rps~~~~l~~l~~  178 (220)
                      |+.+|++  |+++++++.+-+.
T Consensus       286 L~~~p~r~~R~s~~ell~h~~~  307 (370)
T cd05596         286 LTDREVRLGRNGVDEIKSHPFF  307 (370)
T ss_pred             ccChhhccCCCCHHHHhcCccc
Confidence            9999998  9999999987543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.94  E-value=4.8e-27  Score=184.84  Aligned_cols=153  Identities=25%  Similarity=0.353  Sum_probs=113.5

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhh--
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL--   80 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~--   80 (220)
                      .+..++.|++.||+|||+++   ++|+||||+||++++++.++|+|||++........  ......++..|+|||.+.  
T Consensus       112 ~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~  186 (272)
T cd06637         112 WIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACD  186 (272)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCceecccccc--cCCcccccccccCHhHhccc
Confidence            46779999999999999999   99999999999999999999999999865432111  122245678899999986  


Q ss_pred             ---cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcc
Q 027675           81 ---GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLL  157 (220)
Q Consensus        81 ---~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  157 (220)
                         +..++.++|+|||||++|+|++|..||..........      ... ....        ...........+.+++.+
T Consensus       187 ~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~------~~~-~~~~--------~~~~~~~~~~~~~~li~~  251 (272)
T cd06637         187 ENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF------LIP-RNPA--------PRLKSKKWSKKFQSFIES  251 (272)
T ss_pred             cCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH------HHh-cCCC--------CCCCCCCcCHHHHHHHHH
Confidence               3357789999999999999999999986433221111      000 0000        000111123467899999


Q ss_pred             ccCCCCCCCCCHHHHHHH
Q 027675          158 CVQEDPNDRPTMSDVVIM  175 (220)
Q Consensus       158 cl~~~p~~Rps~~~~l~~  175 (220)
                      ||..+|.+|||+.+++++
T Consensus       252 ~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         252 CLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             HcCCChhhCCCHHHHhhC
Confidence            999999999999999876

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.94  E-value=4.7e-27  Score=185.02  Aligned_cols=156  Identities=27%  Similarity=0.367  Sum_probs=115.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ++++.++.|++.||+|||+.+   ++|+||||+||+++.++.++++|||++.......   .......+..|.|||.+.+
T Consensus       112 ~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~---~~~~~~~~~~y~apE~~~~  185 (270)
T cd05047         112 QQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNY  185 (270)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCCCccccchhh---hccCCCCccccCChHHHcc
Confidence            356889999999999999999   9999999999999999999999999875322110   0111122456999999988


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++|+|++ |..||...+......       ....+.....         .......+.+++.+||.
T Consensus       186 ~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~-------~~~~~~~~~~---------~~~~~~~~~~li~~~l~  249 (270)
T cd05047         186 SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE-------KLPQGYRLEK---------PLNCDDEVYDLMRQCWR  249 (270)
T ss_pred             CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHH-------HHhCCCCCCC---------CCcCCHHHHHHHHHHcc
Confidence            888999999999999999997 999986433322111       1111111111         01122367899999999


Q ss_pred             CCCCCCCCHHHHHHHhcCc
Q 027675          161 EDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~  179 (220)
                      .+|.+|||+.+++..|...
T Consensus       250 ~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         250 EKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             cChhhCCCHHHHHHHHHHh
Confidence            9999999999999998643

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.94  E-value=4.3e-27  Score=184.19  Aligned_cols=158  Identities=27%  Similarity=0.332  Sum_probs=114.3

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCC--CcccceeecccCccChhhhh
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT--DGTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~y~aPe~~~   80 (220)
                      .++.++.++++||.|||+.+   ++|+||||+||+++.++.++|+|||++........  ........++..|+|||.+.
T Consensus        99 ~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  175 (262)
T cd05058          99 DLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ  175 (262)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhc
Confidence            45778899999999999999   99999999999999999999999998864322111  00111123456799999998


Q ss_pred             cCCCcccCceeehhHHHHHHHhc-CccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           81 GGFFSVKSDVFSFGVVVLEIISG-KRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      +..++.++|+||||+++|+|++| .+||...+.....       .....+.....    +.     .....+.+++.+||
T Consensus       176 ~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~----~~-----~~~~~~~~li~~cl  239 (262)
T cd05058         176 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDIT-------VYLLQGRRLLQ----PE-----YCPDPLYEVMLSCW  239 (262)
T ss_pred             cCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------HHHhcCCCCCC----CC-----cCCHHHHHHHHHHc
Confidence            88889999999999999999995 5556533322211       11111111100    00     11236789999999


Q ss_pred             CCCCCCCCCHHHHHHHhcCc
Q 027675          160 QEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l~~~  179 (220)
                      ..+|++||++.++++.|+..
T Consensus       240 ~~~p~~Rp~~~~il~~l~~~  259 (262)
T cd05058         240 HPKPEMRPTFSELVSRIEQI  259 (262)
T ss_pred             CCChhhCCCHHHHHHHHHHH
Confidence            99999999999999998654

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.94  E-value=5.3e-27  Score=184.50  Aligned_cols=160  Identities=24%  Similarity=0.306  Sum_probs=110.3

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc-
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG-   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~-   81 (220)
                      .++.++.|++.||+|||+.+   ++||||||+||+++.++.++++|||++................++..|+|||.+.. 
T Consensus       101 ~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  177 (269)
T cd05042         101 VLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR  177 (269)
T ss_pred             HHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhc
Confidence            45789999999999999999   99999999999999999999999998764322111111112234567999998753 


Q ss_pred             ------CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHH
Q 027675           82 ------GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINV  154 (220)
Q Consensus        82 ------~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  154 (220)
                            ..++.++|+||||+++|+|++ |..||.........      ...... .........    ........+.++
T Consensus       178 ~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~------~~~~~~-~~~~~~~~~----~~~~~~~~~~~~  246 (269)
T cd05042         178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVL------KQVVRE-QDIKLPKPQ----LDLKYSDRWYEV  246 (269)
T ss_pred             cccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHH------HHHhhc-cCccCCCCc----ccccCCHHHHHH
Confidence                  346789999999999999998 77787644332211      111111 111111111    111233455667


Q ss_pred             hccccCCCCCCCCCHHHHHHHhc
Q 027675          155 GLLCVQEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       155 i~~cl~~~p~~Rps~~~~l~~l~  177 (220)
                      +..|| .||++||++++|++.|.
T Consensus       247 ~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         247 MQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             HHHHh-cCcccccCHHHHHHHhc
Confidence            77788 59999999999998873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.94  E-value=1.7e-27  Score=188.63  Aligned_cols=166  Identities=24%  Similarity=0.336  Sum_probs=115.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCc-ccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG-TTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~y~aPe~~~   80 (220)
                      ..++.++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++.......... ......++..|.|||.+.
T Consensus       108 ~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  184 (284)
T cd05081         108 RKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLT  184 (284)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhc
Confidence            456789999999999999999   9999999999999999999999999987543221110 111112234589999998


Q ss_pred             cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhh---------HHHHHHHHHhccccccccCCCCCcCcHHHHHHH
Q 027675           81 GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSL---------LGYAWKLWQEGKALDMMDQKPGAISKANEILKC  151 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (220)
                      +..++.++|+||||+++++|++|..++...........         .............         ..........+
T Consensus       185 ~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~  255 (284)
T cd05081         185 ESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGR---------LPAPPGCPAEI  255 (284)
T ss_pred             cCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCc---------CCCCCCCCHHH
Confidence            88889999999999999999998766432211110000         0000011111100         01111123468


Q ss_pred             HHHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          152 INVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       152 ~~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      .+++.+||+.+|++|||+.++++.|+..
T Consensus       256 ~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         256 YAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            8999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.94  E-value=5.3e-27  Score=187.20  Aligned_cols=157  Identities=24%  Similarity=0.328  Sum_probs=116.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .++..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.........  .....+++.|+|||.+.+
T Consensus       116 ~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~  190 (296)
T cd06654         116 GQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTR  190 (296)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccccc--cCcccCCccccCHHHHcC
Confidence            357789999999999999999   999999999999999999999999987643221111  112356778999999988


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+|||||++|+|++|+.||...+.....  .    ... ....       +...........+.+++.+||..
T Consensus       191 ~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~--~----~~~-~~~~-------~~~~~~~~~~~~l~~li~~~l~~  256 (296)
T cd06654         191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--Y----LIA-TNGT-------PELQNPEKLSAIFRDFLNRCLDM  256 (296)
T ss_pred             CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH--H----HHh-cCCC-------CCCCCccccCHHHHHHHHHHCcC
Confidence            88899999999999999999999998643321110  0    000 0000       00001112334678899999999


Q ss_pred             CCCCCCCHHHHHHHhc
Q 027675          162 DPNDRPTMSDVVIMLG  177 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~  177 (220)
                      +|++||++.+++.+-+
T Consensus       257 ~p~~Rpt~~eil~~~~  272 (296)
T cd06654         257 DVEKRGSAKELLQHQF  272 (296)
T ss_pred             CcccCcCHHHHhhChh
Confidence            9999999999998643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.94  E-value=8e-27  Score=184.71  Aligned_cols=159  Identities=21%  Similarity=0.296  Sum_probs=117.0

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhh-
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL-   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~-   80 (220)
                      ..+..++.|+++||.|||+.+   ++||||||+||+++.++.++++|||++........  ......++..|+|||.+. 
T Consensus       103 ~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~  177 (282)
T cd06643         103 PQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRDSFIGTPYWMAPEVVMC  177 (282)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccc--ccccccccccccCHhhccc
Confidence            357889999999999999999   99999999999999999999999998765432211  122245678899999874 


Q ss_pred             ----cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhc
Q 027675           81 ----GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGL  156 (220)
Q Consensus        81 ----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  156 (220)
                          +..++.++|+|||||++|+|++|..||...+......      .... ......       .........+.++|.
T Consensus       178 ~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~------~~~~-~~~~~~-------~~~~~~~~~~~~li~  243 (282)
T cd06643         178 ETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLL------KIAK-SEPPTL-------AQPSRWSSEFKDFLK  243 (282)
T ss_pred             cCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHH------HHhh-cCCCCC-------CCccccCHHHHHHHH
Confidence                3456789999999999999999999986544322111      1100 000000       011122347789999


Q ss_pred             cccCCCCCCCCCHHHHHHHhcCc
Q 027675          157 LCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       157 ~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      +||+.+|.+||++.+++++-+..
T Consensus       244 ~~l~~~p~~Rp~~~~il~~~~~~  266 (282)
T cd06643         244 KCLEKNVDARWTTTQLLQHPFVT  266 (282)
T ss_pred             HHccCChhhCcCHHHHhcCCCEe
Confidence            99999999999999999886544

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.94  E-value=5.1e-27  Score=189.58  Aligned_cols=152  Identities=22%  Similarity=0.330  Sum_probs=114.9

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++.......  .......|+..|+|||.+.+
T Consensus       101 ~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~  175 (323)
T cd05615         101 PQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--VTTRTFCGTPDYIAPEIIAY  175 (323)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCC--ccccCccCCccccCHHHHcC
Confidence            357789999999999999999   9999999999999999999999999876432211  11222457889999999998


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+||||+++|+|++|..||...+......      ..... ..     ..+     ......+.+++.+||+.
T Consensus       176 ~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~------~i~~~-~~-----~~p-----~~~~~~~~~li~~~l~~  238 (323)
T cd05615         176 QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQ------SIMEH-NV-----SYP-----KSLSKEAVSICKGLMTK  238 (323)
T ss_pred             CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHH------HHHhC-CC-----CCC-----ccCCHHHHHHHHHHccc
Confidence            888999999999999999999999997654332211      11111 00     001     11233678899999999


Q ss_pred             CCCCCCCH-----HHHHHH
Q 027675          162 DPNDRPTM-----SDVVIM  175 (220)
Q Consensus       162 ~p~~Rps~-----~~~l~~  175 (220)
                      +|.+|++.     ++++++
T Consensus       239 ~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05615         239 HPSKRLGCGPEGERDIREH  257 (323)
T ss_pred             CHhhCCCCCCCCHHHHhcC
Confidence            99999984     566655

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.94  E-value=9.8e-27  Score=181.50  Aligned_cols=152  Identities=25%  Similarity=0.374  Sum_probs=116.1

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      ++++++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.......     .....+..|.|||.+.+.
T Consensus       101 ~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~y~~pe~~~~~  172 (254)
T cd05083         101 QLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-----DNSKLPVKWTAPEALKHK  172 (254)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC-----CCCCCCceecCHHHhccC
Confidence            56789999999999999999   9999999999999999999999999886532211     112234579999999888


Q ss_pred             CCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           83 FFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      .++.++|+||||+++|+|++ |..||.........       .....+....   .      .......+.+++.+||+.
T Consensus       173 ~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~~~~~---~------~~~~~~~~~~li~~~l~~  236 (254)
T cd05083         173 KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVK-------ECVEKGYRME---P------PEGCPADVYVLMTSCWET  236 (254)
T ss_pred             CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHH-------HHHhCCCCCC---C------CCcCCHHHHHHHHHHcCC
Confidence            88999999999999999997 89888654432221       1111111111   0      112234678999999999


Q ss_pred             CCCCCCCHHHHHHHhcC
Q 027675          162 DPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~~  178 (220)
                      +|++||+++++++.|+.
T Consensus       237 ~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         237 EPKKRPSFHKLREKLEK  253 (254)
T ss_pred             ChhhCcCHHHHHHHHcc
Confidence            99999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.94  E-value=7.3e-27  Score=182.10  Aligned_cols=155  Identities=26%  Similarity=0.404  Sum_probs=117.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|+++|+.|||+.+   ++|+||+|+||+++.++.++|+|||++........  ......++..|++||.+.+
T Consensus        99 ~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~  173 (256)
T cd06612          99 EEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KRNTVIGTPFWMAPEVIQE  173 (256)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc--ccccccCCccccCHHHHhc
Confidence            357789999999999999999   99999999999999999999999999875443221  1122346778999999988


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+||||+++|+|++|..||...........         ...     ...............+.+++.+||+.
T Consensus       174 ~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~---------~~~-----~~~~~~~~~~~~~~~~~~~i~~~l~~  239 (256)
T cd06612         174 IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM---------IPN-----KPPPTLSDPEKWSPEFNDFVKKCLVK  239 (256)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh---------hcc-----CCCCCCCchhhcCHHHHHHHHHHHhc
Confidence            8889999999999999999999999864332211100         000     00111111222345788999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 027675          162 DPNDRPTMSDVVIM  175 (220)
Q Consensus       162 ~p~~Rps~~~~l~~  175 (220)
                      +|++|||+.+++++
T Consensus       240 ~P~~Rps~~~il~~  253 (256)
T cd06612         240 DPEERPSAIQLLQH  253 (256)
T ss_pred             ChhhCcCHHHHhcC
Confidence            99999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.94  E-value=1.1e-26  Score=182.72  Aligned_cols=160  Identities=23%  Similarity=0.339  Sum_probs=111.9

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+..++.|++.|+.|||+.+   ++|+||||+||+++.++.++|+|||++................++..|+|||.+.+.
T Consensus       101 ~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  177 (269)
T cd05087         101 TLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV  177 (269)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccc
Confidence            45678999999999999999   999999999999999999999999987643222111112223456789999988642


Q ss_pred             -------CCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHH
Q 027675           83 -------FFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINV  154 (220)
Q Consensus        83 -------~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  154 (220)
                             .++.++|+||||+++|+|++ |..||...........   .  .  .+.......+.....    ....+.++
T Consensus       178 ~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~---~--~--~~~~~~~~~~~~~~~----~~~~~~~l  246 (269)
T cd05087         178 HGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY---T--V--REQQLKLPKPRLKLP----LSDRWYEV  246 (269)
T ss_pred             cccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH---H--h--hcccCCCCCCccCCC----CChHHHHH
Confidence                   35789999999999999996 9999865443322111   0  0  111111111111111    12246678


Q ss_pred             hccccCCCCCCCCCHHHHHHHhc
Q 027675          155 GLLCVQEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       155 i~~cl~~~p~~Rps~~~~l~~l~  177 (220)
                      +..|| .+|++|||+++|+..|+
T Consensus       247 ~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         247 MQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             HHHHh-cCcccCCCHHHHHHHhc
Confidence            88898 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.94  E-value=5.4e-27  Score=186.34  Aligned_cols=158  Identities=27%  Similarity=0.439  Sum_probs=117.0

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||+++...............++..|+|||.+.+.
T Consensus       120 ~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~  196 (288)
T cd05061         120 EMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG  196 (288)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccC
Confidence            46779999999999999999   999999999999999999999999987643322111111112335679999999888


Q ss_pred             CCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           83 FFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      .++.++|+|||||++|++++ |..||..........       ....+......         ......+.+++.+||+.
T Consensus       197 ~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~-------~~~~~~~~~~~---------~~~~~~~~~li~~~l~~  260 (288)
T cd05061         197 VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK-------FVMDGGYLDQP---------DNCPERVTDLMRMCWQF  260 (288)
T ss_pred             CCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-------HHHcCCCCCCC---------CCCCHHHHHHHHHHcCC
Confidence            88999999999999999998 777876433322111       11111111110         01124788999999999


Q ss_pred             CCCCCCCHHHHHHHhcCc
Q 027675          162 DPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~~~  179 (220)
                      +|++|||+.++++.+...
T Consensus       261 ~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         261 NPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             ChhHCcCHHHHHHHHHhh
Confidence            999999999999988654

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.94  E-value=1.8e-26  Score=180.98  Aligned_cols=160  Identities=25%  Similarity=0.360  Sum_probs=119.6

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+++.++.++++||.|||+.+   ++|+||+|+||+++.++.++++|||++.........  .....++..|.|||.+.+
T Consensus       106 ~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~apE~~~~  180 (267)
T cd08224         106 RTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHE  180 (267)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccCCCcc--cceecCCccccCHHHhcc
Confidence            357889999999999999999   999999999999999999999999987654322211  122356778999999988


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+||||+++|+|++|..||......... ..    .....+..        ...........+.++|.+||..
T Consensus       181 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~----~~~~~~~~--------~~~~~~~~~~~~~~~i~~cl~~  247 (267)
T cd08224         181 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-LC----KKIEKCDY--------PPLPADHYSEELRDLVSRCINP  247 (267)
T ss_pred             CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHH-HH----hhhhcCCC--------CCCChhhcCHHHHHHHHHHcCC
Confidence            88899999999999999999999998533211110 00    01111111        0111113345788999999999


Q ss_pred             CCCCCCCHHHHHHHhcCc
Q 027675          162 DPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~~~  179 (220)
                      +|++||++.++++.+...
T Consensus       248 ~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         248 DPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             CcccCCCHHHHHHHHHHh
Confidence            999999999999998654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.94  E-value=5.7e-27  Score=190.77  Aligned_cols=160  Identities=29%  Similarity=0.419  Sum_probs=117.6

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..+.+++.|+++||.|||+++   ++||||||.||+++.++.++|+|||++................++..|+|||.+.+
T Consensus       179 ~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  255 (343)
T cd05103         179 EDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD  255 (343)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcC
Confidence            356789999999999999999   99999999999999999999999999865432211111111233567999999988


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++|++++ |..||.........      ......+.....    +..     ....+.+++..||+
T Consensus       256 ~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~------~~~~~~~~~~~~----~~~-----~~~~~~~~~~~cl~  320 (343)
T cd05103         256 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF------CRRLKEGTRMRA----PDY-----TTPEMYQTMLDCWH  320 (343)
T ss_pred             CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH------HHHHhccCCCCC----CCC-----CCHHHHHHHHHHcc
Confidence            888999999999999999997 88888543221110      111112211111    111     12367889999999


Q ss_pred             CCCCCCCCHHHHHHHhcCc
Q 027675          161 EDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~  179 (220)
                      .+|++||++.+++++|+..
T Consensus       321 ~~p~~Rps~~eil~~l~~~  339 (343)
T cd05103         321 GEPSQRPTFSELVEHLGNL  339 (343)
T ss_pred             CChhhCcCHHHHHHHHHHH
Confidence            9999999999999998654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.94  E-value=7.7e-27  Score=182.61  Aligned_cols=157  Identities=29%  Similarity=0.474  Sum_probs=117.5

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +++..++.+++.|+.|||+++   ++|+||||+||+++.++.++|+|||++......... .......+..|+|||.+.+
T Consensus       103 ~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~  178 (261)
T cd05034         103 PQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT-AREGAKFPIKWTAPEAANY  178 (261)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhh-hhhccCCCccccCHHHhcc
Confidence            456889999999999999999   999999999999999999999999998754422111 1111223457999999988


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ...+.++|+||||++++++++ |+.||...........      . ..+.....    +     ......+.+++.+||+
T Consensus       179 ~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~------~-~~~~~~~~----~-----~~~~~~~~~~i~~~l~  242 (261)
T cd05034         179 GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQ------V-ERGYRMPR----P-----PNCPEELYDLMLQCWD  242 (261)
T ss_pred             CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH------H-HcCCCCCC----C-----CCCCHHHHHHHHHHcc
Confidence            888999999999999999998 9999864433222111      1 11111000    0     0113467899999999


Q ss_pred             CCCCCCCCHHHHHHHhcC
Q 027675          161 EDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~  178 (220)
                      .+|++||+++++++.|+.
T Consensus       243 ~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         243 KDPEERPTFEYLQSFLED  260 (261)
T ss_pred             cCcccCCCHHHHHHHHhc
Confidence            999999999999998864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.94  E-value=1.1e-26  Score=181.33  Aligned_cols=152  Identities=20%  Similarity=0.318  Sum_probs=116.1

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .++.++.+++.||.+||+++   ++|+||||+||++++++.++++|||.+........  ......++..|+|||.+.+.
T Consensus       101 ~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~  175 (255)
T cd08219         101 TILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--YACTYVGTPYYVPPEIWENM  175 (255)
T ss_pred             HHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc--ccccccCCccccCHHHHccC
Confidence            46788999999999999999   99999999999999999999999999875432211  11224567789999999888


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      ..+.++|+||||+++|+|++|..||...+.....      .... .+...    ..     .......+.+++.+||+.|
T Consensus       176 ~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~------~~~~-~~~~~----~~-----~~~~~~~~~~li~~~l~~~  239 (255)
T cd08219         176 PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLI------LKVC-QGSYK----PL-----PSHYSYELRSLIKQMFKRN  239 (255)
T ss_pred             CcCchhhhhhhchhheehhhccCCCCCCCHHHHH------HHHh-cCCCC----CC-----CcccCHHHHHHHHHHHhCC
Confidence            8899999999999999999999998643322211      1111 11111    01     1112346789999999999


Q ss_pred             CCCCCCHHHHHHH
Q 027675          163 PNDRPTMSDVVIM  175 (220)
Q Consensus       163 p~~Rps~~~~l~~  175 (220)
                      |++||++.+++..
T Consensus       240 P~~Rp~~~~il~~  252 (255)
T cd08219         240 PRSRPSATTILSR  252 (255)
T ss_pred             cccCCCHHHHhhc
Confidence            9999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.94  E-value=2.1e-26  Score=180.31  Aligned_cols=157  Identities=25%  Similarity=0.447  Sum_probs=117.7

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+++.++.+++.||.|||+.+   ++|+||+|+||+++..+.++|+|||.+......... ......++..|+|||.+.+
T Consensus       102 ~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~  177 (260)
T cd05073         102 PKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINF  177 (260)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc-cccCCcccccccCHhHhcc
Confidence            357889999999999999999   999999999999999999999999988754322111 1111234567999999988


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++|++++ |..||...+......       ....+....         ........+.+++.+||.
T Consensus       178 ~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~-------~~~~~~~~~---------~~~~~~~~~~~~i~~~l~  241 (260)
T cd05073         178 GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR-------ALERGYRMP---------RPENCPEELYNIMMRCWK  241 (260)
T ss_pred             CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHH-------HHhCCCCCC---------CcccCCHHHHHHHHHHcc
Confidence            888999999999999999998 898886433222211       111111110         011223468899999999


Q ss_pred             CCCCCCCCHHHHHHHhcC
Q 027675          161 EDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~  178 (220)
                      .+|++||++.++++.|..
T Consensus       242 ~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         242 NRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             cCcccCcCHHHHHHHHhc
Confidence            999999999999998854

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.94  E-value=1.2e-26  Score=182.65  Aligned_cols=158  Identities=25%  Similarity=0.341  Sum_probs=118.6

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+++.++.+++.||+|||+.+   ++|+||||+||+++.++.++++|||++.......... .....++..|+|||.+.+
T Consensus       107 ~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~  182 (270)
T cd05056         107 ASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYK-ASKGKLPIKWMAPESINF  182 (270)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccccccee-cCCCCccccccChhhhcc
Confidence            357789999999999999999   9999999999999999999999999987543321111 111223457999999888


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++|++++ |..||...........       ...+......         ......+.+++.+||.
T Consensus       183 ~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~-------~~~~~~~~~~---------~~~~~~~~~li~~~l~  246 (270)
T cd05056         183 RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR-------IENGERLPMP---------PNCPPTLYSLMTKCWA  246 (270)
T ss_pred             CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-------HHcCCcCCCC---------CCCCHHHHHHHHHHcC
Confidence            888999999999999999986 9999865443322111       1111111110         1123478889999999


Q ss_pred             CCCCCCCCHHHHHHHhcCc
Q 027675          161 EDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~  179 (220)
                      .+|++|||+.+++..|...
T Consensus       247 ~~P~~Rpt~~~~~~~l~~~  265 (270)
T cd05056         247 YDPSKRPRFTELKAQLSDI  265 (270)
T ss_pred             CChhhCcCHHHHHHHHHHH
Confidence            9999999999999998665

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.94  E-value=1.5e-26  Score=187.59  Aligned_cols=169  Identities=25%  Similarity=0.384  Sum_probs=116.4

Q ss_pred             hHHHHHHHHHHHHHHhhhC-CCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            3 MLFNIILGVSRRLLYLHQD-SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~-~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+..++.+++.||.|||+. +   ++|+||||+||+++.++.++|+|||++......    ......++..|+|||.+.+
T Consensus       104 ~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~  176 (333)
T cd06650         104 ILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQG  176 (333)
T ss_pred             HHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh----ccccCCCCccccCHHHhcC
Confidence            4578899999999999974 6   999999999999999999999999987643221    1122456789999999998


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHH-hcc---c-------------------------c
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQ-EGK---A-------------------------L  132 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~---~-------------------------~  132 (220)
                      ..++.++|+|||||++|++++|+.||.................... ...   .                         .
T Consensus       177 ~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (333)
T cd06650         177 THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLD  256 (333)
T ss_pred             CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHH
Confidence            8889999999999999999999999865433222111100000000 000   0                         0


Q ss_pred             ccccCCCCCcCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcC
Q 027675          133 DMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       133 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~  178 (220)
                      ..................+.+++.+||+.||++|||+++++.+-+.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~  302 (333)
T cd06650         257 YIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFI  302 (333)
T ss_pred             HHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHH
Confidence            0000000000001123467899999999999999999999977644

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.94  E-value=4.6e-27  Score=200.29  Aligned_cols=160  Identities=29%  Similarity=0.449  Sum_probs=130.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+.+.|+.||+.|+.||-++.   ++||||...|+||.++..|||+|||+++..-....+....+..-+..|++||.+..
T Consensus       603 ~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly  679 (774)
T KOG1026|consen  603 SQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY  679 (774)
T ss_pred             HHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc
Confidence            357899999999999999998   99999999999999999999999999986544444434433445779999999999


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++||||+||++||+++ |..||......+..       +....|..+..++.+|.         .++++|..||.
T Consensus       680 ~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI-------e~i~~g~lL~~Pe~CP~---------~vY~LM~~CW~  743 (774)
T KOG1026|consen  680 GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI-------ECIRAGQLLSCPENCPT---------EVYSLMLECWN  743 (774)
T ss_pred             CcccchhhhhhhhhhhhhhhccccCcccccchHHHH-------HHHHcCCcccCCCCCCH---------HHHHHHHHHhh
Confidence            999999999999999999996 88887654444332       22345566555555444         88999999999


Q ss_pred             CCCCCCCCHHHHHHHhcCcc
Q 027675          161 EDPNDRPTMSDVVIMLGSEA  180 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~~  180 (220)
                      .+|++||++++|-..|+...
T Consensus       744 ~~P~~RPsF~eI~~~L~~~~  763 (774)
T KOG1026|consen  744 ENPKRRPSFKEIHSRLQAWA  763 (774)
T ss_pred             cCcccCCCHHHHHHHHHHHH
Confidence            99999999999999996653

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.94  E-value=9.6e-27  Score=184.13  Aligned_cols=161  Identities=25%  Similarity=0.379  Sum_probs=118.3

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++......    ......++..|+|||.+.+.
T Consensus        96 ~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~  168 (279)
T cd06619          96 VLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISGE  168 (279)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc----cccCCCCChhhcCceeecCC
Confidence            46789999999999999999   999999999999999999999999998654321    12224567899999999888


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHH-hhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELAL-SLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      .++.++|+||||+++|+|++|..||......... .......... .        ..+...........+.+++.+||..
T Consensus       169 ~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~--------~~~~~~~~~~~~~~~~~li~~~l~~  239 (279)
T cd06619         169 QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV-D--------EDPPVLPVGQFSEKFVHFITQCMRK  239 (279)
T ss_pred             CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHh-c--------cCCCCCCCCcCCHHHHHHHHHHhhC
Confidence            8899999999999999999999998642221110 0011100000 0        0001111111234678999999999


Q ss_pred             CCCCCCCHHHHHHHhcCc
Q 027675          162 DPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~~~  179 (220)
                      +|++||++++++.+-+..
T Consensus       240 ~P~~Rp~~~eil~~~~~~  257 (279)
T cd06619         240 QPKERPAPENLMDHPFIV  257 (279)
T ss_pred             ChhhCCCHHHHhcCcccc
Confidence            999999999999886544

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=7.7e-27  Score=194.78  Aligned_cols=145  Identities=24%  Similarity=0.299  Sum_probs=119.6

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+.-++..|+.||.|||++|   |++||||.+|||++..|.+||+|||++......  ......+-||+.|+|||++.+.
T Consensus       469 rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~--g~~TsTfCGTpey~aPEil~e~  543 (694)
T KOG0694|consen  469 RARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ--GDRTSTFCGTPEFLAPEVLTEQ  543 (694)
T ss_pred             HHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCCC--CCccccccCChhhcChhhhccC
Confidence            45668899999999999999   999999999999999999999999998753322  2234557899999999999999


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      .|+...|.|+|||++|||+.|..||...+.++..+.+                 ......++...+.+.+++++++|..|
T Consensus       544 ~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI-----------------~~d~~~yP~~ls~ea~~il~~ll~k~  606 (694)
T KOG0694|consen  544 SYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI-----------------VNDEVRYPRFLSKEAIAIMRRLLRKN  606 (694)
T ss_pred             cccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-----------------hcCCCCCCCcccHHHHHHHHHHhccC
Confidence            9999999999999999999999999877766655433                 11222333344557788999999999


Q ss_pred             CCCCCCH
Q 027675          163 PNDRPTM  169 (220)
Q Consensus       163 p~~Rps~  169 (220)
                      |++|..+
T Consensus       607 p~kRLG~  613 (694)
T KOG0694|consen  607 PEKRLGS  613 (694)
T ss_pred             cccccCC
Confidence            9999876

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=9.9e-27  Score=204.40  Aligned_cols=161  Identities=32%  Similarity=0.443  Sum_probs=125.7

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.+|++|++||+++.   ++||||...|+|++....||++|||+++..-....+-.......+..|+|||.+..
T Consensus       802 ~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d  878 (1025)
T KOG1095|consen  802 RDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD  878 (1025)
T ss_pred             HHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhh
Confidence            467899999999999999999   99999999999999999999999999984333332222222344578999999999


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++||||||+++||+++ |..||...+......      .. .++.+++.+..++.         .++++|..||+
T Consensus       879 ~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~------~~-~~ggRL~~P~~CP~---------~ly~lM~~CW~  942 (1025)
T KOG1095|consen  879 GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL------DV-LEGGRLDPPSYCPE---------KLYQLMLQCWK  942 (1025)
T ss_pred             cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH------HH-HhCCccCCCCCCCh---------HHHHHHHHHcc
Confidence            999999999999999999998 888886544433321      12 23334444444443         67899999999


Q ss_pred             CCCCCCCCHHHHHHHhcCccc
Q 027675          161 EDPNDRPTMSDVVIMLGSEAV  181 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~~~  181 (220)
                      .+|++||++..+++.+.....
T Consensus       943 ~~pe~RP~F~~i~~q~~~i~~  963 (1025)
T KOG1095|consen  943 HDPEDRPSFRTIVEQDPAISN  963 (1025)
T ss_pred             CChhhCccHHHHHhhhhhhhh
Confidence            999999999999987655433

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.94  E-value=8.2e-27  Score=182.05  Aligned_cols=153  Identities=26%  Similarity=0.366  Sum_probs=117.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||.+........     ....+..|.|||.+.+
T Consensus       102 ~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-----~~~~~~~~~ape~~~~  173 (256)
T cd05039         102 AQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-----SGKLPVKWTAPEALRE  173 (256)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-----cCCCcccccCchhhcC
Confidence            357889999999999999999   99999999999999999999999998875432111     1223457999999988


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||++++++++ |..||...........       ...+.....         .......+.+++.+||.
T Consensus       174 ~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-------~~~~~~~~~---------~~~~~~~~~~li~~~l~  237 (256)
T cd05039         174 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPH-------VEKGYRMEA---------PEGCPPEVYKVMKDCWE  237 (256)
T ss_pred             CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-------HhcCCCCCC---------ccCCCHHHHHHHHHHhc
Confidence            888899999999999999997 9999865543332111       111111111         01123477899999999


Q ss_pred             CCCCCCCCHHHHHHHhcC
Q 027675          161 EDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~  178 (220)
                      .+|++||+++++++.|..
T Consensus       238 ~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         238 LDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             cChhhCcCHHHHHHHHhc
Confidence            999999999999999854

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.94  E-value=6.8e-27  Score=185.58  Aligned_cols=158  Identities=29%  Similarity=0.400  Sum_probs=115.5

Q ss_pred             hHHHHHHHHHHHHHHhhhC-CCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            3 MLFNIILGVSRRLLYLHQD-SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~-~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+..++.++++||+|||+. +   ++||||||+||+++.++.++|+|||++........   .....++..|+|||.+.+
T Consensus       108 ~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~  181 (288)
T cd06616         108 ILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDP  181 (288)
T ss_pred             HHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhccCCc---cccccCccCccCHHHhcc
Confidence            5678999999999999975 7   99999999999999999999999998864332211   112346778999999876


Q ss_pred             C---CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           82 G---FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        82 ~---~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                      .   .++.++|+||||+++|++++|+.||....... .    ...+... +..     +.............+.+++.+|
T Consensus       182 ~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~----~~~~~~~-~~~-----~~~~~~~~~~~~~~l~~li~~~  250 (288)
T cd06616         182 SARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVF-D----QLTQVVK-GDP-----PILSNSEEREFSPSFVNFINLC  250 (288)
T ss_pred             ccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHH-H----HHhhhcC-CCC-----CcCCCcCCCccCHHHHHHHHHH
Confidence            5   57889999999999999999999987544111 0    0111100 000     0011111122445788999999


Q ss_pred             cCCCCCCCCCHHHHHHHhc
Q 027675          159 VQEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       159 l~~~p~~Rps~~~~l~~l~  177 (220)
                      |+.+|++|||+++++.+-+
T Consensus       251 l~~~p~~Rpt~~~i~~~~~  269 (288)
T cd06616         251 LIKDESKRPKYKELLEHPF  269 (288)
T ss_pred             ccCChhhCcCHHHHhcChh
Confidence            9999999999999997743

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.94  E-value=2.6e-26  Score=189.39  Aligned_cols=160  Identities=23%  Similarity=0.275  Sum_probs=112.1

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCC----------------------
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT----------------------   60 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~----------------------   60 (220)
                      .+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++........                      
T Consensus       102 ~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (381)
T cd05626         102 LARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD  178 (381)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccc
Confidence            45678899999999999999   99999999999999999999999998643210000                      


Q ss_pred             -----------------------CcccceeecccCccChhhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHh
Q 027675           61 -----------------------DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALS  117 (220)
Q Consensus        61 -----------------------~~~~~~~~~~~~y~aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~  117 (220)
                                             ........|+..|+|||.+.+..++.++|||||||++|+|++|..||...+......
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~  258 (381)
T cd05626         179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQL  258 (381)
T ss_pred             cccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHH
Confidence                                   000112468899999999998888999999999999999999999997544332211


Q ss_pred             hHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcc--ccCCCCCCCCCHHHHHHHhcC
Q 027675          118 LLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLL--CVQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~--cl~~~p~~Rps~~~~l~~l~~  178 (220)
                      .      .........   .....    .....+.++|.+  |+..++..||++++++.+-+.
T Consensus       259 ~------i~~~~~~~~---~~~~~----~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f  308 (381)
T cd05626         259 K------VINWENTLH---IPPQV----KLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFF  308 (381)
T ss_pred             H------HHccccccC---CCCCC----CCCHHHHHHHHHHccCcccccCCCCHHHHhcCccc
Confidence            1      110000110   11111    122355666766  455666679999999987543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.94  E-value=1e-26  Score=191.79  Aligned_cols=158  Identities=23%  Similarity=0.286  Sum_probs=111.1

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCC-----------------------
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQ-----------------------   59 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~-----------------------   59 (220)
                      .+..++.|++.||+|||+.+   |+||||||+||+++.++.++|+|||++.......                       
T Consensus       102 ~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (382)
T cd05625         102 LARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG  178 (382)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccccccccccccccccccccccccc
Confidence            45678899999999999999   9999999999999999999999999864221000                       


Q ss_pred             ----------------------CCcccceeecccCccChhhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHh
Q 027675           60 ----------------------TDGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALS  117 (220)
Q Consensus        60 ----------------------~~~~~~~~~~~~~y~aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~  117 (220)
                                            .........|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+......
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~  258 (382)
T cd05625         179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQM  258 (382)
T ss_pred             ccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHH
Confidence                                  0000112357889999999998889999999999999999999999997544332211


Q ss_pred             hHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCCCCCCCC---HHHHHHHhc
Q 027675          118 LLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPT---MSDVVIMLG  177 (220)
Q Consensus       118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps---~~~~l~~l~  177 (220)
                            +.........   ....    ........++|.+|+ .+|++|++   +.+++.|-+
T Consensus       259 ------~i~~~~~~~~---~p~~----~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~  307 (382)
T cd05625         259 ------KVINWQTSLH---IPPQ----AKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPF  307 (382)
T ss_pred             ------HHHccCCCcC---CCCc----ccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCC
Confidence                  1111001110   0111    112234566666665 49999997   999887643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.94  E-value=1.7e-26  Score=179.62  Aligned_cols=156  Identities=24%  Similarity=0.322  Sum_probs=116.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+++.++.+++.+|.|||+++   ++|+||+|+||+++.++.++|+|||++......... ......++..|+|||.+.+
T Consensus        93 ~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~  168 (250)
T cd05085          93 KQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLKQIPIKWTAPEALNY  168 (250)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCCCCcccccCHHHhcc
Confidence            457889999999999999999   999999999999999999999999998653322111 1111123457999999988


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++|++++ |..||..........       ....+.....         .......+.+++.+||.
T Consensus       169 ~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~-------~~~~~~~~~~---------~~~~~~~~~~li~~~l~  232 (250)
T cd05085         169 GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQARE-------QVEKGYRMSC---------PQKCPDDVYKVMQRCWD  232 (250)
T ss_pred             CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH-------HHHcCCCCCC---------CCCCCHHHHHHHHHHcc
Confidence            888999999999999999998 888986443322111       1111111110         11123478899999999


Q ss_pred             CCCCCCCCHHHHHHHhc
Q 027675          161 EDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~  177 (220)
                      .+|++||++.++++.|.
T Consensus       233 ~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         233 YKPENRPKFSELQKELA  249 (250)
T ss_pred             cCcccCCCHHHHHHHhc
Confidence            99999999999999874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.94  E-value=1.5e-26  Score=181.66  Aligned_cols=158  Identities=28%  Similarity=0.446  Sum_probs=116.6

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCccc-ceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTT-NRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~-~~~~~~~~y~aPe~~~   80 (220)
                      .+++.++.+++.|++|||+.+   ++|+||||+||+++.++.++++|||++............ .....+..|++||.+.
T Consensus       107 ~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~  183 (268)
T cd05063         107 YQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIA  183 (268)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhh
Confidence            357889999999999999999   999999999999999999999999998754322111111 0111234699999998


Q ss_pred             cCCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           81 GGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      +..++.++|+||||+++|++++ |..||...+.....       .....+.      ..+..   ......+.+++.+||
T Consensus       184 ~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~-------~~i~~~~------~~~~~---~~~~~~~~~li~~c~  247 (268)
T cd05063         184 YRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVM-------KAINDGF------RLPAP---MDCPSAVYQLMLQCW  247 (268)
T ss_pred             cCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHH-------HHHhcCC------CCCCC---CCCCHHHHHHHHHHc
Confidence            8888999999999999999997 99998544332211       1111111      11111   112346789999999


Q ss_pred             CCCCCCCCCHHHHHHHhcC
Q 027675          160 QEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l~~  178 (220)
                      +.+|++||++.++++.|..
T Consensus       248 ~~~p~~Rp~~~~i~~~l~~  266 (268)
T cd05063         248 QQDRARRPRFVDIVNLLDK  266 (268)
T ss_pred             CCCcccCcCHHHHHHHHHh
Confidence            9999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=1.1e-26  Score=184.48  Aligned_cols=158  Identities=23%  Similarity=0.256  Sum_probs=118.6

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++........   .....++..|+|||.+.+.
T Consensus       103 ~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~  176 (285)
T cd05605         103 RAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET---IRGRVGTVGYMAPEVVKNE  176 (285)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc---cccccCCCCccCcHHhcCC
Confidence            56788999999999999999   99999999999999999999999999875432211   1123567899999999888


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      .++.++|+||+|+++|++++|..||............   ........          ..........+.+++.+||..|
T Consensus       177 ~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~---~~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~  243 (285)
T cd05605         177 RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV---ERRVKEDQ----------EEYSEKFSEAARSICRQLLTKD  243 (285)
T ss_pred             CCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHH---HHHhhhcc----------cccCcccCHHHHHHHHHHccCC
Confidence            8899999999999999999999999754432211110   01111100          0111123446789999999999


Q ss_pred             CCCCC-----CHHHHHHHhcCc
Q 027675          163 PNDRP-----TMSDVVIMLGSE  179 (220)
Q Consensus       163 p~~Rp-----s~~~~l~~l~~~  179 (220)
                      |++||     ++++++.+-+..
T Consensus       244 P~~R~~~~~~~~~~l~~~~~~~  265 (285)
T cd05605         244 PGFRLGCRGEGAEEVKAHPFFR  265 (285)
T ss_pred             HHHhcCCCCCCHHHHhcCcCcc
Confidence            99999     899999875443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=2.4e-26  Score=179.77  Aligned_cols=157  Identities=24%  Similarity=0.338  Sum_probs=116.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++........  ......++..|++||.+.+
T Consensus       101 ~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~Pe~~~~  175 (262)
T cd06613         101 LQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA--KRKSFIGTPYWMAPEVAAV  175 (262)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh--ccccccCCccccCchhhcc
Confidence            356789999999999999999   99999999999999999999999998765432211  1122355678999999877


Q ss_pred             C---CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           82 G---FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        82 ~---~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                      .   .++.++|+||||+++|+|++|..||...........      .. ....     ..............+.+++.+|
T Consensus       176 ~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~------~~-~~~~-----~~~~~~~~~~~~~~~~~li~~~  243 (262)
T cd06613         176 ERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL------IS-KSNF-----PPPKLKDKEKWSPVFHDFIKKC  243 (262)
T ss_pred             cccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HH-hccC-----CCccccchhhhhHHHHHHHHHH
Confidence            6   788999999999999999999999864432221110      00 0000     0011112233456788999999


Q ss_pred             cCCCCCCCCCHHHHHHH
Q 027675          159 VQEDPNDRPTMSDVVIM  175 (220)
Q Consensus       159 l~~~p~~Rps~~~~l~~  175 (220)
                      |..+|.+||++.+++.+
T Consensus       244 l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         244 LTKDPKKRPTATKLLQH  260 (262)
T ss_pred             cCCChhhCCCHHHHhcC
Confidence            99999999999999865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.94  E-value=2.5e-26  Score=188.76  Aligned_cols=159  Identities=21%  Similarity=0.195  Sum_probs=114.5

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+..++.|++.||+|||+++   |+||||||+||+++.++.++|+|||++......... ......|++.|+|||.+.+.
T Consensus       143 ~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~  218 (370)
T cd05621         143 WAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV-RCDTAVGTPDYISPEVLKSQ  218 (370)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecccCCce-ecccCCCCcccCCHHHHhcc
Confidence            46778999999999999999   999999999999999999999999998764322111 11234678999999998764


Q ss_pred             C----CcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           83 F----FSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        83 ~----~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                      .    ++.++|+|||||++|+|++|..||...+.....      .+.........       ..........+.+++..|
T Consensus       219 ~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~------~~i~~~~~~~~-------~p~~~~~s~~~~~li~~~  285 (370)
T cd05621         219 GGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTY------SKIMDHKNSLN-------FPEDVEISKHAKNLICAF  285 (370)
T ss_pred             CCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHH------HHHHhCCcccC-------CCCcccCCHHHHHHHHHH
Confidence            3    678999999999999999999999754432221      11111111111       111112234567788888


Q ss_pred             cCCCCCC--CCCHHHHHHHhcC
Q 027675          159 VQEDPND--RPTMSDVVIMLGS  178 (220)
Q Consensus       159 l~~~p~~--Rps~~~~l~~l~~  178 (220)
                      |..++.+  |+++.+++++-+.
T Consensus       286 L~~~~~r~~R~~~~e~l~hp~~  307 (370)
T cd05621         286 LTDREVRLGRNGVEEIKQHPFF  307 (370)
T ss_pred             ccCchhccCCCCHHHHhcCccc
Confidence            8765544  8999999988644

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.94  E-value=9e-27  Score=184.49  Aligned_cols=170  Identities=19%  Similarity=0.261  Sum_probs=114.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|+++||.|||+.+   ++|+||||+||+++.++.++|+|||++.........  .....++..|+|||.+.+
T Consensus        99 ~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~  173 (284)
T cd07839          99 EIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFG  173 (284)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC--cCCCccccCCcChHHHhC
Confidence            357889999999999999999   999999999999999999999999988654322111  112345678999999876


Q ss_pred             C-CCcccCceeehhHHHHHHHhcCccCcccch-hHHHhhH-HH-------HHHHHHhccccccccCCCC----CcCcHHH
Q 027675           82 G-FFSVKSDVFSFGVVVLEIISGKRNTGFYNS-ELALSLL-GY-------AWKLWQEGKALDMMDQKPG----AISKANE  147 (220)
Q Consensus        82 ~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~-~~~~~~~-~~-------~~~~~~~~~~~~~~~~~~~----~~~~~~~  147 (220)
                      . .++.++|+||||+++|+|++|..|+..... ....... ..       .+.................    .......
T Consensus       174 ~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (284)
T cd07839         174 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKL  253 (284)
T ss_pred             CcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccC
Confidence            4 468899999999999999999888532222 1111100 00       0000000000000000000    0001123


Q ss_pred             HHHHHHHhccccCCCCCCCCCHHHHHHHh
Q 027675          148 ILKCINVGLLCVQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       148 ~~~~~~li~~cl~~~p~~Rps~~~~l~~l  176 (220)
                      ...+.+++.+||+.||.+|||+++++.+-
T Consensus       254 ~~~~~~li~~~l~~~P~~R~t~~~il~h~  282 (284)
T cd07839         254 NSTGRDLLQNLLVCNPVQRISAEEALQHP  282 (284)
T ss_pred             CHHHHHHHHHHhcCChhhcCCHHHHhcCC
Confidence            45678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.94  E-value=2.7e-26  Score=181.97  Aligned_cols=165  Identities=22%  Similarity=0.340  Sum_probs=116.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCC-cccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD-GTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~y~aPe~~~   80 (220)
                      .+++.++.+++.||+|||+++   ++||||||+||+++.++.++|+|||++......... .......++..|.|||.+.
T Consensus       109 ~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~  185 (284)
T cd05079         109 KQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI  185 (284)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhc
Confidence            457889999999999999999   999999999999999999999999998754322111 1112234556799999998


Q ss_pred             cCCCcccCceeehhHHHHHHHhcCccCcccchhH--------HHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHH
Q 027675           81 GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSEL--------ALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCI  152 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (220)
                      +..++.++|+||||+++|+|+++..|........        ..............+....         ........+.
T Consensus       186 ~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~  256 (284)
T cd05079         186 QSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLP---------RPPNCPEEVY  256 (284)
T ss_pred             cCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCccCC---------CCCCCCHHHH
Confidence            8888999999999999999999776532110000        0000000111111111110         0111345788


Q ss_pred             HHhccccCCCCCCCCCHHHHHHHhcC
Q 027675          153 NVGLLCVQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       153 ~li~~cl~~~p~~Rps~~~~l~~l~~  178 (220)
                      +++.+||+.+|++||+++++++.++.
T Consensus       257 ~li~~~l~~~p~~Rpt~~~il~~l~~  282 (284)
T cd05079         257 QLMRKCWEFQPSKRTTFQNLIEGFEA  282 (284)
T ss_pred             HHHHHHccCCcccCcCHHHHHHHHHh
Confidence            99999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.94  E-value=2.6e-26  Score=182.72  Aligned_cols=159  Identities=22%  Similarity=0.319  Sum_probs=116.2

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhh-
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL-   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~-   80 (220)
                      ..++.++.|++.+|.|||+.+   ++|+||||+||+++.++.++|+|||++.......  .......++..|+|||.+. 
T Consensus       110 ~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~  184 (292)
T cd06644         110 PQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--QRRDSFIGTPYWMAPEVVMC  184 (292)
T ss_pred             HHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc--cccceecCCccccCceeecc
Confidence            357889999999999999999   9999999999999999999999999876432211  1122345677899999874 


Q ss_pred             ----cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhc
Q 027675           81 ----GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGL  156 (220)
Q Consensus        81 ----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  156 (220)
                          ...++.++|+|||||++|+|++|..||...+.....      .+.. ...       .+...........+.+++.
T Consensus       185 ~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~------~~~~-~~~-------~~~~~~~~~~~~~~~~li~  250 (292)
T cd06644         185 ETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL------LKIA-KSE-------PPTLSQPSKWSMEFRDFLK  250 (292)
T ss_pred             ccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHH------HHHh-cCC-------CccCCCCcccCHHHHHHHH
Confidence                334678899999999999999999998654432211      0110 100       0011111123346788999


Q ss_pred             cccCCCCCCCCCHHHHHHHhcCc
Q 027675          157 LCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       157 ~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      +||..+|++||++++++++-...
T Consensus       251 ~~l~~~p~~Rp~~~~il~~~~~~  273 (292)
T cd06644         251 TALDKHPETRPSAAQLLEHPFVS  273 (292)
T ss_pred             HHhcCCcccCcCHHHHhcCcccc
Confidence            99999999999999999875433

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.94  E-value=1.2e-26  Score=183.73  Aligned_cols=153  Identities=24%  Similarity=0.355  Sum_probs=112.8

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhh--
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL--   80 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~--   80 (220)
                      .++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........  ......++..|+|||.+.  
T Consensus       122 ~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~  196 (282)
T cd06636         122 WIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACD  196 (282)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcc
Confidence            46778899999999999999   99999999999999999999999998764322111  112245678899999875  


Q ss_pred             ---cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcc
Q 027675           81 ---GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLL  157 (220)
Q Consensus        81 ---~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  157 (220)
                         +..++.++|+||||+++|+|++|..||..........      ... .        ..............+.++|.+
T Consensus       197 ~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~------~~~-~--------~~~~~~~~~~~~~~~~~li~~  261 (282)
T cd06636         197 ENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF------LIP-R--------NPPPKLKSKKWSKKFIDFIEG  261 (282)
T ss_pred             cCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh------hHh-h--------CCCCCCcccccCHHHHHHHHH
Confidence               2356789999999999999999999985433211110      000 0        000111111233478899999


Q ss_pred             ccCCCCCCCCCHHHHHHH
Q 027675          158 CVQEDPNDRPTMSDVVIM  175 (220)
Q Consensus       158 cl~~~p~~Rps~~~~l~~  175 (220)
                      ||..||.+||++.+++++
T Consensus       262 cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         262 CLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             HhCCChhhCcCHHHHhcC
Confidence            999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.94  E-value=1.5e-26  Score=181.46  Aligned_cols=148  Identities=23%  Similarity=0.330  Sum_probs=109.1

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCC-------ceecCccceeeecCCCCCcccceeecccCcc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMN-------PKISDFGLTRIFEGKQTDGTTNRVVGTYGYM   74 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~-------~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~   74 (220)
                      ..+++++.|+++||.|||+++   ++||||||+||+++.++.       ++++|||++......      ....++..|+
T Consensus       105 ~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~  175 (262)
T cd05077         105 PWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR------QECVERIPWI  175 (262)
T ss_pred             HHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc------cccccccccc
Confidence            356889999999999999999   999999999999987654       799999987543211      1134567899


Q ss_pred             Chhhhh-cCCCcccCceeehhHHHHHHH-hcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHH
Q 027675           75 SPEYAL-GGFFSVKSDVFSFGVVVLEII-SGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCI  152 (220)
Q Consensus        75 aPe~~~-~~~~~~~~DiwslG~il~~ll-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (220)
                      |||.+. +..++.++||||||+++|+|+ .|..|+..........        ...+.. ..     ..    .....+.
T Consensus       176 aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~--------~~~~~~-~~-----~~----~~~~~~~  237 (262)
T cd05077         176 APECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER--------FYEGQC-ML-----VT----PSCKELA  237 (262)
T ss_pred             ChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH--------HHhcCc-cC-----CC----CChHHHH
Confidence            999886 456788999999999999998 5777775432211110        001110 00     00    1123678


Q ss_pred             HHhccccCCCCCCCCCHHHHHHHh
Q 027675          153 NVGLLCVQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       153 ~li~~cl~~~p~~Rps~~~~l~~l  176 (220)
                      ++|.+||+.||++||++.+++..+
T Consensus       238 ~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         238 DLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             HHHHHHcCCChhhCcCHHHHHHhc
Confidence            899999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.94  E-value=2.8e-26  Score=178.77  Aligned_cols=155  Identities=34%  Similarity=0.497  Sum_probs=116.7

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+++.++.|++.||.+||+.+   ++|+||+|+||+++.++.++|+|||++............ ...++..|++||.+.+
T Consensus       103 ~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~  178 (258)
T smart00219      103 SDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKK-GGKLPIRWMAPESLKD  178 (258)
T ss_pred             HHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccccccccc-cCCCcccccChHHhcc
Confidence            357889999999999999999   999999999999999999999999998765433211111 1224678999999988


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++++|++ |..||...+.......       ...+.....    +     ......+.+++.+||+
T Consensus       179 ~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~-------~~~~~~~~~----~-----~~~~~~~~~~i~~~l~  242 (258)
T smart00219      179 GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEY-------LKKGYRLPK----P-----ENCPPEIYKLMLQCWA  242 (258)
T ss_pred             CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HhcCCCCCC----C-----CcCCHHHHHHHHHHCc
Confidence            888999999999999999998 7888765333222211       111111111    1     1134468889999999


Q ss_pred             CCCCCCCCHHHHHHHh
Q 027675          161 EDPNDRPTMSDVVIML  176 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l  176 (220)
                      .+|++|||+.++++.|
T Consensus       243 ~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      243 EDPEDRPTFSELVEIL  258 (258)
T ss_pred             CChhhCcCHHHHHhhC
Confidence            9999999999999764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=1.7e-26  Score=189.37  Aligned_cols=158  Identities=22%  Similarity=0.221  Sum_probs=114.7

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCc--------------------
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG--------------------   62 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~--------------------   62 (220)
                      .+..++.|++.||+|||+++   ++||||||+||+++.++.++|+|||++..........                    
T Consensus       102 ~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (364)
T cd05599         102 ETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKP  178 (364)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccccccccccccccccccccccccccc
Confidence            56789999999999999999   9999999999999999999999999886432111000                    


Q ss_pred             ----------------ccceeecccCccChhhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHH
Q 027675           63 ----------------TTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLW  126 (220)
Q Consensus        63 ----------------~~~~~~~~~~y~aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~  126 (220)
                                      ......|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+......      ...
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~------~i~  252 (364)
T cd05599         179 MSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYR------KII  252 (364)
T ss_pred             ccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHH------HHH
Confidence                            0011357889999999988889999999999999999999999997544322211      111


Q ss_pred             HhccccccccCCCCCcCcHHHHHHHHHHhccccCCCCCCCCC---HHHHHHHhc
Q 027675          127 QEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPT---MSDVVIMLG  177 (220)
Q Consensus       127 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps---~~~~l~~l~  177 (220)
                      ........   ...    ......+.++|.+|+. +|.+|++   +++++.+-+
T Consensus       253 ~~~~~~~~---~~~----~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~  298 (364)
T cd05599         253 NWKETLQF---PDE----VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPF  298 (364)
T ss_pred             cCCCccCC---CCC----CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCC
Confidence            10111100   011    1123366788888986 9999998   999998754

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.94  E-value=2.1e-26  Score=188.11  Aligned_cols=170  Identities=21%  Similarity=0.204  Sum_probs=118.7

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+..++.|++.||+|||++|   ++||||||+||+++.++.++|+|||++........   .....++..|+|||.+.+.
T Consensus       119 ~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~  192 (353)
T cd07850         119 RMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGM  192 (353)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeCCCCCC---CCCCcccccccCHHHHhCC
Confidence            56778999999999999999   99999999999999999999999999875432211   1223457789999999998


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHH----------------HHHHHHhcccc------cccc----
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGY----------------AWKLWQEGKAL------DMMD----  136 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~----------------~~~~~~~~~~~------~~~~----  136 (220)
                      .++.++|+||||+++|+|++|+.||...+..........                ...........      ....    
T Consensus       193 ~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (353)
T cd07850         193 GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLF  272 (353)
T ss_pred             CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCccccc
Confidence            899999999999999999999999865443221111000                00000000000      0000    


Q ss_pred             CCCCCcCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcC
Q 027675          137 QKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       137 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~  178 (220)
                      ..............+.++|.+||+.||++|||+.+++.+=+.
T Consensus       273 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~  314 (353)
T cd07850         273 PPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYI  314 (353)
T ss_pred             CcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhH
Confidence            000000011234467899999999999999999999977543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.94  E-value=7.4e-27  Score=176.59  Aligned_cols=153  Identities=25%  Similarity=0.419  Sum_probs=116.3

Q ss_pred             HHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc---C
Q 027675            6 NIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG---G   82 (220)
Q Consensus         6 ~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~---~   82 (220)
                      ++...+++||.||-.+.  .++|||+||+|||++..|++||||||.+-+......   .....|-+.|+|||.+.-   .
T Consensus       195 k~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA---htrsAGC~~YMaPERidp~~~~  269 (391)
T KOG0983|consen  195 KMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA---HTRSAGCAAYMAPERIDPPDKP  269 (391)
T ss_pred             hhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc---cccccCCccccCccccCCCCCC
Confidence            45677899999998765  499999999999999999999999999876543322   333567889999999853   3


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      .|+.++|+||||+.++||.||..||...+-+...     ..++..+        .++........+..+++++..||..|
T Consensus       270 kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~-----ltkvln~--------ePP~L~~~~gFSp~F~~fv~~CL~kd  336 (391)
T KOG0983|consen  270 KYDIRADVWSLGITLVELATGQYPYKGCKTDFEV-----LTKVLNE--------EPPLLPGHMGFSPDFQSFVKDCLTKD  336 (391)
T ss_pred             ccchhhhhhhhccchhhhhcccCCCCCCCccHHH-----HHHHHhc--------CCCCCCcccCcCHHHHHHHHHHhhcC
Confidence            5889999999999999999999999864433221     1222221        11222222225668899999999999


Q ss_pred             CCCCCCHHHHHHHh
Q 027675          163 PNDRPTMSDVVIML  176 (220)
Q Consensus       163 p~~Rps~~~~l~~l  176 (220)
                      +.+||...+++++=
T Consensus       337 ~r~RP~Y~~Ll~h~  350 (391)
T KOG0983|consen  337 HRKRPKYNKLLEHP  350 (391)
T ss_pred             cccCcchHHHhcCc
Confidence            99999999999774

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.94  E-value=1.3e-26  Score=184.94  Aligned_cols=157  Identities=22%  Similarity=0.307  Sum_probs=117.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +++..++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........  ......++..|+|||.+.+
T Consensus       115 ~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~  189 (296)
T cd06655         115 AQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTR  189 (296)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc--cCCCcCCCccccCcchhcC
Confidence            467889999999999999999   99999999999999999999999998764332211  1112346778999999988


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+|||||++|++++|..||...+.......      .. ..... .      ..........+.++|.+||..
T Consensus       190 ~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~------~~-~~~~~-~------~~~~~~~~~~~~~li~~~l~~  255 (296)
T cd06655         190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IA-TNGTP-E------LQNPEKLSPIFRDFLNRCLEM  255 (296)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HH-hcCCc-c------cCCcccCCHHHHHHHHHHhhc
Confidence            8889999999999999999999999865443222110      00 01100 0      001111233677899999999


Q ss_pred             CCCCCCCHHHHHHHhc
Q 027675          162 DPNDRPTMSDVVIMLG  177 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~  177 (220)
                      +|++||++.+++.+=+
T Consensus       256 dp~~Rpt~~~il~~~~  271 (296)
T cd06655         256 DVEKRGSAKELLQHPF  271 (296)
T ss_pred             ChhhCCCHHHHhhChH
Confidence            9999999999996643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.94  E-value=1.2e-26  Score=183.83  Aligned_cols=168  Identities=21%  Similarity=0.268  Sum_probs=113.5

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .++.++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||++........  ......++..|+|||.+.+.
T Consensus       102 ~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~  176 (285)
T cd07861         102 LVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR--VYTHEVVTLWYRAPEVLLGS  176 (285)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc--cccCCcccccccChHHhcCC
Confidence            56789999999999999999   99999999999999999999999999865432211  11122456789999988764


Q ss_pred             -CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhH-HHH----HHHHHhccccc----cccCCCC---CcCcHHHHH
Q 027675           83 -FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLL-GYA----WKLWQEGKALD----MMDQKPG---AISKANEIL  149 (220)
Q Consensus        83 -~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~-~~~----~~~~~~~~~~~----~~~~~~~---~~~~~~~~~  149 (220)
                       .++.++|+||||+++|+|++|+.||............ ...    ...+.......    .......   .........
T Consensus       177 ~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (285)
T cd07861         177 PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDE  256 (285)
T ss_pred             CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCH
Confidence             4688999999999999999999998754332111100 000    00000000000    0000000   000011234


Q ss_pred             HHHHHhccccCCCCCCCCCHHHHHHH
Q 027675          150 KCINVGLLCVQEDPNDRPTMSDVVIM  175 (220)
Q Consensus       150 ~~~~li~~cl~~~p~~Rps~~~~l~~  175 (220)
                      .+.++|.+||..||++|||+.+++.+
T Consensus       257 ~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         257 DGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             HHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            66799999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.94  E-value=1.9e-26  Score=179.86  Aligned_cols=155  Identities=31%  Similarity=0.435  Sum_probs=116.2

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +.++.++.+++.|+++||+.+   ++|+||||+||+++.++.++|+|||++......... .......+..|+|||.+.+
T Consensus       100 ~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~~aPe~~~~  175 (256)
T cd05112         100 ETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-SSTGTKFPVKWSSPEVFSF  175 (256)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc-ccCCCccchhhcCHhHhcc
Confidence            357889999999999999999   999999999999999999999999988754322111 1111223457999999988


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++|+|++ |..||...........       ...+...  .  .+..     ....+.+++.+||+
T Consensus       176 ~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~-------~~~~~~~--~--~~~~-----~~~~~~~l~~~~l~  239 (256)
T cd05112         176 SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVET-------INAGFRL--Y--KPRL-----ASQSVYELMQHCWK  239 (256)
T ss_pred             CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH-------HhCCCCC--C--CCCC-----CCHHHHHHHHHHcc
Confidence            888999999999999999998 8999865443322111       1111110  0  0111     23478899999999


Q ss_pred             CCCCCCCCHHHHHHHh
Q 027675          161 EDPNDRPTMSDVVIML  176 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l  176 (220)
                      .+|++||++.++++.|
T Consensus       240 ~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         240 ERPEDRPSFSLLLHQL  255 (256)
T ss_pred             cChhhCCCHHHHHHhh
Confidence            9999999999999886

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.94  E-value=1.9e-26  Score=181.02  Aligned_cols=154  Identities=29%  Similarity=0.454  Sum_probs=115.5

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCC----CcccceeecccCccChhh
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT----DGTTNRVVGTYGYMSPEY   78 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~y~aPe~   78 (220)
                      .+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++........    ........++..|+|||.
T Consensus       107 ~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~  183 (267)
T cd06628         107 LVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEV  183 (267)
T ss_pred             HHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhH
Confidence            46789999999999999999   99999999999999999999999998875542111    011112346778999999


Q ss_pred             hhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           79 ALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        79 ~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                      +.+..++.++|+||||+++|+|++|..||...+.....      .... .....       .  ........+.++|.+|
T Consensus       184 ~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~------~~~~-~~~~~-------~--~~~~~~~~~~~li~~~  247 (267)
T cd06628         184 VKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI------FKIG-ENASP-------E--IPSNISSEAIDFLEKT  247 (267)
T ss_pred             hccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH------HHHh-ccCCC-------c--CCcccCHHHHHHHHHH
Confidence            98888889999999999999999999999753322111      0000 00000       0  1112334778899999


Q ss_pred             cCCCCCCCCCHHHHHHH
Q 027675          159 VQEDPNDRPTMSDVVIM  175 (220)
Q Consensus       159 l~~~p~~Rps~~~~l~~  175 (220)
                      |+.+|++||++.+++++
T Consensus       248 l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         248 FEIDHNKRPTAAELLKH  264 (267)
T ss_pred             ccCCchhCcCHHHHhhC
Confidence            99999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.94  E-value=2.3e-26  Score=181.90  Aligned_cols=166  Identities=25%  Similarity=0.377  Sum_probs=118.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCC-cccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD-GTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~y~aPe~~~   80 (220)
                      ..++.++.|++.||+|||+++   ++|+||||+||+++.++.++|+|||.+......... .......++..|.+||.+.
T Consensus       109 ~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~  185 (284)
T cd05038         109 KRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR  185 (284)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHc
Confidence            457889999999999999999   999999999999999999999999998765422111 1111123345699999998


Q ss_pred             cCCCcccCceeehhHHHHHHHhcCccCcccchhHHH--------hhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHH
Q 027675           81 GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELAL--------SLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCI  152 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (220)
                      +..++.++|+||||+++++|++|..|+.........        ............+...         .........+.
T Consensus       186 ~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~  256 (284)
T cd05038         186 TSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERL---------PRPPSCPDEVY  256 (284)
T ss_pred             cCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCCcC---------CCCccCCHHHH
Confidence            888899999999999999999999887532211100        0011111111111111         11112235788


Q ss_pred             HHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          153 NVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       153 ~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      +++.+||..+|++||++.++++.|...
T Consensus       257 ~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         257 DLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.94  E-value=1.6e-26  Score=181.44  Aligned_cols=157  Identities=24%  Similarity=0.344  Sum_probs=113.7

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhh--
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL--   80 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~--   80 (220)
                      .+..++.|++.||.|||+.+   ++|+|++|+||+++.++.++|+|||++........  ......++..|+|||.+.  
T Consensus       107 ~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~  181 (267)
T cd06646         107 QIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA--KRKSFIGTPYWMAPEVAAVE  181 (267)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc--ccCccccCccccCHhHcccc
Confidence            56778999999999999999   99999999999999999999999999875432211  112235677899999874  


Q ss_pred             -cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           81 -GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        81 -~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                       ...++.++|+||||+++|+|++|+.||...........       ....    ... .+...........+.++|.+||
T Consensus       182 ~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~-------~~~~----~~~-~~~~~~~~~~~~~~~~li~~~l  249 (267)
T cd06646         182 KNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL-------MSKS----NFQ-PPKLKDKTKWSSTFHNFVKISL  249 (267)
T ss_pred             cCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee-------eecC----CCC-CCCCccccccCHHHHHHHHHHh
Confidence             33467899999999999999999999753221111000       0000    000 0111111123457889999999


Q ss_pred             CCCCCCCCCHHHHHHHh
Q 027675          160 QEDPNDRPTMSDVVIML  176 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l  176 (220)
                      ..+|++||+++++++++
T Consensus       250 ~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         250 TKNPKKRPTAERLLTHL  266 (267)
T ss_pred             hCChhhCcCHHHHhcCC
Confidence            99999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.93  E-value=2e-26  Score=184.01  Aligned_cols=159  Identities=23%  Similarity=0.304  Sum_probs=118.6

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++........  ......++..|+|||.+.+
T Consensus       117 ~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~  191 (297)
T cd06659         117 EQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISR  191 (297)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cccceecCccccCHHHHcc
Confidence            357889999999999999999   99999999999999999999999998764332111  1122456789999999988


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+||||+++|+|++|+.||...........       .....     .....  ........+.+++.+||+.
T Consensus       192 ~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~-------~~~~~-----~~~~~--~~~~~~~~l~~~i~~~l~~  257 (297)
T cd06659         192 TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR-------LRDSP-----PPKLK--NAHKISPVLRDFLERMLTR  257 (297)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------HhccC-----CCCcc--ccCCCCHHHHHHHHHHhcC
Confidence            8889999999999999999999999864433222111       00100     00000  0111234578899999999


Q ss_pred             CCCCCCCHHHHHHHhcCc
Q 027675          162 DPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~~~  179 (220)
                      +|++||++++++++-...
T Consensus       258 ~P~~Rps~~~ll~~~~~~  275 (297)
T cd06659         258 EPQERATAQELLDHPFLL  275 (297)
T ss_pred             CcccCcCHHHHhhChhhc
Confidence            999999999999875444

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.93  E-value=9.3e-27  Score=186.10  Aligned_cols=172  Identities=19%  Similarity=0.211  Sum_probs=117.1

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+..++.|+++||.|||+.+   ++|+||||+||+++.++.++|+|||++.........  .....++..|+|||.+.+.
T Consensus       105 ~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~  179 (301)
T cd07873         105 NVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--YSNEVVTLWYRPPDILLGS  179 (301)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc--ccccceeecccCcHHHhCC
Confidence            56788999999999999999   999999999999999999999999988653321111  1123457789999998764


Q ss_pred             -CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHH--------HHHHHhccccccccCCCCCc-----CcHHHH
Q 027675           83 -FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA--------WKLWQEGKALDMMDQKPGAI-----SKANEI  148 (220)
Q Consensus        83 -~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~-----~~~~~~  148 (220)
                       .++.++|+||||+++|+|++|+.||...+...........        +...................     ......
T Consensus       180 ~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (301)
T cd07873         180 TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLD  259 (301)
T ss_pred             CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCC
Confidence             4678999999999999999999999755443222111000        00000000000000000000     001123


Q ss_pred             HHHHHHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          149 LKCINVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       149 ~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      ..+.++|.+||..||.+|||+++++.+-+..
T Consensus       260 ~~~~~li~~ml~~dp~~R~t~~eil~h~~f~  290 (301)
T cd07873         260 SDGAELLSKLLQFEGRKRISAEEAMKHPYFH  290 (301)
T ss_pred             HHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence            3578999999999999999999999865443

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.93  E-value=2.8e-26  Score=180.34  Aligned_cols=158  Identities=28%  Similarity=0.447  Sum_probs=115.2

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceee---cccCccChhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVV---GTYGYMSPEY   78 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~---~~~~y~aPe~   78 (220)
                      .+++.++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++................   .+..|++||.
T Consensus       106 ~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~  182 (269)
T cd05065         106 IQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA  182 (269)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhH
Confidence            357889999999999999999   9999999999999999999999999876543221111111111   1346999999


Q ss_pred             hhcCCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcc
Q 027675           79 ALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLL  157 (220)
Q Consensus        79 ~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  157 (220)
                      +.+..++.++|+||||+++|++++ |..||..........      .. .......     .    .......+.+++.+
T Consensus       183 ~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~------~i-~~~~~~~-----~----~~~~~~~~~~li~~  246 (269)
T cd05065         183 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIN------AI-EQDYRLP-----P----PMDCPTALHQLMLD  246 (269)
T ss_pred             hccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHH------HH-HcCCcCC-----C----cccCCHHHHHHHHH
Confidence            988888999999999999999886 998886443322111      11 1111000     0    01123467889999


Q ss_pred             ccCCCCCCCCCHHHHHHHhcC
Q 027675          158 CVQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       158 cl~~~p~~Rps~~~~l~~l~~  178 (220)
                      ||+.+|++||++.+++..|+.
T Consensus       247 ~l~~~p~~Rp~~~~i~~~l~~  267 (269)
T cd05065         247 CWQKDRNARPKFGQIVSTLDK  267 (269)
T ss_pred             HcCCChhhCcCHHHHHHHHHh
Confidence            999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=2.4e-26  Score=181.25  Aligned_cols=157  Identities=26%  Similarity=0.394  Sum_probs=118.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++........  ......++..|++||.+.+
T Consensus        98 ~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~  172 (274)
T cd06609          98 TYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS--KRNTFVGTPFWMAPEVIKQ  172 (274)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc--ccccccCCccccChhhhcc
Confidence            467889999999999999999   99999999999999999999999999876543221  1222456778999999998


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+||||+++|+|++|..||...+.....       .....+...        ..........+.+++.+||..
T Consensus       173 ~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~-------~~~~~~~~~--------~~~~~~~~~~~~~~l~~~l~~  237 (274)
T cd06609         173 SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL-------FLIPKNNPP--------SLEGNKFSKPFKDFVSLCLNK  237 (274)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHH-------HHhhhcCCC--------CCcccccCHHHHHHHHHHhhC
Confidence            88999999999999999999999998654322111       001111000        000001334678899999999


Q ss_pred             CCCCCCCHHHHHHHhcC
Q 027675          162 DPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~~  178 (220)
                      +|++||++++++++-+-
T Consensus       238 ~p~~Rpt~~~il~~~~~  254 (274)
T cd06609         238 DPKERPSAKELLKHKFI  254 (274)
T ss_pred             ChhhCcCHHHHhhChhh
Confidence            99999999999976533

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.93  E-value=4.4e-26  Score=187.36  Aligned_cols=159  Identities=21%  Similarity=0.204  Sum_probs=114.1

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+..++.|++.||.|||+++   |+||||||+||+++.++.++|+|||++......... ......|++.|+|||.+.+.
T Consensus       143 ~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~  218 (371)
T cd05622         143 WARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQ  218 (371)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc-cccCcccCccccCHHHHhcc
Confidence            45678899999999999999   999999999999999999999999998754322111 11234678999999998754


Q ss_pred             C----CcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           83 F----FSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        83 ~----~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                      .    ++.++|+|||||++|+|++|..||...+.....      .+..........       .........+.++|..|
T Consensus       219 ~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~------~~i~~~~~~~~~-------~~~~~~s~~~~~li~~~  285 (371)
T cd05622         219 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY------SKIMNHKNSLTF-------PDDNDISKEAKNLICAF  285 (371)
T ss_pred             CCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHH------HHHHcCCCcccC-------CCcCCCCHHHHHHHHHH
Confidence            2    678999999999999999999999754432211      111111111111       11112334667888889


Q ss_pred             cCCCCCC--CCCHHHHHHHhcC
Q 027675          159 VQEDPND--RPTMSDVVIMLGS  178 (220)
Q Consensus       159 l~~~p~~--Rps~~~~l~~l~~  178 (220)
                      |..++.+  |+++++++++.+.
T Consensus       286 L~~~~~r~~r~~~~ei~~h~~~  307 (371)
T cd05622         286 LTDREVRLGRNGVEEIKRHLFF  307 (371)
T ss_pred             cCChhhhcCCCCHHHHhcCccc
Confidence            9744443  7899999988754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.93  E-value=3.4e-26  Score=178.58  Aligned_cols=149  Identities=23%  Similarity=0.333  Sum_probs=112.0

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCC-------CceecCccceeeecCCCCCcccceeecccCcc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEM-------NPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM   74 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~-------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~   74 (220)
                      ..++.++.|++.||.|||+++   ++|+||||+||+++.++       .++++|||++.....      .....+...|+
T Consensus       101 ~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~~~~y~  171 (259)
T cd05037         101 HWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS------REERVERIPWI  171 (259)
T ss_pred             HHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCccccccc------ccccccCCCcc
Confidence            357889999999999999999   99999999999999887       799999998865332      11234456899


Q ss_pred             ChhhhhcC--CCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHH
Q 027675           75 SPEYALGG--FFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKC  151 (220)
Q Consensus        75 aPe~~~~~--~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (220)
                      |||.+.+.  .++.++|+||||+++|++++ |..||...........       ......      .+...     ...+
T Consensus       172 aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~-------~~~~~~------~~~~~-----~~~~  233 (259)
T cd05037         172 APECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF-------YQDQHR------LPMPD-----CAEL  233 (259)
T ss_pred             ChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHH-------HhcCCC------CCCCC-----chHH
Confidence            99998876  67899999999999999998 5666654332211110       000000      00000     1578


Q ss_pred             HHHhccccCCCCCCCCCHHHHHHHhc
Q 027675          152 INVGLLCVQEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       152 ~~li~~cl~~~p~~Rps~~~~l~~l~  177 (220)
                      .+++.+||..+|++||++.++++.|.
T Consensus       234 ~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         234 ANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             HHHHHHHhccChhhCCCHHHHHHhcC
Confidence            89999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.93  E-value=4.2e-26  Score=179.15  Aligned_cols=154  Identities=25%  Similarity=0.363  Sum_probs=111.1

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCC-CcccceeecccCccChhhhhc
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT-DGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++........ ........++..|.|||.+.+
T Consensus       107 ~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  183 (266)
T cd06651         107 VTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG  183 (266)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCC
Confidence            45678999999999999999   99999999999999999999999998764322111 111112346778999999988


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+||||+++|++++|+.||.........      .+......         ...........+.+++ +||..
T Consensus       184 ~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~------~~~~~~~~---------~~~~~~~~~~~~~~li-~~~~~  247 (266)
T cd06651         184 EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI------FKIATQPT---------NPQLPSHISEHARDFL-GCIFV  247 (266)
T ss_pred             CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH------HHHhcCCC---------CCCCchhcCHHHHHHH-HHhcC
Confidence            88899999999999999999999998643222111      01000000         0111112223455555 68889


Q ss_pred             CCCCCCCHHHHHHH
Q 027675          162 DPNDRPTMSDVVIM  175 (220)
Q Consensus       162 ~p~~Rps~~~~l~~  175 (220)
                      +|++||++++++.+
T Consensus       248 ~p~~Rp~~~eil~h  261 (266)
T cd06651         248 EARHRPSAEELLRH  261 (266)
T ss_pred             ChhhCcCHHHHhcC
Confidence            99999999999876

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.93  E-value=3.5e-26  Score=181.55  Aligned_cols=157  Identities=25%  Similarity=0.303  Sum_probs=116.8

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++........   .....++..|+|||.+.+.
T Consensus       103 ~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~  176 (285)
T cd05630         103 RAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNE  176 (285)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc---ccCCCCCccccChHHHcCC
Confidence            56788999999999999999   99999999999999999999999998865432211   1123578899999999988


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      .++.++|+||+|+++|+|++|..||............   ........     ..     ........+.+++..||+.|
T Consensus       177 ~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~---~~~~~~~~-----~~-----~~~~~~~~~~~li~~~l~~~  243 (285)
T cd05630         177 RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---ERLVKEVQ-----EE-----YSEKFSPDARSLCKMLLCKD  243 (285)
T ss_pred             CCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH---Hhhhhhhh-----hh-----cCccCCHHHHHHHHHHhhcC
Confidence            8999999999999999999999999753322111110   01100000     00     00112335788999999999


Q ss_pred             CCCCCC-----HHHHHHHhcC
Q 027675          163 PNDRPT-----MSDVVIMLGS  178 (220)
Q Consensus       163 p~~Rps-----~~~~l~~l~~  178 (220)
                      |++|||     +++++++-+.
T Consensus       244 p~~R~s~~~~~~~~~~~h~~~  264 (285)
T cd05630         244 PKERLGCQGGGAREVKEHPLF  264 (285)
T ss_pred             HHHccCCCCCchHHHHcChhh
Confidence            999999     8999986544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.93  E-value=3.7e-26  Score=179.74  Aligned_cols=160  Identities=16%  Similarity=0.268  Sum_probs=109.8

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc-
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG-   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~-   81 (220)
                      .++.++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++................++..|+|||.+.. 
T Consensus       100 ~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  176 (268)
T cd05086         100 LLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEF  176 (268)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccc
Confidence            35688999999999999999   99999999999999999999999998753221111111122345678999998743 


Q ss_pred             ------CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHH
Q 027675           82 ------GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINV  154 (220)
Q Consensus        82 ------~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  154 (220)
                            ..++.++|+||||+++|+|++ +..||..........      +.... ......++.....    ....+.++
T Consensus       177 ~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~------~~~~~-~~~~~~~~~~~~~----~~~~~~~l  245 (268)
T cd05086         177 HGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLN------HVIKD-QQVKLFKPQLELP----YSERWYEV  245 (268)
T ss_pred             cCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHH------HHHhh-cccccCCCccCCC----CcHHHHHH
Confidence                  235678999999999999997 466775443322111      11111 1111111111111    22356778


Q ss_pred             hccccCCCCCCCCCHHHHHHHhc
Q 027675          155 GLLCVQEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       155 i~~cl~~~p~~Rps~~~~l~~l~  177 (220)
                      +..|| .+|++||+++++++.|.
T Consensus       246 ~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         246 LQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             HHHHh-hCcccCCCHHHHHHHhc
Confidence            88899 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.93  E-value=2.8e-26  Score=188.88  Aligned_cols=159  Identities=22%  Similarity=0.236  Sum_probs=112.6

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCC-----------------------
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQ-----------------------   59 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~-----------------------   59 (220)
                      .+..++.|++.||+|||+++   |+||||||+||+++.++.++|+|||++..+....                       
T Consensus       102 ~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (376)
T cd05598         102 LARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS  178 (376)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccccccccccccccccccccc
Confidence            45678899999999999999   9999999999999999999999999864221000                       


Q ss_pred             ------------------CCcccceeecccCccChhhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHH
Q 027675           60 ------------------TDGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGY  121 (220)
Q Consensus        60 ------------------~~~~~~~~~~~~~y~aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~  121 (220)
                                        .........|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......   
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~---  255 (376)
T cd05598         179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLK---  255 (376)
T ss_pred             ccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHH---
Confidence                              00000124678899999999988899999999999999999999999976543322111   


Q ss_pred             HHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCCCCCCC---CHHHHHHHhcC
Q 027675          122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRP---TMSDVVIMLGS  178 (220)
Q Consensus       122 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp---s~~~~l~~l~~  178 (220)
                         ........   ......    .....+.++|.+|+ .+|.+|+   ++.+++.+-+.
T Consensus       256 ---i~~~~~~~---~~~~~~----~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~  304 (376)
T cd05598         256 ---VINWETTL---HIPSQA----KLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFF  304 (376)
T ss_pred             ---HhccCccc---cCCCCC----CCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCc
Confidence               10000000   001111    12234566677766 4999999   99999988543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.93  E-value=2.9e-26  Score=182.29  Aligned_cols=155  Identities=26%  Similarity=0.348  Sum_probs=114.2

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++........  ......++..|+|||.+..
T Consensus       128 ~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~  202 (291)
T cd06639         128 AMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIAC  202 (291)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEeecccchhcccccc--cccCccCCccccChhhhcC
Confidence            356789999999999999999   99999999999999999999999998765432111  1122346778999998764


Q ss_pred             C-----CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhc
Q 027675           82 G-----FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGL  156 (220)
Q Consensus        82 ~-----~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  156 (220)
                      .     .++.++|+||||+++|+|++|+.||..........      +. ..+....       ..........+.++|.
T Consensus       203 ~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~------~~-~~~~~~~-------~~~~~~~~~~l~~li~  268 (291)
T cd06639         203 EQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF------KI-PRNPPPT-------LLHPEKWCRSFNHFIS  268 (291)
T ss_pred             CCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHH------HH-hcCCCCC-------CCcccccCHHHHHHHH
Confidence            3     25789999999999999999999986543321110      10 0111100       0111123346889999


Q ss_pred             cccCCCCCCCCCHHHHHHH
Q 027675          157 LCVQEDPNDRPTMSDVVIM  175 (220)
Q Consensus       157 ~cl~~~p~~Rps~~~~l~~  175 (220)
                      +||+.+|++||++.+++++
T Consensus       269 ~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         269 QCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             HHhhcChhhCcCHHHHhcC
Confidence            9999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.93  E-value=4e-26  Score=180.96  Aligned_cols=156  Identities=26%  Similarity=0.336  Sum_probs=114.5

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc-
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG-   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~-   81 (220)
                      .++.++.|+++||.|||+.+   ++||||||+||+++.++.++|+|||++........  ......++..|+|||.+.. 
T Consensus       125 ~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~  199 (286)
T cd06638         125 IIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACE  199 (286)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchh
Confidence            46779999999999999999   99999999999999999999999999875432211  1122357789999998753 


Q ss_pred             ----CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcc
Q 027675           82 ----GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLL  157 (220)
Q Consensus        82 ----~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  157 (220)
                          ..++.++|+|||||++|+|++|..||..........      +. ........       .........+.++|.+
T Consensus       200 ~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~------~~-~~~~~~~~-------~~~~~~~~~~~~li~~  265 (286)
T cd06638         200 QQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF------KI-PRNPPPTL-------HQPELWSNEFNDFIRK  265 (286)
T ss_pred             hhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh------hc-cccCCCcc-------cCCCCcCHHHHHHHHH
Confidence                346889999999999999999999986433221110      00 00000000       0001123368899999


Q ss_pred             ccCCCCCCCCCHHHHHHHhc
Q 027675          158 CVQEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       158 cl~~~p~~Rps~~~~l~~l~  177 (220)
                      ||+.+|++||++.+++++..
T Consensus       266 ~l~~~p~~Rps~~ell~~~~  285 (286)
T cd06638         266 CLTKDYEKRPTVSDLLQHVF  285 (286)
T ss_pred             HccCCcccCCCHHHHhhccc
Confidence            99999999999999998763

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.93  E-value=3.3e-26  Score=179.67  Aligned_cols=157  Identities=22%  Similarity=0.300  Sum_probs=113.6

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhh-
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL-   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~-   80 (220)
                      .+++.++.|++.|+.|||+.+   ++|+||||+||+++.++.++|+|||++.......  .......++..|+|||.+. 
T Consensus       106 ~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~  180 (267)
T cd06645         106 SQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI--AKRKSFIGTPYWMAPEVAAV  180 (267)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--cccccccCcccccChhhhcc
Confidence            356789999999999999999   9999999999999999999999999986543221  1122345778999999874 


Q ss_pred             --cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           81 --GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        81 --~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                        ...++.++|+|||||++|+|++|..||..........      .........      +...........+.+++.+|
T Consensus       181 ~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~------~~~~~~~~~------~~~~~~~~~~~~~~~li~~~  248 (267)
T cd06645         181 ERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------LMTKSNFQP------PKLKDKMKWSNSFHHFVKMA  248 (267)
T ss_pred             ccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH------hhhccCCCC------CcccccCCCCHHHHHHHHHH
Confidence              3457889999999999999999999975332211110      000000000      00000111233678899999


Q ss_pred             cCCCCCCCCCHHHHHHH
Q 027675          159 VQEDPNDRPTMSDVVIM  175 (220)
Q Consensus       159 l~~~p~~Rps~~~~l~~  175 (220)
                      |+.+|++||++++++++
T Consensus       249 l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         249 LTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             ccCCchhCcCHHHHhcC
Confidence            99999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=3.6e-26  Score=179.75  Aligned_cols=154  Identities=29%  Similarity=0.409  Sum_probs=113.9

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc-
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG-   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~-   81 (220)
                      .++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........  ......++..|+|||.+.. 
T Consensus       114 ~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~  188 (275)
T cd06608         114 WIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLG--RRNTFIGTPYWMAPEVIACD  188 (275)
T ss_pred             HHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCccceecccchh--hhcCccccccccCHhHhccc
Confidence            46779999999999999999   99999999999999999999999998865432211  1222456778999998753 


Q ss_pred             ----CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcc
Q 027675           82 ----GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLL  157 (220)
Q Consensus        82 ----~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  157 (220)
                          ..++.++|+||||+++|++++|..||..........      ... .+       ..............+.+++.+
T Consensus       189 ~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------~~~-~~-------~~~~~~~~~~~~~~~~~li~~  254 (275)
T cd06608         189 EQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF------KIP-RN-------PPPTLKSPENWSKKFNDFISE  254 (275)
T ss_pred             ccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHH------Hhh-cc-------CCCCCCchhhcCHHHHHHHHH
Confidence                246788999999999999999999986432221110      100 10       011111112244578899999


Q ss_pred             ccCCCCCCCCCHHHHHHH
Q 027675          158 CVQEDPNDRPTMSDVVIM  175 (220)
Q Consensus       158 cl~~~p~~Rps~~~~l~~  175 (220)
                      ||..||++|||+.+++++
T Consensus       255 ~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         255 CLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             HhhcChhhCcCHHHHhcC
Confidence            999999999999999875

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.93  E-value=4.9e-26  Score=178.93  Aligned_cols=154  Identities=26%  Similarity=0.374  Sum_probs=117.6

Q ss_pred             hHHHHHHHHHHHHHHhhh-CCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            3 MLFNIILGVSRRLLYLHQ-DSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~-~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+++++.|++.||.|||+ .+   ++|+||+|.||+++.++.++|+|||.+.......   ......++..|++||.+.+
T Consensus       114 ~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~  187 (269)
T cd08528         114 RIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKN  187 (269)
T ss_pred             HHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEecccceeeccccc---ccccccCcccCcChhhhcC
Confidence            568899999999999996 67   9999999999999999999999999987644322   2223456788999999998


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+||||+++|+|++|..||..........       ....+...    ....    ......+.++|.+||+.
T Consensus       188 ~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~-------~~~~~~~~----~~~~----~~~~~~l~~li~~cl~~  252 (269)
T cd08528         188 EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLAT-------KIVEAVYE----PLPE----GMYSEDVTDVITSCLTP  252 (269)
T ss_pred             CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHH-------HHhhccCC----cCCc----ccCCHHHHHHHHHHCCC
Confidence            888999999999999999999999986433222111       11111111    0001    11234678899999999


Q ss_pred             CCCCCCCHHHHHHHhc
Q 027675          162 DPNDRPTMSDVVIMLG  177 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~  177 (220)
                      ||++||++.++..+++
T Consensus       253 ~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         253 DAEARPDIIQVSAMIS  268 (269)
T ss_pred             CCccCCCHHHHHHHhc
Confidence            9999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.93  E-value=2.8e-26  Score=181.44  Aligned_cols=158  Identities=24%  Similarity=0.390  Sum_probs=115.6

Q ss_pred             chHHHHHHHHHHHHHHhhhC-CCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQD-SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~-~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~   80 (220)
                      ++++.++.|++.||.|||++ +   ++||||||+||+++.++.++|+|||++.......   ......++..|+|||.+.
T Consensus       103 ~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~  176 (283)
T cd06617         103 DILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV---AKTIDAGCKPYMAPERIN  176 (283)
T ss_pred             HHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccccc---ccccccCCccccChhhcC
Confidence            35779999999999999997 7   9999999999999999999999999986543211   112234677899999886


Q ss_pred             c----CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhc
Q 027675           81 G----GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGL  156 (220)
Q Consensus        81 ~----~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  156 (220)
                      +    ..++.++|+||||+++|+|++|..||.........     ..... .+.....        ........+.++|.
T Consensus       177 ~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-----~~~~~-~~~~~~~--------~~~~~~~~l~~li~  242 (283)
T cd06617         177 PELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ-----LKQVV-EEPSPQL--------PAEKFSPEFQDFVN  242 (283)
T ss_pred             CcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHH-----HHHHH-hcCCCCC--------CccccCHHHHHHHH
Confidence            5    34578999999999999999999998643221110     01111 1111100        11113346889999


Q ss_pred             cccCCCCCCCCCHHHHHHHhcCc
Q 027675          157 LCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       157 ~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      +||..+|++||++.+++.+-+..
T Consensus       243 ~~l~~~p~~Rp~~~~il~~~~~~  265 (283)
T cd06617         243 KCLKKNYKERPNYPELLQHPFFE  265 (283)
T ss_pred             HHccCChhhCcCHHHHhcCchhh
Confidence            99999999999999999875444

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.93  E-value=2e-26  Score=190.76  Aligned_cols=159  Identities=23%  Similarity=0.343  Sum_probs=118.1

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+++++.|++.||.|||+.+   ++||||||.||+++.++.++|+|||++................++..|+|||.+.+.
T Consensus       240 ~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  316 (401)
T cd05107         240 DLVGFSYQVANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN  316 (401)
T ss_pred             HHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC
Confidence            56789999999999999999   999999999999999999999999998754322111111123456789999999888


Q ss_pred             CCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           83 FFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      .++.++|+||||+++|+|++ |..||.........      ......+.....         .......+.+++.+||..
T Consensus       317 ~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~------~~~~~~~~~~~~---------p~~~~~~l~~li~~cl~~  381 (401)
T cd05107         317 LYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF------YNAIKRGYRMAK---------PAHASDEIYEIMQKCWEE  381 (401)
T ss_pred             CCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH------HHHHHcCCCCCC---------CCCCCHHHHHHHHHHcCC
Confidence            88999999999999999998 88888643322211      111111111110         111234788999999999


Q ss_pred             CCCCCCCHHHHHHHhcCc
Q 027675          162 DPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~~~  179 (220)
                      +|.+||++++|+..|+..
T Consensus       382 ~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         382 KFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             ChhHCcCHHHHHHHHHHH
Confidence            999999999999998643

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=3e-26  Score=191.84  Aligned_cols=151  Identities=30%  Similarity=0.463  Sum_probs=117.8

Q ss_pred             HHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeC-CCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            4 LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLD-HEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         4 ~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      +--+-+||++||.|||.+.   |+|||||-+|++++ -.|.+||+|||.+.+....  ..+...+.||..|+|||++-.+
T Consensus       677 m~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TETFTGTLQYMAPEvIDqG  751 (1226)
T KOG4279|consen  677 MNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTETFTGTLQYMAPEVIDQG  751 (1226)
T ss_pred             HHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC--CccccccccchhhhChHhhccC
Confidence            4456799999999999999   99999999999995 5788999999998765433  3345557899999999999654


Q ss_pred             --CCcccCceeehhHHHHHHHhcCccCcccch-hHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           83 --FFSVKSDVFSFGVVVLEIISGKRNTGFYNS-ELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        83 --~~~~~~DiwslG~il~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                        +|...+|||||||.+.||.||++||..... ...+-..             .+....|..  +.....+..++|.+|+
T Consensus       752 ~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkV-------------GmyKvHP~i--Peelsaeak~FilrcF  816 (1226)
T KOG4279|consen  752 PRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKV-------------GMYKVHPPI--PEELSAEAKNFILRCF  816 (1226)
T ss_pred             CcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhh-------------cceecCCCC--cHHHHHHHHHHHHHHc
Confidence              588999999999999999999999853222 2221111             122233333  3345568899999999


Q ss_pred             CCCCCCCCCHHHHHH
Q 027675          160 QEDPNDRPTMSDVVI  174 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~  174 (220)
                      ..+|.+||++.++|.
T Consensus       817 epd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  817 EPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             CCCcccCccHHHhcc
Confidence            999999999999994

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.93  E-value=3.8e-26  Score=181.29  Aligned_cols=157  Identities=23%  Similarity=0.320  Sum_probs=116.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +.+..++.|++.||++||+++   ++||||+|+||+++.++.++|+|||+.........  ......++..|+|||...+
T Consensus       115 ~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~  189 (285)
T cd06648         115 EQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPEVISR  189 (285)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--ccccccCCccccCHHHhcC
Confidence            356789999999999999999   99999999999999999999999998754332111  1122356788999999988


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+||||+++|+|++|..||...+......      ... ....     .  ...........+.+++.+||..
T Consensus       190 ~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~------~~~-~~~~-----~--~~~~~~~~~~~l~~li~~~l~~  255 (285)
T cd06648         190 LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMK------RIR-DNLP-----P--KLKNLHKVSPRLRSFLDRMLVR  255 (285)
T ss_pred             CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHH------HHH-hcCC-----C--CCcccccCCHHHHHHHHHHccc
Confidence            888999999999999999999999985433221111      111 1100     0  0001111234788999999999


Q ss_pred             CCCCCCCHHHHHHHhc
Q 027675          162 DPNDRPTMSDVVIMLG  177 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~  177 (220)
                      +|++||++.+++++-.
T Consensus       256 ~p~~Rpt~~~il~~~~  271 (285)
T cd06648         256 DPAQRATAAELLNHPF  271 (285)
T ss_pred             ChhhCcCHHHHccCcc
Confidence            9999999999997643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.93  E-value=4.2e-26  Score=180.17  Aligned_cols=155  Identities=25%  Similarity=0.388  Sum_probs=117.1

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..+..++.++++|+.|||+++   ++|+||+|+||+++.++.++++|||++........  ......++..|+|||.+.+
T Consensus       101 ~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~  175 (277)
T cd06642         101 TYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQ  175 (277)
T ss_pred             HHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch--hhhcccCcccccCHHHhCc
Confidence            356789999999999999999   99999999999999999999999998865432211  1122346778999999998


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+||||+++++|++|..|+..........       ....+.         ...........+.+++.+||..
T Consensus       176 ~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-------~~~~~~---------~~~~~~~~~~~~~~li~~~l~~  239 (277)
T cd06642         176 SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF-------LIPKNS---------PPTLEGQYSKPFKEFVEACLNK  239 (277)
T ss_pred             CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh-------hhhcCC---------CCCCCcccCHHHHHHHHHHccC
Confidence            888999999999999999999999986433221110       000100         0011112345678999999999


Q ss_pred             CCCCCCCHHHHHHHhc
Q 027675          162 DPNDRPTMSDVVIMLG  177 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~  177 (220)
                      +|++||++.+++.+-+
T Consensus       240 ~p~~Rp~~~~il~~~~  255 (277)
T cd06642         240 DPRFRPTAKELLKHKF  255 (277)
T ss_pred             CcccCcCHHHHHHhHH
Confidence            9999999999998654

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.93  E-value=3.8e-26  Score=179.01  Aligned_cols=159  Identities=27%  Similarity=0.404  Sum_probs=116.7

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCC--cccceeecccCccChhhhh
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD--GTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~y~aPe~~~   80 (220)
                      .+..++.|++.||.+||+.+   ++|+||+|+||++++++.++|+|||++.........  .......++..|++||.+.
T Consensus       103 ~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~  179 (267)
T cd06610         103 IIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME  179 (267)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHc
Confidence            56789999999999999999   999999999999999999999999987654332211  1122235677899999987


Q ss_pred             cC-CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           81 GG-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        81 ~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      .. .++.++|+||||+++++|++|+.||...+.....      .+....     .................+.+++.+||
T Consensus       180 ~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~------~~~~~~-----~~~~~~~~~~~~~~~~~~~~li~~~l  248 (267)
T cd06610         180 QVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL------MLTLQN-----DPPSLETGADYKKYSKSFRKMISLCL  248 (267)
T ss_pred             cccCcCcccchHhHhHHHHHHHhCCCCccccChhhhH------HHHhcC-----CCCCcCCccccccccHHHHHHHHHHc
Confidence            76 6789999999999999999999998644332111      111110     00000011111123457789999999


Q ss_pred             CCCCCCCCCHHHHHHH
Q 027675          160 QEDPNDRPTMSDVVIM  175 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~  175 (220)
                      ..||++||++++++.+
T Consensus       249 ~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         249 QKDPSKRPTAEELLKH  264 (267)
T ss_pred             CCChhhCcCHHHHhhC
Confidence            9999999999999976

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.93  E-value=2.7e-26  Score=183.22  Aligned_cols=157  Identities=24%  Similarity=0.341  Sum_probs=117.1

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .++..++.+++.||.|||+.+   ++|+||||+||+++.++.++++|||++.........  .....+++.|++||.+.+
T Consensus       115 ~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~  189 (297)
T cd06656         115 GQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTR  189 (297)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCccC--cCcccCCccccCHHHHcC
Confidence            357789999999999999999   999999999999999999999999987654322111  122356778999999988


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+||||+++|++++|..||...+.......      .        .....+...........+.+++.+||..
T Consensus       190 ~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~------~--------~~~~~~~~~~~~~~~~~~~~li~~~l~~  255 (297)
T cd06656         190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------I--------ATNGTPELQNPERLSAVFRDFLNRCLEM  255 (297)
T ss_pred             CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee------e--------ccCCCCCCCCccccCHHHHHHHHHHccC
Confidence            8889999999999999999999999864332111000      0        0001111111122334578899999999


Q ss_pred             CCCCCCCHHHHHHHhc
Q 027675          162 DPNDRPTMSDVVIMLG  177 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~  177 (220)
                      +|++||++++++++=+
T Consensus       256 ~p~~Rps~~~il~~~~  271 (297)
T cd06656         256 DVDRRGSAKELLQHPF  271 (297)
T ss_pred             ChhhCcCHHHHhcCch
Confidence            9999999999998643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.93  E-value=9e-26  Score=166.77  Aligned_cols=151  Identities=21%  Similarity=0.219  Sum_probs=110.1

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ++++.++.|++.||.|||+++         ||+||+++.++.+++  ||++.......       ..+++.|+|||.+.+
T Consensus        17 ~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~-------~~g~~~y~aPE~~~~   78 (176)
T smart00750       17 EEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ-------SRVDPYFMAPEVIQG   78 (176)
T ss_pred             HHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc-------CCCcccccChHHhcC
Confidence            468899999999999999985         999999999999998  99887543221       146789999999999


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHH--HHHHHHhcccc
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEI--LKCINVGLLCV  159 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~cl  159 (220)
                      ..++.++|||||||++|+|++|+.||........  ..   .... .+.....  ... ........  ..+.+++.+||
T Consensus        79 ~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~--~~---~~~~-~~~~~~~--~~~-~~~~~~~~~~~~~~~~i~~cl  149 (176)
T smart00750       79 QSYTEKADIYSLGITLYEALDYELPYNEERELSA--IL---EILL-NGMPADD--PRD-RSNLESVSAARSFADFMRVCA  149 (176)
T ss_pred             CCCcchhhHHHHHHHHHHHHhCCCCccccchhcH--HH---HHHH-HHhccCC--ccc-cccHHHHHhhhhHHHHHHHHH
Confidence            8899999999999999999999999854322111  01   0111 1111000  000 00111112  25899999999


Q ss_pred             CCCCCCCCCHHHHHHHhcCc
Q 027675          160 QEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l~~~  179 (220)
                      ..+|++||++.++++++...
T Consensus       150 ~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      150 SRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             hcccccccCHHHHHHHHHHH
Confidence            99999999999999998544

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=3.2e-26  Score=188.58  Aligned_cols=159  Identities=22%  Similarity=0.258  Sum_probs=113.0

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCC------------C---------
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT------------D---------   61 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~------------~---------   61 (220)
                      .+..++.|++.||+|||+.|   |+||||||+||+++.++.++|+|||++........            .         
T Consensus       102 ~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (377)
T cd05629         102 VTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNS  178 (377)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccccccccccccccccccccccccccc
Confidence            46678999999999999999   99999999999999999999999998853211000            0         


Q ss_pred             ------------------------cccceeecccCccChhhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHh
Q 027675           62 ------------------------GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALS  117 (220)
Q Consensus        62 ------------------------~~~~~~~~~~~y~aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~  117 (220)
                                              .......|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+......
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~  258 (377)
T cd05629         179 VAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYR  258 (377)
T ss_pred             cccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHH
Confidence                                    00011357889999999988889999999999999999999999996544322211


Q ss_pred             hHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCCCCCC---CCHHHHHHHhcC
Q 027675          118 LLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDR---PTMSDVVIMLGS  178 (220)
Q Consensus       118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R---ps~~~~l~~l~~  178 (220)
                            ...........    +.   .......+.++|.+||. +|.+|   +++.+++.+-+.
T Consensus       259 ------~i~~~~~~~~~----p~---~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~  308 (377)
T cd05629         259 ------KIINWRETLYF----PD---DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFF  308 (377)
T ss_pred             ------HHHccCCccCC----CC---CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCc
Confidence                  11100001100    11   11123467788899997 66665   699999987643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.93  E-value=6.8e-26  Score=176.78  Aligned_cols=154  Identities=31%  Similarity=0.460  Sum_probs=118.1

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .++..++.|++.||.|||+.+   ++|+||+|+||+++.++.++++|||++........  ......++..|.|||...+
T Consensus       101 ~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~  175 (256)
T cd08221         101 EMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--MAETVVGTPYYMSPELCQG  175 (256)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc--cccccCCCccccCHhhcCC
Confidence            356789999999999999999   99999999999999999999999999875543221  1222456789999999988


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+||||+++++|++|..||...+......      ... .+.....         .......+.+++.+||..
T Consensus       176 ~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~------~~~-~~~~~~~---------~~~~~~~~~~~i~~~l~~  239 (256)
T cd08221         176 VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVV------KIV-QGNYTPV---------VSVYSSELISLVHSLLQQ  239 (256)
T ss_pred             CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHH------HHH-cCCCCCC---------ccccCHHHHHHHHHHccc
Confidence            888899999999999999999999986533322111      111 1111110         122234678899999999


Q ss_pred             CCCCCCCHHHHHHHh
Q 027675          162 DPNDRPTMSDVVIML  176 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l  176 (220)
                      +|++||+++++++++
T Consensus       240 ~p~~R~s~~~ll~~~  254 (256)
T cd08221         240 DPEKRPTADEVLDQP  254 (256)
T ss_pred             CcccCCCHHHHhhCc
Confidence            999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.93  E-value=3.9e-26  Score=180.82  Aligned_cols=170  Identities=24%  Similarity=0.326  Sum_probs=117.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++........  ......++..|+|||.+.+
T Consensus       100 ~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~  174 (286)
T cd07847         100 HLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--DYTDYVATRWYRAPELLVG  174 (286)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc--cccCcccccccCCHHHHhC
Confidence            357889999999999999999   99999999999999999999999999875443221  1122345678999999876


Q ss_pred             -CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhh-HHHHHHH-------HHhccc-cccccCCCCCcCc-----HH
Q 027675           82 -GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSL-LGYAWKL-------WQEGKA-LDMMDQKPGAISK-----AN  146 (220)
Q Consensus        82 -~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~-~~~~~~~-------~~~~~~-~~~~~~~~~~~~~-----~~  146 (220)
                       ..++.++|+||||+++|+|++|..||........... .......       ...... .....+.+.....     ..
T Consensus       175 ~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (286)
T cd07847         175 DTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPN  254 (286)
T ss_pred             CCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhcc
Confidence             4568899999999999999999999965443221111 1000000       000000 0000011111111     11


Q ss_pred             HHHHHHHHhccccCCCCCCCCCHHHHHHHh
Q 027675          147 EILKCINVGLLCVQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       147 ~~~~~~~li~~cl~~~p~~Rps~~~~l~~l  176 (220)
                      ....+.+++.+||..+|++||++.+++.+-
T Consensus       255 ~~~~~~~li~~~l~~~p~~Rp~~~eil~~~  284 (286)
T cd07847         255 ISSPALSFLKGCLQMDPTERLSCEELLEHP  284 (286)
T ss_pred             CCHHHHHHHHHHhcCCccccCCHHHHhcCC
Confidence            235678999999999999999999998763

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.93  E-value=3.7e-26  Score=180.62  Aligned_cols=169  Identities=22%  Similarity=0.297  Sum_probs=118.7

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.++++||.|||+.+   ++|+||+|+||+++.++.++|+|||.+.......  .......+...|.+||.+.+
T Consensus        98 ~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~  172 (283)
T cd05118          98 SLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYTHYVVTRWYRAPELLLG  172 (283)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--ccccCccCcccccCcHHHhc
Confidence            357889999999999999999   9999999999999999999999999887654322  11122345678999999877


Q ss_pred             C-CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHH--------HHHHHh---ccccccccCCCCC--cCcHHH
Q 027675           82 G-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA--------WKLWQE---GKALDMMDQKPGA--ISKANE  147 (220)
Q Consensus        82 ~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~---~~~~~~~~~~~~~--~~~~~~  147 (220)
                      . ..+.++|+||||+++|++++|+.||...+...........        +.....   .............  ......
T Consensus       173 ~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (283)
T cd05118         173 DKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNA  252 (283)
T ss_pred             CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhh
Confidence            6 6789999999999999999999998655443221111000        000000   0000000000000  011234


Q ss_pred             HHHHHHHhccccCCCCCCCCCHHHHHHH
Q 027675          148 ILKCINVGLLCVQEDPNDRPTMSDVVIM  175 (220)
Q Consensus       148 ~~~~~~li~~cl~~~p~~Rps~~~~l~~  175 (220)
                      ...+.++|.+||+.||.+||++.+++.+
T Consensus       253 ~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         253 SPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             CHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            5678999999999999999999999976

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.93  E-value=9.9e-26  Score=184.81  Aligned_cols=106  Identities=28%  Similarity=0.345  Sum_probs=88.6

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCC---------------------
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD---------------------   61 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~---------------------   61 (220)
                      .+..++.|++.||+|||+++   |+||||||+||+++.++.++|+|||++.........                     
T Consensus       102 ~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (363)
T cd05628         102 ETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS  178 (363)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccccccccccccccccccccccccccc
Confidence            56789999999999999999   999999999999999999999999997643211000                     


Q ss_pred             ------------cccceeecccCccChhhhhcCCCcccCceeehhHHHHHHHhcCccCcccc
Q 027675           62 ------------GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYN  111 (220)
Q Consensus        62 ------------~~~~~~~~~~~y~aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~  111 (220)
                                  .......|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+
T Consensus       179 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~  240 (363)
T cd05628         179 KRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET  240 (363)
T ss_pred             ccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCC
Confidence                        00112468899999999998889999999999999999999999997544

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.93  E-value=4.7e-26  Score=178.06  Aligned_cols=153  Identities=27%  Similarity=0.363  Sum_probs=118.3

Q ss_pred             chHHHHHHHHHHHHHHhh-----hCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccCh
Q 027675            2 EMLFNIILGVSRRLLYLH-----QDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP   76 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH-----~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aP   76 (220)
                      +.++.++.++++||.+||     +.+   ++|+||+|+||+++.++.++|+|||++.........  .....++..|.+|
T Consensus       105 ~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~~p  179 (265)
T cd08217         105 EFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF--AKTYVGTPYYMSP  179 (265)
T ss_pred             HHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEecccccccccCCccc--ccccccCCCccCh
Confidence            357889999999999999     777   999999999999999999999999998765432211  1223567889999


Q ss_pred             hhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhc
Q 027675           77 EYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGL  156 (220)
Q Consensus        77 e~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  156 (220)
                      |.+.+..++.++|+||||+++++|++|..||...+.....       +....+...         .........+.+++.
T Consensus       180 E~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~---------~~~~~~~~~~~~l~~  243 (265)
T cd08217         180 EQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLA-------SKIKEGKFR---------RIPYRYSSELNEVIK  243 (265)
T ss_pred             hhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHH-------HHHhcCCCC---------CCccccCHHHHHHHH
Confidence            9998888899999999999999999999999765422211       111111111         111233457889999


Q ss_pred             cccCCCCCCCCCHHHHHHH
Q 027675          157 LCVQEDPNDRPTMSDVVIM  175 (220)
Q Consensus       157 ~cl~~~p~~Rps~~~~l~~  175 (220)
                      +||..+|++||++++++++
T Consensus       244 ~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         244 SMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             HHccCCcccCCCHHHHhhC
Confidence            9999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.93  E-value=1.1e-26  Score=178.33  Aligned_cols=179  Identities=21%  Similarity=0.266  Sum_probs=122.5

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCC----CCceecCccceeeecCCCCCc-ccceeecccCccChh
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHE----MNPKISDFGLTRIFEGKQTDG-TTNRVVGTYGYMSPE   77 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~----~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~y~aPe   77 (220)
                      ++.+|++||+.|+.|||++.   ++||||||.||++..+    |.|||+|||+++.+....... ..+.++-|..|.|||
T Consensus       133 mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPE  209 (438)
T KOG0666|consen  133 MVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPE  209 (438)
T ss_pred             HHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChH
Confidence            57889999999999999998   9999999999999877    889999999999876544333 333456688999999


Q ss_pred             hhhcC-CCcccCceeehhHHHHHHHhcCccCcccchhHHHhh---HHHHHHHHHh-----ccccccccCCCCC-------
Q 027675           78 YALGG-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSL---LGYAWKLWQE-----GKALDMMDQKPGA-------  141 (220)
Q Consensus        78 ~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~---~~~~~~~~~~-----~~~~~~~~~~~~~-------  141 (220)
                      ++.|. .|+.+.|+|++|||+.||++.++.|.....+.....   .....+++.-     ......+...+..       
T Consensus       210 LLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f  289 (438)
T KOG0666|consen  210 LLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDF  289 (438)
T ss_pred             HhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHh
Confidence            99986 589999999999999999999988854322211100   0000111100     0000000000000       


Q ss_pred             ---cCcHH-----------HHHHHHHHhccccCCCCCCCCCHHHHHHHhcCccccCC
Q 027675          142 ---ISKAN-----------EILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEAVNLA  184 (220)
Q Consensus       142 ---~~~~~-----------~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~~~~~~  184 (220)
                         ..+..           .....++++..+|++||.+|.|+++++++....+-..+
T Consensus       290 ~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~lp  346 (438)
T KOG0666|consen  290 RRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDPLP  346 (438)
T ss_pred             HHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccCCCC
Confidence               00000           01236788999999999999999999998755544333

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.93  E-value=9.5e-26  Score=178.62  Aligned_cols=168  Identities=21%  Similarity=0.261  Sum_probs=117.9

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||++.........   ....++..|+|||.+.+
T Consensus       107 ~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~PE~~~~  180 (287)
T cd07838         107 ETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL---TSVVVTLWYRAPEVLLQ  180 (287)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcceeccCCccc---ccccccccccChHHhcc
Confidence            357889999999999999999   999999999999999999999999988765332211   11235678999999998


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHH-HH----HHHHhccc--cccccCCCC---CcCcHHHHHHH
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGY-AW----KLWQEGKA--LDMMDQKPG---AISKANEILKC  151 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~-~~----~~~~~~~~--~~~~~~~~~---~~~~~~~~~~~  151 (220)
                      ..++.++|+||||+++|+|++|.+||.............. ..    ..+.....  .........   ..........+
T Consensus       181 ~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (287)
T cd07838         181 SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEG  260 (287)
T ss_pred             CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHH
Confidence            8889999999999999999999999875443322211100 00    00000000  000000000   00011234567


Q ss_pred             HHHhccccCCCCCCCCCHHHHHHH
Q 027675          152 INVGLLCVQEDPNDRPTMSDVVIM  175 (220)
Q Consensus       152 ~~li~~cl~~~p~~Rps~~~~l~~  175 (220)
                      .++|.+||+.||++||++.+++.+
T Consensus       261 ~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         261 LDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             HHHHHHHhccCCccCCCHHHHhcC
Confidence            899999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.93  E-value=2.8e-26  Score=184.18  Aligned_cols=170  Identities=21%  Similarity=0.282  Sum_probs=115.1

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCC----CCCceecCccceeeecCCCC-CcccceeecccCccChh
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDH----EMNPKISDFGLTRIFEGKQT-DGTTNRVVGTYGYMSPE   77 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~----~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~y~aPe   77 (220)
                      .++.++.|++.||.|||+.+   ++||||||+||+++.    ++.++|+|||++........ ........++..|+|||
T Consensus       109 ~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE  185 (316)
T cd07842         109 MVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPE  185 (316)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHH
Confidence            56789999999999999999   999999999999999    89999999998875432221 11122234577899999


Q ss_pred             hhhcC-CCcccCceeehhHHHHHHHhcCccCcccchhHH------HhhHHHHHHHHH-----------hc-cccc---cc
Q 027675           78 YALGG-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELA------LSLLGYAWKLWQ-----------EG-KALD---MM  135 (220)
Q Consensus        78 ~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~------~~~~~~~~~~~~-----------~~-~~~~---~~  135 (220)
                      .+.+. .++.++|+||||+++++|++|+.||........      ..........+.           .. ....   ..
T Consensus       186 ~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  265 (316)
T cd07842         186 LLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDF  265 (316)
T ss_pred             HHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhc
Confidence            88764 468899999999999999999999865433220      000000000000           00 0000   00


Q ss_pred             cCCCCCcCcH--------HHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 027675          136 DQKPGAISKA--------NEILKCINVGLLCVQEDPNDRPTMSDVVIM  175 (220)
Q Consensus       136 ~~~~~~~~~~--------~~~~~~~~li~~cl~~~p~~Rps~~~~l~~  175 (220)
                      ..........        .....+.+++.+||..||++|||+.+++.+
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         266 KTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             cCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            0000000000        223468899999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.93  E-value=6.2e-26  Score=178.90  Aligned_cols=157  Identities=24%  Similarity=0.318  Sum_probs=116.0

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++++|||++......... ......++..|++||.+.+
T Consensus       117 ~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~  192 (275)
T cd05046         117 KQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY-KLRNALIPLRWLAPEAVQE  192 (275)
T ss_pred             HHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEcccccccccCccccc-ccCCceeEEeecChhhhcc
Confidence            357889999999999999999   999999999999999999999999987643221111 1112244567999999988


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ...+.++|+||||+++|++++ |..||...........       ...+... .  ..     .......+.+++.+||+
T Consensus       193 ~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~-------~~~~~~~-~--~~-----~~~~~~~l~~~i~~~l~  257 (275)
T cd05046         193 DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNR-------LQAGKLE-L--PV-----PEGCPSRLYKLMTRCWA  257 (275)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHH-------HHcCCcC-C--CC-----CCCCCHHHHHHHHHHcC
Confidence            888899999999999999998 7778754333222111       1111111 0  00     01122478899999999


Q ss_pred             CCCCCCCCHHHHHHHhc
Q 027675          161 EDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~  177 (220)
                      .+|++||++.+++..|+
T Consensus       258 ~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         258 VNPKDRPSFSELVSALG  274 (275)
T ss_pred             CCcccCCCHHHHHHHhc
Confidence            99999999999999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.93  E-value=5.2e-26  Score=182.42  Aligned_cols=173  Identities=23%  Similarity=0.264  Sum_probs=118.9

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+++.++.|+++||.|||+.+   ++|+||||+||+++.++.++|+|||++.........  ......+..|+|||.+.+
T Consensus       108 ~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~  182 (309)
T cd07845         108 SQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP--MTPKVVTLWYRAPELLLG  182 (309)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCccCC--CCcccccccccChhhhcC
Confidence            356889999999999999999   999999999999999999999999998765432111  111233667999999876


Q ss_pred             -CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHH--------HHHHhccccccccCCCCCcCc-----HHH
Q 027675           82 -GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAW--------KLWQEGKALDMMDQKPGAISK-----ANE  147 (220)
Q Consensus        82 -~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~-----~~~  147 (220)
                       ..++.++|+||||+++|+|++|+.||...+............        .....................     ...
T Consensus       183 ~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (309)
T cd07845         183 CTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWL  262 (309)
T ss_pred             CCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhcccc
Confidence             456889999999999999999999997544433222111100        000000000000000000000     112


Q ss_pred             HHHHHHHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          148 ILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       148 ~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      ...+.++|.+||..||++|||+++++.+-+..
T Consensus       263 ~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~  294 (309)
T cd07845         263 SEAGLRLLNFLLMYDPKKRATAEEALESSYFK  294 (309)
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence            45678899999999999999999999886554

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.93  E-value=2.8e-26  Score=183.65  Aligned_cols=172  Identities=21%  Similarity=0.305  Sum_probs=116.5

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCC--cccceeecccCccChhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD--GTTNRVVGTYGYMSPEYA   79 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~y~aPe~~   79 (220)
                      .+++.++.|+++||.|||+++   ++|+||||+||+++.++.++|+|||++.........  .......++..|+|||.+
T Consensus       119 ~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  195 (310)
T cd07865         119 SEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELL  195 (310)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHh
Confidence            467889999999999999999   999999999999999999999999998754322111  111223456789999988


Q ss_pred             hcC-CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHH-----HHHhccccccccC--CCCCc--------C
Q 027675           80 LGG-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWK-----LWQEGKALDMMDQ--KPGAI--------S  143 (220)
Q Consensus        80 ~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~--~~~~~--------~  143 (220)
                      .+. .++.++|+||||+++|+|++|..||...+.............     ...........+.  .+...        .
T Consensus       196 ~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  275 (310)
T cd07865         196 LGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLK  275 (310)
T ss_pred             cCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcc
Confidence            765 367899999999999999999999875544322221111100     0000000000000  00000        0


Q ss_pred             cHHHHHHHHHHhccccCCCCCCCCCHHHHHHHh
Q 027675          144 KANEILKCINVGLLCVQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       144 ~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l  176 (220)
                      .......+.++|.+||..||++|||+++++++-
T Consensus       276 ~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~  308 (310)
T cd07865         276 PYVKDPHALDLIDKLLVLDPAKRIDADTALNHD  308 (310)
T ss_pred             cccCCHHHHHHHHHHhcCChhhccCHHHHhcCC
Confidence            001123567899999999999999999999763

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.93  E-value=3.9e-26  Score=181.07  Aligned_cols=153  Identities=23%  Similarity=0.341  Sum_probs=122.5

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      +.+++++||+.|+.|+|+++   ++|||||.+|||+++++++||+|||++..+...   ...+.+.|++.|++||+..|.
T Consensus       154 EaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~---kfLqTFCGSPLYASPEIvNG~  227 (668)
T KOG0611|consen  154 EARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK---KFLQTFCGSPLYASPEIVNGT  227 (668)
T ss_pred             HHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc---cHHHHhcCCcccCCccccCCC
Confidence            46789999999999999999   999999999999999999999999998765432   233446789999999999998


Q ss_pred             CC-cccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           83 FF-SVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        83 ~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      +| .+..|-||||+++|-|+.|..||++.+.....       +++..|.-.+.     ..      .....-+|++||..
T Consensus       228 PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lv-------rQIs~GaYrEP-----~~------PSdA~gLIRwmLmV  289 (668)
T KOG0611|consen  228 PYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLV-------RQISRGAYREP-----ET------PSDASGLIRWMLMV  289 (668)
T ss_pred             CCCCCccchhhHHHHHHHHhhcccccCCchHHHHH-------HHhhcccccCC-----CC------CchHHHHHHHHHhc
Confidence            87 68899999999999999999999877665443       12222222111     11      11345678889999


Q ss_pred             CCCCCCCHHHHHHHhcCc
Q 027675          162 DPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~~~  179 (220)
                      ||++|.|+++|..|.|--
T Consensus       290 NP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  290 NPERRATIEDIASHWWVN  307 (668)
T ss_pred             CcccchhHHHHhhhheee
Confidence            999999999999998654

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.93  E-value=7.5e-26  Score=175.41  Aligned_cols=154  Identities=29%  Similarity=0.432  Sum_probs=117.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..+..++.+++.||.+||..+   ++|+||+|+||+++.++.++|+|||.+........   .....++..|++||.+.+
T Consensus        98 ~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~  171 (253)
T cd05122          98 SQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWMAPEVING  171 (253)
T ss_pred             HHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc---ccceecCCcccCHHHHcC
Confidence            356789999999999999999   99999999999999999999999998876543221   223456788999999988


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ...+.++|+||||++++++++|..||...+........      . ..       ..............+.+++.+||+.
T Consensus       172 ~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~------~-~~-------~~~~~~~~~~~~~~~~~~i~~~l~~  237 (253)
T cd05122         172 KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI------A-TN-------GPPGLRNPEKWSDEFKDFLKKCLQK  237 (253)
T ss_pred             CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH------H-hc-------CCCCcCcccccCHHHHHHHHHHccC
Confidence            87889999999999999999999998654322211110      0 00       0001111111245788999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 027675          162 DPNDRPTMSDVVIM  175 (220)
Q Consensus       162 ~p~~Rps~~~~l~~  175 (220)
                      ||++|||+.+++++
T Consensus       238 ~p~~R~t~~~~l~~  251 (253)
T cd05122         238 NPEKRPTAEQLLKH  251 (253)
T ss_pred             ChhhCCCHHHHhcC
Confidence            99999999999876

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.93  E-value=5.1e-26  Score=180.60  Aligned_cols=155  Identities=23%  Similarity=0.295  Sum_probs=115.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +.+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++........   .....++..|+|||.+.+
T Consensus       102 ~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~~~aPE~~~~  175 (285)
T cd05632         102 ERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES---IRGRVGTVGYMAPEVLNN  175 (285)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc---ccCCCCCcCccChHHhcC
Confidence            357889999999999999999   99999999999999999999999998865332111   122357889999999988


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+||||+++|+|++|..||............   ........     ..     ........+.+++..||+.
T Consensus       176 ~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~---~~~~~~~~-----~~-----~~~~~~~~~~~li~~~l~~  242 (285)
T cd05632         176 QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV---DRRVLETE-----EV-----YSAKFSEEAKSICKMLLTK  242 (285)
T ss_pred             CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHhhhccc-----cc-----cCccCCHHHHHHHHHHccC
Confidence            88899999999999999999999999754332211111   11111100     00     0111233567889999999


Q ss_pred             CCCCCCC-----HHHHHHH
Q 027675          162 DPNDRPT-----MSDVVIM  175 (220)
Q Consensus       162 ~p~~Rps-----~~~~l~~  175 (220)
                      ||++||+     +.+++.+
T Consensus       243 ~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         243 DPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             CHhHcCCCcccChHHHHcC
Confidence            9999999     7788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.93  E-value=1.2e-25  Score=180.68  Aligned_cols=172  Identities=21%  Similarity=0.219  Sum_probs=116.7

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCC-----CcccceeecccCccChh
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT-----DGTTNRVVGTYGYMSPE   77 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~-----~~~~~~~~~~~~y~aPe   77 (220)
                      .+..++.|+++||.|||+++   |+|+||||+||+++.++.++++||+.+........     ........++..|+|||
T Consensus       102 ~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE  178 (314)
T cd08216         102 AIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPE  178 (314)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHH
Confidence            46778999999999999999   99999999999999999999999998764332111     11112234566899999


Q ss_pred             hhhcC--CCcccCceeehhHHHHHHHhcCccCcccchhHHHhh-H-HHHHHHHHhcc-------cc--------ccccCC
Q 027675           78 YALGG--FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSL-L-GYAWKLWQEGK-------AL--------DMMDQK  138 (220)
Q Consensus        78 ~~~~~--~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~-~-~~~~~~~~~~~-------~~--------~~~~~~  138 (220)
                      .+.+.  .++.++|+||||+++++|++|..||........... . ...........       ..        ......
T Consensus       179 ~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (314)
T cd08216         179 VLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDS  258 (314)
T ss_pred             HhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhh
Confidence            98763  578899999999999999999999975432221100 0 00000000000       00        000001


Q ss_pred             CCCcCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHhc
Q 027675          139 PGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       139 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~  177 (220)
                      ............+.+++.+||..||++|||+++++++-+
T Consensus       259 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~  297 (314)
T cd08216         259 VDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF  297 (314)
T ss_pred             hhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence            111122334467889999999999999999999997754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.93  E-value=5.3e-26  Score=177.89  Aligned_cols=148  Identities=21%  Similarity=0.348  Sum_probs=108.8

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCC--------ceecCccceeeecCCCCCcccceeecccCcc
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMN--------PKISDFGLTRIFEGKQTDGTTNRVVGTYGYM   74 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~--------~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~   74 (220)
                      .+++++.|++.||+|||+.+   ++||||||+||+++.++.        ++++|||++.....      .....++..|+
T Consensus       101 ~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~------~~~~~~~~~y~  171 (258)
T cd05078         101 WKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP------KEILLERIPWV  171 (258)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccccccCC------chhccccCCcc
Confidence            46788999999999999999   999999999999987665        58999988754321      12234567899


Q ss_pred             ChhhhhcC-CCcccCceeehhHHHHHHHhcC-ccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHH
Q 027675           75 SPEYALGG-FFSVKSDVFSFGVVVLEIISGK-RNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCI  152 (220)
Q Consensus        75 aPe~~~~~-~~~~~~DiwslG~il~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (220)
                      |||.+.+. .++.++|+||||+++|++++|. .|+...........       ...  ...    .+.     .....+.
T Consensus       172 aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~-------~~~--~~~----~~~-----~~~~~~~  233 (258)
T cd05078         172 PPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-------YED--RHQ----LPA-----PKWTELA  233 (258)
T ss_pred             CchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH-------HHc--ccc----CCC-----CCcHHHH
Confidence            99998864 4688999999999999999984 55543322221111       000  000    011     1123678


Q ss_pred             HHhccccCCCCCCCCCHHHHHHHhc
Q 027675          153 NVGLLCVQEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       153 ~li~~cl~~~p~~Rps~~~~l~~l~  177 (220)
                      +++.+||+.+|++|||++++++.|.
T Consensus       234 ~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         234 NLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             HHHHHHhccChhhCCCHHHHHHhcC
Confidence            9999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.93  E-value=1.4e-25  Score=177.28  Aligned_cols=155  Identities=25%  Similarity=0.372  Sum_probs=118.5

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      ++..++.+++.||.|||+.+   ++|+||+|+||+++.++.++++|||++........  ......++..|.|||.+.+.
T Consensus       102 ~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~  176 (277)
T cd06640         102 QIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIQQS  176 (277)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--ccccccCcccccCHhHhccC
Confidence            45678999999999999999   99999999999999999999999999875443221  12223456789999999888


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      .++.++|+||||+++|+|++|..||..........       ....+.         ...........+.+++.+||+.+
T Consensus       177 ~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-------~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~  240 (277)
T cd06640         177 AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF-------LIPKNN---------PPTLTGEFSKPFKEFIDACLNKD  240 (277)
T ss_pred             CCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh-------hhhcCC---------CCCCchhhhHHHHHHHHHHcccC
Confidence            88999999999999999999999986443222110       000000         01122234567889999999999


Q ss_pred             CCCCCCHHHHHHHhcC
Q 027675          163 PNDRPTMSDVVIMLGS  178 (220)
Q Consensus       163 p~~Rps~~~~l~~l~~  178 (220)
                      |++||++.+++.+-..
T Consensus       241 p~~Rp~~~~il~~~~~  256 (277)
T cd06640         241 PSFRPTAKELLKHKFI  256 (277)
T ss_pred             cccCcCHHHHHhChHh
Confidence            9999999999987543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.93  E-value=5.2e-26  Score=183.93  Aligned_cols=173  Identities=19%  Similarity=0.192  Sum_probs=113.5

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCC-----CCcccceeecccCccCh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQ-----TDGTTNRVVGTYGYMSP   76 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~~~~~~y~aP   76 (220)
                      ..++.++.|++.||+|||+++   ++||||||+||+++.++.++++||+.........     .........++..|+||
T Consensus       101 ~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP  177 (327)
T cd08227         101 LAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSP  177 (327)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccCh
Confidence            357789999999999999999   9999999999999999999999997643221100     00011112345679999


Q ss_pred             hhhhc--CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHH--HHHHH------Hhc---------ccccccc-
Q 027675           77 EYALG--GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGY--AWKLW------QEG---------KALDMMD-  136 (220)
Q Consensus        77 e~~~~--~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~--~~~~~------~~~---------~~~~~~~-  136 (220)
                      |.+.+  ..++.++|+|||||++|+|++|..||..............  .....      .+.         ....... 
T Consensus       178 E~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (327)
T cd08227         178 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGES  257 (327)
T ss_pred             HHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcc
Confidence            99876  3578999999999999999999999964332211100000  00000      000         0000000 


Q ss_pred             -----------CCCCCcCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHhc
Q 027675          137 -----------QKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       137 -----------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~  177 (220)
                                 ..............+.+++.+||+.||++|||+++++++-+
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~  309 (327)
T cd08227         258 TTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF  309 (327)
T ss_pred             cccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChh
Confidence                       00000011223457889999999999999999999997654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.93  E-value=1.2e-25  Score=182.32  Aligned_cols=178  Identities=21%  Similarity=0.284  Sum_probs=121.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCC--cccceeecccCccChhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD--GTTNRVVGTYGYMSPEYA   79 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~y~aPe~~   79 (220)
                      ..++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.........  .......++..|.|||.+
T Consensus       107 ~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~  183 (334)
T cd07855         107 EHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELL  183 (334)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHh
Confidence            357889999999999999999   999999999999999999999999998754432211  111123567789999988


Q ss_pred             hc-CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHH--------HHHHHhccccccccCCCCC-cC-----c
Q 027675           80 LG-GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA--------WKLWQEGKALDMMDQKPGA-IS-----K  144 (220)
Q Consensus        80 ~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~-~~-----~  144 (220)
                      .+ ..++.++|+||||+++|+|++|+.||...+...........        ................+.. ..     .
T Consensus       184 ~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (334)
T cd07855         184 LSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIF  263 (334)
T ss_pred             cCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHc
Confidence            65 35788999999999999999999999644332221111000        0000000000000000000 00     1


Q ss_pred             HHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcCcccc
Q 027675          145 ANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEAVN  182 (220)
Q Consensus       145 ~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~~~~  182 (220)
                      ......+.++|.+||+.+|++||++.+++.+-+.....
T Consensus       264 ~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~  301 (334)
T cd07855         264 PKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH  301 (334)
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence            12346789999999999999999999999887665333

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=8.7e-26  Score=178.55  Aligned_cols=157  Identities=24%  Similarity=0.363  Sum_probs=115.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhh-
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL-   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~-   80 (220)
                      ..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++.......  .......++..|.+||.+. 
T Consensus       103 ~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~  177 (280)
T cd06611         103 PQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--QKRDTFIGTPYWMAPEVVAC  177 (280)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc--cccceeecchhhcCHHHHhh
Confidence            357889999999999999999   9999999999999999999999999875432211  1122245678899999875 


Q ss_pred             ----cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhc
Q 027675           81 ----GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGL  156 (220)
Q Consensus        81 ----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  156 (220)
                          +..++.++|+||||+++|+|++|+.||...+......      +. ..+..       +...........+.+++.
T Consensus       178 ~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~------~~-~~~~~-------~~~~~~~~~~~~~~~li~  243 (280)
T cd06611         178 ETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLL------KI-LKSEP-------PTLDQPSKWSSSFNDFLK  243 (280)
T ss_pred             cccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHH------HH-hcCCC-------CCcCCcccCCHHHHHHHH
Confidence                3346789999999999999999999986543322111      11 11110       000111122346788999


Q ss_pred             cccCCCCCCCCCHHHHHHHhc
Q 027675          157 LCVQEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       157 ~cl~~~p~~Rps~~~~l~~l~  177 (220)
                      .||+.+|++||++++++++-+
T Consensus       244 ~~l~~~p~~Rps~~~il~~~~  264 (280)
T cd06611         244 SCLVKDPDDRPTAAELLKHPF  264 (280)
T ss_pred             HHhccChhhCcCHHHHhcChh
Confidence            999999999999999998754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.93  E-value=2.5e-26  Score=180.05  Aligned_cols=157  Identities=29%  Similarity=0.469  Sum_probs=115.7

Q ss_pred             hHHHHHHHHHHHHHHhhh-CCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            3 MLFNIILGVSRRLLYLHQ-DSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~-~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+..++.|++.||+|||+ .+   ++|+||+|+||+++.++.++|+|||.+........    ....++..|++||.+.+
T Consensus       101 ~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~~y~~PE~~~~  173 (265)
T cd06605         101 ILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA----KTFVGTSSYMAPERIQG  173 (265)
T ss_pred             HHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh----hcccCChhccCHHHHcC
Confidence            467899999999999999 88   99999999999999999999999998754322111    11456778999999988


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+||||++++++++|..||........ ...........         ..............+.++|.+||..
T Consensus       174 ~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~li~~~l~~  243 (265)
T cd06605         174 NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYIVN---------EPPPRLPSGKFSPDFQDFVNLCLIK  243 (265)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHHhc---------CCCCCCChhhcCHHHHHHHHHHcCC
Confidence            8899999999999999999999999864421110 01111111110         0111111111445688999999999


Q ss_pred             CCCCCCCHHHHHHHh
Q 027675          162 DPNDRPTMSDVVIML  176 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l  176 (220)
                      +|++|||+.+++.+-
T Consensus       244 ~p~~Rpt~~~ll~~~  258 (265)
T cd06605         244 DPRERPSYKELLEHP  258 (265)
T ss_pred             CchhCcCHHHHhhCc
Confidence            999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.93  E-value=7e-26  Score=180.27  Aligned_cols=169  Identities=25%  Similarity=0.264  Sum_probs=116.5

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|+++||.|||+.+   ++|+||||+||+++.++.++|+|||++.........  .....++..|+|||.+.+
T Consensus       106 ~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~  180 (293)
T cd07843         106 SEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP--YTQLVVTLWYRAPELLLG  180 (293)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCccc--cccccccccccCchhhcC
Confidence            357889999999999999999   999999999999999999999999988765432111  122345678999999876


Q ss_pred             CC-CcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHH--------HHHHHHh---cc---ccccccCCCCCcCcHH
Q 027675           82 GF-FSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGY--------AWKLWQE---GK---ALDMMDQKPGAISKAN  146 (220)
Q Consensus        82 ~~-~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~--------~~~~~~~---~~---~~~~~~~~~~~~~~~~  146 (220)
                      .. .+.++|+||||+++++|++|..||..............        .+.....   ..   ................
T Consensus       181 ~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (293)
T cd07843         181 AKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPAL  260 (293)
T ss_pred             CccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhcccccc
Confidence            53 58899999999999999999999975543322211100        0000000   00   0000000000000000


Q ss_pred             -HHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 027675          147 -EILKCINVGLLCVQEDPNDRPTMSDVVIM  175 (220)
Q Consensus       147 -~~~~~~~li~~cl~~~p~~Rps~~~~l~~  175 (220)
                       ....+.++|.+||+.+|++|||+++++.+
T Consensus       261 ~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         261 SLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             CCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence             24467899999999999999999999976

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.93  E-value=5.1e-26  Score=179.85  Aligned_cols=166  Identities=22%  Similarity=0.270  Sum_probs=115.6

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+++.++.|++.||.|||+.+   ++|+||+|+||+++. +.++|+|||++.........   ....++..|+|||.+.+
T Consensus       100 ~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~  172 (282)
T cd07831         100 KRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY---TEYISTRWYRAPECLLT  172 (282)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCCc---CCCCCCcccCChhHhhc
Confidence            467889999999999999999   999999999999999 99999999998754322211   12345778999997654


Q ss_pred             -CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHH-H-------HHHHHhccccccccCCCCCc-----CcHHH
Q 027675           82 -GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGY-A-------WKLWQEGKALDMMDQKPGAI-----SKANE  147 (220)
Q Consensus        82 -~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~-~-------~~~~~~~~~~~~~~~~~~~~-----~~~~~  147 (220)
                       ..++.++|+|||||++|+|++|..||...+.......... .       ........... ........     .....
T Consensus       173 ~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  251 (282)
T cd07831         173 DGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN-YNFPSKKGTGLRKLLPNA  251 (282)
T ss_pred             CCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc-ccCcccccccHHHHcccc
Confidence             4468899999999999999999999965443322111100 0       00000000000 00000000     01123


Q ss_pred             HHHHHHHhccccCCCCCCCCCHHHHHHH
Q 027675          148 ILKCINVGLLCVQEDPNDRPTMSDVVIM  175 (220)
Q Consensus       148 ~~~~~~li~~cl~~~p~~Rps~~~~l~~  175 (220)
                      ...+.++|.+||..+|++||++++++.+
T Consensus       252 ~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         252 SAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             cHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            5688999999999999999999999976

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.93  E-value=3.1e-26  Score=185.89  Aligned_cols=172  Identities=24%  Similarity=0.324  Sum_probs=116.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCC-CcccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT-DGTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~y~aPe~~~   80 (220)
                      ..++.++.|+++||.+||+.+   ++||||||+||+++.++.++|+|||++........ ........++..|+|||.+.
T Consensus       106 ~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  182 (336)
T cd07849         106 DHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIML  182 (336)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhh
Confidence            356789999999999999999   99999999999999999999999999875432211 11112235677899999876


Q ss_pred             c-CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHH-H-------HHHHHhccc---cccccCCCCCc---CcH
Q 027675           81 G-GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGY-A-------WKLWQEGKA---LDMMDQKPGAI---SKA  145 (220)
Q Consensus        81 ~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~-~-------~~~~~~~~~---~~~~~~~~~~~---~~~  145 (220)
                      + ..++.++|+||||+++|+|++|+.||...+.......... .       .........   ...........   ...
T Consensus       183 ~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (336)
T cd07849         183 NSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFP  262 (336)
T ss_pred             CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhc
Confidence            5 4578899999999999999999999965432211110000 0       000000000   00000000000   001


Q ss_pred             HHHHHHHHHhccccCCCCCCCCCHHHHHHHh
Q 027675          146 NEILKCINVGLLCVQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       146 ~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l  176 (220)
                      .....+.++|.+||+.+|++|||+.+++.+-
T Consensus       263 ~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp  293 (336)
T cd07849         263 NADPKALDLLDKMLTFNPHKRITVEEALAHP  293 (336)
T ss_pred             ccCcHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence            1245688999999999999999999999884

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=2e-25  Score=180.89  Aligned_cols=160  Identities=21%  Similarity=0.213  Sum_probs=111.1

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc-
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG-   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~-   81 (220)
                      .+..++.|++.||+|||+++   ++||||||+||+++.++.++|+|||++......... ......+++.|+|||.+.+ 
T Consensus       103 ~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~  178 (331)
T cd05597         103 MARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV-QSNVAVGTPDYISPEILQAM  178 (331)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc-cccceeccccccCHHHHhhc
Confidence            56778999999999999999   999999999999999999999999998654322211 1122457889999999863 


Q ss_pred             ----CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcc
Q 027675           82 ----GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLL  157 (220)
Q Consensus        82 ----~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  157 (220)
                          ..++.++|+|||||++|+|++|+.||...+......      .............   ..   ......+.++|.+
T Consensus       179 ~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~------~i~~~~~~~~~~~---~~---~~~~~~~~~li~~  246 (331)
T cd05597         179 EDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG------KIMNHKEHFQFPP---DV---TDVSEEAKDLIRR  246 (331)
T ss_pred             cccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHH------HHHcCCCcccCCC---cc---CCCCHHHHHHHHH
Confidence                346789999999999999999999986543322111      1111111111111   00   1123356677777


Q ss_pred             ccCCCC--CCCCCHHHHHHHhcC
Q 027675          158 CVQEDP--NDRPTMSDVVIMLGS  178 (220)
Q Consensus       158 cl~~~p--~~Rps~~~~l~~l~~  178 (220)
                      ||..++  ..|+++++++.+-+.
T Consensus       247 ll~~~~~r~~r~~~~~~l~hp~~  269 (331)
T cd05597         247 LICSPETRLGRNGLQDFKDHPFF  269 (331)
T ss_pred             HccCcccccCCCCHHHHhcCCCC
Confidence            665433  348899999988543

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=6.9e-26  Score=184.25  Aligned_cols=161  Identities=22%  Similarity=0.361  Sum_probs=128.2

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceee-CCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILL-DHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili-~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ...+++.||+.|+.|+|+..   ++||||||+|+.+ .+-|-|||+|||++..+.+...   .+...|...|.|||++.|
T Consensus       119 La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k---L~TsCGSLAYSAPEILLG  192 (864)
T KOG4717|consen  119 LAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK---LTTSCGSLAYSAPEILLG  192 (864)
T ss_pred             HHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcch---hhcccchhhccCchhhhc
Confidence            35689999999999999998   9999999999855 7788999999999876654432   233567889999999999


Q ss_pred             CCC-cccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFF-SVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..| .++.||||||+|+|-|++|++||+..++.+..               ..++|+.--  .+......+.++|..||.
T Consensus       193 DsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL---------------TmImDCKYt--vPshvS~eCrdLI~sMLv  255 (864)
T KOG4717|consen  193 DSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL---------------TMIMDCKYT--VPSHVSKECRDLIQSMLV  255 (864)
T ss_pred             CccCCcchhhhHHHHHHHHHHhCCCccccccchhhh---------------hhhhccccc--CchhhhHHHHHHHHHHHh
Confidence            887 47799999999999999999999877665443               123333222  234456689999999999


Q ss_pred             CCCCCCCCHHHHHHHhcCccccCCCC
Q 027675          161 EDPNDRPTMSDVVIMLGSEAVNLASP  186 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~~~~~~~~  186 (220)
                      .||++|.+.++|..+-|-...+.+..
T Consensus       256 RdPkkRAslEeI~s~~Wlq~~D~~~s  281 (864)
T KOG4717|consen  256 RDPKKRASLEEIVSTSWLQAGDRGLS  281 (864)
T ss_pred             cCchhhccHHHHhccccccCCCCCcc
Confidence            99999999999998776665554443

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.93  E-value=1.1e-25  Score=175.61  Aligned_cols=152  Identities=24%  Similarity=0.389  Sum_probs=116.2

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      +++.++.|++.|+.|||+++   ++|+||+|+||+++.++.++++|||++........  ......++..|+|||.+.+.
T Consensus       102 ~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~  176 (256)
T cd08218         102 QILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--LARTCIGTPYYLSPEICENR  176 (256)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh--hhhhccCCccccCHHHhCCC
Confidence            56789999999999999999   99999999999999999999999998875432211  11223467789999999888


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      ..+.++|+||||++++++++|..||...+.....      .+.. .+...    .     ........+.++|.+||+.+
T Consensus       177 ~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~------~~~~-~~~~~----~-----~~~~~~~~~~~li~~~l~~~  240 (256)
T cd08218         177 PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLV------LKII-RGSYP----P-----VSSHYSYDLRNLVSQLFKRN  240 (256)
T ss_pred             CCCCccchhHHHHHHHHHHcCCCCccCCCHHHHH------HHHh-cCCCC----C-----CcccCCHHHHHHHHHHhhCC
Confidence            8889999999999999999999998644332211      1111 11110    0     11122446889999999999


Q ss_pred             CCCCCCHHHHHHH
Q 027675          163 PNDRPTMSDVVIM  175 (220)
Q Consensus       163 p~~Rps~~~~l~~  175 (220)
                      |++||++.+++++
T Consensus       241 p~~Rp~~~~vl~~  253 (256)
T cd08218         241 PRDRPSVNSILEK  253 (256)
T ss_pred             hhhCcCHHHHhhC
Confidence            9999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.93  E-value=1.1e-25  Score=180.63  Aligned_cols=170  Identities=25%  Similarity=0.391  Sum_probs=117.2

Q ss_pred             hHHHHHHHHHHHHHHhhh-CCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            3 MLFNIILGVSRRLLYLHQ-DSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~-~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+..++.|+++||.|||+ .+   ++|+||||+||+++.++.++|+|||++......    ......++..|+|||.+.+
T Consensus       100 ~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~aPE~~~~  172 (308)
T cd06615         100 ILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQG  172 (308)
T ss_pred             HHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc----ccccCCCCcCccChhHhcC
Confidence            467899999999999997 57   999999999999999999999999987543221    1122456789999999988


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccc---------------------cccccCCCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKA---------------------LDMMDQKPG  140 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~  140 (220)
                      ..++.++|+||||+++|+|++|..||...+....................                     .........
T Consensus       173 ~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (308)
T cd06615         173 THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPP  252 (308)
T ss_pred             CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCc
Confidence            88899999999999999999999998643322211111000000000000                     000000000


Q ss_pred             CcCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          141 AISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       141 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      ..........+.+++.+||..+|++||++.+++.+-+..
T Consensus       253 ~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~  291 (308)
T cd06615         253 KLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIK  291 (308)
T ss_pred             cCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhh
Confidence            000111334688999999999999999999999887553

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.93  E-value=1e-25  Score=177.03  Aligned_cols=158  Identities=28%  Similarity=0.446  Sum_probs=116.5

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCccc-ceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTT-NRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~-~~~~~~~~y~aPe~~~   80 (220)
                      .+++.++.|++.||.+||+.+   ++|+||||+||+++.++.++++|||++............ .....+..|.+||.+.
T Consensus       106 ~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~  182 (267)
T cd05066         106 IQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA  182 (267)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhc
Confidence            357889999999999999999   999999999999999999999999988754322111111 1111235799999998


Q ss_pred             cCCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           81 GGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      +..++.++|+||||+++|++++ |..||..........       ...++...      +.   .......+.+++.+||
T Consensus       183 ~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~-------~~~~~~~~------~~---~~~~~~~~~~li~~~l  246 (267)
T cd05066         183 YRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIK-------AIEEGYRL------PA---PMDCPAALHQLMLDCW  246 (267)
T ss_pred             cCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHH-------HHhCCCcC------CC---CCCCCHHHHHHHHHHc
Confidence            8888999999999999999886 999986443322111       11111110      00   0112346788999999


Q ss_pred             CCCCCCCCCHHHHHHHhcC
Q 027675          160 QEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l~~  178 (220)
                      +.+|.+||++.++++.|..
T Consensus       247 ~~~p~~Rp~~~~i~~~l~~  265 (267)
T cd05066         247 QKDRNERPKFEQIVSILDK  265 (267)
T ss_pred             ccCchhCCCHHHHHHHHHh
Confidence            9999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.93  E-value=2e-25  Score=178.94  Aligned_cols=153  Identities=30%  Similarity=0.370  Sum_probs=115.4

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhh--
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL--   80 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~--   80 (220)
                      .+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++......      ....++..|+|||.+.  
T Consensus       116 ~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~  186 (307)
T cd06607         116 EIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA------NSFVGTPYWMAPEVILAM  186 (307)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC------CCccCCccccCceeeecc
Confidence            56789999999999999999   999999999999999999999999987643321      1234677899999874  


Q ss_pred             -cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           81 -GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        81 -~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                       ...++.++|+||||+++|+|++|..||...+.......      .. ..        .............+.+++.+||
T Consensus       187 ~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~------~~-~~--------~~~~~~~~~~~~~~~~li~~~l  251 (307)
T cd06607         187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH------IA-QN--------DSPTLSSNDWSDYFRNFVDSCL  251 (307)
T ss_pred             CCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHH------Hh-cC--------CCCCCCchhhCHHHHHHHHHHh
Confidence             34578899999999999999999999864433221110      00 00        0001111223457899999999


Q ss_pred             CCCCCCCCCHHHHHHHhcCc
Q 027675          160 QEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l~~~  179 (220)
                      ..+|++||++.+++.+.+..
T Consensus       252 ~~~p~~Rp~~~~il~~~~~~  271 (307)
T cd06607         252 QKIPQDRPSSEELLKHRFVL  271 (307)
T ss_pred             cCChhhCcCHHHHhcChhhc
Confidence            99999999999999876544

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.93  E-value=1.6e-26  Score=203.65  Aligned_cols=153  Identities=29%  Similarity=0.384  Sum_probs=117.8

Q ss_pred             HHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCC--CCcccceeecccCccChhhhhcC-
Q 027675            6 NIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQ--TDGTTNRVVGTYGYMSPEYALGG-   82 (220)
Q Consensus         6 ~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~y~aPe~~~~~-   82 (220)
                      -+..|++.|+.|||++|   |+||||||.||+++.+|.+|++|||.+.......  ....-+...||+.|+|||.+.+. 
T Consensus      1338 vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~ 1414 (1509)
T KOG4645|consen 1338 VYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTK 1414 (1509)
T ss_pred             HHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccc
Confidence            35689999999999999   9999999999999999999999999998766442  12233346899999999999754 


Q ss_pred             --CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           83 --FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        83 --~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                        +-..++|||||||++.||.||+.||...+.+-+.=.     ++ ..|...       ..+  ...+....+++.+||.
T Consensus      1415 ~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy-----~V-~~gh~P-------q~P--~~ls~~g~dFle~Cl~ 1479 (1509)
T KOG4645|consen 1415 GKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMY-----HV-AAGHKP-------QIP--ERLSSEGRDFLEHCLE 1479 (1509)
T ss_pred             cCCCCcchhhhcccceEEEeecCCCchhhccchhHHHh-----HH-hccCCC-------CCc--hhhhHhHHHHHHHHHh
Confidence              456789999999999999999999975554332100     00 011111       111  1245577899999999


Q ss_pred             CCCCCCCCHHHHHHHh
Q 027675          161 EDPNDRPTMSDVVIML  176 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l  176 (220)
                      .||+.|+++.|++++-
T Consensus      1480 ~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1480 QDPKMRWTASQLLEHA 1495 (1509)
T ss_pred             cCchhhhHHHHHHHhh
Confidence            9999999999999875

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.93  E-value=7e-26  Score=179.54  Aligned_cols=170  Identities=22%  Similarity=0.351  Sum_probs=117.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+++.++.+++.||.|||+++   ++|+||+|+||+++.++.++|+|||++......... ......++..|+|||.+.+
T Consensus       100 ~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~  175 (288)
T cd07833         100 DAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPAS-PLTDYVATRWYRAPELLVG  175 (288)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCccc-cccCcccccCCcCCchhcC
Confidence            357889999999999999999   999999999999999999999999998754432211 1122456778999999988


Q ss_pred             C-CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHH--------HHHHhccccccccC-CCCCc------CcH
Q 027675           82 G-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAW--------KLWQEGKALDMMDQ-KPGAI------SKA  145 (220)
Q Consensus        82 ~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~-~~~~~------~~~  145 (220)
                      . .++.++|+||||+++|+|++|..||...+............        .............. .....      ...
T Consensus       176 ~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (288)
T cd07833         176 DTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPG  255 (288)
T ss_pred             CCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCC
Confidence            7 78899999999999999999999986543322111100000        00000000000000 00000      001


Q ss_pred             HHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 027675          146 NEILKCINVGLLCVQEDPNDRPTMSDVVIM  175 (220)
Q Consensus       146 ~~~~~~~~li~~cl~~~p~~Rps~~~~l~~  175 (220)
                      .....+.++|.+||..+|++||++++++++
T Consensus       256 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         256 KVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             ccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence            124578999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.93  E-value=1.4e-25  Score=174.53  Aligned_cols=158  Identities=26%  Similarity=0.416  Sum_probs=119.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||.+................++..|.+||...+
T Consensus       101 ~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~  177 (260)
T cd06606         101 PVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG  177 (260)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcC
Confidence            457889999999999999999   99999999999999999999999999876554332111223456789999999988


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ...+.++|+||||++++++++|..||.......     ....+.........         ........+.+++.+||+.
T Consensus       178 ~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~---------~~~~~~~~l~~~i~~~l~~  243 (260)
T cd06606         178 EEYGRAADIWSLGCTVIEMATGKPPWSELGNPM-----AALYKIGSSGEPPE---------IPEHLSEEAKDFLRKCLRR  243 (260)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-----HHHHhccccCCCcC---------CCcccCHHHHHHHHHhCcC
Confidence            888999999999999999999999987544111     11111111011111         1111245788999999999


Q ss_pred             CCCCCCCHHHHHHHh
Q 027675          162 DPNDRPTMSDVVIML  176 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l  176 (220)
                      +|++||++.+++.+-
T Consensus       244 ~p~~Rp~~~~ll~~~  258 (260)
T cd06606         244 DPKKRPTADELLQHP  258 (260)
T ss_pred             ChhhCCCHHHHhhCC
Confidence            999999999999763

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.93  E-value=8.5e-26  Score=178.83  Aligned_cols=159  Identities=22%  Similarity=0.257  Sum_probs=117.6

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhh-
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL-   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~-   80 (220)
                      ..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......    .....++..|+|||.+. 
T Consensus        97 ~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~  169 (279)
T cd05633          97 KEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQK  169 (279)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC----ccCcCCCcCccCHHHhcC
Confidence            457789999999999999999   9999999999999999999999999886443221    11235688999999886 


Q ss_pred             cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           81 GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      +..++.++|+||+||++|+|++|..||............    ...    .. .   .  ..........+.+++.+||.
T Consensus       170 ~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~----~~~----~~-~---~--~~~~~~~~~~~~~li~~~l~  235 (279)
T cd05633         170 GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMT----LT-V---N--VELPDSFSPELKSLLEGLLQ  235 (279)
T ss_pred             CCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHH----HHh----hc-C---C--cCCccccCHHHHHHHHHHhc
Confidence            455788999999999999999999998643322211110    000    00 0   0  00111233477889999999


Q ss_pred             CCCCCCC-----CHHHHHHHhcCccc
Q 027675          161 EDPNDRP-----TMSDVVIMLGSEAV  181 (220)
Q Consensus       161 ~~p~~Rp-----s~~~~l~~l~~~~~  181 (220)
                      .||++||     ++++++++-+....
T Consensus       236 ~~p~~R~~~~~~~~~~~~~h~~~~~~  261 (279)
T cd05633         236 RDVSKRLGCLGRGAQEVKEHVFFKGI  261 (279)
T ss_pred             CCHHHhcCCCCCCHHHHHhCccccCC
Confidence            9999999     69999998655443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.93  E-value=7.5e-26  Score=177.49  Aligned_cols=157  Identities=22%  Similarity=0.309  Sum_probs=115.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCC----CCcccceeecccCccChh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQ----TDGTTNRVVGTYGYMSPE   77 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~~y~aPe   77 (220)
                      +.+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.......    .........++..|+|||
T Consensus       102 ~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe  178 (265)
T cd06631         102 PVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE  178 (265)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChh
Confidence            356788999999999999999   9999999999999999999999999876432110    011112235677899999


Q ss_pred             hhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcc
Q 027675           78 YALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLL  157 (220)
Q Consensus        78 ~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  157 (220)
                      .+.+..++.++|+||||+++|++++|..||...+.......     .....+..    ...     .......+.++|.+
T Consensus       179 ~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~-----~~~~~~~~----~~~-----~~~~~~~~~~~i~~  244 (265)
T cd06631         179 VINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFY-----IGAHRGLM----PRL-----PDSFSAAAIDFVTS  244 (265)
T ss_pred             hhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHH-----hhhccCCC----CCC-----CCCCCHHHHHHHHH
Confidence            99888889999999999999999999999864332211100     00000000    001     11233467899999


Q ss_pred             ccCCCCCCCCCHHHHHHH
Q 027675          158 CVQEDPNDRPTMSDVVIM  175 (220)
Q Consensus       158 cl~~~p~~Rps~~~~l~~  175 (220)
                      ||+.+|++||++.+++.+
T Consensus       245 ~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         245 CLTRDQHERPSALQLLRH  262 (265)
T ss_pred             HhcCCcccCCCHHHHhcC
Confidence            999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.93  E-value=1.8e-25  Score=178.22  Aligned_cols=173  Identities=23%  Similarity=0.258  Sum_probs=116.9

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|+++||.|||+++   ++|+||+|+||+++.++.++|+|||++.........  .....++..|.|||.+.+
T Consensus       102 ~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~  176 (298)
T cd07841         102 ADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK--MTHQVVTRWYRAPELLFG  176 (298)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc--ccccccceeeeCHHHHhC
Confidence            357889999999999999999   999999999999999999999999998765432111  111234668999998865


Q ss_pred             -CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhH-HHH----HHHHHhc-cccccccCCCCC-----cCcHHHHH
Q 027675           82 -GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLL-GYA----WKLWQEG-KALDMMDQKPGA-----ISKANEIL  149 (220)
Q Consensus        82 -~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~-~~~----~~~~~~~-~~~~~~~~~~~~-----~~~~~~~~  149 (220)
                       ..++.++|+|||||++|+|++|.++|............ ...    ...+... ............     ........
T Consensus       177 ~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (298)
T cd07841         177 ARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASD  256 (298)
T ss_pred             CCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccH
Confidence             35688999999999999999998877643332211111 000    0000000 000000000000     01122245


Q ss_pred             HHHHHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          150 KCINVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       150 ~~~~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      .+.++|.+||+.+|++|||+.+++.+=+-.
T Consensus       257 ~~~~li~~~l~~~P~~R~s~~e~l~~~~~~  286 (298)
T cd07841         257 DALDLLQRLLTLNPNKRITARQALEHPYFS  286 (298)
T ss_pred             HHHHHHHHHhcCCcccCcCHHHHhhCcccc
Confidence            788999999999999999999999874333

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.93  E-value=1.9e-25  Score=173.98  Aligned_cols=151  Identities=26%  Similarity=0.334  Sum_probs=118.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +.++.++.+++.||.|||+.+   ++|+||+|.||+++.++.++|+|||++.......    .....++..|++||.+.+
T Consensus       103 ~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~  175 (256)
T cd08530         103 QEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM----AKTQIGTPHYMAPEVWKG  175 (256)
T ss_pred             HHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC----cccccCCccccCHHHHCC
Confidence            356789999999999999999   9999999999999999999999999887554331    112346778999999998


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+||||++++++++|..||...+.......       ...+...         .........+.+++.+||..
T Consensus       176 ~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~-------~~~~~~~---------~~~~~~~~~~~~li~~~l~~  239 (256)
T cd08530         176 RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYK-------VQRGKYP---------PIPPIYSQDLQNFIRSMLQV  239 (256)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------HhcCCCC---------CCchhhCHHHHHHHHHHcCC
Confidence            8889999999999999999999999975543322111       0111111         11123455789999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 027675          162 DPNDRPTMSDVVIM  175 (220)
Q Consensus       162 ~p~~Rps~~~~l~~  175 (220)
                      +|++||++.+++++
T Consensus       240 ~p~~Rp~~~~~l~~  253 (256)
T cd08530         240 KPKLRPNCDKILAS  253 (256)
T ss_pred             CcccCCCHHHHhcC
Confidence            99999999999976

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.93  E-value=6.6e-26  Score=181.57  Aligned_cols=171  Identities=24%  Similarity=0.307  Sum_probs=116.5

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCc---------ccceeecccC
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG---------TTNRVVGTYG   72 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~---------~~~~~~~~~~   72 (220)
                      .++..++.|+++||.|||+.+   ++|+||||+||+++.++.++|+|||++..........         ......++..
T Consensus       115 ~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (311)
T cd07866         115 SQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRW  191 (311)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccC
Confidence            467889999999999999999   9999999999999999999999999987543221110         1112345678


Q ss_pred             ccChhhhhcC-CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHH--------HHHhccccccccCCCCCcC
Q 027675           73 YMSPEYALGG-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWK--------LWQEGKALDMMDQKPGAIS  143 (220)
Q Consensus        73 y~aPe~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~  143 (220)
                      |.|||.+.+. .++.++|+||||+++|+|++|.+||...+.............        ...................
T Consensus       192 y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (311)
T cd07866         192 YRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPR  271 (311)
T ss_pred             cCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCc
Confidence            9999988764 468899999999999999999999976554432221111000        0000000000000000000


Q ss_pred             c-----HHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 027675          144 K-----ANEILKCINVGLLCVQEDPNDRPTMSDVVIM  175 (220)
Q Consensus       144 ~-----~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~  175 (220)
                      .     ......+.+++.+||..||++|||+.+++.+
T Consensus       272 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         272 TLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             cHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            0     1112467899999999999999999999876

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.93  E-value=1.9e-25  Score=175.24  Aligned_cols=155  Identities=24%  Similarity=0.327  Sum_probs=114.4

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCC-cccceeecccCccChhhhhc
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD-GTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+++++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......... .......++..|+|||.+.+
T Consensus       107 ~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  183 (265)
T cd06652         107 VTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG  183 (265)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcC
Confidence            46789999999999999999   999999999999999999999999987643321111 11122346778999999988


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+||||+++|+|++|+.||..........      +....         .............+.+++.+|| .
T Consensus       184 ~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~------~~~~~---------~~~~~~~~~~~~~~~~~i~~~l-~  247 (265)
T cd06652         184 EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIF------KIATQ---------PTNPVLPPHVSDHCRDFLKRIF-V  247 (265)
T ss_pred             CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHH------HHhcC---------CCCCCCchhhCHHHHHHHHHHh-c
Confidence            888999999999999999999999986432222110      11000         0011112233456778888898 4


Q ss_pred             CCCCCCCHHHHHHHh
Q 027675          162 DPNDRPTMSDVVIML  176 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l  176 (220)
                      +|++||++++++++-
T Consensus       248 ~p~~Rp~~~~il~~~  262 (265)
T cd06652         248 EAKLRPSADELLRHT  262 (265)
T ss_pred             ChhhCCCHHHHhcCc
Confidence            999999999999764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=1.4e-25  Score=180.45  Aligned_cols=156  Identities=22%  Similarity=0.244  Sum_probs=116.4

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCC---------------------
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD---------------------   61 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~---------------------   61 (220)
                      .++.++.|+++||+|||+.+   ++|+||||+||+++.++.++|+|||++.........                     
T Consensus       104 ~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (316)
T cd05574         104 VARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSET  180 (316)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhh
Confidence            46678999999999999999   999999999999999999999999987643211100                     


Q ss_pred             ------cccceeecccCccChhhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccc
Q 027675           62 ------GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMM  135 (220)
Q Consensus        62 ------~~~~~~~~~~~y~aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  135 (220)
                            .......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+......      +....       
T Consensus       181 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~------~~~~~-------  247 (316)
T cd05574         181 FSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFS------NILKK-------  247 (316)
T ss_pred             hcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHH------HHhcC-------
Confidence                  01112356778999999998888999999999999999999999986544332211      11100       


Q ss_pred             cCCCCCcCcHHHHHHHHHHhccccCCCCCCCCC----HHHHHHHh
Q 027675          136 DQKPGAISKANEILKCINVGLLCVQEDPNDRPT----MSDVVIML  176 (220)
Q Consensus       136 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps----~~~~l~~l  176 (220)
                        .............+.+++.+||..+|++||+    +++++.+=
T Consensus       248 --~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~  290 (316)
T cd05574         248 --EVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHP  290 (316)
T ss_pred             --CccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCc
Confidence              0111111114457899999999999999999    88988763

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.93  E-value=4.9e-26  Score=186.43  Aligned_cols=158  Identities=23%  Similarity=0.242  Sum_probs=112.4

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCC---------------------
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD---------------------   61 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~---------------------   61 (220)
                      .+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++.........                     
T Consensus       102 ~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (360)
T cd05627         102 ATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS  178 (360)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCccccccccccc
Confidence            46778999999999999999   999999999999999999999999987643211000                     


Q ss_pred             ------------cccceeecccCccChhhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhc
Q 027675           62 ------------GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEG  129 (220)
Q Consensus        62 ------------~~~~~~~~~~~y~aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  129 (220)
                                  .......|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+......      +.....
T Consensus       179 ~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~------~i~~~~  252 (360)
T cd05627         179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYR------KVMNWK  252 (360)
T ss_pred             ccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHHHH------HHHcCC
Confidence                        00112357889999999999889999999999999999999999997544332211      111100


Q ss_pred             cccccccCCCCCcCcHHHHHHHHHHhccccCCCCCCCCC---HHHHHHHhc
Q 027675          130 KALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPT---MSDVVIMLG  177 (220)
Q Consensus       130 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps---~~~~l~~l~  177 (220)
                      ...   ...+...    ....+.++|.+|+ .||.+|++   +.+++.|-+
T Consensus       253 ~~~---~~p~~~~----~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~  295 (360)
T cd05627         253 ETL---VFPPEVP----ISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPF  295 (360)
T ss_pred             Cce---ecCCCCC----CCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCC
Confidence            111   1111111    2235667777766 49999985   788887743

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.93  E-value=2.5e-25  Score=180.37  Aligned_cols=158  Identities=20%  Similarity=0.217  Sum_probs=111.4

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc-
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG-   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~-   81 (220)
                      .+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++........ .......|++.|+|||.+.+ 
T Consensus       103 ~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~  178 (332)
T cd05623         103 MARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAM  178 (332)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCCc-ceecccccCccccCHHHHhcc
Confidence            46778999999999999999   99999999999999999999999998864332111 11222457889999999863 


Q ss_pred             ----CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcc
Q 027675           82 ----GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLL  157 (220)
Q Consensus        82 ----~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  157 (220)
                          ..++.++|+|||||++|+|++|+.||...+.....      .+.............      .......+.+++.+
T Consensus       179 ~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~------~~i~~~~~~~~~p~~------~~~~s~~~~~li~~  246 (332)
T cd05623         179 EDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY------GKIMNHKERFQFPAQ------VTDVSEDAKDLIRR  246 (332)
T ss_pred             ccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHH------HHHhCCCccccCCCc------cccCCHHHHHHHHH
Confidence                35688999999999999999999999654332221      111111111111000      01123466778888


Q ss_pred             ccCCCCCC--CCCHHHHHHHh
Q 027675          158 CVQEDPND--RPTMSDVVIML  176 (220)
Q Consensus       158 cl~~~p~~--Rps~~~~l~~l  176 (220)
                      |+..++++  |+++++++++-
T Consensus       247 ll~~~~~r~~r~~~~~~~~h~  267 (332)
T cd05623         247 LICSREHRLGQNGIEDFKQHP  267 (332)
T ss_pred             HccChhhhcCCCCHHHHhCCC
Confidence            87655544  68999999884

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.93  E-value=6.5e-26  Score=183.73  Aligned_cols=174  Identities=22%  Similarity=0.267  Sum_probs=117.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCC--cccceeecccCccChhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD--GTTNRVVGTYGYMSPEYA   79 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~y~aPe~~   79 (220)
                      ..++.++.|++.||.|||+.|   ++|+||||+||+++.++.++|+|||++.........  .......++..|.|||.+
T Consensus       105 ~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~  181 (332)
T cd07857         105 AHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIM  181 (332)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHH
Confidence            356789999999999999999   999999999999999999999999998754322111  111224577889999987


Q ss_pred             hc-CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHH--------HHHHHhcc---ccccccCCCCC---cCc
Q 027675           80 LG-GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA--------WKLWQEGK---ALDMMDQKPGA---ISK  144 (220)
Q Consensus        80 ~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~---~~~~~~~~~~~---~~~  144 (220)
                      .+ ..++.++|+||+|+++|++++|..||...+...........        ........   ........+..   ...
T Consensus       182 ~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (332)
T cd07857         182 LSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIF  261 (332)
T ss_pred             hCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhC
Confidence            66 45788999999999999999999998754432211110000        00000000   00000000000   000


Q ss_pred             HHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcC
Q 027675          145 ANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       145 ~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~  178 (220)
                      ......+.+++.+||..||++|||+.+++.+=+.
T Consensus       262 ~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~  295 (332)
T cd07857         262 PNANPLALDLLEKLLAFDPTKRISVEEALEHPYL  295 (332)
T ss_pred             CCCCHHHHHHHHHHccCCcccCCCHHHHhcChhh
Confidence            1123468899999999999999999999966443

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.93  E-value=1.7e-25  Score=176.09  Aligned_cols=160  Identities=28%  Similarity=0.391  Sum_probs=115.1

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++++|||++................++..|++||.+...
T Consensus       109 ~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~  185 (272)
T cd06629         109 LVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY  185 (272)
T ss_pred             HHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccc
Confidence            46778999999999999999   999999999999999999999999988653322111112223467789999998765


Q ss_pred             C--CcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           83 F--FSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        83 ~--~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      .  ++.++|+||||++++++++|..||.........      .+..........     ...........+.+++.+||.
T Consensus       186 ~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~------~~~~~~~~~~~~-----~~~~~~~~~~~~~~li~~~l~  254 (272)
T cd06629         186 SQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM------FKLGNKRSAPPI-----PPDVSMNLSPVALDFLNACFT  254 (272)
T ss_pred             cCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHH------HHhhccccCCcC-----CccccccCCHHHHHHHHHHhc
Confidence            4  788999999999999999999998533221111      011101000000     011111234578889999999


Q ss_pred             CCCCCCCCHHHHHHHh
Q 027675          161 EDPNDRPTMSDVVIML  176 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l  176 (220)
                      .+|++||++++++++-
T Consensus       255 ~~p~~Rps~~~il~~~  270 (272)
T cd06629         255 INPDNRPTARELLQHP  270 (272)
T ss_pred             CChhhCCCHHHHhhCC
Confidence            9999999999999873

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.92  E-value=3.1e-25  Score=177.96  Aligned_cols=155  Identities=30%  Similarity=0.375  Sum_probs=116.5

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .++..++.+++.|+.|||+.+   ++||||+|+||+++.++.++++|||++......      ....++..|+|||.+.+
T Consensus       115 ~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~  185 (308)
T cd06634         115 VEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYWMAPEVILA  185 (308)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc------ccccCCccccCHHHHhh
Confidence            356788999999999999999   999999999999999999999999987653321      22346778999999753


Q ss_pred             ---CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           82 ---GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        82 ---~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                         ...+.++|+||||+++|+|++|..||...+......      .. ..+...        ..........+.++|.+|
T Consensus       186 ~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------~~-~~~~~~--------~~~~~~~~~~~~~li~~c  250 (308)
T cd06634         186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HI-AQNESP--------ALQSGHWSEYFRNFVDSC  250 (308)
T ss_pred             cccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH------HH-hhcCCC--------CcCcccccHHHHHHHHHH
Confidence               356889999999999999999999975433222111      00 011110        001112344678999999


Q ss_pred             cCCCCCCCCCHHHHHHHhcCcc
Q 027675          159 VQEDPNDRPTMSDVVIMLGSEA  180 (220)
Q Consensus       159 l~~~p~~Rps~~~~l~~l~~~~  180 (220)
                      |..+|++||++.+++.+.+...
T Consensus       251 l~~~P~~Rp~~~~ll~~~~~~~  272 (308)
T cd06634         251 LQKIPQDRPTSEVLLKHRFVLR  272 (308)
T ss_pred             hhCCcccCCCHHHHhhCccccc
Confidence            9999999999999999876554

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.92  E-value=5.8e-26  Score=202.74  Aligned_cols=155  Identities=18%  Similarity=0.196  Sum_probs=106.6

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCC-------------------CCCceecCccceeeecCCCC--
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDH-------------------EMNPKISDFGLTRIFEGKQT--   60 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~-------------------~~~~~l~d~~~~~~~~~~~~--   60 (220)
                      .+++.+++||++||+|||++|   |+||||||+|||++.                   ++.++++|||+++.......  
T Consensus        80 ~~~~~i~~qi~~al~~lH~~g---IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~  156 (793)
T PLN00181         80 FECFHVFRQIVEIVNAAHSQG---IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERR  156 (793)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccc
Confidence            367889999999999999999   999999999999954                   34466677776653211000  


Q ss_pred             ------------CcccceeecccCccChhhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHh
Q 027675           61 ------------DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQE  128 (220)
Q Consensus        61 ------------~~~~~~~~~~~~y~aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~  128 (220)
                                  ........+++.|+|||.+.+..++.++|||||||++|||+++..|+.....  ...      .. ..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~------~~-~~  227 (793)
T PLN00181        157 IEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMS------SL-RH  227 (793)
T ss_pred             hhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHH------HH-HH
Confidence                        0001113467789999999998899999999999999999998877542110  000      00 00


Q ss_pred             ccccccccCCCCCcCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHhc
Q 027675          129 GKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       129 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~  177 (220)
                      ..    ...  .   .........+++.+||..+|.+||++.+++++-+
T Consensus       228 ~~----~~~--~---~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~  267 (793)
T PLN00181        228 RV----LPP--Q---ILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEF  267 (793)
T ss_pred             hh----cCh--h---hhhcCHHHHHHHHHhCCCChhhCcChHHHhhchh
Confidence            00    000  0   0111234567788899999999999999997654

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.92  E-value=1.2e-25  Score=178.95  Aligned_cols=166  Identities=20%  Similarity=0.258  Sum_probs=114.2

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCC-CCCceecCccceeeecCCCCCcccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDH-EMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~   80 (220)
                      ..++.++.|+++||.|||.++   ++||||+|+||+++. ++.++|+|||++.........  .....+++.|.|||.+.
T Consensus       110 ~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~  184 (295)
T cd07837         110 KTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS--YTHEIVTLWYRAPEVLL  184 (295)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecccceecCCCccc--cCCcccccCCCChHHhh
Confidence            467889999999999999999   999999999999998 888999999988754322111  11124467899999886


Q ss_pred             cC-CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhcc--cc----------ccccCCCCC--cCcH
Q 027675           81 GG-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGK--AL----------DMMDQKPGA--ISKA  145 (220)
Q Consensus        81 ~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~----------~~~~~~~~~--~~~~  145 (220)
                      +. .++.++|+||||+++|+|++|..||...+.......  .. .......  ..          ......+..  ....
T Consensus       185 ~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (295)
T cd07837         185 GSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLH--IF-KLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVP  261 (295)
T ss_pred             CCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH--HH-HHhCCCChhhCcchhhccchhhcCcccchhHHHhcc
Confidence            53 468899999999999999999999865433221110  00 0000000  00          000000000  0001


Q ss_pred             HHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 027675          146 NEILKCINVGLLCVQEDPNDRPTMSDVVIM  175 (220)
Q Consensus       146 ~~~~~~~~li~~cl~~~p~~Rps~~~~l~~  175 (220)
                      .....+.++|.+||..||++||++.+++.+
T Consensus       262 ~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         262 DLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             ccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            234568899999999999999999999976

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.92  E-value=3.1e-25  Score=178.69  Aligned_cols=158  Identities=30%  Similarity=0.372  Sum_probs=117.1

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhh-
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL-   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~-   80 (220)
                      .++..++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....      .....++..|+|||.+. 
T Consensus       125 ~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~  195 (317)
T cd06635         125 VEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP------ANSFVGTPYWMAPEVILA  195 (317)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC------cccccCCccccChhhhhc
Confidence            356789999999999999999   99999999999999999999999998754321      12234677899999874 


Q ss_pred             --cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           81 --GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        81 --~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                        +..++.++|+||||+++|+|++|..||..........      ... .+..        ...........+.+++.+|
T Consensus       196 ~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~------~~~-~~~~--------~~~~~~~~~~~l~~li~~~  260 (317)
T cd06635         196 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIA-QNES--------PTLQSNEWSDYFRNFVDSC  260 (317)
T ss_pred             CCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH------HHH-hccC--------CCCCCccccHHHHHHHHHH
Confidence              3457889999999999999999999985433222111      111 0000        0011112334678999999


Q ss_pred             cCCCCCCCCCHHHHHHHhcCccccC
Q 027675          159 VQEDPNDRPTMSDVVIMLGSEAVNL  183 (220)
Q Consensus       159 l~~~p~~Rps~~~~l~~l~~~~~~~  183 (220)
                      |+.+|.+||++.+++++........
T Consensus       261 l~~~p~~Rpt~~~il~~~~~~~~~~  285 (317)
T cd06635         261 LQKIPQDRPTSEELLKHMFVLRERP  285 (317)
T ss_pred             ccCCcccCcCHHHHHhChhhhccCc
Confidence            9999999999999999886654333

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.92  E-value=1.6e-25  Score=174.57  Aligned_cols=153  Identities=25%  Similarity=0.355  Sum_probs=115.1

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......   ......++..|++||.+..
T Consensus       102 ~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~  175 (258)
T cd06632         102 PVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQ  175 (258)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccccc---cccccCCCcceeCHHHhcC
Confidence            356778999999999999999   9999999999999999999999999876543322   1222456778999999876


Q ss_pred             CC-CcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GF-FSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~-~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      .. ++.++|+||||+++|++++|..||.........      ...........         ........+.+++.+||+
T Consensus       176 ~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~------~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~  240 (258)
T cd06632         176 QGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV------FKIGRSKELPP---------IPDHLSDEAKDFILKCLQ  240 (258)
T ss_pred             CCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH------HHHHhcccCCC---------cCCCcCHHHHHHHHHHhh
Confidence            65 789999999999999999999998654421111      11110001100         011123467889999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 027675          161 EDPNDRPTMSDVVIM  175 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~  175 (220)
                      .+|++||++.+++.+
T Consensus       241 ~~p~~Rp~~~~~l~~  255 (258)
T cd06632         241 RDPSLRPTAAELLEH  255 (258)
T ss_pred             cCcccCcCHHHHhcC
Confidence            999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.92  E-value=2.3e-25  Score=175.02  Aligned_cols=154  Identities=28%  Similarity=0.450  Sum_probs=111.4

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCC-CCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDH-EMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+..++.|++.||.|||+.+   ++|+||||+||+++. ++.++|+|||++........  ......++..|+|||.+.+
T Consensus       109 ~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~  183 (268)
T cd06624         109 TIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDK  183 (268)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccCCC--ccccCCCCccccChhhhcc
Confidence            45678899999999999999   999999999999976 67899999998865432211  1112346788999999865


Q ss_pred             CC--CcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           82 GF--FSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        82 ~~--~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      ..  ++.++|+||||+++|+|++|..||..........     ...   . ..   ...+.  ........+.+++.+||
T Consensus       184 ~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~-----~~~---~-~~---~~~~~--~~~~~~~~~~~li~~~l  249 (268)
T cd06624         184 GPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM-----FKV---G-MF---KIHPE--IPESLSAEAKNFILRCF  249 (268)
T ss_pred             ccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH-----hhh---h-hh---ccCCC--CCcccCHHHHHHHHHHc
Confidence            43  6789999999999999999999986432211110     000   0 00   00000  11123346788999999


Q ss_pred             CCCCCCCCCHHHHHHH
Q 027675          160 QEDPNDRPTMSDVVIM  175 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~  175 (220)
                      ..+|++||++.+++.+
T Consensus       250 ~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         250 EPDPDKRASAHDLLQD  265 (268)
T ss_pred             CCCchhCCCHHHHHhC
Confidence            9999999999999976

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.92  E-value=3e-25  Score=175.80  Aligned_cols=171  Identities=20%  Similarity=0.312  Sum_probs=116.5

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+++.++.|+++||.|||+.+   ++|+||||+||+++.++.++++|||++......... ......++..|+|||.+.+
T Consensus        99 ~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~  174 (286)
T cd07832          99 AQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR-LYSHQVATRWYRAPELLYG  174 (286)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC-ccccccCcccccCceeeec
Confidence            357889999999999999999   999999999999999999999999988754432211 1122356778999998865


Q ss_pred             C-CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhH-HHHH----HHHHhcccc----cc-ccCCCC---CcCcHHH
Q 027675           82 G-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLL-GYAW----KLWQEGKAL----DM-MDQKPG---AISKANE  147 (220)
Q Consensus        82 ~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~-~~~~----~~~~~~~~~----~~-~~~~~~---~~~~~~~  147 (220)
                      . .++.++|+||+|+++++|++|.++|............ ....    ..+......    .. ......   .....+.
T Consensus       175 ~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (286)
T cd07832         175 ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDA  254 (286)
T ss_pred             cccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCc
Confidence            4 4588999999999999999998887654432221111 0000    000000000    00 000000   0000122


Q ss_pred             HHHHHHHhccccCCCCCCCCCHHHHHHHh
Q 027675          148 ILKCINVGLLCVQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       148 ~~~~~~li~~cl~~~p~~Rps~~~~l~~l  176 (220)
                      ...+.+++.+||..+|++||++++++.+-
T Consensus       255 ~~~~~~li~~~l~~~p~~R~~~~~~l~h~  283 (286)
T cd07832         255 SPEALDLLKGLLVYDPSKRLSAAEALRHP  283 (286)
T ss_pred             cHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence            36788999999999999999999999874

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.92  E-value=1.7e-25  Score=196.26  Aligned_cols=156  Identities=29%  Similarity=0.444  Sum_probs=113.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeec--------------C--CCCCcccc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFE--------------G--KQTDGTTN   65 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~--------------~--~~~~~~~~   65 (220)
                      +..|+++++|++||.|+|+.|   |+||||||.|||++.++.|||+|||++....              .  .......+
T Consensus       697 d~~wrLFreIlEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~T  773 (1351)
T KOG1035|consen  697 DEAWRLFREILEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLT  773 (1351)
T ss_pred             HHHHHHHHHHHHHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccc
Confidence            357999999999999999999   9999999999999999999999999997621              0  11111334


Q ss_pred             eeecccCccChhhhhcC---CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCc
Q 027675           66 RVVGTYGYMSPEYALGG---FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI  142 (220)
Q Consensus        66 ~~~~~~~y~aPe~~~~~---~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  142 (220)
                      ..+||.-|+|||++.+.   .|+.|.||||||+|++||+.   ||+.  ..+-...+    ..++++...     .+ ..
T Consensus       774 s~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~T--sMERa~iL----~~LR~g~iP-----~~-~~  838 (1351)
T KOG1035|consen  774 SQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGT--SMERASIL----TNLRKGSIP-----EP-AD  838 (1351)
T ss_pred             cccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCc--hHHHHHHH----HhcccCCCC-----CC-cc
Confidence            46889999999999765   48999999999999999984   3432  11111111    111122221     11 22


Q ss_pred             CcHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 027675          143 SKANEILKCINVGLLCVQEDPNDRPTMSDVVIM  175 (220)
Q Consensus       143 ~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~  175 (220)
                      ........-..+|++|++.||.+||||.++|..
T Consensus       839 f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s  871 (1351)
T KOG1035|consen  839 FFDPEHPEEASLIRWLLSHDPSKRPTATELLNS  871 (1351)
T ss_pred             cccccchHHHHHHHHHhcCCCccCCCHHHHhhc
Confidence            222333345678899999999999999999965

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.92  E-value=9.1e-26  Score=178.80  Aligned_cols=168  Identities=22%  Similarity=0.332  Sum_probs=115.1

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........  ......++..|+|||.+.+
T Consensus       100 ~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~  174 (286)
T cd07846         100 SRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYTDYVATRWYRAPELLVG  174 (286)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc--ccCcccceeeccCcHHhcc
Confidence            467889999999999999999   99999999999999999999999999875433221  1122346778999999876


Q ss_pred             C-CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHH-H-------HHHHHhccccccccCCCCCc--C-----cH
Q 027675           82 G-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGY-A-------WKLWQEGKALDMMDQKPGAI--S-----KA  145 (220)
Q Consensus        82 ~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~-~-------~~~~~~~~~~~~~~~~~~~~--~-----~~  145 (220)
                      . .++.++|+||||+++|+|++|.+||.............. .       ............ ...+...  .     ..
T Consensus       175 ~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  253 (286)
T cd07846         175 DTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG-MRLPEVKEIEPLEKRFP  253 (286)
T ss_pred             ccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc-cccccccCcchHHHhCC
Confidence            4 467889999999999999999998864332111100000 0       000000000000 0000000  0     01


Q ss_pred             HHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 027675          146 NEILKCINVGLLCVQEDPNDRPTMSDVVIM  175 (220)
Q Consensus       146 ~~~~~~~~li~~cl~~~p~~Rps~~~~l~~  175 (220)
                      .....+.+++.+||..+|++||++.+++++
T Consensus       254 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         254 KLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             CcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence            224568899999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.92  E-value=9.1e-26  Score=182.56  Aligned_cols=175  Identities=25%  Similarity=0.292  Sum_probs=120.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCC-CcccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT-DGTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~y~aPe~~~   80 (220)
                      ..++.++.+++.||++||+.|   ++|+||||.||+++.++.++|+|||++........ ........++..|+|||.+.
T Consensus       103 ~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  179 (330)
T cd07834         103 DHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLL  179 (330)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeee
Confidence            356779999999999999999   99999999999999999999999999876543321 01122235677899999998


Q ss_pred             cC-CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHH-----HH---HhccccccccCCCC-Cc-----CcH
Q 027675           81 GG-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWK-----LW---QEGKALDMMDQKPG-AI-----SKA  145 (220)
Q Consensus        81 ~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~-----~~---~~~~~~~~~~~~~~-~~-----~~~  145 (220)
                      +. .++.++|+||||+++|+|++|..||...+.............     ..   .............. ..     ...
T Consensus       180 ~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (330)
T cd07834         180 SSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFP  259 (330)
T ss_pred             cccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcc
Confidence            77 789999999999999999999999975543322111100000     00   00000000000000 00     001


Q ss_pred             HHHHHHHHHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          146 NEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       146 ~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      .....+.++|.+||+.+|++||++++++.+-+-.
T Consensus       260 ~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~  293 (330)
T cd07834         260 GASPEAIDLLEKMLVFDPKKRITADEALAHPYLA  293 (330)
T ss_pred             cCCHHHHHHHHHHccCChhhCCCHHHHHhCccHH
Confidence            1245678999999999999999999999875433

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.92  E-value=3.2e-25  Score=175.89  Aligned_cols=159  Identities=26%  Similarity=0.359  Sum_probs=117.5

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.+++.||.|||+.|   ++|+||+|+||+++.++.++|+|||+.........  ......++..|++||.+.+
T Consensus       116 ~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~  190 (286)
T cd06614         116 PQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKR  190 (286)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccchh--hhccccCCcccCCHhHhcC
Confidence            356789999999999999999   99999999999999999999999998754332111  1122345678999999988


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+||||+++|+|++|..||...+.......      .. ....       ............+.++|.+||+.
T Consensus       191 ~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~------~~-~~~~-------~~~~~~~~~~~~l~~li~~~l~~  256 (286)
T cd06614         191 KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFL------IT-TKGI-------PPLKNPEKWSPEFKDFLNKCLVK  256 (286)
T ss_pred             CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HH-hcCC-------CCCcchhhCCHHHHHHHHHHhcc
Confidence            8889999999999999999999999865433221110      00 0000       01111111234678999999999


Q ss_pred             CCCCCCCHHHHHHHhcCc
Q 027675          162 DPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~~~  179 (220)
                      +|.+||++.+++.+-...
T Consensus       257 ~p~~Rpt~~~il~~~~~~  274 (286)
T cd06614         257 DPEKRPSAEELLQHPFLK  274 (286)
T ss_pred             ChhhCcCHHHHhhChHhh
Confidence            999999999999765433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.92  E-value=1.3e-25  Score=178.41  Aligned_cols=168  Identities=21%  Similarity=0.299  Sum_probs=113.0

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..+..++.|+++||.|||+.+   ++|+||||+||+++.++.++|+|||++.........  .....++..|.|||.+.+
T Consensus       103 ~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~  177 (291)
T cd07844         103 HNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT--YSNEVVTLWYRPPDVLLG  177 (291)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCcc--ccccccccccCCcHHhhc
Confidence            357788999999999999999   999999999999999999999999987643211111  111234678999999876


Q ss_pred             -CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhcc------------cccc----ccCCC--CCc
Q 027675           82 -GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGK------------ALDM----MDQKP--GAI  142 (220)
Q Consensus        82 -~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~----~~~~~--~~~  142 (220)
                       ..++.++|+||+|+++|+|++|..||.........  .....+......            ....    .....  ...
T Consensus       178 ~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (291)
T cd07844         178 STEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ--LHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHA  255 (291)
T ss_pred             CcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH--HHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhC
Confidence             45788999999999999999999998644321110  100111000000            0000    00000  000


Q ss_pred             CcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHh
Q 027675          143 SKANEILKCINVGLLCVQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       143 ~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l  176 (220)
                      ........+.+++.+||+.+|++||++.+++.+-
T Consensus       256 ~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~  289 (291)
T cd07844         256 PRLDRIPHGEELALKFLQYEPKKRISAAEAMKHP  289 (291)
T ss_pred             cCCCCchhHHHHHHHHhccCcccccCHHHHhcCC
Confidence            0011124677899999999999999999998753

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.92  E-value=2.1e-25  Score=173.90  Aligned_cols=152  Identities=31%  Similarity=0.461  Sum_probs=114.6

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCC-CceecCccceeeecCCCCCcccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEM-NPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~   80 (220)
                      ..+..++.+++++|+|||+++   ++|+||+|+||+++.++ .++++|||++........   .....++..|+|||.+.
T Consensus       101 ~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~  174 (256)
T cd08220         101 DTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK---AYTVVGTPCYISPELCE  174 (256)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc---ccccccCCcccCchhcc
Confidence            356789999999999999999   99999999999998654 479999999876543221   12245677899999998


Q ss_pred             cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           81 GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      +...+.++|+||||+++++|++|+.||...+......      ... .+.....    +.     .....+.+++.+||.
T Consensus       175 ~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~------~~~-~~~~~~~----~~-----~~~~~l~~li~~~l~  238 (256)
T cd08220         175 GKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVL------KIM-SGTFAPI----SD-----RYSPDLRQLILSMLN  238 (256)
T ss_pred             CCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHH------HHH-hcCCCCC----CC-----CcCHHHHHHHHHHcc
Confidence            8888999999999999999999999986544322111      111 1111111    11     123467899999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 027675          161 EDPNDRPTMSDVVIM  175 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~  175 (220)
                      .+|++|||+.+++.+
T Consensus       239 ~~p~~Rpt~~~ll~~  253 (256)
T cd08220         239 LDPSKRPQLSQIMAQ  253 (256)
T ss_pred             CChhhCCCHHHHhhC
Confidence            999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.92  E-value=2.7e-25  Score=179.85  Aligned_cols=173  Identities=24%  Similarity=0.269  Sum_probs=114.0

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCC-----CcccceeecccCccChh
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT-----DGTTNRVVGTYGYMSPE   77 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~-----~~~~~~~~~~~~y~aPe   77 (220)
                      .+..++.|++.||+|||+.+   ++||||||+||+++.++.++++||+.+........     ........++..|++||
T Consensus       102 ~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE  178 (328)
T cd08226         102 LIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPE  178 (328)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChh
Confidence            45689999999999999999   99999999999999999999999975432211000     00011112345699999


Q ss_pred             hhhcC--CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHH--------------HHHH---------------
Q 027675           78 YALGG--FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA--------------WKLW---------------  126 (220)
Q Consensus        78 ~~~~~--~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------------~~~~---------------  126 (220)
                      .+.+.  .++.++|+|||||++|+|++|..||...............              ....               
T Consensus       179 ~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (328)
T cd08226         179 LLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESV  258 (328)
T ss_pred             hhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccch
Confidence            98764  4688999999999999999999999654332211100000              0000               


Q ss_pred             -HhccccccccCCCCCcCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcC
Q 027675          127 -QEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       127 -~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~  178 (220)
                       ........................+.+++++||+.||++|||+++++++-+.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~  311 (328)
T cd08226         259 VAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFF  311 (328)
T ss_pred             hccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHH
Confidence             0000000000011111223455678999999999999999999999977643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.92  E-value=8.3e-25  Score=177.24  Aligned_cols=159  Identities=21%  Similarity=0.250  Sum_probs=112.5

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc-
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG-   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~-   81 (220)
                      .+..++.|++.||+|||+.+   |+||||||+||+++.++.++|+|||++......... ......|++.|+|||.+.+ 
T Consensus       103 ~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~  178 (331)
T cd05624         103 MARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-QSSVAVGTPDYISPEILQAM  178 (331)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCce-eeccccCCcccCCHHHHhcc
Confidence            45678899999999999999   999999999999999999999999998654322211 1122457889999999875 


Q ss_pred             ----CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcc
Q 027675           82 ----GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLL  157 (220)
Q Consensus        82 ----~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  157 (220)
                          ..++.++|+||||+++|+|++|+.||...+.....      .+..........    +...  ......+.+++.+
T Consensus       179 ~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~------~~i~~~~~~~~~----p~~~--~~~~~~~~~li~~  246 (331)
T cd05624         179 EDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY------GKIMNHEERFQF----PSHI--TDVSEEAKDLIQR  246 (331)
T ss_pred             ccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHH------HHHHcCCCcccC----CCcc--ccCCHHHHHHHHH
Confidence                35678999999999999999999999654432211      111111111110    1110  1123467788888


Q ss_pred             ccCCCCCC--CCCHHHHHHHhc
Q 027675          158 CVQEDPND--RPTMSDVVIMLG  177 (220)
Q Consensus       158 cl~~~p~~--Rps~~~~l~~l~  177 (220)
                      ||..++++  |+++++++++-+
T Consensus       247 ll~~~~~~~~~~~~~~~~~h~~  268 (331)
T cd05624         247 LICSRERRLGQNGIEDFKKHAF  268 (331)
T ss_pred             HccCchhhcCCCCHHHHhcCCC
Confidence            88766554  578999998754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.92  E-value=1.1e-25  Score=178.95  Aligned_cols=166  Identities=21%  Similarity=0.297  Sum_probs=113.1

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.........  .....++..|+|||.+.+.
T Consensus       104 ~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~  178 (291)
T cd07870         104 NVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT--YSSEVVTLWYRPPDVLLGA  178 (291)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCCCC--CCCccccccccCCceeecC
Confidence            56778999999999999999   999999999999999999999999988643221111  1123457789999988754


Q ss_pred             -CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHH-----------h--ccccccccCCCCC-----cC
Q 027675           83 -FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQ-----------E--GKALDMMDQKPGA-----IS  143 (220)
Q Consensus        83 -~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-----------~--~~~~~~~~~~~~~-----~~  143 (220)
                       .++.++|+||||+++|+|++|..||.........  ....+....           .  .............     ..
T Consensus       179 ~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (291)
T cd07870         179 TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQ--LEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWK  256 (291)
T ss_pred             CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHH--HHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhcc
Confidence             4688899999999999999999999754432111  100110000           0  0000000000000     00


Q ss_pred             cHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 027675          144 KANEILKCINVGLLCVQEDPNDRPTMSDVVIM  175 (220)
Q Consensus       144 ~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~  175 (220)
                      .......+.+++.+|+..||++|||+.+++.+
T Consensus       257 ~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         257 RLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             ccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence            01113467789999999999999999999876

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.92  E-value=2.5e-25  Score=170.08  Aligned_cols=160  Identities=21%  Similarity=0.216  Sum_probs=115.7

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCC---CCCceecCccceeeecCCCCCcccceeecccCccChhhh
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDH---EMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYA   79 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~   79 (220)
                      ++-.|++||..|+.|||..+   |.||||||+|+|...   +..+||+|||++........ ...  ..-|+-|.|||++
T Consensus       162 ea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~-L~T--Pc~TPyYvaPevl  235 (400)
T KOG0604|consen  162 EASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGD-LMT--PCFTPYYVAPEVL  235 (400)
T ss_pred             HHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccccccccCCCcc-ccC--CcccccccCHHHh
Confidence            45678999999999999999   999999999999954   45589999999975442211 111  2337889999999


Q ss_pred             hcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCC--cCcHHHHHHHHHHhcc
Q 027675           80 LGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGA--ISKANEILKCINVGLL  157 (220)
Q Consensus        80 ~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~  157 (220)
                      -...++..+|+||+|+++|-|++|++||-.... ...+          .|...++....-..  ..=...+....++|+.
T Consensus       236 g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg-~ais----------pgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~  304 (400)
T KOG0604|consen  236 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-LAIS----------PGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRK  304 (400)
T ss_pred             CchhcCCCCCccchhHHHHHhhcCCCcccccCC-ccCC----------hhHHhHhhccCccCCChhHhHHHHHHHHHHHH
Confidence            888899999999999999999999999842221 1110          01111111111111  1113345677899999


Q ss_pred             ccCCCCCCCCCHHHHHHHhcCc
Q 027675          158 CVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       158 cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      +|+.+|.+|.|+.+++.+-|..
T Consensus       305 LLkt~PteRlTI~~~m~hpwi~  326 (400)
T KOG0604|consen  305 LLKTEPTERLTIEEVMDHPWIN  326 (400)
T ss_pred             HhcCCchhheeHHHhhcCchhc
Confidence            9999999999999999876543

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.92  E-value=3.2e-25  Score=180.92  Aligned_cols=158  Identities=23%  Similarity=0.269  Sum_probs=123.4

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCC----CCceecCccceeeecCCCCCcccceeecccCccChhh
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHE----MNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEY   78 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~----~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~   78 (220)
                      ....++.|++.++.|||+.|   ++|||+||+|+++...    +.++++|||++.....   ........|++.|+|||.
T Consensus       136 da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEv  209 (382)
T KOG0032|consen  136 DAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEV  209 (382)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC---CceEeeecCCccccCchh
Confidence            45678999999999999999   9999999999999543    4699999999987654   333445789999999999


Q ss_pred             hhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           79 ALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        79 ~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                      +...+++..+|+||+|+++|.|++|..||...........      +. .+..    +.  ....-........++|..|
T Consensus       210 l~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~------i~-~~~~----~f--~~~~w~~is~~akd~i~~l  276 (382)
T KOG0032|consen  210 LGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLA------IL-RGDF----DF--TSEPWDDISESAKDFIRKL  276 (382)
T ss_pred             hcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHH------HH-cCCC----CC--CCCCccccCHHHHHHHHHh
Confidence            9999999999999999999999999999976554433221      11 1111    11  1111123355778999999


Q ss_pred             cCCCCCCCCCHHHHHHHhcCc
Q 027675          159 VQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       159 l~~~p~~Rps~~~~l~~l~~~  179 (220)
                      +..||..|+|+.++++|-|..
T Consensus       277 l~~dp~~R~ta~~~L~HpWi~  297 (382)
T KOG0032|consen  277 LEFDPRKRLTAAQALQHPWIK  297 (382)
T ss_pred             cccCcccCCCHHHHhcCcccc
Confidence            999999999999999986533

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.92  E-value=1.5e-25  Score=182.06  Aligned_cols=172  Identities=24%  Similarity=0.276  Sum_probs=117.6

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +.+..++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++.......  .......++..|+|||.+.+
T Consensus       108 ~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~  182 (337)
T cd07858         108 DHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLN  182 (337)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccCCCc--ccccccccccCccChHHHhc
Confidence            356789999999999999999   9999999999999999999999999987543221  11122346778999998865


Q ss_pred             -CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHH--------HHHHHhcccc---ccccCCCCC---cCcHH
Q 027675           82 -GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA--------WKLWQEGKAL---DMMDQKPGA---ISKAN  146 (220)
Q Consensus        82 -~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~---~~~~~~~~~---~~~~~  146 (220)
                       ..++.++|+||||+++|+|++|+.||...+...........        +.........   .........   .....
T Consensus       183 ~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (337)
T cd07858         183 CSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPH  262 (337)
T ss_pred             CCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHccc
Confidence             45789999999999999999999998654322111110000        0000000000   000000000   00112


Q ss_pred             HHHHHHHHhccccCCCCCCCCCHHHHHHHhcC
Q 027675          147 EILKCINVGLLCVQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       147 ~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~  178 (220)
                      ....+.++|.+||+.+|++|||+++++++-+.
T Consensus       263 ~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~  294 (337)
T cd07858         263 ANPLAIDLLEKMLVFDPSKRITVEEALAHPYL  294 (337)
T ss_pred             CCHHHHHHHHHHhcCChhhccCHHHHHcCcch
Confidence            34567899999999999999999999988443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.92  E-value=1.3e-25  Score=177.82  Aligned_cols=168  Identities=21%  Similarity=0.240  Sum_probs=112.5

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .++.++.|++.||+|||..+   ++|+||+|+||+++.++.++|+|||++........  ......++..|+|||.+.+.
T Consensus       101 ~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~  175 (284)
T cd07860         101 LIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGC  175 (284)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc--ccccccccccccCCeEEecC
Confidence            56789999999999999999   99999999999999999999999998764432211  11122346789999988765


Q ss_pred             C-CcccCceeehhHHHHHHHhcCccCcccchhHHHhh-HHHH-------HHHHHhc-cccccccCCCCCc---CcHHHHH
Q 027675           83 F-FSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSL-LGYA-------WKLWQEG-KALDMMDQKPGAI---SKANEIL  149 (220)
Q Consensus        83 ~-~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~-~~~~-------~~~~~~~-~~~~~~~~~~~~~---~~~~~~~  149 (220)
                      . .+.++|+||||+++|+|++|..||...+....... ....       +.....- .............   .......
T Consensus       176 ~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (284)
T cd07860         176 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDE  255 (284)
T ss_pred             CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCH
Confidence            4 57889999999999999999999864433221110 0000       0000000 0000000000000   0001223


Q ss_pred             HHHHHhccccCCCCCCCCCHHHHHHH
Q 027675          150 KCINVGLLCVQEDPNDRPTMSDVVIM  175 (220)
Q Consensus       150 ~~~~li~~cl~~~p~~Rps~~~~l~~  175 (220)
                      .+.++|.+||+.||++||++++++.+
T Consensus       256 ~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         256 DGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             HHHHHHHHhcCCCcccCCCHHHHhcC
Confidence            56789999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.92  E-value=3e-25  Score=180.13  Aligned_cols=171  Identities=25%  Similarity=0.299  Sum_probs=116.4

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCC---cccceeecccCccChhhh
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD---GTTNRVVGTYGYMSPEYA   79 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~y~aPe~~   79 (220)
                      .++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.........   .......++..|+|||.+
T Consensus       108 ~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  184 (337)
T cd07852         108 HKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEIL  184 (337)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceee
Confidence            45678999999999999999   999999999999999999999999988754332211   122234577889999987


Q ss_pred             hc-CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHH--------HHHH---hccccccccC---CCCCcCc
Q 027675           80 LG-GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAW--------KLWQ---EGKALDMMDQ---KPGAISK  144 (220)
Q Consensus        80 ~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~--------~~~~---~~~~~~~~~~---~~~~~~~  144 (220)
                      .+ ..++.++|+||||+++|+|++|+.||................        ....   ..........   .......
T Consensus       185 ~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (337)
T cd07852         185 LGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELL  264 (337)
T ss_pred             eccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhc
Confidence            65 456889999999999999999999986443322111100000        0000   0000000000   0000000


Q ss_pred             HHHHHHHHHHhccccCCCCCCCCCHHHHHHHh
Q 027675          145 ANEILKCINVGLLCVQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       145 ~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l  176 (220)
                      ......+.++|.+||+.+|++|||+.+++.+-
T Consensus       265 ~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~  296 (337)
T cd07852         265 PKASDDALDLLKKLLVFNPNKRLTAEEALEHP  296 (337)
T ss_pred             cCCCHHHHHHHHHhccCCcccccCHHHHhhCh
Confidence            11345788999999999999999999999763

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.92  E-value=2.1e-25  Score=174.63  Aligned_cols=157  Identities=23%  Similarity=0.284  Sum_probs=117.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++.......   ......++..|++||.+.+
T Consensus        93 ~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~  166 (262)
T cd05572          93 YTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILN  166 (262)
T ss_pred             HHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcCccChhHhcC
Confidence            356778999999999999999   9999999999999999999999999987544321   1122356778999999888


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+||||+++|++++|..||..........    ..+... +        .............+.++|.+||..
T Consensus       167 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~-~--------~~~~~~~~~~~~~~~~~i~~~l~~  233 (262)
T cd05572         167 KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEI----YNDILK-G--------NGKLEFPNYIDKAAKDLIKQLLRR  233 (262)
T ss_pred             CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHH----HHHHhc-c--------CCCCCCCcccCHHHHHHHHHHccC
Confidence            888999999999999999999999997554211110    011110 0        000111111245789999999999


Q ss_pred             CCCCCCC-----HHHHHHHhc
Q 027675          162 DPNDRPT-----MSDVVIMLG  177 (220)
Q Consensus       162 ~p~~Rps-----~~~~l~~l~  177 (220)
                      +|++||+     +++++++-+
T Consensus       234 ~p~~R~~~~~~~~~~l~~~~~  254 (262)
T cd05572         234 NPEERLGNLKGGIKDIKKHKW  254 (262)
T ss_pred             ChhhCcCCcccCHHHHhcChh
Confidence            9999999     899997543

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=1.7e-25  Score=174.94  Aligned_cols=152  Identities=26%  Similarity=0.276  Sum_probs=113.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....      .....++..|.+||.+.+
T Consensus        97 ~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~~~~y~~pe~~~~  167 (260)
T cd05611          97 DWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVGTPDYLAPETILG  167 (260)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCCCcCccChhhhcC
Confidence            357889999999999999999   99999999999999999999999998764322      122346778999999988


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+||||+++|++++|..||...+.......       ...+..    ..  ...........+.+++.+||+.
T Consensus       168 ~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-------~~~~~~----~~--~~~~~~~~~~~~~~~i~~~l~~  234 (260)
T cd05611         168 VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDN-------ILSRRI----NW--PEEVKEFCSPEAVDLINRLLCM  234 (260)
T ss_pred             CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHH-------HHhccc----CC--CCcccccCCHHHHHHHHHHccC
Confidence            7788999999999999999999999965443222111       111110    00  0001112335788999999999


Q ss_pred             CCCCCCCH---HHHHHH
Q 027675          162 DPNDRPTM---SDVVIM  175 (220)
Q Consensus       162 ~p~~Rps~---~~~l~~  175 (220)
                      +|++||++   ++++.+
T Consensus       235 ~p~~R~~~~~~~~~l~~  251 (260)
T cd05611         235 DPAKRLGANGYQEIKSH  251 (260)
T ss_pred             CHHHccCCCcHHHHHcC
Confidence            99999966   466544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.92  E-value=3.5e-25  Score=173.38  Aligned_cols=158  Identities=31%  Similarity=0.483  Sum_probs=115.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcc--cceeecccCccChhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT--TNRVVGTYGYMSPEYA   79 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~--~~~~~~~~~y~aPe~~   79 (220)
                      +.+..++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++...........  .....++..|++||.+
T Consensus        99 ~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~  175 (264)
T cd06626          99 HVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI  175 (264)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhc
Confidence            456789999999999999999   99999999999999999999999999876443221111  1123456789999998


Q ss_pred             hcCC---CcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhc
Q 027675           80 LGGF---FSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGL  156 (220)
Q Consensus        80 ~~~~---~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  156 (220)
                      .+..   .+.++|+||||++++++++|..||...........     ... .+       ..+...........+.+++.
T Consensus       176 ~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~-----~~~-~~-------~~~~~~~~~~~~~~~~~li~  242 (264)
T cd06626         176 TGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMF-----HVG-AG-------HKPPIPDSLQLSPEGKDFLD  242 (264)
T ss_pred             cCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHH-----HHh-cC-------CCCCCCcccccCHHHHHHHH
Confidence            8765   78899999999999999999999964432111100     000 00       11111111112446778999


Q ss_pred             cccCCCCCCCCCHHHHHHH
Q 027675          157 LCVQEDPNDRPTMSDVVIM  175 (220)
Q Consensus       157 ~cl~~~p~~Rps~~~~l~~  175 (220)
                      +||+.+|++||++.+++.+
T Consensus       243 ~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         243 RCLESDPKKRPTASELLQH  261 (264)
T ss_pred             HHccCCcccCCCHHHHhcC
Confidence            9999999999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.92  E-value=2.8e-25  Score=173.78  Aligned_cols=155  Identities=31%  Similarity=0.458  Sum_probs=117.7

Q ss_pred             hHHHHHHHHHHHHHHhhh-CCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            3 MLFNIILGVSRRLLYLHQ-DSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~-~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .++.++.|+++|+.|||+ .+   ++|+||+|+||+++.++.++|+|||++..........  ....++..|.|||.+.+
T Consensus       100 ~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~y~~pE~~~~  174 (264)
T cd06623         100 VLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC--NTFVGTVTYMSPERIQG  174 (264)
T ss_pred             HHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCcc--cceeecccccCHhhhCC
Confidence            567899999999999999 98   9999999999999999999999999987654322221  22456778999999988


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHH-HHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKAN-EILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++|++++|..||............   .... .....         ..... ....+.+++.+||.
T Consensus       175 ~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~---~~~~-~~~~~---------~~~~~~~~~~l~~li~~~l~  241 (264)
T cd06623         175 ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELM---QAIC-DGPPP---------SLPAEEFSPEFRDFISACLQ  241 (264)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHH---HHHh-cCCCC---------CCCcccCCHHHHHHHHHHcc
Confidence            88899999999999999999999998654421111111   1111 10000         01111 34578899999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 027675          161 EDPNDRPTMSDVVIM  175 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~  175 (220)
                      .+|++||++.+++++
T Consensus       242 ~~p~~R~~~~~ll~~  256 (264)
T cd06623         242 KDPKKRPSAAELLQH  256 (264)
T ss_pred             CChhhCCCHHHHHhC
Confidence            999999999999976

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.92  E-value=2.7e-25  Score=196.96  Aligned_cols=156  Identities=26%  Similarity=0.340  Sum_probs=111.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCC----CCeEeccCCCCceeeCC-----------------CCCceecCccceeeecCCCC
Q 027675            2 EMLFNIILGVSRRLLYLHQDSK----LRIIHRDFKTSNILLDH-----------------EMNPKISDFGLTRIFEGKQT   60 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~----~~i~H~dlk~~nili~~-----------------~~~~~l~d~~~~~~~~~~~~   60 (220)
                      ..++.|+.||+.||.|||..+.    ..|+|+||||+|||++.                 .+.++|+|||++....... 
T Consensus       118 ~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-  196 (1021)
T PTZ00266        118 HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES-  196 (1021)
T ss_pred             HHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccc-
Confidence            3578899999999999998431    23999999999999954                 2348999999986543221 


Q ss_pred             CcccceeecccCccChhhhhc--CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCC
Q 027675           61 DGTTNRVVGTYGYMSPEYALG--GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQK  138 (220)
Q Consensus        61 ~~~~~~~~~~~~y~aPe~~~~--~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  138 (220)
                        ......+++.|+|||++.+  ..++.++|||||||++|+|++|..||.........  .    .....+.     .. 
T Consensus       197 --~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~ql--i----~~lk~~p-----~l-  262 (1021)
T PTZ00266        197 --MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQL--I----SELKRGP-----DL-  262 (1021)
T ss_pred             --cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHH--H----HHHhcCC-----CC-
Confidence              1122467889999999865  34788999999999999999999999644322111  1    1111111     00 


Q ss_pred             CCCcCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHh
Q 027675          139 PGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       139 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l  176 (220)
                      +..    .....+.++|..||..+|.+||++.+++.+-
T Consensus       263 pi~----~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~  296 (1021)
T PTZ00266        263 PIK----GKSKELNILIKNLLNLSAKERPSALQCLGYQ  296 (1021)
T ss_pred             CcC----CCCHHHHHHHHHHhcCChhHCcCHHHHhccH
Confidence            001    1234678899999999999999999999543

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.92  E-value=3.8e-25  Score=175.38  Aligned_cols=156  Identities=26%  Similarity=0.392  Sum_probs=113.8

Q ss_pred             hHHHHHHHHHHHHHHhhh-CCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            3 MLFNIILGVSRRLLYLHQ-DSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~-~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+..++.+++.||.|||. .+   ++|+||||+||+++.++.++|+|||++.......    .....++..|+|||.+.+
T Consensus       103 ~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~  175 (286)
T cd06622         103 VLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL----AKTNIGCQSYMAPERIKS  175 (286)
T ss_pred             HHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc----cccCCCccCccCcchhcC
Confidence            568899999999999996 47   9999999999999999999999999876443211    111345678999999865


Q ss_pred             CC------CcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHh
Q 027675           82 GF------FSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVG  155 (220)
Q Consensus        82 ~~------~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  155 (220)
                      ..      ++.++|+|||||++|+|++|..||...........   ..... .+.        + ..........+.++|
T Consensus       176 ~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~-~~~--------~-~~~~~~~~~~~~~li  242 (286)
T cd06622         176 GGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQ---LSAIV-DGD--------P-PTLPSGYSDDAQDFV  242 (286)
T ss_pred             CCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHH---HHHHh-hcC--------C-CCCCcccCHHHHHHH
Confidence            43      47899999999999999999999864322211111   00110 011        0 011122445778999


Q ss_pred             ccccCCCCCCCCCHHHHHHHhcC
Q 027675          156 LLCVQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       156 ~~cl~~~p~~Rps~~~~l~~l~~  178 (220)
                      .+||..+|++||++++++.+-+.
T Consensus       243 ~~~l~~~p~~Rp~~~~l~~~~~~  265 (286)
T cd06622         243 AKCLNKIPNRRPTYAQLLEHPWL  265 (286)
T ss_pred             HHHcccCcccCCCHHHHhcChhh
Confidence            99999999999999999987543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.92  E-value=4.3e-25  Score=173.28  Aligned_cols=159  Identities=28%  Similarity=0.441  Sum_probs=116.5

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCC-CceecCccceeeecCCCC--CcccceeecccCccChhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEM-NPKISDFGLTRIFEGKQT--DGTTNRVVGTYGYMSPEY   78 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~-~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~y~aPe~   78 (220)
                      ..++.++.|++.||.|||+++   ++|+||+|.||+++.++ .++|+|||.+........  ........++..|.|||.
T Consensus       103 ~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~  179 (268)
T cd06630         103 AVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV  179 (268)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhH
Confidence            356789999999999999999   99999999999998776 489999999865432211  111223456788999999


Q ss_pred             hhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           79 ALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        79 ~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                      +.+..++.++|+||+|++++++++|..||...........   ......         ..............+.+++.+|
T Consensus       180 ~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~~---------~~~~~~~~~~~~~~~~~~i~~~  247 (268)
T cd06630         180 LRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL---IFKIAS---------ATTAPSIPEHLSPGLRDVTLRC  247 (268)
T ss_pred             hccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH---HHHHhc---------cCCCCCCchhhCHHHHHHHHHH
Confidence            9888889999999999999999999999864332211111   111100         0011112223445788899999


Q ss_pred             cCCCCCCCCCHHHHHHH
Q 027675          159 VQEDPNDRPTMSDVVIM  175 (220)
Q Consensus       159 l~~~p~~Rps~~~~l~~  175 (220)
                      |..+|++||++.+++++
T Consensus       248 l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         248 LELQPEDRPPSRELLKH  264 (268)
T ss_pred             cCCCcccCcCHHHHhcC
Confidence            99999999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.92  E-value=9.9e-26  Score=178.42  Aligned_cols=169  Identities=21%  Similarity=0.255  Sum_probs=114.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|+++||+|||+++   ++|+||+|+||+++.++.++|+|||++.........  .....++..|+|||.+.+
T Consensus        99 ~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~  173 (283)
T cd07835          99 PLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLG  173 (283)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc--cCccccccCCCCCceeec
Confidence            357889999999999999999   999999999999999999999999998643321111  111234678999998766


Q ss_pred             C-CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhH-HH-------HHHHHHh--ccccccccC--CCCCcCcHHHH
Q 027675           82 G-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLL-GY-------AWKLWQE--GKALDMMDQ--KPGAISKANEI  148 (220)
Q Consensus        82 ~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~-~~-------~~~~~~~--~~~~~~~~~--~~~~~~~~~~~  148 (220)
                      . .++.++|+||||+++|+|++|..||...+........ ..       .+.....  +........  ...........
T Consensus       174 ~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (283)
T cd07835         174 SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLD  253 (283)
T ss_pred             CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCC
Confidence            4 4688999999999999999999998654432211100 00       0000000  000000000  00000111123


Q ss_pred             HHHHHHhccccCCCCCCCCCHHHHHHH
Q 027675          149 LKCINVGLLCVQEDPNDRPTMSDVVIM  175 (220)
Q Consensus       149 ~~~~~li~~cl~~~p~~Rps~~~~l~~  175 (220)
                      ..+.++|.+||+.+|++||++++++.+
T Consensus       254 ~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         254 EDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            467899999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.92  E-value=2.7e-25  Score=176.49  Aligned_cols=164  Identities=29%  Similarity=0.381  Sum_probs=117.7

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........    ....++..|.+||.+.+.
T Consensus       106 ~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~y~~pE~~~~~  178 (287)
T cd06621         106 VLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA----GTFTGTSFYMAPERIQGK  178 (287)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccccccc----ccccCCccccCHHHhcCC
Confidence            46789999999999999999   99999999999999999999999998764332111    123456789999999888


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      .++.++|+||||+++|+|++|..||...... ........ ........... ...+.  ........+.+++.+||..+
T Consensus       179 ~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~-~~~~~~~~~~~-~~~~~--~~~~~~~~~~~li~~~l~~~  253 (287)
T cd06621         179 PYSITSDVWSLGLTLLEVAQNRFPFPPEGEP-PLGPIELL-SYIVNMPNPEL-KDEPG--NGIKWSEEFKDFIKQCLEKD  253 (287)
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCCCcccCC-CCChHHHH-HHHhcCCchhh-ccCCC--CCCchHHHHHHHHHHHcCCC
Confidence            8899999999999999999999998644220 00011111 11111111111 11111  01123456889999999999


Q ss_pred             CCCCCCHHHHHHHhcC
Q 027675          163 PNDRPTMSDVVIMLGS  178 (220)
Q Consensus       163 p~~Rps~~~~l~~l~~  178 (220)
                      |++|||+.+++++-+-
T Consensus       254 p~~Rpt~~eil~~~~~  269 (287)
T cd06621         254 PTRRPTPWDMLEHPWI  269 (287)
T ss_pred             cccCCCHHHHHhCccc
Confidence            9999999999987654

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.92  E-value=2.6e-25  Score=174.95  Aligned_cols=153  Identities=25%  Similarity=0.268  Sum_probs=115.9

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCC-CceecCccceeeecCCCCCcccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEM-NPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~   80 (220)
                      ++++.++.|+++||.|||+.+   ++|+||+|+||+++.++ .++++|||++.......      ...++..|+|||.+.
T Consensus       109 ~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~------~~~~~~~y~aPE~~~  179 (267)
T PHA03390        109 AEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS------CYDGTLDYFSPEKIK  179 (267)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc------cCCCCCcccChhhhc
Confidence            467889999999999999999   99999999999999988 89999999887543221      134677899999999


Q ss_pred             cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           81 GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      +..++.++|+||||+++|+|++|..||......... ...+....      .    ....  ........+.++|.+||+
T Consensus       180 ~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~------~----~~~~--~~~~~~~~~~~li~~~l~  246 (267)
T PHA03390        180 GHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELD-LESLLKRQ------Q----KKLP--FIKNVSKNANDFVQSMLK  246 (267)
T ss_pred             CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhh-HHHHHHhh------c----ccCC--cccccCHHHHHHHHHHhc
Confidence            888899999999999999999999999743322211 11110000      0    0000  111344578899999999


Q ss_pred             CCCCCCCC-HHHHHHHh
Q 027675          161 EDPNDRPT-MSDVVIML  176 (220)
Q Consensus       161 ~~p~~Rps-~~~~l~~l  176 (220)
                      .+|.+||+ +++++++=
T Consensus       247 ~~p~~R~~~~~~~l~h~  263 (267)
T PHA03390        247 YNINYRLTNYNEIIKHP  263 (267)
T ss_pred             cChhhCCchHHHHhcCC
Confidence            99999996 69999763

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.8e-25  Score=185.65  Aligned_cols=157  Identities=24%  Similarity=0.375  Sum_probs=122.6

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhh---
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYA---   79 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~---   79 (220)
                      +|.-++++++.||.|||++.   |+|||||..|||++.+|.++|+|||++-.  ..........+.|++.|+|||+.   
T Consensus       131 QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAK--n~~t~qkRDsFIGTPYWMAPEVvmCE  205 (1187)
T KOG0579|consen  131 QIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAK--NKSTRQKRDSFIGTPYWMAPEVVMCE  205 (1187)
T ss_pred             HHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeeccccccc--chhHHhhhccccCCcccccchheeec
Confidence            56778999999999999999   99999999999999999999999998742  22222233447899999999986   


Q ss_pred             --hcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCC-CCCcCcHHHHHHHHHHhc
Q 027675           80 --LGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQK-PGAISKANEILKCINVGL  156 (220)
Q Consensus        80 --~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~  156 (220)
                        +..+|++++||||||+.+.+|..+.+|-+.-+......      ++         .... |-..-+......+.+++.
T Consensus       206 T~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVll------Ki---------aKSePPTLlqPS~Ws~~F~DfLk  270 (1187)
T KOG0579|consen  206 TFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL------KI---------AKSEPPTLLQPSHWSRSFSDFLK  270 (1187)
T ss_pred             cccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHH------HH---------hhcCCCcccCcchhhhHHHHHHH
Confidence              45689999999999999999999999976544433221      11         1111 222333456678899999


Q ss_pred             cccCCCCCCCCCHHHHHHHhcCc
Q 027675          157 LCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       157 ~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      +||..||..||++.++++|-+-.
T Consensus       271 ~cL~Knp~~Rp~aaqll~Hpfv~  293 (1187)
T KOG0579|consen  271 RCLVKNPRNRPPAAQLLKHPFVQ  293 (1187)
T ss_pred             HHHhcCCccCCCHHHHhhCcccc
Confidence            99999999999999999875433

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.92  E-value=1.8e-25  Score=176.98  Aligned_cols=171  Identities=22%  Similarity=0.243  Sum_probs=116.9

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|+++||+|||+.+   ++|+||+|+||++++++.++|+|||++........... ....++..|+|||.+.+
T Consensus       100 ~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~-~~~~~~~~y~~PE~~~~  175 (287)
T cd07840         100 SQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY-TNRVITLWYRPPELLLG  175 (287)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccc-cccccccccCCceeeEc
Confidence            357889999999999999999   99999999999999999999999999876543321111 11234668999998765


Q ss_pred             C-CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccc--------cccccCCCCCc------CcHH
Q 027675           82 G-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKA--------LDMMDQKPGAI------SKAN  146 (220)
Q Consensus        82 ~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~------~~~~  146 (220)
                      . .++.++|+||||+++|+|++|+.||...+....................        ...........      ....
T Consensus       176 ~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (287)
T cd07840         176 ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHL  255 (287)
T ss_pred             cccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhccc
Confidence            3 5688999999999999999999998755543222111100000000000        00000000000      0000


Q ss_pred             HHHHHHHHhccccCCCCCCCCCHHHHHHHh
Q 027675          147 EILKCINVGLLCVQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       147 ~~~~~~~li~~cl~~~p~~Rps~~~~l~~l  176 (220)
                      +...+.+++.+||..+|++||++++++++-
T Consensus       256 ~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~  285 (287)
T cd07840         256 IDPSALDLLDKLLTLDPKKRISADQALQHE  285 (287)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHhhCc
Confidence            145788999999999999999999998763

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.92  E-value=3.2e-25  Score=175.71  Aligned_cols=156  Identities=22%  Similarity=0.244  Sum_probs=124.0

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecC-------------------------
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEG-------------------------   57 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~-------------------------   57 (220)
                      .++-++..|+-||+|||-.|   |++|||||+||||.++|++-|+||+++.....                         
T Consensus       180 ~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s  256 (459)
T KOG0610|consen  180 AARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPS  256 (459)
T ss_pred             hHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCccccccccc
Confidence            35668899999999999999   99999999999999999999999998754320                         


Q ss_pred             ----C---C-C---------------------CcccceeecccCccChhhhhcCCCcccCceeehhHHHHHHHhcCccCc
Q 027675           58 ----K---Q-T---------------------DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTG  108 (220)
Q Consensus        58 ----~---~-~---------------------~~~~~~~~~~~~y~aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~  108 (220)
                          +   . .                     ....+.++||..|+|||++.|.+-+.+.|.|+||+++|||+.|..||.
T Consensus       257 ~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFK  336 (459)
T KOG0610|consen  257 CFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFK  336 (459)
T ss_pred             ccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcC
Confidence                0   0 0                     011223688999999999999999999999999999999999999998


Q ss_pred             ccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCCCCCCCC----HHHHHHHh
Q 027675          109 FYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPT----MSDVVIML  176 (220)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps----~~~~l~~l  176 (220)
                      +.+.+.....               ++...+.....+.....+.++|+++|..||.+|..    +.+|-+|=
T Consensus       337 G~~~~~Tl~N---------------Iv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~Hp  393 (459)
T KOG0610|consen  337 GSNNKETLRN---------------IVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHP  393 (459)
T ss_pred             CCCchhhHHH---------------HhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCc
Confidence            7666544322               22233333444466678899999999999999999    89998653

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.92  E-value=2e-25  Score=176.26  Aligned_cols=149  Identities=21%  Similarity=0.318  Sum_probs=109.0

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCC-------CceecCccceeeecCCCCCcccceeecccCcc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEM-------NPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM   74 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~-------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~   74 (220)
                      ..++.++.|++.||+|||+++   ++||||||+||+++..+       .++++|||++......      ....++..|+
T Consensus       117 ~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~  187 (274)
T cd05076         117 AWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWI  187 (274)
T ss_pred             HHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcccCccceeeecCCccccccccc------cccccCCccc
Confidence            356789999999999999999   99999999999997643       3799999987532211      1123567899


Q ss_pred             Chhhhhc-CCCcccCceeehhHHHHHHH-hcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHH
Q 027675           75 SPEYALG-GFFSVKSDVFSFGVVVLEII-SGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCI  152 (220)
Q Consensus        75 aPe~~~~-~~~~~~~DiwslG~il~~ll-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (220)
                      |||.+.+ ..++.++|+||||+++|+++ +|..||...........       .....      ..+..     ....+.
T Consensus       188 aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~-------~~~~~------~~~~~-----~~~~~~  249 (274)
T cd05076         188 APECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF-------YEKKH------RLPEP-----SCKELA  249 (274)
T ss_pred             CchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH-------HHhcc------CCCCC-----CChHHH
Confidence            9998875 45789999999999999985 68888864433221111       11100      00110     113578


Q ss_pred             HHhccccCCCCCCCCCHHHHHHHhc
Q 027675          153 NVGLLCVQEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       153 ~li~~cl~~~p~~Rps~~~~l~~l~  177 (220)
                      ++|.+||+.+|++||+++++++.|.
T Consensus       250 ~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         250 TLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HHHHHHcccChhhCcCHHHHHHhhC
Confidence            8999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.92  E-value=2.6e-25  Score=177.33  Aligned_cols=157  Identities=26%  Similarity=0.405  Sum_probs=113.9

Q ss_pred             hHHHHHHHHHHHHHHhhh-CCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            3 MLFNIILGVSRRLLYLHQ-DSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~-~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+..++.+++.|+.|||+ .+   ++||||+|.||++++++.++|+|||++.........   ....++..|+|||.+.+
T Consensus       115 ~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~  188 (296)
T cd06618         115 ILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---TRSAGCAAYMAPERIDP  188 (296)
T ss_pred             HHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCCCcc---cCCCCCccccCHhhcCC
Confidence            467899999999999997 57   999999999999999999999999987654322111   11245678999999875


Q ss_pred             CC----CcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcc
Q 027675           82 GF----FSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLL  157 (220)
Q Consensus        82 ~~----~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  157 (220)
                      ..    ++.++|+||||+++|+|++|+.||........     ........ ....       ..........+.+++.+
T Consensus       189 ~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-----~~~~~~~~-~~~~-------~~~~~~~~~~l~~li~~  255 (296)
T cd06618         189 PDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE-----VLTKILQE-EPPS-------LPPNEGFSPDFCSFVDL  255 (296)
T ss_pred             CCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH-----HHHHHhcC-CCCC-------CCCCCCCCHHHHHHHHH
Confidence            43    67899999999999999999999864322211     01111111 1000       00001223467899999


Q ss_pred             ccCCCCCCCCCHHHHHHHhcC
Q 027675          158 CVQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       158 cl~~~p~~Rps~~~~l~~l~~  178 (220)
                      ||..||++||++++++.+-+.
T Consensus       256 ~l~~~p~~Rp~~~~il~~~~~  276 (296)
T cd06618         256 CLTKDHRKRPKYRELLQHPFI  276 (296)
T ss_pred             HccCChhhCCCHHHHhcChhh
Confidence            999999999999999987643

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.92  E-value=2.1e-25  Score=196.66  Aligned_cols=160  Identities=20%  Similarity=0.274  Sum_probs=114.5

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCC----------------CCcccce
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQ----------------TDGTTNR   66 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~----------------~~~~~~~   66 (220)
                      .+++++.|+++||+|||+.+   ++||||||+||+++.++.++|+|||++.......                .......
T Consensus       114 ~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~  190 (932)
T PRK13184        114 AFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGK  190 (932)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCC
Confidence            46789999999999999999   9999999999999999999999999987542110                0001112


Q ss_pred             eecccCccChhhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHH
Q 027675           67 VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKAN  146 (220)
Q Consensus        67 ~~~~~~y~aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  146 (220)
                      ..|++.|+|||.+.+..++.++|+|||||++|+|++|..||..........          .....    ..........
T Consensus       191 ~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~----------~~~i~----~P~~~~p~~~  256 (932)
T PRK13184        191 IVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISY----------RDVIL----SPIEVAPYRE  256 (932)
T ss_pred             CCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhh----------hhhcc----Chhhcccccc
Confidence            468899999999999889999999999999999999999986432211110          00000    0000000112


Q ss_pred             HHHHHHHHhccccCCCCCCCCC-HHHHHHHhcCc
Q 027675          147 EILKCINVGLLCVQEDPNDRPT-MSDVVIMLGSE  179 (220)
Q Consensus       147 ~~~~~~~li~~cl~~~p~~Rps-~~~~l~~l~~~  179 (220)
                      ....+.+++.+||..||++||+ ++++++.|+..
T Consensus       257 iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~  290 (932)
T PRK13184        257 IPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH  290 (932)
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            2345778999999999999965 55555655443

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.92  E-value=3.9e-25  Score=176.22  Aligned_cols=155  Identities=24%  Similarity=0.354  Sum_probs=116.1

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+..++.+++.||.|||+++   ++|+||+|+||+++.++.++|+|||++........  ......++..|++||.+.+.
T Consensus       116 ~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~  190 (293)
T cd06647         116 QIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRK  190 (293)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc--ccccccCChhhcCchhhccC
Confidence            56789999999999999999   99999999999999999999999998764432211  11223467789999999888


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      .++.++|+||||+++|++++|..||...+.......      .. .       ...+...........+.++|.+||..+
T Consensus       191 ~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------~~-~-------~~~~~~~~~~~~~~~l~~li~~~l~~~  256 (293)
T cd06647         191 AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IA-T-------NGTPELQNPEKLSAIFRDFLNRCLEMD  256 (293)
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------hh-c-------CCCCCCCCccccCHHHHHHHHHHccCC
Confidence            888999999999999999999999964332211100      00 0       011111111122346788999999999


Q ss_pred             CCCCCCHHHHHHHh
Q 027675          163 PNDRPTMSDVVIML  176 (220)
Q Consensus       163 p~~Rps~~~~l~~l  176 (220)
                      |++||++++++.+-
T Consensus       257 p~~Rp~~~~il~h~  270 (293)
T cd06647         257 VEKRGSAKELLQHP  270 (293)
T ss_pred             hhhCcCHHHHhcCH
Confidence            99999999999774

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.92  E-value=4.1e-25  Score=171.96  Aligned_cols=153  Identities=28%  Similarity=0.428  Sum_probs=117.5

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+++.++.++++||.+||+.+   ++|+||+|+||+++.++.++|+|||++.......  .......+++.|+|||...+
T Consensus       103 ~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~  177 (258)
T cd08215         103 EQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--DLAKTVVGTPYYLSPELCQN  177 (258)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc--ceecceeeeecccChhHhcc
Confidence            357889999999999999999   9999999999999999999999999987644322  11222456778999999988


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+||+|+++++|++|..||...+......      .. ..+.    ....+.     .....+.+++.+||..
T Consensus       178 ~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~------~~-~~~~----~~~~~~-----~~~~~~~~~i~~~l~~  241 (258)
T cd08215         178 KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELAL------KI-LKGQ----YPPIPS-----QYSSELRNLVSSLLQK  241 (258)
T ss_pred             CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHH------HH-hcCC----CCCCCC-----CCCHHHHHHHHHHcCC
Confidence            888999999999999999999999986544222111      11 1111    111111     2234678899999999


Q ss_pred             CCCCCCCHHHHHHH
Q 027675          162 DPNDRPTMSDVVIM  175 (220)
Q Consensus       162 ~p~~Rps~~~~l~~  175 (220)
                      +|++||++.+++++
T Consensus       242 ~p~~Rp~~~~ll~~  255 (258)
T cd08215         242 DPEERPSIAQILQS  255 (258)
T ss_pred             ChhhCcCHHHHhcC
Confidence            99999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.92  E-value=3.7e-25  Score=173.03  Aligned_cols=156  Identities=27%  Similarity=0.372  Sum_probs=115.1

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCC------CcccceeecccCccC
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT------DGTTNRVVGTYGYMS   75 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~------~~~~~~~~~~~~y~a   75 (220)
                      ..++.++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||++........      ........++..|++
T Consensus        93 ~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (265)
T cd05579          93 DVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA  169 (265)
T ss_pred             HHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccC
Confidence            357789999999999999999   99999999999999999999999998765332211      011222456778999


Q ss_pred             hhhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHh
Q 027675           76 PEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVG  155 (220)
Q Consensus        76 Pe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  155 (220)
                      ||...+...+.++|+||||+++|++++|..||............       ..+..    ..    .........+.+++
T Consensus       170 Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~-------~~~~~----~~----~~~~~~~~~~~~~i  234 (265)
T cd05579         170 PEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNI-------LNGKI----EW----PEDVEVSDEAIDLI  234 (265)
T ss_pred             HHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------hcCCc----CC----CccccCCHHHHHHH
Confidence            99998887889999999999999999999998654433221110       01010    00    00111245778999


Q ss_pred             ccccCCCCCCCCCH---HHHHHH
Q 027675          156 LLCVQEDPNDRPTM---SDVVIM  175 (220)
Q Consensus       156 ~~cl~~~p~~Rps~---~~~l~~  175 (220)
                      .+||+.+|++|||+   .+++.+
T Consensus       235 ~~~l~~~p~~Rpt~~~~~~~l~~  257 (265)
T cd05579         235 SKLLVPDPEKRLGAKSIEEIKNH  257 (265)
T ss_pred             HHHhcCCHhhcCCCccHHHHhcC
Confidence            99999999999999   665544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=3.4e-25  Score=174.82  Aligned_cols=157  Identities=25%  Similarity=0.415  Sum_probs=116.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.........  .....++..|+|||.+.+
T Consensus       101 ~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~  175 (277)
T cd06917         101 KYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK--RSTFVGTPYWMAPEVITE  175 (277)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc--cccccCCcceeCHHHhcc
Confidence            356789999999999999999   999999999999999999999999998765433211  122356778999998865


Q ss_pred             C-CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 G-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      . .++.++|+||||+++|+|++|..||..........       .....       ..+... .......+.+++.+||+
T Consensus       176 ~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~-------~~~~~-------~~~~~~-~~~~~~~~~~~i~~~l~  240 (277)
T cd06917         176 GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM-------LIPKS-------KPPRLE-DNGYSKLLREFVAACLD  240 (277)
T ss_pred             CCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh-------ccccC-------CCCCCC-cccCCHHHHHHHHHHcC
Confidence            3 46889999999999999999999986433221110       00000       000000 00133467889999999


Q ss_pred             CCCCCCCCHHHHHHHhcC
Q 027675          161 EDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~  178 (220)
                      .||++||++.+++.+-+.
T Consensus       241 ~~p~~R~~~~~il~~~~~  258 (277)
T cd06917         241 EEPKERLSAEELLKSKWI  258 (277)
T ss_pred             CCcccCcCHHHHhhChHh
Confidence            999999999999976544

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.92  E-value=4.5e-25  Score=175.83  Aligned_cols=156  Identities=24%  Similarity=0.337  Sum_probs=115.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +.++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++++|||+.........  ......++..|++||.+.+
T Consensus       116 ~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~pE~~~~  190 (292)
T cd06657         116 EQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISR  190 (292)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--cccccccCccccCHHHhcC
Confidence            356789999999999999999   99999999999999999999999998764432111  1122456778999999888


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+||+|+++|+|++|..||............       .... .....      ........+.+++.+||+.
T Consensus       191 ~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~-------~~~~-~~~~~------~~~~~~~~l~~li~~~l~~  256 (292)
T cd06657         191 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-------RDNL-PPKLK------NLHKVSPSLKGFLDRLLVR  256 (292)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------HhhC-CcccC------CcccCCHHHHHHHHHHHhC
Confidence            78889999999999999999999998643332221110       0000 00000      0111233577889999999


Q ss_pred             CCCCCCCHHHHHHHh
Q 027675          162 DPNDRPTMSDVVIML  176 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l  176 (220)
                      +|.+||++.+++.+=
T Consensus       257 ~P~~R~~~~~ll~~~  271 (292)
T cd06657         257 DPAQRATAAELLKHP  271 (292)
T ss_pred             CcccCcCHHHHhcCh
Confidence            999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.92  E-value=5.5e-25  Score=174.46  Aligned_cols=162  Identities=33%  Similarity=0.486  Sum_probs=117.9

Q ss_pred             chHHHHHHHHHHHHHHhhh-CCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQ-DSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~-~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~   80 (220)
                      ..+..++.+++.||.|||+ .+   ++|+||+|+||++++++.++|+|||++......    ......++..|+|||.+.
T Consensus       103 ~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~----~~~~~~~~~~~~aPE~~~  175 (284)
T cd06620         103 EILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS----IADTFVGTSTYMSPERIQ  175 (284)
T ss_pred             HHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh----ccCccccCcccCCHHHHc
Confidence            3567899999999999997 57   999999999999999999999999987543211    112245678999999998


Q ss_pred             cCCCcccCceeehhHHHHHHHhcCccCcccchhH-----HHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHh
Q 027675           81 GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSEL-----ALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVG  155 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  155 (220)
                      +..++.++|+|||||++|++++|..||.......     ..............         .............+.+++
T Consensus       176 ~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~li  246 (284)
T cd06620         176 GGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE---------PPPRLPSSDFPEDLRDFV  246 (284)
T ss_pred             cCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc---------cCCCCCchhcCHHHHHHH
Confidence            8888999999999999999999999997543321     11111111111111         000001111334678899


Q ss_pred             ccccCCCCCCCCCHHHHHHHhcCc
Q 027675          156 LLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       156 ~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      .+||+.||++||++.+++++....
T Consensus       247 ~~~l~~dp~~Rpt~~e~~~~~~~~  270 (284)
T cd06620         247 DACLLKDPTERPTPQQLCAMPPFI  270 (284)
T ss_pred             HHHhcCCcccCcCHHHHhcCcccc
Confidence            999999999999999999886443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.92  E-value=2.3e-25  Score=181.22  Aligned_cols=166  Identities=21%  Similarity=0.277  Sum_probs=114.2

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +.+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++......     .....++..|+|||.+.+
T Consensus       117 ~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~  188 (342)
T cd07879         117 DKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILN  188 (342)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC-----CCCceeeecccChhhhcC
Confidence            356779999999999999999   999999999999999999999999987643221     112345678999999876


Q ss_pred             -CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHH--------HHHHHhcccccccc---CCCCCcC---cHH
Q 027675           82 -GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA--------WKLWQEGKALDMMD---QKPGAIS---KAN  146 (220)
Q Consensus        82 -~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~---~~~~~~~---~~~  146 (220)
                       ..++.++|+||||+++|+|++|+.||...+...........        .+............   ..+....   ...
T Consensus       189 ~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (342)
T cd07879         189 WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPK  268 (342)
T ss_pred             ccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcC
Confidence             45788999999999999999999999754322211110000        00000000000000   0000000   011


Q ss_pred             HHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 027675          147 EILKCINVGLLCVQEDPNDRPTMSDVVIM  175 (220)
Q Consensus       147 ~~~~~~~li~~cl~~~p~~Rps~~~~l~~  175 (220)
                      ....+.++|.+||+.||++||++.+++.+
T Consensus       269 ~~~~~~~li~~~l~~dP~~R~~~~e~l~h  297 (342)
T cd07879         269 ASPQAVDLLEKMLELDVDKRLTATEALEH  297 (342)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            23467899999999999999999999976

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.92  E-value=4.8e-25  Score=174.39  Aligned_cols=157  Identities=24%  Similarity=0.246  Sum_probs=116.6

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......    .....++..|+|||.+.+
T Consensus        97 ~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~  169 (278)
T cd05606          97 AEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQK  169 (278)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC----CcCcCCCcCCcCcHHhcC
Confidence            467889999999999999999   9999999999999999999999999876443211    112357889999999875


Q ss_pred             C-CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 G-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      . .++.++|+||+|+++|+|++|..||............    ... .....       .  ........+.+++.+||.
T Consensus       170 ~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~----~~~-~~~~~-------~--~~~~~s~~~~~li~~~l~  235 (278)
T cd05606         170 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMT-LTMAV-------E--LPDSFSPELRSLLEGLLQ  235 (278)
T ss_pred             CCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH----HHh-hccCC-------C--CCCcCCHHHHHHHHHHhh
Confidence            4 5789999999999999999999998644222111110    000 00000       0  011124578899999999


Q ss_pred             CCCCCCC-----CHHHHHHHhcCc
Q 027675          161 EDPNDRP-----TMSDVVIMLGSE  179 (220)
Q Consensus       161 ~~p~~Rp-----s~~~~l~~l~~~  179 (220)
                      .+|.+||     ++.+++++-+..
T Consensus       236 ~~p~~R~~~~~~~~~~ll~~~~~~  259 (278)
T cd05606         236 RDVNRRLGCLGRGAQEVKEHPFFR  259 (278)
T ss_pred             cCHHhccCCCCCCHHHHHhCcccc
Confidence            9999999     999999775443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.92  E-value=4.2e-25  Score=175.68  Aligned_cols=151  Identities=26%  Similarity=0.311  Sum_probs=115.9

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..+..++.|+++||.|||+.+   ++|+||+|.||+++.++.++|+|||++......     .....+++.|.+||.+.+
T Consensus       101 ~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~  172 (290)
T cd05580         101 PVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILS  172 (290)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----CCCCCCCccccChhhhcC
Confidence            356778999999999999999   999999999999999999999999998754332     122346778999999988


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ...+.++|+||||+++|+|++|..||...+......      ... .+.. .    .+     ......+.+++.+||..
T Consensus       173 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~~-~~~~-~----~~-----~~~~~~l~~li~~~l~~  235 (290)
T cd05580         173 KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYE------KIL-EGKV-R----FP-----SFFSPDAKDLIRNLLQV  235 (290)
T ss_pred             CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHh-cCCc-c----CC-----ccCCHHHHHHHHHHccC
Confidence            788899999999999999999999986544221111      111 1110 0    01     11234778999999999


Q ss_pred             CCCCCC-----CHHHHHHHhc
Q 027675          162 DPNDRP-----TMSDVVIMLG  177 (220)
Q Consensus       162 ~p~~Rp-----s~~~~l~~l~  177 (220)
                      ||.+|+     ++++++.+-+
T Consensus       236 ~p~~R~~~~~~~~~~l~~~~~  256 (290)
T cd05580         236 DLTKRLGNLKNGVNDIKNHPW  256 (290)
T ss_pred             CHHHccCcccCCHHHHHcCcc
Confidence            999999     8889987654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.92  E-value=5.2e-25  Score=172.07  Aligned_cols=153  Identities=28%  Similarity=0.317  Sum_probs=115.6

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+..++.++++||.|||.++   ++|+||+|+||++++++.++|+|||++.......   ......++..|++||.+.+.
T Consensus       101 ~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~  174 (258)
T cd05578         101 QVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEVLCRQ  174 (258)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc---cccccCCChhhcCHHHHccc
Confidence            57789999999999999999   9999999999999999999999999887543221   11224567789999999888


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      ..+.++|+||||+++|++++|..||............    ..... ...    .     ........+.++|.+||..|
T Consensus       175 ~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~-~~~----~-----~~~~~~~~~~~~i~~~l~~~  240 (258)
T cd05578         175 GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR----AKQET-ADV----L-----YPATWSTEAIDAINKLLERD  240 (258)
T ss_pred             CCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH----HHhcc-ccc----c-----CcccCcHHHHHHHHHHccCC
Confidence            8899999999999999999999998755432111111    11000 000    0     11112357889999999999


Q ss_pred             CCCCCCH--HHHHHH
Q 027675          163 PNDRPTM--SDVVIM  175 (220)
Q Consensus       163 p~~Rps~--~~~l~~  175 (220)
                      |.+||++  ++++.+
T Consensus       241 p~~R~~~~~~~l~~~  255 (258)
T cd05578         241 PQKRLGDNLKDLKNH  255 (258)
T ss_pred             hhHcCCccHHHHhcC
Confidence            9999999  777654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.92  E-value=3.9e-25  Score=176.60  Aligned_cols=167  Identities=25%  Similarity=0.303  Sum_probs=114.7

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++.......... .....++..|++||.+.+
T Consensus       116 ~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~  191 (302)
T cd07864         116 DHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP-YTNKVITLWYRPPELLLG  191 (302)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCcccccccccCCcccc-cccceeccCccChHHhcC
Confidence            467889999999999999999   9999999999999999999999999887543222111 111234668999998865


Q ss_pred             C-CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccc---ccc--------ccCCCCC-----cCc
Q 027675           82 G-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKA---LDM--------MDQKPGA-----ISK  144 (220)
Q Consensus        82 ~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~--------~~~~~~~-----~~~  144 (220)
                      . ..+.++|+||||+++++|++|++||...+.......   ..........   ...        .+.....     ...
T Consensus       192 ~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (302)
T cd07864         192 EERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLEL---ISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF  268 (302)
T ss_pred             CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCCCChhhcccccccccccccccccccccchhhhc
Confidence            4 468899999999999999999999875443222111   1111100000   000        0000000     000


Q ss_pred             HHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 027675          145 ANEILKCINVGLLCVQEDPNDRPTMSDVVIM  175 (220)
Q Consensus       145 ~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~  175 (220)
                      ......+.+++.+||..+|.+||++++++.+
T Consensus       269 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         269 SFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0113467899999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.92  E-value=6.3e-25  Score=176.61  Aligned_cols=153  Identities=29%  Similarity=0.362  Sum_probs=113.7

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhh-
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL-   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~-   80 (220)
                      .+++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++.....      .+...++..|+|||.+. 
T Consensus       121 ~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~  191 (313)
T cd06633         121 VEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP------ANSFVGTPYWMAPEVILA  191 (313)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC------CCCccccccccChhhccc
Confidence            356779999999999999999   99999999999999999999999998753211      12245677899999974 


Q ss_pred             --cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           81 --GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        81 --~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                        +..++.++|+||||+++|+|++|..||...+.......      ... ....        ..........+.+++.+|
T Consensus       192 ~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~------~~~-~~~~--------~~~~~~~~~~l~~li~~~  256 (313)
T cd06633         192 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH------IAQ-NDSP--------TLQSNEWTDSFRGFVDYC  256 (313)
T ss_pred             cCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH------HHh-cCCC--------CCCccccCHHHHHHHHHH
Confidence              34578899999999999999999999864433222111      100 0000        001111233578899999


Q ss_pred             cCCCCCCCCCHHHHHHHhcC
Q 027675          159 VQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       159 l~~~p~~Rps~~~~l~~l~~  178 (220)
                      |+.+|++||++.+++.+-+.
T Consensus       257 l~~~P~~Rp~~~~~l~~~~~  276 (313)
T cd06633         257 LQKIPQERPASAELLRHDFV  276 (313)
T ss_pred             ccCChhhCcCHHHHhcCccc
Confidence            99999999999999977543

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.92  E-value=5.5e-25  Score=188.83  Aligned_cols=170  Identities=15%  Similarity=0.096  Sum_probs=106.1

Q ss_pred             HHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCC-CCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            4 LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDH-EMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         4 ~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      +..++.|++.||.|||+++   |+||||||+||+++. ++.+||+|||++......... ......+++.|+|||.+...
T Consensus       257 i~~i~~qll~aL~yLH~~g---IiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~  332 (566)
T PLN03225        257 IQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMS  332 (566)
T ss_pred             HHHHHHHHHHHHHHHHHCC---EEeCcCCHHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhcc
Confidence            5579999999999999999   999999999999985 578999999998643322111 12234678899999976432


Q ss_pred             ----------------------CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHH--HHHHHHHhccccccccCC
Q 027675           83 ----------------------FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLG--YAWKLWQEGKALDMMDQK  138 (220)
Q Consensus        83 ----------------------~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  138 (220)
                                            .+..++|||||||++|+|+++..++.............  .....+... ........
T Consensus       333 ~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~  411 (566)
T PLN03225        333 TQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKL-VEPRASPD  411 (566)
T ss_pred             CCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHh-hccccchh
Confidence                                  23346699999999999998766543111000000000  000000000 00000000


Q ss_pred             CC--CcCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcC
Q 027675          139 PG--AISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       139 ~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~  178 (220)
                      ..  ............++|.+||+.||++|||++++++|=+.
T Consensus       412 ~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff  453 (566)
T PLN03225        412 LRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYF  453 (566)
T ss_pred             hhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCCcCc
Confidence            00  00000011234589999999999999999999988544

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.92  E-value=9.3e-25  Score=172.53  Aligned_cols=169  Identities=25%  Similarity=0.300  Sum_probs=116.0

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.+++.||.+||+++   ++||||+|+||++++++.++|+|||.+.........  .....++..|+|||.+.+
T Consensus        98 ~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~  172 (282)
T cd07829          98 NLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT--YTHEVVTLWYRAPEILLG  172 (282)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCccc--cCccccCcCcCChHHhcC
Confidence            357889999999999999999   999999999999999999999999988654322111  111234567999999876


Q ss_pred             C-CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHH--------HHHHHHhc----cccccccCCCCCcCcHHHH
Q 027675           82 G-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGY--------AWKLWQEG----KALDMMDQKPGAISKANEI  148 (220)
Q Consensus        82 ~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~----~~~~~~~~~~~~~~~~~~~  148 (220)
                      . .++.++|+||||++++++++|..||...+..........        .+.....-    ...................
T Consensus       173 ~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (282)
T cd07829         173 SKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLD  252 (282)
T ss_pred             CcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhccccc
Confidence            6 778999999999999999999999865443222111100        00000000    0000000000000001124


Q ss_pred             HHHHHHhccccCCCCCCCCCHHHHHHH
Q 027675          149 LKCINVGLLCVQEDPNDRPTMSDVVIM  175 (220)
Q Consensus       149 ~~~~~li~~cl~~~p~~Rps~~~~l~~  175 (220)
                      ..+.+++.+||..+|++||++.+++.+
T Consensus       253 ~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         253 PEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             HHHHHHHHHhhccCcccCCCHHHHhhC
Confidence            578999999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.92  E-value=3.9e-25  Score=174.68  Aligned_cols=157  Identities=25%  Similarity=0.315  Sum_probs=115.5

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........   .....++..|++||.+.+.
T Consensus        96 ~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~  169 (277)
T cd05577          96 RAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTPGYMAPEVLQGE  169 (277)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---cccccCCCCcCCHHHhcCC
Confidence            56778999999999999999   99999999999999999999999998765432111   1123456789999999888


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      .++.++|+||||+++|+|++|+.||............       ...... ....     ........+.++|.+||+.+
T Consensus       170 ~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-------~~~~~~-~~~~-----~~~~~~~~~~~li~~~l~~~  236 (277)
T cd05577         170 VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL-------KRRTLE-MAVE-----YPDKFSPEAKDLCEALLQKD  236 (277)
T ss_pred             CCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHH-------Hhcccc-cccc-----CCccCCHHHHHHHHHHccCC
Confidence            8889999999999999999999998654332111110       000000 0000     11112447789999999999


Q ss_pred             CCCCC-----CHHHHHHHhcC
Q 027675          163 PNDRP-----TMSDVVIMLGS  178 (220)
Q Consensus       163 p~~Rp-----s~~~~l~~l~~  178 (220)
                      |++||     ++.+++.+-+.
T Consensus       237 p~~R~~~~~~~~~~ll~h~~~  257 (277)
T cd05577         237 PEKRLGCRGGSADEVREHPLF  257 (277)
T ss_pred             hhHccCCCcccHHHHHhChhh
Confidence            99999     88888876433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.92  E-value=3.4e-25  Score=180.28  Aligned_cols=175  Identities=20%  Similarity=0.249  Sum_probs=114.7

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCC-CCCceecCccceeeecCCCC-CcccceeecccCccChhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDH-EMNPKISDFGLTRIFEGKQT-DGTTNRVVGTYGYMSPEYA   79 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~-~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~y~aPe~~   79 (220)
                      ..++.++.|+++||.|||+.+   ++||||||+||+++. ++.++++|||.+........ ........++..|+|||.+
T Consensus       114 ~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  190 (342)
T cd07854         114 EHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLL  190 (342)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHH
Confidence            357789999999999999999   999999999999974 55689999999865432111 1111122456789999987


Q ss_pred             hc-CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHH--------HHHHHhccccccc--cCCCCCc---CcH
Q 027675           80 LG-GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA--------WKLWQEGKALDMM--DQKPGAI---SKA  145 (220)
Q Consensus        80 ~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~--~~~~~~~---~~~  145 (220)
                      .+ ..++.++|+|||||++|+|++|+.||...+...........        .............  .......   ...
T Consensus       191 ~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (342)
T cd07854         191 LSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLP  270 (342)
T ss_pred             hCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHcc
Confidence            54 45788999999999999999999999654432211110000        0000000000000  0000000   001


Q ss_pred             HHHHHHHHHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          146 NEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       146 ~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      .....+.+++.+||..||++||++.+++.+=+..
T Consensus       271 ~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~  304 (342)
T cd07854         271 GVNPEALDFLEQILTFNPMDRLTAEEALMHPYMS  304 (342)
T ss_pred             CCCHHHHHHHHHHhCCCchhccCHHHHhCCCccc
Confidence            1234678999999999999999999999775443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2.3e-25  Score=183.59  Aligned_cols=165  Identities=28%  Similarity=0.340  Sum_probs=125.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+.+.++++.+.||+|||+++   ++||||-..|+|+..++.+|++|||+++...........  -.-+..|+|||.+..
T Consensus       262 ~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~~~--~klPirWLAPEtl~~  336 (474)
T KOG0194|consen  262 LEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKKFL--KKLPIRWLAPETLNT  336 (474)
T ss_pred             HHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCCcceeecccc--ccCcceecChhhhcc
Confidence            467889999999999999999   999999999999999999999999998754321111111  123568999999999


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      .-++.++||||||+++||+++ |..||.........      .++...+.......         .....+..++.+||.
T Consensus       337 ~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~------~kI~~~~~r~~~~~---------~~p~~~~~~~~~c~~  401 (474)
T KOG0194|consen  337 GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVK------AKIVKNGYRMPIPS---------KTPKELAKVMKQCWK  401 (474)
T ss_pred             CccccccchhheeeeEEeeeccCCCCCCCCCHHHHH------HHHHhcCccCCCCC---------CCHHHHHHHHHHhcc
Confidence            899999999999999999998 78888766554332      22223333332222         122355667778999


Q ss_pred             CCCCCCCCHHHHHHHhcCccccCCCC
Q 027675          161 EDPNDRPTMSDVVIMLGSEAVNLASP  186 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~~~~~~~~  186 (220)
                      .+|++||+|.++.+.++........+
T Consensus       402 ~~p~~R~tm~~i~~~l~~~~~~~~~~  427 (474)
T KOG0194|consen  402 KDPEDRPTMSTIKKKLEALEKKKEAF  427 (474)
T ss_pred             CChhhccCHHHHHHHHHHHHhccccc
Confidence            99999999999999998776665544

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.91  E-value=9.9e-25  Score=172.37  Aligned_cols=154  Identities=25%  Similarity=0.394  Sum_probs=116.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +.+..++.+++.|+.+||+.+   ++|+||+|.||+++.++.++++|||++........  ......++..|++||.+.+
T Consensus       101 ~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~  175 (277)
T cd06641         101 TQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQ  175 (277)
T ss_pred             HHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh--hhccccCCccccChhhhcc
Confidence            356789999999999999999   99999999999999999999999998765432211  1122345678999999988


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+||||+++|++++|..||..........       ....+...         .........+.+++.+||..
T Consensus       176 ~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-------~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~  239 (277)
T cd06641         176 SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLF-------LIPKNNPP---------TLEGNYSKPLKEFVEACLNK  239 (277)
T ss_pred             CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHH-------HHhcCCCC---------CCCcccCHHHHHHHHHHccC
Confidence            888899999999999999999999986433221111       11111100         01112234678899999999


Q ss_pred             CCCCCCCHHHHHHHh
Q 027675          162 DPNDRPTMSDVVIML  176 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l  176 (220)
                      +|.+||++.+++.+-
T Consensus       240 ~p~~Rp~~~~~l~~~  254 (277)
T cd06641         240 EPSFRPTAKELLKHK  254 (277)
T ss_pred             ChhhCcCHHHHHhCH
Confidence            999999999999863

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.91  E-value=3.5e-25  Score=180.38  Aligned_cols=169  Identities=23%  Similarity=0.280  Sum_probs=116.1

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++......     .....++..|+|||.+.+
T Consensus       120 ~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~  191 (345)
T cd07877         120 DHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLN  191 (345)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEeccccccccccc-----ccccccCCCccCHHHHhC
Confidence            357789999999999999999   999999999999999999999999997653221     122356778999999876


Q ss_pred             -CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHH--------HHHHHhc---cccccccCCCCCcC---cHH
Q 027675           82 -GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA--------WKLWQEG---KALDMMDQKPGAIS---KAN  146 (220)
Q Consensus        82 -~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~---~~~~~~~~~~~~~~---~~~  146 (220)
                       ..++.++|+||||+++|+|++|+.||...+...........        .......   .........+....   ...
T Consensus       192 ~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (345)
T cd07877         192 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG  271 (345)
T ss_pred             ccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCC
Confidence             45788999999999999999999998643332211110000        0000000   00000000000000   001


Q ss_pred             HHHHHHHHhccccCCCCCCCCCHHHHHHHhcC
Q 027675          147 EILKCINVGLLCVQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       147 ~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~  178 (220)
                      ....+.++|.+||..||++||++.+++.+-+.
T Consensus       272 ~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f  303 (345)
T cd07877         272 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF  303 (345)
T ss_pred             CCHHHHHHHHHHcCCChhhcCCHHHHhcChhh
Confidence            23467899999999999999999999977543

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.91  E-value=8e-25  Score=170.65  Aligned_cols=153  Identities=25%  Similarity=0.361  Sum_probs=114.4

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCC-ceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMN-PKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~-~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+..++.++++||.|||+.+   ++|+||+|+||+++.++. ++++|||.+.......  .......++..|+|||...+
T Consensus       102 ~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~ape~~~~  176 (257)
T cd08225         102 QILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM--ELAYTCVGTPYYLSPEICQN  176 (257)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc--ccccccCCCccccCHHHHcC
Confidence            56789999999999999999   999999999999988865 6999999876543221  11122356778999999988


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+||||++++++++|..||...+.....      .... .+.....         .......+.+++.+||..
T Consensus       177 ~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~------~~~~-~~~~~~~---------~~~~~~~~~~~i~~~l~~  240 (257)
T cd08225         177 RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLV------LKIC-QGYFAPI---------SPNFSRDLRSLISQLFKV  240 (257)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH------HHHh-cccCCCC---------CCCCCHHHHHHHHHHhcc
Confidence            88899999999999999999999998643322211      1111 1111100         111234688999999999


Q ss_pred             CCCCCCCHHHHHHHh
Q 027675          162 DPNDRPTMSDVVIML  176 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l  176 (220)
                      +|++|||+.+++++-
T Consensus       241 ~p~~Rpt~~~ll~~~  255 (257)
T cd08225         241 SPRDRPSITSILKRP  255 (257)
T ss_pred             ChhhCcCHHHHhhCC
Confidence            999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.91  E-value=1.5e-24  Score=171.54  Aligned_cols=168  Identities=24%  Similarity=0.288  Sum_probs=115.0

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.+|.|||+++   ++|+||+|+||+++.++.++|+|||++........   .....++..|+|||.+.+
T Consensus        99 ~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~  172 (283)
T cd07830          99 SVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP---YTDYVSTRWYRAPEILLR  172 (283)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC---cCCCCCcccccCceeeec
Confidence            357889999999999999999   99999999999999999999999998875433211   112345778999998754


Q ss_pred             -CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHH-----HHHHHhc-----cccccccCCCCC---cCcHHH
Q 027675           82 -GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA-----WKLWQEG-----KALDMMDQKPGA---ISKANE  147 (220)
Q Consensus        82 -~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~-----~~~~~~~~~~~~---~~~~~~  147 (220)
                       ..++.++|+||||+++++|++|+.||...............     ...+.++     ............   ......
T Consensus       173 ~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (283)
T cd07830         173 STSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNA  252 (283)
T ss_pred             CcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccC
Confidence             45688999999999999999999998654332221111000     0000000     000000000000   000111


Q ss_pred             HHHHHHHhccccCCCCCCCCCHHHHHHH
Q 027675          148 ILKCINVGLLCVQEDPNDRPTMSDVVIM  175 (220)
Q Consensus       148 ~~~~~~li~~cl~~~p~~Rps~~~~l~~  175 (220)
                      ...+.+++.+||+.+|++||++++++.+
T Consensus       253 ~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         253 SPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             CHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            3568899999999999999999999876

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.91  E-value=8.3e-25  Score=175.18  Aligned_cols=156  Identities=22%  Similarity=0.256  Sum_probs=110.7

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCC-------------Ccccceeec
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT-------------DGTTNRVVG   69 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~-------------~~~~~~~~~   69 (220)
                      .+..++.+++.||.|||+.+   ++|+||||.||+++.++.++++|||++........             ........+
T Consensus       102 ~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (305)
T cd05609         102 MARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCG  178 (305)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCcc
Confidence            45778899999999999999   99999999999999999999999998753211000             000111345


Q ss_pred             ccCccChhhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHH
Q 027675           70 TYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEIL  149 (220)
Q Consensus        70 ~~~y~aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (220)
                      +..|+|||.+.+..++.++|+||||+++|++++|..||..........      ... .+.. ..  .  ..  ......
T Consensus       179 ~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~------~~~-~~~~-~~--~--~~--~~~~~~  244 (305)
T cd05609         179 TPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG------QVI-SDDI-EW--P--EG--DEALPA  244 (305)
T ss_pred             CccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHH-hccc-CC--C--Cc--cccCCH
Confidence            678999999988888999999999999999999999986433222111      111 0000 00  0  00  012234


Q ss_pred             HHHHHhccccCCCCCCCCCH---HHHHHH
Q 027675          150 KCINVGLLCVQEDPNDRPTM---SDVVIM  175 (220)
Q Consensus       150 ~~~~li~~cl~~~p~~Rps~---~~~l~~  175 (220)
                      .+.++|.+||+.+|++||+.   .+++++
T Consensus       245 ~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         245 DAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             HHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            67899999999999999985   555554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.91  E-value=7.3e-25  Score=172.86  Aligned_cols=155  Identities=26%  Similarity=0.349  Sum_probs=117.2

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCC------------------cc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD------------------GT   63 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~------------------~~   63 (220)
                      ..++.++.|++.||.+||+.+   ++|+||+|+||+++.++.++++|||++.........                  ..
T Consensus       102 ~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (280)
T cd05581         102 KCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR  178 (280)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccc
Confidence            467889999999999999999   999999999999999999999999998754432210                  11


Q ss_pred             cceeecccCccChhhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcC
Q 027675           64 TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAIS  143 (220)
Q Consensus        64 ~~~~~~~~~y~aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  143 (220)
                      .....++..|.+||...+..++.++|+||||++++++++|..||..........      ....  ..     ..    .
T Consensus       179 ~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------~~~~--~~-----~~----~  241 (280)
T cd05581         179 FASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQ------KILK--LE-----YS----F  241 (280)
T ss_pred             cccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHH------HHHh--cC-----CC----C
Confidence            222355778999999888888999999999999999999999987544221110      1110  00     00    0


Q ss_pred             cHHHHHHHHHHhccccCCCCCCCCCH----HHHHHHh
Q 027675          144 KANEILKCINVGLLCVQEDPNDRPTM----SDVVIML  176 (220)
Q Consensus       144 ~~~~~~~~~~li~~cl~~~p~~Rps~----~~~l~~l  176 (220)
                      .......+.+++.+||+.+|++||++    ++++.+-
T Consensus       242 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~  278 (280)
T cd05581         242 PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHP  278 (280)
T ss_pred             CCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCC
Confidence            01114467899999999999999999    8888763

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.91  E-value=3.7e-25  Score=171.12  Aligned_cols=145  Identities=20%  Similarity=0.190  Sum_probs=108.7

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..+..++.|+++||.|||+.+   ++|+||||+||+++.++.++++|||.+.......     ....++..|+|||...+
T Consensus        85 ~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y~aPE~~~~  156 (237)
T cd05576          85 ECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMYCAPEVGGI  156 (237)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCccccCCcccCC
Confidence            356889999999999999999   9999999999999999999999999765433211     11234567999999887


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+||+|+++|++++|..++........            ......         ........+.+++.+||+.
T Consensus       157 ~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~------------~~~~~~---------~~~~~~~~~~~li~~~l~~  215 (237)
T cd05576         157 SEETEACDWWSLGAILFELLTGKTLVECHPSGIN------------THTTLN---------IPEWVSEEARSLLQQLLQF  215 (237)
T ss_pred             CCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc------------cccccC---------CcccCCHHHHHHHHHHccC
Confidence            7788999999999999999999987643211100            000000         0111234678899999999


Q ss_pred             CCCCCCCH-----HHHHHH
Q 027675          162 DPNDRPTM-----SDVVIM  175 (220)
Q Consensus       162 ~p~~Rps~-----~~~l~~  175 (220)
                      ||++||++     ++++.+
T Consensus       216 dp~~R~~~~~~~~~~~~~h  234 (237)
T cd05576         216 NPTERLGAGVAGVEDIKSH  234 (237)
T ss_pred             CHHHhcCCCccchHHHHcC
Confidence            99999996     666544

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=1.1e-24  Score=169.31  Aligned_cols=153  Identities=29%  Similarity=0.413  Sum_probs=116.1

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +.++.++.|++.||.+||+.+   ++|+||+|.||+++.++.++|+|||++.........  .....++..|++||...+
T Consensus        99 ~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~  173 (254)
T cd06627          99 SLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEM  173 (254)
T ss_pred             HHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc--ccccccchhhcCHhhhcC
Confidence            356789999999999999999   999999999999999999999999998765433221  122346778999999988


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ...+.++|+|++|++++++++|..||.........      ++.. .....    .     ........+.+++.+||..
T Consensus       174 ~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~------~~~~-~~~~~----~-----~~~~~~~~~~~~i~~~l~~  237 (254)
T cd06627         174 SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL------FRIV-QDDHP----P-----LPEGISPELKDFLMQCFQK  237 (254)
T ss_pred             CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH------HHHh-ccCCC----C-----CCCCCCHHHHHHHHHHHhC
Confidence            77889999999999999999999998644321111      1111 01110    0     0111234778999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 027675          162 DPNDRPTMSDVVIM  175 (220)
Q Consensus       162 ~p~~Rps~~~~l~~  175 (220)
                      +|++||++.+++.+
T Consensus       238 ~p~~R~~~~~~l~~  251 (254)
T cd06627         238 DPNLRPTAKQLLKH  251 (254)
T ss_pred             ChhhCcCHHHHhcC
Confidence            99999999999864

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.91  E-value=4.5e-25  Score=179.60  Aligned_cols=170  Identities=24%  Similarity=0.296  Sum_probs=117.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||++......     .....++..|+|||.+.+
T Consensus       118 ~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~  189 (343)
T cd07851         118 DHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLN  189 (343)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccccccccc-----ccCCcccccccCHHHHhC
Confidence            357889999999999999999   999999999999999999999999998754322     122345778999999865


Q ss_pred             -CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHH--------HHHHhccc---cccccCCCCCc---CcHH
Q 027675           82 -GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAW--------KLWQEGKA---LDMMDQKPGAI---SKAN  146 (220)
Q Consensus        82 -~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~---~~~~~~~~~~~---~~~~  146 (220)
                       ..++.++|+||||+++|++++|+.||...+............        ........   ...........   ....
T Consensus       190 ~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (343)
T cd07851         190 WMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSG  269 (343)
T ss_pred             CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhcc
Confidence             357889999999999999999999986544322111100000        00000000   00000000000   0011


Q ss_pred             HHHHHHHHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          147 EILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       147 ~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      ....+.+++.+||..+|++|||+.+++.+-+..
T Consensus       270 ~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~  302 (343)
T cd07851         270 ANPLAIDLLEKMLVLDPDKRITAAEALAHPYLA  302 (343)
T ss_pred             CCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcc
Confidence            245788999999999999999999999875444

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.91  E-value=7.4e-25  Score=181.35  Aligned_cols=153  Identities=22%  Similarity=0.336  Sum_probs=116.7

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeC-CCCCceecCccceeeecCCCCCcccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLD-HEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~   80 (220)
                      +.+.+|++||++||.|||++. ++|+|||||=+||||+ ..|.|||+|+|++.......    .....|||.|+|||.+.
T Consensus       143 kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~----aksvIGTPEFMAPEmYE  217 (632)
T KOG0584|consen  143 KAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH----AKSVIGTPEFMAPEMYE  217 (632)
T ss_pred             HHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc----cceeccCccccChHHHh
Confidence            457899999999999999995 7899999999999996 56889999999997543222    22268999999999887


Q ss_pred             cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           81 GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                       ..|++..||||||+.++||+|+..||.....     .....+++.. |.....+..        -....+.++|.+||.
T Consensus       218 -E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n-----~AQIYKKV~S-GiKP~sl~k--------V~dPevr~fIekCl~  282 (632)
T KOG0584|consen  218 -ENYNELVDVYAFGMCMLEMVTSEYPYSECTN-----PAQIYKKVTS-GIKPAALSK--------VKDPEVREFIEKCLA  282 (632)
T ss_pred             -hhcchhhhhhhhhHHHHHHHhccCChhhhCC-----HHHHHHHHHc-CCCHHHhhc--------cCCHHHHHHHHHHhc
Confidence             6689999999999999999999999863322     2222223321 111111111        113477899999998


Q ss_pred             CCCCCCCCHHHHHHH
Q 027675          161 EDPNDRPTMSDVVIM  175 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~  175 (220)
                      . .++|+|+.++|.+
T Consensus       283 ~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  283 T-KSERLSAKELLKD  296 (632)
T ss_pred             C-chhccCHHHHhhC
Confidence            8 9999999999954

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.91  E-value=9.8e-25  Score=173.76  Aligned_cols=169  Identities=23%  Similarity=0.304  Sum_probs=112.4

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCC-CCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDH-EMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+..++.|++.||+|||+++   ++|+||+|+||+++. ++.++++|||++........  ......++..|+|||.+.+
T Consensus       103 ~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~  177 (294)
T PLN00009        103 LIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR--TFTHEVVTLWYRAPEILLG  177 (294)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCcc--ccccCceeecccCHHHHhC
Confidence            46688999999999999999   999999999999985 45689999999865432211  1122345678999998876


Q ss_pred             C-CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhH-HHHH----HHHHhcccc----ccccCCCCC---cCcHHHH
Q 027675           82 G-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLL-GYAW----KLWQEGKAL----DMMDQKPGA---ISKANEI  148 (220)
Q Consensus        82 ~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~-~~~~----~~~~~~~~~----~~~~~~~~~---~~~~~~~  148 (220)
                      . .++.++|+||||+++|+|++|..||............ ....    ..+......    .........   .......
T Consensus       178 ~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (294)
T PLN00009        178 SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLE  257 (294)
T ss_pred             CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCC
Confidence            4 5688999999999999999999998654332111100 0000    000000000    000000000   0011123


Q ss_pred             HHHHHHhccccCCCCCCCCCHHHHHHHh
Q 027675          149 LKCINVGLLCVQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       149 ~~~~~li~~cl~~~p~~Rps~~~~l~~l  176 (220)
                      ..+.+++.+||+.+|++||++.+++.+-
T Consensus       258 ~~~~~~i~~~l~~~P~~Rps~~~~l~~~  285 (294)
T PLN00009        258 PAGVDLLSKMLRLDPSKRITARAALEHE  285 (294)
T ss_pred             hHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence            4678999999999999999999999763

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.91  E-value=1.1e-24  Score=167.80  Aligned_cols=170  Identities=24%  Similarity=0.223  Sum_probs=121.7

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +++..++.|++.|+++||+.|   |+||||||+||++..++.+|+.|||+++.....   ...+.++.+.-|.|||++.+
T Consensus       118 ~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~  191 (369)
T KOG0665|consen  118 ETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILG  191 (369)
T ss_pred             HHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccCcc---cccCchhheeeccCchheec
Confidence            467789999999999999999   999999999999999999999999999865432   23344566778999999999


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhH---------HHHHHHHHhcc----------cc----ccccC-
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLL---------GYAWKLWQEGK----------AL----DMMDQ-  137 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~---------~~~~~~~~~~~----------~~----~~~~~-  137 (220)
                      .++.+.+||||+||++.||+.|...|.+.+....-...         .+..+....+.          ..    ..+|. 
T Consensus       192 ~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~  271 (369)
T KOG0665|consen  192 MGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSL  271 (369)
T ss_pred             cCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCccc
Confidence            88999999999999999999999888643221111000         01111110000          00    00111 


Q ss_pred             -CCCCcCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHhc
Q 027675          138 -KPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       138 -~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~  177 (220)
                       ...............+++.+||..||++|.+++++|.|=.
T Consensus       272 f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY  312 (369)
T KOG0665|consen  272 FPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPY  312 (369)
T ss_pred             ccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCe
Confidence             1111111233456788999999999999999999998753

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.91  E-value=2.5e-24  Score=196.31  Aligned_cols=172  Identities=22%  Similarity=0.389  Sum_probs=120.2

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .++.+++.|+++|++|||......++|||+||+||+++.++..++. ++.......      .....++..|+|||++.+
T Consensus       780 ~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~~~~  852 (968)
T PLN00113        780 ERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPETRET  852 (968)
T ss_pred             HHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------CCCccccccccCcccccC
Confidence            5678999999999999994422239999999999999988887764 443322111      111245789999999998


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCC--CCcCcHHHHHHHHHHhcccc
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKP--GAISKANEILKCINVGLLCV  159 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl  159 (220)
                      ..++.++||||||+++|||++|+.||...... ......+..............++..  .......+...+.+++.+||
T Consensus       853 ~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl  931 (968)
T PLN00113        853 KDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCT  931 (968)
T ss_pred             CCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhC
Confidence            88999999999999999999999998532211 1112222222221111222222221  12334566778899999999


Q ss_pred             CCCCCCCCCHHHHHHHhcCccc
Q 027675          160 QEDPNDRPTMSDVVIMLGSEAV  181 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l~~~~~  181 (220)
                      +.||++||+++++++.|+....
T Consensus       932 ~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        932 ATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             cCCchhCcCHHHHHHHHHHhhc
Confidence            9999999999999999977644

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.91  E-value=1.4e-24  Score=171.38  Aligned_cols=158  Identities=24%  Similarity=0.316  Sum_probs=129.5

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      +++.++.|++.|++|||+.+   ++|.||...|++|++.-.+||+|-.+++...+........+...+..|+++|.+.+.
T Consensus       397 qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~  473 (563)
T KOG1024|consen  397 QLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNS  473 (563)
T ss_pred             HHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhh
Confidence            46789999999999999999   999999999999999999999999998865554444444444557799999999999


Q ss_pred             CCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           83 FFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      .++..+|+||||+++|||++ |+.|+..-++.+..       .-+.+|.++..+..+|+         +++.+|.-||..
T Consensus       474 ~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~-------~ylkdGyRlaQP~NCPD---------eLf~vMacCWal  537 (563)
T KOG1024|consen  474 HYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME-------HYLKDGYRLAQPFNCPD---------ELFTVMACCWAL  537 (563)
T ss_pred             hhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH-------HHHhccceecCCCCCcH---------HHHHHHHHHHhc
Confidence            99999999999999999997 88888655554433       23345666655555544         778888889999


Q ss_pred             CCCCCCCHHHHHHHhcCc
Q 027675          162 DPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~~~  179 (220)
                      .|++||+++|+...|.+.
T Consensus       538 lpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  538 LPEERPSFSQLVICLSEF  555 (563)
T ss_pred             CcccCCCHHHHHHHHHHH
Confidence            999999999999988654

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.91  E-value=3.2e-24  Score=167.78  Aligned_cols=151  Identities=25%  Similarity=0.350  Sum_probs=113.5

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .++.++.|++.||.|||+.+   ++|+||+|+||++++ +.++++|||++........  ......++..|++||...+.
T Consensus       107 ~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~  180 (260)
T cd08222         107 QVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQ  180 (260)
T ss_pred             HHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecCCCcc--cccCCCCCcCccCHHHHccC
Confidence            56788999999999999999   999999999999975 5699999998865432211  12223467789999999888


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      .++.++|+||||+++|+|++|..||.........      ... ..+...         .........+.++|.+||..+
T Consensus       181 ~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~------~~~-~~~~~~---------~~~~~~~~~~~~li~~~l~~~  244 (260)
T cd08222         181 GYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVV------LRI-VEGPTP---------SLPETYSRQLNSIMQSMLNKD  244 (260)
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH------HHH-HcCCCC---------CCcchhcHHHHHHHHHHhcCC
Confidence            8889999999999999999999998643221111      011 011110         111233457889999999999


Q ss_pred             CCCCCCHHHHHHH
Q 027675          163 PNDRPTMSDVVIM  175 (220)
Q Consensus       163 p~~Rps~~~~l~~  175 (220)
                      |++||++.+++++
T Consensus       245 p~~Rp~~~~il~~  257 (260)
T cd08222         245 PSLRPSAAEILRN  257 (260)
T ss_pred             hhhCcCHHHHhhC
Confidence            9999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.91  E-value=1e-24  Score=172.64  Aligned_cols=167  Identities=23%  Similarity=0.293  Sum_probs=115.1

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +.+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........  ......++..|++||.+.+
T Consensus       100 ~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~  174 (284)
T cd07836         100 NTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN--TFSNEVVTLWYRAPDVLLG  174 (284)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--ccccccccccccChHHhcC
Confidence            356789999999999999999   99999999999999999999999998864332211  1112345678999998866


Q ss_pred             C-CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHH--------HHHHHhccccccccCCCCCc------CcHH
Q 027675           82 G-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA--------WKLWQEGKALDMMDQKPGAI------SKAN  146 (220)
Q Consensus        82 ~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~------~~~~  146 (220)
                      . .++.++|+|+||+++|++++|..||...+...........        ++......  ......+...      ....
T Consensus       175 ~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  252 (284)
T cd07836         175 SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP--EYKPTFPRYPPQDLQQLFPH  252 (284)
T ss_pred             CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCc--hhcccccCCChHHHHHHhhh
Confidence            4 4688999999999999999999998754433221111000        00000000  0000000000      0012


Q ss_pred             HHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 027675          147 EILKCINVGLLCVQEDPNDRPTMSDVVIM  175 (220)
Q Consensus       147 ~~~~~~~li~~cl~~~p~~Rps~~~~l~~  175 (220)
                      ....+.+++.+||+.||++||++.+++.+
T Consensus       253 ~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         253 ADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             cCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            23467899999999999999999999865

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=2.7e-24  Score=168.74  Aligned_cols=155  Identities=25%  Similarity=0.318  Sum_probs=114.0

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCC-CcccceeecccCccChhhhhc
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT-DGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........ ........++..|.|||.+.+
T Consensus       107 ~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  183 (264)
T cd06653         107 VTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG  183 (264)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcC
Confidence            56789999999999999999   99999999999999999999999999875432111 111122456788999999988


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+||||++++++++|+.||.........      .+.....         ............+.+++.+||. 
T Consensus       184 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~~~---------~~~~~p~~~~~~~~~~i~~~l~-  247 (264)
T cd06653         184 EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI------FKIATQP---------TKPMLPDGVSDACRDFLKQIFV-  247 (264)
T ss_pred             CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHH------HHHHcCC---------CCCCCCcccCHHHHHHHHHHhc-
Confidence            88889999999999999999999998643222111      0111000         0011112233468889999998 


Q ss_pred             CCCCCCCHHHHHHHh
Q 027675          162 DPNDRPTMSDVVIML  176 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l  176 (220)
                      +|..||++.+++.+.
T Consensus       248 ~~~~r~~~~~~~~~~  262 (264)
T cd06653         248 EEKRRPTAEFLLRHP  262 (264)
T ss_pred             CcccCccHHHHhcCC
Confidence            579999999998763

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.91  E-value=2.9e-24  Score=166.88  Aligned_cols=152  Identities=28%  Similarity=0.350  Sum_probs=114.9

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..+..++.|+++|+.|||+.+   ++|+||+|+||+++.++.++|+|||++.......  .......++..|.+||...+
T Consensus        93 ~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~Pe~~~~  167 (250)
T cd05123          93 ERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPEYLAPEVLLG  167 (250)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcCCccccChHHhCC
Confidence            356789999999999999999   9999999999999999999999999987644321  11222456778999999988


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ...+.++|+||||+++|++++|..||...+.....      ..... . ...    .+     ......+.+++.+||..
T Consensus       168 ~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~------~~~~~-~-~~~----~~-----~~~~~~l~~~i~~~l~~  230 (250)
T cd05123         168 KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIY------EKILK-D-PLR----FP-----EFLSPEARDLISGLLQK  230 (250)
T ss_pred             CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH------HHHhc-C-CCC----CC-----CCCCHHHHHHHHHHhcC
Confidence            88889999999999999999999999654432111      11111 0 000    00     01134678899999999


Q ss_pred             CCCCCCCH---HHHHHH
Q 027675          162 DPNDRPTM---SDVVIM  175 (220)
Q Consensus       162 ~p~~Rps~---~~~l~~  175 (220)
                      ||++||++   ++++.+
T Consensus       231 ~p~~R~~~~~~~~l~~~  247 (250)
T cd05123         231 DPTKRLGSGGAEEIKAH  247 (250)
T ss_pred             CHhhCCCcccHHHHHhC
Confidence            99999999   677665

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.91  E-value=7.1e-25  Score=175.66  Aligned_cols=154  Identities=24%  Similarity=0.286  Sum_probs=116.4

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .++-++.+|+-||++||..+   |++||+||+|||+++.|+++|+|+|++..+......  .. .+||.+|+|||++.+.
T Consensus       288 ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~--~~-rvGT~GYMAPEvl~ne  361 (591)
T KOG0986|consen  288 RARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI--RG-RVGTVGYMAPEVLQNE  361 (591)
T ss_pred             HHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCCCcc--cc-ccCcccccCHHHHcCC
Confidence            45678899999999999999   999999999999999999999999999876644332  11 3789999999999999


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      .|+...|.|+|||++|+|+.|+-||.....+.--..+        +...+..     ...+....+....+++...|+.|
T Consensus       362 ~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEv--------drr~~~~-----~~ey~~kFS~eakslc~~LL~Kd  428 (591)
T KOG0986|consen  362 VYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEV--------DRRTLED-----PEEYSDKFSEEAKSLCEGLLTKD  428 (591)
T ss_pred             cccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHH--------HHHHhcc-----hhhcccccCHHHHHHHHHHHccC
Confidence            9999999999999999999999999654433321111        1111111     11222334456677777799999


Q ss_pred             CCCCCC-----HHHHHHH
Q 027675          163 PNDRPT-----MSDVVIM  175 (220)
Q Consensus       163 p~~Rps-----~~~~l~~  175 (220)
                      |++|..     +.++.+|
T Consensus       429 p~~RLGcrg~ga~evk~H  446 (591)
T KOG0986|consen  429 PEKRLGCRGEGAQEVKEH  446 (591)
T ss_pred             HHHhccCCCcCcchhhhC
Confidence            999965     4455544

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.91  E-value=1.4e-24  Score=175.98  Aligned_cols=175  Identities=23%  Similarity=0.267  Sum_probs=117.6

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCC------------Ccccceeec
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT------------DGTTNRVVG   69 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~------------~~~~~~~~~   69 (220)
                      ..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||.+........            ........+
T Consensus       119 ~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (335)
T PTZ00024        119 SQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVV  195 (335)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCccceeeccccccccccccccccccccccccccc
Confidence            356789999999999999999   99999999999999999999999999875441100            001111234


Q ss_pred             ccCccChhhhhcC-CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHH-H----HHhccccccc---cC-CC
Q 027675           70 TYGYMSPEYALGG-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWK-L----WQEGKALDMM---DQ-KP  139 (220)
Q Consensus        70 ~~~y~aPe~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~-~----~~~~~~~~~~---~~-~~  139 (220)
                      +..|+|||.+.+. .++.++|+||||+++|+|++|..||...+............. .    +.........   .. .+
T Consensus       196 ~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (335)
T PTZ00024        196 TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKP  275 (335)
T ss_pred             ccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCc
Confidence            6689999998764 358899999999999999999999975554332211100000 0    0000000000   00 00


Q ss_pred             CC--cCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          140 GA--ISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       140 ~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      ..  .........+.+++.+||+.+|++||++++++.+-+..
T Consensus       276 ~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~  317 (335)
T PTZ00024        276 KDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFK  317 (335)
T ss_pred             ccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccC
Confidence            00  00011245678999999999999999999999876543

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.91  E-value=3.4e-24  Score=160.60  Aligned_cols=175  Identities=21%  Similarity=0.302  Sum_probs=122.5

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCC--CCcccceeecccCccChhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQ--TDGTTNRVVGTYGYMSPEYA   79 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~y~aPe~~   79 (220)
                      .+|.++++++..||.|+|.+.   |+|||+|+.|++|+.+|.++|+|||+++.+....  .....++.+-+.+|++||.+
T Consensus       124 s~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEll  200 (376)
T KOG0669|consen  124 SEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELL  200 (376)
T ss_pred             HHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHh
Confidence            468899999999999999999   9999999999999999999999999997654322  11222233448899999999


Q ss_pred             hcC-CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHH--------HHHHHhccccccc--cCCCCCcCc--HH
Q 027675           80 LGG-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA--------WKLWQEGKALDMM--DQKPGAISK--AN  146 (220)
Q Consensus        80 ~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~--~~~~~~~~~--~~  146 (220)
                      .|. .++...|+|..|||+.+|+++.+.++..........+...        |....+-.....+  .+.+.....  .+
T Consensus       201 LG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n  280 (376)
T KOG0669|consen  201 LGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKN  280 (376)
T ss_pred             hcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhh
Confidence            886 5789999999999999999999888754443332222111        1111111111111  001111000  00


Q ss_pred             ------HHHHHHHHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          147 ------EILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       147 ------~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                            .....++++..++++||.+|+++.+++.+-...
T Consensus       281 ~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~  319 (376)
T KOG0669|consen  281 RLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFW  319 (376)
T ss_pred             hcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhh
Confidence                  112567888889999999999999999887555

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=5.6e-24  Score=185.75  Aligned_cols=184  Identities=22%  Similarity=0.208  Sum_probs=132.3

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc-
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG-   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~-   81 (220)
                      ++.-++..|+.||..||+.|   ++||||||+|||++..|++||+|||.+...... ........+|||.|.+||++.. 
T Consensus       176 ~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~d-G~V~s~~aVGTPDYISPEvLqs~  251 (1317)
T KOG0612|consen  176 WARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD-GTVRSSVAVGTPDYISPEVLQSQ  251 (1317)
T ss_pred             HHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCC-CcEEeccccCCCCccCHHHHHhh
Confidence            45678899999999999999   999999999999999999999999997654422 2223344689999999999862 


Q ss_pred             ----CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcc
Q 027675           82 ----GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLL  157 (220)
Q Consensus        82 ----~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  157 (220)
                          +.|+..+|.||+|+++|||+.|..||.-      ++..+-..++..-....   ..+..    ...+....++|..
T Consensus       252 ~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa------dslveTY~KIm~hk~~l---~FP~~----~~VSeeakdLI~~  318 (1317)
T KOG0612|consen  252 GDGKGEYGRECDWWSLGVFMYEMLYGETPFYA------DSLVETYGKIMNHKESL---SFPDE----TDVSEEAKDLIEA  318 (1317)
T ss_pred             cCCccccCCccchhhhHHHHHHHHcCCCcchH------HHHHHHHHHHhchhhhc---CCCcc----cccCHHHHHHHHH
Confidence                4578999999999999999999999842      22222233333222222   11111    2244466677776


Q ss_pred             ccCCCCCCCCC---HHHHHHHh--cCccccCCCCCCchhhhccCCCCCCCCC
Q 027675          158 CVQEDPNDRPT---MSDVVIML--GSEAVNLASPKRPAFVVRRGSSSSASTS  204 (220)
Q Consensus       158 cl~~~p~~Rps---~~~~l~~l--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  204 (220)
                      .+ -+|+.|..   ++++..|-  .+..|+.-....+++++.-+++.++|..
T Consensus       319 ll-~~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevssd~DTsnF  369 (1317)
T KOG0612|consen  319 LL-CDREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSSDDDTSNF  369 (1317)
T ss_pred             Hh-cChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCCCCccccc
Confidence            65 47899988   99999776  5555555555566777776777776655

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=4.2e-24  Score=176.27  Aligned_cols=150  Identities=31%  Similarity=0.405  Sum_probs=122.6

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhh--
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL--   80 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~--   80 (220)
                      +|..|.++.+.||.|||+.+   .+|||||..||++++.|.|||+|||.+....      .-+.++|||.|+|||++.  
T Consensus       127 EIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~------PAnsFvGTPywMAPEVILAM  197 (948)
T KOG0577|consen  127 EIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA------PANSFVGTPYWMAPEVILAM  197 (948)
T ss_pred             HHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC------chhcccCCccccchhHheec
Confidence            46678999999999999999   9999999999999999999999999886532      233478999999999975  


Q ss_pred             -cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           81 -GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        81 -~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                       .+.|+.+.||||||+...||...++|+-.++.....-.+.               ...+......+.+..+.+|+..||
T Consensus       198 DEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIA---------------QNesPtLqs~eWS~~F~~Fvd~CL  262 (948)
T KOG0577|consen  198 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA---------------QNESPTLQSNEWSDYFRNFVDSCL  262 (948)
T ss_pred             cccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHH---------------hcCCCCCCCchhHHHHHHHHHHHH
Confidence             3568999999999999999999999976555554433221               122233345667789999999999


Q ss_pred             CCCCCCCCCHHHHHHHh
Q 027675          160 QEDPNDRPTMSDVVIML  176 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l  176 (220)
                      +.-|.+|||.+++++|-
T Consensus       263 qKipqeRptse~ll~H~  279 (948)
T KOG0577|consen  263 QKIPQERPTSEELLKHR  279 (948)
T ss_pred             hhCcccCCcHHHHhhcc
Confidence            99999999999998764

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.91  E-value=3e-24  Score=173.78  Aligned_cols=169  Identities=24%  Similarity=0.333  Sum_probs=116.4

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc-
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG-   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~-   81 (220)
                      .+..++.|+++||.|||+.+   ++|+||+|.||+++.++.++|+|||.+......     .....++..|+|||.+.+ 
T Consensus       109 ~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~  180 (328)
T cd07856         109 FIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTW  180 (328)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCCC-----cCCCcccccccCceeeecc
Confidence            45678999999999999999   999999999999999999999999988643221     112345678999998765 


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHH-----HHHHH---hccccccccCCCC-CcCc-----HHH
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA-----WKLWQ---EGKALDMMDQKPG-AISK-----ANE  147 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~-----~~~~~---~~~~~~~~~~~~~-~~~~-----~~~  147 (220)
                      ..++.++|+||||+++|+|++|..||...............     .+...   .+...+....... ....     ...
T Consensus       181 ~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (328)
T cd07856         181 QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNA  260 (328)
T ss_pred             CCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCC
Confidence            46789999999999999999999998654432211111000     00000   0000000000000 0001     112


Q ss_pred             HHHHHHHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          148 ILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       148 ~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      ...+.++|.+||+.+|++||++++++.+-+..
T Consensus       261 ~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~  292 (328)
T cd07856         261 DPSAIDLLEKMLVFDPQKRISAAEALAHPYLA  292 (328)
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHhcCCccc
Confidence            35788999999999999999999999886554

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1.9e-24  Score=163.79  Aligned_cols=174  Identities=23%  Similarity=0.303  Sum_probs=123.6

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+.-+++||+.||+|||+.+   |+||||||.|.+++.+..+||||||+++.............. -+.-|.|||++.|.
T Consensus       157 HvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEV-VTQYYRAPEiLMGa  232 (449)
T KOG0664|consen  157 HVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEV-VTQYYRAPELLMGA  232 (449)
T ss_pred             hhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhhhhhhHHHH-HHHHhccHHHhhcc
Confidence            34557899999999999999   999999999999999999999999999987765554444433 36679999999986


Q ss_pred             -CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHH---------HHHHHhcc--ccccccCCCCCc------Cc
Q 027675           83 -FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA---------WKLWQEGK--ALDMMDQKPGAI------SK  144 (220)
Q Consensus        83 -~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~---------~~~~~~~~--~~~~~~~~~~~~------~~  144 (220)
                       .|+...||||.|||+.||+..+..|+-.+.....+.+...         .-..+..+  .++..-..+...      ..
T Consensus       233 RhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~  312 (449)
T KOG0664|consen  233 RRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASP  312 (449)
T ss_pred             hhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCC
Confidence             5899999999999999999999888876666555544332         11111111  111111111110      00


Q ss_pred             HHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcCcc
Q 027675          145 ANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEA  180 (220)
Q Consensus       145 ~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~~  180 (220)
                      ....-.-..+...++..||+.|.+-++.+.++....
T Consensus       313 ~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e  348 (449)
T KOG0664|consen  313 DDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE  348 (449)
T ss_pred             cccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence            111123455667789999999999999998875543

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1.8e-24  Score=179.54  Aligned_cols=156  Identities=26%  Similarity=0.431  Sum_probs=125.8

Q ss_pred             HHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcCC
Q 027675            4 LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGF   83 (220)
Q Consensus         4 ~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~~   83 (220)
                      ++.|+-||..|++||.+++   ++||||...|+|+..+..||++|||+++..........-. ..-+..|.|||.+....
T Consensus       367 LlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAG-AKFPIKWTAPEsLAyNt  442 (1157)
T KOG4278|consen  367 LLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAYNT  442 (1157)
T ss_pred             HHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCceecccC-ccCcccccCcccccccc
Confidence            4678999999999999999   9999999999999999999999999998755332221111 11246899999999999


Q ss_pred             CcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           84 FSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        84 ~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      ++.++|+|+||+++||+.| |--||...+.       ..+..++.++-+++.+..++.         .++++|+.||+++
T Consensus       443 FSiKSDVWAFGVLLWEIATYGMsPYPGidl-------SqVY~LLEkgyRM~~PeGCPp---------kVYeLMraCW~Ws  506 (1157)
T KOG4278|consen  443 FSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------SQVYGLLEKGYRMDGPEGCPP---------KVYELMRACWNWS  506 (1157)
T ss_pred             cccchhhHHHHHHHHHHHhcCCCCCCCccH-------HHHHHHHhccccccCCCCCCH---------HHHHHHHHHhcCC
Confidence            9999999999999999997 6666654332       223456677788887777776         7889999999999


Q ss_pred             CCCCCCHHHHHHHhcCc
Q 027675          163 PNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       163 p~~Rps~~~~l~~l~~~  179 (220)
                      |.+||++.++-+.++-.
T Consensus       507 PsDRPsFaeiHqafEtm  523 (1157)
T KOG4278|consen  507 PSDRPSFAEIHQAFETM  523 (1157)
T ss_pred             cccCccHHHHHHHHHHH
Confidence            99999999998777543

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=2.8e-24  Score=159.55  Aligned_cols=152  Identities=23%  Similarity=0.281  Sum_probs=120.0

Q ss_pred             HHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcCC
Q 027675            4 LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGF   83 (220)
Q Consensus         4 ~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~~   83 (220)
                      ...++.|++.|+.|+|..+   ++||||||+|+|++..+.+|++|||=+......    ......||..|++||...+..
T Consensus       126 ~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~----kR~tlcgt~dyl~pEmv~~~~  198 (281)
T KOG0580|consen  126 AATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSN----KRKTLCGTLDYLPPEMVEGRG  198 (281)
T ss_pred             hhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecCCC----CceeeecccccCCHhhcCCCC
Confidence            4678999999999999999   999999999999999999999999987754321    222356899999999999999


Q ss_pred             CcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCCC
Q 027675           84 FSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDP  163 (220)
Q Consensus        84 ~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  163 (220)
                      .+...|+|++|++.||++.|.+||...+.......+      .       ..+..    .+........++|.+|+..+|
T Consensus       199 hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI------~-------k~~~~----~p~~is~~a~dlI~~ll~~~p  261 (281)
T KOG0580|consen  199 HDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRI------R-------KVDLK----FPSTISGGAADLISRLLVKNP  261 (281)
T ss_pred             ccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHH------H-------Hcccc----CCcccChhHHHHHHHHhccCc
Confidence            999999999999999999999999754433222111      1       00111    112233467889999999999


Q ss_pred             CCCCCHHHHHHHhcCc
Q 027675          164 NDRPTMSDVVIMLGSE  179 (220)
Q Consensus       164 ~~Rps~~~~l~~l~~~  179 (220)
                      .+|.+..+++.+-+..
T Consensus       262 ~~r~~l~~v~~hpwI~  277 (281)
T KOG0580|consen  262 IERLALTEVMDHPWIV  277 (281)
T ss_pred             cccccHHHHhhhHHHH
Confidence            9999999999987654

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.90  E-value=8.7e-25  Score=184.75  Aligned_cols=168  Identities=29%  Similarity=0.441  Sum_probs=129.9

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeec--ccCccChhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVG--TYGYMSPEYA   79 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~--~~~y~aPe~~   79 (220)
                      .+++-|+++|+.|++||-..+   ++||||.+.|||++.+-.+|++|||+++...... ....+...|  +..|.|||.+
T Consensus       731 iQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~-~~~ytt~GGKIPiRWTAPEAI  806 (996)
T KOG0196|consen  731 IQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-EAAYTTLGGKIPIRWTAPEAI  806 (996)
T ss_pred             ehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCC-CccccccCCccceeecChhHh
Confidence            467889999999999999999   9999999999999999999999999998654433 111111112  3589999999


Q ss_pred             hcCCCcccCceeehhHHHHHHHh-cCccCc-ccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcc
Q 027675           80 LGGFFSVKSDVFSFGVVVLEIIS-GKRNTG-FYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLL  157 (220)
Q Consensus        80 ~~~~~~~~~DiwslG~il~~ll~-g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  157 (220)
                      ....++.++|+||+|+++||.++ |+.||- +.+.+..        +...++-++..         +..+...+.++|..
T Consensus       807 a~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVI--------kaIe~gyRLPp---------PmDCP~aL~qLMld  869 (996)
T KOG0196|consen  807 AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI--------KAIEQGYRLPP---------PMDCPAALYQLMLD  869 (996)
T ss_pred             hhcccCchhhccccceEEEEecccCCCcccccchHHHH--------HHHHhccCCCC---------CCCCcHHHHHHHHH
Confidence            99999999999999999999885 888864 3333332        22233333322         23344588999999


Q ss_pred             ccCCCCCCCCCHHHHHHHhcCccccCCCCCCch
Q 027675          158 CVQEDPNDRPTMSDVVIMLGSEAVNLASPKRPA  190 (220)
Q Consensus       158 cl~~~p~~Rps~~~~l~~l~~~~~~~~~~~~~~  190 (220)
                      ||+.|-.+||.+.+|+..|....++...-....
T Consensus       870 CWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~~  902 (996)
T KOG0196|consen  870 CWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTIA  902 (996)
T ss_pred             HHHHHhhcCCCHHHHHHHHHHHhcCchhhcccC
Confidence            999999999999999999988877665554433

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.90  E-value=7.2e-24  Score=183.51  Aligned_cols=160  Identities=26%  Similarity=0.400  Sum_probs=123.5

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCccc-ceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTT-NRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~-~~~~~~~~y~aPe~~~   80 (220)
                      ..++++++||+.|++||++..   ++||||...||++..+..+|++|||+++........... ..-.-+..|+|||.+.
T Consensus       418 ~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~  494 (609)
T KOG0200|consen  418 KDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLF  494 (609)
T ss_pred             HHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhc
Confidence            357899999999999999998   999999999999999999999999999854433322211 1101245699999999


Q ss_pred             cCCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           81 GGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      ...++.++|+||||+++||+++ |..||........      ..+...+|.+++.+.-+         ..+++++|+.||
T Consensus       495 ~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~------l~~~l~~G~r~~~P~~c---------~~eiY~iM~~CW  559 (609)
T KOG0200|consen  495 DRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEE------LLEFLKEGNRMEQPEHC---------SDEIYDLMKSCW  559 (609)
T ss_pred             cCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHH------HHHHHhcCCCCCCCCCC---------CHHHHHHHHHHh
Confidence            9899999999999999999998 7788764221111      12344555555544433         337889999999


Q ss_pred             CCCCCCCCCHHHHHHHhcCc
Q 027675          160 QEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l~~~  179 (220)
                      ..+|++||++.++.+.+...
T Consensus       560 ~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  560 NADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             CCCcccCCCHHHHHHHHHHH
Confidence            99999999999999998663

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.90  E-value=7e-24  Score=168.38  Aligned_cols=158  Identities=24%  Similarity=0.300  Sum_probs=112.5

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+..++.|++++|.|||+.+   ++|+||+|.||+++.++.++++|||++......... ......++..|++||...+.
T Consensus       106 ~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~  181 (288)
T cd05583         106 EVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGG  181 (288)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccccccccccc-ccccccCCccccCHHHhcCC
Confidence            56778899999999999999   999999999999999999999999987654322211 11123467789999998765


Q ss_pred             C--CcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           83 F--FSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        83 ~--~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      .  .+.++|+||||+++|+|++|..||.........  ..........     .  ...    .......+.+++.+||+
T Consensus       182 ~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~~~~~~~~~-----~--~~~----~~~~~~~l~~li~~~l~  248 (288)
T cd05583         182 SGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ--SEISRRILKS-----K--PPF----PKTMSAEARDFIQKLLE  248 (288)
T ss_pred             CCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH--HHHHHHHHcc-----C--CCC----CcccCHHHHHHHHHHhc
Confidence            4  678999999999999999999998532221111  1111111100     0  000    11123467889999999


Q ss_pred             CCCCCCCCHHHHHHHhc
Q 027675          161 EDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~  177 (220)
                      .+|++|||+.++.+.|.
T Consensus       249 ~~p~~R~t~~~~~~~l~  265 (288)
T cd05583         249 KDPKKRLGANGADEIKN  265 (288)
T ss_pred             CCHhhccCcchHHHHhc
Confidence            99999999776655553

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=3.3e-24  Score=174.06  Aligned_cols=156  Identities=21%  Similarity=0.294  Sum_probs=121.9

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      +..-++..+++|++|||.+|   |++|||||+|++++.+|-+||.|||++.........+   .+.||+.|.|||++.+.
T Consensus       521 tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTw---TFcGTpEYVAPEIILnK  594 (732)
T KOG0614|consen  521 TARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTW---TFCGTPEYVAPEIILNK  594 (732)
T ss_pred             hhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCCcee---eecCCcccccchhhhcc
Confidence            34457788999999999999   9999999999999999999999999998766544333   36899999999999988


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      +-+.+.|.|+||+++|||++|.+||...++....+.+   .+....      +.      .+........++|+++...+
T Consensus       595 GHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I---LkGid~------i~------~Pr~I~k~a~~Lik~LCr~~  659 (732)
T KOG0614|consen  595 GHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI---LKGIDK------IE------FPRRITKTATDLIKKLCRDN  659 (732)
T ss_pred             CcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH---Hhhhhh------hh------cccccchhHHHHHHHHHhcC
Confidence            8899999999999999999999999887776544332   111111      01      11112224567888888999


Q ss_pred             CCCCCC-----HHHHHHHhcCc
Q 027675          163 PNDRPT-----MSDVVIMLGSE  179 (220)
Q Consensus       163 p~~Rps-----~~~~l~~l~~~  179 (220)
                      |.+|..     +.+|.+|.|..
T Consensus       660 P~ERLG~~~~gI~DIkkH~Wf~  681 (732)
T KOG0614|consen  660 PTERLGYQKGGINDIKKHRWFE  681 (732)
T ss_pred             cHhhhccccCChHHHHhhhhhh
Confidence            999976     78888877544

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.90  E-value=2e-24  Score=175.88  Aligned_cols=168  Identities=23%  Similarity=0.272  Sum_probs=115.0

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +.++.++.|+++||.|||+.+   ++||||||+||+++.++.++++|||++......     .....++..|++||.+.+
T Consensus       118 ~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~  189 (343)
T cd07880         118 DRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-----MTGYVVTRWYRAPEVILN  189 (343)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccccccccC-----ccccccCCcccCHHHHhC
Confidence            357789999999999999999   999999999999999999999999988653321     112345778999999876


Q ss_pred             -CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhH-HH-------HHHHHHhccccccccCCCCCc------CcHH
Q 027675           82 -GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLL-GY-------AWKLWQEGKALDMMDQKPGAI------SKAN  146 (220)
Q Consensus        82 -~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~-~~-------~~~~~~~~~~~~~~~~~~~~~------~~~~  146 (220)
                       ..++.++|+||||+++|++++|..||...+........ ..       .................+...      ....
T Consensus       190 ~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (343)
T cd07880         190 WMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPN  269 (343)
T ss_pred             CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccC
Confidence             35788999999999999999999998754332111000 00       000000000000000000000      0011


Q ss_pred             HHHHHHHHhccccCCCCCCCCCHHHHHHHhc
Q 027675          147 EILKCINVGLLCVQEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       147 ~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~  177 (220)
                      ....+.++|.+|+..||++|||+.+++.+-+
T Consensus       270 ~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~  300 (343)
T cd07880         270 ANPLAVNVLEKMLVLDAESRITAAEALAHPY  300 (343)
T ss_pred             CChHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence            2335789999999999999999999996543

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.90  E-value=1.4e-23  Score=161.51  Aligned_cols=155  Identities=30%  Similarity=0.375  Sum_probs=116.2

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.+++.++.+||+.+   ++|+||+|.||+++.++.++++|||.+.......   ......+...|.+||.+.+
T Consensus        87 ~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~  160 (244)
T smart00220       87 DEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAPEVLLG  160 (244)
T ss_pred             HHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCHHHHcc
Confidence            457889999999999999999   9999999999999999999999999987654321   1122345778999999988


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+|+||++++++++|..||.........  .    .....+....       ..........+.+++.+||..
T Consensus       161 ~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~--~----~~~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~  227 (244)
T smart00220      161 KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLEL--F----KKIGKPKPPF-------PPPEWKISPEAKDLIRKLLVK  227 (244)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH--H----HHHhccCCCC-------ccccccCCHHHHHHHHHHccC
Confidence            88889999999999999999999998653222111  0    1111111100       000000334788899999999


Q ss_pred             CCCCCCCHHHHHHH
Q 027675          162 DPNDRPTMSDVVIM  175 (220)
Q Consensus       162 ~p~~Rps~~~~l~~  175 (220)
                      +|++||++.+++++
T Consensus       228 ~p~~Rp~~~~~~~~  241 (244)
T smart00220      228 DPEKRLTAEEALQH  241 (244)
T ss_pred             CchhccCHHHHhhC
Confidence            99999999999974

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.90  E-value=1.1e-23  Score=176.58  Aligned_cols=156  Identities=25%  Similarity=0.349  Sum_probs=121.5

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCC-CCcccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQ-TDGTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~y~aPe~~~   80 (220)
                      ..+..++.||+.|+.||..++   ++||||...|+++.....|||+|||+.+...... .+.......-...|+|||.++
T Consensus       212 ~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLr  288 (1039)
T KOG0199|consen  212 SRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLR  288 (1039)
T ss_pred             HHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhc
Confidence            356778999999999999998   9999999999999999899999999998755332 222222223356899999999


Q ss_pred             cCCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           81 GGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      ...++.++|+|.+||.+|||++ |+.||-+.......       +.++++.++.....         +...+++++..||
T Consensus       289 h~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL-------~~iD~~erLpRPk~---------csedIY~imk~cW  352 (1039)
T KOG0199|consen  289 HRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQIL-------KNIDAGERLPRPKY---------CSEDIYQIMKNCW  352 (1039)
T ss_pred             cccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHH-------HhccccccCCCCCC---------ChHHHHHHHHHhc
Confidence            9999999999999999999997 77787655544332       22234444433333         4458899999999


Q ss_pred             CCCCCCCCCHHHHHHHh
Q 027675          160 QEDPNDRPTMSDVVIML  176 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l  176 (220)
                      +.+|++||++..|.+.+
T Consensus       353 ah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  353 AHNPADRPTFSAIREDL  369 (1039)
T ss_pred             cCCccccccHHHHHHhH
Confidence            99999999999997443

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.89  E-value=1e-24  Score=164.35  Aligned_cols=151  Identities=26%  Similarity=0.346  Sum_probs=112.3

Q ss_pred             HHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc--CCCccc
Q 027675           10 GVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG--GFFSVK   87 (220)
Q Consensus        10 ~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~--~~~~~~   87 (220)
                      ..+.||+||-..-  .|+|||+||+|||++..|.+||||||.+-.....   ...+.-.|-..|+|||.+..  .+++.+
T Consensus       175 atV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S---iAkT~daGCrpYmAPERi~p~~~gyDiR  249 (361)
T KOG1006|consen  175 ATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS---IAKTVDAGCRPYMAPERIDPSDKGYDIR  249 (361)
T ss_pred             eehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH---HHhhhccCCccccChhccCCccCCcchh
Confidence            4567999998765  3999999999999999999999999987543322   22233456779999999863  468999


Q ss_pred             CceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCCCCCCC
Q 027675           88 SDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRP  167 (220)
Q Consensus        88 ~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp  167 (220)
                      +|+||||+.++|+.+|..||..|+....+...     +. .+...    .........+....+.++|..||..|-..||
T Consensus       250 SDvWSLGITL~EvAtG~fPyr~w~svfeql~~-----Vv-~gdpp----~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rp  319 (361)
T KOG1006|consen  250 SDVWSLGITLYEVATGNFPYRKWDSVFEQLCQ-----VV-IGDPP----ILLFDKECVHYSFSMVRFINTCLIKDRSDRP  319 (361)
T ss_pred             hhhhhhcceEeeeecCCCCcchHHHHHHHHHH-----HH-cCCCC----eecCcccccccCHHHHHHHHHHhhcccccCc
Confidence            99999999999999999999888764322111     11 11111    1111122344667888999999999999999


Q ss_pred             CHHHHHHH
Q 027675          168 TMSDVVIM  175 (220)
Q Consensus       168 s~~~~l~~  175 (220)
                      .+.+++++
T Consensus       320 ky~~Lk~~  327 (361)
T KOG1006|consen  320 KYDDLKKF  327 (361)
T ss_pred             chhhhhcC
Confidence            99999865

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.89  E-value=1e-23  Score=174.26  Aligned_cols=155  Identities=23%  Similarity=0.303  Sum_probs=122.9

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      ....++.|++.|++|||+++   |+|||||++||+++.+.++||+|||++..+....   ......|++.|+|||++.|.
T Consensus       156 ~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~---~lqt~cgsppyAaPEl~~g~  229 (596)
T KOG0586|consen  156 EARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYGL---MLQTFCGSPPYAAPELFNGK  229 (596)
T ss_pred             hhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecccc---cccccCCCCCccChHhhcCc
Confidence            45678999999999999999   9999999999999999999999999998766322   23335789999999999988


Q ss_pred             CC-cccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           83 FF-SVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        83 ~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      .+ .+++|+||+|+++|-|+.|..||++.+-......               .+....+..+.  -...+.++|+++|-.
T Consensus       230 ~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~r---------------vl~gk~rIp~~--ms~dce~lLrk~lvl  292 (596)
T KOG0586|consen  230 KYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPR---------------VLRGKYRIPFY--MSCDCEDLLRKFLVL  292 (596)
T ss_pred             ccCCcceehhhhhhhheeeeecccccCCcccccccch---------------heeeeecccce--eechhHHHHHHhhcc
Confidence            65 7899999999999999999999986554443211               11112222211  223678889999999


Q ss_pred             CCCCCCCHHHHHHHhcCcc
Q 027675          162 DPNDRPTMSDVVIMLGSEA  180 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~~~~  180 (220)
                      +|.+|++.+++.++-|.-.
T Consensus       293 ~Pskr~~~dqim~~~W~n~  311 (596)
T KOG0586|consen  293 NPSKRGPCDQIMKDRWRND  311 (596)
T ss_pred             CccccCCHHHhhhhcccch
Confidence            9999999999998876553

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.89  E-value=2.1e-23  Score=165.81  Aligned_cols=159  Identities=21%  Similarity=0.266  Sum_probs=113.1

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+..++.|+++||.|||+.+   ++||||+|+||+++.++.++|+|||++......... ......++..|++||.+.+.
T Consensus       106 ~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~  181 (290)
T cd05613         106 EVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGG  181 (290)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceeccccccc-ccccccCCcccCChhhccCC
Confidence            56678889999999999999   999999999999999999999999988754322111 11123567789999998653


Q ss_pred             --CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           83 --FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        83 --~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                        ..+.++|+||||+++|+|++|..||.........  ..........       ..    .........+.+++.+||.
T Consensus       182 ~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~--~~~~~~~~~~-------~~----~~~~~~~~~~~~ll~~~l~  248 (290)
T cd05613         182 DGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKS-------EP----PYPQEMSALAKDIIQRLLM  248 (290)
T ss_pred             CCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccH--HHHHHHhhcc-------CC----CCCccCCHHHHHHHHHHhc
Confidence              3578899999999999999999998632221110  1111111000       00    0111133467889999999


Q ss_pred             CCCCCCC-----CHHHHHHHhcC
Q 027675          161 EDPNDRP-----TMSDVVIMLGS  178 (220)
Q Consensus       161 ~~p~~Rp-----s~~~~l~~l~~  178 (220)
                      .+|++||     ++++++.+-..
T Consensus       249 ~~p~~R~~~~~~~~~~l~~~~~~  271 (290)
T cd05613         249 KDPKKRLGCGPSDADEIKKHPFF  271 (290)
T ss_pred             CCHHHhcCCCCCCHHHHHcCccc
Confidence            9999997     88888877433

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.89  E-value=1.1e-23  Score=174.76  Aligned_cols=157  Identities=25%  Similarity=0.345  Sum_probs=122.9

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .++..+++|+..||.|||+..   ++||||...||++....+|||+|||+++.......+... ...-+..|+|||.+.-
T Consensus       491 ~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINf  566 (974)
T KOG4257|consen  491 RTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINF  566 (974)
T ss_pred             HHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccccchhhcc-ccccceeecCccccch
Confidence            356788999999999999998   999999999999999999999999999987654443333 2234668999999998


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+|=||+.+||++. |..||.+-...+..       ..+.+|.++..++.+         ...++.++.+||+
T Consensus       567 RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-------~~iEnGeRlP~P~nC---------Pp~LYslmskcWa  630 (974)
T KOG4257|consen  567 RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-------GHIENGERLPCPPNC---------PPALYSLMSKCWA  630 (974)
T ss_pred             hcccchhhHHHHHHHHHHHHHhcCCccccccccceE-------EEecCCCCCCCCCCC---------ChHHHHHHHHHhc
Confidence            899999999999999999885 88898754332221       112234444333333         3477889999999


Q ss_pred             CCCCCCCCHHHHHHHhcC
Q 027675          161 EDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~  178 (220)
                      ++|.+||.+.++...|..
T Consensus       631 yeP~kRPrftei~~~lsd  648 (974)
T KOG4257|consen  631 YEPSKRPRFTEIKAILSD  648 (974)
T ss_pred             cCcccCCcHHHHHHHHHH
Confidence            999999999999876643

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.89  E-value=5e-24  Score=163.50  Aligned_cols=154  Identities=23%  Similarity=0.328  Sum_probs=124.3

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      ++-.+++..++||+|||...   -+|||||..||+++-+|..||+|||++.......  ...+.+.|++.|+|||++...
T Consensus       130 EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVI~EI  204 (502)
T KOG0574|consen  130 EISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVIEEI  204 (502)
T ss_pred             HHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH--HhhCccccCcccccHHHHHHh
Confidence            46678999999999999987   8999999999999999999999999986443221  123346899999999999999


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCC-cCcHHHHHHHHHHhccccCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGA-ISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~  161 (220)
                      +|..++||||||+...||..|++||..-....               .+..++..++.. ......+..+-+++++||-.
T Consensus       205 GY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR---------------AIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK  269 (502)
T KOG0574|consen  205 GYDTKADIWSLGITAIEMAEGRPPYSDIHPMR---------------AIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIK  269 (502)
T ss_pred             ccchhhhHhhhcchhhhhhcCCCCcccccccc---------------eeEeccCCCCCCCCChHhhhhHHHHHHHHHhcC
Confidence            99999999999999999999999986433222               122333334433 33445577899999999999


Q ss_pred             CCCCCCCHHHHHHHh
Q 027675          162 DPNDRPTMSDVVIML  176 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l  176 (220)
                      +|++|-|+.++++|-
T Consensus       270 ~PE~R~TA~~L~~H~  284 (502)
T KOG0574|consen  270 KPEERKTALRLCEHT  284 (502)
T ss_pred             CHHHHHHHHHHhhhh
Confidence            999999999999874

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.88  E-value=4.7e-23  Score=169.72  Aligned_cols=165  Identities=23%  Similarity=0.349  Sum_probs=126.9

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      ..++|+.||+.|++||.+.+   ++||||.+.|||++.++.+|++|||+++-.-.......+.+.+-+..|+|+|.+..+
T Consensus       638 ~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillg  714 (807)
T KOG1094|consen  638 PGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLG  714 (807)
T ss_pred             hhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhc
Confidence            45789999999999999999   999999999999999999999999999854444555556666778899999999999


Q ss_pred             CCcccCceeehhHHHHHHHh--cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           83 FFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      .++.++|+|+||+.+||+++  .+.||+...++..   .+.....+..+.....+..      +.-+...++++|.+||.
T Consensus       715 kFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v---ven~~~~~~~~~~~~~l~~------P~~cp~~lyelml~Cw~  785 (807)
T KOG1094|consen  715 KFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV---VENAGEFFRDQGRQVVLSR------PPACPQGLYELMLRCWR  785 (807)
T ss_pred             cccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH---HHhhhhhcCCCCcceeccC------CCcCcHHHHHHHHHHhc
Confidence            99999999999999999874  6778764443332   2222333333222221111      12233467899999999


Q ss_pred             CCCCCCCCHHHHHHHhcCc
Q 027675          161 EDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~  179 (220)
                      ++-++||+++++..+|...
T Consensus       786 ~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  786 RESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             hhhhcCCCHHHHHHHHHHh
Confidence            9999999999999988654

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.88  E-value=1.2e-22  Score=163.54  Aligned_cols=180  Identities=26%  Similarity=0.292  Sum_probs=127.9

Q ss_pred             CchHHHHHHHHHHHHHHhhhCC------CCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCcc
Q 027675            1 MEMLFNIILGVSRRLLYLHQDS------KLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM   74 (220)
Q Consensus         1 ~~~~~~i~~~l~~~l~~LH~~~------~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~   74 (220)
                      |....+|+..|++||+|||..-      +++|.|||||..|||+..++.+.|+|||++..+............+||..|+
T Consensus       306 w~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYM  385 (534)
T KOG3653|consen  306 WNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYM  385 (534)
T ss_pred             HHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhc
Confidence            4578899999999999999653      7789999999999999999999999999999877655555455578999999


Q ss_pred             ChhhhhcC-CCc-----ccCceeehhHHHHHHHhcCccCcccchhHHH--------h--hHHHHHHHH-HhccccccccC
Q 027675           75 SPEYALGG-FFS-----VKSDVFSFGVVVLEIISGKRNTGFYNSELAL--------S--LLGYAWKLW-QEGKALDMMDQ  137 (220)
Q Consensus        75 aPe~~~~~-~~~-----~~~DiwslG~il~~ll~g~~p~~~~~~~~~~--------~--~~~~~~~~~-~~~~~~~~~~~  137 (220)
                      |||++.|. ++.     .+.||||+|+++||+++....+.......++        .  -.+.++... .+..+..+.+.
T Consensus       386 APEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~  465 (534)
T KOG3653|consen  386 APEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDA  465 (534)
T ss_pred             CHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhh
Confidence            99999875 222     4689999999999999855433210000000        0  111122222 12222222221


Q ss_pred             CCCCcCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcCccccCC
Q 027675          138 KPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEAVNLA  184 (220)
Q Consensus       138 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~~~~~~  184 (220)
                          ........-+.+.+..||..|++-|.|+.-+.+.++......+
T Consensus       466 ----W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~  508 (534)
T KOG3653|consen  466 ----WRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE  508 (534)
T ss_pred             ----hhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence                1122345567889999999999999999999999877755443

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=4.5e-23  Score=159.70  Aligned_cols=149  Identities=25%  Similarity=0.310  Sum_probs=113.1

Q ss_pred             HHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcCCC
Q 027675            5 FNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFF   84 (220)
Q Consensus         5 ~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~~~   84 (220)
                      +-+-..|+.||.|||+++   |+.||+|.+|.+++++|.+|++|||++....  ........+.|++.|+|||++...-|
T Consensus       271 RFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I--~~g~t~kTFCGTPEYLAPEVleDnDY  345 (516)
T KOG0690|consen  271 RFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI--KYGDTTKTFCGTPEYLAPEVLEDNDY  345 (516)
T ss_pred             hhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc--cccceeccccCChhhcCchhhccccc
Confidence            345678999999999999   9999999999999999999999999986432  22333445789999999999999999


Q ss_pred             cccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCCCC
Q 027675           85 SVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPN  164 (220)
Q Consensus        85 ~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~  164 (220)
                      ....|.|.+|+++|||++|+.||...+.+.....+..           +.+ ..|+.     .......++..+|..||+
T Consensus       346 graVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~-----------ed~-kFPr~-----ls~eAktLLsGLL~kdP~  408 (516)
T KOG0690|consen  346 GRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM-----------EDL-KFPRT-----LSPEAKTLLSGLLKKDPK  408 (516)
T ss_pred             cceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh-----------hhc-cCCcc-----CCHHHHHHHHHHhhcChH
Confidence            9999999999999999999999976555544332211           000 11111     122456677779999999


Q ss_pred             CCC-----CHHHHHHH
Q 027675          165 DRP-----TMSDVVIM  175 (220)
Q Consensus       165 ~Rp-----s~~~~l~~  175 (220)
                      +|.     ++++|.++
T Consensus       409 kRLGgGpdDakEi~~h  424 (516)
T KOG0690|consen  409 KRLGGGPDDAKEIMRH  424 (516)
T ss_pred             hhcCCCchhHHHHHhh
Confidence            996     35666644

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.88  E-value=7.2e-23  Score=158.08  Aligned_cols=171  Identities=21%  Similarity=0.204  Sum_probs=113.2

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCC---ceecCccceeeecCCCCC-----cccceeecccCcc
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMN---PKISDFGLTRIFEGKQTD-----GTTNRVVGTYGYM   74 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~---~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~y~   74 (220)
                      ++-.+.++|+.||+|||.+|   |.|||+||+|||-.+...   +|||||.+..-.......     .......|+-.|+
T Consensus       177 EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfM  253 (463)
T KOG0607|consen  177 EASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFM  253 (463)
T ss_pred             HHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhc
Confidence            45678999999999999999   999999999999976655   699999886533211111     1111246677999


Q ss_pred             Chhhhh---c--CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCc--HHH
Q 027675           75 SPEYAL---G--GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISK--ANE  147 (220)
Q Consensus        75 aPe~~~---~--~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  147 (220)
                      |||+..   +  .-|+.++|.||||+|+|-|++|++||.+.-........+..=...++.....+.++.-..+..  ...
T Consensus       254 APEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahI  333 (463)
T KOG0607|consen  254 APEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHI  333 (463)
T ss_pred             chhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHh
Confidence            999863   2  357899999999999999999999997543322221111111111111111111121111110  223


Q ss_pred             HHHHHHHhccccCCCCCCCCCHHHHHHHh
Q 027675          148 ILKCINVGLLCVQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       148 ~~~~~~li~~cl~~~p~~Rps~~~~l~~l  176 (220)
                      +....++|..+|..++.+|.++.+++.+-
T Consensus       334 S~eakdlisnLlvrda~~rlsa~~vlnhP  362 (463)
T KOG0607|consen  334 SSEAKDLISNLLVRDAKQRLSAAQVLNHP  362 (463)
T ss_pred             hHHHHHHHHHHHhccHHhhhhhhhccCCc
Confidence            44667888889999999999999999754

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.87  E-value=9.5e-23  Score=166.02  Aligned_cols=169  Identities=21%  Similarity=0.270  Sum_probs=121.7

Q ss_pred             CchHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCC-ceecCccceeeecCCCCCcccceeecccCccChhhh
Q 027675            1 MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMN-PKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYA   79 (220)
Q Consensus         1 ~~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~-~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~   79 (220)
                      ++.+..++.||.-||..|-.-|   ++|.||||+|||++.... +||||||.+.........    -+.-+..|.|||++
T Consensus       535 ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~eneit----PYLVSRFYRaPEIi  607 (752)
T KOG0670|consen  535 IKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSASFASENEIT----PYLVSRFYRAPEII  607 (752)
T ss_pred             ehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCcccccccccccc----HHHHHHhccCccee
Confidence            3568899999999999999999   999999999999987554 799999998765433221    12335579999999


Q ss_pred             hcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhh-HH----HHHHHHHhccccc---------------------
Q 027675           80 LGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSL-LG----YAWKLWQEGKALD---------------------  133 (220)
Q Consensus        80 ~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~-~~----~~~~~~~~~~~~~---------------------  133 (220)
                      .|.+|+...|+||+||.+|||+||+..|.+.......-. .+    +..+.+..+...+                     
T Consensus       608 LG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~  687 (752)
T KOG0670|consen  608 LGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTERE  687 (752)
T ss_pred             ecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccce
Confidence            999999999999999999999999999865433222111 11    1112222211110                     


Q ss_pred             ----cccCCC-------------CCcCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHh
Q 027675          134 ----MMDQKP-------------GAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       134 ----~~~~~~-------------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l  176 (220)
                          +....|             ...........+.+++..||..||++|.|..++|+|-
T Consensus       688 ~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~Hp  747 (752)
T KOG0670|consen  688 KRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHP  747 (752)
T ss_pred             eEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCC
Confidence                000011             1223345567889999999999999999999999873

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.87  E-value=3.9e-23  Score=175.83  Aligned_cols=153  Identities=25%  Similarity=0.368  Sum_probs=112.4

Q ss_pred             HHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCC---CC--CceecCccceeeecCCCC-CcccceeecccCccChh
Q 027675            4 LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDH---EM--NPKISDFGLTRIFEGKQT-DGTTNRVVGTYGYMSPE   77 (220)
Q Consensus         4 ~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~---~~--~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~y~aPe   77 (220)
                      .+.++.|+++||++||+.+   |+||||||.||||+.   ++  .++|+|||++........ ........|+.+|.|||
T Consensus       608 ~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE  684 (903)
T KOG1027|consen  608 PISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPE  684 (903)
T ss_pred             HHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHH
Confidence            4678999999999999999   999999999999976   34  478999999986543322 11223357889999999


Q ss_pred             hhhcCCCcccCceeehhHHHHHHHhc-CccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhc
Q 027675           78 YALGGFFSVKSDVFSFGVVVLEIISG-KRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGL  156 (220)
Q Consensus        78 ~~~~~~~~~~~DiwslG~il~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  156 (220)
                      .+.........||||+||++|+.++| .+||+..-....        .+.........+..      ..++  ...++|.
T Consensus       685 ~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--------NIl~~~~~L~~L~~------~~d~--eA~dLI~  748 (903)
T KOG1027|consen  685 QLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--------NILTGNYTLVHLEP------LPDC--EAKDLIS  748 (903)
T ss_pred             HHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--------hhhcCccceeeecc------CchH--HHHHHHH
Confidence            99998888899999999999999985 899973211110        01111111111111      1111  6678999


Q ss_pred             cccCCCCCCCCCHHHHHHH
Q 027675          157 LCVQEDPNDRPTMSDVVIM  175 (220)
Q Consensus       157 ~cl~~~p~~Rps~~~~l~~  175 (220)
                      +|+..+|..||++.+|+.|
T Consensus       749 ~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  749 RMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             HhcCCCcccCCCHHHHhCC
Confidence            9999999999999999965

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=3.2e-22  Score=159.26  Aligned_cols=143  Identities=22%  Similarity=0.298  Sum_probs=112.8

Q ss_pred             HHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcCC
Q 027675            4 LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGF   83 (220)
Q Consensus         4 ~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~~   83 (220)
                      ++-++..|+-||-+||++|   |++||||.+||+++..|.+||+|||++..-.  ........+-|++.|.|||++...+
T Consensus       452 AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni--~~~~TTkTFCGTPdYiAPEIi~YqP  526 (683)
T KOG0696|consen  452 AVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI--FDGVTTKTFCGTPDYIAPEIIAYQP  526 (683)
T ss_pred             hhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc--cCCcceeeecCCCcccccceEEecc
Confidence            4557889999999999999   9999999999999999999999999976321  2223344578999999999999999


Q ss_pred             CcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCCC
Q 027675           84 FSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDP  163 (220)
Q Consensus        84 ~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  163 (220)
                      |+...|.||+|+++|||+.|++||+..+.+.....+..                 ....++...+.+...++...|...|
T Consensus       527 YgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~e-----------------hnvsyPKslSkEAv~ickg~ltK~P  589 (683)
T KOG0696|consen  527 YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIME-----------------HNVSYPKSLSKEAVAICKGLLTKHP  589 (683)
T ss_pred             cccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH-----------------ccCcCcccccHHHHHHHHHHhhcCC
Confidence            99999999999999999999999988776665433211                 1122223334456677777888999


Q ss_pred             CCCCC
Q 027675          164 NDRPT  168 (220)
Q Consensus       164 ~~Rps  168 (220)
                      .+|..
T Consensus       590 ~kRLG  594 (683)
T KOG0696|consen  590 GKRLG  594 (683)
T ss_pred             ccccC
Confidence            98854

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.87  E-value=1.3e-22  Score=147.89  Aligned_cols=106  Identities=31%  Similarity=0.441  Sum_probs=88.2

Q ss_pred             HHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc---
Q 027675            5 FNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG---   81 (220)
Q Consensus         5 ~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~---   81 (220)
                      =+|+..++.||.|||++-  .++|||+||+|||++..|+||+||||.+-...+.....   -..|-..|+|||.+..   
T Consensus       151 GkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt---~daGCkpYmaPEri~~e~n  225 (282)
T KOG0984|consen  151 GKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKT---MDAGCKPYMAPERINPELN  225 (282)
T ss_pred             hHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhhHHH---HhcCCCccCChhhcCcccC
Confidence            478999999999999976  59999999999999999999999999987655433221   1345668999999853   


Q ss_pred             -CCCcccCceeehhHHHHHHHhcCccCcccchhHH
Q 027675           82 -GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELA  115 (220)
Q Consensus        82 -~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~  115 (220)
                       .+|+.++|+||||+.+.||.+++.||..|.....
T Consensus       226 ~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~  260 (282)
T KOG0984|consen  226 QKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQ  260 (282)
T ss_pred             cccceeehhhhhhhhhhhhhhhccccccccCCHHH
Confidence             3689999999999999999999999987665544

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.86  E-value=4.3e-22  Score=142.66  Aligned_cols=170  Identities=22%  Similarity=0.273  Sum_probs=120.0

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +.+.+++.|+++||.|+|+++   ++|||+||.|.+|+.+|.+|++|||+++.++-...+  ....+-+..|.+|.++.|
T Consensus       101 ~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvrc--ysaevvtlwyrppdvlfg  175 (292)
T KOG0662|consen  101 EIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFG  175 (292)
T ss_pred             HHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceEe--eeceeeeeeccCcceeee
Confidence            357789999999999999999   999999999999999999999999999877644332  222345789999999988


Q ss_pred             C-CCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhcc---ccccccCCCCCcCc---------HHH
Q 027675           82 G-FFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGK---ALDMMDQKPGAISK---------ANE  147 (220)
Q Consensus        82 ~-~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~---------~~~  147 (220)
                      . -++...|+||.|||+.|+.. |++.|.+.+-..+.-.+-+...-..+..   ....++..+...+.         +..
T Consensus       176 akly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~l  255 (292)
T KOG0662|consen  176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKL  255 (292)
T ss_pred             eehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhh
Confidence            6 47889999999999999996 5555665544443322222111111111   11222322222222         111


Q ss_pred             HHHHHHHhccccCCCCCCCCCHHHHHHHh
Q 027675          148 ILKCINVGLLCVQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       148 ~~~~~~li~~cl~~~p~~Rps~~~~l~~l  176 (220)
                      ...-.+++...|.-+|.+|.+++..+++-
T Consensus       256 ns~grdllqkll~cnp~qrisaeaalqhp  284 (292)
T KOG0662|consen  256 NSTGRDLLQKLLKCNPAQRISAEAALQHP  284 (292)
T ss_pred             cchhHHHHHHHhccCcccccCHHHHhcCc
Confidence            23457788888999999999999998874

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.86  E-value=9.7e-23  Score=166.43  Aligned_cols=151  Identities=25%  Similarity=0.290  Sum_probs=116.4

Q ss_pred             HHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCC---CCceecCccceeeecCCCCCcccceeecccCccChhhhhcCC
Q 027675            7 IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHE---MNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGF   83 (220)
Q Consensus         7 i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~~   83 (220)
                      ++-||+.||.|||-++   |+|+||||+||++...   -++||||||+++.++....+   ...+|++.|+|||++...+
T Consensus       669 lvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR---rsVVGTPAYLaPEVLrnkG  742 (888)
T KOG4236|consen  669 LVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR---RSVVGTPAYLAPEVLRNKG  742 (888)
T ss_pred             HHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhh---hhhcCCccccCHHHHhhcc
Confidence            5689999999999999   9999999999999654   34899999999987764432   3368999999999999999


Q ss_pred             CcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCCC
Q 027675           84 FSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDP  163 (220)
Q Consensus        84 ~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  163 (220)
                      |....||||.|+|+|--++|..||....+...+         ++....  +....++.    +.....+++|..+|+..-
T Consensus       743 yNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQ---------IQNAaF--MyPp~PW~----eis~~AidlIn~LLqVkm  807 (888)
T KOG4236|consen  743 YNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQ---------IQNAAF--MYPPNPWS----EISPEAIDLINNLLQVKM  807 (888)
T ss_pred             ccccccceeeeEEEEEEecccccCCCccchhHH---------hhcccc--ccCCCchh----hcCHHHHHHHHHHHHHHH
Confidence            999999999999999999999999643322111         111111  11222222    233466888888999999


Q ss_pred             CCCCCHHHHHHHhcC
Q 027675          164 NDRPTMSDVVIMLGS  178 (220)
Q Consensus       164 ~~Rps~~~~l~~l~~  178 (220)
                      .+|-+.++.+.+.|.
T Consensus       808 ~kRysvdk~lsh~Wl  822 (888)
T KOG4236|consen  808 RKRYSVDKSLSHPWL  822 (888)
T ss_pred             HHhcchHhhccchhh
Confidence            999999998876543

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.85  E-value=1.8e-21  Score=170.69  Aligned_cols=98  Identities=17%  Similarity=0.257  Sum_probs=69.7

Q ss_pred             ecccCccChhhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHH
Q 027675           68 VGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANE  147 (220)
Q Consensus        68 ~~~~~y~aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (220)
                      .|++.|+|||++.+..++.++|||||||++|||++|+.||..........      ..... ..     ..+..  ....
T Consensus       541 vGT~~Y~APE~l~~~~~~~~~DiwSlG~il~ElltG~~pf~~~~~~~~~~------~il~~-~~-----~~p~~--~~~~  606 (669)
T cd05610         541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQ------NILNR-DI-----PWPEG--EEKL  606 (669)
T ss_pred             eeCccccCHHHcCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH------HHHhc-CC-----CCCcc--cccC
Confidence            45788999999999889999999999999999999999996543322211      11111 00     00000  1122


Q ss_pred             HHHHHHHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          148 ILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       148 ~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      ...+.+++.+||..||++||++.+++.+-+..
T Consensus       607 ~~~~~~~l~~lL~~dP~~R~ta~e~l~h~~~~  638 (669)
T cd05610         607 SVNAQNAIEILLTMDPTKRAGLKELKQHPLFH  638 (669)
T ss_pred             CHHHHHHHHHHcccChhHCcCHHHHHhCHhhc
Confidence            34567888889999999999999999886543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=1.7e-21  Score=151.69  Aligned_cols=150  Identities=24%  Similarity=0.339  Sum_probs=108.2

Q ss_pred             HHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcCC
Q 027675            4 LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGF   83 (220)
Q Consensus         4 ~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~~   83 (220)
                      ++-+...++-||.|||++|   |+.||||.+|++++..|.+||+|||++....  ...+....+-|++.|.|||++.|..
T Consensus       353 arfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l--~~gd~tstfcgtpnyiapeilrgee  427 (593)
T KOG0695|consen  353 ARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL--GPGDTTSTFCGTPNYIAPEILRGEE  427 (593)
T ss_pred             hhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC--CCCcccccccCCCcccchhhhcccc
Confidence            4456778999999999999   9999999999999999999999999976422  2234445578999999999999999


Q ss_pred             CcccCceeehhHHHHHHHhcCccCcccchhHHHhh-HHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           84 FSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSL-LGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        84 ~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      |....|.|+||++++||+.|+-||+...-...... ..+...++.+.++ +++..         .+.+.-.+++.-|+.|
T Consensus       428 ygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi-riprs---------lsvkas~vlkgflnkd  497 (593)
T KOG0695|consen  428 YGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI-RIPRS---------LSVKASHVLKGFLNKD  497 (593)
T ss_pred             cCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc-cccce---------eehhhHHHHHHhhcCC
Confidence            99999999999999999999999964322211111 1122222222111 11111         1123445666788999


Q ss_pred             CCCCCC
Q 027675          163 PNDRPT  168 (220)
Q Consensus       163 p~~Rps  168 (220)
                      |++|..
T Consensus       498 p~erlg  503 (593)
T KOG0695|consen  498 PKERLG  503 (593)
T ss_pred             cHHhcC
Confidence            999853

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.85  E-value=1.4e-21  Score=147.93  Aligned_cols=159  Identities=20%  Similarity=0.253  Sum_probs=113.9

Q ss_pred             HHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCC--CCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            4 LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDH--EMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         4 ~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..+++.|++.|+.|+|+++   ++|||||.+||||-.  .-.+||||||+.+..+....+..     ....|.+||....
T Consensus       123 ~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~~~-----~~~~y~~pe~~~~  194 (378)
T KOG1345|consen  123 TKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKYLE-----YVNNYHAPELCDT  194 (378)
T ss_pred             HHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCceehhhh-----hhcccCCcHHHhh
Confidence            3578999999999999999   999999999999943  33599999999875443322211     2447899998743


Q ss_pred             C-----CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhc
Q 027675           82 G-----FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGL  156 (220)
Q Consensus        82 ~-----~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  156 (220)
                      .     ...+..|+|.||++++.+++|.+||+..   ...+..-+.+..+..++....++....      ...++.++-+
T Consensus       195 ~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka---~~~d~~Y~~~~~w~~rk~~~~P~~F~~------fs~~a~r~Fk  265 (378)
T KOG1345|consen  195 VVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA---SIMDKPYWEWEQWLKRKNPALPKKFNP------FSEKALRLFK  265 (378)
T ss_pred             ccccceEecccccchheeeeeeeeecCCCcchhh---hccCchHHHHHHHhcccCccCchhhcc------cCHHHHHHHH
Confidence            2     2467899999999999999999999732   222233345566666666544433222      2235566677


Q ss_pred             cccCCCCCCC---CCHHHHHHHhcCc
Q 027675          157 LCVQEDPNDR---PTMSDVVIMLGSE  179 (220)
Q Consensus       157 ~cl~~~p~~R---ps~~~~l~~l~~~  179 (220)
                      +-|..+|++|   .++++..+.++.+
T Consensus       266 k~lt~~~~drcki~~~kk~rk~~w~E  291 (378)
T KOG1345|consen  266 KSLTPRFKDRCKIWTAKKMRKCLWKE  291 (378)
T ss_pred             HhcCCcccccchhHHHHHHHHHHHHH
Confidence            7899999999   7777777777655

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=3.4e-21  Score=154.73  Aligned_cols=162  Identities=29%  Similarity=0.377  Sum_probs=115.9

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeC---CCCCceecCccceeeecCCCCC-----cccceeecccCc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLD---HEMNPKISDFGLTRIFEGKQTD-----GTTNRVVGTYGY   73 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~---~~~~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~y   73 (220)
                      +++++|+.||+.||.||... +++|+|-||||.|||+.   .-|.+||+|||++.........     .......|+++|
T Consensus       568 KEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWY  646 (775)
T KOG1151|consen  568 KEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWY  646 (775)
T ss_pred             HHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeee
Confidence            46789999999999999998 68899999999999995   3567899999999876543221     122235789999


Q ss_pred             cChhhhhcC----CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHH
Q 027675           74 MSPEYALGG----FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEIL  149 (220)
Q Consensus        74 ~aPe~~~~~----~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (220)
                      ++||-+.-.    ..+.+.|+||+|+|+|.++.|+.||+..-.  ..       +++.+..++..-.  ...+..+....
T Consensus       647 LPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs--QQ-------dILqeNTIlkAtE--VqFP~KPvVss  715 (775)
T KOG1151|consen  647 LPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS--QQ-------DILQENTILKATE--VQFPPKPVVSS  715 (775)
T ss_pred             cCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh--HH-------HHHhhhchhccee--ccCCCCCccCH
Confidence            999987532    468999999999999999999999974221  11       1122222221111  11122223334


Q ss_pred             HHHHHhccccCCCCCCCCCHHHHHHH
Q 027675          150 KCINVGLLCVQEDPNDRPTMSDVVIM  175 (220)
Q Consensus       150 ~~~~li~~cl~~~p~~Rps~~~~l~~  175 (220)
                      ....+|++||++.-++|.+.-++..+
T Consensus       716 eAkaFIRRCLaYRKeDR~DV~qLA~d  741 (775)
T KOG1151|consen  716 EAKAFIRRCLAYRKEDRIDVQQLACD  741 (775)
T ss_pred             HHHHHHHHHHHhhhhhhhhHHHHccC
Confidence            66789999999999999887776643

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.85  E-value=2.8e-21  Score=162.25  Aligned_cols=157  Identities=20%  Similarity=0.298  Sum_probs=109.7

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeC--CCCC--ceecCccceeeecCCCCCcccceeecccCccChhh
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLD--HEMN--PKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEY   78 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~--~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~   78 (220)
                      +++.++.+++.||.|||++|   |+||||||.||++.  .+|+  .||+|||.++......   .-....||..|++||.
T Consensus       121 e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel  194 (732)
T KOG4250|consen  121 EFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS---LFTSLVGTEEYLHPEL  194 (732)
T ss_pred             HHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccccccCCCCC---eeeeecCchhhcChHH
Confidence            56788999999999999999   99999999999984  3344  6999999998765443   2334789999999999


Q ss_pred             hhc-CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHH--------------hccccccccCCCCCcC
Q 027675           79 ALG-GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQ--------------EGKALDMMDQKPGAIS  143 (220)
Q Consensus        79 ~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~  143 (220)
                      +.. ..++..+|.|||||++|++.||..||........  .....+...-              .|...-....+.....
T Consensus       195 ~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~--~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~L  272 (732)
T KOG4250|consen  195 YERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKN--NKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHL  272 (732)
T ss_pred             HhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccc--cchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccc
Confidence            984 7889999999999999999999999954322210  0011111111              1111111111122222


Q ss_pred             cHHHHHHHHHHhccccCCCCCCCC
Q 027675          144 KANEILKCINVGLLCVQEDPNDRP  167 (220)
Q Consensus       144 ~~~~~~~~~~li~~cl~~~p~~Rp  167 (220)
                      ..-....+-..+..+|..+|.+|.
T Consensus       273 s~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  273 SRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             cHHHHhhhhHHHHHHHhhhHHHhC
Confidence            333445566677778999999999

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=2.2e-21  Score=156.90  Aligned_cols=112  Identities=19%  Similarity=0.215  Sum_probs=79.0

Q ss_pred             ecccCccChhhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHh---hHHHH--------HHHHH---------
Q 027675           68 VGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALS---LLGYA--------WKLWQ---------  127 (220)
Q Consensus        68 ~~~~~y~aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~---~~~~~--------~~~~~---------  127 (220)
                      .+|..|.|||++.|.+|+..+||||++|+++||.||...|+....+.+..   .++.+        +++..         
T Consensus       412 IQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFF  491 (590)
T KOG1290|consen  412 IQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFF  491 (590)
T ss_pred             hhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhh
Confidence            34778999999999999999999999999999999999996543332221   12222        11111         


Q ss_pred             --hccccccccCCCCCcCc---------HHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          128 --EGKALDMMDQKPGAISK---------ANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       128 --~~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                        .|..+.+-...++..+.         .++..++-+|+.-||+.+|++||||.+.+++=|.-
T Consensus       492 nr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn  554 (590)
T KOG1290|consen  492 NRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLN  554 (590)
T ss_pred             ccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCcccc
Confidence              22233333333333222         55667899999999999999999999999886554

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.84  E-value=4.7e-21  Score=161.55  Aligned_cols=165  Identities=16%  Similarity=0.093  Sum_probs=107.9

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +.+..++.|++.+|.|||+.+   ++||||||+||+++.++.++|+|||++......... .......++.|.+||.+..
T Consensus       309 ~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aPE~l~~  384 (507)
T PLN03224        309 NVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPPEELVM  384 (507)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeChhhhcC
Confidence            356789999999999999999   999999999999999999999999998643221111 1111223678999998753


Q ss_pred             CC----------------------CcccCceeehhHHHHHHHhcCc-cCcccchhHH--Hh--hHHHHHHHHHhcccccc
Q 027675           82 GF----------------------FSVKSDVFSFGVVVLEIISGKR-NTGFYNSELA--LS--LLGYAWKLWQEGKALDM  134 (220)
Q Consensus        82 ~~----------------------~~~~~DiwslG~il~~ll~g~~-p~~~~~~~~~--~~--~~~~~~~~~~~~~~~~~  134 (220)
                      ..                      ...+.|+||+||++++|+++.. |+........  ..  .....|.....      
T Consensus       385 ~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~------  458 (507)
T PLN03224        385 PQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG------  458 (507)
T ss_pred             CCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc------
Confidence            21                      1234799999999999999875 5532111100  00  00000111100      


Q ss_pred             ccCCCCCcCcHHHHHHHHHHhccccCCCC---CCCCCHHHHHHHhcC
Q 027675          135 MDQKPGAISKANEILKCINVGLLCVQEDP---NDRPTMSDVVIMLGS  178 (220)
Q Consensus       135 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p---~~Rps~~~~l~~l~~  178 (220)
                        ................+++.+||..+|   .+|+|++++|.|-+.
T Consensus       459 --~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f  503 (507)
T PLN03224        459 --QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFF  503 (507)
T ss_pred             --cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCc
Confidence              011111112234567888899998766   689999999988654

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.84  E-value=5.4e-21  Score=162.88  Aligned_cols=162  Identities=23%  Similarity=0.363  Sum_probs=123.2

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.|..||++|+.|||++.   ++||||-..|+|+.....+|+.|||++................-.+.|+|-|.+..
T Consensus       798 q~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~  874 (1177)
T KOG1025|consen  798 QDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRI  874 (1177)
T ss_pred             HHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhc
Confidence            357889999999999999998   99999999999999999999999999876443221111111112457788888888


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|||||||.+||++| |..|+.....++.-       +.++.+.++..+         +.....++-++.+||.
T Consensus       875 ~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~-------dlle~geRLsqP---------piCtiDVy~~mvkCwm  938 (1177)
T KOG1025|consen  875 RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIP-------DLLEKGERLSQP---------PICTIDVYMVMVKCWM  938 (1177)
T ss_pred             cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhh-------HHHhccccCCCC---------CCccHHHHHHHHHHhc
Confidence            899999999999999999997 88887655444332       334444443222         2344577889999999


Q ss_pred             CCCCCCCCHHHHHHHhcCcccc
Q 027675          161 EDPNDRPTMSDVVIMLGSEAVN  182 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~~~~  182 (220)
                      .|++.||+++++...+.+.+++
T Consensus       939 id~~~rp~fkel~~~fs~~ard  960 (1177)
T KOG1025|consen  939 IDADSRPTFKELAEEFSRMARD  960 (1177)
T ss_pred             cCcccCccHHHHHHHHHHHhcC
Confidence            9999999999999888666553

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=1.1e-20  Score=157.43  Aligned_cols=103  Identities=28%  Similarity=0.402  Sum_probs=86.0

Q ss_pred             HHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeec---CCCC--------------------
Q 027675            4 LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFE---GKQT--------------------   60 (220)
Q Consensus         4 ~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~---~~~~--------------------   60 (220)
                      ++-++..|.-|+++.|+.|   ++||||||+||||+.+|.+||+|||++.-+.   +...                    
T Consensus       731 ARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d  807 (1034)
T KOG0608|consen  731 ARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWAD  807 (1034)
T ss_pred             HHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhcc
Confidence            4557788999999999999   9999999999999999999999999985321   0000                    


Q ss_pred             -----------------CcccceeecccCccChhhhhcCCCcccCceeehhHHHHHHHhcCccCcc
Q 027675           61 -----------------DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGF  109 (220)
Q Consensus        61 -----------------~~~~~~~~~~~~y~aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~  109 (220)
                                       +..-...+|++.|.|||++...+++..||.|+.|+|||||+.|++||..
T Consensus       808 ~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~  873 (1034)
T KOG0608|consen  808 ISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLA  873 (1034)
T ss_pred             ccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccC
Confidence                             0000125789999999999999999999999999999999999999964

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.82  E-value=1.7e-20  Score=150.26  Aligned_cols=175  Identities=23%  Similarity=0.240  Sum_probs=122.7

Q ss_pred             chHHHHHHHHHHHHHHhh-----hCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCC--CCCcccceeecccCcc
Q 027675            2 EMLFNIILGVSRRLLYLH-----QDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGK--QTDGTTNRVVGTYGYM   74 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH-----~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~y~   74 (220)
                      +..+++++.++.||++||     .+|++.|.|||||..||++.+++.+.|+|+|++......  ......+..+||..|+
T Consensus       308 ~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYM  387 (513)
T KOG2052|consen  308 EGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYM  387 (513)
T ss_pred             HHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeecc
Confidence            457899999999999999     446889999999999999999999999999999875533  2222334468899999


Q ss_pred             ChhhhhcC------CCcccCceeehhHHHHHHHhc----------CccCcccchhHHHhhHHHHHHHHHhccccccccCC
Q 027675           75 SPEYALGG------FFSVKSDVFSFGVVVLEIISG----------KRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQK  138 (220)
Q Consensus        75 aPe~~~~~------~~~~~~DiwslG~il~~ll~g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  138 (220)
                      |||++...      .--..+||||||+++||+.-.          ..||....+.+.  ..+.+.++.=..+.+.   ..
T Consensus       388 APEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP--s~eeMrkVVCv~~~RP---~i  462 (513)
T KOG2052|consen  388 APEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP--SFEEMRKVVCVQKLRP---NI  462 (513)
T ss_pred             ChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC--CHHHHhcceeecccCC---CC
Confidence            99998542      112469999999999998752          244432211111  1111112111111111   11


Q ss_pred             CCCcCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcCccc
Q 027675          139 PGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEAV  181 (220)
Q Consensus       139 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~~~  181 (220)
                      +........+..+.++|+.||..||.-|-|+-.+.+.|.+...
T Consensus       463 pnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  463 PNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             CcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            2233445677788999999999999999999999998876643

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.82  E-value=2.6e-20  Score=138.11  Aligned_cols=168  Identities=19%  Similarity=0.247  Sum_probs=112.1

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCC-CCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDH-EMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+.-++.++++||.|+|+.|   |.|||+||.|++|+. ...++|+|+|++-+.-....   .+..+.+.-|--||++..
T Consensus       133 dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e---YnVRVASRyfKGPELLVd  206 (338)
T KOG0668|consen  133 DIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVD  206 (338)
T ss_pred             hHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCCce---eeeeeehhhcCCchheee
Confidence            35668899999999999999   999999999999985 45699999999876543322   222334556778998876


Q ss_pred             C-CCcccCceeehhHHHHHHHhcCccC-cccchhHHHhhHHHHH------HHHHh------cccccccc---CCCC----
Q 027675           82 G-FFSVKSDVFSFGVVVLEIISGKRNT-GFYNSELALSLLGYAW------KLWQE------GKALDMMD---QKPG----  140 (220)
Q Consensus        82 ~-~~~~~~DiwslG~il~~ll~g~~p~-~~~~~~~~~~~~~~~~------~~~~~------~~~~~~~~---~~~~----  140 (220)
                      . -++...|+|||||++..|...+.|| .+.+...+...+..+.      +-..+      .+.-.+..   ..++    
T Consensus       207 y~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi  286 (338)
T KOG0668|consen  207 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFI  286 (338)
T ss_pred             chhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhC
Confidence            5 4688999999999999999988886 3333333333222210      00000      00000000   0111    


Q ss_pred             -CcCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHh
Q 027675          141 -AISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       141 -~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l  176 (220)
                       .........+.++++..+|.+|..+|+|+++.+.|-
T Consensus       287 ~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~Hp  323 (338)
T KOG0668|consen  287 NSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHP  323 (338)
T ss_pred             CccccccCChHHHHHHHHHHhhccccccchHHHhcCc
Confidence             011111235678888899999999999999999764

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.82  E-value=4.1e-20  Score=138.87  Aligned_cols=122  Identities=37%  Similarity=0.685  Sum_probs=103.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCC-CCCceecCccceeeecCCCCCcccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDH-EMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~   80 (220)
                      +.++.++.++++++.+||+.+   ++|+||+|.||+++. .+.++++||+.+........  ......+...|.+||...
T Consensus        92 ~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~  166 (215)
T cd00180          92 DEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLL  166 (215)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCCCCccChhHhc
Confidence            357889999999999999999   999999999999999 89999999999875543221  122234567899999988


Q ss_pred             cC-CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           81 GG-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        81 ~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      .. ..+.+.|+|++|++++++                                                ..+.+++..|+
T Consensus       167 ~~~~~~~~~D~~~lg~~~~~l------------------------------------------------~~~~~~l~~~l  198 (215)
T cd00180         167 GKGYYSEKSDIWSLGVILYEL------------------------------------------------PELKDLIRKML  198 (215)
T ss_pred             ccCCCCchhhhHHHHHHHHHH------------------------------------------------HHHHHHHHHHh
Confidence            76 778999999999999998                                                47788889999


Q ss_pred             CCCCCCCCCHHHHHHHh
Q 027675          160 QEDPNDRPTMSDVVIML  176 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l  176 (220)
                      +.+|++||++.++++++
T Consensus       199 ~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         199 QKDPEKRPSAKEILEHL  215 (215)
T ss_pred             hCCcccCcCHHHHhhCC
Confidence            99999999999998764

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.80  E-value=7.1e-20  Score=156.87  Aligned_cols=155  Identities=25%  Similarity=0.377  Sum_probs=123.1

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +.+.-|++.++.|+.+||.+.   ++|||+|-.||+++.++.|||.|||++.......  ...+...|++.|+|||++..
T Consensus       123 ~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~--grRnT~iGtP~WMAPEViac  197 (953)
T KOG0587|consen  123 EWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIAC  197 (953)
T ss_pred             HHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeeeeeeccc--ccccCcCCCcccccceeeec
Confidence            456778999999999999998   9999999999999999999999999986554332  22334688999999999864


Q ss_pred             C-----CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCC-CCCcCcHHHHHHHHHHh
Q 027675           82 G-----FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQK-PGAISKANEILKCINVG  155 (220)
Q Consensus        82 ~-----~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li  155 (220)
                      .     -++.++|+||||++..||-.|.+|+-.+.....+-               .++..+ +..........++.++|
T Consensus       198 ~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF---------------~IpRNPPPkLkrp~kWs~~FndFI  262 (953)
T KOG0587|consen  198 DESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF---------------LIPRNPPPKLKRPKKWSKKFNDFI  262 (953)
T ss_pred             ccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc---------------cCCCCCCccccchhhHHHHHHHHH
Confidence            3     47889999999999999999999986544443321               122222 22233566778999999


Q ss_pred             ccccCCCCCCCCCHHHHHHHh
Q 027675          156 LLCVQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       156 ~~cl~~~p~~Rps~~~~l~~l  176 (220)
                      ..||..|.++||+..++++|-
T Consensus       263 s~cL~Kd~e~RP~~~~ll~hp  283 (953)
T KOG0587|consen  263 STCLVKDYEQRPSTEELLKHP  283 (953)
T ss_pred             HHHHhhccccCcchhhhccCC
Confidence            999999999999999999763

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.79  E-value=8.8e-20  Score=156.89  Aligned_cols=164  Identities=20%  Similarity=0.178  Sum_probs=118.2

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCC--cccceeecccCccChhhhh
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD--GTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~y~aPe~~~   80 (220)
                      .+-.+++|++.|++|+|..|   +.|||+|++|+++..+|.+|++|||.+..+.-....  .....+.|+.+|+|||.+.
T Consensus       421 e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~  497 (601)
T KOG0590|consen  421 EADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLT  497 (601)
T ss_pred             hhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCccccc
Confidence            45678999999999999999   999999999999999999999999997654322221  3344567889999999999


Q ss_pred             cCCCcc-cCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           81 GGFFSV-KSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        81 ~~~~~~-~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      +..|.. ..||||.|+++..|.+|+.||...........        ........-..................+|.+||
T Consensus       498 ~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l  569 (601)
T KOG0590|consen  498 GKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK--------TNNYSDQRNIFEGPNRLLSLLPRETRIIIYRML  569 (601)
T ss_pred             ccccCcchhhhhhccceEEEEecCCCccccccccccchh--------hhccccccccccChHHHHHhchhhHHHHHHHHc
Confidence            988754 49999999999999999999864433322110        000000000001111111222345678889999


Q ss_pred             CCCCCCCCCHHHHHHHhc
Q 027675          160 QEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l~  177 (220)
                      +.||.+|.|+++|++.=|
T Consensus       570 ~~~P~~R~ti~~i~~d~W  587 (601)
T KOG0590|consen  570 QLDPTKRITIEQILNDEW  587 (601)
T ss_pred             cCChhheecHHHHhhChH
Confidence            999999999999995443

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.76  E-value=9.9e-19  Score=139.22  Aligned_cols=172  Identities=20%  Similarity=0.267  Sum_probs=113.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCC-CCCceecCccceeeecCC----------------------
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDH-EMNPKISDFGLTRIFEGK----------------------   58 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~-~~~~~l~d~~~~~~~~~~----------------------   58 (220)
                      ..+..+++.+++||.++|++|   |+||||||.|++++. .+...|+|||++......                      
T Consensus       132 ~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~  208 (418)
T KOG1167|consen  132 AEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDV  208 (418)
T ss_pred             HHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcc
Confidence            457789999999999999999   999999999999975 455789999999721100                      


Q ss_pred             --------------------CCCcccceeecccCccChhhhhcC-CCcccCceeehhHHHHHHHhcCccCcccchhH-HH
Q 027675           59 --------------------QTDGTTNRVVGTYGYMSPEYALGG-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSEL-AL  116 (220)
Q Consensus        59 --------------------~~~~~~~~~~~~~~y~aPe~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~-~~  116 (220)
                                          ..+...-...||++|.|||++... ..+.+.||||.|+|++.++++..||-....+. ..
T Consensus       209 ~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al  288 (418)
T KOG1167|consen  209 HCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADAL  288 (418)
T ss_pred             cccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchH
Confidence                                000111124689999999998765 46889999999999999999999985432221 11


Q ss_pred             hh--HHHHHHHHH-----hcc--ccc--------------------cccCCCC---CcCcH--HHHHHHHHHhccccCCC
Q 027675          117 SL--LGYAWKLWQ-----EGK--ALD--------------------MMDQKPG---AISKA--NEILKCINVGLLCVQED  162 (220)
Q Consensus       117 ~~--~~~~~~~~~-----~~~--~~~--------------------~~~~~~~---~~~~~--~~~~~~~~li~~cl~~~  162 (220)
                      ..  ..+.+....     .|.  ..+                    .+.....   .....  .....+++++.+|++.|
T Consensus       289 ~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~n  368 (418)
T KOG1167|consen  289 AEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELN  368 (418)
T ss_pred             HHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCC
Confidence            10  111111111     111  000                    0000000   00001  11236789999999999


Q ss_pred             CCCCCCHHHHHHHh
Q 027675          163 PNDRPTMSDVVIML  176 (220)
Q Consensus       163 p~~Rps~~~~l~~l  176 (220)
                      |.+|.|++++|+|-
T Consensus       369 p~kRitAEeALkHp  382 (418)
T KOG1167|consen  369 PQKRITAEDALKHP  382 (418)
T ss_pred             hhhcccHHHHhcCc
Confidence            99999999999875

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.73  E-value=2e-18  Score=134.98  Aligned_cols=134  Identities=17%  Similarity=0.226  Sum_probs=91.7

Q ss_pred             HHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc--
Q 027675            4 LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG--   81 (220)
Q Consensus         4 ~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~--   81 (220)
                      ++.+..|+++.+++||..|   ++|+||+++|++++.+|.+.|+||+.....+.....     ...+..|.+||....  
T Consensus       147 rl~lT~Q~I~lvA~Lh~~G---lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~  218 (288)
T PF14531_consen  147 RLSLTVQMIRLVANLHSYG---LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAG  218 (288)
T ss_dssp             HHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhhcc---eEecccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhc
Confidence            3556689999999999999   999999999999999999999999988765432221     122467899997643  


Q ss_pred             ------CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHh
Q 027675           82 ------GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVG  155 (220)
Q Consensus        82 ------~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  155 (220)
                            ..++.+.|.|+||+++|.++++..||+..........               .+..+.      +....+..+|
T Consensus       219 ~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~---------------~f~~C~------~~Pe~v~~LI  277 (288)
T PF14531_consen  219 QFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW---------------DFSRCR------DMPEPVQFLI  277 (288)
T ss_dssp             SCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG---------------GGTTSS---------HHHHHHH
T ss_pred             ccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc---------------cchhcC------CcCHHHHHHH
Confidence                  2468889999999999999999999986544332211               111121      3344677888


Q ss_pred             ccccCCCCCCC
Q 027675          156 LLCVQEDPNDR  166 (220)
Q Consensus       156 ~~cl~~~p~~R  166 (220)
                      ..+|+.||.+|
T Consensus       278 ~~lL~~~~~~R  288 (288)
T PF14531_consen  278 RGLLQRNPEDR  288 (288)
T ss_dssp             HHHT-SSGGGS
T ss_pred             HHHccCCcccC
Confidence            99999999988

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.70  E-value=3.4e-18  Score=141.18  Aligned_cols=99  Identities=25%  Similarity=0.379  Sum_probs=85.8

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      +..-|++|++.|+++||..|   |+|||||-+|+.++.+|.+||+|||.+......    ....++||..|+|||++.|.
T Consensus       671 eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgsaa~~ksg----pfd~f~gtv~~aapevl~g~  743 (772)
T KOG1152|consen  671 EAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSG----PFDVFVGTVDYAAPEVLGGE  743 (772)
T ss_pred             HHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccchhhhcCC----CcceeeeeccccchhhhCCC
Confidence            34568999999999999999   999999999999999999999999988654432    23447899999999999998


Q ss_pred             CC-cccCceeehhHHHHHHHhcCccCc
Q 027675           83 FF-SVKSDVFSFGVVVLEIISGKRNTG  108 (220)
Q Consensus        83 ~~-~~~~DiwslG~il~~ll~g~~p~~  108 (220)
                      .| ....|||+||+++|.++..+.||-
T Consensus       744 ~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  744 KYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             ccCCCcchhhhhhheeeEEEeccCCCc
Confidence            77 566999999999999998888863

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.70  E-value=1.6e-17  Score=145.83  Aligned_cols=151  Identities=23%  Similarity=0.243  Sum_probs=103.1

Q ss_pred             HHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeee-cCCCCCccccee----ecccCccChhhhhc
Q 027675            7 IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIF-EGKQTDGTTNRV----VGTYGYMSPEYALG   81 (220)
Q Consensus         7 i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~-~~~~~~~~~~~~----~~~~~y~aPe~~~~   81 (220)
                      |+.|++.||..+|+.|   ++|||||.+||||+.=+.+.|+||...... -....+.....+    .....|+|||.+..
T Consensus       125 iaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~  201 (1431)
T KOG1240|consen  125 IAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVS  201 (1431)
T ss_pred             HHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhc
Confidence            7899999999999999   999999999999999999999999765431 111111111111    22348999999864


Q ss_pred             C----------C-CcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHH
Q 027675           82 G----------F-FSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEIL  149 (220)
Q Consensus        82 ~----------~-~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (220)
                      .          + .+++-||||+||++.||++ |.++|..      .+...+....      ...........    +..
T Consensus       202 ~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L------SQL~aYr~~~------~~~~e~~Le~I----ed~  265 (1431)
T KOG1240|consen  202 ALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL------SQLLAYRSGN------ADDPEQLLEKI----EDV  265 (1431)
T ss_pred             cccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH------HHHHhHhccC------ccCHHHHHHhC----cCc
Confidence            2          2 5678999999999999997 5777752      1111111100      00000000011    111


Q ss_pred             HHHHHhccccCCCCCCCCCHHHHHHHh
Q 027675          150 KCINVGLLCVQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       150 ~~~~li~~cl~~~p~~Rps~~~~l~~l  176 (220)
                      .+.+++..|++.||++|.++++.|+.-
T Consensus       266 ~~Rnlil~Mi~rdPs~RlSAedyL~~y  292 (1431)
T KOG1240|consen  266 SLRNLILSMIQRDPSKRLSAEDYLQKY  292 (1431)
T ss_pred             cHHHHHHHHHccCchhccCHHHHHHhh
Confidence            568899999999999999999999774

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.68  E-value=5.9e-17  Score=135.75  Aligned_cols=156  Identities=24%  Similarity=0.296  Sum_probs=113.7

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhh--
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL--   80 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~--   80 (220)
                      ++-.+.+..++|++|||+.|   -+|||||-.||++++.|.+++.|||.+-.+....  .....+.|++.|+|||...  
T Consensus       113 qiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati--~KrksfiGtpywmapEvaave  187 (829)
T KOG0576|consen  113 QIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI--AKRKSFIGTPYWMAPEVAAVE  187 (829)
T ss_pred             HHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh--hhhhcccCCccccchhHHHHH
Confidence            34567789999999999999   8999999999999999999999999875443221  2223367899999999874  


Q ss_pred             -cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           81 -GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        81 -~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                       ..++...+|+|++|....|+-..++|.-.-.   .+....    .     ..+..-..+...........+.+|++.||
T Consensus       188 rkggynqlcdiwa~gitAiel~eLqpplfdlh---pmr~l~----L-----mTkS~~qpp~lkDk~kws~~fh~fvK~al  255 (829)
T KOG0576|consen  188 RKGGYNQLCDIWALGITAIELGELQPPLFDLH---PMRALF----L-----MTKSGFQPPTLKDKTKWSEFFHNFVKGAL  255 (829)
T ss_pred             hcccccccccccccccchhhhhhcCCcccccc---hHHHHH----H-----hhccCCCCCcccCCccchHHHHHHHHHHh
Confidence             4578999999999999999887777632111   111110    0     01111122222334455668899999999


Q ss_pred             CCCCCCCCCHHHHHHH
Q 027675          160 QEDPNDRPTMSDVVIM  175 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~  175 (220)
                      ..+|++||+++.++.+
T Consensus       256 tknpKkRptaeklL~h  271 (829)
T KOG0576|consen  256 TKNPKKRPTAEKLLQH  271 (829)
T ss_pred             cCCCccCCChhhheec
Confidence            9999999999998854

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.67  E-value=9.2e-17  Score=122.39  Aligned_cols=103  Identities=31%  Similarity=0.431  Sum_probs=86.0

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhh-hc
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYA-LG   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~-~~   81 (220)
                      .++.++.+++.++.+||+.+   ++|+|+++.||+++.++.++|+|||.......... .......+...|++||.+ ..
T Consensus        99 ~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~  174 (225)
T smart00221       99 EARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALLKTVKGTPFYLAPEVLLGG  174 (225)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-ccccceeccCCcCCHhHhcCC
Confidence            56789999999999999999   99999999999999999999999998876543220 011224556789999998 55


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcc
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGF  109 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~  109 (220)
                      ..++.++|+|+||++++++++|+.||..
T Consensus       175 ~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      175 KGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             CCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            6677899999999999999999999953

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.67  E-value=5e-16  Score=125.46  Aligned_cols=166  Identities=22%  Similarity=0.213  Sum_probs=113.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCC-----CCceecCcccee--eecCCC------CCcccceee
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHE-----MNPKISDFGLTR--IFEGKQ------TDGTTNRVV   68 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~-----~~~~l~d~~~~~--~~~~~~------~~~~~~~~~   68 (220)
                      .++++++.|++.+|++||+.|   ++||||||.|+++...     ..+.+.|||+++  ......      .........
T Consensus       122 ~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~r  198 (322)
T KOG1164|consen  122 KTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFR  198 (322)
T ss_pred             hHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCC
Confidence            578899999999999999999   9999999999999765     358999999998  321111      111112345


Q ss_pred             cccCccChhhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHH
Q 027675           69 GTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEI  148 (220)
Q Consensus        69 ~~~~y~aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (220)
                      ||..|+++....+...+.+.|+||++.++.+++.|..||............   .+.... ...   ..  .....+.+.
T Consensus       199 GT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~---~~~~~~-~~~---~~--~~~~~~~~~  269 (322)
T KOG1164|consen  199 GTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF---EKDPRK-LLT---DR--FGDLKPEEF  269 (322)
T ss_pred             CccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH---HHHhhh-hcc---cc--ccCCChHHH
Confidence            899999999999999999999999999999999999998543322111111   000000 000   00  111222233


Q ss_pred             HHHHHHhccccCCCCCCCCCHHHHHHHhcCcccc
Q 027675          149 LKCINVGLLCVQEDPNDRPTMSDVVIMLGSEAVN  182 (220)
Q Consensus       149 ~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~~~~  182 (220)
                      ..+...   +-..+...+|....+...+......
T Consensus       270 ~~~~~~---~~~~~~~~~Pdy~~~~~~l~~~~~~  300 (322)
T KOG1164|consen  270 AKILEY---IDSLDYEDKPDYEKLAELLKDVFDS  300 (322)
T ss_pred             HHHHHH---hhccCCcCCCCHHHHHHHHHHHHHh
Confidence            333333   4458999999999999887555443

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.67  E-value=2.7e-17  Score=134.74  Aligned_cols=146  Identities=24%  Similarity=0.393  Sum_probs=103.7

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCC----CCcccceeecccCccChhh
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQ----TDGTTNRVVGTYGYMSPEY   78 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~~y~aPe~   78 (220)
                      .+..+++|++.|++|   ++   .+|+|+||.||++..+..++|.|||+........    .....+...++..|++||.
T Consensus       360 ~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQ  433 (516)
T KOG1033|consen  360 LMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQ  433 (516)
T ss_pred             HHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHH
Confidence            467899999999999   77   9999999999999999999999999987544322    1223344688999999999


Q ss_pred             hhcCCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcc
Q 027675           79 ALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLL  157 (220)
Q Consensus        79 ~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  157 (220)
                      +.+..++.+.|||+||+|++|++. ....++...          ....++.+.....         ....-..-+.|+.+
T Consensus       434 i~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~----------t~~d~r~g~ip~~---------~~~d~p~e~~ll~~  494 (516)
T KOG1033|consen  434 IRGQQYSEKVDIYALGLILAELLIQFSTQFERIA----------TLTDIRDGIIPPE---------FLQDYPEEYTLLQQ  494 (516)
T ss_pred             HhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH----------hhhhhhcCCCChH---------HhhcCcHHHHHHHH
Confidence            999999999999999999999997 333221000          0011111111100         01111133577788


Q ss_pred             ccCCCCCCCCCHHHHH
Q 027675          158 CVQEDPNDRPTMSDVV  173 (220)
Q Consensus       158 cl~~~p~~Rps~~~~l  173 (220)
                      ++...|.+||++.+..
T Consensus       495 lls~~p~~RP~~~~~~  510 (516)
T KOG1033|consen  495 LLSPSPEERPSAIEVA  510 (516)
T ss_pred             hcCCCcccCchHHHHh
Confidence            9999999999655443

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.63  E-value=8.1e-16  Score=127.69  Aligned_cols=169  Identities=22%  Similarity=0.336  Sum_probs=115.0

Q ss_pred             HHHHHHHHHHHHHHhhhCCCCCe-EeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            4 LFNIILGVSRRLLYLHQDSKLRI-IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         4 ~~~i~~~l~~~l~~LH~~~~~~i-~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      ...+++++++||.|||...   | +|+.++..|++++....+|++|||+.....................|.|||.+.+.
T Consensus        50 ~~s~~rdi~~Gl~ylh~s~---i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~  126 (484)
T KOG1023|consen   50 ILSFIRDISKGLAYLHNSP---IGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGA  126 (484)
T ss_pred             HHHHHHHHHHHHHHHhcCc---ceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhccc
Confidence            4567899999999999986   5 99999999999999999999999997654321111111112234578999998763


Q ss_pred             -------CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHh
Q 027675           83 -------FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVG  155 (220)
Q Consensus        83 -------~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  155 (220)
                             ..+.+.|+||+|++++|+++...||.........  .+.+..+...+...    ..|...........+..++
T Consensus       127 ~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~--~eii~~~~~~~~~~----~rP~i~~~~e~~~~l~~l~  200 (484)
T KOG1023|consen  127 LSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDP--DEIILRVKKGGSNP----FRPSIELLNELPPELLLLV  200 (484)
T ss_pred             ccccccccccccCCeehHHHHHHHHHhccCccccccccCCh--HHHHHHHHhcCCCC----cCcchhhhhhcchHHHHHH
Confidence                   1467799999999999999999999753333221  11111111111110    1111111112223688899


Q ss_pred             ccccCCCCCCCCCHHHHHHHhcCccc
Q 027675          156 LLCVQEDPNDRPTMSDVVIMLGSEAV  181 (220)
Q Consensus       156 ~~cl~~~p~~Rps~~~~l~~l~~~~~  181 (220)
                      ..||..+|..||+++++...+.....
T Consensus       201 ~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  201 ARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             HHhcccChhhCccHHHHHhhhhhhcc
Confidence            99999999999999999988865533

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.59  E-value=6.4e-15  Score=117.56  Aligned_cols=153  Identities=21%  Similarity=0.204  Sum_probs=101.3

Q ss_pred             HHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceee--CCCCC--ceecCccceeeecCCCCC--ccc--ceeecccCccC
Q 027675            4 LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILL--DHEMN--PKISDFGLTRIFEGKQTD--GTT--NRVVGTYGYMS   75 (220)
Q Consensus         4 ~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili--~~~~~--~~l~d~~~~~~~~~~~~~--~~~--~~~~~~~~y~a   75 (220)
                      ..-|+.|+++|+.|||++|   +.|||+|.+||++  ++++.  +.++|||.+-....+...  ...  -...|....+|
T Consensus       343 ~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmA  419 (598)
T KOG4158|consen  343 GRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMA  419 (598)
T ss_pred             HHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecc
Confidence            3458899999999999999   9999999999999  44444  578999986543321110  000  01244557789


Q ss_pred             hhhhhcCC------CcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHH
Q 027675           76 PEYALGGF------FSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEIL  149 (220)
Q Consensus        76 Pe~~~~~~------~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (220)
                      ||+....+      --.++|.|+.|.+.||++....||.......... ..     .++.+...+.+..+         .
T Consensus       420 PEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~-r~-----Yqe~qLPalp~~vp---------p  484 (598)
T KOG4158|consen  420 PEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT-RT-----YQESQLPALPSRVP---------P  484 (598)
T ss_pred             hhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheech-hh-----hhhhhCCCCcccCC---------h
Confidence            99986431      2368999999999999999999986432222211 11     12222222222222         2


Q ss_pred             HHHHHhccccCCCCCCCCCHHHHHH
Q 027675          150 KCINVGLLCVQEDPNDRPTMSDVVI  174 (220)
Q Consensus       150 ~~~~li~~cl~~~p~~Rps~~~~l~  174 (220)
                      .+.+++...|+.||.+|++..=...
T Consensus       485 ~~rqlV~~lL~r~pskRvsp~iAAN  509 (598)
T KOG4158|consen  485 VARQLVFDLLKRDPSKRVSPNIAAN  509 (598)
T ss_pred             HHHHHHHHHhcCCccccCCccHHHh
Confidence            5567788899999999998765443

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.59  E-value=1e-14  Score=116.28  Aligned_cols=165  Identities=27%  Similarity=0.373  Sum_probs=115.3

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCC-CceecCccceeeecCCCCCc----ccceeecccCccChh
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEM-NPKISDFGLTRIFEGKQTDG----TTNRVVGTYGYMSPE   77 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~-~~~l~d~~~~~~~~~~~~~~----~~~~~~~~~~y~aPe   77 (220)
                      ....++.+++.++.++|..+   ++|||+||+||+++..+ .++++|||.+..........    ......++..|.+||
T Consensus       102 ~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe  178 (384)
T COG0515         102 EALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE  178 (384)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHH
Confidence            46788999999999999999   99999999999999988 69999999987544332211    234467889999999


Q ss_pred             hhhc---CCCcccCceeehhHHHHHHHhcCccCcccchh-HHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHH
Q 027675           78 YALG---GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSE-LALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCIN  153 (220)
Q Consensus        78 ~~~~---~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (220)
                      ...+   .......|+|++|+++++++.|..||...... ......    ......... .................+.+
T Consensus       179 ~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  253 (384)
T COG0515         179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL----KIILELPTP-SLASPLSPSNPELISKAASD  253 (384)
T ss_pred             HhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHH----HHHHhcCCc-ccccccCccccchhhHHHHH
Confidence            9987   56789999999999999999999997654431 000000    111111100 00000000000222346678


Q ss_pred             HhccccCCCCCCCCCHHHHHHH
Q 027675          154 VGLLCVQEDPNDRPTMSDVVIM  175 (220)
Q Consensus       154 li~~cl~~~p~~Rps~~~~l~~  175 (220)
                      ++..|+..+|..|.+..+....
T Consensus       254 ~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         254 LLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             HHHHHHhcCchhcCCHHHHhhc
Confidence            8888999999999999987765

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.58  E-value=2.4e-15  Score=112.64  Aligned_cols=181  Identities=17%  Similarity=0.108  Sum_probs=124.4

Q ss_pred             CchHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCC---CCCceecCccceeeecC-----CCCCcccceeecccC
Q 027675            1 MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDH---EMNPKISDFGLTRIFEG-----KQTDGTTNRVVGTYG   72 (220)
Q Consensus         1 ~~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~---~~~~~l~d~~~~~~~~~-----~~~~~~~~~~~~~~~   72 (220)
                      +++++-++-|++..++|+|.++   ++||||||+|++..-   ..++.++|||++..+..     +...-...+..||..
T Consensus       110 mkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaR  186 (341)
T KOG1163|consen  110 MKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTAR  186 (341)
T ss_pred             HHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeee
Confidence            3678889999999999999999   999999999999954   34578999999975432     223334455788999


Q ss_pred             ccChhhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHH
Q 027675           73 YMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCI  152 (220)
Q Consensus        73 y~aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (220)
                      |++-....+...+.+.|+-|+|.++.++--|..||+.-......+..+.+.+-...-.....+..     +    ..++.
T Consensus       187 YASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G-----~----P~EF~  257 (341)
T KOG1163|consen  187 YASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKG-----F----PAEFA  257 (341)
T ss_pred             ehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCC-----C----cHHHH
Confidence            99999888888899999999999999999999999764443333322221111111111111111     1    12444


Q ss_pred             HHhccccCCCCCCCCCHHHHHHHhcCccccCCCCCCchhhh
Q 027675          153 NVGLLCVQEDPNDRPTMSDVVIMLGSEAVNLASPKRPAFVV  193 (220)
Q Consensus       153 ~li~~cl~~~p~~Rps~~~~l~~l~~~~~~~~~~~~~~~~~  193 (220)
                      -.+..|-..-.++-|+..-+.+.+..+-+...-...-.+.+
T Consensus       258 myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW  298 (341)
T KOG1163|consen  258 MYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDW  298 (341)
T ss_pred             HHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeH
Confidence            45555777788888888888777766656555554444444

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.54  E-value=2.7e-15  Score=131.60  Aligned_cols=142  Identities=21%  Similarity=0.242  Sum_probs=101.5

Q ss_pred             HHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCC------------CCccc-ceeecccCccCh
Q 027675           10 GVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQ------------TDGTT-NRVVGTYGYMSP   76 (220)
Q Consensus        10 ~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~------------~~~~~-~~~~~~~~y~aP   76 (220)
                      +++.+++|||..|   |+|||+||+|.+|..-|.+|++|||+........            ....+ ....+++.|.||
T Consensus       151 dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaP  227 (1205)
T KOG0606|consen  151 DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAP  227 (1205)
T ss_pred             hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccCh
Confidence            4578999999999   9999999999999999999999999987532110            01111 124789999999


Q ss_pred             hhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhc
Q 027675           77 EYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGL  156 (220)
Q Consensus        77 e~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  156 (220)
                      |++...+|....|.|++|+|+|+.+.|..||.....+........  .   ...-.+   .      +.....+..++|.
T Consensus       228 eVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vis--d---~i~wpE---~------dea~p~Ea~dli~  293 (1205)
T KOG0606|consen  228 EVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS--D---DIEWPE---E------DEALPPEAQDLIE  293 (1205)
T ss_pred             hhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhh--h---hccccc---c------CcCCCHHHHHHHH
Confidence            999988899999999999999999999999876554444322110  0   000000   0      1111224566777


Q ss_pred             cccCCCCCCCCC
Q 027675          157 LCVQEDPNDRPT  168 (220)
Q Consensus       157 ~cl~~~p~~Rps  168 (220)
                      ++|..+|.+|--
T Consensus       294 ~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  294 QLLRQNPLCRLG  305 (1205)
T ss_pred             HHHHhChHhhcc
Confidence            788899999943

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.52  E-value=2e-14  Score=109.60  Aligned_cols=153  Identities=20%  Similarity=0.260  Sum_probs=108.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceec--CccceeeecCCCCCcccceeecccCccChhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKIS--DFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYA   79 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~--d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~   79 (220)
                      .+.++++.+++.|++|||+.. +-|..-.|+...++++++-..++.  |--++.....   +      .-.+.|++||.+
T Consensus       289 sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfqe~g---r------~y~pawmspeal  358 (448)
T KOG0195|consen  289 SQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQEVG---R------AYSPAWMSPEAL  358 (448)
T ss_pred             chHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeeeccc---c------ccCcccCCHHHH
Confidence            367899999999999999985 335566788999999988776653  4333322111   1      125789999999


Q ss_pred             hcCC---CcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhc
Q 027675           80 LGGF---FSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGL  156 (220)
Q Consensus        80 ~~~~---~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  156 (220)
                      ...+   .-..+|+|||++++|||.|.+.||......+..-      ++-.+|.+..++.   .      .+..+..+|.
T Consensus       359 qrkped~n~raadmwsfaillwel~trevpfadlspmecgm------kialeglrv~ipp---g------is~hm~klm~  423 (448)
T KOG0195|consen  359 QRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM------KIALEGLRVHIPP---G------ISRHMNKLMN  423 (448)
T ss_pred             hcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh------hhhhccccccCCC---C------ccHHHHHHHH
Confidence            7654   2467999999999999999999998776665532      2223333333322   1      2224555666


Q ss_pred             cccCCCCCCCCCHHHHHHHhcCc
Q 027675          157 LCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       157 ~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      -|+..||.+||.+++++-.|+..
T Consensus       424 icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  424 ICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             HHhcCCCCcCCCcceehhhHHHh
Confidence            69999999999999999888653

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.49  E-value=7.1e-14  Score=109.21  Aligned_cols=172  Identities=17%  Similarity=0.161  Sum_probs=114.9

Q ss_pred             CchHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCC-----CceecCccceeeecCC-----CCCcccceeecc
Q 027675            1 MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEM-----NPKISDFGLTRIFEGK-----QTDGTTNRVVGT   70 (220)
Q Consensus         1 ~~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~-----~~~l~d~~~~~~~~~~-----~~~~~~~~~~~~   70 (220)
                      ++++.-++.|++.-++++|++.   ++.|||||+|+||...+     .+.++|||++......     ...-......||
T Consensus       123 vKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGT  199 (449)
T KOG1165|consen  123 VKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGT  199 (449)
T ss_pred             HHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccc
Confidence            4688899999999999999999   99999999999996443     3789999999764322     222233446788


Q ss_pred             cCccChhhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHH
Q 027675           71 YGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILK  150 (220)
Q Consensus        71 ~~y~aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (220)
                      -.|++.....|...+.+.|+-|||=++.+.+-|..||++-.........+.+.+-.+...+.+.+..      .+.   +
T Consensus       200 ARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc~g------~P~---e  270 (449)
T KOG1165|consen  200 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLCEG------FPE---E  270 (449)
T ss_pred             eeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHHHhc------CHH---H
Confidence            8999999999999999999999999999999999999753333222211111111111111111111      122   3


Q ss_pred             HHHHhccccCCCCCCCCCHHHHHHHhcCccccCC
Q 027675          151 CINVGLLCVQEDPNDRPTMSDVVIMLGSEAVNLA  184 (220)
Q Consensus       151 ~~~li~~cl~~~p~~Rps~~~~l~~l~~~~~~~~  184 (220)
                      +...+...-..+..+-|+.+-+...+........
T Consensus       271 fa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g  304 (449)
T KOG1165|consen  271 FATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLG  304 (449)
T ss_pred             HHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcC
Confidence            3333333444688899998877766544433333

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.46  E-value=6.5e-14  Score=117.23  Aligned_cols=132  Identities=26%  Similarity=0.341  Sum_probs=100.8

Q ss_pred             HHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcCCCc
Q 027675            6 NIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFFS   85 (220)
Q Consensus         6 ~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~~~~   85 (220)
                      .+...++-+++++|+.+   ++|+|+|++||+++.+|.+++.|||+.+........      -|+..|+|||+.++  ..
T Consensus       101 ~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~------cgt~eymApEI~~g--h~  169 (612)
T KOG0603|consen  101 FYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA------CGTYEYRAPEIING--HL  169 (612)
T ss_pred             HHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc------ccchhhhhhHhhhc--cC
Confidence            45678889999999999   999999999999999999999999998754322221      46889999999993  47


Q ss_pred             ccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCCCCC
Q 027675           86 VKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPND  165 (220)
Q Consensus        86 ~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~  165 (220)
                      ...|.||||++.++|++|..||..   +..        +.        ++..  ....+.+......+++..++..+|.+
T Consensus       170 ~a~D~ws~gvl~felltg~~pf~~---~~~--------~~--------Il~~--~~~~p~~l~~~a~~~~~~l~~r~p~n  228 (612)
T KOG0603|consen  170 SAADWWSFGVLAFELLTGTLPFGG---DTM--------KR--------ILKA--ELEMPRELSAEARSLFRQLFKRNPEN  228 (612)
T ss_pred             CcccchhhhhhHHHHhhCCCCCch---HHH--------HH--------Hhhh--ccCCchhhhHHHHHHHHHHHhhCHHH
Confidence            789999999999999999999975   111        00        1111  11222334456677778899999999


Q ss_pred             CCCH
Q 027675          166 RPTM  169 (220)
Q Consensus       166 Rps~  169 (220)
                      |...
T Consensus       229 rLg~  232 (612)
T KOG0603|consen  229 RLGA  232 (612)
T ss_pred             Hhcc
Confidence            9766

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.30  E-value=3.5e-12  Score=103.90  Aligned_cols=73  Identities=21%  Similarity=0.271  Sum_probs=57.6

Q ss_pred             HHHHHHHHHHHHHhhhCCCCCeEeccC-CCCceeeCCCCCceecCccceeeecCCCCCcc------cceeecccCccChh
Q 027675            5 FNIILGVSRRLLYLHQDSKLRIIHRDF-KTSNILLDHEMNPKISDFGLTRIFEGKQTDGT------TNRVVGTYGYMSPE   77 (220)
Q Consensus         5 ~~i~~~l~~~l~~LH~~~~~~i~H~dl-k~~nili~~~~~~~l~d~~~~~~~~~~~~~~~------~~~~~~~~~y~aPe   77 (220)
                      ..++.+++++|.|||+.|   |+|||| ||+||+++.++.++|+|||++...........      -....+++.|.+||
T Consensus       114 ~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe  190 (365)
T PRK09188        114 PAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPD  190 (365)
T ss_pred             HHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcc
Confidence            468899999999999999   999999 99999999999999999999986543221101      02345566788998


Q ss_pred             hhh
Q 027675           78 YAL   80 (220)
Q Consensus        78 ~~~   80 (220)
                      .+.
T Consensus       191 ~~~  193 (365)
T PRK09188        191 ALT  193 (365)
T ss_pred             cCC
Confidence            875

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.25  E-value=5.6e-12  Score=94.42  Aligned_cols=100  Identities=18%  Similarity=0.168  Sum_probs=74.5

Q ss_pred             HHHHHHHHHHHHHhhhCCCCCeEeccC-CCCceeeCCCCCceecCccceeeecCCCCC---cc--------cceeecccC
Q 027675            5 FNIILGVSRRLLYLHQDSKLRIIHRDF-KTSNILLDHEMNPKISDFGLTRIFEGKQTD---GT--------TNRVVGTYG   72 (220)
Q Consensus         5 ~~i~~~l~~~l~~LH~~~~~~i~H~dl-k~~nili~~~~~~~l~d~~~~~~~~~~~~~---~~--------~~~~~~~~~   72 (220)
                      ..++.+++.+|.++|..|   ++|||| ||.||+++.++.++|+|||++.........   ..        ......++.
T Consensus        94 ~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~  170 (218)
T PRK12274         94 LAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPA  170 (218)
T ss_pred             HHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCC
Confidence            357889999999999999   999999 799999999999999999999854432210   00        001123567


Q ss_pred             ccChhhhhcC-CCc-ccCceeehhHHHHHHHhcCccC
Q 027675           73 YMSPEYALGG-FFS-VKSDVFSFGVVVLEIISGKRNT  107 (220)
Q Consensus        73 y~aPe~~~~~-~~~-~~~DiwslG~il~~ll~g~~p~  107 (220)
                      |+.|+...-. ..+ .+.+.++.|+-+|.++|+..+.
T Consensus       171 ~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~  207 (218)
T PRK12274        171 ALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH  207 (218)
T ss_pred             CCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence            7788765433 223 5677888899999999998774

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.22  E-value=1.7e-11  Score=109.09  Aligned_cols=100  Identities=23%  Similarity=0.215  Sum_probs=81.9

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCC-------CCCceecCccceeeecCCCCCcccceeecccCccC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDH-------EMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMS   75 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~-------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~a   75 (220)
                      -++.+..|++..++.||..+   |+||||||+|+++..       ...++|+|||.+.....-.........+++-.+-.
T Consensus       795 lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C  871 (974)
T KOG1166|consen  795 LVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDC  871 (974)
T ss_pred             hhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchh
Confidence            36788999999999999999   999999999999942       33479999998764332222223334567778899


Q ss_pred             hhhhhcCCCcccCceeehhHHHHHHHhcCc
Q 027675           76 PEYALGGFFSVKSDVFSFGVVVLEIISGKR  105 (220)
Q Consensus        76 Pe~~~~~~~~~~~DiwslG~il~~ll~g~~  105 (220)
                      +|...|.+++.++|.|+|+.+++-|+.|+.
T Consensus       872 ~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  872 IEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             HHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            999999999999999999999999999874

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.17  E-value=7.7e-12  Score=108.16  Aligned_cols=160  Identities=24%  Similarity=0.353  Sum_probs=112.8

Q ss_pred             HHHHHHHHHHHHHhh-hCCCCCeEeccCCCCceeeCCCC-CceecCccceeeecC-CCCCcccceeec-ccCccChhhhh
Q 027675            5 FNIILGVSRRLLYLH-QDSKLRIIHRDFKTSNILLDHEM-NPKISDFGLTRIFEG-KQTDGTTNRVVG-TYGYMSPEYAL   80 (220)
Q Consensus         5 ~~i~~~l~~~l~~LH-~~~~~~i~H~dlk~~nili~~~~-~~~l~d~~~~~~~~~-~~~~~~~~~~~~-~~~y~aPe~~~   80 (220)
                      -.++.|+..++.|+| ..+   +.|+|+||+|.+++.++ .+++.|||++..+.. ...........| ++.|.|||...
T Consensus       126 ~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~  202 (601)
T KOG0590|consen  126 SRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLS  202 (601)
T ss_pred             hhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCccccc
Confidence            357889999999999 998   99999999999999999 899999999876554 222222223456 88999999998


Q ss_pred             cC-CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           81 GG-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        81 ~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      +. ......|+||+|+++.-+++|..|+......... ...+  .   +..  ......+..    .......+++..++
T Consensus       203 ~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~--~---~~~--~~~~~~~~~----~~~~~~~~~l~k~l  270 (601)
T KOG0590|consen  203 GKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSW--K---SNK--GRFTQLPWN----SISDQAHDLLHKIL  270 (601)
T ss_pred             chhhcCCCcccccccccccccccCCCCcccccccccc-ceee--c---ccc--cccccCccc----cCChhhhhcccccc
Confidence            84 4478899999999999999999998643332210 0000  0   000  000111111    11225567788899


Q ss_pred             CCCCCCCCCHHHHHHHhcCc
Q 027675          160 QEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l~~~  179 (220)
                      ..+|..|.+.+++-..-+..
T Consensus       271 ~~~~~~r~s~~~~~~d~~~~  290 (601)
T KOG0590|consen  271 KENPSNRLSIEELKLDNWLS  290 (601)
T ss_pred             cCCchhcccccccccccccc
Confidence            99999999999988665444

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.16  E-value=2.1e-10  Score=92.95  Aligned_cols=103  Identities=16%  Similarity=0.245  Sum_probs=82.3

Q ss_pred             CchHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhh
Q 027675            1 MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         1 ~~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~   80 (220)
                      |+-+++.++.++.+.+-||..|   .+-||++++|+++++++.|.|.|-+......+....   ...++...|++||.-.
T Consensus       116 w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng~~~---~cpVg~~eftPPElQ~  189 (637)
T COG4248         116 WDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQINANGTLH---LCPVGVSEFTPPELQT  189 (637)
T ss_pred             cHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceeeccCCceE---ecccCccccCCHHHhc
Confidence            4557889999999999999999   999999999999999999999986554433222111   1136778999999754


Q ss_pred             -----cCCCcccCceeehhHHHHHHHhc-CccCcc
Q 027675           81 -----GGFFSVKSDVFSFGVVVLEIISG-KRNTGF  109 (220)
Q Consensus        81 -----~~~~~~~~DiwslG~il~~ll~g-~~p~~~  109 (220)
                           +...+...|.|.||+++++++.| ++||.+
T Consensus       190 ~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG  224 (637)
T COG4248         190 LPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG  224 (637)
T ss_pred             cccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence                 44567889999999999999976 899864

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.14  E-value=1.8e-11  Score=93.31  Aligned_cols=78  Identities=15%  Similarity=0.273  Sum_probs=58.5

Q ss_pred             HHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcCCCc
Q 027675            6 NIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFFS   85 (220)
Q Consensus         6 ~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~~~~   85 (220)
                      ..+.+++.++..+|..|   ++|||++|.||+++.+| ++++|||...........              ..+.....+.
T Consensus       139 ~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~  200 (232)
T PRK10359        139 DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYG  200 (232)
T ss_pred             HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhc
Confidence            34679999999999999   99999999999999988 999999976533211110              1122333455


Q ss_pred             ccCceeehhHHHHHHH
Q 027675           86 VKSDVFSFGVVVLEII  101 (220)
Q Consensus        86 ~~~DiwslG~il~~ll  101 (220)
                      .++|+|+||+.+..+.
T Consensus       201 ~~~di~~lg~~~~~~~  216 (232)
T PRK10359        201 IKNEIKDLGYYLLIYK  216 (232)
T ss_pred             ccccccceeEeehHHH
Confidence            7899999999877654

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.07  E-value=1.5e-10  Score=86.58  Aligned_cols=49  Identities=22%  Similarity=0.253  Sum_probs=45.1

Q ss_pred             hHHHHHHHHHHHHHHhhh-CCCCCeEeccCCCCceeeCCCCCceecCccceeee
Q 027675            3 MLFNIILGVSRRLLYLHQ-DSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIF   55 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~-~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~   55 (220)
                      .+..++.+++.++.++|+ .|   ++||||||.||+++ ++.++|+|||++...
T Consensus       118 ~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~~~~liDFG~a~~~  167 (190)
T cd05145         118 EAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DGKPYIIDVSQAVEL  167 (190)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CCCEEEEEcccceec
Confidence            567899999999999999 99   99999999999998 789999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.07  E-value=1.1e-10  Score=87.28  Aligned_cols=49  Identities=18%  Similarity=0.199  Sum_probs=44.0

Q ss_pred             chHHHHHHHHHHHHHHh-hhCCCCCeEeccCCCCceeeCCCCCceecCccceee
Q 027675            2 EMLFNIILGVSRRLLYL-HQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRI   54 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~L-H~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~   54 (220)
                      +++..++.|++.+|.++ |+.|   ++||||||.||+++ ++.++|+|||++..
T Consensus       117 ~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~~v~LiDFG~a~~  166 (190)
T cd05147         117 SKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DGKLYIIDVSQSVE  166 (190)
T ss_pred             HHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CCcEEEEEcccccc
Confidence            35788999999999999 6889   99999999999998 47899999999864

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.02  E-value=4.4e-10  Score=88.27  Aligned_cols=153  Identities=18%  Similarity=0.193  Sum_probs=99.6

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCcc--ceeeecCCCCCcccceeecccCccChhhhh
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFG--LTRIFEGKQTDGTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~--~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~   80 (220)
                      ...+|+-||+.||.|||+-. +.|+|+++.-+.|++..+|-+|+..-.  ..................+.+.|.+|+.-.
T Consensus       177 ~wkkw~tqIlsal~yLhs~~-PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~  255 (458)
T KOG1266|consen  177 AWKKWCTQILSALSYLHSCD-PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGT  255 (458)
T ss_pred             HHHHHHHHHHhhhhhhhccC-CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCc
Confidence            34689999999999999984 679999999999999999888875421  111111111111122234567899999988


Q ss_pred             cCCCcccCceeehhHHHHHHHhcCccCcccchh-HHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           81 GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSE-LALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      ..+.+...|||+||+...+|..++.-....... ..+..+   ..     -....-++            .-..++..|+
T Consensus       256 ~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~i---a~-----~i~~len~------------lqr~~i~kcl  315 (458)
T KOG1266|consen  256 TTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENI---AN-----VIIGLENG------------LQRGSITKCL  315 (458)
T ss_pred             ccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhh---hh-----heeeccCc------------cccCcCcccc
Confidence            888889999999999999998877542211111 110000   00     00000011            1134566799


Q ss_pred             CCCCCCCCCHHHHHHHh
Q 027675          160 QEDPNDRPTMSDVVIML  176 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l  176 (220)
                      +-.|..||+|.+++.|.
T Consensus       316 ~~eP~~rp~ar~llfHp  332 (458)
T KOG1266|consen  316 EGEPNGRPDARLLLFHP  332 (458)
T ss_pred             cCCCCCCcchhhhhcCc
Confidence            99999999999988665

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.89  E-value=7.8e-10  Score=94.28  Aligned_cols=153  Identities=20%  Similarity=0.279  Sum_probs=100.4

Q ss_pred             HHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccc-------eeecccCccChhhhh
Q 027675            8 ILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTN-------RVVGTYGYMSPEYAL   80 (220)
Q Consensus         8 ~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~-------~~~~~~~y~aPe~~~   80 (220)
                      +.+++.|+.|+|...+  ++|+.|.|++|.++..+..|++.|+++..........+..       .......|.|||++.
T Consensus       105 l~~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            4566789999998874  9999999999999999999999999876543311111111       012345899999999


Q ss_pred             cCCCcccCceeehhHHHHHHHhcCcc-CcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           81 GGFFSVKSDVFSFGVVVLEIISGKRN-TGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      +...+.++|+||+|+++|.++.|..+ +...+........             ...+......+..+...++.+-+.+++
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~-------------~~~~~~~~~~~s~~~p~el~~~l~k~l  249 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS-------------RNLLNAGAFGYSNNLPSELRESLKKLL  249 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh-------------hcccccccccccccCcHHHHHHHHHHh
Confidence            88788999999999999999954443 3322111111100             000111111111223335666677799


Q ss_pred             CCCCCCCCCHHHHHHH
Q 027675          160 QEDPNDRPTMSDVVIM  175 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~  175 (220)
                      ..+...||++..+...
T Consensus       250 ~~~~~~rp~~~~l~~~  265 (700)
T KOG2137|consen  250 NGDSAVRPTLDLLLSI  265 (700)
T ss_pred             cCCcccCcchhhhhcc
Confidence            9999999977766543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.87  E-value=3.3e-09  Score=94.15  Aligned_cols=196  Identities=20%  Similarity=0.230  Sum_probs=130.4

Q ss_pred             HHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCC------------------------C-
Q 027675            5 FNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGK------------------------Q-   59 (220)
Q Consensus         5 ~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~------------------------~-   59 (220)
                      ...+..+++++++||...   +.|+|++|.|+++..++...+.+|++.......                        . 
T Consensus       907 Rs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~  983 (1205)
T KOG0606|consen  907 RSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQ  983 (1205)
T ss_pred             cchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccc
Confidence            345667889999999998   999999999999999999999998743221100                        0 


Q ss_pred             -CC---cccceeecccCccChhhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccc
Q 027675           60 -TD---GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMM  135 (220)
Q Consensus        60 -~~---~~~~~~~~~~~y~aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  135 (220)
                       ..   .......+++.|.+||...+..-...+|.|++|+.+++.++|.+||..........            .+....
T Consensus       984 l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~------------ni~~~~ 1051 (1205)
T KOG0606|consen  984 LSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFE------------NILNRD 1051 (1205)
T ss_pred             cccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhh------------ccccCC
Confidence             00   01223577899999999999888889999999999999999999986433222211            111111


Q ss_pred             cCCCCCcCcHHHHHHHHHHhccccCCCCCCCCCHH---HHH--HHhcCccccCCCCCCchhhhccCCCCCCCCCCCCCCC
Q 027675          136 DQKPGAISKANEILKCINVGLLCVQEDPNDRPTMS---DVV--IMLGSEAVNLASPKRPAFVVRRGSSSSASTSNKPESN  210 (220)
Q Consensus       136 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~---~~l--~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  210 (220)
                      ...+.  -.........+++...+..+|.+|..+.   ++-  ......++..-+.+.-.++++..+..++|....+-..
T Consensus      1052 ~~~p~--g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~~q~~~~~p~~~s~~dtS~~~~r~~~ 1129 (1205)
T KOG0606|consen 1052 IPWPE--GPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLALQKAEFVPQPESTQDTSYFESRFSE 1129 (1205)
T ss_pred             CCCCC--CccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccccccccCccCCCCCCCCccchhhccccc
Confidence            11111  1122233556666778899999998877   333  2345666666667777777777766666666555443


Q ss_pred             CccccCC
Q 027675          211 NELTHSL  217 (220)
Q Consensus       211 ~~~~~~~  217 (220)
                      ++...++
T Consensus      1130 ~~~~e~~ 1136 (1205)
T KOG0606|consen 1130 ESQDETV 1136 (1205)
T ss_pred             ccccccc
Confidence            4344444

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=98.77  E-value=9.5e-09  Score=77.30  Aligned_cols=48  Identities=21%  Similarity=0.240  Sum_probs=44.4

Q ss_pred             HHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceee
Q 027675            4 LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRI   54 (220)
Q Consensus         4 ~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~   54 (220)
                      ...++.+++.++.++|+.+   ++|+||+|.||+++.++.++|+|||.+..
T Consensus       127 ~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~~~~liDfg~~~~  174 (198)
T cd05144         127 PEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDEKIYIIDWPQMVS  174 (198)
T ss_pred             HHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCCcEEEEECCcccc
Confidence            4578899999999999999   99999999999999999999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=98.76  E-value=7.1e-09  Score=80.28  Aligned_cols=46  Identities=22%  Similarity=0.351  Sum_probs=41.9

Q ss_pred             HHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceee
Q 027675            6 NIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRI   54 (220)
Q Consensus         6 ~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~   54 (220)
                      ..+.+++.+|.+||+.|   |+|+||||.||+++.++.++|+|||.+..
T Consensus       146 ~~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDfg~~~~  191 (239)
T PRK01723        146 EQWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLIDFDRGEL  191 (239)
T ss_pred             HHHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence            34678999999999999   99999999999999988999999998754

>smart00090 RIO RIO-like kinase

Probab=98.75  E-value=1.1e-08  Score=79.17  Aligned_cols=48  Identities=19%  Similarity=0.274  Sum_probs=43.5

Q ss_pred             HHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceee
Q 027675            4 LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRI   54 (220)
Q Consensus         4 ~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~   54 (220)
                      +..++.|++.++.+||..|  .++|+||||+||+++ ++.++|+|||.+..
T Consensus       150 ~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NIli~-~~~i~LiDFg~a~~  197 (237)
T smart00090      150 EFELYDDILEEMRKLYKEG--ELVHGDLSEYNILVH-DGKVVIIDVSQSVE  197 (237)
T ss_pred             HHHHHHHHHHHHHHHHhcC--CEEeCCCChhhEEEE-CCCEEEEEChhhhc
Confidence            5689999999999999986  499999999999999 78899999998764

>cd05119 RIO RIO kinase family, catalytic domain

Probab=98.69  E-value=1.6e-08  Score=75.12  Aligned_cols=48  Identities=19%  Similarity=0.139  Sum_probs=44.3

Q ss_pred             hHHHHHHHHHHHHHHhhh-CCCCCeEeccCCCCceeeCCCCCceecCccceee
Q 027675            3 MLFNIILGVSRRLLYLHQ-DSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRI   54 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~-~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~   54 (220)
                      .+..++.+++.++.++|. .+   ++|+||||+||+++ ++.++++|||.+..
T Consensus       115 ~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~~~~liDfg~a~~  163 (187)
T cd05119         115 DPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DGKVYIIDVPQAVE  163 (187)
T ss_pred             cHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CCcEEEEECccccc
Confidence            567899999999999999 88   99999999999999 88999999998854

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK10345 hypothetical protein; Provisional

Probab=98.62  E-value=4e-08  Score=74.44  Aligned_cols=42  Identities=24%  Similarity=0.354  Sum_probs=35.5

Q ss_pred             HHHHHHHHHH-HHhhhCCCCCeEeccCCCCceeeCCC----CCceecCcc
Q 027675            6 NIILGVSRRL-LYLHQDSKLRIIHRDFKTSNILLDHE----MNPKISDFG   50 (220)
Q Consensus         6 ~i~~~l~~~l-~~LH~~~~~~i~H~dlk~~nili~~~----~~~~l~d~~   50 (220)
                      .++.+++.++ +|||+++   |+||||||+||+++..    +.++|+|++
T Consensus       108 ~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345        108 AQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             HHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            4577888887 9999999   9999999999999743    369999943

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.60  E-value=3.2e-08  Score=83.15  Aligned_cols=154  Identities=25%  Similarity=0.332  Sum_probs=103.1

Q ss_pred             hHHHHHHHHHH----HHHHhhhCCCCCeEeccCCCCceeeCCC-CCceecCccceeeecCCCCCc---ccceeecccCcc
Q 027675            3 MLFNIILGVSR----RLLYLHQDSKLRIIHRDFKTSNILLDHE-MNPKISDFGLTRIFEGKQTDG---TTNRVVGTYGYM   74 (220)
Q Consensus         3 ~~~~i~~~l~~----~l~~LH~~~~~~i~H~dlk~~nili~~~-~~~~l~d~~~~~~~~~~~~~~---~~~~~~~~~~y~   74 (220)
                      .++..+.+..+    ||..+|..+   ++|-|+||.||+...+ ..++++||+++..+.......   +..+..+...|+
T Consensus       219 ~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~  295 (524)
T KOG0601|consen  219 LLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYA  295 (524)
T ss_pred             hhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEe
Confidence            45667777777    999999999   9999999999999999 778999999988665432111   111225677899


Q ss_pred             ChhhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHH
Q 027675           75 SPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINV  154 (220)
Q Consensus        75 aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  154 (220)
                      +||..++. ++...|+|++|.++.+...+.......-...        |...+.+.   +.+..     ...-...+...
T Consensus       296 ~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~--------W~~~r~~~---ip~e~-----~~~~s~~l~~~  358 (524)
T KOG0601|consen  296 AKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSS--------WSQLRQGY---IPLEF-----CEGGSSSLRSV  358 (524)
T ss_pred             Chhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCC--------cccccccc---Cchhh-----hcCcchhhhhH
Confidence            99988775 5789999999999999888776543110000        11111111   00000     00011133337


Q ss_pred             hccccCCCCCCCCCHHHHHHHh
Q 027675          155 GLLCVQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       155 i~~cl~~~p~~Rps~~~~l~~l  176 (220)
                      +.+|++.+|-.|++...+..+-
T Consensus       359 ~~~~~d~~~~~~~~~q~~~~l~  380 (524)
T KOG0601|consen  359 TSQMLDEDPRLRLTAQILTALN  380 (524)
T ss_pred             HHHhcCcchhhhhHHHHHhccc
Confidence            7779999999999987776543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=98.58  E-value=6.3e-08  Score=73.40  Aligned_cols=47  Identities=32%  Similarity=0.461  Sum_probs=43.1

Q ss_pred             HHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceee
Q 027675            4 LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRI   54 (220)
Q Consensus         4 ~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~   54 (220)
                      +..++.+++.+|.++|+.+   ++|+|++|.||+++ ++.++++|||.+..
T Consensus        97 ~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         97 ELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             HHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            4688999999999999999   99999999999999 78899999998754

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=98.53  E-value=9.4e-08  Score=71.78  Aligned_cols=45  Identities=31%  Similarity=0.537  Sum_probs=41.7

Q ss_pred             HHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceee
Q 027675            6 NIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRI   54 (220)
Q Consensus         6 ~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~   54 (220)
                      .++.+++.+|.+||+.+   ++|+|++|.||+++ ++.++++|||++..
T Consensus        94 ~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        94 ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            68999999999999999   99999999999999 78899999998754

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=98.51  E-value=7.6e-08  Score=83.13  Aligned_cols=47  Identities=28%  Similarity=0.441  Sum_probs=42.9

Q ss_pred             HHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceee
Q 027675            4 LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRI   54 (220)
Q Consensus         4 ~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~   54 (220)
                      ...++.+++++|.+||+.+   ++|||+||.||++ .++.++++|||++..
T Consensus       430 ~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        430 NPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             HHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            4678899999999999999   9999999999999 677899999998764

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.28  E-value=9.9e-07  Score=65.95  Aligned_cols=48  Identities=17%  Similarity=0.140  Sum_probs=41.7

Q ss_pred             HHHHHHHHHHHHHHh-hhCCCCCeEeccCCCCceeeCCCCCceecCccceeee
Q 027675            4 LFNIILGVSRRLLYL-HQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIF   55 (220)
Q Consensus         4 ~~~i~~~l~~~l~~L-H~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~   55 (220)
                      +..++.+++.+|..| |+.|   ++||||++.||++. ++.+.++|||.+...
T Consensus       126 ~~~i~~~i~~~l~~l~H~~g---lVHGDLs~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         126 MKNAYYQVLSMMKQLYKECN---LVHADLSEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence            456789999999998 8888   99999999999997 467999999987643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=98.23  E-value=1.4e-06  Score=61.74  Aligned_cols=51  Identities=27%  Similarity=0.253  Sum_probs=43.4

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCcccee
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR   53 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~   53 (220)
                      ....++.++++++..||......++|+|+++.||++++.+.++++||+.+.
T Consensus        87 ~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~  137 (155)
T cd05120          87 EKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG  137 (155)
T ss_pred             HHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence            456788999999999998522239999999999999998899999999865

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.23  E-value=8.3e-07  Score=74.80  Aligned_cols=147  Identities=20%  Similarity=0.189  Sum_probs=96.0

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCC-CCceecCccceeeecCCCCCcccceeecccCc-cChhhhh
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHE-MNPKISDFGLTRIFEGKQTDGTTNRVVGTYGY-MSPEYAL   80 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y-~aPe~~~   80 (220)
                      .++++..+++.++.++|+..   ++|+|++|+||++..+ +..++.||+......-.....    ......| .++....
T Consensus       367 ~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~~~----~~~~r~~p~~~~~~e  439 (524)
T KOG0601|consen  367 PRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSGVF----HHIDRLYPIAEILLE  439 (524)
T ss_pred             hhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccccceecccc----cccccccccchhhcc
Confidence            46788999999999999999   9999999999999887 667899998765311111111    1112234 3555556


Q ss_pred             cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccC-CCCCcCcHHHHHHHHHHhcccc
Q 027675           81 GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQ-KPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      ......++|+++||.-+.+..++.........-                  ..+... .+...-..   ..+..+...+.
T Consensus       440 ~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~------------------~~i~~~~~p~~~~~~---~~~q~~~kv~~  498 (524)
T KOG0601|consen  440 DYPHLSKADIFSLGLSVDEAITGSPLSESGVQS------------------LTIRSGDTPNLPGLK---LQLQVLLKVMI  498 (524)
T ss_pred             ccccccccccccccccccccccCcccCcccccc------------------eeeecccccCCCchH---Hhhhhhhhhhc
Confidence            667889999999999999999887643211100                  000001 11111111   23444455588


Q ss_pred             CCCCCCCCCHHHHHHHhc
Q 027675          160 QEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l~  177 (220)
                      ..++..||.+.++..+..
T Consensus       499 ~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  499 NPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             CCccccchhhhhhcccch
Confidence            899999999988876543

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.20  E-value=2.6e-06  Score=73.01  Aligned_cols=91  Identities=14%  Similarity=0.248  Sum_probs=66.2

Q ss_pred             HHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcCCCcc
Q 027675            7 IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFFSV   86 (220)
Q Consensus         7 i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~~~~~   86 (220)
                      -++||+.||.|||..+  .++|++|....|+++..|.-+|++|.++.....-...  ......-..|..|+.+....  -
T Consensus       109 Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~--~~~~~~~~s~~~P~~~~~s~--~  182 (690)
T KOG1243|consen  109 GLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP--AKSLYLIESFDDPEEIDPSE--W  182 (690)
T ss_pred             HHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc--cccchhhhcccChhhcCccc--c
Confidence            5789999999998665  3999999999999999999999999988654322210  11111122455665433222  4


Q ss_pred             cCceeehhHHHHHHHhc
Q 027675           87 KSDVFSFGVVVLEIISG  103 (220)
Q Consensus        87 ~~DiwslG~il~~ll~g  103 (220)
                      ..|.|-|||++++++.|
T Consensus       183 s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  183 SIDSWGLGCLIEELFNG  199 (690)
T ss_pred             chhhhhHHHHHHHHhCc
Confidence            57999999999999998

>cd05151 ChoK Choline Kinase (ChoK)

Probab=98.14  E-value=2.7e-06  Score=62.02  Aligned_cols=48  Identities=23%  Similarity=0.268  Sum_probs=40.1

Q ss_pred             HHHHHHHHHHHHHhhhCC--CCCeEeccCCCCceeeCCCCCceecCcccee
Q 027675            5 FNIILGVSRRLLYLHQDS--KLRIIHRDFKTSNILLDHEMNPKISDFGLTR   53 (220)
Q Consensus         5 ~~i~~~l~~~l~~LH~~~--~~~i~H~dlk~~nili~~~~~~~l~d~~~~~   53 (220)
                      ..++.+++++|..||..+  ...++|+|+++.||+++ ++.++++||+.+.
T Consensus        86 ~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          86 PENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             HHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            356789999999999987  12249999999999999 6679999999764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.03  E-value=6.7e-06  Score=62.28  Aligned_cols=49  Identities=27%  Similarity=0.371  Sum_probs=43.5

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCC---CceecCccceee
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEM---NPKISDFGLTRI   54 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~---~~~l~d~~~~~~   54 (220)
                      ....++.++++.+.-||..|   ++|+|+++.|||+..++   .+.++||+.++.
T Consensus       119 ~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  119 QRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             hHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            34678999999999999999   99999999999999887   689999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=97.98  E-value=7.4e-06  Score=64.44  Aligned_cols=47  Identities=21%  Similarity=0.263  Sum_probs=41.5

Q ss_pred             HHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCC-------CCCceecCcccee
Q 027675            4 LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDH-------EMNPKISDFGLTR   53 (220)
Q Consensus         4 ~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~-------~~~~~l~d~~~~~   53 (220)
                      ...++.+++..+.-||..|   ++|+|+++.||+++.       +..+.++||+.+.
T Consensus       140 ~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        140 KRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             HHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            4578899999999999999   999999999999975       4568999999764

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=97.96  E-value=1.1e-05  Score=59.10  Aligned_cols=46  Identities=35%  Similarity=0.480  Sum_probs=40.4

Q ss_pred             HHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceee
Q 027675            5 FNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRI   54 (220)
Q Consensus         5 ~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~   54 (220)
                      ..++..+-.-+.-||..|   |+||||.++||.+...+ +.++|||+...
T Consensus        95 ~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          95 PDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             hHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            357788888899999999   99999999999998875 89999999753

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=97.92  E-value=1.9e-05  Score=66.56  Aligned_cols=49  Identities=20%  Similarity=0.287  Sum_probs=41.5

Q ss_pred             HHHHHHHHH-HHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeec
Q 027675            5 FNIILGVSR-RLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFE   56 (220)
Q Consensus         5 ~~i~~~l~~-~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~   56 (220)
                      .+++..++. .+..+|..|   ++|+|++|.||++..++.++++|||++....
T Consensus       259 ~~ia~~~~~~~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       259 KALAENLARSFLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHHHHHHHHHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            346666666 478899999   9999999999999999999999999987543

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=97.83  E-value=5.1e-05  Score=56.49  Aligned_cols=48  Identities=27%  Similarity=0.401  Sum_probs=36.9

Q ss_pred             hHHHHHHHHHHHHHH-hhhCCCCCeEeccCCCCceeeCCCCCceecCccceee
Q 027675            3 MLFNIILGVSRRLLY-LHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRI   54 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~-LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~   54 (220)
                      ....++.+++..+.. +|..|   ++|||+.+.||+++++ .+.++|||.+..
T Consensus       107 ~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iIDf~qav~  155 (188)
T PF01163_consen  107 EPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYIIDFGQAVD  155 (188)
T ss_dssp             THHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE--GTTEEE
T ss_pred             hHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEEecCccee
Confidence            345678888885555 57998   9999999999999887 899999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=97.76  E-value=4.2e-05  Score=56.14  Aligned_cols=47  Identities=38%  Similarity=0.603  Sum_probs=40.4

Q ss_pred             HHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCC---ceecCccceee
Q 027675            5 FNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMN---PKISDFGLTRI   54 (220)
Q Consensus         5 ~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~---~~l~d~~~~~~   54 (220)
                      ..++..+-+.+.-||.++   |+||||..+||++..++.   +.++|||++..
T Consensus       116 ~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen  116 AELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             HHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            467888899999999999   999999999999966554   48999998753

>PRK09902 hypothetical protein; Provisional

Probab=97.55  E-value=0.00011  Score=55.52  Aligned_cols=47  Identities=15%  Similarity=0.113  Sum_probs=42.2

Q ss_pred             HHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCC--ceecCcccee
Q 027675            4 LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMN--PKISDFGLTR   53 (220)
Q Consensus         4 ~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~--~~l~d~~~~~   53 (220)
                      ...++.++++++.-||..|   +.|+|+.+.||+++.++.  +.++||+-.+
T Consensus       130 k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        130 RQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             HHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            3578999999999999999   999999999999987777  8999998654

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.34  E-value=0.00024  Score=53.87  Aligned_cols=43  Identities=21%  Similarity=0.284  Sum_probs=36.8

Q ss_pred             HHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCcccee
Q 027675            7 IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR   53 (220)
Q Consensus         7 i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~   53 (220)
                      +...+++++.-||+.|   ++|||++|.|++++++ .++++|++...
T Consensus       140 ~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~i~iID~~~k~  182 (229)
T PF06176_consen  140 LAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-GIRIIDTQGKR  182 (229)
T ss_pred             HHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-cEEEEECcccc
Confidence            4467889999999999   9999999999999865 49999997544

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=97.23  E-value=0.00097  Score=56.36  Aligned_cols=82  Identities=20%  Similarity=0.429  Sum_probs=62.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +.+|.++.|+..||.++|+.|   +.-+-|.+.+|+++.+..++++..|.........              .+|  +.+
T Consensus       393 ~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~--------------~~~--le~  453 (655)
T KOG3741|consen  393 EVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP--------------TEP--LES  453 (655)
T ss_pred             HHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCCC--------------Ccc--hhH
Confidence            368999999999999999999   8889999999999998888887776543322111              011  111


Q ss_pred             CCCcccCceeehhHHHHHHHhcCc
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKR  105 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~  105 (220)
                         ..+-|.--||.+++-|.+|..
T Consensus       454 ---~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  454 ---QQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             ---HhhhhHHHHHHHHHHHhhccc
Confidence               346777789999999999864

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.08  E-value=0.00077  Score=50.25  Aligned_cols=55  Identities=16%  Similarity=0.024  Sum_probs=48.3

Q ss_pred             CchHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeee
Q 027675            1 MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIF   55 (220)
Q Consensus         1 ~~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~   55 (220)
                      |+.+.+|+.++++.+.+|+......+.-.|++++|+.+++++.++++|.+.+...
T Consensus        58 w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   58 WEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            5678999999999999999865445999999999999999999999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=96.89  E-value=0.0011  Score=57.20  Aligned_cols=39  Identities=21%  Similarity=0.392  Sum_probs=32.8

Q ss_pred             HHHhhhCCCCCeEeccCCCCceeeCCCC----CceecCccceeeec
Q 027675           15 LLYLHQDSKLRIIHRDFKTSNILLDHEM----NPKISDFGLTRIFE   56 (220)
Q Consensus        15 l~~LH~~~~~~i~H~dlk~~nili~~~~----~~~l~d~~~~~~~~   56 (220)
                      +..+...|   ++|+|+||.||+++.++    .++++|||++....
T Consensus       273 ~~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        273 FTQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             HHHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence            34455677   99999999999999888    89999999987654

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=96.71  E-value=0.0024  Score=49.91  Aligned_cols=46  Identities=17%  Similarity=0.200  Sum_probs=39.5

Q ss_pred             HHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccce
Q 027675            4 LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLT   52 (220)
Q Consensus         4 ~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~   52 (220)
                      .-.++..|++-+..+...|   ++|||++.=||+++.+|.+.++||--+
T Consensus       204 ~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg~~~vIDwPQ~  249 (304)
T COG0478         204 PDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDGDIVVIDWPQA  249 (304)
T ss_pred             HHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCCCEEEEeCccc
Confidence            3456777788888888888   999999999999999999999998644

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=96.00  E-value=0.0091  Score=55.23  Aligned_cols=143  Identities=18%  Similarity=0.180  Sum_probs=88.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCC---ceeeCCCCCceec--CccceeeecCCCCCcccceeecccCccCh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTS---NILLDHEMNPKIS--DFGLTRIFEGKQTDGTTNRVVGTYGYMSP   76 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~---nili~~~~~~~l~--d~~~~~~~~~~~~~~~~~~~~~~~~y~aP   76 (220)
                      ++.+.+..++++|+.++|...   ..|.-+...   +-..+..+.+..+  ||+...........   ........+.++
T Consensus       286 ~~~r~~~~~~~~GL~~~h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~  359 (1351)
T KOG1035|consen  286 ETLRILHQKLLEGLAYLHSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNAD  359 (1351)
T ss_pred             HHHHHHHHHHhhhHHHHHHhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccc
Confidence            456678889999999999986   666666555   3344455555555  77766543322111   111224456677


Q ss_pred             hhhhcCCC--cccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHH
Q 027675           77 EYALGGFF--SVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINV  154 (220)
Q Consensus        77 e~~~~~~~--~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  154 (220)
                      +.......  ....|+|++|.....+..|..+-.......                      .........    .+.+.
T Consensus       360 e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~~~----------------------~~l~~~~~~----~~~d~  413 (1351)
T KOG1035|consen  360 EDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAVPV----------------------SLLDVLSTS----ELLDA  413 (1351)
T ss_pred             cccccccchhhhhhHHHHHHHHHhhhhhcCcccccccchh----------------------hhhccccch----hhhhh
Confidence            76665443  344799999999999988775532111000                      000000000    34566


Q ss_pred             hccccCCCCCCCCCHHHHHHHh
Q 027675          155 GLLCVQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       155 i~~cl~~~p~~Rps~~~~l~~l  176 (220)
                      ...|+..++++|+++.+++.+.
T Consensus       414 ~~~~~~~~~~~Rl~~~~ll~~~  435 (1351)
T KOG1035|consen  414 LPKCLDEDSEERLSALELLTHP  435 (1351)
T ss_pred             hhhhcchhhhhccchhhhhhch
Confidence            7779999999999999999775

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.91  E-value=0.014  Score=47.72  Aligned_cols=85  Identities=20%  Similarity=0.222  Sum_probs=58.5

Q ss_pred             CchHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhh
Q 027675            1 MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         1 ~~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~   80 (220)
                      ++++.+++++-+..+.-+..+.  .+-||++.-.||+|+ .|++.|+||.+++.......       ......--|..+.
T Consensus       320 ~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsRl~~~q~~-------isy~rldhp~lF~  389 (488)
T COG5072         320 SEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSRLSYSQGI-------ISYNRLDHPDLFN  389 (488)
T ss_pred             HHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeeecccCCce-------eeccccCchhhhc
Confidence            3578889999888787777765  589999999999999 99999999999874221111       1111234566666


Q ss_pred             cCCCcccCceeehhHH
Q 027675           81 GGFFSVKSDVFSFGVV   96 (220)
Q Consensus        81 ~~~~~~~~DiwslG~i   96 (220)
                      |.. +.+-+||-+.-.
T Consensus       390 G~d-d~QFeIYrlMr~  404 (488)
T COG5072         390 GVD-DYQFEIYRLMRR  404 (488)
T ss_pred             Ccc-ceeeeHHHHHHH
Confidence            543 556666654443

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=95.91  E-value=0.013  Score=45.44  Aligned_cols=47  Identities=21%  Similarity=0.264  Sum_probs=41.0

Q ss_pred             HHHHHHHHHHHHHHhhh-CCCCCeEeccCCCCceeeCCCCCceecCccceee
Q 027675            4 LFNIILGVSRRLLYLHQ-DSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRI   54 (220)
Q Consensus         4 ~~~i~~~l~~~l~~LH~-~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~   54 (220)
                      ...+..++++.+.-|.. .+   ++|+||+.=|||+. ++.+.++|++-+..
T Consensus       168 ~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~  215 (268)
T COG1718         168 AEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVT  215 (268)
T ss_pred             HHHHHHHHHHHHHHHHHhcC---cccccchhhheEEE-CCeEEEEECccccc
Confidence            55678899999999988 66   99999999999999 77899999997754

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=95.49  E-value=0.01  Score=44.86  Aligned_cols=30  Identities=20%  Similarity=0.420  Sum_probs=25.6

Q ss_pred             CCeEeccCCCCceeeCC--CCCceecCcccee
Q 027675           24 LRIIHRDFKTSNILLDH--EMNPKISDFGLTR   53 (220)
Q Consensus        24 ~~i~H~dlk~~nili~~--~~~~~l~d~~~~~   53 (220)
                      ..++|+|+++.||+++.  ++.+.++||+.+.
T Consensus       174 ~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         174 PGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             cEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence            35999999999999988  5667899998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=95.25  E-value=0.041  Score=44.03  Aligned_cols=31  Identities=26%  Similarity=0.368  Sum_probs=26.5

Q ss_pred             CCCeEeccCCCCceeeCCC----CCceecCcccee
Q 027675           23 KLRIIHRDFKTSNILLDHE----MNPKISDFGLTR   53 (220)
Q Consensus        23 ~~~i~H~dlk~~nili~~~----~~~~l~d~~~~~   53 (220)
                      ...++|+|+.+.||+++++    +.+.++||+.+.
T Consensus       178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            3459999999999999885    789999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=95.12  E-value=0.022  Score=43.75  Aligned_cols=29  Identities=21%  Similarity=0.381  Sum_probs=25.4

Q ss_pred             CeEeccCCCCceeeCC-CCCceecCcccee
Q 027675           25 RIIHRDFKTSNILLDH-EMNPKISDFGLTR   53 (220)
Q Consensus        25 ~i~H~dlk~~nili~~-~~~~~l~d~~~~~   53 (220)
                      .++|+|+.+.||+++. ++.+.++||..+.
T Consensus       171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            4999999999999997 5779999998653

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=94.93  E-value=0.036  Score=43.75  Aligned_cols=47  Identities=21%  Similarity=0.274  Sum_probs=35.7

Q ss_pred             HHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCcccee
Q 027675            6 NIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR   53 (220)
Q Consensus         6 ~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~   53 (220)
                      +.+..+-.++.-++... ..++|+|+.++|++.++.+.++|+||..+.
T Consensus       136 ~~~~~l~~~l~~~~~~~-~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg  182 (269)
T COG0510         136 KKLKELRRALEEVPKDD-LVPCHNDLNPGNLLLTDKGGLFLIDWEYAG  182 (269)
T ss_pred             HHHHHHHHHhhhcCCCc-eeeecCCCCccceEEcCCCcEEEEecccCC
Confidence            34455555555555551 249999999999999999999999998764

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=94.77  E-value=0.04  Score=44.26  Aligned_cols=29  Identities=28%  Similarity=0.443  Sum_probs=25.5

Q ss_pred             CeEeccCCCCceeeCCCCCceecCcccee
Q 027675           25 RIIHRDFKTSNILLDHEMNPKISDFGLTR   53 (220)
Q Consensus        25 ~i~H~dlk~~nili~~~~~~~l~d~~~~~   53 (220)
                      .++|+|+++.|++++.++.+.++||+.+.
T Consensus       188 ~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       188 GVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             ccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            49999999999999988767899998764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=94.55  E-value=0.052  Score=43.54  Aligned_cols=28  Identities=29%  Similarity=0.449  Sum_probs=24.3

Q ss_pred             CeEeccCCCCceeeCCCCCceecCcccee
Q 027675           25 RIIHRDFKTSNILLDHEMNPKISDFGLTR   53 (220)
Q Consensus        25 ~i~H~dlk~~nili~~~~~~~l~d~~~~~   53 (220)
                      .++|||+.+.||+++. +.+.++||+.+.
T Consensus       188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       188 GFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             ceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            3899999999999987 678899998654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=94.47  E-value=0.023  Score=43.17  Aligned_cols=30  Identities=33%  Similarity=0.422  Sum_probs=20.3

Q ss_pred             CCeEeccCCCCceeeC-CCCCceecCcccee
Q 027675           24 LRIIHRDFKTSNILLD-HEMNPKISDFGLTR   53 (220)
Q Consensus        24 ~~i~H~dlk~~nili~-~~~~~~l~d~~~~~   53 (220)
                      ..++|+|+.+.||+++ .++.+.++||+.+.
T Consensus       166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             EEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             cEEEEeccccccceeeeccceeEEEecccce
Confidence            3499999999999999 55556799998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=94.46  E-value=0.053  Score=41.78  Aligned_cols=30  Identities=23%  Similarity=0.343  Sum_probs=24.8

Q ss_pred             CCeEeccCCCCceeeCCCCCceecCcccee
Q 027675           24 LRIIHRDFKTSNILLDHEMNPKISDFGLTR   53 (220)
Q Consensus        24 ~~i~H~dlk~~nili~~~~~~~l~d~~~~~   53 (220)
                      ..++|+|+.+.||++++.+...++||+.+.
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~  193 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLG  193 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence            348999999999999876556799999764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=94.33  E-value=0.033  Score=42.13  Aligned_cols=29  Identities=28%  Similarity=0.491  Sum_probs=20.8

Q ss_pred             CeEeccCCCCceee-CCCCCceecCcccee
Q 027675           25 RIIHRDFKTSNILL-DHEMNPKISDFGLTR   53 (220)
Q Consensus        25 ~i~H~dlk~~nili-~~~~~~~l~d~~~~~   53 (220)
                      .+.|+|+.+.||++ ..++.++++||..+.
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            59999999999999 888999999998764

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=94.30  E-value=0.059  Score=42.93  Aligned_cols=29  Identities=28%  Similarity=0.435  Sum_probs=25.5

Q ss_pred             CeEeccCCCCceeeCCCCCceecCcccee
Q 027675           25 RIIHRDFKTSNILLDHEMNPKISDFGLTR   53 (220)
Q Consensus        25 ~i~H~dlk~~nili~~~~~~~l~d~~~~~   53 (220)
                      .++|+|+.+.|+++++++.+.++||+.+.
T Consensus       176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         176 GVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             cCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            39999999999999987777899998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=94.24  E-value=0.05  Score=41.68  Aligned_cols=39  Identities=23%  Similarity=0.273  Sum_probs=32.6

Q ss_pred             HHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccc
Q 027675           12 SRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGL   51 (220)
Q Consensus        12 ~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~   51 (220)
                      +++|...|+.. ...+|||..|+||+-++.|.+||.|-+.
T Consensus       151 i~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  151 IKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             HHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhh
Confidence            46788888553 3599999999999999999999999654

The function of this family is unknown.

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=94.15  E-value=0.041  Score=42.28  Aligned_cols=29  Identities=21%  Similarity=0.264  Sum_probs=25.4

Q ss_pred             CCeEeccCCCCceeeCCCCCceecCcccee
Q 027675           24 LRIIHRDFKTSNILLDHEMNPKISDFGLTR   53 (220)
Q Consensus        24 ~~i~H~dlk~~nili~~~~~~~l~d~~~~~   53 (220)
                      ..++|+|+.|.||++++.+ +.++||+.+.
T Consensus       153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       153 STCLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            3578999999999999888 9999998764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=93.92  E-value=0.043  Score=42.85  Aligned_cols=28  Identities=18%  Similarity=0.300  Sum_probs=24.7

Q ss_pred             CeEeccCCCCceeeCCCCCceecCcccee
Q 027675           25 RIIHRDFKTSNILLDHEMNPKISDFGLTR   53 (220)
Q Consensus        25 ~i~H~dlk~~nili~~~~~~~l~d~~~~~   53 (220)
                      .++|+|+.+.||++++++ +.++||+.+.
T Consensus       147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       147 APLHMDVHAYNLVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             eeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence            589999999999999877 7899998764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK10271 thiK thiamine kinase; Provisional

Probab=93.75  E-value=0.042  Score=40.81  Aligned_cols=29  Identities=17%  Similarity=0.297  Sum_probs=25.2

Q ss_pred             CCeEeccCCCCceeeCCCCCceecCcccee
Q 027675           24 LRIIHRDFKTSNILLDHEMNPKISDFGLTR   53 (220)
Q Consensus        24 ~~i~H~dlk~~nili~~~~~~~l~d~~~~~   53 (220)
                      ...+|+|+.|.|+++.+++ ++++|++.+.
T Consensus        77 ~~p~H~D~~~~N~~~~~~~-~~lIDwe~a~  105 (188)
T PRK10271         77 LAPLHMDVHAGNLVHSASG-LRLIDWEYAG  105 (188)
T ss_pred             eeeecCCCCCccEEEECCC-EEEEeCCccc
Confidence            3589999999999998877 8899998764

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=93.63  E-value=0.041  Score=42.56  Aligned_cols=30  Identities=27%  Similarity=0.293  Sum_probs=25.8

Q ss_pred             CCeEeccCCCCceeeCCCCCceecCcccee
Q 027675           24 LRIIHRDFKTSNILLDHEMNPKISDFGLTR   53 (220)
Q Consensus        24 ~~i~H~dlk~~nili~~~~~~~l~d~~~~~   53 (220)
                      ..++|+|+.+.||++++.+.+.|+||+.+.
T Consensus       163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            459999999999999987777899998653

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=93.53  E-value=0.12  Score=44.60  Aligned_cols=39  Identities=28%  Similarity=0.425  Sum_probs=32.9

Q ss_pred             HHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeec
Q 027675           15 LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFE   56 (220)
Q Consensus        15 l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~   56 (220)
                      +..+-..|   ++|+|.+|.||++..+|.+.+.|||+.....
T Consensus       278 ~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         278 LRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             HHHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence            34444567   9999999999999999999999999987654

>PRK05231 homoserine kinase; Provisional

Probab=93.47  E-value=0.041  Score=44.41  Aligned_cols=29  Identities=24%  Similarity=0.392  Sum_probs=24.6

Q ss_pred             CeEeccCCCCceeeCCCCCceecCcccee
Q 027675           25 RIIHRDFKTSNILLDHEMNPKISDFGLTR   53 (220)
Q Consensus        25 ~i~H~dlk~~nili~~~~~~~l~d~~~~~   53 (220)
                      .++|+|+.+.||+++.+....++||+.+.
T Consensus       188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        188 GVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             ccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            39999999999999866556899998764

>PLN02236 choline kinase

Probab=92.96  E-value=0.098  Score=42.88  Aligned_cols=29  Identities=24%  Similarity=0.431  Sum_probs=25.3

Q ss_pred             CeEeccCCCCceeeCC-CCCceecCcccee
Q 027675           25 RIIHRDFKTSNILLDH-EMNPKISDFGLTR   53 (220)
Q Consensus        25 ~i~H~dlk~~nili~~-~~~~~l~d~~~~~   53 (220)
                      .++|+|+++.||++++ ++.+.++||+.+.
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            5999999999999976 4679999998764

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=92.53  E-value=0.23  Score=37.16  Aligned_cols=29  Identities=24%  Similarity=0.416  Sum_probs=23.8

Q ss_pred             CeEeccCCCCceeeCCCC-----CceecCcccee
Q 027675           25 RIIHRDFKTSNILLDHEM-----NPKISDFGLTR   53 (220)
Q Consensus        25 ~i~H~dlk~~nili~~~~-----~~~l~d~~~~~   53 (220)
                      .++|||+.+.||++..++     .+.++||..+.
T Consensus       121 vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~  154 (196)
T smart00587      121 VLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH  154 (196)
T ss_pred             EEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence            599999999999997543     47899998664

subfamily of choline kinases

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=92.53  E-value=0.2  Score=40.87  Aligned_cols=29  Identities=31%  Similarity=0.582  Sum_probs=25.3

Q ss_pred             CeEeccCCCCceeeCCCCC-ceecCcccee
Q 027675           25 RIIHRDFKTSNILLDHEMN-PKISDFGLTR   53 (220)
Q Consensus        25 ~i~H~dlk~~nili~~~~~-~~l~d~~~~~   53 (220)
                      .++|+|+.+.||+++.... +.++||+-+.
T Consensus       198 ~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         198 QIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             eeeecCCCccceeEcCCCCeeeEEEccccc
Confidence            3899999999999998875 7899998764

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=92.36  E-value=0.24  Score=40.34  Aligned_cols=46  Identities=20%  Similarity=0.275  Sum_probs=38.2

Q ss_pred             HHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCcccee
Q 027675            5 FNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR   53 (220)
Q Consensus         5 ~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~   53 (220)
                      -.+...+..-+..|-.+|   ++|||++-=||++.+++.+.++||--..
T Consensus       205 ~~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  205 PTLYDDLMGLIVRLANHG---LIHGDFNEFNIMVKDDDKIVVIDFPQMV  250 (465)
T ss_pred             HHHHHHHHHHHHHHHHcC---ceecccchheeEEecCCCEEEeechHhh
Confidence            345556666677888999   9999999999999999999999996543

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=92.30  E-value=0.16  Score=40.90  Aligned_cols=29  Identities=17%  Similarity=0.283  Sum_probs=26.5

Q ss_pred             CeEeccCCCCceeeCCCCCceecCcccee
Q 027675           25 RIIHRDFKTSNILLDHEMNPKISDFGLTR   53 (220)
Q Consensus        25 ~i~H~dlk~~nili~~~~~~~l~d~~~~~   53 (220)
                      .++|+|+.+.|++++.++.+.++||..+.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            49999999999999999899999998765

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=92.03  E-value=0.12  Score=41.72  Aligned_cols=33  Identities=18%  Similarity=0.414  Sum_probs=29.1

Q ss_pred             CCCeEeccCCCCceeeCCCCCceecCccceeee
Q 027675           23 KLRIIHRDFKTSNILLDHEMNPKISDFGLTRIF   55 (220)
Q Consensus        23 ~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~   55 (220)
                      .++++|||+++.|+++++.+.+-++||+++...
T Consensus       197 ~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         197 PPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             CceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence            557999999999999999888999999987643

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=91.93  E-value=0.071  Score=45.73  Aligned_cols=84  Identities=20%  Similarity=0.215  Sum_probs=45.7

Q ss_pred             cccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCCCC
Q 027675           85 SVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPN  164 (220)
Q Consensus        85 ~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~  164 (220)
                      .+++|||++|.++.++.-|...+..-....+.   ....+..-............  ....+....++++...|+...|.
T Consensus       109 ~pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l---~~i~k~~~~d~~~~~~a~e~--~~~~~~d~~~~~~~~~c~~~~~~  183 (725)
T KOG1093|consen  109 GPKSDVWSLGFIILELYLGISLEAELTESEYL---EILLKYYTDDQELLSTAMEH--LIQLLADKKRLPLLKKCLWLEPI  183 (725)
T ss_pred             CcchhhhhHHHHHHHHHHhhHHHHHHHHHHHH---HHHHHhccCchhHHHHHHHH--HHHHhhhHhHHHHhccCCccccc
Confidence            36999999999999999887554321111111   11111111100000000000  12233345678888899999999


Q ss_pred             CCCCHHHHH
Q 027675          165 DRPTMSDVV  173 (220)
Q Consensus       165 ~Rps~~~~l  173 (220)
                      .||...++.
T Consensus       184 ir~l~~~~~  192 (725)
T KOG1093|consen  184 IRPLPMELS  192 (725)
T ss_pred             cccchhHHh
Confidence            988766554

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=91.83  E-value=0.12  Score=40.94  Aligned_cols=31  Identities=19%  Similarity=0.491  Sum_probs=25.3

Q ss_pred             CCeEeccCCCCceeeCCCCC-ceecCccceee
Q 027675           24 LRIIHRDFKTSNILLDHEMN-PKISDFGLTRI   54 (220)
Q Consensus        24 ~~i~H~dlk~~nili~~~~~-~~l~d~~~~~~   54 (220)
                      ..++|+|+++.||++++++. ..++||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            35999999999999997555 46999997653

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=91.48  E-value=0.34  Score=40.55  Aligned_cols=31  Identities=23%  Similarity=0.367  Sum_probs=25.7

Q ss_pred             CCCeEeccCCCCceeeCCCCCceecCccceee
Q 027675           23 KLRIIHRDFKTSNILLDHEMNPKISDFGLTRI   54 (220)
Q Consensus        23 ~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~   54 (220)
                      ...++|||+.+.||++..+ .++++|+.++..
T Consensus       222 ~~~l~HgDl~~gni~~~~~-~~~viD~E~a~~  252 (401)
T PRK09550        222 AEALLHGDLHTGSIFVTEE-ETKVIDPEFAFY  252 (401)
T ss_pred             CCceeeccCCcccEEeeCC-CcEEEecccccc
Confidence            3359999999999999776 589999987653

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=91.36  E-value=0.4  Score=39.09  Aligned_cols=30  Identities=23%  Similarity=0.380  Sum_probs=25.4

Q ss_pred             CCeEeccCCCCceeeCC-CCCceecCcccee
Q 027675           24 LRIIHRDFKTSNILLDH-EMNPKISDFGLTR   53 (220)
Q Consensus        24 ~~i~H~dlk~~nili~~-~~~~~l~d~~~~~   53 (220)
                      ..++|+|+.+.||++.+ ++.++++||+.+.
T Consensus       182 ~v~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        182 VVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             eEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence            35899999999999975 4679999998764

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=90.67  E-value=0.1  Score=50.50  Aligned_cols=95  Identities=12%  Similarity=-0.017  Sum_probs=69.8

Q ss_pred             HHHHHHhhhCC--CCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcCCCcccCc
Q 027675           12 SRRLLYLHQDS--KLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFFSVKSD   89 (220)
Q Consensus        12 ~~~l~~LH~~~--~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~~~~~~~D   89 (220)
                      +....-+|...  +..-+|+++|+-|.+|..+-.+++.++|+.+...+  ....-+...+++.|..+++.....++.++|
T Consensus      1345 vl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsd 1422 (2724)
T KOG1826|consen 1345 VLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSD 1422 (2724)
T ss_pred             HhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHH
Confidence            44444444332  44578999999999999999999999999873221  122223345677888899888888888899


Q ss_pred             eeehhHHHHHHHhcCccCc
Q 027675           90 VFSFGVVVLEIISGKRNTG  108 (220)
Q Consensus        90 iwslG~il~~ll~g~~p~~  108 (220)
                      +|..|+.+|....|..+|-
T Consensus      1423 ilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1423 ILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred             HHHHHHHHHHHhcccHHHH
Confidence            9999999999888877653

>PRK06148 hypothetical protein; Provisional

Probab=90.23  E-value=0.27  Score=46.20  Aligned_cols=30  Identities=33%  Similarity=0.464  Sum_probs=24.7

Q ss_pred             CeEeccCCCCceeeCCCC--Cc-eecCccceee
Q 027675           25 RIIHRDFKTSNILLDHEM--NP-KISDFGLTRI   54 (220)
Q Consensus        25 ~i~H~dlk~~nili~~~~--~~-~l~d~~~~~~   54 (220)
                      .++|+|+++.||+++.++  .+ -|+|||-+..
T Consensus       204 ~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        204 QVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             ceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            399999999999998775  44 5999997653

>PHA03111 Ser/Thr kinase; Provisional

Probab=89.56  E-value=1.1  Score=36.63  Aligned_cols=38  Identities=21%  Similarity=0.228  Sum_probs=23.9

Q ss_pred             HHHHHHHHHHHHHHhhhC-CCCCeEeccCCCCceeeCCC
Q 027675            4 LFNIILGVSRRLLYLHQD-SKLRIIHRDFKTSNILLDHE   41 (220)
Q Consensus         4 ~~~i~~~l~~~l~~LH~~-~~~~i~H~dlk~~nili~~~   41 (220)
                      +..++.|++--.-.+... +-..++|.||||+|||+-++
T Consensus       281 ikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds  319 (444)
T PHA03111        281 IKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDS  319 (444)
T ss_pred             HHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecC
Confidence            345666775544334222 12239999999999999544

>PRK12396 5-methylribose kinase; Reviewed

Probab=88.81  E-value=0.63  Score=38.90  Aligned_cols=31  Identities=19%  Similarity=0.387  Sum_probs=25.8

Q ss_pred             CCCeEeccCCCCceeeCCCCCceecCccceee
Q 027675           23 KLRIIHRDFKTSNILLDHEMNPKISDFGLTRI   54 (220)
Q Consensus        23 ~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~   54 (220)
                      ...++|||+.+.||+++++ ..+++|..++..
T Consensus       226 ~~aLlHGDlHtGSI~v~~~-~~kvIDpEFAfy  256 (409)
T PRK12396        226 AQALIHGDLHTGSVFVKND-STKVIDPEFAFY  256 (409)
T ss_pred             chhhccCcCCCCCEEecCC-ceEEEccccccc
Confidence            3359999999999999986 489999887754

>PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins

Probab=88.79  E-value=0.38  Score=27.15  Aligned_cols=41  Identities=41%  Similarity=0.590  Sum_probs=30.4

Q ss_pred             cccCCCCCCchhhhccCCCCCCCCCCC----CCCCCccccC-CCCC
Q 027675          180 AVNLASPKRPAFVVRRGSSSSASTSNK----PESNNELTHS-LEGR  220 (220)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~-~~~~  220 (220)
                      ...++.|..|.|...+......+++..    .-+.+++|.| ++||
T Consensus         3 ~~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R   48 (48)
T PF11883_consen    3 TATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR   48 (48)
T ss_pred             cccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence            456889999999998776666555444    4588999988 4765

; GO: 0004674 protein serine/threonine kinase activity

>PRK11768 serine/threonine protein kinase; Provisional

Probab=88.70  E-value=0.6  Score=37.94  Aligned_cols=26  Identities=31%  Similarity=0.521  Sum_probs=22.3

Q ss_pred             eEeccCCCCceeeCCCCCceecCcccee
Q 027675           26 IIHRDFKTSNILLDHEMNPKISDFGLTR   53 (220)
Q Consensus        26 i~H~dlk~~nili~~~~~~~l~d~~~~~   53 (220)
                      ++|+|+.+.||++. + .+.++||+.+.
T Consensus       198 liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        198 RLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             ceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            89999999999995 3 57899998764

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=88.39  E-value=0.7  Score=36.76  Aligned_cols=31  Identities=35%  Similarity=0.442  Sum_probs=23.9

Q ss_pred             CCCeEeccCCCCceeeCCC--C---CceecCcccee
Q 027675           23 KLRIIHRDFKTSNILLDHE--M---NPKISDFGLTR   53 (220)
Q Consensus        23 ~~~i~H~dlk~~nili~~~--~---~~~l~d~~~~~   53 (220)
                      ...++|||+..+||++..+  |   .+.++||-+++
T Consensus       214 ~~vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~  249 (294)
T PF02958_consen  214 FNVLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR  249 (294)
T ss_pred             ceEEEcCccCHHhEeEccccccccccceeecccccc
Confidence            3369999999999999654  3   47888886553

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=88.09  E-value=0.88  Score=37.58  Aligned_cols=30  Identities=17%  Similarity=0.315  Sum_probs=24.7

Q ss_pred             CCeEeccCCCCceeeCCCCCceecCccceee
Q 027675           24 LRIIHRDFKTSNILLDHEMNPKISDFGLTRI   54 (220)
Q Consensus        24 ~~i~H~dlk~~nili~~~~~~~l~d~~~~~~   54 (220)
                      ..++|||+.+.||++++++ ++++|+.++..
T Consensus       192 ~~llHGDl~~gNi~~~~~~-~~~iD~e~~~~  221 (370)
T TIGR01767       192 ETLLHGDLHSGSIFVSEHE-TKVIDPEFAFY  221 (370)
T ss_pred             ceeeeccCCcccEEEcCCC-CEEEcCccccc
Confidence            3599999999999997764 77999987653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=87.83  E-value=0.34  Score=42.72  Aligned_cols=90  Identities=23%  Similarity=0.266  Sum_probs=65.9

Q ss_pred             HHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcCCCcc
Q 027675            7 IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFFSV   86 (220)
Q Consensus         7 i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~~~~~   86 (220)
                      +++.-.++++++|+..   -+|+|    ||+... +..+..+|+.........   ..+...+++.+.+||......+..
T Consensus       341 ~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~  409 (829)
T KOG0576|consen  341 PLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDG  409 (829)
T ss_pred             hhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc---ccccCCCCCCCCCchhhccccccc
Confidence            4455567889999875   58888    666554 568888998765443322   223356788999999998888899


Q ss_pred             cCceeehhHHHHHHHhcCccC
Q 027675           87 KSDVFSFGVVVLEIISGKRNT  107 (220)
Q Consensus        87 ~~DiwslG~il~~ll~g~~p~  107 (220)
                      .-|.|+++.-..++.-|.+|.
T Consensus       410 ~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  410 CPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             CCCccCCCcchhhcCCCCCCC
Confidence            999999998777777676664

>PLN02756 S-methyl-5-thioribose kinase

Probab=87.79  E-value=0.97  Score=37.99  Aligned_cols=31  Identities=13%  Similarity=0.313  Sum_probs=25.6

Q ss_pred             CCCeEeccCCCCceeeCCCCCceecCccceee
Q 027675           23 KLRIIHRDFKTSNILLDHEMNPKISDFGLTRI   54 (220)
Q Consensus        23 ~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~   54 (220)
                      ...++|||+.+.||++..++ .+++|..++..
T Consensus       229 ~~~L~HGDl~~g~i~~~~~~-~~~id~ef~~~  259 (418)
T PLN02756        229 AQALVHGDLHTGSVMVTPDS-TQVIDPEFAFY  259 (418)
T ss_pred             ccceeecCCCCCcEEEcCCC-ceEecchhhcc
Confidence            45699999999999999875 88888776643

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=86.30  E-value=1.2  Score=36.50  Aligned_cols=16  Identities=38%  Similarity=0.607  Sum_probs=14.0

Q ss_pred             CeEeccCCCCceeeCC
Q 027675           25 RIIHRDFKTSNILLDH   40 (220)
Q Consensus        25 ~i~H~dlk~~nili~~   40 (220)
                      .++|.||||+|||+-+
T Consensus       299 nF~H~DLKPdNILiFd  314 (434)
T PF05445_consen  299 NFLHVDLKPDNILIFD  314 (434)
T ss_pred             eeeecccCcCcEEEec
Confidence            3999999999999954

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>PRK06149 hypothetical protein; Provisional

Probab=82.64  E-value=1.2  Score=41.85  Aligned_cols=28  Identities=21%  Similarity=0.366  Sum_probs=23.1

Q ss_pred             eEeccCCCCceeeCCCC--C---ceecCcccee
Q 027675           26 IIHRDFKTSNILLDHEM--N---PKISDFGLTR   53 (220)
Q Consensus        26 i~H~dlk~~nili~~~~--~---~~l~d~~~~~   53 (220)
                      ++|+|++..||+++.+.  .   ..++|||.+.
T Consensus       210 ~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~  242 (972)
T PRK06149        210 AVHLDITDDNVVGSRDADGRWQPDGVIDFGDLV  242 (972)
T ss_pred             ccCCCCCcccEEEcCCCCCCcceeEEEEcccch
Confidence            99999999999998653  3   3689999764

>PRK10593 hypothetical protein; Provisional

Probab=80.36  E-value=1.5  Score=35.15  Aligned_cols=28  Identities=18%  Similarity=0.307  Sum_probs=21.9

Q ss_pred             CCCeEeccCCCCceeeCCC-CC-ceecCcc
Q 027675           23 KLRIIHRDFKTSNILLDHE-MN-PKISDFG   50 (220)
Q Consensus        23 ~~~i~H~dlk~~nili~~~-~~-~~l~d~~   50 (220)
                      ..+++|||+.+.||+++.+ +. +.++|..
T Consensus       192 ~psLlHGDlw~gNvl~~~~~~~i~~liDPa  221 (297)
T PRK10593        192 NCVLVHGNFTLRSMLKDPRSDQLLAMLNPG  221 (297)
T ss_pred             CCeeEeCCCCcccEEECCCCCceEEEECch
Confidence            3569999999999999865 43 5677765

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=80.20  E-value=3.2  Score=31.27  Aligned_cols=39  Identities=21%  Similarity=0.299  Sum_probs=27.8

Q ss_pred             HHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCC----CceecC
Q 027675            7 IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEM----NPKISD   48 (220)
Q Consensus         7 i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~----~~~l~d   48 (220)
                      +...+-+-..+|-..+   |+.+|++|.||++....    .+.++|
T Consensus       123 ~~~~L~~f~~~l~~~~---Iv~~dl~~~NIv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  123 LRQALDEFKRYLLDHH---IVIRDLNPHNIVVQRRDSGEFRLVLID  165 (199)
T ss_pred             HHHHHHHHHHHHHHcC---CeecCCCcccEEEEecCCCceEEEEEe
Confidence            3344445567788888   99999999999995433    356666

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	220
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-26
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		8e-26
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		5e-20
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		4e-19
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-18
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-18
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-18
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		7e-18
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-14
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-13
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-13
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		5e-13
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-13
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-13
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-13
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		9e-13
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		9e-13
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		9e-13
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		5e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		8e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		8e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		8e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		8e-12
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-11
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-11
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-11
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-11
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-11
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-11
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-11
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-11
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-11
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-11
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-11
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-11
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-11
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-11
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-11
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-11
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-11
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		4e-11
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		5e-11
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		7e-11
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		8e-11
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		8e-11
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		8e-11
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		8e-11
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		9e-11
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		9e-11
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		9e-11
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		9e-11
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-10
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-10
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-10
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-10
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-10
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-10
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-10
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-10
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-10
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-10
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-10
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-10
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-10
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-10
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-10
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-10
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-10
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-10
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-10
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-10
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-10
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-10
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-10
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-10
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-10
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-10
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-10
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-10
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-10
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-10
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-10
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-10
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-10
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-10
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-10
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-10
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-10
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-10
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-10
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-10
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-10
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-10
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-10
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		4e-10
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		4e-10
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-10
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-10
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-10
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		4e-10
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-10
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-10
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-10
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-10
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		4e-10
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-10
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-10
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-10
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-10
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-10
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		4e-10
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		4e-10
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		5e-10
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-10
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-10
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		6e-10
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		6e-10
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		6e-10
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		6e-10
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		6e-10
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		6e-10
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		6e-10
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		6e-10
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		6e-10
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-10
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		6e-10
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		6e-10
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		6e-10
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-10
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		7e-10
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		8e-10
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		9e-10
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-10
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		9e-10
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		9e-10
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-09
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-09
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-09
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-09
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-09
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-09
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-09
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-09
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-09
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-09
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-09
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-09
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-09
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-09
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-09
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-09
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-09
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-09
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-09
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-09
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-09
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-09
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-09
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-09
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-09
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-09
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-09
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-09
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-09
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-09
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-09
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-09
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-09
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-09
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-09
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-09
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-09
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-09
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-09
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-09
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-09
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-09
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-09
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-09
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-09
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-09
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-09
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		4e-09
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-09
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		5e-09
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		5e-09
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		5e-09
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		5e-09
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-09
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-09
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		5e-09
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		5e-09
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		5e-09
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		5e-09
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		5e-09
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		5e-09
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		5e-09
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		5e-09
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		5e-09
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		6e-09
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		6e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		6e-09
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		6e-09
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-09
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		6e-09
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		6e-09
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		6e-09
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		6e-09
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		6e-09
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		6e-09
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		6e-09
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		6e-09
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		6e-09
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		6e-09
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		6e-09
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		6e-09
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		6e-09
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		6e-09
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		6e-09
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-09
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		6e-09
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		7e-09
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		7e-09
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-09
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		8e-09
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		8e-09
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		9e-09
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		9e-09
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		9e-09
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		9e-09
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-08
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-08
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-08
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-08
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-08
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-08
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-08
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-08
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-08
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-08
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-08
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-08
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-08
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-08
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-08
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-08
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-08
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-08
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-08
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-08
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-08
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-08
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-08
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-08
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-08
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-08
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-08
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-08
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-08
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-08
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-08
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-08
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-08
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-08
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-08
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-08
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-08
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-08
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-08
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-08
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-08
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-08
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-08
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-08
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-08
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-08
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-08
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-08
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-08
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-08
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-08
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-08
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-08
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-08
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-08
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-08
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-08
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-08
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-08
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-08
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-08
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-08
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-08
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-08
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-08
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-08
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-08
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-08
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-08
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-08
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-08
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-08
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-08
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		4e-08
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-08
3g51_A	325	Structural Diversity Of The Active Conformation Of		4e-08
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-08
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-08
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-08
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-08
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		4e-08
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-08
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		4e-08
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-08
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-08
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-08
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-08
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-08
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-08
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		4e-08
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-08
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-08
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-08
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		4e-08
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-08
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		5e-08
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-08
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-08
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		5e-08
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		5e-08
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		5e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		5e-08
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-08
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-08
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		6e-08
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-08
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-08
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-08
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-08
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-08
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		7e-08
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-08
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-08
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		7e-08
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		7e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		7e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		7e-08
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-08
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		7e-08
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		7e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		7e-08
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		7e-08
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		7e-08
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-08
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		7e-08
3b2t_A	311	Structure Of Phosphotransferase Length = 311		7e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		7e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		7e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		7e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		7e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		7e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		7e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		7e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		7e-08
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		7e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		7e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		7e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		8e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		8e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		8e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		8e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		8e-08
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		8e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		8e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		8e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		8e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		8e-08
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		8e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		8e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		8e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		8e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		8e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		8e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		8e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		8e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		8e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		8e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		8e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		8e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		8e-08
1fvr_A	327	Tie2 Kinase Domain Length = 327		8e-08
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		8e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		9e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		9e-08
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		9e-08
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		9e-08
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		9e-08
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		9e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		9e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-07
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-07
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-07
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-07
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-07
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-07
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-07
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-07
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-07
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-07
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-07
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-07
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-07
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-07
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-07
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-07
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-07
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-07
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-07
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-07
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-07
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-07
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-07
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-07
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-07
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-07
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-07
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-07
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-07
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-07
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-07
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-07
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-07
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-07
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-07
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-07
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-07
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-07
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-07
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-07
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-07
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-07
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-07
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-07
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-07
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-07
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-07
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-07
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-07
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-07
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-07
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-07
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-07
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-07
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-07
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-07
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-07
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-07
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-07
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-07
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-07
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-07
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-07
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-07
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-07
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-07
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-07
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-07
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-07
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-07
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-07
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-07
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-07
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-07
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-07
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-07
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-07
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-07
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-07
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-07
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-07
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-07
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-07
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-07
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-07
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-07
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-07
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-07
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-07
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-07
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-07
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-07
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-07
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-07
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-07
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-07
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-07
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-07
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-07
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-07
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-07
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-07
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-07
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-07
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-07
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-07
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-07
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-07
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-07
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-07
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-07
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-07
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-07
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-07
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-07
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-07
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-07
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-07
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-07
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-07
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-07
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-07
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-07
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-07
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-07
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-07
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-07
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-07
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-07
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-07
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-07
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-07
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-07
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-07
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-07
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		4e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		4e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-07
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-07
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-07
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-07
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-07
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-07
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		4e-07
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		4e-07
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		4e-07
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-07
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-07
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-07
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-07
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-07
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-07
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-07
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-07
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		4e-07
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-07
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-07
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		4e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-07
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-07
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		4e-07
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		4e-07
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		5e-07
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		5e-07
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		5e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		5e-07
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		5e-07
4ae6_A	343	Structure And Function Of The Human Sperm-specific		5e-07
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-07
4ae9_A	343	Structure And Function Of The Human Sperm-specific		5e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		5e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-07
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		5e-07
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-07
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-07
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		5e-07
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		5e-07
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		5e-07
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		5e-07
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		5e-07
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		5e-07
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		5e-07
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-07
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		5e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		5e-07
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		5e-07
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		6e-07
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		6e-07
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		6e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		6e-07
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		6e-07
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		6e-07
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		6e-07
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		6e-07
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		6e-07
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-07
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		6e-07
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-07
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		6e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		7e-07
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		7e-07
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		7e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		7e-07
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		7e-07
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		7e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		7e-07
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		7e-07
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		7e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		8e-07
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		8e-07
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		8e-07
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		8e-07
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		8e-07
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		8e-07
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		8e-07
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		8e-07
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		8e-07
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		8e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-07
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		9e-07
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		9e-07
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		9e-07
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		9e-07
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-06
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-06
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-06
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-06
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-06
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-06
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-06
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-06
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-06
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-06
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-06
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-06
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-06
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-06
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-06
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-06
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-06
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-06
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-06
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-06
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-06
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-06
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-06
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-06
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-06
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-06
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-06
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-06
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-06
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-06
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-06
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-06
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-06
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-06
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-06
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-06
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-06
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-06
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-06
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-06
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-06
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-06
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-06
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-06
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-06
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-06
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-06
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-06
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-06
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-06
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-06
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-06
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-06
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-06
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-06
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-06
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-06
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-06
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-06
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-06
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-06
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-06
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-06
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-06
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-06
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-06
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-06
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-06
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-06
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-06
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-06
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-06
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-06
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-06
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-06
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-06
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-06
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-06
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-06
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-06
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-06
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-06
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-06
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-06
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-06
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-06
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-06
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-06
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-06
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-06
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		4e-06
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		4e-06
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		4e-06
4fl2_A	636	Structural And Biophysical Characterization Of The		4e-06
4fl3_A	635	Structural And Biophysical Characterization Of The		5e-06
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		5e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		5e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		5e-06
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		5e-06
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		5e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		5e-06
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		5e-06
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-06
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		6e-06
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-06
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		6e-06
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		6e-06
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		6e-06
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		6e-06
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		6e-06
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		6e-06
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		6e-06
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-06
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		6e-06
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-06
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		9e-06
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		9e-06
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-05
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-05
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-05
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-05
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-05
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-05
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-05
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-05
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-05
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-05
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-05
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-05
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-05
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		3e-05
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-05
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-05
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-05
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-05
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-05
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-05
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-05
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		4e-05
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-05
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		4e-05
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		4e-05
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-05
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		5e-05
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		5e-05
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		5e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		5e-05
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-05
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		5e-05
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		5e-05
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		5e-05
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		6e-05
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		6e-05
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-05
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		6e-05
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		6e-05
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		6e-05
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		6e-05
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		6e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-05
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-05
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		6e-05
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		6e-05
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-05
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-05
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-05
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		7e-05
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		7e-05
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		7e-05
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		7e-05
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		8e-05
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		8e-05
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-05
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		8e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		8e-05
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		8e-05
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		9e-05
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-04
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-04
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		1e-04
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		1e-04
3soa_A	444	Full-Length Human Camkii Length = 444		1e-04
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-04
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-04
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-04
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-04
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-04
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-04
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-04
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		3e-04
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-04
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		4e-04
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		4e-04
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-04
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-04
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		4e-04
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		4e-04
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		5e-04
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		5e-04
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		5e-04
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		5e-04
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		5e-04
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		5e-04
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		5e-04
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		6e-04
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		6e-04
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		7e-04
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		7e-04
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		7e-04
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		8e-04
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		8e-04
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		8e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  115 bits (288), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 71/174 (40%), Positives = 98/174 (56%), Gaps = 7/174 (4%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           I LG +R L YLH     +IIHRD K +NILLD E    + DFGL ++ + K        
Sbjct: 144 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXH-VXXA 202
Query: 67  VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELA----LSLLGYA 122
           V GT G+++PEY   G  S K+DVF +GV++LE+I+G+R   F  + LA    + LL + 
Sbjct: 203 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR--AFDLARLANDDDVMLLDWV 260
Query: 123 WKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
             L +E K   ++D       K  E+ + I V LLC Q  P +RP MS+VV ML
Sbjct: 261 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 314

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  113 bits (283), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 70/174 (40%), Positives = 97/174 (55%), Gaps = 7/174 (4%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           I LG +R L YLH     +IIHRD K +NILLD E    + DFGL ++ + K        
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXH-VXXA 194
Query: 67  VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELA----LSLLGYA 122
           V G  G+++PEY   G  S K+DVF +GV++LE+I+G+R   F  + LA    + LL + 
Sbjct: 195 VRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR--AFDLARLANDDDVMLLDWV 252
Query: 123 WKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
             L +E K   ++D       K  E+ + I V LLC Q  P +RP MS+VV ML
Sbjct: 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 94.0 bits (232), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 60/177 (33%), Positives = 92/177 (51%), Gaps = 7/177 (3%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           E    I +G +R L YLH  +   IIHRD K+ NILLD    PKI+DFG+++  +G + D
Sbjct: 139 EQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK--KGTELD 193
Query: 62  GT--TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLL 119
            T     V GT GY+ PEY + G  + KSDV+SFGVV+ E++  +           ++L 
Sbjct: 194 QTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA 253
Query: 120 GYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
            +A +    G+   ++D       +   + K  +  + C+     DRP+M DV+  L
Sbjct: 254 EWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 91.3 bits (225), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 59/177 (33%), Positives = 91/177 (51%), Gaps = 7/177 (3%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           E    I +G +R L YLH  +   IIHRD K+ NILLD    PKI+DFG+++  +G +  
Sbjct: 139 EQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK--KGTELG 193
Query: 62  GT--TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLL 119
            T     V GT GY+ PEY + G  + KSDV+SFGVV+ E++  +           ++L 
Sbjct: 194 QTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA 253
Query: 120 GYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
            +A +    G+   ++D       +   + K  +  + C+     DRP+M DV+  L
Sbjct: 254 EWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 89.4 bits (220), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/174 (36%), Positives = 89/174 (51%), Gaps = 6/174 (3%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           M   I  G +  + +LH++     IHRD K++NILLD     KISDFGL R  E      
Sbjct: 134 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 63  TTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA 122
             +R+VGT  YM+PE AL G  + KSD++SFGVV+LEII+G      +  E  L L    
Sbjct: 191 MXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR-EPQLLLDIKE 248
Query: 123 WKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
               +E    D +D+K    + +  +    +V   C+ E  N RP +  V  +L
Sbjct: 249 EIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 89.0 bits (219), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/174 (36%), Positives = 88/174 (50%), Gaps = 6/174 (3%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           M   I  G +  + +LH++     IHRD K++NILLD     KISDFGL R  E      
Sbjct: 134 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 63  TTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA 122
              R+VGT  YM+PE AL G  + KSD++SFGVV+LEII+G      +  E  L L    
Sbjct: 191 MXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR-EPQLLLDIKE 248
Query: 123 WKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
               +E    D +D+K    + +  +    +V   C+ E  N RP +  V  +L
Sbjct: 249 EIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/174 (36%), Positives = 88/174 (50%), Gaps = 6/174 (3%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           M   I  G +  + +LH++     IHRD K++NILLD     KISDFGL R  E      
Sbjct: 128 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 184
Query: 63  TTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA 122
              R+VGT  YM+PE AL G  + KSD++SFGVV+LEII+G      +  E  L L    
Sbjct: 185 MXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR-EPQLLLDIKE 242
Query: 123 WKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
               +E    D +D+K    + +  +    +V   C+ E  N RP +  V  +L
Sbjct: 243 EIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 295

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 87.0 bits (214), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 61/170 (35%), Positives = 87/170 (51%), Gaps = 6/170 (3%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           I  G +  + +LH++     IHRD K++NILLD     KISDFGL R  E        +R
Sbjct: 129 IAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSR 185
Query: 67  VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLW 126
           +VGT  Y +PE AL G  + KSD++SFGVV+LEII+G      +  E  L L        
Sbjct: 186 IVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR-EPQLLLDIKEEIED 243
Query: 127 QEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
           +E    D +D+K    + +  +    +V   C+ E  N RP +  V  +L
Sbjct: 244 EEKTIEDYIDKKXND-ADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLL 292

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 90/180 (50%), Gaps = 27/180 (15%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP--------KISDFGLTR 53
           ++L N  + ++R + YLH ++ + IIHRD K+SNIL+  ++          KI+DFGL R
Sbjct: 105 DILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164
Query: 54  IFEGKQTDGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSE 113
             E  +T  T     G Y +M+PE      FS  SDV+S+GV++ E+++G+    F    
Sbjct: 165 --EWHRT--TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE--VPFR--- 215
Query: 114 LALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
             +  L  A+ +     AL +    P   +K  E          C   DP+ RP+ ++++
Sbjct: 216 -GIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMED---------CWNPDPHSRPSFTNIL 265

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/121 (36%), Positives = 70/121 (57%), Gaps = 7/121 (5%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           ++L  + + V + L YL +  K +I+HRD K SNIL++     K+ DFG++    G+  D
Sbjct: 123 QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLID 176
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELAL-SLLG 120
              N  VGT  YMSPE   G  +SV+SD++S G+ ++E+  G+   G  +  +A+  LL 
Sbjct: 177 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLD 236
Query: 121 Y 121
           Y
Sbjct: 237 Y 237

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 40/103 (38%), Positives = 62/103 (60%), Gaps = 6/103 (5%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           E+L  + + V R L YL +  K +I+HRD K SNIL++     K+ DFG++    G+  D
Sbjct: 114 EILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLID 167
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
              N  VGT  YM+PE   G  +SV+SD++S G+ ++E+  G+
Sbjct: 168 SMANSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGR 210

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 39/103 (37%), Positives = 62/103 (60%), Gaps = 6/103 (5%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           ++L  + + V + L YL +  K +I+HRD K SNIL++     K+ DFG++    G+  D
Sbjct: 166 QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLID 219
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
              N  VGT  YMSPE   G  +SV+SD++S G+ ++E+  G+
Sbjct: 220 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 39/103 (37%), Positives = 62/103 (60%), Gaps = 6/103 (5%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           ++L  + + V + L YL +  K +I+HRD K SNIL++     K+ DFG++    G+  D
Sbjct: 131 QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLID 184
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
              N  VGT  YMSPE   G  +SV+SD++S G+ ++E+  G+
Sbjct: 185 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 70.1 bits (170), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 39/103 (37%), Positives = 62/103 (60%), Gaps = 6/103 (5%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           ++L  + + V + L YL +  K +I+HRD K SNIL++     K+ DFG++    G+  D
Sbjct: 104 QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLID 157
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
              N  VGT  YMSPE   G  +SV+SD++S G+ ++E+  G+
Sbjct: 158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 70.1 bits (170), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 39/103 (37%), Positives = 62/103 (60%), Gaps = 6/103 (5%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           ++L  + + V + L YL +  K +I+HRD K SNIL++     K+ DFG++    G+  D
Sbjct: 104 QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLID 157
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
              N  VGT  YMSPE   G  +SV+SD++S G+ ++E+  G+
Sbjct: 158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 70.1 bits (170), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 39/103 (37%), Positives = 62/103 (60%), Gaps = 6/103 (5%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           ++L  + + V + L YL +  K +I+HRD K SNIL++     K+ DFG++    G+  D
Sbjct: 104 QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLID 157
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
              N  VGT  YMSPE   G  +SV+SD++S G+ ++E+  G+
Sbjct: 158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 70.1 bits (170), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 39/103 (37%), Positives = 62/103 (60%), Gaps = 6/103 (5%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           ++L  + + V + L YL +  K +I+HRD K SNIL++     K+ DFG++    G+  D
Sbjct: 104 QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLID 157
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
              N  VGT  YMSPE   G  +SV+SD++S G+ ++E+  G+
Sbjct: 158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 70.1 bits (170), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 39/103 (37%), Positives = 62/103 (60%), Gaps = 6/103 (5%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           ++L  + + V + L YL +  K +I+HRD K SNIL++     K+ DFG++    G+  D
Sbjct: 104 QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLID 157
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
              N  VGT  YMSPE   G  +SV+SD++S G+ ++E+  G+
Sbjct: 158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 39/103 (37%), Positives = 62/103 (60%), Gaps = 6/103 (5%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           ++L  + + V + L YL +  K +I+HRD K SNIL++     K+ DFG++    G+  D
Sbjct: 107 QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLID 160
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
              N  VGT  YMSPE   G  +SV+SD++S G+ ++E+  G+
Sbjct: 161 EMANEFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 56/101 (55%), Gaps = 4/101 (3%)
Query: 5   FNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQTDGT 63
             +I    + L + HQ+    IIHRD K +NIL+      K+ DFG+ R I +   +   
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQ 175
Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           T  V+GT  Y+SPE A G     +SDV+S G V+ E+++G+
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 56/101 (55%), Gaps = 4/101 (3%)
Query: 5   FNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQTDGT 63
             +I    + L + HQ+    IIHRD K +NI++      K+ DFG+ R I +   +   
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 175
Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           T  V+GT  Y+SPE A G     +SDV+S G V+ E+++G+
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 56/101 (55%), Gaps = 4/101 (3%)
Query: 5   FNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQTDGT 63
             +I    + L + HQ+    IIHRD K +NI++      K+ DFG+ R I +   +   
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 175
Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           T  V+GT  Y+SPE A G     +SDV+S G V+ E+++G+
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 56/101 (55%), Gaps = 4/101 (3%)
Query: 5   FNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQTDGT 63
             +I    + L + HQ+    IIHRD K +NI++      K+ DFG+ R I +   +   
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 175
Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           T  V+GT  Y+SPE A G     +SDV+S G V+ E+++G+
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 56/101 (55%), Gaps = 4/101 (3%)
Query: 5   FNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQTDGT 63
             +I    + L + HQ+    IIHRD K +NI++      K+ DFG+ R I +   +   
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 175
Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           T  V+GT  Y+SPE A G     +SDV+S G V+ E+++G+
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 74/146 (50%), Gaps = 24/146 (16%)
Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTY--GYMSPEYALGGFF 84
           IHRD + +NIL+   ++ KI+DFGL R+ E  +    T R    +   + +PE    G F
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDAE---XTAREGAKFPIKWTAPEAINYGTF 187
Query: 85  SVKSDVFSFGVVVLEIISGKR--NTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           ++KSDV+SFG+++ EI++  R    G  N E+  +L        + G  +   D  P   
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL--------ERGYRMVRPDNCP--- 236
Query: 143 SKANEILKCINVGLLCVQEDPNDRPT 168
               E+ + +    LC +E P DRPT
Sbjct: 237 ---EELYQLMR---LCWKERPEDRPT 256

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 56/101 (55%), Gaps = 4/101 (3%)
Query: 5   FNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQTDGT 63
             +I    + L + HQ+    IIHRD K +NI++      K+ DFG+ R I +   +   
Sbjct: 136 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 192
Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           T  V+GT  Y+SPE A G     +SDV+S G V+ E+++G+
Sbjct: 193 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 233

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 74/146 (50%), Gaps = 24/146 (16%)
Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTY--GYMSPEYALGGFF 84
           IHRD + +NIL+   ++ KI+DFGL R+ E  +    T R    +   + +PE    G F
Sbjct: 132 IHRDLRAANILVSDTLSCKIADFGLARLIEDNE---XTAREGAKFPIKWTAPEAINYGTF 188
Query: 85  SVKSDVFSFGVVVLEIISGKR--NTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           ++KSDV+SFG+++ EI++  R    G  N E+  +L        + G  +   D  P   
Sbjct: 189 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL--------ERGYRMVRPDNCP--- 237
Query: 143 SKANEILKCINVGLLCVQEDPNDRPT 168
               E+ + +    LC +E P DRPT
Sbjct: 238 ---EELYQLMR---LCWKERPEDRPT 257

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 74/146 (50%), Gaps = 24/146 (16%)
Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTY--GYMSPEYALGGFF 84
           IHRD + +NIL+   ++ KI+DFGL R+ E  +    T R    +   + +PE    G F
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNE---XTAREGAKFPIKWTAPEAINYGTF 187
Query: 85  SVKSDVFSFGVVVLEIISGKR--NTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           ++KSDV+SFG+++ EI++  R    G  N E+  +L        + G  +   D  P   
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL--------ERGYRMVRPDNCP--- 236
Query: 143 SKANEILKCINVGLLCVQEDPNDRPT 168
               E+ + +    LC +E P DRPT
Sbjct: 237 ---EELYQLMR---LCWKERPEDRPT 256

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 74/146 (50%), Gaps = 24/146 (16%)
Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTY--GYMSPEYALGGFF 84
           IHRD + +NIL+   ++ KI+DFGL R+ E  +    T R    +   + +PE    G F
Sbjct: 133 IHRDLRAANILVSDTLSCKIADFGLARLIEDNE---XTAREGAKFPIKWTAPEAINYGTF 189
Query: 85  SVKSDVFSFGVVVLEIISGKR--NTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           ++KSDV+SFG+++ EI++  R    G  N E+  +L        + G  +   D  P   
Sbjct: 190 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL--------ERGYRMVRPDNCP--- 238
Query: 143 SKANEILKCINVGLLCVQEDPNDRPT 168
               E+ + +    LC +E P DRPT
Sbjct: 239 ---EELYQLMR---LCWKERPEDRPT 258

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 74/147 (50%), Gaps = 24/147 (16%)
Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTY--GYMSPEYALGGFF 84
           IHRD + +NIL+   ++ KI+DFGL R+ E  +    T R    +   + +PE    G F
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNE---XTAREGAKFPIKWTAPEAINYGTF 187
Query: 85  SVKSDVFSFGVVVLEIISGKR--NTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           ++KSDV+SFG+++ EI++  R    G  N E+  +L        + G  +   D  P   
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL--------ERGYRMVRPDNCP--- 236
Query: 143 SKANEILKCINVGLLCVQEDPNDRPTM 169
               E+ + +    LC +E P DRPT 
Sbjct: 237 ---EELYQLMR---LCWKERPEDRPTF 257

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 74/146 (50%), Gaps = 24/146 (16%)
Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTY--GYMSPEYALGGFF 84
           IHRD + +NIL+   ++ KI+DFGL R+ E  +    T R    +   + +PE    G F
Sbjct: 140 IHRDLRAANILVSDTLSCKIADFGLARLIEDNE---XTAREGAKFPIKWTAPEAINYGTF 196
Query: 85  SVKSDVFSFGVVVLEIISGKR--NTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           ++KSDV+SFG+++ EI++  R    G  N E+  +L        + G  +   D  P   
Sbjct: 197 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL--------ERGYRMVRPDNCP--- 245
Query: 143 SKANEILKCINVGLLCVQEDPNDRPT 168
               E+ + +    LC +E P DRPT
Sbjct: 246 ---EELYQLMR---LCWKERPEDRPT 265

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 74/146 (50%), Gaps = 24/146 (16%)
Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTY--GYMSPEYALGGFF 84
           IHRD + +NIL+   ++ KI+DFGL R+ E  +    T R    +   + +PE    G F
Sbjct: 137 IHRDLRAANILVSDTLSCKIADFGLARLIEDNE---XTAREGAKFPIKWTAPEAINYGTF 193
Query: 85  SVKSDVFSFGVVVLEIISGKR--NTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           ++KSDV+SFG+++ EI++  R    G  N E+  +L        + G  +   D  P   
Sbjct: 194 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL--------ERGYRMVRPDNCP--- 242
Query: 143 SKANEILKCINVGLLCVQEDPNDRPT 168
               E+ + +    LC +E P DRPT
Sbjct: 243 ---EELYQLMR---LCWKERPEDRPT 262

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 62/112 (55%), Gaps = 13/112 (11%)
Query: 4   LFNIILGVSRRLLYLHQD--------SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIF 55
           L ++   +SR L YLH+D         K  I HRDFK+ N+LL  ++   ++DFGL   F
Sbjct: 114 LCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRF 173
Query: 56  EGKQTDGTTNRVVGTYGYMSPEYALGGF-FS----VKSDVFSFGVVVLEIIS 102
           E  +  G T+  VGT  YM+PE   G   F     ++ D+++ G+V+ E++S
Sbjct: 174 EPGKPPGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 74/147 (50%), Gaps = 24/147 (16%)
Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTY--GYMSPEYALGGFF 84
           IHRD + +NIL+   ++ KI+DFGL R+ E  +    T R    +   + +PE    G F
Sbjct: 139 IHRDLRAANILVSDTLSCKIADFGLARLIEDNE---XTAREGAKFPIKWTAPEAINYGTF 195
Query: 85  SVKSDVFSFGVVVLEIISGKR--NTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           ++KSDV+SFG+++ EI++  R    G  N E+  +L        + G  +   D  P   
Sbjct: 196 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL--------ERGYRMVRPDNCP--- 244
Query: 143 SKANEILKCINVGLLCVQEDPNDRPTM 169
               E+ + +    LC +E P DRPT 
Sbjct: 245 ---EELYQLMR---LCWKERPEDRPTF 265

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 74/147 (50%), Gaps = 24/147 (16%)
Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTY--GYMSPEYALGGFF 84
           IHRD + +NIL+   ++ KI+DFGL R+ E  +    T R    +   + +PE    G F
Sbjct: 136 IHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTF 192
Query: 85  SVKSDVFSFGVVVLEIISGKR--NTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           ++KSDV+SFG+++ EI++  R    G  N E+  +L        + G  +   D  P   
Sbjct: 193 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL--------ERGYRMVRPDNCP--- 241
Query: 143 SKANEILKCINVGLLCVQEDPNDRPTM 169
               E+ + +    LC +E P DRPT 
Sbjct: 242 ---EELYQLMR---LCWKERPEDRPTF 262

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 74/146 (50%), Gaps = 24/146 (16%)
Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTY--GYMSPEYALGGFF 84
           IHRD + +NIL+   ++ KI+DFGL R+ E  +    T R    +   + +PE    G F
Sbjct: 137 IHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTF 193
Query: 85  SVKSDVFSFGVVVLEIISGKR--NTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           ++KSDV+SFG+++ EI++  R    G  N E+  +L        + G  +   D  P   
Sbjct: 194 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL--------ERGYRMVRPDNCP--- 242
Query: 143 SKANEILKCINVGLLCVQEDPNDRPT 168
               E+ + +    LC +E P DRPT
Sbjct: 243 ---EELYQLMR---LCWKERPEDRPT 262

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 74/147 (50%), Gaps = 24/147 (16%)
Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTY--GYMSPEYALGGFF 84
           IHRD + +NIL+   ++ KI+DFGL R+ E  +    T R    +   + +PE    G F
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTF 187
Query: 85  SVKSDVFSFGVVVLEIISGKR--NTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           ++KSDV+SFG+++ EI++  R    G  N E+  +L        + G  +   D  P   
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL--------ERGYRMVRPDNCP--- 236
Query: 143 SKANEILKCINVGLLCVQEDPNDRPTM 169
               E+ + +    LC +E P DRPT 
Sbjct: 237 ---EELYQLMR---LCWKERPEDRPTF 257

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 74/146 (50%), Gaps = 24/146 (16%)
Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTY--GYMSPEYALGGFF 84
           IHRD + +NIL+   ++ KI+DFGL R+ E  +    T R    +   + +PE    G F
Sbjct: 141 IHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTF 197
Query: 85  SVKSDVFSFGVVVLEIISGKR--NTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           ++KSDV+SFG+++ EI++  R    G  N E+  +L        + G  +   D  P   
Sbjct: 198 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL--------ERGYRMVRPDNCP--- 246
Query: 143 SKANEILKCINVGLLCVQEDPNDRPT 168
               E+ + +    LC +E P DRPT
Sbjct: 247 ---EELYQLMR---LCWKERPEDRPT 266

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 74/146 (50%), Gaps = 24/146 (16%)
Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTY--GYMSPEYALGGFF 84
           IHRD + +NIL+   ++ KI+DFGL R+ E  +    T R    +   + +PE    G F
Sbjct: 126 IHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTF 182
Query: 85  SVKSDVFSFGVVVLEIISGKR--NTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           ++KSDV+SFG+++ EI++  R    G  N E+  +L        + G  +   D  P   
Sbjct: 183 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL--------ERGYRMVRPDNCP--- 231
Query: 143 SKANEILKCINVGLLCVQEDPNDRPT 168
               E+ + +    LC +E P DRPT
Sbjct: 232 ---EELYQLMR---LCWKERPEDRPT 251

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 70/154 (45%), Gaps = 19/154 (12%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFF 84
           + +HRD    N ++ H+   KI DFG+TR            + +    +M+PE    G F
Sbjct: 150 KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVF 209
Query: 85  SVKSDVFSFGVVVLEIISGKRN--TGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           +  SD++SFGVV+ EI S       G  N ++         K   +G  LD  D  P  +
Sbjct: 210 TTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL--------KFVMDGGYLDQPDNCPERV 261
Query: 143 SKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
           +         ++  +C Q +PN RPT  ++V +L
Sbjct: 262 T---------DLMRMCWQFNPNMRPTFLEIVNLL 286

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 55/95 (57%), Gaps = 4/95 (4%)
Query: 24  LRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGF 83
           +RI+HRD K  NIL+D     KI DFG+ +    + +   TN V+GT  Y SPE A G  
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNHVLGTVQYFSPEQAKGEA 188
Query: 84  FSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSL 118
               +D++S G+V+ E++ G+     +N E A+S+
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPP---FNGETAVSI 220

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 40/111 (36%), Positives = 61/111 (54%), Gaps = 12/111 (10%)
Query: 4   LFNIILGVSRRLLYLHQD-------SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFE 56
           L +I   ++R L YLH+D        K  I HRD K+ N+LL + +   I+DFGL   FE
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182
Query: 57  GKQTDGTTNRVVGTYGYMSPEYALGGF-FS----VKSDVFSFGVVVLEIIS 102
             ++ G T+  VGT  YM+PE   G   F     ++ D+++ G+V+ E+ S
Sbjct: 183 AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 80/151 (52%), Gaps = 24/151 (15%)
Query: 22  SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTY--GYMSPEYA 79
            ++  IHRD +++NIL+ + +  KI+DFGL R+ E  +    T R    +   + +PE A
Sbjct: 122 ERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNE---XTARQGAKFPIKWTAPEAA 178
Query: 80  LGGFFSVKSDVFSFGVVVLEIISGKR--NTGFYNSELALSLLGYAWKLWQEGKALDMMDQ 137
           L G F++KSDV+SFG+++ E+++  R    G  N E+          L Q  +   M   
Sbjct: 179 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREV----------LEQVERGYRMPCP 228
Query: 138 KPGAISKANEILKCINVGLLCVQEDPNDRPT 168
           +   IS  +E++      + C ++DP +RPT
Sbjct: 229 QDCPIS-LHELM------IHCWKKDPEERPT 252

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 90/201 (44%), Gaps = 41/201 (20%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           E+L  I L   + L +L ++  L+IIHRD K SNILLD   N K+ DFG++    G+  D
Sbjct: 125 EILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGIS----GQLVD 178
Query: 62  G-TTNRVVGTYGYMSPEY----ALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELAL 116
                R  G   YM+PE     A    + V+SDV+S G+ + E+ +G+     +NS    
Sbjct: 179 SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS---- 234
Query: 117 SLLGYAWKLWQEGKALDMMDQ----KPGAISKANE---ILKCINVGLLCVQEDPNDRPTM 169
                           D + Q     P  +S + E       IN   LC+ +D + RP  
Sbjct: 235 --------------VFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKY 280
Query: 170 SDV-----VIMLGSEAVNLAS 185
            ++     ++M    AV +A 
Sbjct: 281 KELLKHPFILMYEERAVEVAC 301

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 75/151 (49%), Gaps = 24/151 (15%)
Query: 22  SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTY--GYMSPEYA 79
            ++  +HRD + +NIL+   +  K++DFGL R+ E  +    T R    +   + +PE A
Sbjct: 131 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---XTARQGAKFPIKWTAPEAA 187
Query: 80  LGGFFSVKSDVFSFGVVVLEIISGKR--NTGFYNSELALSLLGYAWKLWQEGKALDMMDQ 137
           L G F++KSDV+SFG+++ E+ +  R    G  N E+   +        + G  +    +
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV--------ERGYRMPCPPE 239
Query: 138 KPGAISKANEILKCINVGLLCVQEDPNDRPT 168
            P ++      L C      C ++DP +RPT
Sbjct: 240 CPESLHD----LMC-----QCWRKDPEERPT 261

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 63.5 bits (153), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 39/98 (39%), Positives = 57/98 (58%), Gaps = 9/98 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           IILG    L +LH      I++RD K  NILLD + + KI+DFG+ +  E    D  TN 
Sbjct: 128 IILG----LQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNE 178
Query: 67  VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
             GT  Y++PE  LG  ++   D +SFGV++ E++ G+
Sbjct: 179 FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 63.5 bits (153), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 89/176 (50%), Gaps = 18/176 (10%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           +  I+  V   L YLH++ +   IHRD K  NILL  + + +I+DFG++  F     D T
Sbjct: 118 IATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVS-AFLATGGDIT 173
Query: 64  TNRV----VGTYGYMSPEY--ALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALS 117
            N+V    VGT  +M+PE    + G +  K+D++SFG+  +E+ +G      Y     L 
Sbjct: 174 RNKVRKTFVGTPCWMAPEVMEQVRG-YDFKADIWSFGITAIELATGAAPYHKYPPMKVLM 232
Query: 118 LLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
           L      L  +  +L+   Q    + K  +  +   +  LC+Q+DP  RPT ++++
Sbjct: 233 L-----TLQNDPPSLETGVQDKEMLKKYGKSFR--KMISLCLQKDPEKRPTAAELL 281

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 65/114 (57%), Gaps = 3/114 (2%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGT 70
           V++ + YLH  +   I+HR+ K+ N+L+D +   K+ DFGL+R+     T  ++    GT
Sbjct: 146 VAKGMNYLHNRNP-PIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGT 202
Query: 71  YGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWK 124
             +M+PE       + KSDV+SFGV++ E+ + ++  G  N    ++ +G+  K
Sbjct: 203 PEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK 256

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 63.5 bits (153), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 74/146 (50%), Gaps = 24/146 (16%)
Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTY--GYMSPEYALGGFF 84
           IHR+ + +NIL+   ++ KI+DFGL R+ E  +    T R    +   + +PE    G F
Sbjct: 127 IHRNLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTF 183
Query: 85  SVKSDVFSFGVVVLEIISGKR--NTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           ++KSDV+SFG+++ EI++  R    G  N E+  +L        + G  +   D  P   
Sbjct: 184 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL--------ERGYRMVRPDNCP--- 232
Query: 143 SKANEILKCINVGLLCVQEDPNDRPT 168
               E+ + +    LC +E P DRPT
Sbjct: 233 ---EELYQLMR---LCWKERPEDRPT 252

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 63.5 bits (153), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 75/151 (49%), Gaps = 24/151 (15%)
Query: 22  SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTY--GYMSPEYA 79
            ++  +HRD + +NIL+   +  K++DFGL R+ E  +    T R    +   + +PE A
Sbjct: 120 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAA 176
Query: 80  LGGFFSVKSDVFSFGVVVLEIISGKR--NTGFYNSELALSLLGYAWKLWQEGKALDMMDQ 137
           L G F++KSDV+SFG+++ E+ +  R    G  N E+   +        + G  +    +
Sbjct: 177 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV--------ERGYRMPCPPE 228
Query: 138 KPGAISKANEILKCINVGLLCVQEDPNDRPT 168
            P ++      L C      C ++DP +RPT
Sbjct: 229 CPESLHD----LMC-----QCWRKDPEERPT 250

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 32/89 (35%), Positives = 50/89 (56%), Gaps = 3/89 (3%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH      IIHRD K  NILL+ +M+ +I+DFG  ++   +      N  VGT  Y+
Sbjct: 145 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 201
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           SPE       S  SD+++ G ++ ++++G
Sbjct: 202 SPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 63.5 bits (153), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 77/155 (49%), Gaps = 18/155 (11%)
Query: 19  HQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEY 78
           H  S+ R++HRD K +N+ +      K+ D GL R F  K T    + +VGT  YMSPE 
Sbjct: 151 HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPER 207
Query: 79  ALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQK 138
                ++ KSD++S G ++ E+ + +  + FY  ++          L+   K ++  D  
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQ--SPFYGDKM---------NLYSLCKKIEQCDYP 256
Query: 139 P-GAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
           P  +   + E+ + +N   +C+  DP  RP ++ V
Sbjct: 257 PLPSDHYSEELRQLVN---MCINPDPEKRPDVTYV 288

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 75/151 (49%), Gaps = 24/151 (15%)
Query: 22  SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTY--GYMSPEYA 79
            ++  +HRD + +NIL+   +  K++DFGL R+ E  +    T R    +   + +PE A
Sbjct: 131 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAA 187
Query: 80  LGGFFSVKSDVFSFGVVVLEIISGKR--NTGFYNSELALSLLGYAWKLWQEGKALDMMDQ 137
           L G F++KSDV+SFG+++ E+ +  R    G  N E+   +        + G  +    +
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV--------ERGYRMPCPPE 239
Query: 138 KPGAISKANEILKCINVGLLCVQEDPNDRPT 168
            P ++      L C      C ++DP +RPT
Sbjct: 240 CPESLHD----LMC-----QCWRKDPEERPT 261

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 75/151 (49%), Gaps = 24/151 (15%)
Query: 22  SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTY--GYMSPEYA 79
            ++  +HRD + +NIL+   +  K++DFGL R+ E  +    T R    +   + +PE A
Sbjct: 131 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAA 187
Query: 80  LGGFFSVKSDVFSFGVVVLEIISGKR--NTGFYNSELALSLLGYAWKLWQEGKALDMMDQ 137
           L G F++KSDV+SFG+++ E+ +  R    G  N E+   +        + G  +    +
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV--------ERGYRMPCPPE 239
Query: 138 KPGAISKANEILKCINVGLLCVQEDPNDRPT 168
            P ++      L C      C ++DP +RPT
Sbjct: 240 CPESLHD----LMC-----QCWRKDPEERPT 261

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 75/151 (49%), Gaps = 24/151 (15%)
Query: 22  SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTY--GYMSPEYA 79
            ++  +HRD + +NIL+   +  K++DFGL R+ E  +    T R    +   + +PE A
Sbjct: 122 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAA 178
Query: 80  LGGFFSVKSDVFSFGVVVLEIISGKR--NTGFYNSELALSLLGYAWKLWQEGKALDMMDQ 137
           L G F++KSDV+SFG+++ E+ +  R    G  N E+   +        + G  +    +
Sbjct: 179 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV--------ERGYRMPCPPE 230
Query: 138 KPGAISKANEILKCINVGLLCVQEDPNDRPT 168
            P ++      L C      C ++DP +RPT
Sbjct: 231 CPESLHD----LMC-----QCWRKDPEERPT 252

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 89/176 (50%), Gaps = 18/176 (10%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           +  I+  V   L YLH++ +   IHRD K  NILL  + + +I+DFG++  F     D T
Sbjct: 123 IATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVS-AFLATGGDIT 178
Query: 64  TNRV----VGTYGYMSPEY--ALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALS 117
            N+V    VGT  +M+PE    + G +  K+D++SFG+  +E+ +G      Y     L 
Sbjct: 179 RNKVRKTFVGTPCWMAPEVMEQVRG-YDFKADIWSFGITAIELATGAAPYHKYPPMKVLM 237
Query: 118 LLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
           L      L  +  +L+   Q    + K  +  +   +  LC+Q+DP  RPT ++++
Sbjct: 238 LT-----LQNDPPSLETGVQDKEMLKKYGKSFR--KMISLCLQKDPEKRPTAAELL 286

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 75/151 (49%), Gaps = 24/151 (15%)
Query: 22  SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTY--GYMSPEYA 79
            ++  +HRD + +NIL+   +  K++DFGL R+ E  +    T R    +   + +PE A
Sbjct: 131 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAA 187
Query: 80  LGGFFSVKSDVFSFGVVVLEIISGKR--NTGFYNSELALSLLGYAWKLWQEGKALDMMDQ 137
           L G F++KSDV+SFG+++ E+ +  R    G  N E+   +        + G  +    +
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV--------ERGYRMPCPPE 239
Query: 138 KPGAISKANEILKCINVGLLCVQEDPNDRPT 168
            P ++      L C      C ++DP +RPT
Sbjct: 240 CPESLHD----LMC-----QCWRKDPEERPT 261

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 75/151 (49%), Gaps = 24/151 (15%)
Query: 22  SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTY--GYMSPEYA 79
            ++  +HRD + +NIL+   +  K++DFGL R+ E  +    T R    +   + +PE A
Sbjct: 131 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAA 187
Query: 80  LGGFFSVKSDVFSFGVVVLEIISGKR--NTGFYNSELALSLLGYAWKLWQEGKALDMMDQ 137
           L G F++KSDV+SFG+++ E+ +  R    G  N E+   +        + G  +    +
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV--------ERGYRMPCPPE 239
Query: 138 KPGAISKANEILKCINVGLLCVQEDPNDRPT 168
            P ++      L C      C ++DP +RPT
Sbjct: 240 CPESLHD----LMC-----QCWRKDPEERPT 261

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 75/151 (49%), Gaps = 24/151 (15%)
Query: 22  SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTY--GYMSPEYA 79
            ++  +HRD + +NIL+   +  K++DFGL R+ E  +    T R    +   + +PE A
Sbjct: 131 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAA 187
Query: 80  LGGFFSVKSDVFSFGVVVLEIISGKR--NTGFYNSELALSLLGYAWKLWQEGKALDMMDQ 137
           L G F++KSDV+SFG+++ E+ +  R    G  N E+   +        + G  +    +
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV--------ERGYRMPCPPE 239
Query: 138 KPGAISKANEILKCINVGLLCVQEDPNDRPT 168
            P ++      L C      C ++DP +RPT
Sbjct: 240 CPESLHD----LMC-----QCWRKDPEERPT 261

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 75/151 (49%), Gaps = 24/151 (15%)
Query: 22  SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTY--GYMSPEYA 79
            ++  +HRD + +NIL+   +  K++DFGL R+ E  +    T R    +   + +PE A
Sbjct: 131 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAA 187
Query: 80  LGGFFSVKSDVFSFGVVVLEIISGKR--NTGFYNSELALSLLGYAWKLWQEGKALDMMDQ 137
           L G F++KSDV+SFG+++ E+ +  R    G  N E+   +        + G  +    +
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV--------ERGYRMPCPPE 239
Query: 138 KPGAISKANEILKCINVGLLCVQEDPNDRPT 168
            P ++      L C      C ++DP +RPT
Sbjct: 240 CPESLHD----LMC-----QCWRKDPEERPT 261

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 69/154 (44%), Gaps = 19/154 (12%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFF 84
           + +HRD    N ++ H+   KI DFG+TR            + +    +M+PE    G F
Sbjct: 147 KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVF 206
Query: 85  SVKSDVFSFGVVVLEIISGKRN--TGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           +  SD++SFGVV+ EI S       G  N ++         K   +G  LD  D  P  +
Sbjct: 207 TTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL--------KFVMDGGYLDQPDNCPERV 258
Query: 143 SKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
           +         ++  +C Q +P  RPT  ++V +L
Sbjct: 259 T---------DLMRMCWQFNPKMRPTFLEIVNLL 283

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 20/170 (11%)
Query: 8   ILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP-KISDFGLTRIFEGKQTDGTTNR 66
            L  S+ + YLH      +IHRD K  N+LL       KI DFG        QT  T N+
Sbjct: 109 CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNNK 165
Query: 67  VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLW 126
             G+  +M+PE   G  +S K DVFS+G+++ E+I+  R   F   E+        W + 
Sbjct: 166 --GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVIT--RRKPF--DEIGGPAFRIMWAV- 218
Query: 127 QEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
             G    ++   P  I          ++   C  +DP+ RP+M ++V ++
Sbjct: 219 HNGTRPPLIKNLPKPIE---------SLMTRCWSKDPSQRPSMEEIVKIM 259

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/98 (39%), Positives = 57/98 (58%), Gaps = 9/98 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           IILG    L +LH      I++RD K  NILLD + + KI+DFG+ +  E    D  TN 
Sbjct: 127 IILG----LQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNX 177
Query: 67  VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
             GT  Y++PE  LG  ++   D +SFGV++ E++ G+
Sbjct: 178 FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 69/154 (44%), Gaps = 19/154 (12%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFF 84
           + +HRD    N ++ H+   KI DFG+TR            + +    +M+PE    G F
Sbjct: 150 KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVF 209
Query: 85  SVKSDVFSFGVVVLEIISGKRN--TGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           +  SD++SFGVV+ EI S       G  N ++         K   +G  LD  D  P  +
Sbjct: 210 TTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL--------KFVMDGGYLDQPDNCPERV 261
Query: 143 SKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
           +         ++  +C Q +P  RPT  ++V +L
Sbjct: 262 T---------DLMRMCWQFNPKMRPTFLEIVNLL 286

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 63/114 (55%), Gaps = 3/114 (2%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGT 70
           V++ + YLH  +   I+HRD K+ N+L+D +   K+ DFGL+R+         +    GT
Sbjct: 146 VAKGMNYLHNRNP-PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFL--XSKXAAGT 202
Query: 71  YGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWK 124
             +M+PE       + KSDV+SFGV++ E+ + ++  G  N    ++ +G+  K
Sbjct: 203 PEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK 256

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 20/170 (11%)
Query: 8   ILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP-KISDFGLTRIFEGKQTDGTTNR 66
            L  S+ + YLH      +IHRD K  N+LL       KI DFG        QT  T N+
Sbjct: 108 CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNNK 164
Query: 67  VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLW 126
             G+  +M+PE   G  +S K DVFS+G+++ E+I+  R   F   E+        W + 
Sbjct: 165 --GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVIT--RRKPF--DEIGGPAFRIMWAV- 217
Query: 127 QEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
             G    ++   P  I          ++   C  +DP+ RP+M ++V ++
Sbjct: 218 HNGTRPPLIKNLPKPIE---------SLMTRCWSKDPSQRPSMEEIVKIM 258

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 51/90 (56%), Gaps = 5/90 (5%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L +LHQ +   II+RD K  N+LLD + N +ISD GL    +  QT   T    GT G+M
Sbjct: 302 LEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KTKGYAGTPGFM 356
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           +PE  LG  +    D F+ GV + E+I+ +
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/113 (37%), Positives = 58/113 (51%), Gaps = 10/113 (8%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L +LHQ +   II+RD K  N+LLD + N +ISD GL    +  QT   T    GT G+M
Sbjct: 302 LEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KTKGYAGTPGFM 356
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGK-----RNTGFYNSELALSLLGYA 122
           +PE  LG  +    D F+ GV + E+I+ +     R     N EL   +L  A
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA 409

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/113 (37%), Positives = 58/113 (51%), Gaps = 10/113 (8%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L +LHQ +   II+RD K  N+LLD + N +ISD GL    +  QT   T    GT G+M
Sbjct: 302 LEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KTKGYAGTPGFM 356
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGK-----RNTGFYNSELALSLLGYA 122
           +PE  LG  +    D F+ GV + E+I+ +     R     N EL   +L  A
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA 409

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 51/90 (56%), Gaps = 5/90 (5%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L +LHQ +   II+RD K  N+LLD + N +ISD GL    +  QT   T    GT G+M
Sbjct: 302 LEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KTKGYAGTPGFM 356
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           +PE  LG  +    D F+ GV + E+I+ +
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 72/146 (49%), Gaps = 24/146 (16%)
Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTY--GYMSPEYALGGFF 84
           IHRD + +NIL+   +  KI+DFGL R+ E  +    T R    +   + +PE    G F
Sbjct: 133 IHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGSF 189
Query: 85  SVKSDVFSFGVVVLEIISGKR--NTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           ++KSDV+SFG++++EI++  R    G  N E+  +L        + G  +   +  P  +
Sbjct: 190 TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL--------ERGYRMPRPENCPEEL 241
Query: 143 SKANEILKCINVGLLCVQEDPNDRPT 168
                     N+ + C +  P +RPT
Sbjct: 242 ---------YNIMMRCWKNRPEERPT 258

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 22  SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTY--GYMSPEYA 79
            ++  +HRD   +NIL+   +  K++DFGL R+ E  +    T R    +   + +PE A
Sbjct: 131 ERMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAA 187
Query: 80  LGGFFSVKSDVFSFGVVVLEIISGKR--NTGFYNSELALSLLGYAWKLWQEGKALDMMDQ 137
           L G F++KSDV+SFG+++ E+ +  R    G  N E+   +        + G  +    +
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV--------ERGYRMPCPPE 239
Query: 138 KPGAISKANEILKCINVGLLCVQEDPNDRPT 168
            P ++      L C      C ++DP +RPT
Sbjct: 240 CPESLHD----LMC-----QCWRKDPEERPT 261

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 75/151 (49%), Gaps = 24/151 (15%)
Query: 23  KLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTY--GYMSPEYAL 80
           ++  +HRD + +NIL+   +  K++DFGL R+ E  +    T R    +   + +PE AL
Sbjct: 299 RMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNE---YTARQGAKFPIKWTAPEAAL 355
Query: 81  GGFFSVKSDVFSFGVVVLEIISGKR--NTGFYNSELALSLLGYAWKLWQEGKALDMMDQK 138
            G F++KSDV+SFG+++ E+ +  R    G  N E+   +        + G  +    + 
Sbjct: 356 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV--------ERGYRMPCPPEC 407
Query: 139 PGAISKANEILKCINVGLLCVQEDPNDRPTM 169
           P ++      L C      C ++DP +RPT 
Sbjct: 408 PESLHD----LMC-----QCWRKDPEERPTF 429

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 89/188 (47%), Gaps = 23/188 (12%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L  ++ G++  + YL   +++  +HRD    NIL++  +  K+SDFGL+R  E   +D T
Sbjct: 120 LVGMLRGIASGMRYL---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPT 176
Query: 64  TNRVVG---TYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLL 119
               +G      + +PE      F+  SD +S+G+V+ E++S G+R     +++  ++ +
Sbjct: 177 ETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAI 236
Query: 120 GYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE 179
              ++L             P   +  ++++      L C Q+D N RP    VV  L   
Sbjct: 237 EQDYRL----------PPPPDCPTSLHQLM------LDCWQKDRNARPRFPQVVSALDKM 280
Query: 180 AVNLASPK 187
             N AS K
Sbjct: 281 IRNPASLK 288

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 75/151 (49%), Gaps = 24/151 (15%)
Query: 22  SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTY--GYMSPEYA 79
            ++  +HRD + +NIL+   +  K++DFGL R+ E  +    T R    +   + +PE A
Sbjct: 121 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---XTARQGAKFPIKWTAPEAA 177
Query: 80  LGGFFSVKSDVFSFGVVVLEIISGKR--NTGFYNSELALSLLGYAWKLWQEGKALDMMDQ 137
           L G F++KSDV+SFG+++ E+ +  R    G  N E+   +        + G  +    +
Sbjct: 178 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV--------ERGYRMPCPPE 229
Query: 138 KPGAISKANEILKCINVGLLCVQEDPNDRPT 168
            P ++      L C      C +++P +RPT
Sbjct: 230 CPESLHD----LMC-----QCWRKEPEERPT 251

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 75/154 (48%), Gaps = 24/154 (15%)
Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTY--GYMSPEYALGGFF 84
           IHRD + +NIL+   +  KI+DFGL R+ E  +    T R    +   + +PE    G F
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGSF 362
Query: 85  SVKSDVFSFGVVVLEIISGKR--NTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           ++KSDV+SFG++++EI++  R    G  N E+  +L        + G  +   +  P  +
Sbjct: 363 TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL--------ERGYRMPRPENCPEEL 414
Query: 143 SKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
                     N+ + C +  P +RPT   +  +L
Sbjct: 415 ---------YNIMMRCWKNRPEERPTFEYIQSVL 439

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 49/89 (55%), Gaps = 3/89 (3%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH      IIHRD K  NILL+ +M+ +I+DFG  ++   +      N  VGT  Y+
Sbjct: 123 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 179
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           SPE          SD+++ G ++ ++++G
Sbjct: 180 SPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 49/89 (55%), Gaps = 3/89 (3%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH      IIHRD K  NILL+ +M+ +I+DFG  ++   +      N  VGT  Y+
Sbjct: 145 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           SPE          SD+++ G ++ ++++G
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 49/89 (55%), Gaps = 3/89 (3%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH      IIHRD K  NILL+ +M+ +I+DFG  ++   +      N  VGT  Y+
Sbjct: 122 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 178
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           SPE          SD+++ G ++ ++++G
Sbjct: 179 SPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 49/89 (55%), Gaps = 3/89 (3%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH      IIHRD K  NILL+ +M+ +I+DFG  ++   +      N  VGT  Y+
Sbjct: 148 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 204
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           SPE          SD+++ G ++ ++++G
Sbjct: 205 SPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 49/89 (55%), Gaps = 3/89 (3%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH      IIHRD K  NILL+ +M+ +I+DFG  ++   +      N  VGT  Y+
Sbjct: 143 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYV 199
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           SPE          SD+++ G ++ ++++G
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 49/89 (55%), Gaps = 3/89 (3%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH      IIHRD K  NILL+ +M+ +I+DFG  ++   +      N  VGT  Y+
Sbjct: 145 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           SPE          SD+++ G ++ ++++G
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 49/89 (55%), Gaps = 3/89 (3%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH      IIHRD K  NILL+ +M+ +I+DFG  ++   +      N  VGT  Y+
Sbjct: 146 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 202
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           SPE          SD+++ G ++ ++++G
Sbjct: 203 SPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 49/89 (55%), Gaps = 3/89 (3%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH      IIHRD K  NILL+ +M+ +I+DFG  ++   +      N  VGT  Y+
Sbjct: 143 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           SPE          SD+++ G ++ ++++G
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 49/89 (55%), Gaps = 3/89 (3%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH      IIHRD K  NILL+ +M+ +I+DFG  ++   +      N  VGT  Y+
Sbjct: 121 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 177
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           SPE          SD+++ G ++ ++++G
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 49/89 (55%), Gaps = 3/89 (3%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH      IIHRD K  NILL+ +M+ +I+DFG  ++   +      N  VGT  Y+
Sbjct: 150 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 206
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           SPE          SD+++ G ++ ++++G
Sbjct: 207 SPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 49/89 (55%), Gaps = 3/89 (3%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH      IIHRD K  NILL+ +M+ +I+DFG  ++   +      N  VGT  Y+
Sbjct: 146 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 202
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           SPE          SD+++ G ++ ++++G
Sbjct: 203 SPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 49/89 (55%), Gaps = 3/89 (3%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH      IIHRD K  NILL+ +M+ +I+DFG  ++   +      N  VGT  Y+
Sbjct: 145 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           SPE          SD+++ G ++ ++++G
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 59/107 (55%), Gaps = 6/107 (5%)
Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           M+ L +I    +R + YLH  S   IIHRD K++NI L  +   KI DFGL  +      
Sbjct: 107 MKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSG 163
Query: 61  DGTTNRVVGTYGYMSPEYAL---GGFFSVKSDVFSFGVVVLEIISGK 104
                ++ G+  +M+PE         +S +SDV++FG+V+ E+++G+
Sbjct: 164 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 210

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 75/151 (49%), Gaps = 24/151 (15%)
Query: 22  SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTY--GYMSPEYA 79
            ++  +HRD + +NIL+   +  K++DFGL R+ E  +    T R    +   + +PE A
Sbjct: 128 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---WTARQGAKFPIKWTAPEAA 184
Query: 80  LGGFFSVKSDVFSFGVVVLEIISGKR--NTGFYNSELALSLLGYAWKLWQEGKALDMMDQ 137
           L G F++KSDV+SFG+++ E+ +  R    G  N E+   +        + G  +    +
Sbjct: 185 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV--------ERGYRMPCPPE 236
Query: 138 KPGAISKANEILKCINVGLLCVQEDPNDRPT 168
            P ++      L C      C +++P +RPT
Sbjct: 237 CPESLHD----LMC-----QCWRKEPEERPT 258

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 49/89 (55%), Gaps = 3/89 (3%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH      IIHRD K  NILL+ +M+ +I+DFG  ++   +      N  VGT  Y+
Sbjct: 143 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           SPE          SD+++ G ++ ++++G
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 49/89 (55%), Gaps = 3/89 (3%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH      IIHRD K  NILL+ +M+ +I+DFG  ++   +      N  VGT  Y+
Sbjct: 145 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           SPE          SD+++ G ++ ++++G
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 70/154 (45%), Gaps = 19/154 (12%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFF 84
           + +HR+    N ++ H+   KI DFG+TR            + +    +M+PE    G F
Sbjct: 150 KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF 209
Query: 85  SVKSDVFSFGVVVLEIISGKRN--TGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           +  SD++SFGVV+ EI S       G  N ++         K   +G  LD  D  P  +
Sbjct: 210 TTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL--------KFVMDGGYLDQPDNCPERV 261
Query: 143 SKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
           +         ++  +C Q +PN RPT  ++V +L
Sbjct: 262 T---------DLMRMCWQFNPNMRPTFLEIVNLL 286

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 49/89 (55%), Gaps = 3/89 (3%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH      IIHRD K  NILL+ +M+ +I+DFG  ++   +      N  VGT  Y+
Sbjct: 120 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 176
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           SPE          SD+++ G ++ ++++G
Sbjct: 177 SPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 49/89 (55%), Gaps = 3/89 (3%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH      IIHRD K  NILL+ +M+ +I+DFG  ++   +      N  VGT  Y+
Sbjct: 143 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           SPE          SD+++ G ++ ++++G
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 71/154 (46%), Gaps = 19/154 (12%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFF 84
           + +HR+    N ++ H+   KI DFG+TR            + +    +M+PE    G F
Sbjct: 151 KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF 210
Query: 85  SVKSDVFSFGVVVLEIISGKRN--TGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           +  SD++SFGVV+ EI S       G  N ++         K   +G  LD  D  P   
Sbjct: 211 TTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL--------KFVMDGGYLDQPDNCP--- 259
Query: 143 SKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
            +  ++++      +C Q +PN RPT  ++V +L
Sbjct: 260 ERVTDLMR------MCWQFNPNMRPTFLEIVNLL 287

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 75/151 (49%), Gaps = 24/151 (15%)
Query: 22  SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTY--GYMSPEYA 79
            ++  +HRD + +NIL+   +  K++DFGL R+ E  +    T R    +   + +PE A
Sbjct: 124 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAA 180
Query: 80  LGGFFSVKSDVFSFGVVVLEIISGKR--NTGFYNSELALSLLGYAWKLWQEGKALDMMDQ 137
           L G F++KSDV+SFG+++ E+ +  R    G  N E+   +        + G  +    +
Sbjct: 181 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV--------ERGYRMPCPPE 232
Query: 138 KPGAISKANEILKCINVGLLCVQEDPNDRPT 168
            P ++      L C      C +++P +RPT
Sbjct: 233 CPESLHD----LMC-----QCWRKEPEERPT 254

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 49/89 (55%), Gaps = 3/89 (3%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH      IIHRD K  NILL+ +M+ +I+DFG  ++   +      N  VGT  Y+
Sbjct: 127 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 183
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           SPE          SD+++ G ++ ++++G
Sbjct: 184 SPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 75/151 (49%), Gaps = 24/151 (15%)
Query: 22  SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTY--GYMSPEYA 79
            ++  +HRD + +NIL+   +  K++DFGL R+ E  +    T R    +   + +PE A
Sbjct: 128 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAA 184
Query: 80  LGGFFSVKSDVFSFGVVVLEIISGKR--NTGFYNSELALSLLGYAWKLWQEGKALDMMDQ 137
           L G F++KSDV+SFG+++ E+ +  R    G  N E+   +        + G  +    +
Sbjct: 185 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV--------ERGYRMPCPPE 236
Query: 138 KPGAISKANEILKCINVGLLCVQEDPNDRPT 168
            P ++      L C      C +++P +RPT
Sbjct: 237 CPESLHD----LMC-----QCWRKEPEERPT 258

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 89/188 (47%), Gaps = 23/188 (12%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L  ++ G++  + YL   +++  +HRD    NIL++  +  K+SDFGL+R  E   +D T
Sbjct: 118 LVGMLRGIASGMRYL---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPT 174
Query: 64  TNRVVG---TYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLL 119
               +G      + +PE      F+  SD +S+G+V+ E++S G+R     +++  ++ +
Sbjct: 175 YTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAI 234
Query: 120 GYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE 179
              ++L             P   +  ++++      L C Q+D N RP    VV  L   
Sbjct: 235 EQDYRL----------PPPPDCPTSLHQLM------LDCWQKDRNARPRFPQVVSALDKM 278
Query: 180 AVNLASPK 187
             N AS K
Sbjct: 279 IRNPASLK 286

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 49/89 (55%), Gaps = 3/89 (3%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH      IIHRD K  NILL+ +M+ +I+DFG  ++   +      N  VGT  Y+
Sbjct: 145 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           SPE          SD+++ G ++ ++++G
Sbjct: 202 SPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 52/91 (57%), Gaps = 4/91 (4%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           ++YLH    + I HRD K  N+LLD   N KISDFGL  +F     +   N++ GT  Y+
Sbjct: 117 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 75  SPE-YALGGFFSVKSDVFSFGVVVLEIISGK 104
           +PE      F +   DV+S G+V+  +++G+
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 49/89 (55%), Gaps = 3/89 (3%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH      IIHRD K  NILL+ +M+ +I+DFG  ++   +      N  VGT  Y+
Sbjct: 142 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 198
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           SPE          SD+++ G ++ ++++G
Sbjct: 199 SPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 49/89 (55%), Gaps = 3/89 (3%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH      IIHRD K  NILL+ +M+ +I+DFG  ++   +      N  VGT  Y+
Sbjct: 142 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 198
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           SPE          SD+++ G ++ ++++G
Sbjct: 199 SPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 69/154 (44%), Gaps = 19/154 (12%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFF 84
           + +HRD    N ++ H+   KI DFG+TR            + +    +M+PE    G F
Sbjct: 150 KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAPESLKDGVF 209
Query: 85  SVKSDVFSFGVVVLEIISGKRN--TGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           +  SD++SFGVV+ EI S       G  N ++         K   +G  LD  D  P  +
Sbjct: 210 TTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL--------KFVMDGGYLDQPDNCPERV 261
Query: 143 SKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
           +         ++  +C Q +P  RPT  ++V +L
Sbjct: 262 T---------DLMRMCWQFNPKMRPTFLEIVNLL 286

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 69/154 (44%), Gaps = 19/154 (12%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFF 84
           + +HRD    N ++ H+   KI DFG+TR            + +    +M+PE    G F
Sbjct: 150 KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF 209
Query: 85  SVKSDVFSFGVVVLEIISGKRN--TGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           +  SD++SFGVV+ EI S       G  N ++         K   +G  LD  D  P  +
Sbjct: 210 TTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL--------KFVMDGGYLDQPDNCPERV 261
Query: 143 SKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
           +         ++  +C Q +P  RPT  ++V +L
Sbjct: 262 T---------DLMRMCWQFNPKMRPTFLEIVNLL 286

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 69/154 (44%), Gaps = 19/154 (12%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFF 84
           + +HRD    N ++ H+   KI DFG+TR            + +    +M+PE    G F
Sbjct: 149 KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF 208
Query: 85  SVKSDVFSFGVVVLEIISGKRN--TGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           +  SD++SFGVV+ EI S       G  N ++         K   +G  LD  D  P  +
Sbjct: 209 TTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL--------KFVMDGGYLDQPDNCPERV 260
Query: 143 SKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
           +         ++  +C Q +P  RPT  ++V +L
Sbjct: 261 T---------DLMRMCWQFNPKMRPTFLEIVNLL 285

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 75/151 (49%), Gaps = 24/151 (15%)
Query: 23  KLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTY--GYMSPEYAL 80
           ++  +HRD + +NIL+   +  K++DFGL R+ E  +    T R    +   + +PE AL
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAAL 354
Query: 81  GGFFSVKSDVFSFGVVVLEIISGKR--NTGFYNSELALSLLGYAWKLWQEGKALDMMDQK 138
            G F++KSDV+SFG+++ E+ +  R    G  N E+   +        + G  +    + 
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV--------ERGYRMPCPPEC 406
Query: 139 PGAISKANEILKCINVGLLCVQEDPNDRPTM 169
           P ++      L C      C +++P +RPT 
Sbjct: 407 PESLHD----LMC-----QCWRKEPEERPTF 428

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 75/151 (49%), Gaps = 24/151 (15%)
Query: 23  KLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTY--GYMSPEYAL 80
           ++  +HRD + +NIL+   +  K++DFGL R+ E  +    T R    +   + +PE AL
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAAL 354
Query: 81  GGFFSVKSDVFSFGVVVLEIISGKR--NTGFYNSELALSLLGYAWKLWQEGKALDMMDQK 138
            G F++KSDV+SFG+++ E+ +  R    G  N E+   +        + G  +    + 
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV--------ERGYRMPCPPEC 406
Query: 139 PGAISKANEILKCINVGLLCVQEDPNDRPTM 169
           P ++      L C      C +++P +RPT 
Sbjct: 407 PESLHD----LMC-----QCWRKEPEERPTF 428

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 52/91 (57%), Gaps = 4/91 (4%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           ++YLH    + I HRD K  N+LLD   N KISDFGL  +F     +   N++ GT  Y+
Sbjct: 118 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 75  SPE-YALGGFFSVKSDVFSFGVVVLEIISGK 104
           +PE      F +   DV+S G+V+  +++G+
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 81/177 (45%), Gaps = 23/177 (12%)
Query: 9   LGVSRRLLYLHQDSK-------LRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           L  SR LLY  Q  K        R +HRD    NIL++ E + KI+DFGL ++    + D
Sbjct: 108 LDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK-D 166
Query: 62  GTTNRVVGTYG--YMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLL 119
               R  G     + +PE      FS +SDV+SFGVV+ E+ +    +   ++E  L ++
Sbjct: 167 XXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF-LRMM 225
Query: 120 GYAWKLWQEGKAL------DMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMS 170
           G    +    + L        +   P   ++ +E++K      LC    P DRP+ S
Sbjct: 226 GCERDVPALCRLLELLEEGQRLPAPPACPAEVHELMK------LCWAPSPQDRPSFS 276

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 52/91 (57%), Gaps = 4/91 (4%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           ++YLH    + I HRD K  N+LLD   N KISDFGL  +F     +   N++ GT  Y+
Sbjct: 118 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 75  SPE-YALGGFFSVKSDVFSFGVVVLEIISGK 104
           +PE      F +   DV+S G+V+  +++G+
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 75/151 (49%), Gaps = 24/151 (15%)
Query: 23  KLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTY--GYMSPEYAL 80
           ++  +HRD + +NIL+   +  K++DFGL R+ E  +    T R    +   + +PE AL
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAAL 354
Query: 81  GGFFSVKSDVFSFGVVVLEIISGKR--NTGFYNSELALSLLGYAWKLWQEGKALDMMDQK 138
            G F++KSDV+SFG+++ E+ +  R    G  N E+   +        + G  +    + 
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV--------ERGYRMPCPPEC 406
Query: 139 PGAISKANEILKCINVGLLCVQEDPNDRPTM 169
           P ++      L C      C +++P +RPT 
Sbjct: 407 PESLHD----LMC-----QCWRKEPEERPTF 428

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 52/91 (57%), Gaps = 4/91 (4%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           ++YLH    + I HRD K  N+LLD   N KISDFGL  +F     +   N++ GT  Y+
Sbjct: 117 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 75  SPE-YALGGFFSVKSDVFSFGVVVLEIISGK 104
           +PE      F +   DV+S G+V+  +++G+
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 52/91 (57%), Gaps = 4/91 (4%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           ++YLH    + I HRD K  N+LLD   N KISDFGL  +F     +   N++ GT  Y+
Sbjct: 118 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 75  SPE-YALGGFFSVKSDVFSFGVVVLEIISGK 104
           +PE      F +   DV+S G+V+  +++G+
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 52/91 (57%), Gaps = 4/91 (4%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           ++YLH    + I HRD K  N+LLD   N KISDFGL  +F     +   N++ GT  Y+
Sbjct: 118 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 75  SPE-YALGGFFSVKSDVFSFGVVVLEIISGK 104
           +PE      F +   DV+S G+V+  +++G+
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 52/91 (57%), Gaps = 4/91 (4%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           ++YLH    + I HRD K  N+LLD   N KISDFGL  +F     +   N++ GT  Y+
Sbjct: 118 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 75  SPE-YALGGFFSVKSDVFSFGVVVLEIISGK 104
           +PE      F +   DV+S G+V+  +++G+
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 52/91 (57%), Gaps = 4/91 (4%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           ++YLH    + I HRD K  N+LLD   N KISDFGL  +F     +   N++ GT  Y+
Sbjct: 118 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 75  SPE-YALGGFFSVKSDVFSFGVVVLEIISGK 104
           +PE      F +   DV+S G+V+  +++G+
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 52/91 (57%), Gaps = 4/91 (4%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           ++YLH    + I HRD K  N+LLD   N KISDFGL  +F     +   N++ GT  Y+
Sbjct: 116 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
Query: 75  SPE-YALGGFFSVKSDVFSFGVVVLEIISGK 104
           +PE      F +   DV+S G+V+  +++G+
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGE 203

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 52/91 (57%), Gaps = 4/91 (4%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           ++YLH    + I HRD K  N+LLD   N KISDFGL  +F     +   N++ GT  Y+
Sbjct: 117 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 75  SPE-YALGGFFSVKSDVFSFGVVVLEIISGK 104
           +PE      F +   DV+S G+V+  +++G+
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 52/91 (57%), Gaps = 4/91 (4%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           ++YLH    + I HRD K  N+LLD   N KISDFGL  +F     +   N++ GT  Y+
Sbjct: 117 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 75  SPE-YALGGFFSVKSDVFSFGVVVLEIISGK 104
           +PE      F +   DV+S G+V+  +++G+
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 52/91 (57%), Gaps = 4/91 (4%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           ++YLH    + I HRD K  N+LLD   N KISDFGL  +F     +   N++ GT  Y+
Sbjct: 117 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 75  SPE-YALGGFFSVKSDVFSFGVVVLEIISGK 104
           +PE      F +   DV+S G+V+  +++G+
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 52/91 (57%), Gaps = 4/91 (4%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           ++YLH    + I HRD K  N+LLD   N KISDFGL  +F     +   N++ GT  Y+
Sbjct: 117 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 75  SPE-YALGGFFSVKSDVFSFGVVVLEIISGK 104
           +PE      F +   DV+S G+V+  +++G+
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 52/91 (57%), Gaps = 4/91 (4%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           ++YLH    + I HRD K  N+LLD   N KISDFGL  +F     +   N++ GT  Y+
Sbjct: 117 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 75  SPE-YALGGFFSVKSDVFSFGVVVLEIISGK 104
           +PE      F +   DV+S G+V+  +++G+
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 52/91 (57%), Gaps = 4/91 (4%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           ++YLH    + I HRD K  N+LLD   N KISDFGL  +F     +   N++ GT  Y+
Sbjct: 117 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 75  SPE-YALGGFFSVKSDVFSFGVVVLEIISGK 104
           +PE      F +   DV+S G+V+  +++G+
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 52/91 (57%), Gaps = 4/91 (4%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           ++YLH    + I HRD K  N+LLD   N KISDFGL  +F     +   N++ GT  Y+
Sbjct: 118 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 75  SPE-YALGGFFSVKSDVFSFGVVVLEIISGK 104
           +PE      F +   DV+S G+V+  +++G+
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 84/173 (48%), Gaps = 27/173 (15%)
Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           +  L ++   ++  + Y+    ++  +HRD + +NIL+   +  K++DFGL R+ E  + 
Sbjct: 362 LPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE- 417
Query: 61  DGTTNRVVGTY--GYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKR--NTGFYNSELAL 116
              T R    +   + +PE AL G F++KSDV+SFG+++ E+ +  R    G  N E+  
Sbjct: 418 --YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD 475
Query: 117 SLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTM 169
            +        + G  +    + P ++      L C      C +++P +RPT 
Sbjct: 476 QV--------ERGYRMPCPPECPESLHD----LMC-----QCWRKEPEERPTF 511

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 83/175 (47%), Gaps = 21/175 (12%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L  ++ G+S  + YL   S +  +HRD    NIL++  +  K+SDFGL+R+ E       
Sbjct: 126 LVGMLRGISAGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 182
Query: 64  TNRVVGT-YGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGY 121
           T R       + +PE      F+  SDV+S+G+V+ E++S G+R      ++  +     
Sbjct: 183 TTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVI----- 237
Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
             K  +EG  L      P A+ +         + L C Q++ N RP   ++V ML
Sbjct: 238 --KAVEEGYRLPSPMDCPAALYQ---------LMLDCWQKERNSRPKFDEIVNML 281

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 28/196 (14%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L  ++ G++  + YL   S +  +HRD    NIL++  +  K+SDFGL+R+ E       
Sbjct: 149 LVGMLRGIASGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 205
Query: 64  TNRVVGT-YGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGY 121
           T R       + SPE      F+  SDV+S+G+V+ E++S G+R     +++  +     
Sbjct: 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI----- 260
Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML----- 176
             K   EG  L      P A+ +         + L C Q+D N+RP    +V +L     
Sbjct: 261 --KAVDEGYRLPPPMDCPAALYQ---------LMLDCWQKDRNNRPKFEQIVSILDKLIR 309
Query: 177 --GSEAVNLASPKRPA 190
             GS  +  ++  RP+
Sbjct: 310 NPGSLKIITSAAARPS 325

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 52/91 (57%), Gaps = 4/91 (4%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           ++YLH    + I HRD K  N+LLD   N KISDFGL  +F     +   N++ GT  Y+
Sbjct: 117 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 75  SPE-YALGGFFSVKSDVFSFGVVVLEIISGK 104
           +PE      F +   DV+S G+V+  +++G+
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 52/91 (57%), Gaps = 4/91 (4%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           ++YLH    + I HRD K  N+LLD   N KISDFGL  +F     +   N++ GT  Y+
Sbjct: 117 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 75  SPE-YALGGFFSVKSDVFSFGVVVLEIISGK 104
           +PE      F +   DV+S G+V+  +++G+
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 52/91 (57%), Gaps = 4/91 (4%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           ++YLH    + I HRD K  N+LLD   N KISDFGL  +F     +   N++ GT  Y+
Sbjct: 118 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 174
Query: 75  SPE-YALGGFFSVKSDVFSFGVVVLEIISGK 104
           +PE      F +   DV+S G+V+  +++G+
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 28/196 (14%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L  ++ G++  + YL   S +  +HRD    NIL++  +  K+SDFGL+R+ E       
Sbjct: 149 LVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 205
Query: 64  TNRVVGT-YGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGY 121
           T R       + SPE      F+  SDV+S+G+V+ E++S G+R     +++  +     
Sbjct: 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI----- 260
Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML----- 176
             K   EG  L      P A+ +         + L C Q+D N+RP    +V +L     
Sbjct: 261 --KAVDEGYRLPPPMDCPAALYQ---------LMLDCWQKDRNNRPKFEQIVSILDKLIR 309
Query: 177 --GSEAVNLASPKRPA 190
             GS  +  ++  RP+
Sbjct: 310 NPGSLKIITSAAARPS 325

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 28/196 (14%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L  ++ G++  + YL   S +  +HRD    NIL++  +  K+SDFGL+R+ E       
Sbjct: 149 LVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 205
Query: 64  TNRVVGT-YGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGY 121
           T R       + SPE      F+  SDV+S+G+V+ E++S G+R     +++  +     
Sbjct: 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI----- 260
Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML----- 176
             K   EG  L      P A+ +         + L C Q+D N+RP    +V +L     
Sbjct: 261 --KAVDEGYRLPPPMDCPAALYQ---------LMLDCWQKDRNNRPKFEQIVSILDKLIR 309
Query: 177 --GSEAVNLASPKRPA 190
             GS  +  ++  RP+
Sbjct: 310 NPGSLKIITSAAARPS 325

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 52/91 (57%), Gaps = 4/91 (4%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           ++YLH    + I HRD K  N+LLD   N KISDFGL  +F     +   N++ GT  Y+
Sbjct: 117 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 75  SPE-YALGGFFSVKSDVFSFGVVVLEIISGK 104
           +PE      F +   DV+S G+V+  +++G+
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 52/91 (57%), Gaps = 4/91 (4%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           ++YLH    + I HRD K  N+LLD   N KISDFGL  +F     +   N++ GT  Y+
Sbjct: 117 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 75  SPE-YALGGFFSVKSDVFSFGVVVLEIISGK 104
           +PE      F +   DV+S G+V+  +++G+
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 28/196 (14%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L  ++ G++  + YL   S +  +HRD    NIL++  +  K+SDFGL+R+ E       
Sbjct: 149 LVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 205
Query: 64  TNRVVGT-YGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGY 121
           T R       + SPE      F+  SDV+S+G+V+ E++S G+R     +++  +     
Sbjct: 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI----- 260
Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML----- 176
             K   EG  L      P A+ +         + L C Q+D N+RP    +V +L     
Sbjct: 261 --KAVDEGYRLPPPMDCPAALYQ---------LMLDCWQKDRNNRPKFEQIVSILDKLIR 309
Query: 177 --GSEAVNLASPKRPA 190
             GS  +  ++  RP+
Sbjct: 310 NPGSLKIITSAAARPS 325

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 28/196 (14%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L  ++ G++  + YL   S +  +HRD    NIL++  +  K+SDFGL+R+ E       
Sbjct: 147 LVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 203
Query: 64  TNRVVGT-YGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGY 121
           T R       + SPE      F+  SDV+S+G+V+ E++S G+R     +++  +     
Sbjct: 204 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI----- 258
Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML----- 176
             K   EG  L      P A+ +         + L C Q+D N+RP    +V +L     
Sbjct: 259 --KAVDEGYRLPPPMDCPAALYQ---------LMLDCWQKDRNNRPKFEQIVSILDKLIR 307
Query: 177 --GSEAVNLASPKRPA 190
             GS  +  ++  RP+
Sbjct: 308 NPGSLKIITSAAARPS 323

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 28/196 (14%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L  ++ G++  + YL   S +  +HRD    NIL++  +  K+SDFGL+R+ E       
Sbjct: 149 LVGMLRGIASGMKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 205
Query: 64  TNRVVGT-YGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGY 121
           T R       + SPE      F+  SDV+S+G+V+ E++S G+R     +++  +     
Sbjct: 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI----- 260
Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML----- 176
             K   EG  L      P A+ +         + L C Q+D N+RP    +V +L     
Sbjct: 261 --KAVDEGYRLPPPMDCPAALYQ---------LMLDCWQKDRNNRPKFEQIVSILDKLIR 309
Query: 177 --GSEAVNLASPKRPA 190
             GS  +  ++  RP+
Sbjct: 310 NPGSLKIITSAAARPS 325

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 91/196 (46%), Gaps = 28/196 (14%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L  ++ G++  + YL   S +  +HRD    NIL++  +  K+SDFGL+R+ E       
Sbjct: 120 LVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 176
Query: 64  TNRVVGT-YGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGY 121
           T R       + SPE      F+  SDV+S+G+V+ E++S G+R     +++  +  +  
Sbjct: 177 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV-- 234
Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML----- 176
                 EG  L      P A+ +         + L C Q+D N+RP    +V +L     
Sbjct: 235 -----DEGYRLPPPMDCPAALYQ---------LMLDCWQKDRNNRPKFEQIVSILDKLIR 280
Query: 177 --GSEAVNLASPKRPA 190
             GS  +  ++  RP+
Sbjct: 281 NPGSLKIITSAAARPS 296

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 91/196 (46%), Gaps = 28/196 (14%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L  ++ G++  + YL   S +  +HRD    NIL++  +  K+SDFGL+R+ E       
Sbjct: 120 LVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 176
Query: 64  TNRVVGT-YGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGY 121
           T R       + SPE      F+  SDV+S+G+V+ E++S G+R     +++  +  +  
Sbjct: 177 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV-- 234
Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML----- 176
                 EG  L      P A+ +         + L C Q+D N+RP    +V +L     
Sbjct: 235 -----DEGYRLPPPMDCPAALYQ---------LMLDCWQKDRNNRPKFEQIVSILDKLIR 280
Query: 177 --GSEAVNLASPKRPA 190
             GS  +  ++  RP+
Sbjct: 281 NPGSLKIITSAAARPS 296

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 28/196 (14%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L  ++ G++  + YL   S +  +HRD    NIL++  +  K+SDFGL+R+ E       
Sbjct: 149 LVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 205
Query: 64  TNRVVGT-YGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGY 121
           T R       + SPE      F+  SDV+S+G+V+ E++S G+R     +++  +     
Sbjct: 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI----- 260
Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML----- 176
             K   EG  L      P A+ +         + L C Q+D N+RP    +V +L     
Sbjct: 261 --KAVDEGYRLPPPMDCPAALYQ---------LMLDCWQKDRNNRPKFEQIVSILDKLIR 309
Query: 177 --GSEAVNLASPKRPA 190
             GS  +  ++  RP+
Sbjct: 310 NPGSLKIITSAAARPS 325

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 28/196 (14%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L  ++ G++  + YL   S +  +HRD    NIL++  +  K+SDFGL+R+ E       
Sbjct: 149 LVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 205
Query: 64  TNRVVGT-YGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGY 121
           T R       + SPE      F+  SDV+S+G+V+ E++S G+R     +++  +     
Sbjct: 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI----- 260
Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML----- 176
             K   EG  L      P A+ +         + L C Q+D N+RP    +V +L     
Sbjct: 261 --KAVDEGYRLPPPMDCPAALYQ---------LMLDCWQKDRNNRPKFEQIVSILDKLIR 309
Query: 177 --GSEAVNLASPKRPA 190
             GS  +  ++  RP+
Sbjct: 310 NPGSLKIITSAAARPS 325

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 28/196 (14%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L  ++ G++  + YL   S +  +HRD    NIL++  +  K+SDFGL+R+ E       
Sbjct: 137 LVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 193
Query: 64  TNRVVGT-YGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGY 121
           T R       + SPE      F+  SDV+S+G+V+ E++S G+R     +++  +     
Sbjct: 194 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI----- 248
Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML----- 176
             K   EG  L      P A+ +         + L C Q+D N+RP    +V +L     
Sbjct: 249 --KAVDEGYRLPPPMDCPAALYQ---------LMLDCWQKDRNNRPKFEQIVSILDKLIR 297
Query: 177 --GSEAVNLASPKRPA 190
             GS  +  ++  RP+
Sbjct: 298 NPGSLKIITSAAARPS 313

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 63/115 (54%), Gaps = 5/115 (4%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           ++L N  + +++ ++YL +    R++HRD    N+L+    + KI+DFGL R+ EG + +
Sbjct: 140 QLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE 196
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSEL 114
              +       +M+ E      F+ +SDV+S+GV + E+++  GK   G    E+
Sbjct: 197 YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI 251

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 81/177 (45%), Gaps = 23/177 (12%)
Query: 9   LGVSRRLLYLHQDSK-------LRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           L  SR LLY  Q  K        R +HRD    NIL++ E + KI+DFGL ++    + D
Sbjct: 124 LDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK-D 182
Query: 62  GTTNRVVGTYG--YMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLL 119
               R  G     + +PE      FS +SDV+SFGVV+ E+ +    +   ++E  L ++
Sbjct: 183 YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF-LRMM 241
Query: 120 GYAWKLWQEGKAL------DMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMS 170
           G    +    + L        +   P   ++ +E++K      LC    P DRP+ S
Sbjct: 242 GCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMK------LCWAPSPQDRPSFS 292

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 62/109 (56%), Gaps = 10/109 (9%)
Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           M+ L +I    +R + YLH  S   IIHRD K++NI L  +   KI DFGL    E  + 
Sbjct: 119 MKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLAT--EKSRW 173
Query: 61  DGTTN--RVVGTYGYMSPEYAL---GGFFSVKSDVFSFGVVVLEIISGK 104
            G+    ++ G+  +M+PE         +S +SDV++FG+V+ E+++G+
Sbjct: 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 63/115 (54%), Gaps = 5/115 (4%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           ++L N  + +++ ++YL +    R++HRD    N+L+    + KI+DFGL R+ EG + +
Sbjct: 117 QLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE 173
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSEL 114
              +       +M+ E      F+ +SDV+S+GV + E+++  GK   G    E+
Sbjct: 174 YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI 228

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 82/177 (46%), Gaps = 23/177 (12%)
Query: 9   LGVSRRLLYLHQDSK-------LRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           L  SR LLY  Q  K        R +HRD    NIL++ E + KI+DFGL ++    + D
Sbjct: 112 LDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK-D 170
Query: 62  GTTNRVVGTYG--YMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLL 119
               R  G     + +PE      FS +SDV+SFGVV+ E+ +    +   ++E  L ++
Sbjct: 171 YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF-LRMM 229
Query: 120 GYA------WKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMS 170
           G         +L +  +    +   P   ++ +E++K      LC    P DRP+ S
Sbjct: 230 GCERDVPALCRLLELLEEGQRLPAPPACPAEVHELMK------LCWAPSPQDRPSFS 280

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 90/196 (45%), Gaps = 28/196 (14%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L  ++ G++  + YL   S +  +HRD    NIL++  +  K+SDFGL R+ E       
Sbjct: 149 LVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAY 205
Query: 64  TNRVVGT-YGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGY 121
           T R       + SPE      F+  SDV+S+G+V+ E++S G+R     +++  +     
Sbjct: 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI----- 260
Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML----- 176
             K   EG  L      P A+ +         + L C Q+D N+RP    +V +L     
Sbjct: 261 --KAVDEGYRLPPPMDCPAALYQ---------LMLDCWQKDRNNRPKFEQIVSILDKLIR 309
Query: 177 --GSEAVNLASPKRPA 190
             GS  +  ++  RP+
Sbjct: 310 NPGSLKIITSAAARPS 325

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 81/177 (45%), Gaps = 23/177 (12%)
Query: 9   LGVSRRLLYLHQDSK-------LRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           L  SR LLY  Q  K        R +HRD    NIL++ E + KI+DFGL ++    + D
Sbjct: 111 LDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK-D 169
Query: 62  GTTNRVVGTYG--YMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLL 119
               R  G     + +PE      FS +SDV+SFGVV+ E+ +    +   ++E  L ++
Sbjct: 170 YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF-LRMM 228
Query: 120 GYAWKLWQEGKAL------DMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMS 170
           G    +    + L        +   P   ++ +E++K      LC    P DRP+ S
Sbjct: 229 GSERDVPALSRLLELLEEGQRLPAPPACPAEVHELMK------LCWAPSPQDRPSFS 279

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 81/171 (47%), Gaps = 28/171 (16%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L  I+LG      YLH++   R+IHRD K  N+ L+ ++  KI DFGL    E    DG 
Sbjct: 147 LRQIVLGCQ----YLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE---YDGE 196
Query: 64  TNRVV-GTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA 122
             +V+ GT  Y++PE       S + DV+S G ++  ++ GK    F  S L  + L   
Sbjct: 197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK--PPFETSCLKETYLRIK 254
Query: 123 WKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
              +   K ++     P A S   ++L          Q DP  RPT+++++
Sbjct: 255 KNEYSIPKHIN-----PVAASLIQKML----------QTDPTARPTINELL 290

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 81/171 (47%), Gaps = 28/171 (16%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L  I+LG      YLH++   R+IHRD K  N+ L+ ++  KI DFGL    E    DG 
Sbjct: 145 LRQIVLGCQ----YLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE---YDGE 194
Query: 64  TNRVV-GTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA 122
             +V+ GT  Y++PE       S + DV+S G ++  ++ GK    F  S L  + L   
Sbjct: 195 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK--PPFETSCLKETYLRIK 252
Query: 123 WKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
              +   K ++     P A S   ++L          Q DP  RPT+++++
Sbjct: 253 KNEYSIPKHIN-----PVAASLIQKML----------QTDPTARPTINELL 288

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 62/109 (56%), Gaps = 10/109 (9%)
Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           M+ L +I    +R + YLH  S   IIHRD K++NI L  +   KI DFGL    E  + 
Sbjct: 119 MKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLAT--EKSRW 173
Query: 61  DGTTN--RVVGTYGYMSPEYAL---GGFFSVKSDVFSFGVVVLEIISGK 104
            G+    ++ G+  +M+PE         +S +SDV++FG+V+ E+++G+
Sbjct: 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 56/94 (59%), Gaps = 5/94 (5%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGT 70
           +S  L YLH+     II+RD K  N+LLD E + K++D+G+ +  EG +   TT+   GT
Sbjct: 130 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGT 184
Query: 71  YGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
             Y++PE   G  +    D ++ GV++ E+++G+
Sbjct: 185 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 218

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 81/171 (47%), Gaps = 28/171 (16%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L  I+LG      YLH++   R+IHRD K  N+ L+ ++  KI DFGL    E    DG 
Sbjct: 121 LRQIVLGCQ----YLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE---YDGE 170
Query: 64  TNRVV-GTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA 122
             +V+ GT  Y++PE       S + DV+S G ++  ++ GK    F  S L  + L   
Sbjct: 171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK--PPFETSCLKETYLRIK 228
Query: 123 WKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
              +   K ++     P A S   ++L          Q DP  RPT+++++
Sbjct: 229 KNEYSIPKHIN-----PVAASLIQKML----------QTDPTARPTINELL 264

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 57/101 (56%), Gaps = 9/101 (8%)
Query: 8   ILGVSRRLL----YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           I  V R  L    +LH +   ++IHRD K+ NILL  + + K++DFG       +Q+  +
Sbjct: 118 IAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174
Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           T  +VGT  +M+PE      +  K D++S G++ +E+I G+
Sbjct: 175 T--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 56/94 (59%), Gaps = 5/94 (5%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGT 70
           +S  L YLH+     II+RD K  N+LLD E + K++D+G+ +  EG +   TT+   GT
Sbjct: 162 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGT 216
Query: 71  YGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
             Y++PE   G  +    D ++ GV++ E+++G+
Sbjct: 217 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 57/103 (55%), Gaps = 9/103 (8%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD-- 61
           +  I+    + L YLH    +R IHRD K  NILL+ E + K++DFG+     G+ TD  
Sbjct: 127 IATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVA----GQLTDXM 179
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
              N V+GT  +M+PE      ++  +D++S G+  +E+  GK
Sbjct: 180 AKRNXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 84/174 (48%), Gaps = 23/174 (13%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L  ++ G++  + YL   + +  +HRD    NIL++  +  K+SDFGL+R  E   +D T
Sbjct: 137 LVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 193
Query: 64  TNRVVG---TYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLL 119
               +G      + +PE      F+  SDV+S+G+V+ E++S G+R      ++  ++ +
Sbjct: 194 YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI 253
Query: 120 GYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
              ++L      +D     P A+ +         + L C Q+D N RP    +V
Sbjct: 254 EQDYRL---PPPMDC----PSALHQ---------LMLDCWQKDRNHRPKFGQIV 291

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 56/94 (59%), Gaps = 5/94 (5%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGT 70
           +S  L YLH+     II+RD K  N+LLD E + K++D+G+ +  EG +   TT+   GT
Sbjct: 119 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGT 173
Query: 71  YGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
             Y++PE   G  +    D ++ GV++ E+++G+
Sbjct: 174 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 59/107 (55%), Gaps = 6/107 (5%)
Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           M  L +I    ++ + YLH  S   IIHRD K++NI L  ++  KI DFGL  +      
Sbjct: 105 MIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 161
Query: 61  DGTTNRVVGTYGYMSPEYAL---GGFFSVKSDVFSFGVVVLEIISGK 104
                ++ G+  +M+PE         +S +SDV++FG+V+ E+++G+
Sbjct: 162 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 208

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 59/107 (55%), Gaps = 6/107 (5%)
Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           M  L +I    ++ + YLH  S   IIHRD K++NI L  ++  KI DFGL  +      
Sbjct: 103 MIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159
Query: 61  DGTTNRVVGTYGYMSPEYAL---GGFFSVKSDVFSFGVVVLEIISGK 104
                ++ G+  +M+PE         +S +SDV++FG+V+ E+++G+
Sbjct: 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 59/107 (55%), Gaps = 6/107 (5%)
Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           M  L +I    ++ + YLH  S   IIHRD K++NI L  ++  KI DFGL  +      
Sbjct: 103 MIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159
Query: 61  DGTTNRVVGTYGYMSPEYAL---GGFFSVKSDVFSFGVVVLEIISGK 104
                ++ G+  +M+PE         +S +SDV++FG+V+ E+++G+
Sbjct: 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/88 (38%), Positives = 49/88 (55%), Gaps = 7/88 (7%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           Y HQ    RI+HRD K  N+LLD +MN KI+DFG +  F      G  +   G+  Y +P
Sbjct: 126 YCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEF---TVGGKLDTFCGSPPYAAP 179
Query: 77  EYALGGFFS-VKSDVFSFGVVVLEIISG 103
           E   G  +   + DV+S GV++  ++SG
Sbjct: 180 ELFQGKKYDGPEVDVWSLGVILYTLVSG 207

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 56/94 (59%), Gaps = 5/94 (5%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGT 70
           +S  L YLH+     II+RD K  N+LLD E + K++D+G+ +  EG +   TT+   GT
Sbjct: 115 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGT 169
Query: 71  YGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
             Y++PE   G  +    D ++ GV++ E+++G+
Sbjct: 170 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 203

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 59/107 (55%), Gaps = 6/107 (5%)
Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           M  L +I    ++ + YLH  S   IIHRD K++NI L  ++  KI DFGL  +      
Sbjct: 131 MIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 187
Query: 61  DGTTNRVVGTYGYMSPEYAL---GGFFSVKSDVFSFGVVVLEIISGK 104
                ++ G+  +M+PE         +S +SDV++FG+V+ E+++G+
Sbjct: 188 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 59/107 (55%), Gaps = 6/107 (5%)
Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           M  L +I    ++ + YLH  S   IIHRD K++NI L  ++  KI DFGL  +      
Sbjct: 130 MIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 186
Query: 61  DGTTNRVVGTYGYMSPEYAL---GGFFSVKSDVFSFGVVVLEIISGK 104
                ++ G+  +M+PE         +S +SDV++FG+V+ E+++G+
Sbjct: 187 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 233

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 59/107 (55%), Gaps = 6/107 (5%)
Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           M  L +I    ++ + YLH  S   IIHRD K++NI L  ++  KI DFGL  +      
Sbjct: 108 MIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 164
Query: 61  DGTTNRVVGTYGYMSPEYAL---GGFFSVKSDVFSFGVVVLEIISGK 104
                ++ G+  +M+PE         +S +SDV++FG+V+ E+++G+
Sbjct: 165 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 90/196 (45%), Gaps = 28/196 (14%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L  ++ G++  + YL   S +  +HRD    NIL++  +  K+SDFGL R+ E       
Sbjct: 149 LVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAY 205
Query: 64  TNRVVGT-YGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGY 121
           T R       + SPE      F+  SDV+S+G+V+ E++S G+R     +++  +     
Sbjct: 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI----- 260
Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML----- 176
             K   EG  L      P A+ +         + L C Q+D N+RP    +V +L     
Sbjct: 261 --KAVDEGYRLPPPMDCPAALYQ---------LMLDCWQKDRNNRPKFEQIVSILDKLIR 309
Query: 177 --GSEAVNLASPKRPA 190
             GS  +  ++  RP+
Sbjct: 310 NPGSLKIITSAAARPS 325

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 56/101 (55%), Gaps = 9/101 (8%)
Query: 6   NIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTN 65
            I+  + + L YLH + K   IHRD K +N+LL  + + K++DFG+     G+ TD    
Sbjct: 120 TILREILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVA----GQLTDTQIK 172
Query: 66  R--VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           R   VGT  +M+PE      +  K+D++S G+  +E+  G+
Sbjct: 173 RNXFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGE 213

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 69/157 (43%), Gaps = 19/157 (12%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFF 84
           + +HRD    N ++  +   KI DFG+TR            + +    +MSPE    G F
Sbjct: 143 KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPESLKDGVF 202
Query: 85  SVKSDVFSFGVVVLEI--ISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           +  SDV+SFGVV+ EI  ++ +   G  N ++         +   EG  LD  D  P  +
Sbjct: 203 TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL--------RFVMEGGLLDKPDNCPDML 254
Query: 143 SKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE 179
                    + +  +C Q +P  RP+  +++  +  E
Sbjct: 255 ---------LELMRMCWQYNPKMRPSFLEIISSIKEE 282

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 59/107 (55%), Gaps = 6/107 (5%)
Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           M  L +I    ++ + YLH  S   IIHRD K++NI L  ++  KI DFGL  +      
Sbjct: 108 MIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 164
Query: 61  DGTTNRVVGTYGYMSPEYAL---GGFFSVKSDVFSFGVVVLEIISGK 104
                ++ G+  +M+PE         +S +SDV++FG+V+ E+++G+
Sbjct: 165 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 57/104 (54%), Gaps = 13/104 (12%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           ML  I+ G+     YLH + K   IHRD K +N+LL  + + K++DFG+     G+ TD 
Sbjct: 125 MLKEILKGLD----YLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVA----GQLTDT 173
Query: 63  TTNR--VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
              R   VGT  +M+PE      +  K+D++S G+  +E+  G+
Sbjct: 174 QIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGE 217

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/88 (38%), Positives = 48/88 (54%), Gaps = 7/88 (7%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           Y HQ    RI+HRD K  N+LLD +MN KI+DFG +  F      G  +   G   Y +P
Sbjct: 129 YCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEF---TVGGKLDAFCGAPPYAAP 182
Query: 77  EYALGGFFS-VKSDVFSFGVVVLEIISG 103
           E   G  +   + DV+S GV++  ++SG
Sbjct: 183 ELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/91 (38%), Positives = 50/91 (54%), Gaps = 3/91 (3%)
Query: 26  IIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFFS 85
           ++HRD K +N+ LD + N K+ DFGL RI     +   T   VGT  YMSPE      ++
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYMSPEQMNRMSYN 194
Query: 86  VKSDVFSFGVVVLEIIS-GKRNTGFYNSELA 115
            KSD++S G ++ E+ +     T F   ELA
Sbjct: 195 EKSDIWSLGCLLYELCALMPPFTAFSQKELA 225

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 19/157 (12%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFF 84
           + +HRD    N ++  +   KI DFG+TR            + +    +MSPE    G F
Sbjct: 152 KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPESLKDGVF 211
Query: 85  SVKSDVFSFGVVVLEI--ISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           +  SDV+SFGVV+ EI  ++ +   G  N ++         +   EG  LD  D  P  +
Sbjct: 212 TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL--------RFVMEGGLLDKPDNCPDML 263
Query: 143 SKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE 179
               E+++      +C Q +P  RP+  +++  +  E
Sbjct: 264 F---ELMR------MCWQYNPKMRPSFLEIISSIKEE 291

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 73/179 (40%), Gaps = 21/179 (11%)
Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           ME L +    V+R + +L   S  + IHRD    NILL      KI DFGL R       
Sbjct: 198 MEDLISYSFQVARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPD 254
Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSL 118
                       +M+PE      +S KSDV+S+GV++ EI S  G    G    E   S 
Sbjct: 255 YVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSR 314
Query: 119 LGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLG 177
           L       +EG  +   +     I           + L C   DP +RP  +++V  LG
Sbjct: 315 L-------REGMRMRAPEYSTPEI---------YQIMLDCWHRDPKERPRFAELVEKLG 357

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 76/147 (51%), Gaps = 24/147 (16%)
Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTY--GYMSPEYALGGFF 84
           IHRD + +N+L+   +  KI+DFGL R+ E  +    T R    +   + +PE    G F
Sbjct: 132 IHRDLRAANVLVSESLMCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGCF 188
Query: 85  SVKSDVFSFGVVVLEIIS-GK-RNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           ++KSDV+SFG+++ EI++ GK    G  N+++  +L         +G  +  ++  P  +
Sbjct: 189 TIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTAL--------SQGYRMPRVENCPDEL 240
Query: 143 SKANEILKCINVGLLCVQEDPNDRPTM 169
               +I+K      +C +E   +RPT 
Sbjct: 241 Y---DIMK------MCWKEKAEERPTF 258

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 49/91 (53%), Gaps = 3/91 (3%)
Query: 26  IIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFFS 85
           ++HRD K +N+ LD + N K+ DFGL RI      +      VGT  YMSPE      ++
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDEDFAKEFVGTPYYMSPEQMNRMSYN 194
Query: 86  VKSDVFSFGVVVLEIIS-GKRNTGFYNSELA 115
            KSD++S G ++ E+ +     T F   ELA
Sbjct: 195 EKSDIWSLGCLLYELCALMPPFTAFSQKELA 225

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 80/171 (46%), Gaps = 28/171 (16%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L  I+LG      YLH++   R+IHRD K  N+ L+ ++  KI DFGL    E    DG 
Sbjct: 127 LRQIVLGCQ----YLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE---YDGE 176
Query: 64  TNR-VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA 122
             + + GT  Y++PE       S + DV+S G ++  ++ GK    F  S L  + L   
Sbjct: 177 RKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK--PPFETSCLKETYLRIK 234
Query: 123 WKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
              +   K ++     P A S   ++L          Q DP  RPT+++++
Sbjct: 235 KNEYSIPKHIN-----PVAASLIQKML----------QTDPTARPTINELL 270

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 80/176 (45%), Gaps = 23/176 (13%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L  ++ GV   + YL   S L  +HRD    N+L+D  +  K+SDFGL+R+ E    D  
Sbjct: 153 LVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE-DDPDAA 208
Query: 64  TNRVVGTYG--YMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLG 120
                G     + +PE      FS  SDV+SFGVV+ E+++ G+R      +   +S + 
Sbjct: 209 XTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV- 267
Query: 121 YAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
                 +EG  L      P A+ +         + L C  +D   RP  S +V +L
Sbjct: 268 ------EEGYRLPAPMGCPHALHQ---------LMLDCWHKDRAQRPRFSQIVSVL 308

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 80/171 (46%), Gaps = 28/171 (16%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L  I+LG      YLH++   R+IHRD K  N+ L+ ++  KI DFGL    E    DG 
Sbjct: 123 LRQIVLGCQ----YLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE---YDGE 172
Query: 64  TNR-VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA 122
             + + GT  Y++PE       S + DV+S G ++  ++ GK    F  S L  + L   
Sbjct: 173 RKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK--PPFETSCLKETYLRIK 230
Query: 123 WKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
              +   K ++     P A S   ++L          Q DP  RPT+++++
Sbjct: 231 KNEYSIPKHIN-----PVAASLIQKML----------QTDPTARPTINELL 266

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 84/183 (45%), Gaps = 23/183 (12%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQT 60
           E L  + L V   + YL + S   +IHRD    N L+      K+SDFG+TR + + + T
Sbjct: 103 ETLLGMCLDVCEGMAYLEEAS---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 159
Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLL 119
             T  +      + SPE      +S KSDV+SFGV++ E+ S GK      ++   +  +
Sbjct: 160 SSTGTKF--PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 217
Query: 120 GYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE 179
              ++L+           KP   S    + + +N    C +E P DRP  S ++  L + 
Sbjct: 218 STGFRLY-----------KPRLAS--THVYQIMN---HCWKERPEDRPAFSRLLRQLAAI 261
Query: 180 AVN 182
           A +
Sbjct: 262 AAS 264

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 93/194 (47%), Gaps = 28/194 (14%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           E +  + L V R L YLH      +IHRD K+ +ILL  +   K+SDFG    F  + + 
Sbjct: 141 EQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFG----FCAQVSK 193
Query: 62  GTTNR--VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLL 119
               R  +VGT  +M+PE      +  + D++S G++V+E+I G+    ++N        
Sbjct: 194 EVPKRKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE--PPYFNEP------ 245
Query: 120 GYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE 179
                L    +  D +  +   + K + +L+   + L+ V+E P+ R T  +   +LG  
Sbjct: 246 ----PLQAMRRIRDSLPPRVKDLHKVSSVLRGF-LDLMLVRE-PSQRATAQE---LLGHP 296
Query: 180 AVNLASPKRPAFVV 193
            + LA P  P+ +V
Sbjct: 297 FLKLAGP--PSCIV 308

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/88 (37%), Positives = 51/88 (57%), Gaps = 8/88 (9%)
Query: 18  LHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLT-RIFEGKQTDGTTNRVVGTYGYMSP 76
           LH++   RI++RD K  NILLD   + +ISD GL   + EG+   G     VGT GYM+P
Sbjct: 302 LHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAP 354
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISGK 104
           E      ++   D ++ G ++ E+I+G+
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 54/101 (53%), Gaps = 9/101 (8%)
Query: 6   NIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTN 65
            I+  + + L YLH + K   IHRD K +N+LL      K++DFG+     G+ TD    
Sbjct: 123 TILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQIK 175
Query: 66  R--VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           R   VGT  +M+PE      +  K+D++S G+  +E+  G+
Sbjct: 176 RNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 216

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/88 (37%), Positives = 51/88 (57%), Gaps = 8/88 (9%)
Query: 18  LHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLT-RIFEGKQTDGTTNRVVGTYGYMSP 76
           LH++   RI++RD K  NILLD   + +ISD GL   + EG+   G     VGT GYM+P
Sbjct: 302 LHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAP 354
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISGK 104
           E      ++   D ++ G ++ E+I+G+
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 77/176 (43%), Gaps = 31/176 (17%)
Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           +E+   I  GV     Y+H     ++IHRD K SNI L      KI DFGL       + 
Sbjct: 139 LELFEQITKGVD----YIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGLVTSL---KN 188
Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLG 120
           DG   R  GT  YMSPE      +  + D+++ G+++ E++    +T F  S+    L  
Sbjct: 189 DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV-CDTAFETSKFFTDL-- 245
Query: 121 YAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
                 ++G   D+ D+K   + +              + + P DRP  S+++  L
Sbjct: 246 ------RDGIISDIFDKKEKTLLQK------------LLSKKPEDRPNTSEILRTL 283

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 54/101 (53%), Gaps = 9/101 (8%)
Query: 6   NIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTN 65
            I+  + + L YLH + K   IHRD K +N+LL      K++DFG+     G+ TD    
Sbjct: 108 TILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQIK 160
Query: 66  R--VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           R   VGT  +M+PE      +  K+D++S G+  +E+  G+
Sbjct: 161 RNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 201

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 80/171 (46%), Gaps = 28/171 (16%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L  I+LG      YLH++   R+IHRD K  N+ L+ ++  KI DFGL    E    DG 
Sbjct: 123 LRQIVLGCQ----YLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE---YDGE 172
Query: 64  TNR-VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA 122
             + + GT  Y++PE       S + DV+S G ++  ++ GK    F  S L  + L   
Sbjct: 173 RKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK--PPFETSCLKETYLRIK 230
Query: 123 WKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
              +   K ++     P A S   ++L          Q DP  RPT+++++
Sbjct: 231 KNEYSIPKHIN-----PVAASLIQKML----------QTDPTARPTINELL 266

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 87/187 (46%), Gaps = 21/187 (11%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L  ++ G+   + YL   S +  +HRD    NIL++  +  K+SDFG++R+ E       
Sbjct: 118 LVGMLRGIGSGMKYL---SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAY 174
Query: 64  TNRVVGT-YGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGY 121
           T R       + +PE      F+  SDV+S+G+V+ E++S G+R     +++  +  +  
Sbjct: 175 TTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI-- 232
Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEAV 181
                +EG  L      P A+ +         + L C Q++ +DRP    +V ML     
Sbjct: 233 -----EEGYRLPPPMDCPIALHQ---------LMLDCWQKERSDRPKFGQIVNMLDKLIR 278
Query: 182 NLASPKR 188
           N  S KR
Sbjct: 279 NPNSLKR 285

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 54/101 (53%), Gaps = 9/101 (8%)
Query: 6   NIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTN 65
            I+  + + L YLH + K   IHRD K +N+LL      K++DFG+     G+ TD    
Sbjct: 108 TILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQIK 160
Query: 66  R--VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           R   VGT  +M+PE      +  K+D++S G+  +E+  G+
Sbjct: 161 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 201

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 87/187 (46%), Gaps = 21/187 (11%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L  ++ G+   + YL   S +  +HRD    NIL++  +  K+SDFG++R+ E       
Sbjct: 112 LVGMLRGIGSGMKYL---SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAY 168
Query: 64  TNRVVGT-YGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGY 121
           T R       + +PE      F+  SDV+S+G+V+ E++S G+R     +++  +  +  
Sbjct: 169 TTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI-- 226
Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEAV 181
                +EG  L      P A+ +         + L C Q++ +DRP    +V ML     
Sbjct: 227 -----EEGYRLPPPMDCPIALHQ---------LMLDCWQKERSDRPKFGQIVNMLDKLIR 272
Query: 182 NLASPKR 188
           N  S KR
Sbjct: 273 NPNSLKR 279

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 57/107 (53%), Gaps = 6/107 (5%)
Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           M  L +I    ++ + YLH  +   IIHRD K++NI L   +  KI DFGL  +      
Sbjct: 131 MFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187
Query: 61  DGTTNRVVGTYGYMSPEYAL---GGFFSVKSDVFSFGVVVLEIISGK 104
                +  G+  +M+PE         FS +SDV+S+G+V+ E+++G+
Sbjct: 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGE 234

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 87/187 (46%), Gaps = 21/187 (11%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L  ++ G+   + YL   S +  +HRD    NIL++  +  K+SDFG++R+ E       
Sbjct: 133 LVGMLRGIGSGMKYL---SDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAY 189
Query: 64  TNRVVGT-YGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGY 121
           T R       + +PE      F+  SDV+S+G+V+ E++S G+R     +++  +  +  
Sbjct: 190 TTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI-- 247
Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEAV 181
                +EG  L      P A+ +         + L C Q++ +DRP    +V ML     
Sbjct: 248 -----EEGYRLPPPMDCPIALHQ---------LMLDCWQKERSDRPKFGQIVNMLDKLIR 293
Query: 182 NLASPKR 188
           N  S KR
Sbjct: 294 NPNSLKR 300

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 80/176 (45%), Gaps = 23/176 (13%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L  ++ GV   + YL   S L  +HRD    N+L+D  +  K+SDFGL+R+ E    D  
Sbjct: 153 LVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE-DDPDAA 208
Query: 64  TNRVVGTYG--YMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLG 120
                G     + +PE      FS  SDV+SFGVV+ E+++ G+R      +   +S + 
Sbjct: 209 YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV- 267
Query: 121 YAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
                 +EG  L      P A+ +         + L C  +D   RP  S +V +L
Sbjct: 268 ------EEGYRLPAPMGCPHALHQ---------LMLDCWHKDRAQRPRFSQIVSVL 308

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 56/101 (55%), Gaps = 9/101 (8%)
Query: 8   ILGVSRRLL----YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           I  V R  L    +LH +   ++IHRD K+ NILL  + + K++DFG       +Q+   
Sbjct: 118 IAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K 172
Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
            + +VGT  +M+PE      +  K D++S G++ +E+I G+
Sbjct: 173 RSEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 76/146 (52%), Gaps = 24/146 (16%)
Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTY--GYMSPEYALGGFF 84
           IHRD + +N+L+   +  KI+DFGL R+ E  +    T R    +   + +PE    G F
Sbjct: 131 IHRDLRAANVLVSESLMCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGCF 187
Query: 85  SVKSDVFSFGVVVLEIIS-GK-RNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           ++KS+V+SFG+++ EI++ GK    G  N+++  +L         +G  +  M+  P  +
Sbjct: 188 TIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSAL--------SQGYRMPRMENCPDEL 239
Query: 143 SKANEILKCINVGLLCVQEDPNDRPT 168
               +I+K      +C +E   +RPT
Sbjct: 240 Y---DIMK------MCWKEKAEERPT 256

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 48/90 (53%), Gaps = 5/90 (5%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           +LYLH      I+HRD   SN+LL   MN KI+DFGL    +       T  + GT  Y+
Sbjct: 125 MLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYI 179
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           SPE A      ++SDV+S G +   ++ G+
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTLLIGR 209

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/79 (40%), Positives = 45/79 (56%), Gaps = 1/79 (1%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIF-EGKQTDGTTNRVVGTYGYMSPEYALGGF 83
           R IHRD  T NIL+++E   KI DFGLT++  + K+             + +PE      
Sbjct: 138 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 197
Query: 84  FSVKSDVFSFGVVVLEIIS 102
           FSV SDV+SFGVV+ E+ +
Sbjct: 198 FSVASDVWSFGVVLYELFT 216

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 19/157 (12%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFF 84
           + +HRD    N ++  +   KI DFG+TR            + +    +MSPE    G F
Sbjct: 180 KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF 239
Query: 85  SVKSDVFSFGVVVLEI--ISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           +  SDV+SFGVV+ EI  ++ +   G  N ++         +   EG  LD  D  P  +
Sbjct: 240 TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL--------RFVMEGGLLDKPDNCPDML 291
Query: 143 SKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE 179
               E+++      +C Q +P  RP+  +++  +  E
Sbjct: 292 F---ELMR------MCWQYNPKMRPSFLEIISSIKEE 319

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 57/101 (56%), Gaps = 9/101 (8%)
Query: 8   ILGVSRRLL----YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           I  V R  L    +LH +   ++IHR+ K+ NILL  + + K++DFG       +Q+  +
Sbjct: 119 IAAVCRECLQALEFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 175
Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           T  +VGT  +M+PE      +  K D++S G++ +E+I G+
Sbjct: 176 T--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 25/173 (14%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L  +   +S  + YL    K   IHRD    N L+      K++DFGL+R+  G   D 
Sbjct: 110 VLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---DT 163
Query: 63  TTNRVVGTY--GYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLL 119
            T      +   + +PE      FS+KSDV++FGV++ EI + G       +      LL
Sbjct: 164 XTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELL 223
Query: 120 GYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
              ++          M++  G   K  E+++       C Q +P+DRP+ +++
Sbjct: 224 EKDYR----------MERPEGCPEKVYELMRA------CWQWNPSDRPSFAEI 260

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 54/101 (53%), Gaps = 9/101 (8%)
Query: 6   NIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTN 65
            I+  + + L YLH + K   IHRD K +N+LL      K++DFG+     G+ TD    
Sbjct: 128 TILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQIK 180
Query: 66  R--VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           R   VGT  +M+PE      +  K+D++S G+  +E+  G+
Sbjct: 181 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 221

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/79 (40%), Positives = 45/79 (56%), Gaps = 1/79 (1%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIF-EGKQTDGTTNRVVGTYGYMSPEYALGGF 83
           R IHRD  T NIL+++E   KI DFGLT++  + K+             + +PE      
Sbjct: 132 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 191
Query: 84  FSVKSDVFSFGVVVLEIIS 102
           FSV SDV+SFGVV+ E+ +
Sbjct: 192 FSVASDVWSFGVVLYELFT 210

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/79 (40%), Positives = 45/79 (56%), Gaps = 1/79 (1%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIF-EGKQTDGTTNRVVGTYGYMSPEYALGGF 83
           R IHRD  T NIL+++E   KI DFGLT++  + K+             + +PE      
Sbjct: 133 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 192
Query: 84  FSVKSDVFSFGVVVLEIIS 102
           FSV SDV+SFGVV+ E+ +
Sbjct: 193 FSVASDVWSFGVVLYELFT 211

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 51/99 (51%), Gaps = 15/99 (15%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIF--EGKQTDGTTN------- 65
           + YLH    + IIHRD  + N L+    N  ++DFGL R+   E  Q +G  +       
Sbjct: 121 MAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRK 177
Query: 66  ---RVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEII 101
               VVG   +M+PE   G  +  K DVFSFG+V+ EII
Sbjct: 178 KRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/79 (40%), Positives = 45/79 (56%), Gaps = 1/79 (1%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIF-EGKQTDGTTNRVVGTYGYMSPEYALGGF 83
           R IHRD  T NIL+++E   KI DFGLT++  + K+             + +PE      
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 193
Query: 84  FSVKSDVFSFGVVVLEIIS 102
           FSV SDV+SFGVV+ E+ +
Sbjct: 194 FSVASDVWSFGVVLYELFT 212

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 56/101 (55%), Gaps = 9/101 (8%)
Query: 8   ILGVSRRLL----YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           I  V R  L    +LH +   ++IHRD K+ NILL  + + K++DFG       +Q+  +
Sbjct: 118 IAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174
Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
              +VGT  +M+PE      +  K D++S G++ +E+I G+
Sbjct: 175 X--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/79 (40%), Positives = 45/79 (56%), Gaps = 1/79 (1%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIF-EGKQTDGTTNRVVGTYGYMSPEYALGGF 83
           R IHRD  T NIL+++E   KI DFGLT++  + K+             + +PE      
Sbjct: 140 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 199
Query: 84  FSVKSDVFSFGVVVLEIIS 102
           FSV SDV+SFGVV+ E+ +
Sbjct: 200 FSVASDVWSFGVVLYELFT 218

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/79 (40%), Positives = 45/79 (56%), Gaps = 1/79 (1%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIF-EGKQTDGTTNRVVGTYGYMSPEYALGGF 83
           R IHRD  T NIL+++E   KI DFGLT++  + K+             + +PE      
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 193
Query: 84  FSVKSDVFSFGVVVLEIIS 102
           FSV SDV+SFGVV+ E+ +
Sbjct: 194 FSVASDVWSFGVVLYELFT 212

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 72/152 (47%), Gaps = 30/152 (19%)
Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFFSV 86
           IHRD + +NIL+   +  KI+DFGL R+       G    +  T    +PE    G F++
Sbjct: 300 IHRDLRAANILVSASLVCKIADFGLARV-------GAKFPIKWT----APEAINFGSFTI 348
Query: 87  KSDVFSFGVVVLEIISGKR--NTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISK 144
           KSDV+SFG++++EI++  R    G  N E+  +L        + G  +   +  P  +  
Sbjct: 349 KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL--------ERGYRMPRPENCPEEL-- 398
Query: 145 ANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
                   N+ + C +  P +RPT   +  +L
Sbjct: 399 -------YNIMMRCWKNRPEERPTFEYIQSVL 423

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/79 (40%), Positives = 45/79 (56%), Gaps = 1/79 (1%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIF-EGKQTDGTTNRVVGTYGYMSPEYALGGF 83
           R IHRD  T NIL+++E   KI DFGLT++  + K+             + +PE      
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 196
Query: 84  FSVKSDVFSFGVVVLEIIS 102
           FSV SDV+SFGVV+ E+ +
Sbjct: 197 FSVASDVWSFGVVLYELFT 215

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 32/79 (40%), Positives = 45/79 (56%), Gaps = 1/79 (1%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIF-EGKQTDGTTNRVVGTYGYMSPEYALGGF 83
           R IHRD  T NIL+++E   KI DFGLT++  + K+             + +PE      
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 196
Query: 84  FSVKSDVFSFGVVVLEIIS 102
           FSV SDV+SFGVV+ E+ +
Sbjct: 197 FSVASDVWSFGVVLYELFT 215

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 32/79 (40%), Positives = 45/79 (56%), Gaps = 1/79 (1%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIF-EGKQTDGTTNRVVGTYGYMSPEYALGGF 83
           R IHRD  T NIL+++E   KI DFGLT++  + K+             + +PE      
Sbjct: 152 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 211
Query: 84  FSVKSDVFSFGVVVLEIIS 102
           FSV SDV+SFGVV+ E+ +
Sbjct: 212 FSVASDVWSFGVVLYELFT 230

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 59/108 (54%), Gaps = 12/108 (11%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLT-RIFEGKQTD 61
           +L  + + + + L YL +  K  +IHRD K SNILLD     K+ DFG++ R+ + K  D
Sbjct: 125 ILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD 182
Query: 62  GTTNRVVGTYGYMSPEY-----ALGGFFSVKSDVFSFGVVVLEIISGK 104
               R  G   YM+PE           + +++DV+S G+ ++E+ +G+
Sbjct: 183 ----RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 32/79 (40%), Positives = 45/79 (56%), Gaps = 1/79 (1%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIF-EGKQTDGTTNRVVGTYGYMSPEYALGGF 83
           R IHRD  T NIL+++E   KI DFGLT++  + K+             + +PE      
Sbjct: 141 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 200
Query: 84  FSVKSDVFSFGVVVLEIIS 102
           FSV SDV+SFGVV+ E+ +
Sbjct: 201 FSVASDVWSFGVVLYELFT 219

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 25/173 (14%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L  +   +S  + YL    K   IHRD    N L+      K++DFGL+R+  G   D 
Sbjct: 110 VLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---DT 163
Query: 63  TTNRVVGTY--GYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLL 119
            T      +   + +PE      FS+KSDV++FGV++ EI + G       +      LL
Sbjct: 164 XTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELL 223
Query: 120 GYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
              ++          M++  G   K  E+++       C Q +P+DRP+ +++
Sbjct: 224 EKDYR----------MERPEGCPEKVYELMRA------CWQWNPSDRPSFAEI 260

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 56/101 (55%), Gaps = 9/101 (8%)
Query: 8   ILGVSRRLL----YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           I  V R  L    +LH +   ++IHRD K+ NILL  + + K++DFG       +Q+  +
Sbjct: 119 IAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 175
Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
              +VGT  +M+PE      +  K D++S G++ +E+I G+
Sbjct: 176 X--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 32/79 (40%), Positives = 45/79 (56%), Gaps = 1/79 (1%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIF-EGKQTDGTTNRVVGTYGYMSPEYALGGF 83
           R IHRD  T NIL+++E   KI DFGLT++  + K+             + +PE      
Sbjct: 139 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 198
Query: 84  FSVKSDVFSFGVVVLEIIS 102
           FSV SDV+SFGVV+ E+ +
Sbjct: 199 FSVASDVWSFGVVLYELFT 217

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 19/157 (12%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFF 84
           + +HRD    N ++  +   KI DFG+TR            + +    +MSPE    G F
Sbjct: 151 KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF 210
Query: 85  SVKSDVFSFGVVVLEI--ISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           +  SDV+SFGVV+ EI  ++ +   G  N ++         +   EG  LD  D  P  +
Sbjct: 211 TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL--------RFVMEGGLLDKPDNCPDML 262
Query: 143 SKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE 179
               E+++      +C Q +P  RP+  +++  +  E
Sbjct: 263 F---ELMR------MCWQYNPKMRPSFLEIISSIKEE 290

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 32/79 (40%), Positives = 45/79 (56%), Gaps = 1/79 (1%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIF-EGKQTDGTTNRVVGTYGYMSPEYALGGF 83
           R IHRD  T NIL+++E   KI DFGLT++  + K+             + +PE      
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 196
Query: 84  FSVKSDVFSFGVVVLEIIS 102
           FSV SDV+SFGVV+ E+ +
Sbjct: 197 FSVASDVWSFGVVLYELFT 215

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 32/79 (40%), Positives = 45/79 (56%), Gaps = 1/79 (1%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIF-EGKQTDGTTNRVVGTYGYMSPEYALGGF 83
           R IHRD  T NIL+++E   KI DFGLT++  + K+             + +PE      
Sbjct: 165 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 224
Query: 84  FSVKSDVFSFGVVVLEIIS 102
           FSV SDV+SFGVV+ E+ +
Sbjct: 225 FSVASDVWSFGVVLYELFT 243

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 19/157 (12%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFF 84
           + +HRD    N ++  +   KI DFG+TR            + +    +MSPE    G F
Sbjct: 149 KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF 208
Query: 85  SVKSDVFSFGVVVLEI--ISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           +  SDV+SFGVV+ EI  ++ +   G  N ++         +   EG  LD  D  P  +
Sbjct: 209 TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL--------RFVMEGGLLDKPDNCPDML 260
Query: 143 SKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE 179
               E+++      +C Q +P  RP+  +++  +  E
Sbjct: 261 F---ELMR------MCWQYNPKMRPSFLEIISSIKEE 288

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 72/157 (45%), Gaps = 19/157 (12%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFF 84
           + +HRD    N ++  +   KI DFG+TR            + +    +MSPE    G F
Sbjct: 145 KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF 204
Query: 85  SVKSDVFSFGVVVLEI--ISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           +  SDV+SFGVV+ EI  ++ +   G  N ++   ++        EG  LD  D  P  +
Sbjct: 205 TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM--------EGGLLDKPDNCPDML 256
Query: 143 SKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE 179
               E+++      +C Q +P  RP+  +++  +  E
Sbjct: 257 F---ELMR------MCWQYNPKMRPSFLEIISSIKEE 284

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 19/157 (12%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFF 84
           + +HRD    N ++  +   KI DFG+TR            + +    +MSPE    G F
Sbjct: 148 KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF 207
Query: 85  SVKSDVFSFGVVVLEI--ISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           +  SDV+SFGVV+ EI  ++ +   G  N ++         +   EG  LD  D  P  +
Sbjct: 208 TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL--------RFVMEGGLLDKPDNCPDML 259
Query: 143 SKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE 179
               E+++      +C Q +P  RP+  +++  +  E
Sbjct: 260 F---ELMR------MCWQYNPKMRPSFLEIISSIKEE 287

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 32/79 (40%), Positives = 45/79 (56%), Gaps = 1/79 (1%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIF-EGKQTDGTTNRVVGTYGYMSPEYALGGF 83
           R IHRD  T NIL+++E   KI DFGLT++  + K+             + +PE      
Sbjct: 152 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 211
Query: 84  FSVKSDVFSFGVVVLEIIS 102
           FSV SDV+SFGVV+ E+ +
Sbjct: 212 FSVASDVWSFGVVLYELFT 230

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 19/157 (12%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFF 84
           + +HRD    N ++  +   KI DFG+TR            + +    +MSPE    G F
Sbjct: 151 KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF 210
Query: 85  SVKSDVFSFGVVVLEI--ISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           +  SDV+SFGVV+ EI  ++ +   G  N ++         +   EG  LD  D  P  +
Sbjct: 211 TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL--------RFVMEGGLLDKPDNCPDML 262
Query: 143 SKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE 179
               E+++      +C Q +P  RP+  +++  +  E
Sbjct: 263 F---ELMR------MCWQYNPKMRPSFLEIISSIKEE 290

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 19/157 (12%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFF 84
           + +HRD    N ++  +   KI DFG+TR            + +    +MSPE    G F
Sbjct: 158 KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF 217
Query: 85  SVKSDVFSFGVVVLEI--ISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           +  SDV+SFGVV+ EI  ++ +   G  N ++         +   EG  LD  D  P  +
Sbjct: 218 TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL--------RFVMEGGLLDKPDNCPDML 269
Query: 143 SKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE 179
               E+++      +C Q +P  RP+  +++  +  E
Sbjct: 270 F---ELMR------MCWQYNPKMRPSFLEIISSIKEE 297

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 62/109 (56%), Gaps = 10/109 (9%)
Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           M  L +I    ++ + YLH  S   IIHRD K++NI L  ++  KI DFGL    E  + 
Sbjct: 123 MIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLAT--EKSRW 177
Query: 61  DGTTN--RVVGTYGYMSPEYAL---GGFFSVKSDVFSFGVVVLEIISGK 104
            G+    ++ G+  +M+PE         +S +SDV++FG+V+ E+++G+
Sbjct: 178 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 226

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 19/157 (12%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFF 84
           + +HRD    N ++  +   KI DFG+TR            + +    +MSPE    G F
Sbjct: 152 KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF 211
Query: 85  SVKSDVFSFGVVVLEI--ISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           +  SDV+SFGVV+ EI  ++ +   G  N ++         +   EG  LD  D  P  +
Sbjct: 212 TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL--------RFVMEGGLLDKPDNCPDML 263
Query: 143 SKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE 179
               E+++      +C Q +P  RP+  +++  +  E
Sbjct: 264 F---ELMR------MCWQYNPKMRPSFLEIISSIKEE 291

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 62/109 (56%), Gaps = 10/109 (9%)
Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           M  L +I    ++ + YLH  S   IIHRD K++NI L  ++  KI DFGL    E  + 
Sbjct: 103 MIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLAT--EKSRW 157
Query: 61  DGTTN--RVVGTYGYMSPEYAL---GGFFSVKSDVFSFGVVVLEIISGK 104
            G+    ++ G+  +M+PE         +S +SDV++FG+V+ E+++G+
Sbjct: 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 62/109 (56%), Gaps = 10/109 (9%)
Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           M  L +I    ++ + YLH  S   IIHRD K++NI L  ++  KI DFGL    E  + 
Sbjct: 131 MIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLAT--EKSRW 185
Query: 61  DGTTN--RVVGTYGYMSPEYAL---GGFFSVKSDVFSFGVVVLEIISGK 104
            G+    ++ G+  +M+PE         +S +SDV++FG+V+ E+++G+
Sbjct: 186 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 32/89 (35%), Positives = 50/89 (56%), Gaps = 5/89 (5%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L++LH      II+RD K  N+LLDHE + K++DFG+ +  EG     TT    GT  Y+
Sbjct: 137 LMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYI 191
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           +PE      +    D ++ GV++ E++ G
Sbjct: 192 APEILQEMLYGPAVDWWAMGVLLYEMLCG 220

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 19/157 (12%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFF 84
           + +HRD    N ++  +   KI DFG+TR            + +    +MSPE    G F
Sbjct: 158 KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF 217
Query: 85  SVKSDVFSFGVVVLEI--ISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           +  SDV+SFGVV+ EI  ++ +   G  N ++         +   EG  LD  D  P  +
Sbjct: 218 TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL--------RFVMEGGLLDKPDNCPDML 269
Query: 143 SKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE 179
               E+++      +C Q +P  RP+  +++  +  E
Sbjct: 270 F---ELMR------MCWQYNPKMRPSFLEIISSIKEE 297

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 48/91 (52%), Gaps = 3/91 (3%)
Query: 26  IIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFFS 85
           ++HRD K +N+ LD + N K+ DFGL RI             VGT  YMSPE      ++
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKAFVGTPYYMSPEQMNRMSYN 194
Query: 86  VKSDVFSFGVVVLEIIS-GKRNTGFYNSELA 115
            KSD++S G ++ E+ +     T F   ELA
Sbjct: 195 EKSDIWSLGCLLYELCALMPPFTAFSQKELA 225

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 71/153 (46%), Gaps = 19/153 (12%)
Query: 22  SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG 81
           S   ++H+D  T N+L+  ++N KISD GL R              +    +M+PE  + 
Sbjct: 162 SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY 221
Query: 82  GFFSVKSDVFSFGVVVLEIISG--KRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKP 139
           G FS+ SD++S+GVV+ E+ S   +   G+ N ++         ++ +  + L   D  P
Sbjct: 222 GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV--------EMIRNRQVLPCPDDCP 273
Query: 140 GAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
             +     +++C N       E P+ RP   D+
Sbjct: 274 AWVYAL--MIECWN-------EFPSRRPRFKDI 297

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 25/173 (14%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L  +   +S  + YL    K   IHRD    N L+      K++DFGL+R+  G   D 
Sbjct: 110 VLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---DT 163
Query: 63  TTNRVVGTY--GYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLL 119
            T      +   + +PE      FS+KSDV++FGV++ EI + G       +      LL
Sbjct: 164 FTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELL 223
Query: 120 GYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
              ++          M++  G   K  E+++       C Q +P+DRP+ +++
Sbjct: 224 EKDYR----------MERPEGCPEKVYELMRA------CWQWNPSDRPSFAEI 260

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 81/178 (45%), Gaps = 33/178 (18%)
Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           +EM +++  G++   L  HQ      IHRD    N L+D ++  K+SDFG+TR       
Sbjct: 107 LEMCYDVCEGMA--FLESHQ-----FIHRDLAARNCLVDRDLCVKVSDFGMTRYV----L 155
Query: 61  DGTTNRVVGT---YGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFY-NSELA 115
           D      VGT     + +PE      +S KSDV++FG+++ E+ S GK     Y NSE+ 
Sbjct: 156 DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV 215
Query: 116 LSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
           L  +    +L++   A D + Q                +   C  E P  RPT   ++
Sbjct: 216 LK-VSQGHRLYRPHLASDTIYQ----------------IMYSCWHELPEKRPTFQQLL 256

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 71/153 (46%), Gaps = 19/153 (12%)
Query: 22  SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG 81
           S   ++H+D  T N+L+  ++N KISD GL R              +    +M+PE  + 
Sbjct: 145 SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY 204
Query: 82  GFFSVKSDVFSFGVVVLEIISG--KRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKP 139
           G FS+ SD++S+GVV+ E+ S   +   G+ N ++         ++ +  + L   D  P
Sbjct: 205 GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV--------EMIRNRQVLPCPDDCP 256
Query: 140 GAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
             +     +++C N       E P+ RP   D+
Sbjct: 257 AWVYAL--MIECWN-------EFPSRRPRFKDI 280

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 80/173 (46%), Gaps = 24/173 (13%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQTDG 62
           L +    V+R + YL   +  + IHRD    N+L+  +   KI+DFGL R I        
Sbjct: 152 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKK 208
Query: 63  TTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLG 120
           TTN  +    +M+PE      ++ +SDV+SFGV++ EI +  G    G    EL      
Sbjct: 209 TTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL------ 261
Query: 121 YAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
             +KL +EG  +D    KP   +  NE+   +     C    P+ RPT   +V
Sbjct: 262 --FKLLKEGHRMD----KPSNCT--NELYMMMRD---CWHAVPSQRPTFKQLV 303

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 25/173 (14%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L  +   +S  + YL    K   IHRD    N L+      K++DFGL+R+  G   D 
Sbjct: 113 VLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---DT 166
Query: 63  TTNRVVGTY--GYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLL 119
            T      +   + +PE      FS+KSDV++FGV++ EI + G       +      LL
Sbjct: 167 XTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 226
Query: 120 GYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
              ++          M++  G   K  E+++       C Q +P+DRP+ +++
Sbjct: 227 EKDYR----------MERPEGCPEKVYELMRA------CWQWNPSDRPSFAEI 263

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 56.6 bits (135), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 25/173 (14%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L  +   +S  + YL    K   IHRD    N L+      K++DFGL+R+  G   D 
Sbjct: 117 VLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---DT 170
Query: 63  TTNRVVGTY--GYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLL 119
            T      +   + +PE      FS+KSDV++FGV++ EI + G       +      LL
Sbjct: 171 XTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 230
Query: 120 GYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
              ++          M++  G   K  E+++       C Q +P+DRP+ +++
Sbjct: 231 EKDYR----------MERPEGCPEKVYELMRA------CWQWNPSDRPSFAEI 267

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 83/174 (47%), Gaps = 23/174 (13%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L  ++ G++  + YL   + +  +HR     NIL++  +  K+SDFGL+R  E   +D T
Sbjct: 111 LVGMLRGIAAGMKYL---ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 167
Query: 64  TNRVVG---TYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLL 119
               +G      + +PE      F+  SDV+S+G+V+ E++S G+R      ++  ++ +
Sbjct: 168 YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI 227
Query: 120 GYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
              ++L      +D     P A+ +         + L C Q+D N RP    +V
Sbjct: 228 EQDYRL---PPPMDC----PSALHQ---------LMLDCWQKDRNHRPKFGQIV 265

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 58/102 (56%), Gaps = 10/102 (9%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L+ ++ GV+    + HQ    RI+HRD K  N+L++ +   K++DFGL R F G      
Sbjct: 125 LYQLLRGVA----HCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSY 176
Query: 64  TNRVVGTYGYMSPEYALGG-FFSVKSDVFSFGVVVLEIISGK 104
           T+ VV T  Y +P+  +G   +S   D++S G +  E+I+GK
Sbjct: 177 THEVV-TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 58/102 (56%), Gaps = 10/102 (9%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L+ ++ GV+    + HQ    RI+HRD K  N+L++ +   K++DFGL R F G      
Sbjct: 125 LYQLLRGVA----HCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSY 176
Query: 64  TNRVVGTYGYMSPEYALGG-FFSVKSDVFSFGVVVLEIISGK 104
           T+ VV T  Y +P+  +G   +S   D++S G +  E+I+GK
Sbjct: 177 THEVV-TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 25/173 (14%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L  +   +S  + YL    K   IHRD    N L+      K++DFGL+R+  G   D 
Sbjct: 114 VLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---DT 167
Query: 63  TTNRVVGTY--GYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLL 119
            T      +   + +PE      FS+KSDV++FGV++ EI + G       +      LL
Sbjct: 168 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 227
Query: 120 GYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
              ++          M++  G   K  E+++       C Q +P+DRP+ +++
Sbjct: 228 EKDYR----------MERPEGCPEKVYELMRA------CWQWNPSDRPSFAEI 264

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 69/157 (43%), Gaps = 19/157 (12%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFF 84
           + +HRD    N  +  +   KI DFG+TR            + +    +MSPE    G F
Sbjct: 145 KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF 204
Query: 85  SVKSDVFSFGVVVLEI--ISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           +  SDV+SFGVV+ EI  ++ +   G  N ++   ++        EG  LD  D  P  +
Sbjct: 205 TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM--------EGGLLDKPDNCPDML 256
Query: 143 SKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE 179
                    + +  +C Q +P  RP+  +++  +  E
Sbjct: 257 ---------LELMRMCWQYNPKMRPSFLEIISSIKEE 284

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 87/179 (48%), Gaps = 29/179 (16%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           ++L  I + + + L +LH  SKL +IHRD K SN+L++     K+ DFG++    G   D
Sbjct: 153 DILGKIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS----GYLVD 206
Query: 62  GTTNRV-VGTYGYMSPEYALGGF----FSVKSDVFSFGVVVLEIISGKRNTGFYNSELAL 116
                +  G   YM+PE          +SVKSD++S G+ ++E                L
Sbjct: 207 SVAKTIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIE----------------L 250
Query: 117 SLLGYAWKLW-QEGKALDMMDQKPGAISKANEI-LKCINVGLLCVQEDPNDRPTMSDVV 173
           ++L + +  W    + L  + ++P     A++   + ++    C++++  +RPT  +++
Sbjct: 251 AILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELM 309

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 25/173 (14%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L  +   +S  + YL    K   IHRD    N L+      K++DFGL+R+  G   D 
Sbjct: 117 VLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---DT 170
Query: 63  TTNRVVGTY--GYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLL 119
            T      +   + +PE      FS+KSDV++FGV++ EI + G       +      LL
Sbjct: 171 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 230
Query: 120 GYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
              ++          M++  G   K  E+++       C Q +P+DRP+ +++
Sbjct: 231 EKDYR----------MERPEGCPEKVYELMRA------CWQWNPSDRPSFAEI 267

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 25/173 (14%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L  +   +S  + YL    K   IHRD    N L+      K++DFGL+R+  G   D 
Sbjct: 114 VLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---DT 167
Query: 63  TTNRVVGTY--GYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLL 119
            T      +   + +PE      FS+KSDV++FGV++ EI + G       +      LL
Sbjct: 168 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 227
Query: 120 GYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
              ++          M++  G   K  E+++       C Q +P+DRP+ +++
Sbjct: 228 EKDYR----------MERPEGCPEKVYELMRA------CWQWNPSDRPSFAEI 264

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 57/105 (54%), Gaps = 9/105 (8%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           E +  +   V + L YLH      +IHRD K+ +ILL  +   K+SDFG    F  + + 
Sbjct: 141 EQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFG----FCAQISK 193
Query: 62  GTTNR--VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
               R  +VGT  +M+PE      ++ + D++S G++V+E++ G+
Sbjct: 194 DVPKRKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 80/173 (46%), Gaps = 24/173 (13%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQTDG 62
           L +    V+R + YL   +  + IHRD    N+L+  +   KI+DFGL R I        
Sbjct: 152 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 63  TTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLG 120
           TTN  +    +M+PE      ++ +SDV+SFGV++ EI +  G    G    EL      
Sbjct: 209 TTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL------ 261
Query: 121 YAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
             +KL +EG  +D    KP   +  NE+   +     C    P+ RPT   +V
Sbjct: 262 --FKLLKEGHRMD----KPSNCT--NELYMMMRD---CWHAVPSQRPTFKQLV 303

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 25/173 (14%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L  +   +S  + YL    K   IHRD    N L+      K++DFGL+R+  G   D 
Sbjct: 112 VLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---DT 165
Query: 63  TTNRVVGTY--GYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLL 119
            T      +   + +PE      FS+KSDV++FGV++ EI + G       +      LL
Sbjct: 166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225
Query: 120 GYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
              ++          M++  G   K  E+++       C Q +P+DRP+ +++
Sbjct: 226 EKDYR----------MERPEGCPEKVYELMRA------CWQWNPSDRPSFAEI 262

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 25/173 (14%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L  +   +S  + YL    K   IHRD    N L+      K++DFGL+R+  G   D 
Sbjct: 112 VLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---DT 165
Query: 63  TTNRVVGTY--GYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLL 119
            T      +   + +PE      FS+KSDV++FGV++ EI + G       +      LL
Sbjct: 166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225
Query: 120 GYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
              ++          M++  G   K  E+++       C Q +P+DRP+ +++
Sbjct: 226 EKDYR----------MERPEGCPEKVYELMRA------CWQWNPSDRPSFAEI 262

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 25/173 (14%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L  +   +S  + YL    K   IHRD    N L+      K++DFGL+R+  G   D 
Sbjct: 112 VLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---DT 165
Query: 63  TTNRVVGTY--GYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLL 119
            T      +   + +PE      FS+KSDV++FGV++ EI + G       +      LL
Sbjct: 166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225
Query: 120 GYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
              ++          M++  G   K  E+++       C Q +P+DRP+ +++
Sbjct: 226 EKDYR----------MERPEGCPEKVYELMRA------CWQWNPSDRPSFAEI 262

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 80/173 (46%), Gaps = 24/173 (13%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQTDG 62
           L +    V+R + YL   +  + IHRD    N+L+  +   KI+DFGL R I        
Sbjct: 152 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 63  TTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLG 120
           TTN  +    +M+PE      ++ +SDV+SFGV++ EI +  G    G    EL      
Sbjct: 209 TTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL------ 261
Query: 121 YAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
             +KL +EG  +D    KP   +  NE+   +     C    P+ RPT   +V
Sbjct: 262 --FKLLKEGHRMD----KPSNCT--NELYMMMRD---CWHAVPSQRPTFKQLV 303

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 80/173 (46%), Gaps = 24/173 (13%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQTDG 62
           L +    V+R + YL   +  + IHRD    N+L+  +   KI+DFGL R I        
Sbjct: 152 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 63  TTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLG 120
           TTN  +    +M+PE      ++ +SDV+SFGV++ EI +  G    G    EL      
Sbjct: 209 TTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL------ 261
Query: 121 YAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
             +KL +EG  +D    KP   +  NE+   +     C    P+ RPT   +V
Sbjct: 262 --FKLLKEGHRMD----KPSNCT--NELYMMMRD---CWHAVPSQRPTFKQLV 303

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 25/173 (14%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L  +   +S  + YL    K   IHRD    N L+      K++DFGL+R+  G   D 
Sbjct: 117 VLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---DT 170
Query: 63  TTNRVVGTY--GYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLL 119
            T      +   + +PE      FS+KSDV++FGV++ EI + G       +      LL
Sbjct: 171 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 230
Query: 120 GYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
              ++          M++  G   K  E+++       C Q +P+DRP+ +++
Sbjct: 231 EKDYR----------MERPEGCPEKVYELMRA------CWQWNPSDRPSFAEI 267

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 25/173 (14%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L  +   +S  + YL    K   IHRD    N L+      K++DFGL+R+  G   D 
Sbjct: 112 VLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---DT 165
Query: 63  TTNRVVGTY--GYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLL 119
            T      +   + +PE      FS+KSDV++FGV++ EI + G       +      LL
Sbjct: 166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225
Query: 120 GYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
              ++          M++  G   K  E+++       C Q +P+DRP+ +++
Sbjct: 226 EKDYR----------MERPEGCPEKVYELMRA------CWQWNPSDRPSFAEI 262

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 25/173 (14%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L  +   +S  + YL    K   IHRD    N L+      K++DFGL+R+  G   D 
Sbjct: 117 VLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---DT 170
Query: 63  TTNRVVGTY--GYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLL 119
            T      +   + +PE      FS+KSDV++FGV++ EI + G       +      LL
Sbjct: 171 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 230
Query: 120 GYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
              ++          M++  G   K  E+++       C Q +P+DRP+ +++
Sbjct: 231 EKDYR----------MERPEGCPEKVYELMRA------CWQWNPSDRPSFAEI 267

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 25/173 (14%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L  +   +S  + YL    K   IHRD    N L+      K++DFGL+R+  G   D 
Sbjct: 116 VLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---DT 169
Query: 63  TTNRVVGTY--GYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLL 119
            T      +   + +PE      FS+KSDV++FGV++ EI + G       +      LL
Sbjct: 170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 229
Query: 120 GYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
              ++          M++  G   K  E+++       C Q +P+DRP+ +++
Sbjct: 230 EKDYR----------MERPEGCPEKVYELMRA------CWQWNPSDRPSFAEI 266

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 80/173 (46%), Gaps = 24/173 (13%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQTDG 62
           L +    V+R + YL   +  + IHRD    N+L+  +   KI+DFGL R I        
Sbjct: 137 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 63  TTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLG 120
           TTN  +    +M+PE      ++ +SDV+SFGV++ EI +  G    G    EL      
Sbjct: 194 TTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL------ 246
Query: 121 YAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
             +KL +EG  +D    KP   +  NE+   +     C    P+ RPT   +V
Sbjct: 247 --FKLLKEGHRMD----KPSNCT--NELYMMMRD---CWHAVPSQRPTFKQLV 288

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 80/173 (46%), Gaps = 24/173 (13%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQTDG 62
           L +    V+R + YL   +  + IHRD    N+L+  +   KI+DFGL R I        
Sbjct: 145 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 201
Query: 63  TTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLG 120
           TTN  +    +M+PE      ++ +SDV+SFGV++ EI +  G    G    EL      
Sbjct: 202 TTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL------ 254
Query: 121 YAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
             +KL +EG  +D    KP   +  NE+   +     C    P+ RPT   +V
Sbjct: 255 --FKLLKEGHRMD----KPSNCT--NELYMMMRD---CWHAVPSQRPTFKQLV 296

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 25/173 (14%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L  +   +S  + YL    K   IHRD    N L+      K++DFGL+R+  G   D 
Sbjct: 112 VLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---DT 165
Query: 63  TTNRVVGTY--GYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLL 119
            T      +   + +PE      FS+KSDV++FGV++ EI + G       +      LL
Sbjct: 166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225
Query: 120 GYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
              ++          M++  G   K  E+++       C Q +P+DRP+ +++
Sbjct: 226 EKDYR----------MERPEGCPEKVYELMRA------CWQWNPSDRPSFAEI 262

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 80/173 (46%), Gaps = 24/173 (13%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQTDG 62
           L +    V+R + YL   +  + IHRD    N+L+  +   KI+DFGL R I        
Sbjct: 144 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 200
Query: 63  TTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLG 120
           TTN  +    +M+PE      ++ +SDV+SFGV++ EI +  G    G    EL      
Sbjct: 201 TTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL------ 253
Query: 121 YAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
             +KL +EG  +D    KP   +  NE+   +     C    P+ RPT   +V
Sbjct: 254 --FKLLKEGHRMD----KPSNCT--NELYMMMRD---CWHAVPSQRPTFKQLV 295

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 80/173 (46%), Gaps = 24/173 (13%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQTDG 62
           L +    V+R + YL   +  + IHRD    N+L+  +   KI+DFGL R I        
Sbjct: 141 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 197
Query: 63  TTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLG 120
           TTN  +    +M+PE      ++ +SDV+SFGV++ EI +  G    G    EL      
Sbjct: 198 TTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL------ 250
Query: 121 YAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
             +KL +EG  +D    KP   +  NE+   +     C    P+ RPT   +V
Sbjct: 251 --FKLLKEGHRMD----KPSNCT--NELYMMMRD---CWHAVPSQRPTFKQLV 292

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 85/174 (48%), Gaps = 28/174 (16%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQTDG 62
           L +    +S+ + YL   ++++++HRD    NIL+      KISDFGL+R ++E    D 
Sbjct: 152 LISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE---EDS 205
Query: 63  TTNRVVG--TYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSL 118
              R  G     +M+ E      ++ +SDV+SFGV++ EI++  G    G     L    
Sbjct: 206 XVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL---- 261
Query: 119 LGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
               + L + G  ++  D      + + E+ + +   L C +++P+ RP  +D+
Sbjct: 262 ----FNLLKTGHRMERPD------NCSEEMYRLM---LQCWKQEPDKRPVFADI 302

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 25/173 (14%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L  +   +S  + YL    K   IHRD    N L+      K++DFGL+R+  G   D 
Sbjct: 125 VLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---DT 178
Query: 63  TTNRVVGTY--GYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLL 119
            T      +   + +PE      FS+KSDV++FGV++ EI + G       +      LL
Sbjct: 179 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 238
Query: 120 GYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
              ++          M++  G   K  E+++       C Q +P+DRP+ +++
Sbjct: 239 EKDYR----------MERPEGCPEKVYELMRA------CWQWNPSDRPSFAEI 275

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 25/173 (14%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L  +   +S  + YL    K   IHRD    N L+      K++DFGL+R+  G   D 
Sbjct: 117 VLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---DT 170
Query: 63  TTNRVVGTY--GYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLL 119
            T      +   + +PE      FS+KSDV++FGV++ EI + G       +      LL
Sbjct: 171 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 230
Query: 120 GYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
              ++          M++  G   K  E+++       C Q +P+DRP+ +++
Sbjct: 231 EKDYR----------MERPEGCPEKVYELMRA------CWQWNPSDRPSFAEI 267

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 25/173 (14%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L  +   +S  + YL    K   IHRD    N L+      K++DFGL+R+  G   D 
Sbjct: 112 VLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---DT 165
Query: 63  TTNRVVGTY--GYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLL 119
            T      +   + +PE      FS+KSDV++FGV++ EI + G       +      LL
Sbjct: 166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225
Query: 120 GYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
              ++          M++  G   K  E+++       C Q +P+DRP+ +++
Sbjct: 226 EKDYR----------MERPEGCPEKVYELMRA------CWQWNPSDRPSFAEI 262

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 54/99 (54%), Gaps = 12/99 (12%)
Query: 6   NIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTN 65
            IILG+       H  ++  +++RD K +NILLD   + +ISD GL   F  K+   +  
Sbjct: 300 EIILGLE------HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-- 350
Query: 66  RVVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISG 103
             VGT+GYM+PE    G  +   +D FS G ++ +++ G
Sbjct: 351 --VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 54/99 (54%), Gaps = 12/99 (12%)
Query: 6   NIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTN 65
            IILG+       H  ++  +++RD K +NILLD   + +ISD GL   F  K+   +  
Sbjct: 300 EIILGLE------HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-- 350
Query: 66  RVVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISG 103
             VGT+GYM+PE    G  +   +D FS G ++ +++ G
Sbjct: 351 --VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 54/99 (54%), Gaps = 12/99 (12%)
Query: 6   NIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTN 65
            IILG+       H  ++  +++RD K +NILLD   + +ISD GL   F  K+   +  
Sbjct: 300 EIILGLE------HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-- 350
Query: 66  RVVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISG 103
             VGT+GYM+PE    G  +   +D FS G ++ +++ G
Sbjct: 351 --VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 54/99 (54%), Gaps = 12/99 (12%)
Query: 6   NIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTN 65
            IILG+       H  ++  +++RD K +NILLD   + +ISD GL   F  K+   +  
Sbjct: 299 EIILGLE------HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-- 349
Query: 66  RVVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISG 103
             VGT+GYM+PE    G  +   +D FS G ++ +++ G
Sbjct: 350 --VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 386

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 77/172 (44%), Gaps = 23/172 (13%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L  +   +S  + YL    K   IHRD    N L+      K++DFGL+R+  G   D 
Sbjct: 131 VLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTG---DT 184
Query: 63  TTNRVVGTY--GYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLG 120
            T      +   + +PE      FS+KSDV++FGV++ EI +      +  S      L 
Sbjct: 185 YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIAT------YGMSPYPGIDLS 238
Query: 121 YAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
             + L ++G     M+Q  G   K  E+++       C +  P DRP+ ++ 
Sbjct: 239 QVYDLLEKGYR---MEQPEGCPPKVYELMRA------CWKWSPADRPSFAET 281

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 85/174 (48%), Gaps = 28/174 (16%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQTDG 62
           L +    +S+ + YL   ++++++HRD    NIL+      KISDFGL+R ++E    D 
Sbjct: 152 LISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE---EDS 205
Query: 63  TTNRVVG--TYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSL 118
              R  G     +M+ E      ++ +SDV+SFGV++ EI++  G    G     L    
Sbjct: 206 YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL---- 261
Query: 119 LGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
               + L + G  ++  D      + + E+ + +   L C +++P+ RP  +D+
Sbjct: 262 ----FNLLKTGHRMERPD------NCSEEMYRLM---LQCWKQEPDKRPVFADI 302

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 81/189 (42%), Gaps = 32/189 (16%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L  +   V+  ++YL   + L  +HRD  T N L+   +  KI DFG++R          
Sbjct: 160 LLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV 216
Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYA 122
             R +    +M PE  L   F+ +SDV+SFGVV+ EI + GK+                 
Sbjct: 217 GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ----------------P 260
Query: 123 WKLWQEGKALDMMDQ-----KPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLG 177
           W      +A+D + Q     +P A       +  I  G  C Q +P  R ++ DV   L 
Sbjct: 261 WYQLSNTEAIDCITQGRELERPRACPPE---VYAIMRG--CWQREPQQRHSIKDVHARL- 314
Query: 178 SEAVNLASP 186
            +A+  A P
Sbjct: 315 -QALAQAPP 322

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 52/102 (50%), Gaps = 6/102 (5%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQT 60
           E L  + L V   + YL +     +IHRD    N L+      K+SDFG+TR + + + T
Sbjct: 104 ETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160
Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS 102
             T  +      + SPE      +S KSDV+SFGV++ E+ S
Sbjct: 161 SSTGTKF--PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 200

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 53/102 (51%), Gaps = 10/102 (9%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGT 70
           V   L YLH      II+RD K  NILLD   + KI+DFG       K     T  + GT
Sbjct: 115 VCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGF-----AKYVPDVTYXLCGT 166
Query: 71  YGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNS 112
             Y++PE      ++   D +SFG+++ E+++G   T FY+S
Sbjct: 167 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY--TPFYDS 206

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 56/99 (56%), Gaps = 3/99 (3%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L N  + +++ + YL     +R++HRD    N+L+    + KI+DFGL R+ +  +T+  
Sbjct: 121 LLNWCMQIAKGMSYLED---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYH 177
Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS 102
            +       +M+ E  L   F+ +SDV+S+GV V E+++
Sbjct: 178 ADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMT 216

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 80/173 (46%), Gaps = 24/173 (13%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQTDG 62
           L +    V+R + YL   +  + IHRD    N+L+  +   KI+DFGL R I        
Sbjct: 193 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 249
Query: 63  TTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLG 120
           TTN  +    +M+PE      ++ +SDV+SFGV++ EI +  G    G    EL      
Sbjct: 250 TTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL------ 302
Query: 121 YAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
             +KL +EG  +D    KP   +  NE+   +     C    P+ RPT   +V
Sbjct: 303 --FKLLKEGHRMD----KPSNCT--NELYMMMRD---CWHAVPSQRPTFKQLV 344

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 25/173 (14%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L  +   +S  + YL    K   IHRD    N L+      K++DFGL+R+  G   D 
Sbjct: 113 VLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---DT 166
Query: 63  TTNRVVGTY--GYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLL 119
            T      +   + +PE      FS+KSDV++FGV++ EI + G       +      LL
Sbjct: 167 YTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 226
Query: 120 GYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
              ++          M++  G   K  E+++       C Q +P+DRP+ +++
Sbjct: 227 EKDYR----------MERPEGCPEKVYELMRA------CWQWNPSDRPSFAEI 263

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 81/181 (44%), Gaps = 23/181 (12%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQT 60
           E L  + L V   + YL +     +IHRD    N L+      K+SDFG+TR + + + T
Sbjct: 101 ETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157
Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLL 119
             T  +      + SPE      +S KSDV+SFGV++ E+ S GK      ++   +  +
Sbjct: 158 SSTGTKF--PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 215
Query: 120 GYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE 179
              ++L+           KP   S    + + +N    C +E P DRP  S ++  L   
Sbjct: 216 STGFRLY-----------KPRLAS--THVYQIMN---HCWKERPEDRPAFSRLLRQLAEI 259
Query: 180 A 180
           A
Sbjct: 260 A 260

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 81/181 (44%), Gaps = 23/181 (12%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQT 60
           E L  + L V   + YL +     +IHRD    N L+      K+SDFG+TR + + + T
Sbjct: 106 ETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162
Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLL 119
             T  +      + SPE      +S KSDV+SFGV++ E+ S GK      ++   +  +
Sbjct: 163 SSTGTKF--PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 220
Query: 120 GYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE 179
              ++L+           KP   S    + + +N    C +E P DRP  S ++  L   
Sbjct: 221 STGFRLY-----------KPRLAS--THVYQIMN---HCWRERPEDRPAFSRLLRQLAEI 264
Query: 180 A 180
           A
Sbjct: 265 A 265

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 81/181 (44%), Gaps = 23/181 (12%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQT 60
           E L  + L V   + YL +     +IHRD    N L+      K+SDFG+TR + + + T
Sbjct: 103 ETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 159
Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLL 119
             T  +      + SPE      +S KSDV+SFGV++ E+ S GK      ++   +  +
Sbjct: 160 SSTGTKF--PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 217
Query: 120 GYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE 179
              ++L+           KP   S    + + +N    C +E P DRP  S ++  L   
Sbjct: 218 STGFRLY-----------KPRLAS--THVYQIMN---HCWKERPEDRPAFSRLLRQLAEI 261
Query: 180 A 180
           A
Sbjct: 262 A 262

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/79 (40%), Positives = 45/79 (56%), Gaps = 1/79 (1%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIF-EGKQTDGTTNRVVGTYGYMSPEYALGGF 83
           R IHRD  T NIL+++E   KI DFGLT++  + K+             + +PE      
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK 193
Query: 84  FSVKSDVFSFGVVVLEIIS 102
           FSV SDV+SFGVV+ E+ +
Sbjct: 194 FSVASDVWSFGVVLYELFT 212

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 25/173 (14%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L  +   +S  + YL    K   IHRD    N L+      K++DFGL+R+  G   D 
Sbjct: 114 VLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---DT 167
Query: 63  TTNRVVGTY--GYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLL 119
            T      +   + +PE      FS+KSDV++FGV++ EI + G       +      LL
Sbjct: 168 YTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 227
Query: 120 GYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
              ++          M++  G   K  E+++       C Q +P+DRP+ +++
Sbjct: 228 EKDYR----------MERPEGCPEKVYELMRA------CWQWNPSDRPSFAEI 264

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 81/189 (42%), Gaps = 32/189 (16%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L  +   V+  ++YL   + L  +HRD  T N L+   +  KI DFG++R          
Sbjct: 131 LLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV 187
Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYA 122
             R +    +M PE  L   F+ +SDV+SFGVV+ EI + GK+                 
Sbjct: 188 GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ----------------P 231
Query: 123 WKLWQEGKALDMMDQ-----KPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLG 177
           W      +A+D + Q     +P A       +  I  G  C Q +P  R ++ DV   L 
Sbjct: 232 WYQLSNTEAIDCITQGRELERPRACPPE---VYAIMRG--CWQREPQQRHSIKDVHARL- 285
Query: 178 SEAVNLASP 186
            +A+  A P
Sbjct: 286 -QALAQAPP 293

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 81/181 (44%), Gaps = 23/181 (12%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQT 60
           E L  + L V   + YL +     +IHRD    N L+      K+SDFG+TR + + + T
Sbjct: 123 ETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 179
Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLL 119
             T  +      + SPE      +S KSDV+SFGV++ E+ S GK      ++   +  +
Sbjct: 180 SSTGTKF--PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 237
Query: 120 GYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE 179
              ++L+           KP   S    + + +N    C +E P DRP  S ++  L   
Sbjct: 238 STGFRLY-----------KPRLAS--THVYQIMN---HCWKERPEDRPAFSRLLRQLAEI 281
Query: 180 A 180
           A
Sbjct: 282 A 282

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 57/102 (55%), Gaps = 10/102 (9%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           LF ++ G+S    + H     R++HRD K  N+L++ E   K++DFGL R F G      
Sbjct: 109 LFQLLQGLS----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTY 160
Query: 64  TNRVVGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEIISGK 104
           T+ VV T  Y +PE  LG  ++S   D++S G +  E+++ +
Sbjct: 161 THEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 81/189 (42%), Gaps = 32/189 (16%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L  +   V+  ++YL   + L  +HRD  T N L+   +  KI DFG++R          
Sbjct: 137 LLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV 193
Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYA 122
             R +    +M PE  L   F+ +SDV+SFGVV+ EI + GK+                 
Sbjct: 194 GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ----------------P 237
Query: 123 WKLWQEGKALDMMDQ-----KPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLG 177
           W      +A+D + Q     +P A       +  I  G  C Q +P  R ++ DV   L 
Sbjct: 238 WYQLSNTEAIDCITQGRELERPRACPPE---VYAIMRG--CWQREPQQRHSIKDVHARL- 291
Query: 178 SEAVNLASP 186
            +A+  A P
Sbjct: 292 -QALAQAPP 299

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 53/90 (58%), Gaps = 9/90 (10%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGL-TRI-FEGKQTDGTTNRVVGTYGYM 74
           YLH +   R+IHRD K  N+ L+ +M+ KI DFGL T+I F+G++       + GT  Y+
Sbjct: 157 YLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER----KKXLCGTPNYI 209
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           +PE       S + D++S G ++  ++ GK
Sbjct: 210 APEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 53/90 (58%), Gaps = 9/90 (10%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGL-TRI-FEGKQTDGTTNRVVGTYGYM 74
           YLH +   R+IHRD K  N+ L+ +M+ KI DFGL T+I F+G++       + GT  Y+
Sbjct: 157 YLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER----KKTLCGTPNYI 209
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           +PE       S + D++S G ++  ++ GK
Sbjct: 210 APEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 21/154 (13%)
Query: 22  SKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQTDGTTNRVVGTYGYMSPEYAL 80
           S+ + +HRD  T N L+   M  KI+DFGL+R I+         N  +    +M PE   
Sbjct: 191 SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPI-RWMPPESIF 249
Query: 81  GGFFSVKSDVFSFGVVVLEIISG--KRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQK 138
              ++ +SDV+++GVV+ EI S   +   G  + E+   +        ++G  L   +  
Sbjct: 250 YNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYV--------RDGNILACPENC 301
Query: 139 PGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
           P         L+  N+  LC  + P DRP+   +
Sbjct: 302 P---------LELYNLMRLCWSKLPADRPSFCSI 326

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 57/105 (54%), Gaps = 9/105 (8%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           E +  + L V + L  LH      +IHRD K+ +ILL H+   K+SDFG    F  + + 
Sbjct: 247 EQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFG----FCAQVSK 299
Query: 62  GTTNR--VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
               R  +VGT  +M+PE      +  + D++S G++V+E++ G+
Sbjct: 300 EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 344

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 53/90 (58%), Gaps = 9/90 (10%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGL-TRI-FEGKQTDGTTNRVVGTYGYM 74
           YLH +   R+IHRD K  N+ L+ +M+ KI DFGL T+I F+G++       + GT  Y+
Sbjct: 157 YLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKD----LCGTPNYI 209
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           +PE       S + D++S G ++  ++ GK
Sbjct: 210 APEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 57/100 (57%), Gaps = 10/100 (10%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLD---HEMNPKISDFGLTRIFEGKQTDGT 63
           II  V   + Y+H++   +I+HRD K  N+LL+    + N +I DFGL+  FE  +    
Sbjct: 131 IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---K 184
Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
               +GT  Y++PE  L G +  K DV+S GV++  ++SG
Sbjct: 185 MKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 53/90 (58%), Gaps = 9/90 (10%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGL-TRI-FEGKQTDGTTNRVVGTYGYM 74
           YLH +   R+IHRD K  N+ L+ +M+ KI DFGL T+I F+G++       + GT  Y+
Sbjct: 141 YLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKD----LCGTPNYI 193
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           +PE       S + D++S G ++  ++ GK
Sbjct: 194 APEVLCKKGHSFEVDIWSLGCILYTLLVGK 223

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 57/105 (54%), Gaps = 9/105 (8%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           E +  + L V + L  LH      +IHRD K+ +ILL H+   K+SDFG    F  + + 
Sbjct: 125 EQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFG----FCAQVSK 177
Query: 62  GTTNR--VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
               R  +VGT  +M+PE      +  + D++S G++V+E++ G+
Sbjct: 178 EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 222

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 57/100 (57%), Gaps = 10/100 (10%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLD---HEMNPKISDFGLTRIFEGKQTDGT 63
           II  V   + Y+H++   +I+HRD K  N+LL+    + N +I DFGL+  FE  +    
Sbjct: 154 IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---K 207
Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
               +GT  Y++PE  L G +  K DV+S GV++  ++SG
Sbjct: 208 MKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 54/99 (54%), Gaps = 6/99 (6%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH  S+  +++RD K  N++LD + + KI+DFGL +  EG +   T     GT  Y+
Sbjct: 261 LDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYL 316
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSE 113
           +PE      +    D +  GVV+ E++ G+    FYN +
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 353

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/80 (38%), Positives = 47/80 (58%), Gaps = 2/80 (2%)
Query: 24  LRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGF 83
           L II+RD K  NILLD E + K++DFGL++  E    +       GT  YM+PE      
Sbjct: 146 LGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRG 203
Query: 84  FSVKSDVFSFGVVVLEIISG 103
            +  +D +SFGV++ E+++G
Sbjct: 204 HTQSADWWSFGVLMFEMLTG 223

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 57/100 (57%), Gaps = 10/100 (10%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLD---HEMNPKISDFGLTRIFEGKQTDGT 63
           II  V   + Y+H++   +I+HRD K  N+LL+    + N +I DFGL+  FE  +    
Sbjct: 155 IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---K 208
Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
               +GT  Y++PE  L G +  K DV+S GV++  ++SG
Sbjct: 209 MKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 87/179 (48%), Gaps = 29/179 (16%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           ++L  I + + + L +LH  SKL +IHRD K SN+L++     K+ DFG++    G   D
Sbjct: 109 DILGKIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS----GYLVD 162
Query: 62  GTTNRV-VGTYGYMSPEYALGGF----FSVKSDVFSFGVVVLEIISGKRNTGFYNSELAL 116
                +  G   YM+PE          +SVKSD++S G+ ++E                L
Sbjct: 163 DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIE----------------L 206
Query: 117 SLLGYAWKLW-QEGKALDMMDQKPGAISKANEI-LKCINVGLLCVQEDPNDRPTMSDVV 173
           ++L + +  W    + L  + ++P     A++   + ++    C++++  +RPT  +++
Sbjct: 207 AILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELM 265

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 57/105 (54%), Gaps = 9/105 (8%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           E +  + L V + L  LH      +IHRD K+ +ILL H+   K+SDFG    F  + + 
Sbjct: 127 EQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFG----FCAQVSK 179
Query: 62  GTTNR--VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
               R  +VGT  +M+PE      +  + D++S G++V+E++ G+
Sbjct: 180 EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 224

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/80 (38%), Positives = 47/80 (58%), Gaps = 2/80 (2%)
Query: 24  LRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGF 83
           L II+RD K  NILLD E + K++DFGL++  E    +       GT  YM+PE      
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRG 202
Query: 84  FSVKSDVFSFGVVVLEIISG 103
            +  +D +SFGV++ E+++G
Sbjct: 203 HTQSADWWSFGVLMFEMLTG 222

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 54/99 (54%), Gaps = 6/99 (6%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH  S+  +++RD K  N++LD + + KI+DFGL +  EG +   T     GT  Y+
Sbjct: 264 LDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYL 319
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSE 113
           +PE      +    D +  GVV+ E++ G+    FYN +
Sbjct: 320 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 356

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 84/174 (48%), Gaps = 28/174 (16%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQTDG 62
           L +    +S+ + YL   +++ ++HRD    NIL+      KISDFGL+R ++E    D 
Sbjct: 152 LISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYE---EDS 205
Query: 63  TTNRVVG--TYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSL 118
              R  G     +M+ E      ++ +SDV+SFGV++ EI++  G    G     L    
Sbjct: 206 XVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL---- 261
Query: 119 LGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
               + L + G  ++  D      + + E+ + +   L C +++P+ RP  +D+
Sbjct: 262 ----FNLLKTGHRMERPD------NCSEEMYRLM---LQCWKQEPDKRPVFADI 302

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 57/105 (54%), Gaps = 9/105 (8%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           E +  + L V + L  LH      +IHRD K+ +ILL H+   K+SDFG    F  + + 
Sbjct: 170 EQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFG----FCAQVSK 222
Query: 62  GTTNR--VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
               R  +VGT  +M+PE      +  + D++S G++V+E++ G+
Sbjct: 223 EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 267

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 77/176 (43%), Gaps = 31/176 (17%)
Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           +E+   I  GV     Y+H     ++I+RD K SNI L      KI DFGL       + 
Sbjct: 125 LELFEQITKGVD----YIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KN 174
Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLG 120
           DG   R  GT  YMSPE      +  + D+++ G+++ E++    +T F  S+    L  
Sbjct: 175 DGKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV-CDTAFETSKFFTDL-- 231
Query: 121 YAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
                 ++G   D+ D+K   + +              + + P DRP  S+++  L
Sbjct: 232 ------RDGIISDIFDKKEKTLLQK------------LLSKKPEDRPNTSEILRTL 269

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 75/172 (43%), Gaps = 22/172 (12%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L +    ++R + YL   +  + IHRD    N+L+      KI+DFGL R          
Sbjct: 159 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKK 215
Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLGY 121
           T        +M+PE      ++ +SDV+SFGV++ EI +  G    G    EL       
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL------- 268
Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
            +KL +EG  +D    KP   +  NE+   +     C    P+ RPT   +V
Sbjct: 269 -FKLLKEGHRMD----KPANCT--NELYMMMRD---CWHAVPSQRPTFKQLV 310

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 54/107 (50%), Gaps = 10/107 (9%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           E +  I   + R L +LHQ    ++IHRD K  N+LL      K+ DFG++   +  +T 
Sbjct: 129 EWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD--RTV 183
Query: 62  GTTNRVVGTYGYMSPEYAL-----GGFFSVKSDVFSFGVVVLEIISG 103
           G  N  +GT  +M+PE           +  KSD++S G+  +E+  G
Sbjct: 184 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/80 (38%), Positives = 47/80 (58%), Gaps = 2/80 (2%)
Query: 24  LRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGF 83
           L II+RD K  NILLD E + K++DFGL++  E    +       GT  YM+PE      
Sbjct: 149 LGIIYRDLKPENILLDEEGHIKLTDFGLSK--EAIDHEKKAYSFCGTVEYMAPEVVNRQG 206
Query: 84  FSVKSDVFSFGVVVLEIISG 103
            S  +D +S+GV++ E+++G
Sbjct: 207 HSHSADWWSYGVLMFEMLTG 226

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 57/105 (54%), Gaps = 9/105 (8%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           E +  + L V + L  LH      +IHRD K+ +ILL H+   K+SDFG    F  + + 
Sbjct: 116 EQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFG----FCAQVSK 168
Query: 62  GTTNR--VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
               R  +VGT  +M+PE      +  + D++S G++V+E++ G+
Sbjct: 169 EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 213

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 75/172 (43%), Gaps = 22/172 (12%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L +    ++R + YL   +  + IHRD    N+L+      KI+DFGL R          
Sbjct: 159 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKK 215
Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLGY 121
           T        +M+PE      ++ +SDV+SFGV++ EI +  G    G    EL       
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL------- 268
Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
            +KL +EG  +D    KP   +  NE+   +     C    P+ RPT   +V
Sbjct: 269 -FKLLKEGHRMD----KPANCT--NELYMMMRD---CWHAVPSQRPTFKQLV 310

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 57/105 (54%), Gaps = 9/105 (8%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           E +  + L V + L  LH      +IHRD K+ +ILL H+   K+SDFG    F  + + 
Sbjct: 120 EQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFG----FCAQVSK 172
Query: 62  GTTNR--VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
               R  +VGT  +M+PE      +  + D++S G++V+E++ G+
Sbjct: 173 EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 217

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 57/100 (57%), Gaps = 10/100 (10%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLD---HEMNPKISDFGLTRIFEGKQTDGT 63
           II  V   + Y+H++   +I+HRD K  N+LL+    + N +I DFGL+  FE  +    
Sbjct: 137 IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---K 190
Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
               +GT  Y++PE  L G +  K DV+S GV++  ++SG
Sbjct: 191 MKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 52/104 (50%), Gaps = 8/104 (7%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           + L    L V   + YL  ++    +HRD    N+L+  +   K+SDFGLT+  E   T 
Sbjct: 108 DCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQ 162
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKR 105
            T    V    + +PE      FS KSDV+SFG+++ EI S  R
Sbjct: 163 DTGKLPV---KWTAPEALREAAFSTKSDVWSFGILLWEIYSFGR 203

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/175 (24%), Positives = 85/175 (48%), Gaps = 21/175 (12%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFE-GKQTDG 62
           L  ++ G++  + YL   + +  +HRD    NIL++  +  K+SDFGL+R+ E   +   
Sbjct: 149 LVGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY 205
Query: 63  TTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGY 121
           TT+       + +PE      F+  SDV+SFG+V+ E+++ G+R     ++   +  +  
Sbjct: 206 TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND 265
Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
            ++L             P  +   + I + +   + C Q++   RP  +D+V +L
Sbjct: 266 GFRL-------------PTPMDCPSAIYQLM---MQCWQQERARRPKFADIVSIL 304

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/80 (38%), Positives = 47/80 (58%), Gaps = 2/80 (2%)
Query: 24  LRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGF 83
           L II+RD K  NILLD E + K++DFGL++  E    +       GT  YM+PE      
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRG 202
Query: 84  FSVKSDVFSFGVVVLEIISG 103
            +  +D +SFGV++ E+++G
Sbjct: 203 HTQSADWWSFGVLMFEMLTG 222

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/100 (39%), Positives = 57/100 (57%), Gaps = 10/100 (10%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILL---DHEMNPKISDFGLTRIFEGKQTDGT 63
           II  V   + Y+H   K  I+HRD K  NILL   + + + KI DFGL+  F+  Q    
Sbjct: 126 IIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKM 180
Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
            +R +GT  Y++PE  L G +  K DV+S GV++  ++SG
Sbjct: 181 KDR-IGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 54/99 (54%), Gaps = 6/99 (6%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH  S+  +++RD K  N++LD + + KI+DFGL +  EG +   T     GT  Y+
Sbjct: 123 LDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYL 178
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSE 113
           +PE      +    D +  GVV+ E++ G+    FYN +
Sbjct: 179 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 215

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/100 (39%), Positives = 57/100 (57%), Gaps = 10/100 (10%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILL---DHEMNPKISDFGLTRIFEGKQTDGT 63
           II  V   + Y+H   K  I+HRD K  NILL   + + + KI DFGL+  F+  Q    
Sbjct: 126 IIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKM 180
Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
            +R +GT  Y++PE  L G +  K DV+S GV++  ++SG
Sbjct: 181 KDR-IGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 57/102 (55%), Gaps = 10/102 (9%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           LF ++ G++    + H     R++HRD K  N+L++ E   K++DFGL R F G      
Sbjct: 109 LFQLLQGLA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTY 160
Query: 64  TNRVVGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEIISGK 104
           T+ VV T  Y +PE  LG  ++S   D++S G +  E+++ +
Sbjct: 161 THEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 57/102 (55%), Gaps = 10/102 (9%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           LF ++ G++    + H     R++HRD K  N+L++ E   K++DFGL R F G      
Sbjct: 108 LFQLLQGLA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTY 159
Query: 64  TNRVVGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEIISGK 104
           T+ VV T  Y +PE  LG  ++S   D++S G +  E+++ +
Sbjct: 160 THEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 54/99 (54%), Gaps = 6/99 (6%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH  S+  +++RD K  N++LD + + KI+DFGL +  EG +   T     GT  Y+
Sbjct: 122 LDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYL 177
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSE 113
           +PE      +    D +  GVV+ E++ G+    FYN +
Sbjct: 178 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 214

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/100 (39%), Positives = 57/100 (57%), Gaps = 10/100 (10%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILL---DHEMNPKISDFGLTRIFEGKQTDGT 63
           II  V   + Y+H   K  I+HRD K  NILL   + + + KI DFGL+  F+  Q    
Sbjct: 126 IIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKM 180
Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
            +R +GT  Y++PE  L G +  K DV+S GV++  ++SG
Sbjct: 181 KDR-IGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 57/102 (55%), Gaps = 10/102 (9%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           LF ++ G++    + H     R++HRD K  N+L++ E   K++DFGL R F G      
Sbjct: 108 LFQLLQGLA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTY 159
Query: 64  TNRVVGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEIISGK 104
           T+ VV T  Y +PE  LG  ++S   D++S G +  E+++ +
Sbjct: 160 THEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 54/99 (54%), Gaps = 6/99 (6%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH  S+  +++RD K  N++LD + + KI+DFGL +  EG +   T     GT  Y+
Sbjct: 121 LDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYL 176
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSE 113
           +PE      +    D +  GVV+ E++ G+    FYN +
Sbjct: 177 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 213

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 57/102 (55%), Gaps = 10/102 (9%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           LF ++ G++    + H     R++HRD K  N+L++ E   K++DFGL R F G      
Sbjct: 108 LFQLLQGLA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTY 159
Query: 64  TNRVVGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEIISGK 104
           T+ VV T  Y +PE  LG  ++S   D++S G +  E+++ +
Sbjct: 160 THEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 57/102 (55%), Gaps = 10/102 (9%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           LF ++ G++    + H     R++HRD K  N+L++ E   K++DFGL R F G      
Sbjct: 113 LFQLLQGLA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTY 164
Query: 64  TNRVVGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEIISGK 104
           T+ VV T  Y +PE  LG  ++S   D++S G +  E+++ +
Sbjct: 165 THEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 57/102 (55%), Gaps = 10/102 (9%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           LF ++ G++    + H     R++HRD K  N+L++ E   K++DFGL R F G      
Sbjct: 109 LFQLLQGLA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTY 160
Query: 64  TNRVVGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEIISGK 104
           T+ VV T  Y +PE  LG  ++S   D++S G +  E+++ +
Sbjct: 161 THEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 57/102 (55%), Gaps = 10/102 (9%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           LF ++ G++    + H     R++HRD K  N+L++ E   K++DFGL R F G      
Sbjct: 108 LFQLLQGLA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTY 159
Query: 64  TNRVVGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEIISGK 104
           T+ VV T  Y +PE  LG  ++S   D++S G +  E+++ +
Sbjct: 160 THEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 53/109 (48%), Gaps = 13/109 (11%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +  +I L ++  + +LH      ++HRD K SNI    +   K+ DFGL    +  + + 
Sbjct: 119 VCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 175
Query: 63  TT----------NRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEII 101
           T              VGT  YMSPE   G  +S K D+FS G+++ E++
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 182 YVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 57/102 (55%), Gaps = 10/102 (9%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           LF ++ G++    + H     R++HRD K  N+L++ E   K++DFGL R F G      
Sbjct: 109 LFQLLQGLA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTY 160
Query: 64  TNRVVGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEIISGK 104
           T+ VV T  Y +PE  LG  ++S   D++S G +  E+++ +
Sbjct: 161 THEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 57/102 (55%), Gaps = 10/102 (9%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           LF ++ G++    + H     R++HRD K  N+L++ E   K++DFGL R F G      
Sbjct: 109 LFQLLQGLA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTY 160
Query: 64  TNRVVGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEIISGK 104
           T+ VV T  Y +PE  LG  ++S   D++S G +  E+++ +
Sbjct: 161 THEVV-TLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 52/99 (52%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 159 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 210
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    +++  D++S G ++ E+++G+
Sbjct: 211 YVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 51/98 (52%), Gaps = 9/98 (9%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLD---HEMNPKISDFGLTRIFEGKQTDGTTNRV 67
           +S  L YLH++   RIIHRD K  NI+L      +  KI D G  +  E  Q +  T   
Sbjct: 131 ISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGELCTE-F 184
Query: 68  VGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKR 105
           VGT  Y++PE      ++V  D +SFG +  E I+G R
Sbjct: 185 VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 222

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 54/95 (56%), Gaps = 7/95 (7%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR-VVG 69
           +S  L +LH   K  II+RD K  N++LD E + KI+DFG+ +       DG T R   G
Sbjct: 129 ISIGLFFLH---KRGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMMDGVTTREFCG 182
Query: 70  TYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           T  Y++PE      +    D +++GV++ E+++G+
Sbjct: 183 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 217

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 57/102 (55%), Gaps = 10/102 (9%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           LF ++ G++    + H     R++HRD K  N+L++ E   K++DFGL R F G      
Sbjct: 110 LFQLLQGLA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTY 161
Query: 64  TNRVVGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEIISGK 104
           T+ VV T  Y +PE  LG  ++S   D++S G +  E+++ +
Sbjct: 162 THEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 57/102 (55%), Gaps = 10/102 (9%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           LF ++ G++    + H     R++HRD K  N+L++ E   K++DFGL R F G      
Sbjct: 116 LFQLLQGLA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTY 167
Query: 64  TNRVVGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEIISGK 104
           T+ VV T  Y +PE  LG  ++S   D++S G +  E+++ +
Sbjct: 168 THEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 80/172 (46%), Gaps = 23/172 (13%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L  +   +S  + YL    K   IHR+    N L+      K++DFGL+R+  G   D 
Sbjct: 358 VLLYMATQISSAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG---DT 411
Query: 63  TTNRVVGTY--GYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLG 120
            T      +   + +PE      FS+KSDV++FGV++ EI +      +  S      L 
Sbjct: 412 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSPYPGIDLS 465
Query: 121 YAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
             ++L ++      M++  G   K  E+++       C Q +P+DRP+ +++
Sbjct: 466 QVYELLEKDY---RMERPEGCPEKVYELMRA------CWQWNPSDRPSFAEI 508

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 51/98 (52%), Gaps = 9/98 (9%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLD---HEMNPKISDFGLTRIFEGKQTDGTTNRV 67
           +S  L YLH++   RIIHRD K  NI+L      +  KI D G  +  E  Q +  T   
Sbjct: 130 ISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGELCTE-F 183
Query: 68  VGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKR 105
           VGT  Y++PE      ++V  D +SFG +  E I+G R
Sbjct: 184 VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 80/172 (46%), Gaps = 23/172 (13%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L  +   +S  + YL    K   IHR+    N L+      K++DFGL+R+  G   D 
Sbjct: 319 VLLYMATQISSAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG---DT 372
Query: 63  TTNRVVGTY--GYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLG 120
            T      +   + +PE      FS+KSDV++FGV++ EI +      +  S      L 
Sbjct: 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSPYPGIDLS 426
Query: 121 YAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
             ++L ++      M++  G   K  E+++       C Q +P+DRP+ +++
Sbjct: 427 QVYELLEKDY---RMERPEGCPEKVYELMRA------CWQWNPSDRPSFAEI 469

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/79 (39%), Positives = 45/79 (56%), Gaps = 1/79 (1%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIF-EGKQTDGTTNRVVGTYGYMSPEYALGGF 83
           R IHR+  T NIL+++E   KI DFGLT++  + K+             + +PE      
Sbjct: 135 RYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK 194
Query: 84  FSVKSDVFSFGVVVLEIIS 102
           FSV SDV+SFGVV+ E+ +
Sbjct: 195 FSVASDVWSFGVVLYELFT 213

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 52/93 (55%), Gaps = 5/93 (5%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGT 70
           +S  L +LHQ     II+RD K  NI+L+H+ + K++DFGL +  E       T+   GT
Sbjct: 130 ISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHXFCGT 184
Query: 71  YGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
             YM+PE  +    +   D +S G ++ ++++G
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 52/93 (55%), Gaps = 5/93 (5%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGT 70
           +S  L +LHQ     II+RD K  NI+L+H+ + K++DFGL +  E       T+   GT
Sbjct: 130 ISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCGT 184
Query: 71  YGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
             YM+PE  +    +   D +S G ++ ++++G
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 57/102 (55%), Gaps = 10/102 (9%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           LF ++ G++    + H     R++HRD K  N+L++ E   K++DFGL R F G      
Sbjct: 116 LFQLLQGLA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTY 167
Query: 64  TNRVVGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEIISGK 104
           T+ VV T  Y +PE  LG  ++S   D++S G +  E+++ +
Sbjct: 168 THEVV-TLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/84 (39%), Positives = 46/84 (54%), Gaps = 6/84 (7%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEY---ALG 81
           RIIHRD K  NILLD   +  I+DF +  +   ++T  TT  + GT  YM+PE      G
Sbjct: 135 RIIHRDMKPDNILLDEHGHVHITDFNIAAML-PRETQITT--MAGTKPYMAPEMFSSRKG 191
Query: 82  GFFSVKSDVFSFGVVVLEIISGKR 105
             +S   D +S GV   E++ G+R
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/89 (38%), Positives = 48/89 (53%), Gaps = 9/89 (10%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFE-GKQTDGTTNRVVGTYGYMS 75
           Y HQ     I+HRD K  N+LLD +MN KI+DFG +  F  G + D       G   Y +
Sbjct: 128 YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDA----FCGAPPYAA 180
Query: 76  PEYALGGFFS-VKSDVFSFGVVVLEIISG 103
           PE   G  +   + DV+S GV++  ++SG
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 52/103 (50%), Gaps = 10/103 (9%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           +M+F ++ G+     +LH     R++HRD K  NIL+      K++DFGL RI+  +   
Sbjct: 124 DMMFQLLRGLD----FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM-- 174
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
                VV T  Y +PE  L   ++   D++S G +  E+   K
Sbjct: 175 -ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 34/89 (38%), Positives = 49/89 (55%), Gaps = 9/89 (10%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFE-GKQTDGTTNRVVGTYGYMS 75
           Y HQ     I+HRD K  N+LLD +MN KI+DFG +  F  G + D       G+  Y +
Sbjct: 128 YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLD----EFCGSPPYAA 180
Query: 76  PEYALGGFFS-VKSDVFSFGVVVLEIISG 103
           PE   G  +   + DV+S GV++  ++SG
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 56/100 (56%), Gaps = 10/100 (10%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLD---HEMNPKISDFGLTRIFEGKQTDGT 63
           II  V   + Y H++   +I+HRD K  N+LL+    + N +I DFGL+  FE  +    
Sbjct: 131 IIRQVLSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---K 184
Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
               +GT  Y++PE  L G +  K DV+S GV++  ++SG
Sbjct: 185 XKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 52/103 (50%), Gaps = 10/103 (9%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           +M+F ++ G+     +LH     R++HRD K  NIL+      K++DFGL RI+  +   
Sbjct: 124 DMMFQLLRGLD----FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM-- 174
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
                VV T  Y +PE  L   ++   D++S G +  E+   K
Sbjct: 175 -ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 75/172 (43%), Gaps = 22/172 (12%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L +    ++R + YL   +  + IHRD    N+L+      KI+DFGL R          
Sbjct: 159 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLGY 121
           T        +M+PE      ++ +SDV+SFGV++ EI +  G    G    EL       
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL------- 268
Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
            +KL +EG  +D    KP   +  NE+   +     C    P+ RPT   +V
Sbjct: 269 -FKLLKEGHRMD----KPANCT--NELYMMMRD---CWHAVPSQRPTFKQLV 310

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 75/172 (43%), Gaps = 22/172 (12%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L +    ++R + YL   +  + IHRD    N+L+      KI+DFGL R          
Sbjct: 159 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKN 215
Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLGY 121
           T        +M+PE      ++ +SDV+SFGV++ EI +  G    G    EL       
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL------- 268
Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
            +KL +EG  +D    KP   +  NE+   +     C    P+ RPT   +V
Sbjct: 269 -FKLLKEGHRMD----KPANCT--NELYMMMRD---CWHAVPSQRPTFKQLV 310

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 75/172 (43%), Gaps = 22/172 (12%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L +    ++R + YL   +  + IHRD    N+L+      KI+DFGL R          
Sbjct: 159 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLGY 121
           T        +M+PE      ++ +SDV+SFGV++ EI +  G    G    EL       
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL------- 268
Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
            +KL +EG  +D    KP   +  NE+   +     C    P+ RPT   +V
Sbjct: 269 -FKLLKEGHRMD----KPANCT--NELYMMMRD---CWHAVPSQRPTFKQLV 310

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 52/90 (57%), Gaps = 9/90 (10%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRV-VGTYGYMS 75
           Y H+    +I+HRD K  N+LLD  +N KI+DFGL+ I     TDG   +   G+  Y +
Sbjct: 123 YCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIM----TDGNFLKTSCGSPNYAA 175
Query: 76  PEYALGGFFS-VKSDVFSFGVVVLEIISGK 104
           PE   G  ++  + DV+S G+V+  ++ G+
Sbjct: 176 PEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 75/172 (43%), Gaps = 22/172 (12%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L +    ++R + YL   +  + IHRD    N+L+      KI+DFGL R          
Sbjct: 159 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLGY 121
           T        +M+PE      ++ +SDV+SFGV++ EI +  G    G    EL       
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL------- 268
Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
            +KL +EG  +D    KP   +  NE+   +     C    P+ RPT   +V
Sbjct: 269 -FKLLKEGHRMD----KPANCT--NELYMMMRD---CWHAVPSQRPTFKQLV 310

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 75/172 (43%), Gaps = 22/172 (12%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L +    ++R + YL   +  + IHRD    N+L+      KI+DFGL R          
Sbjct: 159 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLGY 121
           T        +M+PE      ++ +SDV+SFGV++ EI +  G    G    EL       
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL------- 268
Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
            +KL +EG  +D    KP   +  NE+   +     C    P+ RPT   +V
Sbjct: 269 -FKLLKEGHRMD----KPANCT--NELYMMMRD---CWHAVPSQRPTFKQLV 310

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 52/103 (50%), Gaps = 10/103 (9%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           +M+F ++ G+     +LH     R++HRD K  NIL+      K++DFGL RI+  +   
Sbjct: 124 DMMFQLLRGLD----FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM-- 174
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
                VV T  Y +PE  L   ++   D++S G +  E+   K
Sbjct: 175 -ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 75/172 (43%), Gaps = 22/172 (12%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L +    ++R + YL   +  + IHRD    N+L+      KI+DFGL R          
Sbjct: 148 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 204
Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLGY 121
           T        +M+PE      ++ +SDV+SFGV++ EI +  G    G    EL       
Sbjct: 205 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL------- 257
Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
            +KL +EG  +D    KP   +  NE+   +     C    P+ RPT   +V
Sbjct: 258 -FKLLKEGHRMD----KPANCT--NELYMMMRD---CWHAVPSQRPTFKQLV 299

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 75/172 (43%), Gaps = 22/172 (12%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L +    ++R + YL   +  + IHRD    N+L+      KI+DFGL R          
Sbjct: 159 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLGY 121
           T        +M+PE      ++ +SDV+SFGV++ EI +  G    G    EL       
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL------- 268
Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
            +KL +EG  +D    KP   +  NE+   +     C    P+ RPT   +V
Sbjct: 269 -FKLLKEGHRMD----KPANCT--NELYMMMRD---CWHAVPSQRPTFKQLV 310

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 75/172 (43%), Gaps = 22/172 (12%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L +    ++R + YL   +  + IHRD    N+L+      KI+DFGL R          
Sbjct: 205 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261
Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLGY 121
           T        +M+PE      ++ +SDV+SFGV++ EI +  G    G    EL       
Sbjct: 262 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL------- 314
Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
            +KL +EG  +D    KP   +  NE+   +     C    P+ RPT   +V
Sbjct: 315 -FKLLKEGHRMD----KPANCT--NELYMMMRD---CWHAVPSQRPTFKQLV 356

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 75/172 (43%), Gaps = 22/172 (12%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L +    ++R + YL   +  + IHRD    N+L+      KI+DFGL R          
Sbjct: 151 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 207
Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLGY 121
           T        +M+PE      ++ +SDV+SFGV++ EI +  G    G    EL       
Sbjct: 208 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL------- 260
Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
            +KL +EG  +D    KP   +  NE+   +     C    P+ RPT   +V
Sbjct: 261 -FKLLKEGHRMD----KPANCT--NELYMMMRD---CWHAVPSQRPTFKQLV 302

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/89 (38%), Positives = 49/89 (55%), Gaps = 9/89 (10%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFE-GKQTDGTTNRVVGTYGYMS 75
           Y HQ     I+HRD K  N+LLD +MN KI+DFG +  F  G + D       G+  Y +
Sbjct: 121 YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT----FCGSPPYAA 173
Query: 76  PEYALGGFFS-VKSDVFSFGVVVLEIISG 103
           PE   G  +   + DV+S GV++  ++SG
Sbjct: 174 PELFQGKKYDGPEVDVWSLGVILYTLVSG 202

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/89 (38%), Positives = 49/89 (55%), Gaps = 9/89 (10%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFE-GKQTDGTTNRVVGTYGYMS 75
           Y HQ     I+HRD K  N+LLD +MN KI+DFG +  F  G + D       G+  Y +
Sbjct: 128 YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT----FCGSPPYAA 180
Query: 76  PEYALGGFFS-VKSDVFSFGVVVLEIISG 103
           PE   G  +   + DV+S GV++  ++SG
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/89 (38%), Positives = 49/89 (55%), Gaps = 9/89 (10%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFE-GKQTDGTTNRVVGTYGYMS 75
           Y HQ     I+HRD K  N+LLD +MN KI+DFG +  F  G + D       G+  Y +
Sbjct: 128 YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT----FCGSPPYAA 180
Query: 76  PEYALGGFFS-VKSDVFSFGVVVLEIISG 103
           PE   G  +   + DV+S GV++  ++SG
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/89 (38%), Positives = 49/89 (55%), Gaps = 9/89 (10%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFE-GKQTDGTTNRVVGTYGYMS 75
           Y HQ     I+HRD K  N+LLD +MN KI+DFG +  F  G + D       G+  Y +
Sbjct: 128 YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT----FCGSPPYAA 180
Query: 76  PEYALGGFFS-VKSDVFSFGVVVLEIISG 103
           PE   G  +   + DV+S GV++  ++SG
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 75/172 (43%), Gaps = 22/172 (12%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L +    ++R + YL   +  + IHRD    N+L+      KI+DFGL R          
Sbjct: 146 LVSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKK 202
Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLGY 121
           T        +M+PE      ++ +SDV+SFGV++ EI +  G    G    EL       
Sbjct: 203 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL------- 255
Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
            +KL +EG  +D    KP   +  NE+   +     C    P+ RPT   +V
Sbjct: 256 -FKLLKEGHRMD----KPANCT--NELYMMMRD---CWHAVPSQRPTFKQLV 297

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 137 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 188
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 135 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 186
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 140 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 191
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 192 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 129 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 180
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 181 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 142 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 193
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 194 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 142 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 193
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 194 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 52/104 (50%), Gaps = 8/104 (7%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           + L    L V   + YL  ++    +HRD    N+L+  +   K+SDFGLT+  E   T 
Sbjct: 289 DCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQ 343
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKR 105
            T    V    + +PE      FS KSDV+SFG+++ EI S  R
Sbjct: 344 DTGKLPV---KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 384

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 182 XVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 142 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 193
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 194 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 141 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 192
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 193 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 136 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 187
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 135 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTG 186
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 150 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 201
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 202 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 34/89 (38%), Positives = 49/89 (55%), Gaps = 9/89 (10%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFE-GKQTDGTTNRVVGTYGYMS 75
           Y HQ     I+HRD K  N+LLD +MN KI+DFG +  F  G + D       G+  Y +
Sbjct: 129 YCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT----FCGSPPYAA 181
Query: 76  PEYALGGFFS-VKSDVFSFGVVVLEIISG 103
           PE   G  +   + DV+S GV++  ++SG
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 153 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 204
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 205 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 132 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 183
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 132 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 183
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 127 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 178
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 179 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 52/104 (50%), Gaps = 8/104 (7%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           + L    L V   + YL  ++    +HRD    N+L+  +   K+SDFGLT+  E   T 
Sbjct: 102 DCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQ 156
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKR 105
            T    V    + +PE      FS KSDV+SFG+++ EI S  R
Sbjct: 157 DTGKLPV---KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 135 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTG 186
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 149 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 200
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 201 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 141 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTG 192
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 193 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 150 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 201
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 202 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 136 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 187
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 132 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 183
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 127 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 178
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 179 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 32/109 (29%), Positives = 53/109 (48%), Gaps = 13/109 (11%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD- 61
           +  +I + ++  + +LH      ++HRD K SNI    +   K+ DFGL    +  + + 
Sbjct: 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 221
Query: 62  ---------GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEII 101
                     T    VGT  YMSPE   G  +S K D+FS G+++ E++
Sbjct: 222 TVLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 135 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 186
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTG 181
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 126 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 177
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 149 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 200
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 201 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 81/185 (43%), Gaps = 41/185 (22%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           + L +    V+R + YL Q    + IHRD    NIL+      KI+DFGL+R        
Sbjct: 142 QQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-------- 190
Query: 62  GTTNRVVGTYG-----YMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSEL 114
           G    V  T G     +M+ E      ++  SDV+S+GV++ EI+S  G    G   +EL
Sbjct: 191 GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 250
Query: 115 ALSL-LGYAWK--LWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSD 171
              L  GY  +  L  + +  D+M Q                    C +E P +RP+ + 
Sbjct: 251 YEKLPQGYRLEKPLNCDDEVYDLMRQ--------------------CWREKPYERPSFAQ 290
Query: 172 VVIML 176
           +++ L
Sbjct: 291 ILVSL 295

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 126 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 177
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 126 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 177
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 136 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 187
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 52/104 (50%), Gaps = 8/104 (7%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           + L    L V   + YL  ++    +HRD    N+L+  +   K+SDFGLT+  E   T 
Sbjct: 117 DCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQ 171
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKR 105
            T    V    + +PE      FS KSDV+SFG+++ EI S  R
Sbjct: 172 DTGKLPV---KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 212

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 56/101 (55%), Gaps = 10/101 (9%)
Query: 6   NIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHE---MNPKISDFGLTRIFEGKQTDG 62
           NI+  +   + YLH   K  I+HRD K  NILL+++   +N KI DFGL+  F     D 
Sbjct: 150 NIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF---SKDY 203
Query: 63  TTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
                +GT  Y++PE  L   ++ K DV+S GV++  ++ G
Sbjct: 204 KLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 29/80 (36%), Positives = 47/80 (58%), Gaps = 6/80 (7%)
Query: 26  IIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRV-VGTYGYMSPEYALGGFF 84
           ++HRD K  N+LLD  MN KI+DFGL+ +     +DG   R   G+  Y +PE   G  +
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMM----SDGEFLRXSCGSPNYAAPEVISGRLY 192
Query: 85  S-VKSDVFSFGVVVLEIISG 103
           +  + D++S GV++  ++ G
Sbjct: 193 AGPEVDIWSSGVILYALLCG 212

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 81/185 (43%), Gaps = 41/185 (22%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           + L +    V+R + YL Q    + IHRD    NIL+      KI+DFGL+R        
Sbjct: 132 QQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-------- 180
Query: 62  GTTNRVVGTYG-----YMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSEL 114
           G    V  T G     +M+ E      ++  SDV+S+GV++ EI+S  G    G   +EL
Sbjct: 181 GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 240
Query: 115 ALSL-LGYAWK--LWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSD 171
              L  GY  +  L  + +  D+M Q                    C +E P +RP+ + 
Sbjct: 241 YEKLPQGYRLEKPLNCDDEVYDLMRQ--------------------CWREKPYERPSFAQ 280
Query: 172 VVIML 176
           +++ L
Sbjct: 281 ILVSL 285

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 128 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 179
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 180 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 39/105 (37%), Positives = 56/105 (53%), Gaps = 18/105 (17%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L+ +++G+     +LH      IIHRD K SNI++  +   KI DFGL R      T G
Sbjct: 131 LLYQMLVGIK----HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR------TAG 177
Query: 63  T----TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           T    T  VV  Y Y +PE  LG  +    D++S GV++ E+I G
Sbjct: 178 TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/105 (37%), Positives = 56/105 (53%), Gaps = 18/105 (17%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L+ +++G+     +LH      IIHRD K SNI++  +   KI DFGL R      T G
Sbjct: 131 LLYQMLVGIK----HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR------TAG 177
Query: 63  T----TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           T    T  VV  Y Y +PE  LG  +    D++S GV++ E+I G
Sbjct: 178 TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 150 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMXG 201
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 202 XVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMAG 181
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 182 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 52/96 (54%), Gaps = 5/96 (5%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD-GTTNRVVG 69
           + R L Y+H  +   ++HRD K SN+L++   + KI DFGL RI + +    G     V 
Sbjct: 153 ILRGLKYIHSAN---VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVA 209
Query: 70  TYGYMSPEYALGGFFSVKS-DVFSFGVVVLEIISGK 104
           T  Y +PE  L      KS D++S G ++ E++S +
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 84/188 (44%), Gaps = 24/188 (12%)
Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           +  + +I   ++  ++YL   +    +HRD  T N L+   +  KI DFG++R       
Sbjct: 132 LSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 188
Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFY--NSELALSL 118
                  +    +M PE  +   F+ +SDV+SFGV++ EI +  +   F   N+E+   +
Sbjct: 189 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 248
Query: 119 LGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGS 178
                    +G+ L+    +P    K     +  +V L C Q +P  R  + ++  +L  
Sbjct: 249 --------TQGRVLE----RPRVCPK-----EVYDVMLGCWQREPQQRLNIKEIYKIL-- 289
Query: 179 EAVNLASP 186
            A+  A+P
Sbjct: 290 HALGKATP 297

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 136 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR-----HTDDEMTG 187
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 132 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR-----HTDDEMTG 183
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/83 (38%), Positives = 48/83 (57%), Gaps = 9/83 (10%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRV-VGTYGYMS 75
           Y H+    +I+HRD K  N+LLD  +N KI+DFGL+ I     TDG   +   G+  Y +
Sbjct: 128 YCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM----TDGNFLKTSCGSPNYAA 180
Query: 76  PEYALGGFFS-VKSDVFSFGVVV 97
           PE   G  ++  + DV+S GV++
Sbjct: 181 PEVISGKLYAGPEVDVWSCGVIL 203

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMAG 181
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 182 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 153 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMXG 204
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 205 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/80 (37%), Positives = 47/80 (58%), Gaps = 3/80 (3%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG-F 83
           R++HRD K  N+L++ E   KI+DFGL R F G      T+ VV T  Y +P+  +G   
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEVV-TLWYRAPDVLMGSKK 177
Query: 84  FSVKSDVFSFGVVVLEIISG 103
           +S   D++S G +  E+++G
Sbjct: 178 YSTTIDIWSVGCIFAEMVNG 197

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/83 (38%), Positives = 48/83 (57%), Gaps = 9/83 (10%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRV-VGTYGYMS 75
           Y H+    +I+HRD K  N+LLD  +N KI+DFGL+ I     TDG   +   G+  Y +
Sbjct: 118 YCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM----TDGNFLKTSCGSPNYAA 170
Query: 76  PEYALGGFFS-VKSDVFSFGVVV 97
           PE   G  ++  + DV+S GV++
Sbjct: 171 PEVISGKLYAGPEVDVWSCGVIL 193

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/83 (38%), Positives = 48/83 (57%), Gaps = 9/83 (10%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRV-VGTYGYMS 75
           Y H+    +I+HRD K  N+LLD  +N KI+DFGL+ I     TDG   +   G+  Y +
Sbjct: 127 YCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM----TDGNFLKTSCGSPNYAA 179
Query: 76  PEYALGGFFS-VKSDVFSFGVVV 97
           PE   G  ++  + DV+S GV++
Sbjct: 180 PEVISGKLYAGPEVDVWSCGVIL 202

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLCR-----HTDDEMTG 181
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 74/169 (43%), Gaps = 30/169 (17%)
Query: 10  GVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVG 69
           G  + L YLH  +   +IHRD K  NILL      K+ DFG   I          N  VG
Sbjct: 162 GALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVG 212
Query: 70  TYGYMSPEYALG---GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLW 126
           T  +M+PE  L    G +  K DV+S G+  +E+   +R    +N     +L   A    
Sbjct: 213 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHIA---- 266
Query: 127 QEGKALDMMDQKPGAIS-KANEILKCINVGLLCVQEDPNDRPTMSDVVI 174
                    ++ P   S   +E  +  N    C+Q+ P DRPT S+V++
Sbjct: 267 --------QNESPALQSGHWSEYFR--NFVDSCLQKIPQDRPT-SEVLL 304

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD-GTTNRVVG 69
           + R L Y+H  +   ++HRD K SN+LL+   + KI DFGL R+ +      G     V 
Sbjct: 133 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 70  TYGYMSPEYALGGFFSVKS-DVFSFGVVVLEIISGK 104
           T  Y +PE  L      KS D++S G ++ E++S +
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/80 (37%), Positives = 47/80 (58%), Gaps = 3/80 (3%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG-F 83
           R++HRD K  N+L++ E   KI+DFGL R F G      T+ VV T  Y +P+  +G   
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEVV-TLWYRAPDVLMGSKK 177
Query: 84  FSVKSDVFSFGVVVLEIISG 103
           +S   D++S G +  E+++G
Sbjct: 178 YSTTIDIWSVGCIFAEMVNG 197

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD-GTTNRVVG 69
           + R L Y+H  +   ++HRD K SN+LL+   + KI DFGL R+ +      G     V 
Sbjct: 135 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 70  TYGYMSPEYALGGFFSVKS-DVFSFGVVVLEIISGK 104
           T  Y +PE  L      KS D++S G ++ E++S +
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD-GTTNRVVG 69
           + R L Y+H  +   ++HRD K SN+LL+   + KI DFGL R+ +      G     V 
Sbjct: 137 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 70  TYGYMSPEYALGGFFSVKS-DVFSFGVVVLEIISGK 104
           T  Y +PE  L      KS D++S G ++ E++S +
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      TD     
Sbjct: 126 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMAG 177
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 178 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+++D +   K++DFGL      K+  G T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGL-----AKRVKGRTWXLCGTPEYLAP 207
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD-GTTNRVVG 69
           + R L Y+H  +   ++HRD K SN+LL+   + KI DFGL R+ +      G     V 
Sbjct: 135 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 70  TYGYMSPEYALGGFFSVKS-DVFSFGVVVLEIISGK 104
           T  Y +PE  L      KS D++S G ++ E++S +
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/83 (38%), Positives = 48/83 (57%), Gaps = 9/83 (10%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRV-VGTYGYMS 75
           Y H+    +I+HRD K  N+LLD  +N KI+DFGL+ I     TDG   +   G+  Y +
Sbjct: 122 YCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM----TDGNFLKTSCGSPNYAA 174
Query: 76  PEYALGGFFS-VKSDVFSFGVVV 97
           PE   G  ++  + DV+S GV++
Sbjct: 175 PEVISGKLYAGPEVDVWSCGVIL 197

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD-GTTNRVVG 69
           + R L Y+H  +   ++HRD K SN+LL+   + KI DFGL R+ +      G     V 
Sbjct: 131 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 70  TYGYMSPEYALGGFFSVKS-DVFSFGVVVLEIISGK 104
           T  Y +PE  L      KS D++S G ++ E++S +
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD-GTTNRVVG 69
           + R L Y+H  +   ++HRD K SN+LL+   + KI DFGL R+ +      G     V 
Sbjct: 137 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 70  TYGYMSPEYALGGFFSVKS-DVFSFGVVVLEIISGK 104
           T  Y +PE  L      KS D++S G ++ E++S +
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD-GTTNRVVG 69
           + R L Y+H  +   ++HRD K SN+LL+   + KI DFGL R+ +      G     V 
Sbjct: 131 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 70  TYGYMSPEYALGGFFSVKS-DVFSFGVVVLEIISGK 104
           T  Y +PE  L      KS D++S G ++ E++S +
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 55/100 (55%), Gaps = 10/100 (10%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP---KISDFGLTRIFEGKQTDGT 63
           II  V   + YLH   K  I+HRD K  N+LL+ +      KI DFGL+ +FE ++    
Sbjct: 141 IIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---K 194
Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
               +GT  Y++PE  L   +  K DV+S GV++  +++G
Sbjct: 195 MKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAG 233

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD-GTTNRVVG 69
           + R L Y+H  +   ++HRD K SN+LL+   + KI DFGL R+ +      G     V 
Sbjct: 153 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 70  TYGYMSPEYALGGFFSVKS-DVFSFGVVVLEIISGK 104
           T  Y +PE  L      KS D++S G ++ E++S +
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 74/169 (43%), Gaps = 30/169 (17%)
Query: 10  GVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVG 69
           G  + L YLH  +   +IHRD K  NILL      K+ DFG   I          N  VG
Sbjct: 123 GALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVG 173
Query: 70  TYGYMSPEYALG---GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLW 126
           T  +M+PE  L    G +  K DV+S G+  +E+   +R    +N     +L   A    
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHIA---- 227
Query: 127 QEGKALDMMDQKPGAIS-KANEILKCINVGLLCVQEDPNDRPTMSDVVI 174
                    ++ P   S   +E  +  N    C+Q+ P DRPT S+V++
Sbjct: 228 --------QNESPALQSGHWSEYFR--NFVDSCLQKIPQDRPT-SEVLL 265

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD-GTTNRVVG 69
           + R L Y+H  +   ++HRD K SN+LL+   + KI DFGL R+ +      G     V 
Sbjct: 141 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 197
Query: 70  TYGYMSPEYALGGFFSVKS-DVFSFGVVVLEIISGK 104
           T  Y +PE  L      KS D++S G ++ E++S +
Sbjct: 198 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD-GTTNRVVG 69
           + R L Y+H  +   ++HRD K SN+LL+   + KI DFGL R+ +      G     V 
Sbjct: 133 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 70  TYGYMSPEYALGGFFSVKS-DVFSFGVVVLEIISGK 104
           T  Y +PE  L      KS D++S G ++ E++S +
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD-GTTNRVVG 69
           + R L Y+H  +   ++HRD K SN+LL+   + KI DFGL R+ +      G     V 
Sbjct: 138 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 194
Query: 70  TYGYMSPEYALGGFFSVKS-DVFSFGVVVLEIISGK 104
           T  Y +PE  L      KS D++S G ++ E++S +
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD-GTTNRVVG 69
           + R L Y+H  +   ++HRD K SN+LL+   + KI DFGL R+ +      G     V 
Sbjct: 139 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 195
Query: 70  TYGYMSPEYALGGFFSVKS-DVFSFGVVVLEIISGK 104
           T  Y +PE  L      KS D++S G ++ E++S +
Sbjct: 196 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD-GTTNRVVG 69
           + R L Y+H  +   ++HRD K SN+LL+   + KI DFGL R+ +      G     V 
Sbjct: 130 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 186
Query: 70  TYGYMSPEYALGGFFSVKS-DVFSFGVVVLEIISGK 104
           T  Y +PE  L      KS D++S G ++ E++S +
Sbjct: 187 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD-GTTNRVVG 69
           + R L Y+H  +   ++HRD K SN+LL+   + KI DFGL R+ +      G     V 
Sbjct: 137 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 70  TYGYMSPEYALGGFFSVKS-DVFSFGVVVLEIISGK 104
           T  Y +PE  L      KS D++S G ++ E++S +
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 66/153 (43%), Gaps = 14/153 (9%)
Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFFSV 86
           +HRD    N+L+ H    KI DFGL R                   +M+PE    G +++
Sbjct: 194 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTI 253
Query: 87  KSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKAN 146
           KSDV+S+G+++ EI S     G  N    + +    +KL Q G     MDQ   A  +  
Sbjct: 254 KSDVWSYGILLWEIFS----LGV-NPYPGIPVDANFYKLIQNGFK---MDQPFYATEEIY 305
Query: 147 EILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE 179
            I++       C   D   RP+  ++   LG +
Sbjct: 306 IIMQS------CWAFDSRKRPSFPNLTSFLGCQ 332

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 75/172 (43%), Gaps = 22/172 (12%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L +    ++R + YL   +  + IHRD    N+L+      +I+DFGL R          
Sbjct: 159 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKK 215
Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLGY 121
           T        +M+PE      ++ +SDV+SFGV++ EI +  G    G    EL       
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL------- 268
Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
            +KL +EG  +D    KP   +  NE+   +     C    P+ RPT   +V
Sbjct: 269 -FKLLKEGHRMD----KPANCT--NELYMMMRD---CWHAVPSQRPTFKQLV 310

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD-GTTNRVVG 69
           + R L Y+H  +   ++HRD K SN+LL+   + KI DFGL R+ +      G     V 
Sbjct: 133 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 70  TYGYMSPEYALGGFFSVKS-DVFSFGVVVLEIISGK 104
           T  Y +PE  L      KS D++S G ++ E++S +
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/80 (36%), Positives = 47/80 (58%), Gaps = 6/80 (7%)
Query: 26  IIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRV-VGTYGYMSPEYALGGFF 84
           ++HRD K  N+LLD  MN KI+DFGL+ +     +DG   R   G+  Y +PE   G  +
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMM----SDGEFLRTSCGSPNYAAPEVISGRLY 187
Query: 85  S-VKSDVFSFGVVVLEIISG 103
           +  + D++S GV++  ++ G
Sbjct: 188 AGPEVDIWSCGVILYALLCG 207

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD-GTTNRVVG 69
           + R L Y+H  +   ++HRD K SN+LL+   + KI DFGL R+ +      G     V 
Sbjct: 153 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 70  TYGYMSPEYALGGFFSVKS-DVFSFGVVVLEIISGK 104
           T  Y +PE  L      KS D++S G ++ E++S +
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 58/106 (54%), Gaps = 6/106 (5%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L + H++   +I+HRD K  N+L++     K+ DFGL R F G   +  ++ VV T  Y 
Sbjct: 121 LAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV-TLWYR 175
Query: 75  SPEYALGG-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLL 119
           +P+  +G   +S   D++S G ++ E+I+GK      N E  L L+
Sbjct: 176 APDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLI 221

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 68/159 (42%), Gaps = 17/159 (10%)
Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFFSV 86
           IHRD    NILL H    KI DFGL R  +                +M+PE      ++ 
Sbjct: 190 IHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF 249
Query: 87  KSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKAN 146
           +SDV+S+G+ + E+ S        +    + +    +K+ +EG  +   +  P  +    
Sbjct: 250 ESDVWSYGIFLWELFSLGS-----SPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMY--- 301
Query: 147 EILKCINVGLLCVQEDPNDRPTMSDVVIMLG---SEAVN 182
           +I+K       C   DP  RPT   +V ++    SE+ N
Sbjct: 302 DIMK------TCWDADPLKRPTFKQIVQLIEKQISESTN 334

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD-GTTNRVVG 69
           + R L Y+H  +   ++HRD K SN+LL+   + KI DFGL R+ +      G     V 
Sbjct: 133 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 70  TYGYMSPEYALGGFFSVKS-DVFSFGVVVLEIISGK 104
           T  Y +PE  L      KS D++S G ++ E++S +
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD-GTTNRVVG 69
           + R L Y+H  +   ++HRD K SN+LL+   + KI DFGL R+ +      G     V 
Sbjct: 137 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 70  TYGYMSPEYALGGFFSVKS-DVFSFGVVVLEIISGK 104
           T  Y +PE  L      KS D++S G ++ E++S +
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH      +++RD K  N++LD + + KI+DFGL +  EG     T     GT  Y+
Sbjct: 123 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYL 177
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSE 113
           +PE      +    D +  GVV+ E++ G+    FYN +
Sbjct: 178 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 214

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 64/156 (41%), Gaps = 18/156 (11%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFF 84
           + IHRD    NILL  +   KI DFGL R                   +M+PE      +
Sbjct: 168 KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVY 227
Query: 85  SVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           +++SDV+SFGV++ EI S       G    E     L       +EG  +   D     +
Sbjct: 228 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-------KEGTRMRAPDYTTPEM 280
Query: 143 SKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGS 178
            +           L C   +P+ RPT S++V  LG+
Sbjct: 281 YQTM---------LDCWHGEPSQRPTFSELVEHLGN 307

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 64/156 (41%), Gaps = 18/156 (11%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFF 84
           + IHRD    NILL  +   KI DFGL R                   +M+PE      +
Sbjct: 159 KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVY 218
Query: 85  SVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           +++SDV+SFGV++ EI S       G    E     L       +EG  +   D     +
Sbjct: 219 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-------KEGTRMRAPDYTTPEM 271
Query: 143 SKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGS 178
            +           L C   +P+ RPT S++V  LG+
Sbjct: 272 YQTM---------LDCWHGEPSQRPTFSELVEHLGN 298

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 44/80 (55%), Gaps = 2/80 (2%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGT--YGYMSPEYALGG 82
           + +HRD    N +LD +   K++DFGL R    K+ D   N+        +M+ E     
Sbjct: 151 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 210
Query: 83  FFSVKSDVFSFGVVVLEIIS 102
            F+ KSDV+SFGV++ E+++
Sbjct: 211 KFTTKSDVWSFGVLLWELMT 230

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 64/156 (41%), Gaps = 18/156 (11%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFF 84
           + IHRD    NILL  +   KI DFGL R                   +M+PE      +
Sbjct: 168 KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVY 227
Query: 85  SVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           +++SDV+SFGV++ EI S       G    E     L       +EG  +   D     +
Sbjct: 228 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-------KEGTRMRAPDYTTPEM 280
Query: 143 SKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGS 178
            +           L C   +P+ RPT S++V  LG+
Sbjct: 281 YQTM---------LDCWHGEPSQRPTFSELVEHLGN 307

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD-GTTNRVVG 69
           + R L Y+H  +   ++HRD K SN+LL+   + KI DFGL R+ +      G     V 
Sbjct: 137 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA 193
Query: 70  TYGYMSPEYALGGFFSVKS-DVFSFGVVVLEIISGK 104
           T  Y +PE  L      KS D++S G ++ E++S +
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 44/80 (55%), Gaps = 2/80 (2%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGT--YGYMSPEYALGG 82
           + +HRD    N +LD +   K++DFGL R    K+ D   N+        +M+ E     
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 212
Query: 83  FFSVKSDVFSFGVVVLEIIS 102
            F+ KSDV+SFGV++ E+++
Sbjct: 213 KFTTKSDVWSFGVLLWELMT 232

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD-GTTNRVVG 69
           + R L Y+H  +   ++HRD K SN+LL+   + KI DFGL R+ +      G     V 
Sbjct: 138 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA 194
Query: 70  TYGYMSPEYALGGFFSVKS-DVFSFGVVVLEIISGK 104
           T  Y +PE  L      KS D++S G ++ E++S +
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD-GTTNRVVG 69
           + R L Y+H  +   ++HRD K SN+LL+   + KI DFGL R+ +      G     V 
Sbjct: 137 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 70  TYGYMSPEYALGGFFSVKS-DVFSFGVVVLEIISGK 104
           T  Y +PE  L      KS D++S G ++ E++S +
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 64/156 (41%), Gaps = 18/156 (11%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFF 84
           + IHRD    NILL  +   KI DFGL R                   +M+PE      +
Sbjct: 159 KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVY 218
Query: 85  SVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           +++SDV+SFGV++ EI S       G    E     L       +EG  +   D     +
Sbjct: 219 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-------KEGTRMRAPDYTTPEM 271
Query: 143 SKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGS 178
            +           L C   +P+ RPT S++V  LG+
Sbjct: 272 YQTM---------LDCWHGEPSQRPTFSELVEHLGN 298

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 56/102 (54%), Gaps = 10/102 (9%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           LF ++ G++    + H     R++HRD K  N+L++ E   K++DFGL R F G      
Sbjct: 108 LFQLLQGLA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTY 159
Query: 64  TNRVVGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEIISGK 104
            + VV T  Y +PE  LG  ++S   D++S G +  E+++ +
Sbjct: 160 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH      +++RD K  N++LD + + KI+DFGL +  EG     T     GT  Y+
Sbjct: 118 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYL 172
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSE 113
           +PE      +    D +  GVV+ E++ G+    FYN +
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 209

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/80 (36%), Positives = 47/80 (58%), Gaps = 3/80 (3%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG-F 83
           R++HRD K  N+L++ E   KI+DFGL R F G      T+ +V T  Y +P+  +G   
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-TLWYRAPDVLMGSKK 177
Query: 84  FSVKSDVFSFGVVVLEIISG 103
           +S   D++S G +  E+++G
Sbjct: 178 YSTTIDIWSVGCIFAEMVNG 197

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 56/102 (54%), Gaps = 10/102 (9%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           LF ++ G++    + H     R++HRD K  N+L++ E   K++DFGL R F G      
Sbjct: 109 LFQLLQGLA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTY 160
Query: 64  TNRVVGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEIISGK 104
            + VV T  Y +PE  LG  ++S   D++S G +  E+++ +
Sbjct: 161 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI D+GL R      TD     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDYGLAR-----HTDDEMTG 181
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 44/80 (55%), Gaps = 2/80 (2%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGT--YGYMSPEYALGG 82
           + +HRD    N +LD +   K++DFGL R    K+ D   N+        +M+ E     
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 212
Query: 83  FFSVKSDVFSFGVVVLEIIS 102
            F+ KSDV+SFGV++ E+++
Sbjct: 213 KFTTKSDVWSFGVLLWELMT 232

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 44/80 (55%), Gaps = 2/80 (2%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGT--YGYMSPEYALGG 82
           + +HRD    N +LD +   K++DFGL R    K+ D   N+        +M+ E     
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 213
Query: 83  FFSVKSDVFSFGVVVLEIIS 102
            F+ KSDV+SFGV++ E+++
Sbjct: 214 KFTTKSDVWSFGVLLWELMT 233

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 56/102 (54%), Gaps = 10/102 (9%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           LF ++ G++    + H     R++HRD K  N+L++ E   K++DFGL R F G      
Sbjct: 111 LFQLLQGLA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTY 162
Query: 64  TNRVVGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEIISGK 104
            + VV T  Y +PE  LG  ++S   D++S G +  E+++ +
Sbjct: 163 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 56/102 (54%), Gaps = 10/102 (9%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           LF ++ G++    + H     R++HRD K  N+L++ E   K++DFGL R F G      
Sbjct: 109 LFQLLQGLA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTY 160
Query: 64  TNRVVGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEIISGK 104
            + VV T  Y +PE  LG  ++S   D++S G +  E+++ +
Sbjct: 161 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 44/80 (55%), Gaps = 2/80 (2%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVG--TYGYMSPEYALGG 82
           + +HRD    N +LD +   K++DFGL R    K+ D   N+        +M+ E     
Sbjct: 212 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 271
Query: 83  FFSVKSDVFSFGVVVLEIIS 102
            F+ KSDV+SFGV++ E+++
Sbjct: 272 KFTTKSDVWSFGVLLWELMT 291

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 55/102 (53%), Gaps = 10/102 (9%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           LF ++ G    L + H     R++HRD K  N+L++ E   K++DFGL R F G      
Sbjct: 112 LFQLLQG----LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTY 163
Query: 64  TNRVVGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEIISGK 104
            + VV T  Y +PE  LG  ++S   D++S G +  E+++ +
Sbjct: 164 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 56/102 (54%), Gaps = 10/102 (9%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           LF ++ G++    + H     R++HRD K  N+L++ E   K++DFGL R F G      
Sbjct: 112 LFQLLQGLA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTY 163
Query: 64  TNRVVGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEIISGK 104
            + VV T  Y +PE  LG  ++S   D++S G +  E+++ +
Sbjct: 164 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 56/102 (54%), Gaps = 10/102 (9%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           LF ++ G++    + H     R++HRD K  N+L++ E   K++DFGL R F G      
Sbjct: 111 LFQLLQGLA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTY 162
Query: 64  TNRVVGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEIISGK 104
            + VV T  Y +PE  LG  ++S   D++S G +  E+++ +
Sbjct: 163 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 68/159 (42%), Gaps = 17/159 (10%)
Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFFSV 86
           IHRD    NILL H    KI DFGL R  +                +M+PE      ++ 
Sbjct: 190 IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF 249
Query: 87  KSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKAN 146
           +SDV+S+G+ + E+ S        +    + +    +K+ +EG  +   +  P  +    
Sbjct: 250 ESDVWSYGIFLWELFSLGS-----SPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMY--- 301
Query: 147 EILKCINVGLLCVQEDPNDRPTMSDVVIMLG---SEAVN 182
           +I+K       C   DP  RPT   +V ++    SE+ N
Sbjct: 302 DIMK------TCWDADPLKRPTFKQIVQLIEKQISESTN 334

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 56/102 (54%), Gaps = 10/102 (9%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           LF ++ G++    + H     R++HRD K  N+L++ E   K++DFGL R F G      
Sbjct: 111 LFQLLQGLA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTY 162
Query: 64  TNRVVGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEIISGK 104
            + VV T  Y +PE  LG  ++S   D++S G +  E+++ +
Sbjct: 163 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 68/159 (42%), Gaps = 17/159 (10%)
Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFFSV 86
           IHRD    NILL H    KI DFGL R  +                +M+PE      ++ 
Sbjct: 167 IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF 226
Query: 87  KSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKAN 146
           +SDV+S+G+ + E+ S        +    + +    +K+ +EG  +   +  P  +    
Sbjct: 227 ESDVWSYGIFLWELFSLGS-----SPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMY--- 278
Query: 147 EILKCINVGLLCVQEDPNDRPTMSDVVIMLG---SEAVN 182
           +I+K       C   DP  RPT   +V ++    SE+ N
Sbjct: 279 DIMK------TCWDADPLKRPTFKQIVQLIEKQISESTN 311

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 56/102 (54%), Gaps = 10/102 (9%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           LF ++ G++    + H     R++HRD K  N+L++ E   K++DFGL R F G      
Sbjct: 110 LFQLLQGLA----FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTY 161
Query: 64  TNRVVGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEIISGK 104
            + VV T  Y +PE  LG  ++S   D++S G +  E+++ +
Sbjct: 162 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 56/102 (54%), Gaps = 10/102 (9%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           LF ++ G++    + H     R++HRD K  N+L++ E   K++DFGL R F G      
Sbjct: 113 LFQLLQGLA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTY 164
Query: 64  TNRVVGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEIISGK 104
            + VV T  Y +PE  LG  ++S   D++S G +  E+++ +
Sbjct: 165 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD-GTTNRVVG 69
           + R L Y+H  +   ++HRD K SN+LL+   + KI DFGL R+ +      G     V 
Sbjct: 135 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 70  TYGYMSPEYALGGFFSVKS-DVFSFGVVVLEIISGK 104
           T  Y +PE  L      KS D++S G ++ E++S +
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 56/102 (54%), Gaps = 10/102 (9%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           LF ++ G++    + H     R++HRD K  N+L++ E   K++DFGL R F G      
Sbjct: 112 LFQLLQGLA----FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTY 163
Query: 64  TNRVVGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEIISGK 104
            + VV T  Y +PE  LG  ++S   D++S G +  E+++ +
Sbjct: 164 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 56/102 (54%), Gaps = 10/102 (9%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           LF ++ G++    + H     R++HRD K  N+L++ E   K++DFGL R F G      
Sbjct: 112 LFQLLQGLA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTY 163
Query: 64  TNRVVGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEIISGK 104
            + VV T  Y +PE  LG  ++S   D++S G +  E+++ +
Sbjct: 164 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 68/159 (42%), Gaps = 17/159 (10%)
Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFFSV 86
           IHRD    NILL H    KI DFGL R  +                +M+PE      ++ 
Sbjct: 185 IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF 244
Query: 87  KSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKAN 146
           +SDV+S+G+ + E+ S        +    + +    +K+ +EG  +   +  P  +    
Sbjct: 245 ESDVWSYGIFLWELFSLGS-----SPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMY--- 296
Query: 147 EILKCINVGLLCVQEDPNDRPTMSDVVIMLG---SEAVN 182
           +I+K       C   DP  RPT   +V ++    SE+ N
Sbjct: 297 DIMK------TCWDADPLKRPTFKQIVQLIEKQISESTN 329

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 44/80 (55%), Gaps = 2/80 (2%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGT--YGYMSPEYALGG 82
           + +HRD    N +LD +   K++DFGL R    K+ D   N+        +M+ E     
Sbjct: 158 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 217
Query: 83  FFSVKSDVFSFGVVVLEIIS 102
            F+ KSDV+SFGV++ E+++
Sbjct: 218 KFTTKSDVWSFGVLLWELMT 237

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 56/102 (54%), Gaps = 10/102 (9%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           LF ++ G++    + H     R++HRD K  N+L++ E   K++DFGL R F G      
Sbjct: 109 LFQLLQGLA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTY 160
Query: 64  TNRVVGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEIISGK 104
            + VV T  Y +PE  LG  ++S   D++S G +  E+++ +
Sbjct: 161 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 56/102 (54%), Gaps = 10/102 (9%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           LF ++ G++    + H     R++HRD K  N+L++ E   K++DFGL R F G      
Sbjct: 109 LFQLLQGLA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTY 160
Query: 64  TNRVVGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEIISGK 104
            + VV T  Y +PE  LG  ++S   D++S G +  E+++ +
Sbjct: 161 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+L+D +   K++DFG       K+  G T  + GT  Y++P
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGF-----AKRVKGRTWXLCGTPEYLAP 208
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 49/81 (60%), Gaps = 6/81 (7%)
Query: 26  IIHRDFKTSNILLDHEMNPKISDFGLTR--IFEGKQTDGTTNRVVGTYGYMSPEYALGGF 83
           II+RD K  N++LD E + KI+DFG+ +  I++G     TT    GT  Y++PE      
Sbjct: 463 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV----TTKXFCGTPDYIAPEIIAYQP 518
Query: 84  FSVKSDVFSFGVVVLEIISGK 104
           +    D ++FGV++ E+++G+
Sbjct: 519 YGKSVDWWAFGVLLYEMLAGQ 539

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 56/102 (54%), Gaps = 10/102 (9%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           LF ++ G++    + H     R++HRD K  N+L++ E   K++DFGL R F G      
Sbjct: 110 LFQLLQGLA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTY 161
Query: 64  TNRVVGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEIISGK 104
            + VV T  Y +PE  LG  ++S   D++S G +  E+++ +
Sbjct: 162 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 56/102 (54%), Gaps = 10/102 (9%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           LF ++ G++    + H     R++HRD K  N+L++ E   K++DFGL R F G      
Sbjct: 112 LFQLLQGLA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTY 163
Query: 64  TNRVVGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEIISGK 104
            + VV T  Y +PE  LG  ++S   D++S G +  E+++ +
Sbjct: 164 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 56/102 (54%), Gaps = 10/102 (9%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           LF ++ G++    + H     R++HRD K  N+L++ E   K++DFGL R F G      
Sbjct: 111 LFQLLQGLA----FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTY 162
Query: 64  TNRVVGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEIISGK 104
            + VV T  Y +PE  LG  ++S   D++S G +  E+++ +
Sbjct: 163 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 56/102 (54%), Gaps = 10/102 (9%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           LF ++ G++    + H     R++HRD K  N+L++ E   K++DFGL R F G      
Sbjct: 108 LFQLLQGLA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTY 159
Query: 64  TNRVVGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEIISGK 104
            + VV T  Y +PE  LG  ++S   D++S G +  E+++ +
Sbjct: 160 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 68/159 (42%), Gaps = 17/159 (10%)
Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFFSV 86
           IHRD    NILL H    KI DFGL R  +                +M+PE      ++ 
Sbjct: 183 IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF 242
Query: 87  KSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKAN 146
           +SDV+S+G+ + E+ S        +    + +    +K+ +EG  +   +  P  +    
Sbjct: 243 ESDVWSYGIFLWELFSLGS-----SPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMY--- 294
Query: 147 EILKCINVGLLCVQEDPNDRPTMSDVVIMLG---SEAVN 182
           +I+K       C   DP  RPT   +V ++    SE+ N
Sbjct: 295 DIMK------TCWDADPLKRPTFKQIVQLIEKQISESTN 327

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 54/105 (51%), Gaps = 18/105 (17%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L+ ++ G+     +LH      IIHRD K SNI++  +   KI DFGL R      T G
Sbjct: 131 LLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAG 177
Query: 63  T----TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           T    T  VV  Y Y +PE  LG  +    D++S G ++ E+I G
Sbjct: 178 TSFMMTPEVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH     +IIHRD K SN+L+  + + KI+DFG++  F+G  +D   +  VGT  +M+P
Sbjct: 152 YLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG--SDALLSNTVGTPAFMAP 206
Query: 77  E--YALGGFFSVKS-DVFSFGVVVLEIISGK 104
           E        FS K+ DV++ GV +   + G+
Sbjct: 207 ESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 56/102 (54%), Gaps = 10/102 (9%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           LF ++ G++    + H     R++HRD K  N+L++ E   K++DFGL R F G      
Sbjct: 112 LFQLLQGLA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTY 163
Query: 64  TNRVVGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEIISGK 104
            + VV T  Y +PE  LG  ++S   D++S G +  E+++ +
Sbjct: 164 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+L+D +   K++DFG       K+  G T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGF-----AKRVKGRTWXLCGTPEYLAP 207
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           ++  + R L Y+H      IIHRD K SN+ ++ +   +I DFGL R     Q D     
Sbjct: 128 LVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADEEMTG 179
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E++ GK
Sbjct: 180 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 56/102 (54%), Gaps = 10/102 (9%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           LF ++ G++    + H     R++HRD K  N+L++ E   K++DFGL R F G      
Sbjct: 110 LFQLLQGLA----FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTY 161
Query: 64  TNRVVGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEIISGK 104
            + VV T  Y +PE  LG  ++S   D++S G +  E+++ +
Sbjct: 162 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD-GTTNRVVG 69
           + R L Y+H  +   ++HRD K SN+LL+   + KI DFGL R+ +      G     V 
Sbjct: 133 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVA 189
Query: 70  TYGYMSPEYALGGFFSVKS-DVFSFGVVVLEIISGK 104
           T  Y +PE  L      KS D++S G ++ E++S +
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+L+D +   K++DFG       K+  G T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGF-----AKRVKGRTWXLCGTPEYLAP 207
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+L+D +   K++DFG       K+  G T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGF-----AKRVKGRTWXLCGTPEYLAP 207
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 56/102 (54%), Gaps = 10/102 (9%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           LF ++ G++    + H     R++HRD K  N+L++ E   K++DFGL R F G      
Sbjct: 109 LFQLLQGLA----FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTY 160
Query: 64  TNRVVGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEIISGK 104
            + VV T  Y +PE  LG  ++S   D++S G +  E+++ +
Sbjct: 161 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 56/102 (54%), Gaps = 10/102 (9%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           LF ++ G++    + H     R++HRD K  N+L++ E   K++DFGL R F G      
Sbjct: 110 LFQLLQGLA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTY 161
Query: 64  TNRVVGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEIISGK 104
            + VV T  Y +PE  LG  ++S   D++S G +  E+++ +
Sbjct: 162 XHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 52/101 (51%), Gaps = 10/101 (9%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L+ ++ G+     +LH      IIHRD K SNI++  +   KI DFGL R      T+ 
Sbjct: 131 LLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNF 180
Query: 63  TTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
                V T  Y +PE  LG  ++   D++S G ++ E++ G
Sbjct: 181 MMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH      +++RD K  N++LD + + KI+DFGL +  EG     T     GT  Y+
Sbjct: 118 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYL 172
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSE 113
           +PE      +    D +  GVV+ E++ G+    FYN +
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 209

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH      +++RD K  N++LD + + KI+DFGL +  EG     T     GT  Y+
Sbjct: 118 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYL 172
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSE 113
           +PE      +    D +  GVV+ E++ G+    FYN +
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 209

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH      +++RD K  N++LD + + KI+DFGL +  EG     T     GT  Y+
Sbjct: 118 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYL 172
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSE 113
           +PE      +    D +  GVV+ E++ G+    FYN +
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 209

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 64/156 (41%), Gaps = 18/156 (11%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFF 84
           + IHRD    NILL  +   KI DFGL R                   +M+PE      +
Sbjct: 168 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVY 227
Query: 85  SVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           +++SDV+SFGV++ EI S       G    E     L       +EG  +   D     +
Sbjct: 228 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-------KEGTRMRAPDYTTPEM 280
Query: 143 SKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGS 178
            +           L C   +P+ RPT S++V  LG+
Sbjct: 281 YQTM---------LDCWHGEPSQRPTFSELVEHLGN 307

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/116 (26%), Positives = 60/116 (51%), Gaps = 5/116 (4%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           + L N  + +++ + YL      R++HRD    N+L+    + KI+DFGL ++   ++ +
Sbjct: 127 QYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 183
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELA 115
                      +M+ E  L   ++ +SDV+S+GV V E+++   K   G   SE++
Sbjct: 184 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 239

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/116 (26%), Positives = 60/116 (51%), Gaps = 5/116 (4%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           + L N  + +++ + YL      R++HRD    N+L+    + KI+DFGL ++   ++ +
Sbjct: 117 QYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELA 115
                      +M+ E  L   ++ +SDV+S+GV V E+++   K   G   SE++
Sbjct: 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/80 (36%), Positives = 47/80 (58%), Gaps = 6/80 (7%)
Query: 26  IIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR-VVGTYGYMSPEYALGGFF 84
           ++HRD K  N+LLD  MN KI+DFGL+ +     +DG   R   G+  Y +PE   G  +
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMM----SDGEFLRDSCGSPNYAAPEVISGRLY 187
Query: 85  S-VKSDVFSFGVVVLEIISG 103
           +  + D++S GV++  ++ G
Sbjct: 188 AGPEVDIWSCGVILYALLCG 207

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH      +++RD K  N++LD + + KI+DFGL +  EG     T     GT  Y+
Sbjct: 121 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYL 175
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSE 113
           +PE      +    D +  GVV+ E++ G+    FYN +
Sbjct: 176 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 212

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 44/80 (55%), Gaps = 2/80 (2%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGT--YGYMSPEYALGG 82
           + +HRD    N +LD +   K++DFGL R    K+ D   N+        +M+ E     
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQ 213
Query: 83  FFSVKSDVFSFGVVVLEIIS 102
            F+ KSDV+SFGV++ E+++
Sbjct: 214 KFTTKSDVWSFGVLLWELMT 233

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/116 (26%), Positives = 60/116 (51%), Gaps = 5/116 (4%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           + L N  + +++ + YL      R++HRD    N+L+    + KI+DFGL ++   ++ +
Sbjct: 121 QYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 177
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELA 115
                      +M+ E  L   ++ +SDV+S+GV V E+++   K   G   SE++
Sbjct: 178 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 233

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/116 (26%), Positives = 60/116 (51%), Gaps = 5/116 (4%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           + L N  + +++ + YL      R++HRD    N+L+    + KI+DFGL ++   ++ +
Sbjct: 117 QYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELA 115
                      +M+ E  L   ++ +SDV+S+GV V E+++   K   G   SE++
Sbjct: 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/116 (26%), Positives = 60/116 (51%), Gaps = 5/116 (4%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           + L N  + +++ + YL      R++HRD    N+L+    + KI+DFGL ++   ++ +
Sbjct: 117 QYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELA 115
                      +M+ E  L   ++ +SDV+S+GV V E+++   K   G   SE++
Sbjct: 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 49/81 (60%), Gaps = 6/81 (7%)
Query: 26  IIHRDFKTSNILLDHEMNPKISDFGLTR--IFEGKQTDGTTNRVVGTYGYMSPEYALGGF 83
           II+RD K  N++LD E + KI+DFG+ +  I++G     TT    GT  Y++PE      
Sbjct: 142 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV----TTKXFCGTPDYIAPEIIAYQP 197
Query: 84  FSVKSDVFSFGVVVLEIISGK 104
           +    D ++FGV++ E+++G+
Sbjct: 198 YGKSVDWWAFGVLLYEMLAGQ 218

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/80 (35%), Positives = 45/80 (56%), Gaps = 3/80 (3%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTT--NRVVGTYGYMSPEYALGG 82
           + +HRD    N+L++ E   KI DFGLT+  E  +   T   +R    + Y +PE  +  
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECLMQS 204
Query: 83  FFSVKSDVFSFGVVVLEIIS 102
            F + SDV+SFGV + E+++
Sbjct: 205 KFYIASDVWSFGVTLHELLT 224

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/116 (26%), Positives = 60/116 (51%), Gaps = 5/116 (4%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           + L N  + +++ + YL      R++HRD    N+L+    + KI+DFGL ++   ++ +
Sbjct: 151 QYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 207
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELA 115
                      +M+ E  L   ++ +SDV+S+GV V E+++   K   G   SE++
Sbjct: 208 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 263

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 52/95 (54%), Gaps = 3/95 (3%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGT 70
           V   +L L    KL II+RD K  NILLD   +  ++DFGL++ F   +T+   +   GT
Sbjct: 165 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGT 223
Query: 71  YGYMSPEYALGG--FFSVKSDVFSFGVVVLEIISG 103
             YM+P+   GG        D +S GV++ E+++G
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 74/180 (41%), Gaps = 21/180 (11%)
Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           +E L      V++ + +L   +  + IHRD    NILL  +   KI DFGL R       
Sbjct: 147 LEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD 203
Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSL 118
                       +M+PE      ++++SDV+SFGV++ EI S       G    E     
Sbjct: 204 XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 263
Query: 119 LGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGS 178
           L       +EG  +   D     + +           L C   +P+ RPT S++V  LG+
Sbjct: 264 L-------KEGTRMRAPDYTTPEMYQTM---------LDCWHGEPSQRPTFSELVEHLGN 307

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/116 (26%), Positives = 60/116 (51%), Gaps = 5/116 (4%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           + L N  + +++ + YL      R++HRD    N+L+    + KI+DFGL ++   ++ +
Sbjct: 120 QYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 176
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELA 115
                      +M+ E  L   ++ +SDV+S+GV V E+++   K   G   SE++
Sbjct: 177 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/116 (26%), Positives = 60/116 (51%), Gaps = 5/116 (4%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           + L N  + +++ + YL      R++HRD    N+L+    + KI+DFGL ++   ++ +
Sbjct: 123 QYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 179
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELA 115
                      +M+ E  L   ++ +SDV+S+GV V E+++   K   G   SE++
Sbjct: 180 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 235

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/116 (26%), Positives = 60/116 (51%), Gaps = 5/116 (4%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           + L N  + +++ + YL      R++HRD    N+L+    + KI+DFGL ++   ++ +
Sbjct: 118 QYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 174
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELA 115
                      +M+ E  L   ++ +SDV+S+GV V E+++   K   G   SE++
Sbjct: 175 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 230

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/116 (26%), Positives = 60/116 (51%), Gaps = 5/116 (4%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           + L N  + +++ + YL      R++HRD    N+L+    + KI+DFGL ++   ++ +
Sbjct: 120 QYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 176
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELA 115
                      +M+ E  L   ++ +SDV+S+GV V E+++   K   G   SE++
Sbjct: 177 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/116 (26%), Positives = 60/116 (51%), Gaps = 5/116 (4%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           + L N  + +++ + YL      R++HRD    N+L+    + KI+DFGL ++   ++ +
Sbjct: 120 QYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 176
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELA 115
                      +M+ E  L   ++ +SDV+S+GV V E+++   K   G   SE++
Sbjct: 177 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/116 (26%), Positives = 60/116 (51%), Gaps = 5/116 (4%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           + L N  + +++ + YL      R++HRD    N+L+    + KI+DFGL ++   ++ +
Sbjct: 118 QYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 174
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELA 115
                      +M+ E  L   ++ +SDV+S+GV V E+++   K   G   SE++
Sbjct: 175 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 230

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/116 (26%), Positives = 60/116 (51%), Gaps = 5/116 (4%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           + L N  + +++ + YL      R++HRD    N+L+    + KI+DFGL ++   ++ +
Sbjct: 117 QYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELA 115
                      +M+ E  L   ++ +SDV+S+GV V E+++   K   G   SE++
Sbjct: 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/116 (26%), Positives = 60/116 (51%), Gaps = 5/116 (4%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           + L N  + +++ + YL      R++HRD    N+L+    + KI+DFGL ++   ++ +
Sbjct: 119 QYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 175
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELA 115
                      +M+ E  L   ++ +SDV+S+GV V E+++   K   G   SE++
Sbjct: 176 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/80 (35%), Positives = 45/80 (56%), Gaps = 3/80 (3%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTT--NRVVGTYGYMSPEYALGG 82
           + +HRD    N+L++ E   KI DFGLT+  E  +   T   +R    + Y +PE  +  
Sbjct: 134 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECLMQS 192
Query: 83  FFSVKSDVFSFGVVVLEIIS 102
            F + SDV+SFGV + E+++
Sbjct: 193 KFYIASDVWSFGVTLHELLT 212

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH      +++RD K  N++LD + + KI+DFGL +  EG     T     GT  Y+
Sbjct: 118 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYL 172
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSE 113
           +PE      +    D +  GVV+ E++ G+    FYN +
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 209

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/116 (26%), Positives = 60/116 (51%), Gaps = 5/116 (4%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           + L N  + +++ + YL      R++HRD    N+L+    + KI+DFGL ++   ++ +
Sbjct: 124 QYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 180
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELA 115
                      +M+ E  L   ++ +SDV+S+GV V E+++   K   G   SE++
Sbjct: 181 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/116 (26%), Positives = 60/116 (51%), Gaps = 5/116 (4%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           + L N  + +++ + YL      R++HRD    N+L+    + KI+DFGL ++   ++ +
Sbjct: 124 QYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 180
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELA 115
                      +M+ E  L   ++ +SDV+S+GV V E+++   K   G   SE++
Sbjct: 181 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/116 (26%), Positives = 60/116 (51%), Gaps = 5/116 (4%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           + L N  + +++ + YL      R++HRD    N+L+    + KI+DFGL ++   ++ +
Sbjct: 117 QYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELA 115
                      +M+ E  L   ++ +SDV+S+GV V E+++   K   G   SE++
Sbjct: 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/116 (26%), Positives = 60/116 (51%), Gaps = 5/116 (4%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           + L N  + +++ + YL      R++HRD    N+L+    + KI+DFGL ++   ++ +
Sbjct: 120 QYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 176
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELA 115
                      +M+ E  L   ++ +SDV+S+GV V E+++   K   G   SE++
Sbjct: 177 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/116 (26%), Positives = 60/116 (51%), Gaps = 5/116 (4%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           + L N  + +++ + YL      R++HRD    N+L+    + KI+DFGL ++   ++ +
Sbjct: 119 QYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 175
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELA 115
                      +M+ E  L   ++ +SDV+S+GV V E+++   K   G   SE++
Sbjct: 176 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/116 (26%), Positives = 60/116 (51%), Gaps = 5/116 (4%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           + L N  + +++ + YL      R++HRD    N+L+    + KI+DFGL ++   ++ +
Sbjct: 124 QYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 180
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELA 115
                      +M+ E  L   ++ +SDV+S+GV V E+++   K   G   SE++
Sbjct: 181 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 26/80 (32%), Positives = 44/80 (55%), Gaps = 2/80 (2%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFF 84
           +I+HRD K+ NI L  +   ++ DFG+ R+     T       +GT  Y+SPE      +
Sbjct: 145 KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--TVELARACIGTPYYLSPEICENKPY 202
Query: 85  SVKSDVFSFGVVVLEIISGK 104
           + KSD+++ G V+ E+ + K
Sbjct: 203 NNKSDIWALGCVLYELCTLK 222

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 53/103 (51%), Gaps = 10/103 (9%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGT 70
           ++  L YLH    L I++RD K  NILLD + +  ++DFGL +  E  + + TT+   GT
Sbjct: 148 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGT 202
Query: 71  YGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG-----KRNTG 108
             Y++PE      +    D +  G V+ E++ G      RNT 
Sbjct: 203 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA 245

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/116 (26%), Positives = 60/116 (51%), Gaps = 5/116 (4%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           + L N  + +++ + YL      R++HRD    N+L+    + KI+DFGL ++   ++ +
Sbjct: 111 QYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 167
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELA 115
                      +M+ E  L   ++ +SDV+S+GV V E+++   K   G   SE++
Sbjct: 168 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 223

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/116 (26%), Positives = 60/116 (51%), Gaps = 5/116 (4%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           + L N  + +++ + YL      R++HRD    N+L+    + KI+DFGL ++   ++ +
Sbjct: 142 QYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 198
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELA 115
                      +M+ E  L   ++ +SDV+S+GV V E+++   K   G   SE++
Sbjct: 199 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 254

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           ++  + R L Y+H      IIHRD K SN+ ++ +   +I DFGL R     Q D     
Sbjct: 136 LVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTG 187
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E++ GK
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 46/97 (47%), Gaps = 7/97 (7%)
Query: 8   ILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRV 67
           I  ++  L Y H     R+IHRD K  N+LL      KI+DFG +      + D     +
Sbjct: 140 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDD----L 192
Query: 68  VGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
            GT  Y+ PE   G     K D++S GV+  E + GK
Sbjct: 193 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 54/105 (51%), Gaps = 18/105 (17%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L+ ++ G+     +LH      IIHRD K SNI++  +   KI DFGL R      T G
Sbjct: 132 LLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAG 178
Query: 63  T----TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           T    T  VV  Y Y +PE  LG  +    D++S G ++ E+I G
Sbjct: 179 TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 75/171 (43%), Gaps = 23/171 (13%)
Query: 9   LGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQ-TDGTTNRV 67
           L + + + YL     +  +HRD    NIL+      K+ DFGL+R  E +     +  R+
Sbjct: 116 LQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL 172
Query: 68  VGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLW 126
                +MSPE      F+  SDV+ F V + EI+S GK+   +  ++  + +L       
Sbjct: 173 --PIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL------- 223
Query: 127 QEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLG 177
           ++G  L   D  P  +           +   C   DP+DRP  +++V  L 
Sbjct: 224 EKGDRLPKPDLCPPVL---------YTLMTRCWDYDPSDRPRFTELVCSLS 265

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 75/171 (43%), Gaps = 23/171 (13%)
Query: 9   LGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQ-TDGTTNRV 67
           L + + + YL     +  +HRD    NIL+      K+ DFGL+R  E +     +  R+
Sbjct: 120 LQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL 176
Query: 68  VGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLW 126
                +MSPE      F+  SDV+ F V + EI+S GK+   +  ++  + +L       
Sbjct: 177 --PIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL------- 227
Query: 127 QEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLG 177
           ++G  L   D  P  +           +   C   DP+DRP  +++V  L 
Sbjct: 228 EKGDRLPKPDLCPPVL---------YTLMTRCWDYDPSDRPRFTELVCSLS 269

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 55/105 (52%), Gaps = 18/105 (17%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L+ +++G+     +LH      IIHRD K SNI++  +   KI DFGL R      T G
Sbjct: 131 LLYQMLVGIK----HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR------TAG 177
Query: 63  T----TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           T    T  VV  Y Y +PE  LG  +    D++S G ++ E+I G
Sbjct: 178 TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 54/105 (51%), Gaps = 18/105 (17%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L+ ++ G+     +LH      IIHRD K SNI++  +   KI DFGL R      T G
Sbjct: 131 LLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAG 177
Query: 63  T----TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           T    T  VV  Y Y +PE  LG  +    D++S G ++ E+I G
Sbjct: 178 TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+++D +   +++DFGL      K+  G T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGL-----AKRVKGRTWXLCGTPEYLAP 207
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           ++  + R L Y+H      IIHRD K SN+ ++ +   +I DFGL R     Q D     
Sbjct: 136 LVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTG 187
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E++ GK
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 47/97 (48%), Gaps = 7/97 (7%)
Query: 8   ILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRV 67
           I  ++  L Y H     R+IHRD K  N+LL      KI+DFG +       +  TT  +
Sbjct: 140 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT--L 192
Query: 68  VGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
            GT  Y+ PE   G     K D++S GV+  E + GK
Sbjct: 193 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+++D +   K++DFG       K+  G T  + GT  Y++P
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGF-----AKRVKGRTWXLCGTPEYLAP 208
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+++D +   K++DFG       K+  G T  + GT  Y++P
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGF-----AKRVKGRTWXLCGTPEYLAP 208
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+++D +   K++DFG       K+  G T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGF-----AKRVKGRTWXLCGTPEYLAP 207
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+++D +   K++DFG       K+  G T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGF-----AKRVKGRTWXLCGTPEYLAP 207
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+++D +   K++DFG       K+  G T  + GT  Y++P
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGF-----AKRVKGRTWXLCGTPEYLAP 208
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 83/178 (46%), Gaps = 29/178 (16%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           ++L  I + + + L +LH  SKL +IHRD K SN+L++     K  DFG++    G   D
Sbjct: 136 DILGKIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFGIS----GYLVD 189
Query: 62  GTTNRV-VGTYGYMSPEYALGGF----FSVKSDVFSFGVVVLEIISGKRNTGFYNSELAL 116
                +  G   Y +PE          +SVKSD++S G+  +E                L
Sbjct: 190 DVAKDIDAGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIE----------------L 233
Query: 117 SLLGYAWKLW-QEGKALDMMDQKPGAISKANEI-LKCINVGLLCVQEDPNDRPTMSDV 172
           ++L + +  W    + L  + ++P     A++   + ++    C++++  +RPT  ++
Sbjct: 234 AILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPEL 291

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 64/156 (41%), Gaps = 18/156 (11%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFF 84
           + IHRD    NILL  +   KI DFGL R                   +M+PE      +
Sbjct: 159 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 218
Query: 85  SVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           +++SDV+SFGV++ EI S       G    E     L       +EG  +   D     +
Sbjct: 219 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-------KEGTRMRAPDYTTPEM 271
Query: 143 SKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGS 178
            +           L C   +P+ RPT S++V  LG+
Sbjct: 272 YQTM---------LDCWHGEPSQRPTFSELVEHLGN 298

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+++D +   K++DFG       K+  G T  + GT  Y++P
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGF-----AKRVKGRTWXLCGTPEYLAP 208
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 75/171 (43%), Gaps = 23/171 (13%)
Query: 9   LGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQ-TDGTTNRV 67
           L + + + YL     +  +HRD    NIL+      K+ DFGL+R  E +     +  R+
Sbjct: 132 LQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL 188
Query: 68  VGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLW 126
                +MSPE      F+  SDV+ F V + EI+S GK+   +  ++  + +L       
Sbjct: 189 --PIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL------- 239
Query: 127 QEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLG 177
           ++G  L   D  P  +           +   C   DP+DRP  +++V  L 
Sbjct: 240 EKGDRLPKPDLCPPVL---------YTLMTRCWDYDPSDRPRFTELVCSLS 281

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 47/97 (48%), Gaps = 7/97 (7%)
Query: 8   ILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRV 67
           I  ++  L Y H     R+IHRD K  N+LL      KI+DFG +       +  TT  +
Sbjct: 131 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT--L 183
Query: 68  VGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
            GT  Y+ PE   G     K D++S GV+  E + GK
Sbjct: 184 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 220

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/89 (37%), Positives = 47/89 (52%), Gaps = 9/89 (10%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFE-GKQTDGTTNRVVGTYGYMS 75
           Y HQ     I+HRD K  N+LLD + N KI+DFG +  F  G + D       G   Y +
Sbjct: 128 YCHQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDA----FCGAPPYAA 180
Query: 76  PEYALGGFFS-VKSDVFSFGVVVLEIISG 103
           PE   G  +   + DV+S GV++  ++SG
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 81/185 (43%), Gaps = 41/185 (22%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           + L +    V+R + YL Q    + IHR+    NIL+      KI+DFGL+R        
Sbjct: 139 QQLLHFAADVARGMDYLSQK---QFIHRNLAARNILVGENYVAKIADFGLSR-------- 187
Query: 62  GTTNRVVGTYG-----YMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSEL 114
           G    V  T G     +M+ E      ++  SDV+S+GV++ EI+S  G    G   +EL
Sbjct: 188 GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 247
Query: 115 ALSL-LGYAWK--LWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSD 171
              L  GY  +  L  + +  D+M Q                    C +E P +RP+ + 
Sbjct: 248 YEKLPQGYRLEKPLNCDDEVYDLMRQ--------------------CWREKPYERPSFAQ 287
Query: 172 VVIML 176
           +++ L
Sbjct: 288 ILVSL 292

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 54/105 (51%), Gaps = 18/105 (17%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L+ ++ G+     +LH      IIHRD K SNI++  +   KI DFGL R      T G
Sbjct: 131 LLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAG 177
Query: 63  T----TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           T    T  VV  Y Y +PE  LG  +    D++S G ++ E+I G
Sbjct: 178 TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 64/156 (41%), Gaps = 18/156 (11%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFF 84
           + IHRD    NILL  +   KI DFGL R                   +M+PE      +
Sbjct: 170 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 229
Query: 85  SVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           +++SDV+SFGV++ EI S       G    E     L       +EG  +   D     +
Sbjct: 230 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-------KEGTRMRAPDYTTPEM 282
Query: 143 SKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGS 178
            +           L C   +P+ RPT S++V  LG+
Sbjct: 283 YQTM---------LDCWHGEPSQRPTFSELVEHLGN 309

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 64/156 (41%), Gaps = 18/156 (11%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFF 84
           + IHRD    NILL  +   KI DFGL R                   +M+PE      +
Sbjct: 159 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 218
Query: 85  SVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           +++SDV+SFGV++ EI S       G    E     L       +EG  +   D     +
Sbjct: 219 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-------KEGTRMRAPDYTTPEM 271
Query: 143 SKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGS 178
            +           L C   +P+ RPT S++V  LG+
Sbjct: 272 YQTM---------LDCWHGEPSQRPTFSELVEHLGN 298

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 64/156 (41%), Gaps = 18/156 (11%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFF 84
           + IHRD    NILL  +   KI DFGL R                   +M+PE      +
Sbjct: 168 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 227
Query: 85  SVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           +++SDV+SFGV++ EI S       G    E     L       +EG  +   D     +
Sbjct: 228 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-------KEGTRMRAPDYTTPEM 280
Query: 143 SKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGS 178
            +           L C   +P+ RPT S++V  LG+
Sbjct: 281 YQTM---------LDCWHGEPSQRPTFSELVEHLGN 307

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 9/101 (8%)
Query: 6   NIILGVSRRLLYLHQDSKLRIIHRDFKTSNILL---DHEMNPKISDFGLTRIFEGKQTDG 62
            +I  V   + YLH   ++ I+HRD K  N+L    D E    ISDFGL+++ EGK    
Sbjct: 124 TLIRQVLDAVYYLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM-EGKGDVM 179
Query: 63  TTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           +T    GT GY++PE      +S   D +S GV+   ++ G
Sbjct: 180 ST--ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 9   LGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVV 68
           L V++ + YL   +  + +HRD    N +LD +   K++DFGL R    K+     N+  
Sbjct: 139 LQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTG 195
Query: 69  GT--YGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS 102
                 +M+ E      F+ KSDV+SFGV++ E+++
Sbjct: 196 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+L+D +   +++DFG       K+  G T  + GT  Y++P
Sbjct: 177 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGF-----AKRVKGATWTLCGTPEYLAP 228
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 229 EIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 54/104 (51%), Gaps = 16/104 (15%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L+ ++ G+     +LH      IIHRD K SNI++  +   KI DFGL R      T G
Sbjct: 133 LLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAG 179
Query: 63  TTNRVVG---TYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           T+  +V    T  Y +PE  LG  +    D++S G ++ E+I G
Sbjct: 180 TSFMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 54/105 (51%), Gaps = 18/105 (17%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L+ ++ G+     +LH      IIHRD K SNI++  +   KI DFGL R      T G
Sbjct: 131 LLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAG 177
Query: 63  T----TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           T    T  VV  Y Y +PE  LG  +    D++S G ++ E+I G
Sbjct: 178 TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 48/98 (48%), Gaps = 9/98 (9%)
Query: 8   ILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLT-RIFEGKQTDGTTNR 66
           I  ++  L Y H     R+IHRD K  N+LL      KI+DFG +      ++TD     
Sbjct: 114 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD----- 165
Query: 67  VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           + GT  Y+ PE   G     K D++S GV+  E + GK
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 64/156 (41%), Gaps = 18/156 (11%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFF 84
           + IHRD    NILL  +   KI DFGL R                   +M+PE      +
Sbjct: 213 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 272
Query: 85  SVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           +++SDV+SFGV++ EI S       G    E     L       +EG  +   D     +
Sbjct: 273 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-------KEGTRMRAPDYTTPEM 325
Query: 143 SKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGS 178
            +           L C   +P+ RPT S++V  LG+
Sbjct: 326 YQTM---------LDCWHGEPSQRPTFSELVEHLGN 352

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 54/105 (51%), Gaps = 18/105 (17%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L+ ++ G+     +LH      IIHRD K SNI++  +   KI DFGL R      T G
Sbjct: 131 LLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR------TAG 177
Query: 63  T----TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           T    T  VV  Y Y +PE  LG  +    D++S G ++ E+I G
Sbjct: 178 TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 64/156 (41%), Gaps = 18/156 (11%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFF 84
           + IHRD    NILL  +   KI DFGL R                   +M+PE      +
Sbjct: 205 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 264
Query: 85  SVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           +++SDV+SFGV++ EI S       G    E     L       +EG  +   D     +
Sbjct: 265 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-------KEGTRMRAPDYTTPEM 317
Query: 143 SKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGS 178
            +           L C   +P+ RPT S++V  LG+
Sbjct: 318 YQTM---------LDCWHGEPSQRPTFSELVEHLGN 344

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 54/100 (54%), Gaps = 10/100 (10%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNIL-LDHEMNPKI--SDFGLTRIFEGKQTDGT 63
           +I  V   + YLH++    I+HRD K  N+L L  E N KI  +DFGL+++    + +G 
Sbjct: 111 VIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGI 163
Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
            +   GT GY++PE      +S   D +S GV+   ++ G
Sbjct: 164 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 54/105 (51%), Gaps = 18/105 (17%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L+ ++ G+     +LH      IIHRD K SNI++  +   KI DFGL R      T G
Sbjct: 131 LLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR------TAG 177
Query: 63  T----TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           T    T  VV  Y Y +PE  LG  +    D++S G ++ E+I G
Sbjct: 178 TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 64/156 (41%), Gaps = 18/156 (11%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFF 84
           + IHRD    NILL  +   KI DFGL R                   +M+PE      +
Sbjct: 211 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 270
Query: 85  SVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           +++SDV+SFGV++ EI S       G    E     L       +EG  +   D     +
Sbjct: 271 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-------KEGTRMRAPDYTTPEM 323
Query: 143 SKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGS 178
            +           L C   +P+ RPT S++V  LG+
Sbjct: 324 YQTM---------LDCWHGEPSQRPTFSELVEHLGN 350

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+L+D +   +++DFG       K+  G T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGF-----AKRVKGRTWXLCGTPEYLAP 207
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 48/98 (48%), Gaps = 9/98 (9%)
Query: 8   ILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLT-RIFEGKQTDGTTNR 66
           I  ++  L Y H     R+IHRD K  N+LL      KI+DFG +      ++TD     
Sbjct: 119 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD----- 170
Query: 67  VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           + GT  Y+ PE   G     K D++S GV+  E + GK
Sbjct: 171 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+L+D +   +++DFG       K+  G T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGF-----AKRVKGRTWXLCGTPEYLAP 207
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 48/98 (48%), Gaps = 9/98 (9%)
Query: 8   ILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLT-RIFEGKQTDGTTNR 66
           I  ++  L Y H     R+IHRD K  N+LL      KI+DFG +      ++TD     
Sbjct: 115 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD----- 166
Query: 67  VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           + GT  Y+ PE   G     K D++S GV+  E + GK
Sbjct: 167 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 58/104 (55%), Gaps = 5/104 (4%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGK-QTDG 62
           L  ++ G++  + YL   + +  +HRD    NIL++  +  K+SDFGL+R+ E   +   
Sbjct: 147 LVGMLRGIAAGMRYL---ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVY 203
Query: 63  TTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKR 105
           TT        + +PE      F+  SDV+S+G+V+ E++S G+R
Sbjct: 204 TTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER 247

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+L+D +   +++DFG       K+  G T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGF-----AKRVKGRTWXLAGTPEYLAP 207
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+L+D +   +++DFG       K+  G T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGF-----AKRVKGRTWXLCGTPEYLAP 207
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+L+D +   +++DFG       K+  G T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGF-----AKRVKGRTWXLCGTPEYLAP 207
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 48/98 (48%), Gaps = 9/98 (9%)
Query: 8   ILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLT-RIFEGKQTDGTTNR 66
           I  ++  L Y H     R+IHRD K  N+LL      KI+DFG +      ++TD     
Sbjct: 114 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD----- 165
Query: 67  VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           + GT  Y+ PE   G     K D++S GV+  E + GK
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+L+D +   +++DFG       K+  G T  + GT  Y++P
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGF-----AKRVKGRTWXLCGTPEYLAP 208
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+L+D +   +++DFG       K+  G T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGF-----AKRVKGRTWXLCGTPEYLAP 207
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 53/103 (51%), Gaps = 10/103 (9%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           E+L  + +G+     YL + +    +HRD    N+LL +    KISDFGL++   G    
Sbjct: 114 ELLHQVSMGMK----YLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKAL-GADDS 165
Query: 62  GTTNRVVGTY--GYMSPEYALGGFFSVKSDVFSFGVVVLEIIS 102
             T R  G +   + +PE      FS +SDV+S+GV + E +S
Sbjct: 166 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 208

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+L+D +   +++DFG       K+  G T  + GT  Y++P
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGF-----AKRVKGRTWXLCGTPEYLAP 208
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+L+D +   +++DFG       K+  G T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGF-----AKRVKGRTWXLCGTPEYLAP 207
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+L+D +   +++DFG       K+  G T  + GT  Y++P
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGF-----AKRVKGRTWXLCGTPEYLAP 208
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+L+D +   +++DFG       K+  G T  + GT  Y++P
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGF-----AKRVKGRTWXLCGTPEYLAP 208
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+L+D +   +++DFG       K+  G T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGF-----AKRVKGRTWXLCGTPEYLAP 207
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+L+D +   +++DFG       K+  G T  + GT  Y++P
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGF-----AKRVKGRTWXLCGTPEYLAP 208
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 64/156 (41%), Gaps = 18/156 (11%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFF 84
           + IHRD    NILL  +   KI DFGL R                   +M+PE      +
Sbjct: 218 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 277
Query: 85  SVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           +++SDV+SFGV++ EI S       G    E     L       +EG  +   D     +
Sbjct: 278 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-------KEGTRMRAPDYTTPEM 330
Query: 143 SKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGS 178
            +           L C   +P+ RPT S++V  LG+
Sbjct: 331 YQTM---------LDCWHGEPSQRPTFSELVEHLGN 357

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+L+D +   +++DFG       K+  G T  + GT  Y++P
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGF-----AKRVKGRTWXLCGTPEYLAP 208
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 47/97 (48%), Gaps = 7/97 (7%)
Query: 8   ILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRV 67
           I  ++  L Y H     R+IHRD K  N+LL      KI+DFG +       +  TT  +
Sbjct: 119 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT--L 171
Query: 68  VGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
            GT  Y+ PE   G     K D++S GV+  E + GK
Sbjct: 172 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+L+D +   +++DFG       K+  G T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGF-----AKRVKGRTWXLCGTPEYLAP 207
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+L+D +   +++DFG       K+  G T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGF-----AKRVKGRTWXLCGTPEYLAP 207
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+L+D +   +++DFG       K+  G T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGF-----AKRVKGRTWXLCGTPEYLAP 207
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 47/97 (48%), Gaps = 7/97 (7%)
Query: 8   ILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRV 67
           I  ++  L Y H     R+IHRD K  N+LL      KI+DFG +       +  TT  +
Sbjct: 119 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT--L 171
Query: 68  VGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
            GT  Y+ PE   G     K D++S GV+  E + GK
Sbjct: 172 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+L+D +   +++DFG       K+  G T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGF-----AKRVKGRTWXLCGTPEYLAP 207
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+L+D +   +++DFG       K+  G T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGF-----AKRVKGRTWXLCGTPEYLAP 207
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+L+D +   +++DFG       K+  G T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGF-----AKRVKGRTWXLCGTPEYLAP 207
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+L+D +   +++DFG       K+  G T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGF-----AKRVKGRTWXLCGTPEYLAP 207
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+L+D +   +++DFG       K+  G T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGF-----AKRVKGRTWXLCGTPEYLAP 207
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 47/97 (48%), Gaps = 7/97 (7%)
Query: 8   ILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRV 67
           I  ++  L Y H     R+IHRD K  N+LL      KI+DFG +       +  TT  +
Sbjct: 117 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT--L 169
Query: 68  VGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
            GT  Y+ PE   G     K D++S GV+  E + GK
Sbjct: 170 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+L+D +   +++DFG       K+  G T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGF-----AKRVKGRTWXLCGTPEYLAP 207
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 79/170 (46%), Gaps = 25/170 (14%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQT 60
           + L  +   V   + YL  +SK + +HRD    N L++ +   K+SDFGL+R + + ++T
Sbjct: 120 QQLLEMCKDVCEAMEYL--ESK-QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEET 176
Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKR-NTGFYNSELALSL 118
               ++    +    PE  +   FS KSD+++FGV++ EI S GK     F NSE A   
Sbjct: 177 SSVGSKFPVRWS--PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA--- 231
Query: 119 LGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPT 168
                    E  A  +   +P   S+     K   +   C  E  ++RPT
Sbjct: 232 ---------EHIAQGLRLYRPHLASE-----KVYTIMYSCWHEKADERPT 267

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+L+D +   +++DFG       K+  G T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGF-----AKRVKGRTWXLCGTPEYLAP 207
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+L+D +   +++DFG       K+  G T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGF-----AKRVKGRTWXLCGTPEYLAP 207
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/88 (36%), Positives = 48/88 (54%), Gaps = 11/88 (12%)
Query: 23  KLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR-VVGTYGYMSPEYALG 81
           KL I+HRD K  NILLD +MN K++DFG    F  +   G   R V GT  Y++PE    
Sbjct: 129 KLNIVHRDLKPENILLDDDMNIKLTDFG----FSCQLDPGEKLREVCGTPSYLAPEIIEC 184
Query: 82  GF------FSVKSDVFSFGVVVLEIISG 103
                   +  + D++S GV++  +++G
Sbjct: 185 SMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+L+D +   +++DFG       K+  G T  + GT  Y++P
Sbjct: 149 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGF-----AKRVKGRTWXLCGTPEYLAP 200
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 201 EIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 47/97 (48%), Gaps = 7/97 (7%)
Query: 8   ILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRV 67
           I  ++  L Y H     R+IHRD K  N+LL      KI+DFG +       +  TT  +
Sbjct: 114 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT--L 166
Query: 68  VGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
            GT  Y+ PE   G     K D++S GV+  E + GK
Sbjct: 167 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+L+D +   +++DFG       K+  G T  + GT  Y++P
Sbjct: 149 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGF-----AKRVKGRTWXLCGTPEYLAP 200
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 201 EIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+L+D +   +++DFG       K+  G T  + GT  Y++P
Sbjct: 151 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGF-----AKRVKGRTWXLCGTPEYLAP 202
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 203 EIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 64/156 (41%), Gaps = 18/156 (11%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFF 84
           + IHRD    NILL  +   KI DFGL R                   +M+PE      +
Sbjct: 220 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 279
Query: 85  SVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           +++SDV+SFGV++ EI S       G    E     L       +EG  +   D     +
Sbjct: 280 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-------KEGTRMRAPDYTTPEM 332
Query: 143 SKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGS 178
            +           L C   +P+ RPT S++V  LG+
Sbjct: 333 YQTM---------LDCWHGEPSQRPTFSELVEHLGN 359

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 89/180 (49%), Gaps = 30/180 (16%)
Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDH--EMNP---KISDFGLTRIF 55
           + ++ +I LG+     Y+ Q+    I+HRD ++ NI L    E  P   K++DFGL+   
Sbjct: 125 LRLMLDIALGIE----YM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS--- 176
Query: 56  EGKQTDGTTNRVVGTYGYMSPEY--ALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSE 113
             +Q+  + + ++G + +M+PE   A    ++ K+D +SF +++  I++G+   G ++ E
Sbjct: 177 --QQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE---GPFD-E 230
Query: 114 LALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
            +   + +   + +EG    + +  P  +          NV  LC   DP  RP  S +V
Sbjct: 231 YSYGKIKFINMIREEGLRPTIPEDCPPRLR---------NVIELCWSGDPKKRPHFSYIV 281

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 64/156 (41%), Gaps = 18/156 (11%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFF 84
           + IHRD    NILL  +   KI DFGL R                   +M+PE      +
Sbjct: 164 KXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 223
Query: 85  SVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           +++SDV+SFGV++ EI S       G    E     L       +EG  +   D     +
Sbjct: 224 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-------KEGTRMRAPDYTTPEM 276
Query: 143 SKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGS 178
            +           L C   +P+ RPT S++V  LG+
Sbjct: 277 YQTM---------LDCWHGEPSQRPTFSELVEHLGN 303

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+L+D +   +++DFG       K+  G T  + GT  Y++P
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGF-----AKRVKGRTWTLCGTPEYLAP 208
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 31/116 (26%), Positives = 59/116 (50%), Gaps = 5/116 (4%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           + L N  + ++  + YL      R++HRD    N+L+    + KI+DFGL ++   ++ +
Sbjct: 114 QYLLNWCVQIAEGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 170
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELA 115
                      +M+ E  L   ++ +SDV+S+GV V E+++   K   G   SE++
Sbjct: 171 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 226

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 64/155 (41%), Gaps = 14/155 (9%)
Query: 26  IIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFFS 85
            IHRD    N+LL +    KI DFGL R                   +M+PE      ++
Sbjct: 187 CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT 246
Query: 86  VKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKA 145
           V+SDV+S+G+++ EI S   N   Y   L  S     +KL ++G     M Q   A    
Sbjct: 247 VQSDVWSYGILLWEIFSLGLNP--YPGILVNSKF---YKLVKDGY---QMAQPAFAPKNI 298
Query: 146 NEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEA 180
             I++       C   +P  RPT   +   L  +A
Sbjct: 299 YSIMQA------CWALEPTHRPTFQQICSFLQEQA 327

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 41/174 (23%), Positives = 80/174 (45%), Gaps = 26/174 (14%)
Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGK- 58
           ++ L   ++ ++  + YL   S    IHRD    N +L  +M   ++DFGL+R I+ G  
Sbjct: 136 LQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY 192
Query: 59  QTDGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRN--TGFYNSELAL 116
              G  +++     +++ E      ++V SDV++FGV + EI++  +    G  N+E+  
Sbjct: 193 YRQGCASKL--PVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN 250
Query: 117 SLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMS 170
            L+G            + + Q P  + +  +++        C   DP  RP+ +
Sbjct: 251 YLIGG-----------NRLKQPPECMEEVYDLM------YQCWSADPKQRPSFT 287

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+L+D +   +++DFG       K+  G T  + GT  Y++P
Sbjct: 177 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGF-----AKRVKGRTWXLCGTPEYLAP 228
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 229 EIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 46/97 (47%), Gaps = 7/97 (7%)
Query: 8   ILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRV 67
           I  ++  L Y H     R+IHRD K  N+LL      KI+DFG +      + D     +
Sbjct: 115 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDT----L 167
Query: 68  VGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
            GT  Y+ PE   G     K D++S GV+  E + GK
Sbjct: 168 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 64/154 (41%), Gaps = 14/154 (9%)
Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFFSV 86
           IHRD    N+LL +    KI DFGL R                   +M+PE      ++V
Sbjct: 174 IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTV 233
Query: 87  KSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKAN 146
           +SDV+S+G+++ EI S   N   Y   L  S     +KL ++G     M Q   A     
Sbjct: 234 QSDVWSYGILLWEIFSLGLNP--YPGILVNSKF---YKLVKDGY---QMAQPAFAPKNIY 285
Query: 147 EILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEA 180
            I++       C   +P  RPT   +   L  +A
Sbjct: 286 SIMQA------CWALEPTHRPTFQQICSFLQEQA 313

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+L+D +   +++DFG       K+  G T  + GT  Y++P
Sbjct: 177 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGF-----AKRVKGRTWXLCGTPEYLAP 228
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 229 EIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 64/155 (41%), Gaps = 14/155 (9%)
Query: 26  IIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFFS 85
            IHRD    N+LL +    KI DFGL R                   +M+PE      ++
Sbjct: 179 CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT 238
Query: 86  VKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKA 145
           V+SDV+S+G+++ EI S   N   Y   L  S     +KL ++G     M Q   A    
Sbjct: 239 VQSDVWSYGILLWEIFSLGLNP--YPGILVNSKF---YKLVKDGY---QMAQPAFAPKNI 290
Query: 146 NEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEA 180
             I++       C   +P  RPT   +   L  +A
Sbjct: 291 YSIMQA------CWALEPTHRPTFQQICSFLQEQA 319

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 64/154 (41%), Gaps = 14/154 (9%)
Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFFSV 86
           IHRD    N+LL +    KI DFGL R                   +M+PE      ++V
Sbjct: 186 IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTV 245
Query: 87  KSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKAN 146
           +SDV+S+G+++ EI S   N   Y   L  S     +KL ++G     M Q   A     
Sbjct: 246 QSDVWSYGILLWEIFSLGLNP--YPGILVNSKF---YKLVKDGY---QMAQPAFAPKNIY 297
Query: 147 EILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEA 180
            I++       C   +P  RPT   +   L  +A
Sbjct: 298 SIMQA------CWALEPTHRPTFQQICSFLQEQA 325

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/88 (36%), Positives = 48/88 (54%), Gaps = 11/88 (12%)
Query: 23  KLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR-VVGTYGYMSPEYALG 81
           KL I+HRD K  NILLD +MN K++DFG    F  +   G   R V GT  Y++PE    
Sbjct: 142 KLNIVHRDLKPENILLDDDMNIKLTDFG----FSCQLDPGEKLRSVCGTPSYLAPEIIEC 197
Query: 82  GF------FSVKSDVFSFGVVVLEIISG 103
                   +  + D++S GV++  +++G
Sbjct: 198 SMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      T      
Sbjct: 137 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMTG 188
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 10/101 (9%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L+ ++ G+     +LH      IIHRD K SNI++  +   KI DFGL R      T+ 
Sbjct: 129 LLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TASTNF 178
Query: 63  TTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
                V T  Y +PE  LG  +    D++S G ++ E++ G
Sbjct: 179 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      T      
Sbjct: 137 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMTG 188
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 84/179 (46%), Gaps = 29/179 (16%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLD-HEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGY 73
           L YLH +   +I+HRD K  N+L++ +    KISDFG ++   G   +  T    GT  Y
Sbjct: 135 LKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQY 189
Query: 74  MSPEYALGG--FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKA 131
           M+PE    G   +   +D++S G  ++E+ +GK    FY        LG       +   
Sbjct: 190 MAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK--PPFYE-------LGEPQAAMFKVGM 240
Query: 132 LDMMDQKPGAISKANE--ILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEAVNLASPKR 188
             +  + P ++S   +  ILKC        + DP+ R   +D+++    E + ++S K+
Sbjct: 241 FKVHPEIPESMSAEAKAFILKCF-------EPDPDKRACANDLLV---DEFLKVSSKKK 289

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 32/88 (36%), Positives = 48/88 (54%), Gaps = 11/88 (12%)
Query: 23  KLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR-VVGTYGYMSPEYALG 81
           KL I+HRD K  NILLD +MN K++DFG    F  +   G   R V GT  Y++PE    
Sbjct: 142 KLNIVHRDLKPENILLDDDMNIKLTDFG----FSCQLDPGEKLREVCGTPSYLAPEIIEC 197
Query: 82  GF------FSVKSDVFSFGVVVLEIISG 103
                   +  + D++S GV++  +++G
Sbjct: 198 SMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 64/154 (41%), Gaps = 14/154 (9%)
Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFFSV 86
           IHRD    N+LL +    KI DFGL R                   +M+PE      ++V
Sbjct: 182 IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTV 241
Query: 87  KSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKAN 146
           +SDV+S+G+++ EI S   N   Y   L  S     +KL ++G     M Q   A     
Sbjct: 242 QSDVWSYGILLWEIFSLGLNP--YPGILVNSKF---YKLVKDGY---QMAQPAFAPKNIY 293
Query: 147 EILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEA 180
            I++       C   +P  RPT   +   L  +A
Sbjct: 294 SIMQA------CWALEPTHRPTFQQICSFLQEQA 321

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+L+D +   +++DFG       K+  G T  + GT  Y++P
Sbjct: 142 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGF-----AKRVKGRTWTLCGTPEYLAP 193
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 194 EIILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 64/154 (41%), Gaps = 14/154 (9%)
Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFFSV 86
           IHRD    N+LL +    KI DFGL R                   +M+PE      ++V
Sbjct: 186 IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTV 245
Query: 87  KSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKAN 146
           +SDV+S+G+++ EI S   N   Y   L  S     +KL ++G     M Q   A     
Sbjct: 246 QSDVWSYGILLWEIFSLGLNP--YPGILVNSKF---YKLVKDGY---QMAQPAFAPKNIY 297
Query: 147 EILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEA 180
            I++       C   +P  RPT   +   L  +A
Sbjct: 298 SIMQA------CWALEPTHRPTFQQICSFLQEQA 325

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL R      T      
Sbjct: 137 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMTG 188
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+L+D +   +++DFG       K+  G T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGF-----AKRVKGRTWXLXGTPEYLAP 207
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 52/103 (50%), Gaps = 6/103 (5%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           E + +++    R L +LH +    I+HRD K  NIL+      K++DFGL RI+  +   
Sbjct: 112 ETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-- 166
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
              + VV T  Y +PE  L   ++   D++S G +  E+   K
Sbjct: 167 -ALDPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+L+D +   +++DFG       K+  G T  + GT  Y++P
Sbjct: 143 YLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGF-----AKRVKGRTWXLCGTPEYLAP 194
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 195 EIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 66/156 (42%), Gaps = 18/156 (11%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFF 84
           + IHRD    NILL  +   KI DFGL R                   +M+PE      +
Sbjct: 164 KXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 223
Query: 85  SVKSDVFSFGVVVLEIIS--GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAI 142
           +++SDV+SFGV++ EI S       G    E     L       +EG  +   D      
Sbjct: 224 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFXRRL-------KEGTRMRAPDY----- 271
Query: 143 SKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGS 178
               E+ + +   L C   +P+ RPT S++V  LG+
Sbjct: 272 -TTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGN 303

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 47/97 (48%), Gaps = 7/97 (7%)
Query: 8   ILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRV 67
           I  ++  L Y H     R+IHRD K  N+LL      KI+DFG +       +  TT  +
Sbjct: 117 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT--L 169
Query: 68  VGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
            GT  Y+ PE   G     K D++S GV+  E + GK
Sbjct: 170 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI  FGL R      TD     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILGFGLAR-----HTDDEMTG 181
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 47/97 (48%), Gaps = 7/97 (7%)
Query: 8   ILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRV 67
           I  ++  L Y H     R+IHRD K  N+LL      KI+DFG +       +  TT  +
Sbjct: 118 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT--L 170
Query: 68  VGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
            GT  Y+ PE   G     K D++S GV+  E + GK
Sbjct: 171 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 207

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 47/97 (48%), Gaps = 7/97 (7%)
Query: 8   ILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRV 67
           I  ++  L Y H     R+IHRD K  N+LL      KI+DFG +       +  TT  +
Sbjct: 113 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT--L 165
Query: 68  VGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
            GT  Y+ PE   G     K D++S GV+  E + GK
Sbjct: 166 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 202

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI D GL R      TD     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDAGLAR-----HTDDEMTG 181
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 47/97 (48%), Gaps = 7/97 (7%)
Query: 8   ILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRV 67
           I  ++  L Y H     R+IHRD K  N+LL      KI+DFG +       +  TT  +
Sbjct: 119 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT--L 171
Query: 68  VGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
            GT  Y+ PE   G     K D++S GV+  E + GK
Sbjct: 172 CGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 46/97 (47%), Gaps = 7/97 (7%)
Query: 8   ILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRV 67
           I  ++  L Y H     R+IHRD K  N+LL      KI+DFG +      + D     +
Sbjct: 117 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDD----L 169
Query: 68  VGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
            GT  Y+ PE   G     K D++S GV+  E + GK
Sbjct: 170 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DF L R      TD     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFYLAR-----HTDDEMTG 181
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 9/90 (10%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDH---EMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGY 73
           YLH++    I+HRD K  N+L      +   KI+DFGL++I E +    T   V GT GY
Sbjct: 163 YLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT---VCGTPGY 216
Query: 74  MSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
            +PE   G  +  + D++S G++   ++ G
Sbjct: 217 CAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 47/97 (48%), Gaps = 7/97 (7%)
Query: 8   ILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRV 67
           I  ++  L Y H     R+IHRD K  N+LL      KI+DFG +       +  TT  +
Sbjct: 111 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT--L 163
Query: 68  VGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
            GT  Y+ PE   G     K D++S GV+  E + GK
Sbjct: 164 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 200

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 27/87 (31%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+++D +   +++DFG       K+  G T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGF-----AKRVKGRTWXLCGTPEYLAP 207
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 9   LGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVV 68
           L V++ + YL   +  + +HRD    N +LD +   K++DFGL R    K+     N+  
Sbjct: 140 LQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG 196
Query: 69  GTY--GYMSPEYALGGFFSVKSDVFSFGVVVLEIIS 102
                 +M+ E      F+ KSDV+SFGV++ E+++
Sbjct: 197 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 9   LGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVV 68
           L V++ + YL   +  + +HRD    N +LD +   K++DFGL R    K+     N+  
Sbjct: 139 LQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG 195
Query: 69  GTY--GYMSPEYALGGFFSVKSDVFSFGVVVLEIIS 102
                 +M+ E      F+ KSDV+SFGV++ E+++
Sbjct: 196 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 9   LGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVV 68
           L V++ + YL   +  + +HRD    N +LD +   K++DFGL R    K+     N+  
Sbjct: 140 LQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG 196
Query: 69  GT--YGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS 102
                 +M+ E      F+ KSDV+SFGV++ E+++
Sbjct: 197 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 9   LGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVV 68
           L V++ + YL   +  + +HRD    N +LD +   K++DFGL R    K+     N+  
Sbjct: 159 LQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG 215
Query: 69  GTY--GYMSPEYALGGFFSVKSDVFSFGVVVLEIIS 102
                 +M+ E      F+ KSDV+SFGV++ E+++
Sbjct: 216 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 251

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 9   LGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVV 68
           L V++ + YL   +  + +HRD    N +LD +   K++DFGL R    K+     N+  
Sbjct: 132 LQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG 188
Query: 69  GT--YGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS 102
                 +M+ E      F+ KSDV+SFGV++ E+++
Sbjct: 189 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 224

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 9   LGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVV 68
           L V++ + YL   +  + +HRD    N +LD +   K++DFGL R    K+     N+  
Sbjct: 158 LQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG 214
Query: 69  GTY--GYMSPEYALGGFFSVKSDVFSFGVVVLEIIS 102
                 +M+ E      F+ KSDV+SFGV++ E+++
Sbjct: 215 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 250

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 6/103 (5%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           E + +++    R L +LH +    I+HRD K  NIL+      K++DFGL RI+  +   
Sbjct: 120 ETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-- 174
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
                VV T  Y +PE  L   ++   D++S G +  E+   K
Sbjct: 175 -ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 9   LGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVV 68
           L V++ + YL   +  + +HRD    N +LD +   K++DFGL R    K+     N+  
Sbjct: 138 LQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG 194
Query: 69  GTY--GYMSPEYALGGFFSVKSDVFSFGVVVLEIIS 102
                 +M+ E      F+ KSDV+SFGV++ E+++
Sbjct: 195 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 9   LGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVV 68
           L V++ + YL   +  + +HRD    N +LD +   K++DFGL R    K+     N+  
Sbjct: 137 LQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG 193
Query: 69  GTY--GYMSPEYALGGFFSVKSDVFSFGVVVLEIIS 102
                 +M+ E      F+ KSDV+SFGV++ E+++
Sbjct: 194 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 229

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI D GL R      TD     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDRGLAR-----HTDDEMTG 181
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 50.1 bits (118), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 9   LGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVV 68
           L V++ + YL   +  + +HRD    N +LD +   K++DFGL R    K+     N+  
Sbjct: 135 LQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG 191
Query: 69  GTY--GYMSPEYALGGFFSVKSDVFSFGVVVLEIIS 102
                 +M+ E      F+ KSDV+SFGV++ E+++
Sbjct: 192 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 50.1 bits (118), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 46/93 (49%), Gaps = 8/93 (8%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           II  V     Y+H +    I HRD K SNIL+D     K+SDFG +     K+  G+   
Sbjct: 156 IIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSR-- 211
Query: 67  VVGTYGYMSPEY--ALGGFFSVKSDVFSFGVVV 97
             GTY +M PE+      +   K D++S G+ +
Sbjct: 212 --GTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 50.1 bits (118), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 77/165 (46%), Gaps = 26/165 (15%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLD-HEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGY 73
           L YLH +   +I+HRD K  N+L++ +    KISDFG ++   G   +  T    GT  Y
Sbjct: 121 LKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQY 175
Query: 74  MSPEYALGG--FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKA 131
           M+PE    G   +   +D++S G  ++E+ +GK    FY        LG       +   
Sbjct: 176 MAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK--PPFYE-------LGEPQAAMFKVGM 226
Query: 132 LDMMDQKPGAISKANE--ILKCINVGLLCVQEDPNDRPTMSDVVI 174
             +  + P ++S   +  ILKC        + DP+ R   +D+++
Sbjct: 227 FKVHPEIPESMSAEAKAFILKCF-------EPDPDKRACANDLLV 264

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 50.1 bits (118), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 44/97 (45%), Gaps = 7/97 (7%)
Query: 8   ILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRV 67
           I  ++  L Y H     R+IHRD K  N+LL      KI+DFG    +           +
Sbjct: 114 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTEL 166
Query: 68  VGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
            GT  Y+ PE   G     K D++S GV+  E + GK
Sbjct: 167 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 78/170 (45%), Gaps = 25/170 (14%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQT 60
           + L  +   V   + YL  +SK + +HRD    N L++ +   K+SDFGL+R + + + T
Sbjct: 104 QQLLEMCKDVCEAMEYL--ESK-QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 160
Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKR-NTGFYNSELALSL 118
               ++    +    PE  +   FS KSD+++FGV++ EI S GK     F NSE A   
Sbjct: 161 SSVGSKFPVRWS--PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA--- 215
Query: 119 LGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPT 168
                    E  A  +   +P   S+     K   +   C  E  ++RPT
Sbjct: 216 ---------EHIAQGLRLYRPHLASE-----KVYTIMYSCWHEKADERPT 251

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 6/103 (5%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           E + +++    R L +LH +    I+HRD K  NIL+      K++DFGL RI+  +   
Sbjct: 112 ETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL 168
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
                VV T  Y +PE  L   ++   D++S G +  E+   K
Sbjct: 169 AP---VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 9/91 (9%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L Y+H      IIHRD K  N+ ++ +   KI DFGL R     Q D      V T  Y 
Sbjct: 141 LRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMXGXVVTRWYR 192
Query: 75  SPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
           +PE  L    ++   D++S G ++ E+I+GK
Sbjct: 193 APEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 78/170 (45%), Gaps = 25/170 (14%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQT 60
           + L  +   V   + YL  +SK + +HRD    N L++ +   K+SDFGL+R + + + T
Sbjct: 105 QQLLEMCKDVCEAMEYL--ESK-QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 161
Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKR-NTGFYNSELALSL 118
               ++    +    PE  +   FS KSD+++FGV++ EI S GK     F NSE A   
Sbjct: 162 SSVGSKFPVRWS--PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA--- 216
Query: 119 LGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPT 168
                    E  A  +   +P   S+     K   +   C  E  ++RPT
Sbjct: 217 ---------EHIAQGLRLYRPHLASE-----KVYTIMYSCWHEKADERPT 252

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 27/87 (31%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+L+D +   +++DFG       K+  G T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGF-----AKRVKGRTWXLCGTPEYLAP 207
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ ++ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 47/97 (48%), Gaps = 7/97 (7%)
Query: 8   ILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRV 67
           I  ++  L Y H     R+IHRD K  N+LL      KI+DFG +       +  TT  +
Sbjct: 115 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--CHAPSSRRTT--L 167
Query: 68  VGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
            GT  Y+ PE   G     K D++S GV+  E + GK
Sbjct: 168 SGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 9/100 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNIL---LDHEMNPKISDFGLTRIFEGKQTDGT 63
           +I  V   + YLH    L I+HRD K  N+L   LD +    ISDFGL+++   +     
Sbjct: 121 LIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSV 174
Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
            +   GT GY++PE      +S   D +S GV+   ++ G
Sbjct: 175 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 54/106 (50%), Gaps = 18/106 (16%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L+ ++ G+     +LH      IIHRD K SNI++  +   KI DFGL R      T G
Sbjct: 132 LLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAG 178
Query: 63  T----TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           T    T  VV  Y Y +PE  LG  +    D++S G ++ E++  K
Sbjct: 179 TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 54/106 (50%), Gaps = 18/106 (16%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L+ ++ G+     +LH      IIHRD K SNI++  +   KI DFGL R      T G
Sbjct: 125 LLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAG 171
Query: 63  T----TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           T    T  VV  Y Y +PE  LG  +    D++S G ++ E++  K
Sbjct: 172 TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 54/106 (50%), Gaps = 18/106 (16%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L+ ++ G+     +LH      IIHRD K SNI++  +   KI DFGL R      T G
Sbjct: 132 LLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAG 178
Query: 63  T----TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           T    T  VV  Y Y +PE  LG  +    D++S G ++ E++  K
Sbjct: 179 TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 54/106 (50%), Gaps = 18/106 (16%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L+ ++ G+     +LH      IIHRD K SNI++  +   KI DFGL R      T G
Sbjct: 131 LLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAG 177
Query: 63  T----TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           T    T  VV  Y Y +PE  LG  +    D++S G ++ E++  K
Sbjct: 178 TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 54/106 (50%), Gaps = 18/106 (16%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L+ ++ G+     +LH      IIHRD K SNI++  +   KI DFGL R      T G
Sbjct: 124 LLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAG 170
Query: 63  T----TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           T    T  VV  Y Y +PE  LG  +    D++S G ++ E++  K
Sbjct: 171 TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 54/106 (50%), Gaps = 18/106 (16%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L+ ++ G+     +LH      IIHRD K SNI++  +   KI DFGL R      T G
Sbjct: 131 LLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAG 177
Query: 63  T----TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           T    T  VV  Y Y +PE  LG  +    D++S G ++ E++  K
Sbjct: 178 TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 9/100 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNIL---LDHEMNPKISDFGLTRIFEGKQTDGT 63
           +I  V   + YLH    L I+HRD K  N+L   LD +    ISDFGL+++   +     
Sbjct: 121 LIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSV 174
Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
            +   GT GY++PE      +S   D +S GV+   ++ G
Sbjct: 175 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 54/106 (50%), Gaps = 18/106 (16%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L+ ++ G+     +LH      IIHRD K SNI++  +   KI DFGL R      T G
Sbjct: 125 LLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAG 171
Query: 63  T----TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           T    T  VV  Y Y +PE  LG  +    D++S G ++ E++  K
Sbjct: 172 TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 78/170 (45%), Gaps = 25/170 (14%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQT 60
           + L  +   V   + YL  +SK + +HRD    N L++ +   K+SDFGL+R + + + T
Sbjct: 111 QQLLEMCKDVCEAMEYL--ESK-QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 167
Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKR-NTGFYNSELALSL 118
               ++    +    PE  +   FS KSD+++FGV++ EI S GK     F NSE A   
Sbjct: 168 SSVGSKFPVRWS--PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA--- 222
Query: 119 LGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPT 168
                    E  A  +   +P   S+     K   +   C  E  ++RPT
Sbjct: 223 ---------EHIAQGLRLYRPHLASE-----KVYTIMYSCWHEKADERPT 258

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 9/99 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI D GL R      TD     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDGGLAR-----HTDDEMTG 181
Query: 67  VVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 54/106 (50%), Gaps = 18/106 (16%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L+ ++ G+     +LH      IIHRD K SNI++  +   KI DFGL R      T G
Sbjct: 169 LLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAG 215
Query: 63  T----TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           T    T  VV  Y Y +PE  LG  +    D++S G ++ E++  K
Sbjct: 216 TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 54/106 (50%), Gaps = 18/106 (16%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L+ ++ G+     +LH      IIHRD K SNI++  +   KI DFGL R      T G
Sbjct: 130 LLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAG 176
Query: 63  T----TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           T    T  VV  Y Y +PE  LG  +    D++S G ++ E++  K
Sbjct: 177 TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 78/170 (45%), Gaps = 25/170 (14%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQT 60
           + L  +   V   + YL  +SK + +HRD    N L++ +   K+SDFGL+R + + + T
Sbjct: 120 QQLLEMCKDVCEAMEYL--ESK-QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 176
Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKR-NTGFYNSELALSL 118
               ++    +    PE  +   FS KSD+++FGV++ EI S GK     F NSE A   
Sbjct: 177 SSVGSKFPVRWS--PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA--- 231
Query: 119 LGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPT 168
                    E  A  +   +P   S+     K   +   C  E  ++RPT
Sbjct: 232 ---------EHIAQGLRLYRPHLASE-----KVYTIMYSCWHEKADERPT 267

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 9/100 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNIL---LDHEMNPKISDFGLTRIFEGKQTDGT 63
           +I  V   + YLH    L I+HRD K  N+L   LD +    ISDFGL+++   +     
Sbjct: 121 LIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSV 174
Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
            +   GT GY++PE      +S   D +S GV+   ++ G
Sbjct: 175 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 5/116 (4%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           + L N  + +++ + YL      R++HRD    N+L+    + KI+DFG  ++   ++ +
Sbjct: 121 QYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE 177
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELA 115
                      +M+ E  L   ++ +SDV+S+GV V E+++   K   G   SE++
Sbjct: 178 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 233

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 9/100 (9%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNIL---LDHEMNPKISDFGLTRIFEGKQTDGT 63
           +I  V   + YLH    L I+HRD K  N+L   LD +    ISDFGL+++   +     
Sbjct: 121 LIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSV 174
Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
            +   GT GY++PE      +S   D +S GV+   ++ G
Sbjct: 175 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 5/116 (4%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           + L N  + +++ + YL      R++HRD    N+L+    + KI+DFG  ++   ++ +
Sbjct: 119 QYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE 175
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELA 115
                      +M+ E  L   ++ +SDV+S+GV V E+++   K   G   SE++
Sbjct: 176 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/88 (36%), Positives = 49/88 (55%), Gaps = 6/88 (6%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLHQ     I+HRD K +N+LLD     K++DFGL + F G       ++VV T  Y 
Sbjct: 125 LEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYXHQVV-TRWYR 179
Query: 75  SPEYALGG-FFSVKSDVFSFGVVVLEII 101
           +PE   G   + V  D+++ G ++ E++
Sbjct: 180 APELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 54/106 (50%), Gaps = 18/106 (16%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L+ ++ G+     +LH      IIHRD K SNI++  +   KI DFGL R      T G
Sbjct: 131 LLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAG 177
Query: 63  TT----NRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           T+      VV  Y Y +PE  LG  +    D++S G ++ E++  K
Sbjct: 178 TSFMMEPEVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 78/170 (45%), Gaps = 25/170 (14%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQT 60
           + L  +   V   + YL  +SK + +HRD    N L++ +   K+SDFGL+R + + + T
Sbjct: 100 QQLLEMCKDVCEAMEYL--ESK-QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156
Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKR-NTGFYNSELALSL 118
               ++    +    PE  +   FS KSD+++FGV++ EI S GK     F NSE A   
Sbjct: 157 SSVGSKFPVRWS--PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA--- 211
Query: 119 LGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPT 168
                    E  A  +   +P   S+     K   +   C  E  ++RPT
Sbjct: 212 ---------EHIAQGLRLYRPHLASE-----KVYTIMYSCWHEKADERPT 247

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 5/116 (4%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           + L N  + +++ + YL      R++HRD    N+L+    + KI+DFG  ++   ++ +
Sbjct: 119 QYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE 175
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELA 115
                      +M+ E  L   ++ +SDV+S+GV V E+++   K   G   SE++
Sbjct: 176 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 5/116 (4%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           + L N  + +++ + YL      R++HRD    N+L+    + KI+DFG  ++   ++ +
Sbjct: 124 QYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE 180
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELA 115
                      +M+ E  L   ++ +SDV+S+GV V E+++   K   G   SE++
Sbjct: 181 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 54/106 (50%), Gaps = 18/106 (16%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L+ ++ G+     +LH      IIHRD K SNI++  +   KI DFGL R      T G
Sbjct: 136 LLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAG 182
Query: 63  T----TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           T    T  VV  Y Y +PE  LG  +    D++S G ++ E++  K
Sbjct: 183 TSFMMTPYVVTRY-YRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 54/106 (50%), Gaps = 18/106 (16%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L+ ++ G+     +LH      IIHRD K SNI++  +   KI DFGL R      T G
Sbjct: 169 LLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAG 215
Query: 63  T----TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           T    T  VV  Y Y +PE  LG  +    D++S G ++ E++  K
Sbjct: 216 TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 5/116 (4%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           + L N  + +++ + YL      R++HRD    N+L+    + KI+DFG  ++   ++ +
Sbjct: 117 QYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE 173
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELA 115
                      +M+ E  L   ++ +SDV+S+GV V E+++   K   G   SE++
Sbjct: 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 5/116 (4%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           + L N  + +++ + YL      R++HRD    N+L+    + KI+DFG  ++   ++ +
Sbjct: 119 QYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE 175
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS--GKRNTGFYNSELA 115
                      +M+ E  L   ++ +SDV+S+GV V E+++   K   G   SE++
Sbjct: 176 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 54/106 (50%), Gaps = 18/106 (16%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L+ ++ G+     +LH      IIHRD K SNI++  +   KI DFGL R      T G
Sbjct: 125 LLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAG 171
Query: 63  T----TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           T    T  VV  Y Y +PE  LG  +    D++S G ++ E++  K
Sbjct: 172 TSFMMTPYVVTRY-YRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/130 (33%), Positives = 64/130 (49%), Gaps = 13/130 (10%)
Query: 26  IIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG---- 81
            IHRD K  N+LLD   + K++DFG T +   K+     +  VGT  Y+SPE        
Sbjct: 194 FIHRDVKPDNMLLDKSGHLKLADFG-TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 252
Query: 82  GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGA 141
           G++  + D +S GV + E++ G  +T FY    A SL+G   K+     +L   D     
Sbjct: 253 GYYGRECDWWSVGVFLYEMLVG--DTPFY----ADSLVGTYSKIMNHKNSLTFPDD--ND 304
Query: 142 ISKANEILKC 151
           ISK  + L C
Sbjct: 305 ISKEAKNLIC 314

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 54/106 (50%), Gaps = 18/106 (16%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L+ ++ G+     +LH      IIHRD K SNI++  +   KI DFGL R      T G
Sbjct: 131 LLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR------TAG 177
Query: 63  T----TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           T    T  VV  Y Y +PE  LG  +    D++S G ++ E++  K
Sbjct: 178 TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/130 (33%), Positives = 64/130 (49%), Gaps = 13/130 (10%)
Query: 26  IIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG---- 81
            IHRD K  N+LLD   + K++DFG T +   K+     +  VGT  Y+SPE        
Sbjct: 189 FIHRDVKPDNMLLDKSGHLKLADFG-TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 247
Query: 82  GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGA 141
           G++  + D +S GV + E++ G  +T FY    A SL+G   K+     +L   D     
Sbjct: 248 GYYGRECDWWSVGVFLYEMLVG--DTPFY----ADSLVGTYSKIMNHKNSLTFPDD--ND 299
Query: 142 ISKANEILKC 151
           ISK  + L C
Sbjct: 300 ISKEAKNLIC 309

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 44/97 (45%), Gaps = 7/97 (7%)
Query: 8   ILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRV 67
           I  ++  L Y H     R+IHRD K  N+LL      KI+DFG    +           +
Sbjct: 116 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXL 168
Query: 68  VGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
            GT  Y+ PE   G     K D++S GV+  E + GK
Sbjct: 169 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 54/106 (50%), Gaps = 18/106 (16%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L+ ++ G+     +LH      IIHRD K SNI++  +   KI DFGL R      T G
Sbjct: 131 LLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR------TAG 177
Query: 63  T----TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           T    T  VV  Y Y +PE  LG  +    D++S G ++ E++  K
Sbjct: 178 TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 44/97 (45%), Gaps = 7/97 (7%)
Query: 8   ILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRV 67
           I  ++  L Y H     R+IHRD K  N+LL      KI+DFG    +           +
Sbjct: 114 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTXL 166
Query: 68  VGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
            GT  Y+ PE   G     K D++S GV+  E + GK
Sbjct: 167 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 78/170 (45%), Gaps = 25/170 (14%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQT 60
           + L  +   V   + YL  +SK + +HRD    N L++ +   K+SDFGL+R + + + T
Sbjct: 105 QQLLEMCKDVCEAMEYL--ESK-QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 161
Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKR-NTGFYNSELALSL 118
               ++    +    PE  +   FS KSD+++FGV++ EI S GK     F NSE A   
Sbjct: 162 SSRGSKFPVRWS--PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA--- 216
Query: 119 LGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPT 168
                    E  A  +   +P   S+     K   +   C  E  ++RPT
Sbjct: 217 ---------EHIAQGLRLYRPHLASE-----KVYTIMYSCWHEKADERPT 252

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 47/100 (47%), Gaps = 13/100 (13%)
Query: 8   ILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR- 66
           I  ++  L Y H     R+IHRD K  N+LL      KI+DFG +           ++R 
Sbjct: 117 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRR 166
Query: 67  --VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
             + GT  Y+ PE   G     K D++S GV+  E + GK
Sbjct: 167 AALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 54/106 (50%), Gaps = 18/106 (16%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L+ ++ G+     +LH      IIHRD K SNI++  +   KI DFGL R      T G
Sbjct: 131 LLYQMLXGIK----HLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR------TAG 177
Query: 63  T----TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           T    T  VV  Y Y +PE  LG  +    D++S G ++ E++  K
Sbjct: 178 TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 54/106 (50%), Gaps = 18/106 (16%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L+ ++ G+     +LH      IIHRD K SNI++  +   KI DFGL R      T G
Sbjct: 131 LLYQMLXGIK----HLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR------TAG 177
Query: 63  T----TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           T    T  VV  Y Y +PE  LG  +    D++S G ++ E++  K
Sbjct: 178 TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/130 (33%), Positives = 64/130 (49%), Gaps = 13/130 (10%)
Query: 26  IIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG---- 81
            IHRD K  N+LLD   + K++DFG T +   K+     +  VGT  Y+SPE        
Sbjct: 194 FIHRDVKPDNMLLDKSGHLKLADFG-TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 252
Query: 82  GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGA 141
           G++  + D +S GV + E++ G  +T FY    A SL+G   K+     +L   D     
Sbjct: 253 GYYGRECDWWSVGVFLYEMLVG--DTPFY----ADSLVGTYSKIMNHKNSLTFPDD--ND 304
Query: 142 ISKANEILKC 151
           ISK  + L C
Sbjct: 305 ISKEAKNLIC 314

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 54/106 (50%), Gaps = 18/106 (16%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L+ ++ G+     +LH      IIHRD K SNI++  +   KI DFGL R      T G
Sbjct: 124 LLYQMLXGIK----HLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR------TAG 170
Query: 63  T----TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           T    T  VV  Y Y +PE  LG  +    D++S G ++ E++  K
Sbjct: 171 TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 55/104 (52%), Gaps = 15/104 (14%)
Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIF---EG 57
           M+ML N        L Y+H++   +I+HRD K +N+L+  +   K++DFGL R F   + 
Sbjct: 131 MQMLLN-------GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 180
Query: 58  KQTDGTTNRVVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEI 100
            Q +   NRVV T  Y  PE  LG   +    D++  G ++ E+
Sbjct: 181 SQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 47/97 (48%), Gaps = 7/97 (7%)
Query: 8   ILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRV 67
           I  ++  L Y H     R+IHRD K  N+LL      KI++FG +       +  TT  +
Sbjct: 116 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTT--L 168
Query: 68  VGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
            GT  Y+ PE   G     K D++S GV+  E + GK
Sbjct: 169 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 55/104 (52%), Gaps = 15/104 (14%)
Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIF---EG 57
           M+ML N        L Y+H++   +I+HRD K +N+L+  +   K++DFGL R F   + 
Sbjct: 131 MQMLLN-------GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 180
Query: 58  KQTDGTTNRVVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEI 100
            Q +   NRVV T  Y  PE  LG   +    D++  G ++ E+
Sbjct: 181 SQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 26/87 (29%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+++D +   +++DFG       K+  G T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGF-----AKRVKGRTWXLCGTPEYLAP 207
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 208 EIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 55/104 (52%), Gaps = 15/104 (14%)
Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIF---EG 57
           M+ML N        L Y+H++   +I+HRD K +N+L+  +   K++DFGL R F   + 
Sbjct: 130 MQMLLN-------GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179
Query: 58  KQTDGTTNRVVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEI 100
            Q +   NRVV T  Y  PE  LG   +    D++  G ++ E+
Sbjct: 180 SQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 222

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/118 (31%), Positives = 57/118 (48%), Gaps = 23/118 (19%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQ------- 59
           ++  + + + YLH      ++HRD K SNILL+ E + K++DFGL+R F   +       
Sbjct: 114 VVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170
Query: 60  ---TDGTTN---------RVVGTYGYMSPEYALGGFFSVKS-DVFSFGVVVLEIISGK 104
               + T N           V T  Y +PE  LG     K  D++S G ++ EI+ GK
Sbjct: 171 LSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 55/104 (52%), Gaps = 15/104 (14%)
Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIF---EG 57
           M+ML N        L Y+H++   +I+HRD K +N+L+  +   K++DFGL R F   + 
Sbjct: 131 MQMLLN-------GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 180
Query: 58  KQTDGTTNRVVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEI 100
            Q +   NRVV T  Y  PE  LG   +    D++  G ++ E+
Sbjct: 181 SQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 51/104 (49%), Gaps = 12/104 (11%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           +  ++  VS  + YL + +    +HRD    N+LL  +   KISDFGL++     +    
Sbjct: 113 IIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYK 169
Query: 64  TNRVVGTYG-----YMSPEYALGGFFSVKSDVFSFGVVVLEIIS 102
                 T+G     + +PE      FS KSDV+SFGV++ E  S
Sbjct: 170 AQ----THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 44/97 (45%), Gaps = 7/97 (7%)
Query: 8   ILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRV 67
           I  ++  L Y H     R+IHRD K  N+LL      KI+DFG    +           +
Sbjct: 117 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXL 169
Query: 68  VGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
            GT  Y+ PE   G     K D++S GV+  E + GK
Sbjct: 170 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 88/180 (48%), Gaps = 30/180 (16%)
Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDH--EMNP---KISDFGLTRIF 55
           + ++ +I LG+     Y+ Q+    I+HRD ++ NI L    E  P   K++DFG +   
Sbjct: 125 LRLMLDIALGIE----YM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTS--- 176
Query: 56  EGKQTDGTTNRVVGTYGYMSPEY--ALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSE 113
             +Q+  + + ++G + +M+PE   A    ++ K+D +SF +++  I++G+   G ++ E
Sbjct: 177 --QQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE---GPFD-E 230
Query: 114 LALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
            +   + +   + +EG    + +  P  +          NV  LC   DP  RP  S +V
Sbjct: 231 YSYGKIKFINMIREEGLRPTIPEDCPPRLR---------NVIELCWSGDPKKRPHFSYIV 281

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 44/97 (45%), Gaps = 7/97 (7%)
Query: 8   ILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRV 67
           I  ++  L Y H     R+IHRD K  N+LL      KI+DFG    +           +
Sbjct: 114 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXL 166
Query: 68  VGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
            GT  Y+ PE   G     K D++S GV+  E + GK
Sbjct: 167 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 47/100 (47%), Gaps = 13/100 (13%)
Query: 8   ILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR- 66
           I  ++  L Y H     R+IHRD K  N+LL      KI+DFG +           ++R 
Sbjct: 114 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRR 163
Query: 67  --VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
             + GT  Y+ PE   G     K D++S GV+  E + GK
Sbjct: 164 AALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 47/97 (48%), Gaps = 7/97 (7%)
Query: 8   ILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRV 67
           I  ++  L Y H     R+IHRD K  N+LL      KI++FG +       +  TT  +
Sbjct: 117 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTT--L 169
Query: 68  VGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
            GT  Y+ PE   G     K D++S GV+  E + GK
Sbjct: 170 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 44/97 (45%), Gaps = 7/97 (7%)
Query: 8   ILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRV 67
           I  ++  L Y H     R+IHRD K  N+LL      KI+DFG    +           +
Sbjct: 119 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXL 171
Query: 68  VGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
            GT  Y+ PE   G     K D++S GV+  E + GK
Sbjct: 172 XGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 54/106 (50%), Gaps = 18/106 (16%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L+ ++ G+     +LH      IIHRD K SNI++  +   KI DFGL R      T G
Sbjct: 131 LLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAG 177
Query: 63  TT----NRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           T+      VV  Y Y +PE  LG  +    D++S G ++ E++  K
Sbjct: 178 TSFMMEPEVVTRY-YRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 6/103 (5%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           E + +++    R L +LH +    I+HRD K  NIL+      K++DFGL RI+  +   
Sbjct: 112 ETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-- 166
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
                VV T  Y +PE  L   ++   D++S G +  E+   K
Sbjct: 167 -ALFPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/87 (31%), Positives = 47/87 (54%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+L+D +   +++DFG       K+  G T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGF-----AKRVKGRTWXLCGTPEYLAP 207
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
              L   ++   D ++ GV++ E+ +G
Sbjct: 208 AIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 48/90 (53%), Gaps = 10/90 (11%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNP---KISDFGLTRIFEGKQTDGTTNRVVGTYGY 73
           YLH   K  I+HRD K  N+LL+ +      KI DFGL+  FE     G     +GT  Y
Sbjct: 136 YLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFE---VGGKMKERLGTAYY 189
Query: 74  MSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           ++PE  L   +  K DV+S GV++  ++ G
Sbjct: 190 IAPE-VLRKKYDEKCDVWSCGVILYILLCG 218

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 62/150 (41%), Gaps = 25/150 (16%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG----TTNRVVGTYGYMSPEYAL 80
           R IHRD    N+LL      KI DFGL R     Q D       +R V  + + +PE   
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRAL--PQNDDHYVMQEHRKV-PFAWCAPESLK 197
Query: 81  GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA--WKLWQEGKALDMMDQK 138
              FS  SD + FGV + E+ +       Y  E  + L G     K+ +EG+ L   +  
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFT-------YGQEPWIGLNGSQILHKIDKEGERLPRPEDC 250
Query: 139 PGAISKANEILKCINVGLLCVQEDPNDRPT 168
           P  I          NV + C    P DRPT
Sbjct: 251 PQDI---------YNVMVQCWAHKPEDRPT 271

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 48/90 (53%), Gaps = 10/90 (11%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNP---KISDFGLTRIFEGKQTDGTTNRVVGTYGY 73
           YLH   K  I+HRD K  N+LL+ +      KI DFGL+  FE     G     +GT  Y
Sbjct: 119 YLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFE---VGGKMKERLGTAYY 172
Query: 74  MSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           ++PE  L   +  K DV+S GV++  ++ G
Sbjct: 173 IAPE-VLRKKYDEKCDVWSCGVILYILLCG 201

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 62/150 (41%), Gaps = 25/150 (16%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG----TTNRVVGTYGYMSPEYAL 80
           R IHRD    N+LL      KI DFGL R     Q D       +R V  + + +PE   
Sbjct: 135 RFIHRDLAARNLLLATRDLVKIGDFGLMRAL--PQNDDHYVMQEHRKV-PFAWCAPESLK 191
Query: 81  GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA--WKLWQEGKALDMMDQK 138
              FS  SD + FGV + E+ +       Y  E  + L G     K+ +EG+ L   +  
Sbjct: 192 TRTFSHASDTWMFGVTLWEMFT-------YGQEPWIGLNGSQILHKIDKEGERLPRPEDC 244
Query: 139 PGAISKANEILKCINVGLLCVQEDPNDRPT 168
           P  I          NV + C    P DRPT
Sbjct: 245 PQDI---------YNVMVQCWAHKPEDRPT 265

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 62/150 (41%), Gaps = 25/150 (16%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG----TTNRVVGTYGYMSPEYAL 80
           R IHRD    N+LL      KI DFGL R     Q D       +R V  + + +PE   
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRAL--PQNDDHXVMQEHRKV-PFAWCAPESLK 197
Query: 81  GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA--WKLWQEGKALDMMDQK 138
              FS  SD + FGV + E+ +       Y  E  + L G     K+ +EG+ L   +  
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFT-------YGQEPWIGLNGSQILHKIDKEGERLPRPEDC 250
Query: 139 PGAISKANEILKCINVGLLCVQEDPNDRPT 168
           P  I          NV + C    P DRPT
Sbjct: 251 PQDI---------YNVMVQCWAHKPEDRPT 271

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 88/180 (48%), Gaps = 30/180 (16%)
Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDH--EMNP---KISDFGLTRIF 55
           + ++ +I LG+     Y+ Q+    I+HRD ++ NI L    E  P   K++DF L+   
Sbjct: 125 LRLMLDIALGIE----YM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLS--- 176
Query: 56  EGKQTDGTTNRVVGTYGYMSPEY--ALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSE 113
             +Q+  + + ++G + +M+PE   A    ++ K+D +SF +++  I++G+   G ++ E
Sbjct: 177 --QQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE---GPFD-E 230
Query: 114 LALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
            +   + +   + +EG    + +  P  +          NV  LC   DP  RP  S +V
Sbjct: 231 YSYGKIKFINMIREEGLRPTIPEDCPPRLR---------NVIELCWSGDPKKRPHFSYIV 281

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 77/172 (44%), Gaps = 20/172 (11%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQTDG 62
           L +  L V+R + YL   ++ + +HRD    N +LD     K++DFGL R I + +    
Sbjct: 126 LISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSV 182
Query: 63  TTNRVVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGY 121
             +R        +   +L  + F+ KSDV+SFGV++ E+++  R    Y       L  +
Sbjct: 183 QQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT--RGAPPYRHIDPFDLTHF 240
Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
                 +G+ L   +  P ++ +  +          C + DP  RPT   +V
Sbjct: 241 L----AQGRRLPQPEYCPDSLYQVMQ---------QCWEADPAVRPTFRVLV 279

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/84 (33%), Positives = 42/84 (50%), Gaps = 9/84 (10%)
Query: 26  IIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT--------TNRVVGTYGYMSPE 77
           +IHRD K SN+L++   + K+ DFGL RI +    D +            V T  Y +PE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPE 192
Query: 78  YAL-GGFFSVKSDVFSFGVVVLEI 100
             L    +S   DV+S G ++ E+
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 62/150 (41%), Gaps = 25/150 (16%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG----TTNRVVGTYGYMSPEYAL 80
           R IHRD    N+LL      KI DFGL R     Q D       +R V  + + +PE   
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRAL--PQNDDHXVMQEHRKV-PFAWCAPESLK 187
Query: 81  GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA--WKLWQEGKALDMMDQK 138
              FS  SD + FGV + E+ +       Y  E  + L G     K+ +EG+ L   +  
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFT-------YGQEPWIGLNGSQILHKIDKEGERLPRPEDC 240
Query: 139 PGAISKANEILKCINVGLLCVQEDPNDRPT 168
           P  I          NV + C    P DRPT
Sbjct: 241 PQDI---------YNVMVQCWAHKPEDRPT 261

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 62/150 (41%), Gaps = 25/150 (16%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG----TTNRVVGTYGYMSPEYAL 80
           R IHRD    N+LL      KI DFGL R     Q D       +R V  + + +PE   
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRAL--PQNDDHYVMQEHRKV-PFAWCAPESLK 187
Query: 81  GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA--WKLWQEGKALDMMDQK 138
              FS  SD + FGV + E+ +       Y  E  + L G     K+ +EG+ L   +  
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFT-------YGQEPWIGLNGSQILHKIDKEGERLPRPEDC 240
Query: 139 PGAISKANEILKCINVGLLCVQEDPNDRPT 168
           P  I          NV + C    P DRPT
Sbjct: 241 PQDI---------YNVMVQCWAHKPEDRPT 261

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/84 (33%), Positives = 42/84 (50%), Gaps = 9/84 (10%)
Query: 26  IIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT--------TNRVVGTYGYMSPE 77
           +IHRD K SN+L++   + K+ DFGL RI +    D +            V T  Y +PE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPE 192
Query: 78  YAL-GGFFSVKSDVFSFGVVVLEI 100
             L    +S   DV+S G ++ E+
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 51/91 (56%), Gaps = 10/91 (10%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH +   +IIHRD K  NIL   + + K++DFG++   +  +T    +  +GT  +M
Sbjct: 148 LNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWM 202
Query: 75  SPEYALGGF-----FSVKSDVFSFGVVVLEI 100
           +PE  +        +  K+DV+S G+ ++E+
Sbjct: 203 APEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 51/104 (49%), Gaps = 12/104 (11%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           +  ++  VS  + YL + +    +HRD    N+LL  +   KISDFGL++     +    
Sbjct: 107 IIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 163
Query: 64  TNRVVGTYG-----YMSPEYALGGFFSVKSDVFSFGVVVLEIIS 102
                 T+G     + +PE      FS KSDV+SFGV++ E  S
Sbjct: 164 AQ----THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 203

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 51/104 (49%), Gaps = 12/104 (11%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           +  ++  VS  + YL + +    +HRD    N+LL  +   KISDFGL++     +    
Sbjct: 119 IIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 175
Query: 64  TNRVVGTYG-----YMSPEYALGGFFSVKSDVFSFGVVVLEIIS 102
                 T+G     + +PE      FS KSDV+SFGV++ E  S
Sbjct: 176 AQ----THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 53/103 (51%), Gaps = 10/103 (9%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           E+L  + +G+     YL + +    +HR+    N+LL +    KISDFGL++   G    
Sbjct: 440 ELLHQVSMGMK----YLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKAL-GADDS 491
Query: 62  GTTNRVVGTY--GYMSPEYALGGFFSVKSDVFSFGVVVLEIIS 102
             T R  G +   + +PE      FS +SDV+S+GV + E +S
Sbjct: 492 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 62/150 (41%), Gaps = 25/150 (16%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG----TTNRVVGTYGYMSPEYAL 80
           R IHRD    N+LL      KI DFGL R     Q D       +R V  + + +PE   
Sbjct: 135 RFIHRDLAARNLLLATRDLVKIGDFGLMRAL--PQNDDHYVMQEHRKV-PFAWCAPESLK 191
Query: 81  GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA--WKLWQEGKALDMMDQK 138
              FS  SD + FGV + E+ +       Y  E  + L G     K+ +EG+ L   +  
Sbjct: 192 TRTFSHASDTWMFGVTLWEMFT-------YGQEPWIGLNGSQILHKIDKEGERLPRPEDC 244
Query: 139 PGAISKANEILKCINVGLLCVQEDPNDRPT 168
           P  I          NV + C    P DRPT
Sbjct: 245 PQDI---------YNVMVQCWAHKPEDRPT 265

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 51/104 (49%), Gaps = 12/104 (11%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           +  ++  VS  + YL + +    +HRD    N+LL  +   KISDFGL++     +    
Sbjct: 109 IIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165
Query: 64  TNRVVGTYG-----YMSPEYALGGFFSVKSDVFSFGVVVLEIIS 102
                 T+G     + +PE      FS KSDV+SFGV++ E  S
Sbjct: 166 AQ----THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 205

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 62/150 (41%), Gaps = 25/150 (16%)
Query: 25  RIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG----TTNRVVGTYGYMSPEYAL 80
           R IHRD    N+LL      KI DFGL R     Q D       +R V  + + +PE   
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRAL--PQNDDHYVMQEHRKV-PFAWCAPESLK 187
Query: 81  GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA--WKLWQEGKALDMMDQK 138
              FS  SD + FGV + E+ +       Y  E  + L G     K+ +EG+ L   +  
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFT-------YGQEPWIGLNGSQILHKIDKEGERLPRPEDC 240
Query: 139 PGAISKANEILKCINVGLLCVQEDPNDRPT 168
           P  I          NV + C    P DRPT
Sbjct: 241 PQDI---------YNVMVQCWAHKPEDRPT 261

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/111 (32%), Positives = 55/111 (49%), Gaps = 19/111 (17%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR---------I 54
           LF  IL     L Y+H      IIHRD K  NI +D   N KI DFGL +          
Sbjct: 121 LFRQILEA---LSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 55  FEGKQTDGTTNRV---VGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEII 101
            + +   G+++ +   +GT  Y++ E   G G ++ K D++S G++  E+I
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 51/104 (49%), Gaps = 12/104 (11%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           +  ++  VS  + YL + +    +HRD    N+LL  +   KISDFGL++     +    
Sbjct: 129 IIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 185
Query: 64  TNRVVGTYG-----YMSPEYALGGFFSVKSDVFSFGVVVLEIIS 102
                 T+G     + +PE      FS KSDV+SFGV++ E  S
Sbjct: 186 AQ----THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 51/104 (49%), Gaps = 12/104 (11%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           +  ++  VS  + YL + +    +HRD    N+LL  +   KISDFGL++     +    
Sbjct: 129 IIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 185
Query: 64  TNRVVGTYG-----YMSPEYALGGFFSVKSDVFSFGVVVLEIIS 102
                 T+G     + +PE      FS KSDV+SFGV++ E  S
Sbjct: 186 AQ----THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 49/93 (52%), Gaps = 12/93 (12%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           +LH ++   I+HRD K  NILLD  M  ++SDFG +   E  +       + GT GY++P
Sbjct: 215 FLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAP 268
Query: 77  EYALGGF------FSVKSDVFSFGVVVLEIISG 103
           E            +  + D+++ GV++  +++G
Sbjct: 269 EILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 51/104 (49%), Gaps = 12/104 (11%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           +  ++  VS  + YL + +    +HRD    N+LL  +   KISDFGL++     +    
Sbjct: 127 IIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 183
Query: 64  TNRVVGTYG-----YMSPEYALGGFFSVKSDVFSFGVVVLEIIS 102
                 T+G     + +PE      FS KSDV+SFGV++ E  S
Sbjct: 184 AQ----THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 223

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 51/104 (49%), Gaps = 12/104 (11%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           +  ++  VS  + YL + +    +HRD    N+LL  +   KISDFGL++     +    
Sbjct: 113 IIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 169
Query: 64  TNRVVGTYG-----YMSPEYALGGFFSVKSDVFSFGVVVLEIIS 102
                 T+G     + +PE      FS KSDV+SFGV++ E  S
Sbjct: 170 AQ----THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 8   ILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRV 67
           I  ++  L Y H     R+IHRD K  N+LL      KI+DFG +       +  TT  +
Sbjct: 118 ITELANALSYCHSK---RVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRTT--L 170
Query: 68  VGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
            GT  Y+ PE   G     K D++S GV+  E + G
Sbjct: 171 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 51/100 (51%), Gaps = 16/100 (16%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR---------IFEGKQTDGTTN 65
           L Y+H      IIHRD K  NI +D   N KI DFGL +           + +   G+++
Sbjct: 129 LSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 66  RV---VGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEII 101
            +   +GT  Y++ E   G G ++ K D++S G++  E+I
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 45/96 (46%), Gaps = 7/96 (7%)
Query: 8   ILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRV 67
           I  ++  L Y H     R+IHRD K  N+LL      KI+DFG +      + D     +
Sbjct: 118 ITELANALSYCHSK---RVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDT----L 170
Query: 68  VGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
            GT  Y+ PE   G     K D++S GV+  E + G
Sbjct: 171 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 14/93 (15%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR--VVGTYG 72
           L YLH +   +IIHRD K  NIL   + + K++DFG++     K T     R   +GT  
Sbjct: 148 LNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS----AKNTRXIQRRDSFIGTPY 200
Query: 73  YMSPEYALGGF-----FSVKSDVFSFGVVVLEI 100
           +M+PE  +        +  K+DV+S G+ ++E+
Sbjct: 201 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 14/93 (15%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR--VVGTYG 72
           L YLH +   +IIHRD K  NIL   + + K++DFG++     K T     R   +GT  
Sbjct: 148 LNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS----AKNTRXIQRRDXFIGTPY 200
Query: 73  YMSPEYALGGF-----FSVKSDVFSFGVVVLEI 100
           +M+PE  +        +  K+DV+S G+ ++E+
Sbjct: 201 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 55/99 (55%), Gaps = 14/99 (14%)
Query: 11  VSRRLL----YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           V R++L    +LH     RIIHRD K  N+L+  E + +++DFG++   +  +T    + 
Sbjct: 114 VCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSA--KNLKTLQKRDS 168
Query: 67  VVGTYGYMSPEYALGGF-----FSVKSDVFSFGVVVLEI 100
            +GT  +M+PE  +        +  K+D++S G+ ++E+
Sbjct: 169 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 207

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 55/99 (55%), Gaps = 14/99 (14%)
Query: 11  VSRRLL----YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           V R++L    +LH     RIIHRD K  N+L+  E + +++DFG++   +  +T    + 
Sbjct: 122 VCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSA--KNLKTLQKRDS 176
Query: 67  VVGTYGYMSPEYALGGF-----FSVKSDVFSFGVVVLEI 100
            +GT  +M+PE  +        +  K+D++S G+ ++E+
Sbjct: 177 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 215

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 28/84 (33%), Positives = 42/84 (50%), Gaps = 9/84 (10%)
Query: 26  IIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTN--------RVVGTYGYMSPE 77
           +IHRD K SN+L++   + K+ DFGL RI +    D +            V T  Y +PE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPE 192
Query: 78  YAL-GGFFSVKSDVFSFGVVVLEI 100
             L    +S   DV+S G ++ E+
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 72/149 (48%), Gaps = 26/149 (17%)
Query: 23  KLRIIHRDFKTSNILLDHEMNPKISDFG-LTRIFEGKQTDGT--TNRVVGTYGYMSPEYA 79
           +L  +HRD K  NIL+D   + +++DFG   ++ E    DGT  ++  VGT  Y+SPE  
Sbjct: 193 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME----DGTVQSSVAVGTPDYISPEIL 248
Query: 80  LG-----GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDM 134
                  G +  + D +S GV + E++ G+  T FY   L  +           GK ++ 
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGE--TPFYAESLVETY----------GKIMNH 296
Query: 135 MD--QKPGAISKANEILKCINVGLLCVQE 161
            +  Q P  ++  +E  K +   L+C +E
Sbjct: 297 KERFQFPTQVTDVSENAKDLIRRLICSRE 325

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 51/104 (49%), Gaps = 12/104 (11%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           +  ++  VS  + YL + +    +HRD    N+LL  +   KISDFGL++     +    
Sbjct: 472 IIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 528
Query: 64  TNRVVGTYG-----YMSPEYALGGFFSVKSDVFSFGVVVLEIIS 102
                 T+G     + +PE      FS KSDV+SFGV++ E  S
Sbjct: 529 AQ----THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 51/104 (49%), Gaps = 12/104 (11%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           +  ++  VS  + YL + +    +HRD    N+LL  +   KISDFGL++     +    
Sbjct: 471 IIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527
Query: 64  TNRVVGTYG-----YMSPEYALGGFFSVKSDVFSFGVVVLEIIS 102
                 T+G     + +PE      FS KSDV+SFGV++ E  S
Sbjct: 528 AQ----THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/109 (33%), Positives = 52/109 (47%), Gaps = 13/109 (11%)
Query: 5   FNIILGVSRRLLYLH-----QDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIF--EG 57
             I+L ++  L +LH        K  I HRD K+ NIL+       I+D GL  +     
Sbjct: 108 LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQST 167
Query: 58  KQTDGTTNRVVGTYGYMSPEY-----ALGGFFSVKS-DVFSFGVVVLEI 100
            Q D   N  VGT  YM+PE       +  F S K  D+++FG+V+ E+
Sbjct: 168 NQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 27/87 (31%), Positives = 47/87 (54%), Gaps = 8/87 (9%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP 76
           YLH    L +I+RD K  N+L+D +   +++DFG       K+  G T  + GT   ++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGF-----AKRVKGRTWXLCGTPEALAP 207
Query: 77  EYALGGFFSVKSDVFSFGVVVLEIISG 103
           E  L   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/112 (32%), Positives = 53/112 (47%), Gaps = 14/112 (12%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHE-MNPKISDFGLTRIFEGKQTDG------TTNRV 67
           L YLH     RI+H D K  N+LL  +  +  + DFG        Q DG      T + +
Sbjct: 198 LEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCL---QPDGLGKSLLTGDYI 251
Query: 68  VGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRN-TGFYNSELALSL 118
            GT  +M+PE  LG     K DV+S   ++L +++G    T F+   L L +
Sbjct: 252 PGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKI 303

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/109 (33%), Positives = 52/109 (47%), Gaps = 13/109 (11%)
Query: 5   FNIILGVSRRLLYLH-----QDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIF--EG 57
             I+L ++  L +LH        K  I HRD K+ NIL+       I+D GL  +     
Sbjct: 108 LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQST 167
Query: 58  KQTDGTTNRVVGTYGYMSPEY-----ALGGFFSVKS-DVFSFGVVVLEI 100
            Q D   N  VGT  YM+PE       +  F S K  D+++FG+V+ E+
Sbjct: 168 NQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/109 (33%), Positives = 52/109 (47%), Gaps = 13/109 (11%)
Query: 5   FNIILGVSRRLLYLH-----QDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIF--EG 57
             I+L ++  L +LH        K  I HRD K+ NIL+       I+D GL  +     
Sbjct: 137 LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQST 196
Query: 58  KQTDGTTNRVVGTYGYMSPEY-----ALGGFFSVKS-DVFSFGVVVLEI 100
            Q D   N  VGT  YM+PE       +  F S K  D+++FG+V+ E+
Sbjct: 197 NQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/112 (32%), Positives = 53/112 (47%), Gaps = 14/112 (12%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHE-MNPKISDFGLTRIFEGKQTDG------TTNRV 67
           L YLH     RI+H D K  N+LL  +  +  + DFG        Q DG      T + +
Sbjct: 179 LEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCL---QPDGLGKDLLTGDYI 232
Query: 68  VGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRN-TGFYNSELALSL 118
            GT  +M+PE  LG     K DV+S   ++L +++G    T F+   L L +
Sbjct: 233 PGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKI 284

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 68/180 (37%), Gaps = 35/180 (19%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMN---PKISDFGLTRIFEGKQT 60
           L ++   ++    YL ++     IHRD    N LL         KI DFG+ R       
Sbjct: 157 LLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 213
Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLG 120
                  +    +M PE  + G F+ K+D +SFGV++ EI S             L  + 
Sbjct: 214 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------------LGYMP 260
Query: 121 YAWKLWQE-------GKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
           Y  K  QE       G  +D     PG + +         +   C Q  P DRP  + ++
Sbjct: 261 YPSKSNQEVLEFVTSGGRMDPPKNCPGPVYR---------IMTQCWQHQPEDRPNFAIIL 311

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 69/181 (38%), Gaps = 37/181 (20%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP----KISDFGLTRIFEGKQ 59
           L ++   ++    YL ++     IHRD    N LL     P    KI DFG+ R      
Sbjct: 142 LLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMARDIYRAS 197
Query: 60  TDGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLL 119
                   +    +M PE  + G F+ K+D +SFGV++ EI S             L  +
Sbjct: 198 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------------LGYM 244
Query: 120 GYAWKLWQE-------GKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
            Y  K  QE       G  +D     PG + +         +   C Q  P DRP  + +
Sbjct: 245 PYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYR---------IMTQCWQHQPEDRPNFAII 295
Query: 173 V 173
           +
Sbjct: 296 L 296

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 68/180 (37%), Gaps = 35/180 (19%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMN---PKISDFGLTRIFEGKQT 60
           L ++   ++    YL ++     IHRD    N LL         KI DFG+ R       
Sbjct: 142 LLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 198
Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLG 120
                  +    +M PE  + G F+ K+D +SFGV++ EI S             L  + 
Sbjct: 199 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------------LGYMP 245
Query: 121 YAWKLWQE-------GKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
           Y  K  QE       G  +D     PG + +         +   C Q  P DRP  + ++
Sbjct: 246 YPSKSNQEVLEFVTSGGRMDPPKNCPGPVYR---------IMTQCWQHQPEDRPNFAIIL 296

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 69/181 (38%), Gaps = 37/181 (20%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP----KISDFGLTRIFEGKQ 59
           L ++   ++    YL ++     IHRD    N LL     P    KI DFG+ R      
Sbjct: 169 LLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMARDIYRAS 224
Query: 60  TDGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLL 119
                   +    +M PE  + G F+ K+D +SFGV++ EI S             L  +
Sbjct: 225 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------------LGYM 271
Query: 120 GYAWKLWQE-------GKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
            Y  K  QE       G  +D     PG + +         +   C Q  P DRP  + +
Sbjct: 272 PYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYR---------IMTQCWQHQPEDRPNFAII 322
Query: 173 V 173
           +
Sbjct: 323 L 323

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 69/181 (38%), Gaps = 37/181 (20%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP----KISDFGLTRIFEGKQ 59
           L ++   ++    YL ++     IHRD    N LL     P    KI DFG+ R      
Sbjct: 159 LLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMARDIYRAS 214
Query: 60  TDGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLL 119
                   +    +M PE  + G F+ K+D +SFGV++ EI S             L  +
Sbjct: 215 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------------LGYM 261
Query: 120 GYAWKLWQE-------GKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
            Y  K  QE       G  +D     PG + +         +   C Q  P DRP  + +
Sbjct: 262 PYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYR---------IMTQCWQHQPEDRPNFAII 312
Query: 173 V 173
           +
Sbjct: 313 L 313

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 68/180 (37%), Gaps = 35/180 (19%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMN---PKISDFGLTRIFEGKQT 60
           L ++   ++    YL ++     IHRD    N LL         KI DFG+ R       
Sbjct: 157 LLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 213
Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLG 120
                  +    +M PE  + G F+ K+D +SFGV++ EI S             L  + 
Sbjct: 214 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------------LGYMP 260
Query: 121 YAWKLWQE-------GKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
           Y  K  QE       G  +D     PG + +         +   C Q  P DRP  + ++
Sbjct: 261 YPSKSNQEVLEFVTSGGRMDPPKNCPGPVYR---------IMTQCWQHQPEDRPNFAIIL 311

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 68/180 (37%), Gaps = 35/180 (19%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMN---PKISDFGLTRIFEGKQT 60
           L ++   ++    YL ++     IHRD    N LL         KI DFG+ R       
Sbjct: 157 LLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 213
Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLG 120
                  +    +M PE  + G F+ K+D +SFGV++ EI S             L  + 
Sbjct: 214 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------------LGYMP 260
Query: 121 YAWKLWQE-------GKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
           Y  K  QE       G  +D     PG + +         +   C Q  P DRP  + ++
Sbjct: 261 YPSKSNQEVLEFVTSGGRMDPPKNCPGPVYR---------IMTQCWQHQPEDRPNFAIIL 311

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 44/97 (45%), Gaps = 7/97 (7%)
Query: 8   ILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRV 67
           I  ++  L Y H     ++IHRD K  N+LL      KI+DFG    +           +
Sbjct: 114 ITELANALSYCHSK---KVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAAL 166
Query: 68  VGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
            GT  Y+ PE   G     K D++S GV+  E + GK
Sbjct: 167 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 48/99 (48%), Gaps = 3/99 (3%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           + +I   ++  ++YL   +    +HRD  T N L+   +  KI DFG++R          
Sbjct: 130 MLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRV 186
Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS 102
               +    +M PE  +   F+ +SDV+S GVV+ EI +
Sbjct: 187 GGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 68/180 (37%), Gaps = 35/180 (19%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMN---PKISDFGLTRIFEGKQT 60
           L ++   ++    YL ++     IHRD    N LL         KI DFG+ R       
Sbjct: 134 LLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 190
Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLG 120
                  +    +M PE  + G F+ K+D +SFGV++ EI S             L  + 
Sbjct: 191 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------------LGYMP 237
Query: 121 YAWKLWQE-------GKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
           Y  K  QE       G  +D     PG + +         +   C Q  P DRP  + ++
Sbjct: 238 YPSKSNQEVLEFVTSGGRMDPPKNCPGPVYR---------IMTQCWQHQPEDRPNFAIIL 288

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 68/180 (37%), Gaps = 35/180 (19%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMN---PKISDFGLTRIFEGKQT 60
           L ++   ++    YL ++     IHRD    N LL         KI DFG+ R       
Sbjct: 143 LLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 199
Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLG 120
                  +    +M PE  + G F+ K+D +SFGV++ EI S             L  + 
Sbjct: 200 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------------LGYMP 246
Query: 121 YAWKLWQE-------GKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
           Y  K  QE       G  +D     PG + +         +   C Q  P DRP  + ++
Sbjct: 247 YPSKSNQEVLEFVTSGGRMDPPKNCPGPVYR---------IMTQCWQHQPEDRPNFAIIL 297

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 68/180 (37%), Gaps = 35/180 (19%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMN---PKISDFGLTRIFEGKQT 60
           L ++   ++    YL ++     IHRD    N LL         KI DFG+ R       
Sbjct: 149 LLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 205
Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLG 120
                  +    +M PE  + G F+ K+D +SFGV++ EI S             L  + 
Sbjct: 206 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------------LGYMP 252
Query: 121 YAWKLWQE-------GKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
           Y  K  QE       G  +D     PG + +         +   C Q  P DRP  + ++
Sbjct: 253 YPSKSNQEVLEFVTSGGRMDPPKNCPGPVYR---------IMTQCWQHQPEDRPNFAIIL 303

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 79/176 (44%), Gaps = 23/176 (13%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQTDGTTNRVVG 69
           +   + YLH       IHRD    N+LLD++   KI DFGL + + EG +          
Sbjct: 143 ICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDS 199
Query: 70  TYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAW------ 123
              + +PE      F   SDV+SFGV + E+++   ++    ++  L L+G A       
Sbjct: 200 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQMTVL 258
Query: 124 ---KLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
              +L + G+ L   D+ P  +     ++K       C + + + RPT  +++ +L
Sbjct: 259 RLTELLERGERLPRPDKCPAEV---YHLMKN------CWETEASFRPTFENLIPIL 305

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 68/180 (37%), Gaps = 35/180 (19%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMN---PKISDFGLTRIFEGKQT 60
           L ++   ++    YL ++     IHRD    N LL         KI DFG+ R       
Sbjct: 143 LLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 199
Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLG 120
                  +    +M PE  + G F+ K+D +SFGV++ EI S             L  + 
Sbjct: 200 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------------LGYMP 246
Query: 121 YAWKLWQE-------GKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
           Y  K  QE       G  +D     PG + +         +   C Q  P DRP  + ++
Sbjct: 247 YPSKSNQEVLEFVTSGGRMDPPKNCPGPVYR---------IMTQCWQHQPEDRPNFAIIL 297

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 68/180 (37%), Gaps = 35/180 (19%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMN---PKISDFGLTRIFEGKQT 60
           L ++   ++    YL ++     IHRD    N LL         KI DFG+ R       
Sbjct: 160 LLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY 216
Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLG 120
                  +    +M PE  + G F+ K+D +SFGV++ EI S             L  + 
Sbjct: 217 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------------LGYMP 263
Query: 121 YAWKLWQE-------GKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
           Y  K  QE       G  +D     PG + +         +   C Q  P DRP  + ++
Sbjct: 264 YPSKSNQEVLEFVTSGGRMDPPKNCPGPVYR---------IMTQCWQHQPEDRPNFAIIL 314

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 69/181 (38%), Gaps = 37/181 (20%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP----KISDFGLTRIFEGKQ 59
           L ++   ++    YL ++     IHRD    N LL     P    KI DFG+ R      
Sbjct: 183 LLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMARDIYRAG 238
Query: 60  TDGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLL 119
                   +    +M PE  + G F+ K+D +SFGV++ EI S             L  +
Sbjct: 239 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------------LGYM 285
Query: 120 GYAWKLWQE-------GKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
            Y  K  QE       G  +D     PG + +         +   C Q  P DRP  + +
Sbjct: 286 PYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYR---------IMTQCWQHQPEDRPNFAII 336
Query: 173 V 173
           +
Sbjct: 337 L 337

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 53/108 (49%), Gaps = 15/108 (13%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT----TNRVVGT 70
           +L L     + +IHRD K  N+LLD   + K++DFG        + D T     +  VGT
Sbjct: 184 VLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCM-----KMDETGMVHCDTAVGT 238
Query: 71  YGYMSPEYALG----GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSEL 114
             Y+SPE        G++  + D +S GV + E++ G  +T FY   L
Sbjct: 239 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG--DTPFYADSL 284

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 69/148 (46%), Gaps = 24/148 (16%)
Query: 23  KLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT--TNRVVGTYGYMSPEYAL 80
           +L  +HRD K  N+LLD   + +++DFG          DGT  ++  VGT  Y+SPE   
Sbjct: 193 QLHYVHRDIKPDNVLLDVNGHIRLADFGSCL---KMNDDGTVQSSVAVGTPDYISPEILQ 249
Query: 81  G-----GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMM 135
                 G +  + D +S GV + E++ G+  T FY   L  +           GK ++  
Sbjct: 250 AMEDGMGKYGPECDWWSLGVCMYEMLYGE--TPFYAESLVETY----------GKIMNHE 297
Query: 136 D--QKPGAISKANEILKCINVGLLCVQE 161
           +  Q P  ++  +E  K +   L+C +E
Sbjct: 298 ERFQFPSHVTDVSEEAKDLIQRLICSRE 325

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/103 (30%), Positives = 54/103 (52%), Gaps = 10/103 (9%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
            LF ++ G++    Y H+    +++HRD K  N+L++     K++DFGL R  +   T  
Sbjct: 105 FLFQLLRGLA----YCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARA-KSIPTKT 156
Query: 63  TTNRVVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
             N VV T  Y  P+  LG   +S + D++  G +  E+ +G+
Sbjct: 157 YDNEVV-TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 69/148 (46%), Gaps = 24/148 (16%)
Query: 23  KLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT--TNRVVGTYGYMSPEYAL 80
           +L  +HRD K  N+LLD   + +++DFG          DGT  ++  VGT  Y+SPE   
Sbjct: 209 QLHYVHRDIKPDNVLLDVNGHIRLADFGSCL---KMNDDGTVQSSVAVGTPDYISPEILQ 265
Query: 81  G-----GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMM 135
                 G +  + D +S GV + E++ G+  T FY   L  +           GK ++  
Sbjct: 266 AMEDGMGKYGPECDWWSLGVCMYEMLYGE--TPFYAESLVETY----------GKIMNHE 313
Query: 136 D--QKPGAISKANEILKCINVGLLCVQE 161
           +  Q P  ++  +E  K +   L+C +E
Sbjct: 314 ERFQFPSHVTDVSEEAKDLIQRLICSRE 341

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/82 (35%), Positives = 39/82 (47%), Gaps = 3/82 (3%)
Query: 23  KLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG 82
           K   IHRD K  NIL+      K+ DFG  R+  G       +  V T  Y SPE  +G 
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG--PSDYYDDEVATRWYRSPELLVGD 177
Query: 83  F-FSVKSDVFSFGVVVLEIISG 103
             +    DV++ G V  E++SG
Sbjct: 178 TQYGPPVDVWAIGCVFAELLSG 199

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/111 (31%), Positives = 53/111 (47%), Gaps = 19/111 (17%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR---------I 54
           LF  IL     L Y+H      IIHR+ K  NI +D   N KI DFGL +          
Sbjct: 121 LFRQILEA---LSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 55  FEGKQTDGTTNRV---VGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEII 101
            + +   G+++ +   +GT  Y++ E   G G ++ K D +S G++  E I
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 52/101 (51%), Gaps = 8/101 (7%)
Query: 6   NIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMN---PKISDFGLTRIFEGKQTDG 62
           + I  +   +L+ HQ   + ++HRD K  N+LL  ++     K++DFGL    EG+Q   
Sbjct: 125 HCIQQILEAVLHCHQ---MGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ-- 179
Query: 63  TTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
                 GT GY+SPE      +    D+++ GV++  ++ G
Sbjct: 180 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 220

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 51/104 (49%), Gaps = 9/104 (8%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           E +  ++  + + L Y+H      ++HRD K  N+ ++ +   KI DFGL R       D
Sbjct: 126 EKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR-----HAD 177
Query: 62  GTTNRVVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
                 V T  Y +PE  L    ++   D++S G ++ E+++GK
Sbjct: 178 AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 51/104 (49%), Gaps = 9/104 (8%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           E +  ++  + + L Y+H      ++HRD K  N+ ++ +   KI DFGL R       D
Sbjct: 144 EKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR-----HAD 195
Query: 62  GTTNRVVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
                 V T  Y +PE  L    ++   D++S G ++ E+++GK
Sbjct: 196 AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/80 (35%), Positives = 42/80 (52%), Gaps = 8/80 (10%)
Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVG----TYGYMSPEYALGG 82
           IHRD    N L+  +   KISDFG++R    ++ DG      G       + +PE    G
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSR----EEADGVXAASGGLRQVPVKWTAPEALNYG 290
Query: 83  FFSVKSDVFSFGVVVLEIIS 102
            +S +SDV+SFG+++ E  S
Sbjct: 291 RYSSESDVWSFGILLWETFS 310

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/112 (30%), Positives = 53/112 (47%), Gaps = 21/112 (18%)
Query: 10  GVSRRLLYLHQD------SKLRIIHRDFKTSNILLDHEMNPKISDFGLT------RIFEG 57
            V+R L YLH +       K  I HRD  + N+L+ ++    ISDFGL+      R+   
Sbjct: 119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRP 178
Query: 58  KQTDGTTNRVVGTYGYMSPEYALGGFFSVKS--------DVFSFGVVVLEII 101
            + D      VGT  YM+PE  L G  +++         D+++ G++  EI 
Sbjct: 179 GEEDNAAISEVGTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 57/109 (52%), Gaps = 15/109 (13%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP-----KISDFGLTRIFEG 57
           +L+ I+ G+     YLH +    ++HRD K +NIL+  E  P     KI+D G  R+F  
Sbjct: 133 LLYQILDGIH----YLHANW---VLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNS 184
Query: 58  K-QTDGTTNRVVGTYGYMSPEYALGGFFSVKS-DVFSFGVVVLEIISGK 104
             +     + VV T+ Y +PE  LG     K+ D+++ G +  E+++ +
Sbjct: 185 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 68/180 (37%), Gaps = 35/180 (19%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMN---PKISDFGLTRIFEGKQT 60
           L ++   ++    YL ++     IHRD    N LL         KI DFG+ +       
Sbjct: 143 LLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASY 199
Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLG 120
                  +    +M PE  + G F+ K+D +SFGV++ EI S             L  + 
Sbjct: 200 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------------LGYMP 246
Query: 121 YAWKLWQE-------GKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
           Y  K  QE       G  +D     PG + +         +   C Q  P DRP  + ++
Sbjct: 247 YPSKSNQEVLEFVTSGGRMDPPKNCPGPVYR---------IMTQCWQHQPEDRPNFAIIL 297

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 47/91 (51%), Gaps = 4/91 (4%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGT 70
           +S  L YL  +SK R +HRD    N+L+      K+ DFGL+R  E   T    ++    
Sbjct: 120 LSTALAYL--ESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STXXKASKGKLP 175
Query: 71  YGYMSPEYALGGFFSVKSDVFSFGVVVLEII 101
             +M+PE      F+  SDV+ FGV + EI+
Sbjct: 176 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/80 (35%), Positives = 42/80 (52%), Gaps = 8/80 (10%)
Query: 27  IHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVG----TYGYMSPEYALGG 82
           IHRD    N L+  +   KISDFG++R    ++ DG      G       + +PE    G
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSR----EEADGVYAASGGLRQVPVKWTAPEALNYG 290
Query: 83  FFSVKSDVFSFGVVVLEIIS 102
            +S +SDV+SFG+++ E  S
Sbjct: 291 RYSSESDVWSFGILLWETFS 310

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/86 (36%), Positives = 44/86 (51%), Gaps = 8/86 (9%)
Query: 23  KLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFE--GKQTDGTTNRVVGTYGYMSPEY-- 78
           K  I HRDFK+ N+L+   +   I+D GL  +        D   N  VGT  YM+PE   
Sbjct: 131 KPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVLD 190
Query: 79  ---ALGGFFSVK-SDVFSFGVVVLEI 100
                  F S K +D+++FG+V+ EI
Sbjct: 191 EQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 73/148 (49%), Gaps = 24/148 (16%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP---KISDFGLTRIFEGKQT 60
            + ++L V     YLH++    IIHRD K  N+LL  +      KI+DFG ++I  G+ +
Sbjct: 120 FYQMLLAVQ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETS 171
Query: 61  DGTTNRVVGTYGYMSPEYALG---GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALS 117
              T  + GT  Y++PE  +      ++   D +S GV++   +SG      + ++++L 
Sbjct: 172 LMRT--LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 229
Query: 118 ------LLGYAWKLWQE--GKALDMMDQ 137
                    +  ++W E   KALD++ +
Sbjct: 230 DQITSGKYNFIPEVWAEVSEKALDLVKK 257

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 73/148 (49%), Gaps = 24/148 (16%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP---KISDFGLTRIFEGKQT 60
            + ++L V     YLH++    IIHRD K  N+LL  +      KI+DFG ++I  G+ +
Sbjct: 120 FYQMLLAVQ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETS 171
Query: 61  DGTTNRVVGTYGYMSPEYALG---GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALS 117
              T  + GT  Y++PE  +      ++   D +S GV++   +SG      + ++++L 
Sbjct: 172 LMRT--LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 229
Query: 118 ------LLGYAWKLWQE--GKALDMMDQ 137
                    +  ++W E   KALD++ +
Sbjct: 230 DQITSGKYNFIPEVWAEVSEKALDLVKK 257

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 73/148 (49%), Gaps = 24/148 (16%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP---KISDFGLTRIFEGKQT 60
            + ++L V     YLH++    IIHRD K  N+LL  +      KI+DFG ++I  G+ +
Sbjct: 119 FYQMLLAVQ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETS 170
Query: 61  DGTTNRVVGTYGYMSPEYALG---GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALS 117
              T  + GT  Y++PE  +      ++   D +S GV++   +SG      + ++++L 
Sbjct: 171 LMRT--LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 228
Query: 118 ------LLGYAWKLWQE--GKALDMMDQ 137
                    +  ++W E   KALD++ +
Sbjct: 229 DQITSGKYNFIPEVWAEVSEKALDLVKK 256

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 41/86 (47%), Gaps = 7/86 (8%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L +LH      ++H D K +NI L      K+ DFGL        T G      G   YM
Sbjct: 170 LAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVEL---GTAGAGEVQEGDPRYM 223
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEI 100
           +PE  L G +   +DVFS G+ +LE+
Sbjct: 224 APEL-LQGSYGTAADVFSLGLTILEV 248

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 73/148 (49%), Gaps = 24/148 (16%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP---KISDFGLTRIFEGKQT 60
            + ++L V     YLH++    IIHRD K  N+LL  +      KI+DFG ++I  G+ +
Sbjct: 120 FYQMLLAVQ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETS 171
Query: 61  DGTTNRVVGTYGYMSPEYALG---GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALS 117
              T  + GT  Y++PE  +      ++   D +S GV++   +SG      + ++++L 
Sbjct: 172 LMRT--LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 229
Query: 118 ------LLGYAWKLWQE--GKALDMMDQ 137
                    +  ++W E   KALD++ +
Sbjct: 230 DQITSGKYNFIPEVWAEVSEKALDLVKK 257

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 73/148 (49%), Gaps = 24/148 (16%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP---KISDFGLTRIFEGKQT 60
            + ++L V     YLH++    IIHRD K  N+LL  +      KI+DFG ++I  G+ +
Sbjct: 126 FYQMLLAVQ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETS 177
Query: 61  DGTTNRVVGTYGYMSPEYALG---GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALS 117
              T  + GT  Y++PE  +      ++   D +S GV++   +SG      + ++++L 
Sbjct: 178 LMRT--LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 235
Query: 118 ------LLGYAWKLWQE--GKALDMMDQ 137
                    +  ++W E   KALD++ +
Sbjct: 236 DQITSGKYNFIPEVWAEVSEKALDLVKK 263

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 40/91 (43%), Gaps = 5/91 (5%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH      I+H+D K  N+LL      KIS  G+         D T     G+  + 
Sbjct: 122 LEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ 178
Query: 75  SPEYA--LGGFFSVKSDVFSFGVVVLEIISG 103
            PE A  L  F   K D++S GV +  I +G
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/178 (24%), Positives = 79/178 (44%), Gaps = 23/178 (12%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQTDGTTNRVVG 69
           +   + YLH       IHR+    N+LLD++   KI DFGL + + EG +          
Sbjct: 126 ICEGMAYLHSQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 182
Query: 70  TYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAW------ 123
              + +PE      F   SDV+SFGV + E+++   ++    ++  L L+G A       
Sbjct: 183 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQMTVL 241
Query: 124 ---KLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGS 178
              +L + G+ L   D+ P  +          ++   C + + + RPT  +++ +L +
Sbjct: 242 RLTELLERGERLPRPDKCPCEV---------YHLMKNCWETEASFRPTFENLIPILKT 290

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/178 (24%), Positives = 79/178 (44%), Gaps = 23/178 (12%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQTDGTTNRVVG 69
           +   + YLH       IHR+    N+LLD++   KI DFGL + + EG +          
Sbjct: 126 ICEGMAYLHAQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 182
Query: 70  TYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAW------ 123
              + +PE      F   SDV+SFGV + E+++   ++    ++  L L+G A       
Sbjct: 183 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQMTVL 241
Query: 124 ---KLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGS 178
              +L + G+ L   D+ P  +          ++   C + + + RPT  +++ +L +
Sbjct: 242 RLTELLERGERLPRPDKCPCEV---------YHLMKNCWETEASFRPTFENLIPILKT 290

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 78/174 (44%), Gaps = 26/174 (14%)
Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLT-RIFEGK- 58
           ++ L   ++ ++  + YL   S    +HRD    N +L  +M   ++DFGL+ +I+ G  
Sbjct: 146 LQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDY 202
Query: 59  QTDGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRN--TGFYNSELAL 116
              G   ++     +++ E      ++ KSDV++FGV + EI +       G  N E+  
Sbjct: 203 YRQGRIAKM--PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD 260
Query: 117 SLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMS 170
            LL +  +L Q    LD          +  EI+        C + DP DRPT S
Sbjct: 261 YLL-HGHRLKQPEDCLD----------ELYEIMYS------CWRTDPLDRPTFS 297

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/101 (26%), Positives = 51/101 (50%), Gaps = 9/101 (8%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNIL-LDHEMNP---KISDFGLTRIFEGKQTDG 62
           ++  +++ + YLH      ++HRD K SNIL +D   NP   +I DFG  +    +  +G
Sbjct: 121 VLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE--NG 175
Query: 63  TTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
                  T  +++PE      +    D++S GV++  +++G
Sbjct: 176 LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 26/86 (30%), Positives = 41/86 (47%), Gaps = 4/86 (4%)
Query: 18  LHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPE 77
           LH   + ++IHRD K  N+L+ ++   KI+DFG    +           + GT  Y+ PE
Sbjct: 128 LHYCHERKVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGTLDYLPPE 183
Query: 78  YALGGFFSVKSDVFSFGVVVLEIISG 103
              G     K D++  GV+  E + G
Sbjct: 184 MIEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 26/86 (30%), Positives = 41/86 (47%), Gaps = 4/86 (4%)
Query: 18  LHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPE 77
           LH   + ++IHRD K  N+L+ ++   KI+DFG    +           + GT  Y+ PE
Sbjct: 127 LHYCHERKVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGTLDYLPPE 182
Query: 78  YALGGFFSVKSDVFSFGVVVLEIISG 103
              G     K D++  GV+  E + G
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 47/91 (51%), Gaps = 4/91 (4%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGT 70
           +S  L YL  +SK R +HRD    N+L+      K+ DFGL+R  E   T    ++    
Sbjct: 125 LSTALAYL--ESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLP 180
Query: 71  YGYMSPEYALGGFFSVKSDVFSFGVVVLEII 101
             +M+PE      F+  SDV+ FGV + EI+
Sbjct: 181 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 211

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 33/112 (29%), Positives = 53/112 (47%), Gaps = 14/112 (12%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMN-PKISDFGLTRIFEGKQTDG------TTNRV 67
           L YLH     RI+H D K  N+LL  + +   + DFG        Q DG      T + +
Sbjct: 163 LEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCL---QPDGLGKSLLTGDYI 216
Query: 68  VGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRN-TGFYNSELALSL 118
            GT  +M+PE  +G     K D++S   ++L +++G    T ++   L L +
Sbjct: 217 PGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI 268

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 33/112 (29%), Positives = 52/112 (46%), Gaps = 14/112 (12%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHE-MNPKISDFGLTRIFEGKQTDG------TTNRV 67
           L YLH     RI+H D K  N+LL  +     + DFG        Q DG      T + +
Sbjct: 179 LEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCL---QPDGLGKSLLTGDYI 232
Query: 68  VGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRN-TGFYNSELALSL 118
            GT  +M+PE  +G     K D++S   ++L +++G    T ++   L L +
Sbjct: 233 PGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI 284

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 47/91 (51%), Gaps = 4/91 (4%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGT 70
           +S  L YL  +SK R +HRD    N+L+      K+ DFGL+R  E   T    ++    
Sbjct: 123 LSTALAYL--ESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLP 178
Query: 71  YGYMSPEYALGGFFSVKSDVFSFGVVVLEII 101
             +M+PE      F+  SDV+ FGV + EI+
Sbjct: 179 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 209

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 47/91 (51%), Gaps = 4/91 (4%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGT 70
           +S  L YL  +SK R +HRD    N+L+      K+ DFGL+R  E   T    ++    
Sbjct: 117 LSTALAYL--ESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLP 172
Query: 71  YGYMSPEYALGGFFSVKSDVFSFGVVVLEII 101
             +M+PE      F+  SDV+ FGV + EI+
Sbjct: 173 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 203

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 47/91 (51%), Gaps = 4/91 (4%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGT 70
           +S  L YL  +SK R +HRD    N+L+      K+ DFGL+R  E   T    ++    
Sbjct: 122 LSTALAYL--ESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLP 177
Query: 71  YGYMSPEYALGGFFSVKSDVFSFGVVVLEII 101
             +M+PE      F+  SDV+ FGV + EI+
Sbjct: 178 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 29/101 (28%), Positives = 50/101 (49%), Gaps = 8/101 (7%)
Query: 6   NIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMN---PKISDFGLTRIFEGKQTDG 62
           + I  +   +L+ HQ   + ++HRD K  N+LL  +      K++DFGL    +G Q   
Sbjct: 107 HCIQQILEAVLHCHQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQ-- 161
Query: 63  TTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
                 GT GY+SPE      +    D+++ GV++  ++ G
Sbjct: 162 AWFGFAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 47/91 (51%), Gaps = 4/91 (4%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGT 70
           +S  L YL  +SK R +HRD    N+L+      K+ DFGL+R  E   T    ++    
Sbjct: 148 LSTALAYL--ESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLP 203
Query: 71  YGYMSPEYALGGFFSVKSDVFSFGVVVLEII 101
             +M+PE      F+  SDV+ FGV + EI+
Sbjct: 204 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 234

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 47/91 (51%), Gaps = 4/91 (4%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGT 70
           +S  L YL  +SK R +HRD    N+L+      K+ DFGL+R  E   T    ++    
Sbjct: 120 LSTALAYL--ESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLP 175
Query: 71  YGYMSPEYALGGFFSVKSDVFSFGVVVLEII 101
             +M+PE      F+  SDV+ FGV + EI+
Sbjct: 176 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 27/101 (26%), Positives = 50/101 (49%), Gaps = 9/101 (8%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNIL-LDHEMNP---KISDFGLTRIFEGKQTDG 62
           ++  +++ + YLH      ++HRD K SNIL +D   NP   +I DFG  +    +  +G
Sbjct: 121 VLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE--NG 175
Query: 63  TTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
                  T  +++PE      +    D++S GV++   ++G
Sbjct: 176 LLXTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTG 216

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 53/114 (46%), Gaps = 15/114 (13%)
Query: 1   MEMLFNIILGVSRRLLYLHQD-----SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIF 55
           +E +  + L  +  L +LH +      K  I HRD K+ NIL+       I+D GL  + 
Sbjct: 105 VEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VR 163
Query: 56  EGKQTDG---TTNRVVGTYGYMSPEYA-----LGGFFSVK-SDVFSFGVVVLEI 100
               TD      N  VGT  YM+PE       +  F S K +D+++ G+V  EI
Sbjct: 164 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 73/148 (49%), Gaps = 24/148 (16%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP---KISDFGLTRIFEGKQT 60
            + ++L V     YLH++    IIHRD K  N+LL  +      KI+DFG ++I  G+ +
Sbjct: 245 FYQMLLAVQ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETS 296
Query: 61  DGTTNRVVGTYGYMSPEYALG---GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALS 117
              T  + GT  Y++PE  +      ++   D +S GV++   +SG      + ++++L 
Sbjct: 297 LMRT--LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 354
Query: 118 ------LLGYAWKLWQE--GKALDMMDQ 137
                    +  ++W E   KALD++ +
Sbjct: 355 DQITSGKYNFIPEVWAEVSEKALDLVKK 382

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 53/114 (46%), Gaps = 15/114 (13%)
Query: 1   MEMLFNIILGVSRRLLYLHQD-----SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIF 55
           +E +  + L  +  L +LH +      K  I HRD K+ NIL+       I+D GL  + 
Sbjct: 99  VEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VR 157
Query: 56  EGKQTDG---TTNRVVGTYGYMSPEYA-----LGGFFSVK-SDVFSFGVVVLEI 100
               TD      N  VGT  YM+PE       +  F S K +D+++ G+V  EI
Sbjct: 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 47/91 (51%), Gaps = 4/91 (4%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGT 70
           +S  L YL  +SK R +HRD    N+L+      K+ DFGL+R  E   T    ++    
Sbjct: 120 LSTALAYL--ESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLP 175
Query: 71  YGYMSPEYALGGFFSVKSDVFSFGVVVLEII 101
             +M+PE      F+  SDV+ FGV + EI+
Sbjct: 176 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 33/112 (29%), Positives = 52/112 (46%), Gaps = 14/112 (12%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHE-MNPKISDFGLTRIFEGKQTDG------TTNRV 67
           L YLH     RI+H D K  N+LL  +     + DFG        Q DG      T + +
Sbjct: 177 LEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCL---QPDGLGKSLLTGDYI 230
Query: 68  VGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRN-TGFYNSELALSL 118
            GT  +M+PE  +G     K D++S   ++L +++G    T ++   L L +
Sbjct: 231 PGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI 282

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 53/114 (46%), Gaps = 15/114 (13%)
Query: 1   MEMLFNIILGVSRRLLYLHQD-----SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIF 55
           +E +  + L  +  L +LH +      K  I HRD K+ NIL+       I+D GL  + 
Sbjct: 100 VEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VR 158
Query: 56  EGKQTDG---TTNRVVGTYGYMSPEYA-----LGGFFSVK-SDVFSFGVVVLEI 100
               TD      N  VGT  YM+PE       +  F S K +D+++ G+V  EI
Sbjct: 159 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 49/101 (48%), Gaps = 13/101 (12%)
Query: 6   NIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP--KISDFGLTRIFEGKQTDGT 63
            +I GVS    Y H    +++ HRD K  N LLD    P  KI+DFG ++          
Sbjct: 123 QLISGVS----YAH---AMQVAHRDLKLENTLLDGSPAPRLKIADFGYSK---ASVLHSQ 172
Query: 64  TNRVVGTYGYMSPEYALGGFFSVK-SDVFSFGVVVLEIISG 103
               VGT  Y++PE  L   +  K +DV+S GV +  ++ G
Sbjct: 173 PKSAVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 53/114 (46%), Gaps = 15/114 (13%)
Query: 1   MEMLFNIILGVSRRLLYLHQD-----SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIF 55
           +E +  + L  +  L +LH +      K  I HRD K+ NIL+       I+D GL  + 
Sbjct: 102 VEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VR 160
Query: 56  EGKQTDG---TTNRVVGTYGYMSPEYA-----LGGFFSVK-SDVFSFGVVVLEI 100
               TD      N  VGT  YM+PE       +  F S K +D+++ G+V  EI
Sbjct: 161 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 44/93 (47%), Gaps = 4/93 (4%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQTDGTTNRVVG 69
           +   + YLH       IHR     N+LLD++   KI DFGL + + EG +          
Sbjct: 120 ICEGMAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 176
Query: 70  TYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS 102
              + +PE      F   SDV+SFGV + E+++
Sbjct: 177 PVFWYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 47/91 (51%), Gaps = 4/91 (4%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGT 70
           +S  L YL  +SK R +HRD    N+L+      K+ DFGL+R  E   T    ++    
Sbjct: 120 LSTALAYL--ESK-RFVHRDIAARNVLVSATDCVKLGDFGLSRYMED-STYYKASKGKLP 175
Query: 71  YGYMSPEYALGGFFSVKSDVFSFGVVVLEII 101
             +M+PE      F+  SDV+ FGV + EI+
Sbjct: 176 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 44/93 (47%), Gaps = 4/93 (4%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQTDGTTNRVVG 69
           +   + YLH       IHR     N+LLD++   KI DFGL + + EG +          
Sbjct: 121 ICEGMAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 177
Query: 70  TYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS 102
              + +PE      F   SDV+SFGV + E+++
Sbjct: 178 PVFWYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 53/114 (46%), Gaps = 15/114 (13%)
Query: 1   MEMLFNIILGVSRRLLYLHQD-----SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIF 55
           +E +  + L  +  L +LH +      K  I HRD K+ NIL+       I+D GL  + 
Sbjct: 138 VEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VR 196
Query: 56  EGKQTDG---TTNRVVGTYGYMSPEYA-----LGGFFSVK-SDVFSFGVVVLEI 100
               TD      N  VGT  YM+PE       +  F S K +D+++ G+V  EI
Sbjct: 197 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 35/113 (30%), Positives = 52/113 (46%), Gaps = 13/113 (11%)
Query: 1   MEMLFNIILGVSRRLLYLHQD-----SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIF 55
           +E +  + L  +  L +LH +      K  I HRD K+ NIL+       I+D GL    
Sbjct: 125 VEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 184
Query: 56  EGK--QTDGTTNRVVGTYGYMSPEYA-----LGGFFSVK-SDVFSFGVVVLEI 100
           +      D   N  VGT  YM+PE       +  F S K +D+++ G+V  EI
Sbjct: 185 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 23/101 (22%), Positives = 51/101 (50%), Gaps = 3/101 (2%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           ++L N  + +++ + YL +     ++HR+    N+LL      +++DFG+  +       
Sbjct: 133 QLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 189
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS 102
              +       +M+ E    G ++ +SDV+S+GV V E+++
Sbjct: 190 LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 41/81 (50%), Gaps = 3/81 (3%)
Query: 26  IIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG-FF 84
           ++HRD K  N+L++     K++DFGL R F G      +  VV T  Y  P+   G   +
Sbjct: 122 VLHRDLKPQNLLINRNGELKLADFGLARAF-GIPVRCYSAEVV-TLWYRPPDVLFGAKLY 179
Query: 85  SVKSDVFSFGVVVLEIISGKR 105
           S   D++S G +  E+ +  R
Sbjct: 180 STSIDMWSAGCIFAELANAAR 200

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 23/101 (22%), Positives = 51/101 (50%), Gaps = 3/101 (2%)
Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           ++L N  + +++ + YL +     ++HR+    N+LL      +++DFG+  +       
Sbjct: 115 QLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 171
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS 102
              +       +M+ E    G ++ +SDV+S+GV V E+++
Sbjct: 172 LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 73/148 (49%), Gaps = 24/148 (16%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP---KISDFGLTRIFEGKQT 60
            + ++L V     YLH++    IIHRD K  N+LL  +      KI+DFG ++I  G+ +
Sbjct: 259 FYQMLLAVQ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETS 310
Query: 61  DGTTNRVVGTYGYMSPEYALG---GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALS 117
              T  + GT  Y++PE  +      ++   D +S GV++   +SG      + ++++L 
Sbjct: 311 LMRT--LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 368
Query: 118 ------LLGYAWKLWQE--GKALDMMDQ 137
                    +  ++W E   KALD++ +
Sbjct: 369 DQITSGKYNFIPEVWAEVSEKALDLVKK 396

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 47/91 (51%), Gaps = 4/91 (4%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGT 70
           +S  L YL  +SK R +HRD    N+L+      K+ DFGL+R  E   T    ++    
Sbjct: 500 LSTALAYL--ESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLP 555
Query: 71  YGYMSPEYALGGFFSVKSDVFSFGVVVLEII 101
             +M+PE      F+  SDV+ FGV + EI+
Sbjct: 556 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 43.5 bits (101), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 48/99 (48%), Gaps = 13/99 (13%)
Query: 15  LLYLHQD-----SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIF--EGKQTDGTTNRV 67
           L +LH +      K  I HRD K+ NIL+       I+D GL   F  +  + D   N  
Sbjct: 147 LCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR 206
Query: 68  VGTYGYMSPEYA-----LGGFFS-VKSDVFSFGVVVLEI 100
           VGT  YM PE          F S + +D++SFG+++ E+
Sbjct: 207 VGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 43.5 bits (101), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 55/113 (48%), Gaps = 22/113 (19%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDH--EMNP-KISDFGLTRIFEGKQTDGT 63
           ++  V+  L +LH      I HRD K  NIL +H  +++P KI DFGL     G + +G 
Sbjct: 116 VVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFGLG---SGIKLNGD 169
Query: 64  TNRV--------VGTYGYMSPEYA-----LGGFFSVKSDVFSFGVVVLEIISG 103
            + +         G+  YM+PE           +  + D++S GV++  ++SG
Sbjct: 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 43.5 bits (101), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 48/101 (47%), Gaps = 13/101 (12%)
Query: 6   NIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP--KISDFGLTRIFEGKQTDGT 63
            +I GVS    Y H    +++ HRD K  N LLD    P  KI DFG ++          
Sbjct: 123 QLISGVS----YCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQ 172
Query: 64  TNRVVGTYGYMSPEYALGGFFSVK-SDVFSFGVVVLEIISG 103
               VGT  Y++PE  L   +  K +DV+S GV +  ++ G
Sbjct: 173 PKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 48/101 (47%), Gaps = 13/101 (12%)
Query: 6   NIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP--KISDFGLTRIFEGKQTDGT 63
            +I GVS    Y H    +++ HRD K  N LLD    P  KI DFG ++          
Sbjct: 122 QLISGVS----YCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQ 171
Query: 64  TNRVVGTYGYMSPEYALGGFFSVK-SDVFSFGVVVLEIISG 103
               VGT  Y++PE  L   +  K +DV+S GV +  ++ G
Sbjct: 172 PKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 212

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 81/189 (42%), Gaps = 22/189 (11%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           LF II G+     + H  +   IIHRD K  NIL+      K+ DFG  R          
Sbjct: 130 LFQIINGIG----FCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--V 180
Query: 64  TNRVVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA 122
            +  V T  Y +PE  +G   +    DV++ G +V E+  G+     +  +  +      
Sbjct: 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE---PLFPGDSDID----- 232
Query: 123 WKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDR--PTMSDVVIMLGSEA 180
            +L+     L  +  +   +   N +   + +  +  + +P +R  P +S+VVI L  + 
Sbjct: 233 -QLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEI-KEREPLERRYPKLSEVVIDLAKKC 290
Query: 181 VNLASPKRP 189
           +++   KRP
Sbjct: 291 LHIDPDKRP 299

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 47/91 (51%), Gaps = 4/91 (4%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGT 70
           +S  L YL  +SK R +HRD    N+L+      K+ DFGL+R  E   T    ++    
Sbjct: 500 LSTALAYL--ESK-RFVHRDIAARNVLVSATDCVKLGDFGLSRYMED-STYYKASKGKLP 555
Query: 71  YGYMSPEYALGGFFSVKSDVFSFGVVVLEII 101
             +M+PE      F+  SDV+ FGV + EI+
Sbjct: 556 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/103 (29%), Positives = 52/103 (50%), Gaps = 17/103 (16%)
Query: 11  VSRRLL----YLHQDSKLRIIHRDFKTSNILLDHEMNP------KISDFGLTRIFEGKQT 60
           +S++LL    Y+H+  +  IIH D K  N+L++   +P      KI+D G    ++   T
Sbjct: 136 ISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 193
Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           +    R      Y SPE  LG  +   +D++S   ++ E+I+G
Sbjct: 194 NSIQTR-----EYRSPEVLLGAPWGCGADIWSTACLIFELITG 231

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/103 (29%), Positives = 52/103 (50%), Gaps = 17/103 (16%)
Query: 11  VSRRLL----YLHQDSKLRIIHRDFKTSNILLDHEMNP------KISDFGLTRIFEGKQT 60
           +S++LL    Y+H+  +  IIH D K  N+L++   +P      KI+D G    ++   T
Sbjct: 136 ISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 193
Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           +    R      Y SPE  LG  +   +D++S   ++ E+I+G
Sbjct: 194 NSIQTR-----EYRSPEVLLGAPWGCGADIWSTACLIFELITG 231

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/101 (28%), Positives = 52/101 (51%), Gaps = 8/101 (7%)
Query: 6   NIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMN---PKISDFGLTRIFEGKQTDG 62
           + I  +   +L+ HQ   + ++HR+ K  N+LL  ++     K++DFGL    EG+Q   
Sbjct: 114 HCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW 170
Query: 63  TTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
                 GT GY+SPE      +    D+++ GV++  ++ G
Sbjct: 171 FG--FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 43/90 (47%), Gaps = 9/90 (10%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNP--KISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           Y H    ++I HRD K  N LLD    P  KI DFG ++              VGT  Y+
Sbjct: 131 YCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYI 184
Query: 75  SPEYALGGFFSVK-SDVFSFGVVVLEIISG 103
           +PE  L   +  K +DV+S GV +  ++ G
Sbjct: 185 APEVLLRQEYDGKIADVWSCGVTLYVMLVG 214

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMN---PKISDFGLTRIFEGKQTDGTTNRVVGTYGY 73
           ++HQ     I+HRD K  N+LL  +      K++DFGL    +G+Q         GT GY
Sbjct: 145 HIHQHD---IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFG--FAGTPGY 199
Query: 74  MSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           +SPE      +    D+++ GV++  ++ G
Sbjct: 200 LSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/121 (27%), Positives = 56/121 (46%), Gaps = 28/121 (23%)
Query: 3   MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG 62
           +L+N++LG +    ++H+     IIHRD K +N LL+ + + K+ DFGL R    ++   
Sbjct: 134 ILYNLLLGEN----FIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTN 186
Query: 63  TTNRV--------------------VGTYGYMSPEYALGGFFSVKS-DVFSFGVVVLEII 101
             N +                    V T  Y +PE  L      KS D++S G +  E++
Sbjct: 187 IVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246
Query: 102 S 102
           +
Sbjct: 247 N 247

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 47/96 (48%), Gaps = 6/96 (6%)
Query: 13  RRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR--IFEGKQTDGTTNRVVGT 70
           R L Y+H     ++IHRD K SN+L++     KI DFG+ R       +        V T
Sbjct: 170 RGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 226
Query: 71  YGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGKR 105
             Y +PE  L    ++   D++S G +  E+++ ++
Sbjct: 227 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 56/115 (48%), Gaps = 9/115 (7%)
Query: 17  YLHQDSKLRIIHRDFKTSNILLDHE--MNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           ++HQ   + I+H D K  NIL  +      KI DFGL R ++ ++         GT  ++
Sbjct: 202 HMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN---FGTPEFL 255
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISG-KRNTGFYNSELALSLLGYAWKLWQE 128
           +PE     F S  +D++S GV+   ++SG     G  ++E   ++L   W L  E
Sbjct: 256 APEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDE 310

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 47/96 (48%), Gaps = 6/96 (6%)
Query: 13  RRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR--IFEGKQTDGTTNRVVGT 70
           R L Y+H     ++IHRD K SN+L++     KI DFG+ R       +        V T
Sbjct: 169 RGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 225
Query: 71  YGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGKR 105
             Y +PE  L    ++   D++S G +  E+++ ++
Sbjct: 226 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/83 (36%), Positives = 41/83 (49%), Gaps = 8/83 (9%)
Query: 25  RIIHRDFKTSNILL---DHEMNP--KISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYA 79
           R +HRD K  N+LL   D    P  KI DFGL R F G      T+ ++ T  Y  PE  
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTHEII-TLWYRPPEIL 209
Query: 80  LGG-FFSVKSDVFSFGVVVLEII 101
           LG   +S   D++S   +  E++
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEML 232

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 54/108 (50%), Gaps = 8/108 (7%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP--KISDFGLTRIFEGKQTDGTTNRVV 68
           V + L ++H+++    +H D K  NI+   + +   K+ DFGLT   + KQ+   T    
Sbjct: 264 VCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT---T 317
Query: 69  GTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELAL 116
           GT  + +PE A G      +D++S GV+   ++SG    G  N +  L
Sbjct: 318 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL 365

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 44/83 (53%), Gaps = 7/83 (8%)
Query: 23  KLRIIHRDFKTSNILLDHEMNP--KISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL 80
           K RIIH D K  NILL  +     K+ DFG +  +E ++        + +  Y +PE  L
Sbjct: 218 KNRIIHCDLKPENILLKQQGRSGIKVIDFG-SSCYEHQR----VYXXIQSRFYRAPEVIL 272
Query: 81  GGFFSVKSDVFSFGVVVLEIISG 103
           G  + +  D++S G ++ E+++G
Sbjct: 273 GARYGMPIDMWSLGCILAELLTG 295

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 54/108 (50%), Gaps = 8/108 (7%)
Query: 11  VSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP--KISDFGLTRIFEGKQTDGTTNRVV 68
           V + L ++H+++    +H D K  NI+   + +   K+ DFGLT   + KQ+   T    
Sbjct: 158 VCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT---T 211
Query: 69  GTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELAL 116
           GT  + +PE A G      +D++S GV+   ++SG    G  N +  L
Sbjct: 212 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL 259

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/101 (25%), Positives = 50/101 (49%), Gaps = 9/101 (8%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNIL-LDHEMNP---KISDFGLTRIFEGKQTDG 62
           ++  + + + YLH      ++HRD K SNIL +D   NP   +I DFG  +    +  +G
Sbjct: 126 VLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAE--NG 180
Query: 63  TTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
                  T  +++PE      +    D++S G+++  +++G
Sbjct: 181 LLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 44/83 (53%), Gaps = 7/83 (8%)
Query: 23  KLRIIHRDFKTSNILLDHEMNP--KISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL 80
           K RIIH D K  NILL  +     K+ DFG +  +E ++        + +  Y +PE  L
Sbjct: 218 KNRIIHCDLKPENILLKQQGRSGIKVIDFG-SSCYEHQR----VYTXIQSRFYRAPEVIL 272
Query: 81  GGFFSVKSDVFSFGVVVLEIISG 103
           G  + +  D++S G ++ E+++G
Sbjct: 273 GARYGMPIDMWSLGCILAELLTG 295

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 25/81 (30%), Positives = 41/81 (50%), Gaps = 3/81 (3%)
Query: 26  IIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG-FF 84
           ++HRD K  N+L++     K+++FGL R F G      +  VV T  Y  P+   G   +
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV-TLWYRPPDVLFGAKLY 179
Query: 85  SVKSDVFSFGVVVLEIISGKR 105
           S   D++S G +  E+ +  R
Sbjct: 180 STSIDMWSAGCIFAELANAGR 200

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 4/90 (4%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           LL+L    +L IIH D K  NILL    NPK S   +       Q      + + +  Y 
Sbjct: 151 LLFL-ATPELSIIHCDLKPENILL---CNPKRSAIKIVDFGSSCQLGQRIYQXIQSRFYR 206
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           SPE  LG  + +  D++S G +++E+ +G+
Sbjct: 207 SPEVLLGMPYDLAIDMWSLGCILVEMHTGE 236

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 4/90 (4%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           LL+L    +L IIH D K  NILL    NPK S   +       Q      + + +  Y 
Sbjct: 170 LLFL-ATPELSIIHCDLKPENILL---CNPKRSAIKIVDFGSSCQLGQRIYQXIQSRFYR 225
Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           SPE  LG  + +  D++S G +++E+ +G+
Sbjct: 226 SPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 44/83 (53%), Gaps = 7/83 (8%)
Query: 23  KLRIIHRDFKTSNILLDHEMNP--KISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL 80
           K RIIH D K  NILL  +     K+ DFG +  +E ++        + +  Y +PE  L
Sbjct: 218 KNRIIHCDLKPENILLKQQGRSGIKVIDFG-SSCYEHQR----VYTXIQSRFYRAPEVIL 272
Query: 81  GGFFSVKSDVFSFGVVVLEIISG 103
           G  + +  D++S G ++ E+++G
Sbjct: 273 GARYGMPIDMWSLGCILAELLTG 295

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 51/95 (53%), Gaps = 6/95 (6%)
Query: 13  RRLLYLHQDSKLRIIHRDFKTSNILLDHE-MNPKISDFGLTRIFEGKQTD-GTTNRVVGT 70
           R L Y+H  +   ++HRD K +N+ ++ E +  KI DFGL RI +   +  G  +  + T
Sbjct: 131 RGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 71  YGYMSPEYALGGFFSVKS-DVFSFGVVVLEIISGK 104
             Y SP   L      K+ D+++ G +  E+++GK
Sbjct: 188 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 47/94 (50%), Gaps = 8/94 (8%)
Query: 13  RRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP-KISDFGLTRIFEGKQTDGTTNRVVGTY 71
           R L Y+H    + I HRD K  N+LLD      K+ DFG  +I    + +   + +   Y
Sbjct: 152 RSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN--VSXICSRY 206
Query: 72  GYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
            Y +PE   G   ++   D++S G V+ E++ G+
Sbjct: 207 -YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 50/103 (48%), Gaps = 17/103 (16%)
Query: 6   NIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP--KISDFGLTR--IFEGKQTD 61
            +I GVS    Y H    +++ HRD K  N LLD    P  KI  FG ++  +   +  D
Sbjct: 123 QLISGVS----YCH---AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKD 175
Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVK-SDVFSFGVVVLEIISG 103
                 VGT  Y++PE  L   +  K +DV+S GV +  ++ G
Sbjct: 176 -----TVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 74/171 (43%), Gaps = 31/171 (18%)
Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDH-----EMNPKISDFGLTRIFE-GKQTDGTTNRVV 68
           L +LH    L I+HRD K  NIL+       ++   ISDFGL +    G+ +    + V 
Sbjct: 131 LAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP 187
Query: 69  GTYGYMSPEY-----ALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYA 122
           GT G+++PE           ++V  D+FS G V   +IS G    G      A  LLG  
Sbjct: 188 GTEGWIAPEMLSEDCKENPTYTV--DIFSAGCVFYYVISEGSHPFGKSLQRQANILLGAC 245
Query: 123 WKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
                   +LD +  +      A E+++ +      +  DP  RP+   V+
Sbjct: 246 --------SLDCLHPEKHEDVIARELIEKM------IAMDPQKRPSAKHVL 282

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 54/113 (47%), Gaps = 22/113 (19%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDH--EMNP-KISDFGLTRIFEGKQTDGT 63
           ++  V+  L +LH      I HRD K  NIL +H  +++P KI DF L     G + +G 
Sbjct: 116 VVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLG---SGIKLNGD 169
Query: 64  TNRV--------VGTYGYMSPEYA-----LGGFFSVKSDVFSFGVVVLEIISG 103
            + +         G+  YM+PE           +  + D++S GV++  ++SG
Sbjct: 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 26/101 (25%), Positives = 50/101 (49%), Gaps = 9/101 (8%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNIL-LDHEMNP---KISDFGLTRIFEGKQTDG 62
           ++  + + + YLH      ++HRD K SNIL +D   NP   +I DFG  +    +  +G
Sbjct: 126 VLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAE--NG 180
Query: 63  TTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
                  T  +++PE      +    D++S G+++  +++G
Sbjct: 181 LLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 41/81 (50%), Gaps = 5/81 (6%)
Query: 26  IIHRDFKTSNILLDHEMN---PKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG 82
           I+HRD K  N+LL  +      K++DFGL    +G Q         GT GY+SPE     
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQ--AWFGFAGTPGYLSPEVLRKD 181
Query: 83  FFSVKSDVFSFGVVVLEIISG 103
            +    D+++ GV++  ++ G
Sbjct: 182 PYGKPVDMWACGVILYILLVG 202

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 50/100 (50%), Gaps = 10/100 (10%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILL--DHEMNP-KISDFGLTRIFEGKQTDGT 63
           I+  V   + Y H   KL + HRD K  N L   D   +P K+ DFGL   F+  +   T
Sbjct: 111 IMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT 167
Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
               VGT  Y+SP+  L G +  + D +S GV++  ++ G
Sbjct: 168 K---VGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 203

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 41/81 (50%), Gaps = 5/81 (6%)
Query: 26  IIHRDFKTSNILLDHEMN---PKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG 82
           I+HRD K  N+LL  +      K++DFGL    +G Q         GT GY+SPE     
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPGYLSPEVLRKD 181
Query: 83  FFSVKSDVFSFGVVVLEIISG 103
            +    D+++ GV++  ++ G
Sbjct: 182 PYGKPVDMWACGVILYILLVG 202

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 50/100 (50%), Gaps = 10/100 (10%)
Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILL--DHEMNP-KISDFGLTRIFEGKQTDGT 63
           I+  V   + Y H   KL + HRD K  N L   D   +P K+ DFGL   F+  +   T
Sbjct: 128 IMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT 184
Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
               VGT  Y+SP+  L G +  + D +S GV++  ++ G
Sbjct: 185 K---VGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 220

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 47/101 (46%), Gaps = 13/101 (12%)
Query: 6   NIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP--KISDFGLTRIFEGKQTDGT 63
            +I GVS    Y H    +++ HRD K  N LLD    P  KI  FG ++          
Sbjct: 123 QLISGVS----YCH---AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSK---SSVLHSQ 172
Query: 64  TNRVVGTYGYMSPEYALGGFFSVK-SDVFSFGVVVLEIISG 103
               VGT  Y++PE  L   +  K +DV+S GV +  ++ G
Sbjct: 173 PKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 69/157 (43%), Gaps = 29/157 (18%)
Query: 26  IIHRDFKTSNILLDHE---MNPKISDFGLTRIFEGKQTDGTTNRV-VGTYGYMSPEYALG 81
           ++HRD K  N+L   E   +  KI DFG  R+   K  D    +    T  Y +PE    
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARL---KPPDNQPLKTPCFTLHYAAPELLNQ 183
Query: 82  GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQ-KPG 140
             +    D++S GV++  ++SG+    F + + +L+             A+++M + K G
Sbjct: 184 NGYDESCDLWSLGVILYTMLSGQ--VPFQSHDRSLTCTS----------AVEIMKKIKKG 231
Query: 141 AISKANEILKCIN-------VGLLCVQEDPNDRPTMS 170
             S   E  K ++        GLL V  DPN R  MS
Sbjct: 232 DFSFEGEAWKNVSQEAKDLIQGLLTV--DPNKRLKMS 266

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 50/113 (44%), Gaps = 14/113 (12%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           +++I+LG       LH   +  ++HRD    NILL    +  I DF L R       D  
Sbjct: 140 MYHILLG-------LHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR---EDTADAN 189
Query: 64  TNRVVGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEIISGK---RNTGFYNS 112
               V    Y +PE  +    F+   D++S G V+ E+ + K   R + FYN 
Sbjct: 190 KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ 242

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 50/113 (44%), Gaps = 14/113 (12%)
Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           +++I+LG       LH   +  ++HRD    NILL    +  I DF L R       D  
Sbjct: 140 MYHILLG-------LHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR---EDTADAN 189
Query: 64  TNRVVGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEIISGK---RNTGFYNS 112
               V    Y +PE  +    F+   D++S G V+ E+ + K   R + FYN 
Sbjct: 190 KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ 242

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	220
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-77
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-76
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-62
3soc_A	322	Activin receptor type-2A; structural genomics cons	6e-57
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-44
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-34
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-33
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	6e-33
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-32
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-32
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-32
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-31
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-29
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-29
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	9e-29
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-28
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-28
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	5e-27
2a19_B	284	Interferon-induced, double-stranded RNA-activated	5e-26
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	7e-26
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-24
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	8e-24
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-23
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	6e-23
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	9e-23
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-22
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	7e-22
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-21
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-21
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-21
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-21
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-21
2dyl_A	318	Dual specificity mitogen-activated protein kinase	6e-21
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-20
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-20
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-20
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	8e-20
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-19
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-19
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-19
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-19
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-19
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-19
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	5e-19
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	6e-19
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	6e-19
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	6e-19
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	7e-19
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	9e-19
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-18
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-18
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-18
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-18
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-18
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-18
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-18
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-18
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-18
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-18
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-18
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-18
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-18
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-18
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-18
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	6e-18
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	7e-18
3pls_A	298	Macrophage-stimulating protein receptor; protein k	8e-18
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	8e-18
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	8e-18
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	8e-18
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-17
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-17
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-17
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-17
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-17
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-17
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-17
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-17
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-17
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-17
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	4e-17
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-17
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	5e-17
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-17
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	5e-17
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	7e-17
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	7e-17
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	9e-17
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	9e-17
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	9e-17
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	9e-17
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	9e-17
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-16
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-16
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-16
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-16
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-16
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-16
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-16
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-16
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-16
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-16
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-16
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-16
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-16
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-16
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-16
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-16
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-16
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-16
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-16
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-16
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	7e-16
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	8e-16
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-15
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-15
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-15
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-15
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-15
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-15
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-15
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-15
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-15
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	5e-15
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	6e-15
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	7e-15
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	8e-15
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	8e-15
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-14
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-14
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-14
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-14
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-14
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-14
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-14
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-14
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-14
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	4e-14
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-14
3o0g_A	292	Cell division protein kinase 5; kinase activator c	5e-14
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	6e-14
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	7e-14
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-13
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-13
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-13
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-13
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-13
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-13
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-13
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-13
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-13
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-13
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-13
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	4e-13
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-13
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-13
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	5e-13
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	6e-13
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	7e-13
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	7e-13
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	7e-13
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	8e-13
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	9e-13
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	9e-13
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	9e-13
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-12
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-12
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-12
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-12
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-12
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-12
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-12
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-12
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-12
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-12
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-12
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-12
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-12
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-12
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-12
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-12
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-12
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-12
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-12
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-12
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-12
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-12
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-12
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	5e-12
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	6e-12
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	7e-12
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-11
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-11
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-11
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-11
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-11
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-11
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-11
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-11
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-11
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-11
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-11
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-11
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	4e-11
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	5e-11
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	5e-11
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	6e-11
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	7e-11
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	7e-11
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-10
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-10
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-10
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-10
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-10
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-09
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-09
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-09
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-08
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-08
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-08
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	5e-08
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	9e-08
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	4e-07
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-05
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-05
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	8e-05
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-04
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-04
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-04
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-04
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	5e-04
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	6e-04
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	7e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	9e-04

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  234 bits (600), Expect = 1e-77
 Identities = 62/178 (34%), Positives = 88/178 (49%), Gaps = 8/178 (4%)

Query: 5   FNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTT 64
             I  G +  + +LH++     IHRD K++NILLD     KISDFGL R  E       T
Sbjct: 136 CKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT 192

Query: 65  NRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWK 124
           +R+VGT  YM+PE  L G  + KSD++SFGVV+LEII+G      +       LL    +
Sbjct: 193 SRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP--QLLLDIKEE 249

Query: 125 LWQEGKAL-DMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEAV 181
           +  E K + D +D+K         +    +V   C+ E  N RP +  V  +L     
Sbjct: 250 IEDEEKTIEDYIDKKMNDADS-TSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  232 bits (593), Expect = 2e-76
 Identities = 71/179 (39%), Positives = 101/179 (56%), Gaps = 3/179 (1%)

Query: 5   FNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTT 64
             I LG +R L YLH     +IIHRD K +NILLD E    + DFGL ++ + K T  TT
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 193

Query: 65  NRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNT--GFYNSELALSLLGYA 122
             V GT G+++PEY   G  S K+DVF +GV++LE+I+G+R        ++  + LL + 
Sbjct: 194 -AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252

Query: 123 WKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEAV 181
             L +E K   ++D       K  E+ + I V LLC Q  P +RP MS+VV ML  + +
Sbjct: 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  196 bits (500), Expect = 2e-62
 Identities = 61/172 (35%), Positives = 91/172 (52%), Gaps = 7/172 (4%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIF-EGKQTDGTTN 65
           I +G +R L YLH  +   IIHRD K+ NILLD    PKI+DFG+++   E  QT  +T 
Sbjct: 144 ICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST- 199

Query: 66  RVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKL 125
            V GT GY+ PEY + G  + KSDV+SFGVV+ E++  +           ++L  +A + 
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259

Query: 126 WQEGKALDMMDQK-PGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
              G+   ++D      I     + K  +  + C+     DRP+M DV+  L
Sbjct: 260 HNNGQLEQIVDPNLADKIRP-ESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  182 bits (463), Expect = 6e-57
 Identities = 50/196 (25%), Positives = 80/196 (40%), Gaps = 24/196 (12%)

Query: 2   EMLFNIILGVSRRLLYLHQD-------SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRI 54
             L +I   ++R L YLH+D        K  I HRD K+ N+LL + +   I+DFGL   
Sbjct: 121 NELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180

Query: 55  FEGKQTDGTTNRVVGTYGYMSPEYALGGF-----FSVKSDVFSFGVVVLEIISGKRNTGF 109
           FE  ++ G T+  VGT  YM+PE   G         ++ D+++ G+V+ E+ S       
Sbjct: 181 FEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240

Query: 110 YNSELALSLLGYAWKLWQEGKALDMMD----QK-----PGAISKANEILKCINVGLLCVQ 160
              E    +L +  ++ Q     DM +    +K          K   +         C  
Sbjct: 241 PVDEY---MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWD 297

Query: 161 EDPNDRPTMSDVVIML 176
            D   R +   V   +
Sbjct: 298 HDAEARLSAGCVGERI 313

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  151 bits (382), Expect = 1e-44
 Identities = 43/219 (19%), Positives = 76/219 (34%), Gaps = 30/219 (13%)

Query: 1   MEMLFNIILGVSRRLLYLHQD------SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRI 54
                 +   V+R L YLH +       K  I HRD  + N+L+ ++    ISDFGL+  
Sbjct: 110 WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR 169

Query: 55  FEG------KQTDGTTNRVVGTYGYMSPEYALGGF-------FSVKSDVFSFGVVVLEII 101
             G       + D      VGT  YM+PE   G            + D+++ G++  EI 
Sbjct: 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

Query: 102 SGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMD----QK-----PGAISKANEILKCI 152
               +       +    + +  ++       DM      +K     P A  + +  ++ +
Sbjct: 230 MRCTDLFPG-ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSL 288

Query: 153 -NVGLLCVQEDPNDRPTMSDVVIMLGSEAVNLASPKRPA 190
                 C  +D   R T       +    +     K  +
Sbjct: 289 KETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVS 327

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  123 bits (312), Expect = 1e-34
 Identities = 46/190 (24%), Positives = 79/190 (41%), Gaps = 20/190 (10%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMN-PKISDFGLTRIFEGKQ 59
                +  L  S+ + YLH      +IHRD K  N+LL       KI DFG     +   
Sbjct: 101 AAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM 160

Query: 60  TDGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLL 119
           T+       G+  +M+PE   G  +S K DVFS+G+++ E+I+ ++    +  E+     
Sbjct: 161 TNNK-----GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK---PF-DEIGGPAF 211

Query: 120 GYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE 179
              W +   G    ++   P  I     ++        C  +DP+ RP+M ++V ++   
Sbjct: 212 RIMWAV-HNGTRPPLIKNLPKPIE---SLMTR------CWSKDPSQRPSMEEIVKIMTHL 261

Query: 180 AVNLASPKRP 189
                    P
Sbjct: 262 MRYFPGADEP 271

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  120 bits (304), Expect = 2e-33
 Identities = 41/176 (23%), Positives = 84/176 (47%), Gaps = 18/176 (10%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
                ++   V++ + YLH      I+HR+ K+ N+L+D +   K+ DFGL+R+     T
Sbjct: 136 ERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA--ST 192

Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLG 120
             ++    GT  +M+PE       + KSDV+SFGV++ E+ + ++    + +   L+   
Sbjct: 193 FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ---PWGN---LNPAQ 246

Query: 121 YAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
               +  + K L++       ++    I++       C   +P  RP+ + ++ +L
Sbjct: 247 VVAAVGFKCKRLEIPRNLNPQVA---AIIE------GCWTNEPWKRPSFATIMDLL 293

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  117 bits (296), Expect = 1e-32
 Identities = 50/184 (27%), Positives = 93/184 (50%), Gaps = 27/184 (14%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP--------KISDFGLT 52
            ++L N  + ++R + YLH ++ + IIHRD K+SNIL+  ++          KI+DFGL 
Sbjct: 104 PDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163

Query: 53  RIFEGKQTDGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNS 112
           R +   +T   +    G Y +M+PE      FS  SDV+S+GV++ E+++G+     +  
Sbjct: 164 REWH--RTTKMSA--AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEV---PFRG 216

Query: 113 ELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
              +  L  A+ +     AL +    P   +   ++++       C   DP+ RP+ +++
Sbjct: 217 ---IDGLAVAYGVAMNKLALPIPSTCPEPFA---KLME------DCWNPDPHSRPSFTNI 264

Query: 173 VIML 176
           +  L
Sbjct: 265 LDQL 268

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  117 bits (295), Expect = 3e-32
 Identities = 42/180 (23%), Positives = 82/180 (45%), Gaps = 19/180 (10%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           M+ L +I    +R + YLH      IIHRD K++NI L  +   KI DFGL         
Sbjct: 119 MKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175

Query: 61  DGTTNRVVGTYGYMSPE---YALGGFFSVKSDVFSFGVVVLEIISGKR-NTGFYNSELAL 116
                ++ G+  +M+PE         +S +SDV++FG+V+ E+++G+   +   N +  +
Sbjct: 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII 235

Query: 117 SLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
            ++G             +        S   + +K   +   C+++  ++RP+   ++  +
Sbjct: 236 EMVGRG----------SLSPDLSKVRSNCPKRMK--RLMAECLKKKRDERPSFPRILAEI 283

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  117 bits (294), Expect = 3e-32
 Identities = 38/183 (20%), Positives = 84/183 (45%), Gaps = 26/183 (14%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLD-----HEMNPKISDFGLTRIF 55
             +   ++L ++  + Y+       I+HRD ++ NI L        +  K++DFGL++  
Sbjct: 121 WSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ- 178

Query: 56  EGKQTDGTTNRVVGTYGYMSPE--YALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSE 113
               +  + + ++G + +M+PE   A    ++ K+D +SF +++  I++G+     +  E
Sbjct: 179 ----SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG---PF-DE 230

Query: 114 LALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
            +   + +   + +EG    + +  P  +     +++      LC   DP  RP  S +V
Sbjct: 231 YSYGKIKFINMIREEGLRPTIPEDCPPRLR---NVIE------LCWSGDPKKRPHFSYIV 281

Query: 174 IML 176
             L
Sbjct: 282 KEL 284

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  114 bits (288), Expect = 4e-31
 Identities = 45/191 (23%), Positives = 72/191 (37%), Gaps = 35/191 (18%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
                +    ++  + YLH    + IIHRD  + N L+    N  ++DFGL R+   ++T
Sbjct: 107 WSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163

Query: 61  DGTTNR------------VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKR--- 105
                R            VVG   +M+PE   G  +  K DVFSFG+V+ EII       
Sbjct: 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP 223

Query: 106 NTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPND 165
           +      +  L++        +           P +       ++C      C   DP  
Sbjct: 224 DYLPRTMDFGLNV--------RGFLDRYCPPNCPPSFFPI--TVRC------C-DLDPEK 266

Query: 166 RPTMSDVVIML 176
           RP+   +   L
Sbjct: 267 RPSFVKLEHWL 277

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  108 bits (273), Expect = 4e-29
 Identities = 35/180 (19%), Positives = 73/180 (40%), Gaps = 28/180 (15%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
                   L ++R + +LH   +  I      + ++++D +M  +IS   +   F+    
Sbjct: 110 QSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR 168

Query: 61  DGTTNRVVGTYGYMSPEYALGG----FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELAL 116
                  +    +++PE AL           +D++SF V++ E+++ +     +     L
Sbjct: 169 -------MYAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVTREV---PFAD---L 214

Query: 117 SLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
           S +    K+  EG    +       +SK   ++K      +C+ EDP  RP    +V +L
Sbjct: 215 SNMEIGMKVALEGLRPTIPPGISPHVSK---LMK------ICMNEDPAKRPKFDMIVPIL 265

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  109 bits (274), Expect = 5e-29
 Identities = 44/196 (22%), Positives = 74/196 (37%), Gaps = 22/196 (11%)

Query: 1   MEMLFNIILGVSRRLLYLHQD-----SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIF 55
                 I+L ++  L +LH +      K  I HRD K+ NIL+       I+D GL  + 
Sbjct: 104 TVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH 163

Query: 56  E--GKQTDGTTNRVVGTYGYMSPE------YALGGFFSVKSDVFSFGVVVLEIISGKRNT 107
                Q D   N  VGT  YM+PE               + D+++FG+V+ E+     + 
Sbjct: 164 SQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSN 223

Query: 108 GFYNSELAL---SLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINV--GLL--CVQ 160
           G    +       ++          K + +  Q+P  I         +     L+  C  
Sbjct: 224 GIVE-DYKPPFYDVVPNDPSFEDMRKVVCVDQQRP-NIPNRWFSDPTLTSLAKLMKECWY 281

Query: 161 EDPNDRPTMSDVVIML 176
           ++P+ R T   +   L
Sbjct: 282 QNPSARLTALRIKKTL 297

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  109 bits (273), Expect = 9e-29
 Identities = 46/200 (23%), Positives = 73/200 (36%), Gaps = 30/200 (15%)

Query: 1   MEMLFNIILGVSRRLLYLHQD-----SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIF 55
            + +  +       L +LH +      K  I HRD K+ NIL+       I+D GL   F
Sbjct: 133 AKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF 192

Query: 56  EG--KQTDGTTNRVVGTYGYMSPEYALGGFFSV-------KSDVFSFGVVVLEIISGKRN 106
                + D   N  VGT  YM PE  L    +         +D++SFG+++ E+     +
Sbjct: 193 ISDTNEVDIPPNTRVGTKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS 251

Query: 107 TGFYNSELALSLLGYAWKLWQEGKALDMMD------QKPGAISKANEILKCIN--VGLL- 157
            G          L Y   +  +    DM +       +P +        +C+     L+ 
Sbjct: 252 GGIVEE----YQLPYHDLVPSDPSYEDMREIVCIKKLRP-SFPNRWSSDECLRQMGKLMT 306

Query: 158 -CVQEDPNDRPTMSDVVIML 176
            C   +P  R T   V   L
Sbjct: 307 ECWAHNPASRLTALRVKKTL 326

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  108 bits (271), Expect = 2e-28
 Identities = 41/188 (21%), Positives = 70/188 (37%), Gaps = 31/188 (16%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           +     I   + + + YLH      I+H+D K+ N+  D      I+DFGL  I    Q 
Sbjct: 129 VNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA 184

Query: 61  DGTTNR---VVGTYGYMSPE---------YALGGFFSVKSDVFSFGVVVLEIISGKRNTG 108
               ++     G   +++PE               FS  SDVF+ G +  E+ +      
Sbjct: 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAR----- 239

Query: 109 FYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPT 168
               E           +WQ G  +     + G   + ++IL        C   +  +RPT
Sbjct: 240 ----EWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILL------FCWAFEQEERPT 289

Query: 169 MSDVVIML 176
            + ++ ML
Sbjct: 290 FTKLMDML 297

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  104 bits (262), Expect = 5e-27
 Identities = 46/201 (22%), Positives = 75/201 (37%), Gaps = 32/201 (15%)

Query: 1   MEMLFNIILGVSRRLLYLHQD-----SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIF 55
           +E +  + L  +  L +LH +      K  I HRD K+ NIL+       I+D GL    
Sbjct: 138 VEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 197

Query: 56  EGKQ--TDGTTNRVVGTYGYMSPEYALGGFFSV-------KSDVFSFGVVVLEIISGKRN 106
           +      D   N  VGT  YM+PE  L    ++       ++D+++ G+V  EI      
Sbjct: 198 DSATDTIDIAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 256

Query: 107 TGFYNSELALSLLGYAWKLWQEGKALDMMD----QK-----PGAISKANEILKCINVGLL 157
            G +        L Y   +  +    +M      QK     P       E L+ +   ++
Sbjct: 257 GGIHEDY----QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQS-CEALRVM-AKIM 310

Query: 158 --CVQEDPNDRPTMSDVVIML 176
             C   +   R T   +   L
Sbjct: 311 RECWYANGAARLTALRIKKTL 331

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  100 bits (252), Expect = 5e-26
 Identities = 44/173 (25%), Positives = 71/173 (41%), Gaps = 33/173 (19%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           +E+   I  G    + Y+H     ++I+RD K SNI L      KI DFGL    +    
Sbjct: 125 LELFEQITKG----VDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK---N 174

Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLG 120
           DG   R  GT  YMSPE      +  + D+++ G+++ E++     T F  S+    L  
Sbjct: 175 DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD-TAFETSKFFTDL-- 231

Query: 121 YAWKLWQEGKALDMMDQKPGAISK-ANEILKCINVGLLCVQEDPNDRPTMSDV 172
                 ++G              K    +L+        + + P DRP  S++
Sbjct: 232 ------RDGI-------ISDIFDKKEKTLLQ------KLLSKKPEDRPNTSEI 265

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  101 bits (253), Expect = 7e-26
 Identities = 41/176 (23%), Positives = 70/176 (39%), Gaps = 35/176 (19%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTN- 65
           I   V     +LH      ++HRD K SNI    +   K+ DFGL    +  + + T   
Sbjct: 173 IAEAVE----FLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 225

Query: 66  ---------RVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELAL 116
                      VGT  YMSPE   G  +S K D+FS G+++ E++    +T      +  
Sbjct: 226 PMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSF-STQMERVRIIT 284

Query: 117 SLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
            +        +  K   +  QK     + + +++        +   P +RP  +D+
Sbjct: 285 DV--------RNLKFPLLFTQKY---PQEHMMVQ------DMLSPSPTERPEATDI 323

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 96.6 bits (241), Expect = 3e-24
 Identities = 40/167 (23%), Positives = 63/167 (37%), Gaps = 31/167 (18%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
            +L     L +LH      ++H D K +NI L      K+ DFGL        T G    
Sbjct: 166 TLLA----LAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG---TAGAGEV 215

Query: 67  VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLW 126
             G   YM+PE  L G +   +DVFS G+ +LE+         +  E            W
Sbjct: 216 QEGDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNMEL--PHGGE-----------GW 261

Query: 127 QEGKALDMMDQKPGAISK-ANEILKCINVGLLCVQEDPNDRPTMSDV 172
           Q+ +   +  +    +S     +L       + ++ DP  R T   +
Sbjct: 262 QQLRQGYLPPEFTAGLSSELRSVLV------MMLEPDPKLRATAEAL 302

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 96.5 bits (240), Expect = 8e-24
 Identities = 52/211 (24%), Positives = 87/211 (41%), Gaps = 38/211 (18%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           + + V + L YL    K +I+HRD K SNIL++     K+ DFG++    G+  D   N 
Sbjct: 136 VSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANS 189

Query: 67  VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK-----RNTGFYNSELALSLLGY 121
            VGT  YMSPE   G  +SV+SD++S G+ ++E+  G+      +           + G 
Sbjct: 190 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 249

Query: 122 AWKLWQEGKALDMMDQKPGAISKAN----EILKCINVGL------------------LCV 159
           A +     +       K G  S+      E+L  I                       C+
Sbjct: 250 AAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCL 309

Query: 160 QEDPNDRPTMSDV-----VIMLGSEAVNLAS 185
            ++P +R  +  +     +    +E V+ A 
Sbjct: 310 IKNPAERADLKQLMVHAFIKRSDAEEVDFAG 340

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 94.4 bits (235), Expect = 3e-23
 Identities = 37/159 (23%), Positives = 67/159 (42%), Gaps = 23/159 (14%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L ++H     +I+HRD K+ NI L  +   ++ DFG+ R+             +GT  Y+
Sbjct: 138 LKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYL 192

Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDM 134
           SPE      ++ KSD+++ G V+ E+ + K    F     A S+     K+   G     
Sbjct: 193 SPEICENKPYNNKSDIWALGCVLYELCTLKH--AFE----AGSMKNLVLKI-ISGS---- 241

Query: 135 MDQKPGAISKA-NEILKCINVGLLCVQEDPNDRPTMSDV 172
                   S     ++          + +P DRP+++ +
Sbjct: 242 FPPVSLHYSYDLRSLVS------QLFKRNPRDRPSVNSI 274

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 92.8 bits (231), Expect = 6e-23
 Identities = 38/177 (21%), Positives = 61/177 (34%), Gaps = 37/177 (20%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           I   V     +LH      ++HRD K SNI    +   K+ DFGL    +  + + T   
Sbjct: 127 IAEAVE----FLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179

Query: 67  V----------VGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELAL 116
                      VGT  YMSPE   G  +S K D+FS G+++ E++       F       
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL-----YPFS----TQ 230

Query: 117 SLLGYAWKLWQEGKALDMMDQKPGAISK-ANEILKCINVGLLCVQEDPNDRPTMSDV 172
                     +  K                  +++        +   P +RP   ++
Sbjct: 231 MERVRTLTDVRNLK----FPPLFTQKYPCEYVMVQ------DMLSPSPMERPEAINI 277

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 91.9 bits (229), Expect = 9e-23
 Identities = 48/161 (29%), Positives = 73/161 (45%), Gaps = 22/161 (13%)

Query: 15  LLYLHQ--DSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYG 72
           L   H+  D    ++HRD K +N+ LD + N K+ DFGL RI     +   T   VGT  
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPY 181

Query: 73  YMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKAL 132
           YMSPE      ++ KSD++S G ++ E+ +      F     A S    A K+ +EGK  
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP--PFT----AFSQKELAGKI-REGK-- 232

Query: 133 DMMDQKPGAISK-ANEILKCINVGLLCVQEDPNDRPTMSDV 172
               + P   S   NEI+         +      RP++ ++
Sbjct: 233 --FRRIPYRYSDELNEIIT------RMLNLKDYHRPSVEEI 265

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 91.2 bits (227), Expect = 3e-22
 Identities = 42/180 (23%), Positives = 66/180 (36%), Gaps = 37/180 (20%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFE---------- 56
           I+  +S    Y+H      IIHRD K  NI +D   N KI DFGL +             
Sbjct: 125 ILEALS----YIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177

Query: 57  --GKQTDGTTNRVVGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSE 113
                +       +GT  Y++ E   G G ++ K D++S G++  E+I           E
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPF----STGME 233

Query: 114 LALSLLGYAWKLWQEGKALDMMDQKPGAISK-ANEILKCINVGLLCVQEDPNDRPTMSDV 172
                     K  +    ++          K   +I++      L +  DPN RP    +
Sbjct: 234 RVN-----ILKKLRSVS-IEFPPDFDDNKMKVEKKIIR------LLIDHDPNKRPGARTL 281

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 91.2 bits (227), Expect = 7e-22
 Identities = 42/182 (23%), Positives = 71/182 (39%), Gaps = 30/182 (16%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           ++ L  ++   +  + YL        IHRD    N L+  +   KISDFG++R       
Sbjct: 212 VKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEA---- 264

Query: 61  DGTTNRVVGTYGY----MSPEYALGGFFSVKSDVFSFGVVVLEIISGKRN--TGFYNSEL 114
           DG      G         +PE    G +S +SDV+SFG+++ E  S   +      N + 
Sbjct: 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT 324

Query: 115 ALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVI 174
              +        ++G  L   +  P A+     ++        C   +P  RP+ S +  
Sbjct: 325 REFV--------EKGGRLPCPELCPDAVF---RLM------EQCWAYEPGQRPSFSTIYQ 367

Query: 175 ML 176
            L
Sbjct: 368 EL 369

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 89.2 bits (222), Expect = 1e-21
 Identities = 34/103 (33%), Positives = 55/103 (53%), Gaps = 11/103 (10%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD-GTTN 65
           I + + + L +LH  SKL +IHRD K SN+L++     K+ DFG++    G   D    +
Sbjct: 114 IAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS----GYLVDDVAKD 167

Query: 66  RVVGTYGYMSPE----YALGGFFSVKSDVFSFGVVVLEIISGK 104
              G   YM+PE          +SVKSD++S G+ ++E+   +
Sbjct: 168 IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 88.8 bits (221), Expect = 2e-21
 Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 4/101 (3%)

Query: 6   NIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT-T 64
            +I    + L + HQ     IIHRD K +NI++      K+ DFG+ R         T T
Sbjct: 120 EVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176

Query: 65  NRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKR 105
             V+GT  Y+SPE A G     +SDV+S G V+ E+++G+ 
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 88.4 bits (220), Expect = 2e-21
 Identities = 34/100 (34%), Positives = 52/100 (52%), Gaps = 4/100 (4%)

Query: 6   NIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTN 65
           N    +   + + H    +RI+HRD K  NIL+D     KI DFG+ +      +   TN
Sbjct: 115 NFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE-TSLTQTN 170

Query: 66  RVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKR 105
            V+GT  Y SPE A G      +D++S G+V+ E++ G+ 
Sbjct: 171 HVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEP 210

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 88.9 bits (221), Expect = 2e-21
 Identities = 42/159 (26%), Positives = 74/159 (46%), Gaps = 20/159 (12%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L ++H     R++HRD K +N+ +      K+ D GL R F  K T   +  +VGT  YM
Sbjct: 149 LEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 203

Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDM 134
           SPE      ++ KSD++S G ++ E+ + +    FY     ++L      L ++ +  D 
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEMAALQS--PFYGD--KMNLYS----LCKKIEQCDY 255

Query: 135 MDQKPGAISKA-NEILKCINVGLLCVQEDPNDRPTMSDV 172
                   S+   +++       +C+  DP  RP ++ V
Sbjct: 256 PPLPSDHYSEELRQLVN------MCINPDPEKRPDVTYV 288

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 87.8 bits (218), Expect = 6e-21
 Identities = 33/104 (31%), Positives = 53/104 (50%), Gaps = 12/104 (11%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD-GTTN 65
           + + + + L YL    K  +IHRD K SNILLD     K+ DFG      G+  D    +
Sbjct: 129 MTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFG----ISGRLVDDKAKD 182

Query: 66  RVVGTYGYMSPE-----YALGGFFSVKSDVFSFGVVVLEIISGK 104
           R  G   YM+PE           + +++DV+S G+ ++E+ +G+
Sbjct: 183 RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 88.3 bits (219), Expect = 1e-20
 Identities = 44/185 (23%), Positives = 67/185 (36%), Gaps = 43/185 (23%)

Query: 6   NIILGVSRRLLYLHQDSKLRIIHRDFKTSNILL-----DHEMNPKISDFGLTRIFE-GKQ 59
            ++   +  L +LH    L I+HRD K  NIL+       ++   ISDFGL +    G+ 
Sbjct: 122 TLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178

Query: 60  TDGTTNRVVGTYGYMSPEYALGGFF---SVKSDVFSFGVVVLEIISG---------KRNT 107
           +    + V GT G+++PE          +   D+FS G V   +IS          +R  
Sbjct: 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA 238

Query: 108 GFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRP 167
                  +L  L          + L               I K I +       DP  RP
Sbjct: 239 NILLGACSLDCLHPEKHEDVIAREL---------------IEKMIAM-------DPQKRP 276

Query: 168 TMSDV 172
           +   V
Sbjct: 277 SAKHV 281

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 86.9 bits (216), Expect = 1e-20
 Identities = 26/101 (25%), Positives = 43/101 (42%), Gaps = 6/101 (5%)

Query: 6   NIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQTDGTT 64
            I+  +   L   H        HRD K  NIL+  +    + DFG+     + K T    
Sbjct: 138 AIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT--QL 192

Query: 65  NRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKR 105
              VGT  YM+PE       + ++D+++   V+ E ++G  
Sbjct: 193 GNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSP 233

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 87.0 bits (216), Expect = 1e-20
 Identities = 38/103 (36%), Positives = 54/103 (52%), Gaps = 11/103 (10%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           I L   + L +L     L+IIHRD K SNILLD   N K+ DFG++    G+  D     
Sbjct: 130 ITLATVKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGIS----GQLVDSIAKT 183

Query: 67  V-VGTYGYMSPE----YALGGFFSVKSDVFSFGVVVLEIISGK 104
              G   YM+PE     A    + V+SDV+S G+ + E+ +G+
Sbjct: 184 RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 86.4 bits (214), Expect = 8e-20
 Identities = 23/99 (23%), Positives = 42/99 (42%), Gaps = 11/99 (11%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
            +L +   L YLH    + +++ D K  NI+L  E   K+ D G            +   
Sbjct: 187 YLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVS------RINSFGY 236

Query: 67  VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKR 105
           + GT G+ +PE    G  +V +D+++ G  +  +     
Sbjct: 237 LYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLP 274

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 84.4 bits (209), Expect = 1e-19
 Identities = 32/158 (20%), Positives = 60/158 (37%), Gaps = 21/158 (13%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNP-KISDFGLTRIFEGKQTDGTTNR---VVGT 70
           L YLH     RI+H D K  N+LL  + +   + DFG     +      +      + GT
Sbjct: 163 LEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219

Query: 71  YGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGK 130
             +M+PE  +G     K D++S   ++L +++G      Y             K+  E  
Sbjct: 220 ETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC------LKIASEPP 273

Query: 131 ALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPT 168
               + + P + +               ++++P  R +
Sbjct: 274 P---IREIPPSCAPL-----TAQAIQEGLRKEPVHRAS 303

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 85.2 bits (211), Expect = 1e-19
 Identities = 40/178 (22%), Positives = 74/178 (41%), Gaps = 23/178 (12%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
             +L  +   +S  + YL    K   IHR+    N L+      K++DFGL+R+  G   
Sbjct: 317 AVVLLYMATQISSAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373

Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRN--TGFYNSELALSL 118
                       + +PE      FS+KSDV++FGV++ EI +   +   G   S++   L
Sbjct: 374 TAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 432

Query: 119 LGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
                   ++   ++  +  P  +           +   C Q +P+DRP+ +++    
Sbjct: 433 --------EKDYRMERPEGCPEKVY---------ELMRACWQWNPSDRPSFAEIHQAF 473

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 83.9 bits (208), Expect = 2e-19
 Identities = 38/198 (19%), Positives = 65/198 (32%), Gaps = 47/198 (23%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           +  L      +   + YLH       IHRD    N+LLD++   KI DFGL +       
Sbjct: 133 LAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP---- 185

Query: 61  DGTTNRVVGTYG-----YMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELA 115
           +G     V   G     + +PE      F   SDV+SFGV + E+++             
Sbjct: 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT------------- 232

Query: 116 LSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVG-----------------LLC 158
                +             +            + + +  G                   C
Sbjct: 233 -----HCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNC 287

Query: 159 VQEDPNDRPTMSDVVIML 176
            + + + RPT  +++ +L
Sbjct: 288 WETEASFRPTFENLIPIL 305

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 83.2 bits (206), Expect = 4e-19
 Identities = 40/169 (23%), Positives = 65/169 (38%), Gaps = 29/169 (17%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           +  +HQ     I+H D K +N L+  +   K+ DFG+    +   T    +  VGT  YM
Sbjct: 121 VHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176

Query: 75  SPE-----------YALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAW 123
            PE                  S KSDV+S G ++  +  GK  T F      +S L    
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQIINQISKL---H 231

Query: 124 KLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
            +      ++     P    K        +V   C++ DP  R ++ ++
Sbjct: 232 AIIDPNHEIEF----PDIPEKD-----LQDVLKCCLKRDPKQRISIPEL 271

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 82.7 bits (205), Expect = 4e-19
 Identities = 37/186 (19%), Positives = 70/186 (37%), Gaps = 29/186 (15%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
                + + + + YL      + +HRD    N+L++ E   KI DFGLT+  E       
Sbjct: 128 QLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE----TDK 180

Query: 64  TNRVVGTYG-----YMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALS 117
               V         + +PE  +   F + SDV+SFGV + E+++    ++      L + 
Sbjct: 181 EYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMI 240

Query: 118 LLGYAW-------KLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMS 170
              +            +EGK L      P  +           +   C +  P++R +  
Sbjct: 241 GPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVY---------QLMRKCWEFQPSNRTSFQ 291

Query: 171 DVVIML 176
           +++   
Sbjct: 292 NLIEGF 297

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 82.4 bits (204), Expect = 4e-19
 Identities = 35/156 (22%), Positives = 64/156 (41%), Gaps = 23/156 (14%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEM-NPKISDFGLTRIFEGKQTDGTTNRVVGTYGY 73
           L +LH  +   IIHRD K  NI +     + KI D GL  +    +       V+GT  +
Sbjct: 142 LQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEF 196

Query: 74  MSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALD 133
           M+PE      +    DV++FG+ +LE+ + +       +   +                 
Sbjct: 197 MAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV------------- 242

Query: 134 MMDQKPGAISK-ANEILKCINVGLLCVQEDPNDRPT 168
               KP +  K A   +K   +   C++++ ++R +
Sbjct: 243 TSGVKPASFDKVAIPEVK--EIIEGCIRQNKDERYS 276

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 82.4 bits (204), Expect = 5e-19
 Identities = 40/169 (23%), Positives = 65/169 (38%), Gaps = 29/169 (17%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           +  +HQ     I+H D K +N L+  +   K+ DFG+    +   T    +  VGT  YM
Sbjct: 140 VHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 195

Query: 75  SPE-----------YALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAW 123
            PE                  S KSDV+S G ++  +  GK  T F      +S L    
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQIINQISKL---H 250

Query: 124 KLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
            +      ++     P    K        +V   C++ DP  R ++ ++
Sbjct: 251 AIIDPNHEIEF----PDIPEKD-----LQDVLKCCLKRDPKQRISIPEL 290

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 83.3 bits (206), Expect = 6e-19
 Identities = 43/179 (24%), Positives = 82/179 (45%), Gaps = 25/179 (13%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           +  L ++   ++  + Y+    ++  +HRD + +NIL+   +  K++DFGL R+ E  + 
Sbjct: 279 LPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335

Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRN--TGFYNSELALSL 118
                       + +PE AL G F++KSDV+SFG+++ E+ +  R    G  N E+   +
Sbjct: 336 TARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 394

Query: 119 L-GYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
             GY             M   P      ++++        C +++P +RPT   +   L
Sbjct: 395 ERGY------------RMPCPPECPESLHDLM------CQCWRKEPEERPTFEYLQAFL 435

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 83.4 bits (206), Expect = 6e-19
 Identities = 41/178 (23%), Positives = 83/178 (46%), Gaps = 23/178 (12%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           +  L ++   ++  + Y+    ++  +HRD + +NIL+   +  K++DFGL R+ E  + 
Sbjct: 362 LPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418

Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRN--TGFYNSELALSL 118
                       + +PE AL G F++KSDV+SFG+++ E+ +  R    G  N E+   +
Sbjct: 419 TARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 477

Query: 119 LGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
                   + G  +    + P ++          ++   C +++P +RPT   +   L
Sbjct: 478 --------ERGYRMPCPPECPESLH---------DLMCQCWRKEPEERPTFEYLQAFL 518

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 82.9 bits (205), Expect = 6e-19
 Identities = 39/169 (23%), Positives = 64/169 (37%), Gaps = 29/169 (17%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           +  +HQ     I+H D K +N L+  +   K+ DFG+    +   T    +  VG   YM
Sbjct: 168 VHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYM 223

Query: 75  SPE-----------YALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAW 123
            PE                  S KSDV+S G ++  +  GK  T F      +S L    
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQIINQISKL---H 278

Query: 124 KLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
            +      ++     P    K        +V   C++ DP  R ++ ++
Sbjct: 279 AIIDPNHEIEF----PDIPEKD-----LQDVLKCCLKRDPKQRISIPEL 318

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 83.2 bits (206), Expect = 7e-19
 Identities = 45/180 (25%), Positives = 84/180 (46%), Gaps = 27/180 (15%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           +  L +    ++  + ++    +   IHRD + +NIL+   +  KI+DFGL R+ E    
Sbjct: 283 LPKLIDFSAQIAEGMAFI---EQRNYIHRDLRAANILVSASLVCKIADFGLARVIED--- 336

Query: 61  DGTTNRVVGTYGY--MSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKR-NTGFYNSELAL 116
           +  T R    +     +PE    G F++KSDV+SFG++++EI++ G+    G  N E+  
Sbjct: 337 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR 396

Query: 117 SLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
           +L        + G  +   +  P  +          N+ + C +  P +RPT   +  +L
Sbjct: 397 AL--------ERGYRMPRPENCPEELY---------NIMMRCWKNRPEERPTFEYIQSVL 439

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 81.5 bits (202), Expect = 9e-19
 Identities = 45/181 (24%), Positives = 73/181 (40%), Gaps = 29/181 (16%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
            + L  +   V   + YL      + +HRD    N L++ +   K+SDFGL+R       
Sbjct: 119 TQQLLEMCKDVCEAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL---- 171

Query: 61  DGTTNRVVGT---YGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRN--TGFYNSELA 115
           D      VG+     +  PE  +   FS KSD+++FGV++ EI S  +     F NSE A
Sbjct: 172 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA 231

Query: 116 LSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIM 175
             +         +G  L         +     I+        C  E  ++RPT   ++  
Sbjct: 232 EHI--------AQGLRLYRPHLASEKV---YTIM------YSCWHEKADERPTFKILLSN 274

Query: 176 L 176
           +
Sbjct: 275 I 275

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 81.7 bits (202), Expect = 1e-18
 Identities = 43/198 (21%), Positives = 70/198 (35%), Gaps = 46/198 (23%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
              L      + + + YL      R IHRD  T NIL+++E   KI DFGLT++      
Sbjct: 144 HIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLP---- 196

Query: 61  DGTTNRVVGTYG-----YMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELA 115
                  V   G     + +PE      FSV SDV+SFGVV+ E+ +    +    +E  
Sbjct: 197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF- 255

Query: 116 LSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVG-----------------LLC 158
                           + M+            +++ +                      C
Sbjct: 256 ----------------MRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTEC 299

Query: 159 VQEDPNDRPTMSDVVIML 176
              + N RP+  D+ + +
Sbjct: 300 WNNNVNQRPSFRDLALRV 317

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 81.1 bits (201), Expect = 1e-18
 Identities = 43/180 (23%), Positives = 76/180 (42%), Gaps = 27/180 (15%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
             +L  +   +S  + YL    K   IHRD    N L+      K++DFGL+R+  G   
Sbjct: 110 AVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--- 163

Query: 61  DGTTNRVVGTYGY--MSPEYALGGFFSVKSDVFSFGVVVLEIISGKRN--TGFYNSELAL 116
           D  T      +     +PE      FS+KSDV++FGV++ EI +   +   G   S++  
Sbjct: 164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 223

Query: 117 SLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
            L        ++   ++  +  P  +           +   C Q +P+DRP+ +++    
Sbjct: 224 LL--------EKDYRMERPEGCPEKVY---------ELMRACWQWNPSDRPSFAEIHQAF 266

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 81.1 bits (201), Expect = 1e-18
 Identities = 49/193 (25%), Positives = 88/193 (45%), Gaps = 34/193 (17%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           +  + +I   ++  ++YL   +    +HRD  T N L+   +  KI DFG++R      T
Sbjct: 132 LSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVY--ST 186

Query: 61  DGTTNRVVGTYG-----YMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKR-NTGFYNSE 113
           D      VG +      +M PE  +   F+ +SDV+SFGV++ EI + GK+      N+E
Sbjct: 187 DYYR---VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE 243

Query: 114 LALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
           + +  +        +G+ L+     P  +          +V L C Q +P  R  + ++ 
Sbjct: 244 V-IECI-------TQGRVLERPRVCPKEVY---------DVMLGCWQREPQQRLNIKEIY 286

Query: 174 IMLGSEAVNLASP 186
            +L   A+  A+P
Sbjct: 287 KIL--HALGKATP 297

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 80.8 bits (200), Expect = 1e-18
 Identities = 43/198 (21%), Positives = 70/198 (35%), Gaps = 46/198 (23%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
              L      + + + YL      R IHRD  T NIL+++E   KI DFGLT++      
Sbjct: 113 HIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLP---- 165

Query: 61  DGTTNRVVGTYG-----YMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELA 115
                  V   G     + +PE      FSV SDV+SFGVV+ E+ +    +    +E  
Sbjct: 166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF- 224

Query: 116 LSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVG-----------------LLC 158
                           + M+            +++ +                      C
Sbjct: 225 ----------------MRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTEC 268

Query: 159 VQEDPNDRPTMSDVVIML 176
              + N RP+  D+ + +
Sbjct: 269 WNNNVNQRPSFRDLALRV 286

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 81.6 bits (202), Expect = 2e-18
 Identities = 48/184 (26%), Positives = 76/184 (41%), Gaps = 34/184 (18%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQ 59
            + L +    ++R + YL   +  + IHRD    N+L+      KI+DFGL R I     
Sbjct: 202 FKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID- 257

Query: 60  TDGTTNRVVGTYG-----YMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRN--TGFYNS 112
                     T G     +M+PE      ++ +SDV+SFGV++ EI +   +   G    
Sbjct: 258 -----YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312

Query: 113 ELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
           EL   LL       +EG     MD+     ++   ++        C    P+ RPT   +
Sbjct: 313 EL-FKLL-------KEGH---RMDKPANCTNELYMMM------RDCWHAVPSQRPTFKQL 355

Query: 173 VIML 176
           V  L
Sbjct: 356 VEDL 359

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 80.3 bits (199), Expect = 2e-18
 Identities = 46/181 (25%), Positives = 74/181 (40%), Gaps = 29/181 (16%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
              L  +   V   + +L      + IHRD    N L+D ++  K+SDFG+TR       
Sbjct: 103 PSQLLEMCYDVCEGMAFL---ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVL---- 155

Query: 61  DGTTNRVVGT---YGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRN--TGFYNSELA 115
           D      VGT     + +PE      +S KSDV++FG+++ E+ S  +     + NSE+ 
Sbjct: 156 DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV 215

Query: 116 LSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIM 175
           L +         +G  L         I    +I+        C  E P  RPT   ++  
Sbjct: 216 LKV--------SQGHRLYRPHLASDTI---YQIM------YSCWHELPEKRPTFQQLLSS 258

Query: 176 L 176
           +
Sbjct: 259 I 259

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 80.3 bits (199), Expect = 2e-18
 Identities = 49/181 (27%), Positives = 70/181 (38%), Gaps = 29/181 (16%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
            E L  + L V   + YL    +  +IHRD    N L+      K+SDFG+TR       
Sbjct: 103 AETLLGMCLDVCEGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL---- 155

Query: 61  DGTTNRVVGT---YGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRN--TGFYNSELA 115
           D       GT     + SPE      +S KSDV+SFGV++ E+ S  +       NSE+ 
Sbjct: 156 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV 215

Query: 116 LSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIM 175
             +          G  L         +           +   C +E P DRP  S ++  
Sbjct: 216 EDI--------STGFRLYKPRLASTHVY---------QIMNHCWRERPEDRPAFSRLLRQ 258

Query: 176 L 176
           L
Sbjct: 259 L 259

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 81.2 bits (201), Expect = 2e-18
 Identities = 48/184 (26%), Positives = 75/184 (40%), Gaps = 34/184 (18%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQ 59
            + L +    ++R + YL   +  + IHRD    N+L+      KI+DFGL R I     
Sbjct: 156 FKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDY 212

Query: 60  TDGTTN-----RVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRN--TGFYNS 112
              TTN     +      +M+PE      ++ +SDV+SFGV++ EI +   +   G    
Sbjct: 213 YKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266

Query: 113 ELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
           EL   LL       +EG  +D        +           +   C    P+ RPT   +
Sbjct: 267 EL-FKLL-------KEGHRMDKPANCTNELY---------MMMRDCWHAVPSQRPTFKQL 309

Query: 173 VIML 176
           V  L
Sbjct: 310 VEDL 313

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 80.4 bits (199), Expect = 2e-18
 Identities = 44/184 (23%), Positives = 75/184 (40%), Gaps = 32/184 (17%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           ++ L    L V++ + YL   +  + +HRD    N +LD +   K++DFGL R       
Sbjct: 127 VKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY---- 179

Query: 61  DGTTNRVVGTYG------YMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRN-TGFYNS 112
           D     V    G      +M+ E      F+ KSDV+SFGV++ E+++ G          
Sbjct: 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 239

Query: 113 ELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
           ++    L        +G+ L   +  P  +           V L C       RP+ S++
Sbjct: 240 DI-TVYL-------LQGRRLLQPEYCPDPLY---------EVMLKCWHPKAEMRPSFSEL 282

Query: 173 VIML 176
           V  +
Sbjct: 283 VSRI 286

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 80.9 bits (200), Expect = 2e-18
 Identities = 29/100 (29%), Positives = 45/100 (45%), Gaps = 12/100 (12%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           ++   S    Y+H  ++  I HRD K SNIL+D     K+SDFG +        D     
Sbjct: 160 VLNSFS----YIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV----DKKIKG 209

Query: 67  VVGTYGYMSPEYALG--GFFSVKSDVFSFGVVVLEIISGK 104
             GTY +M PE+      +   K D++S G+ +  +    
Sbjct: 210 SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 80.8 bits (200), Expect = 2e-18
 Identities = 51/184 (27%), Positives = 79/184 (42%), Gaps = 34/184 (18%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQ 59
           +  L  +   V+  ++YL   + L  +HRD  T N L+   +  KI DFG++R I+    
Sbjct: 157 LGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS--- 210

Query: 60  TDGTTNRVVGTYG-----YMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKR-NTGFYNS 112
           TD      VG        +M PE  L   F+ +SDV+SFGVV+ EI + GK+      N+
Sbjct: 211 TDYYR---VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT 267

Query: 113 ELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
           E              +G+ L+     P  +           +   C Q +P  R ++ DV
Sbjct: 268 EA--------IDCITQGRELERPRACPPEVY---------AIMRGCWQREPQQRHSIKDV 310

Query: 173 VIML 176
              L
Sbjct: 311 HARL 314

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 79.9 bits (198), Expect = 3e-18
 Identities = 48/181 (26%), Positives = 85/181 (46%), Gaps = 29/181 (16%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           +  L ++   ++  + ++    +   IHRD + +NIL+   ++ KI+DFGL R+ E    
Sbjct: 108 INKLLDMAAQIAEGMAFI---EERNYIHRDLRAANILVSDTLSCKIADFGLARLIE---- 160

Query: 61  DGTTNRVVGT---YGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRN--TGFYNSELA 115
           D       G      + +PE    G F++KSDV+SFG+++ EI++  R    G  N E+ 
Sbjct: 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 220

Query: 116 LSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIM 175
            +L        + G  +   D  P  +    +++       LC +E P DRPT   +  +
Sbjct: 221 QNL--------ERGYRMVRPDNCPEEL---YQLM------RLCWKERPEDRPTFDYLRSV 263

Query: 176 L 176
           L
Sbjct: 264 L 264

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 80.5 bits (199), Expect = 4e-18
 Identities = 51/231 (22%), Positives = 77/231 (33%), Gaps = 55/231 (23%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
              L      + + + YL      R +HRD    NIL++ E + KI+DFGL ++      
Sbjct: 126 ASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLP---- 178

Query: 61  DGTTNRVVGTYG-----YMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELA 115
                 VV   G     + +PE      FS +SDV+SFGVV+ E+ +             
Sbjct: 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT------------- 225

Query: 116 LSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVG-----------------LLC 158
                Y  K          M      +   + +L+ +  G                  LC
Sbjct: 226 -----YCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLC 280

Query: 159 VQEDPNDRPTMSDVVIMLGSEAVNLASPKRPAFVVRRGSSSSASTSNKPES 209
               P DRP+ S +   L          +  AF        +A    K  S
Sbjct: 281 WAPSPQDRPSFSALGPQLDMLWSGSRGCETHAF--------TAHPEGKHHS 323

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 80.5 bits (199), Expect = 4e-18
 Identities = 57/209 (27%), Positives = 87/209 (41%), Gaps = 25/209 (11%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           +  L  ++ G++  + YL   S +  +HRD    NIL++  +  K+SDFGL R+ E    
Sbjct: 146 VIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE-DDP 201

Query: 61  DGTTNRVVGTYGY--MSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRN-TGFYNSELAL 116
           +       G       SPE      F+  SDV+S+G+V+ E++S G+R      N +   
Sbjct: 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD--- 258

Query: 117 SLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
                  K   EG  L      P A+           + L C Q+D N+RP    +V +L
Sbjct: 259 -----VIKAVDEGYRLPPPMDCPAALY---------QLMLDCWQKDRNNRPKFEQIVSIL 304

Query: 177 GSEAVNLASPKRPAFVVRRGSSSSASTSN 205
                N  S K       R S+     SN
Sbjct: 305 DKLIRNPGSLKIITSAAARPSNLLLDQSN 333

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 79.6 bits (197), Expect = 5e-18
 Identities = 44/183 (24%), Positives = 81/183 (44%), Gaps = 32/183 (17%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
                +++  ++  + YL   S   ++H+D  T N+L+  ++N KISD GL R       
Sbjct: 127 PPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVY--AA 181

Query: 61  DGTTNRVVGTYG-----YMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRN-TGFYNSE 113
           D      +         +M+PE  + G FS+ SD++S+GVV+ E+ S G +   G+ N +
Sbjct: 182 DYYK---LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 238

Query: 114 LALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
           + + ++       +  + L   D  P  +           + + C  E P+ RP   D+ 
Sbjct: 239 V-VEMI-------RNRQVLPCPDDCPAWVY---------ALMIECWNEFPSRRPRFKDIH 281

Query: 174 IML 176
             L
Sbjct: 282 SRL 284

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 80.2 bits (198), Expect = 6e-18
 Identities = 43/180 (23%), Positives = 77/180 (42%), Gaps = 24/180 (13%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           ++ L    L V++ + +L   +  + +HRD    N +LD +   K++DFGL R    K+ 
Sbjct: 191 VKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247

Query: 61  DGTTNRVVGTY--GYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRN-TGFYNSELAL 116
           D   N+        +M+ E      F+ KSDV+SFGV++ E+++ G          ++  
Sbjct: 248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-T 306

Query: 117 SLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
             L        +G+ L   +  P  +           V L C       RP+ S++V  +
Sbjct: 307 VYL-------LQGRRLLQPEYCPDPLY---------EVMLKCWHPKAEMRPSFSELVSRI 350

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 78.9 bits (195), Expect = 7e-18
 Identities = 41/157 (26%), Positives = 68/157 (43%), Gaps = 22/157 (14%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLD-HEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGY 73
           L YLH +   +I+HRD K  N+L++ +    KISDFG ++   G      T    GT  Y
Sbjct: 135 LKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQY 189

Query: 74  MSPEYALGGF--FSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKA 131
           M+PE    G   +   +D++S G  ++E+ +GK          A         +++ G  
Sbjct: 190 MAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA--------MFKVGMF 241

Query: 132 LDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPT 168
             +  + P ++S            L C + DP+ R  
Sbjct: 242 -KVHPEIPESMSAE-----AKAFILKCFEPDPDKRAC 272

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 79.2 bits (196), Expect = 8e-18
 Identities = 42/180 (23%), Positives = 74/180 (41%), Gaps = 24/180 (13%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           ++ L +  L V+R + YL   ++ + +HRD    N +LD     K++DFGL R    ++ 
Sbjct: 123 VKDLISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179

Query: 61  DGTTNRVVGTY--GYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRN--TGFYNSELAL 116
                         + + E      F+ KSDV+SFGV++ E+++            +L  
Sbjct: 180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL-T 238

Query: 117 SLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
             L        +G+ L   +  P ++           V   C + DP  RPT   +V  +
Sbjct: 239 HFL-------AQGRRLPQPEYCPDSLY---------QVMQQCWEADPAVRPTFRVLVGEV 282

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 79.3 bits (196), Expect = 8e-18
 Identities = 56/209 (26%), Positives = 89/209 (42%), Gaps = 27/209 (12%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           +  L  ++ G++  + YL   + +  +HRD    NIL++  +  K+SDFGL+R+ E    
Sbjct: 146 VLQLVGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD-- 200

Query: 61  DGTTNRVVGT---YGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRN-TGFYNSELA 115
              T    G      + +PE      F+  SDV+SFG+V+ E+++ G+R      N E  
Sbjct: 201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-- 258

Query: 116 LSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIM 175
                   K   +G  L      P AI           + + C Q++   RP  +D+V +
Sbjct: 259 ------VMKAINDGFRLPTPMDCPSAIY---------QLMMQCWQQERARRPKFADIVSI 303

Query: 176 LGSEAVNLASPKRPAFVVRRGSSSSASTS 204
           L        S K  A    R S    STS
Sbjct: 304 LDKLIRAPDSLKTLADFDPRVSIRLPSTS 332

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 79.3 bits (196), Expect = 8e-18
 Identities = 47/184 (25%), Positives = 77/184 (41%), Gaps = 34/184 (18%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQ 59
           +  +  +   ++  + YL   +  + +HRD    N ++  +   KI DFG+TR I+E   
Sbjct: 137 LSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 193

Query: 60  TDGTTNRVVGTYGY-----MSPEYALGGFFSVKSDVFSFGVVVLEIISGKRN--TGFYNS 112
                    G  G      MSPE    G F+  SDV+SFGVV+ EI +       G  N 
Sbjct: 194 Y------RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 247

Query: 113 ELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
           ++ L  +        EG  LD  D  P  +           +  +C Q +P  RP+  ++
Sbjct: 248 QV-LRFV-------MEGGLLDKPDNCPDMLF---------ELMRMCWQYNPKMRPSFLEI 290

Query: 173 VIML 176
           +  +
Sbjct: 291 ISSI 294

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 78.8 bits (195), Expect = 8e-18
 Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 12/93 (12%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I G+     YLH     +IIHRD K SN+L+  + + KI+DFG++  F+G   D   + 
Sbjct: 146 LIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS--DALLSN 196

Query: 67  VVGTYGYMSPE---YALGGFFSVKSDVFSFGVV 96
            VGT  +M+PE        F     DV++ GV 
Sbjct: 197 TVGTPAFMAPESLSETRKIFSGKALDVWAMGVT 229

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 79.7 bits (196), Expect = 1e-17
 Identities = 33/102 (32%), Positives = 47/102 (46%), Gaps = 13/102 (12%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLD---HEMNPKISDFGLTRIFEGKQTDGT 63
           I   +     YLH+    RIIHRD K  NI+L      +  KI D G  +  +  +    
Sbjct: 130 ISSALR----YLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE 182

Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKR 105
               VGT  Y++PE      ++V  D +SFG +  E I+G R
Sbjct: 183 ---FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 78.9 bits (195), Expect = 1e-17
 Identities = 49/186 (26%), Positives = 78/186 (41%), Gaps = 38/186 (20%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQ 59
            + L +    V+R + YL   +  + IHRD    N+L+  +   KI+DFGL R I     
Sbjct: 190 SKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 246

Query: 60  TDGTTN-----RVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRN--TGFYNS 112
              TTN     +      +M+PE      ++ +SDV+SFGV++ EI +   +   G    
Sbjct: 247 YKKTTNGRLPVK------WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300

Query: 113 ELALSLL--GYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMS 170
           EL   LL  G+             MD+     ++   ++        C    P+ RPT  
Sbjct: 301 EL-FKLLKEGH------------RMDKPSNCTNELYMMM------RDCWHAVPSQRPTFK 341

Query: 171 DVVIML 176
            +V  L
Sbjct: 342 QLVEDL 347

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 78.5 bits (194), Expect = 2e-17
 Identities = 54/194 (27%), Positives = 82/194 (42%), Gaps = 25/194 (12%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           +  L  ++ GV   + YL   S L  +HRD    N+L+D  +  K+SDFGL+R+ E    
Sbjct: 150 IMQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE-DDP 205

Query: 61  DGTTNRVVGTYGY--MSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRN-TGFYNSELAL 116
           D       G       +PE      FS  SDV+SFGVV+ E+++ G+R      N +   
Sbjct: 206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD--- 262

Query: 117 SLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
                     +EG  L      P A+           + L C  +D   RP  S +V +L
Sbjct: 263 -----VISSVEEGYRLPAPMGCPHALH---------QLMLDCWHKDRAQRPRFSQIVSVL 308

Query: 177 GSEAVNLASPKRPA 190
            +   +  S +  A
Sbjct: 309 DALIRSPESLRATA 322

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 79.3 bits (196), Expect = 2e-17
 Identities = 45/180 (25%), Positives = 72/180 (40%), Gaps = 31/180 (17%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
            + L    L V   + YL        +HRD    N+L+  +   K+SDFGLT+       
Sbjct: 288 GDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK------- 337

Query: 61  DGTTNRVVGTYGY--MSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKR-NTGFYNSELAL 116
           + ++ +  G       +PE      FS KSDV+SFG+++ EI S G+         ++  
Sbjct: 338 EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 397

Query: 117 SLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
            +        ++G  +D  D  P A+          +V   C   D   RPT   +   L
Sbjct: 398 RV--------EKGYKMDAPDGCPPAVY---------DVMKNCWHLDAATRPTFLQLREQL 440

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 79.4 bits (196), Expect = 2e-17
 Identities = 38/98 (38%), Positives = 52/98 (53%), Gaps = 9/98 (9%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           I+ G    L +LHQ     II+RD K  N+LLD + N +ISD GL    E K     T  
Sbjct: 298 IVSG----LEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAV--ELKAGQTKTKG 348

Query: 67  VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
             GT G+M+PE  LG  +    D F+ GV + E+I+ +
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 77.8 bits (192), Expect = 2e-17
 Identities = 38/192 (19%), Positives = 66/192 (34%), Gaps = 50/192 (26%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP----------------- 44
             L +++L V R L Y+H      ++H D K SNI +     P                 
Sbjct: 115 AELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKV 171

Query: 45  --KISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEII 101
             KI D G        Q         G   +++ E     +    K+D+F+  + V+   
Sbjct: 172 MFKIGDLGHVTRISSPQV------EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAA 225

Query: 102 SGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISK-ANEILKCINVGLLCVQ 160
             +           L   G  W   ++G+   +    P  +S+   E+LK      + + 
Sbjct: 226 GAEP----------LPRNGDQWHEIRQGRLPRI----PQVLSQEFTELLK------VMIH 265

Query: 161 EDPNDRPTMSDV 172
            DP  RP+   +
Sbjct: 266 PDPERRPSAMAL 277

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 78.1 bits (193), Expect = 3e-17
 Identities = 52/217 (23%), Positives = 90/217 (41%), Gaps = 45/217 (20%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
            + L +    V+R + YL   S+ + IHRD    NIL+      KI+DFGL+R  E    
Sbjct: 141 SQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE---- 193

Query: 61  DGTTNRVVGTYG-----YMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRN-TGFYNSE 113
                 V  T G     +M+ E      ++  SDV+S+GV++ EI+S G     G   +E
Sbjct: 194 ----VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 249

Query: 114 LALSLL--GYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSD 171
           L    L  GY             +++      +  +++        C +E P +RP+ + 
Sbjct: 250 L-YEKLPQGY------------RLEKPLNCDDEVYDLM------RQCWREKPYERPSFAQ 290

Query: 172 VVIMLG------SEAVNLASPKRPAFVVRRGSSSSAS 202
           +++ L          VN    ++  +     S+  A+
Sbjct: 291 ILVSLNRMLEERKTYVNTTLYEKFTYAGIDCSAEEAA 327

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 77.2 bits (191), Expect = 3e-17
 Identities = 48/181 (26%), Positives = 75/181 (41%), Gaps = 29/181 (16%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           +  L    L + + + YL     +  +HRD    NIL+      K+ DFGL+R  E    
Sbjct: 112 VLTLVLYSLQICKAMAYL---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE---- 164

Query: 61  DGTTNRVVGT---YGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRN-TGFYNSELA 115
           D    +   T     +MSPE      F+  SDV+ F V + EI+S GK+      N +  
Sbjct: 165 DEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD-V 223

Query: 116 LSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIM 175
           + +L       ++G  L   D  P  +           +   C   DP+DRP  +++V  
Sbjct: 224 IGVL-------EKGDRLPKPDLCPPVLY---------TLMTRCWDYDPSDRPRFTELVCS 267

Query: 176 L 176
           L
Sbjct: 268 L 268

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 77.7 bits (192), Expect = 3e-17
 Identities = 45/190 (23%), Positives = 74/190 (38%), Gaps = 43/190 (22%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQ 59
              L +    V++ + +L   +    IHRD    N+LL +    KI DFGL R I     
Sbjct: 163 TRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN--- 216

Query: 60  TDGTTNRVVGTYG-----YMSPEYALGGFFSVKSDVFSFGVVVLEIIS-------GKRNT 107
               +N +V         +M+PE      ++V+SDV+S+G+++ EI S       G    
Sbjct: 217 ---DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV- 272

Query: 108 GFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRP 167
              NS+    L+       ++G  +      P  I          ++   C   +P  RP
Sbjct: 273 ---NSKF-YKLV-------KDGYQMAQPAFAPKNIY---------SIMQACWALEPTHRP 312

Query: 168 TMSDVVIMLG 177
           T   +   L 
Sbjct: 313 TFQQICSFLQ 322

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 78.3 bits (193), Expect = 4e-17
 Identities = 47/197 (23%), Positives = 65/197 (32%), Gaps = 58/197 (29%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP-------------KISDFGLTR 53
           I  GV+    +LH    L+IIHRD K  NIL+                    ISDFGL +
Sbjct: 124 IASGVA----HLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 176

Query: 54  IFEGKQT--DGTTNRVVGTYGYMSPEYALGGFFSV-------KSDVFSFGVVVLEIISG- 103
             +  Q+      N   GT G+ +PE                  D+FS G V   I+S  
Sbjct: 177 KLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG 236

Query: 104 --------KRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVG 155
                    R +       +L  +          +A D+             I + I+  
Sbjct: 237 KHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDL-------------ISQMIDH- 282

Query: 156 LLCVQEDPNDRPTMSDV 172
                 DP  RPT   V
Sbjct: 283 ------DPLKRPTAMKV 293

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 77.3 bits (191), Expect = 4e-17
 Identities = 40/180 (22%), Positives = 78/180 (43%), Gaps = 26/180 (14%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
            + L N  + +++ + YL      R++HRD    N+L+    + KI+DFGL ++      
Sbjct: 116 SQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AE 170

Query: 61  DGTTNRVVGTY--GYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKR-NTGFYNSELAL 116
           +   +   G     +M+ E  L   ++ +SDV+S+GV V E+++ G +   G   SE++ 
Sbjct: 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 230

Query: 117 SLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
            L        ++G+ L         +           +   C   D + RP   +++I  
Sbjct: 231 IL--------EKGERLPQPPICTIDVY---------MIMRKCWMIDADSRPKFRELIIEF 273

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 77.4 bits (191), Expect = 5e-17
 Identities = 46/189 (24%), Positives = 75/189 (39%), Gaps = 44/189 (23%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEG-- 57
                 I   V+  + YL   S+ + +HRD  T N L+   M  KI+DFGL+R I+    
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229

Query: 58  --KQTDGTTNRVVGTYGY------MSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRN-T 107
                +                  M PE      ++ +SDV+++GVV+ EI S G +   
Sbjct: 230 YKADGND-----------AIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278

Query: 108 GFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRP 167
           G  + E+            ++G  L   +  P  +          N+  LC  + P DRP
Sbjct: 279 GMAHEEV--------IYYVRDGNILACPENCPLELY---------NLMRLCWSKLPADRP 321

Query: 168 TMSDVVIML 176
           +   +  +L
Sbjct: 322 SFCSIHRIL 330

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 76.5 bits (189), Expect = 5e-17
 Identities = 45/181 (24%), Positives = 73/181 (40%), Gaps = 29/181 (16%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           +  L      +S  L YL      R +HRD    N+L+      K+ DFGL+R  E    
Sbjct: 115 LASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME---- 167

Query: 61  DGTTNRVVGT---YGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRN-TGFYNSELA 115
           D T  +         +M+PE      F+  SDV+ FGV + EI+  G +   G  N+++ 
Sbjct: 168 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 227

Query: 116 LSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIM 175
             +        + G+ L M    P  +          ++   C   DP+ RP  +++   
Sbjct: 228 GRI--------ENGERLPMPPNCPPTLY---------SLMTKCWAYDPSRRPRFTELKAQ 270

Query: 176 L 176
           L
Sbjct: 271 L 271

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 76.9 bits (190), Expect = 5e-17
 Identities = 50/202 (24%), Positives = 77/202 (38%), Gaps = 69/202 (34%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQ 59
           +E L      V++ + +L   +  + IHRD    NILL  +   KI DFGL R I++   
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK--- 200

Query: 60  TDGTTNRVVGTYG-----YMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSEL 114
                + V          +M+PE      ++++SDV+SFGV++ EI S            
Sbjct: 201 ---DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------------ 245

Query: 115 ALSLLG---YAWKLWQEGKALDMMDQKPGAISKANEILKCINVG---------------- 155
               LG   Y                 PG +    E  + +  G                
Sbjct: 246 ----LGASPY-----------------PG-VKIDEEFCRRLKEGTRMRAPDYTTPEMYQT 283

Query: 156 -LLCVQEDPNDRPTMSDVVIML 176
            L C   +P+ RPT S++V  L
Sbjct: 284 MLDCWHGEPSQRPTFSELVEHL 305

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 76.9 bits (190), Expect = 5e-17
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 3/90 (3%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH      IIHRD K  NILL+ +M+ +I+DFG  ++   +      N  VGT  Y+
Sbjct: 143 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 199

Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           SPE          SD+++ G ++ ++++G 
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGL 229

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 76.6 bits (189), Expect = 7e-17
 Identities = 43/184 (23%), Positives = 74/184 (40%), Gaps = 34/184 (18%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQ 59
           ++ L   ++ ++  + YL   S    +HRD    N +L  +M   ++DFGL++ I+    
Sbjct: 146 LQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYS--- 199

Query: 60  TDGTTNRVVGTYG-----YMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRN-TGFYNS 112
            D       G        +++ E      ++ KSDV++FGV + EI + G     G  N 
Sbjct: 200 GDYYR---QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH 256

Query: 113 ELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
           E+    L         G  L   +     +           +   C + DP DRPT S +
Sbjct: 257 EM-YDYL-------LHGHRLKQPEDCLDELY---------EIMYSCWRTDPLDRPTFSVL 299

Query: 173 VIML 176
            + L
Sbjct: 300 RLQL 303

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 76.6 bits (189), Expect = 7e-17
 Identities = 41/184 (22%), Positives = 76/184 (41%), Gaps = 34/184 (18%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQ 59
           ++ L   ++ ++  + YL   S    IHRD    N +L  +M   ++DFGL+R I+    
Sbjct: 136 LQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYS--- 189

Query: 60  TDGTTNRVVGTYG-----YMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRN--TGFYNS 112
            D       G        +++ E      ++V SDV++FGV + EI++  +    G  N+
Sbjct: 190 GDYYR---QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA 246

Query: 113 ELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
           E+  + L         G  L    +    +          ++   C   DP  RP+ + +
Sbjct: 247 EI-YNYL-------IGGNRLKQPPECMEEVY---------DLMYQCWSADPKQRPSFTCL 289

Query: 173 VIML 176
            + L
Sbjct: 290 RMEL 293

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 77.6 bits (191), Expect = 9e-17
 Identities = 35/101 (34%), Positives = 51/101 (50%), Gaps = 16/101 (15%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           IILG    L ++H      +++RD K +NILLD   + +ISD GL   F         + 
Sbjct: 301 IILG----LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHA 349

Query: 67  VVGTYGYMSPEYALGGF---FSVKSDVFSFGVVVLEIISGK 104
            VGT+GYM+PE    G     S   D FS G ++ +++ G 
Sbjct: 350 SVGTHGYMAPEVLQKGVAYDSSA--DWFSLGCMLFKLLRGH 388

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 76.1 bits (188), Expect = 9e-17
 Identities = 31/100 (31%), Positives = 43/100 (43%), Gaps = 9/100 (9%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I G+     YLH      I+H+D K  N+LL      KIS  G+         D T   
Sbjct: 118 LIDGLE----YLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170

Query: 67  VVGTYGYMSPEYALG--GFFSVKSDVFSFGVVVLEIISGK 104
             G+  +  PE A G   F   K D++S GV +  I +G 
Sbjct: 171 SQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 77.0 bits (189), Expect = 9e-17
 Identities = 16/105 (15%), Positives = 31/105 (29%), Gaps = 9/105 (8%)

Query: 5   FNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTT 64
             + L V R L  LH      ++H   +  +I+LD      ++ F      +G       
Sbjct: 214 LQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR-DGASAVSPI 269

Query: 65  NRVVGTYGYMSPEYALG-----GFFSVKSDVFSFGVVVLEIISGK 104
            R        +              +   D ++ G+ +  I    
Sbjct: 270 GRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 76.5 bits (188), Expect = 9e-17
 Identities = 49/191 (25%), Positives = 81/191 (42%), Gaps = 43/191 (22%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQ 59
           +E L      V++ + +L   +  + IHRD    NILL  +   KI DFGL R I++   
Sbjct: 192 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP- 247

Query: 60  TDGTTNRVVGTYG-----YMSPEYALGGFFSVKSDVFSFGVVVLEIIS-------GKRNT 107
                + V          +M+PE      ++++SDV+SFGV++ EI S       G +  
Sbjct: 248 -----DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI- 301

Query: 108 GFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRP 167
              + E          +  +EG     M        +  + +      L C   +P+ RP
Sbjct: 302 ---DEEF--------CRRLKEGT---RMRAPDYTTPEMYQTM------LDCWHGEPSQRP 341

Query: 168 TMSDVVIMLGS 178
           T S++V  LG+
Sbjct: 342 TFSELVEHLGN 352

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 75.8 bits (187), Expect = 9e-17
 Identities = 46/180 (25%), Positives = 79/180 (43%), Gaps = 25/180 (13%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
            + +  ++  VS  + YL    +   +HRD    N+LL  +   KISDFGL++     + 
Sbjct: 116 DKNIIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE- 171

Query: 61  DGTTNRVVGTY--GYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRN-TGFYNSELAL 116
           +    +  G +   + +PE      FS KSDV+SFGV++ E  S G++   G   SE+  
Sbjct: 172 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA 231

Query: 117 SLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
            L        ++G+ +      P  +          ++  LC   D  +RP  + V + L
Sbjct: 232 ML--------EKGERMGCPAGCPREMY---------DLMNLCWTYDVENRPGFAAVELRL 274

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 75.7 bits (187), Expect = 1e-16
 Identities = 44/180 (24%), Positives = 70/180 (38%), Gaps = 31/180 (17%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
            + L    L V   + YL        +HRD    N+L+  +   K+SDFGLT+       
Sbjct: 116 GDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK------- 165

Query: 61  DGTTNRVVGTYGY--MSPEYALGGFFSVKSDVFSFGVVVLEIISGKRN--TGFYNSELAL 116
           + ++ +  G       +PE      FS KSDV+SFG+++ EI S  R         ++  
Sbjct: 166 EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 225

Query: 117 SLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
            +        ++G  +D  D  P A+           V   C   D   RP+   +   L
Sbjct: 226 RV--------EKGYKMDAPDGCPPAVY---------EVMKNCWHLDAAMRPSFLQLREQL 268

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 76.1 bits (188), Expect = 1e-16
 Identities = 43/184 (23%), Positives = 73/184 (39%), Gaps = 33/184 (17%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQ 59
           +E L +    V++ + +L   +    IHRD    NILL H    KI DFGL R I     
Sbjct: 144 LEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200

Query: 60  TDGTTN-----RVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRN--TGFYNS 112
                N     +      +M+PE      ++ +SDV+S+G+ + E+ S   +   G    
Sbjct: 201 YVVKGNARLPVK------WMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254

Query: 113 ELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
                ++       +EG  +   +  P  +          ++   C   DP  RPT   +
Sbjct: 255 SKFYKMI-------KEGFRMLSPEHAPAEMY---------DIMKTCWDADPLKRPTFKQI 298

Query: 173 VIML 176
           V ++
Sbjct: 299 VQLI 302

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 76.8 bits (189), Expect = 1e-16
 Identities = 44/180 (24%), Positives = 71/180 (39%), Gaps = 27/180 (15%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           +  L      +S  L YL      R +HRD    N+L+      K+ DFGL+R  E    
Sbjct: 490 LASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED--- 543

Query: 61  DGTTNRVVGTY--GYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRN-TGFYNSELAL 116
                   G     +M+PE      F+  SDV+ FGV + EI+  G +   G  N+++  
Sbjct: 544 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 603

Query: 117 SLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
            +        + G+ L M    P  +          ++   C   DP+ RP  +++   L
Sbjct: 604 RI--------ENGERLPMPPNCPPTLY---------SLMTKCWAYDPSRRPRFTELKAQL 646

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 75.7 bits (187), Expect = 2e-16
 Identities = 45/184 (24%), Positives = 83/184 (45%), Gaps = 34/184 (18%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQ 59
           M  L +    +S+ + YL   ++++++HRD    NIL+      KISDFGL+R ++E   
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205

Query: 60  TDGTTN-----RVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRN--TGFYNS 112
               +      +      +M+ E      ++ +SDV+SFGV++ EI++   N   G    
Sbjct: 206 YVKRSQGRIPVK------WMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259

Query: 113 ELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
            L  +LL       + G  ++  D     +           + L C +++P+ RP  +D+
Sbjct: 260 RL-FNLL-------KTGHRMERPDNCSEEMY---------RLMLQCWKQEPDKRPVFADI 302

Query: 173 VIML 176
              L
Sbjct: 303 SKDL 306

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 75.4 bits (186), Expect = 2e-16
 Identities = 43/190 (22%), Positives = 76/190 (40%), Gaps = 27/190 (14%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           +  +  ++  VS  + YL    +   +HRD    N+LL +    KISDFGL++       
Sbjct: 109 VSNVAELLHQVSMGMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG--AD 163

Query: 61  DGTTNRVVGT---YGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRN-TGFYNSELA 115
           D              + +PE      FS +SDV+S+GV + E +S G++        E  
Sbjct: 164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-V 222

Query: 116 LSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIM 175
           ++ +       ++GK ++   + P  +           +   C      DRP    V   
Sbjct: 223 MAFI-------EQGKRMECPPECPPELY---------ALMSDCWIYKWEDRPDFLTVEQR 266

Query: 176 LGSEAVNLAS 185
           + +   +LAS
Sbjct: 267 MRACYYSLAS 276

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 74.9 bits (185), Expect = 2e-16
 Identities = 35/91 (38%), Positives = 48/91 (52%), Gaps = 8/91 (8%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           ++ GV     YLH    + I HRD K  N+LLD   N KISDFGL  +F     +   N+
Sbjct: 114 LMAGVV----YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166

Query: 67  VVGTYGYMSPEYALG-GFFSVKSDVFSFGVV 96
           + GT  Y++PE      F +   DV+S G+V
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIV 197

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 76.5 bits (188), Expect = 2e-16
 Identities = 42/201 (20%), Positives = 76/201 (37%), Gaps = 27/201 (13%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           +  +  ++  VS  + YL    +   +HR+    N+LL +    KISDFGL++       
Sbjct: 435 VSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALG--AD 489

Query: 61  DGTTNRVVGT---YGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRN-TGFYNSELA 115
           D              + +PE      FS +SDV+S+GV + E +S G++        E+ 
Sbjct: 490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM 549

Query: 116 LSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIM 175
             +        ++GK ++   + P  +           +   C      DRP    V   
Sbjct: 550 AFI--------EQGKRMECPPECPPELY---------ALMSDCWIYKWEDRPDFLTVEQR 592

Query: 176 LGSEAVNLASPKRPAFVVRRG 196
           + +   +LAS       +   
Sbjct: 593 MRACYYSLASKVEGGSALEVA 613

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 75.1 bits (185), Expect = 3e-16
 Identities = 46/226 (20%), Positives = 88/226 (38%), Gaps = 40/226 (17%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
            + L N  + +++ + YL      R++HRD    N+L+    + KI+DFGL ++      
Sbjct: 116 SQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AE 170

Query: 61  DGTTNRVVGTY--GYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKR-NTGFYNSELAL 116
           +   +   G     +M+ E  L   ++ +SDV+S+GV V E+++ G +   G   SE++ 
Sbjct: 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 230

Query: 117 SLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
            L        ++G+ L         +           + + C   D + RP   +++I  
Sbjct: 231 IL--------EKGERLPQPPICTIDVY---------MIMVKCWMIDADSRPKFRELIIEF 273

Query: 177 --------------GSEAVNLASPKRPAFVVRRGSSSSASTSNKPE 208
                         G E ++L SP    F                +
Sbjct: 274 SKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDAD 319

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 75.4 bits (185), Expect = 3e-16
 Identities = 17/109 (15%), Positives = 34/109 (31%), Gaps = 24/109 (22%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  ++     LH      ++H   +  +I+LD      ++ F           DG    
Sbjct: 215 VIRLLA----SLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLV------RDGARVV 261

Query: 67  VVGTYGYMSPEYAL-----------GGFFSVKSDVFSFGVVVLEIISGK 104
              + G+  PE                  +   D ++ G+V+  I    
Sbjct: 262 SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 75.0 bits (185), Expect = 3e-16
 Identities = 47/184 (25%), Positives = 71/184 (38%), Gaps = 33/184 (17%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQ 59
            E L      V++ + +L        +HRD    N+L+ H    KI DFGL R I     
Sbjct: 171 FEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227

Query: 60  TDGTTN-----RVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRN--TGFYNS 112
                N     +      +M+PE    G +++KSDV+S+G+++ EI S   N   G    
Sbjct: 228 YVVRGNARLPVK------WMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 281

Query: 113 ELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
                L+       Q G     MDQ   A  +   I+        C   D   RP+  ++
Sbjct: 282 ANFYKLI-------QNGF---KMDQPFYATEEIYIIM------QSCWAFDSRKRPSFPNL 325

Query: 173 VIML 176
              L
Sbjct: 326 TSFL 329

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 74.2 bits (183), Expect = 3e-16
 Identities = 31/90 (34%), Positives = 41/90 (45%), Gaps = 7/90 (7%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L Y H     R+IHRD K  N+LL      KI+DFG +      +         GT  Y+
Sbjct: 122 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-DL---CGTLDYL 174

Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
            PE   G     K D++S GV+  E + GK
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 74.7 bits (184), Expect = 3e-16
 Identities = 35/187 (18%), Positives = 64/187 (34%), Gaps = 39/187 (20%)

Query: 6   NIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTN 65
            ++LG+ R L  +H        HRD K +NILL  E  P + D G               
Sbjct: 138 WLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQA 194

Query: 66  RVV-------GTYGYMSPE------YALGGFFSVKSDVFSFGVVVLEIISGK---RNTGF 109
             +        T  Y +PE      + +      ++DV+S G V+  ++ G+        
Sbjct: 195 LTLQDWAAQRCTISYRAPELFSVQSHCVIDE---RTDVWSLGCVLYAMMFGEGPYDMVFQ 251

Query: 110 YNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTM 169
               +AL++                         + +  L  +   ++    DP+ RP +
Sbjct: 252 KGDSVALAVQN---------------QLSIPQSPRHSSALWQLLNSMM--TVDPHQRPHI 294

Query: 170 SDVVIML 176
             ++  L
Sbjct: 295 PLLLSQL 301

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 74.7 bits (184), Expect = 3e-16
 Identities = 35/91 (38%), Positives = 48/91 (52%), Gaps = 8/91 (8%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           ++ GV     YLH    + I HRD K  N+LLD   N KISDFGL  +F     +   N+
Sbjct: 114 LMAGVV----YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166

Query: 67  VVGTYGYMSPEYALG-GFFSVKSDVFSFGVV 96
           + GT  Y++PE      F +   DV+S G+V
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIV 197

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 75.1 bits (184), Expect = 3e-16
 Identities = 20/167 (11%), Positives = 38/167 (22%), Gaps = 30/167 (17%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
              L       ++H  F   N+ +  +    + D             GT           
Sbjct: 207 AANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW------KVGTRGPASSVPVTY 257

Query: 75  SPEYALGG---FFSVKSDVFSFGVVVLEIISGK-----RNTGFYNSELALSLLGYAWKLW 126
           +P   L      F+   + +  G+ +  +            G   S    SL        
Sbjct: 258 APREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSL 317

Query: 127 QEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
             G    + D           ++       L    D   R    + +
Sbjct: 318 AFGSCTPLPDF-------VKTLIG----RFLNF--DRRRRLLPLEAM 351

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 74.6 bits (184), Expect = 4e-16
 Identities = 36/99 (36%), Positives = 53/99 (53%), Gaps = 11/99 (11%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           I+LG      YLH+    R+IHRD K  N+ L+ ++  KI DFGL    E    DG   +
Sbjct: 150 IVLGCQ----YLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE---YDGERKK 199

Query: 67  VV-GTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           V+ GT  Y++PE       S + DV+S G ++  ++ GK
Sbjct: 200 VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 74.7 bits (184), Expect = 4e-16
 Identities = 37/180 (20%), Positives = 73/180 (40%), Gaps = 26/180 (14%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
            ++L N  + +++ + YL    +  ++HR+    N+LL      +++DFG+  +      
Sbjct: 114 PQLLLNWGVQIAKGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD-- 168

Query: 61  DGTTNRVVGTY--GYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRN-TGFYNSELAL 116
           D             +M+ E    G ++ +SDV+S+GV V E+++ G     G   +E+  
Sbjct: 169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD 228

Query: 117 SLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
            L        ++G+ L         +           V + C   D N RPT  ++    
Sbjct: 229 LL--------EKGERLAQPQICTIDVY---------MVMVKCWMIDENIRPTFKELANEF 271

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 74.7 bits (184), Expect = 4e-16
 Identities = 47/187 (25%), Positives = 69/187 (36%), Gaps = 37/187 (19%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLD---HEMNPKISDFGLTR-IFE 56
           M  L ++   ++    YL    +   IHRD    N LL         KI DFG+ R I+ 
Sbjct: 139 MLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 195

Query: 57  GKQTDGTTNRVVGTYGY-----MSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKR-NTGF 109
                       G         M PE  + G F+ K+D +SFGV++ EI S G       
Sbjct: 196 ASYY------RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 249

Query: 110 YNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTM 169
            N E+ L  +         G  +D     PG +           +   C Q  P DRP  
Sbjct: 250 SNQEV-LEFV-------TSGGRMDPPKNCPGPVY---------RIMTQCWQHQPEDRPNF 292

Query: 170 SDVVIML 176
           + ++  +
Sbjct: 293 AIILERI 299

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 74.7 bits (184), Expect = 4e-16
 Identities = 47/187 (25%), Positives = 69/187 (36%), Gaps = 37/187 (19%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLD---HEMNPKISDFGLTR-IFE 56
           M  L ++   ++    YL    +   IHRD    N LL         KI DFG+ R I+ 
Sbjct: 180 MLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 236

Query: 57  GKQTDGTTNRVVGTYGY-----MSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKR-NTGF 109
                       G         M PE  + G F+ K+D +SFGV++ EI S G       
Sbjct: 237 AGYY------RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 290

Query: 110 YNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTM 169
            N E+ L  +         G  +D     PG +           +   C Q  P DRP  
Sbjct: 291 SNQEV-LEFV-------TSGGRMDPPKNCPGPVY---------RIMTQCWQHQPEDRPNF 333

Query: 170 SDVVIML 176
           + ++  +
Sbjct: 334 AIILERI 340

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 74.4 bits (183), Expect = 5e-16
 Identities = 39/216 (18%), Positives = 73/216 (33%), Gaps = 43/216 (19%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
               V     ++H+  K  IIHRD K  N+LL ++   K+ DFG             + +
Sbjct: 145 TCRAVQ----HMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQ 199

Query: 67  ----------VVGTYGYMSPE---YALGGFFSVKSDVFSFGVVVLEIISGKRNTGFY-NS 112
                        T  Y +PE            K D+++ G ++  +   +    F   +
Sbjct: 200 RRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ--HPFEDGA 257

Query: 113 ELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
           +L +    Y+                P   ++       I      +Q +P +R ++++V
Sbjct: 258 KLRIVNGKYSI---------------PPHDTQYTVFHSLIRA---MLQVNPEERLSIAEV 299

Query: 173 V----IMLGSEAVNLASPKRPAFVVRRGSSSSASTS 204
           V     +  +  VN  SP         G  S+  + 
Sbjct: 300 VHQLQEIAAARNVNPKSPITELLEQNGGYGSATLSR 335

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 74.2 bits (183), Expect = 5e-16
 Identities = 36/99 (36%), Positives = 53/99 (53%), Gaps = 11/99 (11%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           I+LG      YLH+    R+IHRD K  N+ L+ ++  KI DFGL    E    DG   +
Sbjct: 124 IVLGCQ----YLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE---YDGERKK 173

Query: 67  VV-GTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           V+ GT  Y++PE       S + DV+S G ++  ++ GK
Sbjct: 174 VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 74.8 bits (184), Expect = 7e-16
 Identities = 36/99 (36%), Positives = 53/99 (53%), Gaps = 12/99 (12%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTR-IFEGKQTDGTTN 65
           I  G    L  LH   + RI++RD K  NILLD   + +ISD GL   + EG+    T  
Sbjct: 295 ICCG----LEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ----TIK 343

Query: 66  RVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
             VGT GYM+PE      ++   D ++ G ++ E+I+G+
Sbjct: 344 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 73.6 bits (181), Expect = 8e-16
 Identities = 31/92 (33%), Positives = 52/92 (56%), Gaps = 9/92 (9%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR--VVGTYG 72
           L YLH      +IHRD K+ +ILL  +   K+SDFG    F  + +     R  +VGT  
Sbjct: 154 LAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFG----FCAQISKDVPKRKSLVGTPY 206

Query: 73  YMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           +M+PE      ++ + D++S G++V+E++ G+
Sbjct: 207 WMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 73.3 bits (180), Expect = 1e-15
 Identities = 31/192 (16%), Positives = 60/192 (31%), Gaps = 38/192 (19%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILL----DHEMNPKISDFGLTRIFEGKQTDG 62
           ++ G++    +L    +  I+HR+ K  NI+     D +   K++DFG  R  E  +   
Sbjct: 121 VVGGMN----HLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV 173

Query: 63  TTNRVVGTYGYMSPE--------YALGGFFSVKSDVFSFGVVVLEIISGK-----RNTGF 109
           +   + GT  Y+ P+              +    D++S GV      +G           
Sbjct: 174 S---LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230

Query: 110 YNSEL--------ALSLLGYAWKLWQEGKALDMMDQKPGAISK-ANEILKCINVGLLCVQ 160
            N E+            +    K                ++S+    +L  +   +L   
Sbjct: 231 RNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA- 289

Query: 161 EDPNDRPTMSDV 172
            D          
Sbjct: 290 -DQEKCWGFDQF 300

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 72.7 bits (179), Expect = 1e-15
 Identities = 42/183 (22%), Positives = 64/183 (34%), Gaps = 30/183 (16%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           +  L    + V+  + YL      R IHRD    N+LL      KI DFGL R     Q 
Sbjct: 120 LGTLSRYAVQVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP--QN 174

Query: 61  DGTTNRVVGT---YGYMSPEYALGGFFSVKSDVFSFGVVVLEIIS-GKRN-TGFYNSEL- 114
           D            + + +PE      FS  SD + FGV + E+ + G+    G   S++ 
Sbjct: 175 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL 234

Query: 115 -ALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
             +   G              + +          ++      + C    P DRPT   + 
Sbjct: 235 HKIDKEGE------------RLPRPEDCPQDIYNVM------VQCWAHKPEDRPTFVALR 276

Query: 174 IML 176
             L
Sbjct: 277 DFL 279

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 73.2 bits (180), Expect = 1e-15
 Identities = 30/127 (23%), Positives = 49/127 (38%), Gaps = 24/127 (18%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           ++  V     YL       IIHRD K  NI++  +   K+ DFG     E          
Sbjct: 139 LVSAVG----YLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE---RGKLFYT 188

Query: 67  VVGTYGYMSPEYALG-GFFSVKSDVFSFGVV--VL-----------EIISGKRNTGFYNS 112
             GT  Y +PE  +G  +   + +++S GV    L           E +    +  +  S
Sbjct: 189 FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVS 248

Query: 113 ELALSLL 119
           +  +SL+
Sbjct: 249 KELMSLV 255

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 72.2 bits (178), Expect = 2e-15
 Identities = 28/90 (31%), Positives = 43/90 (47%), Gaps = 7/90 (7%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L Y H   + ++IHRD K  N+L+ ++   KI+DFG +      +   T     GT  Y+
Sbjct: 127 LHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR-TM---CGTLDYL 179

Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
            PE   G     K D++  GV+  E + G 
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 72.3 bits (178), Expect = 2e-15
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 9/92 (9%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR--VVGTYG 72
           L +LH +   ++IHRD K+ NILL  + + K++DFG    F  + T   + R  +VGT  
Sbjct: 129 LEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSTMVGTPY 181

Query: 73  YMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           +M+PE      +  K D++S G++ +E+I G+
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 72.6 bits (178), Expect = 3e-15
 Identities = 24/110 (21%), Positives = 45/110 (40%), Gaps = 22/110 (20%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILL----DHEMNPKISDFGLTRIFEGKQTDG 62
           ++ G++    +L    +  I+HR+ K  NI+     D +   K++DFG  R  E  +   
Sbjct: 121 VVGGMN----HLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV 173

Query: 63  TTNRVVGTYGYMSPE--------YALGGFFSVKSDVFSFGVVVLEIISGK 104
           +   + GT  Y+ P+              +    D++S GV      +G 
Sbjct: 174 S---LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 71.4 bits (176), Expect = 3e-15
 Identities = 36/98 (36%), Positives = 50/98 (51%), Gaps = 9/98 (9%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           II G+     YLH      I+HRD   SN+LL   MN KI+DFGL    +       T  
Sbjct: 121 IITGML----YLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-- 171

Query: 67  VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           + GT  Y+SPE A      ++SDV+S G +   ++ G+
Sbjct: 172 LCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 71.9 bits (177), Expect = 4e-15
 Identities = 34/91 (37%), Positives = 46/91 (50%), Gaps = 11/91 (12%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           I+  V     Y HQ    RI+HRD K  N+LLD +MN KI+DFG +  F      G  + 
Sbjct: 123 IVSAVQ----YCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEF---TVGGKLDA 172

Query: 67  VVGTYGYMSPEYALG-GFFSVKSDVFSFGVV 96
             G   Y +PE   G  +   + DV+S GV+
Sbjct: 173 FCGAPPYAAPELFQGKKYDGPEVDVWSLGVI 203

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 71.6 bits (176), Expect = 4e-15
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 9/92 (9%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR--VVGTYG 72
           L YLH     R IHRD K  NILL+ E + K++DFG      G+ TD    R  V+GT  
Sbjct: 138 LEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFG----VAGQLTDTMAKRNTVIGTPF 190

Query: 73  YMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           +M+PE      ++  +D++S G+  +E+  GK
Sbjct: 191 WMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 71.2 bits (175), Expect = 5e-15
 Identities = 43/165 (26%), Positives = 73/165 (44%), Gaps = 37/165 (22%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR--VVGTYG 72
           L YLH +   + IHRD K +N+LL      K++DFG      G+ TD    R   VGT  
Sbjct: 132 LDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFG----VAGQLTDTQIKRNTFVGTPF 184

Query: 73  YMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKAL 132
           +M+PE      +  K+D++S G+  +E+  G+     ++    +             K L
Sbjct: 185 WMAPEVIKQSAYDSKADIWSLGITAIELARGEPP---HSELHPM-------------KVL 228

Query: 133 DMMDQKP-----GAISKA-NEILKCINVGLLCVQEDPNDRPTMSD 171
            ++ +       G  SK   E ++       C+ ++P+ RPT  +
Sbjct: 229 FLIPKNNPPTLEGNYSKPLKEFVE------ACLNKEPSFRPTAKE 267

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 71.6 bits (176), Expect = 6e-15
 Identities = 34/96 (35%), Positives = 46/96 (47%), Gaps = 13/96 (13%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YL      RIIHRD K  NILLD   +  I+DF +  +      +     + GT  YM
Sbjct: 128 LDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR---ETQITTMAGTKPYM 181

Query: 75  SPE-----YALGGFFSVKSDVFSFGVVVLEIISGKR 105
           +PE        G  F+V  D +S GV   E++ G+R
Sbjct: 182 APEMFSSRKGAGYSFAV--DWWSLGVTAYELLRGRR 215

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 71.1 bits (175), Expect = 7e-15
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 8/94 (8%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT---TNRVVGTY 71
           L Y+H++   +I+HRD K +N+L+  +   K++DFGL R F   +       TNRVV T 
Sbjct: 137 LYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV-TL 192

Query: 72  GYMSPEYALGG-FFSVKSDVFSFGVVVLEIISGK 104
            Y  PE  LG   +    D++  G ++ E+ +  
Sbjct: 193 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 70.8 bits (174), Expect = 8e-15
 Identities = 32/187 (17%), Positives = 64/187 (34%), Gaps = 39/187 (20%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP--------KISDFGLT 52
           +     +   ++  + +L    +  +IH +    NILL  E +         K+SD G++
Sbjct: 112 ILWKLEVAKQLAAAMHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS 168

Query: 53  RIFEGKQTDGTTNRVVGTYGYMSPEYAL-GGFFSVKSDVFSFGVVVLEIISGKRN--TGF 109
                   D    R+     ++ PE        ++ +D +SFG  + EI SG     +  
Sbjct: 169 ITVLP--KDILQERI----PWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL 222

Query: 110 YNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTM 169
            +               ++   L        A           N+   C+  +P+ RP+ 
Sbjct: 223 DSQRKLQFY--------EDRHQLPAPKAAELA-----------NLINNCMDYEPDHRPSF 263

Query: 170 SDVVIML 176
             ++  L
Sbjct: 264 RAIIRDL 270

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 71.7 bits (176), Expect = 8e-15
 Identities = 43/176 (24%), Positives = 77/176 (43%), Gaps = 34/176 (19%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILL---DHEMNPKISDFGLTRIFEGKQT 60
           +   +L     + YLH+     I+HRD K  N+LL   + +   KI DFGL+ +FE ++ 
Sbjct: 141 IIKQVLSG---VTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK- 193

Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFY---NSELALS 117
                  +GT  Y++PE  L   +  K DV+S GV++  +++G     F    + E+   
Sbjct: 194 --KMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYP--PFGGQTDQEILRK 248

Query: 118 LLGYAWKLWQEGKALDMMDQKPGAISK-ANEILKCINVGLLCVQEDPNDRPTMSDV 172
           +         +GK       +   +S+ A +++K     +L    D   R +    
Sbjct: 249 VE--------KGK-YTFDSPEWKNVSEGAKDLIK----QMLQF--DSQRRISAQQA 289

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 70.7 bits (174), Expect = 1e-14
 Identities = 31/90 (34%), Positives = 47/90 (52%), Gaps = 6/90 (6%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L +LH     R++HRD K  NIL+      K++DFGL RI+  +     T+ VV T  Y 
Sbjct: 133 LDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVV-TLWYR 186

Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           +PE  L   ++   D++S G +  E+   K
Sbjct: 187 APEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 70.9 bits (174), Expect = 1e-14
 Identities = 34/103 (33%), Positives = 55/103 (53%), Gaps = 13/103 (12%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILL---DHEMNPKISDFGLTRIFEGKQT 60
           +   +L     + Y+H+    +I+HRD K  N+LL     + N +I DFGL+  FE  + 
Sbjct: 131 IIRQVLSG---ITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK- 183

Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
                  +GT  Y++PE  L G +  K DV+S GV++  ++SG
Sbjct: 184 --KMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 69.6 bits (171), Expect = 2e-14
 Identities = 32/99 (32%), Positives = 49/99 (49%), Gaps = 15/99 (15%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           +   +L V   +  LH   KL I+HRD K  NILLD +MN K++DFG +   +  +    
Sbjct: 129 IMRALLEV---ICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE 182

Query: 64  TNRVVGTYGYMSPE------YALGGFFSVKSDVFSFGVV 96
              V GT  Y++PE            +  + D++S GV+
Sbjct: 183 ---VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 218

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 69.5 bits (171), Expect = 2e-14
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 6/90 (6%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L +LH +    I+HRD K  NIL+      K++DFGL RI+  +     T  VV T  Y 
Sbjct: 133 LDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LTPVVV-TLWYR 186

Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           +PE  L   ++   D++S G +  E+   K
Sbjct: 187 APEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 70.1 bits (172), Expect = 3e-14
 Identities = 35/105 (33%), Positives = 52/105 (49%), Gaps = 13/105 (12%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILL---DHEMNPKISDFGLTRIFEGKQT 60
           +   IL     + YLH+     I+HRD K  NILL   +  +N KI DFGL+  F     
Sbjct: 151 IMKQILSG---ICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY- 203

Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKR 105
                  +GT  Y++PE  L   ++ K DV+S GV++  ++ G  
Sbjct: 204 --KLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYP 245

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 69.2 bits (170), Expect = 3e-14
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 6/91 (6%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L + H++   +I+HRD K  N+L++     K+ DFGL R F G   +  ++ VV T  Y 
Sbjct: 121 LAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV-TLWYR 175

Query: 75  SPEYALGG-FFSVKSDVFSFGVVVLEIISGK 104
           +P+  +G   +S   D++S G ++ E+I+GK
Sbjct: 176 APDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 69.1 bits (170), Expect = 3e-14
 Identities = 33/91 (36%), Positives = 52/91 (57%), Gaps = 6/91 (6%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           + + HQ    RI+HRD K  N+L++ +   K++DFGL R F G      T+ VV T  Y 
Sbjct: 132 VAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLWYR 186

Query: 75  SPEYALGG-FFSVKSDVFSFGVVVLEIISGK 104
           +P+  +G   +S   D++S G +  E+I+GK
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 69.6 bits (170), Expect = 4e-14
 Identities = 25/107 (23%), Positives = 45/107 (42%), Gaps = 14/107 (13%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFG----LTRIFEGKQT-D 61
           I+ GV + L Y+H       +HR  K S+IL+  +    +S       +    + ++   
Sbjct: 133 ILQGVLKALDYIHHMGY---VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVH 189

Query: 62  GTTNRVVGTYGYMSPE----YALGGFFSVKSDVFSFGVVVLEIISGK 104
                 V    ++SPE       G  +  KSD++S G+   E+ +G 
Sbjct: 190 DFPKYSVKVLPWLSPEVLQQNLQG--YDAKSDIYSVGITACELANGH 234

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 69.1 bits (169), Expect = 4e-14
 Identities = 28/107 (26%), Positives = 42/107 (39%), Gaps = 12/107 (11%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILL--DHEMNPKISDFGLTRIFEGKQT- 60
           +   I      L YLH      I HRD K  N L   +     K+ DFGL++ F      
Sbjct: 173 IMRQIFSA---LHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNG 226

Query: 61  -DGTTNRVVGTYGYMSPE--YALGGFFSVKSDVFSFGVVVLEIISGK 104
                    GT  +++PE        +  K D +S GV++  ++ G 
Sbjct: 227 EYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 68.8 bits (169), Expect = 4e-14
 Identities = 28/97 (28%), Positives = 47/97 (48%), Gaps = 13/97 (13%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILL---DHEMNPKISDFGLTRIFEGKQT 60
           +   +L     + YLH   +  I+HRD K  N+L    +      I+DFGL+++ +    
Sbjct: 111 VIQQVLSA---VKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ---- 160

Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVV 97
           +G  +   GT GY++PE      +S   D +S GV+ 
Sbjct: 161 NGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 68.3 bits (168), Expect = 5e-14
 Identities = 27/92 (29%), Positives = 44/92 (47%), Gaps = 6/92 (6%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L + H      ++HRD K  N+L++     K+++FGL R F G      +  VV T  Y 
Sbjct: 114 LGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV-TLWYR 168

Query: 75  SPEYALGG-FFSVKSDVFSFGVVVLEIISGKR 105
            P+   G   +S   D++S G +  E+ +  R
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 68.9 bits (169), Expect = 6e-14
 Identities = 33/103 (32%), Positives = 53/103 (51%), Gaps = 13/103 (12%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILL---DHEMNPKISDFGLTRIFEGKQT 60
           +   +      + Y+H+     I+HRD K  NILL   + + + KI DFGL+  F+    
Sbjct: 126 IIKQVFSG---ITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT- 178

Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
                  +GT  Y++PE  L G +  K DV+S GV++  ++SG
Sbjct: 179 --KMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 68.6 bits (168), Expect = 7e-14
 Identities = 28/99 (28%), Positives = 45/99 (45%), Gaps = 15/99 (15%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           +   +L     + +LH      I+HRD K  NILLD  M  ++SDFG +   E       
Sbjct: 205 IMRSLLEA---VSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP---GEK 255

Query: 64  TNRVVGTYGYMSPE------YALGGFFSVKSDVFSFGVV 96
              + GT GY++PE            +  + D+++ GV+
Sbjct: 256 LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVI 294

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 68.0 bits (167), Expect = 1e-13
 Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 6/91 (6%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L Y H+    +++HRD K  N+L++     K++DFGL R      T    N VV T  Y 
Sbjct: 113 LAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-TLWYR 167

Query: 75  SPEYALGG-FFSVKSDVFSFGVVVLEIISGK 104
            P+  LG   +S + D++  G +  E+ +G+
Sbjct: 168 PPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 68.2 bits (167), Expect = 1e-13
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 8/98 (8%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           I+      L YLH  S+  +++RD K  N++LD + + KI+DFGL +  EG +   T   
Sbjct: 257 IVSA----LDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKT 308

Query: 67  VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
             GT  Y++PE      +    D +  GVV+ E++ G+
Sbjct: 309 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 67.2 bits (165), Expect = 1e-13
 Identities = 31/91 (34%), Positives = 50/91 (54%), Gaps = 6/91 (6%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           + Y H     R++HRD K  N+L++ E   KI+DFGL R F G      T+ +V T  Y 
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-TLWYR 167

Query: 75  SPEYALGG-FFSVKSDVFSFGVVVLEIISGK 104
           +P+  +G   +S   D++S G +  E+++G 
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 66.5 bits (163), Expect = 2e-13
 Identities = 31/96 (32%), Positives = 48/96 (50%), Gaps = 13/96 (13%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILL---DHEMNPKISDFGLTRIFEGKQT 60
           +   +      + Y+H+     I+HRD K  NILL   + + + KI DFGL+  F+    
Sbjct: 126 IIKQVFSG---ITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT- 178

Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVV 96
                  +GT  Y++PE  L G +  K DV+S GV+
Sbjct: 179 --KMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVI 211

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 66.6 bits (163), Expect = 3e-13
 Identities = 33/103 (32%), Positives = 52/103 (50%), Gaps = 10/103 (9%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           I   + R L +LHQ    ++IHRD K  N+LL      K+ DFG++   +  +T G  N 
Sbjct: 134 ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNT 188

Query: 67  VVGTYGYMSPE-----YALGGFFSVKSDVFSFGVVVLEIISGK 104
            +GT  +M+PE           +  KSD++S G+  +E+  G 
Sbjct: 189 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 66.2 bits (162), Expect = 3e-13
 Identities = 28/97 (28%), Positives = 47/97 (48%), Gaps = 14/97 (14%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR--VVGTYG 72
           L +LH     RIIHRD K  N+L+  E + +++DFG       K       R   +GT  
Sbjct: 130 LNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFG----VSAKNLKTLQKRDSFIGTPY 182

Query: 73  YMSPEYALGGFFS-----VKSDVFSFGVVVLEIISGK 104
           +M+PE  +           K+D++S G+ ++E+   +
Sbjct: 183 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 66.9 bits (163), Expect = 3e-13
 Identities = 17/101 (16%), Positives = 30/101 (29%), Gaps = 14/101 (13%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNP-----------KISDFGLTRIFEGKQTDGT 63
           +  +H      IIH D K  N +L +                + D G +   +       
Sbjct: 185 IEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTI 241

Query: 64  TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
                 T G+   E      ++ + D F     V  ++ G 
Sbjct: 242 FTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 66.5 bits (163), Expect = 3e-13
 Identities = 37/100 (37%), Positives = 58/100 (58%), Gaps = 13/100 (13%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           I L     L YLH+     II+RD K  N+LLD E + K++D+G+ +  EG +   TT+ 
Sbjct: 119 ISLA----LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTST 169

Query: 67  VVGTYGYMSPEYALGG--FFSVKSDVFSFGVVVLEIISGK 104
             GT  Y++PE   G    FSV  D ++ GV++ E+++G+
Sbjct: 170 FCGTPNYIAPEILRGEDYGFSV--DWWALGVLMFEMMAGR 207

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 66.1 bits (162), Expect = 3e-13
 Identities = 29/96 (30%), Positives = 41/96 (42%), Gaps = 13/96 (13%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILL---DHEMNPKISDFGLTRIFEGKQT 60
           L   ++     L Y H      ++H+D K  NIL          KI DFGL  +F+  + 
Sbjct: 129 LMKQMMNA---LAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH 182

Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVV 96
                   GT  YM+PE       + K D++S GVV
Sbjct: 183 STN---AAGTALYMAPE-VFKRDVTFKCDIWSAGVV 214

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 66.0 bits (162), Expect = 4e-13
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 9/98 (9%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           + L     L +LH    L II+RD K  NILLD E + K++DFGL++  E    +     
Sbjct: 135 LALA----LDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYS 185

Query: 67  VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
             GT  YM+PE       +  +D +SFGV++ E+++G 
Sbjct: 186 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 67.0 bits (163), Expect = 4e-13
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 9/98 (9%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           I +G    L +L       II+RD K  N++LD E + KI+DFG+ +  E      TT  
Sbjct: 451 IAIG----LFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKT 501

Query: 67  VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
             GT  Y++PE      +    D ++FGV++ E+++G+
Sbjct: 502 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 65.7 bits (161), Expect = 4e-13
 Identities = 29/96 (30%), Positives = 44/96 (45%), Gaps = 13/96 (13%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILL---DHEMNPKISDFGLTRIFEGKQT 60
           +   +L     + Y H+   L + HRD K  N L      +   K+ DFGL   F+  + 
Sbjct: 111 IMKDVLSA---VAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM 164

Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVV 96
             T    VGT  Y+SP+  L G +  + D +S GV+
Sbjct: 165 MRT---KVGTPYYVSPQ-VLEGLYGPECDEWSAGVM 196

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 66.2 bits (162), Expect = 4e-13
 Identities = 37/100 (37%), Positives = 58/100 (58%), Gaps = 13/100 (13%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           I L     L YLH+     II+RD K  N+LLD E + K++D+G+ +  EG +   TT+ 
Sbjct: 162 ISLA----LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTST 212

Query: 67  VVGTYGYMSPEYALGG--FFSVKSDVFSFGVVVLEIISGK 104
             GT  Y++PE   G    FSV  D ++ GV++ E+++G+
Sbjct: 213 FCGTPNYIAPEILRGEDYGFSV--DWWALGVLMFEMMAGR 250

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 65.8 bits (161), Expect = 4e-13
 Identities = 32/94 (34%), Positives = 51/94 (54%), Gaps = 7/94 (7%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGL-TRIFEGKQTDGTTNR--VVGTY 71
           L YLH++ +   IHRD K  NILL  + + +I+DFG+   +  G        R   VGT 
Sbjct: 134 LEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190

Query: 72  GYMSPE-YALGGFFSVKSDVFSFGVVVLEIISGK 104
            +M+PE       +  K+D++SFG+  +E+ +G 
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 65.8 bits (161), Expect = 5e-13
 Identities = 27/96 (28%), Positives = 36/96 (37%), Gaps = 11/96 (11%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP---KISDFGLTRIFEGKQT 60
               IL     L Y H      IIHRD K   +LL  + N    K+  FG+         
Sbjct: 135 YMRQILEA---LRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL 188

Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVV 96
                  VGT  +M+PE      +    DV+  GV+
Sbjct: 189 VAGG--RVGTPHFMAPEVVKREPYGKPVDVWGCGVI 222

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 65.7 bits (161), Expect = 6e-13
 Identities = 33/91 (36%), Positives = 50/91 (54%), Gaps = 6/91 (6%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLHQ     I+HRD K +N+LLD     K++DFGL + F G      T++VV T  Y 
Sbjct: 125 LEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVV-TRWYR 179

Query: 75  SPEYALGG-FFSVKSDVFSFGVVVLEIISGK 104
           +PE   G   + V  D+++ G ++ E++   
Sbjct: 180 APELLFGARMYGVGVDMWAVGCILAELLLRV 210

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 65.8 bits (161), Expect = 7e-13
 Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 11/96 (11%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP---KISDFGLTRIFEGKQT 60
               IL     +L+ HQ   + ++HR+ K  N+LL  ++     K++DFGL    EG+Q 
Sbjct: 115 CIQQILEA---VLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168

Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVV 96
                   GT GY+SPE      +    D+++ GV+
Sbjct: 169 AWFG--FAGTPGYLSPEVLRKDPYGKPVDLWACGVI 202

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 65.3 bits (160), Expect = 7e-13
 Identities = 31/98 (31%), Positives = 49/98 (50%), Gaps = 9/98 (9%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           I+      L YLH      +++RD K  N++LD + + KI+DFGL +  EG     T   
Sbjct: 114 IVSA----LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKT 164

Query: 67  VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
             GT  Y++PE      +    D +  GVV+ E++ G+
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 65.3 bits (160), Expect = 7e-13
 Identities = 30/98 (30%), Positives = 52/98 (53%), Gaps = 9/98 (9%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           I +     L +LH   +  II+RD K  NI+L+H+ + K++DFGL +  E       T+ 
Sbjct: 130 ISMA----LGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHT 180

Query: 67  VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
             GT  YM+PE  +    +   D +S G ++ ++++G 
Sbjct: 181 FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 64.9 bits (159), Expect = 8e-13
 Identities = 27/96 (28%), Positives = 41/96 (42%), Gaps = 12/96 (12%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP---KISDFGLTRIFEGKQT 60
               IL     + Y H      I+HR+ K  N+LL  +      K++DFGL         
Sbjct: 110 CIQQILES---IAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN---D 160

Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVV 96
               +   GT GY+SPE      +S   D+++ GV+
Sbjct: 161 SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVI 196

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 65.3 bits (160), Expect = 9e-13
 Identities = 39/97 (40%), Positives = 56/97 (57%), Gaps = 9/97 (9%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           IILG    L +LH      I++RD K  NILLD + + KI+DFG+ +  E    D  TN 
Sbjct: 127 IILG----LQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNT 177

Query: 67  VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISG 103
             GT  Y++PE  LG  ++   D +SFGV++ E++ G
Sbjct: 178 FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 214

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 65.1 bits (159), Expect = 9e-13
 Identities = 32/93 (34%), Positives = 42/93 (45%), Gaps = 12/93 (12%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH      +IHRD K  NILL      K+ DFG             +   VGT  +M
Sbjct: 167 LAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG----SASIMAPANS--FVGTPYWM 217

Query: 75  SPEYALG---GFFSVKSDVFSFGVVVLEIISGK 104
           +PE  L    G +  K DV+S G+  +E+   K
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAERK 250

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 64.9 bits (159), Expect = 9e-13
 Identities = 32/102 (31%), Positives = 46/102 (45%), Gaps = 10/102 (9%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           LF II G+     + H      IIHRD K  NIL+      K+ DFG  R       +  
Sbjct: 130 LFQIINGIG----FCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVY 181

Query: 64  TNRVVGTYGYMSPEYALGG-FFSVKSDVFSFGVVVLEIISGK 104
            + V  T  Y +PE  +G   +    DV++ G +V E+  G+
Sbjct: 182 DDEVA-TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 65.0 bits (159), Expect = 1e-12
 Identities = 27/97 (27%), Positives = 41/97 (42%), Gaps = 12/97 (12%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILL-DHEMNP---KISDFGLTRIFEGKQ 59
           +   I      + YLH      ++HRD K SNIL  D   NP   +I DFG  +    + 
Sbjct: 121 VLFTITKT---VEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174

Query: 60  TDGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVV 96
               T     T  +++PE      +    D++S GV+
Sbjct: 175 GLLMT--PCYTANFVAPEVLERQGYDAACDIWSLGVL 209

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 64.5 bits (158), Expect = 1e-12
 Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 11/91 (12%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           I+  V     Y H   +  ++HRD K  N+LLD  MN KI+DFGL+ +    +   T+  
Sbjct: 120 ILSAVD----YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS-- 170

Query: 67  VVGTYGYMSPEYALG-GFFSVKSDVFSFGVV 96
             G+  Y +PE   G  +   + D++S GV+
Sbjct: 171 -CGSPNYAAPEVISGRLYAGPEVDIWSCGVI 200

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 65.1 bits (159), Expect = 1e-12
 Identities = 36/181 (19%), Positives = 57/181 (31%), Gaps = 62/181 (34%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHE-MNPKISDFGLTRIFEGKQTDGTTN 65
           ++  V     + H      ++HRD K  NIL+D      K+ DFG   +      D    
Sbjct: 158 VLEAVR----HCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYT 206

Query: 66  RVVGTYGYMSPEYALG-GFFSVKSDVFSFGVV--VL-----------EIISGKRNTGFYN 111
              GT  Y  PE+     +    + V+S G++   +           EII G+       
Sbjct: 207 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 266

Query: 112 SELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSD 171
           S     L                             I  C+ +        P+DRPT  +
Sbjct: 267 SSECQHL-----------------------------IRWCLAL-------RPSDRPTFEE 290

Query: 172 V 172
           +
Sbjct: 291 I 291

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 65.0 bits (159), Expect = 1e-12
 Identities = 32/98 (32%), Positives = 49/98 (50%), Gaps = 9/98 (9%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           I       L YLH    L I++RD K  NILLD + +  ++DFGL +  E  + + TT+ 
Sbjct: 148 IASA----LGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTST 198

Query: 67  VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
             GT  Y++PE      +    D +  G V+ E++ G 
Sbjct: 199 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 64.6 bits (158), Expect = 1e-12
 Identities = 23/99 (23%), Positives = 44/99 (44%), Gaps = 13/99 (13%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP-KISDFGLTRIFEGKQTDGTTN 65
           ++  +     + H      ++HRD K  NIL+D      K+ DFG   +      D    
Sbjct: 148 VVAAIQ----HCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH----DEPYT 196

Query: 66  RVVGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEIISG 103
              GT  Y  PE+     + ++ + V+S G+++ +++ G
Sbjct: 197 DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 65.2 bits (159), Expect = 1e-12
 Identities = 29/98 (29%), Positives = 49/98 (50%), Gaps = 13/98 (13%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNP----KISDFGLTRIF---EGKQTDGTTNRV 67
           + YLH +    ++HRD K +NIL+  E       KI+D G  R+F        D     V
Sbjct: 141 IHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL-DPVV 196

Query: 68  VGTYGYMSPEYALGG-FFSVKSDVFSFGVVVLEIISGK 104
           V T+ Y +PE  LG   ++   D+++ G +  E+++ +
Sbjct: 197 V-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 64.9 bits (159), Expect = 1e-12
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 9/98 (9%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           I +G    L +L       II+RD K  N++LD E + KI+DFG+ +  E      TT  
Sbjct: 130 IAIG----LFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKT 180

Query: 67  VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
             GT  Y++PE      +    D ++FGV++ E+++G+
Sbjct: 181 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 64.7 bits (158), Expect = 1e-12
 Identities = 26/83 (31%), Positives = 42/83 (50%), Gaps = 8/83 (9%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNP--KISDFGLTRIFEGKQTDGTTNRVVGTYG 72
           + ++HQ   + I+H D K  NIL  +      KI DFGL R ++ ++         GT  
Sbjct: 200 IRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV---NFGTPE 253

Query: 73  YMSPEYALGGFFSVKSDVFSFGV 95
           +++PE     F S  +D++S GV
Sbjct: 254 FLAPEVVNYDFVSFPTDMWSVGV 276

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 64.6 bits (158), Expect = 1e-12
 Identities = 32/91 (35%), Positives = 47/91 (51%), Gaps = 11/91 (12%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           II  +     Y H   + +I+HRD K  N+LLD  +N KI+DFGL+ I        T+  
Sbjct: 117 IICAIE----YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS-- 167

Query: 67  VVGTYGYMSPEYALG-GFFSVKSDVFSFGVV 96
             G+  Y +PE   G  +   + DV+S G+V
Sbjct: 168 -CGSPNYAAPEVINGKLYAGPEVDVWSCGIV 197

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 64.6 bits (158), Expect = 1e-12
 Identities = 27/96 (28%), Positives = 42/96 (43%), Gaps = 12/96 (12%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP---KISDFGLTRIFEGKQT 60
               IL     + Y H      I+HR+ K  N+LL  +      K++DFGL       + 
Sbjct: 133 CIQQILES---IAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE- 185

Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVV 96
               +   GT GY+SPE      +S   D+++ GV+
Sbjct: 186 --AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVI 219

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 64.4 bits (157), Expect = 2e-12
 Identities = 31/91 (34%), Positives = 48/91 (52%), Gaps = 11/91 (12%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           I+ GV     Y H   +  ++HRD K  N+LLD  MN KI+DFGL+ +    +   T+  
Sbjct: 125 ILSGVD----YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS-- 175

Query: 67  VVGTYGYMSPEYALG-GFFSVKSDVFSFGVV 96
             G+  Y +PE   G  +   + D++S GV+
Sbjct: 176 -CGSPNYAAPEVISGRLYAGPEVDIWSSGVI 205

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 64.2 bits (157), Expect = 2e-12
 Identities = 29/96 (30%), Positives = 42/96 (43%), Gaps = 11/96 (11%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNP-----KISDFGLTRIFEGKQTDGTTNRVVG 69
           + + H     R +HRD K  N+LL           KI DFGL R F G      T+ ++ 
Sbjct: 145 VNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTHEII- 199

Query: 70  TYGYMSPEYALGG-FFSVKSDVFSFGVVVLEIISGK 104
           T  Y  PE  LG   +S   D++S   +  E++   
Sbjct: 200 TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 64.2 bits (157), Expect = 2e-12
 Identities = 34/98 (34%), Positives = 52/98 (53%), Gaps = 9/98 (9%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           II      L++LH      II+RD K  N+LLDHE + K++DFG+ +  EG     TT  
Sbjct: 133 IISA----LMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTAT 183

Query: 67  VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
             GT  Y++PE      +    D ++ GV++ E++ G 
Sbjct: 184 FCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 63.4 bits (155), Expect = 2e-12
 Identities = 27/97 (27%), Positives = 42/97 (43%), Gaps = 13/97 (13%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP----KISDFGLTRIFEGKQ 59
               IL     + YLH     RI H D K  NI+L  +  P    K+ DFG+    E   
Sbjct: 113 FLKQILDG---VHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN 166

Query: 60  TDGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVV 96
                  + GT  +++PE        +++D++S GV+
Sbjct: 167 EFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 200

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 63.7 bits (156), Expect = 3e-12
 Identities = 29/93 (31%), Positives = 44/93 (47%), Gaps = 6/93 (6%)

Query: 13  RRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYG 72
           + + + H+      IHRD K  NIL+      K+ DFG  R+     +D   + V  T  
Sbjct: 113 QAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVA-TRW 167

Query: 73  YMSPEYALGG-FFSVKSDVFSFGVVVLEIISGK 104
           Y SPE  +G   +    DV++ G V  E++SG 
Sbjct: 168 YRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 63.9 bits (156), Expect = 3e-12
 Identities = 31/96 (32%), Positives = 46/96 (47%), Gaps = 12/96 (12%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILL---DHEMNPKISDFGLTRIFEGKQT 60
               IL     + YLH+     I+HRD K  N+L      +   KI+DFGL++I E    
Sbjct: 153 AVKQILEA---VAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH--- 203

Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVV 96
                 V GT GY +PE   G  +  + D++S G++
Sbjct: 204 QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGII 239

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 63.5 bits (155), Expect = 3e-12
 Identities = 24/94 (25%), Positives = 44/94 (46%), Gaps = 6/94 (6%)

Query: 13  RRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP-KISDFGLTRIFEGKQTDGTTNRVVGTY 71
           R +  LH  S + + HRD K  N+L++      K+ DFG  +      ++     +   Y
Sbjct: 140 RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS--PSEPNVAYICSRY 196

Query: 72  GYMSPEYALGG-FFSVKSDVFSFGVVVLEIISGK 104
            Y +PE   G   ++   D++S G +  E++ G+
Sbjct: 197 -YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 63.6 bits (155), Expect = 3e-12
 Identities = 29/102 (28%), Positives = 47/102 (46%), Gaps = 11/102 (10%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           +  +H   +L  +HRD K  NIL+D   + +++DFG       +     ++  VGT  Y+
Sbjct: 188 IDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL-MEDGTVQSSVAVGTPDYI 243

Query: 75  SPEYALGGFFSVKS-----DVFSFGVVVLEIISGKRNTGFYN 111
           SPE                D +S GV + E++ G+  T FY 
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE--TPFYA 283

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 63.4 bits (155), Expect = 3e-12
 Identities = 28/97 (28%), Positives = 42/97 (43%), Gaps = 13/97 (13%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP----KISDFGLTRIFEGKQ 59
               IL     + YLH    L+I H D K  NI+L     P    KI DFGL    +   
Sbjct: 119 FLKQILNG---VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172

Query: 60  TDGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVV 96
                  + GT  +++PE        +++D++S GV+
Sbjct: 173 E---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 63.5 bits (155), Expect = 3e-12
 Identities = 25/84 (29%), Positives = 39/84 (46%), Gaps = 10/84 (11%)

Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNP----KISDFGLTRIFEGKQTDGTTNRVVGTYG 72
           YLH     +I H D K  NI+L  +  P    K+ DFGL    E          + GT  
Sbjct: 130 YLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPE 183

Query: 73  YMSPEYALGGFFSVKSDVFSFGVV 96
           +++PE        +++D++S GV+
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVI 207

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 63.5 bits (155), Expect = 4e-12
 Identities = 22/96 (22%), Positives = 40/96 (41%), Gaps = 11/96 (11%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILL---DHEMNPKISDFGLTRIFEGKQT 60
           +   ++     + ++H    + ++HRD K  N+L    +  +  KI DFG  R+      
Sbjct: 111 IMRKLVSA---VSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164

Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVV 96
              T     T  Y +PE      +    D++S GV+
Sbjct: 165 PLKT--PCFTLHYAAPELLNQNGYDESCDLWSLGVI 198

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 63.6 bits (155), Expect = 4e-12
 Identities = 20/84 (23%), Positives = 35/84 (41%), Gaps = 8/84 (9%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNP--KISDFGLTRIFEGKQTDGTTNRVVGTYG 72
           L ++H+     I+H D K  NI+ + +     KI DFGL       +          T  
Sbjct: 162 LKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV---TTATAE 215

Query: 73  YMSPEYALGGFFSVKSDVFSFGVV 96
           + +PE          +D+++ GV+
Sbjct: 216 FAAPEIVDREPVGFYTDMWAIGVL 239

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 62.7 bits (153), Expect = 5e-12
 Identities = 25/84 (29%), Positives = 39/84 (46%), Gaps = 10/84 (11%)

Query: 17  YLHQDSKLRIIHRDFKTSNILLDHEMNP----KISDFGLTRIFEGKQTDGTTNRVVGTYG 72
           YLH     +I H D K  NI+L  +  P    K+ DFGL    E          + GT  
Sbjct: 130 YLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPE 183

Query: 73  YMSPEYALGGFFSVKSDVFSFGVV 96
           +++PE        +++D++S GV+
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVI 207

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 63.2 bits (154), Expect = 6e-12
 Identities = 31/104 (29%), Positives = 47/104 (45%), Gaps = 13/104 (12%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           +  +H+   L  +HRD K  NILLD   + +++DFG         T   +   VGT  Y+
Sbjct: 175 IDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV-RSLVAVGTPDYL 230

Query: 75  SPE-------YALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYN 111
           SPE           G +  + D ++ GV   E+  G+  T FY 
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ--TPFYA 272

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 62.6 bits (153), Expect = 7e-12
 Identities = 20/90 (22%), Positives = 32/90 (35%), Gaps = 11/90 (12%)

Query: 8   ILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP--KISDFGLTRIFEGKQTDGTTN 65
           +      L +LH      I H D +  NI+     +   KI +FG  R  +         
Sbjct: 111 VCEA---LQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFR 161

Query: 66  RVVGTYGYMSPEYALGGFFSVKSDVFSFGV 95
            +     Y +PE       S  +D++S G 
Sbjct: 162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGT 191

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 62.4 bits (152), Expect = 1e-11
 Identities = 32/93 (34%), Positives = 44/93 (47%), Gaps = 13/93 (13%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDH--EMNPKISDFGLTRIFEGKQTDGTT 64
           ++ GVS    Y H    ++I HRD K  N LLD       KI DFG ++         +T
Sbjct: 125 LLSGVS----YCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 177

Query: 65  NRVVGTYGYMSPEYALG-GFFSVKSDVFSFGVV 96
              VGT  Y++PE  L   +    +DV+S GV 
Sbjct: 178 ---VGTPAYIAPEVLLRQEYDGKIADVWSCGVT 207

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 61.9 bits (151), Expect = 1e-11
 Identities = 30/99 (30%), Positives = 46/99 (46%), Gaps = 15/99 (15%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILL---DHEMNPKISDFGLTRIFEGKQT 60
            F  +L     + YLH   +  IIHRD K  N+LL   + +   KI+DFG ++I      
Sbjct: 119 YFYQMLLA---VQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172

Query: 61  DGTTNRVVGTYGYMSPE---YALGGFFSVKSDVFSFGVV 96
             T   + GT  Y++PE         ++   D +S GV+
Sbjct: 173 MRT---LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 208

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 61.9 bits (151), Expect = 1e-11
 Identities = 35/103 (33%), Positives = 53/103 (51%), Gaps = 16/103 (15%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG-TTN 65
           I+L     L +LH   KL II+RD K  NILLD   +  ++DFGL++  E    +     
Sbjct: 168 IVLA----LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK--EFVADETERAY 218

Query: 66  RVVGTYGYMSPE----YALGGFFSVKSDVFSFGVVVLEIISGK 104
              GT  YM+P+       G   +V  D +S GV++ E+++G 
Sbjct: 219 DFCGTIEYMAPDIVRGGDSGHDKAV--DWWSLGVLMYELLTGA 259

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 62.0 bits (151), Expect = 1e-11
 Identities = 30/102 (29%), Positives = 47/102 (46%), Gaps = 16/102 (15%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP---KISDFGLTRIFEGK 58
              + ++L V     YLH   +  IIHRD K  N+LL  +      KI+DFG ++I    
Sbjct: 243 LYFYQMLLAVQ----YLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 295

Query: 59  QTDGTTNRVVGTYGYMSPE---YALGGFFSVKSDVFSFGVVV 97
               T   + GT  Y++PE         ++   D +S GV++
Sbjct: 296 SLMRT---LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 61.5 bits (150), Expect = 1e-11
 Identities = 27/89 (30%), Positives = 47/89 (52%), Gaps = 8/89 (8%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
             YLH    L +I+RD K  N+L+D +   +++DFG       K+  G T  + GT   +
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA-----KRVKGRTWTLCGTPEAL 205

Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           +PE  L   ++   D ++ GV++ E+ +G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 61.6 bits (150), Expect = 2e-11
 Identities = 33/92 (35%), Positives = 46/92 (50%), Gaps = 6/92 (6%)

Query: 13  RRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYG 72
             + +LH      IIHRD K SNI++  +   KI DFGL R      +   T  VV T  
Sbjct: 138 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVV-TRY 191

Query: 73  YMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           Y +PE  LG  +    D++S G ++ E+I G 
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 61.6 bits (150), Expect = 2e-11
 Identities = 21/83 (25%), Positives = 34/83 (40%), Gaps = 10/83 (12%)

Query: 17  YLHQDSKLRIIHRDFKTSNILL---DHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGY 73
           +LH      I HRD K  N+L    + +   K++DFG  +                T  Y
Sbjct: 143 FLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT----QNALQTPCYTPYY 195

Query: 74  MSPEYALGGFFSVKSDVFSFGVV 96
           ++PE      +    D++S GV+
Sbjct: 196 VAPEVLGPEKYDKSCDMWSLGVI 218

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 61.8 bits (150), Expect = 2e-11
 Identities = 25/83 (30%), Positives = 40/83 (48%), Gaps = 8/83 (9%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNP--KISDFGLTRIFEGKQTDGTTNRVVGTYG 72
           L ++H+      +H D K  NI+   + +   K+ DFGLT   + KQ+        GT  
Sbjct: 268 LCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAE 321

Query: 73  YMSPEYALGGFFSVKSDVFSFGV 95
           + +PE A G      +D++S GV
Sbjct: 322 FAAPEVAEGKPVGYYTDMWSVGV 344

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 61.6 bits (150), Expect = 2e-11
 Identities = 32/101 (31%), Positives = 48/101 (47%), Gaps = 10/101 (9%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L  +H    +  IHRD K  N+LLD   + K++DFG       +      +  VGT  Y+
Sbjct: 181 LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYI 236

Query: 75  SPEYALG----GFFSVKSDVFSFGVVVLEIISGKRNTGFYN 111
           SPE        G++  + D +S GV + E++ G   T FY 
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD--TPFYA 275

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 60.7 bits (148), Expect = 3e-11
 Identities = 27/95 (28%), Positives = 44/95 (46%), Gaps = 8/95 (8%)

Query: 13  RRLLYLHQDSKLRIIHRDFKTSNILLDHE-MNPKISDFGLTRIFEGKQTDGTTNRVVGTY 71
           + L Y H  S   I+HRD K  N+++DHE    ++ D+GL   +   Q      RV   Y
Sbjct: 141 KALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--YNVRVASRY 195

Query: 72  GYMSPEYALGG-FFSVKSDVFSFGVVVLEIISGKR 105
            +  PE  +    +    D++S G ++  +I  K 
Sbjct: 196 -FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 61.0 bits (148), Expect = 3e-11
 Identities = 32/92 (34%), Positives = 46/92 (50%), Gaps = 6/92 (6%)

Query: 13  RRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYG 72
             + +LH      IIHRD K SNI++  +   KI DFGL R      +   T  VV T  
Sbjct: 175 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVV-TRY 228

Query: 73  YMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           Y +PE  LG  +    D++S G ++ E++  K
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 60.8 bits (148), Expect = 3e-11
 Identities = 29/94 (30%), Positives = 46/94 (48%), Gaps = 8/94 (8%)

Query: 13  RRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP-KISDFGLTRIFEGKQTDGTTNRVVGTY 71
           R L Y+H    + I HRD K  N+LLD      K+ DFG  +I    +     + +   Y
Sbjct: 152 RSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP--NVSYICSRY 206

Query: 72  GYMSPEYALGG-FFSVKSDVFSFGVVVLEIISGK 104
            Y +PE   G   ++   D++S G V+ E++ G+
Sbjct: 207 -YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 60.3 bits (147), Expect = 4e-11
 Identities = 27/92 (29%), Positives = 43/92 (46%), Gaps = 12/92 (13%)

Query: 8   ILGVSRRLLYLHQDSKLRIIHRDFKTSNILL---DHEMNPKISDFGLTRIFEGKQTDGTT 64
           IL     + YLHQ     I+H D K  NILL       + KI DFG++R           
Sbjct: 140 ILEG---VYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE---L 190

Query: 65  NRVVGTYGYMSPEYALGGFFSVKSDVFSFGVV 96
             ++GT  Y++PE       +  +D+++ G++
Sbjct: 191 REIMGTPEYLAPEILNYDPITTATDMWNIGII 222

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 60.1 bits (146), Expect = 5e-11
 Identities = 28/94 (29%), Positives = 48/94 (51%), Gaps = 8/94 (8%)

Query: 13  RRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP-KISDFGLTRIFEGKQTDGTTNRVVGTY 71
           R + ++H    L I HRD K  N+L++ + N  K+ DFG  +      ++ +   +   +
Sbjct: 152 RAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLI--PSEPSVAYICSRF 206

Query: 72  GYMSPEYALGG-FFSVKSDVFSFGVVVLEIISGK 104
            Y +PE  LG   ++   D++S G V  E+I GK
Sbjct: 207 -YRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 60.0 bits (146), Expect = 5e-11
 Identities = 40/204 (19%), Positives = 59/204 (28%), Gaps = 61/204 (29%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP---KISDFGLTRIFEGKQT 60
           +   +      L +LH      I HRD K  NIL +H       KI DF L    +    
Sbjct: 116 VVQDVASA---LDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169

Query: 61  DGTTNR-----VVGTYGYMSPEYALGGFFSVKS-----DVFSFGVVVLEIISGKRNTGFY 110
               +        G+  YM+PE                D++S G V+L I+         
Sbjct: 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG-VILYIL--------- 219

Query: 111 NSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVG--------------- 155
                  L GY         +    D+     +  N + + I  G               
Sbjct: 220 -------LSGYP-PFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCA 271

Query: 156 -------LLCVQEDPNDRPTMSDV 172
                  LL    D   R + + V
Sbjct: 272 AKDLISKLLVR--DAKQRLSAAQV 293

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 59.9 bits (146), Expect = 6e-11
 Identities = 32/89 (35%), Positives = 47/89 (52%), Gaps = 8/89 (8%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L YLH      II+RD K  NILLD   + KI+DFG       K     T  + GT  Y+
Sbjct: 119 LEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFA-----KYVPDVTYTLCGTPDYI 170

Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISG 103
           +PE      ++   D +SFG+++ E+++G
Sbjct: 171 APEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 59.7 bits (145), Expect = 7e-11
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 9/93 (9%)

Query: 13  RRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYG 72
           R L Y+H      IIHRD K SN+ ++ +   KI DFGL R    + T       V T  
Sbjct: 143 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG-----YVATRW 194

Query: 73  YMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
           Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 59.6 bits (145), Expect = 7e-11
 Identities = 28/93 (30%), Positives = 48/93 (51%), Gaps = 9/93 (9%)

Query: 13  RRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYG 72
           + L Y+H      ++HRD K  N+ ++ +   KI DFGL R  + + T       V T  
Sbjct: 137 KGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG-----YVVTRW 188

Query: 73  YMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
           Y +PE  L    ++   D++S G ++ E+++GK
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 59.3 bits (144), Expect = 1e-10
 Identities = 29/94 (30%), Positives = 46/94 (48%), Gaps = 8/94 (8%)

Query: 13  RRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP-KISDFGLTRIFEGKQTDGTTNRVVGTY 71
           R L Y+H      I HRD K  N+LLD +    K+ DFG  +     + +   + +   Y
Sbjct: 167 RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY 221

Query: 72  GYMSPEYALGG-FFSVKSDVFSFGVVVLEIISGK 104
            Y +PE   G   ++   DV+S G V+ E++ G+
Sbjct: 222 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 59.0 bits (143), Expect = 1e-10
 Identities = 23/83 (27%), Positives = 35/83 (42%), Gaps = 9/83 (10%)

Query: 17  YLHQDSKLRIIHRDFKTSNILL---DHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGY 73
           YLH    + I HRD K  N+L          K++DFG  +      +  T      T  Y
Sbjct: 176 YLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT---PCYTPYY 229

Query: 74  MSPEYALGGFFSVKSDVFSFGVV 96
           ++PE      +    D++S GV+
Sbjct: 230 VAPEVLGPEKYDKSCDMWSLGVI 252

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 58.6 bits (142), Expect = 2e-10
 Identities = 28/96 (29%), Positives = 44/96 (45%), Gaps = 13/96 (13%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNP------KISDFGLTRIFEGKQTDGTTNRVV 68
           L Y+H   +  IIH D K  N+L++   +P      KI+D G          D      +
Sbjct: 144 LDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC-----WYDEHYTNSI 196

Query: 69  GTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
            T  Y SPE  LG  +   +D++S   ++ E+I+G 
Sbjct: 197 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 58.5 bits (142), Expect = 2e-10
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 9/93 (9%)

Query: 13  RRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYG 72
           + L Y+H      IIHRD K  N+ ++ +   KI DFGL R  + + T       V T  
Sbjct: 139 KGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG-----YVVTRW 190

Query: 73  YMSPEYALG-GFFSVKSDVFSFGVVVLEIISGK 104
           Y +PE  L    ++   D++S G ++ E+I+GK
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 57.3 bits (139), Expect = 5e-10
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 7/95 (7%)

Query: 13  RRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIF--EGKQTDGTTNRVVGT 70
           R L Y+H  +   ++HRD K SN+LL+   + KI DFGL R+   +   T   T  V  T
Sbjct: 139 RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-T 194

Query: 71  YGYMSPEYALG-GFFSVKSDVFSFGVVVLEIISGK 104
             Y +PE  L    ++   D++S G ++ E++S +
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 55.8 bits (135), Expect = 1e-09
 Identities = 27/93 (29%), Positives = 40/93 (43%), Gaps = 7/93 (7%)

Query: 13  RRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYG 72
             L  LH+     ++HRD    NILL    +  I DF L R          T+ V     
Sbjct: 145 LGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDT--ADANKTHYVT-HRW 198

Query: 73  YMSPEYALG-GFFSVKSDVFSFGVVVLEIISGK 104
           Y +PE  +    F+   D++S G V+ E+ + K
Sbjct: 199 YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 55.4 bits (134), Expect = 2e-09
 Identities = 29/96 (30%), Positives = 51/96 (53%), Gaps = 8/96 (8%)

Query: 13  RRLLYLHQDSKLRIIHRDFKTSNILLDHE-MNPKISDFGLTRIFEGKQTDGT--TNRVVG 69
           R L Y+H  +   ++HRD K +N+ ++ E +  KI DFGL RI +   +     +  +V 
Sbjct: 131 RGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV- 186

Query: 70  TYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
           T  Y SP   L    ++   D+++ G +  E+++GK
Sbjct: 187 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 54.6 bits (132), Expect = 3e-09
 Identities = 31/101 (30%), Positives = 48/101 (47%), Gaps = 12/101 (11%)

Query: 13  RRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRV----- 67
           R +  LH  +   +IHRD K SN+L++   + K+ DFGL RI +    D +         
Sbjct: 123 RAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179

Query: 68  ---VGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEIISGK 104
              V T  Y +PE  L    +S   DV+S G ++ E+   +
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 53.2 bits (128), Expect = 1e-08
 Identities = 31/96 (32%), Positives = 48/96 (50%), Gaps = 16/96 (16%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNP--KISDFGLTRIFEGKQTDGTTNRVVGTY- 71
           LL+L    +L IIH D K  NILL +      KI DFG +    G++        +  Y 
Sbjct: 170 LLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFG-SSCQLGQR--------IYQYI 219

Query: 72  ---GYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
               Y SPE  LG  + +  D++S G +++E+ +G+
Sbjct: 220 QSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 52.4 bits (126), Expect = 2e-08
 Identities = 32/96 (33%), Positives = 48/96 (50%), Gaps = 18/96 (18%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNP--KISDFGLTRIFEGKQTDGTTNRVVGTY- 71
           L  LH   K RIIH D K  NILL  +     K+ DFG +  +E        ++ V TY 
Sbjct: 213 LDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-CYE--------HQRVYTYI 260

Query: 72  ---GYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
               Y +PE  LG  + +  D++S G ++ E+++G 
Sbjct: 261 QSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 52.1 bits (125), Expect = 3e-08
 Identities = 19/76 (25%), Positives = 37/76 (48%), Gaps = 7/76 (9%)

Query: 4   LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT 63
           L+N+++G    + Y+H      I+HRD K +N L++ + + K+ DFGL R  +  +   +
Sbjct: 162 LYNLLVG----VKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNS 214

Query: 64  TNRVVGTYGYMSPEYA 79
              +      M+    
Sbjct: 215 QLPISPREDDMNLVTF 230

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 51.3 bits (123), Expect = 5e-08
 Identities = 18/71 (25%), Positives = 29/71 (40%), Gaps = 3/71 (4%)

Query: 13  RRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYG 72
               ++H+     IIHRD K +N LL+ + + K+ DFGL R    ++     N +     
Sbjct: 140 LGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196

Query: 73  YMSPEYALGGF 83
                  L   
Sbjct: 197 PGPHNKNLKKQ 207

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 50.7 bits (121), Expect = 9e-08
 Identities = 44/252 (17%), Positives = 81/252 (32%), Gaps = 91/252 (36%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILL----------------------- 38
           +++  ++ G+     YLH  +K RIIH D K  NILL                       
Sbjct: 150 KIIQQVLQGLD----YLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAP 203

Query: 39  --------------------------DHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYG 72
                                       ++  KI+D G         T+      + T  
Sbjct: 204 PPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTE-----DIQTRQ 258

Query: 73  YMSPEYALGGFFSVKSDVFSFGVVVLEIISGKR------NTGFYNSE--LAL--SLLG-- 120
           Y S E  +G  ++  +D++S   +  E+ +G           +   E  +AL   LLG  
Sbjct: 259 YRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKV 318

Query: 121 ---------YAWKLW-QEGKALDMMDQKPGAISK---------ANEILKCINVGLLCVQE 161
                    Y+ + + ++G    +   KP  + +           E     +  L  ++ 
Sbjct: 319 PRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLEL 378

Query: 162 DPNDRPTMSDVV 173
            P  R T ++ +
Sbjct: 379 IPEKRATAAECL 390

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 48.5 bits (116), Expect = 4e-07
 Identities = 35/112 (31%), Positives = 54/112 (48%), Gaps = 23/112 (20%)

Query: 13  RRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRV----- 67
           + + YLH  S   ++HRD K SNILL+ E + K++DFGL+R F   +       +     
Sbjct: 120 KVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176

Query: 68  --------------VGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGK 104
                         V T  Y +PE  LG   ++   D++S G ++ EI+ GK
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 44.2 bits (105), Expect = 1e-05
 Identities = 25/109 (22%), Positives = 42/109 (38%), Gaps = 27/109 (24%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNP-------------------KISDFGLTRIF 55
           L +LH   + ++ H D K  NIL  +                       +++DFG +  F
Sbjct: 136 LRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-SATF 191

Query: 56  EGKQTDGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           + +        +V T  Y  PE  L   ++   DV+S G ++ E   G 
Sbjct: 192 DHE----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 42.6 bits (101), Expect = 4e-05
 Identities = 25/109 (22%), Positives = 41/109 (37%), Gaps = 27/109 (24%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNP-------------------KISDFGLTRIF 55
           + +LH     ++ H D K  NIL                          K+ DFG    +
Sbjct: 131 VNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA-TY 186

Query: 56  EGKQTDGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
           + +      + +V T  Y +PE  L   +S   DV+S G +++E   G 
Sbjct: 187 DDE----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGF 231

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 41.5 bits (98), Expect = 8e-05
 Identities = 29/110 (26%), Positives = 40/110 (36%), Gaps = 23/110 (20%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR-------- 66
           L YL    K+ + H D K  NILLD     K            K     T          
Sbjct: 150 LNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206

Query: 67  ------------VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
                       ++ T  Y +PE  L   + V SD++SFG V+ E+ +G 
Sbjct: 207 GCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 41.0 bits (95), Expect = 1e-04
 Identities = 15/82 (18%), Positives = 24/82 (29%), Gaps = 6/82 (7%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           +    +I+  ++  L        LR  HRD    N+LL      K+      +      T
Sbjct: 160 LATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSS----T 213

Query: 61  DGTTNRVVGTYGYMSPEYALGG 82
             +    V    Y        G
Sbjct: 214 IPSCGLQVSIIDYTLSRLERDG 235

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 40.5 bits (95), Expect = 2e-04
 Identities = 8/99 (8%), Positives = 23/99 (23%), Gaps = 32/99 (32%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
            +  ++      H+     +       S + +                      DG    
Sbjct: 134 AMQSLAAAADAAHRAG---VALSIDHPSRVRVS--------------------IDGDV-- 168

Query: 67  VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKR 105
           V+     M          + + D+   G  +  ++  + 
Sbjct: 169 VLAYPATMPDA-------NPQDDIRGIGASLYALLVNRW 200

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 40.0 bits (94), Expect = 2e-04
 Identities = 14/38 (36%), Positives = 19/38 (50%), Gaps = 6/38 (15%)

Query: 17  YLHQDSKLRIIHRDFKTSNILLDHE---MNPKISDFGL 51
           YLH    + I HRD K  N+L   +      K++DFG 
Sbjct: 132 YLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF 166

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 40.1 bits (94), Expect = 3e-04
 Identities = 27/106 (25%), Positives = 43/106 (40%), Gaps = 21/106 (19%)

Query: 13  RRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPK-----ISDFGLTRIFEGKQTDGTTNR- 66
            R+ Y+H  +   +I+RD K  N L+    N       I DF L + +     D  T + 
Sbjct: 116 SRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY----IDPETKKH 168

Query: 67  --------VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
                   + GT  YMS    LG   S + D+ + G + +  + G 
Sbjct: 169 IPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 39.4 bits (92), Expect = 5e-04
 Identities = 21/102 (20%), Positives = 43/102 (42%), Gaps = 18/102 (17%)

Query: 14  RLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKI--SDFGLTRIFEGKQTDGTTNR----- 66
            L Y+H+      +H D K SN+LL+++   ++   D+GL   +         ++     
Sbjct: 164 ILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY----CPEGVHKAYAAD 216

Query: 67  ----VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
                 GT  + S +   G   S + D+   G  +++ ++G 
Sbjct: 217 PKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 38.9 bits (91), Expect = 6e-04
 Identities = 29/104 (27%), Positives = 42/104 (40%), Gaps = 19/104 (18%)

Query: 13  RRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPK---ISDFGLTRIFEGKQTDGTTNRVV- 68
            R+ Y+H  +    IHRD K  N L+          I DFGL + +     D  T++ + 
Sbjct: 116 SRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY----RDARTHQHIP 168

Query: 69  --------GTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
                   GT  Y S    LG   S + D+ S G V++    G 
Sbjct: 169 YRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 38.9 bits (91), Expect = 7e-04
 Identities = 25/105 (23%), Positives = 44/105 (41%), Gaps = 21/105 (20%)

Query: 14  RLLYLHQDSKLRIIHRDFKTSNILLDHEMNPK-----ISDFGLTRIFEGKQTDGTTNR-- 66
           R+  +H+ S   +++RD K  N L+    +       + DFG+ + +     D  T +  
Sbjct: 118 RVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY----RDPVTKQHI 170

Query: 67  -------VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
                  + GT  YMS    LG   S + D+ + G V +  + G 
Sbjct: 171 PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 215

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 39.1 bits (90), Expect = 9e-04
 Identities = 28/223 (12%), Positives = 68/223 (30%), Gaps = 74/223 (33%)

Query: 1   MEMLFNIILGVSRRL---------LYLHQDS---KLR--IIHRDFKTSNILLDHEMNPKI 46
           +EML  ++  +             + L   S   +LR  +  + ++   ++L +  N K 
Sbjct: 199 LEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKA 258

Query: 47  SD-FGL-------TRIFEGKQTD-GTTNRVVG-TYGYMSPEYALGGFFSVKS-DVFS--F 93
            + F L       TR           T+ +   T  ++S ++        +   +     
Sbjct: 259 WNAFNLSCKILLTTR-------FKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYL 311

Query: 94  GVVV----LEIISGKRNTGFYNSELALSLLGYA-------WKLWQEGKALDMMDQKPGAI 142
                    E+++         +   LS++  +       W  W+               
Sbjct: 312 DCRPQDLPREVLTT--------NPRRLSIIAESIRDGLATWDNWKHVN-----------C 352

Query: 143 SKANEILK-CINVGLLCVQEDPND-RPTMSDVVIMLGSEAVNL 183
            K   I++  +NV       +P + R     + +     + ++
Sbjct: 353 DKLTTIIESSLNV------LEPAEYRKMFDRLSVF--PPSAHI 387

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	220
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.97
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.97
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.97
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.97
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.97
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.97
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.97
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	99.97
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.97
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.97
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.97
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.97
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.97
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.97
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.97
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.97
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.97
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.97
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.97
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.97
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.97
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.97
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.97
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.97
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.97
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.97
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.97
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.97
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.97
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.96
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.96
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.96
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.96
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.96
3niz_A	311	Rhodanese family protein; structural genomics, str	99.96
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.96
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.96
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.96
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.96
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.96
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.96
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.96
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.96
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.96
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.96
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.96
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.96
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.96
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.96
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.96
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.96
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.96
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.96
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.96
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.96
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.96
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.96
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.96
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.96
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.96
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.96
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.96
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.96
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.96
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.96
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.96
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.96
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.96
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.96
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.96
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.96
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.96
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.96
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.96
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.96
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.96
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.96
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.96
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.96
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.96
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.96
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.96
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.96
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.96
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.96
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.96
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.96
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.96
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.96
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.96
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.96
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.96
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.96
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.96
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.96
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.96
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.96
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.96
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.96
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.96
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.96
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.96
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.96
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.96
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.96
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.96
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.96
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.96
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.96
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.96
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.96
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.96
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.96
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.96
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.96
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.96
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.96
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.96
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.96
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.96
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.96
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.96
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.96
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.96
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.96
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.96
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.96
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.96
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.96
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.96
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.96
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.96
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.96
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.96
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.96
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.96
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.96
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.96
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.96
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.96
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.96
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.96
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.96
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.96
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.96
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.96
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.96
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.96
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.96
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.96
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.96
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.96
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.96
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.96
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.96
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.96
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.96
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.95
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.95
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.95
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.95
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.95
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.95
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.95
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.95
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.95
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.95
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.95
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.95
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.95
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.95
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.95
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.95
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.95
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.95
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.95
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.95
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.95
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.95
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.95
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.95
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.95
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.95
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.95
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.95
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.95
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.95
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.95
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.95
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.95
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.95
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.95
3bhy_A	283	Death-associated protein kinase 3; death associate	99.95
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.95
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.95
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.95
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.95
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.95
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.95
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.95
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.95
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.95
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.95
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.95
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.95
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.95
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.95
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.95
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.95
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.95
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.95
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.95
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.95
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.95
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.95
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.95
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.95
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.95
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.95
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.94
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.94
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.94
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.94
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.94
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.94
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.94
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.94
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.92
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.92
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.91
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.89
3uqc_A	286	Probable conserved transmembrane protein; structur	99.89
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.79
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.53
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.27
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.06
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	98.57
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	97.46
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	97.38
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	97.27
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	97.22
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	96.28
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.02
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	95.69
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	95.52
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	94.05
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	94.05
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	93.41
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	93.14
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	93.01
3ats_A	357	Putative uncharacterized protein; hypothetical pro	92.91
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	92.62
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	92.44
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	92.14
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	91.72
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	91.68
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	91.38
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	90.71
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	90.56
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	89.69
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	89.11
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	88.82
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	86.59
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	84.1
3mes_A	424	Choline kinase; malaria, structural genomics, stru	83.35

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.2e-38  Score=253.33  Aligned_cols=169  Identities=25%  Similarity=0.364  Sum_probs=123.0

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .++++|+.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++...............||+.|+|||++.+
T Consensus       132 ~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~  208 (307)
T 3omv_A          132 FQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRM  208 (307)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhc
Confidence            467899999999999999999   99999999999999999999999999976443222223334578999999999974


Q ss_pred             C---CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           82 G---FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        82 ~---~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                      .   .++.++|||||||++|||++|+.||...+......      .....+........     ........+.++|.+|
T Consensus       209 ~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~------~~~~~~~~~p~~~~-----~~~~~~~~l~~li~~c  277 (307)
T 3omv_A          209 QDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQII------FMVGRGYASPDLSK-----LYKNCPKAMKRLVADC  277 (307)
T ss_dssp             CSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH------HHHHTTCCCCCSTT-----SCTTSCHHHHHHHHHH
T ss_pred             cCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHH------HHHhcCCCCCCccc-----ccccchHHHHHHHHHH
Confidence            3   58899999999999999999999997544332211      11112211111111     1112234678899999


Q ss_pred             cCCCCCCCCCHHHHHHHhcCccccCC
Q 027675          159 VQEDPNDRPTMSDVVIMLGSEAVNLA  184 (220)
Q Consensus       159 l~~~p~~Rps~~~~l~~l~~~~~~~~  184 (220)
                      |+.||++|||+.+|+++|+.+....+
T Consensus       278 l~~dP~~RPs~~ei~~~Le~l~~~lp  303 (307)
T 3omv_A          278 VKKVKEERPLFPQILSSIELLQHSLP  303 (307)
T ss_dssp             TCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred             cCCCHhHCcCHHHHHHHHHHHhccCC
Confidence            99999999999999999977654444

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=9.6e-38  Score=248.66  Aligned_cols=159  Identities=25%  Similarity=0.387  Sum_probs=126.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..+++|+.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++...............|++.|+|||.+.+
T Consensus       145 ~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~  221 (308)
T 4gt4_A          145 PDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY  221 (308)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC
Confidence            357889999999999999999   99999999999999999999999999875443322222334567889999999999


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|||||||++|||++ |..||...+......       ....+.....++         .....+.++|.+||+
T Consensus       222 ~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~-------~i~~~~~~~~p~---------~~~~~~~~li~~C~~  285 (308)
T 4gt4_A          222 GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE-------MIRNRQVLPCPD---------DCPAWVYALMIECWN  285 (308)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH-------HHHTTCCCCCCT---------TCCHHHHHHHHHHTC
T ss_pred             CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH-------HHHcCCCCCCcc---------cchHHHHHHHHHHcC
Confidence            999999999999999999998 899997655443221       122333322221         123467899999999


Q ss_pred             CCCCCCCCHHHHHHHhcCc
Q 027675          161 EDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~  179 (220)
                      .||++|||+.+|++.|+..
T Consensus       286 ~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          286 EFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             SSGGGSCCHHHHHHHHHTS
T ss_pred             CChhHCcCHHHHHHHHHhc
Confidence            9999999999999999754

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.1e-37  Score=250.50  Aligned_cols=161  Identities=28%  Similarity=0.374  Sum_probs=120.2

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .++++|+.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++...............|++.|+|||.+.+
T Consensus       158 ~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~  234 (329)
T 4aoj_A          158 GQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY  234 (329)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcC
Confidence            457899999999999999999   99999999999999999999999999976543332223334568899999999999


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|||||||++|||++ |+.||...+......       ....+.....+.         .....+.++|.+||+
T Consensus       235 ~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~-------~i~~g~~~~~p~---------~~~~~~~~li~~cl~  298 (329)
T 4aoj_A          235 RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID-------CITQGRELERPR---------ACPPEVYAIMRGCWQ  298 (329)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH-------HHHHTCCCCCCT---------TCCHHHHHHHHHHCC
T ss_pred             CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH-------HHHcCCCCCCcc---------cccHHHHHHHHHHcC
Confidence            999999999999999999998 899997655433221       112232222211         122467899999999


Q ss_pred             CCCCCCCCHHHHHHHhcCccc
Q 027675          161 EDPNDRPTMSDVVIMLGSEAV  181 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~~~  181 (220)
                      .||++|||+++|+++|+....
T Consensus       299 ~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          299 REPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             SSTTTSCCHHHHHHHHHHHHH
T ss_pred             cChhHCcCHHHHHHHHHHHhh
Confidence            999999999999999977644

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4.1e-37  Score=247.59  Aligned_cols=159  Identities=24%  Similarity=0.322  Sum_probs=124.7

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +++..++.||+.||+|||+++   |+||||||+|||++.+|.+||+|||++........  ......||+.|+|||++.+
T Consensus       170 ~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GTp~YmAPEvl~~  244 (346)
T 4fih_A          170 EQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISR  244 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC--cccccccCcCcCCHHHHCC
Confidence            467889999999999999999   99999999999999999999999999986543222  2234679999999999999


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|||||||++|+|++|+.||...+.......+       ..+..       +...........+.++|.+||+.
T Consensus       245 ~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i-------~~~~~-------~~~~~~~~~s~~~~dli~~~L~~  310 (346)
T 4fih_A          245 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-------RDNLP-------PRLKNLHKVSPSLKGFLDRLLVR  310 (346)
T ss_dssp             CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-------HHSSC-------CCCSCGGGSCHHHHHHHHHHSCS
T ss_pred             CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH-------HcCCC-------CCCCccccCCHHHHHHHHHHcCC
Confidence            99999999999999999999999999755443322111       11110       11111112334778999999999


Q ss_pred             CCCCCCCHHHHHHHhcCc
Q 027675          162 DPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~~~  179 (220)
                      ||++|||++|+++|=+..
T Consensus       311 dP~~R~ta~e~l~Hp~~~  328 (346)
T 4fih_A          311 DPAQRATAAELLKHPFLA  328 (346)
T ss_dssp             STTTSCCHHHHTTCGGGG
T ss_pred             ChhHCcCHHHHhcCHhhc
Confidence            999999999999875443

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.6e-37  Score=249.17  Aligned_cols=163  Identities=20%  Similarity=0.228  Sum_probs=122.1

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCC-CceecCccceeeecCCCC---CcccceeecccCccChh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEM-NPKISDFGLTRIFEGKQT---DGTTNRVVGTYGYMSPE   77 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~-~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~y~aPe   77 (220)
                      +++..++.|++.||+|||+++   |+||||||+|||++.+| .+||+|||+++.......   ........||+.|+|||
T Consensus       150 ~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE  226 (336)
T 4g3f_A          150 DRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE  226 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHH
Confidence            367889999999999999999   99999999999999988 599999999986543211   11122356899999999


Q ss_pred             hhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcc
Q 027675           78 YALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLL  157 (220)
Q Consensus        78 ~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  157 (220)
                      ++.+..++.++|||||||++|+|++|+.||...+......      ++........   .     ........+.++|.+
T Consensus       227 ~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~------~i~~~~~~~~---~-----~~~~~s~~~~~li~~  292 (336)
T 4g3f_A          227 VVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL------KIASEPPPIR---E-----IPPSCAPLTAQAIQE  292 (336)
T ss_dssp             HHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHH------HHHHSCCGGG---G-----SCTTSCHHHHHHHHH
T ss_pred             HHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH------HHHcCCCCch---h-----cCccCCHHHHHHHHH
Confidence            9999999999999999999999999999997544332221      1111111000   0     111223467889999


Q ss_pred             ccCCCCCCCCCHHHHHHHhcCccc
Q 027675          158 CVQEDPNDRPTMSDVVIMLGSEAV  181 (220)
Q Consensus       158 cl~~~p~~Rps~~~~l~~l~~~~~  181 (220)
                      ||+.||++|||+.|+++++.....
T Consensus       293 ~L~~dP~~R~sa~el~~~l~~~l~  316 (336)
T 4g3f_A          293 GLRKEPVHRASAMELRRKVGKALQ  316 (336)
T ss_dssp             HTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HccCCHhHCcCHHHHHHHHHHHHh
Confidence            999999999999999998865533

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=8.1e-38  Score=248.11  Aligned_cols=161  Identities=24%  Similarity=0.368  Sum_probs=126.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .++++|+.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++...............+++.|+|||.+.+
T Consensus       128 ~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~  204 (299)
T 4asz_A          128 SQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY  204 (299)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcC
Confidence            457899999999999999999   99999999999999999999999999975443222222233467889999999999


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|||||||++|||+| |+.||...+......       ....+.....+.         .....+.++|.+||+
T Consensus       205 ~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~-------~i~~~~~~~~p~---------~~~~~~~~li~~cl~  268 (299)
T 4asz_A          205 RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE-------CITQGRVLQRPR---------TCPQEVYELMLGCWQ  268 (299)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-------HHHHTCCCCCCT---------TCCHHHHHHHHHHTC
T ss_pred             CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-------HHHcCCCCCCCc---------cchHHHHHHHHHHcC
Confidence            999999999999999999998 899997655433221       122233222211         123467899999999


Q ss_pred             CCCCCCCCHHHHHHHhcCccc
Q 027675          161 EDPNDRPTMSDVVIMLGSEAV  181 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~~~  181 (220)
                      .||++|||+++|++.|+....
T Consensus       269 ~dP~~RPs~~~i~~~L~~~~~  289 (299)
T 4asz_A          269 REPHMRKNIKGIHTLLQNLAK  289 (299)
T ss_dssp             SSGGGSCCHHHHHHHHHHHHH
T ss_pred             CChhHCcCHHHHHHHHHHHHh
Confidence            999999999999999976643

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.3e-37  Score=250.54  Aligned_cols=160  Identities=29%  Similarity=0.404  Sum_probs=126.9

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ++++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++...............+|+.|+|||.+.+
T Consensus       185 ~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~  261 (353)
T 4ase_A          185 EHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD  261 (353)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhHhhCC---eecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc
Confidence            357889999999999999999   99999999999999999999999999986543333333444578899999999999


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|||||||++|||++ |..||........      ..+....+.....++.         ....+.++|.+||+
T Consensus       262 ~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~------~~~~i~~g~~~~~p~~---------~~~~~~~li~~c~~  326 (353)
T 4ase_A          262 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGTRMRAPDY---------TTPEMYQTMLDCWH  326 (353)
T ss_dssp             CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH------HHHHHHHTCCCCCCTT---------CCHHHHHHHHHHTC
T ss_pred             CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH------HHHHHHcCCCCCCCcc---------CCHHHHHHHHHHcC
Confidence            999999999999999999998 8999975443221      1122233333322221         22367889999999


Q ss_pred             CCCCCCCCHHHHHHHhcCc
Q 027675          161 EDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~  179 (220)
                      .||++|||+.+|+++|+..
T Consensus       327 ~dP~~RPt~~eil~~L~~l  345 (353)
T 4ase_A          327 GEPSQRPTFSELVEHLGNL  345 (353)
T ss_dssp             SSGGGSCCHHHHHHHHHHH
T ss_pred             cChhHCcCHHHHHHHHHHH
Confidence            9999999999999998655

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.7e-37  Score=244.48  Aligned_cols=150  Identities=26%  Similarity=0.386  Sum_probs=120.0

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++................||+.|+|||++.+.
T Consensus       133 ~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~  209 (311)
T 4aw0_A          133 CTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK  209 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHS
T ss_pred             HHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCC
Confidence            57789999999999999999   999999999999999999999999999876543333333446799999999999999


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      .++.++|||||||++|+|++|..||...+......      +... +.. ..    +.     .....+.++|.+||+.|
T Consensus       210 ~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~------~i~~-~~~-~~----p~-----~~s~~~~dli~~lL~~d  272 (311)
T 4aw0_A          210 SACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFA------KIIK-LEY-DF----PE-----KFFPKARDLVEKLLVLD  272 (311)
T ss_dssp             CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHH-TCC-CC----CT-----TCCHHHHHHHHHHSCSS
T ss_pred             CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHc-CCC-CC----Cc-----ccCHHHHHHHHHHccCC
Confidence            99999999999999999999999997655433321      1111 111 01    11     12346789999999999


Q ss_pred             CCCCCCHHHH
Q 027675          163 PNDRPTMSDV  172 (220)
Q Consensus       163 p~~Rps~~~~  172 (220)
                      |++|||++|+
T Consensus       273 p~~R~t~~e~  282 (311)
T 4aw0_A          273 ATKRLGCEEM  282 (311)
T ss_dssp             GGGSTTSGGG
T ss_pred             HhHCcChHHH
Confidence            9999999985

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3.3e-36  Score=247.92  Aligned_cols=159  Identities=23%  Similarity=0.302  Sum_probs=124.2

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +.+..++.||+.||+|||++|   |+||||||+|||++.+|.+||+|||++........  ......||+.|+|||++.+
T Consensus       247 ~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GTp~YmAPEvl~~  321 (423)
T 4fie_A          247 EQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISR  321 (423)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--CBCCCEECTTTCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc--cccccccCcCcCCHHHHCC
Confidence            357889999999999999999   99999999999999999999999999986543322  2234679999999999999


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|||||||++|+|++|+.||...+.......+       ..+...       ...........+.++|.+||+.
T Consensus       322 ~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i-------~~~~~~-------~~~~~~~~s~~~~dli~~~L~~  387 (423)
T 4fie_A          322 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-------RDNLPP-------RLKNLHKVSPSLKGFLDRLLVR  387 (423)
T ss_dssp             CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-------HHSCCC-------CCSCTTSSCHHHHHHHHHHSCS
T ss_pred             CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH-------HcCCCC-------CCcccccCCHHHHHHHHHHcCC
Confidence            99999999999999999999999999755443332111       111110       0011111234678999999999


Q ss_pred             CCCCCCCHHHHHHHhcCc
Q 027675          162 DPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~~~  179 (220)
                      ||++|||+.|+++|=+..
T Consensus       388 dP~~R~ta~ell~Hp~~~  405 (423)
T 4fie_A          388 DPAQRATAAELLKHPFLA  405 (423)
T ss_dssp             STTTSCCHHHHTTCGGGG
T ss_pred             ChhHCcCHHHHhcCHHhc
Confidence            999999999999875443

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.3e-37  Score=247.78  Aligned_cols=152  Identities=22%  Similarity=0.360  Sum_probs=120.5

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      +++.|+.||+.||+|||++|   |+||||||+|||++.+|.+||+|||+++.....  ........||+.|+|||++.+.
T Consensus       126 ~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--~~~~~~~~GT~~YmAPE~l~~~  200 (350)
T 4b9d_A          126 QILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST--VELARACIGTPYYLSPEICENK  200 (350)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH--HHHHHHHHSCCTTCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC--cccccccCCCccccCHHHHCCC
Confidence            57789999999999999999   999999999999999999999999999754321  1112335789999999999999


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      .++.++|||||||++|+|++|+.||...+......      +... +...    ..+     ......+.++|.+||+.|
T Consensus       201 ~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~------~i~~-~~~~----~~~-----~~~s~~~~~li~~~L~~d  264 (350)
T 4b9d_A          201 PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVL------KIIS-GSFP----PVS-----LHYSYDLRSLVSQLFKRN  264 (350)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH------HHHH-TCCC----CCC-----TTSCHHHHHHHHHHTCSS
T ss_pred             CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH------HHHc-CCCC----CCC-----ccCCHHHHHHHHHHccCC
Confidence            99999999999999999999999997655443321      1111 1111    111     112346789999999999


Q ss_pred             CCCCCCHHHHHHH
Q 027675          163 PNDRPTMSDVVIM  175 (220)
Q Consensus       163 p~~Rps~~~~l~~  175 (220)
                      |++|||+++++++
T Consensus       265 P~~R~s~~e~l~h  277 (350)
T 4b9d_A          265 PRDRPSVNSILEK  277 (350)
T ss_dssp             GGGSCCHHHHHTS
T ss_pred             hhHCcCHHHHhcC
Confidence            9999999999975

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.9e-36  Score=237.13  Aligned_cols=153  Identities=22%  Similarity=0.320  Sum_probs=112.9

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +.+..++.||+.||+|||+++   |+||||||+||+++.++.+||+|||++.......   ......||+.|+|||++.+
T Consensus       112 ~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~---~~~~~~GT~~Y~APE~~~~  185 (275)
T 3hyh_A          112 QEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEVISG  185 (275)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------------------CTTSCHHHHSS
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCCC---ccCCeeECcccCChhhhcC
Confidence            357889999999999999999   9999999999999999999999999997543321   2233578999999999998


Q ss_pred             CCC-cccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFF-SVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..+ +.++|||||||++|+|++|+.||...+.......      . ..+.. .    .+.     .....+.++|.+||+
T Consensus       186 ~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~------i-~~~~~-~----~p~-----~~s~~~~~li~~~L~  248 (275)
T 3hyh_A          186 KLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKN------I-SNGVY-T----LPK-----FLSPGAAGLIKRMLI  248 (275)
T ss_dssp             SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------H-HHTCC-C----CCT-----TSCHHHHHHHHHHSC
T ss_pred             CCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHH------H-HcCCC-C----CCC-----CCCHHHHHHHHHHcc
Confidence            876 5789999999999999999999975543332211      1 11111 0    111     123467899999999


Q ss_pred             CCCCCCCCHHHHHHHhc
Q 027675          161 EDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~  177 (220)
                      .||++|||++|+++|=+
T Consensus       249 ~dP~~R~s~~eil~hpw  265 (275)
T 3hyh_A          249 VNPLNRISIHEIMQDDW  265 (275)
T ss_dssp             SSGGGSCCHHHHHHCHH
T ss_pred             CChhHCcCHHHHHcCcc
Confidence            99999999999998754

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4.6e-36  Score=237.95  Aligned_cols=155  Identities=24%  Similarity=0.294  Sum_probs=119.7

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..+..++.|++.||+|||+++   |+||||||+|||++.+|.+||+|||+++.......  ......||+.|+|||++.+
T Consensus       126 ~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GT~~YmAPE~~~~  200 (304)
T 3ubd_A          126 EDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNR  200 (304)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-----C--CCCSCCCCGGGCCHHHHHT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccCCCc--cccccccCcccCCHHHhcc
Confidence            357789999999999999999   99999999999999999999999999975432221  1223578999999999999


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|||||||++|+|++|+.||...+.......      .. .+..     ..+.     ..+..+.++|.+||+.
T Consensus       201 ~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~------i~-~~~~-----~~p~-----~~s~~~~~li~~~L~~  263 (304)
T 3ubd_A          201 RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTM------IL-KAKL-----GMPQ-----FLSPEAQSLLRMLFKR  263 (304)
T ss_dssp             SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HH-HCCC-----CCCT-----TSCHHHHHHHHHHTCS
T ss_pred             CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHH------HH-cCCC-----CCCC-----cCCHHHHHHHHHHccc
Confidence            9999999999999999999999999976554433221      11 1111     0111     1234678999999999


Q ss_pred             CCCCCCC-----HHHHHHHhcC
Q 027675          162 DPNDRPT-----MSDVVIMLGS  178 (220)
Q Consensus       162 ~p~~Rps-----~~~~l~~l~~  178 (220)
                      ||++|||     ++++++|-+.
T Consensus       264 dP~~R~ta~~~~~~eil~Hp~f  285 (304)
T 3ubd_A          264 NPANRLGAGPDGVEEIKRHSFF  285 (304)
T ss_dssp             SGGGSTTCSTTTHHHHHTSGGG
T ss_pred             CHHHCCCCCcCCHHHHHcCccc
Confidence            9999998     4789876543

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1e-35  Score=234.70  Aligned_cols=156  Identities=22%  Similarity=0.353  Sum_probs=116.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeC-CCCCceecCccceeeecCCCCCcccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLD-HEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~   80 (220)
                      +.+..|+.||+.||+|||+++ ..|+||||||+|||++ .++.+||+|||++.....    .......||+.|+|||++.
T Consensus       129 ~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~----~~~~~~~GTp~YmAPE~~~  203 (290)
T 3fpq_A          129 KVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAPEMYE  203 (290)
T ss_dssp             HHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT----TSBEESCSSCCCCCGGGGG
T ss_pred             HHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC----CccCCcccCccccCHHHcC
Confidence            357789999999999999874 2399999999999997 478999999999974322    1233467999999999987


Q ss_pred             cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           81 GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      + .++.++|||||||++|+|++|+.||.........      .+....+......        .......+.++|.+||+
T Consensus       204 ~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~------~~~i~~~~~~~~~--------~~~~~~~~~~li~~~L~  268 (290)
T 3fpq_A          204 E-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI------YRRVTSGVKPASF--------DKVAIPEVKEIIEGCIR  268 (290)
T ss_dssp             T-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH------HHHHTTTCCCGGG--------GGCCCHHHHHHHHHHSC
T ss_pred             C-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHH------HHHHHcCCCCCCC--------CccCCHHHHHHHHHHcc
Confidence            6 5899999999999999999999999643322211      1111111111111        11112357889999999


Q ss_pred             CCCCCCCCHHHHHHHhc
Q 027675          161 EDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~  177 (220)
                      .||++|||++++++|=+
T Consensus       269 ~dP~~R~s~~e~l~Hp~  285 (290)
T 3fpq_A          269 QNKDERYSIKDLLNHAF  285 (290)
T ss_dssp             SSGGGSCCHHHHHTSGG
T ss_pred             CChhHCcCHHHHhcCcc
Confidence            99999999999998744

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.2e-35  Score=234.99  Aligned_cols=176  Identities=23%  Similarity=0.236  Sum_probs=121.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCC-----CCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCC--cccceeecccCcc
Q 027675            2 EMLFNIILGVSRRLLYLHQDS-----KLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD--GTTNRVVGTYGYM   74 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~-----~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~y~   74 (220)
                      +.+++++.|++.||+|||+++     ...|+||||||+|||++.++.+||+|||+++........  .......||+.|+
T Consensus       100 ~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ym  179 (303)
T 3hmm_A          100 EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM  179 (303)
T ss_dssp             HHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGC
T ss_pred             HHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeeccccccccccc
Confidence            467899999999999999871     112999999999999999999999999999865433221  1222356899999


Q ss_pred             ChhhhhcC------CCcccCceeehhHHHHHHHhcCccCcccchhHHH--------hhHHHHHHHHHhccccccccCCCC
Q 027675           75 SPEYALGG------FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELAL--------SLLGYAWKLWQEGKALDMMDQKPG  140 (220)
Q Consensus        75 aPe~~~~~------~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~  140 (220)
                      |||++.+.      .++.++|||||||++|||++|.+||.........        .......+.........   ..+.
T Consensus       180 APE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp---~~p~  256 (303)
T 3hmm_A          180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRP---NIPN  256 (303)
T ss_dssp             CHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCC---CCCG
T ss_pred             CHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCC---CCCc
Confidence            99999764      3577899999999999999998877533221100        00011111111111110   1111


Q ss_pred             CcCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcCcc
Q 027675          141 AISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEA  180 (220)
Q Consensus       141 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~~  180 (220)
                      ..........+.++|.+||+.||++|||+.+|++.|+...
T Consensus       257 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~  296 (303)
T 3hmm_A          257 RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            1223345567889999999999999999999999997653

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.6e-34  Score=229.37  Aligned_cols=155  Identities=23%  Similarity=0.334  Sum_probs=109.1

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCC----------cccceeecccC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD----------GTTNRVVGTYG   72 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~----------~~~~~~~~~~~   72 (220)
                      .++.++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++........          .......||+.
T Consensus       119 ~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~  195 (299)
T 4g31_A          119 VCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKL  195 (299)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCT
T ss_pred             HHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCcc
Confidence            36789999999999999999   999999999999999999999999999765432111          11123468999


Q ss_pred             ccChhhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHH
Q 027675           73 YMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCI  152 (220)
Q Consensus        73 y~aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (220)
                      |+|||++.+..++.++|||||||++|||++   ||....  .....   .... .....         ............
T Consensus       196 YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~~---~~~~-~~~~~---------p~~~~~~~~~~~  257 (299)
T 4g31_A          196 YMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--ERVRT---LTDV-RNLKF---------PPLFTQKYPCEY  257 (299)
T ss_dssp             TSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHHH---HHHH-HTTCC---------CHHHHHHCHHHH
T ss_pred             ccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHHH---HHHH-hcCCC---------CCCCcccCHHHH
Confidence            999999999999999999999999999995   654211  11100   0111 11110         011122334567


Q ss_pred             HHhccccCCCCCCCCCHHHHHHHhcC
Q 027675          153 NVGLLCVQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       153 ~li~~cl~~~p~~Rps~~~~l~~l~~  178 (220)
                      ++|.+||+.||++|||+.+++++-+.
T Consensus       258 ~li~~~L~~dP~~Rps~~eil~h~~~  283 (299)
T 4g31_A          258 VMVQDMLSPSPMERPEAINIIENAVF  283 (299)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred             HHHHHHcCCChhHCcCHHHHhcCHhh
Confidence            89999999999999999999986543

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.1e-34  Score=235.11  Aligned_cols=175  Identities=20%  Similarity=0.214  Sum_probs=122.5

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCC--CCcccceeecccCccChhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQ--TDGTTNRVVGTYGYMSPEYA   79 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~y~aPe~~   79 (220)
                      +.+..+++||+.||.|||++|   |+||||||+|||++.++.+||+|||+++......  .........||+.|+|||++
T Consensus       158 ~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~  234 (398)
T 4b99_A          158 EHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELM  234 (398)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHh
Confidence            357889999999999999999   9999999999999999999999999997543211  11222335789999999998


Q ss_pred             hcC-CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHH--------HhccccccccCC-CCCcCcH----
Q 027675           80 LGG-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLW--------QEGKALDMMDQK-PGAISKA----  145 (220)
Q Consensus        80 ~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~-~~~~~~~----  145 (220)
                      .+. .++.++||||+||++|+|++|++||...+.......+.......        ............ .......    
T Consensus       235 ~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (398)
T 4b99_A          235 LSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVY  314 (398)
T ss_dssp             TTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHS
T ss_pred             cCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhC
Confidence            875 46899999999999999999999997665544433221110000        000000000000 0001111    


Q ss_pred             -HHHHHHHHHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          146 -NEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       146 -~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                       .....+.+||.+||..||++|||++++++|=+..
T Consensus       315 ~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~  349 (398)
T 4b99_A          315 PGADRQALSLLGRMLRFEPSARISAAAALRHPFLA  349 (398)
T ss_dssp             TTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGT
T ss_pred             CCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhC
Confidence             1234678999999999999999999999875443

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3e-33  Score=224.20  Aligned_cols=177  Identities=32%  Similarity=0.519  Sum_probs=139.5

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++................+++.|+|||.+.+
T Consensus       139 ~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  215 (321)
T 2qkw_B          139 EQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIK  215 (321)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcC
Confidence            467889999999999999999   99999999999999999999999999876443222222333457889999999998


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+||||+++|+|++|+.||.............+.......+......+..............+.+++.+||+.
T Consensus       216 ~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  295 (321)
T 2qkw_B          216 GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLAL  295 (321)
T ss_dssp             CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCS
T ss_pred             CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCC
Confidence            88999999999999999999999998754443333333333333334444444455444555677888999999999999


Q ss_pred             CCCCCCCHHHHHHHhcCccc
Q 027675          162 DPNDRPTMSDVVIMLGSEAV  181 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~~~~~  181 (220)
                      ||++|||+.+++++|+...+
T Consensus       296 dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          296 SSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             SGGGSCCHHHHHHHHHHHHH
T ss_pred             CcccCcCHHHHHHHHHHHhh
Confidence            99999999999999976643

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.7e-33  Score=227.75  Aligned_cols=106  Identities=26%  Similarity=0.362  Sum_probs=86.7

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCC-CCceecCccceeeecCCCCC-------------------
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHE-MNPKISDFGLTRIFEGKQTD-------------------   61 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~-~~~~l~d~~~~~~~~~~~~~-------------------   61 (220)
                      +++..+++||+.||+|||++|   |+||||||+|||++.+ +.+||+|||+++........                   
T Consensus       117 ~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (361)
T 4f9c_A          117 QEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKC  193 (361)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccc
Confidence            467889999999999999999   9999999999999876 78999999999754321110                   


Q ss_pred             -------cccceeecccCccChhhhhcC-CCcccCceeehhHHHHHHHhcCccCccc
Q 027675           62 -------GTTNRVVGTYGYMSPEYALGG-FFSVKSDVFSFGVVVLEIISGKRNTGFY  110 (220)
Q Consensus        62 -------~~~~~~~~~~~y~aPe~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~  110 (220)
                             .......||+.|+|||++.+. .++.++||||+||++|+|++|+.||...
T Consensus       194 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~  250 (361)
T 4f9c_A          194 SICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA  250 (361)
T ss_dssp             ------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred             cccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence                   011224689999999999876 4789999999999999999999998543

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.97  E-value=4.4e-32  Score=217.74  Aligned_cols=175  Identities=40%  Similarity=0.607  Sum_probs=136.4

Q ss_pred             chHHHHHHHHHHHHHHhhhC---CCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhh
Q 027675            2 EMLFNIILGVSRRLLYLHQD---SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEY   78 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~---~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~   78 (220)
                      ..++.++.|++.||.|||+.   +   ++||||||+||+++.++.++|+|||++........ .......+++.|+|||.
T Consensus       131 ~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~  206 (326)
T 3uim_A          131 PKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEY  206 (326)
T ss_dssp             HHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEECTTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEECCCCCEEeccCccccccCcccc-cccccccCCcCccCHHH
Confidence            35788999999999999999   8   99999999999999999999999999976543222 22233457899999999


Q ss_pred             hhcCCCcccCceeehhHHHHHHHhcCccCcccchh--HHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhc
Q 027675           79 ALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSE--LALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGL  156 (220)
Q Consensus        79 ~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  156 (220)
                      +.+..++.++||||||+++|+|++|..||......  .......+..............+..............+.+++.
T Consensus       207 ~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  286 (326)
T 3uim_A          207 LSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVAL  286 (326)
T ss_dssp             HHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHH
T ss_pred             hccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHH
Confidence            98888899999999999999999999999632211  1111222333333334444444555555666778889999999


Q ss_pred             cccCCCCCCCCCHHHHHHHhcCcc
Q 027675          157 LCVQEDPNDRPTMSDVVIMLGSEA  180 (220)
Q Consensus       157 ~cl~~~p~~Rps~~~~l~~l~~~~  180 (220)
                      +||+.||++|||+.+++++|+...
T Consensus       287 ~cl~~dP~~Rps~~ell~~L~~~~  310 (326)
T 3uim_A          287 LCTQSSPMERPKMSEVVRMLEGDG  310 (326)
T ss_dssp             HHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred             HHhCcCCccCCCHHHHHHHhcCcc
Confidence            999999999999999999997653

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.97  E-value=1.1e-31  Score=212.56  Aligned_cols=173  Identities=16%  Similarity=0.142  Sum_probs=127.6

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCC-----ceecCccceeeecCCCCC-----cccceeeccc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMN-----PKISDFGLTRIFEGKQTD-----GTTNRVVGTY   71 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~-----~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~   71 (220)
                      ..++.++.|++.||.|||+++   ++||||||+||+++.++.     ++|+|||++.........     .......+++
T Consensus       106 ~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~  182 (298)
T 1csn_A          106 KTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA  182 (298)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCT
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCc
Confidence            467899999999999999999   999999999999987766     999999999865433221     1123356789


Q ss_pred             CccChhhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHH
Q 027675           72 GYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKC  151 (220)
Q Consensus        72 ~y~aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (220)
                      .|.|||.+.+..++.++||||||+++|+|++|+.||.............................         .....+
T Consensus       183 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~l  253 (298)
T 1csn_A          183 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA---------GFPEEF  253 (298)
T ss_dssp             TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTT---------TSCHHH
T ss_pred             ccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHh---------hCcHHH
Confidence            99999999998899999999999999999999999976443322222211111111111111100         112477


Q ss_pred             HHHhccccCCCCCCCCCHHHHHHHhcCccccCCCC
Q 027675          152 INVGLLCVQEDPNDRPTMSDVVIMLGSEAVNLASP  186 (220)
Q Consensus       152 ~~li~~cl~~~p~~Rps~~~~l~~l~~~~~~~~~~  186 (220)
                      .+++.+||+.||++||+++++++.|+.........
T Consensus       254 ~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~  288 (298)
T 1csn_A          254 YKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT  288 (298)
T ss_dssp             HHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCC
Confidence            89999999999999999999999997765544433

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.97  E-value=7.2e-32  Score=231.29  Aligned_cols=157  Identities=23%  Similarity=0.249  Sum_probs=122.0

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCC--CCceecCccceeeecCCCCCcccceeecccCccChhhhh
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHE--MNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~--~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~   80 (220)
                      ++..++.||+.||+|||+++   |+||||||+||+++.+  +.+||+|||++.......   ......||+.|+|||++.
T Consensus       256 ~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~---~~~~~~GT~~y~APEv~~  329 (573)
T 3uto_A          256 EAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAE  329 (573)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS---EEEEECSSGGGCCHHHHT
T ss_pred             HHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC---ceeeeEECccccCHHHhC
Confidence            57889999999999999999   9999999999999854  789999999998754322   223357899999999999


Q ss_pred             cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           81 GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      +..++.++|||||||++|+|++|..||...+.......+      . .+..      .............+.+||.+||.
T Consensus       330 ~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i------~-~~~~------~~~~~~~~~~s~~~~dli~~~L~  396 (573)
T 3uto_A          330 GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV------K-SCDW------NMDDSAFSGISEDGKDFIRKLLL  396 (573)
T ss_dssp             TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH------H-TTCC------CCCSGGGTTSCHHHHHHHHTTSC
T ss_pred             CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH------H-hCCC------CCCcccccCCCHHHHHHHHHHcc
Confidence            999999999999999999999999999765554332211      1 1100      00000111123467899999999


Q ss_pred             CCCCCCCCHHHHHHHhcC
Q 027675          161 EDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~  178 (220)
                      .||++|||+.|+++|=+.
T Consensus       397 ~dp~~R~t~~e~l~Hpw~  414 (573)
T 3uto_A          397 ADPNTRMTIHQALEHPWL  414 (573)
T ss_dssp             SSGGGSCCHHHHHHSTTT
T ss_pred             CChhHCcCHHHHhcCcCc
Confidence            999999999999997543

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.97  E-value=8.3e-32  Score=216.32  Aligned_cols=162  Identities=22%  Similarity=0.349  Sum_probs=123.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++................++..|+|||.+.+
T Consensus       115 ~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  191 (325)
T 3kex_A          115 QLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF  191 (325)
T ss_dssp             THHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhcc
Confidence            467899999999999999999   99999999999999999999999999976543333333334556778999999998


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++|+|++ |..||...........       ...+........         ....+.++|.+||.
T Consensus       192 ~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-------~~~~~~~~~~~~---------~~~~~~~li~~~l~  255 (325)
T 3kex_A          192 GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL-------LEKGERLAQPQI---------CTIDVYMVMVKCWM  255 (325)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHH-------HHTTCBCCCCTT---------BCTTTTHHHHHHTC
T ss_pred             CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHH-------HHcCCCCCCCCc---------CcHHHHHHHHHHcC
Confidence            889999999999999999999 9999976544332211       112222111111         11246788899999


Q ss_pred             CCCCCCCCHHHHHHHhcCcccc
Q 027675          161 EDPNDRPTMSDVVIMLGSEAVN  182 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~~~~  182 (220)
                      .||++||++.+++++|......
T Consensus       256 ~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          256 IDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             SCTTTSCCHHHHHHHHHHHTTS
T ss_pred             CChhhCcCHHHHHHHHHHHHhc
Confidence            9999999999999999776543

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.97  E-value=9.7e-33  Score=222.06  Aligned_cols=161  Identities=22%  Similarity=0.398  Sum_probs=118.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++................++..|+|||.+.+
T Consensus       117 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  193 (327)
T 3lzb_A          117 QYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH  193 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcC
Confidence            357889999999999999999   99999999999999999999999999876543322222222345668999999999


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++||||||+++|+|++ |..||...........       ...+.....         .......+.++|.+||.
T Consensus       194 ~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~-------~~~~~~~~~---------~~~~~~~l~~li~~~l~  257 (327)
T 3lzb_A          194 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-------LEKGERLPQ---------PPICTIDVYMIMRKCWM  257 (327)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-------HHTTCCCCC---------CTTBCHHHHHHHHHHTC
T ss_pred             CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH-------HHcCCCCCC---------CccCCHHHHHHHHHHcC
Confidence            999999999999999999999 9999976554443221       111111111         11123367889999999


Q ss_pred             CCCCCCCCHHHHHHHhcCccc
Q 027675          161 EDPNDRPTMSDVVIMLGSEAV  181 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~~~  181 (220)
                      .||++||++.++++.|+....
T Consensus       258 ~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          258 IDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             SSGGGSCCHHHHHHHHHHHHT
T ss_pred             CChhHCcCHHHHHHHHHHHHh
Confidence            999999999999999976643

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.97  E-value=7.5e-32  Score=214.07  Aligned_cols=159  Identities=25%  Similarity=0.348  Sum_probs=123.0

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++........  ......+++.|+|||.+.+
T Consensus       116 ~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~  190 (297)
T 3fxz_A          116 GQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTR  190 (297)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCGGGCCHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--ccCCccCCcCccChhhhcC
Confidence            357889999999999999999   99999999999999999999999999876543222  2223567899999999999


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++||||||+++|+|++|..||...+........      ...+.        +...........+.++|.+||+.
T Consensus       191 ~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~------~~~~~--------~~~~~~~~~~~~~~~li~~~l~~  256 (297)
T 3fxz_A          191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI------ATNGT--------PELQNPEKLSAIFRDFLNRCLEM  256 (297)
T ss_dssp             SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------HHHCS--------CCCSCGGGSCHHHHHHHHHHSCS
T ss_pred             CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhCCC--------CCCCCccccCHHHHHHHHHHccC
Confidence            99999999999999999999999999755443322111      11111        01111112234678999999999


Q ss_pred             CCCCCCCHHHHHHHhcCc
Q 027675          162 DPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~~~  179 (220)
                      ||++|||+++++++-+..
T Consensus       257 dp~~Rps~~ell~h~~~~  274 (297)
T 3fxz_A          257 DVEKRGSAKELLQHQFLK  274 (297)
T ss_dssp             STTTSCCHHHHTTCGGGG
T ss_pred             ChhHCcCHHHHhhChhhc
Confidence            999999999999876544

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=99.97  E-value=4.9e-32  Score=233.07  Aligned_cols=156  Identities=24%  Similarity=0.243  Sum_probs=119.5

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhh-c
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL-G   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~-~   81 (220)
                      .+..++.||+.||+|||++|   |+||||||+|||++.+|.+||+|||++.......    .....||+.|+|||++. +
T Consensus       293 ~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~  365 (689)
T 3v5w_A          293 DMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKG  365 (689)
T ss_dssp             HHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTT
T ss_pred             HHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecCCCC----CCCccCCcCccCHHHHhCC
Confidence            56789999999999999999   9999999999999999999999999998654322    22357999999999996 4


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+|||||++|+|++|.+||...+........   .... ....     ..+.     ..+..+.++|.+||+.
T Consensus       366 ~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~---~~i~-~~~~-----~~p~-----~~S~~a~dLI~~lL~~  431 (689)
T 3v5w_A          366 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---RMTL-TMAV-----ELPD-----SFSPELRSLLEGLLQR  431 (689)
T ss_dssp             CCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHH---HHHH-HCCC-----CCCT-----TSCHHHHHHHHHHTCS
T ss_pred             CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---Hhhc-CCCC-----CCCc-----cCCHHHHHHHHHHccC
Confidence            57899999999999999999999999654332221111   1111 1110     0111     1234678999999999


Q ss_pred             CCCCCCC-----HHHHHHHhcCc
Q 027675          162 DPNDRPT-----MSDVVIMLGSE  179 (220)
Q Consensus       162 ~p~~Rps-----~~~~l~~l~~~  179 (220)
                      ||++|++     +++|++|-+..
T Consensus       432 dP~~Rl~~~~~ga~ei~~HpfF~  454 (689)
T 3v5w_A          432 DVNRRLGCLGRGAQEVKESPFFR  454 (689)
T ss_dssp             CGGGCTTCSSSTHHHHTTSGGGT
T ss_pred             CHhHCCCCCCCCHHHHhcCcccc
Confidence            9999998     79999776443

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.97  E-value=8.2e-32  Score=220.11  Aligned_cols=159  Identities=28%  Similarity=0.364  Sum_probs=123.5

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++................+++.|+|||.+.+
T Consensus       203 ~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  279 (370)
T 2psq_A          203 KDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD  279 (370)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC
Confidence            356789999999999999999   99999999999999999999999999986543322222222345678999999999


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+|||||++|+|++ |..||..........       ....+......         ......+.++|.+||+
T Consensus       280 ~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~-------~~~~~~~~~~~---------~~~~~~l~~li~~~l~  343 (370)
T 2psq_A          280 RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK-------LLKEGHRMDKP---------ANCTNELYMMMRDCWH  343 (370)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-------HHHTTCCCCCC---------TTSCHHHHHHHHHHTC
T ss_pred             CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-------HHhcCCCCCCC---------CCCCHHHHHHHHHHcC
Confidence            889999999999999999998 999987654433221       11122211111         1123468899999999


Q ss_pred             CCCCCCCCHHHHHHHhcCc
Q 027675          161 EDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~  179 (220)
                      .||++||++.++++.|+..
T Consensus       344 ~dP~~Rpt~~ell~~L~~i  362 (370)
T 2psq_A          344 AVPSQRPTFKQLVEDLDRI  362 (370)
T ss_dssp             SSGGGSCCHHHHHHHHHHH
T ss_pred             CChhhCcCHHHHHHHHHHH
Confidence            9999999999999999765

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.97  E-value=2.2e-32  Score=219.90  Aligned_cols=161  Identities=22%  Similarity=0.407  Sum_probs=123.2

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++................++..|+|||.+.+
T Consensus       117 ~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  193 (327)
T 3poz_A          117 QYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH  193 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhcc
Confidence            357889999999999999999   99999999999999999999999999876543333222233345678999999999


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++||||||+++|+|++ |..||...........       ...+.....         .......+.+++.+||+
T Consensus       194 ~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-------~~~~~~~~~---------~~~~~~~~~~li~~~l~  257 (327)
T 3poz_A          194 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-------LEKGERLPQ---------PPICTIDVYMIMVKCWM  257 (327)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-------HHTTCCCCC---------CTTBCHHHHHHHHHHTC
T ss_pred             CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHH-------HHcCCCCCC---------CccCCHHHHHHHHHHcC
Confidence            999999999999999999999 9999976554433221       111111111         11123467889999999


Q ss_pred             CCCCCCCCHHHHHHHhcCccc
Q 027675          161 EDPNDRPTMSDVVIMLGSEAV  181 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~~~  181 (220)
                      .||++||++.+++++|+....
T Consensus       258 ~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          258 IDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             SCGGGSCCHHHHHHHHHHHHT
T ss_pred             CChhhCCCHHHHHHHHHHHHh
Confidence            999999999999999876644

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.97  E-value=4.5e-32  Score=217.66  Aligned_cols=173  Identities=27%  Similarity=0.317  Sum_probs=124.9

Q ss_pred             chHHHHHHHHHHHHHHhhhC----------CCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeeccc
Q 027675            2 EMLFNIILGVSRRLLYLHQD----------SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTY   71 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~----------~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~   71 (220)
                      ..++.++.|++.||.|||+.          +   ++||||||+||+++.++.+||+|||++................+++
T Consensus       121 ~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~  197 (322)
T 3soc_A          121 NELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTR  197 (322)
T ss_dssp             HHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCG
T ss_pred             HHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCc
Confidence            46789999999999999999          8   9999999999999999999999999998765443333333356789


Q ss_pred             CccChhhhhcC-----CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhH---------HHHHHHHHhccccccccC
Q 027675           72 GYMSPEYALGG-----FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLL---------GYAWKLWQEGKALDMMDQ  137 (220)
Q Consensus        72 ~y~aPe~~~~~-----~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~  137 (220)
                      .|+|||.+.+.     .++.++|||||||++|+|++|..||............         ..............   .
T Consensus       198 ~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~  274 (322)
T 3soc_A          198 RYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRP---V  274 (322)
T ss_dssp             GGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCC---C
T ss_pred             cccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCC---C
Confidence            99999999863     4567889999999999999999998653322111110         00011111111110   0


Q ss_pred             CCCCcCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcCcc
Q 027675          138 KPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEA  180 (220)
Q Consensus       138 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~~  180 (220)
                      .............+.++|.+||+.||++|||+.++++.|+...
T Consensus       275 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~  317 (322)
T 3soc_A          275 LRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ  317 (322)
T ss_dssp             CCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            1111122334566899999999999999999999999997653

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.97  E-value=2.7e-31  Score=213.34  Aligned_cols=161  Identities=26%  Similarity=0.318  Sum_probs=121.0

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||+|||+.|   |+||||||+||+++.++.++|+|||++................|++.|+|||.+.+
T Consensus       105 ~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  181 (323)
T 3tki_A          105 PDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR  181 (323)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhcc
Confidence            367899999999999999999   99999999999999999999999999875432222222233567899999999988


Q ss_pred             CCC-cccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFF-SVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..+ +.++||||||+++|+|++|..||...........      ........        ..........+.++|.+||.
T Consensus       182 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~------~~~~~~~~--------~~~~~~~~~~~~~li~~~L~  247 (323)
T 3tki_A          182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS------DWKEKKTY--------LNPWKKIDSAPLALLHKILV  247 (323)
T ss_dssp             SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHH------HHHTTCTT--------STTGGGSCHHHHHHHHHHSC
T ss_pred             CCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHH------HHhccccc--------CCccccCCHHHHHHHHHHcc
Confidence            765 7789999999999999999999975443221110      00011000        00011123467789999999


Q ss_pred             CCCCCCCCHHHHHHHhcCc
Q 027675          161 EDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~  179 (220)
                      .||++|||+++++++-+..
T Consensus       248 ~dP~~R~t~~eil~h~~~~  266 (323)
T 3tki_A          248 ENPSARITIPDIKKDRWYN  266 (323)
T ss_dssp             SSTTTSCCHHHHTTCTTTT
T ss_pred             CChhhCcCHHHHhhChhhc
Confidence            9999999999999886544

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.97  E-value=3e-31  Score=209.81  Aligned_cols=171  Identities=19%  Similarity=0.169  Sum_probs=125.9

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceee---CCCCCceecCccceeeecCCCCC-----cccceeecccCc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILL---DHEMNPKISDFGLTRIFEGKQTD-----GTTNRVVGTYGY   73 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili---~~~~~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~y   73 (220)
                      ..++.++.|++.||.|||+++   ++||||||+||++   +.++.++|+|||++.........     .......+++.|
T Consensus       105 ~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y  181 (296)
T 4hgt_A          105 KTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY  181 (296)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGG
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccc
Confidence            467899999999999999999   9999999999999   78889999999999865433221     112235678999


Q ss_pred             cChhhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHH
Q 027675           74 MSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCIN  153 (220)
Q Consensus        74 ~aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (220)
                      +|||.+.+..++.++||||||+++|+|++|..||.............................         .....+.+
T Consensus       182 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~l~~  252 (296)
T 4hgt_A          182 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK---------GYPSEFAT  252 (296)
T ss_dssp             CCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTT---------TSCHHHHH
T ss_pred             cchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhc---------cCCHHHHH
Confidence            999999998899999999999999999999999975433222111111111110100000000         01236889


Q ss_pred             HhccccCCCCCCCCCHHHHHHHhcCccccCC
Q 027675          154 VGLLCVQEDPNDRPTMSDVVIMLGSEAVNLA  184 (220)
Q Consensus       154 li~~cl~~~p~~Rps~~~~l~~l~~~~~~~~  184 (220)
                      ++.+||+.||++|||+.++++.|+.......
T Consensus       253 li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~  283 (296)
T 4hgt_A          253 YLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             HHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence            9999999999999999999999977655443

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.97  E-value=2.8e-31  Score=212.01  Aligned_cols=167  Identities=25%  Similarity=0.394  Sum_probs=117.2

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .++.++.|++.||+|||+++ .+++||||||+||+++.++.++|+|||++.......  .......+++.|+|||.+.+.
T Consensus       138 ~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~  214 (309)
T 3p86_A          138 RRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDE  214 (309)
T ss_dssp             HHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-------------------CCTTSCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccccc--cccccCCCCccccChhhhcCC
Confidence            57889999999999999985 249999999999999999999999999986533221  112234678899999999998


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      .++.++|+||||+++|+|++|..||...+........      ..........         ......+.++|.+||+.|
T Consensus       215 ~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~------~~~~~~~~~~---------~~~~~~l~~li~~~l~~d  279 (309)
T 3p86_A          215 PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV------GFKCKRLEIP---------RNLNPQVAAIIEGCWTNE  279 (309)
T ss_dssp             CCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH------HHSCCCCCCC---------TTSCHHHHHHHHHHTCSS
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhcCCCCCCC---------ccCCHHHHHHHHHHccCC
Confidence            8999999999999999999999999765544332211      1111111111         112236789999999999


Q ss_pred             CCCCCCHHHHHHHhcCccccCCCCC
Q 027675          163 PNDRPTMSDVVIMLGSEAVNLASPK  187 (220)
Q Consensus       163 p~~Rps~~~~l~~l~~~~~~~~~~~  187 (220)
                      |++|||+.++++.|+.......+++
T Consensus       280 P~~Rps~~~ll~~L~~~~~~~~p~~  304 (309)
T 3p86_A          280 PWKRPSFATIMDLLRPLIKSAVPPP  304 (309)
T ss_dssp             GGGSCCHHHHHHHHHHHHC------
T ss_pred             hhhCcCHHHHHHHHHHHHHhCCCCC
Confidence            9999999999999977765544443

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.97  E-value=7e-31  Score=211.26  Aligned_cols=169  Identities=18%  Similarity=0.161  Sum_probs=124.9

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCC-----ceecCccceeeecCCCCCc-----ccceeeccc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMN-----PKISDFGLTRIFEGKQTDG-----TTNRVVGTY   71 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~-----~~l~d~~~~~~~~~~~~~~-----~~~~~~~~~   71 (220)
                      .+++.++.|++.||+|||+.+   |+||||||+||+++.++.     ++|+|||++..........     ......|++
T Consensus       105 ~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~  181 (330)
T 2izr_A          105 KTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTA  181 (330)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCT
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCc
Confidence            467889999999999999999   999999999999998887     9999999998654322111     123356889


Q ss_pred             CccChhhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHH
Q 027675           72 GYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKC  151 (220)
Q Consensus        72 ~y~aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (220)
                      .|+|||.+.+..++.++|+||||+++|+|++|..||..............+............   .  .    ... .+
T Consensus       182 ~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~---~--~----~~p-~~  251 (330)
T 2izr_A          182 RYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVL---C--E----NFP-EM  251 (330)
T ss_dssp             TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHH---T--T----TCH-HH
T ss_pred             cccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHH---h--c----cCh-HH
Confidence            999999999998999999999999999999999999765433322222111111100000000   0  0    011 67


Q ss_pred             HHHhccccCCCCCCCCCHHHHHHHhcCccccC
Q 027675          152 INVGLLCVQEDPNDRPTMSDVVIMLGSEAVNL  183 (220)
Q Consensus       152 ~~li~~cl~~~p~~Rps~~~~l~~l~~~~~~~  183 (220)
                      .+++..||+.||.+||+++++++.|.......
T Consensus       252 ~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~  283 (330)
T 2izr_A          252 ATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK  283 (330)
T ss_dssp             HHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence            88999999999999999999999886554433

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.97  E-value=5.2e-31  Score=208.48  Aligned_cols=175  Identities=18%  Similarity=0.156  Sum_probs=126.9

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeC---CCCCceecCccceeeecCCCCC-----cccceeecccCc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLD---HEMNPKISDFGLTRIFEGKQTD-----GTTNRVVGTYGY   73 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~---~~~~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~y   73 (220)
                      ..++.++.|++.||.|||+++   ++||||||+||+++   .++.++|+|||++.........     .......++..|
T Consensus       105 ~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y  181 (296)
T 3uzp_A          105 KTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY  181 (296)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTT
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccccccccccccccccccc
Confidence            367889999999999999999   99999999999994   7888999999998865433221     112335678899


Q ss_pred             cChhhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHH
Q 027675           74 MSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCIN  153 (220)
Q Consensus        74 ~aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (220)
                      .|||.+.+..++.++||||||+++|+|++|+.||.............................         .....+.+
T Consensus       182 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~l~~  252 (296)
T 3uzp_A          182 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK---------GYPSEFAT  252 (296)
T ss_dssp             CCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTT---------TSCHHHHH
T ss_pred             CChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHh---------hCCHHHHH
Confidence            999999998899999999999999999999999975432211111111111110100000000         11236888


Q ss_pred             HhccccCCCCCCCCCHHHHHHHhcCccccCCCCCC
Q 027675          154 VGLLCVQEDPNDRPTMSDVVIMLGSEAVNLASPKR  188 (220)
Q Consensus       154 li~~cl~~~p~~Rps~~~~l~~l~~~~~~~~~~~~  188 (220)
                      ++.+||+.||++|||+.++++.|+...........
T Consensus       253 li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~  287 (296)
T 3uzp_A          253 YLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD  287 (296)
T ss_dssp             HHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSS
T ss_pred             HHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccc
Confidence            99999999999999999999999776555444433

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.97  E-value=5.1e-31  Score=216.23  Aligned_cols=167  Identities=28%  Similarity=0.350  Sum_probs=128.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++................+++.|+|||.+.+
T Consensus       191 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  267 (382)
T 3tt0_A          191 KDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD  267 (382)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC
Confidence            357899999999999999999   99999999999999999999999999876543322222233455778999999999


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++||||||+++|+|++ |..||.........       .....+......         ......+.++|.+||+
T Consensus       268 ~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~-------~~~~~~~~~~~~---------~~~~~~l~~li~~~l~  331 (382)
T 3tt0_A          268 RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF-------KLLKEGHRMDKP---------SNCTNELYMMMRDCWH  331 (382)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-------HHHHTTCCCCCC---------SSCCHHHHHHHHHHTC
T ss_pred             CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCCCCCCC---------ccCCHHHHHHHHHHcC
Confidence            989999999999999999999 99998765543322       111222211111         1123367889999999


Q ss_pred             CCCCCCCCHHHHHHHhcCccccCCCCC
Q 027675          161 EDPNDRPTMSDVVIMLGSEAVNLASPK  187 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~~~~~~~~~  187 (220)
                      .||++|||+++++++|+..........
T Consensus       332 ~dP~~Rps~~ell~~L~~~~~~~~~~~  358 (382)
T 3tt0_A          332 AVPSQRPTFKQLVEDLDRIVALTSNQE  358 (382)
T ss_dssp             SSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred             CChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence            999999999999999987755444433

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.97  E-value=4.1e-31  Score=222.53  Aligned_cols=166  Identities=19%  Similarity=0.199  Sum_probs=124.6

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceee---CCCCCceecCccceeeecCCCCC-----cccceeecccCc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILL---DHEMNPKISDFGLTRIFEGKQTD-----GTTNRVVGTYGY   73 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili---~~~~~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~y   73 (220)
                      ++++.|+.||+.||.|||+++   |+||||||+|||+   +.++.++|+|||++.........     .......++..|
T Consensus       103 ~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y  179 (483)
T 3sv0_A          103 KTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY  179 (483)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccc
Confidence            467899999999999999999   9999999999999   57889999999999865433221     112245788999


Q ss_pred             cChhhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHH
Q 027675           74 MSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCIN  153 (220)
Q Consensus        74 ~aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (220)
                      +|||.+.+..++.++|||||||++|+|++|..||..............................         ....+.+
T Consensus       180 ~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~---------~p~~l~~  250 (483)
T 3sv0_A          180 ASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRG---------YPTEFAS  250 (483)
T ss_dssp             CCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTT---------SCHHHHH
T ss_pred             cCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcC---------CcHHHHH
Confidence            9999999999999999999999999999999999764443222222111111111111111111         1236789


Q ss_pred             HhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          154 VGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       154 li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      +|..||+.+|++||++.+|++.|+..
T Consensus       251 li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          251 YFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             HHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             HHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            99999999999999999999888655

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.97  E-value=8e-31  Score=207.19  Aligned_cols=166  Identities=25%  Similarity=0.416  Sum_probs=116.1

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhh-
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL-   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~-   80 (220)
                      .+++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++................+++.|.|||.+. 
T Consensus       120 ~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  196 (289)
T 3og7_A          120 KKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM  196 (289)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC-
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcc
Confidence            467899999999999999999   9999999999999999999999999987544322222223356789999999986 


Q ss_pred             --cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           81 --GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        81 --~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                        +..++.++||||||+++|+|++|..||..........      .....+.........     .......+.++|.+|
T Consensus       197 ~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~  265 (289)
T 3og7_A          197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII------EMVGRGSLSPDLSKV-----RSNCPKRMKRLMAEC  265 (289)
T ss_dssp             ---CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHH------HHHHHTSCCCCTTSS-----CTTSCHHHHHHHHHH
T ss_pred             cCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHH------HHhcccccCcchhhc-----cccCCHHHHHHHHHH
Confidence              5567889999999999999999999997544332211      111122111111111     112234788999999


Q ss_pred             cCCCCCCCCCHHHHHHHhcCccc
Q 027675          159 VQEDPNDRPTMSDVVIMLGSEAV  181 (220)
Q Consensus       159 l~~~p~~Rps~~~~l~~l~~~~~  181 (220)
                      |+.||++|||+.++++.|+...+
T Consensus       266 l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          266 LKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             TCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             ccCChhhCCCHHHHHHHHHHHhh
Confidence            99999999999999999977643

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.97  E-value=2.5e-31  Score=213.09  Aligned_cols=161  Identities=21%  Similarity=0.351  Sum_probs=116.7

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++................+++.|.|||.+.+
T Consensus       137 ~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  213 (323)
T 3qup_A          137 QTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD  213 (323)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcC
Confidence            357899999999999999999   99999999999999999999999999876543322222222345678999999999


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++||||||+++|+|++ |..||...........       ...+.....         .......+.+++.+||+
T Consensus       214 ~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~-------~~~~~~~~~---------~~~~~~~l~~li~~~l~  277 (323)
T 3qup_A          214 NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY-------LIGGNRLKQ---------PPECMEEVYDLMYQCWS  277 (323)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-------HHTTCCCCC---------CTTCCHHHHHHHHHTTC
T ss_pred             CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHH-------HhcCCCCCC---------CCccCHHHHHHHHHHcc
Confidence            889999999999999999999 8999876544332211       111111111         11122468899999999


Q ss_pred             CCCCCCCCHHHHHHHhcCccc
Q 027675          161 EDPNDRPTMSDVVIMLGSEAV  181 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~~~  181 (220)
                      .||++|||+.++++.|+....
T Consensus       278 ~dp~~Rps~~~l~~~l~~~l~  298 (323)
T 3qup_A          278 ADPKQRPSFTCLRMELENILG  298 (323)
T ss_dssp             SSGGGSCCHHHHHHHHHHHHH
T ss_pred             CChhhCcCHHHHHHHHHHHHH
Confidence            999999999999988876633

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.97  E-value=5.9e-31  Score=214.50  Aligned_cols=183  Identities=16%  Similarity=0.152  Sum_probs=129.1

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeC--CCCCceecCccceeeecCCCCC-----cccceeecccCcc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLD--HEMNPKISDFGLTRIFEGKQTD-----GTTNRVVGTYGYM   74 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~--~~~~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~y~   74 (220)
                      .+++.|+.|++.||.|||+++   |+||||||+||+++  .++.++|+|||++.........     .......+++.|+
T Consensus       152 ~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~  228 (364)
T 3op5_A          152 KTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFT  228 (364)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCcc
Confidence            467899999999999999999   99999999999998  8899999999999764422111     1112245889999


Q ss_pred             ChhhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHH
Q 027675           75 SPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINV  154 (220)
Q Consensus        75 aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  154 (220)
                      |||.+.+..++.++|||||||++|+|++|..||...........  ....... .......+.+....   .....+.++
T Consensus       229 aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~l  302 (364)
T 3op5_A          229 SIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVR--DSKIRYR-ENIASLMDKCFPAA---NAPGEIAKY  302 (364)
T ss_dssp             CHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH--HHHHHHH-HCHHHHHHHHSCTT---CCCHHHHHH
T ss_pred             CHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHH--HHHHHhh-hhHHHHHHHhcccc---cCHHHHHHH
Confidence            99999998899999999999999999999999974322211110  0111110 11111111111100   112367888


Q ss_pred             hccccCCCCCCCCCHHHHHHHhcCccccCCCCCCchhhh
Q 027675          155 GLLCVQEDPNDRPTMSDVVIMLGSEAVNLASPKRPAFVV  193 (220)
Q Consensus       155 i~~cl~~~p~~Rps~~~~l~~l~~~~~~~~~~~~~~~~~  193 (220)
                      +..||..||++||++.++++.|..............+.+
T Consensus       303 i~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw  341 (364)
T 3op5_A          303 METVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDL  341 (364)
T ss_dssp             HHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC
T ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccce
Confidence            999999999999999999999977655554444443333

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.97  E-value=1.3e-30  Score=207.40  Aligned_cols=171  Identities=35%  Similarity=0.490  Sum_probs=126.6

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++................+++.|+|||.+.+
T Consensus       133 ~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~  209 (307)
T 2nru_A          133 HMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG  209 (307)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC
Confidence            357889999999999999999   99999999999999999999999999876543322222333467889999998876


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccc-cccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKA-LDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                       .++.++|+||||+++|+|++|..||...........  ........... ....+. ............+.+++.+||.
T Consensus       210 -~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~  285 (307)
T 2nru_A          210 -EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD--IKEEIEDEEKTIEDYIDK-KMNDADSTSVEAMYSVASQCLH  285 (307)
T ss_dssp             -EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH--HHHHHHTTSCCHHHHSCS-SCSCCCHHHHHHHHHHHHHHTC
T ss_pred             -CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH--HHHHhhhhhhhhhhhccc-cccccchHHHHHHHHHHHHHcC
Confidence             478899999999999999999999975443321111  11111111111 111111 1122345667789999999999


Q ss_pred             CCCCCCCCHHHHHHHhcCc
Q 027675          161 EDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~  179 (220)
                      .||++|||+++++++|+..
T Consensus       286 ~~p~~Rps~~~l~~~L~~l  304 (307)
T 2nru_A          286 EKKNKRPDIKKVQQLLQEM  304 (307)
T ss_dssp             SSTTTSCCHHHHHHHHHHH
T ss_pred             CCcccCcCHHHHHHHHHHH
Confidence            9999999999999999765

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.97  E-value=5.1e-31  Score=210.00  Aligned_cols=172  Identities=23%  Similarity=0.229  Sum_probs=122.9

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+++.++.|++.||+|||+++   ++||||||+||+++.++.++|+|||++........   .....+++.|+|||.+.+
T Consensus       120 ~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~  193 (308)
T 3g33_A          120 ETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQ  193 (308)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEeeCccccccCCCcc---cCCccccccccCchHHcC
Confidence            357889999999999999999   99999999999999999999999999865432221   223467899999999999


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccc-----cccccCCCCCcCc-----HHHHHHH
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKA-----LDMMDQKPGAISK-----ANEILKC  151 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~-----~~~~~~~  151 (220)
                      ..++.++|||||||++|+|++|..||...+....................     .............     ......+
T Consensus       194 ~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (308)
T 3g33_A          194 STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESG  273 (308)
T ss_dssp             SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHH
T ss_pred             CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHH
Confidence            88999999999999999999999999765544332221110000000000     0000000000000     1123467


Q ss_pred             HHHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          152 INVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       152 ~~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      .++|.+||+.||++|||+.+++++-+..
T Consensus       274 ~~li~~~L~~dP~~R~t~~e~l~h~~~~  301 (308)
T 3g33_A          274 AQLLLEMLTFNPHKRISAFRALQHSYLH  301 (308)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHTSTTC-
T ss_pred             HHHHHHHhcCCCccCCCHHHHhcCcccc
Confidence            8999999999999999999999886544

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.97  E-value=2.3e-31  Score=216.14  Aligned_cols=160  Identities=29%  Similarity=0.414  Sum_probs=123.2

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+++   |+||||||+||+++.++.++|+|||++................++..|+|||.+.+
T Consensus       193 ~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  269 (359)
T 3vhe_A          193 EHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD  269 (359)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcC
Confidence            357889999999999999999   99999999999999999999999999875543333233334566788999999999


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++||||||+++|+|++ |..||.........      ......+.......         .....+.+++.+||+
T Consensus       270 ~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~------~~~~~~~~~~~~~~---------~~~~~l~~li~~~l~  334 (359)
T 3vhe_A          270 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF------CRRLKEGTRMRAPD---------YTTPEMYQTMLDCWH  334 (359)
T ss_dssp             CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH------HHHHHHTCCCCCCT---------TCCHHHHHHHHHHTC
T ss_pred             CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH------HHHHHcCCCCCCCC---------CCCHHHHHHHHHHcc
Confidence            889999999999999999998 99999754432211      11111221111111         122367889999999


Q ss_pred             CCCCCCCCHHHHHHHhcCc
Q 027675          161 EDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~  179 (220)
                      .||++|||+.+++++|+..
T Consensus       335 ~dP~~Rps~~ell~~L~~~  353 (359)
T 3vhe_A          335 GEPSQRPTFSELVEHLGNL  353 (359)
T ss_dssp             SSGGGSCCHHHHHHHHHHH
T ss_pred             CChhhCCCHHHHHHHHHHH
Confidence            9999999999999999765

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.97  E-value=9.5e-31  Score=210.35  Aligned_cols=163  Identities=19%  Similarity=0.259  Sum_probs=121.2

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCC---CCCceecCccceeeecCCCCCcccceeecccCccChhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDH---EMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEY   78 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~   78 (220)
                      ..++.++.|++.||+|||++|   ++||||||+||+++.   ++.++|+|||++........   .....+++.|+|||.
T Consensus       131 ~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~  204 (327)
T 3lm5_A          131 NDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEI  204 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCccccccCCccc---cccccCCcCccCCee
Confidence            357899999999999999999   999999999999987   78999999999976543221   222467899999999


Q ss_pred             hhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           79 ALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        79 ~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                      +.+..++.++|+||||+++|+|++|..||...+........      . .... ..     ...........+.++|.+|
T Consensus       205 ~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i------~-~~~~-~~-----~~~~~~~~~~~~~~li~~~  271 (327)
T 3lm5_A          205 LNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI------S-QVNV-DY-----SEETFSSVSQLATDFIQSL  271 (327)
T ss_dssp             HTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------H-HTCC-CC-----CTTTTTTSCHHHHHHHHHH
T ss_pred             ecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHH------H-hccc-cc-----CchhhcccCHHHHHHHHHH
Confidence            99988999999999999999999999999765543332111      1 0000 00     0000111234678899999


Q ss_pred             cCCCCCCCCCHHHHHHHhcCccccC
Q 027675          159 VQEDPNDRPTMSDVVIMLGSEAVNL  183 (220)
Q Consensus       159 l~~~p~~Rps~~~~l~~l~~~~~~~  183 (220)
                      |+.||++|||+++++++-+....+.
T Consensus       272 L~~dP~~Rpt~~~ll~h~~~~~~~~  296 (327)
T 3lm5_A          272 LVKNPEKRPTAEICLSHSWLQQWDF  296 (327)
T ss_dssp             SCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred             cCCChhhCcCHHHHhCCHhhccccc
Confidence            9999999999999998876554443

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.97  E-value=2.8e-30  Score=209.07  Aligned_cols=171  Identities=16%  Similarity=0.217  Sum_probs=123.1

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCC--CceecCccceeeecCCCC-----CcccceeecccCcc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEM--NPKISDFGLTRIFEGKQT-----DGTTNRVVGTYGYM   74 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~--~~~l~d~~~~~~~~~~~~-----~~~~~~~~~~~~y~   74 (220)
                      .+++.++.|++.||+|||+++   |+||||||+||+++.++  .++|+|||++........     ........++..|+
T Consensus       151 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~  227 (345)
T 2v62_A          151 STVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFT  227 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTC
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCcccc
Confidence            467899999999999999999   99999999999998777  899999999976532211     11113346789999


Q ss_pred             ChhhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHH
Q 027675           75 SPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINV  154 (220)
Q Consensus        75 aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  154 (220)
                      |||.+.+..++.++||||||+++|+|++|..||.......... . ..................+..    .....+.++
T Consensus       228 aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~l  301 (345)
T 2v62_A          228 SLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV-Q-TAKTNLLDELPQSVLKWAPSG----SSCCEIAQF  301 (345)
T ss_dssp             CHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH-H-HHHHHHHHTTTHHHHHHSCTT----SCCHHHHHH
T ss_pred             CHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH-H-HHHHhhcccccHHHHhhcccc----ccHHHHHHH
Confidence            9999999889999999999999999999999995422211111 0 000111000000000000000    122368889


Q ss_pred             hccccCCCCCCCCCHHHHHHHhcCccc
Q 027675          155 GLLCVQEDPNDRPTMSDVVIMLGSEAV  181 (220)
Q Consensus       155 i~~cl~~~p~~Rps~~~~l~~l~~~~~  181 (220)
                      |.+||+.||++||+++++++.|+....
T Consensus       302 i~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          302 LVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             HHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             HHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            999999999999999999999987654

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.97  E-value=4.1e-31  Score=210.76  Aligned_cols=159  Identities=26%  Similarity=0.392  Sum_probs=123.3

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      +++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++................+++.|.|||.+.+.
T Consensus       151 ~~~~i~~qi~~~l~~lH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  227 (314)
T 2ivs_A          151 DLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH  227 (314)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHHCC---CcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCC
Confidence            57889999999999999999   999999999999999999999999998765433222222223456789999999988


Q ss_pred             CCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           83 FFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      .++.++|+||||+++|+|++ |..||...........       ...+.....         .......+.+++.+||+.
T Consensus       228 ~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~-------~~~~~~~~~---------~~~~~~~~~~li~~~l~~  291 (314)
T 2ivs_A          228 IYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNL-------LKTGHRMER---------PDNCSEEMYRLMLQCWKQ  291 (314)
T ss_dssp             EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-------HHTTCCCCC---------CTTCCHHHHHHHHHHTCS
T ss_pred             CcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------hhcCCcCCC---------CccCCHHHHHHHHHHccC
Confidence            88999999999999999999 9999976554332211       111111111         111234688999999999


Q ss_pred             CCCCCCCHHHHHHHhcCcc
Q 027675          162 DPNDRPTMSDVVIMLGSEA  180 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~~~~  180 (220)
                      ||++||++.+++++|+...
T Consensus       292 dp~~Rps~~~l~~~l~~~~  310 (314)
T 2ivs_A          292 EPDKRPVFADISKDLEKMM  310 (314)
T ss_dssp             SGGGSCCHHHHHHHHHHHH
T ss_pred             ChhhCcCHHHHHHHHHHHH
Confidence            9999999999999987653

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.97  E-value=9.3e-31  Score=210.63  Aligned_cols=155  Identities=26%  Similarity=0.350  Sum_probs=121.0

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||+|||+++   ++||||||+||+++.++.++|+|||++.......   ......+++.|+|||.+.+
T Consensus       114 ~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~  187 (328)
T 3fe3_A          114 KEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG---KLDAFCGAPPYAAPELFQG  187 (328)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC---GGGTTSSSGGGCCHHHHHT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCCC---ccccccCCcceeCcccccC
Confidence            357889999999999999999   9999999999999999999999999986543221   2233568899999999998


Q ss_pred             CCCc-ccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFS-VKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~-~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..+. .++|||||||++|+|++|..||...+........      . .+..     ..+.     .....+.+++.+||.
T Consensus       188 ~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i------~-~~~~-----~~p~-----~~s~~~~~li~~~L~  250 (328)
T 3fe3_A          188 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV------L-RGKY-----RIPF-----YMSTDCENLLKRFLV  250 (328)
T ss_dssp             CCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------H-HCCC-----CCCT-----TSCHHHHHHHHHHCC
T ss_pred             CCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHH------H-hCCC-----CCCC-----CCCHHHHHHHHHHCC
Confidence            7764 7899999999999999999999765544332211      1 1111     0111     123467889999999


Q ss_pred             CCCCCCCCHHHHHHHhcCc
Q 027675          161 EDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~  179 (220)
                      .||.+|||+++++++-+..
T Consensus       251 ~dP~~R~t~~eil~h~~~~  269 (328)
T 3fe3_A          251 LNPIKRGTLEQIMKDRWIN  269 (328)
T ss_dssp             SSTTTSCCHHHHTTCTTTT
T ss_pred             CChhHCcCHHHHhcCHhhc
Confidence            9999999999999886544

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.97  E-value=9.6e-31  Score=214.26  Aligned_cols=159  Identities=24%  Similarity=0.307  Sum_probs=121.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++................++..|+|||.+.+
T Consensus       213 ~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  289 (377)
T 3cbl_A          213 KTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNY  289 (377)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhcc
Confidence            467889999999999999999   99999999999999999999999999875432211111111234567999999998


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++|+|++ |..||..........       ....+.......         .....+.++|.+||+
T Consensus       290 ~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~-------~~~~~~~~~~~~---------~~~~~l~~li~~cl~  353 (377)
T 3cbl_A          290 GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTRE-------FVEKGGRLPCPE---------LCPDAVFRLMEQCWA  353 (377)
T ss_dssp             CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHH-------HHHTTCCCCCCT---------TCCHHHHHHHHHHTC
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-------HHHcCCCCCCCC---------CCCHHHHHHHHHHcC
Confidence            889999999999999999998 999987655433221       112222211111         122367889999999


Q ss_pred             CCCCCCCCHHHHHHHhcCc
Q 027675          161 EDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~  179 (220)
                      .||++|||+.++++.|+..
T Consensus       354 ~dP~~Rps~~~i~~~L~~i  372 (377)
T 3cbl_A          354 YEPGQRPSFSTIYQELQSI  372 (377)
T ss_dssp             SSGGGSCCHHHHHHHHHHH
T ss_pred             CCchhCcCHHHHHHHHHHH
Confidence            9999999999999998765

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=6.7e-31  Score=212.31  Aligned_cols=161  Identities=27%  Similarity=0.421  Sum_probs=123.7

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .++.++.|++.||.|||++|   ++||||||+||+++.++.++|+|||++................+++.|.|||.+.+.
T Consensus       173 ~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~  249 (344)
T 1rjb_A          173 DLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG  249 (344)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC
Confidence            56789999999999999999   999999999999999999999999998765433332233334567789999999988


Q ss_pred             CCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           83 FFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      .++.++||||||+++|+|++ |..||.........      ......+.....    +     ......+.++|.+||..
T Consensus       250 ~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~------~~~~~~~~~~~~----~-----~~~~~~l~~li~~~l~~  314 (344)
T 1rjb_A          250 IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF------YKLIQNGFKMDQ----P-----FYATEEIYIIMQSCWAF  314 (344)
T ss_dssp             CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH------HHHHHTTCCCCC----C-----TTCCHHHHHHHHHHTCS
T ss_pred             CCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHH------HHHHhcCCCCCC----C-----CCCCHHHHHHHHHHcCC
Confidence            89999999999999999998 99999654432211      111112111111    1     11234688899999999


Q ss_pred             CCCCCCCHHHHHHHhcCccc
Q 027675          162 DPNDRPTMSDVVIMLGSEAV  181 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~~~~~  181 (220)
                      ||++|||+.+++++|+....
T Consensus       315 dp~~Rps~~~l~~~l~~~~~  334 (344)
T 1rjb_A          315 DSRKRPSFPNLTSFLGCQLA  334 (344)
T ss_dssp             SGGGSCCHHHHHHHHHHHC-
T ss_pred             CchhCcCHHHHHHHHHHHHH
Confidence            99999999999999976644

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.96  E-value=2.4e-30  Score=207.54  Aligned_cols=159  Identities=23%  Similarity=0.314  Sum_probs=122.6

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++........  ......+++.|+|||.+.+
T Consensus       141 ~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~  215 (321)
T 2c30_A          141 EQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISR  215 (321)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcC
Confidence            467889999999999999999   99999999999999999999999999876543221  1233567899999999998


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+||||+++|+|++|..||...........       .......       ...........+.+++.+||+.
T Consensus       216 ~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~-------~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~  281 (321)
T 2c30_A          216 SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR-------LRDSPPP-------KLKNSHKVSPVLRDFLERMLVR  281 (321)
T ss_dssp             CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-------HHHSSCC-------CCTTGGGSCHHHHHHHHHHSCS
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------HhcCCCC-------CcCccccCCHHHHHHHHHHccC
Confidence            8899999999999999999999999975443322111       1111110       0111112234678899999999


Q ss_pred             CCCCCCCHHHHHHHhcCc
Q 027675          162 DPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~~~  179 (220)
                      ||++|||+.+++++-+..
T Consensus       282 dp~~Rps~~ell~hp~~~  299 (321)
T 2c30_A          282 DPQERATAQELLDHPFLL  299 (321)
T ss_dssp             STTTSCCHHHHHTSGGGG
T ss_pred             ChhhCcCHHHHhcChhhc
Confidence            999999999999886554

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.96  E-value=2.9e-31  Score=216.61  Aligned_cols=160  Identities=26%  Similarity=0.345  Sum_probs=121.6

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCC---ceecCccceeeecCCCCCcccceeecccCccChhhh
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMN---PKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYA   79 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~---~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~   79 (220)
                      .++.++.|++.||.|||+++   |+||||||+||+++.++.   ++|+|||++................+++.|+|||.+
T Consensus       182 ~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~  258 (367)
T 3l9p_A          182 DLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAF  258 (367)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHH
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHh
Confidence            57889999999999999999   999999999999996554   999999998754322222222234567889999999


Q ss_pred             hcCCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           80 LGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        80 ~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                      .+..++.++|||||||++|+|++ |..||...........       ...+......         ......+.++|.+|
T Consensus       259 ~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~-------i~~~~~~~~~---------~~~~~~l~~li~~~  322 (367)
T 3l9p_A          259 MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF-------VTSGGRMDPP---------KNCPGPVYRIMTQC  322 (367)
T ss_dssp             HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-------HHTTCCCCCC---------TTCCHHHHHHHHHH
T ss_pred             cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HHcCCCCCCC---------ccCCHHHHHHHHHH
Confidence            98889999999999999999998 9999976554332211       1111111111         11223678999999


Q ss_pred             cCCCCCCCCCHHHHHHHhcCccc
Q 027675          159 VQEDPNDRPTMSDVVIMLGSEAV  181 (220)
Q Consensus       159 l~~~p~~Rps~~~~l~~l~~~~~  181 (220)
                      |+.||++||++.+++++|+....
T Consensus       323 l~~dP~~Rps~~eil~~l~~~~~  345 (367)
T 3l9p_A          323 WQHQPEDRPNFAIILERIEYCTQ  345 (367)
T ss_dssp             TCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCCCHhHCcCHHHHHHHHHHHhh
Confidence            99999999999999999976644

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.96  E-value=6.9e-31  Score=209.63  Aligned_cols=163  Identities=22%  Similarity=0.337  Sum_probs=119.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++................+++.|.|||.+.+
T Consensus       147 ~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  223 (313)
T 3brb_A          147 QTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD  223 (313)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHS
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcC
Confidence            467899999999999999999   99999999999999999999999999875443222222223455778999999999


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++|+|++ |..||...........       ...+......         ......+.+++.+||.
T Consensus       224 ~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-------~~~~~~~~~~---------~~~~~~l~~li~~~l~  287 (313)
T 3brb_A          224 RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY-------LLHGHRLKQP---------EDCLDELYEIMYSCWR  287 (313)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-------HHTTCCCCCB---------TTCCHHHHHHHHHTTC
T ss_pred             CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH-------HHcCCCCCCC---------ccccHHHHHHHHHHcC
Confidence            889999999999999999999 8888875544332211       1111111111         1122468899999999


Q ss_pred             CCCCCCCCHHHHHHHhcCccccC
Q 027675          161 EDPNDRPTMSDVVIMLGSEAVNL  183 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~~~~~  183 (220)
                      .||++|||+.+++++|+......
T Consensus       288 ~dp~~Rps~~~l~~~L~~l~~~l  310 (313)
T 3brb_A          288 TDPLDRPTFSVLRLQLEKLLESL  310 (313)
T ss_dssp             SSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             CChhhCcCHHHHHHHHHHHHHhc
Confidence            99999999999999997765443

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.96  E-value=1.8e-30  Score=202.88  Aligned_cols=160  Identities=26%  Similarity=0.394  Sum_probs=122.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.......... .....++..|.|||.+.+
T Consensus       104 ~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~  179 (268)
T 3sxs_A          104 SQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS-SVGTKFPVKWSAPEVFHY  179 (268)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE-CCSCCCCGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhhc-ccCCCcCcccCCHHHHhc
Confidence            467899999999999999999   9999999999999999999999999987654322111 111234567999999998


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++|+|++ |..||............       ..+.....    + ..    ....+.+++.+||+
T Consensus       180 ~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~-------~~~~~~~~----~-~~----~~~~l~~li~~~l~  243 (268)
T 3sxs_A          180 FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV-------SQGHRLYR----P-HL----ASDTIYQIMYSCWH  243 (268)
T ss_dssp             SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-------HTTCCCCC----C-TT----SCHHHHHHHHHTTC
T ss_pred             cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHH-------HcCCCCCC----C-Cc----ChHHHHHHHHHHcC
Confidence            889999999999999999998 99999765544332111       11111100    1 11    12367889999999


Q ss_pred             CCCCCCCCHHHHHHHhcCccc
Q 027675          161 EDPNDRPTMSDVVIMLGSEAV  181 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~~~  181 (220)
                      .||++|||+.+++++|+....
T Consensus       244 ~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          244 ELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             SSGGGSCCHHHHHHHHGGGCC
T ss_pred             CChhhCcCHHHHHHHHHHhhh
Confidence            999999999999999987643

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.96  E-value=1.7e-30  Score=207.48  Aligned_cols=172  Identities=24%  Similarity=0.282  Sum_probs=120.0

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+++   |+||||||+||+++.++.++|+|||++........  ......+++.|+|||.+.+
T Consensus       119 ~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~  193 (311)
T 3niz_A          119 SQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR--SYTHEVVTLWYRAPDVLMG  193 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-----CCCCCCTTCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCcc--cccCCcccCCcCCHHHhcC
Confidence            357889999999999999999   99999999999999999999999999876542221  1222456889999999876


Q ss_pred             -CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHH--------HHh-----ccccccccCCCCCcCcHHH
Q 027675           82 -GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKL--------WQE-----GKALDMMDQKPGAISKANE  147 (220)
Q Consensus        82 -~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~--------~~~-----~~~~~~~~~~~~~~~~~~~  147 (220)
                       ..++.++|+||||+++|+|++|..||..................        ..+     ..........+........
T Consensus       194 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (311)
T 3niz_A          194 SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGF  273 (311)
T ss_dssp             CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTC
T ss_pred             CCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCccc
Confidence             45789999999999999999999999765544332221110000        000     0000000000000000112


Q ss_pred             HHHHHHHhccccCCCCCCCCCHHHHHHHhcC
Q 027675          148 ILKCINVGLLCVQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       148 ~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~  178 (220)
                      ...+.++|.+||+.||++|||+++++++-+.
T Consensus       274 ~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  304 (311)
T 3niz_A          274 CQEGIDLLSNMLCFDPNKRISARDAMNHPYF  304 (311)
T ss_dssp             CHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred             CHHHHHHHHHHcCCChhHCCCHHHHhcCccc
Confidence            3467899999999999999999999987543

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.96  E-value=8.7e-31  Score=207.70  Aligned_cols=170  Identities=22%  Similarity=0.236  Sum_probs=121.0

Q ss_pred             chHHHHHHHHHHHHHHhh--------hCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCc--ccceeeccc
Q 027675            2 EMLFNIILGVSRRLLYLH--------QDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG--TTNRVVGTY   71 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH--------~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~   71 (220)
                      ..+++++.|++.||.|||        +.+   ++||||||+||+++.++.++|+|||++..........  ......+++
T Consensus       105 ~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~  181 (301)
T 3q4u_A          105 VSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK  181 (301)
T ss_dssp             HHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCG
T ss_pred             HHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEeeCCCeeeccccccccccccccccccc
Confidence            357889999999999999        888   9999999999999999999999999987654322211  112236789


Q ss_pred             CccChhhhhcC------CCcccCceeehhHHHHHHHhc----------CccCcccchhHHHhhHHHHHHHHHhccccccc
Q 027675           72 GYMSPEYALGG------FFSVKSDVFSFGVVVLEIISG----------KRNTGFYNSELALSLLGYAWKLWQEGKALDMM  135 (220)
Q Consensus        72 ~y~aPe~~~~~------~~~~~~DiwslG~il~~ll~g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  135 (220)
                      .|+|||.+.+.      .++.++||||||+++|+|++|          ..||.........  ..............   
T Consensus       182 ~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~--~~~~~~~~~~~~~~---  256 (301)
T 3q4u_A          182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS--FEDMRKVVCVDQQR---  256 (301)
T ss_dssp             GGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC--HHHHHHHHTTSCCC---
T ss_pred             ceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcc--hhhhhHHHhccCCC---
Confidence            99999999876      445789999999999999999          6676432211100  00011111111100   


Q ss_pred             cCCCCCcCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          136 DQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       136 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      ...+...........+.+++.+||+.||++|||+.++++.|+..
T Consensus       257 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          257 PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            11111122334567889999999999999999999999998653

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.96  E-value=6.9e-30  Score=204.48  Aligned_cols=174  Identities=16%  Similarity=0.163  Sum_probs=126.2

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceee----CCCCCceecCccceeeecCCCCCcccceeecccCccChh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILL----DHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPE   77 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili----~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe   77 (220)
                      .+++.++.|++.||.|||+++   |+||||||+||++    +.++.++|+|||++........   .....++..|+|||
T Consensus       112 ~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE  185 (319)
T 4euu_A          112 SEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPD  185 (319)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCC---BCCCCSCGGGCCHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCc---eeecccCCCccCHH
Confidence            357889999999999999999   9999999999999    7777799999999976543221   12245788999999


Q ss_pred             hhh--------cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccc---cc----------c-c
Q 027675           78 YAL--------GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKA---LD----------M-M  135 (220)
Q Consensus        78 ~~~--------~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~----------~-~  135 (220)
                      .+.        +..++.++|||||||++|+|++|..||.........  .....+.......   ..          . .
T Consensus       186 ~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~  263 (319)
T 4euu_A          186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKIITGKPSGAISGVQKAENGPIDWSG  263 (319)
T ss_dssp             HHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC--HHHHHHHHHHCCTTCCEEEECSTTCCEEEES
T ss_pred             HhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh--HHHHHHHhcCCCcccchhhhcccCCccccCc
Confidence            986        467889999999999999999999999643322111  1111122111110   00          0 0


Q ss_pred             cCCCCCcCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcCccccC
Q 027675          136 DQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEAVNL  183 (220)
Q Consensus       136 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~~~~~  183 (220)
                      ...............+.+++.+||+.||++|||+++++++....+...
T Consensus       264 ~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~~  311 (319)
T 4euu_A          264 DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRG  311 (319)
T ss_dssp             SCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC--
T ss_pred             cCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhcC
Confidence            111222344566778899999999999999999999999987665433

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.96  E-value=2.6e-30  Score=216.95  Aligned_cols=171  Identities=21%  Similarity=0.197  Sum_probs=119.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..+..++.|++.||+|||+.|   |+||||||+||+++.++.+||+|||+++......   ......+++.|+|||++.+
T Consensus       164 ~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~  237 (464)
T 3ttj_A          164 ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILG  237 (464)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC-----CC---CC----CCCTTCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc---ccCCCcccccccCHHHHcC
Confidence            357789999999999999999   9999999999999999999999999987654321   1233567899999999999


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHH----------------HHHHHhccccc------cc-cC-
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA----------------WKLWQEGKALD------MM-DQ-  137 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~------~~-~~-  137 (220)
                      ..++.++|||||||++|+|++|+.||...+.......+...                ...........      .. +. 
T Consensus       238 ~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (464)
T 3ttj_A          238 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSL  317 (464)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGG
T ss_pred             CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccc
Confidence            99999999999999999999999999765543332211100                00000000000      00 00 


Q ss_pred             -CCCCcCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcC
Q 027675          138 -KPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       138 -~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~  178 (220)
                       .............+.++|.+||..||++|||++++++|-+.
T Consensus       318 ~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~  359 (464)
T 3ttj_A          318 FPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI  359 (464)
T ss_dssp             SCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred             cccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhh
Confidence             00000111225678999999999999999999999987654

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.96  E-value=1.2e-30  Score=214.32  Aligned_cols=172  Identities=25%  Similarity=0.297  Sum_probs=118.4

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCC-------------------CCcc
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQ-------------------TDGT   63 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~-------------------~~~~   63 (220)
                      .+..++.|++.||+|||+.|   |+||||||+||+++.++.++|+|||+++......                   ....
T Consensus       110 ~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (388)
T 3oz6_A          110 HKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI  186 (388)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC------------
T ss_pred             HHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccccccccccccccccccccccccccccccc
Confidence            46778999999999999999   9999999999999999999999999997643210                   0111


Q ss_pred             cceeecccCccChhhhhc-CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHH-----HH-----------
Q 027675           64 TNRVVGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWK-----LW-----------  126 (220)
Q Consensus        64 ~~~~~~~~~y~aPe~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~-----~~-----------  126 (220)
                      .....+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||...+.......+.....     ..           
T Consensus       187 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~  266 (388)
T 3oz6_A          187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTM  266 (388)
T ss_dssp             ---CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHH
T ss_pred             ccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHH
Confidence            223468899999999987 5689999999999999999999999976554433222110000     00           


Q ss_pred             -Hhccc-cccccCCCCCcCc------------HHHHHHHHHHhccccCCCCCCCCCHHHHHHHhc
Q 027675          127 -QEGKA-LDMMDQKPGAISK------------ANEILKCINVGLLCVQEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       127 -~~~~~-~~~~~~~~~~~~~------------~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~  177 (220)
                       ..-.. .............            ......+.+++.+||+.||++|||++++++|-+
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~  331 (388)
T 3oz6_A          267 IESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPF  331 (388)
T ss_dssp             HHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTT
T ss_pred             HHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHH
Confidence             00000 0000000000000            011346789999999999999999999998854

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.96  E-value=2.3e-30  Score=215.36  Aligned_cols=171  Identities=21%  Similarity=0.238  Sum_probs=122.5

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCC--ceecCccceeeecCCCCCcccceeecccCccChhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMN--PKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYA   79 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~   79 (220)
                      ..++.++.||+.||+|||+.+   |+||||||+||+++.++.  ++|+|||++.......     ....+++.|+|||.+
T Consensus       200 ~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~  271 (429)
T 3kvw_A          200 PLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV-----YTYIQSRFYRAPEVI  271 (429)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCEETTCCC-----CSSCSCGGGCCHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccceecCCcc-----cccCCCCCccChHHH
Confidence            357889999999999999999   999999999999999887  9999999987543221     124678899999999


Q ss_pred             hcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHH-----HHHHHhccccc-ccc-----------------
Q 027675           80 LGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA-----WKLWQEGKALD-MMD-----------------  136 (220)
Q Consensus        80 ~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~-~~~-----------------  136 (220)
                      .+..++.++|||||||++|+|++|.+||...+...........     ........... .++                 
T Consensus       272 ~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (429)
T 3kvw_A          272 LGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGS  351 (429)
T ss_dssp             HTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--
T ss_pred             hCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCccccccccccccc
Confidence            9988999999999999999999999999765544332221110     00000000000 000                 


Q ss_pred             -------------CCCCCcCcH------HHHHHHHHHhccccCCCCCCCCCHHHHHHHhcCcc
Q 027675          137 -------------QKPGAISKA------NEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEA  180 (220)
Q Consensus       137 -------------~~~~~~~~~------~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~~  180 (220)
                                   ..+......      .....+.++|.+||+.||++|||+++++++-+...
T Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~  414 (429)
T 3kvw_A          352 VVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRR  414 (429)
T ss_dssp             CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC-
T ss_pred             ccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhcc
Confidence                         000000000      11346889999999999999999999999876553

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.96  E-value=1.6e-31  Score=211.63  Aligned_cols=168  Identities=24%  Similarity=0.310  Sum_probs=118.7

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCC-cccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD-GTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~y~aPe~~~   80 (220)
                      .+++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++......... .......++..|+|||.+.
T Consensus       114 ~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  190 (295)
T 3ugc_A          114 IKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT  190 (295)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhc
Confidence            357889999999999999999   999999999999999999999999998764432111 1111223456799999999


Q ss_pred             cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhh---------HHHHHHHHHhccccccccCCCCCcCcHHHHHHH
Q 027675           81 GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSL---------LGYAWKLWQEGKALDMMDQKPGAISKANEILKC  151 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (220)
                      +..++.++||||||+++|+|++|..|+...........         ..........+.....         .......+
T Consensus       191 ~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~l  261 (295)
T 3ugc_A          191 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR---------PDGCPDEI  261 (295)
T ss_dssp             HCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCC---------CTTCCHHH
T ss_pred             CCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCCC---------CcCcCHHH
Confidence            98899999999999999999999988764322211100         0011111111111111         11223478


Q ss_pred             HHHhccccCCCCCCCCCHHHHHHHhcCccc
Q 027675          152 INVGLLCVQEDPNDRPTMSDVVIMLGSEAV  181 (220)
Q Consensus       152 ~~li~~cl~~~p~~Rps~~~~l~~l~~~~~  181 (220)
                      .++|.+||+.||++|||+.++++.|+....
T Consensus       262 ~~li~~~l~~dp~~Rps~~el~~~L~~l~~  291 (295)
T 3ugc_A          262 YMIMTECWNNNVNQRPSFRDLALRVDQIRD  291 (295)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence            899999999999999999999999976643

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.96  E-value=6.3e-31  Score=214.84  Aligned_cols=156  Identities=10%  Similarity=-0.008  Sum_probs=114.7

Q ss_pred             HHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc--C
Q 027675            5 FNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG--G   82 (220)
Q Consensus         5 ~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~--~   82 (220)
                      +.++.||+.||+|||+++   |+||||||+||+++.++.+||+|||++......     .....+++.|+|||.+.+  .
T Consensus       197 ~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~  268 (371)
T 3q60_A          197 HILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTA  268 (371)
T ss_dssp             HHHHHHHHHHHHHHHHTT---EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEE
T ss_pred             HHHHHHHHHHHHHHHHCC---CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCC
Confidence            567799999999999999   999999999999999999999999999764321     112345689999999987  6


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      .++.++|||||||++|+|++|..||............        .......................+.++|.+||+.|
T Consensus       269 ~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  340 (371)
T 3q60_A          269 TFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWK--------RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFD  340 (371)
T ss_dssp             ECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCC--------BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSS
T ss_pred             CcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchh--------hhhhhhccccccchhhccCCCHHHHHHHHHHcCCC
Confidence            7899999999999999999999999754332111000        00000000001111111123447889999999999


Q ss_pred             CCCCCCHHHHHHHh
Q 027675          163 PNDRPTMSDVVIML  176 (220)
Q Consensus       163 p~~Rps~~~~l~~l  176 (220)
                      |++|||+.+++++-
T Consensus       341 P~~Rpt~~e~l~hp  354 (371)
T 3q60_A          341 RRRRLLPLEAMETP  354 (371)
T ss_dssp             TTTCCCHHHHTTSH
T ss_pred             hhhCCCHHHHhcCH
Confidence            99999999999654

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.96  E-value=6.5e-30  Score=208.48  Aligned_cols=170  Identities=22%  Similarity=0.246  Sum_probs=118.4

Q ss_pred             chHHHHHHHHHHHHHHhhhC-CCCCeEeccCCCCceeeC------CCCCceecCccceeeecCCCCCcccceeecccCcc
Q 027675            2 EMLFNIILGVSRRLLYLHQD-SKLRIIHRDFKTSNILLD------HEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM   74 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~-~~~~i~H~dlk~~nili~------~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~   74 (220)
                      ..++.++.|++.||.|||++ +   |+||||||+||+++      ..+.++|+|||++.......     ....+++.|+
T Consensus       131 ~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~  202 (373)
T 1q8y_A          131 IYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYR  202 (373)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGC
T ss_pred             HHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCcCcceEEEcccccccccCCCC-----CCCCCCcccc
Confidence            35788999999999999998 9   99999999999994      44479999999987654321     2235788999


Q ss_pred             ChhhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHH-----------hcc----------ccc
Q 027675           75 SPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQ-----------EGK----------ALD  133 (220)
Q Consensus        75 aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-----------~~~----------~~~  133 (220)
                      |||.+.+..++.++||||||+++|+|++|..||....................           .+.          ...
T Consensus       203 aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~  282 (373)
T 1q8y_A          203 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLR  282 (373)
T ss_dssp             CHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBS
T ss_pred             CcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhc
Confidence            99999998899999999999999999999999975432211111100100000           000          000


Q ss_pred             cccC-C---------CCCcCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          134 MMDQ-K---------PGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       134 ~~~~-~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      .... .         ............+.++|.+||+.||++|||+++++++-+..
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  338 (373)
T 1q8y_A          283 NISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLK  338 (373)
T ss_dssp             SCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGT
T ss_pred             ccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhh
Confidence            0000 0         00112345667889999999999999999999999876544

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.96  E-value=1.2e-30  Score=210.51  Aligned_cols=161  Identities=27%  Similarity=0.366  Sum_probs=122.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+++.++.|+++||.|||+++   ++||||||+||+++.++.++|+|||++................++..|+|||.+.+
T Consensus       174 ~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  250 (343)
T 1luf_A          174 AEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY  250 (343)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc
Confidence            356789999999999999999   99999999999999999999999999875433222222223456778999999998


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++|+|++ |..||..........       ....+......    .     .....+.++|.+||+
T Consensus       251 ~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~-------~~~~~~~~~~~----~-----~~~~~l~~li~~~l~  314 (343)
T 1luf_A          251 NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIY-------YVRDGNILACP----E-----NCPLELYNLMRLCWS  314 (343)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-------HHHTTCCCCCC----T-----TCCHHHHHHHHHHTC
T ss_pred             CCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHH-------HHhCCCcCCCC----C-----CCCHHHHHHHHHHcc
Confidence            889999999999999999998 999987554433221       11122221111    1     122367889999999


Q ss_pred             CCCCCCCCHHHHHHHhcCccc
Q 027675          161 EDPNDRPTMSDVVIMLGSEAV  181 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~~~  181 (220)
                      .||++||++.++++.|+....
T Consensus       315 ~~p~~Rps~~~~~~~L~~~~~  335 (343)
T 1luf_A          315 KLPADRPSFCSIHRILQRMCE  335 (343)
T ss_dssp             SSGGGSCCHHHHHHHHHHTTC
T ss_pred             cCcccCCCHHHHHHHHHHHHh
Confidence            999999999999999977644

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.96  E-value=7.1e-31  Score=212.39  Aligned_cols=158  Identities=22%  Similarity=0.318  Sum_probs=111.9

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc-
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG-   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~-   81 (220)
                      +++.++.|++.||.|||+++   |+||||||+||+++ ++.++|+|||++................|++.|+|||.+.+ 
T Consensus       109 ~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  184 (343)
T 3dbq_A          109 ERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM  184 (343)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhc
Confidence            57889999999999999999   99999999999996 57799999999876543332222334568999999999865 


Q ss_pred             ----------CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHH
Q 027675           82 ----------GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKC  151 (220)
Q Consensus        82 ----------~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (220)
                                ..++.++||||||+++|+|++|..||.........     .............    +.     .....+
T Consensus       185 ~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-----~~~~~~~~~~~~~----~~-----~~~~~l  250 (343)
T 3dbq_A          185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK-----LHAIIDPNHEIEF----PD-----IPEKDL  250 (343)
T ss_dssp             C-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-----HHHHHCTTSCCCC----CC-----CSCHHH
T ss_pred             cccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH-----HHHHhcCCcccCC----cc-----cCCHHH
Confidence                      56788999999999999999999999643322111     0111111111100    11     112367


Q ss_pred             HHHhccccCCCCCCCCCHHHHHHHhcC
Q 027675          152 INVGLLCVQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       152 ~~li~~cl~~~p~~Rps~~~~l~~l~~  178 (220)
                      .++|.+||+.||++|||+.+++++-+.
T Consensus       251 ~~li~~~L~~dp~~Rpt~~e~l~hp~~  277 (343)
T 3dbq_A          251 QDVLKCCLKRDPKQRISIPELLAHPYV  277 (343)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred             HHHHHHHcCCChhHCCCHHHHHhCccc
Confidence            889999999999999999999987643

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.96  E-value=9.5e-31  Score=212.73  Aligned_cols=167  Identities=25%  Similarity=0.294  Sum_probs=119.5

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCC-------------------------CCCceecCccceeeec
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDH-------------------------EMNPKISDFGLTRIFE   56 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~-------------------------~~~~~l~d~~~~~~~~   56 (220)
                      ..++.++.||+.||.|||+.+   |+||||||+||+++.                         ++.++|+|||++....
T Consensus       137 ~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~  213 (360)
T 3llt_A          137 EDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKS  213 (360)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecC
Confidence            357889999999999999999   999999999999975                         7889999999987543


Q ss_pred             CCCCCcccceeecccCccChhhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHH-----HHHhc--
Q 027675           57 GKQTDGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWK-----LWQEG--  129 (220)
Q Consensus        57 ~~~~~~~~~~~~~~~~y~aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~--  129 (220)
                      ...     ....+++.|+|||.+.+..++.++|||||||++|+|++|..||...+.............     .....  
T Consensus       214 ~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  288 (360)
T 3llt_A          214 DYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATK  288 (360)
T ss_dssp             SCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTT
T ss_pred             CCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhh
Confidence            221     234678899999999999999999999999999999999999976554433222211100     00000  


Q ss_pred             -ccccc------ccCCCCCcCcHH---------------HHHHHHHHhccccCCCCCCCCCHHHHHHHh
Q 027675          130 -KALDM------MDQKPGAISKAN---------------EILKCINVGLLCVQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       130 -~~~~~------~~~~~~~~~~~~---------------~~~~~~~li~~cl~~~p~~Rps~~~~l~~l  176 (220)
                       .....      ....+.......               ....+.++|.+||+.||++|||+++++++-
T Consensus       289 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp  357 (360)
T 3llt_A          289 TNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHK  357 (360)
T ss_dssp             SGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred             ccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCc
Confidence             00000      000011111100               114677999999999999999999999764

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.96  E-value=3.5e-30  Score=206.24  Aligned_cols=159  Identities=26%  Similarity=0.404  Sum_probs=122.5

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++................+++.|.|||.+.+
T Consensus       138 ~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  214 (322)
T 1p4o_A          138 SKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD  214 (322)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhcc
Confidence            357789999999999999999   99999999999999999999999999875433222222223345778999999998


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++|+|++ |..||...........       ...+......         ......+.++|.+||+
T Consensus       215 ~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-------~~~~~~~~~~---------~~~~~~l~~li~~~l~  278 (322)
T 1p4o_A          215 GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF-------VMEGGLLDKP---------DNCPDMLFELMRMCWQ  278 (322)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH-------HHTTCCCCCC---------TTCCHHHHHHHHHHTC
T ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHH-------HHcCCcCCCC---------CCCCHHHHHHHHHHcC
Confidence            889999999999999999999 8899876544332211       1111111111         1123467889999999


Q ss_pred             CCCCCCCCHHHHHHHhcCc
Q 027675          161 EDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~  179 (220)
                      .||++|||+.+++++|+..
T Consensus       279 ~dp~~Rps~~e~l~~L~~~  297 (322)
T 1p4o_A          279 YNPKMRPSFLEIISSIKEE  297 (322)
T ss_dssp             SSGGGSCCHHHHHHHHGGG
T ss_pred             CCcccCcCHHHHHHHHHHh
Confidence            9999999999999999766

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.96  E-value=1.4e-30  Score=209.30  Aligned_cols=162  Identities=30%  Similarity=0.412  Sum_probs=122.0

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCc-ccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG-TTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~y~aPe~~~   80 (220)
                      ..++.++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++.......... ......++..|+|||.+.
T Consensus       151 ~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~  227 (325)
T 3kul_A          151 MQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA  227 (325)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhc
Confidence            367889999999999999999   9999999999999999999999999988654322111 111123456799999999


Q ss_pred             cCCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           81 GGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      +..++.++||||||+++|+|++ |..||............       ..+.....         .......+.++|.+||
T Consensus       228 ~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~-------~~~~~~~~---------~~~~~~~l~~li~~~l  291 (325)
T 3kul_A          228 FRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV-------EEGYRLPA---------PMGCPHALHQLMLDCW  291 (325)
T ss_dssp             HCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH-------HTTCCCCC---------CTTCCHHHHHHHHHHT
T ss_pred             CCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH-------HcCCCCCC---------CCCcCHHHHHHHHHHc
Confidence            8889999999999999999998 99998755544332211       11111111         1122346888999999


Q ss_pred             CCCCCCCCCHHHHHHHhcCcccc
Q 027675          160 QEDPNDRPTMSDVVIMLGSEAVN  182 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l~~~~~~  182 (220)
                      ..||++|||+.++++.|+.....
T Consensus       292 ~~dp~~Rps~~eil~~L~~l~~~  314 (325)
T 3kul_A          292 HKDRAQRPRFSQIVSVLDALIRS  314 (325)
T ss_dssp             CSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             cCChhhCcCHHHHHHHHHHHHhC
Confidence            99999999999999999776443

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.96  E-value=3e-30  Score=211.93  Aligned_cols=168  Identities=24%  Similarity=0.239  Sum_probs=121.8

Q ss_pred             chHHHHHHHHHHHHHHhhhC-CCCCeEeccCCCCceeeCCCC--------------------------------------
Q 027675            2 EMLFNIILGVSRRLLYLHQD-SKLRIIHRDFKTSNILLDHEM--------------------------------------   42 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~-~~~~i~H~dlk~~nili~~~~--------------------------------------   42 (220)
                      ..++.++.||+.||.|||++ |   |+||||||+||+++.++                                      
T Consensus       146 ~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (397)
T 1wak_A          146 PCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLV  222 (397)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSC
T ss_pred             HHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccc
Confidence            35788999999999999998 8   99999999999998775                                      


Q ss_pred             -----------CceecCccceeeecCCCCCcccceeecccCccChhhhhcCCCcccCceeehhHHHHHHHhcCccCcccc
Q 027675           43 -----------NPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYN  111 (220)
Q Consensus        43 -----------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~  111 (220)
                                 .++|+|||++......     .....++..|+|||.+.+..++.++|||||||++|+|++|..||....
T Consensus       223 ~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~  297 (397)
T 1wak_A          223 NPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHS  297 (397)
T ss_dssp             CTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred             cccccccccccceEecccccccccccc-----CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence                       7999999998765432     122457889999999999889999999999999999999999997544


Q ss_pred             hhHHHh---hHHHHHHH--------HHhcccc-----------ccccCCC---------CCcCcHHHHHHHHHHhccccC
Q 027675          112 SELALS---LLGYAWKL--------WQEGKAL-----------DMMDQKP---------GAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus       112 ~~~~~~---~~~~~~~~--------~~~~~~~-----------~~~~~~~---------~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ......   ........        ...+...           ......+         ...........+.++|.+||+
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  377 (397)
T 1wak_A          298 GEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLE  377 (397)
T ss_dssp             CSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGC
T ss_pred             ccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhc
Confidence            321111   11111110        0000000           0000000         011234566788999999999


Q ss_pred             CCCCCCCCHHHHHHHhc
Q 027675          161 EDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~  177 (220)
                      .||++|||+++++++-+
T Consensus       378 ~dP~~Rpt~~e~l~hp~  394 (397)
T 1wak_A          378 LIPEKRATAAECLRHPW  394 (397)
T ss_dssp             SSGGGSCCHHHHHTSGG
T ss_pred             cChhhcCCHHHHhhCcc
Confidence            99999999999998743

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.96  E-value=2.9e-30  Score=204.76  Aligned_cols=155  Identities=22%  Similarity=0.288  Sum_probs=117.1

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++........  ......+++.|+|||.+.+
T Consensus       137 ~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~  211 (298)
T 2zv2_A          137 DQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSE  211 (298)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhcc
Confidence            357889999999999999999   99999999999999999999999999876543221  1223467899999999876


Q ss_pred             CC---CcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           82 GF---FSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        82 ~~---~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                      ..   .+.++|+||||+++|+|++|..||..........      ... .... ..   ...    ......+.++|.+|
T Consensus       212 ~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~------~~~-~~~~-~~---~~~----~~~~~~l~~li~~~  276 (298)
T 2zv2_A          212 TRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHS------KIK-SQAL-EF---PDQ----PDIAEDLKDLITRM  276 (298)
T ss_dssp             TCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHH-HCCC-CC---CSS----SCCCHHHHHHHHHH
T ss_pred             CCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHH------HHh-cccC-CC---CCc----cccCHHHHHHHHHH
Confidence            54   3678999999999999999999997544322211      111 1111 00   000    11224678999999


Q ss_pred             cCCCCCCCCCHHHHHHHh
Q 027675          159 VQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       159 l~~~p~~Rps~~~~l~~l  176 (220)
                      |+.||++|||+.+++++-
T Consensus       277 l~~dp~~R~s~~e~l~hp  294 (298)
T 2zv2_A          277 LDKNPESRIVVPEIKLHP  294 (298)
T ss_dssp             TCSCTTTSCCHHHHTTCH
T ss_pred             hhcChhhCCCHHHHhcCc
Confidence            999999999999998763

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.96  E-value=3.4e-30  Score=208.01  Aligned_cols=155  Identities=23%  Similarity=0.270  Sum_probs=120.2

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +.++.++.|++.||.|||++|   |+||||||+||+++.++.++|+|||++.......  .......|++.|+|||.+.+
T Consensus       105 ~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~  179 (337)
T 1o6l_A          105 ERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLED  179 (337)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT--CCBCCCEECGGGCCGGGGSS
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccCC--CcccccccChhhCChhhhcC
Confidence            356789999999999999999   9999999999999999999999999987432211  12233568999999999998


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+||||+++|+|++|..||...+.......      ... +.. .    .+.     .....+.++|.+||+.
T Consensus       180 ~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~------i~~-~~~-~----~p~-----~~s~~~~~li~~lL~~  242 (337)
T 1o6l_A          180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL------ILM-EEI-R----FPR-----TLSPEAKSLLAGLLKK  242 (337)
T ss_dssp             SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HHH-CCC-C----CCT-----TSCHHHHHHHHHHTCS
T ss_pred             CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHH------HHc-CCC-C----CCC-----CCCHHHHHHHHHHhhc
Confidence            8899999999999999999999999975544332211      111 110 0    111     1234678899999999


Q ss_pred             CCCCCC-----CHHHHHHHhcC
Q 027675          162 DPNDRP-----TMSDVVIMLGS  178 (220)
Q Consensus       162 ~p~~Rp-----s~~~~l~~l~~  178 (220)
                      ||++||     +++++++|-+.
T Consensus       243 dP~~R~g~~~~~~~ei~~h~~f  264 (337)
T 1o6l_A          243 DPKQRLGGGPSDAKEVMEHRFF  264 (337)
T ss_dssp             STTTSTTCSTTTHHHHHTSGGG
T ss_pred             CHHHhcCCCCCCHHHHHcCCCc
Confidence            999999     89999987543

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.96  E-value=1.1e-30  Score=214.76  Aligned_cols=158  Identities=22%  Similarity=0.318  Sum_probs=113.1

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc-
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG-   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~-   81 (220)
                      .++.++.|++.||.|||+.+   |+||||||+||+++ ++.+||+|||++................|++.|+|||.+.+ 
T Consensus       156 ~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  231 (390)
T 2zmd_A          156 ERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM  231 (390)
T ss_dssp             HHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC
T ss_pred             HHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhc
Confidence            57889999999999999999   99999999999995 58899999999876543222222233568999999999875 


Q ss_pred             ----------CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHH
Q 027675           82 ----------GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKC  151 (220)
Q Consensus        82 ----------~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (220)
                                ..++.++|||||||++|+|++|..||.........     .............    +..     ....+
T Consensus       232 ~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~-----~~~~~~~~~~~~~----~~~-----~~~~~  297 (390)
T 2zmd_A          232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK-----LHAIIDPNHEIEF----PDI-----PEKDL  297 (390)
T ss_dssp             ------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH-----HHHHHCTTSCCCC----CCC-----SCHHH
T ss_pred             cccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHH-----HHHHhCccccCCC----Ccc-----chHHH
Confidence                      35788999999999999999999999643322110     1111111111110    111     12367


Q ss_pred             HHHhccccCCCCCCCCCHHHHHHHhcC
Q 027675          152 INVGLLCVQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       152 ~~li~~cl~~~p~~Rps~~~~l~~l~~  178 (220)
                      .++|.+||+.||++|||+.+++++-+.
T Consensus       298 ~~li~~~L~~dP~~Rps~~ell~hp~~  324 (390)
T 2zmd_A          298 QDVLKCCLKRDPKQRISIPELLAHPYV  324 (390)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred             HHHHHHHcccChhhCCCHHHHhhCcCc
Confidence            889999999999999999999977543

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.96  E-value=1.1e-29  Score=202.52  Aligned_cols=164  Identities=26%  Similarity=0.421  Sum_probs=119.2

Q ss_pred             hHHHHHHHHHHHHHHhhh---CCCCCeEeccCCCCceeeCCCCC-ceecCccceeeecCCCCCcccceeecccCccChhh
Q 027675            3 MLFNIILGVSRRLLYLHQ---DSKLRIIHRDFKTSNILLDHEMN-PKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEY   78 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~---~~~~~i~H~dlk~~nili~~~~~-~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~   78 (220)
                      .++.++.|+++||.|||+   ++   ++||||||+||+++.++. ++|+|||++......     .....++..|+|||.
T Consensus       103 ~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~  174 (307)
T 2eva_A          103 HAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWMAPEV  174 (307)
T ss_dssp             HHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEECCCCC-----------------CCTTSSCHHH
T ss_pred             HHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEcccccccccccc-----cccCCCCCceEChhh
Confidence            567899999999999999   77   999999999999988887 799999998654321     122357889999999


Q ss_pred             hhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           79 ALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        79 ~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                      +.+..++.++||||||+++|+|++|..||..........    .+.. ..+......         ......+.+++.+|
T Consensus       175 ~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~~---------~~~~~~l~~li~~~  240 (307)
T 2eva_A          175 FEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI----MWAV-HNGTRPPLI---------KNLPKPIESLMTRC  240 (307)
T ss_dssp             HTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHH----HHHH-HTTCCCCCB---------TTCCHHHHHHHHHH
T ss_pred             hCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHH----HHHH-hcCCCCCcc---------cccCHHHHHHHHHH
Confidence            999889999999999999999999999997543322111    1111 111111111         11223678899999


Q ss_pred             cCCCCCCCCCHHHHHHHhcCccccCCCCCC
Q 027675          159 VQEDPNDRPTMSDVVIMLGSEAVNLASPKR  188 (220)
Q Consensus       159 l~~~p~~Rps~~~~l~~l~~~~~~~~~~~~  188 (220)
                      |+.||++|||++++++.|+......+....
T Consensus       241 l~~dp~~Rps~~ell~~L~~~~~~~~~~~~  270 (307)
T 2eva_A          241 WSKDPSQRPSMEEIVKIMTHLMRYFPGADE  270 (307)
T ss_dssp             TCSSGGGSCCHHHHHHHHHHHGGGCCCTTS
T ss_pred             hcCChhhCcCHHHHHHHHHHHHHhccCCCC
Confidence            999999999999999999877665554443

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.96  E-value=2.4e-29  Score=203.84  Aligned_cols=176  Identities=20%  Similarity=0.244  Sum_probs=123.6

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCC--CCcccceeecccCccChhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQ--TDGTTNRVVGTYGYMSPEYA   79 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~y~aPe~~   79 (220)
                      .+++.++.|++.||.|||++|   |+||||||+||+++.++.++|+|||++.......  .........+++.|+|||.+
T Consensus       124 ~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  200 (351)
T 3mi9_A          124 SEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELL  200 (351)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhh
Confidence            467899999999999999999   9999999999999999999999999987654221  11122234668899999998


Q ss_pred             hcC-CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHH--------HhccccccccCCCCCcCcHHH---
Q 027675           80 LGG-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLW--------QEGKALDMMDQKPGAISKANE---  147 (220)
Q Consensus        80 ~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~---  147 (220)
                      .+. .++.++|||||||++|+|++|..||...................        .....................   
T Consensus       201 ~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (351)
T 3mi9_A          201 LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLK  280 (351)
T ss_dssp             TTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHH
T ss_pred             cCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhh
Confidence            764 57899999999999999999999997655443332221110000        000000000000000111111   


Q ss_pred             ----HHHHHHHhccccCCCCCCCCCHHHHHHHhcCcc
Q 027675          148 ----ILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEA  180 (220)
Q Consensus       148 ----~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~~  180 (220)
                          ...+.++|.+||+.||++|||+++++++-+...
T Consensus       281 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  317 (351)
T 3mi9_A          281 AYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  317 (351)
T ss_dssp             HHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGS
T ss_pred             hccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCC
Confidence                235789999999999999999999999876543

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.96  E-value=1.6e-30  Score=208.80  Aligned_cols=169  Identities=25%  Similarity=0.345  Sum_probs=122.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCC-cccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD-GTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~y~aPe~~~   80 (220)
                      ..++.++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++......... .......++..|+|||.+.
T Consensus       127 ~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  203 (327)
T 3lxl_A          127 SRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS  203 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhc
Confidence            467889999999999999999   999999999999999999999999999865432211 1112234566799999999


Q ss_pred             cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhh--------HHHHHHHHHhccccccccCCCCCcCcHHHHHHHH
Q 027675           81 GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSL--------LGYAWKLWQEGKALDMMDQKPGAISKANEILKCI  152 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (220)
                      +..++.++||||||+++|+|++|..||...........        ..........+....         ........+.
T Consensus       204 ~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~l~  274 (327)
T 3lxl_A          204 DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLP---------APPACPAEVH  274 (327)
T ss_dssp             HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCCC---------CCTTCCHHHH
T ss_pred             cCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccCCC---------CCCcccHHHH
Confidence            98889999999999999999999999864332211100        011111111111111         1112334688


Q ss_pred             HHhccccCCCCCCCCCHHHHHHHhcCcccc
Q 027675          153 NVGLLCVQEDPNDRPTMSDVVIMLGSEAVN  182 (220)
Q Consensus       153 ~li~~cl~~~p~~Rps~~~~l~~l~~~~~~  182 (220)
                      ++|.+||+.||++|||+.+++++|+.....
T Consensus       275 ~li~~~l~~dP~~Rps~~ell~~L~~~~~~  304 (327)
T 3lxl_A          275 ELMKLCWAPSPQDRPSFSALGPQLDMLWSG  304 (327)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred             HHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            999999999999999999999999776443

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.96  E-value=1.5e-30  Score=207.68  Aligned_cols=161  Identities=28%  Similarity=0.399  Sum_probs=123.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++................+++.|+|||.+.+
T Consensus       148 ~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  224 (316)
T 2xir_A          148 EHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD  224 (316)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcc
Confidence            357889999999999999999   99999999999999999999999999875443322222333456778999999999


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++|+|++ |..||.........      ......+......    .     .....+.+++.+||+
T Consensus       225 ~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~------~~~~~~~~~~~~~----~-----~~~~~l~~li~~~l~  289 (316)
T 2xir_A          225 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF------CRRLKEGTRMRAP----D-----YTTPEMYQTMLDCWH  289 (316)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH------HHHHHHTCCCCCC----T-----TCCHHHHHHHHHHTC
T ss_pred             ccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHH------HHHhccCccCCCC----C-----CCCHHHHHHHHHHcC
Confidence            889999999999999999998 99998654432211      1111122111111    1     122367889999999


Q ss_pred             CCCCCCCCHHHHHHHhcCcc
Q 027675          161 EDPNDRPTMSDVVIMLGSEA  180 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~~  180 (220)
                      .||++|||+.+++++|+...
T Consensus       290 ~dp~~Rps~~ell~~L~~~~  309 (316)
T 2xir_A          290 GEPSQRPTFSELVEHLGNLL  309 (316)
T ss_dssp             SSGGGSCCHHHHHHHHHHHH
T ss_pred             CChhhCcCHHHHHHHHHHHH
Confidence            99999999999999997653

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.96  E-value=1.5e-30  Score=207.47  Aligned_cols=161  Identities=25%  Similarity=0.405  Sum_probs=123.2

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++................+++.|.|||.+.+
T Consensus       145 ~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  221 (313)
T 1t46_A          145 EDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN  221 (313)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC
Confidence            357889999999999999999   99999999999999999999999999876544332222233455678999999998


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++|+|++ |..||..........      .....+.....     .    ......+.+++.+||.
T Consensus       222 ~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~------~~~~~~~~~~~-----~----~~~~~~l~~li~~~l~  286 (313)
T 1t46_A          222 CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY------KMIKEGFRMLS-----P----EHAPAEMYDIMKTCWD  286 (313)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH------HHHHHTCCCCC-----C----TTSCHHHHHHHHHHTC
T ss_pred             CCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHH------HHhccCCCCCC-----c----ccCCHHHHHHHHHHcC
Confidence            889999999999999999998 999987544322111      11111111100     0    1123467889999999


Q ss_pred             CCCCCCCCHHHHHHHhcCcc
Q 027675          161 EDPNDRPTMSDVVIMLGSEA  180 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~~  180 (220)
                      .||++|||+.++++.|+...
T Consensus       287 ~dp~~Rps~~ell~~L~~~~  306 (313)
T 1t46_A          287 ADPLKRPTFKQIVQLIEKQI  306 (313)
T ss_dssp             SSGGGSCCHHHHHHHHHHHH
T ss_pred             CCchhCcCHHHHHHHHHHHH
Confidence            99999999999999996653

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.96  E-value=4.5e-30  Score=205.54  Aligned_cols=172  Identities=24%  Similarity=0.272  Sum_probs=120.6

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+..++.|++.||.|||++|   |+||||||+||+++.++.++|+|||++........  ......+++.|+|||.+.+.
T Consensus       109 ~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~  183 (317)
T 2pmi_A          109 LVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN--TFSSEVVTLWYRAPDVLMGS  183 (317)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETTSCCC--CCCCCCSCCTTCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecCCCcc--cCCCCcccccccCchHhhCC
Confidence            46788999999999999999   99999999999999999999999999876542211  12224578899999999764


Q ss_pred             -CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhcc---cccccc------CCCCCc--------Cc
Q 027675           83 -FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGK---ALDMMD------QKPGAI--------SK  144 (220)
Q Consensus        83 -~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~------~~~~~~--------~~  144 (220)
                       .++.++|||||||++|+|++|..||...+...................   ......      ......        ..
T Consensus       184 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (317)
T 2pmi_A          184 RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTK  263 (317)
T ss_dssp             CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCS
T ss_pred             CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhccccc
Confidence             578999999999999999999999976655433222111000000000   000000      000000        00


Q ss_pred             HHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          145 ANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       145 ~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      ......+.++|.+||+.||++|||+++++++-+..
T Consensus       264 ~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~  298 (317)
T 2pmi_A          264 EPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFA  298 (317)
T ss_dssp             SCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGG
T ss_pred             ccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhh
Confidence            01234688999999999999999999999875443

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.96  E-value=4.9e-30  Score=210.76  Aligned_cols=175  Identities=19%  Similarity=0.191  Sum_probs=117.7

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCC-----CCCcccceeecccCccCh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGK-----QTDGTTNRVVGTYGYMSP   76 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~-----~~~~~~~~~~~~~~y~aP   76 (220)
                      ..++.++.||+.||+|||+++   |+||||||+||+++.++.++|+|||.+......     ..........++..|+||
T Consensus       128 ~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  204 (389)
T 3gni_B          128 LAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP  204 (389)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCH
Confidence            357889999999999999999   999999999999999999999999987643211     111111223567889999


Q ss_pred             hhhhc--CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHH-HHH-HHHHhc------------------ccccc
Q 027675           77 EYALG--GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLG-YAW-KLWQEG------------------KALDM  134 (220)
Q Consensus        77 e~~~~--~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~-~~~-~~~~~~------------------~~~~~  134 (220)
                      |.+.+  ..++.++|||||||++|+|++|..||...+......... ... ......                  .....
T Consensus       205 E~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (389)
T 3gni_B          205 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDS  284 (389)
T ss_dssp             HHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------------------------------
T ss_pred             HHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccc
Confidence            99987  568999999999999999999999996543332211100 000 000000                  00000


Q ss_pred             ---------ccCCCCCcCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          135 ---------MDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       135 ---------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                               ....+...........+.++|.+||+.||++|||+.+++++-+..
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~  338 (389)
T 3gni_B          285 LTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK  338 (389)
T ss_dssp             ---------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGG
T ss_pred             cccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHH
Confidence                     000000011122345688999999999999999999999875443

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.96  E-value=2.2e-30  Score=208.59  Aligned_cols=174  Identities=22%  Similarity=0.226  Sum_probs=120.3

Q ss_pred             chHHHHHHHHHHHHHHhhhC---------CCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCC------Ccccce
Q 027675            2 EMLFNIILGVSRRLLYLHQD---------SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT------DGTTNR   66 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~---------~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~------~~~~~~   66 (220)
                      ..++.++.|++.||.|||+.         +   |+||||||+||+++.++.++|+|||++........      ......
T Consensus       111 ~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~  187 (336)
T 3g2f_A          111 VSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAIS  187 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CC
T ss_pred             hHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEeeccceeecccccccCcccccccccc
Confidence            35678999999999999999         8   99999999999999999999999999976543211      111112


Q ss_pred             eecccCccChhhhhc-------CCCcccCceeehhHHHHHHHhcCccCcccchh-HHHhh----------HHHHHHHHHh
Q 027675           67 VVGTYGYMSPEYALG-------GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSE-LALSL----------LGYAWKLWQE  128 (220)
Q Consensus        67 ~~~~~~y~aPe~~~~-------~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~-~~~~~----------~~~~~~~~~~  128 (220)
                      ..++..|+|||.+.+       ..++.++|||||||++|+|++|..||...... .....          ..........
T Consensus       188 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (336)
T 3g2f_A          188 EVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSR  267 (336)
T ss_dssp             TTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTT
T ss_pred             CCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcc
Confidence            357889999999986       34567899999999999999997775322111 00000          0000111111


Q ss_pred             ccccccccCCCCCcCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcCcc
Q 027675          129 GKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEA  180 (220)
Q Consensus       129 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~~  180 (220)
                      ...  .................+.++|.+||+.||++|||+.++++.|+...
T Consensus       268 ~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll  317 (336)
T 3g2f_A          268 EKQ--RPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM  317 (336)
T ss_dssp             SCC--CCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccc--CCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence            111  11111112223345667899999999999999999999999886654

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.96  E-value=7.3e-30  Score=213.03  Aligned_cols=159  Identities=21%  Similarity=0.236  Sum_probs=120.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeC---CCCCceecCccceeeecCCCCCcccceeecccCccChhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLD---HEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEY   78 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~   78 (220)
                      ..+..++.|++.||.|||++|   |+||||||+||+++   .++.++|+|||++........  ......|++.|+|||.
T Consensus       110 ~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~  184 (444)
T 3soa_A          110 ADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ--AWFGFAGTPGYLSPEV  184 (444)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC--BCCCSCSCGGGCCHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc--eeecccCCcccCCHHH
Confidence            357789999999999999999   99999999999998   467899999999875543221  1123468899999999


Q ss_pred             hhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           79 ALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        79 ~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                      +.+..++.++|||||||++|+|++|..||...+........       ..+... .... ..    ......+.++|.+|
T Consensus       185 l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i-------~~~~~~-~~~~-~~----~~~s~~~~~li~~~  251 (444)
T 3soa_A          185 LRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI-------KAGAYD-FPSP-EW----DTVTPEAKDLINKM  251 (444)
T ss_dssp             HTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-------HHTCCC-CCTT-TT----TTSCHHHHHHHHHH
T ss_pred             hcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHH-------HhCCCC-CCcc-cc----ccCCHHHHHHHHHH
Confidence            99988999999999999999999999999755443322111       111110 0000 00    11234678999999


Q ss_pred             cCCCCCCCCCHHHHHHHhcC
Q 027675          159 VQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       159 l~~~p~~Rps~~~~l~~l~~  178 (220)
                      |+.||++|||+.+++++-+.
T Consensus       252 L~~dP~~Rpta~e~L~hp~~  271 (444)
T 3soa_A          252 LTINPSKRITAAEALKHPWI  271 (444)
T ss_dssp             SCSSTTTSCCHHHHHHSCTT
T ss_pred             cCCChhHCCCHHHHhcCccc
Confidence            99999999999999988654

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.96  E-value=2.9e-30  Score=203.90  Aligned_cols=168  Identities=22%  Similarity=0.299  Sum_probs=116.9

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++........  ......+++.|+|||.+.+.
T Consensus       101 ~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~  175 (288)
T 1ob3_A          101 TAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGS  175 (288)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc--ccccccccccccCchheeCC
Confidence            56789999999999999999   99999999999999999999999999875432211  12224568899999999764


Q ss_pred             -CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhcc------cccc--cc-------CCCCCcCcHH
Q 027675           83 -FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGK------ALDM--MD-------QKPGAISKAN  146 (220)
Q Consensus        83 -~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~~--~~-------~~~~~~~~~~  146 (220)
                       .++.++|+||||+++|+|++|..||...+........   ........      ....  .+       ..+.......
T Consensus       176 ~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (288)
T 1ob3_A          176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI---FRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKG  252 (288)
T ss_dssp             CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCS
T ss_pred             CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHHCCCChhhchhhhcccccccccccccCccHHHHhhh
Confidence             5789999999999999999999999765543322111   11100000      0000  00       0000000011


Q ss_pred             HHHHHHHHhccccCCCCCCCCCHHHHHHHhcC
Q 027675          147 EILKCINVGLLCVQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       147 ~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~  178 (220)
                      ....+.++|.+||+.||++|||+.+++++-+.
T Consensus       253 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f  284 (288)
T 1ob3_A          253 LDESGIDLLSKMLKLDPNQRITAKQALEHAYF  284 (288)
T ss_dssp             CCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred             cCHHHHHHHHHHcCCCcccCCCHHHHhcCcch
Confidence            23467899999999999999999999987543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.96  E-value=6.3e-30  Score=202.24  Aligned_cols=169  Identities=18%  Similarity=0.236  Sum_probs=118.5

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||++|   |+||||||+||+++.++.++|+|||++........  ......+++.|+|||.+.+
T Consensus       101 ~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~  175 (292)
T 3o0g_A          101 EIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFG  175 (292)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS--CCCSCCSCGGGCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCccc--cccCCccccCCcChHHHcC
Confidence            357889999999999999999   99999999999999999999999999976543221  1222456889999999987


Q ss_pred             CC-CcccCceeehhHHHHHHHhcCccC-cccchhHHHhhHHHHHHHHHhcc------ccccccC---------CCCCcCc
Q 027675           82 GF-FSVKSDVFSFGVVVLEIISGKRNT-GFYNSELALSLLGYAWKLWQEGK------ALDMMDQ---------KPGAISK  144 (220)
Q Consensus        82 ~~-~~~~~DiwslG~il~~ll~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~---------~~~~~~~  144 (220)
                      .. ++.++||||||+++|+|++|..|| ...+.......   .........      .....+.         .......
T Consensus       176 ~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~---i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (292)
T 3o0g_A          176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR---IFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVV  252 (292)
T ss_dssp             CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHH---HHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTS
T ss_pred             CCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHH---HHHHhCCCChhhhhhhcccccccccccccCCcchhhcc
Confidence            65 799999999999999999888775 33222221111   111100000      0000000         0000011


Q ss_pred             HHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcC
Q 027675          145 ANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       145 ~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~  178 (220)
                      ......+.++|.+||+.||++|||+++++++-+-
T Consensus       253 ~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  286 (292)
T 3o0g_A          253 PKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF  286 (292)
T ss_dssp             TTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             cccChHHHHHHHHHhccChhhCCCHHHHhcCccc
Confidence            1234467899999999999999999999987543

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.96  E-value=4.4e-30  Score=206.94  Aligned_cols=161  Identities=28%  Similarity=0.357  Sum_probs=123.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|+++||.|||+.+   ++||||||+||+++.++.++|+|||++................+++.|.|||.+.+
T Consensus       157 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  233 (334)
T 2pvf_A          157 KDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD  233 (334)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcC
Confidence            357889999999999999999   99999999999999999999999999876543322222222345678999999998


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++|+|++ |..||..........       ....+......         ......+.++|.+||+
T Consensus       234 ~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~-------~~~~~~~~~~~---------~~~~~~l~~li~~~l~  297 (334)
T 2pvf_A          234 RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK-------LLKEGHRMDKP---------ANCTNELYMMMRDCWH  297 (334)
T ss_dssp             CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH-------HHHHTCCCCCC---------TTCCHHHHHHHHHHTC
T ss_pred             CCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHH-------HHhcCCCCCCC---------ccCCHHHHHHHHHHcc
Confidence            888999999999999999999 999987654433221       11122111111         1123467889999999


Q ss_pred             CCCCCCCCHHHHHHHhcCccc
Q 027675          161 EDPNDRPTMSDVVIMLGSEAV  181 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~~~  181 (220)
                      .||++||++.++++.|+....
T Consensus       298 ~dp~~Rps~~ell~~L~~l~~  318 (334)
T 2pvf_A          298 AVPSQRPTFKQLVEDLDRILT  318 (334)
T ss_dssp             SSGGGSCCHHHHHHHHHHHHH
T ss_pred             CChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999976643

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.96  E-value=7.9e-30  Score=202.61  Aligned_cols=158  Identities=22%  Similarity=0.226  Sum_probs=120.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++................++..|.|||.+.+
T Consensus       109 ~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  185 (305)
T 2wtk_C          109 CQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANG  185 (305)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccC
Confidence            357889999999999999999   99999999999999999999999999876543322222333467889999999986


Q ss_pred             CC--CcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           82 GF--FSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        82 ~~--~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      ..  .+.++|+||||+++|+|++|..||...+.......       ...+.. ..    +.     .....+.++|.+||
T Consensus       186 ~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------i~~~~~-~~----~~-----~~~~~l~~li~~~l  248 (305)
T 2wtk_C          186 LDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFEN-------IGKGSY-AI----PG-----DCGPPLSDLLKGML  248 (305)
T ss_dssp             CSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-------HHHCCC-CC----CS-----SSCHHHHHHHHHHT
T ss_pred             cccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH-------HhcCCC-CC----CC-----ccCHHHHHHHHHHc
Confidence            54  36789999999999999999999976543332211       111111 00    11     12236788999999


Q ss_pred             CCCCCCCCCHHHHHHHhcCc
Q 027675          160 QEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l~~~  179 (220)
                      ..||++|||+.+++++-+..
T Consensus       249 ~~dp~~Rps~~~ll~~~~~~  268 (305)
T 2wtk_C          249 EYEPAKRFSIRQIRQHSWFR  268 (305)
T ss_dssp             CSSTTTSCCHHHHHHSHHHH
T ss_pred             cCChhhCCCHHHHhcCcccc
Confidence            99999999999999876443

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.96  E-value=1.3e-30  Score=211.81  Aligned_cols=155  Identities=22%  Similarity=0.258  Sum_probs=117.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.||+.||+|||+++   |+||||||+||+++.++.++|+|||++.......  .......|++.|+|||.+.+
T Consensus       124 ~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~  198 (353)
T 3txo_A          124 ARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG--VTTATFCGTPDYIAPEILQE  198 (353)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----------CCGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecccCC--ccccccCCCcCeEChhhcCC
Confidence            357789999999999999999   9999999999999999999999999986432211  12233568999999999998


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+|||||++|+|++|..||...+.......+      .. +..    . .+.     .....+.++|.+||+.
T Consensus       199 ~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i------~~-~~~----~-~p~-----~~~~~~~~li~~lL~~  261 (353)
T 3txo_A          199 MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI------LN-DEV----V-YPT-----WLHEDATGILKSFMTK  261 (353)
T ss_dssp             HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HH-CCC----C-CCT-----TSCHHHHHHHHHHTCS
T ss_pred             CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHH------Hc-CCC----C-CCC-----CCCHHHHHHHHHHhhh
Confidence            88899999999999999999999999765544332211      11 111    0 011     1233678899999999


Q ss_pred             CCCCCCCH------HHHHHHhcC
Q 027675          162 DPNDRPTM------SDVVIMLGS  178 (220)
Q Consensus       162 ~p~~Rps~------~~~l~~l~~  178 (220)
                      ||++||++      +++++|-+.
T Consensus       262 dP~~R~~~~~~~~~~~il~hp~f  284 (353)
T 3txo_A          262 NPTMRLGSLTQGGEHAILRHPFF  284 (353)
T ss_dssp             SGGGSTTSGGGTCTHHHHTSGGG
T ss_pred             CHHHccCCcccCCHHHHhhCCcc
Confidence            99999999      889876543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.96  E-value=1.2e-30  Score=208.27  Aligned_cols=161  Identities=25%  Similarity=0.321  Sum_probs=114.0

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCC-CcccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT-DGTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~y~aPe~~~   80 (220)
                      +.++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++........ ........|++.|+|||.+.
T Consensus       116 ~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  192 (311)
T 3ork_A          116 KRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR  192 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhc
Confidence            457889999999999999999   99999999999999999999999999875433211 11222345789999999999


Q ss_pred             cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           81 GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      +..++.++||||||+++|+|++|..||..........      ...........       .........+.++|.+||+
T Consensus       193 ~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~------~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~  259 (311)
T 3ork_A          193 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY------QHVREDPIPPS-------ARHEGLSADLDAVVLKALA  259 (311)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH------HHHHCCCCCHH-------HHSTTCCHHHHHHHHHHTC
T ss_pred             CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH------HHhcCCCCCcc-------cccCCCCHHHHHHHHHHHh
Confidence            9889999999999999999999999997654433211      11111111000       0001123467899999999


Q ss_pred             CCCCCCCCHHHHHHHhcC
Q 027675          161 EDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~  178 (220)
                      .||++||++.+++.+-..
T Consensus       260 ~dP~~R~~~~~~l~~~l~  277 (311)
T 3ork_A          260 KNPENRYQTAAEMRADLV  277 (311)
T ss_dssp             SSGGGSCSSHHHHHHHHH
T ss_pred             cCHhhChhhHHHHHHHHH
Confidence            999999988888765533

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.96  E-value=5.2e-30  Score=201.40  Aligned_cols=154  Identities=23%  Similarity=0.331  Sum_probs=117.9

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.......    .....+++.|.|||.+.+
T Consensus       109 ~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~  181 (279)
T 3fdn_A          109 QRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPPEMIEG  181 (279)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC------------CCCCTTCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCccc----ccccCCCCCccCHhHhcc
Confidence            357889999999999999999   9999999999999999999999999875433221    223467889999999999


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+||||+++|+|++|..||...+........       .....     ..+.     .....+.++|.+||+.
T Consensus       182 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-------~~~~~-----~~~~-----~~~~~~~~li~~~l~~  244 (279)
T 3fdn_A          182 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-------SRVEF-----TFPD-----FVTEGARDLISRLLKH  244 (279)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-------HHTCC-----CCCT-----TSCHHHHHHHHHHCCS
T ss_pred             CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHH-------HhCCC-----CCCC-----cCCHHHHHHHHHHhcc
Confidence            88899999999999999999999999755443322111       11000     0111     1223678899999999


Q ss_pred             CCCCCCCHHHHHHHhcCc
Q 027675          162 DPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~~~  179 (220)
                      ||++|||+++++++-+..
T Consensus       245 ~p~~Rps~~e~l~h~~~~  262 (279)
T 3fdn_A          245 NPSQRPMLREVLEHPWIT  262 (279)
T ss_dssp             SGGGSCCHHHHHHCHHHH
T ss_pred             ChhhCCCHHHHhhCcccc
Confidence            999999999999886543

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.96  E-value=5.1e-30  Score=200.46  Aligned_cols=158  Identities=29%  Similarity=0.453  Sum_probs=115.7

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCC--------CCCceecCccceeeecCCCCCcccceeecccCc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDH--------EMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGY   73 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~--------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y   73 (220)
                      ..++.++.|++.||.|||+++...++||||||+||+++.        ++.++|+|||++.......    .....+++.|
T Consensus       105 ~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y  180 (271)
T 3dtc_A          105 DILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT----KMSAAGAYAW  180 (271)
T ss_dssp             HHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-----------------CCGGG
T ss_pred             HHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccccccccc----ccCCCCccce
Confidence            357889999999999999997444789999999999986        6779999999987543222    1124578899


Q ss_pred             cChhhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHH
Q 027675           74 MSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCIN  153 (220)
Q Consensus        74 ~aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (220)
                      .|||.+.+..++.++|+||||+++|+|++|..||...+.......      .........         ........+.+
T Consensus       181 ~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~------~~~~~~~~~---------~~~~~~~~~~~  245 (271)
T 3dtc_A          181 MAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYG------VAMNKLALP---------IPSTCPEPFAK  245 (271)
T ss_dssp             SCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH------HHTSCCCCC---------CCTTCCHHHHH
T ss_pred             eCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh------hhcCCCCCC---------CCcccCHHHHH
Confidence            999999998899999999999999999999999976544332211      111111111         11112346889


Q ss_pred             HhccccCCCCCCCCCHHHHHHHhcC
Q 027675          154 VGLLCVQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       154 li~~cl~~~p~~Rps~~~~l~~l~~  178 (220)
                      ++.+||+.||++|||+.+++++|+.
T Consensus       246 li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          246 LMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             HHHHHhcCCcccCcCHHHHHHHHhc
Confidence            9999999999999999999999864

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.96  E-value=5.4e-30  Score=208.64  Aligned_cols=159  Identities=19%  Similarity=0.184  Sum_probs=121.0

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCC----CceecCccceeeecCCCCCcccceeecccCccChh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEM----NPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPE   77 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe   77 (220)
                      ..++.++.|++.||.|||++|   |+||||||+||+++.++    .++|+|||++.......   ......|++.|+|||
T Consensus       115 ~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE  188 (361)
T 2yab_A          115 EEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPE  188 (361)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTC---CCCCCCSCGGGCCHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCC---ccccCCCCccEECch
Confidence            357889999999999999999   99999999999998877    69999999987654322   122346899999999


Q ss_pred             hhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcc
Q 027675           78 YALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLL  157 (220)
Q Consensus        78 ~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  157 (220)
                      .+.+..++.++|+||||+++|+|++|..||...+.......+      . .+..      .............+.++|.+
T Consensus       189 ~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i------~-~~~~------~~~~~~~~~~s~~~~~li~~  255 (361)
T 2yab_A          189 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI------T-AVSY------DFDEEFFSQTSELAKDFIRK  255 (361)
T ss_dssp             HHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH------H-TTCC------CCCHHHHTTSCHHHHHHHHH
T ss_pred             HHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------H-hcCC------CCCchhccCCCHHHHHHHHH
Confidence            999888999999999999999999999999765443322111      0 1100      00000001123467899999


Q ss_pred             ccCCCCCCCCCHHHHHHHhcCc
Q 027675          158 CVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       158 cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      ||..||++|||+.+++++-+..
T Consensus       256 ~L~~dP~~R~t~~e~l~hp~~~  277 (361)
T 2yab_A          256 LLVKETRKRLTIQEALRHPWIT  277 (361)
T ss_dssp             HSCSSTTTSCCHHHHHTSTTTS
T ss_pred             HCCCChhHCcCHHHHhcCcCcC
Confidence            9999999999999999876543

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=7.3e-30  Score=205.41  Aligned_cols=172  Identities=22%  Similarity=0.247  Sum_probs=119.3

Q ss_pred             chHHHHHHHHHHHHHHhhhC--------CCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCc--ccceeeccc
Q 027675            2 EMLFNIILGVSRRLLYLHQD--------SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG--TTNRVVGTY   71 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~--------~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~   71 (220)
                      ..++.++.|++.||.|||++        +   ++||||||+||+++.++.++|+|||++..........  ......+++
T Consensus       134 ~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~  210 (337)
T 3mdy_A          134 KSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK  210 (337)
T ss_dssp             HHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCG
T ss_pred             HHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCc
Confidence            45788999999999999998        8   9999999999999999999999999987543322111  111246788


Q ss_pred             CccChhhhhcCCCccc------CceeehhHHHHHHHhc----------CccCcccchhHHHhhHHHHHHHHHhccccccc
Q 027675           72 GYMSPEYALGGFFSVK------SDVFSFGVVVLEIISG----------KRNTGFYNSELALSLLGYAWKLWQEGKALDMM  135 (220)
Q Consensus        72 ~y~aPe~~~~~~~~~~------~DiwslG~il~~ll~g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  135 (220)
                      .|+|||.+.+......      +|||||||++|+|++|          ..||.........  ..............   
T Consensus       211 ~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~--~~~~~~~~~~~~~~---  285 (337)
T 3mdy_A          211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS--YEDMREIVCIKKLR---  285 (337)
T ss_dssp             GGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC--HHHHHHHHTTSCCC---
T ss_pred             ceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCc--hhhhHHHHhhhccC---
Confidence            9999999987665554      8999999999999999          4454322111100  00011111111100   


Q ss_pred             cCCCCCcCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcCccc
Q 027675          136 DQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEAV  181 (220)
Q Consensus       136 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~~~  181 (220)
                      ...+...........+.++|.+||+.||++|||+.+++++|+....
T Consensus       286 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~  331 (337)
T 3mdy_A          286 PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE  331 (337)
T ss_dssp             CCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence            1111111223566788999999999999999999999999976644

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=3.8e-30  Score=206.45  Aligned_cols=158  Identities=17%  Similarity=0.213  Sum_probs=121.0

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCC--CCCceecCccceeeecCCCCCcccceeecccCccChhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDH--EMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYA   79 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~   79 (220)
                      ..++.++.|++.||.|||++|   ++||||||+||+++.  ++.++|+|||++......   .......+++.|.|||.+
T Consensus       102 ~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~  175 (321)
T 1tki_A          102 REIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG---DNFRLLFTAPEYYAPEVH  175 (321)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT---CEEEEEESCGGGSCHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC---CccccccCChhhcCcHHh
Confidence            357889999999999999999   999999999999987  788999999998765432   122335688999999999


Q ss_pred             hcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           80 LGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        80 ~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      .+..++.++|+||||+++|+|++|..||...+.......      ........       ...........+.++|.+||
T Consensus       176 ~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~------i~~~~~~~-------~~~~~~~~s~~~~~li~~~L  242 (321)
T 1tki_A          176 QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIEN------IMNAEYTF-------DEEAFKEISIEAMDFVDRLL  242 (321)
T ss_dssp             TTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH------HHHTCCCC-------CHHHHTTSCHHHHHHHHTTS
T ss_pred             cCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHH------HHcCCCCC-------ChhhhccCCHHHHHHHHHHc
Confidence            988889999999999999999999999976544332211      11110000       00000112346789999999


Q ss_pred             CCCCCCCCCHHHHHHHhcC
Q 027675          160 QEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l~~  178 (220)
                      ..||++|||+.+++++-+.
T Consensus       243 ~~dp~~Rpt~~e~l~hp~~  261 (321)
T 1tki_A          243 VKERKSRMTASEALQHPWL  261 (321)
T ss_dssp             CSSGGGSCCHHHHHHSHHH
T ss_pred             CCChhHCcCHHHHhcChhh
Confidence            9999999999999987643

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=1.1e-29  Score=205.55  Aligned_cols=172  Identities=23%  Similarity=0.243  Sum_probs=122.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++........  ......+++.|.|||.+.+
T Consensus       112 ~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~  186 (346)
T 1ua2_A          112 SHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFG  186 (346)
T ss_dssp             SHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceeccCCcc--cCCcccccccccCchHhhC
Confidence            467899999999999999999   99999999999999999999999999875432211  1223467889999999976


Q ss_pred             C-CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccc---ccc---ccC---CCCCcCc-----HH
Q 027675           82 G-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKA---LDM---MDQ---KPGAISK-----AN  146 (220)
Q Consensus        82 ~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~---~~~---~~~~~~~-----~~  146 (220)
                      . .++.++|+|||||++|+|++|.+||...+........   .........   ...   .+.   .......     ..
T Consensus       187 ~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (346)
T 1ua2_A          187 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI---FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSA  263 (346)
T ss_dssp             CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTT
T ss_pred             CCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHH---HHHcCCCChhhhhhhccCcccccccccCCCChHHhhcc
Confidence            4 4788999999999999999999998765543322111   111000000   000   000   0000000     11


Q ss_pred             HHHHHHHHhccccCCCCCCCCCHHHHHHHhcCccc
Q 027675          147 EILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEAV  181 (220)
Q Consensus       147 ~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~~~  181 (220)
                      ....+.++|.+||..||++|||+.+++++-+....
T Consensus       264 ~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~  298 (346)
T 1ua2_A          264 AGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  298 (346)
T ss_dssp             CCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             CCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence            23578899999999999999999999988765543

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.96  E-value=7.6e-30  Score=207.00  Aligned_cols=175  Identities=14%  Similarity=0.139  Sum_probs=125.9

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCC--CceecCccceeeecCCCCC-----cccceeecccCcc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEM--NPKISDFGLTRIFEGKQTD-----GTTNRVVGTYGYM   74 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~--~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~y~   74 (220)
                      ..++.++.|++.||.|||+++   ++||||||+||+++.++  .++|+|||++.........     .......+++.|+
T Consensus       159 ~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~  235 (352)
T 2jii_A          159 RSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFI  235 (352)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTC
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCcccc
Confidence            467899999999999999999   99999999999999988  8999999998754322110     1112236788999


Q ss_pred             ChhhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHH
Q 027675           75 SPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINV  154 (220)
Q Consensus        75 aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  154 (220)
                      |||.+.+..++.++||||||+++|+|++|..||......... ......... . ...........   .......+.++
T Consensus       236 aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~-~-~~~~~~~~~~~---~~~~~~~l~~l  309 (352)
T 2jii_A          236 SMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTED-IMKQKQKFV-D-KPGPFVGPCGH---WIRPSETLQKY  309 (352)
T ss_dssp             CHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH-HHHHHHHHH-H-SCCCEECTTSC---EECCCHHHHHH
T ss_pred             CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHH-HHHHHHhcc-C-Chhhhhhhccc---cCCCcHHHHHH
Confidence            999999988999999999999999999999999754322111 111111111 1 11111111110   00112468889


Q ss_pred             hccccCCCCCCCCCHHHHHHHhcCccccCCC
Q 027675          155 GLLCVQEDPNDRPTMSDVVIMLGSEAVNLAS  185 (220)
Q Consensus       155 i~~cl~~~p~~Rps~~~~l~~l~~~~~~~~~  185 (220)
                      |.+||+.||++||+++++++.|+........
T Consensus       310 i~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~  340 (352)
T 2jii_A          310 LKVVMALTYEEKPPYAMLRNNLEALLQDLRV  340 (352)
T ss_dssp             HHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence            9999999999999999999999776554443

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.96  E-value=2.1e-30  Score=208.47  Aligned_cols=160  Identities=26%  Similarity=0.397  Sum_probs=121.9

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++................++..|.|||.+.+.
T Consensus       165 ~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  241 (333)
T 2i1m_A          165 DLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC  241 (333)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccC
Confidence            57889999999999999999   999999999999999999999999998755433222222334556789999999988


Q ss_pred             CCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           83 FFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      .++.++||||||+++|+|++ |..||.........      ......+.....    +.     .....+.++|.+||+.
T Consensus       242 ~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~------~~~~~~~~~~~~----~~-----~~~~~l~~li~~~l~~  306 (333)
T 2i1m_A          242 VYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF------YKLVKDGYQMAQ----PA-----FAPKNIYSIMQACWAL  306 (333)
T ss_dssp             CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH------HHHHHHTCCCCC----CT-----TCCHHHHHHHHHHTCS
T ss_pred             CCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH------HHHHhcCCCCCC----CC-----CCCHHHHHHHHHHhcc
Confidence            89999999999999999998 88998654332211      111111111111    11     1123678899999999


Q ss_pred             CCCCCCCHHHHHHHhcCcc
Q 027675          162 DPNDRPTMSDVVIMLGSEA  180 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~~~~  180 (220)
                      ||++|||+.++++.|+...
T Consensus       307 ~p~~Rps~~~l~~~L~~~~  325 (333)
T 2i1m_A          307 EPTHRPTFQQICSFLQEQA  325 (333)
T ss_dssp             SGGGSCCHHHHHHHHHHHH
T ss_pred             ChhhCcCHHHHHHHHHHHH
Confidence            9999999999999996653

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.96  E-value=2.4e-30  Score=206.31  Aligned_cols=163  Identities=27%  Similarity=0.391  Sum_probs=120.2

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCc------------ccceeec
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG------------TTNRVVG   69 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~------------~~~~~~~   69 (220)
                      .+++.++.|++.||+|||+++   ++||||||+||+++.++.++|+|||++..........            ......|
T Consensus       108 ~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g  184 (310)
T 3s95_A          108 SQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG  184 (310)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCS
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCC
Confidence            467889999999999999999   9999999999999999999999999997654322111            0113467


Q ss_pred             ccCccChhhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHH
Q 027675           70 TYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEIL  149 (220)
Q Consensus        70 ~~~y~aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (220)
                      ++.|+|||.+.+..++.++||||||+++|+|++|..|+.............. ......        ..+..     ...
T Consensus       185 t~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~-~~~~~~--------~~~~~-----~~~  250 (310)
T 3s95_A          185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV-RGFLDR--------YCPPN-----CPP  250 (310)
T ss_dssp             CGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH-HHHHHH--------TCCTT-----CCT
T ss_pred             CcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh-hccccc--------cCCCC-----CCH
Confidence            8899999999999899999999999999999999998864332221110000 000000        00000     112


Q ss_pred             HHHHHhccccCCCCCCCCCHHHHHHHhcCccc
Q 027675          150 KCINVGLLCVQEDPNDRPTMSDVVIMLGSEAV  181 (220)
Q Consensus       150 ~~~~li~~cl~~~p~~Rps~~~~l~~l~~~~~  181 (220)
                      .+.+++.+||+.||++|||+.++++.|+....
T Consensus       251 ~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~  282 (310)
T 3s95_A          251 SFFPITVRCCDLDPEKRPSFVKLEHWLETLRM  282 (310)
T ss_dssp             THHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            57889999999999999999999999976644

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.96  E-value=5.3e-30  Score=209.80  Aligned_cols=145  Identities=15%  Similarity=0.101  Sum_probs=112.2

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.|+.|++.||+|||+++   |+||||||+||+++.++.+||+|||++.....     ......| +.|+|||.+.+
T Consensus       206 ~~~~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~  276 (377)
T 3byv_A          206 HARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEAR  276 (377)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcc
Confidence            346779999999999999999   99999999999999999999999999875322     2223456 89999999988


Q ss_pred             C-----------CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHH
Q 027675           82 G-----------FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILK  150 (220)
Q Consensus        82 ~-----------~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (220)
                      .           .++.++|||||||++|+|++|..||..........               .......      .....
T Consensus       277 ~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~---------------~~~~~~~------~~~~~  335 (377)
T 3byv_A          277 RATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSE---------------WIFRSCK------NIPQP  335 (377)
T ss_dssp             HTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSG---------------GGGSSCC------CCCHH
T ss_pred             cccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchh---------------hhhhhcc------CCCHH
Confidence            7           78999999999999999999999986433221110               0111111      11236


Q ss_pred             HHHHhccccCCCCCCCCCHHHHHHHh
Q 027675          151 CINVGLLCVQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       151 ~~~li~~cl~~~p~~Rps~~~~l~~l  176 (220)
                      +.++|.+||+.||++|||+.+++++-
T Consensus       336 ~~~li~~~L~~dp~~Rpt~~e~l~hp  361 (377)
T 3byv_A          336 VRALLEGFLRYPKEDRLLPLQAMETP  361 (377)
T ss_dssp             HHHHHHHHTCSSGGGCCCHHHHHTSH
T ss_pred             HHHHHHHHcCCCchhCCCHHHHhhCh
Confidence            78899999999999999999999753

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.96  E-value=4.2e-29  Score=204.81  Aligned_cols=169  Identities=22%  Similarity=0.231  Sum_probs=120.9

Q ss_pred             chHHHHHHHHHHHHHHhh--hCCCCCeEeccCCCCceeeC--CCCCceecCccceeeecCCCCCcccceeecccCccChh
Q 027675            2 EMLFNIILGVSRRLLYLH--QDSKLRIIHRDFKTSNILLD--HEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPE   77 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH--~~~~~~i~H~dlk~~nili~--~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe   77 (220)
                      ..++.++.|++.||.|||  +.+   |+||||||+||+++  .++.++|+|||++.......     ....+++.|+|||
T Consensus       157 ~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE  228 (382)
T 2vx3_A          157 NLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI-----YQYIQSRFYRSPE  228 (382)
T ss_dssp             HHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECCCTTCEETTCCC-----CSSCSCGGGCCHH
T ss_pred             HHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEeccCceeccccc-----ccccCCccccChH
Confidence            357889999999999999  467   99999999999995  47789999999997654321     2246788999999


Q ss_pred             hhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHH-----HHHHhcc-----ccccccC----------
Q 027675           78 YALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAW-----KLWQEGK-----ALDMMDQ----------  137 (220)
Q Consensus        78 ~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~-----~~~~~~~----------  137 (220)
                      .+.+..++.++|||||||++|+|++|..||...+............     .......     .....+.          
T Consensus       229 ~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (382)
T 2vx3_A          229 VLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDG  308 (382)
T ss_dssp             HHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTT
T ss_pred             HHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhcccccccccccccc
Confidence            9999889999999999999999999999998655443322211100     0000000     0000000          


Q ss_pred             ----C-----------------------CCCcCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcC
Q 027675          138 ----K-----------------------PGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       138 ----~-----------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~  178 (220)
                          .                       ........+...+.++|.+||+.||++|||+++++++-+.
T Consensus       309 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f  376 (382)
T 2vx3_A          309 KREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFF  376 (382)
T ss_dssp             CCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred             ccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCccc
Confidence                0                       0001123344578999999999999999999999987543

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.96  E-value=7e-30  Score=205.26  Aligned_cols=159  Identities=21%  Similarity=0.211  Sum_probs=120.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCC----CceecCccceeeecCCCCCcccceeecccCccChh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEM----NPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPE   77 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe   77 (220)
                      ..++.++.|++.||.|||+.+   ++||||||+||+++.++    .++|+|||++........   .....+++.|+|||
T Consensus       114 ~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE  187 (326)
T 2y0a_A          114 EEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPE  187 (326)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSC---CCCCCSCTTTCCHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCc---cccccCCcCcCCce
Confidence            357889999999999999999   99999999999998887    799999999876543221   22346789999999


Q ss_pred             hhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcc
Q 027675           78 YALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLL  157 (220)
Q Consensus        78 ~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  157 (220)
                      .+.+..++.++|+||||+++|+|++|..||............      ... ..      .............+.++|.+
T Consensus       188 ~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~------~~~-~~------~~~~~~~~~~~~~~~~li~~  254 (326)
T 2y0a_A          188 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------SAV-NY------EFEDEYFSNTSALAKDFIRR  254 (326)
T ss_dssp             HHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH------HHT-CC------CCCHHHHTTSCHHHHHHHHH
T ss_pred             eecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH------Hhc-CC------CcCccccccCCHHHHHHHHH
Confidence            999888999999999999999999999999654433322111      000 00      00000001123467899999


Q ss_pred             ccCCCCCCCCCHHHHHHHhcCc
Q 027675          158 CVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       158 cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      ||..||++|||+.+++++-+..
T Consensus       255 ~L~~dP~~Rpt~~e~l~hp~~~  276 (326)
T 2y0a_A          255 LLVKDPKKRMTIQDSLQHPWIK  276 (326)
T ss_dssp             HSCSSGGGSCCHHHHHHSTTTS
T ss_pred             HccCChhhCCCHHHHhcCCCcc
Confidence            9999999999999999986543

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.96  E-value=1.9e-30  Score=209.41  Aligned_cols=154  Identities=22%  Similarity=0.264  Sum_probs=118.2

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+.|   ++||||||+||+++.++.++|+|||++.......   ......|++.|+|||.+.+
T Consensus       108 ~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~---~~~~~~gt~~y~aPE~~~~  181 (336)
T 3h4j_B          108 DEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEVING  181 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB---TTCCCTTSTTTSCGGGSCC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCCc---ccccccCCcCcCCHHHHcC
Confidence            357889999999999999999   9999999999999999999999999987543322   1223467899999999988


Q ss_pred             CCC-cccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFF-SVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..+ +.++||||||+++|+|++|..||..........               ........  ........+.++|.+||.
T Consensus       182 ~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~---------------~i~~~~~~--~p~~~s~~~~~li~~~L~  244 (336)
T 3h4j_B          182 KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK---------------KVNSCVYV--MPDFLSPGAQSLIRRMIV  244 (336)
T ss_dssp             SGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC---------------CCCSSCCC--CCTTSCHHHHHHHHTTSC
T ss_pred             CCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH---------------HHHcCCCC--CcccCCHHHHHHHHHHcC
Confidence            765 689999999999999999999996433222110               00000000  111123467899999999


Q ss_pred             CCCCCCCCHHHHHHHhcC
Q 027675          161 EDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~  178 (220)
                      .||.+|||+++++++-+.
T Consensus       245 ~dP~~Rpt~~eil~hp~~  262 (336)
T 3h4j_B          245 ADPMQRITIQEIRRDPWF  262 (336)
T ss_dssp             SSGGGSCCHHHHTTCHHH
T ss_pred             CChhHCcCHHHHHhChhh
Confidence            999999999999977543

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.96  E-value=9.3e-30  Score=204.31  Aligned_cols=170  Identities=19%  Similarity=0.216  Sum_probs=117.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+.|   |+||||||+||+++.++.++|+|||++........  ......++..|+|||.+.+
T Consensus       100 ~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~  174 (324)
T 3mtl_A          100 HNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--TYDNEVVTLWYRPPDILLG  174 (324)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC--------------CGGGCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc--ccccccCcccccChhhhcC
Confidence            357789999999999999999   99999999999999999999999999875432211  1222456889999999887


Q ss_pred             -CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhcccc---c--------cccCCCCCcC-----c
Q 027675           82 -GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKAL---D--------MMDQKPGAIS-----K  144 (220)
Q Consensus        82 -~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~--------~~~~~~~~~~-----~  144 (220)
                       ..++.++||||||+++|+|++|..||...+.........   .........   .        ..........     .
T Consensus       175 ~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (324)
T 3mtl_A          175 STDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIF---RILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHA  251 (324)
T ss_dssp             CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---HHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHC
T ss_pred             CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---HHhCCCChHhchhhhcchhhcccccccccchhhhhhc
Confidence             467899999999999999999999997665544332211   111000000   0        0000000000     0


Q ss_pred             HHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          145 ANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       145 ~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      ......+.++|.+||+.||++|||+++++++-+..
T Consensus       252 ~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  286 (324)
T 3mtl_A          252 PRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL  286 (324)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGG
T ss_pred             CCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhh
Confidence            11234678999999999999999999999876544

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.96  E-value=6.2e-30  Score=205.04  Aligned_cols=168  Identities=23%  Similarity=0.266  Sum_probs=121.0

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+.|   ++|+||||+||+++.++.++|+|||++.......   ......++..|.|||.+.+
T Consensus       120 ~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~  193 (326)
T 1blx_A          120 ETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQ  193 (326)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecCcccccccCCC---CccccccccceeCHHHHhc
Confidence            357889999999999999999   9999999999999999999999999986543211   1223467889999999998


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccc----------cc---cCCCCCcCcHHHH
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALD----------MM---DQKPGAISKANEI  148 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~---~~~~~~~~~~~~~  148 (220)
                      ..++.++|+||||+++|+|++|..||.............   ..........          ..   .............
T Consensus       194 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (326)
T 1blx_A          194 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL---DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDID  270 (326)
T ss_dssp             CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---HHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCC
T ss_pred             CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH---HHcCCCCcccCccccccchhhhcccCcchhhhccccCC
Confidence            889999999999999999999999997655433221111   1000000000          00   0000000011123


Q ss_pred             HHHHHHhccccCCCCCCCCCHHHHHHHhcC
Q 027675          149 LKCINVGLLCVQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       149 ~~~~~li~~cl~~~p~~Rps~~~~l~~l~~  178 (220)
                      ..+.++|.+||..||++|||+.+++++-+.
T Consensus       271 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~  300 (326)
T 1blx_A          271 ELGKDLLLKCLTFNPAKRISAYSALSHPYF  300 (326)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred             HHHHHHHHHHcCCCcccCCCHHHHhcCccc
Confidence            467899999999999999999999976543

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.96  E-value=1.1e-30  Score=209.06  Aligned_cols=168  Identities=22%  Similarity=0.290  Sum_probs=123.0

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCC-cccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD-GTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~y~aPe~~~   80 (220)
                      ..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++......... .......++..|+|||.+.
T Consensus       134 ~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  210 (318)
T 3lxp_A          134 AQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK  210 (318)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhc
Confidence            467899999999999999999   999999999999999999999999999865432211 1122234567799999999


Q ss_pred             cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHh--------hHHHHHHHHHhccccccccCCCCCcCcHHHHHHHH
Q 027675           81 GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALS--------LLGYAWKLWQEGKALDMMDQKPGAISKANEILKCI  152 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (220)
                      +..++.++||||||+++|+|++|..||..........        ...........+....         ........+.
T Consensus       211 ~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~l~  281 (318)
T 3lxp_A          211 EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLP---------RPDKCPAEVY  281 (318)
T ss_dssp             HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCC---------CCTTCCHHHH
T ss_pred             CCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCCC---------CCccccHHHH
Confidence            9888999999999999999999999986432221110        0001111111111111         1112234788


Q ss_pred             HHhccccCCCCCCCCCHHHHHHHhcCccc
Q 027675          153 NVGLLCVQEDPNDRPTMSDVVIMLGSEAV  181 (220)
Q Consensus       153 ~li~~cl~~~p~~Rps~~~~l~~l~~~~~  181 (220)
                      ++|.+||+.||++|||+.++++.|+....
T Consensus       282 ~li~~~l~~dP~~Rps~~ell~~L~~l~~  310 (318)
T 3lxp_A          282 HLMKNCWETEASFRPTFENLIPILKTVHE  310 (318)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            99999999999999999999999976643

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.96  E-value=7.6e-30  Score=213.68  Aligned_cols=161  Identities=25%  Similarity=0.416  Sum_probs=122.9

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++......... ......++..|+|||.+.+
T Consensus       284 ~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~  359 (454)
T 1qcf_A          284 PKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINF  359 (454)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHH-TTCSSSSCGGGSCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCcee-ccCCCcccccccCHHHhcc
Confidence            357789999999999999999   999999999999999999999999998754321100 0111234568999999998


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++||||||+++|+|++ |..||...........       ...+......         ......+.++|.+||+
T Consensus       360 ~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~-------i~~~~~~~~~---------~~~~~~l~~li~~cl~  423 (454)
T 1qcf_A          360 GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA-------LERGYRMPRP---------ENCPEELYNIMMRCWK  423 (454)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-------HHHTCCCCCC---------TTSCHHHHHHHHHHTC
T ss_pred             CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HHcCCCCCCC---------CCCCHHHHHHHHHHcc
Confidence            889999999999999999999 9999976554332211       1122111111         1123468899999999


Q ss_pred             CCCCCCCCHHHHHHHhcCcccc
Q 027675          161 EDPNDRPTMSDVVIMLGSEAVN  182 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~~~~  182 (220)
                      .||++|||+++|++.|+.....
T Consensus       424 ~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          424 NRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             SSGGGSCCHHHHHHHHHTSSSS
T ss_pred             CChhHCcCHHHHHHHHHHHHhc
Confidence            9999999999999999777443

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.96  E-value=2.4e-30  Score=203.58  Aligned_cols=158  Identities=25%  Similarity=0.349  Sum_probs=112.2

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++......... ......+++.|.|||.+.+
T Consensus       116 ~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~  191 (281)
T 1mp8_A          116 ASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINF  191 (281)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCccccc-ccccCCCcccccChhhccc
Confidence            357889999999999999999   999999999999999999999999998765432211 1122344668999999998


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++|+|++ |..||...........       ...+.....         .......+.+++.+||.
T Consensus       192 ~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~-------i~~~~~~~~---------~~~~~~~l~~li~~~l~  255 (281)
T 1mp8_A          192 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR-------IENGERLPM---------PPNCPPTLYSLMTKCWA  255 (281)
T ss_dssp             CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-------HHTTCCCCC---------CTTCCHHHHHHHHHHTC
T ss_pred             CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHH-------HHcCCCCCC---------CCCCCHHHHHHHHHHcc
Confidence            889999999999999999996 9999875544332211       111111111         11123467889999999


Q ss_pred             CCCCCCCCHHHHHHHhcCc
Q 027675          161 EDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~  179 (220)
                      .||++|||+.++++.|+..
T Consensus       256 ~~p~~Rps~~~l~~~l~~~  274 (281)
T 1mp8_A          256 YDPSRRPRFTELKAQLSTI  274 (281)
T ss_dssp             SSGGGSCCHHHHHHHHHHH
T ss_pred             CChhhCcCHHHHHHHHHHH
Confidence            9999999999999998655

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.96  E-value=7.7e-30  Score=199.87  Aligned_cols=161  Identities=26%  Similarity=0.322  Sum_probs=119.7

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++................++..|.|||.+.+
T Consensus       105 ~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  181 (276)
T 2yex_A          105 PDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR  181 (276)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTC
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhc
Confidence            357889999999999999999   99999999999999999999999999875432221112223467889999999987


Q ss_pred             CCC-cccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFF-SVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..+ +.++|+||||+++|+|++|..||..........      .........    .    .........+.++|.+||+
T Consensus       182 ~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~~~~~~----~----~~~~~~~~~~~~li~~~l~  247 (276)
T 2yex_A          182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY------SDWKEKKTY----L----NPWKKIDSAPLALLHKILV  247 (276)
T ss_dssp             SSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHH------HHHHTTCTT----S----TTGGGSCHHHHHHHHHHSC
T ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH------HHhhhcccc----c----CchhhcCHHHHHHHHHHCC
Confidence            665 778999999999999999999997544322110      001111000    0    0011123467889999999


Q ss_pred             CCCCCCCCHHHHHHHhcCc
Q 027675          161 EDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~  179 (220)
                      .||++|||+.+++++-+..
T Consensus       248 ~~p~~Rps~~~il~~~~~~  266 (276)
T 2yex_A          248 ENPSARITIPDIKKDRWYN  266 (276)
T ss_dssp             SSTTTSCCHHHHTTCTTTT
T ss_pred             CCchhCCCHHHHhcCcccc
Confidence            9999999999999876443

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.96  E-value=7.3e-30  Score=207.18  Aligned_cols=156  Identities=22%  Similarity=0.230  Sum_probs=117.4

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCC---ceecCccceeeecCCCCCcccceeecccCccChhhh
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMN---PKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYA   79 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~---~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~   79 (220)
                      .++.++.|++.||.|||+++   |+||||||+||+++.++.   ++|+|||++........  ......+++.|+|||.+
T Consensus       131 ~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~  205 (351)
T 3c0i_A          131 VASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVV  205 (351)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCe--eecCCcCCcCccCHHHH
Confidence            56789999999999999999   999999999999986655   99999999976543221  12234678999999999


Q ss_pred             hcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           80 LGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        80 ~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      .+..++.++|||||||++|+|++|..||.........       .. ..+.......      ........+.++|.+||
T Consensus       206 ~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-------~i-~~~~~~~~~~------~~~~~s~~~~~li~~~L  271 (351)
T 3c0i_A          206 KREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFE-------GI-IKGKYKMNPR------QWSHISESAKDLVRRML  271 (351)
T ss_dssp             TTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHH-------HH-HHTCCCCCHH------HHTTSCHHHHHHHHHHT
T ss_pred             cCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHH-------HH-HcCCCCCCcc------ccccCCHHHHHHHHHHC
Confidence            9988999999999999999999999999754322111       11 1111100000      00012346789999999


Q ss_pred             CCCCCCCCCHHHHHHHhc
Q 027675          160 QEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l~  177 (220)
                      ..||++|||+.+++++-+
T Consensus       272 ~~dP~~R~s~~e~l~hp~  289 (351)
T 3c0i_A          272 MLDPAERITVYEALNHPW  289 (351)
T ss_dssp             CSSTTTSCCHHHHHTSHH
T ss_pred             CCChhHCcCHHHHhcChh
Confidence            999999999999997543

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.96  E-value=1.6e-30  Score=203.37  Aligned_cols=159  Identities=31%  Similarity=0.421  Sum_probs=120.9

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +.++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++......... ......++..|.|||.+.+
T Consensus       106 ~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~  181 (269)
T 4hcu_A          106 ETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSF  181 (269)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH-STTSTTCCGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccc-cccCcccccccCCHHHhcC
Confidence            357889999999999999999   999999999999999999999999998654321110 1111234567999999998


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++|+|++ |..||............       ..+....    .+ .    .....+.+++.+||+
T Consensus       182 ~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~-------~~~~~~~----~~-~----~~~~~~~~li~~~l~  245 (269)
T 4hcu_A          182 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-------STGFRLY----KP-R----LASTHVYQIMNHCWR  245 (269)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-------HTTCCCC----CC-T----TSCHHHHHHHHHHTC
T ss_pred             CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH-------hcCccCC----CC-C----cCCHHHHHHHHHHcc
Confidence            889999999999999999999 99999765544332111       1111110    01 1    123467889999999


Q ss_pred             CCCCCCCCHHHHHHHhcCcc
Q 027675          161 EDPNDRPTMSDVVIMLGSEA  180 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~~  180 (220)
                      .||++||++.+++++|+...
T Consensus       246 ~~p~~Rps~~~ll~~l~~l~  265 (269)
T 4hcu_A          246 ERPEDRPAFSRLLRQLAEIA  265 (269)
T ss_dssp             SSGGGSCCHHHHHHHHHHHH
T ss_pred             CCcccCcCHHHHHHHHHHHH
Confidence            99999999999999997653

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.96  E-value=9.5e-30  Score=209.91  Aligned_cols=163  Identities=17%  Similarity=0.179  Sum_probs=115.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCC---CCCceecCccceeeecCCCCCcccceeecccCccChhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDH---EMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEY   78 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~   78 (220)
                      ..++.++.|++.||.|||+.+   |+||||||+||+++.   ++.+||+|||++.......   ......+++.|+|||+
T Consensus       161 ~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~  234 (400)
T 1nxk_A          161 REASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEV  234 (400)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--------------CTTCCGGG
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccccccCCCC---ccccCCCCCCccCHhh
Confidence            357889999999999999999   999999999999987   7889999999987643221   1223467889999999


Q ss_pred             hhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           79 ALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        79 ~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                      +.+..++.++|||||||++|+|++|..||...........  .. .....+... ....     ........+.++|.+|
T Consensus       235 ~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~--~~-~~i~~~~~~-~~~~-----~~~~~s~~~~~li~~~  305 (400)
T 1nxk_A          235 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG--MK-TRIRMGQYE-FPNP-----EWSEVSEEVKMLIRNL  305 (400)
T ss_dssp             SCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS--HH-HHHHHTCCC-CCTT-----TTTTSCHHHHHHHHTT
T ss_pred             cCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH--HH-HHHHcCccc-CCCc-----ccccCCHHHHHHHHHH
Confidence            9888899999999999999999999999964332211000  00 011111110 0000     0011234678999999


Q ss_pred             cCCCCCCCCCHHHHHHHhcCc
Q 027675          159 VQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       159 l~~~p~~Rps~~~~l~~l~~~  179 (220)
                      |..||++|||+.+++++-+..
T Consensus       306 L~~dP~~Rpt~~eil~hp~~~  326 (400)
T 1nxk_A          306 LKTEPTQRMTITEFMNHPWIM  326 (400)
T ss_dssp             SCSSGGGSCCHHHHHHSHHHH
T ss_pred             CCCChhHCcCHHHHhcCcccc
Confidence            999999999999999876543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.96  E-value=2.6e-30  Score=206.39  Aligned_cols=151  Identities=23%  Similarity=0.272  Sum_probs=113.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||+|||+.+   |+||||||+||+++.++.++|+|||++........   .....|++.|+|||.+.+
T Consensus       157 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~  230 (311)
T 3p1a_A          157 AQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA---GEVQEGDPRYMAPELLQG  230 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC---------CCCCCGGGCCGGGGGT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccCCC---CcccCCCccccCHhHhcC
Confidence            467889999999999999999   99999999999999999999999999876543221   223457889999999887


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                       .++.++||||||+++|+|++|..++.....  ..        ....+....        .........+.++|.+||+.
T Consensus       231 -~~~~~~DiwslG~il~el~~g~~~~~~~~~--~~--------~~~~~~~~~--------~~~~~~~~~l~~li~~~L~~  291 (311)
T 3p1a_A          231 -SYGTAADVFSLGLTILEVACNMELPHGGEG--WQ--------QLRQGYLPP--------EFTAGLSSELRSVLVMMLEP  291 (311)
T ss_dssp             -CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH--HH--------HHTTTCCCH--------HHHTTSCHHHHHHHHHHSCS
T ss_pred             -CCCchhhHHHHHHHHHHHHhCCCCCCCccH--HH--------HHhccCCCc--------ccccCCCHHHHHHHHHHcCC
Confidence             689999999999999999999766532211  11        111111100        00011234788999999999


Q ss_pred             CCCCCCCHHHHHHHhc
Q 027675          162 DPNDRPTMSDVVIMLG  177 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~  177 (220)
                      ||++|||+++++++-+
T Consensus       292 dP~~Rpt~~ell~hp~  307 (311)
T 3p1a_A          292 DPKLRATAEALLALPV  307 (311)
T ss_dssp             STTTSCCHHHHHTSGG
T ss_pred             ChhhCcCHHHHHhCcc
Confidence            9999999999998753

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.96  E-value=1.8e-29  Score=204.80  Aligned_cols=153  Identities=22%  Similarity=0.238  Sum_probs=121.0

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||++|   |+||||||+||+++.++.++|+|||++......     .....|++.|+|||.+.+
T Consensus       141 ~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-----~~~~~gt~~y~aPE~~~~  212 (350)
T 1rdq_E          141 PHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILS  212 (350)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC-----cccccCCccccCHHHhcC
Confidence            357789999999999999999   999999999999999999999999998765432     123467899999999999


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+|||||++|+|++|..||...+......      +.. .+.. .    .+.     .....+.++|.+||+.
T Consensus       213 ~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~------~i~-~~~~-~----~p~-----~~~~~~~~li~~lL~~  275 (350)
T 1rdq_E          213 KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE------KIV-SGKV-R----FPS-----HFSSDLKDLLRNLLQV  275 (350)
T ss_dssp             CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHH-HCCC-C----CCT-----TCCHHHHHHHHHHSCS
T ss_pred             CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHH------HHH-cCCC-C----CCC-----CCCHHHHHHHHHHhhc
Confidence            889999999999999999999999997554333221      111 1111 0    111     1234678999999999


Q ss_pred             CCCCCCC-----HHHHHHHhcCc
Q 027675          162 DPNDRPT-----MSDVVIMLGSE  179 (220)
Q Consensus       162 ~p~~Rps-----~~~~l~~l~~~  179 (220)
                      ||++||+     +++++++-+..
T Consensus       276 dp~~R~~~~~~~~~ei~~h~~f~  298 (350)
T 1rdq_E          276 DLTKRFGNLKNGVNDIKNHKWFA  298 (350)
T ss_dssp             CTTTCTTSSTTTTHHHHTSGGGT
T ss_pred             CHHhccCCccCCHHHHHhCcCcC
Confidence            9999998     99999776543

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.96  E-value=2.2e-30  Score=203.82  Aligned_cols=158  Identities=25%  Similarity=0.384  Sum_probs=120.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++......... ......+++.|+|||.+.+
T Consensus       120 ~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~  195 (283)
T 3gen_A          120 QQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMY  195 (283)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH-STTSTTSCGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccccc-cccCCccCcccCCHHHhcc
Confidence            467899999999999999999   999999999999999999999999998654321110 1111234567999999998


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++|+|++ |..||...+........       ..+.....    + ..    ....+.+++.+||+
T Consensus       196 ~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~-------~~~~~~~~----~-~~----~~~~l~~li~~~l~  259 (283)
T 3gen_A          196 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-------AQGLRLYR----P-HL----ASEKVYTIMYSCWH  259 (283)
T ss_dssp             CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-------HTTCCCCC----C-TT----CCHHHHHHHHHTTC
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHH-------hcccCCCC----C-Cc----CCHHHHHHHHHHcc
Confidence            889999999999999999998 99999765544332211       11111101    1 11    12367889999999


Q ss_pred             CCCCCCCCHHHHHHHhcCc
Q 027675          161 EDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~  179 (220)
                      .||++|||+++++++|...
T Consensus       260 ~~p~~Rps~~~ll~~L~~~  278 (283)
T 3gen_A          260 EKADERPTFKILLSNILDV  278 (283)
T ss_dssp             SSGGGSCCHHHHHHHHHHH
T ss_pred             CChhHCcCHHHHHHHHHHH
Confidence            9999999999999999655

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.96  E-value=1.7e-29  Score=199.90  Aligned_cols=156  Identities=23%  Similarity=0.313  Sum_probs=120.9

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+++.++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++........  ......+++.|.|||.+.+
T Consensus       115 ~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~  189 (294)
T 2rku_A          115 PEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSK  189 (294)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCcc--ccccccCCCCcCCcchhcc
Confidence            357889999999999999999   99999999999999999999999999876542211  1223467889999999998


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+||||+++|+|++|..||...........      . ..+. ..    .+.     .....+.+++.+||+.
T Consensus       190 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~------~-~~~~-~~----~~~-----~~~~~~~~li~~~l~~  252 (294)
T 2rku_A          190 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR------I-KKNE-YS----IPK-----HINPVAASLIQKMLQT  252 (294)
T ss_dssp             SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH------H-HTTC-CC----CCT-----TSCHHHHHHHHHHTCS
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------H-hhcc-CC----Ccc-----ccCHHHHHHHHHHccc
Confidence            8889999999999999999999999976544332111      1 1111 00    011     1123678899999999


Q ss_pred             CCCCCCCHHHHHHHhcCc
Q 027675          162 DPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~~~  179 (220)
                      ||++|||+++++++-+..
T Consensus       253 ~p~~Rps~~~ll~~~~~~  270 (294)
T 2rku_A          253 DPTARPTINELLNDEFFT  270 (294)
T ss_dssp             SGGGSCCGGGGGGSHHHH
T ss_pred             ChhhCcCHHHHhhChhee
Confidence            999999999999875443

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.96  E-value=6.8e-30  Score=213.87  Aligned_cols=164  Identities=23%  Similarity=0.389  Sum_probs=121.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+++.++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++......... ......++..|+|||.+.+
T Consensus       280 ~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~  355 (452)
T 1fmk_A          280 PQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALY  355 (452)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCcee-cccCCcccccccCHhHHhc
Confidence            367899999999999999999   999999999999999999999999998754322111 1112344678999999998


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++||||||+++|+|++ |..||..........       ....+......         ......+.++|.+||+
T Consensus       356 ~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~-------~i~~~~~~~~~---------~~~~~~l~~li~~cl~  419 (452)
T 1fmk_A          356 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD-------QVERGYRMPCP---------PECPESLHDLMCQCWR  419 (452)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH-------HHHTTCCCCCC---------TTSCHHHHHHHHHHTC
T ss_pred             CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHH-------HHHcCCCCCCC---------CCCCHHHHHHHHHHcc
Confidence            889999999999999999999 999997554433221       11122111111         1123467899999999


Q ss_pred             CCCCCCCCHHHHHHHhcCccccCCC
Q 027675          161 EDPNDRPTMSDVVIMLGSEAVNLAS  185 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~~~~~~~  185 (220)
                      .||++|||++++++.|+.......+
T Consensus       420 ~dP~~Rpt~~~l~~~L~~~~~~~~~  444 (452)
T 1fmk_A          420 KEPEERPTFEYLQAFLEDYFTSTEP  444 (452)
T ss_dssp             SSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred             CChhhCcCHHHHHHHHHHHhccCCc
Confidence            9999999999999999877554433

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=6.9e-30  Score=202.21  Aligned_cols=163  Identities=25%  Similarity=0.313  Sum_probs=120.7

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCC--CCcccceeecccCccChhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQ--TDGTTNRVVGTYGYMSPEYA   79 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~y~aPe~~   79 (220)
                      ..++.++.|++.||.|||++|   ++||||||+||+++.++.++|+|||++.......  .........++..|.|||.+
T Consensus       124 ~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  200 (298)
T 3pls_A          124 KDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESL  200 (298)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhh
Confidence            457889999999999999999   9999999999999999999999999986433211  11112223557789999999


Q ss_pred             hcCCCcccCceeehhHHHHHHHhcCcc-CcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           80 LGGFFSVKSDVFSFGVVVLEIISGKRN-TGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        80 ~~~~~~~~~DiwslG~il~~ll~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                      .+..++.++|+||||+++|+|++|..| |...+.......       ...+.....         .......+.+++.+|
T Consensus       201 ~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~-------~~~~~~~~~---------~~~~~~~l~~li~~~  264 (298)
T 3pls_A          201 QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHF-------LAQGRRLPQ---------PEYCPDSLYQVMQQC  264 (298)
T ss_dssp             TTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHH-------HHTTCCCCC---------CTTCCHHHHHHHHHH
T ss_pred             ccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHH-------hhcCCCCCC---------CccchHHHHHHHHHH
Confidence            998899999999999999999995544 544333322211       111111111         111224678999999


Q ss_pred             cCCCCCCCCCHHHHHHHhcCccccC
Q 027675          159 VQEDPNDRPTMSDVVIMLGSEAVNL  183 (220)
Q Consensus       159 l~~~p~~Rps~~~~l~~l~~~~~~~  183 (220)
                      |+.||++|||+.++++.|+......
T Consensus       265 l~~~p~~Rps~~~ll~~l~~~~~~l  289 (298)
T 3pls_A          265 WEADPAVRPTFRVLVGEVEQIVSAL  289 (298)
T ss_dssp             TCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ccCChhhCcCHHHHHHHHHHHHHHH
Confidence            9999999999999999997664443

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.96  E-value=1.3e-29  Score=204.36  Aligned_cols=154  Identities=23%  Similarity=0.318  Sum_probs=119.9

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++........  ......++..|+|||.+.+
T Consensus       141 ~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~  215 (335)
T 2owb_A          141 PEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSK  215 (335)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHHT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCcc--cccccCCCccccCHHHhcc
Confidence            357889999999999999999   99999999999999999999999999876542221  1223467889999999998


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+||||+++|+|++|..||...........      .. .+.. ..    +.     .....+.++|.+||+.
T Consensus       216 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~------~~-~~~~-~~----~~-----~~~~~~~~li~~~l~~  278 (335)
T 2owb_A          216 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR------IK-KNEY-SI----PK-----HINPVAASLIQKMLQT  278 (335)
T ss_dssp             SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH------HH-HTCC-CC----CT-----TSCHHHHHHHHHHTCS
T ss_pred             CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHH------Hh-cCCC-CC----Cc-----cCCHHHHHHHHHHccC
Confidence            8889999999999999999999999976543332111      11 1110 00    11     1123678899999999


Q ss_pred             CCCCCCCHHHHHHHhc
Q 027675          162 DPNDRPTMSDVVIMLG  177 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~  177 (220)
                      ||++||++.+++++-+
T Consensus       279 dp~~Rps~~ell~~~~  294 (335)
T 2owb_A          279 DPTARPTINELLNDEF  294 (335)
T ss_dssp             SGGGSCCGGGGGGSHH
T ss_pred             ChhHCcCHHHHhcCcc
Confidence            9999999999997654

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.96  E-value=8.6e-29  Score=205.39  Aligned_cols=170  Identities=20%  Similarity=0.192  Sum_probs=118.9

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCC-CCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHE-MNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .++.++.||+.||.|||+++   |+||||||+||+++.+ +.+||+|||+++.......   .....+++.|+|||++.+
T Consensus       157 ~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~  230 (420)
T 1j1b_A          157 YVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFG  230 (420)
T ss_dssp             HHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhhcccCCC---ceeeeeCCCcCCHHHHcC
Confidence            46789999999999999999   9999999999999865 5579999999986543221   222467889999999976


Q ss_pred             C-CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHH-----HHHHHh-ccccccccCCCCCc------CcHHHH
Q 027675           82 G-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA-----WKLWQE-GKALDMMDQKPGAI------SKANEI  148 (220)
Q Consensus        82 ~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~-----~~~~~~-~~~~~~~~~~~~~~------~~~~~~  148 (220)
                      . .++.++|||||||++|+|++|+.||...+.......+...     ...+.. ..............      ......
T Consensus       231 ~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~  310 (420)
T 1j1b_A          231 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTP  310 (420)
T ss_dssp             CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSC
T ss_pred             CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCC
Confidence            5 6899999999999999999999999765543322211100     000000 00000000000000      011123


Q ss_pred             HHHHHHhccccCCCCCCCCCHHHHHHHhcC
Q 027675          149 LKCINVGLLCVQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       149 ~~~~~li~~cl~~~p~~Rps~~~~l~~l~~  178 (220)
                      ..+.++|.+||..||++||++.++++|-+.
T Consensus       311 ~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f  340 (420)
T 1j1b_A          311 PEAIALCSRLLEYTPTARLTPLEACAHSFF  340 (420)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             HHHHHHHHHhccCChhHCCCHHHHhCCHhh
Confidence            578899999999999999999999977644

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.96  E-value=2.3e-29  Score=202.34  Aligned_cols=168  Identities=21%  Similarity=0.272  Sum_probs=122.1

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCC-------------------CCCceecCccceeeecCCCCCc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDH-------------------EMNPKISDFGLTRIFEGKQTDG   62 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~-------------------~~~~~l~d~~~~~~~~~~~~~~   62 (220)
                      ..++.++.|++.||+|||+++   ++||||||+||+++.                   ++.++|+|||++......    
T Consensus       118 ~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----  190 (339)
T 1z57_A          118 DHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH----  190 (339)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC----
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc----
Confidence            357889999999999999999   999999999999987                   667999999998754322    


Q ss_pred             ccceeecccCccChhhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHH-----HHHhcccccc---
Q 027675           63 TTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWK-----LWQEGKALDM---  134 (220)
Q Consensus        63 ~~~~~~~~~~y~aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~---  134 (220)
                       .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.............     ..........   
T Consensus       191 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~  269 (339)
T 1z57_A          191 -HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHH  269 (339)
T ss_dssp             -CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEET
T ss_pred             -cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhh
Confidence             1224678899999999998899999999999999999999999976655443322211100     0000000000   


Q ss_pred             ------------------ccC-CCCCcCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHhc
Q 027675          135 ------------------MDQ-KPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       135 ------------------~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~  177 (220)
                                        ... .............+.++|.+||+.||++|||+.+++++-+
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~  331 (339)
T 1z57_A          270 DRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPF  331 (339)
T ss_dssp             TEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGG
T ss_pred             ccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHH
Confidence                              000 0001112344567899999999999999999999997743

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=3.1e-29  Score=204.66  Aligned_cols=168  Identities=23%  Similarity=0.239  Sum_probs=120.7

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc-
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG-   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~-   81 (220)
                      .+..++.|++.||+|||+.|   ++||||||+||+++.++.++|+|||+++.....     .....++..|+|||.+.+ 
T Consensus       129 ~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~  200 (367)
T 1cm8_A          129 RIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNW  200 (367)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecccccccc-----cCcCcCCCCcCCHHHHhCC
Confidence            57789999999999999999   999999999999999999999999999864432     222467889999999987 


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHH-----HHHHhc-------cccccc--cCCCCCcCcHHH
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAW-----KLWQEG-------KALDMM--DQKPGAISKANE  147 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~-------~~~~~~--~~~~~~~~~~~~  147 (220)
                      ..++.++|+|||||++|+|++|+.||...+.......+....     .....-       ......  ............
T Consensus       201 ~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (367)
T 1cm8_A          201 MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNA  280 (367)
T ss_dssp             TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTC
T ss_pred             CCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCC
Confidence            678999999999999999999999997655433322111000     000000       000000  000000011122


Q ss_pred             HHHHHHHhccccCCCCCCCCCHHHHHHHhcC
Q 027675          148 ILKCINVGLLCVQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       148 ~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~  178 (220)
                      ...+.+++.+||..||++|||++++++|-+.
T Consensus       281 ~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f  311 (367)
T 1cm8_A          281 SPLAVNLLEKMLVLDAEQRVTAGEALAHPYF  311 (367)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred             CHHHHHHHHHHccCChhHCCCHHHHhcChHH
Confidence            3468899999999999999999999987543

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.96  E-value=1.1e-29  Score=210.45  Aligned_cols=143  Identities=14%  Similarity=0.101  Sum_probs=111.1

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhh---
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYA---   79 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~---   79 (220)
                      .++.++.|+++||+|||+++   |+||||||+||+++.++.+||+|||++......     .....| +.|+|||.+   
T Consensus       212 ~~~~i~~qi~~aL~~LH~~~---iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~  282 (413)
T 3dzo_A          212 ARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAER  282 (413)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHhCC---cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhcc
Confidence            56788899999999999999   999999999999999999999999998754322     222355 899999999   


Q ss_pred             -------hcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHH
Q 027675           80 -------LGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCI  152 (220)
Q Consensus        80 -------~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (220)
                             .+..++.++|||||||++|+|++|+.||...+......               ........      ....+.
T Consensus       283 ~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~---------------~~~~~~~~------~~~~~~  341 (413)
T 3dzo_A          283 MLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSE---------------WIFRSCKN------IPQPVR  341 (413)
T ss_dssp             TSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSG---------------GGGSSCCC------CCHHHH
T ss_pred             ccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHH---------------HHHhhccc------CCHHHH
Confidence                   44457889999999999999999999996543222110               11111111      124688


Q ss_pred             HHhccccCCCCCCCCCHHHHHHH
Q 027675          153 NVGLLCVQEDPNDRPTMSDVVIM  175 (220)
Q Consensus       153 ~li~~cl~~~p~~Rps~~~~l~~  175 (220)
                      ++|.+||+.||++||++.+++++
T Consensus       342 ~li~~~l~~dP~~Rpt~~~~l~~  364 (413)
T 3dzo_A          342 ALLEGFLRYPKEDRLLPLQAMET  364 (413)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHccCChhhCcCHHHHHhC
Confidence            99999999999999998777643

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.96  E-value=3.1e-29  Score=198.73  Aligned_cols=164  Identities=26%  Similarity=0.327  Sum_probs=118.7

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++........ .......+++.|+|||.+.+
T Consensus       111 ~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~  186 (294)
T 4eqm_A          111 DTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-TQTNHVLGTVQYFSPEQAKG  186 (294)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--------------CCSSCCHHHHHT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccccccc-cccCccccCccccCHhHhcC
Confidence            467889999999999999999   99999999999999999999999999865432221 11223467899999999999


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+||||+++|+|++|..||...+......      +.... ........     ........+.++|.+||+.
T Consensus       187 ~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~------~~~~~-~~~~~~~~-----~~~~~~~~l~~li~~~l~~  254 (294)
T 4eqm_A          187 EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAI------KHIQD-SVPNVTTD-----VRKDIPQSLSNVILRATEK  254 (294)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHH------HHHSS-CCCCHHHH-----SCTTSCHHHHHHHHHHSCS
T ss_pred             CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH------HHhhc-cCCCcchh-----cccCCCHHHHHHHHHHhcC
Confidence            889999999999999999999999997654433211      11111 11000000     0011234678899999999


Q ss_pred             CCCCCC-CHHHHHHHhcCccc
Q 027675          162 DPNDRP-TMSDVVIMLGSEAV  181 (220)
Q Consensus       162 ~p~~Rp-s~~~~l~~l~~~~~  181 (220)
                      ||++|| +++++.+.|.....
T Consensus       255 dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          255 DKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             SGGGSCSSHHHHHHHHHTSSS
T ss_pred             CHhHccccHHHHHHHHHHHHh
Confidence            999998 88888888876543

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.96  E-value=1.3e-29  Score=205.07  Aligned_cols=170  Identities=18%  Similarity=0.263  Sum_probs=122.5

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceee-------------------CCCCCceecCccceeeecCCCCCc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILL-------------------DHEMNPKISDFGLTRIFEGKQTDG   62 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili-------------------~~~~~~~l~d~~~~~~~~~~~~~~   62 (220)
                      .+++.++.|++.||.|||+++   |+||||||+||++                   +.++.++|+|||++.......   
T Consensus       123 ~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---  196 (355)
T 2eu9_A          123 PHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH---  196 (355)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCC---
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCccccccccc---
Confidence            367889999999999999999   9999999999999                   567889999999987543221   


Q ss_pred             ccceeecccCccChhhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHH-----HHHhcccccc---
Q 027675           63 TTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWK-----LWQEGKALDM---  134 (220)
Q Consensus        63 ~~~~~~~~~~y~aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~---  134 (220)
                        ....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.................     ..........   
T Consensus       197 --~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~  274 (355)
T 2eu9_A          197 --TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYK  274 (355)
T ss_dssp             --CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEET
T ss_pred             --cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcc
Confidence              224678899999999998899999999999999999999999976554433222111100     0000000000   


Q ss_pred             ------------------ccC-CCCCcCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          135 ------------------MDQ-KPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       135 ------------------~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                                        ... .............+.++|.+||+.||++|||+.+++++-+..
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~  338 (355)
T 2eu9_A          275 GGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFA  338 (355)
T ss_dssp             TEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGG
T ss_pred             cccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence                              000 000112233456788999999999999999999999775443

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.96  E-value=1.6e-29  Score=202.56  Aligned_cols=151  Identities=26%  Similarity=0.279  Sum_probs=119.2

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .++.++.|++.||.|||++|   |+||||||+||+++.++.++|+|||++......     .....|++.|+|||.+.+.
T Consensus       107 ~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~  178 (318)
T 1fot_A          107 VAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTK  178 (318)
T ss_dssp             HHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc-----cccccCCccccCHhHhcCC
Confidence            56789999999999999999   999999999999999999999999998764332     2224678999999999998


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      .++.++|+|||||++|+|++|..||...+......      +.... ..    . .+.     .....+.++|.+||..|
T Consensus       179 ~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~------~i~~~-~~----~-~p~-----~~~~~~~~li~~lL~~d  241 (318)
T 1fot_A          179 PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE------KILNA-EL----R-FPP-----FFNEDVKDLLSRLITRD  241 (318)
T ss_dssp             CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHHHC-CC----C-CCT-----TSCHHHHHHHHHHTCSC
T ss_pred             CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH------HHHhC-CC----C-CCC-----CCCHHHHHHHHHHhccC
Confidence            89999999999999999999999997544332221      11111 10    0 111     12346789999999999


Q ss_pred             CCCCC-----CHHHHHHHhcC
Q 027675          163 PNDRP-----TMSDVVIMLGS  178 (220)
Q Consensus       163 p~~Rp-----s~~~~l~~l~~  178 (220)
                      |++||     +++++++|-+.
T Consensus       242 p~~R~~~~~~~~~~i~~hp~f  262 (318)
T 1fot_A          242 LSQRLGNLQNGTEDVKNHPWF  262 (318)
T ss_dssp             TTTCTTSSTTTTHHHHTSGGG
T ss_pred             HHHcCCCcCCCHHHHhcCccc
Confidence            99999     99999976543

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.96  E-value=9.3e-30  Score=206.67  Aligned_cols=154  Identities=21%  Similarity=0.281  Sum_probs=119.0

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||++|   |+||||||+||+++.++.++|+|||++.......  .......|++.|+|||.+.+
T Consensus       121 ~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~  195 (353)
T 2i0e_A          121 PHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAY  195 (353)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccccCC--cccccccCCccccChhhhcC
Confidence            357789999999999999999   9999999999999999999999999987432211  12233568999999999999


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+|||||++|+|++|..||...+......      .... +.. .    .+.     .....+.++|.+||..
T Consensus       196 ~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~------~i~~-~~~-~----~p~-----~~s~~~~~li~~lL~~  258 (353)
T 2i0e_A          196 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ------SIME-HNV-A----YPK-----SMSKEAVAICKGLMTK  258 (353)
T ss_dssp             CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHH-CCC-C----CCT-----TSCHHHHHHHHHHTCS
T ss_pred             CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHH------HHHh-CCC-C----CCC-----CCCHHHHHHHHHHhhc
Confidence            889999999999999999999999997654433221      1111 110 0    111     1234678999999999


Q ss_pred             CCCCCCC-----HHHHHHHhc
Q 027675          162 DPNDRPT-----MSDVVIMLG  177 (220)
Q Consensus       162 ~p~~Rps-----~~~~l~~l~  177 (220)
                      ||++||+     ++++++|-+
T Consensus       259 dP~~R~~~~~~~~~~i~~h~~  279 (353)
T 2i0e_A          259 HPGKRLGCGPEGERDIKEHAF  279 (353)
T ss_dssp             CTTSCTTCSTTHHHHHHTSGG
T ss_pred             CHHHcCCCCCCCHHHHhcCcc
Confidence            9999995     688887653

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.96  E-value=7.1e-30  Score=200.54  Aligned_cols=160  Identities=26%  Similarity=0.423  Sum_probs=122.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++......... ......++..|.|||.+.+
T Consensus       109 ~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~  184 (279)
T 1qpc_A          109 NKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINY  184 (279)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-CCTTCCCCTTTSCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcccc-cccCCCCccCccChhhhcc
Confidence            457899999999999999999   999999999999999999999999998765432211 1112344668999999998


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++|+|++ |..||...........       ...+.....         .......+.+++.+||.
T Consensus       185 ~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-------~~~~~~~~~---------~~~~~~~l~~li~~~l~  248 (279)
T 1qpc_A          185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN-------LERGYRMVR---------PDNCPEELYQLMRLCWK  248 (279)
T ss_dssp             CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-------HHTTCCCCC---------CTTCCHHHHHHHHHHTC
T ss_pred             CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHH-------HhcccCCCC---------cccccHHHHHHHHHHhc
Confidence            888999999999999999999 8999875544332211       111111111         11123477899999999


Q ss_pred             CCCCCCCCHHHHHHHhcCccc
Q 027675          161 EDPNDRPTMSDVVIMLGSEAV  181 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~~~  181 (220)
                      .||++|||+.++++.|+....
T Consensus       249 ~~p~~Rps~~~l~~~l~~~~~  269 (279)
T 1qpc_A          249 ERPEDRPTFDYLRSVLEDFFT  269 (279)
T ss_dssp             SSGGGSCCHHHHHHHHHHHHH
T ss_pred             cChhhCCCHHHHHHHHHHHHH
Confidence            999999999999999876643

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.96  E-value=1.2e-29  Score=206.68  Aligned_cols=156  Identities=20%  Similarity=0.252  Sum_probs=118.0

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCC---CceecCccceeeecCCCCCcccceeecccCccChhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEM---NPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEY   78 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~   78 (220)
                      ..++.++.|++.||.|||+++   |+||||||+||+++.++   .++|+|||++........   .....+++.|+|||.
T Consensus       128 ~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~  201 (362)
T 2bdw_A          128 ADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEV  201 (362)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS---CCCSCSCTTTCCHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc---cccCCCCccccCHHH
Confidence            357889999999999999999   99999999999997654   499999999876543221   123467899999999


Q ss_pred             hhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           79 ALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        79 ~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                      +.+..++.++|||||||++|+|++|..||...+.......       ...+...    ...  .........+.++|.+|
T Consensus       202 ~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~-------i~~~~~~----~~~--~~~~~~~~~~~~li~~~  268 (362)
T 2bdw_A          202 LKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ-------IKAGAYD----YPS--PEWDTVTPEAKSLIDSM  268 (362)
T ss_dssp             HTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-------HHHTCCC----CCT--TGGGGSCHHHHHHHHHH
T ss_pred             HccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHH-------HHhCCCC----CCc--ccccCCCHHHHHHHHHH
Confidence            9998899999999999999999999999975443322211       1111110    000  00011234678999999


Q ss_pred             cCCCCCCCCCHHHHHHHh
Q 027675          159 VQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       159 l~~~p~~Rps~~~~l~~l  176 (220)
                      |..||++||++.+++++-
T Consensus       269 L~~dP~~R~t~~e~l~hp  286 (362)
T 2bdw_A          269 LTVNPKKRITADQALKVP  286 (362)
T ss_dssp             SCSSGGGSCCHHHHTTSH
T ss_pred             cCCChhhCcCHHHHhcCc
Confidence            999999999999999764

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.96  E-value=3.9e-30  Score=208.27  Aligned_cols=154  Identities=25%  Similarity=0.293  Sum_probs=119.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +.++.++.|++.||.|||++|   |+||||||+||+++.++.++|+|||++.......  .......|++.|+|||.+.+
T Consensus       118 ~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~  192 (345)
T 1xjd_A          118 SRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLG  192 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhcccCC--CcccCCCCCcccCChhhhcC
Confidence            357789999999999999999   9999999999999999999999999987532211  12233568899999999999


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+|||||++|+|++|..||...+.......+      . .+..    . .+.     .....+.++|.+||..
T Consensus       193 ~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i------~-~~~~----~-~p~-----~~s~~~~~li~~lL~~  255 (345)
T 1xjd_A          193 QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI------R-MDNP----F-YPR-----WLEKEAKDLLVKLFVR  255 (345)
T ss_dssp             CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------H-HCCC----C-CCT-----TSCHHHHHHHHHHSCS
T ss_pred             CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH------H-hCCC----C-CCc-----ccCHHHHHHHHHHhcC
Confidence            88999999999999999999999999765543322111      1 1110    0 011     1234678999999999


Q ss_pred             CCCCCCCHH-HHHHHhc
Q 027675          162 DPNDRPTMS-DVVIMLG  177 (220)
Q Consensus       162 ~p~~Rps~~-~~l~~l~  177 (220)
                      ||++||++. ++++|-+
T Consensus       256 dp~~R~~~~~~i~~hp~  272 (345)
T 1xjd_A          256 EPEKRLGVRGDIRQHPL  272 (345)
T ss_dssp             SGGGSBTTBSCGGGSGG
T ss_pred             CHhHcCCChHHHHcCcc
Confidence            999999998 8876543

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=7.6e-30  Score=205.59  Aligned_cols=161  Identities=26%  Similarity=0.403  Sum_probs=116.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCc-ccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG-TTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~y~aPe~~~   80 (220)
                      ..++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++.......... ......++..|.|||.+.
T Consensus       147 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  223 (333)
T 1mqb_A          147 LQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS  223 (333)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcc
Confidence            357889999999999999999   9999999999999999999999999987644321111 111123456799999999


Q ss_pred             cCCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           81 GGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      +..++.++|+||||+++|+|++ |..||..........       ....+.....         .......+.++|.+||
T Consensus       224 ~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~-------~~~~~~~~~~---------~~~~~~~l~~li~~~l  287 (333)
T 1mqb_A          224 YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK-------AINDGFRLPT---------PMDCPSAIYQLMMQCW  287 (333)
T ss_dssp             SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH-------HHHTTCCCCC---------CTTCBHHHHHHHHHHT
T ss_pred             cCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHH-------HHHCCCcCCC---------cccCCHHHHHHHHHHc
Confidence            8889999999999999999998 999986554432221       1111111111         1112346788999999


Q ss_pred             CCCCCCCCCHHHHHHHhcCccc
Q 027675          160 QEDPNDRPTMSDVVIMLGSEAV  181 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l~~~~~  181 (220)
                      +.||++||++.++++.|+....
T Consensus       288 ~~~p~~Rps~~~l~~~L~~~~~  309 (333)
T 1mqb_A          288 QQERARRPKFADIVSILDKLIR  309 (333)
T ss_dssp             CSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCChhhCcCHHHHHHHHHHHHh
Confidence            9999999999999999976543

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.96  E-value=1e-29  Score=201.38  Aligned_cols=162  Identities=26%  Similarity=0.332  Sum_probs=119.9

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCC--CcccceeecccCccChhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT--DGTTNRVVGTYGYMSPEYA   79 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~y~aPe~~   79 (220)
                      ..++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++........  ........+++.|.|||.+
T Consensus       128 ~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  204 (298)
T 3f66_A          128 KDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL  204 (298)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHh
Confidence            457889999999999999999   99999999999999999999999999875432211  1112223456789999999


Q ss_pred             hcCCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           80 LGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        80 ~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                      .+..++.++|+||||+++|+|++ +.+||...+.......       ...+.....    +.     .....+.+++.+|
T Consensus       205 ~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~----~~-----~~~~~l~~li~~~  268 (298)
T 3f66_A          205 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY-------LLQGRRLLQ----PE-----YCPDPLYEVMLKC  268 (298)
T ss_dssp             HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHH-------HHTTCCCCC----CT-----TCCHHHHHHHHHH
T ss_pred             cCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHH-------HhcCCCCCC----Cc-----cCCHHHHHHHHHH
Confidence            99889999999999999999999 5666654443322211       111111111    11     1123678899999


Q ss_pred             cCCCCCCCCCHHHHHHHhcCcccc
Q 027675          159 VQEDPNDRPTMSDVVIMLGSEAVN  182 (220)
Q Consensus       159 l~~~p~~Rps~~~~l~~l~~~~~~  182 (220)
                      |+.||++|||+.++++.|+.....
T Consensus       269 l~~~p~~Rps~~ell~~L~~~~~~  292 (298)
T 3f66_A          269 WHPKAEMRPSFSELVSRISAIFST  292 (298)
T ss_dssp             TCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             cCCChhhCcCHHHHHHHHHHHHHh
Confidence            999999999999999999766443

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.96  E-value=3.3e-29  Score=204.71  Aligned_cols=171  Identities=20%  Similarity=0.180  Sum_probs=115.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++.......   ......+++.|+|||.+.+
T Consensus       127 ~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~  200 (371)
T 2xrw_A          127 ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILG  200 (371)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-------------------CTTCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccccccccc---ccCCceecCCccCHHHhcC
Confidence            356789999999999999999   9999999999999999999999999987543221   1223467889999999999


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHH----------------HHHHHHhccccc------c-cc--
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGY----------------AWKLWQEGKALD------M-MD--  136 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~------~-~~--  136 (220)
                      ..++.++|||||||++|+|++|..||...+..........                ............      . .+  
T Consensus       201 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (371)
T 2xrw_A          201 MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVL  280 (371)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGG
T ss_pred             CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhccccc
Confidence            8899999999999999999999999976554322211100                000000000000      0 00  


Q ss_pred             CCCCCcCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcC
Q 027675          137 QKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       137 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~  178 (220)
                      ..............+.++|.+||..||++|||+++++++-+.
T Consensus       281 ~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~  322 (371)
T 2xrw_A          281 FPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI  322 (371)
T ss_dssp             SCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred             CcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcch
Confidence            000001112235678999999999999999999999987644

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.96  E-value=7.6e-30  Score=210.73  Aligned_cols=176  Identities=20%  Similarity=0.288  Sum_probs=113.7

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceee----CCCCCceecCccceeeecCCCC-CcccceeecccCccChh
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILL----DHEMNPKISDFGLTRIFEGKQT-DGTTNRVVGTYGYMSPE   77 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili----~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~y~aPe   77 (220)
                      .++.++.||+.||.|||+++   |+||||||+||++    +.++.++|+|||++........ ........+++.|+|||
T Consensus       129 ~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE  205 (405)
T 3rgf_A          129 MVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE  205 (405)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHH
T ss_pred             HHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCch
Confidence            47889999999999999999   9999999999999    6778999999999876543211 11223356789999999


Q ss_pred             hhhcC-CCcccCceeehhHHHHHHHhcCccCcccchhHHH------hhHHHHHHHHHhc--ccccccc------------
Q 027675           78 YALGG-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELAL------SLLGYAWKLWQEG--KALDMMD------------  136 (220)
Q Consensus        78 ~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~------~~~~~~~~~~~~~--~~~~~~~------------  136 (220)
                      .+.+. .++.++|||||||++|+|++|..||.........      .....+.......  .......            
T Consensus       206 ~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~  285 (405)
T 3rgf_A          206 LLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDF  285 (405)
T ss_dssp             HHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHC
T ss_pred             hhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhc
Confidence            99874 4899999999999999999999999644332100      0000000000000  0000000            


Q ss_pred             -CCCCCcCc-H--------HHHHHHHHHhccccCCCCCCCCCHHHHHHHhcCccc
Q 027675          137 -QKPGAISK-A--------NEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEAV  181 (220)
Q Consensus       137 -~~~~~~~~-~--------~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~~~  181 (220)
                       ........ .        .....+.++|.+||+.||++|||++++++|-+....
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~  340 (405)
T 3rgf_A          286 RRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLED  340 (405)
T ss_dssp             CGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSS
T ss_pred             cccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccC
Confidence             00000000 0        002367899999999999999999999988765543

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.96  E-value=1.2e-29  Score=208.93  Aligned_cols=170  Identities=21%  Similarity=0.220  Sum_probs=120.1

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeC-CCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLD-HEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .++.++.|++.||+|||+++   |+||||||+||+++ .++.++|+|||++........   .....+++.|+|||.+.+
T Consensus       142 ~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~  215 (394)
T 4e7w_A          142 LIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP---NVSYICSRYYRAPELIFG  215 (394)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSSCSCGGGCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCC---CcccccCcCccCHHHHcC
Confidence            46789999999999999999   99999999999998 789999999999976543222   222467889999999876


Q ss_pred             C-CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHH--------HHHHHhccccccccCCCCC----cCcHHHH
Q 027675           82 G-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA--------WKLWQEGKALDMMDQKPGA----ISKANEI  148 (220)
Q Consensus        82 ~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~----~~~~~~~  148 (220)
                      . .++.++|||||||++|+|++|..||...+.......+...        ...................    .......
T Consensus       216 ~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (394)
T 4e7w_A          216 ATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTP  295 (394)
T ss_dssp             CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCC
T ss_pred             CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCC
Confidence            5 5899999999999999999999999765544332211110        0000000000000000000    0011123


Q ss_pred             HHHHHHhccccCCCCCCCCCHHHHHHHhcC
Q 027675          149 LKCINVGLLCVQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       149 ~~~~~li~~cl~~~p~~Rps~~~~l~~l~~  178 (220)
                      ..+.++|.+||+.||++|||+.++++|-+.
T Consensus       296 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  325 (394)
T 4e7w_A          296 PDAIDLISRLLEYTPSARLTAIEALCHPFF  325 (394)
T ss_dssp             HHHHHHHHHHCCSSGGGSCCHHHHHTSGGG
T ss_pred             HHHHHHHHHHhCCChhhCCCHHHHhcChhh
Confidence            478899999999999999999999987543

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.96  E-value=4.5e-30  Score=210.02  Aligned_cols=161  Identities=29%  Similarity=0.408  Sum_probs=112.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCc-ccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG-TTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~y~aPe~~~   80 (220)
                      .+++.++.|++.||.|||+++   |+||||||+||+++.++.++|+|||++.......... ......++..|+|||.+.
T Consensus       147 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  223 (373)
T 2qol_A          147 IQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA  223 (373)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhc
Confidence            357889999999999999999   9999999999999999999999999987644321111 111123356799999999


Q ss_pred             cCCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           81 GGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      +..++.++||||||+++|++++ |..||...........       ...+.....     .    ......+.++|.+||
T Consensus       224 ~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~-------i~~~~~~~~-----~----~~~~~~l~~li~~cl  287 (373)
T 2qol_A          224 YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA-------VDEGYRLPP-----P----MDCPAALYQLMLDCW  287 (373)
T ss_dssp             HCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHH-------HHTTEECCC-----C----TTCBHHHHHHHHHHT
T ss_pred             cCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HHcCCCCCC-----C----ccccHHHHHHHHHHh
Confidence            8889999999999999999997 9999865544332211       111111111     1    112346789999999


Q ss_pred             CCCCCCCCCHHHHHHHhcCccc
Q 027675          160 QEDPNDRPTMSDVVIMLGSEAV  181 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l~~~~~  181 (220)
                      +.||++||++.++++.|+....
T Consensus       288 ~~dp~~RPs~~~i~~~L~~~~~  309 (373)
T 2qol_A          288 QKDRNNRPKFEQIVSILDKLIR  309 (373)
T ss_dssp             CSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CcChhhCcCHHHHHHHHHHHHh
Confidence            9999999999999999976644

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.96  E-value=2.5e-29  Score=206.82  Aligned_cols=163  Identities=26%  Similarity=0.339  Sum_probs=119.5

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +.++.++.||+.||.|||+++   |+||||||+||+++.++.++|+|||++......  ........|++.|+|||++.+
T Consensus       153 ~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~--~~~~~~~~gt~~Y~aPE~l~~  227 (396)
T 4dc2_A          153 EHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTTSTFCGTPNYIAPEILRG  227 (396)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--TCCBCCCCBCGGGCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecccC--CCccccccCCcccCCchhhcC
Confidence            357789999999999999999   999999999999999999999999998742221  112333568999999999999


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHH--HhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELA--LSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      ..++.++|+|||||++|+|++|..||........  ................     ..+.     .....+.++|.+||
T Consensus       228 ~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-----~~p~-----~~s~~~~~li~~lL  297 (396)
T 4dc2_A          228 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-----RIPR-----SLSVKAASVLKSFL  297 (396)
T ss_dssp             CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC-----CCCT-----TSCHHHHHHHHHHT
T ss_pred             CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc-----CCCC-----cCCHHHHHHHHHHh
Confidence            9999999999999999999999999964321111  0011111111111111     0111     12346789999999


Q ss_pred             CCCCCCCCCH------HHHHHHhcCc
Q 027675          160 QEDPNDRPTM------SDVVIMLGSE  179 (220)
Q Consensus       160 ~~~p~~Rps~------~~~l~~l~~~  179 (220)
                      +.||++||++      +++++|-+..
T Consensus       298 ~~dP~~R~~~~~~~~~~ei~~Hpff~  323 (396)
T 4dc2_A          298 NKDPKERLGCHPQTGFADIQGHPFFR  323 (396)
T ss_dssp             CSCTTTSTTCSTTTHHHHHHHSTTTT
T ss_pred             cCCHhHcCCCCCCCCHHHHhcCcccc
Confidence            9999999995      7888776543

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=1.4e-29  Score=207.18  Aligned_cols=163  Identities=26%  Similarity=0.343  Sum_probs=114.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCC--cccceeecccCccChhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD--GTTNRVVGTYGYMSPEYA   79 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~y~aPe~~   79 (220)
                      ..++.++.|+++||.|||+++   |+||||||+||+++.++.+||+|||++.........  .......++..|+|||.+
T Consensus       192 ~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  268 (373)
T 3c1x_A          192 KDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL  268 (373)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHh
Confidence            357889999999999999999   999999999999999999999999998754322111  111223456789999999


Q ss_pred             hcCCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           80 LGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        80 ~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                      .+..++.++|+||||+++|+|++ |.+||...+.......       ...+.....    +.     .....+.++|.+|
T Consensus       269 ~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~-------~~~~~~~~~----p~-----~~~~~l~~li~~c  332 (373)
T 3c1x_A          269 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY-------LLQGRRLLQ----PE-----YCPDPLYEVMLKC  332 (373)
T ss_dssp             HHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHH-------HHTTCCCCC----CT-----TCCHHHHHHHHHH
T ss_pred             cCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHH-------HHcCCCCCC----CC-----CCCHHHHHHHHHH
Confidence            99889999999999999999999 6777765443322111       111211111    11     1223678899999


Q ss_pred             cCCCCCCCCCHHHHHHHhcCccccC
Q 027675          159 VQEDPNDRPTMSDVVIMLGSEAVNL  183 (220)
Q Consensus       159 l~~~p~~Rps~~~~l~~l~~~~~~~  183 (220)
                      |..||++||++.++++.|+......
T Consensus       333 l~~dp~~RPs~~ell~~L~~i~~~~  357 (373)
T 3c1x_A          333 WHPKAEMRPSFSELVSRISAIFSTF  357 (373)
T ss_dssp             TCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             cCCChhhCcCHHHHHHHHHHHHHhc
Confidence            9999999999999999997764433

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.96  E-value=3.7e-29  Score=205.47  Aligned_cols=159  Identities=19%  Similarity=0.215  Sum_probs=120.7

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCC--CCCceecCccceeeecCCCCCcccceeecccCccChhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDH--EMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYA   79 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~   79 (220)
                      ..++.++.|++.||.|||+++   |+||||||+||+++.  .+.++|+|||++.......   ......+++.|+|||.+
T Consensus       149 ~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~  222 (387)
T 1kob_A          149 AEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIV  222 (387)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS---CEEEECSSGGGCCHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCc---ceeeeccCCCccCchhc
Confidence            367889999999999999999   999999999999974  5679999999987654322   12234678999999999


Q ss_pred             hcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           80 LGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        80 ~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      .+..++.++|||||||++|+|++|..||...+.......      .. .... .. ..    .........+.++|.+||
T Consensus       223 ~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~------i~-~~~~-~~-~~----~~~~~~s~~~~~li~~~L  289 (387)
T 1kob_A          223 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQN------VK-RCDW-EF-DE----DAFSSVSPEAKDFIKNLL  289 (387)
T ss_dssp             TTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH------HH-HCCC-CC-CS----STTTTSCHHHHHHHHTTS
T ss_pred             cCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHH------HH-hCCC-CC-Cc----cccccCCHHHHHHHHHHc
Confidence            998899999999999999999999999976544322211      11 1110 00 00    001112346789999999


Q ss_pred             CCCCCCCCCHHHHHHHhcCc
Q 027675          160 QEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l~~~  179 (220)
                      +.||++|||+.+++++-+..
T Consensus       290 ~~dP~~Rpt~~ell~hp~~~  309 (387)
T 1kob_A          290 QKEPRKRLTVHDALEHPWLK  309 (387)
T ss_dssp             CSSGGGSCCHHHHHTSTTTS
T ss_pred             CCChhHCcCHHHHhhCcccc
Confidence            99999999999999876443

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.96  E-value=2.3e-29  Score=198.22  Aligned_cols=152  Identities=21%  Similarity=0.251  Sum_probs=119.0

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++.......    .....++..|.|||.+.+
T Consensus       114 ~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~  186 (284)
T 2vgo_A          114 QRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEG  186 (284)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSSC----BCCCCSCGGGCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcccc----cccccCCCCcCCHHHhcc
Confidence            357889999999999999999   9999999999999999999999999986543221    223467889999999999


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+||||+++|+|++|..||...........      .. ... .    ..+     ......+.++|.+||..
T Consensus       187 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~------~~-~~~-~----~~~-----~~~~~~~~~li~~~l~~  249 (284)
T 2vgo_A          187 KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRR------IV-NVD-L----KFP-----PFLSDGSKDLISKLLRY  249 (284)
T ss_dssp             CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH------HH-TTC-C----CCC-----TTSCHHHHHHHHHHSCS
T ss_pred             CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHH------Hh-ccc-c----CCC-----CcCCHHHHHHHHHHhhc
Confidence            8889999999999999999999999975544332211      11 100 0    001     11234678899999999


Q ss_pred             CCCCCCCHHHHHHHhc
Q 027675          162 DPNDRPTMSDVVIMLG  177 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~  177 (220)
                      ||++||++++++++-+
T Consensus       250 ~p~~Rps~~~ll~h~~  265 (284)
T 2vgo_A          250 HPPQRLPLKGVMEHPW  265 (284)
T ss_dssp             SGGGSCCHHHHHTCHH
T ss_pred             CHhhCCCHHHHhhCHH
Confidence            9999999999997643

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.96  E-value=1.3e-29  Score=199.25  Aligned_cols=158  Identities=27%  Similarity=0.375  Sum_probs=118.7

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++......... ......++..|.|||.+.+
T Consensus       113 ~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~  188 (281)
T 3cc6_A          113 LTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY-KASVTRLPIKWMSPESINF  188 (281)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC----------CCCCCGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccccccccc-ccccCCCCcceeCchhhcc
Confidence            357889999999999999999   999999999999999999999999998754432211 1122345678999999998


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++|+|++ |..||...........       ...+.....    +.     .....+.+++.+||.
T Consensus       189 ~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~-------~~~~~~~~~----~~-----~~~~~l~~li~~~l~  252 (281)
T 3cc6_A          189 RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV-------LEKGDRLPK----PD-----LCPPVLYTLMTRCWD  252 (281)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHH-------HHHTCCCCC----CT-----TCCHHHHHHHHHHTC
T ss_pred             CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHH-------HhcCCCCCC----CC-----CCCHHHHHHHHHHcc
Confidence            889999999999999999998 9999865444332211       111111111    11     122467889999999


Q ss_pred             CCCCCCCCHHHHHHHhcCc
Q 027675          161 EDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~  179 (220)
                      .||++||++.+++++|+..
T Consensus       253 ~~p~~Rps~~ell~~L~~~  271 (281)
T 3cc6_A          253 YDPSDRPRFTELVCSLSDV  271 (281)
T ss_dssp             SSGGGSCCHHHHHHHHHHH
T ss_pred             CCchhCcCHHHHHHHHHHH
Confidence            9999999999999998654

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.96  E-value=3e-29  Score=209.85  Aligned_cols=153  Identities=28%  Similarity=0.364  Sum_probs=119.4

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .++.++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++.......     ....++..|+|||.+.+.
T Consensus       290 ~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-----~~~~~~~~y~aPE~~~~~  361 (450)
T 1k9a_A          290 CLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREK  361 (450)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-----------CCCTTTSCHHHHHSS
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-----cCCCCCcceeCHHHhcCC
Confidence            57889999999999999999   9999999999999999999999999987533211     112456789999999998


Q ss_pred             CCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           83 FFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      .++.++|+||||+++|+|++ |..||..........       ....+.......         .....+.++|.+||..
T Consensus       362 ~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~-------~i~~~~~~~~p~---------~~~~~l~~li~~cl~~  425 (450)
T 1k9a_A          362 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-------RVEKGYKMDAPD---------GCPPAVYDVMKNCWHL  425 (450)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHH-------HHHTTCCCCCCT---------TCCHHHHHHHHHHTCS
T ss_pred             CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-------HHHcCCCCCCCC---------cCCHHHHHHHHHHcCC
Confidence            99999999999999999998 999997654433221       111222221111         1234778999999999


Q ss_pred             CCCCCCCHHHHHHHhcCc
Q 027675          162 DPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~~~  179 (220)
                      ||++|||+.++++.|+..
T Consensus       426 dp~~Rpt~~~l~~~L~~i  443 (450)
T 1k9a_A          426 DAATRPTFLQLREQLEHI  443 (450)
T ss_dssp             SGGGSCCHHHHHHHHHHH
T ss_pred             ChhHCcCHHHHHHHHHHH
Confidence            999999999999988654

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.96  E-value=1.3e-29  Score=201.98  Aligned_cols=173  Identities=23%  Similarity=0.329  Sum_probs=117.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||++|   ++||||||+||+++.++.++|+|||++........  ......++..|+|||.+.+
T Consensus       102 ~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~  176 (311)
T 4agu_A          102 HLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD--YYDDEVATRWYRSPELLVG  176 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--------------GGGCCHHHHHT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc--ccCCCcCCccccChHHHhc
Confidence            357889999999999999999   99999999999999999999999999876542221  1223457889999999986


Q ss_pred             -CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHH--------HHHHHhcccccccc-CCCCCcCc-----HH
Q 027675           82 -GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA--------WKLWQEGKALDMMD-QKPGAISK-----AN  146 (220)
Q Consensus        82 -~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~-~~~~~~~~-----~~  146 (220)
                       ..++.++|+||||+++|+|++|..||...............        .............. ..+.....     ..
T Consensus       177 ~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (311)
T 4agu_A          177 DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPN  256 (311)
T ss_dssp             CSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTT
T ss_pred             CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhccc
Confidence             56789999999999999999999999765544332221110        00111111000000 00000000     12


Q ss_pred             HHHHHHHHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          147 EILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       147 ~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      ....+.++|.+||+.||++|||+++++++-+..
T Consensus       257 ~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  289 (311)
T 4agu_A          257 ISYPALGLLKGCLHMDPTERLTCEQLLHHPYFE  289 (311)
T ss_dssp             CCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGT
T ss_pred             ccHHHHHHHHHHccCChhhcCCHHHHhcChHHH
Confidence            234678999999999999999999999875433

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.96  E-value=1e-29  Score=212.49  Aligned_cols=156  Identities=22%  Similarity=0.268  Sum_probs=120.0

Q ss_pred             chHHHHHHHHHHHHHHhhh-CCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQ-DSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~-~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~   80 (220)
                      ..++.++.|++.||+|||+ .|   |+||||||+||+++.++.++|+|||++.......  .......|++.|+|||.+.
T Consensus       248 ~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~  322 (446)
T 4ejn_A          248 DRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKTFCGTPEYLAPEVLE  322 (446)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-------CCSSSCGGGCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccCCC--cccccccCCccccCHhhcC
Confidence            3577899999999999998 88   9999999999999999999999999986422111  1122356889999999999


Q ss_pred             cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           81 GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      +..++.++|+|||||++|+|++|..||...+........      ... .. .    .+.     .....+.++|.+||+
T Consensus       323 ~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i------~~~-~~-~----~p~-----~~~~~~~~li~~~L~  385 (446)
T 4ejn_A          323 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------LME-EI-R----FPR-----TLGPEAKSLLSGLLK  385 (446)
T ss_dssp             TSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHC-CC-C----CCT-----TSCHHHHHHHHHHTC
T ss_pred             CCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH------HhC-CC-C----CCc-----cCCHHHHHHHHHHcc
Confidence            989999999999999999999999999765544332211      111 10 0    111     122467899999999


Q ss_pred             CCCCCCC-----CHHHHHHHhcCc
Q 027675          161 EDPNDRP-----TMSDVVIMLGSE  179 (220)
Q Consensus       161 ~~p~~Rp-----s~~~~l~~l~~~  179 (220)
                      .||++||     +++++++|-+..
T Consensus       386 ~dP~~R~~~~~~t~~ell~hp~f~  409 (446)
T 4ejn_A          386 KDPKQRLGGGSEDAKEIMQHRFFA  409 (446)
T ss_dssp             SSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred             cCHHHhCCCCCCCHHHHHhCcccc
Confidence            9999999     999999876544

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.96  E-value=4.2e-29  Score=201.50  Aligned_cols=148  Identities=21%  Similarity=0.298  Sum_probs=117.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+++   |+||||||+||+++.++.++|+|||++........   .....+++.|+|||.+.+
T Consensus       130 ~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~  203 (335)
T 3dls_A          130 PLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMG  203 (335)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccceECCCCCc---eeccCCCccccChhhhcC
Confidence            357889999999999999999   99999999999999999999999999876543221   223567899999999988


Q ss_pred             CCC-cccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFF-SVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..+ +.++||||||+++|+|++|..||........                 ... ..+..     ....+.++|.+||+
T Consensus       204 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-----------------~~~-~~~~~-----~~~~l~~li~~~L~  260 (335)
T 3dls_A          204 NPYRGPELEMWSLGVTLYTLVFEENPFCELEETVE-----------------AAI-HPPYL-----VSKELMSLVSGLLQ  260 (335)
T ss_dssp             CCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTT-----------------TCC-CCSSC-----CCHHHHHHHHHHTC
T ss_pred             CCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHh-----------------hcc-CCCcc-----cCHHHHHHHHHHcc
Confidence            776 7889999999999999999999864221100                 000 01111     23367899999999


Q ss_pred             CCCCCCCCHHHHHHHhcC
Q 027675          161 EDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~  178 (220)
                      .||++|||+++++++-+.
T Consensus       261 ~dP~~Rps~~ell~hp~~  278 (335)
T 3dls_A          261 PVPERRTTLEKLVTDPWV  278 (335)
T ss_dssp             SSGGGSCCHHHHHHCTTT
T ss_pred             CChhhCcCHHHHhcCccc
Confidence            999999999999998654

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.96  E-value=4.1e-30  Score=206.67  Aligned_cols=162  Identities=19%  Similarity=0.211  Sum_probs=105.0

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCc----------ccceeeccc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG----------TTNRVVGTY   71 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~----------~~~~~~~~~   71 (220)
                      .+++.++.|++.||.|||+.+ ..++||||||+||+++.++.++|+|||++..........          ......+++
T Consensus       136 ~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~  214 (337)
T 3ll6_A          136 DTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTP  214 (337)
T ss_dssp             HHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC----------------------
T ss_pred             HHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCC
Confidence            467899999999999999874 239999999999999999999999999987644321110          111234788


Q ss_pred             CccChhhh---hcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHH
Q 027675           72 GYMSPEYA---LGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEI  148 (220)
Q Consensus        72 ~y~aPe~~---~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (220)
                      .|+|||.+   .+..++.++||||||+++|+|++|..||.........          ......    .....     ..
T Consensus       215 ~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~----------~~~~~~----~~~~~-----~~  275 (337)
T 3ll6_A          215 MYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV----------NGKYSI----PPHDT-----QY  275 (337)
T ss_dssp             ---------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------------------CCC----CTTCC-----SS
T ss_pred             CcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhh----------cCcccC----Ccccc-----cc
Confidence            99999998   4566789999999999999999999998643221110          000000    00111     11


Q ss_pred             HHHHHHhccccCCCCCCCCCHHHHHHHhcCccccC
Q 027675          149 LKCINVGLLCVQEDPNDRPTMSDVVIMLGSEAVNL  183 (220)
Q Consensus       149 ~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~~~~~  183 (220)
                      ..+.++|.+||+.||++|||+.+++++|+......
T Consensus       276 ~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~  310 (337)
T 3ll6_A          276 TVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR  310 (337)
T ss_dssp             GGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             hHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence            24678899999999999999999999997765543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.96  E-value=3.8e-29  Score=201.99  Aligned_cols=158  Identities=20%  Similarity=0.228  Sum_probs=116.1

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCC--CceecCccceeeecCCCCC--cccceeecccCccChhh
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEM--NPKISDFGLTRIFEGKQTD--GTTNRVVGTYGYMSPEY   78 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~--~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~y~aPe~   78 (220)
                      .++.++.|++.||+|||+.+   ++||||||+||+++.++  .++|+|||++.........  .......+++.|+|||.
T Consensus       169 ~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~  245 (345)
T 3hko_A          169 LISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEV  245 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHH
T ss_pred             HHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchh
Confidence            46789999999999999999   99999999999998776  7999999998764321111  11223467889999999


Q ss_pred             hhc--CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhc
Q 027675           79 ALG--GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGL  156 (220)
Q Consensus        79 ~~~--~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  156 (220)
                      +.+  ..++.++||||||+++|+|++|..||..........      .........       ...........+.++|.
T Consensus       246 ~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~------~~~~~~~~~-------~~~~~~~~~~~~~~li~  312 (345)
T 3hko_A          246 LNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTIS------QVLNKKLCF-------ENPNYNVLSPLARDLLS  312 (345)
T ss_dssp             HTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHHCCCCT-------TSGGGGGSCHHHHHHHH
T ss_pred             hccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHH------HHHhccccc-------CCcccccCCHHHHHHHH
Confidence            975  567899999999999999999999997655443221      111111110       00011112346789999


Q ss_pred             cccCCCCCCCCCHHHHHHHh
Q 027675          157 LCVQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       157 ~cl~~~p~~Rps~~~~l~~l  176 (220)
                      +||+.||++||++.+++++-
T Consensus       313 ~~l~~~p~~Rps~~~~l~hp  332 (345)
T 3hko_A          313 NLLNRNVDERFDAMRALQHP  332 (345)
T ss_dssp             HHSCSCTTTSCCHHHHHHSH
T ss_pred             HHcCCChhHCCCHHHHhcCh
Confidence            99999999999999999764

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.96  E-value=9.1e-30  Score=204.78  Aligned_cols=173  Identities=19%  Similarity=0.166  Sum_probs=114.5

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeC-----CCCCceecCccceeeecCCCCCcccceeecccCccCh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLD-----HEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP   76 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~-----~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aP   76 (220)
                      ..++.++.||+.||.|||+++   |+||||||+||+++     ..+.++|+|||++........  ......++..|+||
T Consensus       132 ~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aP  206 (329)
T 3gbz_A          132 RVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR--QFTHEIITLWYRPP  206 (329)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-------------CCTTCCH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCccccCCccc--ccCCCcCCccccCH
Confidence            357889999999999999999   99999999999994     445599999999875432211  12224568899999


Q ss_pred             hhhhcC-CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhcccc------ccccCCCCC-cCcHH--
Q 027675           77 EYALGG-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKAL------DMMDQKPGA-ISKAN--  146 (220)
Q Consensus        77 e~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~-~~~~~--  146 (220)
                      |.+.+. .++.++|||||||++|+|++|..||.........................      ......+.. .....  
T Consensus       207 E~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (329)
T 3gbz_A          207 EILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRV  286 (329)
T ss_dssp             HHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHH
T ss_pred             HHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhh
Confidence            999875 47999999999999999999999997655433222111100000000000      000000000 00001  


Q ss_pred             ----HHHHHHHHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          147 ----EILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       147 ----~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                          ....+.++|.+||+.||++|||+++++++-+..
T Consensus       287 ~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  323 (329)
T 3gbz_A          287 LGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFS  323 (329)
T ss_dssp             HGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred             cccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccC
Confidence                234678999999999999999999999876544

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=9e-30  Score=200.89  Aligned_cols=161  Identities=23%  Similarity=0.313  Sum_probs=123.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCC-cccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD-GTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~y~aPe~~~   80 (220)
                      ..++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++......... .......++..|.|||.+.
T Consensus       110 ~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  186 (287)
T 1u59_A          110 SNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN  186 (287)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhc
Confidence            467899999999999999999   999999999999999999999999998765432211 1111123467899999999


Q ss_pred             cCCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           81 GGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      +..++.++|+||||+++|+|++ |..||...........       ...+.....         .......+.++|.+||
T Consensus       187 ~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-------i~~~~~~~~---------~~~~~~~l~~li~~~l  250 (287)
T 1u59_A          187 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF-------IEQGKRMEC---------PPECPPELYALMSDCW  250 (287)
T ss_dssp             HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH-------HHTTCCCCC---------CTTCCHHHHHHHHHTT
T ss_pred             cCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH-------HhcCCcCCC---------CCCcCHHHHHHHHHHc
Confidence            8888999999999999999998 9999976554332211       111211111         1122347889999999


Q ss_pred             CCCCCCCCCHHHHHHHhcCccc
Q 027675          160 QEDPNDRPTMSDVVIMLGSEAV  181 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l~~~~~  181 (220)
                      ..||++||++.+++++|+....
T Consensus       251 ~~~p~~Rps~~~l~~~l~~~~~  272 (287)
T 1u59_A          251 IYKWEDRPDFLTVEQRMRACYY  272 (287)
T ss_dssp             CSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCChhhCcCHHHHHHHHHHHHH
Confidence            9999999999999999976643

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.96  E-value=1.9e-29  Score=201.64  Aligned_cols=166  Identities=22%  Similarity=0.260  Sum_probs=115.5

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCC---CCCcccceeecccCccChhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGK---QTDGTTNRVVGTYGYMSPEY   78 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~~y~aPe~   78 (220)
                      ..++.++.|++.||.|||+++   ++||||||+||+++ ++.++|+|||++......   ..........++..|.|||.
T Consensus       130 ~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~  205 (319)
T 2y4i_B          130 NKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI  205 (319)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHH
Confidence            467899999999999999999   99999999999998 679999999987643211   11111222357789999999


Q ss_pred             hhc---------CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHH
Q 027675           79 ALG---------GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEIL  149 (220)
Q Consensus        79 ~~~---------~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (220)
                      +.+         ..++.++||||||+++|+|++|..||...........       ...+........        ....
T Consensus       206 ~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-------~~~~~~~~~~~~--------~~~~  270 (319)
T 2y4i_B          206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ-------MGTGMKPNLSQI--------GMGK  270 (319)
T ss_dssp             HSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHH-------HHTTCCCCCCCS--------SCCT
T ss_pred             hhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------hccCCCCCCCcC--------CCCH
Confidence            875         3468899999999999999999999976554432211       111111111100        1122


Q ss_pred             HHHHHhccccCCCCCCCCCHHHHHHHhcCccccCCCC
Q 027675          150 KCINVGLLCVQEDPNDRPTMSDVVIMLGSEAVNLASP  186 (220)
Q Consensus       150 ~~~~li~~cl~~~p~~Rps~~~~l~~l~~~~~~~~~~  186 (220)
                      .+.+++.+||..||++|||+.++++.|+.........
T Consensus       271 ~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~  307 (319)
T 2y4i_B          271 EISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRL  307 (319)
T ss_dssp             THHHHHHHHHCSSTTTSCCHHHHHHHHTTC-------
T ss_pred             HHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccC
Confidence            5788999999999999999999999998886654443

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.96  E-value=8.8e-30  Score=204.31  Aligned_cols=154  Identities=23%  Similarity=0.374  Sum_probs=115.3

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCC----------cccceeecccC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD----------GTTNRVVGTYG   72 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~----------~~~~~~~~~~~   72 (220)
                      .++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++.........          .......+++.
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            37889999999999999999   999999999999999999999999998865432110          11122467899


Q ss_pred             ccChhhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHH
Q 027675           73 YMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCI  152 (220)
Q Consensus        73 y~aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (220)
                      |+|||.+.+..++.++|+||||+++|+|++|..|+..     .....    ......         ............+.
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~----~~~~~~---------~~~~~~~~~~~~~~  303 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRII----TDVRNL---------KFPLLFTQKYPQEH  303 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHH----HHHHTT---------CCCHHHHHHCHHHH
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHH----HHhhcc---------CCCcccccCChhHH
Confidence            9999999998899999999999999999998766421     10000    001011         11111223345678


Q ss_pred             HHhccccCCCCCCCCCHHHHHHHhc
Q 027675          153 NVGLLCVQEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       153 ~li~~cl~~~p~~Rps~~~~l~~l~  177 (220)
                      ++|.+||+.||++|||+++++++-+
T Consensus       304 ~li~~~l~~~p~~Rps~~~~l~~~~  328 (332)
T 3qd2_B          304 MMVQDMLSPSPTERPEATDIIENAI  328 (332)
T ss_dssp             HHHHHHHCSSGGGSCCHHHHHHSTT
T ss_pred             HHHHHHccCCCCcCCCHHHHhhchh
Confidence            9999999999999999999998753

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.96  E-value=3.2e-29  Score=197.23  Aligned_cols=156  Identities=20%  Similarity=0.271  Sum_probs=118.5

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCC---ceecCccceeeecCCCCCcccceeecccCccChhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMN---PKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEY   78 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~---~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~   78 (220)
                      ..++.++.|++.||.|||+.+   ++||||||+||+++.++.   ++|+|||++........   .....+++.|+|||.
T Consensus       105 ~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~  178 (284)
T 3kk8_A          105 ADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEV  178 (284)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB---CCCSCSCGGGCCHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc---ccCCCCCcCCcCchh
Confidence            357889999999999999999   999999999999976655   99999999876543222   122467889999999


Q ss_pred             hhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           79 ALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        79 ~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                      +.+..++.++|+||||+++|+|++|..||...+........       ..+... .....     .......+.+++.+|
T Consensus       179 ~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~-------~~~~~~-~~~~~-----~~~~~~~~~~li~~~  245 (284)
T 3kk8_A          179 LKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI-------KAGAYD-YPSPE-----WDTVTPEAKSLIDSM  245 (284)
T ss_dssp             HTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHTCCC-CCTTT-----TTTSCHHHHHHHHHH
T ss_pred             hcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHH-------Hhcccc-CCchh-----hcccCHHHHHHHHHH
Confidence            99988999999999999999999999999755443322111       111110 00000     011224678999999


Q ss_pred             cCCCCCCCCCHHHHHHHh
Q 027675          159 VQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       159 l~~~p~~Rps~~~~l~~l  176 (220)
                      |+.||++|||+.+++++-
T Consensus       246 l~~dp~~Rps~~~~l~h~  263 (284)
T 3kk8_A          246 LTVNPKKRITADQALKVP  263 (284)
T ss_dssp             SCSSTTTSCCHHHHTTSH
T ss_pred             cccChhhCCCHHHHhcCc
Confidence            999999999999999764

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.96  E-value=2.3e-29  Score=205.10  Aligned_cols=175  Identities=22%  Similarity=0.261  Sum_probs=121.7

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCC-CcccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT-DGTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~y~aPe~~~   80 (220)
                      .+++.++.|++.||.|||++|   |+||||||+||+++.++.++|+|||++........ ........+++.|+|||.+.
T Consensus       128 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  204 (364)
T 3qyz_A          128 DHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML  204 (364)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhc
Confidence            357889999999999999999   99999999999999999999999999976543211 11123346789999999876


Q ss_pred             c-CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHH-----HHHHHh-------ccccccccCCCC--CcCcH
Q 027675           81 G-GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA-----WKLWQE-------GKALDMMDQKPG--AISKA  145 (220)
Q Consensus        81 ~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~-----~~~~~~-------~~~~~~~~~~~~--~~~~~  145 (220)
                      + ..++.++|+|||||++|+|++|..||...+...........     ......       ............  .....
T Consensus       205 ~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (364)
T 3qyz_A          205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFP  284 (364)
T ss_dssp             TBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCT
T ss_pred             CCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCC
Confidence            4 45799999999999999999999999765543332221100     000000       000000000000  00001


Q ss_pred             HHHHHHHHHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          146 NEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       146 ~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      .....+.++|.+||+.||++|||+.+++++-+..
T Consensus       285 ~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~  318 (364)
T 3qyz_A          285 NADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE  318 (364)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGT
T ss_pred             CCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchh
Confidence            1234678999999999999999999999876544

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.96  E-value=1.3e-29  Score=205.43  Aligned_cols=154  Identities=31%  Similarity=0.367  Sum_probs=118.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhh-
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL-   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~-   80 (220)
                      .+++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++.....      .....+++.|+|||.+. 
T Consensus       154 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~------~~~~~gt~~y~aPE~~~~  224 (348)
T 1u5q_A          154 VEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILA  224 (348)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------BCCCCSCGGGCCHHHHHT
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC------CCcccCCcceeCHhhhcc
Confidence            357889999999999999999   99999999999999999999999999865432      12246789999999985 


Q ss_pred             --cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           81 --GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        81 --~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                        +..++.++||||||+++|+|++|..||...+......      .... +.....    .    .......+.++|.+|
T Consensus       225 ~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~------~~~~-~~~~~~----~----~~~~~~~l~~li~~~  289 (348)
T 1u5q_A          225 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQ-NESPAL----Q----SGHWSEYFRNFVDSC  289 (348)
T ss_dssp             TSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHH-SCCCCC----C----CTTSCHHHHHHHHHH
T ss_pred             ccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH------HHHh-cCCCCC----C----CCCCCHHHHHHHHHH
Confidence              4567899999999999999999999986554332211      1111 111100    0    011234678899999


Q ss_pred             cCCCCCCCCCHHHHHHHhcCc
Q 027675          159 VQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       159 l~~~p~~Rps~~~~l~~l~~~  179 (220)
                      |+.||++|||+++++++.+..
T Consensus       290 l~~dP~~Rps~~~ll~h~~~~  310 (348)
T 1u5q_A          290 LQKIPQDRPTSEVLLKHRFVL  310 (348)
T ss_dssp             TCSSGGGSCCHHHHTTCHHHH
T ss_pred             cccChhhCcCHHHHhhChhhh
Confidence            999999999999999876543

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.96  E-value=9.6e-30  Score=200.65  Aligned_cols=156  Identities=24%  Similarity=0.391  Sum_probs=109.1

Q ss_pred             chHHHHHHHHHHHHHHhhhC-CCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhh-
Q 027675            2 EMLFNIILGVSRRLLYLHQD-SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYA-   79 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~-~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~-   79 (220)
                      ..++.++.|++.||.|||++ +   ++||||||+||+++.++.++|+|||++........   .....+++.|+|||.+ 
T Consensus       109 ~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~  182 (290)
T 3fme_A          109 DILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA---KDIDAGCKPYMAPERIN  182 (290)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------------------CCCCCCSCHHHHS
T ss_pred             HHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccccccc---ccccCCCccccChhhcC
Confidence            35778999999999999998 9   99999999999999999999999999875443221   1223578899999996 


Q ss_pred             ---hcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhc
Q 027675           80 ---LGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGL  156 (220)
Q Consensus        80 ---~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  156 (220)
                         .+..++.++|+||||+++|+|++|..||...........     ...... ....    +.    ......+.+++.
T Consensus       183 ~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-----~~~~~~-~~~~----~~----~~~~~~~~~li~  248 (290)
T 3fme_A          183 PELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLK-----QVVEEP-SPQL----PA----DKFSAEFVDFTS  248 (290)
T ss_dssp             CCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHH-----HHHHSC-CCCC----CT----TTSCHHHHHHHH
T ss_pred             hhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHH-----HHhccC-CCCc----cc----ccCCHHHHHHHH
Confidence               455678999999999999999999999975433222111     111111 1100    01    112346789999


Q ss_pred             cccCCCCCCCCCHHHHHHHhc
Q 027675          157 LCVQEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       157 ~cl~~~p~~Rps~~~~l~~l~  177 (220)
                      +||+.||++|||+.+++++-+
T Consensus       249 ~~l~~~p~~Rpt~~e~l~hp~  269 (290)
T 3fme_A          249 QCLKKNSKERPTYPELMQHPF  269 (290)
T ss_dssp             HHTCSSGGGSCCHHHHTTSHH
T ss_pred             HHhhcChhhCcCHHHHHhCcc
Confidence            999999999999999998653

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.96  E-value=1.8e-29  Score=198.20  Aligned_cols=153  Identities=27%  Similarity=0.345  Sum_probs=115.2

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .++.++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++.......     ....++..|.|||.+.+.
T Consensus       118 ~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~  189 (278)
T 1byg_A          118 CLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREK  189 (278)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc-----cCCCccccccCHHHhCCC
Confidence            57889999999999999999   9999999999999999999999999986543221     122456789999999988


Q ss_pred             CCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           83 FFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      .++.++|+||||+++|+|++ |..||...........       ...+.....         .......+.++|.+||..
T Consensus       190 ~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~-------~~~~~~~~~---------~~~~~~~l~~li~~~l~~  253 (278)
T 1byg_A          190 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-------VEKGYKMDA---------PDGCPPAVYEVMKNCWHL  253 (278)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH-------HTTTCCCCC---------CTTCCHHHHHHHHHHTCS
T ss_pred             CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HhcCCCCCC---------cccCCHHHHHHHHHHhcC
Confidence            89999999999999999998 9999875543332211       111111111         111234678899999999


Q ss_pred             CCCCCCCHHHHHHHhcCc
Q 027675          162 DPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~~~  179 (220)
                      ||++||++.++++.|+..
T Consensus       254 ~p~~Rps~~~l~~~L~~i  271 (278)
T 1byg_A          254 DAAMRPSFLQLREQLEHI  271 (278)
T ss_dssp             SGGGSCCHHHHHHHHHHH
T ss_pred             ChhhCCCHHHHHHHHHHH
Confidence            999999999999998655

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.96  E-value=9.8e-30  Score=201.05  Aligned_cols=159  Identities=26%  Similarity=0.370  Sum_probs=121.1

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCc-ccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG-TTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~y~aPe~~~   80 (220)
                      ..++.++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++.......... ......++..|.|||.+.
T Consensus       117 ~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  193 (291)
T 1xbb_A          117 KNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN  193 (291)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhc
Confidence            357889999999999999999   9999999999999999999999999987654322111 111123457799999999


Q ss_pred             cCCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           81 GGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      +..++.++|+||||+++|+|++ |..||..........       ....+.....         .......+.++|.+||
T Consensus       194 ~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-------~~~~~~~~~~---------~~~~~~~l~~li~~~l  257 (291)
T 1xbb_A          194 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA-------MLEKGERMGC---------PAGCPREMYDLMNLCW  257 (291)
T ss_dssp             HCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH-------HHHTTCCCCC---------CTTCCHHHHHHHHHHT
T ss_pred             cCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH-------HHHcCCCCCC---------CCCCCHHHHHHHHHHc
Confidence            8888999999999999999999 999997655433221       1112211111         1112346889999999


Q ss_pred             CCCCCCCCCHHHHHHHhcCc
Q 027675          160 QEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l~~~  179 (220)
                      +.||++||++.++++.|+..
T Consensus       258 ~~dp~~Rps~~~l~~~L~~~  277 (291)
T 1xbb_A          258 TYDVENRPGFAAVELRLRNY  277 (291)
T ss_dssp             CSSTTTSCCHHHHHHHHHHH
T ss_pred             CCChhhCcCHHHHHHHHHHH
Confidence            99999999999999998655

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.96  E-value=3.3e-29  Score=204.86  Aligned_cols=156  Identities=21%  Similarity=0.195  Sum_probs=119.0

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceee--CCCCCceecCccceeeecCCCCCcccceeecccCccChhhhh
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILL--DHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili--~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~   80 (220)
                      .++.++.|++.||.|||+.+   |+||||||+||++  +.++.++|+|||++........   .....+++.|+|||.+.
T Consensus       188 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~  261 (373)
T 2x4f_A          188 DTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LKVNFGTPEFLAPEVVN  261 (373)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CCCCCSSCTTCCHHHHT
T ss_pred             HHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---cccccCCCcEeChhhcc
Confidence            56789999999999999999   9999999999999  5677899999999886543222   22245789999999999


Q ss_pred             cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           81 GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      +..++.++|||||||++|+|++|..||...+.......      .......  .     ...........+.++|.+||+
T Consensus       262 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~------i~~~~~~--~-----~~~~~~~~~~~~~~li~~~L~  328 (373)
T 2x4f_A          262 YDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNN------ILACRWD--L-----EDEEFQDISEEAKEFISKLLI  328 (373)
T ss_dssp             TCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH------HHHTCCC--S-----CSGGGTTSCHHHHHHHHTTSC
T ss_pred             CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HHhccCC--C-----ChhhhccCCHHHHHHHHHHcC
Confidence            88889999999999999999999999976554332211      1111100  0     000001123478899999999


Q ss_pred             CCCCCCCCHHHHHHHhc
Q 027675          161 EDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~  177 (220)
                      .||++|||+.+++++-+
T Consensus       329 ~dp~~Rps~~e~l~hp~  345 (373)
T 2x4f_A          329 KEKSWRISASEALKHPW  345 (373)
T ss_dssp             SSGGGSCCHHHHHHSHH
T ss_pred             CChhhCCCHHHHhcCcC
Confidence            99999999999998643

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.96  E-value=1.1e-29  Score=204.02  Aligned_cols=159  Identities=26%  Similarity=0.357  Sum_probs=120.2

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++.......   ......++..|.|||.+.+
T Consensus       142 ~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~  215 (327)
T 1fvr_A          142 QQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNY  215 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeEEEcccCcCccccccc---cccCCCCCccccChhhhcc
Confidence            357889999999999999999   9999999999999999999999999986322111   1112345678999999998


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++|+|++ |..||...........       ...+....     .    .......+.++|.+||.
T Consensus       216 ~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~-------~~~~~~~~-----~----~~~~~~~l~~li~~~l~  279 (327)
T 1fvr_A          216 SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-------LPQGYRLE-----K----PLNCDDEVYDLMRQCWR  279 (327)
T ss_dssp             CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-------GGGTCCCC-----C----CTTBCHHHHHHHHHHTC
T ss_pred             ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHH-------hhcCCCCC-----C----CCCCCHHHHHHHHHHcc
Confidence            888999999999999999998 9999976544332211       11111110     0    11123468899999999


Q ss_pred             CCCCCCCCHHHHHHHhcCcccc
Q 027675          161 EDPNDRPTMSDVVIMLGSEAVN  182 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~~~~  182 (220)
                      .||++|||+.+++++|......
T Consensus       280 ~dp~~Rps~~ell~~L~~~~~~  301 (327)
T 1fvr_A          280 EKPYERPSFAQILVSLNRMLEE  301 (327)
T ss_dssp             SSGGGSCCHHHHHHHHHHHHHS
T ss_pred             CChhhCcCHHHHHHHHHHHHHh
Confidence            9999999999999999765443

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.96  E-value=4e-29  Score=200.25  Aligned_cols=158  Identities=20%  Similarity=0.187  Sum_probs=120.5

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCC----CceecCccceeeecCCCCCcccceeecccCccChh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEM----NPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPE   77 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe   77 (220)
                      ..++.++.|++.||.|||+.+   ++||||||+||+++.++    .++|+|||++........   .....+++.|+|||
T Consensus       115 ~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE  188 (321)
T 2a2a_A          115 EEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPE  188 (321)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCC---CCCCCSCGGGCCHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCccceecCcccc---ccccCCCCCccCcc
Confidence            367889999999999999999   99999999999999888    799999999876543221   12345788999999


Q ss_pred             hhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcc
Q 027675           78 YALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLL  157 (220)
Q Consensus        78 ~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  157 (220)
                      .+.+..++.++|+||||+++|+|++|..||............      . ....      .............+.++|.+
T Consensus       189 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i------~-~~~~------~~~~~~~~~~~~~~~~li~~  255 (321)
T 2a2a_A          189 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI------T-SVSY------DFDEEFFSHTSELAKDFIRK  255 (321)
T ss_dssp             HHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH------H-TTCC------CCCHHHHTTCCHHHHHHHHT
T ss_pred             cccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHH------H-hccc------ccChhhhcccCHHHHHHHHH
Confidence            999888999999999999999999999999755443322111      0 1000      00000001123467899999


Q ss_pred             ccCCCCCCCCCHHHHHHHhcC
Q 027675          158 CVQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       158 cl~~~p~~Rps~~~~l~~l~~  178 (220)
                      ||..||++|||+.+++++-+.
T Consensus       256 ~l~~dp~~Rps~~e~l~hp~~  276 (321)
T 2a2a_A          256 LLVKETRKRLTIQEALRHPWI  276 (321)
T ss_dssp             TSCSSTTTSCCHHHHHHSTTT
T ss_pred             HcCCChhhCcCHHHHhcCccc
Confidence            999999999999999987654

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.96  E-value=1.2e-29  Score=199.07  Aligned_cols=155  Identities=26%  Similarity=0.375  Sum_probs=99.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +.++.++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++........  ......+++.|.|||.+.+
T Consensus       112 ~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~  186 (278)
T 3cok_A          112 NEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE--KHYTLCGTPNYISPEIATR  186 (278)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-------------------------
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC--cceeccCCCCcCCcchhcC
Confidence            357889999999999999999   99999999999999999999999999876442211  1122457889999999998


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+||||+++|+|++|..||...........           ....  +..    ........+.++|.+||..
T Consensus       187 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-----------~~~~--~~~----~~~~~~~~~~~li~~~l~~  249 (278)
T 3cok_A          187 SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK-----------VVLA--DYE----MPSFLSIEAKDLIHQLLRR  249 (278)
T ss_dssp             -----CTHHHHHHHHHHHHHHSSCSSCCCSCC----------------CCSS--CCC----CCTTSCHHHHHHHHHHSCS
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHH-----------Hhhc--ccC----CccccCHHHHHHHHHHccc
Confidence            8889999999999999999999999975433221110           0000  000    0111234678999999999


Q ss_pred             CCCCCCCHHHHHHHhcC
Q 027675          162 DPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~~  178 (220)
                      ||++|||+++++++-+.
T Consensus       250 dp~~Rps~~~~l~h~~~  266 (278)
T 3cok_A          250 NPADRLSLSSVLDHPFM  266 (278)
T ss_dssp             SGGGSCCHHHHTTSTTT
T ss_pred             CHhhCCCHHHHhcCccc
Confidence            99999999999987543

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.96  E-value=2.4e-29  Score=203.66  Aligned_cols=162  Identities=26%  Similarity=0.334  Sum_probs=118.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +.++.++.|++.||.|||+++   |+||||||+||+++.++.++|+|||++.......  .......|++.|+|||.+.+
T Consensus       110 ~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~  184 (345)
T 3a8x_A          110 EHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRG  184 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT--CCBCCCCSCGGGCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCCC--CcccccCCCccccCccccCC
Confidence            357789999999999999999   9999999999999999999999999987432211  12233568899999999999


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHH--HhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELA--LSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      ..++.++|+|||||++|+|++|..||........  ................ .    .+.     .....+.++|.+||
T Consensus       185 ~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~----~p~-----~~s~~~~~li~~lL  254 (345)
T 3a8x_A          185 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-R----IPR-----SLSVKAASVLKSFL  254 (345)
T ss_dssp             CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC-C----CCT-----TSCHHHHHHHHHHT
T ss_pred             CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC-C----CCC-----CCCHHHHHHHHHHh
Confidence            8899999999999999999999999964221110  0011111111111111 0    111     12346788999999


Q ss_pred             CCCCCCCCCH------HHHHHHhcC
Q 027675          160 QEDPNDRPTM------SDVVIMLGS  178 (220)
Q Consensus       160 ~~~p~~Rps~------~~~l~~l~~  178 (220)
                      +.||++||++      +++++|-+.
T Consensus       255 ~~dP~~R~~~~~~~~~~~i~~hp~f  279 (345)
T 3a8x_A          255 NKDPKERLGCHPQTGFADIQGHPFF  279 (345)
T ss_dssp             CSSTTTSTTCCTTTHHHHHHTSGGG
T ss_pred             cCCHhHCCCCCCcCCHHHHhcCCcc
Confidence            9999999995      788876543

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.96  E-value=1e-29  Score=200.61  Aligned_cols=160  Identities=28%  Similarity=0.361  Sum_probs=120.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCC-cccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD-GTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~y~aPe~~~   80 (220)
                      ..++.++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++......... .......++..|.|||.+.
T Consensus       121 ~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  197 (291)
T 1u46_A          121 GTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK  197 (291)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhc
Confidence            357889999999999999999   999999999999999999999999998765432211 1112234566899999999


Q ss_pred             cCCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           81 GGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      +..++.++|+||||+++|+|++ |..||...+......      ..........         ........+.++|.+||
T Consensus       198 ~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~------~~~~~~~~~~---------~~~~~~~~l~~li~~~l  262 (291)
T 1u46_A          198 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH------KIDKEGERLP---------RPEDCPQDIYNVMVQCW  262 (291)
T ss_dssp             HCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH------HHHTSCCCCC---------CCTTCCHHHHHHHHHHT
T ss_pred             CCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHH------HHHccCCCCC---------CCcCcCHHHHHHHHHHc
Confidence            8888999999999999999999 999997655433221      1111111110         11122346889999999


Q ss_pred             CCCCCCCCCHHHHHHHhcCc
Q 027675          160 QEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l~~~  179 (220)
                      ..||++|||+.++++.|...
T Consensus       263 ~~~p~~Rps~~~l~~~l~~~  282 (291)
T 1u46_A          263 AHKPEDRPTFVALRDFLLEA  282 (291)
T ss_dssp             CSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCcccCcCHHHHHHHHHHh
Confidence            99999999999999999655

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.96  E-value=3.1e-30  Score=204.71  Aligned_cols=166  Identities=21%  Similarity=0.305  Sum_probs=120.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCC-cccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD-GTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~y~aPe~~~   80 (220)
                      ..++.++.|++.||+|||+++   ++||||||+||+++.++.++|+|||++......... .......++..|.|||.+.
T Consensus       126 ~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  202 (302)
T 4e5w_A          126 KQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLM  202 (302)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeec
Confidence            357889999999999999999   999999999999999999999999998765432211 1122234566799999999


Q ss_pred             cCCCcccCceeehhHHHHHHHhcCccCcccchhHHH--------hhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHH
Q 027675           81 GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELAL--------SLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCI  152 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (220)
                      +..++.++|+||||+++|+|++|..|+.........        ............+....         ........+.
T Consensus       203 ~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~l~  273 (302)
T 4e5w_A          203 QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLP---------CPPNCPDEVY  273 (302)
T ss_dssp             HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCC---------CCTTCCHHHH
T ss_pred             CCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCCC---------CCCCCCHHHH
Confidence            988899999999999999999999886422111000        00011111111111111         1112234788


Q ss_pred             HHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          153 NVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       153 ~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      ++|.+||+.||++|||+.++++.|+..
T Consensus       274 ~li~~~l~~dp~~Rps~~~ll~~L~~l  300 (302)
T 4e5w_A          274 QLMRKCWEFQPSNRTSFQNLIEGFEAL  300 (302)
T ss_dssp             HHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence            999999999999999999999998653

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.96  E-value=2.5e-29  Score=202.18  Aligned_cols=154  Identities=23%  Similarity=0.270  Sum_probs=116.2

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .++.++.|++.||.|||++|   |+||||||+||+++.++.++|+|||++........  ......|++.|+|||.+.+.
T Consensus       122 ~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~  196 (327)
T 3a62_A          122 TACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHTFCGTIEYMAPEILMRS  196 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC------------CTTSSCCTTSCHHHHTTS
T ss_pred             HHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccccccCCc--cccccCCCcCccCHhhCcCC
Confidence            56789999999999999999   99999999999999999999999999864322111  12224578899999999988


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      .++.++|+||||+++|+|++|..||...+.......      .... ..     ..+.     .....+.++|.+||..|
T Consensus       197 ~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~------i~~~-~~-----~~p~-----~~~~~~~~li~~~L~~d  259 (327)
T 3a62_A          197 GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDK------ILKC-KL-----NLPP-----YLTQEARDLLKKLLKRN  259 (327)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH------HHHT-CC-----CCCT-----TSCHHHHHHHHHHSCSC
T ss_pred             CCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHH------HHhC-CC-----CCCC-----CCCHHHHHHHHHHHhcC
Confidence            889999999999999999999999976554332211      1111 10     0111     12346789999999999


Q ss_pred             CCCCC-----CHHHHHHHhcC
Q 027675          163 PNDRP-----TMSDVVIMLGS  178 (220)
Q Consensus       163 p~~Rp-----s~~~~l~~l~~  178 (220)
                      |++||     ++.++++|-+.
T Consensus       260 p~~R~~~~~~~~~e~l~hp~f  280 (327)
T 3a62_A          260 AASRLGAGPGDAGEVQAHPFF  280 (327)
T ss_dssp             GGGSTTSSTTTHHHHHHSGGG
T ss_pred             HhhccCCCCCCHHHHHcCCcc
Confidence            99999     88899987654

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.96  E-value=1.8e-29  Score=213.52  Aligned_cols=158  Identities=24%  Similarity=0.372  Sum_probs=121.6

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .++.++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++......... ......++..|+|||.+.+.
T Consensus       319 ~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~  394 (495)
T 1opk_A          319 VLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYN  394 (495)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE-CCTTCCCCGGGCCHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCcee-ecCCCcCCcceeCHhHHhcC
Confidence            56789999999999999999   999999999999999999999999998764322111 11112345689999999988


Q ss_pred             CCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           83 FFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      .++.++||||||+++|+|++ |..||...+......       ....+......         ......+.++|.+||+.
T Consensus       395 ~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~-------~~~~~~~~~~~---------~~~~~~l~~li~~cl~~  458 (495)
T 1opk_A          395 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-------LLEKDYRMERP---------EGCPEKVYELMRACWQW  458 (495)
T ss_dssp             EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-------HHHTTCCCCCC---------TTCCHHHHHHHHHHTCS
T ss_pred             CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHH-------HHHcCCCCCCC---------CCCCHHHHHHHHHHcCc
Confidence            89999999999999999998 999987654433221       11122111111         11234678899999999


Q ss_pred             CCCCCCCHHHHHHHhcCcc
Q 027675          162 DPNDRPTMSDVVIMLGSEA  180 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~~~~  180 (220)
                      ||++|||+.++++.|+...
T Consensus       459 dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          459 NPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             SGGGSCCHHHHHHHHHTSC
T ss_pred             ChhHCcCHHHHHHHHHHHH
Confidence            9999999999999997764

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.96  E-value=4.2e-29  Score=218.06  Aligned_cols=154  Identities=21%  Similarity=0.280  Sum_probs=120.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.||+.||+|||+++   |+||||||+|||++.++.++|+|||++.......  .......|++.|+|||++.+
T Consensus       442 ~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~  516 (674)
T 3pfq_A          442 PHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAY  516 (674)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCCTT--CCBCCCCSCSSSCCHHHHTC
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccccCC--cccccccCCCcccCHhhhcC
Confidence            357789999999999999999   9999999999999999999999999987533221  12333578999999999999


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+||||+++|||++|..||...+.......      +.. ...     ..+     ......+.++|.+||+.
T Consensus       517 ~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~------i~~-~~~-----~~p-----~~~s~~~~~li~~lL~~  579 (674)
T 3pfq_A          517 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS------IME-HNV-----AYP-----KSMSKEAVAICKGLMTK  579 (674)
T ss_dssp             CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HHS-SCC-----CCC-----TTSCHHHHHHHHHHSCS
T ss_pred             CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHH------HHh-CCC-----CCC-----ccCCHHHHHHHHHHccC
Confidence            9999999999999999999999999976554433221      111 110     011     11234678999999999


Q ss_pred             CCCCCCCH-----HHHHHHhc
Q 027675          162 DPNDRPTM-----SDVVIMLG  177 (220)
Q Consensus       162 ~p~~Rps~-----~~~l~~l~  177 (220)
                      ||++||++     ++|++|-+
T Consensus       580 dP~~R~~~~~~~~~ei~~h~f  600 (674)
T 3pfq_A          580 HPGKRLGCGPEGERDIKEHAF  600 (674)
T ss_dssp             SSTTCTTCSTTHHHHHHSSGG
T ss_pred             CHHHCCCCCCCcHHHHhcCcc
Confidence            99999998     88886643

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.96  E-value=1.8e-29  Score=206.09  Aligned_cols=170  Identities=23%  Similarity=0.290  Sum_probs=112.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+.|   ++||||||+||+++.++.++|+|||+++.....     .....++..|+|||.+.+
T Consensus       132 ~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~  203 (367)
T 2fst_X          132 DHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLN  203 (367)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC--------------------CCCTTCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccccccccc-----CCCcCcCcCccChHHHcC
Confidence            357889999999999999999   999999999999999999999999998754321     223467889999999987


Q ss_pred             -CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHH-----HHHHh---c---cccccccCCCCCcCc---HH
Q 027675           82 -GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAW-----KLWQE---G---KALDMMDQKPGAISK---AN  146 (220)
Q Consensus        82 -~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-----~~~~~---~---~~~~~~~~~~~~~~~---~~  146 (220)
                       ..++.++|||||||++|+|++|+.||...+.......+....     .....   .   .........+.....   ..
T Consensus       204 ~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (367)
T 2fst_X          204 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG  283 (367)
T ss_dssp             CCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTT
T ss_pred             CcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCC
Confidence             578999999999999999999999997655443322211100     00000   0   000000000000000   01


Q ss_pred             HHHHHHHHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          147 EILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       147 ~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      ....+.++|.+||..||++|||+.+++.+-+..
T Consensus       284 ~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~  316 (367)
T 2fst_X          284 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA  316 (367)
T ss_dssp             CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             CCHHHHHHHHHhCCCCcccCcCHHHHhcChhhh
Confidence            134678999999999999999999999875433

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.96  E-value=1.3e-29  Score=203.63  Aligned_cols=160  Identities=26%  Similarity=0.369  Sum_probs=119.2

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCC---CCceecCccceeeecCCCCCcccceeecccCccChhhh
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHE---MNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYA   79 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~   79 (220)
                      .++.++.|++.||.|||+.+   ++||||||+||+++.+   ..++|+|||++................+++.|.|||.+
T Consensus       141 ~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  217 (327)
T 2yfx_A          141 DLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF  217 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHH
T ss_pred             HHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHh
Confidence            57889999999999999999   9999999999999844   45999999998654322222222223567789999999


Q ss_pred             hcCCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           80 LGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        80 ~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                      .+..++.++|+||||+++|+|++ |..||...........       ...+.....    +     ......+.++|.+|
T Consensus       218 ~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-------~~~~~~~~~----~-----~~~~~~l~~li~~~  281 (327)
T 2yfx_A          218 MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF-------VTSGGRMDP----P-----KNCPGPVYRIMTQC  281 (327)
T ss_dssp             HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-------HHTTCCCCC----C-----TTCCHHHHHHHHHH
T ss_pred             cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHH-------HhcCCCCCC----C-----CCCCHHHHHHHHHH
Confidence            98889999999999999999998 9999875543332211       111111111    1     11224678899999


Q ss_pred             cCCCCCCCCCHHHHHHHhcCccc
Q 027675          159 VQEDPNDRPTMSDVVIMLGSEAV  181 (220)
Q Consensus       159 l~~~p~~Rps~~~~l~~l~~~~~  181 (220)
                      |+.||++||++.+++++|+....
T Consensus       282 l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          282 WQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             TCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hcCChhhCcCHHHHHHHHHHHhc
Confidence            99999999999999999976643

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.96  E-value=5.5e-29  Score=208.64  Aligned_cols=98  Identities=27%  Similarity=0.458  Sum_probs=79.6

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCC--------------------
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD--------------------   61 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~--------------------   61 (220)
                      ..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++........                    
T Consensus       156 ~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (458)
T 3rp9_A          156 LHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPH  232 (458)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccc
Confidence            357889999999999999999   999999999999999999999999999764321110                    


Q ss_pred             -----cccceeecccCccChhhh-hcCCCcccCceeehhHHHHHHHh
Q 027675           62 -----GTTNRVVGTYGYMSPEYA-LGGFFSVKSDVFSFGVVVLEIIS  102 (220)
Q Consensus        62 -----~~~~~~~~~~~y~aPe~~-~~~~~~~~~DiwslG~il~~ll~  102 (220)
                           .......+++.|+|||++ .+..++.++|||||||++|||++
T Consensus       233 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt  279 (458)
T 3rp9_A          233 TKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN  279 (458)
T ss_dssp             ------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred             cccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence                 112234678999999986 45668999999999999999998

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.96  E-value=1.5e-29  Score=199.52  Aligned_cols=157  Identities=26%  Similarity=0.414  Sum_probs=121.3

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .++.++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++........ .......++..|.|||.+.+.
T Consensus       112 ~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~  187 (288)
T 3kfa_A          112 VLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYN  187 (288)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS-EEETTEEECGGGCCHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCcc-ccccCCccccCcCChhhhccC
Confidence            56789999999999999999   99999999999999999999999999875443221 122223456789999999988


Q ss_pred             CCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           83 FFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      .++.++|+||||+++|+|++ |..||...+........       ........    +     ......+.+++.+||..
T Consensus       188 ~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~-------~~~~~~~~----~-----~~~~~~l~~li~~~l~~  251 (288)
T 3kfa_A          188 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-------EKDYRMER----P-----EGCPEKVYELMRACWQW  251 (288)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-------HTTCCCCC----C-----TTCCHHHHHHHHHHTCS
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------hccCCCCC----C-----CCCCHHHHHHHHHHhCC
Confidence            89999999999999999999 99998765443322111       11111111    1     11224688999999999


Q ss_pred             CCCCCCCHHHHHHHhcCc
Q 027675          162 DPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~~~  179 (220)
                      ||++|||+.++++.|+..
T Consensus       252 dp~~Rps~~~~~~~l~~~  269 (288)
T 3kfa_A          252 NPSDRPSFAEIHQAFETM  269 (288)
T ss_dssp             SGGGSCCHHHHHHHHHHH
T ss_pred             ChhhCcCHHHHHHHHHHH
Confidence            999999999999988655

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.96  E-value=3.8e-29  Score=202.84  Aligned_cols=160  Identities=22%  Similarity=0.313  Sum_probs=112.7

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCC---CCCceecCccceeeecCCCCCcccceeecccCccChhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDH---EMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEY   78 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~   78 (220)
                      .+++.++.|++.||.|||+.+   ++||||||+||+++.   ++.++|+|||++.......   ......+++.|+|||.
T Consensus       148 ~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~  221 (349)
T 2w4o_A          148 RDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---LMKTVCGTPGYCAPEI  221 (349)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-------------------CGGGSCHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCccc---ccccccCCCCccCHHH
Confidence            357889999999999999999   999999999999975   8889999999987543221   1223467889999999


Q ss_pred             hhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           79 ALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        79 ~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                      +.+..++.++|||||||++|+|++|..||.........      .......... ....     ........+.++|.+|
T Consensus       222 ~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------~~~i~~~~~~-~~~~-----~~~~~~~~~~~li~~~  289 (349)
T 2w4o_A          222 LRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM------FRRILNCEYY-FISP-----WWDEVSLNAKDLVRKL  289 (349)
T ss_dssp             HTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHH------HHHHHTTCCC-CCTT-----TTTTSCHHHHHHHHTT
T ss_pred             hcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHH------HHHHHhCCCc-cCCc-----hhhhCCHHHHHHHHHH
Confidence            99988999999999999999999999998644333211      0111111110 0000     0011234678999999


Q ss_pred             cCCCCCCCCCHHHHHHHhcCc
Q 027675          159 VQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       159 l~~~p~~Rps~~~~l~~l~~~  179 (220)
                      |+.||++|||+.+++++-+..
T Consensus       290 L~~dP~~Rpt~~e~l~hp~~~  310 (349)
T 2w4o_A          290 IVLDPKKRLTTFQALQHPWVT  310 (349)
T ss_dssp             SCSSGGGSCCHHHHHHSTTTT
T ss_pred             ccCChhhCcCHHHHhcCcccC
Confidence            999999999999999886544

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.96  E-value=2.9e-29  Score=205.77  Aligned_cols=156  Identities=26%  Similarity=0.370  Sum_probs=117.7

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||++|   |+||||||+||+++.++.++|+|||++.......   ......|++.|+|||.+.+
T Consensus       115 ~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~  188 (384)
T 4fr4_A          115 ETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET---QITTMAGTKPYMAPEMFSS  188 (384)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTC---CBCCCCSCGGGCCGGGTCC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCCC---ceeccCCCccccCCeeecc
Confidence            357889999999999999999   9999999999999999999999999997654322   2233568999999999864


Q ss_pred             ---CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           82 ---GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        82 ---~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                         ..++.++|+|||||++|+|++|..||..............    ......     ..+     ......+.++|.+|
T Consensus       189 ~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~----~~~~~~-----~~p-----~~~s~~~~~li~~l  254 (384)
T 4fr4_A          189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT----FETTVV-----TYP-----SAWSQEMVSLLKKL  254 (384)
T ss_dssp             CSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH----HHHCCC-----CCC-----TTSCHHHHHHHHHH
T ss_pred             CCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH----Hhhccc-----CCC-----CcCCHHHHHHHHHH
Confidence               4578999999999999999999999975433322211111    111100     011     11234788999999


Q ss_pred             cCCCCCCCCC-HHHHHHHhc
Q 027675          159 VQEDPNDRPT-MSDVVIMLG  177 (220)
Q Consensus       159 l~~~p~~Rps-~~~~l~~l~  177 (220)
                      |+.||++||+ +++++.+-+
T Consensus       255 L~~dP~~R~s~~~~l~~hp~  274 (384)
T 4fr4_A          255 LEPNPDQRFSQLSDVQNFPY  274 (384)
T ss_dssp             SCSSGGGSCCSHHHHHTSGG
T ss_pred             hcCCHhHhcccHHHHHcChh
Confidence            9999999998 788886543

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.96  E-value=7.7e-29  Score=197.75  Aligned_cols=157  Identities=24%  Similarity=0.330  Sum_probs=120.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.+++.||.|||+.|   ++|+||||+||+++.++.++|+|||++........  ......++..|.|||.+.+
T Consensus       125 ~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~  199 (314)
T 3com_A          125 DEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQE  199 (314)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS--CBCCCCSCGGGCCHHHHSS
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc--ccCccCCCCCccChhhcCC
Confidence            357889999999999999999   99999999999999999999999999876543221  1223457889999999998


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+||||+++|+|++|..||...........       ......       +...........+.++|.+||..
T Consensus       200 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------~~~~~~-------~~~~~~~~~~~~l~~li~~~l~~  265 (314)
T 3com_A          200 IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFM-------IPTNPP-------PTFRKPELWSDNFTDFVKQCLVK  265 (314)
T ss_dssp             SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-------HHHSCC-------CCCSSGGGSCHHHHHHHHHHTCS
T ss_pred             CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHH-------HhcCCC-------cccCCcccCCHHHHHHHHHHccC
Confidence            8899999999999999999999999975443322111       111110       00111111234688999999999


Q ss_pred             CCCCCCCHHHHHHHhc
Q 027675          162 DPNDRPTMSDVVIMLG  177 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~  177 (220)
                      ||++|||+.+++++-+
T Consensus       266 dp~~Rpt~~~ll~~~~  281 (314)
T 3com_A          266 SPEQRATATQLLQHPF  281 (314)
T ss_dssp             CTTTSCCHHHHTTSHH
T ss_pred             ChhhCcCHHHHHhCHH
Confidence            9999999999997653

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.96  E-value=1.1e-28  Score=205.34  Aligned_cols=162  Identities=20%  Similarity=0.199  Sum_probs=120.1

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhh-
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL-   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~-   80 (220)
                      ..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++........ .......|++.|+|||++. 
T Consensus       175 ~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~  250 (437)
T 4aw2_A          175 EMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQA  250 (437)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC-cccccccCCcCeeChHHHhh
Confidence            356789999999999999999   99999999999999999999999999875443221 1122246899999999987 


Q ss_pred             ----cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhc
Q 027675           81 ----GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGL  156 (220)
Q Consensus        81 ----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  156 (220)
                          +..++.++|+|||||++|+|++|+.||...+.......+      .............  .    .....+.++|.
T Consensus       251 ~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i------~~~~~~~~~p~~~--~----~~s~~~~dLi~  318 (437)
T 4aw2_A          251 MEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI------MNHKERFQFPTQV--T----DVSENAKDLIR  318 (437)
T ss_dssp             HHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HTHHHHCCCCSSC--C----CSCHHHHHHHH
T ss_pred             cccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhh------hhccccccCCccc--c----cCCHHHHHHHH
Confidence                456789999999999999999999999765543332211      1111111111110  0    12336788999


Q ss_pred             cccCCCCCC--CCCHHHHHHHhcCc
Q 027675          157 LCVQEDPND--RPTMSDVVIMLGSE  179 (220)
Q Consensus       157 ~cl~~~p~~--Rps~~~~l~~l~~~  179 (220)
                      +||..+|++  ||+++++++|-+..
T Consensus       319 ~lL~~~~~r~~r~~~~eil~Hpff~  343 (437)
T 4aw2_A          319 RLICSREHRLGQNGIEDFKKHPFFS  343 (437)
T ss_dssp             TTSSCGGGCTTTTTTHHHHTSGGGT
T ss_pred             HHhcccccccCCCCHHHHhCCCccC
Confidence            999999998  99999999876443

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.96  E-value=1.6e-29  Score=204.55  Aligned_cols=162  Identities=20%  Similarity=0.252  Sum_probs=117.9

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCC-C---CceecCccceeeecCCCCCcccceeecccCccChh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHE-M---NPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPE   77 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~-~---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe   77 (220)
                      ..++.++.|++.||.|||++|   |+||||||+||++.+. +   .++|+|||++........  ......+++.|+|||
T Consensus       116 ~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE  190 (342)
T 2qr7_A          116 REASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG--LLMTPCYTANFVAPE  190 (342)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC--CBCCSSCCSSCCCHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC--ceeccCCCccccCHH
Confidence            357889999999999999999   9999999999998543 3   489999999876543221  122245688999999


Q ss_pred             hhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcc
Q 027675           78 YALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLL  157 (220)
Q Consensus        78 ~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  157 (220)
                      .+.+..++.++|+|||||++|+|++|..||............    .....+... ...     .........+.++|.+
T Consensus       191 ~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~----~~i~~~~~~-~~~-----~~~~~~s~~~~~li~~  260 (342)
T 2qr7_A          191 VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL----ARIGSGKFS-LSG-----GYWNSVSDTAKDLVSK  260 (342)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH----HHHHHCCCC-CCS-----TTTTTSCHHHHHHHHH
T ss_pred             HhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH----HHHccCCcc-cCc-----cccccCCHHHHHHHHH
Confidence            998877889999999999999999999999753322222111    111111111 000     0011123467899999


Q ss_pred             ccCCCCCCCCCHHHHHHHhcC
Q 027675          158 CVQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       158 cl~~~p~~Rps~~~~l~~l~~  178 (220)
                      ||..||++||++.+++++-+.
T Consensus       261 ~L~~dP~~R~t~~~il~hp~~  281 (342)
T 2qr7_A          261 MLHVDPHQRLTAALVLRHPWI  281 (342)
T ss_dssp             HTCSSTTTSCCHHHHTTSHHH
T ss_pred             HCCCChhHCcCHHHHhcCCee
Confidence            999999999999999976543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.96  E-value=1.1e-29  Score=204.44  Aligned_cols=171  Identities=20%  Similarity=0.297  Sum_probs=117.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++........  ......++..|+|||.+.+
T Consensus       124 ~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~  198 (331)
T 4aaa_A          124 QVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVATRWYRAPELLVG  198 (331)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC--------------CCCCCTTCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCcc--ccCCCcCCccccCcccccC
Confidence            457889999999999999999   99999999999999999999999999875432211  1222457889999999987


Q ss_pred             C-CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHH--------HHHHHhccccccccC-CCCCcCc-----HH
Q 027675           82 G-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA--------WKLWQEGKALDMMDQ-KPGAISK-----AN  146 (220)
Q Consensus        82 ~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~-~~~~~~~-----~~  146 (220)
                      . .++.++|+||||+++|+|++|..||...............        ...+........... .......     ..
T Consensus       199 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (331)
T 4aaa_A          199 DVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPK  278 (331)
T ss_dssp             CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTT
T ss_pred             CCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccc
Confidence            5 6789999999999999999999999765544322211100        111111111000000 0000000     12


Q ss_pred             HHHHHHHHhccccCCCCCCCCCHHHHHHHhc
Q 027675          147 EILKCINVGLLCVQEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       147 ~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~  177 (220)
                      ....+.++|.+||+.||++|||+.+++++-+
T Consensus       279 ~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~  309 (331)
T 4aaa_A          279 LSEVVIDLAKKCLHIDPDKRPFCAELLHHDF  309 (331)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred             hhHHHHHHHHHHhccCcccCCCHHHHhcCch
Confidence            2457889999999999999999999997643

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.96  E-value=8.3e-30  Score=204.79  Aligned_cols=167  Identities=21%  Similarity=0.219  Sum_probs=102.7

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCC---CceecCccceeeecCCCCCcccceeecccCccChhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEM---NPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEY   78 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~   78 (220)
                      .+++.++.|++.||.|||+++   ++||||||+||+++.++   .++|+|||++........  ......+++.|+|||.
T Consensus       106 ~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~  180 (325)
T 3kn6_A          106 TEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PLKTPCFTLHYAAPEL  180 (325)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC---------------------
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--cccccCCCcCccCHHH
Confidence            357889999999999999999   99999999999997665   699999999875443221  1222456889999999


Q ss_pred             hhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           79 ALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        79 ~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                      +.+..++.++||||||+++|+|++|..||...+.................+..      .............+.++|.+|
T Consensus       181 ~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~------~~~~~~~~~~s~~~~~li~~~  254 (325)
T 3kn6_A          181 LNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF------SFEGEAWKNVSQEAKDLIQGL  254 (325)
T ss_dssp             ---CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC------CCCSHHHHTSCHHHHHHHHHH
T ss_pred             hcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC------CCCcccccCCCHHHHHHHHHH
Confidence            99988999999999999999999999999754332111111111111111111      001111112345788999999


Q ss_pred             cCCCCCCCCCHHHHHHHhcCc
Q 027675          159 VQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       159 l~~~p~~Rps~~~~l~~l~~~  179 (220)
                      |..||++|||+.+++++-+..
T Consensus       255 L~~dP~~Rpt~~ell~h~w~~  275 (325)
T 3kn6_A          255 LTVDPNKRLKMSGLRYNEWLQ  275 (325)
T ss_dssp             HCCCTTTCCCTTTSTTCGGGC
T ss_pred             CCCChhHCCCHHHHhcChhhc
Confidence            999999999999999776543

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.95  E-value=1.2e-29  Score=206.64  Aligned_cols=160  Identities=21%  Similarity=0.217  Sum_probs=109.2

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCC--ceecCccceeeecCCCCCcccceeecccCccChhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMN--PKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYA   79 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~   79 (220)
                      ..++.++.|++.||.|||++|   |+||||||+||+++.++.  ++|+|||++.......   ......+++.|+|||.+
T Consensus       116 ~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~  189 (361)
T 3uc3_A          116 DEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVL  189 (361)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------------------CTTSCHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccccC---CCCCCcCCCCcCChhhh
Confidence            367889999999999999999   999999999999987765  9999999986432211   12234678999999999


Q ss_pred             hcCCCccc-CceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           80 LGGFFSVK-SDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        80 ~~~~~~~~-~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                      .+..+..+ +|||||||++|+|++|..||.........  ............         ...........+.++|.+|
T Consensus       190 ~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--~~~~~~~~~~~~---------~~~~~~~~s~~~~~li~~~  258 (361)
T 3uc3_A          190 LRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY--RKTIQRILSVKY---------SIPDDIRISPECCHLISRI  258 (361)
T ss_dssp             HCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH--HHHHHHHHTTCC---------CCCTTSCCCHHHHHHHHHH
T ss_pred             cCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH--HHHHHHHhcCCC---------CCCCcCCCCHHHHHHHHHH
Confidence            88777555 89999999999999999999754332111  111111111100         0000111234678999999


Q ss_pred             cCCCCCCCCCHHHHHHHhcC
Q 027675          159 VQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       159 l~~~p~~Rps~~~~l~~l~~  178 (220)
                      |..||++|||+.++++|-+.
T Consensus       259 L~~dP~~Rps~~ell~hp~f  278 (361)
T 3uc3_A          259 FVADPATRISIPEIKTHSWF  278 (361)
T ss_dssp             SCSCTTTSCCHHHHHTSHHH
T ss_pred             ccCChhHCcCHHHHHhCcch
Confidence            99999999999999987544

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.95  E-value=4.8e-29  Score=196.01  Aligned_cols=155  Identities=23%  Similarity=0.348  Sum_probs=119.2

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .++.++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++........   .....+++.|.|||.+.+.
T Consensus       123 ~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~  196 (284)
T 2a19_B          123 LALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQ  196 (284)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCS
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEEECcchhheecccccc---ccccCCcccccChhhhccC
Confidence            57889999999999999999   99999999999999999999999999876543221   1224578899999999998


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      .++.++|+||||+++|+|++|..|+.....         .......+..        ...    ....+.++|.+||..|
T Consensus       197 ~~~~~~Di~slG~il~~l~~~~~~~~~~~~---------~~~~~~~~~~--------~~~----~~~~~~~li~~~l~~d  255 (284)
T 2a19_B          197 DYGKEVDLYALGLILAELLHVCDTAFETSK---------FFTDLRDGII--------SDI----FDKKEKTLLQKLLSKK  255 (284)
T ss_dssp             CCCTHHHHHHHHHHHHHHHSCCSSHHHHHH---------HHHHHHTTCC--------CTT----SCHHHHHHHHHHTCSS
T ss_pred             CCcchhhhHHHHHHHHHHHhcCCcchhHHH---------HHHHhhcccc--------ccc----CCHHHHHHHHHHccCC
Confidence            899999999999999999999988632110         0011111111        111    1235778999999999


Q ss_pred             CCCCCCHHHHHHHhcCccccCC
Q 027675          163 PNDRPTMSDVVIMLGSEAVNLA  184 (220)
Q Consensus       163 p~~Rps~~~~l~~l~~~~~~~~  184 (220)
                      |++|||+.+++++|+.......
T Consensus       256 p~~Rps~~e~l~~l~~~~~~~~  277 (284)
T 2a19_B          256 PEDRPNTSEILRTLTVWKKSPE  277 (284)
T ss_dssp             GGGSCCHHHHHHHHHHHTC---
T ss_pred             hhhCcCHHHHHHHHHHHhhCCC
Confidence            9999999999999987755443

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.95  E-value=5.1e-29  Score=209.43  Aligned_cols=152  Identities=25%  Similarity=0.387  Sum_probs=118.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +.++.++.|++.||.|||+++   |+||||||+||+++.++.++|+|||++.......   ......|++.|+|||.+.+
T Consensus       116 ~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~  189 (476)
T 2y94_A          116 KESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISG  189 (476)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTTC---CBCCCCSCSTTCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccccc---cccccCCCcCeEChhhccC
Confidence            357889999999999999999   9999999999999999999999999987654322   1223467899999999988


Q ss_pred             CCC-cccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFF-SVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..+ +.++|+|||||++|+|++|..||...+......      +.. .+..     ..+.     .....+.++|.+||+
T Consensus       190 ~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~------~i~-~~~~-----~~p~-----~~s~~~~~Li~~~L~  252 (476)
T 2y94_A          190 RLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFK------KIC-DGIF-----YTPQ-----YLNPSVISLLKHMLQ  252 (476)
T ss_dssp             CCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHH------HHH-TTCC-----CCCT-----TCCHHHHHHHHHHTC
T ss_pred             CCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHH------HHh-cCCc-----CCCc-----cCCHHHHHHHHHHcC
Confidence            765 689999999999999999999997544332221      111 1110     0111     112367889999999


Q ss_pred             CCCCCCCCHHHHHHHh
Q 027675          161 EDPNDRPTMSDVVIML  176 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l  176 (220)
                      .||++|||+++++++-
T Consensus       253 ~dP~~Rpt~~eil~hp  268 (476)
T 2y94_A          253 VDPMKRATIKDIREHE  268 (476)
T ss_dssp             SSTTTSCCHHHHHTCH
T ss_pred             CCchhCcCHHHHHhCH
Confidence            9999999999999754

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.95  E-value=8.3e-29  Score=198.87  Aligned_cols=170  Identities=17%  Similarity=0.201  Sum_probs=118.1

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCC-CceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEM-NPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .++.++.|++.||.|||+++   ++||||||+||+++.++ .++|+|||++........   .....++..|.|||.+.+
T Consensus       131 ~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~  204 (330)
T 3nsz_A          131 DIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVD  204 (330)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSCGGGCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc---cccccccccccChhhhcC
Confidence            57889999999999999999   99999999999998777 799999999976543222   222457888999999987


Q ss_pred             -CCCcccCceeehhHHHHHHHhcCccCcccchh-HHHhhH-HH-----HHHHHHhcc--------------ccccccCCC
Q 027675           82 -GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSE-LALSLL-GY-----AWKLWQEGK--------------ALDMMDQKP  139 (220)
Q Consensus        82 -~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~-~~~~~~-~~-----~~~~~~~~~--------------~~~~~~~~~  139 (220)
                       ..++.++|||||||++|+|++|..||...... ...... ..     .........              .........
T Consensus       205 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (330)
T 3nsz_A          205 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFV  284 (330)
T ss_dssp             CCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGC
T ss_pred             CCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhc
Confidence             56899999999999999999999998433222 111110 00     000000000              000000000


Q ss_pred             CCcCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcC
Q 027675          140 GAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       140 ~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~  178 (220)
                      ...........+.++|.+||+.||++|||+++++++-+.
T Consensus       285 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  323 (330)
T 3nsz_A          285 HSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF  323 (330)
T ss_dssp             CTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGG
T ss_pred             cccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccH
Confidence            111111134578899999999999999999999987543

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.95  E-value=4.1e-29  Score=196.98  Aligned_cols=158  Identities=24%  Similarity=0.426  Sum_probs=118.1

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCC-----ceecCccceeeecCCCCCcccceeecccCccCh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMN-----PKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSP   76 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~-----~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aP   76 (220)
                      ..++.++.|++.||.|||+++ .+++||||||+||+++.++.     ++|+|||++.....     ......+++.|+||
T Consensus       122 ~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aP  195 (287)
T 4f0f_A          122 SVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAP  195 (287)
T ss_dssp             HHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS-----CEECCCCCCTTSCG
T ss_pred             HHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCCccccccc-----cccccCCCccccCc
Confidence            357889999999999999985 23999999999999988776     99999999864322     12234678899999


Q ss_pred             hhhh--cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHH
Q 027675           77 EYAL--GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINV  154 (220)
Q Consensus        77 e~~~--~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  154 (220)
                      |.+.  +..++.++|+||||+++|+|++|..||............    .....+.....         .......+.++
T Consensus       196 E~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~----~~~~~~~~~~~---------~~~~~~~l~~l  262 (287)
T 4f0f_A          196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFIN----MIREEGLRPTI---------PEDCPPRLRNV  262 (287)
T ss_dssp             GGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHH----HHHHSCCCCCC---------CTTSCHHHHHH
T ss_pred             hhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHH----HHhccCCCCCC---------CcccCHHHHHH
Confidence            9984  445688999999999999999999999755433321111    11111111111         11123478899


Q ss_pred             hccccCCCCCCCCCHHHHHHHhcC
Q 027675          155 GLLCVQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       155 i~~cl~~~p~~Rps~~~~l~~l~~  178 (220)
                      |.+||+.||++|||++++++.|+.
T Consensus       263 i~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          263 IELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             HHHHhcCChhhCcCHHHHHHHHHh
Confidence            999999999999999999999864

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.95  E-value=3e-29  Score=205.02  Aligned_cols=152  Identities=22%  Similarity=0.223  Sum_probs=116.8

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .++.++.|++.||+|||++|   |+||||||+||+++.+|.++|+|||++.......  .......|++.|+|||.+.+.
T Consensus       140 ~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~  214 (373)
T 2r5t_A          140 RARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--STTSTFCGTPEYLAPEVLHKQ  214 (373)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC--CCCCSBSCCCCCCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccCC--CccccccCCccccCHHHhCCC
Confidence            56779999999999999999   9999999999999999999999999986432211  122335689999999999998


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      .++.++|+|||||++|+|++|..||...+.......      ... +..    .. +.     .....+.++|.+||+.|
T Consensus       215 ~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~------i~~-~~~----~~-~~-----~~~~~~~~li~~lL~~d  277 (373)
T 2r5t_A          215 PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN------ILN-KPL----QL-KP-----NITNSARHLLEGLLQKD  277 (373)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHH------HHH-SCC----CC-CS-----SSCHHHHHHHHHHTCSS
T ss_pred             CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHH------HHh-ccc----CC-CC-----CCCHHHHHHHHHHcccC
Confidence            899999999999999999999999975544332211      111 110    00 11     12236788999999999


Q ss_pred             CCCCCCH----HHHHHHh
Q 027675          163 PNDRPTM----SDVVIML  176 (220)
Q Consensus       163 p~~Rps~----~~~l~~l  176 (220)
                      |++||++    .+++.|-
T Consensus       278 p~~R~~~~~~~~~i~~h~  295 (373)
T 2r5t_A          278 RTKRLGAKDDFMEIKSHV  295 (373)
T ss_dssp             GGGSTTTTTTHHHHHTSG
T ss_pred             HHhCCCCCCCHHHHhCCc
Confidence            9999997    4666554

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.95  E-value=1.1e-29  Score=198.03  Aligned_cols=159  Identities=31%  Similarity=0.411  Sum_probs=120.2

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++......... ......++..|.|||.+.+
T Consensus       104 ~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~  179 (267)
T 3t9t_A          104 ETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSF  179 (267)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH-STTSTTCCGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccccc-ccccccccccccChhhhcC
Confidence            357889999999999999999   999999999999999999999999998654321100 1111234567999999998


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|+||||+++|+|++ |..||...........       ...+....    .+.     .....+.+++.+||+
T Consensus       180 ~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-------i~~~~~~~----~~~-----~~~~~l~~li~~~l~  243 (267)
T 3t9t_A          180 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED-------ISTGFRLY----KPR-----LASTHVYQIMNHCWR  243 (267)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-------HHTTCCCC----CCT-----TSCHHHHHHHHHHTC
T ss_pred             CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHH-------HhcCCcCC----CCc-----cCcHHHHHHHHHHcc
Confidence            889999999999999999999 8999875543332211       11111110    011     123467889999999


Q ss_pred             CCCCCCCCHHHHHHHhcCcc
Q 027675          161 EDPNDRPTMSDVVIMLGSEA  180 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~~  180 (220)
                      .||++||++.+++++|+...
T Consensus       244 ~~p~~Rps~~~ll~~L~~l~  263 (267)
T 3t9t_A          244 ERPEDRPAFSRLLRQLAEIA  263 (267)
T ss_dssp             SSGGGSCCHHHHHHHHHHHH
T ss_pred             CChhhCcCHHHHHHHHHHHH
Confidence            99999999999999997653

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.95  E-value=2e-29  Score=200.84  Aligned_cols=164  Identities=24%  Similarity=0.346  Sum_probs=113.4

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++........  ......++..|.|||.+.+.
T Consensus       137 ~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~  211 (310)
T 2wqm_A          137 TVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHEN  211 (310)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------------------CCSSCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCc--cccccCCCeeEeChHHhCCC
Confidence            57889999999999999999   99999999999999999999999999875433211  12224578899999999988


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      .++.++|+||||+++|+|++|..||.........    .. ...........    ..    ......+.+++.+||+.|
T Consensus       212 ~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~----~~-~~~~~~~~~~~----~~----~~~~~~l~~li~~~l~~d  278 (310)
T 2wqm_A          212 GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS----LC-KKIEQCDYPPL----PS----DHYSEELRQLVNMCINPD  278 (310)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHH----HH-HHHHTTCSCCC----CT----TTSCHHHHHHHHHHTCSS
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCCcccchhHHH----HH-HHhhcccCCCC----cc----cccCHHHHHHHHHHcCCC
Confidence            8999999999999999999999998543221111    00 11111111110    00    112336788999999999


Q ss_pred             CCCCCCHHHHHHHhcCccccCC
Q 027675          163 PNDRPTMSDVVIMLGSEAVNLA  184 (220)
Q Consensus       163 p~~Rps~~~~l~~l~~~~~~~~  184 (220)
                      |++|||+.++++.|+.......
T Consensus       279 p~~Rps~~~il~~l~~l~~~~~  300 (310)
T 2wqm_A          279 PEKRPDVTYVYDVAKRMHACTA  300 (310)
T ss_dssp             GGGSCCHHHHHHHHHHHHHHHC
T ss_pred             hhhCCCHHHHHHHHHHHHHhhh
Confidence            9999999999999977644333

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.95  E-value=2.7e-29  Score=202.51  Aligned_cols=171  Identities=22%  Similarity=0.237  Sum_probs=120.9

Q ss_pred             chHHHHHHHHHHHHHHhh--------hCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCc--ccceeeccc
Q 027675            2 EMLFNIILGVSRRLLYLH--------QDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG--TTNRVVGTY   71 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH--------~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~   71 (220)
                      +.++.++.|++.||.|||        +.+   ++||||||+||+++.++.++|+|||++..........  ......+++
T Consensus       139 ~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~  215 (342)
T 1b6c_B          139 EGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK  215 (342)
T ss_dssp             HHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCG
T ss_pred             HHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCc
Confidence            467899999999999999        888   9999999999999999999999999987654332111  112346788


Q ss_pred             CccChhhhhcCC------CcccCceeehhHHHHHHHhc----------CccCcccchhHHHhhHHHHHHHHHhccccccc
Q 027675           72 GYMSPEYALGGF------FSVKSDVFSFGVVVLEIISG----------KRNTGFYNSELALSLLGYAWKLWQEGKALDMM  135 (220)
Q Consensus        72 ~y~aPe~~~~~~------~~~~~DiwslG~il~~ll~g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  135 (220)
                      .|.|||.+.+..      ++.++||||||+++|+|++|          ..||.........  ..............   
T Consensus       216 ~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~--~~~~~~~~~~~~~~---  290 (342)
T 1b6c_B          216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS--VEEMRKVVCEQKLR---  290 (342)
T ss_dssp             GGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC--HHHHHHHHTTSCCC---
T ss_pred             ccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCccc--HHHHHHHHHHHHhC---
Confidence            999999997752      33689999999999999999          5666432211100  00011111111110   


Q ss_pred             cCCCCCcCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcCcc
Q 027675          136 DQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEA  180 (220)
Q Consensus       136 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~~  180 (220)
                      ...+...........+.++|.+||+.||++|||+.+++++|+...
T Consensus       291 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~  335 (342)
T 1b6c_B          291 PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  335 (342)
T ss_dssp             CCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence            001111122355668899999999999999999999999997663

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.95  E-value=6.2e-30  Score=205.41  Aligned_cols=166  Identities=25%  Similarity=0.318  Sum_probs=120.5

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCc-ccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG-TTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~y~aPe~~~   80 (220)
                      .+++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.......... ......++..|.|||.+.
T Consensus       145 ~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  221 (326)
T 2w1i_A          145 IKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT  221 (326)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhc
Confidence            357889999999999999999   9999999999999999999999999987654322111 111223456799999999


Q ss_pred             cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHh---------hHHHHHHHHHhccccccccCCCCCcCcHHHHHHH
Q 027675           81 GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALS---------LLGYAWKLWQEGKALDMMDQKPGAISKANEILKC  151 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (220)
                      +..++.++|+||||+++|+|++|..|+..........         ...........+.....         .......+
T Consensus       222 ~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~l  292 (326)
T 2w1i_A          222 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR---------PDGCPDEI  292 (326)
T ss_dssp             HCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCC---------CTTCCHHH
T ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCC---------CCcccHHH
Confidence            8888999999999999999999998875322111100         00011111111111111         11123468


Q ss_pred             HHHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          152 INVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       152 ~~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      .++|.+||+.||++|||+.++++.|+..
T Consensus       293 ~~li~~cl~~dP~~Rps~~el~~~L~~l  320 (326)
T 2w1i_A          293 YMIMTECWNNNVNQRPSFRDLALRVDQI  320 (326)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            8999999999999999999999998765

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.95  E-value=5.1e-29  Score=196.51  Aligned_cols=154  Identities=23%  Similarity=0.349  Sum_probs=112.4

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceee---CCCCCceecCccceeeecCCCCCcccceeecccCccChhhh
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILL---DHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYA   79 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~   79 (220)
                      .++.++.|++.||+|||+.+   ++||||||+||++   +.++.++|+|||++.......   ......+++.|+|||.+
T Consensus       125 ~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~  198 (285)
T 3is5_A          125 YVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE---HSTNAAGTALYMAPEVF  198 (285)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-------------CTTGGGCCHHHH
T ss_pred             HHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc---cCcCcccccCcCChHHh
Confidence            57889999999999999999   9999999999999   456779999999987543321   12234678899999988


Q ss_pred             hcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           80 LGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        80 ~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      .+ .++.++|+||||+++|+|++|..||..............      ..... ...   ...    ....+.+++.+||
T Consensus       199 ~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~------~~~~~-~~~---~~~----~~~~~~~li~~~L  263 (285)
T 3is5_A          199 KR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY------KEPNY-AVE---CRP----LTPQAVDLLKQML  263 (285)
T ss_dssp             TT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------CCCCC-CC-----CC----CCHHHHHHHHHHT
T ss_pred             cc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhcc------CCccc-ccc---cCc----CCHHHHHHHHHHc
Confidence            64 578999999999999999999999976554433221111      11000 000   000    1236778999999


Q ss_pred             CCCCCCCCCHHHHHHHhc
Q 027675          160 QEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l~  177 (220)
                      +.||++|||+.+++++-+
T Consensus       264 ~~dP~~Rps~~e~l~hp~  281 (285)
T 3is5_A          264 TKDPERRPSAAQVLHHEW  281 (285)
T ss_dssp             CSCTTTSCCHHHHHTSGG
T ss_pred             cCChhhCcCHHHHhcCHH
Confidence            999999999999997643

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.95  E-value=4.6e-29  Score=198.17  Aligned_cols=156  Identities=25%  Similarity=0.381  Sum_probs=121.0

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++........  ......++..|.|||.+.+
T Consensus       119 ~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~  193 (303)
T 3a7i_A          119 TQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQ  193 (303)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC--CBCCCCSCGGGCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcccc--ccCccCCCcCccCHHHHhc
Confidence            357889999999999999999   99999999999999999999999999876543221  1223467889999999999


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+||||+++|+|++|..||...........       ...+.....     ..    .....+.+++.+||..
T Consensus       194 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------~~~~~~~~~-----~~----~~~~~l~~li~~~l~~  257 (303)
T 3a7i_A          194 SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL-------IPKNNPPTL-----EG----NYSKPLKEFVEACLNK  257 (303)
T ss_dssp             CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-------HHHSCCCCC-----CS----SCCHHHHHHHHHHCCS
T ss_pred             CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHH-------hhcCCCCCC-----cc----ccCHHHHHHHHHHcCC
Confidence            8889999999999999999999999975544332211       111111110     11    1223678999999999


Q ss_pred             CCCCCCCHHHHHHHhcC
Q 027675          162 DPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~~  178 (220)
                      ||++|||+.+++++.+.
T Consensus       258 dp~~Rps~~~ll~~~~~  274 (303)
T 3a7i_A          258 EPSFRPTAKELLKHKFI  274 (303)
T ss_dssp             SGGGSCCHHHHTTCHHH
T ss_pred             ChhhCcCHHHHhhChhh
Confidence            99999999999987643

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.95  E-value=1.3e-28  Score=193.09  Aligned_cols=156  Identities=22%  Similarity=0.235  Sum_probs=118.0

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceee---CCCCCceecCccceeeecCCCCCcccceeecccCccChhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILL---DHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEY   78 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~   78 (220)
                      ..++.++.|++.||.|||+++   ++|+||||+||++   +.++.++|+|||++........   .....+++.|+|||.
T Consensus       106 ~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~  179 (277)
T 3f3z_A          106 SDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---MRTKVGTPYYVSPQV  179 (277)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc---hhccCCCCCccChHH
Confidence            357889999999999999999   9999999999999   7888999999999876543221   222467889999999


Q ss_pred             hhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           79 ALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        79 ~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                      +.+. ++.++|+||||+++|+|++|..||............       ..+...      ............+.++|.+|
T Consensus       180 ~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-------~~~~~~------~~~~~~~~~~~~~~~li~~~  245 (277)
T 3f3z_A          180 LEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI-------REGTFT------FPEKDWLNVSPQAESLIRRL  245 (277)
T ss_dssp             HTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHCCCC------CCHHHHTTSCHHHHHHHHHH
T ss_pred             hccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHH-------HhCCCC------CCchhhhcCCHHHHHHHHHH
Confidence            8765 889999999999999999999999765443322111       111110      00000001234778999999


Q ss_pred             cCCCCCCCCCHHHHHHHhc
Q 027675          159 VQEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       159 l~~~p~~Rps~~~~l~~l~  177 (220)
                      |+.||++|||+.+++++-+
T Consensus       246 l~~dp~~R~s~~~~l~h~~  264 (277)
T 3f3z_A          246 LTKSPKQRITSLQALEHEW  264 (277)
T ss_dssp             TCSSTTTSCCHHHHTTSHH
T ss_pred             ccCChhhCcCHHHHhcCHH
Confidence            9999999999999997643

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.95  E-value=2e-28  Score=202.37  Aligned_cols=161  Identities=21%  Similarity=0.204  Sum_probs=120.6

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .++.++.|++.||+|||+++   |+||||||+||+++.++.++|+|||++........ .......|++.|+|||++.+.
T Consensus       169 ~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~  244 (410)
T 3v8s_A          169 WARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQ  244 (410)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeeccCCc-ccccCCcCCccccCHHHhhcc
Confidence            56789999999999999999   99999999999999999999999999876443221 112235689999999999876


Q ss_pred             C----CcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           83 F----FSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        83 ~----~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                      .    ++.++|+|||||++|+|++|..||...+.......+      .........   ....    .....+.++|.+|
T Consensus       245 ~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i------~~~~~~~~~---p~~~----~~s~~~~~li~~l  311 (410)
T 3v8s_A          245 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI------MNHKNSLTF---PDDN----DISKEAKNLICAF  311 (410)
T ss_dssp             TTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HTHHHHCCC---CTTC----CCCHHHHHHHHHH
T ss_pred             CCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHH------HhccccccC---CCcc----cccHHHHHHHHHH
Confidence            5    788999999999999999999999755443322111      111000001   1111    1223678899999


Q ss_pred             cCCCCCC--CCCHHHHHHHhcCcc
Q 027675          159 VQEDPND--RPTMSDVVIMLGSEA  180 (220)
Q Consensus       159 l~~~p~~--Rps~~~~l~~l~~~~  180 (220)
                      |+.+|.+  ||+++++++|-+...
T Consensus       312 L~~~~~rlgR~~~~ei~~Hp~f~~  335 (410)
T 3v8s_A          312 LTDREVRLGRNGVEEIKRHLFFKN  335 (410)
T ss_dssp             SSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred             ccChhhhCCCCCHHHHhcCccccC
Confidence            9999999  999999998865543

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.95  E-value=3.4e-29  Score=205.43  Aligned_cols=171  Identities=19%  Similarity=0.178  Sum_probs=119.7

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeC-CCCCceecCccceeeecCCCCCcccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLD-HEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~   80 (220)
                      ..++.++.|++.||.|||+.|   |+||||||+||+++ .++.++|+|||++........   .....++..|+|||.+.
T Consensus       141 ~~~~~i~~qi~~aL~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~  214 (383)
T 3eb0_A          141 NLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELML  214 (383)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHT
T ss_pred             HHHHHHHHHHHHHHHHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhc
Confidence            357789999999999999999   99999999999997 688899999999976543221   22245688999999988


Q ss_pred             cC-CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHH------HHHHhccccccccCCCCCc------CcHHH
Q 027675           81 GG-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAW------KLWQEGKALDMMDQKPGAI------SKANE  147 (220)
Q Consensus        81 ~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~------~~~~~  147 (220)
                      +. .++.++|||||||++|+|++|..||...+............      ...................      .....
T Consensus       215 ~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (383)
T 3eb0_A          215 GATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGT  294 (383)
T ss_dssp             TCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTC
T ss_pred             CCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCC
Confidence            75 48999999999999999999999997655443322211100      0000000000000000000      01112


Q ss_pred             HHHHHHHhccccCCCCCCCCCHHHHHHHhcC
Q 027675          148 ILKCINVGLLCVQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       148 ~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~  178 (220)
                      ...+.++|.+||+.||++|||+.++++|-+.
T Consensus       295 ~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  325 (383)
T 3eb0_A          295 PSLAIDLLEQILRYEPDLRINPYEAMAHPFF  325 (383)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHHTSGGG
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcCHHH
Confidence            3468899999999999999999999976543

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.95  E-value=8.5e-29  Score=202.26  Aligned_cols=170  Identities=21%  Similarity=0.259  Sum_probs=117.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||+|||+++   |+||||||+||+++.++.++|+|||++......     .....+++.|+|||.+.+
T Consensus       144 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~  215 (371)
T 4exu_A          144 EKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILS  215 (371)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC-------------CTTCCCTTSCHHHHSC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcccccccC-----cCCcccCccccCHHHhcC
Confidence            457889999999999999999   999999999999999999999999998754322     122456889999999987


Q ss_pred             -CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHH-----HHHHhc------cccccccCCCCCc---CcHH
Q 027675           82 -GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAW-----KLWQEG------KALDMMDQKPGAI---SKAN  146 (220)
Q Consensus        82 -~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~------~~~~~~~~~~~~~---~~~~  146 (220)
                       ..++.++|+||||+++|+|++|..||...+............     ......      .............   ....
T Consensus       216 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (371)
T 4exu_A          216 WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPR  295 (371)
T ss_dssp             CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTT
T ss_pred             CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccc
Confidence             678999999999999999999999997654433222111000     000000      0000000000000   0011


Q ss_pred             HHHHHHHHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          147 EILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       147 ~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      ....+.++|.+||+.||++|||+.+++++-+..
T Consensus       296 ~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  328 (371)
T 4exu_A          296 ASPQAADLLEKMLELDVDKRLTAAQALTHPFFE  328 (371)
T ss_dssp             SCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred             cChHHHHHHHHHCCCChhhcCCHHHHhcCcccc
Confidence            245788999999999999999999999886543

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.95  E-value=3.5e-29  Score=213.53  Aligned_cols=163  Identities=23%  Similarity=0.391  Sum_probs=123.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+++.|+.||+.||+|||+++   |+||||||+||+++.++.+||+|||++......... ......++..|+|||.+.+
T Consensus       363 ~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~  438 (535)
T 2h8h_A          363 PQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALY  438 (535)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH-TTCSTTSCGGGSCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee-cccCCcCcccccCHHHhcc
Confidence            467899999999999999999   999999999999999999999999998654321100 0111234568999999998


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++||||||+++|+|++ |..||..........       ....+......         ......+.++|.+||+
T Consensus       439 ~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~-------~i~~~~~~~~~---------~~~~~~l~~li~~cl~  502 (535)
T 2h8h_A          439 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD-------QVERGYRMPCP---------PECPESLHDLMCQCWR  502 (535)
T ss_dssp             CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHH-------HHHTTCCCCCC---------TTCCHHHHHHHHHHTC
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-------HHHcCCCCCCC---------CCCCHHHHHHHHHHcC
Confidence            889999999999999999999 899997554433221       11122211111         1123467899999999


Q ss_pred             CCCCCCCCHHHHHHHhcCccccCC
Q 027675          161 EDPNDRPTMSDVVIMLGSEAVNLA  184 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~~~~~~  184 (220)
                      .||++|||+++|++.|+.......
T Consensus       503 ~dP~~RPt~~~l~~~L~~~~~~~~  526 (535)
T 2h8h_A          503 KEPEERPTFEYLQAFLEDYFTSTE  526 (535)
T ss_dssp             SSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred             CChhHCcCHHHHHHHHHHHhhccC
Confidence            999999999999999987754443

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.95  E-value=5.1e-29  Score=198.72  Aligned_cols=164  Identities=18%  Similarity=0.194  Sum_probs=112.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++......... ......++..|.|||.+.+
T Consensus       134 ~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~  209 (309)
T 2h34_A          134 PRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT-QLGNTVGTLYYMAPERFSE  209 (309)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----------------CCGGGCCGGGTCC
T ss_pred             HHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccccccc-cccccCCCcCccCHHHHcC
Confidence            357889999999999999999   999999999999999999999999998754432211 1223457889999999998


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+||||+++|+|++|..||.........       ..... ..... ....     ......+.++|.+||+.
T Consensus       210 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-------~~~~~-~~~~~-~~~~-----~~~~~~l~~li~~~l~~  275 (309)
T 2h34_A          210 SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMG-------AHINQ-AIPRP-STVR-----PGIPVAFDAVIARGMAK  275 (309)
T ss_dssp             ----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHH-------HHHHS-CCCCG-GGTS-----TTCCTHHHHHHHHHTCS
T ss_pred             CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHH-------HHhcc-CCCCc-cccC-----CCCCHHHHHHHHHhccC
Confidence            88899999999999999999999999754433211       11111 11000 0001     11123678899999999


Q ss_pred             CCCCCC-CHHHHHHHhcCccccC
Q 027675          162 DPNDRP-TMSDVVIMLGSEAVNL  183 (220)
Q Consensus       162 ~p~~Rp-s~~~~l~~l~~~~~~~  183 (220)
                      ||++|| +++++++.|+......
T Consensus       276 dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          276 NPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             SGGGSCSSHHHHHHHHHHTCC--
T ss_pred             CHHHHHHhHHHHHHHHHHHHHhh
Confidence            999999 9999999997664433

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.95  E-value=1.1e-28  Score=200.13  Aligned_cols=170  Identities=21%  Similarity=0.241  Sum_probs=118.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||++|   ++||||||+||+++.++.++|+|||++......     .....+++.|+|||.+.+
T Consensus       126 ~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~  197 (353)
T 3coi_A          126 EKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILS  197 (353)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC-------------CCSBCCSCHHHHSC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCCCCC-----ccccccCcCcCCHHHHhC
Confidence            357889999999999999999   999999999999999999999999998653321     222457889999999887


Q ss_pred             -CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHH-----HHHHh-------ccccccccC--CCCCcCcHH
Q 027675           82 -GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAW-----KLWQE-------GKALDMMDQ--KPGAISKAN  146 (220)
Q Consensus        82 -~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-----~~~~~-------~~~~~~~~~--~~~~~~~~~  146 (220)
                       ..++.++|+||||+++|+|++|..||...+............     .....       .........  .........
T Consensus       198 ~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (353)
T 3coi_A          198 WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPR  277 (353)
T ss_dssp             CSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTT
T ss_pred             cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCC
Confidence             567899999999999999999999997655433221110000     00000       000000000  000011112


Q ss_pred             HHHHHHHHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          147 EILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       147 ~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      ....+.++|.+||+.||++|||+++++++-+..
T Consensus       278 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~  310 (353)
T 3coi_A          278 ASPQAADLLEKMLELDVDKRLTAAQALTHPFFE  310 (353)
T ss_dssp             SCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred             cCHHHHHHHHHHcCCCcccCCCHHHHhcCcchh
Confidence            345788999999999999999999999876543

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.95  E-value=3.9e-28  Score=200.75  Aligned_cols=159  Identities=21%  Similarity=0.211  Sum_probs=117.2

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhh--
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL--   80 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~--   80 (220)
                      .++.++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++........ .......|++.|+|||.+.  
T Consensus       163 ~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~  238 (412)
T 2vd5_A          163 MARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAV  238 (412)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheeccCCCc-cccceeccccCcCCHHHHhhc
Confidence            56789999999999999999   99999999999999999999999999876543211 1122346899999999987  


Q ss_pred             -----cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHh
Q 027675           81 -----GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVG  155 (220)
Q Consensus        81 -----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  155 (220)
                           +..++.++|+|||||++|+|++|+.||...+.......+      .........    +.  ........+.++|
T Consensus       239 ~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i------~~~~~~~~~----p~--~~~~~s~~~~dli  306 (412)
T 2vd5_A          239 GGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKI------VHYKEHLSL----PL--VDEGVPEEARDFI  306 (412)
T ss_dssp             HTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HTHHHHCCC----C------CCCHHHHHHH
T ss_pred             ccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHH------HhcccCcCC----Cc--cccCCCHHHHHHH
Confidence                 345789999999999999999999999765543322111      110000000    00  0011234778999


Q ss_pred             ccccCCCCCCC---CCHHHHHHHhcC
Q 027675          156 LLCVQEDPNDR---PTMSDVVIMLGS  178 (220)
Q Consensus       156 ~~cl~~~p~~R---ps~~~~l~~l~~  178 (220)
                      .+||. +|++|   |+++++++|-+.
T Consensus       307 ~~lL~-~p~~Rlgr~~~~ei~~Hpff  331 (412)
T 2vd5_A          307 QRLLC-PPETRLGRGGAGDFRTHPFF  331 (412)
T ss_dssp             HTTSS-CGGGCTTTTTHHHHHTSGGG
T ss_pred             HHHcC-ChhhcCCCCCHHHHhcCCCc
Confidence            99999 99998   599999977543

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.95  E-value=3.8e-29  Score=216.35  Aligned_cols=161  Identities=22%  Similarity=0.302  Sum_probs=120.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCC-cccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD-GTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~y~aPe~~~   80 (220)
                      ..++.++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++......... .......++..|+|||.+.
T Consensus       436 ~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~  512 (613)
T 2ozo_A          436 SNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN  512 (613)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhc
Confidence            467889999999999999999   999999999999999999999999998754322111 1111123356899999999


Q ss_pred             cCCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           81 GGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      +..++.++||||||+++|+|++ |..||...+......       ....+.......         .....+.++|.+||
T Consensus       513 ~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~-------~i~~~~~~~~p~---------~~~~~l~~li~~cl  576 (613)
T 2ozo_A          513 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA-------FIEQGKRMECPP---------ECPPELYALMSDCW  576 (613)
T ss_dssp             HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHH-------HHHTTCCCCCCT---------TCCHHHHHHHHHTT
T ss_pred             CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH-------HHHcCCCCCCCC---------cCCHHHHHHHHHHc
Confidence            8889999999999999999998 999997655443221       112222221111         12347889999999


Q ss_pred             CCCCCCCCCHHHHHHHhcCccc
Q 027675          160 QEDPNDRPTMSDVVIMLGSEAV  181 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l~~~~~  181 (220)
                      +.||++||++.++++.|+....
T Consensus       577 ~~dP~~RPs~~~l~~~L~~~~~  598 (613)
T 2ozo_A          577 IYKWEDRPDFLTVEQRMRACYY  598 (613)
T ss_dssp             CSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCChhHCcCHHHHHHHHHHHHH
Confidence            9999999999999998866533

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.95  E-value=2.2e-28  Score=198.60  Aligned_cols=173  Identities=18%  Similarity=0.245  Sum_probs=121.6

Q ss_pred             hHHHHHHHHHHHHHHhh--hCCCCCeEeccCCCCceeeCC-CCCceecCccceeeecCCCCCcccceeecccCccChhhh
Q 027675            3 MLFNIILGVSRRLLYLH--QDSKLRIIHRDFKTSNILLDH-EMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYA   79 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH--~~~~~~i~H~dlk~~nili~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~   79 (220)
                      .++.++.|++.||.|||  +.+   |+||||||+||+++. ++.++|+|||++........   .....+++.|+|||.+
T Consensus       130 ~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~  203 (360)
T 3e3p_A          130 LIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELI  203 (360)
T ss_dssp             HHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHH
T ss_pred             HHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHH
Confidence            46789999999999999  998   999999999999986 88999999999876543221   1224568899999998


Q ss_pred             hcCC-CcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHH---------HHHHHhccccccccCCCC------CcC
Q 027675           80 LGGF-FSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA---------WKLWQEGKALDMMDQKPG------AIS  143 (220)
Q Consensus        80 ~~~~-~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~------~~~  143 (220)
                      .+.. ++.++||||||+++|+|++|..||...+...........         ..................      ...
T Consensus       204 ~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (360)
T 3e3p_A          204 FGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDH  283 (360)
T ss_dssp             TTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTC
T ss_pred             cCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchh
Confidence            7654 799999999999999999999999765544332221110         000000000000000000      000


Q ss_pred             cHHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcCccc
Q 027675          144 KANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEAV  181 (220)
Q Consensus       144 ~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~~~  181 (220)
                      .......+.++|.+||+.||++|||+.+++++-+....
T Consensus       284 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  321 (360)
T 3e3p_A          284 SLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL  321 (360)
T ss_dssp             CCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             hccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence            11134578999999999999999999999988655433

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.95  E-value=9.1e-30  Score=207.01  Aligned_cols=177  Identities=24%  Similarity=0.389  Sum_probs=122.1

Q ss_pred             hHHHHHHHHHHHHHHhhhC-CCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            3 MLFNIILGVSRRLLYLHQD-SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~-~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+..++.+++.||.|||+. +   ++||||||+||+++.++.++|+|||++......    ......+++.|+|||.+.+
T Consensus       132 ~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~  204 (360)
T 3eqc_A          132 ILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQG  204 (360)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----C----CCCCTTCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc----cccCCCCCCCeECHHHHcC
Confidence            5678999999999999986 8   999999999999999999999999988643221    1122467889999999999


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHH---------Hhccc------------------ccc
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLW---------QEGKA------------------LDM  134 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~---------~~~~~------------------~~~  134 (220)
                      ..++.++|+||||+++|+|++|..||...+...............         ..+..                  ...
T Consensus       205 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (360)
T 3eqc_A          205 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYI  284 (360)
T ss_dssp             CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHH
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHH
Confidence            889999999999999999999999997655443322111000000         00000                  000


Q ss_pred             ccCCCCCcCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcCccccCCCC
Q 027675          135 MDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEAVNLASP  186 (220)
Q Consensus       135 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~~~~~~~~  186 (220)
                      ................+.++|.+||+.||++|||+++++++-+.........
T Consensus       285 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~  336 (360)
T 3eqc_A          285 VNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEV  336 (360)
T ss_dssp             HHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHSCC
T ss_pred             hccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHhhh
Confidence            0000000111112346889999999999999999999998765554443333

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.95  E-value=8.1e-29  Score=202.03  Aligned_cols=157  Identities=24%  Similarity=0.354  Sum_probs=117.9

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+.|   ++|+||||+||+++.++.++|+|||++........   .....+++.|+|||.+.+
T Consensus       200 ~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~  273 (365)
T 2y7j_A          200 KETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKC  273 (365)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecCcccccCCCcc---cccCCCCCCccChhhccc
Confidence            357889999999999999999   99999999999999999999999999876543221   223567899999999864


Q ss_pred             C------CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHh
Q 027675           82 G------FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVG  155 (220)
Q Consensus        82 ~------~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  155 (220)
                      .      .++.++|+||||+++|+|++|..||...........       ...+..... ..     ........+.++|
T Consensus       274 ~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~-------i~~~~~~~~-~~-----~~~~~~~~~~~li  340 (365)
T 2y7j_A          274 SMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM-------IMEGQYQFS-SP-----EWDDRSSTVKDLI  340 (365)
T ss_dssp             TTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-------HHHTCCCCC-HH-----HHSSSCHHHHHHH
T ss_pred             cccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHH-------HHhCCCCCC-Cc-----ccccCCHHHHHHH
Confidence            3      578899999999999999999999965443322111       111111000 00     0001124678999


Q ss_pred             ccccCCCCCCCCCHHHHHHHhc
Q 027675          156 LLCVQEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       156 ~~cl~~~p~~Rps~~~~l~~l~  177 (220)
                      .+||+.||++|||+.+++++-+
T Consensus       341 ~~~L~~dP~~Rps~~ell~hp~  362 (365)
T 2y7j_A          341 SRLLQVDPEARLTAEQALQHPF  362 (365)
T ss_dssp             HHHSCSSTTTSCCHHHHHHSGG
T ss_pred             HHHcCCChhHCcCHHHHhcCcc
Confidence            9999999999999999998754

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.95  E-value=2.1e-29  Score=201.31  Aligned_cols=162  Identities=20%  Similarity=0.225  Sum_probs=117.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCc-------ccceeecccCcc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG-------TTNRVVGTYGYM   74 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~-------~~~~~~~~~~y~   74 (220)
                      ..++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++..........       ......+++.|.
T Consensus       134 ~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~  210 (317)
T 2buj_A          134 DQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYR  210 (317)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGC
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccC
Confidence            357889999999999999999   9999999999999999999999999876532111100       001134578899


Q ss_pred             ChhhhhcCC---CcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHH
Q 027675           75 SPEYALGGF---FSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKC  151 (220)
Q Consensus        75 aPe~~~~~~---~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (220)
                      |||.+.+..   ++.++||||||+++|+|++|..||..........     .........     ...    .......+
T Consensus       211 aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-----~~~~~~~~~-----~~~----~~~~~~~l  276 (317)
T 2buj_A          211 APELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV-----ALAVQNQLS-----IPQ----SPRHSSAL  276 (317)
T ss_dssp             CGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCH-----HHHHHCC-------CCC----CTTSCHHH
T ss_pred             CHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchh-----hHHhhccCC-----CCc----cccCCHHH
Confidence            999987653   6889999999999999999999985321111000     000111000     000    11123468


Q ss_pred             HHHhccccCCCCCCCCCHHHHHHHhcCcc
Q 027675          152 INVGLLCVQEDPNDRPTMSDVVIMLGSEA  180 (220)
Q Consensus       152 ~~li~~cl~~~p~~Rps~~~~l~~l~~~~  180 (220)
                      .++|.+||+.||++||++.+++++|+...
T Consensus       277 ~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          277 WQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             HHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence            89999999999999999999999997763

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.95  E-value=4.9e-29  Score=216.34  Aligned_cols=159  Identities=25%  Similarity=0.366  Sum_probs=120.1

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCC-CcccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT-DGTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~y~aPe~~~   80 (220)
                      ..++.|+.||+.||+|||+++   |+||||||+||+++.++.+||+|||++........ ........++..|+|||.+.
T Consensus       469 ~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~  545 (635)
T 4fl3_A          469 KNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN  545 (635)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhc
Confidence            357889999999999999999   99999999999999999999999999875432211 11122233467899999999


Q ss_pred             cCCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           81 GGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      +..++.++||||||+++|+|++ |..||..........       ....+.......         .....+.++|..||
T Consensus       546 ~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~-------~i~~~~~~~~p~---------~~~~~l~~li~~cl  609 (635)
T 4fl3_A          546 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA-------MLEKGERMGCPA---------GCPREMYDLMNLCW  609 (635)
T ss_dssp             HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH-------HHHTTCCCCCCT---------TCCHHHHHHHHHHT
T ss_pred             CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-------HHHcCCCCCCCC---------CCCHHHHHHHHHHc
Confidence            9889999999999999999998 999997655543321       112222221111         12347889999999


Q ss_pred             CCCCCCCCCHHHHHHHhcCc
Q 027675          160 QEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l~~~  179 (220)
                      +.||++||+++++++.|+..
T Consensus       610 ~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          610 TYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             CSSTTTSCCHHHHHHHHHHH
T ss_pred             CCCHhHCcCHHHHHHHHHHH
Confidence            99999999999999998654

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.95  E-value=2.6e-29  Score=200.55  Aligned_cols=158  Identities=22%  Similarity=0.317  Sum_probs=111.1

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc-
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG-   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~-   81 (220)
                      .++.++.|+++||.|||+++   ++||||||+||++++ +.++|+|||++................+++.|+|||.+.+ 
T Consensus       128 ~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  203 (313)
T 3cek_A          128 ERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM  203 (313)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhc
Confidence            57889999999999999999   999999999999964 7899999999875443222222233467889999999875 


Q ss_pred             ----------CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHH
Q 027675           82 ----------GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKC  151 (220)
Q Consensus        82 ----------~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (220)
                                ..++.++|+||||+++|+|++|..||.........     .............    +..     ....+
T Consensus       204 ~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-----~~~~~~~~~~~~~----~~~-----~~~~l  269 (313)
T 3cek_A          204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK-----LHAIIDPNHEIEF----PDI-----PEKDL  269 (313)
T ss_dssp             C----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-----HHHHHCTTSCCCC----CCC-----SCHHH
T ss_pred             ccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH-----HHHHHhcccccCC----ccc-----chHHH
Confidence                      35788999999999999999999999654322111     1111111111111    111     12367


Q ss_pred             HHHhccccCCCCCCCCCHHHHHHHhcC
Q 027675          152 INVGLLCVQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       152 ~~li~~cl~~~p~~Rps~~~~l~~l~~  178 (220)
                      .++|.+||+.||++||++.+++++-+.
T Consensus       270 ~~li~~~l~~dp~~Rps~~ell~h~~~  296 (313)
T 3cek_A          270 QDVLKCCLKRDPKQRISIPELLAHPYV  296 (313)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred             HHHHHHHccCCcccCcCHHHHhcCccc
Confidence            889999999999999999999977643

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.95  E-value=6.4e-29  Score=199.21  Aligned_cols=154  Identities=25%  Similarity=0.349  Sum_probs=111.1

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhh--
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL--   80 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~--   80 (220)
                      .++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++........  ......++..|+|||.+.  
T Consensus       130 ~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~  204 (326)
T 2x7f_A          130 WIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACD  204 (326)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--
T ss_pred             HHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcCceecCcCcc--ccccccCCccccChhhhccc
Confidence            56789999999999999999   99999999999999999999999999865432211  122246788999999986  


Q ss_pred             ---cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcc
Q 027675           81 ---GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLL  157 (220)
Q Consensus        81 ---~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  157 (220)
                         +..++.++|+||||+++|+|++|..||..........      .. ........    .    .......+.++|.+
T Consensus       205 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~-~~~~~~~~----~----~~~~~~~l~~li~~  269 (326)
T 2x7f_A          205 ENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF------LI-PRNPAPRL----K----SKKWSKKFQSFIES  269 (326)
T ss_dssp             ------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HH-HHSCCCCC----S----CSCSCHHHHHHHHH
T ss_pred             cccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH------Hh-hcCccccC----C----ccccCHHHHHHHHH
Confidence               4567899999999999999999999996554332211      11 11111100    0    01122467899999


Q ss_pred             ccCCCCCCCCCHHHHHHHh
Q 027675          158 CVQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       158 cl~~~p~~Rps~~~~l~~l  176 (220)
                      ||..||++||++.+++++-
T Consensus       270 ~l~~dp~~Rps~~~ll~hp  288 (326)
T 2x7f_A          270 CLVKNHSQRPATEQLMKHP  288 (326)
T ss_dssp             HCCSSGGGSCCHHHHHTSH
T ss_pred             HhccChhhCCCHHHHhhCh
Confidence            9999999999999999764

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.95  E-value=3.2e-29  Score=198.75  Aligned_cols=167  Identities=26%  Similarity=0.373  Sum_probs=115.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCC---CcccceeecccCccChhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT---DGTTNRVVGTYGYMSPEY   78 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~y~aPe~   78 (220)
                      ..++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++........   ........+++.|.|||.
T Consensus       121 ~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  197 (303)
T 2vwi_A          121 STIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV  197 (303)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHH
Confidence            357889999999999999999   99999999999999999999999999865432111   111223467889999999


Q ss_pred             hhc-CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcc
Q 027675           79 ALG-GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLL  157 (220)
Q Consensus        79 ~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  157 (220)
                      +.+ ..++.++|+||||+++|+|++|..||...........      ... ......................+.++|.+
T Consensus       198 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~------~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~  270 (303)
T 2vwi_A          198 MEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML------TLQ-NDPPSLETGVQDKEMLKKYGKSFRKMISL  270 (303)
T ss_dssp             HHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH------HHT-SSCCCTTC-----CCCCCCCHHHHHHHHH
T ss_pred             hccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH------Hhc-cCCCccccccccchhhhhhhHHHHHHHHH
Confidence            876 4578999999999999999999999976544322111      110 11000000000000001122467889999


Q ss_pred             ccCCCCCCCCCHHHHHHHhcC
Q 027675          158 CVQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       158 cl~~~p~~Rps~~~~l~~l~~  178 (220)
                      ||+.||++||++.+++++-+.
T Consensus       271 ~l~~dp~~Rps~~~ll~h~~~  291 (303)
T 2vwi_A          271 CLQKDPEKRPTAAELLRHKFF  291 (303)
T ss_dssp             HCCSSGGGSCCHHHHHTSTTC
T ss_pred             HccCChhhCcCHHHHhhChhh
Confidence            999999999999999987543

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.95  E-value=4e-29  Score=197.10  Aligned_cols=153  Identities=21%  Similarity=0.339  Sum_probs=114.5

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCC--------ceecCccceeeecCCCCCcccceeecccCc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMN--------PKISDFGLTRIFEGKQTDGTTNRVVGTYGY   73 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~--------~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y   73 (220)
                      ..++.++.|++.||.|||+++   ++||||||+||+++.++.        ++|+|||++....      ......++..|
T Consensus       113 ~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~------~~~~~~~~~~y  183 (289)
T 4fvq_A          113 LWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL------PKDILQERIPW  183 (289)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTS------CHHHHHHTTTT
T ss_pred             HHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeeeccCccccccc------CccccCCcCcc
Confidence            357889999999999999999   999999999999988877        9999999875322      12224567889


Q ss_pred             cChhhhhc-CCCcccCceeehhHHHHHHHhcC-ccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHH
Q 027675           74 MSPEYALG-GFFSVKSDVFSFGVVVLEIISGK-RNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKC  151 (220)
Q Consensus        74 ~aPe~~~~-~~~~~~~DiwslG~il~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (220)
                      +|||.+.+ ..++.++||||||+++|+|++|. +|+...........       ....  .......         ...+
T Consensus       184 ~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~-------~~~~--~~~~~~~---------~~~l  245 (289)
T 4fvq_A          184 VPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF-------YEDR--HQLPAPK---------AAEL  245 (289)
T ss_dssp             SCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-------HHTT--CCCCCCS---------SCTT
T ss_pred             cCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH-------hhcc--CCCCCCC---------CHHH
Confidence            99999987 66899999999999999999954 45543333222111       1111  0111111         1256


Q ss_pred             HHHhccccCCCCCCCCCHHHHHHHhcCccc
Q 027675          152 INVGLLCVQEDPNDRPTMSDVVIMLGSEAV  181 (220)
Q Consensus       152 ~~li~~cl~~~p~~Rps~~~~l~~l~~~~~  181 (220)
                      .+++.+||+.||++|||+.+++++|+....
T Consensus       246 ~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          246 ANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             HHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            788999999999999999999999977744

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.95  E-value=6.5e-29  Score=202.05  Aligned_cols=172  Identities=18%  Similarity=0.161  Sum_probs=114.9

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++.......   ......+++.|+|||.+.+
T Consensus       134 ~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~  207 (362)
T 3pg1_A          134 QHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQ  207 (362)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcC
Confidence            357889999999999999999   9999999999999999999999999986433221   1222457888999999887


Q ss_pred             -CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHH-----HH-------HhccccccccCCCCC---cCcH
Q 027675           82 -GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWK-----LW-------QEGKALDMMDQKPGA---ISKA  145 (220)
Q Consensus        82 -~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~-----~~-------~~~~~~~~~~~~~~~---~~~~  145 (220)
                       ..++.++|+||||+++|+|++|..||.................     ..       ............+..   ....
T Consensus       208 ~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (362)
T 3pg1_A          208 FKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVP  287 (362)
T ss_dssp             CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHST
T ss_pred             CCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCC
Confidence             5689999999999999999999999976554332221110000     00       000000000000000   0011


Q ss_pred             HHHHHHHHHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          146 NEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       146 ~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      .....+.++|.+||+.||++|||+.+++++-+..
T Consensus       288 ~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  321 (362)
T 3pg1_A          288 TADPVALDLIAKMLEFNPQRRISTEQALRHPYFE  321 (362)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGT
T ss_pred             CCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhh
Confidence            1234688999999999999999999999876544

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.95  E-value=9.6e-29  Score=200.24  Aligned_cols=172  Identities=24%  Similarity=0.279  Sum_probs=119.2

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCc--------ccceeecccCc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG--------TTNRVVGTYGY   73 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~--------~~~~~~~~~~y   73 (220)
                      ..++.++.|++.||.|||++|   ++||||||+||+++.++.++|+|||++..........        ......+++.|
T Consensus       112 ~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  188 (353)
T 2b9h_A          112 DHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWY  188 (353)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGG
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccc
Confidence            357889999999999999999   9999999999999999999999999987654221110        11123568899


Q ss_pred             cChhhhhc-CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhcccc------------ccccCCCC
Q 027675           74 MSPEYALG-GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKAL------------DMMDQKPG  140 (220)
Q Consensus        74 ~aPe~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~  140 (220)
                      +|||.+.+ ..++.++|+||||+++|+|++|..||...+.........   .........            +.....+.
T Consensus       189 ~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (353)
T 2b9h_A          189 RAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIF---GIIGTPHSDNDLRCIESPRAREYIKSLPM  265 (353)
T ss_dssp             CCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---HHHCCCCSTTTTTTCCCHHHHHHHHTSCC
T ss_pred             cCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH---HHhCCCchhccccccccchhhHHhhcccC
Confidence            99998765 568899999999999999999999997655433221110   000000000            00000000


Q ss_pred             C-cCc-----HHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          141 A-ISK-----ANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       141 ~-~~~-----~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      . ...     ......+.++|.+||..||++|||+++++++-+..
T Consensus       266 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  310 (353)
T 2b9h_A          266 YPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQ  310 (353)
T ss_dssp             CCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             CCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence            0 000     11234678999999999999999999999876543

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.95  E-value=1.1e-28  Score=194.13  Aligned_cols=156  Identities=20%  Similarity=0.234  Sum_probs=116.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCC----CceecCccceeeecCCCCCcccceeecccCccChh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEM----NPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPE   77 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe   77 (220)
                      ..++.++.|++.||.|||+.+   ++|+||||+||+++.++    .++|+|||++........   .....+++.|.|||
T Consensus       108 ~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE  181 (283)
T 3bhy_A          108 DEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPE  181 (283)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-----------CCCGGGCCHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccceeccCCCc---ccccCCCcCccCcc
Confidence            467899999999999999999   99999999999998877    799999999876433211   12245788999999


Q ss_pred             hhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcc
Q 027675           78 YALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLL  157 (220)
Q Consensus        78 ~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  157 (220)
                      .+.+..++.++|+||||+++|+|++|..||............       .....      .............+.+++.+
T Consensus       182 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-------~~~~~------~~~~~~~~~~~~~~~~li~~  248 (283)
T 3bhy_A          182 IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI-------SAVNY------DFDEEYFSNTSELAKDFIRR  248 (283)
T ss_dssp             HHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-------HTTCC------CCCHHHHTTCCHHHHHHHHT
T ss_pred             eecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHh-------Hhccc------CCcchhcccCCHHHHHHHHH
Confidence            999888999999999999999999999999765443322111       01000      00000001123467899999


Q ss_pred             ccCCCCCCCCCHHHHHHHh
Q 027675          158 CVQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       158 cl~~~p~~Rps~~~~l~~l  176 (220)
                      ||..||++||++.+++++-
T Consensus       249 ~l~~dp~~Rps~~~~l~h~  267 (283)
T 3bhy_A          249 LLVKDPKRRMTIAQSLEHS  267 (283)
T ss_dssp             TSCSSGGGSCCHHHHHHCH
T ss_pred             HccCCHhHCcCHHHHHhCH
Confidence            9999999999999999764

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.95  E-value=1.6e-29  Score=201.87  Aligned_cols=169  Identities=22%  Similarity=0.238  Sum_probs=114.0

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCC---ceecCccceeeecCCCC-----CcccceeecccCc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMN---PKISDFGLTRIFEGKQT-----DGTTNRVVGTYGY   73 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~---~~l~d~~~~~~~~~~~~-----~~~~~~~~~~~~y   73 (220)
                      ..++.++.|++.||.|||+++   ++||||||+||+++.++.   ++|+|||++........     ........++..|
T Consensus       111 ~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y  187 (316)
T 2ac3_A          111 LEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY  187 (316)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGG
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCc
Confidence            357789999999999999999   999999999999988776   89999999865431110     0111123478899


Q ss_pred             cChhhhhc-----CCCcccCceeehhHHHHHHHhcCccCcccchhHHH--------hhHHHHHHHHHhccccccccCCCC
Q 027675           74 MSPEYALG-----GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELAL--------SLLGYAWKLWQEGKALDMMDQKPG  140 (220)
Q Consensus        74 ~aPe~~~~-----~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~  140 (220)
                      +|||.+.+     ..++.++|||||||++|+|++|..||.........        ............+... ....   
T Consensus       188 ~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~-~~~~---  263 (316)
T 2ac3_A          188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYE-FPDK---  263 (316)
T ss_dssp             CCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCC-CCHH---
T ss_pred             cChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcc-cCch---
Confidence            99999875     44688999999999999999999999654321100        0000011111111110 0000   


Q ss_pred             CcCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          141 AISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       141 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                        ........+.++|.+||..||++|||+.+++++-+..
T Consensus       264 --~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~  300 (316)
T 2ac3_A          264 --DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ  300 (316)
T ss_dssp             --HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC
T ss_pred             --hcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhc
Confidence              0001234678999999999999999999999986544

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.95  E-value=6.2e-29  Score=195.06  Aligned_cols=160  Identities=24%  Similarity=0.304  Sum_probs=119.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCC--CCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDS--KLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYA   79 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~--~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~   79 (220)
                      ..++.++.|++.||.|||+.+  ...++|+||||+||+++.++.++|+|||++.......  .......++..|.|||.+
T Consensus       111 ~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~  188 (279)
T 2w5a_A          111 EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFAKTFVGTPYYMSPEQM  188 (279)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---C--HHHHHHHSCCTTCCHHHH
T ss_pred             HHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeecccc--ccccccCCCccccChHHh
Confidence            357899999999999999875  2339999999999999999999999999986543221  112224578899999999


Q ss_pred             hcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           80 LGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        80 ~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      .+..++.++|+||||+++|+|++|..||...+......       ....+......         ......+.++|.+||
T Consensus       189 ~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------~i~~~~~~~~~---------~~~~~~l~~li~~~l  252 (279)
T 2w5a_A          189 NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG-------KIREGKFRRIP---------YRYSDELNEIITRML  252 (279)
T ss_dssp             HCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------HHHHTCCCCCC---------TTSCHHHHHHHHHHT
T ss_pred             ccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHH-------HHhhcccccCC---------cccCHHHHHHHHHHc
Confidence            99889999999999999999999999997655433221       11122221111         112346789999999


Q ss_pred             CCCCCCCCCHHHHHHHhcCc
Q 027675          160 QEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l~~~  179 (220)
                      +.||++||++.+++++++..
T Consensus       253 ~~~p~~Rps~~~ll~~~~~~  272 (279)
T 2w5a_A          253 NLKDYHRPSVEEILENPLIL  272 (279)
T ss_dssp             CSSGGGSCCHHHHHTSTTCC
T ss_pred             CCCcccCCCHHHHHhChhhh
Confidence            99999999999999998655

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=1.5e-28  Score=199.76  Aligned_cols=162  Identities=23%  Similarity=0.305  Sum_probs=118.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+++   |+||||||+||+++.++.++|+|||++......... ......+++.|+|||.+.+
T Consensus       159 ~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~  234 (355)
T 1vzo_A          159 HEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRG  234 (355)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCC-cccCcccCcCccChhhhcC
Confidence            357789999999999999999   999999999999999999999999998764322111 1222467899999999986


Q ss_pred             C--CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           82 G--FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        82 ~--~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      .  .++.++|||||||++|+|++|..||...........  ........ .     ...+     ......+.++|.+||
T Consensus       235 ~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~--~~~~~~~~-~-----~~~~-----~~~~~~~~~li~~~L  301 (355)
T 1vzo_A          235 GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE--ISRRILKS-E-----PPYP-----QEMSALAKDLIQRLL  301 (355)
T ss_dssp             CC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH--HHHHHHHC-C-----CCCC-----TTSCHHHHHHHHHHT
T ss_pred             CCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHH--HHHHHhcc-C-----CCCC-----cccCHHHHHHHHHHh
Confidence            3  468899999999999999999999964332211111  11111110 0     0011     112346788999999


Q ss_pred             CCCCCCCC-----CHHHHHHHhcCcc
Q 027675          160 QEDPNDRP-----TMSDVVIMLGSEA  180 (220)
Q Consensus       160 ~~~p~~Rp-----s~~~~l~~l~~~~  180 (220)
                      ..||++||     ++++++++.+...
T Consensus       302 ~~dP~~R~~~~~~s~~ell~h~~f~~  327 (355)
T 1vzo_A          302 MKDPKKRLGCGPRDADEIKEHLFFQK  327 (355)
T ss_dssp             CSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             hhCHHHhcCCCCCCHHHHHcCcchhc
Confidence            99999999     9999999876553

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.95  E-value=9.4e-29  Score=205.85  Aligned_cols=102  Identities=27%  Similarity=0.456  Sum_probs=81.9

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCC--------------------
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD--------------------   61 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~--------------------   61 (220)
                      ..++.++.||+.||+|||+.|   |+||||||+||+++.++.+||+|||+++........                    
T Consensus       129 ~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  205 (432)
T 3n9x_A          129 EHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLK  205 (432)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC--------------------------
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchh
Confidence            457889999999999999999   999999999999999999999999999865432111                    


Q ss_pred             cccceeecccCccChhhh-hcCCCcccCceeehhHHHHHHHhcCcc
Q 027675           62 GTTNRVVGTYGYMSPEYA-LGGFFSVKSDVFSFGVVVLEIISGKRN  106 (220)
Q Consensus        62 ~~~~~~~~~~~y~aPe~~-~~~~~~~~~DiwslG~il~~ll~g~~p  106 (220)
                      .......+++.|+|||.+ .+..++.++|||||||++|+|++|..|
T Consensus       206 ~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p  251 (432)
T 3n9x_A          206 KQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS  251 (432)
T ss_dssp             -----CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTT
T ss_pred             ccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccc
Confidence            112345778999999986 455689999999999999999985444

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.95  E-value=1.8e-28  Score=204.31  Aligned_cols=160  Identities=27%  Similarity=0.349  Sum_probs=114.2

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCC-------------CCceecCccceeeecCCCCC--ccccee
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHE-------------MNPKISDFGLTRIFEGKQTD--GTTNRV   67 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~-------------~~~~l~d~~~~~~~~~~~~~--~~~~~~   67 (220)
                      .++.++.|++.||.|||+++   |+||||||+||+++.+             +.++|+|||++.........  ......
T Consensus       116 ~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~  192 (434)
T 2rio_A          116 NPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP  192 (434)
T ss_dssp             CHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC------------
T ss_pred             hHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCC
Confidence            35679999999999999999   9999999999999654             46999999999865432211  112234


Q ss_pred             ecccCccChhhhhc-------CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCC
Q 027675           68 VGTYGYMSPEYALG-------GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKP  139 (220)
Q Consensus        68 ~~~~~y~aPe~~~~-------~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  139 (220)
                      .|++.|+|||.+.+       ..++.++|||||||++|+|++ |..||........        .........    ...
T Consensus       193 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~--------~i~~~~~~~----~~~  260 (434)
T 2rio_A          193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES--------NIIRGIFSL----DEM  260 (434)
T ss_dssp             --CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH--------HHHHTCCCC----CCC
T ss_pred             CCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH--------HHhcCCCCc----ccc
Confidence            68899999999976       567899999999999999998 9999864332221        011111111    011


Q ss_pred             CCcCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHhc
Q 027675          140 GAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       140 ~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~  177 (220)
                      ...........+.++|.+||+.||++|||+.+++++-+
T Consensus       261 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~  298 (434)
T 2rio_A          261 KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL  298 (434)
T ss_dssp             TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             cccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCc
Confidence            12223455678899999999999999999999997653

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.95  E-value=1.1e-28  Score=201.12  Aligned_cols=154  Identities=13%  Similarity=0.102  Sum_probs=117.0

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCC-----------CCCceecCccceeeecCCCCCcccceeecc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDH-----------EMNPKISDFGLTRIFEGKQTDGTTNRVVGT   70 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~-----------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~   70 (220)
                      ..++.++.|++.||+|||+.+   |+||||||+||+++.           ++.++|+|||++................|+
T Consensus       172 ~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt  248 (365)
T 3e7e_A          172 GLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCET  248 (365)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCT
T ss_pred             HHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCC
Confidence            357899999999999999999   999999999999998           899999999999754422222233345689


Q ss_pred             cCccChhhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHH
Q 027675           71 YGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILK  150 (220)
Q Consensus        71 ~~y~aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (220)
                      +.|+|||.+.+..++.++|||||||++|+|++|+.||........              ..    ........   ....
T Consensus       249 ~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--------------~~----~~~~~~~~---~~~~  307 (365)
T 3e7e_A          249 SGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC--------------KP----EGLFRRLP---HLDM  307 (365)
T ss_dssp             TSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE--------------EE----CSCCTTCS---SHHH
T ss_pred             CCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce--------------ee----chhccccC---cHHH
Confidence            999999999999899999999999999999999999853322111              00    01111111   1335


Q ss_pred             HHHHhccccCCCCCCC-CCHHHHHHHhcCc
Q 027675          151 CINVGLLCVQEDPNDR-PTMSDVVIMLGSE  179 (220)
Q Consensus       151 ~~~li~~cl~~~p~~R-ps~~~~l~~l~~~  179 (220)
                      +.+++..||+.+|.+| |++.++.+.|+..
T Consensus       308 ~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~  337 (365)
T 3e7e_A          308 WNEFFHVMLNIPDCHHLPSLDLLRQKLKKV  337 (365)
T ss_dssp             HHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence            6678888999999999 6677777666544

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.95  E-value=2.2e-29  Score=201.84  Aligned_cols=148  Identities=22%  Similarity=0.356  Sum_probs=115.6

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeC-CCCCceecCccceeeecCCCCCcccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLD-HEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~   80 (220)
                      ..++.++.|+++||.|||+.+   |+||||||+||+++ +++.++|+|||++.......    .....++..|+|||.+.
T Consensus       149 ~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~  221 (320)
T 3a99_A          149 ELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIR  221 (320)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeCcccccccccc----ccCCCCCccCCChHHhc
Confidence            357889999999999999999   99999999999998 77899999999987654322    22245788999999998


Q ss_pred             cCCC-cccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           81 GGFF-SVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        81 ~~~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      +..+ +.++|+||||+++|+|++|..||.......             .+...    . . .    .....+.++|.+||
T Consensus       222 ~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-------------~~~~~----~-~-~----~~~~~~~~li~~~l  278 (320)
T 3a99_A          222 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII-------------RGQVF----F-R-Q----RVSSECQHLIRWCL  278 (320)
T ss_dssp             HSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH-------------HCCCC----C-S-S----CCCHHHHHHHHHHT
T ss_pred             cCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhh-------------ccccc----c-c-c----cCCHHHHHHHHHHc
Confidence            7665 688999999999999999999986422110             01100    0 0 1    11236789999999


Q ss_pred             CCCCCCCCCHHHHHHHhcCc
Q 027675          160 QEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l~~~  179 (220)
                      +.||++|||+++++++-+..
T Consensus       279 ~~dp~~Rps~~~ll~hp~~~  298 (320)
T 3a99_A          279 ALRPSDRPTFEEIQNHPWMQ  298 (320)
T ss_dssp             CSSGGGSCCHHHHHTSGGGS
T ss_pred             cCChhhCcCHHHHhcCHhhc
Confidence            99999999999999876443

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.95  E-value=1.5e-28  Score=202.53  Aligned_cols=170  Identities=17%  Similarity=0.185  Sum_probs=122.5

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceee----CCCCCceecCccceeeecCCCCCcccceeecccCccChh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILL----DHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPE   77 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili----~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe   77 (220)
                      ..++.++.|++.||+|||+++   |+||||||+||++    +.++.++|+|||++........   .....++..|+|||
T Consensus       112 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE  185 (396)
T 4eut_A          112 SEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPD  185 (396)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGG---SSCSSSCCTTCCHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCc---cccccCCccccCHH
Confidence            357889999999999999999   9999999999999    7777799999999976543221   12245788999999


Q ss_pred             hhhc--------CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhcccc-------------c-cc
Q 027675           78 YALG--------GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKAL-------------D-MM  135 (220)
Q Consensus        78 ~~~~--------~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~-~~  135 (220)
                      .+.+        ..++.++|||||||++|+|++|..||.........  .....+........             . ..
T Consensus       186 ~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~  263 (396)
T 4eut_A          186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKIITGKPSGAISGVQKAENGPIDWSG  263 (396)
T ss_dssp             HHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHHHHHSCCTTCCEEEECSTTCCEEEES
T ss_pred             HhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHHHhcCCCcccchhheeccCCCcccCc
Confidence            9865        45678999999999999999999999643322111  11111221111100             0 00


Q ss_pred             cCCCCCcCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          136 DQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       136 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      ...............+.+++.+||+.||++||++.++++.+...
T Consensus       264 ~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i  307 (396)
T 4eut_A          264 DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (396)
T ss_dssp             SCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             cCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence            11112233456677889999999999999999999999877543

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.95  E-value=2e-28  Score=193.57  Aligned_cols=157  Identities=26%  Similarity=0.369  Sum_probs=115.1

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCC-CCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDH-EMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .++.++.|++.||.|||+++   ++|+||||+||+++. ++.++|+|||++........  ......++..|.|||.+.+
T Consensus       123 ~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~  197 (295)
T 2clq_A          123 TIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQYMAPEIIDK  197 (295)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------CCCCCCGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC--cccccCCCccccChhhhcC
Confidence            46778999999999999999   999999999999987 88999999999876432211  1223457889999999876


Q ss_pred             CC--CcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           82 GF--FSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        82 ~~--~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      ..  ++.++|+||||+++|+|++|..||...........     ..........    .+     ......+.++|.+||
T Consensus       198 ~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-----~~~~~~~~~~----~~-----~~~~~~~~~li~~~l  263 (295)
T 2clq_A          198 GPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF-----KVGMFKVHPE----IP-----ESMSAEAKAFILKCF  263 (295)
T ss_dssp             GGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH-----HHHHHCCCCC----CC-----TTSCHHHHHHHHHTT
T ss_pred             CCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH-----hhcccccccc----cc-----ccCCHHHHHHHHHHc
Confidence            43  78899999999999999999999864433221110     1000111100    01     112346788999999


Q ss_pred             CCCCCCCCCHHHHHHHhcC
Q 027675          160 QEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l~~  178 (220)
                      +.||++||++.+++.+-+.
T Consensus       264 ~~dp~~Rps~~~ll~~~~~  282 (295)
T 2clq_A          264 EPDPDKRACANDLLVDEFL  282 (295)
T ss_dssp             CSSTTTSCCHHHHHTSGGG
T ss_pred             cCChhhCCCHHHHhcChhh
Confidence            9999999999999976543

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.95  E-value=9e-29  Score=208.67  Aligned_cols=157  Identities=27%  Similarity=0.309  Sum_probs=119.1

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceee---CCCCCceecCccceeeecCCCCCcccceeecccCccChhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILL---DHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEY   78 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~   78 (220)
                      ..++.++.|++.||.|||+++   |+||||||+||++   +.++.++|+|||++.......   ......+++.|+|||.
T Consensus       126 ~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~  199 (484)
T 3nyv_A          126 VDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYIAPEV  199 (484)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC---SHHHHTTGGGTCCHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc---ccccCCCCccccCcee
Confidence            357889999999999999999   9999999999999   567889999999987544322   1223467899999999


Q ss_pred             hhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           79 ALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        79 ~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                      +.+ .++.++|||||||++|+|++|..||...+........       ..+...      ............+.++|.+|
T Consensus       200 ~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i-------~~~~~~------~~~~~~~~~s~~~~~li~~~  265 (484)
T 3nyv_A          200 LHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV-------EKGKYT------FELPQWKKVSESAKDLIRKM  265 (484)
T ss_dssp             HHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHCCCC------CCSGGGGGSCHHHHHHHHHH
T ss_pred             ecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-------HcCCCC------CCCcccccCCHHHHHHHHHH
Confidence            887 5889999999999999999999999765544332111       111111      00001112234678999999


Q ss_pred             cCCCCCCCCCHHHHHHHhcC
Q 027675          159 VQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       159 l~~~p~~Rps~~~~l~~l~~  178 (220)
                      |+.||++|||+.+++++-+.
T Consensus       266 L~~dp~~R~s~~e~l~h~~~  285 (484)
T 3nyv_A          266 LTYVPSMRISARDALDHEWI  285 (484)
T ss_dssp             TCSSGGGSCCHHHHHTSHHH
T ss_pred             CCCChhHCcCHHHHhhChhh
Confidence            99999999999999976543

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.95  E-value=2.5e-28  Score=206.14  Aligned_cols=158  Identities=27%  Similarity=0.306  Sum_probs=117.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeC---CCCCceecCccceeeecCCCCCcccceeecccCccChhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLD---HEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEY   78 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~   78 (220)
                      ..++.++.|++.||.|||+++   |+||||||+||+++   .++.++|+|||++.......   ......+++.|+|||.
T Consensus       121 ~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~  194 (486)
T 3mwu_A          121 HDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEV  194 (486)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-------CCTTGGGGCCGGG
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC---ccCCCcCCCCCCCHHH
Confidence            357889999999999999999   99999999999995   45679999999986543221   1222467899999999


Q ss_pred             hhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           79 ALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        79 ~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                      +.+. ++.++|||||||++|+|++|..||...+.......      . ..+...      ............+.++|.+|
T Consensus       195 ~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~------i-~~~~~~------~~~~~~~~~s~~~~~li~~~  260 (486)
T 3mwu_A          195 LRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR------V-ETGKYA------FDLPQWRTISDDAKDLIRKM  260 (486)
T ss_dssp             GGSC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------H-HHTCCC------SCSGGGGGSCHHHHHHHHHH
T ss_pred             hCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------H-HhCCCC------CCCcccCCCCHHHHHHHHHH
Confidence            8864 88999999999999999999999976554332211      1 111110      00001111234678999999


Q ss_pred             cCCCCCCCCCHHHHHHHhcCc
Q 027675          159 VQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       159 l~~~p~~Rps~~~~l~~l~~~  179 (220)
                      |..||++|||+.+++++-+..
T Consensus       261 L~~dp~~R~t~~~~l~hp~~~  281 (486)
T 3mwu_A          261 LTFHPSLRITATQCLEHPWIQ  281 (486)
T ss_dssp             TCSSTTTSCCHHHHHHCHHHH
T ss_pred             cCCChhhCcCHHHHhcCHhhc
Confidence            999999999999999876543

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.95  E-value=4.5e-28  Score=201.72  Aligned_cols=158  Identities=25%  Similarity=0.285  Sum_probs=111.6

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCC-----CCCceecCccceeeecCCCC-CcccceeecccCccCh
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDH-----EMNPKISDFGLTRIFEGKQT-DGTTNRVVGTYGYMSP   76 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~-----~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~y~aP   76 (220)
                      .++.++.|++.||.|||+.+   |+||||||+||+++.     ...++|+|||++........ ........|++.|+||
T Consensus       119 ~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~AP  195 (432)
T 3p23_A          119 EPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP  195 (432)
T ss_dssp             CHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCG
T ss_pred             hHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccCh
Confidence            46789999999999999999   999999999999953     23477999999876542211 1122335689999999


Q ss_pred             hhhhc---CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHH
Q 027675           77 EYALG---GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCI  152 (220)
Q Consensus        77 e~~~~---~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (220)
                      |.+.+   ..++.++|||||||++|+|++ |..||+..........        .....      .............+.
T Consensus       196 E~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~--------~~~~~------~~~~~~~~~~~~~~~  261 (432)
T 3p23_A          196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL--------LGACS------LDCLHPEKHEDVIAR  261 (432)
T ss_dssp             GGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHH--------TTCCC------CTTSCTTCHHHHHHH
T ss_pred             hhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHH--------hccCC------ccccCccccccHHHH
Confidence            99873   456789999999999999999 9999864333222110        00000      011111223445678


Q ss_pred             HHhccccCCCCCCCCCHHHHHHHhc
Q 027675          153 NVGLLCVQEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       153 ~li~~cl~~~p~~Rps~~~~l~~l~  177 (220)
                      ++|.+||+.||++|||+++++++-+
T Consensus       262 ~li~~~L~~dP~~Rps~~evl~hp~  286 (432)
T 3p23_A          262 ELIEKMIAMDPQKRPSAKHVLKHPF  286 (432)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHTSTT
T ss_pred             HHHHHHHhCCHhhCCCHHHHHhCcc
Confidence            9999999999999999999997654

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.95  E-value=2.5e-28  Score=190.59  Aligned_cols=155  Identities=18%  Similarity=0.256  Sum_probs=117.2

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+.+ ..++||||||+||+++.++.++++||++......       ....+++.|+|||.+.+
T Consensus       111 ~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-------~~~~~t~~y~aPE~~~~  182 (271)
T 3kmu_A          111 SQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-------PGRMYAPAWVAPEALQK  182 (271)
T ss_dssp             HHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-------TTCBSCGGGSCHHHHHS
T ss_pred             HHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc-------cCccCCccccChhhhcc
Confidence            467899999999999999874 3499999999999999999999998887643211       12356889999999987


Q ss_pred             CCCcc---cCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           82 GFFSV---KSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        82 ~~~~~---~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                      ...+.   ++||||||+++|+|++|..||..........      .....+......         ......+.+++..|
T Consensus       183 ~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------~~~~~~~~~~~~---------~~~~~~~~~li~~~  247 (271)
T 3kmu_A          183 KPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGM------KVALEGLRPTIP---------PGISPHVSKLMKIC  247 (271)
T ss_dssp             CGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHH------HHHHSCCCCCCC---------TTCCHHHHHHHHHH
T ss_pred             CCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHH------HHHhcCCCCCCC---------CCCCHHHHHHHHHH
Confidence            65444   7999999999999999999997554433221      111121111111         11234678999999


Q ss_pred             cCCCCCCCCCHHHHHHHhcCc
Q 027675          159 VQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       159 l~~~p~~Rps~~~~l~~l~~~  179 (220)
                      |+.||++|||++++++.|+..
T Consensus       248 l~~~p~~Rps~~~il~~L~~l  268 (271)
T 3kmu_A          248 MNEDPAKRPKFDMIVPILEKM  268 (271)
T ss_dssp             TCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCChhhCcCHHHHHHHHHHh
Confidence            999999999999999998765

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.95  E-value=1.1e-28  Score=199.12  Aligned_cols=162  Identities=18%  Similarity=0.207  Sum_probs=99.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCC---CCCceecCccceeeecCCCCCcccceeecccCccChhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDH---EMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEY   78 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~   78 (220)
                      .+++.++.|++.||.|||+++   ++||||||+||+++.   ++.++|+|||++.......    .....+++.|+|||.
T Consensus       128 ~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~  200 (336)
T 3fhr_A          128 REAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA----LQTPCYTPYYVAPEV  200 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-----------------------
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccceeccccc----cccCCCCcCccChhh
Confidence            467899999999999999999   999999999999976   4459999999987544221    122456889999999


Q ss_pred             hhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           79 ALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        79 ~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                      +.+..++.++|+||||+++|+|++|..||............   ......+    ....  ...........+.++|.+|
T Consensus       201 ~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~----~~~~--~~~~~~~~~~~~~~li~~~  271 (336)
T 3fhr_A          201 LGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM---KRRIRLG----QYGF--PNPEWSEVSEDAKQLIRLL  271 (336)
T ss_dssp             ---CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------------CC--CTTTSTTCCHHHHHHHHHH
T ss_pred             hCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH---HHhhhcc----cccc--CchhhccCCHHHHHHHHHH
Confidence            98888899999999999999999999998643332211000   0000000    0000  0000112234678999999


Q ss_pred             cCCCCCCCCCHHHHHHHhcCc
Q 027675          159 VQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       159 l~~~p~~Rps~~~~l~~l~~~  179 (220)
                      |+.||++|||+.+++++-+..
T Consensus       272 L~~dP~~Rpt~~ell~hp~~~  292 (336)
T 3fhr_A          272 LKTDPTERLTITQFMNHPWIN  292 (336)
T ss_dssp             SCSSGGGSCCHHHHHHSHHHH
T ss_pred             CCCChhHCcCHHHHhcCcccc
Confidence            999999999999999876443

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.95  E-value=8.7e-29  Score=196.34  Aligned_cols=158  Identities=20%  Similarity=0.335  Sum_probs=115.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhh-
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL-   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~-   80 (220)
                      ..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......  .......++..|.|||.+. 
T Consensus       117 ~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~  191 (302)
T 2j7t_A          117 PQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL--QKRDSFIGTPYWMAPEVVMC  191 (302)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH--HC-----CCGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc--cccccccCChhhcCCeeecc
Confidence            357889999999999999999   9999999999999999999999999864321110  0111235788999999984 


Q ss_pred             ----cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhc
Q 027675           81 ----GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGL  156 (220)
Q Consensus        81 ----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  156 (220)
                          +..++.++|+||||+++|+|++|..||...+......      ..... ..       +...........+.++|.
T Consensus       192 ~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~~-~~-------~~~~~~~~~~~~l~~li~  257 (302)
T 2j7t_A          192 ETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL------KIAKS-DP-------PTLLTPSKWSVEFRDFLK  257 (302)
T ss_dssp             HHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHS-CC-------CCCSSGGGSCHHHHHHHH
T ss_pred             ccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH------HHhcc-CC-------cccCCccccCHHHHHHHH
Confidence                5567899999999999999999999997655433221      11111 10       001111122346789999


Q ss_pred             cccCCCCCCCCCHHHHHHHhcC
Q 027675          157 LCVQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       157 ~cl~~~p~~Rps~~~~l~~l~~  178 (220)
                      +||..||++|||+.+++++-+.
T Consensus       258 ~~l~~dp~~Rps~~~ll~h~~~  279 (302)
T 2j7t_A          258 IALDKNPETRPSAAQLLEHPFV  279 (302)
T ss_dssp             HHSCSCTTTSCCHHHHTTSTTT
T ss_pred             HHcccChhhCCCHHHHhcChHH
Confidence            9999999999999999987543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.95  E-value=1.7e-28  Score=195.13  Aligned_cols=156  Identities=23%  Similarity=0.287  Sum_probs=118.5

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceee---CCCCCceecCccceeeecCCCCCcccceeecccCccChhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILL---DHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEY   78 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~   78 (220)
                      ..++.++.|++.||.|||+.+   ++|+||||+||++   +.++.++|+|||++......    ......+++.|.|||.
T Consensus       106 ~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~  178 (304)
T 2jam_A          106 KDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTPGYVAPEV  178 (304)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB----TTHHHHSCCCBCCTTT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC----ccccccCCCCccChHH
Confidence            357889999999999999999   9999999999999   77888999999998643321    1222457889999999


Q ss_pred             hhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           79 ALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        79 ~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                      +.+..++.++|+||||+++|+|++|..||...........       ...+... ....     ........+.++|.+|
T Consensus       179 ~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-------i~~~~~~-~~~~-----~~~~~~~~~~~li~~~  245 (304)
T 2jam_A          179 LAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEK-------IKEGYYE-FESP-----FWDDISESAKDFICHL  245 (304)
T ss_dssp             BSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-------HHHCCCC-CCTT-----TTTTSCHHHHHHHHHH
T ss_pred             hccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHH-------HHcCCCC-CCcc-----ccccCCHHHHHHHHHH
Confidence            9988899999999999999999999999975443322211       1111110 0000     0111234678999999


Q ss_pred             cCCCCCCCCCHHHHHHHhc
Q 027675          159 VQEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       159 l~~~p~~Rps~~~~l~~l~  177 (220)
                      |+.||++|||+++++++-+
T Consensus       246 l~~dp~~Rps~~~~l~h~~  264 (304)
T 2jam_A          246 LEKDPNERYTCEKALSHPW  264 (304)
T ss_dssp             HCSSTTTSCCHHHHHTSHH
T ss_pred             cCCChhHCcCHHHHhcCcc
Confidence            9999999999999997654

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.95  E-value=3e-28  Score=207.27  Aligned_cols=157  Identities=27%  Similarity=0.336  Sum_probs=118.1

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .++.++.||+.||.|||+++   |+||||||+||+++.+|.++|+|||++........  ......|++.|+|||.+.+.
T Consensus       290 ~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~  364 (543)
T 3c4z_A          290 RAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGE  364 (543)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC--CBCCCCSCTTTSCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccCCCc--ccccccCCccccChhhhcCC
Confidence            56788999999999999999   99999999999999999999999999976543221  12234689999999999998


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      .++.++|+|||||++|+|++|..||.........  ........ ....     ..+     ......+.++|.+||+.|
T Consensus       365 ~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~--~~~~~~i~-~~~~-----~~p-----~~~s~~~~~li~~lL~~d  431 (543)
T 3c4z_A          365 EYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQRVL-EQAV-----TYP-----DKFSPASKDFCEALLQKD  431 (543)
T ss_dssp             CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH--HHHHHHHH-HCCC-----CCC-----TTSCHHHHHHHHHHSCSS
T ss_pred             CCChHHhcCcchHHHHHHHhCCCCCCCCccchhH--HHHHHHHh-hccc-----CCC-----cccCHHHHHHHHHhccCC
Confidence            8999999999999999999999999754321110  00111111 1110     011     112346788999999999


Q ss_pred             CCCCCCH-----HHHHHHhc
Q 027675          163 PNDRPTM-----SDVVIMLG  177 (220)
Q Consensus       163 p~~Rps~-----~~~l~~l~  177 (220)
                      |++||++     ++++.|-+
T Consensus       432 P~~R~~~~~~~a~ei~~Hpf  451 (543)
T 3c4z_A          432 PEKRLGFRDGSCDGLRTHPL  451 (543)
T ss_dssp             GGGSCCCBTTBSHHHHTSGG
T ss_pred             HhHCCCCcccCHHHHHcCcc
Confidence            9999964     78886653

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.95  E-value=5.3e-28  Score=204.49  Aligned_cols=155  Identities=28%  Similarity=0.351  Sum_probs=116.5

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCC---CCceecCccceeeecCCCCCcccceeecccCccChhhh
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHE---MNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYA   79 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~   79 (220)
                      .++.++.|++.||.|||+++   |+||||||+||+++..   +.++|+|||++........   .....+++.|+|||.+
T Consensus       137 ~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l  210 (494)
T 3lij_A          137 DAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK---MKERLGTAYYIAPEVL  210 (494)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBC---BCCCCSCTTTCCHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcc---ccccCCCcCeeCHHHH
Confidence            56789999999999999999   9999999999999764   4499999999876543221   2234688999999988


Q ss_pred             hcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           80 LGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        80 ~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      .+ .++.++|||||||++|+|++|..||............       ..+....  ....    .......+.++|.+||
T Consensus       211 ~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i-------~~~~~~~--~~~~----~~~~s~~~~~li~~~L  276 (494)
T 3lij_A          211 RK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV-------EKGKYTF--DSPE----WKNVSEGAKDLIKQML  276 (494)
T ss_dssp             TT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHTCCCC--CSGG----GTTSCHHHHHHHHHHT
T ss_pred             cc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------HhCCCCC--Cchh----cccCCHHHHHHHHHHC
Confidence            74 5889999999999999999999999765544332111       1111100  0000    0112346789999999


Q ss_pred             CCCCCCCCCHHHHHHHhc
Q 027675          160 QEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l~  177 (220)
                      +.||++|||+.+++++-+
T Consensus       277 ~~dp~~R~s~~e~l~hp~  294 (494)
T 3lij_A          277 QFDSQRRISAQQALEHPW  294 (494)
T ss_dssp             CSSTTTSCCHHHHHTCHH
T ss_pred             CCChhhCccHHHHhcCcc
Confidence            999999999999997643

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.95  E-value=5.2e-28  Score=191.52  Aligned_cols=158  Identities=23%  Similarity=0.323  Sum_probs=118.9

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhh-
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL-   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~-   80 (220)
                      ..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++........   .....+++.|.|||.+. 
T Consensus       124 ~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~  197 (298)
T 1phk_A          124 KETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIEC  197 (298)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccchhhcCCCcc---cccccCCccccCHHHhcc
Confidence            367889999999999999999   99999999999999999999999999876543221   22245788999999985 


Q ss_pred             -----cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHh
Q 027675           81 -----GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVG  155 (220)
Q Consensus        81 -----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  155 (220)
                           ...++.++|+||||+++|+|++|..||...+.......      .. .+... .     ...........+.+++
T Consensus       198 ~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~------~~-~~~~~-~-----~~~~~~~~~~~l~~li  264 (298)
T 1phk_A          198 SMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM------IM-SGNYQ-F-----GSPEWDDYSDTVKDLV  264 (298)
T ss_dssp             HHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HH-HTCCC-C-----CTTTGGGSCHHHHHHH
T ss_pred             ccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHH------Hh-cCCcc-c-----CcccccccCHHHHHHH
Confidence                 34578899999999999999999999975443322211      11 11110 0     0001112234688999


Q ss_pred             ccccCCCCCCCCCHHHHHHHhcC
Q 027675          156 LLCVQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       156 ~~cl~~~p~~Rps~~~~l~~l~~  178 (220)
                      .+||+.||++|||+.+++++-+.
T Consensus       265 ~~~l~~dp~~Rps~~~ll~h~~~  287 (298)
T 1phk_A          265 SRFLVVQPQKRYTAEEALAHPFF  287 (298)
T ss_dssp             HHHCCSSGGGSCCHHHHTTSGGG
T ss_pred             HHHccCCcccCCCHHHHHhChHh
Confidence            99999999999999999976543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.95  E-value=3.9e-28  Score=196.29  Aligned_cols=162  Identities=24%  Similarity=0.309  Sum_probs=118.8

Q ss_pred             chHHHHHHHHHHHHHHhhh-CCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQ-DSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~-~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~   80 (220)
                      ..++.++.|++.||.|||+ .|   ++|+||||+||+++.++.++|+|||++......    ......++..|.|||.+.
T Consensus       151 ~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~  223 (348)
T 2pml_X          151 QVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFS  223 (348)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGS
T ss_pred             HHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhc
Confidence            3578899999999999999 99   999999999999999999999999998765432    223346788999999998


Q ss_pred             cC-CCcc-cCceeehhHHHHHHHhcCccCcccch-hHHHhhHHHHHHHHHhccccccccCCC----------CCcCcHHH
Q 027675           81 GG-FFSV-KSDVFSFGVVVLEIISGKRNTGFYNS-ELALSLLGYAWKLWQEGKALDMMDQKP----------GAISKANE  147 (220)
Q Consensus        81 ~~-~~~~-~~DiwslG~il~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~  147 (220)
                      +. .++. ++|+||||+++|+|++|..||..... ......       ...+.. .......          ........
T Consensus       224 ~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-------i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  295 (348)
T 2pml_X          224 NESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN-------IRTKNI-EYPLDRNHFLYPLTNKKSTCSNNFL  295 (348)
T ss_dssp             SCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHH-------HTSCCC-CCCCSSSSSTTTTCC--------CC
T ss_pred             CCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH-------HhccCc-CCccchhhhhccccccccccchhhc
Confidence            77 5555 99999999999999999999975544 221111       111110 0000000          00000223


Q ss_pred             HHHHHHHhccccCCCCCCCCCHHHHHHHhcC
Q 027675          148 ILKCINVGLLCVQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       148 ~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~  178 (220)
                      ...+.++|.+||+.||++|||+.+++++-+.
T Consensus       296 ~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f  326 (348)
T 2pml_X          296 SNEDIDFLKLFLRKNPAERITSEDALKHEWL  326 (348)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHHTSGGG
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcCccc
Confidence            3578899999999999999999999987543

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.95  E-value=1.6e-28  Score=192.39  Aligned_cols=153  Identities=24%  Similarity=0.347  Sum_probs=110.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++.......   ......+++.|.|||.+.+
T Consensus       111 ~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~  184 (276)
T 2h6d_A          111 MEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISG  184 (276)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----------------CCTGGGTT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCc---ceecccCCccccCHHHHcC
Confidence            357889999999999999999   9999999999999999999999999987543221   1122456889999999987


Q ss_pred             CCC-cccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFF-SVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..+ +.++|+||||+++|+|++|..||...........       ...+..     ..+.     .....+.+++.+||+
T Consensus       185 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-------~~~~~~-----~~~~-----~~~~~l~~li~~~l~  247 (276)
T 2h6d_A          185 RLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKK-------IRGGVF-----YIPE-----YLNRSVATLLMHMLQ  247 (276)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-------HHHCCC-----CCCT-----TSCHHHHHHHHHHTC
T ss_pred             CCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH-------hhcCcc-----cCch-----hcCHHHHHHHHHHcc
Confidence            755 6899999999999999999999975443322111       111110     0111     112367889999999


Q ss_pred             CCCCCCCCHHHHHHHhc
Q 027675          161 EDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~  177 (220)
                      .||++|||+.+++++-+
T Consensus       248 ~~p~~Rps~~~~l~h~~  264 (276)
T 2h6d_A          248 VDPLKRATIKDIREHEW  264 (276)
T ss_dssp             SSGGGSCCHHHHHHSHH
T ss_pred             CChhhCCCHHHHHhChh
Confidence            99999999999998743

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.95  E-value=6.3e-29  Score=199.49  Aligned_cols=159  Identities=28%  Similarity=0.379  Sum_probs=99.7

Q ss_pred             hHHHHHHHHHHHHHHhhhC-CCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhh--
Q 027675            3 MLFNIILGVSRRLLYLHQD-SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYA--   79 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~-~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~--   79 (220)
                      .++.++.|++.||.|||+. +   ++||||||+||+++.++.++|+|||++........   .....++..|+|||.+  
T Consensus       126 ~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~  199 (327)
T 3aln_A          126 ILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDP  199 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC---------------------------
T ss_pred             HHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecccccc---cccCCCCccccCceeecc
Confidence            5678999999999999998 9   99999999999999999999999999865432211   1223578899999998  


Q ss_pred             --hcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcc
Q 027675           80 --LGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLL  157 (220)
Q Consensus        80 --~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  157 (220)
                        .+..++.++|+||||+++|+|++|..||..........           ......................+.++|.+
T Consensus       200 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~  268 (327)
T 3aln_A          200 SASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL-----------TQVVKGDPPQLSNSEEREFSPSFINFVNL  268 (327)
T ss_dssp             ------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------------CCCCCSCCCCCCCCSSCCCCHHHHHHHHH
T ss_pred             ccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHH-----------HHHhcCCCCCCCCcccccCCHHHHHHHHH
Confidence              45567899999999999999999999997543221100           00000000000000111123478899999


Q ss_pred             ccCCCCCCCCCHHHHHHHhcC
Q 027675          158 CVQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       158 cl~~~p~~Rps~~~~l~~l~~  178 (220)
                      ||+.||++||++.+++++-+.
T Consensus       269 ~l~~dp~~Rps~~ell~hp~~  289 (327)
T 3aln_A          269 CLTKDESKRPKYKELLKHPFI  289 (327)
T ss_dssp             HTCSSGGGSCCHHHHTTSHHH
T ss_pred             HhhCChhhCcCHHHHHhChHH
Confidence            999999999999999976543

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.95  E-value=3.1e-28  Score=207.98  Aligned_cols=159  Identities=24%  Similarity=0.280  Sum_probs=120.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.||+.||.|||+++   |+||||||+||+++.++.++|+|||++.......   ......|++.|+|||.+.+
T Consensus       286 ~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~  359 (576)
T 2acx_A          286 ARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKN  359 (576)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTC---CEECCCSCGGGCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccCc---cccccCCCccccCHHHHcC
Confidence            356789999999999999999   9999999999999999999999999997654322   1222468999999999999


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|+|||||++|+|++|..||...........   ..........     ..+     ......+.++|.+||+.
T Consensus       360 ~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~---i~~~i~~~~~-----~~p-----~~~s~~~~dLI~~lL~~  426 (576)
T 2acx_A          360 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE---VERLVKEVPE-----EYS-----ERFSPQARSLCSQLLCK  426 (576)
T ss_dssp             CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHH---HHHHHHHCCC-----CCC-----TTSCHHHHHHHHHHTCS
T ss_pred             CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHH---HHHHhhcccc-----cCC-----ccCCHHHHHHHHHhccC
Confidence            8899999999999999999999999975432211100   0011111100     011     11234778999999999


Q ss_pred             CCCCCC-----CHHHHHHHhcCc
Q 027675          162 DPNDRP-----TMSDVVIMLGSE  179 (220)
Q Consensus       162 ~p~~Rp-----s~~~~l~~l~~~  179 (220)
                      ||++||     +++++++|-+..
T Consensus       427 dP~~R~g~~~~sa~eil~HpfF~  449 (576)
T 2acx_A          427 DPAERLGCRGGSAREVKEHPLFK  449 (576)
T ss_dssp             SGGGSTTCSSSHHHHHHTSGGGT
T ss_pred             CHHHcCCCCCCCHHHHHhChhhc
Confidence            999999     789999775443

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.95  E-value=5.2e-28  Score=191.00  Aligned_cols=156  Identities=22%  Similarity=0.340  Sum_probs=115.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeC-CCCCceecCccceeeecCCCCCcccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLD-HEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~   80 (220)
                      ..++.++.|++.||.|||+.+ ..++|+||||+||+++ .++.++|+|||++......    ......+++.|+|||.+.
T Consensus       129 ~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~  203 (290)
T 1t4h_A          129 KVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYE  203 (290)
T ss_dssp             HHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGG
T ss_pred             HHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc----ccccccCCcCcCCHHHHh
Confidence            357889999999999999874 2399999999999997 7889999999998643321    222346788999999887


Q ss_pred             cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           81 GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      + .++.++|+||||+++|+|++|..||..........      .....+......        .......+.++|.+||+
T Consensus       204 ~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~------~~~~~~~~~~~~--------~~~~~~~l~~li~~~l~  268 (290)
T 1t4h_A          204 E-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY------RRVTSGVKPASF--------DKVAIPEVKEIIEGCIR  268 (290)
T ss_dssp             T-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH------HHHTTTCCCGGG--------GGCCCHHHHHHHHHHSC
T ss_pred             c-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHH------HHHhccCCcccc--------CCCCCHHHHHHHHHHcc
Confidence            5 48899999999999999999999996543322211      111111111111        11112367899999999


Q ss_pred             CCCCCCCCHHHHHHHhc
Q 027675          161 EDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~  177 (220)
                      .||++|||+.+++++-+
T Consensus       269 ~dp~~Rps~~ell~h~~  285 (290)
T 1t4h_A          269 QNKDERYSIKDLLNHAF  285 (290)
T ss_dssp             SSGGGSCCHHHHHTSGG
T ss_pred             CChhhCCCHHHHhhCcc
Confidence            99999999999998754

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.95  E-value=1.6e-28  Score=193.04  Aligned_cols=150  Identities=21%  Similarity=0.247  Sum_probs=112.2

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCC-------------------CCceecCccceeeecCCCCCc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHE-------------------MNPKISDFGLTRIFEGKQTDG   62 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~-------------------~~~~l~d~~~~~~~~~~~~~~   62 (220)
                      ..++.++.|++.||.|||+++   ++||||||+||+++.+                   ..++|+|||.+.......   
T Consensus       115 ~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---  188 (289)
T 1x8b_A          115 AELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ---  188 (289)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCSC---
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc---
Confidence            357889999999999999999   9999999999999844                   478999999987654322   


Q ss_pred             ccceeecccCccChhhhhcC-CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCC
Q 027675           63 TTNRVVGTYGYMSPEYALGG-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGA  141 (220)
Q Consensus        63 ~~~~~~~~~~y~aPe~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  141 (220)
                         ...++..|.|||.+.+. .++.++||||||+++|+|++|.+++.....  .        .....+......    . 
T Consensus       189 ---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--~--------~~~~~~~~~~~~----~-  250 (289)
T 1x8b_A          189 ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ--W--------HEIRQGRLPRIP----Q-  250 (289)
T ss_dssp             ---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH--H--------HHHHTTCCCCCS----S-
T ss_pred             ---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH--H--------HHHHcCCCCCCC----c-
Confidence               13478899999999876 566899999999999999999877643221  1        111111111111    1 


Q ss_pred             cCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          142 ISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       142 ~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                          .....+.+++.+||+.||++|||+.+++++-+..
T Consensus       251 ----~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~  284 (289)
T 1x8b_A          251 ----VLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL  284 (289)
T ss_dssp             ----CCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC-
T ss_pred             ----ccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhh
Confidence                1224678999999999999999999999876443

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.95  E-value=2.7e-28  Score=194.76  Aligned_cols=157  Identities=25%  Similarity=0.416  Sum_probs=109.0

Q ss_pred             chHHHHHHHHHHHHHHhhhC-CCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQD-SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~-~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~   80 (220)
                      ..++.++.|++.||.|||++ +   ++|+||||+||+++.++.++|+|||++........   .....+++.|+|||.+.
T Consensus       124 ~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~  197 (318)
T 2dyl_A          124 RILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA---KDRSAGCAAYMAPERID  197 (318)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----------------CCTTCCHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc---ccccCCCccccChhhcc
Confidence            35778999999999999995 8   99999999999999999999999999865432211   22245788999999984


Q ss_pred             -----cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHh
Q 027675           81 -----GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVG  155 (220)
Q Consensus        81 -----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  155 (220)
                           +..++.++||||||+++|+|++|..||.........     ...... +.....    +.   .......+.++|
T Consensus       198 ~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~~~~~~-~~~~~~----~~---~~~~~~~l~~li  264 (318)
T 2dyl_A          198 PPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV-----LTKVLQ-EEPPLL----PG---HMGFSGDFQSFV  264 (318)
T ss_dssp             --------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-----HHHHHH-SCCCCC----CS---SSCCCHHHHHHH
T ss_pred             cccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHH-----HHHHhc-cCCCCC----Cc---cCCCCHHHHHHH
Confidence                 446788999999999999999999999753322111     111111 111100    00   011223678899


Q ss_pred             ccccCCCCCCCCCHHHHHHHhc
Q 027675          156 LLCVQEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       156 ~~cl~~~p~~Rps~~~~l~~l~  177 (220)
                      .+||+.||.+||++++++++-+
T Consensus       265 ~~~l~~dp~~Rps~~~ll~h~~  286 (318)
T 2dyl_A          265 KDCLTKDHRKRPKYNKLLEHSF  286 (318)
T ss_dssp             HHHTCSCTTTSCCHHHHTTSHH
T ss_pred             HHHccCChhHCcCHHHHhhCHH
Confidence            9999999999999999997653

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.94  E-value=2e-28  Score=203.11  Aligned_cols=160  Identities=24%  Similarity=0.306  Sum_probs=111.7

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCC---CceecCccceeeecCCCCCcccceeecccCccChhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEM---NPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEY   78 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~   78 (220)
                      .+++.++.|++.||+|||+++   |+||||||+||+++.++   .++|+|||++.......   ......|++.|+|||.
T Consensus       239 ~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~  312 (419)
T 3i6u_A          239 ATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEV  312 (419)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC--------------CTTCCTTT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeecccceecCCCc---cccccCCCCCccCcee
Confidence            357889999999999999999   99999999999997554   49999999987543221   1223567899999999


Q ss_pred             hhc---CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHh
Q 027675           79 ALG---GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVG  155 (220)
Q Consensus        79 ~~~---~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  155 (220)
                      +.+   ..++.++|+||||+++|+|++|..||..........      .....+.......      ........+.++|
T Consensus       313 ~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~------~~i~~~~~~~~~~------~~~~~~~~~~~li  380 (419)
T 3i6u_A          313 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK------DQITSGKYNFIPE------VWAEVSEKALDLV  380 (419)
T ss_dssp             TC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHH------HHHHTTCCCCCHH------HHTTSCHHHHHHH
T ss_pred             eecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHH------HHHhcCCCCCCch------hhcccCHHHHHHH
Confidence            853   567889999999999999999999996533221110      1111111100000      0011234688999


Q ss_pred             ccccCCCCCCCCCHHHHHHHhcCc
Q 027675          156 LLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       156 ~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      .+||+.||++|||+++++++-+..
T Consensus       381 ~~~L~~dP~~Rps~~e~l~hp~~~  404 (419)
T 3i6u_A          381 KKLLVVDPKARFTTEEALRHPWLQ  404 (419)
T ss_dssp             HHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred             HHHccCChhHCcCHHHHhCCcccC
Confidence            999999999999999999886543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.94  E-value=1e-28  Score=197.14  Aligned_cols=174  Identities=21%  Similarity=0.260  Sum_probs=116.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeC-CCCCceecCccceeeecCCCC-CcccceeecccCccChhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLD-HEMNPKISDFGLTRIFEGKQT-DGTTNRVVGTYGYMSPEYA   79 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~-~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~y~aPe~~   79 (220)
                      ..++.++.|++.||+|||+++   ++||||||+||+++ .++.++|+|||++........ ........++..|.|||.+
T Consensus       120 ~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  196 (320)
T 2i6l_A          120 EHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLL  196 (320)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHh
Confidence            357889999999999999999   99999999999996 567899999999875432111 1111223457789999988


Q ss_pred             hc-CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHH--------HHHHhcc----ccccccCCCC-CcCcH
Q 027675           80 LG-GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAW--------KLWQEGK----ALDMMDQKPG-AISKA  145 (220)
Q Consensus        80 ~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~----~~~~~~~~~~-~~~~~  145 (220)
                      .+ ..++.++|+||||+++|+|++|..||................        .......    .......... .....
T Consensus       197 ~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (320)
T 2i6l_A          197 LSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLP  276 (320)
T ss_dssp             HCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHST
T ss_pred             cCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcc
Confidence            76 568899999999999999999999997655433221110000        0000000    0000000000 00001


Q ss_pred             HHHHHHHHHhccccCCCCCCCCCHHHHHHHhcC
Q 027675          146 NEILKCINVGLLCVQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       146 ~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~  178 (220)
                      .....+.++|.+||+.||++|||+++++++-+.
T Consensus       277 ~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  309 (320)
T 2i6l_A          277 GISREAVDFLEQILTFSPMDRLTAEEALSHPYM  309 (320)
T ss_dssp             TCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHH
T ss_pred             hhhHHHHHHHHHHcCCCccccCCHHHHhCCccc
Confidence            123478899999999999999999999976543

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.94  E-value=7.1e-28  Score=204.17  Aligned_cols=157  Identities=28%  Similarity=0.337  Sum_probs=118.6

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCC---CceecCccceeeecCCCCCcccceeecccCccChhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEM---NPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEY   78 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~   78 (220)
                      ..++.++.|++.||.|||+.+   |+||||||+||+++.++   .++|+|||++.......   ......+++.|+|||.
T Consensus       146 ~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~  219 (504)
T 3q5i_A          146 CDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEV  219 (504)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHH
Confidence            357889999999999999999   99999999999998776   58999999997654322   1223468899999999


Q ss_pred             hhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           79 ALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        79 ~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                      +.+ .++.++|||||||++|+|++|..||...+........       ..+.......      ........+.++|.+|
T Consensus       220 ~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i-------~~~~~~~~~~------~~~~~s~~~~~li~~~  285 (504)
T 3q5i_A          220 LKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV-------EKGKYYFDFN------DWKNISDEAKELIKLM  285 (504)
T ss_dssp             HTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHCCCCCCHH------HHTTSCHHHHHHHHHH
T ss_pred             hcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------HcCCCCCCcc------ccCCCCHHHHHHHHHH
Confidence            875 5889999999999999999999999765544332211       1111100000      0001234688999999


Q ss_pred             cCCCCCCCCCHHHHHHHhcC
Q 027675          159 VQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       159 l~~~p~~Rps~~~~l~~l~~  178 (220)
                      |+.||.+|||+++++++-+.
T Consensus       286 L~~dp~~R~t~~e~l~h~~~  305 (504)
T 3q5i_A          286 LTYDYNKRCTAEEALNSRWI  305 (504)
T ss_dssp             TCSSTTTSCCHHHHHTSHHH
T ss_pred             cCCChhHCCCHHHHhcCHhh
Confidence            99999999999999976543

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.94  E-value=6.6e-28  Score=209.97  Aligned_cols=158  Identities=25%  Similarity=0.345  Sum_probs=118.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||.|||+++   |+||||||+||+++.++.++|+|||++......... ......+++.|+|||.+.+
T Consensus       491 ~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~  566 (656)
T 2j0j_A          491 ASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINF  566 (656)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-----------CCGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecCCCcce-eccCCCCCcceeCHHHhcC
Confidence            356789999999999999999   999999999999999999999999998754332211 1112345678999999998


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++||||||+++|+|++ |..||...........       ...+......         ......+.++|.+||.
T Consensus       567 ~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~-------i~~~~~~~~~---------~~~~~~l~~li~~~l~  630 (656)
T 2j0j_A          567 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR-------IENGERLPMP---------PNCPPTLYSLMTKCWA  630 (656)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-------HHHTCCCCCC---------TTCCHHHHHHHHHHTC
T ss_pred             CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-------HHcCCCCCCC---------ccccHHHHHHHHHHcC
Confidence            889999999999999999997 9999876544332211       1111111111         1123467899999999


Q ss_pred             CCCCCCCCHHHHHHHhcCc
Q 027675          161 EDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~  179 (220)
                      .||++|||+.++++.|+..
T Consensus       631 ~dP~~RPs~~el~~~L~~i  649 (656)
T 2j0j_A          631 YDPSRRPRFTELKAQLSTI  649 (656)
T ss_dssp             SSGGGSCCHHHHHHHHHHH
T ss_pred             CChhHCcCHHHHHHHHHHH
Confidence            9999999999999988654

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.94  E-value=1e-27  Score=191.21  Aligned_cols=148  Identities=22%  Similarity=0.363  Sum_probs=115.6

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeC-CCCCceecCccceeeecCCCCCcccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLD-HEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~   80 (220)
                      ..++.++.|++.||.|||+++   ++||||||+||+++ .++.++|+|||++.......    .....++..|.|||.+.
T Consensus       139 ~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~  211 (312)
T 2iwi_A          139 GPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWIS  211 (312)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeee
Confidence            357889999999999999999   99999999999998 78899999999987654322    22345788999999988


Q ss_pred             cCCC-cccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           81 GGFF-SVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        81 ~~~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      +..+ +.++|+||||+++|+|++|..||......            . ... ..    .+     ......+.++|.+||
T Consensus       212 ~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------------~-~~~-~~----~~-----~~~~~~~~~li~~~l  268 (312)
T 2iwi_A          212 RHQYHALPATVWSLGILLYDMVCGDIPFERDQEI------------L-EAE-LH----FP-----AHVSPDCCALIRRCL  268 (312)
T ss_dssp             HSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH------------H-HTC-CC----CC-----TTSCHHHHHHHHHHT
T ss_pred             cCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH------------h-hhc-cC----Cc-----ccCCHHHHHHHHHHc
Confidence            7655 45899999999999999999998632110            0 000 00    00     112336788999999


Q ss_pred             CCCCCCCCCHHHHHHHhcCc
Q 027675          160 QEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l~~~  179 (220)
                      +.||++|||+++++++-+..
T Consensus       269 ~~~p~~Rps~~e~l~~~~~~  288 (312)
T 2iwi_A          269 APKPSSRPSLEEILLDPWMQ  288 (312)
T ss_dssp             CSSTTTSCCHHHHHHSTTTC
T ss_pred             cCChhhCcCHHHHhcChhhc
Confidence            99999999999999976544

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.94  E-value=6.4e-28  Score=193.30  Aligned_cols=158  Identities=24%  Similarity=0.311  Sum_probs=115.0

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCC---ceecCccceeeecCCCCCcccceeecccCccChhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMN---PKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEY   78 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~---~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~   78 (220)
                      ..++.++.|++.||.|||+++   ++||||||+||+++.++.   ++|+|||++......   .......+++.|.|||.
T Consensus       114 ~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~  187 (322)
T 2ycf_A          114 ATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---SLMRTLCGTPTYLAPEV  187 (322)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCC---HHHHHHHSCCTTCCHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCccceecccc---cccccccCCcCccCchh
Confidence            357789999999999999999   999999999999987665   999999998764321   11223457889999999


Q ss_pred             hh---cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHh
Q 027675           79 AL---GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVG  155 (220)
Q Consensus        79 ~~---~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  155 (220)
                      +.   +..++.++|+||||+++|+|++|..||.........  .    .....+.......      ........+.++|
T Consensus       188 ~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~----~~~~~~~~~~~~~------~~~~~~~~~~~li  255 (322)
T 2ycf_A          188 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--K----DQITSGKYNFIPE------VWAEVSEKALDLV  255 (322)
T ss_dssp             HHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH--H----HHHHHTCCCCCHH------HHTTSCHHHHHHH
T ss_pred             hccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH--H----HHHHhCccccCch------hhhhcCHHHHHHH
Confidence            74   456788999999999999999999999643322111  0    1111111100000      0011234678999


Q ss_pred             ccccCCCCCCCCCHHHHHHHhc
Q 027675          156 LLCVQEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       156 ~~cl~~~p~~Rps~~~~l~~l~  177 (220)
                      .+||..||++||++.+++++-+
T Consensus       256 ~~~l~~dP~~Rps~~~~l~h~~  277 (322)
T 2ycf_A          256 KKLLVVDPKARFTTEEALRHPW  277 (322)
T ss_dssp             HHHSCSSTTTSCCHHHHHTSGG
T ss_pred             HHHcccCHhhCCCHHHHhhCcC
Confidence            9999999999999999997643

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.94  E-value=2e-27  Score=188.16  Aligned_cols=160  Identities=24%  Similarity=0.364  Sum_probs=109.6

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCC------------CCcccceeec
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQ------------TDGTTNRVVG   69 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~------------~~~~~~~~~~   69 (220)
                      ..++.++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++.......            .........+
T Consensus       116 ~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (303)
T 1zy4_A          116 DEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIG  192 (303)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCCCSCTTC------------------------
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCC
Confidence            357789999999999999999   9999999999999999999999999986543211            0111223457


Q ss_pred             ccCccChhhhhcC-CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHH
Q 027675           70 TYGYMSPEYALGG-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEI  148 (220)
Q Consensus        70 ~~~y~aPe~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (220)
                      +..|.|||.+.+. .++.++|+||||+++|+|++   ||.....  ....   ... .... ....     .........
T Consensus       193 ~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~--~~~~---~~~-~~~~-~~~~-----~~~~~~~~~  257 (303)
T 1zy4_A          193 TAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME--RVNI---LKK-LRSV-SIEF-----PPDFDDNKM  257 (303)
T ss_dssp             -CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH--HHHH---HHH-HHST-TCCC-----CTTCCTTTS
T ss_pred             cccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh--HHHH---HHh-cccc-cccc-----Cccccccch
Confidence            8899999999865 57899999999999999998   4332111  1111   111 1111 0001     111112233


Q ss_pred             HHHHHHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          149 LKCINVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       149 ~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      ..+.++|.+||+.||++|||+.+++++-+..
T Consensus       258 ~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~  288 (303)
T 1zy4_A          258 KVEKKIIRLLIDHDPNKRPGARTLLNSGWLP  288 (303)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHSSCSC
T ss_pred             HHHHHHHHHHHhcCcccCcCHHHHhCCCCcC
Confidence            4678899999999999999999999986553

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.94  E-value=1.8e-27  Score=187.70  Aligned_cols=155  Identities=27%  Similarity=0.298  Sum_probs=114.9

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCC---CCceecCccceeeecCCCCCcccceeecccCccChhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHE---MNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEY   78 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~   78 (220)
                      ..++.++.|++.||.|||+++   ++|+||||+||+++.+   +.++|+|||++........   .....+++.|.|||.
T Consensus       121 ~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~  194 (287)
T 2wei_A          121 HDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEV  194 (287)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS---CSCHHHHHTTCCHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc---cccccCcccccChHH
Confidence            357889999999999999999   9999999999999764   4699999999865432221   112346789999999


Q ss_pred             hhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           79 ALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        79 ~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                      +.+. ++.++|+||||+++|+|++|..||...+......       ....+.....      ..........+.++|.+|
T Consensus       195 ~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-------~~~~~~~~~~------~~~~~~~~~~~~~li~~~  260 (287)
T 2wei_A          195 LRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK-------RVETGKYAFD------LPQWRTISDDAKDLIRKM  260 (287)
T ss_dssp             HTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------HHHHCCCCCC------SGGGTTSCHHHHHHHHHH
T ss_pred             hcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHH-------HHHcCCCCCC------chhhhhcCHHHHHHHHHH
Confidence            8765 7899999999999999999999997654433211       1111111100      000011234678999999


Q ss_pred             cCCCCCCCCCHHHHHHHh
Q 027675          159 VQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       159 l~~~p~~Rps~~~~l~~l  176 (220)
                      |..||++|||+.+++++-
T Consensus       261 l~~dp~~Rps~~ell~hp  278 (287)
T 2wei_A          261 LTFHPSLRITATQCLEHP  278 (287)
T ss_dssp             TCSSGGGSCCHHHHHHSH
T ss_pred             cccChhhCcCHHHHhcCH
Confidence            999999999999999864

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.92  E-value=1.7e-26  Score=199.59  Aligned_cols=165  Identities=23%  Similarity=0.214  Sum_probs=113.1

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCC---ceecCccceeeecCCCCCcccceeecccCccChhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMN---PKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEY   78 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~---~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~   78 (220)
                      ..++.++.+++.||+|||+.|   ++||||||+||+++.++.   ++|+|||++........   .....++..|+|||.
T Consensus       121 ~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~  194 (676)
T 3qa8_A          121 GPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGTLQYLAPEL  194 (676)
T ss_dssp             SHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCC---CCCCCSCCTTCSSCS
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccccccccccccc---cccccCCcccCChHH
Confidence            467899999999999999999   999999999999987765   89999999876543221   223467889999999


Q ss_pred             hhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccc-------cccC-CCCCcCcHHHHHH
Q 027675           79 ALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALD-------MMDQ-KPGAISKANEILK  150 (220)
Q Consensus        79 ~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~-~~~~~~~~~~~~~  150 (220)
                      +.+..++.++|+||||+++|+|++|..||............ .............       .... .............
T Consensus       195 l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~-i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~  273 (676)
T 3qa8_A          195 LEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK-VREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGK  273 (676)
T ss_dssp             SCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTT-CC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHH
T ss_pred             hccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhh-hhcccchhhhhhhhhccccccccccCCchhhchhhhHH
Confidence            99888999999999999999999999998643221110000 0000000000000       0000 0011122335567


Q ss_pred             HHHHhccccCCCCCCCCCHHHHH
Q 027675          151 CINVGLLCVQEDPNDRPTMSDVV  173 (220)
Q Consensus       151 ~~~li~~cl~~~p~~Rps~~~~l  173 (220)
                      +.++|.+||..||++|||+.+++
T Consensus       274 L~dLI~~mL~~DP~kRPTa~elL  296 (676)
T 3qa8_A          274 LERWLQCMLMWHQRQRGTDPQNP  296 (676)
T ss_dssp             HHHHHHHHSCSSCC---CCTTCC
T ss_pred             HHHHHHHHccCCHhhCcCHHHHh
Confidence            89999999999999999998754

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.92  E-value=1.1e-25  Score=178.59  Aligned_cols=138  Identities=17%  Similarity=0.221  Sum_probs=99.9

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCC---CCCceecCccceeeecCCCCCcccceeecccCccChhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDH---EMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEY   78 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~   78 (220)
                      ..++.++.|++.||.|||+.+   ++||||||+||+++.   ++.++|+|||++....                      
T Consensus       117 ~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~----------------------  171 (299)
T 3m2w_A          117 REASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT----------------------  171 (299)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECT----------------------
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccccccc----------------------
Confidence            357899999999999999999   999999999999998   7889999999875422                      


Q ss_pred             hhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCc---HHHHHHHHHHh
Q 027675           79 ALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISK---ANEILKCINVG  155 (220)
Q Consensus        79 ~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li  155 (220)
                        +..++.++|+||||+++|+|++|..||..........            ...............   ......+.++|
T Consensus       172 --~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (299)
T 3m2w_A          172 --GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP------------GMKTRIRMGQYEFPNPEWSEVSEEVKMLI  237 (299)
T ss_dssp             --TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C------------CSCCSSCTTCCSSCHHHHTTSCHHHHHHH
T ss_pred             --cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH------------HHHHHHhhccccCCchhcccCCHHHHHHH
Confidence              1235678999999999999999999986433221110            000000000000000   11245788999


Q ss_pred             ccccCCCCCCCCCHHHHHHHhcC
Q 027675          156 LLCVQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       156 ~~cl~~~p~~Rps~~~~l~~l~~  178 (220)
                      .+||+.||++|||+.+++++-+.
T Consensus       238 ~~~l~~dP~~Rps~~e~l~hp~~  260 (299)
T 3m2w_A          238 RNLLKTEPTQRMTITEFMNHPWI  260 (299)
T ss_dssp             HHHTCSSTTTSCCHHHHHTSHHH
T ss_pred             HHHcccChhhCCCHHHHhcChhh
Confidence            99999999999999999986543

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.91  E-value=2.6e-25  Score=194.64  Aligned_cols=142  Identities=20%  Similarity=0.269  Sum_probs=109.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+++.++.||+.||.|||++|   |+||||||+||+++.+ .++|+|||++......      ....|++.|+|||++.+
T Consensus       182 ~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~  251 (681)
T 2pzi_A          182 AEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRT  251 (681)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEETTCC------SCCCCCTTTSCTTHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhcccC------CccCCCccccCHHHHcC
Confidence            467899999999999999999   9999999999999885 8999999998764332      23467899999999887


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      .. +.++||||||+++|+|++|..||......                       ..+...........+.++|.+||+.
T Consensus       252 ~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~-----------------------~~~~~~~~~~~~~~l~~li~~~l~~  307 (681)
T 2pzi_A          252 GP-TVATDIYTVGRTLAALTLDLPTRNGRYVD-----------------------GLPEDDPVLKTYDSYGRLLRRAIDP  307 (681)
T ss_dssp             CS-CHHHHHHHHHHHHHHHHSCCCEETTEECS-----------------------SCCTTCHHHHHCHHHHHHHHHHTCS
T ss_pred             CC-CCceehhhhHHHHHHHHhCCCCCcccccc-----------------------cccccccccccCHHHHHHHhhhccC
Confidence            64 88999999999999999998887521100                       0111111122335788999999999


Q ss_pred             CCCCCCCHHH-HHHHhc
Q 027675          162 DPNDRPTMSD-VVIMLG  177 (220)
Q Consensus       162 ~p~~Rps~~~-~l~~l~  177 (220)
                      ||++||+..+ +...+.
T Consensus       308 dP~~R~~~~~~l~~~l~  324 (681)
T 2pzi_A          308 DPRQRFTTAEEMSAQLT  324 (681)
T ss_dssp             SGGGSCSSHHHHHHHHH
T ss_pred             ChhhCCCHHHHHHHHHH
Confidence            9999996554 444443

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.89  E-value=4.2e-24  Score=172.08  Aligned_cols=150  Identities=14%  Similarity=0.032  Sum_probs=109.4

Q ss_pred             chHHHHHHHHHHHHHHhh-hCCCCCeEeccCCCCceeeCCCC--------------------CceecCccceeeecCCCC
Q 027675            2 EMLFNIILGVSRRLLYLH-QDSKLRIIHRDFKTSNILLDHEM--------------------NPKISDFGLTRIFEGKQT   60 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH-~~~~~~i~H~dlk~~nili~~~~--------------------~~~l~d~~~~~~~~~~~~   60 (220)
                      ..++.+++||+.||.||| +.+   |+||||||+||+++.++                    .+||+|||+++....   
T Consensus       161 ~~~~~i~~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~---  234 (336)
T 2vuw_A          161 ATAKSILHQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD---  234 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET---
T ss_pred             HHHHHHHHHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC---
Confidence            467899999999999999 899   99999999999999887                    899999999976542   


Q ss_pred             CcccceeecccCccChhhhhcCCCcccCceeehhHH-HHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCC
Q 027675           61 DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVV-VLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKP  139 (220)
Q Consensus        61 ~~~~~~~~~~~~y~aPe~~~~~~~~~~~DiwslG~i-l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  139 (220)
                          ....|++.|+|||++.+.. +.++|||||++. .+++++|..||........     ........ .   ......
T Consensus       235 ----~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~-----~~~~~~~~-~---~~~~~~  300 (336)
T 2vuw_A          235 ----GIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHY-----LTDKMLKQ-M---TFKTKC  300 (336)
T ss_dssp             ----TEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHH-----HHHHHHHT-C---CCSSCC
T ss_pred             ----CcEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhH-----HHHhhhhh-h---ccCccc
Confidence                1246889999999998876 889999998766 7778889888742110000     00011100 0   011111


Q ss_pred             CCcCcHHHHHHHHHHhccccCCCCCCCCCHHHHH-HHh
Q 027675          140 GAISKANEILKCINVGLLCVQEDPNDRPTMSDVV-IML  176 (220)
Q Consensus       140 ~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l-~~l  176 (220)
                      ...........+.++|.+||+.|     |+++++ +|=
T Consensus       301 ~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp  333 (336)
T 2vuw_A          301 NTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHS  333 (336)
T ss_dssp             CSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCG
T ss_pred             chhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCC
Confidence            12223456678999999999976     999999 663

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.89  E-value=1.6e-24  Score=170.97  Aligned_cols=134  Identities=10%  Similarity=0.021  Sum_probs=98.2

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      ++.+++.|++.||.|||++|   |+||||||+||+++.++.++|++++                      |.+       
T Consensus       130 ~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~----------------------~~~-------  177 (286)
T 3uqc_A          130 GAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA----------------------TMP-------  177 (286)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC----------------------CCT-------
T ss_pred             HHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc----------------------ccC-------
Confidence            46789999999999999999   9999999999999999999987443                      222       


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCC--cCcHHHHHHHHHHhccccC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGA--ISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~  160 (220)
                      .++.++||||||+++|+|++|+.||...+.......            ...........  .........+.++|.+||+
T Consensus       178 ~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  245 (286)
T 3uqc_A          178 DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP------------AERDTAGQPIEPADIDRDIPFQISAVAARSVQ  245 (286)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE------------CCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHC
T ss_pred             CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH------------HHHHhccCCCChhhcccCCCHHHHHHHHHHcc
Confidence            257899999999999999999999975433211000            00000000000  0001123468899999999


Q ss_pred             CCCCCCCCHHHHHHHhcCccc
Q 027675          161 EDPNDRPTMSDVVIMLGSEAV  181 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~~~  181 (220)
                      .||++| |+.++++.|.....
T Consensus       246 ~dP~~R-s~~el~~~L~~~~~  265 (286)
T 3uqc_A          246 GDGGIR-SASTLLNLMQQATA  265 (286)
T ss_dssp             TTSSCC-CHHHHHHHHHHHHC
T ss_pred             cCCccC-CHHHHHHHHHHHhc
Confidence            999999 99999999976644

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.79  E-value=1.4e-20  Score=161.30  Aligned_cols=96  Identities=18%  Similarity=0.134  Sum_probs=64.8

Q ss_pred             HHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcCCC
Q 027675            5 FNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGGFF   84 (220)
Q Consensus         5 ~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~~~   84 (220)
                      .+|+.||+.||+|+|++|   |+||||||+|||++.+|.+||+|||+++.......  ......||+.|+|||++.+. +
T Consensus       342 ~~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~--~~~t~vGTp~YmAPE~l~g~-~  415 (569)
T 4azs_A          342 EKILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS--WPTNLVQSFFVFVNELFAEN-K  415 (569)
T ss_dssp             HHHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC---C--CSHHHHHHHHHHHHHHC-----
T ss_pred             HHHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCCc--cccCceechhhccHHHhCCC-C
Confidence            468999999999999999   99999999999999999999999999875443222  12235789999999999875 4


Q ss_pred             cccCceeehhHHHHHHHhcCcc
Q 027675           85 SVKSDVFSFGVVVLEIISGKRN  106 (220)
Q Consensus        85 ~~~~DiwslG~il~~ll~g~~p  106 (220)
                      ...+|+|++|++++++.++..+
T Consensus       416 ~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          416 SWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             -------------CCCCTTHHH
T ss_pred             CCcccccccccchhhhccccch
Confidence            6789999999998887766544

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.53  E-value=9.1e-16  Score=130.83  Aligned_cols=99  Identities=20%  Similarity=0.243  Sum_probs=78.9

Q ss_pred             HHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCc-----ccceeecccCccChhh
Q 027675            4 LFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG-----TTNRVVGTYGYMSPEY   78 (220)
Q Consensus         4 ~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~-----~~~~~~~~~~y~aPe~   78 (220)
                      ++.++.|+++||.|||+++   |+||||||+||+++.  .++|+|||+++.........     ......+++.|+|||.
T Consensus       433 ~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv  507 (540)
T 3en9_A          433 NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEI  507 (540)
T ss_dssp             CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHH
T ss_pred             HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHH
Confidence            4679999999999999999   999999999999999  99999999998654321111     1124578999999999


Q ss_pred             hhc--CCCcccCceeehhHHHHHHHhcCccC
Q 027675           79 ALG--GFFSVKSDVFSFGVVVLEIISGKRNT  107 (220)
Q Consensus        79 ~~~--~~~~~~~DiwslG~il~~ll~g~~p~  107 (220)
                      +.+  ..|+..+|+|+..+-..+...++..|
T Consensus       508 ~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          508 WERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             HHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            986  56788899998877777766655544

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.27  E-value=1.3e-12  Score=102.60  Aligned_cols=60  Identities=17%  Similarity=0.047  Sum_probs=51.8

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ....++.|++.||.|||+.|   |+||||||+||+++ ++.++|+|||+++.               ...+.|||.+..
T Consensus       194 ~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~r  253 (282)
T 1zar_A          194 NPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILER  253 (282)
T ss_dssp             CHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence            45689999999999999999   99999999999999 99999999998853               234678887653

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.06  E-value=1.9e-10  Score=89.01  Aligned_cols=47  Identities=19%  Similarity=0.218  Sum_probs=43.8

Q ss_pred             hHHHHHHHHHHHHHHhh-hCCCCCeEeccCCCCceeeCCCCCceecCccceee
Q 027675            3 MLFNIILGVSRRLLYLH-QDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRI   54 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH-~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~   54 (220)
                      .+..++.|++.+|.+|| +.|   |+||||||.||+++.  .++|+|||++..
T Consensus       171 ~~~~i~~qi~~~l~~lH~~~g---ivHrDlkp~NILl~~--~~~liDFG~a~~  218 (258)
T 1zth_A          171 DVEGIFNDVVENVKRLYQEAE---LVHADLSEYNIMYID--KVYFIDMGQAVT  218 (258)
T ss_dssp             CHHHHHHHHHHHHHHHHHTSC---EECSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEEcC--cEEEEECccccc
Confidence            56789999999999999 999   999999999999998  899999999864

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=98.57  E-value=3.9e-08  Score=80.03  Aligned_cols=49  Identities=27%  Similarity=0.342  Sum_probs=42.7

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCC----------ceecCccceee
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMN----------PKISDFGLTRI   54 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~----------~~l~d~~~~~~   54 (220)
                      ....++.|++.+|.+||+.|   ++||||||.|||+++++.          +.++||+-+..
T Consensus       206 ~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          206 DPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             CHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence            45678999999999999999   999999999999987763          78999986654

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=97.46  E-value=2.1e-05  Score=61.85  Aligned_cols=82  Identities=22%  Similarity=0.308  Sum_probs=48.1

Q ss_pred             CCeEeccCCCCceeeCC--CCCceecCccceeeecCCCC-----Cc---cc----ceeecccCccC-hhhhhcCCCcccC
Q 027675           24 LRIIHRDFKTSNILLDH--EMNPKISDFGLTRIFEGKQT-----DG---TT----NRVVGTYGYMS-PEYALGGFFSVKS   88 (220)
Q Consensus        24 ~~i~H~dlk~~nili~~--~~~~~l~d~~~~~~~~~~~~-----~~---~~----~~~~~~~~y~a-Pe~~~~~~~~~~~   88 (220)
                      ..++|+|+++.||+++.  .+.+.++||+.+........     ..   ..    ..+...+.... |+.....  ....
T Consensus       191 ~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~--~~~~  268 (304)
T 3sg8_A          191 PCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKY--RMKE  268 (304)
T ss_dssp             CEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHH--HHHH
T ss_pred             ceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHH--HHHH
Confidence            35899999999999987  45578999998765432100     00   00    00000001111 2222111  1225


Q ss_pred             ceeehhHHHHHHHhcCccC
Q 027675           89 DVFSFGVVVLEIISGKRNT  107 (220)
Q Consensus        89 DiwslG~il~~ll~g~~p~  107 (220)
                      +.|+++.++|.+.+|..+|
T Consensus       269 ~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          269 KYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHHHHHHHHHcCCHHH
Confidence            7899999999999998764

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=97.38  E-value=0.00012  Score=56.06  Aligned_cols=29  Identities=24%  Similarity=0.326  Sum_probs=24.2

Q ss_pred             CeEeccCCCCceeeCCCCCceecCcccee
Q 027675           25 RIIHRDFKTSNILLDHEMNPKISDFGLTR   53 (220)
Q Consensus        25 ~i~H~dlk~~nili~~~~~~~l~d~~~~~   53 (220)
                      .++|||+++.||++++.+.+.++||+.+.
T Consensus       184 ~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          184 VFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             EEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             eEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence            48999999999999775556799998764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=97.27  E-value=0.00027  Score=56.78  Aligned_cols=31  Identities=19%  Similarity=0.473  Sum_probs=26.2

Q ss_pred             CCeEeccCCCCceeeCCCCC--ceecCccceee
Q 027675           24 LRIIHRDFKTSNILLDHEMN--PKISDFGLTRI   54 (220)
Q Consensus        24 ~~i~H~dlk~~nili~~~~~--~~l~d~~~~~~   54 (220)
                      ..++|||+++.||+++.++.  +.++||+.+..
T Consensus       216 ~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          216 TSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             ceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence            35999999999999987754  58999998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=97.22  E-value=0.00019  Score=54.61  Aligned_cols=28  Identities=21%  Similarity=0.257  Sum_probs=24.3

Q ss_pred             eEeccCCCCceeeCCCCCceecCcccee
Q 027675           26 IIHRDFKTSNILLDHEMNPKISDFGLTR   53 (220)
Q Consensus        26 i~H~dlk~~nili~~~~~~~l~d~~~~~   53 (220)
                      ++|+|+++.||++++.+.+.++||+.+.
T Consensus       186 l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          186 VTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             EECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             EECCCCCCCcEEEECCcEEEEEcchhcc
Confidence            9999999999999776556799999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=96.28  E-value=0.0053  Score=48.45  Aligned_cols=29  Identities=24%  Similarity=0.380  Sum_probs=26.2

Q ss_pred             CeEeccCCCCceeeCCCCCceecCcccee
Q 027675           25 RIIHRDFKTSNILLDHEMNPKISDFGLTR   53 (220)
Q Consensus        25 ~i~H~dlk~~nili~~~~~~~l~d~~~~~   53 (220)
                      .++|||+++.||+++.++.+.++||+.+.
T Consensus       223 ~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          223 NLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             ceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            49999999999999888889999999764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.02  E-value=0.0074  Score=44.89  Aligned_cols=86  Identities=9%  Similarity=0.050  Sum_probs=50.8

Q ss_pred             chHHHHHHHHHHHHHHhhh-CCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQ-DSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~-~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~   80 (220)
                      +++|.++.|.+.+|.-+-. ..   -..+=+.+..|++..+|.|.+.+-. ..              .....+.+||...
T Consensus        49 EqaWALc~Qc~~~L~~~~~~~~---~~~~i~~~~~i~l~~dG~V~f~~~~-s~--------------~~~~~~~~pe~~~  110 (229)
T 2yle_A           49 EQAWAVCYQCCGSLRAAARRRQ---PRHRVRSAAQIRVWRDGAVTLAPAA-DD--------------AGEPPPVAGKLGY  110 (229)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTC---CCCCCCSGGGEEEETTSCEEECCC---------------------------CCSS
T ss_pred             HHHHHHHHHHHHHHHhhhhccc---CCceecCCcceEEecCCceeccccc-cc--------------ccccCCCChhhcc
Confidence            4789999999998877622 11   1123344678888888887765411 00              0122456777653


Q ss_pred             cCCCcccCceeehhHHHHHHHhcCcc
Q 027675           81 GGFFSVKSDVFSFGVVVLEIISGKRN  106 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~g~~p  106 (220)
                       ...+.+.-|||||+++|.-+.-..+
T Consensus       111 -~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A          111 -SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             -SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             -ccchHHHHHHHHHHHHHHHhhcCCC
Confidence             3346778899999999998864443

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=95.69  E-value=0.0094  Score=48.87  Aligned_cols=30  Identities=17%  Similarity=0.334  Sum_probs=26.3

Q ss_pred             CeEeccCCCCceeeCCCCCceecCccceeee
Q 027675           25 RIIHRDFKTSNILLDHEMNPKISDFGLTRIF   55 (220)
Q Consensus        25 ~i~H~dlk~~nili~~~~~~~l~d~~~~~~~   55 (220)
                      .++|||+++.||+++.++ +.++||+.+...
T Consensus       233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             EEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             eEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            499999999999998876 999999987653

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=94.05  E-value=0.069  Score=42.05  Aligned_cols=30  Identities=30%  Similarity=0.502  Sum_probs=25.9

Q ss_pred             CeEeccCCCCceeeCCC----CCceecCccceee
Q 027675           25 RIIHRDFKTSNILLDHE----MNPKISDFGLTRI   54 (220)
Q Consensus        25 ~i~H~dlk~~nili~~~----~~~~l~d~~~~~~   54 (220)
                      .++|||+.+.||+++.+    +.+.++||+.+..
T Consensus       184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            59999999999999874    5689999998764

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=94.05  E-value=0.019  Score=43.75  Aligned_cols=30  Identities=27%  Similarity=0.372  Sum_probs=25.6

Q ss_pred             CeEeccCCCCceeeCCCCCceecCccceee
Q 027675           25 RIIHRDFKTSNILLDHEMNPKISDFGLTRI   54 (220)
Q Consensus        25 ~i~H~dlk~~nili~~~~~~~l~d~~~~~~   54 (220)
                      .++|+|+.+.||+++..+.+.|+||+.+..
T Consensus       194 ~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          194 VVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             EEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             EEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence            489999999999998877677999987653

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=93.41  E-value=0.061  Score=42.15  Aligned_cols=28  Identities=29%  Similarity=0.407  Sum_probs=24.1

Q ss_pred             CeEeccCCCCceeeCCCCCceecCccceee
Q 027675           25 RIIHRDFKTSNILLDHEMNPKISDFGLTRI   54 (220)
Q Consensus        25 ~i~H~dlk~~nili~~~~~~~l~d~~~~~~   54 (220)
                      .++|||+++.||+++ + .+.++||+.+..
T Consensus       196 ~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          196 LRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             EECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             eeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            489999999999998 4 789999987654

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=93.01  E-value=0.085  Score=41.17  Aligned_cols=31  Identities=32%  Similarity=0.475  Sum_probs=25.6

Q ss_pred             CCeEeccCCCCceeeCC---CCCc-eecCccceee
Q 027675           24 LRIIHRDFKTSNILLDH---EMNP-KISDFGLTRI   54 (220)
Q Consensus        24 ~~i~H~dlk~~nili~~---~~~~-~l~d~~~~~~   54 (220)
                      ..++|+|+++.||+++.   ++.+ .++||+.+..
T Consensus       190 ~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          190 PRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             CEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             CeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence            34899999999999987   4554 7999997764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=92.91  E-value=0.031  Score=44.45  Aligned_cols=30  Identities=13%  Similarity=0.266  Sum_probs=25.1

Q ss_pred             CeEeccCCCCceeeCCCCCceecCccceee
Q 027675           25 RIIHRDFKTSNILLDHEMNPKISDFGLTRI   54 (220)
Q Consensus        25 ~i~H~dlk~~nili~~~~~~~l~d~~~~~~   54 (220)
                      .++|+|+.+.||++++...+.++||+.+..
T Consensus       223 ~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~  252 (357)
T 3ats_A          223 VLLWGDARVGNVLYRDFQPVAVLDWEMVAL  252 (357)
T ss_dssp             EEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred             eEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence            499999999999998644468999998754

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=92.62  E-value=0.033  Score=43.56  Aligned_cols=30  Identities=20%  Similarity=0.270  Sum_probs=25.2

Q ss_pred             CeEeccCCCCceeeCCCCCceecCccceee
Q 027675           25 RIIHRDFKTSNILLDHEMNPKISDFGLTRI   54 (220)
Q Consensus        25 ~i~H~dlk~~nili~~~~~~~l~d~~~~~~   54 (220)
                      .++|+|+++.||+++.++.+.++||+.+..
T Consensus       188 ~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          188 GVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             EEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            499999999999998765568999987653

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=92.44  E-value=0.11  Score=41.30  Aligned_cols=31  Identities=23%  Similarity=0.363  Sum_probs=27.1

Q ss_pred             CCeEeccCCCCceeeCCCCCceecCccceee
Q 027675           24 LRIIHRDFKTSNILLDHEMNPKISDFGLTRI   54 (220)
Q Consensus        24 ~~i~H~dlk~~nili~~~~~~~l~d~~~~~~   54 (220)
                      ..++|+|+.+.||+++.++.+.++||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            3599999999999999888899999987654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=92.14  E-value=0.16  Score=41.00  Aligned_cols=29  Identities=24%  Similarity=0.382  Sum_probs=24.8

Q ss_pred             CeEeccCCCCceeeCCCCCceecCccceee
Q 027675           25 RIIHRDFKTSNILLDHEMNPKISDFGLTRI   54 (220)
Q Consensus        25 ~i~H~dlk~~nili~~~~~~~l~d~~~~~~   54 (220)
                      .++|||+.+.||+++.+ .+.++||..+..
T Consensus       228 ~L~HGDl~~~Nil~~~~-~~~lID~e~a~~  256 (397)
T 2olc_A          228 TLIHGDLHTGSIFASEH-ETKVIDPEFAFY  256 (397)
T ss_dssp             EEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             ceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence            49999999999999875 488999987654

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=91.72  E-value=0.074  Score=42.58  Aligned_cols=30  Identities=20%  Similarity=0.433  Sum_probs=24.5

Q ss_pred             CCeEeccCCCCceeeCCCCCceecCccceee
Q 027675           24 LRIIHRDFKTSNILLDHEMNPKISDFGLTRI   54 (220)
Q Consensus        24 ~~i~H~dlk~~nili~~~~~~~l~d~~~~~~   54 (220)
                      ..++|+|+.+.||+++.++ +.++||+.+..
T Consensus       212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~  241 (369)
T 3c5i_A          212 IVFCHNDLQENNIINTNKC-LRLIDFEYSGF  241 (369)
T ss_dssp             EEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred             eEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence            3599999999999998654 89999987754

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=91.68  E-value=0.12  Score=42.98  Aligned_cols=16  Identities=31%  Similarity=0.463  Sum_probs=14.6

Q ss_pred             CCeEeccCCCCceeeC
Q 027675           24 LRIIHRDFKTSNILLD   39 (220)
Q Consensus        24 ~~i~H~dlk~~nili~   39 (220)
                      ..++|+|+.+.||+++
T Consensus       290 ~v~cHnDl~~gNIL~~  305 (458)
T 2qg7_A          290 IVLCHCDLLSSNIINT  305 (458)
T ss_dssp             EEEECSCCCGGGEEEC
T ss_pred             eeEEecCCCCCcEEee
Confidence            3599999999999998

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=91.38  E-value=0.15  Score=39.59  Aligned_cols=31  Identities=26%  Similarity=0.233  Sum_probs=25.4

Q ss_pred             CCCeEeccCCCCceeeCCCCCceecCccceee
Q 027675           23 KLRIIHRDFKTSNILLDHEMNPKISDFGLTRI   54 (220)
Q Consensus        23 ~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~   54 (220)
                      ...++|+|+.+.||+ ..++.+.++||+.+..
T Consensus       172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            345999999999999 5566789999987754

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=90.71  E-value=0.087  Score=43.32  Aligned_cols=31  Identities=26%  Similarity=0.404  Sum_probs=24.8

Q ss_pred             CCeEeccCCCCceeeCCC----------------------------CCceecCccceee
Q 027675           24 LRIIHRDFKTSNILLDHE----------------------------MNPKISDFGLTRI   54 (220)
Q Consensus        24 ~~i~H~dlk~~nili~~~----------------------------~~~~l~d~~~~~~   54 (220)
                      ..++|+|+.+.||+++.+                            +.+.++||+.+..
T Consensus       249 ~v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~~  307 (429)
T 1nw1_A          249 VTFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASY  307 (429)
T ss_dssp             EEEECSCCCGGGEEEEC------------------------------CCEECCCTTCEE
T ss_pred             eEEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCCc
Confidence            359999999999999875                            6789999987754

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=89.11  E-value=0.17  Score=40.90  Aligned_cols=31  Identities=29%  Similarity=0.390  Sum_probs=26.5

Q ss_pred             CCeEeccCCCCceeeCCC----CCceecCccceee
Q 027675           24 LRIIHRDFKTSNILLDHE----MNPKISDFGLTRI   54 (220)
Q Consensus        24 ~~i~H~dlk~~nili~~~----~~~~l~d~~~~~~   54 (220)
                      ..++|+|+.+.||+++.+    +.+.++||+.+..
T Consensus       220 ~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          220 VVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             EEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             cEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            359999999999999876    6889999987753

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=88.82  E-value=0.2  Score=40.73  Aligned_cols=30  Identities=27%  Similarity=0.406  Sum_probs=25.1

Q ss_pred             CeEeccCCCCceee------CCCCCceecCccceee
Q 027675           25 RIIHRDFKTSNILL------DHEMNPKISDFGLTRI   54 (220)
Q Consensus        25 ~i~H~dlk~~nili------~~~~~~~l~d~~~~~~   54 (220)
                      .++|+|+.+.||++      ++...+.++||..+..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            47899999999999      4566799999998754

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=86.59  E-value=0.48  Score=36.35  Aligned_cols=25  Identities=24%  Similarity=0.294  Sum_probs=20.6

Q ss_pred             CCCeEeccCCCCceeeCCCCCceecC
Q 027675           23 KLRIIHRDFKTSNILLDHEMNPKISD   48 (220)
Q Consensus        23 ~~~i~H~dlk~~nili~~~~~~~l~d   48 (220)
                      .+.++|+|+.+.|++++.++. .++|
T Consensus       187 ~p~LvHGDlw~gNvl~~~~g~-~~iD  211 (288)
T 3f7w_A          187 PPARIHGDLWNGNVLWQDDGA-VVID  211 (288)
T ss_dssp             CCEEECSCCSGGGEEEETTEE-EECS
T ss_pred             CCeeeecCCCCCcEEEcCCCe-EEEe
Confidence            457999999999999998874 4556

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=84.10  E-value=0.72  Score=34.16  Aligned_cols=44  Identities=7%  Similarity=0.108  Sum_probs=34.6

Q ss_pred             hHHHHHHHHHHHHH-HhhhCCCCCeEeccCCCCceeeCCCCCceecCccc
Q 027675            3 MLFNIILGVSRRLL-YLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGL   51 (220)
Q Consensus         3 ~~~~i~~~l~~~l~-~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~   51 (220)
                      .+++++.+|+.... +++  .   -+|--+.|+|++++.++.+++.-.|+
T Consensus        86 eKlrll~nl~~L~~~~~~--~---r~tf~l~P~NL~f~~~~~p~i~hRGi  130 (219)
T 4ano_A           86 SRIRAAIHLVSKVKHHSA--R---RLIFIVCPENLMFNRALEPFFLHVGV  130 (219)
T ss_dssp             HHHHHHHHHHHHHSSCCS--S---SEECCCCGGGEEECTTCCEEESCCEE
T ss_pred             HHHHHHHHHHHHHHHhhh--C---ceeEEEeCceEEEeCCCcEEEEEcCC
Confidence            56777888777554 333  2   67889999999999999999988875

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=83.35  E-value=0.43  Score=39.19  Aligned_cols=30  Identities=27%  Similarity=0.520  Sum_probs=25.8

Q ss_pred             CCeEeccCCCCceeeCCCCCceecCccceee
Q 027675           24 LRIIHRDFKTSNILLDHEMNPKISDFGLTRI   54 (220)
Q Consensus        24 ~~i~H~dlk~~nili~~~~~~~l~d~~~~~~   54 (220)
                      ..++|+|+.+.||+ ..++.+.++||..+..
T Consensus       262 ~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          262 LVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             EEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             ceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            35999999999999 7778899999988754

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	220
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-43
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-38
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-37
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-37
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-36
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-36
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-35
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-35
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	7e-35
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-34
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-34
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	8e-34
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-33
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-33
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	6e-33
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	7e-33
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-32
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	6e-32
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	7e-32
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	7e-32
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	9e-32
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-31
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-31
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-30
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-30
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-30
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-30
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-29
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-28
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-28
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-27
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-25
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	6e-25
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	8e-24
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-23
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-23
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-22
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-22
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-22
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	6e-21
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-20
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-20
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-20
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-20
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	6e-20
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-19
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-19
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-19
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-19
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-19
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-19
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-19
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-19
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-17
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-16
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-16
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-15
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-15
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-14
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-13
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-12
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	8e-11
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-06

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (363), Expect = 4e-43
 Identities = 42/179 (23%), Positives = 80/179 (44%), Gaps = 17/179 (9%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           M  L +I    ++ + YLH  S   IIHRD K++NI L  ++  KI DFGL  +      
Sbjct: 103 MIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159

Query: 61  DGTTNRVVGTYGYMSPEYALG---GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALS 117
                ++ G+  +M+PE         +S +SDV++FG+V+ E+++G+      N+   + 
Sbjct: 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI- 218

Query: 118 LLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
                  +   G     + +      KA        +   C+++  ++RP    ++  +
Sbjct: 219 -----IFMVGRGYLSPDLSKVRSNCPKA-----MKRLMAECLKKKRDERPLFPQILASI 267

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 4e-38
 Identities = 40/193 (20%), Positives = 69/193 (35%), Gaps = 18/193 (9%)

Query: 2   EMLFNIILGVSRRLLYLHQD-----SKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFE 56
           E +  + L  +  L +LH +      K  I HRD K+ NIL+       I+D GL    +
Sbjct: 100 EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159

Query: 57  --GKQTDGTTNRVVGTYGYMSPEYALGGF------FSVKSDVFSFGVVVLEIISGKRNTG 108
                 D   N  VGT  YM+PE               ++D+++ G+V  EI       G
Sbjct: 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219

Query: 109 FYNSE----LALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCI-NVGLLCVQEDP 163
            +         L     + +  ++      +        ++ E L+ +  +   C   + 
Sbjct: 220 IHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANG 279

Query: 164 NDRPTMSDVVIML 176
             R T   +   L
Sbjct: 280 AARLTALRIKKTL 292

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 1e-37
 Identities = 39/190 (20%), Positives = 80/190 (42%), Gaps = 19/190 (10%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           +  L ++   ++  + Y+ +   +  +HRD + +NIL+   +  K++DFGL R+ E  + 
Sbjct: 112 LPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168

Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLG 120
                       + +PE AL G F++KSDV+SFG+++ E+ +  R          +    
Sbjct: 169 TARQG-AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---- 223

Query: 121 YAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSEA 180
                 + G  +      P    +        ++   C +++P +RPT   +   L    
Sbjct: 224 --LDQVERGYRMPC----PPECPE-----SLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272

Query: 181 VNLASPKRPA 190
            +     +P 
Sbjct: 273 TSTEPQYQPG 282

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  129 bits (325), Expect = 4e-37
 Identities = 42/175 (24%), Positives = 70/175 (40%), Gaps = 18/175 (10%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
                I   V+  + YL +    + +HRD  T N L+   M  KI+DFGL+R        
Sbjct: 140 AEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 196

Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGY 121
                      +M PE      ++ +SDV+++GVV+ EI S      +  +   +     
Sbjct: 197 KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV----- 251

Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
                ++G  L   +  P         L+  N+  LC  + P DRP+   +  +L
Sbjct: 252 -IYYVRDGNILACPENCP---------LELYNLMRLCWSKLPADRPSFCSIHRIL 296

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 1e-36
 Identities = 44/178 (24%), Positives = 72/178 (40%), Gaps = 17/178 (9%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           E L      V++ + +L        +HRD    N+L+ H    KI DFGL R        
Sbjct: 164 EDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220

Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGY 121
                      +M+PE    G +++KSDV+S+G+++ EI S   N        A      
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN----- 275

Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE 179
            +KL Q G  +D    +P   ++     +   +   C   D   RP+  ++   LG +
Sbjct: 276 FYKLIQNGFKMD----QPFYATE-----EIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 324

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 3e-36
 Identities = 42/176 (23%), Positives = 80/176 (45%), Gaps = 19/176 (10%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           +  L ++   ++  + ++ + +    IHRD + +NIL+   ++ KI+DFGL R+ E  + 
Sbjct: 108 INKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164

Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLG 120
                       + +PE    G F++KSDV+SFG+++ EI++  R      +   +    
Sbjct: 165 TARE-GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV---- 219

Query: 121 YAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
              +  + G  +   D  P          +   +  LC +E P DRPT   +  +L
Sbjct: 220 --IQNLERGYRMVRPDNCPE---------ELYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 1e-35
 Identities = 38/204 (18%), Positives = 80/204 (39%), Gaps = 32/204 (15%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           + L N  + +++ + YL      R++HRD    N+L+    + KI+DFGL ++   ++ +
Sbjct: 111 QYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 167

Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGY 121
                      +M+ E  L   ++ +SDV+S+GV V E+++                   
Sbjct: 168 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS---------------K 212

Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML----- 176
            +      +   ++++           +    + + C   D + RP   +++I       
Sbjct: 213 PYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272

Query: 177 ---------GSEAVNLASPKRPAF 191
                    G E ++L SP    F
Sbjct: 273 DPQRYLVIQGDERMHLPSPTDSNF 296

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  124 bits (311), Expect = 4e-35
 Identities = 42/178 (23%), Positives = 74/178 (41%), Gaps = 21/178 (11%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
             L  ++ G++  + YL     +  +HRD    NIL++  +  K+SDFGL+R  E   +D
Sbjct: 128 IQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184

Query: 62  GTTNRVVG---TYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSL 118
            T    +G      + +PE      F+  SDV+S+G+V+ E++S                
Sbjct: 185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE------------- 231

Query: 119 LGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
               +        ++ ++Q        +       + L C Q+D N RP    +V  L
Sbjct: 232 --RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (308), Expect = 7e-35
 Identities = 39/177 (22%), Positives = 78/177 (44%), Gaps = 19/177 (10%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFE-GKQ 59
           +  L  ++ G++  + YL     +  +HRD    NIL++  +  K+SDFGL+R+ E   +
Sbjct: 109 VLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 165

Query: 60  TDGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLL 119
              TT+       + +PE      F+  SDV+SFG+V+ E+++      +  S       
Sbjct: 166 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS------- 218

Query: 120 GYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
                     + +  ++      +  +       + + C Q++   RP  +D+V +L
Sbjct: 219 --------NHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 2e-34
 Identities = 44/178 (24%), Positives = 73/178 (41%), Gaps = 17/178 (9%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           +E L      V++ + +L      + IHRD    NILL  +   KI DFGL R       
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLG 120
                       +M+PE      ++++SDV+SFGV++ EI      +   +    + +  
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF-----SLGASPYPGVKIDE 244

Query: 121 YAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGS 178
              +  +EG  +   D             +     L C   +P+ RPT S++V  LG+
Sbjct: 245 EFCRRLKEGTRMRAPDYTTP---------EMYQTMLDCWHGEPSQRPTFSELVEHLGN 293

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 3e-34
 Identities = 39/161 (24%), Positives = 64/161 (39%), Gaps = 17/161 (10%)

Query: 18  LHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR--VVGTYGYMS 75
           +   +  + +HRD    N +LD +   K++DFGL R    K+ D   N+        +M+
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202

Query: 76  PEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMM 135
            E      F+ KSDV+SFGV++ E+++       Y      +       L Q  + L   
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP--PYPDV---NTFDITVYLLQGRRLLQ-- 255

Query: 136 DQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
              P              V L C       RP+ S++V  +
Sbjct: 256 ---PEYCPD-----PLYEVMLKCWHPKAEMRPSFSELVSRI 288

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 8e-34
 Identities = 44/173 (25%), Positives = 74/173 (42%), Gaps = 18/173 (10%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
                     +   ++YLH    + I HRD K  N+LLD   N KISDFGL  +F     
Sbjct: 102 EPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158

Query: 61  DGTTNRVVGTYGYMSPEYALGG-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLL 119
           +   N++ GT  Y++PE      F +   DV+S G+V+  +++G+      +        
Sbjct: 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--- 215

Query: 120 GYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
              +  W+E K    ++      S    +L         + E+P+ R T+ D+
Sbjct: 216 ---YSDWKEKK--TYLNPWKKIDSAPLALLHK------ILVENPSARITIPDI 257

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (303), Expect = 1e-33
 Identities = 47/198 (23%), Positives = 80/198 (40%), Gaps = 33/198 (16%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           ++L  + + V + L YL    K +I+HRD K SNIL++     K+ DFG++        D
Sbjct: 104 QILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----D 157

Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKR---------------- 105
              N  VGT  YMSPE   G  +SV+SD++S G+ ++E+  G+                 
Sbjct: 158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGC 217

Query: 106 -------NTGFYNSELALSLLGYAWKLWQEGKALDMMDQ----KPGAISKANEILKCINV 154
                   T          L  Y           +++D      P  +      L+  + 
Sbjct: 218 QVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDF 277

Query: 155 GLLCVQEDPNDRPTMSDV 172
              C+ ++P +R  +  +
Sbjct: 278 VNKCLIKNPAERADLKQL 295

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (298), Expect = 1e-33
 Identities = 42/160 (26%), Positives = 67/160 (41%), Gaps = 18/160 (11%)

Query: 18  LHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPE 77
           +    +  +IHRD    N L+      K+SDFG+TR     Q   ++        + SPE
Sbjct: 114 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPE 172

Query: 78  YALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMD 136
                 +S KSDV+SFGV++ E+ S GK      ++   +  +   ++L+          
Sbjct: 173 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY---------- 222

Query: 137 QKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
            KP   S          +   C +E P DRP  S ++  L
Sbjct: 223 -KPRLAST-----HVYQIMNHCWKERPEDRPAFSRLLRQL 256

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (295), Expect = 6e-33
 Identities = 43/178 (24%), Positives = 74/178 (41%), Gaps = 23/178 (12%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           + +  ++  VS  + YL +      +HRD    N+LL  +   KISDFGL++     +  
Sbjct: 107 KNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163

Query: 62  GTTN-RVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRN--TGFYNSELALSL 118
                       + +PE      FS KSDV+SFGV++ E  S  +    G   SE+    
Sbjct: 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT--- 220

Query: 119 LGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
                 + ++G+ +      P    +     +  ++  LC   D  +RP  + V + L
Sbjct: 221 -----AMLEKGERMGC----PAGCPR-----EMYDLMNLCWTYDVENRPGFAAVELRL 264

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 7e-33
 Identities = 40/176 (22%), Positives = 70/176 (39%), Gaps = 17/176 (9%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           +E L +    V++ + +L        IHRD    NILL H    KI DFGL R  +    
Sbjct: 144 LEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200

Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLG 120
                       +M+PE      ++ +SDV+S+G+ + E+ S   +              
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS-------------- 246

Query: 121 YAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
               +  + K   M+ +    +S  +   +  ++   C   DP  RPT   +V ++
Sbjct: 247 PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 6e-32
 Identities = 33/173 (19%), Positives = 73/173 (42%), Gaps = 21/173 (12%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHE-MNPKISDFGLTRIFEGKQT 60
           ++L +    + + L +LH  +   IIHRD K  NI +     + KI D GL  +      
Sbjct: 112 KVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA 170

Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLG 120
                 V+GT  +M+PE     +     DV++FG+ +LE+ + +    +   +       
Sbjct: 171 ----KAVIGTPEFMAPEMYEEKY-DESVDVYAFGMCMLEMATSEYP--YSECQ------- 216

Query: 121 YAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
            A ++++   +                  +   +   C++++ ++R ++ D++
Sbjct: 217 NAAQIYRRVTSGVKPASFDKVAIP-----EVKEIIEGCIRQNKDERYSIKDLL 264

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  115 bits (289), Expect = 6e-32
 Identities = 37/175 (21%), Positives = 70/175 (40%), Gaps = 19/175 (10%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
            +L  +   +S  + YL +      IHRD    N L+      K++DFGL+R+  G    
Sbjct: 115 VVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 171

Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGY 121
                      + +PE      FS+KSDV++FGV++ EI +   +               
Sbjct: 172 AHAG-AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP-------------- 216

Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
            +      +  +++++            K   +   C Q +P+DRP+ +++    
Sbjct: 217 -YPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 7e-32
 Identities = 43/175 (24%), Positives = 75/175 (42%), Gaps = 21/175 (12%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           + L +    V+R + YL Q    + IHRD    NIL+      KI+DFGL+R  E     
Sbjct: 127 QQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQE---VY 180

Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGY 121
                      +M+ E      ++  SDV+S+GV++ EI+S         +   L     
Sbjct: 181 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL----- 235

Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
            ++   +G  L+    KP          +  ++   C +E P +RP+ + +++ L
Sbjct: 236 -YEKLPQGYRLE----KPLNCDD-----EVYDLMRQCWREKPYERPSFAQILVSL 280

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 7e-32
 Identities = 36/176 (20%), Positives = 68/176 (38%), Gaps = 19/176 (10%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
            + L  +   V   + YL      + +HRD    N L++ +   K+SDFGL+R     + 
Sbjct: 99  TQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155

Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLG 120
             +         +  PE  +   FS KSD+++FGV++ EI S  +               
Sbjct: 156 TSSVG-SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK--------------- 199

Query: 121 YAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
             ++ +   +  + + Q            K   +   C  E  ++RPT   ++  +
Sbjct: 200 MPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 9e-32
 Identities = 45/175 (25%), Positives = 65/175 (37%), Gaps = 23/175 (13%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           + L    L V   + YL        +HRD    N+L+  +   K+SDFGLT+     Q  
Sbjct: 103 DCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT 159

Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGY 121
           G          + +PE      FS KSDV+SFG+++ EI S  R          +     
Sbjct: 160 GK-----LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV----- 209

Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
                ++G  +D  D  P A            V   C   D   RP+   +   L
Sbjct: 210 -VPRVEKGYKMDAPDGCPPA---------VYEVMKNCWHLDAAMRPSFLQLREQL 254

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 1e-31
 Identities = 42/188 (22%), Positives = 72/188 (38%), Gaps = 23/188 (12%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
             +  ++  VS  + YL +      +HRD    N+LL +    KISDFGL++      + 
Sbjct: 109 SNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 165

Query: 62  GT-TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRN--TGFYNSELALSL 118
            T  +       + +PE      FS +SDV+S+GV + E +S  +         E+    
Sbjct: 166 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---- 221

Query: 119 LGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGS 178
                   ++GK ++     P          +   +   C      DRP    V   + +
Sbjct: 222 ----MAFIEQGKRMEC----PPECPP-----ELYALMSDCWIYKWEDRPDFLTVEQRMRA 268

Query: 179 EAVNLASP 186
              +LAS 
Sbjct: 269 CYYSLASK 276

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 2e-31
 Identities = 45/175 (25%), Positives = 77/175 (44%), Gaps = 22/175 (12%)

Query: 2   EMLFNIILGVSRRLLYLHQ--DSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQ 59
           E +  ++  ++  L   H+  D    ++HRD K +N+ LD + N K+ DFGL RI     
Sbjct: 109 EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT 168

Query: 60  TDGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKR-NTGFYNSELALSL 118
           +       VGT  YMSPE      ++ KSD++S G ++ E+ +     T F   EL    
Sbjct: 169 S--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL---- 222

Query: 119 LGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
                   +EGK   +  +      + NEI+         +      RP++ +++
Sbjct: 223 ----AGKIREGKFRRIPYRYS---DELNEIITR------MLNLKDYHRPSVEEIL 264

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 1e-30
 Identities = 37/172 (21%), Positives = 67/172 (38%), Gaps = 24/172 (13%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           +     I  ++  L Y H     R+IHRD K  N+LL      KI+DFG +      +  
Sbjct: 106 QRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR- 161

Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGY 121
                + GT  Y+ PE   G     K D++S GV+  E + GK     + +         
Sbjct: 162 ---TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP---PFEANTYQETY-- 213

Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
                   +   +    P  +++        ++    ++ +P+ RP + +V+
Sbjct: 214 -------KRISRVEFTFPDFVTEG-----ARDLISRLLKHNPSQRPMLREVL 253

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (279), Expect = 2e-30
 Identities = 42/179 (23%), Positives = 73/179 (40%), Gaps = 18/179 (10%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           +  +  +   ++  + YL+ +   + +HRD    N ++  +   KI DFG+TR       
Sbjct: 132 LSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 188

Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLG 120
                + +    +MSPE    G F+  SDV+SFGVV+ EI +         S   +    
Sbjct: 189 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV---- 244

Query: 121 YAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE 179
              +   EG  LD  D  P              +  +C Q +P  RP+  +++  +  E
Sbjct: 245 --LRFVMEGGLLDKPDNCPD---------MLFELMRMCWQYNPKMRPSFLEIISSIKEE 292

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (277), Expect = 3e-30
 Identities = 46/175 (26%), Positives = 73/175 (41%), Gaps = 18/175 (10%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           + L +    V+R + YL      + IHRD    N+L+  +   KI+DFGL R        
Sbjct: 135 KDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191

Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGY 121
             T        +M+PE      ++ +SDV+SFGV++ EI +   +         L     
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL----- 246

Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
            +KL +EG  +D    KP   +      +   +   C    P+ RPT   +V  L
Sbjct: 247 -FKLLKEGHRMD----KPSNCTN-----ELYMMMRDCWHAVPSQRPTFKQLVEDL 291

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 3e-30
 Identities = 43/177 (24%), Positives = 65/177 (36%), Gaps = 18/177 (10%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           +  L    + V+  + YL      R IHRD    N+LL      KI DFGL R       
Sbjct: 110 LGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 166

Query: 61  DGT-TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLL 119
                      + + +PE      FS  SD + FGV + E+ +  +      +   +   
Sbjct: 167 HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI--- 223

Query: 120 GYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
               K+ +EG+ L     +P    +        NV + C    P DRPT   +   L
Sbjct: 224 --LHKIDKEGERLP----RPEDCPQ-----DIYNVMVQCWAHKPEDRPTFVALRDFL 269

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  108 bits (272), Expect = 3e-29
 Identities = 49/175 (28%), Positives = 70/175 (40%), Gaps = 27/175 (15%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
             +  +  G  + L YLH      +IHRD K  NILL      K+ DFG   I       
Sbjct: 115 VEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA----- 166

Query: 62  GTTNRVVGTYGYMSPEYALG---GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSL 118
              N  VGT  +M+PE  L    G +  K DV+S G+  +E+   K      N+  AL  
Sbjct: 167 -PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-- 223

Query: 119 LGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVV 173
               + + Q          + G  S+        N    C+Q+ P DRPT   ++
Sbjct: 224 ----YHIAQNES----PALQSGHWSEY-----FRNFVDSCLQKIPQDRPTSEVLL 265

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (265), Expect = 1e-28
 Identities = 41/176 (23%), Positives = 65/176 (36%), Gaps = 19/176 (10%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
           +  L      +S  L YL      R +HRD    N+L+      K+ DFGL+R  E   T
Sbjct: 107 LASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DST 162

Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLG 120
               ++      +M+PE      F+  SDV+ FGV + EI+              +    
Sbjct: 163 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---- 218

Query: 121 YAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML 176
                 + G+ L M    P             ++   C   DP+ RP  +++   L
Sbjct: 219 --IGRIENGERLPM----PPNCPPT-----LYSLMTKCWAYDPSRRPRFTELKAQL 263

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 4e-28
 Identities = 38/176 (21%), Positives = 71/176 (40%), Gaps = 24/176 (13%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
             +  +       L YLH     +IIHRD K  NIL   + + K++DFG++      +T 
Sbjct: 110 SQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT--RTI 164

Query: 62  GTTNRVVGTYGYMSPEYALG-----GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELAL 116
              +  +GT  +M+PE  +        +  K+DV+S G+ ++E+   +      N     
Sbjct: 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM--- 221

Query: 117 SLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
                   L +  K+      +P   S         +    C++++ + R T S +
Sbjct: 222 ------RVLLKIAKSEPPTLAQPSRWSSN-----FKDFLKKCLEKNVDARWTTSQL 266

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (260), Expect = 1e-27
 Identities = 38/171 (22%), Positives = 71/171 (41%), Gaps = 19/171 (11%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
             +  +     + L +LH     ++IHRD K+ NILL  + + K++DFG       +Q+ 
Sbjct: 116 GQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171

Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGY 121
              + +VGT  +M+PE      +  K D++S G++ +E+I G+    + N          
Sbjct: 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP--YLNEN-------P 221

Query: 122 AWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
              L+          Q P  +S         +    C+  D   R +  ++
Sbjct: 222 LRALYLIATNGTPELQNPEKLSAI-----FRDFLNRCLDMDVEKRGSAKEL 267

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.4 bits (242), Expect = 4e-25
 Identities = 34/170 (20%), Positives = 64/170 (37%), Gaps = 25/170 (14%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
                +  +  L       IIHRD K  NILL+ +M+ +I+DFG  ++   +      N 
Sbjct: 110 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS 169

Query: 67  VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLW 126
            VGT  Y+SPE          SD+++ G ++ ++++G                      +
Sbjct: 170 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP-------------------PF 210

Query: 127 QEGKALDMMDQ----KPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
           + G    +  +    +     K     + +   LL +  D   R    ++
Sbjct: 211 RAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL--DATKRLGCEEM 258

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.3 bits (241), Expect = 6e-25
 Identities = 41/182 (22%), Positives = 74/182 (40%), Gaps = 16/182 (8%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT 60
            E + +++  + R L +LH     R++HRD K  NIL+      K++DFGL RI+  +  
Sbjct: 115 TETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA 171

Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKR----NTGFYNSELAL 116
             +   VV T  Y +PE  L   ++   D++S G +  E+   K     ++        L
Sbjct: 172 LTS---VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 228

Query: 117 SLLGYAWKL-WQEGKALDMMDQKPGAISKANEILKCINVGLL-----CVQEDPNDRPTMS 170
            ++G   +  W    AL        +     + +  I+         C+  +P  R +  
Sbjct: 229 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY 288

Query: 171 DV 172
             
Sbjct: 289 SA 290

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 94.1 bits (233), Expect = 8e-24
 Identities = 36/184 (19%), Positives = 61/184 (33%), Gaps = 20/184 (10%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNIL---LDHEMNPKISDFGLTRIFEG 57
           ++ +  +   +  R+ Y+H       IHRD K  N L           I DFGL + +  
Sbjct: 102 LKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158

Query: 58  KQTDG-----TTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNS 112
            +T           + GT  Y S    LG   S + D+ S G V++    G        +
Sbjct: 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 218

Query: 113 ELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
                     ++   E K    ++          E    +N    C     +D+P  S +
Sbjct: 219 ATKR----QKYERISEKKMSTPIEVLCKGYPS--EFATYLN---FCRSLRFDDKPDYSYL 269

Query: 173 VIML 176
             + 
Sbjct: 270 RQLF 273

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 92.6 bits (229), Expect = 3e-23
 Identities = 28/186 (15%), Positives = 61/186 (32%), Gaps = 22/186 (11%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP-----KISDFGLTRIF 55
           ++ +      +  R+  +H+     +++RD K  N L+    +       + DFG+ + +
Sbjct: 100 VKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156

Query: 56  EGKQTDG-----TTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFY 110
               T           + GT  YMS    LG   S + D+ + G V +  + G       
Sbjct: 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 216

Query: 111 NSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMS 170
            +          ++   E K    + +      +  E  K ++          +  P   
Sbjct: 217 KAATNK----QKYERIGEKKQSTPLRELCAGFPE--EFYKYMH---YARNLAFDATPDYD 267

Query: 171 DVVIML 176
            +  + 
Sbjct: 268 YLQGLF 273

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score = 93.2 bits (231), Expect = 4e-23
 Identities = 41/174 (23%), Positives = 72/174 (41%), Gaps = 23/174 (13%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP--KISDFGLTRIFEGKQ 59
           +     +  V + L ++H   +   +H D K  NI+   + +   K+ DFGLT   + KQ
Sbjct: 124 DEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180

Query: 60  TDGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLL 119
           +   T    GT  + +PE A G      +D++S GV+   ++SG    G  N +  L  +
Sbjct: 181 SVKVT---TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV 237

Query: 120 GYAWKLWQEGKALDMMDQKPGAISK-ANEILKCINVGLLCVQEDPNDRPTMSDV 172
                   +    +M D     IS+   + ++        +  DPN R T+   
Sbjct: 238 --------KSCDWNMDDSAFSGISEDGKDFIRK------LLLADPNTRMTIHQA 277

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 90.9 bits (225), Expect = 1e-22
 Identities = 39/177 (22%), Positives = 71/177 (40%), Gaps = 25/177 (14%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           +    I+  +   +  LH   KL I+HRD K  NILLD +MN K++DFG +   +     
Sbjct: 110 KETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD---PG 163

Query: 62  GTTNRVVGTYGYMSPEYALGGF------FSVKSDVFSFGVVVLEIISGKRNTGFYNSELA 115
                V GT  Y++PE            +  + D++S GV++  +++G     F++ +  
Sbjct: 164 EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP--FWHRKQM 221

Query: 116 LSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
           L L     ++   G       +         +++         +   P  R T  + 
Sbjct: 222 LML-----RMIMSGNYQFGSPEWDDYSDTVKDLVSR------FLVVQPQKRYTAEEA 267

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.3 bits (223), Expect = 3e-22
 Identities = 38/176 (21%), Positives = 65/176 (36%), Gaps = 18/176 (10%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR--VVGTYG 72
           L  L+   + +I+HRD K +N+L+  +   K++DFGL R F   +          V T  
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186

Query: 73  YMSPEYALGG-FFSVKSDVFSFGVVVLEIISGKR--------NTGFYNSELALSLLGYAW 123
           Y  PE  LG   +    D++  G ++ E+ +           +     S+L  S+    W
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246

Query: 124 KLWQEGKALDMMDQKPGAISKANEILKCINVGLL-------CVQEDPNDRPTMSDV 172
                 +  + ++   G   K  + LK               +  DP  R    D 
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score = 90.5 bits (224), Expect = 3e-22
 Identities = 34/174 (19%), Positives = 62/174 (35%), Gaps = 23/174 (13%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP--KISDFGLTRIFEGKQ 59
             + N +      L ++H+     I+H D K  NI+ + +     KI DFGL        
Sbjct: 127 AEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKL---N 180

Query: 60  TDGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRN-TGFYNSELALSL 118
            D        T  + +PE          +D+++ GV+   ++SG     G  + E     
Sbjct: 181 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET---- 236

Query: 119 LGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
                +  +        D       +A + +K        +Q++P  R T+ D 
Sbjct: 237 ----LQNVKRCDWEFDEDAFSSVSPEAKDFIKN------LLQKEPRKRLTVHDA 280

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 86.7 bits (214), Expect = 6e-21
 Identities = 28/91 (30%), Positives = 44/91 (48%), Gaps = 5/91 (5%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
            L L       II+RD K  NILLD   + KI+DFG  +             + GT  Y+
Sbjct: 114 CLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY-----TLCGTPDYI 168

Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGKR 105
           +PE      ++   D +SFG+++ E+++G  
Sbjct: 169 APEVVSTKPYNKSIDWWSFGILIYEMLAGYT 199

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.5 bits (211), Expect = 1e-20
 Identities = 28/173 (16%), Positives = 57/173 (32%), Gaps = 21/173 (12%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP--KISDFGLTRIFEGKQ 59
             + + +  V   L +LH      I H D +  NI+     +   KI +FG  R  +   
Sbjct: 102 REIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158

Query: 60  TDGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLL 119
                        Y +PE       S  +D++S G +V  ++SG        ++  +  +
Sbjct: 159 NFRLLF---TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI 215

Query: 120 GYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
                     +     +       +A + +         + ++   R T S+ 
Sbjct: 216 -------MNAEYTFDEEAFKEISIEAMDFVDR------LLVKERKSRMTASEA 255

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.5 bits (211), Expect = 2e-20
 Identities = 32/175 (18%), Positives = 70/175 (40%), Gaps = 20/175 (11%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNP---KISDFGLTRIFEGK 58
                I+  +   + YLH    + I HRD K  N+L   +      K++DFG  +     
Sbjct: 111 REASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 167

Query: 59  QTDGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSL 118
            +  T      T  Y++PE      +    D++S GV++  ++ G      + S   L++
Sbjct: 168 NSLTTPCY---TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP---PFYSNHGLAI 221

Query: 119 LGYAWKLWQEGKALDMMDQKPGAISK-ANEILKCINVGLLCVQEDPNDRPTMSDV 172
                   + G+  +  + +   +S+    +++        ++ +P  R T+++ 
Sbjct: 222 SPGMKTRIRMGQ-YEFPNPEWSEVSEEVKMLIRN------LLKTEPTQRMTITEF 269

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.2 bits (210), Expect = 2e-20
 Identities = 42/158 (26%), Positives = 72/158 (45%), Gaps = 21/158 (13%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           +L L       I++RD K  NILLD + + KI+DFG+ +  E    D  TN   GT  Y+
Sbjct: 113 ILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNTFCGTPDYI 170

Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDM 134
           +PE  LG  ++   D +SFGV++ E++ G+  + F+  +          +L+   +  + 
Sbjct: 171 APEILLGQKYNHSVDWWSFGVLLYEMLIGQ--SPFHGQDEE--------ELFHSIRMDNP 220

Query: 135 MDQKPGAISK-ANEILKCINVGLLCVQEDPNDRPTMSD 171
               P  + K A ++L            +P  R  +  
Sbjct: 221 --FYPRWLEKEAKDLLVK------LFVREPEKRLGVRG 250

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 84.0 bits (207), Expect = 3e-20
 Identities = 47/177 (26%), Positives = 78/177 (44%), Gaps = 18/177 (10%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           +    +I    + L + HQ     IIHRD K +NI++      K+ DFG+ R        
Sbjct: 111 KRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 167

Query: 62  GT-TNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLG 120
            T T  V+GT  Y+SPE A G     +SDV+S G V+ E+++G+    F       S + 
Sbjct: 168 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP--FTGD----SPVS 221

Query: 121 YAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRP-TMSDVVIML 176
            A++  +E         +   +S          V L  + ++P +R  T +++   L
Sbjct: 222 VAYQHVREDPIPP--SARHEGLSAD-----LDAVVLKALAKNPENRYQTAAEMRADL 271

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 84.4 bits (208), Expect = 6e-20
 Identities = 39/169 (23%), Positives = 69/169 (40%), Gaps = 22/169 (13%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
             +      +   L ++H      +++RD K +NILLD   + +ISD GL   F  K+  
Sbjct: 107 ADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 161

Query: 62  GTTNRVVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLG 120
              +  VGT+GYM+PE    G  +   +D FS G ++ +++ G      + ++    +  
Sbjct: 162 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID- 218

Query: 121 YAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTM 169
                      L M  + P + S         ++    +Q D N R   
Sbjct: 219 --------RMTLTMAVELPDSFSPE-----LRSLLEGLLQRDVNRRLGC 254

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.7 bits (206), Expect = 1e-19
 Identities = 41/187 (21%), Positives = 72/187 (38%), Gaps = 19/187 (10%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIF-EGKQT 60
           + +   +  + R L Y+H      ++HRD K SN+LL+   + KI DFGL R+       
Sbjct: 109 DHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 165

Query: 61  DGTTNRVVGTYGYMSPEYALGGFFSVKS-DVFSFGVVVLEIISGK--------RNTGFYN 111
            G     V T  Y +PE  L      KS D++S G ++ E++S +         +   + 
Sbjct: 166 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 225

Query: 112 SELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEIL------KCINVGLLCVQEDPND 165
             +  S            KA + +   P         L      K +++    +  +P+ 
Sbjct: 226 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK 285

Query: 166 RPTMSDV 172
           R  +   
Sbjct: 286 RIEVEQA 292

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.4 bits (203), Expect = 1e-19
 Identities = 33/160 (20%), Positives = 60/160 (37%), Gaps = 29/160 (18%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHE-MNPKISDFGLTRIFEGKQTDGTTNRVVGTYGY 73
           L  +       ++HRD K  NIL+D      K+ DFG   + +    D       GT  Y
Sbjct: 120 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 175

Query: 74  MSPEYALGG-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKAL 132
             PE+     +    + V+S G+++ +++ G     F + E                + +
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP--FEHDE----------------EII 217

Query: 133 DMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
                    +S       C ++   C+   P+DRPT  ++
Sbjct: 218 RGQVFFRQRVSSE-----CQHLIRWCLALRPSDRPTFEEI 252

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.7 bits (203), Expect = 1e-19
 Identities = 31/173 (17%), Positives = 59/173 (34%), Gaps = 18/173 (10%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L  L       ++HRD K  N+L++     K+++FGL R F        +  VV  +   
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-YSAEVVTLWYRP 169

Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKL--------W 126
                    +S   D++S G +  E+ +  R    +        L   ++L        W
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRP--LFPGNDVDDQLKRIFRLLGTPTEEQW 227

Query: 127 QEGKALDMMDQKPGAISKANEILKCINVG-----LL--CVQEDPNDRPTMSDV 172
                L      P   +  + +     +      LL   ++ +P  R +  + 
Sbjct: 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.2 bits (202), Expect = 2e-19
 Identities = 40/173 (23%), Positives = 64/173 (36%), Gaps = 15/173 (8%)

Query: 13  RRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYG 72
           + L  L      R++HRD K  N+L++ E   K++DFGL R F       T    V T  
Sbjct: 110 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLW 167

Query: 73  YMSPE-YALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQE--- 128
           Y +PE      ++S   D++S G +  E+++ +      +    L  +        E   
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 227

Query: 129 GKALDMMDQKPGAISKANEILKCINVGLL---------CVQEDPNDRPTMSDV 172
                M D KP     A +    +   L           +  DPN R +    
Sbjct: 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 81.9 bits (201), Expect = 3e-19
 Identities = 40/171 (23%), Positives = 65/171 (38%), Gaps = 15/171 (8%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L  +      R++HRD K  N+L++ E   KI+DFGL R F            + T  Y 
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFG--IPVRKYTHEIVTLWYR 167

Query: 75  SPEYALG-GFFSVKSDVFSFGVVVLEIISGKR----NTGFYNSELALSLLG-YAWKLWQE 128
           +P+  +G   +S   D++S G +  E+++G       +          +LG    K W  
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227

Query: 129 GKALDMMDQKPGAISKA--NEILKCINVGLL-----CVQEDPNDRPTMSDV 172
              L   D              LK ++   +      ++ DPN R T    
Sbjct: 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.7 bits (201), Expect = 3e-19
 Identities = 35/163 (21%), Positives = 63/163 (38%), Gaps = 22/163 (13%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNP----KISDFGLTRIFEGKQTDGTTNRVVGT 70
           L  ++    L+I H D K  NI+L     P    KI DFGL    +          + GT
Sbjct: 123 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGT 179

Query: 71  YGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGK 130
             +++PE        +++D++S GV+   ++SG         +  L+ +           
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV--------SAV 231

Query: 131 ALDMMDQKPGAISK-ANEILKCINVGLLCVQEDPNDRPTMSDV 172
             +  D+     S  A + ++        + +DP  R T+ D 
Sbjct: 232 NYEFEDEYFSNTSALAKDFIRR------LLVKDPKKRMTIQDS 268

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.1 bits (202), Expect = 3e-19
 Identities = 27/91 (29%), Positives = 45/91 (49%), Gaps = 2/91 (2%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           +  L       +++RD K  N++LD + + KI+DFGL +  EG     T     GT  Y+
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYL 172

Query: 75  SPEYALGGFFSVKSDVFSFGVVVLEIISGKR 105
           +PE      +    D +  GVV+ E++ G+ 
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.8 bits (201), Expect = 3e-19
 Identities = 39/170 (22%), Positives = 64/170 (37%), Gaps = 14/170 (8%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           L  L    +  I+HRD K +N+LLD     K++DFGL + F            V T  Y 
Sbjct: 110 LQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYR 167

Query: 75  SPEYALG-GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALS-----LLGYAWKLWQE 128
           +PE   G   + V  D+++ G ++ E++         +    L+     L     + W +
Sbjct: 168 APELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 227

Query: 129 GKAL-DMMDQKPGAISKANEILKCINVGLL-----CVQEDPNDRPTMSDV 172
             +L D +  K       + I       LL         +P  R T +  
Sbjct: 228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 75.8 bits (186), Expect = 4e-17
 Identities = 33/172 (19%), Positives = 60/172 (34%), Gaps = 18/172 (10%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
                +I  V   + YLH    +    +        LD +    ISDFGL+++ +     
Sbjct: 107 RDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED---PG 163

Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRN-TGFYNSELALSLLG 120
              +   GT GY++PE      +S   D +S GV+   ++ G        +++L   +L 
Sbjct: 164 SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQIL- 222

Query: 121 YAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDV 172
                       +        IS +       +     +++DP  R T    
Sbjct: 223 --------KAEYEFDSPYWDDISDS-----AKDFIRHLMEKDPEKRFTCEQA 261

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.4 bits (182), Expect = 2e-16
 Identities = 37/185 (20%), Positives = 71/185 (38%), Gaps = 20/185 (10%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHE-MNPKISDFGLTRIFEGKQT 60
             +   +  + R L Y+H      I HRD K  N+LLD +    K+ DFG  +     + 
Sbjct: 122 IYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 178

Query: 61  DGTTNRVVGTYGYMSPEYALGGF-FSVKSDVFSFGVVVLEIISGKR----NTGFYNSELA 115
           + +    + +  Y +PE   G   ++   DV+S G V+ E++ G+     ++G       
Sbjct: 179 NVSY---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235

Query: 116 LSLLG--------YAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPNDRP 167
           + +LG             + E K   +       + +     + I +    ++  P  R 
Sbjct: 236 IKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 295

Query: 168 TMSDV 172
           T  + 
Sbjct: 296 TPLEA 300

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 73.7 bits (180), Expect = 4e-16
 Identities = 25/104 (24%), Positives = 48/104 (46%), Gaps = 8/104 (7%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
                    +     YLH    L +I+RD K  N+L+D +   +++DFG  +  +G+   
Sbjct: 141 PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT 197

Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKR 105
                + GT   ++PE  L   ++   D ++ GV++ E+ +G  
Sbjct: 198 -----LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.4 bits (174), Expect = 2e-15
 Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 18/159 (11%)

Query: 15  LLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYM 74
           +L L    KL II+RD K  NILLD   +  ++DFGL++ F   +T+       GT  YM
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYM 197

Query: 75  SPEYALGGF--FSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKAL 132
           +P+   GG        D +S GV++ E+++G     F       S      ++ +  + L
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP--FTVDGEKNSQ----AEISR--RIL 249

Query: 133 DMMDQKPGAISK-ANEILKCINVGLLCVQEDPNDRPTMS 170
                 P  +S  A ++++        + +DP  R    
Sbjct: 250 KSEPPYPQEMSALAKDLIQR------LLMKDPKKRLGCG 282

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 70.6 bits (172), Expect = 5e-15
 Identities = 42/186 (22%), Positives = 73/186 (39%), Gaps = 23/186 (12%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           + +  ++  + + L Y+H      IIHRD K  N+ ++ +   KI DFGL R     Q D
Sbjct: 121 DRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QAD 172

Query: 62  GTTNRVVGTYGYMSPEYALGG-FFSVKSDVFSFGVVVLEIISGKR--------NTGFYNS 112
                 V T  Y +PE  L    ++   D++S G ++ E+I+GK         +      
Sbjct: 173 SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM 232

Query: 113 ELALSLLGYAWKLWQEGKALDMMDQKPGAISKA-NEILKCINVGLL-----CVQEDPNDR 166
           ++  +      +  Q  +A + M   P    K    IL   +   +      +  D   R
Sbjct: 233 KVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQR 292

Query: 167 PTMSDV 172
            T  + 
Sbjct: 293 VTAGEA 298

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 69.1 bits (168), Expect = 1e-14
 Identities = 33/190 (17%), Positives = 63/190 (33%), Gaps = 29/190 (15%)

Query: 6   NIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHE-MNPKISDFGLTRIFEGKQTDGTT 64
             +  + + L Y H    + I+HRD K  N+++DHE    ++ D+GL   +   Q     
Sbjct: 133 FYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--- 186

Query: 65  NRVVGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELAL-----SL 118
           N  V +  +  PE  +    +    D++S G ++  +I  K      +           +
Sbjct: 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 246

Query: 119 LGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLL----------------CVQED 162
           LG         K    +D +   I   +   +                        ++ D
Sbjct: 247 LGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYD 306

Query: 163 PNDRPTMSDV 172
              R T  + 
Sbjct: 307 HQSRLTAREA 316

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 65.4 bits (158), Expect = 3e-13
 Identities = 24/105 (22%), Positives = 45/105 (42%), Gaps = 3/105 (2%)

Query: 1   MEMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHE-MNPKISDFGLTRIFEGKQ 59
           +  +  I   +   L Y+H+  +  IIH D K  N+L++       +    +  +     
Sbjct: 124 LIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 181

Query: 60  TDGTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
            D      + T  Y SPE  LG  +   +D++S   ++ E+I+G 
Sbjct: 182 YDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.8 bits (154), Expect = 1e-12
 Identities = 32/103 (31%), Positives = 49/103 (47%), Gaps = 6/103 (5%)

Query: 2   EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD 61
           E +  ++  +   + +LH      IIHRD K SNI++  +   KI DFGL R      T 
Sbjct: 119 ERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTS 172

Query: 62  GTTNRVVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLEIISGK 104
                 V T  Y +PE  LG  +    D++S G ++ E++  K
Sbjct: 173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 58.4 bits (140), Expect = 8e-11
 Identities = 43/187 (22%), Positives = 76/187 (40%), Gaps = 35/187 (18%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           +I  + R L Y+H      IIHRD K SN+ ++ +   KI DFGL      + TD     
Sbjct: 126 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL-----ARHTDDEMTG 177

Query: 67  VVGTYGYMSPEYALG-GFFSVKSDVFSFGVVVLEIISGK----------------RNTGF 109
            V T  Y +PE  L    ++   D++S G ++ E+++G+                R  G 
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 237

Query: 110 YNSELALSLLGYA----WKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQEDPND 165
             +EL   +   +     +   +   ++  +   GA   A ++L+        +  D + 
Sbjct: 238 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEK------MLVLDSDK 291

Query: 166 RPTMSDV 172
           R T +  
Sbjct: 292 RITAAQA 298

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 44.0 bits (103), Expect = 3e-06
 Identities = 17/94 (18%), Positives = 31/94 (32%), Gaps = 11/94 (11%)

Query: 7   IILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNR 66
           ++  +   +   +      I+H D    N+L+  E    I DF  +     +       R
Sbjct: 108 VLDMILEEVAKFYHR---GIVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGWREILER 163

Query: 67  -VVGTYGYMSPEYALGGFFSVKSDVFSFGVVVLE 99
            V     Y S  Y        + D+ S    +L+
Sbjct: 164 DVRNIITYFSRTY------RTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	220
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.98
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.98
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.98
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	99.98
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.97
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.97
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.97
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.97
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.97
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.97
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	99.97
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.97
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.97
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.97
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.97
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.97
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.97
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.97
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.97
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.97
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.97
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.97
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.96
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.96
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.96
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.96
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.96
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.96
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.26
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.7
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	94.01
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	92.87
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	92.67
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	90.24
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	86.19

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-37  Score=242.85  Aligned_cols=169  Identities=25%  Similarity=0.383  Sum_probs=123.1

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+++.++.|+++||+|||+++   |+||||||+||+++.++.+||+|||++................|++.|+|||.+.+
T Consensus       104 ~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~  180 (276)
T d1uwha_         104 IKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM  180 (276)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhc
Confidence            467899999999999999999   99999999999999999999999999876543333333344578999999999865


Q ss_pred             C---CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           82 G---FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        82 ~---~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                      .   .++.++|||||||++|||++|+.||...+......      .....+.........+     ......+.++|.+|
T Consensus       181 ~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~------~~~~~~~~~p~~~~~~-----~~~~~~l~~li~~c  249 (276)
T d1uwha_         181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII------FMVGRGYLSPDLSKVR-----SNCPKAMKRLMAEC  249 (276)
T ss_dssp             CSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH------HHHHHTSCCCCGGGSC-----TTCCHHHHHHHHHH
T ss_pred             ccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHH------HHHhcCCCCCcchhcc-----ccchHHHHHHHHHH
Confidence            3   47889999999999999999999997544332211      1111221111111111     11234788999999


Q ss_pred             cCCCCCCCCCHHHHHHHhcCccccCC
Q 027675          159 VQEDPNDRPTMSDVVIMLGSEAVNLA  184 (220)
Q Consensus       159 l~~~p~~Rps~~~~l~~l~~~~~~~~  184 (220)
                      |+.||++|||+++++++|+...+..+
T Consensus       250 l~~dp~~RPt~~~il~~Le~l~~~~P  275 (276)
T d1uwha_         250 LKKKRDERPLFPQILASIELLARSLP  275 (276)
T ss_dssp             TCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             cCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence            99999999999999999987765543

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-36  Score=235.89  Aligned_cols=159  Identities=26%  Similarity=0.324  Sum_probs=120.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+++.++.|++.||+|||++|   |+||||||+||+++.++.+||+|||++................||+.|+|||.+.+
T Consensus       103 ~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~  179 (271)
T d1nvra_         103 PDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR  179 (271)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcC
Confidence            357889999999999999999   99999999999999999999999999986543322222334578999999999988


Q ss_pred             CCC-cccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFF-SVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..+ +.++|||||||++|+|++|+.||...........      ........        ..........+.++|.+||+
T Consensus       180 ~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~------~~~~~~~~--------~~~~~~~s~~~~~li~~~L~  245 (271)
T d1nvra_         180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS------DWKEKKTY--------LNPWKKIDSAPLALLHKILV  245 (271)
T ss_dssp             SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH------HHHTTCTT--------STTGGGSCHHHHHHHHHHSC
T ss_pred             CCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHH------HHhcCCCC--------CCccccCCHHHHHHHHHHcC
Confidence            776 6789999999999999999999975443222111      01111100        00011123467789999999


Q ss_pred             CCCCCCCCHHHHHHHhc
Q 027675          161 EDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~  177 (220)
                      .||++|||+++++++=+
T Consensus       246 ~dP~~R~t~~eil~hpw  262 (271)
T d1nvra_         246 ENPSARITIPDIKKDRW  262 (271)
T ss_dssp             SSTTTSCCHHHHTTCTT
T ss_pred             CChhHCcCHHHHhcCHh
Confidence            99999999999998743

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-36  Score=236.31  Aligned_cols=157  Identities=24%  Similarity=0.340  Sum_probs=122.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .++..++.|++.||+|||++|   |+||||||+||+++.++.+||+|||++........  ......|++.|+|||.+.+
T Consensus       116 ~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~Y~aPE~~~~  190 (293)
T d1yhwa1         116 GQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTR  190 (293)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCGGGCCHHHHSS
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc--cccccccCCCccChhhhcC
Confidence            357889999999999999999   99999999999999999999999999986543222  2233568999999999999


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|||||||++|+|++|..||...+......      .....+.        +...........+.++|.+||+.
T Consensus       191 ~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~------~~~~~~~--------~~~~~~~~~s~~~~~li~~~L~~  256 (293)
T d1yhwa1         191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------LIATNGT--------PELQNPEKLSAIFRDFLNRCLDM  256 (293)
T ss_dssp             SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHHCS--------CCCSSGGGSCHHHHHHHHHHTCS
T ss_pred             CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHH------HHHhCCC--------CCCCCcccCCHHHHHHHHHHccC
Confidence            989999999999999999999999997554433221      1111111        01111112234788999999999


Q ss_pred             CCCCCCCHHHHHHHhc
Q 027675          162 DPNDRPTMSDVVIMLG  177 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~  177 (220)
                      ||++|||++|+++|=+
T Consensus       257 dP~~R~s~~eil~Hp~  272 (293)
T d1yhwa1         257 DVEKRGSAKELLQHQF  272 (293)
T ss_dssp             STTTSCCHHHHTTCGG
T ss_pred             ChhHCcCHHHHhcCHh
Confidence            9999999999998744

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-36  Score=241.22  Aligned_cols=158  Identities=27%  Similarity=0.414  Sum_probs=124.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|+++||+|||+++   |+||||||+||+++.++.+||+|||+++...............+++.|+|||.+.+
T Consensus       164 ~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~  240 (325)
T d1rjba_         164 EDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE  240 (325)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC
Confidence            357889999999999999999   99999999999999999999999999976554333333334567889999999999


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|||||||++|||++ |..||...+.....      .+....+.....+         ......+.++|.+||+
T Consensus       241 ~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~------~~~~~~~~~~~~p---------~~~~~~l~~li~~cl~  305 (325)
T d1rjba_         241 GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF------YKLIQNGFKMDQP---------FYATEEIYIIMQSCWA  305 (325)
T ss_dssp             CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH------HHHHHTTCCCCCC---------TTCCHHHHHHHHHHTC
T ss_pred             CCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHH------HHHHhcCCCCCCC---------CcCCHHHHHHHHHHcC
Confidence            999999999999999999997 89999754433221      1222222222111         1123478899999999


Q ss_pred             CCCCCCCCHHHHHHHhc
Q 027675          161 EDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~  177 (220)
                      .||++|||+++|+++|.
T Consensus       306 ~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         306 FDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             SSGGGSCCHHHHHHHHH
T ss_pred             CChhHCcCHHHHHHHHh
Confidence            99999999999999984

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-36  Score=234.46  Aligned_cols=150  Identities=24%  Similarity=0.347  Sum_probs=119.7

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.||+.||+|||+++   |+||||||+||+++.++.+||+|||++......    ......||+.|+|||.+.+
T Consensus       106 ~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~----~~~~~~Gt~~Y~APE~~~~  178 (263)
T d2j4za1         106 QRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEG  178 (263)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC----CCEETTEEGGGCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC----cccccCCCCcccCHHHHcC
Confidence            357889999999999999999   999999999999999999999999998754322    2233568999999999999


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|||||||++|+|++|+.||...+.......      .. ....     ..+.     .....+.++|.+||+.
T Consensus       179 ~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~------i~-~~~~-----~~p~-----~~s~~~~~li~~~L~~  241 (263)
T d2j4za1         179 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR------IS-RVEF-----TFPD-----FVTEGARDLISRLLKH  241 (263)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH------HH-TTCC-----CCCT-----TSCHHHHHHHHHHTCS
T ss_pred             CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHH------HH-cCCC-----CCCc-----cCCHHHHHHHHHHccC
Confidence            9999999999999999999999999976554332211      11 1110     0111     1234678899999999


Q ss_pred             CCCCCCCHHHHHHH
Q 027675          162 DPNDRPTMSDVVIM  175 (220)
Q Consensus       162 ~p~~Rps~~~~l~~  175 (220)
                      ||++|||++|+++|
T Consensus       242 dp~~R~t~~eil~h  255 (263)
T d2j4za1         242 NPSQRPMLREVLEH  255 (263)
T ss_dssp             SGGGSCCHHHHHTC
T ss_pred             CHhHCcCHHHHHcC
Confidence            99999999999975

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-36  Score=238.48  Aligned_cols=160  Identities=28%  Similarity=0.389  Sum_probs=119.5

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+++.++.|++.||+|||+++   |+||||||+||+++.++.+||+|||+++...............||+.|+|||.+.+
T Consensus       134 ~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~  210 (299)
T d1ywna1         134 EHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD  210 (299)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhc
Confidence            357889999999999999999   99999999999999999999999999976554433333444578899999999999


Q ss_pred             CCCcccCceeehhHHHHHHHhcC-ccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGK-RNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|||||||++|||++|. +||.........      ......+......+.         ....+.++|.+||+
T Consensus       211 ~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~------~~~~~~~~~~~~~~~---------~~~~l~~li~~cl~  275 (299)
T d1ywna1         211 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF------CRRLKEGTRMRAPDY---------TTPEMYQTMLDCWH  275 (299)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH------HHHHHHTCCCCCCTT---------CCHHHHHHHHHHTC
T ss_pred             CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH------HHHHhcCCCCCCCcc---------CCHHHHHHHHHHcC
Confidence            99999999999999999999864 567544332211      122223333222211         12367899999999


Q ss_pred             CCCCCCCCHHHHHHHhcCc
Q 027675          161 EDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~  179 (220)
                      .||++|||+++++++|+..
T Consensus       276 ~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         276 GEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             SSGGGSCCHHHHHHHHHHH
T ss_pred             CChhHCcCHHHHHHHHHHH
Confidence            9999999999999999754

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-36  Score=233.89  Aligned_cols=152  Identities=25%  Similarity=0.363  Sum_probs=116.6

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||+|||+++   |+||||||+||+++.++.++|+|||++................||+.|+|||++.+
T Consensus       108 ~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~  184 (288)
T d1uu3a_         108 TCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE  184 (288)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeecc
Confidence            357889999999999999999   99999999999999999999999999986543332333334578999999999999


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|||||||++|+|++|..||...+.......      .. .+. ...    +.     .....+.++|.+||+.
T Consensus       185 ~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~------i~-~~~-~~~----p~-----~~s~~~~~li~~~L~~  247 (288)
T d1uu3a_         185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK------II-KLE-YDF----PE-----KFFPKARDLVEKLLVL  247 (288)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HH-TTC-CCC----CT-----TCCHHHHHHHHTTSCS
T ss_pred             CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHH------HH-cCC-CCC----Cc-----cCCHHHHHHHHHHccC
Confidence            9999999999999999999999999976554433211      11 111 001    11     1234678999999999


Q ss_pred             CCCCCCCHHHHH
Q 027675          162 DPNDRPTMSDVV  173 (220)
Q Consensus       162 ~p~~Rps~~~~l  173 (220)
                      ||++|||++|++
T Consensus       248 dP~~R~t~~e~~  259 (288)
T d1uu3a_         248 DATKRLGCEEME  259 (288)
T ss_dssp             SGGGSTTSGGGT
T ss_pred             CHhHCcCHHHHc
Confidence            999999999864

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9.1e-36  Score=234.90  Aligned_cols=161  Identities=27%  Similarity=0.374  Sum_probs=115.2

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcc---cceeecccCccChhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGT---TNRVVGTYGYMSPEY   78 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~---~~~~~~~~~y~aPe~   78 (220)
                      .++++++.|+++||.|||+++   ++||||||+|||++.++.+||+|||+++..........   .....+++.|+|||.
T Consensus       128 ~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~  204 (299)
T d1jpaa_         128 IQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA  204 (299)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHH
T ss_pred             HHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHH
Confidence            457899999999999999999   99999999999999999999999999976543221111   111346788999999


Q ss_pred             hhcCCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcc
Q 027675           79 ALGGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLL  157 (220)
Q Consensus        79 ~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  157 (220)
                      +.+..++.++|||||||++|||++ |..||...........       ...+.....         .......+.++|.+
T Consensus       205 ~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~-------i~~~~~~~~---------~~~~~~~l~~li~~  268 (299)
T d1jpaa_         205 IQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINA-------IEQDYRLPP---------PMDCPSALHQLMLD  268 (299)
T ss_dssp             HHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-------HHTTCCCCC---------CTTCCHHHHHHHHH
T ss_pred             HhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHH-------HHcCCCCCC---------CccchHHHHHHHHH
Confidence            999899999999999999999998 8999876554432211       112221111         11123467889999


Q ss_pred             ccCCCCCCCCCHHHHHHHhcCccc
Q 027675          158 CVQEDPNDRPTMSDVVIMLGSEAV  181 (220)
Q Consensus       158 cl~~~p~~Rps~~~~l~~l~~~~~  181 (220)
                      ||+.||++|||+.++++.|+...+
T Consensus       269 cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         269 CWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             HTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HcCCCHhHCcCHHHHHHHHHHHhc
Confidence            999999999999999999876543

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-35  Score=231.75  Aligned_cols=156  Identities=23%  Similarity=0.324  Sum_probs=119.1

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhh-
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL-   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~-   80 (220)
                      +++..++.||+.||.|||+++   |+||||||+||+++.++.+||+|||++.......  .......|++.|+|||.+. 
T Consensus       110 ~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~~~~~~~Gt~~y~APE~l~~  184 (288)
T d2jfla1         110 SQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSFIGTPYWMAPEVVMC  184 (288)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--HHHTCCCSCCTTCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc--ccccccccccccCCHHHHhh
Confidence            357889999999999999999   9999999999999999999999999986543211  1122356899999999984 


Q ss_pred             ----cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhc
Q 027675           81 ----GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGL  156 (220)
Q Consensus        81 ----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  156 (220)
                          +..++.++|||||||++|+|++|+.||...+......      +... +..       +...........+.++|.
T Consensus       185 ~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~------~i~~-~~~-------~~~~~~~~~s~~~~~li~  250 (288)
T d2jfla1         185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL------KIAK-SEP-------PTLAQPSRWSSNFKDFLK  250 (288)
T ss_dssp             CSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH------HHHH-SCC-------CCCSSGGGSCHHHHHHHH
T ss_pred             cccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHH------HHHc-CCC-------CCCCccccCCHHHHHHHH
Confidence                4457899999999999999999999997655433221      1111 111       111111223457889999


Q ss_pred             cccCCCCCCCCCHHHHHHHh
Q 027675          157 LCVQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       157 ~cl~~~p~~Rps~~~~l~~l  176 (220)
                      +||+.||++|||++|+++|=
T Consensus       251 ~~L~~dp~~R~t~~ell~hp  270 (288)
T d2jfla1         251 KCLEKNVDARWTTSQLLQHP  270 (288)
T ss_dssp             HHSCSSTTTSCCHHHHTTSG
T ss_pred             HHccCChhHCcCHHHHhcCc
Confidence            99999999999999999864

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-35  Score=228.13  Aligned_cols=158  Identities=28%  Similarity=0.364  Sum_probs=113.2

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +.++.++.|++.||+|||+++   |+||||||+||+++.++.+||+|||+++........ ......++..|+|||.+.+
T Consensus       101 ~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~  176 (263)
T d1sm2a_         101 ETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSF  176 (263)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-------------------CTTSCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce-eecceecCcccCChHHhcC
Confidence            457889999999999999999   999999999999999999999999998765432221 1223467889999999999


Q ss_pred             CCCcccCceeehhHHHHHHHhc-CccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISG-KRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++||||||+++|||+++ .+||...+.......       ...+.....+.         .....+.++|.+||+
T Consensus       177 ~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~-------i~~~~~~~~p~---------~~~~~l~~li~~cl~  240 (263)
T d1sm2a_         177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED-------ISTGFRLYKPR---------LASTHVYQIMNHCWK  240 (263)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHH-------HHHTCCCCCCT---------TSCHHHHHHHHHHTC
T ss_pred             CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHH-------HHhcCCCCCcc---------ccCHHHHHHHHHHcc
Confidence            9999999999999999999995 555554433322211       11222211111         122467899999999


Q ss_pred             CCCCCCCCHHHHHHHhcCc
Q 027675          161 EDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~  179 (220)
                      .||++|||+++++++|+..
T Consensus       241 ~~p~~Rps~~~il~~L~~i  259 (263)
T d1sm2a_         241 ERPEDRPAFSRLLRQLAEI  259 (263)
T ss_dssp             SSGGGSCCHHHHHHHHHHH
T ss_pred             CCHhHCcCHHHHHHHHHHH
Confidence            9999999999999999765

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-35  Score=235.00  Aligned_cols=160  Identities=23%  Similarity=0.409  Sum_probs=122.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..+++++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++................+++.|+|||.+.+
T Consensus       111 ~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~  187 (317)
T d1xkka_         111 QYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH  187 (317)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhc
Confidence            357889999999999999999   99999999999999999999999999986544333333333467899999999999


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|||||||++|||++ |.+||...+......       ....+......         ......+.++|.+||.
T Consensus       188 ~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~-------~i~~~~~~~~p---------~~~~~~~~~li~~cl~  251 (317)
T d1xkka_         188 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-------ILEKGERLPQP---------PICTIDVYMIMVKCWM  251 (317)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHH-------HHHHTCCCCCC---------TTBCHHHHHHHHHHTC
T ss_pred             CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHH-------HHHcCCCCCCC---------cccCHHHHHHHHHhCC
Confidence            999999999999999999998 788887655443321       12222222111         1122467889999999


Q ss_pred             CCCCCCCCHHHHHHHhcCcc
Q 027675          161 EDPNDRPTMSDVVIMLGSEA  180 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~~  180 (220)
                      .||++|||+.+++++|....
T Consensus       252 ~dP~~RPs~~eil~~l~~~~  271 (317)
T d1xkka_         252 IDADSRPKFRELIIEFSKMA  271 (317)
T ss_dssp             SSGGGSCCHHHHHHHHHHHH
T ss_pred             CChhhCcCHHHHHHHHHHHH
Confidence            99999999999999986653

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-35  Score=228.11  Aligned_cols=156  Identities=25%  Similarity=0.349  Sum_probs=111.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCC--CCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDS--KLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYA   79 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~--~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~   79 (220)
                      ..++.++.|++.||.|||+++  ...|+||||||+||+++.++.+||+|||++........  ......|++.|+|||.+
T Consensus       109 ~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l  186 (269)
T d2java1         109 EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKAFVGTPYYMSPEQM  186 (269)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-------------CCCSCCCHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCCC--ccccCCCCcccCCHHHH
Confidence            357899999999999999864  12499999999999999999999999999876543221  12235789999999999


Q ss_pred             hcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           80 LGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        80 ~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      .+..++.++|||||||++|+|++|..||...+......      + ...+......         ...+..+.++|.+||
T Consensus       187 ~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~------~-i~~~~~~~~~---------~~~s~~l~~li~~~L  250 (269)
T d2java1         187 NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG------K-IREGKFRRIP---------YRYSDELNEIITRML  250 (269)
T ss_dssp             TTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH------H-HHHTCCCCCC---------TTSCHHHHHHHHHHT
T ss_pred             cCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHH------H-HHcCCCCCCC---------cccCHHHHHHHHHHc
Confidence            99999999999999999999999999997655443221      1 1122221111         112346889999999


Q ss_pred             CCCCCCCCCHHHHHHH
Q 027675          160 QEDPNDRPTMSDVVIM  175 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~  175 (220)
                      +.||++|||+.|++++
T Consensus       251 ~~dp~~Rps~~ell~h  266 (269)
T d2java1         251 NLKDYHRPSVEEILEN  266 (269)
T ss_dssp             CSSGGGSCCHHHHHTS
T ss_pred             CCChhHCcCHHHHHhC
Confidence            9999999999999976

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-35  Score=235.92  Aligned_cols=168  Identities=26%  Similarity=0.426  Sum_probs=118.4

Q ss_pred             chHHHHHHHHHHHHHHhhh-CCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQ-DSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~-~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~   80 (220)
                      ..+..++.|++.||.|||+ ++   |+||||||+||+++.++.+||+|||++.......    .....||+.|+|||++.
T Consensus       104 ~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~  176 (322)
T d1s9ja_         104 QILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQ  176 (322)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT----C---CCSSCCCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCCc----cccccCCccccCchHHc
Confidence            3578899999999999997 58   9999999999999999999999999987543221    22357899999999999


Q ss_pred             cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHh---------cc------------------ccc
Q 027675           81 GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQE---------GK------------------ALD  133 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~---------~~------------------~~~  133 (220)
                      +..++.++||||+||++|+|++|+.||...+.................         ..                  ...
T Consensus       177 ~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (322)
T d1s9ja_         177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDY  256 (322)
T ss_dssp             CSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHH
T ss_pred             CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhh
Confidence            999999999999999999999999999654433221110000000000         00                  000


Q ss_pred             cccCCCCCcCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHh
Q 027675          134 MMDQKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       134 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l  176 (220)
                      .....+........+..+.++|.+||..||++|||++|+++|=
T Consensus       257 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hp  299 (322)
T d1s9ja_         257 IVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA  299 (322)
T ss_dssp             HHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             hhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCH
Confidence            0000111111111234688999999999999999999999863

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-35  Score=227.07  Aligned_cols=157  Identities=27%  Similarity=0.439  Sum_probs=120.1

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..+++|+.|+++||.|||+++   |+||||||+||+++.++.+||+|||+++........ ......+++.|+|||.+.+
T Consensus       109 ~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~  184 (272)
T d1qpca_         109 NKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINY  184 (272)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-CCTTCCCCTTTSCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccc-cccccCCcccccChHHHhC
Confidence            467899999999999999999   999999999999999999999999999865432211 1222457789999999998


Q ss_pred             CCCcccCceeehhHHHHHHHhcCcc-CcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRN-TGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|||||||++|||++|..| +...+.....       .....+......+         .....+.++|.+||+
T Consensus       185 ~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~-------~~i~~~~~~~~p~---------~~~~~l~~li~~cl~  248 (272)
T d1qpca_         185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI-------QNLERGYRMVRPD---------NCPEELYQLMRLCWK  248 (272)
T ss_dssp             CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-------HHHHTTCCCCCCT---------TCCHHHHHHHHHHTC
T ss_pred             CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHhcCCCCCcc---------cChHHHHHHHHHHcC
Confidence            8899999999999999999996554 4443332221       1112222221111         122367899999999


Q ss_pred             CCCCCCCCHHHHHHHhcC
Q 027675          161 EDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~  178 (220)
                      .||++|||++++++.|+.
T Consensus       249 ~~P~~Rpt~~ei~~~L~~  266 (272)
T d1qpca_         249 ERPEDRPTFDYLRSVLED  266 (272)
T ss_dssp             SSGGGSCCHHHHHHHHHH
T ss_pred             CCHhHCcCHHHHHHHhhh
Confidence            999999999999998854

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-35  Score=228.70  Aligned_cols=161  Identities=25%  Similarity=0.366  Sum_probs=116.0

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCC-cccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD-GTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~y~aPe~~~   80 (220)
                      .++++++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++........ .......++..|+|||.+.
T Consensus       110 ~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~  186 (283)
T d1mqba_         110 LQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS  186 (283)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHH
T ss_pred             HHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHc
Confidence            467899999999999999999   999999999999999999999999999764432211 1122245678899999999


Q ss_pred             cCCCcccCceeehhHHHHHHHhcCccC-cccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           81 GGFFSVKSDVFSFGVVVLEIISGKRNT-GFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      +..++.++|||||||++|||+++..|+ ...+.....       +....+.......         .....+.++|.+||
T Consensus       187 ~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~-------~~i~~~~~~~~~~---------~~~~~l~~li~~cl  250 (283)
T d1mqba_         187 YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM-------KAINDGFRLPTPM---------DCPSAIYQLMMQCW  250 (283)
T ss_dssp             SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-------HHHHTTCCCCCCT---------TCBHHHHHHHHHHT
T ss_pred             cCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHH-------HHHhccCCCCCch---------hhHHHHHHHHHHHC
Confidence            999999999999999999999965554 333322221       1222222221111         12246789999999


Q ss_pred             CCCCCCCCCHHHHHHHhcCccc
Q 027675          160 QEDPNDRPTMSDVVIMLGSEAV  181 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l~~~~~  181 (220)
                      +.||++|||+.+|++.|+...+
T Consensus       251 ~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         251 QQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             CSSTTTSCCHHHHHHHHHHHHH
T ss_pred             cCCHhHCcCHHHHHHHHHHHhh
Confidence            9999999999999999876543

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3e-35  Score=232.29  Aligned_cols=160  Identities=26%  Similarity=0.353  Sum_probs=123.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..+++++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++................+++.|+|||.+.+
T Consensus       140 ~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  216 (301)
T d1lufa_         140 AEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY  216 (301)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHhhhcccCC---eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc
Confidence            357899999999999999999   99999999999999999999999999875443322233333557789999999999


Q ss_pred             CCCcccCceeehhHHHHHHHhcC-ccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGK-RNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|||||||++|||++|. +||...+.......       ..++........         ....+.++|.+||+
T Consensus       217 ~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~-------v~~~~~~~~p~~---------~~~~~~~li~~cl~  280 (301)
T d1lufa_         217 NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYY-------VRDGNILACPEN---------CPLELYNLMRLCWS  280 (301)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-------HHTTCCCCCCTT---------CCHHHHHHHHHHTC
T ss_pred             CCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHH-------HHcCCCCCCCcc---------chHHHHHHHHHHcC
Confidence            99999999999999999999985 56765544433211       222332222111         12367899999999


Q ss_pred             CCCCCCCCHHHHHHHhcCcc
Q 027675          161 EDPNDRPTMSDVVIMLGSEA  180 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~~  180 (220)
                      .||++||||.+|++.|+..+
T Consensus       281 ~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         281 KLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             SSGGGSCCHHHHHHHHHHTT
T ss_pred             CChhHCcCHHHHHHHHHHhc
Confidence            99999999999999997653

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-35  Score=227.40  Aligned_cols=158  Identities=25%  Similarity=0.371  Sum_probs=121.7

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCC-CcccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT-DGTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~y~aPe~~~   80 (220)
                      .++++++.|++.||+|||+++   |+||||||+||+++.++.++++|||+++....... ........+++.|+|||.+.
T Consensus       107 ~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~  183 (277)
T d1xbba_         107 KNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN  183 (277)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHH
T ss_pred             HHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhc
Confidence            467899999999999999999   99999999999999999999999999976543221 11222346788999999999


Q ss_pred             cCCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           81 GGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      +..++.++||||||+++|||++ |+.||...+.....       .....+.....+.         .....+.++|.+||
T Consensus       184 ~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~-------~~i~~~~~~~~p~---------~~~~~~~~li~~cl  247 (277)
T d1xbba_         184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-------AMLEKGERMGCPA---------GCPREMYDLMNLCW  247 (277)
T ss_dssp             HCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-------HHHHTTCCCCCCT---------TCCHHHHHHHHHHT
T ss_pred             CCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHH-------HHHHcCCCCCCCc---------ccCHHHHHHHHHHc
Confidence            9889999999999999999997 89999765543322       1122232222211         12246789999999


Q ss_pred             CCCCCCCCCHHHHHHHhcC
Q 027675          160 QEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l~~  178 (220)
                      +.||++|||+++|++.|+.
T Consensus       248 ~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         248 TYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             CSSTTTSCCHHHHHHHHHH
T ss_pred             CCCHhHCcCHHHHHHHhhC
Confidence            9999999999999877643

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-35  Score=228.16  Aligned_cols=159  Identities=23%  Similarity=0.316  Sum_probs=124.1

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCC-cccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTD-GTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~y~aPe~~~   80 (220)
                      .++++++.|+++||.|||+++   ++||||||+||+++.++.+||+|||+++........ .......+++.|+|||.+.
T Consensus       109 ~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  185 (285)
T d1u59a_         109 SNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN  185 (285)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHh
Confidence            467899999999999999999   999999999999999999999999999865432211 1122235678999999999


Q ss_pred             cCCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           81 GGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      +..++.++|||||||++|||++ |..||...+.....       .....+.....+..         ....+.++|.+||
T Consensus       186 ~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~-------~~i~~~~~~~~p~~---------~~~~l~~li~~cl  249 (285)
T d1u59a_         186 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-------AFIEQGKRMECPPE---------CPPELYALMSDCW  249 (285)
T ss_dssp             HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH-------HHHHTTCCCCCCTT---------CCHHHHHHHHHTT
T ss_pred             CCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCCCCCCCCc---------CCHHHHHHHHHHc
Confidence            8889999999999999999998 89999765543322       11223333222211         2246789999999


Q ss_pred             CCCCCCCCCHHHHHHHhcCc
Q 027675          160 QEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l~~~  179 (220)
                      +.||++|||+.+|++.|+..
T Consensus       250 ~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         250 IYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             CSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCHhHCcCHHHHHHHHHHH
Confidence            99999999999999888543

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-34  Score=221.78  Aligned_cols=157  Identities=25%  Similarity=0.350  Sum_probs=123.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..+++++.|+++||+|||+++   |+||||||+||+++.++.+||+|||+++........ ......++..|+|||.+.+
T Consensus       100 ~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~  175 (258)
T d1k2pa_         100 QQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMY  175 (258)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-CCCCSCCCGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce-eecccCCCCCcCCcHHhcC
Confidence            357899999999999999999   999999999999999999999999998765433222 2222457888999999999


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++||||||+++|||++ |+.||...+.......       ...+.....+.         .....+.++|.+||+
T Consensus       176 ~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~-------i~~~~~~~~p~---------~~~~~l~~li~~cl~  239 (258)
T d1k2pa_         176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH-------IAQGLRLYRPH---------LASEKVYTIMYSCWH  239 (258)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH-------HHTTCCCCCCT---------TCCHHHHHHHHHTTC
T ss_pred             CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHH-------HHhCCCCCCcc---------cccHHHHHHHHHHcc
Confidence            999999999999999999998 8999987665443221       11222211111         122468899999999


Q ss_pred             CCCCCCCCHHHHHHHhcC
Q 027675          161 EDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~  178 (220)
                      .||++|||+++++++|..
T Consensus       240 ~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         240 EKADERPTFKILLSNILD  257 (258)
T ss_dssp             SSGGGSCCHHHHHHHHHC
T ss_pred             CCHhHCcCHHHHHHHhhC
Confidence            999999999999999843

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.6e-35  Score=230.75  Aligned_cols=151  Identities=31%  Similarity=0.412  Sum_probs=117.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.||+.||.|||++|   |+||||||+||+++.++.+||+|||++.....      .....||+.|+|||.+.+
T Consensus       115 ~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------~~~~~GT~~Y~APE~~~~  185 (309)
T d1u5ra_         115 VEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILA  185 (309)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------BCCCCSCGGGCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC------CCccccCccccCHHHHhc
Confidence            357899999999999999999   99999999999999999999999999875432      223568999999999864


Q ss_pred             ---CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           82 ---GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        82 ---~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                         ..++.++|||||||++|+|++|..||...+.....      .+.... .....        ........+.++|.+|
T Consensus       186 ~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~------~~i~~~-~~~~~--------~~~~~s~~~~~li~~~  250 (309)
T d1u5ra_         186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQN-ESPAL--------QSGHWSEYFRNFVDSC  250 (309)
T ss_dssp             TTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHHS-CCCCC--------SCTTSCHHHHHHHHHH
T ss_pred             cCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHH------HHHHhC-CCCCC--------CCCCCCHHHHHHHHHH
Confidence               35788999999999999999999999654433221      111111 11111        1111234788999999


Q ss_pred             cCCCCCCCCCHHHHHHHh
Q 027675          159 VQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       159 l~~~p~~Rps~~~~l~~l  176 (220)
                      |+.||++|||++++++|-
T Consensus       251 L~~dP~~Rpt~~ell~Hp  268 (309)
T d1u5ra_         251 LQKIPQDRPTSEVLLKHR  268 (309)
T ss_dssp             TCSSGGGSCCHHHHTTCH
T ss_pred             CcCChhHCcCHHHHHhCH
Confidence            999999999999999763

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.3e-34  Score=227.02  Aligned_cols=158  Identities=24%  Similarity=0.364  Sum_probs=120.5

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++........ ......++..|+|||.+.+
T Consensus       115 ~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~  190 (287)
T d1opja_         115 VVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAY  190 (287)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE-EETTEEECGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCce-eeccccccccccChHHHcC
Confidence            357889999999999999999   999999999999999999999999998754432221 2222456788999999999


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCc-ccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTG-FYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|||||||++|||++|..||. ..+.....       +....+.......         .....+.++|.+||+
T Consensus       191 ~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~-------~~i~~~~~~~~~~---------~~~~~l~~li~~cl~  254 (287)
T d1opja_         191 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-------ELLEKDYRMERPE---------GCPEKVYELMRACWQ  254 (287)
T ss_dssp             CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-------HHHHTTCCCCCCT---------TCCHHHHHHHHHHTC
T ss_pred             CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHH-------HHHhcCCCCCCCc---------cchHHHHHHHHHHcC
Confidence            999999999999999999999766653 33322211       1222222221111         123468899999999


Q ss_pred             CCCCCCCCHHHHHHHhcCc
Q 027675          161 EDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~  179 (220)
                      .||++|||+.++++.|+..
T Consensus       255 ~dP~~Rps~~ei~~~L~~~  273 (287)
T d1opja_         255 WNPSDRPSFAEIHQAFETM  273 (287)
T ss_dssp             SSGGGSCCHHHHHHHHHHT
T ss_pred             CCHhHCcCHHHHHHHHHHH
Confidence            9999999999999988654

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-34  Score=225.19  Aligned_cols=155  Identities=22%  Similarity=0.357  Sum_probs=115.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeC-CCCCceecCccceeeecCCCCCcccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLD-HEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~   80 (220)
                      +.++.++.|+++||+|||+++ ..|+||||||+||+++ .++.+||+|||++.....    .......||+.|+|||.+.
T Consensus       112 ~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~----~~~~~~~GT~~Y~aPE~~~  186 (270)
T d1t4ha_         112 KVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAPEMYE  186 (270)
T ss_dssp             HHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT----TSBEESCSSCCCCCGGGGG
T ss_pred             HHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC----CccCCcccCccccCHHHhC
Confidence            457889999999999999874 3499999999999996 578999999999864322    1223457899999999987


Q ss_pred             cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           81 GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      + .++.++|||||||++|+|++|+.||.........      .+....+.....        ........+.++|.+||+
T Consensus       187 ~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~------~~~i~~~~~~~~--------~~~~~~~~~~~li~~~l~  251 (270)
T d1t4ha_         187 E-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI------YRRVTSGVKPAS--------FDKVAIPEVKEIIEGCIR  251 (270)
T ss_dssp             T-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH------HHHHTTTCCCGG--------GGGCCCHHHHHHHHHHSC
T ss_pred             C-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHH------HHHHHcCCCCcc--------cCccCCHHHHHHHHHHcc
Confidence            6 5899999999999999999999999644322211      011111111111        111122357889999999


Q ss_pred             CCCCCCCCHHHHHHHh
Q 027675          161 EDPNDRPTMSDVVIML  176 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l  176 (220)
                      .||++|||++|+++|=
T Consensus       252 ~dp~~R~s~~ell~Hp  267 (270)
T d1t4ha_         252 QNKDERYSIKDLLNHA  267 (270)
T ss_dssp             SSGGGSCCHHHHHTSG
T ss_pred             CCHhHCcCHHHHhCCc
Confidence            9999999999999863

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.5e-34  Score=227.34  Aligned_cols=157  Identities=22%  Similarity=0.259  Sum_probs=110.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeC---CCCCceecCccceeeecCCCCCcccceeecccCccChhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLD---HEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEY   78 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~   78 (220)
                      ..+..++.||+.||+|||+++   |+||||||+||++.   .++.+||+|||++.......   ......||+.|+|||.
T Consensus       107 ~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~---~~~~~~GT~~y~APE~  180 (307)
T d1a06a_         107 RDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEV  180 (307)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC---------------------CTTSCHHH
T ss_pred             HHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccCCC---eeeeeeeCccccCcHH
Confidence            357889999999999999999   99999999999994   57889999999987544322   1223568999999999


Q ss_pred             hhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           79 ALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        79 ~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                      +.+..++.++|||||||++|+|++|..||...........      .. .+..      .............+.++|.+|
T Consensus       181 ~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~------i~-~~~~------~~~~~~~~~~s~~~~~li~~~  247 (307)
T d1a06a_         181 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQ------IL-KAEY------EFDSPYWDDISDSAKDFIRHL  247 (307)
T ss_dssp             HTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH------HH-TTCC------CCCTTTTTTSCHHHHHHHHHH
T ss_pred             HcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHH------Hh-ccCC------CCCCccccCCCHHHHHHHHHH
Confidence            9999999999999999999999999999975444332211      11 1111      000111112234678999999


Q ss_pred             cCCCCCCCCCHHHHHHHhc
Q 027675          159 VQEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       159 l~~~p~~Rps~~~~l~~l~  177 (220)
                      |+.||++|||++|+++|-+
T Consensus       248 L~~dP~~R~s~~eil~hp~  266 (307)
T d1a06a_         248 MEKDPEKRFTCEQALQHPW  266 (307)
T ss_dssp             SCSSGGGSCCHHHHHHSTT
T ss_pred             ccCCHhHCcCHHHHhcCHh
Confidence            9999999999999999743

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-34  Score=225.23  Aligned_cols=159  Identities=29%  Similarity=0.369  Sum_probs=126.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+++.+++|++.||+|||+.+   |+||||||+||+++.++.+||+|||++................+++.|+|||.+.+
T Consensus       135 ~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~  211 (299)
T d1fgka_         135 KDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD  211 (299)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC
Confidence            467899999999999999999   99999999999999999999999999886654433333344567889999999999


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++||||||+++|+|++ |.+||...+.....       .....+.......         .....+.++|.+||+
T Consensus       212 ~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~-------~~i~~~~~~~~p~---------~~~~~l~~li~~cl~  275 (299)
T d1fgka_         212 RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF-------KLLKEGHRMDKPS---------NCTNELYMMMRDCWH  275 (299)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-------HHHHTTCCCCCCS---------SCCHHHHHHHHHHTC
T ss_pred             CCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH-------HHHHcCCCCCCCc---------cchHHHHHHHHHHcc
Confidence            999999999999999999998 68888755543322       2222332222211         122368899999999


Q ss_pred             CCCCCCCCHHHHHHHhcCc
Q 027675          161 EDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~  179 (220)
                      .||++|||+.+|++.|+..
T Consensus       276 ~dP~~Rps~~eil~~L~~i  294 (299)
T d1fgka_         276 AVPSQRPTFKQLVEDLDRI  294 (299)
T ss_dssp             SSGGGSCCHHHHHHHHHHH
T ss_pred             CCHhHCcCHHHHHHHHHHH
Confidence            9999999999999999654

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=4.4e-34  Score=229.59  Aligned_cols=156  Identities=23%  Similarity=0.265  Sum_probs=120.7

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCC--CCCceecCccceeeecCCCCCcccceeecccCccChhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDH--EMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYA   79 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~   79 (220)
                      +.++.++.||+.||+|||++|   |+||||||+||+++.  ++.+||+|||++.......   ......||+.|+|||++
T Consensus       124 ~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~---~~~~~~gT~~Y~aPEv~  197 (350)
T d1koaa2         124 DEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVA  197 (350)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS---CEEEECSCTTTCCHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc---ccceecCcccccCHHHH
Confidence            467889999999999999999   999999999999954  6789999999998654322   22335789999999999


Q ss_pred             hcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           80 LGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        80 ~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      .+..++.++|||||||++|+|++|+.||...+.......      ......       .............+.++|.+||
T Consensus       198 ~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~------i~~~~~-------~~~~~~~~~~s~~~~~li~~~L  264 (350)
T d1koaa2         198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRN------VKSCDW-------NMDDSAFSGISEDGKDFIRKLL  264 (350)
T ss_dssp             HTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HHHTCC-------CSCCGGGGGCCHHHHHHHHHHC
T ss_pred             cCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHH------HHhCCC-------CCCcccccCCCHHHHHHHHHHc
Confidence            999999999999999999999999999976554332211      111110       0011111122346789999999


Q ss_pred             CCCCCCCCCHHHHHHHh
Q 027675          160 QEDPNDRPTMSDVVIML  176 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l  176 (220)
                      ..||++|||++++++|=
T Consensus       265 ~~dP~~R~t~~eil~hp  281 (350)
T d1koaa2         265 LADPNTRMTIHQALEHP  281 (350)
T ss_dssp             CSSGGGSCCHHHHHHST
T ss_pred             cCChhHCcCHHHHhcCc
Confidence            99999999999999973

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=4.4e-34  Score=229.73  Aligned_cols=156  Identities=19%  Similarity=0.204  Sum_probs=121.5

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeC--CCCCceecCccceeeecCCCCCcccceeecccCccChhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLD--HEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYA   79 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~--~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~   79 (220)
                      .+++.|+.||+.||+|||++|   |+||||||+|||++  .++.+||+|||++.......   ......+++.|+|||++
T Consensus       127 ~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~  200 (352)
T d1koba_         127 AEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIV  200 (352)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS---CEEEECSSGGGCCHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC---ceeeccCcccccCHHHH
Confidence            357889999999999999999   99999999999997  67889999999998754322   22335678999999999


Q ss_pred             hcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           80 LGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        80 ~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      .+..++.++|||||||++|+|++|..||...+.......      .. .+..      .............+.++|.+||
T Consensus       201 ~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~------i~-~~~~------~~~~~~~~~~s~~~~~li~~~L  267 (352)
T d1koba_         201 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQN------VK-RCDW------EFDEDAFSSVSPEAKDFIKNLL  267 (352)
T ss_dssp             TTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH------HH-HCCC------CCCSSTTTTSCHHHHHHHHTTS
T ss_pred             cCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HH-hCCC------CCCcccccCCCHHHHHHHHHHc
Confidence            999999999999999999999999999976554433211      11 1111      0011111122346789999999


Q ss_pred             CCCCCCCCCHHHHHHHh
Q 027675          160 QEDPNDRPTMSDVVIML  176 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l  176 (220)
                      +.||++|||++++++|-
T Consensus       268 ~~dp~~R~s~~eil~Hp  284 (352)
T d1koba_         268 QKEPRKRLTVHDALEHP  284 (352)
T ss_dssp             CSSGGGSCCHHHHHTST
T ss_pred             cCChhHCcCHHHHhcCH
Confidence            99999999999999873

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-34  Score=226.99  Aligned_cols=169  Identities=24%  Similarity=0.292  Sum_probs=121.7

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +.+..++.|++.||+|||+++   |+||||||+|||++.++.++|+|||++......   .......||+.|+|||.+.+
T Consensus       116 ~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~  189 (305)
T d1blxa_         116 ETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQ  189 (305)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchhhhhhhccc---ccCCCcccChhhcCcchhcC
Confidence            357789999999999999999   999999999999999999999999997653322   22334578999999999999


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHH-----HHHhcccc-c----cccCCCCCcCcHHHHHHH
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWK-----LWQEGKAL-D----MMDQKPGAISKANEILKC  151 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~-~----~~~~~~~~~~~~~~~~~~  151 (220)
                      ..++.++||||+||++|+|++|..||...+.............     .+...... .    .....+...........+
T Consensus       190 ~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  269 (305)
T d1blxa_         190 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELG  269 (305)
T ss_dssp             CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHH
T ss_pred             CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHH
Confidence            9999999999999999999999999976554433222111000     00000000 0    000000000111123467


Q ss_pred             HHHhccccCCCCCCCCCHHHHHHHh
Q 027675          152 INVGLLCVQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       152 ~~li~~cl~~~p~~Rps~~~~l~~l  176 (220)
                      .++|.+||+.||++|||++|+++|=
T Consensus       270 ~dli~~mL~~dP~~R~sa~e~L~Hp  294 (305)
T d1blxa_         270 KDLLLKCLTFNPAKRISAYSALSHP  294 (305)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred             HHHHHHHCcCChhHCcCHHHHhcCh
Confidence            8899999999999999999999874

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-34  Score=223.78  Aligned_cols=168  Identities=23%  Similarity=0.219  Sum_probs=120.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..+..+++||+.||+|||++|   |+||||||+||+++.++.+||+|||++.........  .....+++.|+|||.+.+
T Consensus       100 ~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~  174 (299)
T d1ua2a_         100 SHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFG  174 (299)
T ss_dssp             SHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC--CCCSCCCCTTCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCccc--ccceecChhhccHHHHcc
Confidence            467899999999999999999   999999999999999999999999998754432221  122467899999999875


Q ss_pred             C-CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhc--------ccccc-ccCCCCCcCc-----HH
Q 027675           82 G-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEG--------KALDM-MDQKPGAISK-----AN  146 (220)
Q Consensus        82 ~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~-~~~~~~~~~~-----~~  146 (220)
                      . .++.++|||||||++|+|++|.+||...+.......+.   +.....        ..... ..........     ..
T Consensus       175 ~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (299)
T d1ua2a_         175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIF---ETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSA  251 (299)
T ss_dssp             CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---HHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTT
T ss_pred             CCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHH---HhcCCCChhhccchhccchhhhhccCCCCChHHhccc
Confidence            4 57899999999999999999999997655444322211   111000        00000 0000000000     11


Q ss_pred             HHHHHHHHhccccCCCCCCCCCHHHHHHHhc
Q 027675          147 EILKCINVGLLCVQEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       147 ~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~  177 (220)
                      ....+.++|.+||+.||++|||++|+++|=+
T Consensus       252 ~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~  282 (299)
T d1ua2a_         252 AGDDLLDLIQGLFLFNPCARITATQALKMKY  282 (299)
T ss_dssp             CCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHhCCHh
Confidence            2346889999999999999999999998743

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-34  Score=223.25  Aligned_cols=158  Identities=25%  Similarity=0.341  Sum_probs=114.2

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|+++||.|||+++   ++||||||+||+++.++.+||+|||++........ .......+++.|+|||.+.+
T Consensus       108 ~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~apE~l~~  183 (273)
T d1mp8a_         108 ASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINF  183 (273)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccCCcc-eeccceecCcccchhhHhcc
Confidence            457889999999999999999   99999999999999999999999999876443222 12223456889999999999


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|||||||++|||++ |.+||...+......       ....+.......         .....+.++|.+||+
T Consensus       184 ~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~-------~i~~~~~~~~~~---------~~~~~~~~li~~cl~  247 (273)
T d1mp8a_         184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG-------RIENGERLPMPP---------NCPPTLYSLMTKCWA  247 (273)
T ss_dssp             CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH-------HHHTTCCCCCCT---------TCCHHHHHHHHHHTC
T ss_pred             CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHH-------HHHcCCCCCCCC---------CCCHHHHHHHHHHcC
Confidence            999999999999999999997 888987655443221       112222221111         123468899999999


Q ss_pred             CCCCCCCCHHHHHHHhcCc
Q 027675          161 EDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~  179 (220)
                      .||++|||+.+|+++|+..
T Consensus       248 ~dp~~Rps~~ei~~~L~~i  266 (273)
T d1mp8a_         248 YDPSRRPRFTELKAQLSTI  266 (273)
T ss_dssp             SSGGGSCCHHHHHHHHHHH
T ss_pred             CCHhHCcCHHHHHHHHHHH
Confidence            9999999999999998654

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5e-34  Score=229.33  Aligned_cols=151  Identities=21%  Similarity=0.239  Sum_probs=120.1

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.||+.||.|||+++   |+||||||+|||++.+|.+||+|||++......     .....|++.|+|||++.+
T Consensus       141 ~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~~~~  212 (350)
T d1rdqe_         141 PHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILS  212 (350)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc-----cccccCccccCCHHHHcC
Confidence            357889999999999999999   999999999999999999999999999865432     223578999999999999


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|||||||++|+|++|..||...+.......      .. .+..     ..+.     .....+.++|.+||..
T Consensus       213 ~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~------i~-~~~~-----~~p~-----~~s~~~~~li~~~L~~  275 (350)
T d1rdqe_         213 KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK------IV-SGKV-----RFPS-----HFSSDLKDLLRNLLQV  275 (350)
T ss_dssp             CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HH-HCCC-----CCCT-----TCCHHHHHHHHHHSCS
T ss_pred             CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHH------Hh-cCCC-----CCCc-----cCCHHHHHHHHHHhhh
Confidence            9999999999999999999999999975543332211      11 1111     0111     1233678999999999


Q ss_pred             CCCCCC-----CHHHHHHHhc
Q 027675          162 DPNDRP-----TMSDVVIMLG  177 (220)
Q Consensus       162 ~p~~Rp-----s~~~~l~~l~  177 (220)
                      ||++|+     |++++++|=+
T Consensus       276 dP~kR~~~~r~t~~ell~Hp~  296 (350)
T d1rdqe_         276 DLTKRFGNLKNGVNDIKNHKW  296 (350)
T ss_dssp             CTTTCTTSSTTTTHHHHTSGG
T ss_pred             CHHhccccccccHHHHHcCcc
Confidence            999994     9999998643

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-34  Score=227.23  Aligned_cols=153  Identities=23%  Similarity=0.273  Sum_probs=120.7

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .++.++.|++.||+|||++|   |+||||||+||+++.+|.+||+|||++........  ......||+.|+|||++.+.
T Consensus       106 ~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~  180 (337)
T d1o6la_         106 RARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDN  180 (337)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSS
T ss_pred             HHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCCc--ccccceeCHHHhhhhhccCC
Confidence            57789999999999999999   99999999999999999999999999875432221  22335789999999999999


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      .++.++|+|||||++|+|++|++||...+.......      . ..+. ..    .+.     ..+..+.++|.+||+.|
T Consensus       181 ~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~------i-~~~~-~~----~p~-----~~s~~~~dli~~~L~~d  243 (337)
T d1o6la_         181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL------I-LMEE-IR----FPR-----TLSPEAKSLLAGLLKKD  243 (337)
T ss_dssp             CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------H-HHCC-CC----CCT-----TSCHHHHHHHHHHTCSS
T ss_pred             CCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHH------H-hcCC-CC----CCc-----cCCHHHHHHHHhhccCC
Confidence            999999999999999999999999976654433211      1 1111 11    111     12346789999999999


Q ss_pred             CCCCCC-----HHHHHHHhc
Q 027675          163 PNDRPT-----MSDVVIMLG  177 (220)
Q Consensus       163 p~~Rps-----~~~~l~~l~  177 (220)
                      |++|++     ++++++|-+
T Consensus       244 P~~R~~~~~~~~~eil~Hp~  263 (337)
T d1o6la_         244 PKQRLGGGPSDAKEVMEHRF  263 (337)
T ss_dssp             TTTSTTCSTTTHHHHHTSGG
T ss_pred             chhhcccccccHHHHHcCcc
Confidence            999994     899998643

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-34  Score=223.35  Aligned_cols=161  Identities=24%  Similarity=0.390  Sum_probs=117.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .+++.++.||+.||+|||+++   ++||||||+||+++.++.+||+|||+++........ ......+++.|.|||.+.+
T Consensus       113 ~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~  188 (285)
T d1fmka3         113 PQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALY  188 (285)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCce-eeccccccccccChHHHhC
Confidence            468899999999999999999   999999999999999999999999998754332221 2223457889999999999


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccC-cccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNT-GFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++||||||+++|||++|..|+ ...........       ...+......         ......+.++|.+||+
T Consensus       189 ~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~-------i~~~~~~~~~---------~~~~~~l~~li~~cl~  252 (285)
T d1fmka3         189 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-------VERGYRMPCP---------PECPESLHDLMCQCWR  252 (285)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-------HHTTCCCCCC---------TTSCHHHHHHHHHHTC
T ss_pred             CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHH-------HHhcCCCCCC---------cccCHHHHHHHHHHcc
Confidence            99999999999999999999965554 43333222211       1111111111         1122367899999999


Q ss_pred             CCCCCCCCHHHHHHHhcCcccc
Q 027675          161 EDPNDRPTMSDVVIMLGSEAVN  182 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~~~~  182 (220)
                      .||++||++++|++.|+.....
T Consensus       253 ~dP~~Rps~~~i~~~L~~~~~~  274 (285)
T d1fmka3         253 KEPEERPTFEYLQAFLEDYFTS  274 (285)
T ss_dssp             SSGGGSCCHHHHHHHHHTTTSC
T ss_pred             cCHhHCcCHHHHHHHHhhhhcC
Confidence            9999999999999998765443

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.3e-33  Score=224.10  Aligned_cols=149  Identities=26%  Similarity=0.304  Sum_probs=118.8

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+..++.||+.||+|||+++   |+||||||+||+++.+|.+||+|||++......     .....|++.|+|||.+.+.
T Consensus       105 ~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~l~~~  176 (316)
T d1fota_         105 VAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTK  176 (316)
T ss_dssp             HHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTC
T ss_pred             HHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc-----cccccCcccccCHHHHcCC
Confidence            46778999999999999999   999999999999999999999999999865432     2235789999999999999


Q ss_pred             CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQED  162 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  162 (220)
                      .++.++|||||||++|+|++|+.||...+......      +.. .+..     ..+.     .....+.+++.+||..|
T Consensus       177 ~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~------~i~-~~~~-----~~p~-----~~s~~~~~li~~~L~~d  239 (316)
T d1fota_         177 PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE------KIL-NAEL-----RFPP-----FFNEDVKDLLSRLITRD  239 (316)
T ss_dssp             CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHH-HCCC-----CCCT-----TSCHHHHHHHHHHTCSC
T ss_pred             CCCchhhccccchhHHHHHhCCCCCCCcCHHHHHH------HHH-cCCC-----CCCC-----CCCHHHHHHHHHHhhhC
Confidence            99999999999999999999999997654433221      111 1111     0111     11236788999999999


Q ss_pred             CCCCC-----CHHHHHHHh
Q 027675          163 PNDRP-----TMSDVVIML  176 (220)
Q Consensus       163 p~~Rp-----s~~~~l~~l  176 (220)
                      |.+|+     |++++++|=
T Consensus       240 p~~R~~~~r~t~~~il~Hp  258 (316)
T d1fota_         240 LSQRLGNLQNGTEDVKNHP  258 (316)
T ss_dssp             TTTCTTSSTTTTHHHHTSG
T ss_pred             HHhccccchhhHHHHHcCc
Confidence            99996     999999763

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.9e-33  Score=227.10  Aligned_cols=155  Identities=23%  Similarity=0.217  Sum_probs=118.7

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.||+.||+|||+++   |+||||||+|||++.+|.+||+|||++.......    .....||+.|+|||.+.+
T Consensus       107 ~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~----~~~~~GT~~y~APE~~~~  179 (364)
T d1omwa3         107 ADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQK  179 (364)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSSSC----CCSCCSCGGGCCHHHHST
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCCCc----ccccccccccchhHHhhc
Confidence            357889999999999999999   9999999999999999999999999998654322    223468999999999864


Q ss_pred             -CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 -GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 -~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                       ..++.++|||||||++|+|++|+.||............       ... .    ......  .......+.++|.+||+
T Consensus       180 ~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~-------~~~-~----~~~~~~--~~~~s~~~~~li~~~L~  245 (364)
T d1omwa3         180 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-------RMT-L----TMAVEL--PDSFSPELRSLLEGLLQ  245 (364)
T ss_dssp             TCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH-------HHS-S----SCCCCC--CSSSCHHHHHHHHHHTC
T ss_pred             CCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------Hhc-c----cCCCCC--CCCCCHHHHHHHHHHcc
Confidence             56899999999999999999999999754433222111       000 0    000000  01123467899999999


Q ss_pred             CCCCCCCC-----HHHHHHHhc
Q 027675          161 EDPNDRPT-----MSDVVIMLG  177 (220)
Q Consensus       161 ~~p~~Rps-----~~~~l~~l~  177 (220)
                      .||++|||     ++++++|=+
T Consensus       246 ~dP~~R~t~~~~~a~eil~Hp~  267 (364)
T d1omwa3         246 RDVNRRLGCLGRGAQEVKESPF  267 (364)
T ss_dssp             SSTTTSTTTSSSTHHHHHTSGG
T ss_pred             cCHHHhCCCcccCHHHHHcCcc
Confidence            99999999     799997643

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=5e-34  Score=222.16  Aligned_cols=159  Identities=28%  Similarity=0.361  Sum_probs=121.6

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCc-ccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDG-TTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~y~aPe~~~   80 (220)
                      ..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++.......... ......++..|.|||.+.
T Consensus       111 ~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  187 (273)
T d1u46a_         111 GTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK  187 (273)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHh
Confidence            467899999999999999999   9999999999999999999999999998654332211 222345677899999999


Q ss_pred             cCCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           81 GGFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      +..++.++||||||+++|||++ |..||...+......      +....+.......         .....+.++|.+||
T Consensus       188 ~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~------~i~~~~~~~~~~~---------~~~~~l~~li~~cl  252 (273)
T d1u46a_         188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH------KIDKEGERLPRPE---------DCPQDIYNVMVQCW  252 (273)
T ss_dssp             HCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH------HHHTSCCCCCCCT---------TCCHHHHHHHHHHT
T ss_pred             CCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHH------HHHhCCCCCCCcc---------cccHHHHHHHHHHc
Confidence            9999999999999999999998 899997655444321      2222222221111         11236789999999


Q ss_pred             CCCCCCCCCHHHHHHHhcC
Q 027675          160 QEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l~~  178 (220)
                      ..||++|||+.+|++.|.+
T Consensus       253 ~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         253 AHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             CSSGGGSCCHHHHHHHHHH
T ss_pred             CCChhHCcCHHHHHHHHHh
Confidence            9999999999999998854

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=1.2e-33  Score=225.84  Aligned_cols=159  Identities=18%  Similarity=0.203  Sum_probs=119.0

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCC---CCCceecCccceeeecCCCCCcccceeecccCccChhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDH---EMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEY   78 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~   78 (220)
                      .+++.++.||+.||+|||++|   |+||||||+||+++.   .+.+||+|||++........   .....|++.|+|||.
T Consensus       111 ~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~  184 (335)
T d2ozaa1         111 REASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEV  184 (335)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCC---CCCCSCCCSSCCCCC
T ss_pred             HHHHHHHHHHHHHHHHHHHcC---CccccccccccccccccccccccccccceeeeccCCCc---cccccCCcccCCcHH
Confidence            357899999999999999999   999999999999975   45699999999986543322   223568999999999


Q ss_pred             hhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccc
Q 027675           79 ALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLC  158 (220)
Q Consensus        79 ~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  158 (220)
                      +.+..++.++|||||||++|+|++|+.||...+........       ..  .................+..+.++|.+|
T Consensus       185 ~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~-------~~--~i~~~~~~~~~~~~~~~s~~~~~li~~~  255 (335)
T d2ozaa1         185 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-------KT--RIRMGQYEFPNPEWSEVSEEVKMLIRNL  255 (335)
T ss_dssp             CCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------------CCCSCSSSCCTTHHHHSCHHHHHHHHHH
T ss_pred             HcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH-------HH--HHhcCCCCCCCcccccCCHHHHHHHHHH
Confidence            99988999999999999999999999999654332221110       00  0000011111111123356789999999


Q ss_pred             cCCCCCCCCCHHHHHHH
Q 027675          159 VQEDPNDRPTMSDVVIM  175 (220)
Q Consensus       159 l~~~p~~Rps~~~~l~~  175 (220)
                      |+.||++|||+.+++.|
T Consensus       256 L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         256 LKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             SCSSTTTSCCHHHHHHS
T ss_pred             ccCChhHCcCHHHHHcC
Confidence            99999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=3.4e-33  Score=221.07  Aligned_cols=158  Identities=27%  Similarity=0.396  Sum_probs=124.8

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .+++++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++...............+++.|.|||.+.+.
T Consensus       134 ~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~  210 (308)
T d1p4oa_         134 KMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG  210 (308)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccC
Confidence            57889999999999999999   999999999999999999999999998765443333334445678999999999999


Q ss_pred             CCcccCceeehhHHHHHHHhcC-ccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           83 FFSVKSDVFSFGVVVLEIISGK-RNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        83 ~~~~~~DiwslG~il~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      .++.++|+||||+++|||++|. +||...+.......       ..++........         ....+.++|.+||+.
T Consensus       211 ~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~-------i~~~~~~~~p~~---------~~~~l~~li~~cl~~  274 (308)
T d1p4oa_         211 VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF-------VMEGGLLDKPDN---------CPDMLFELMRMCWQY  274 (308)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH-------HHTTCCCCCCTT---------CCHHHHHHHHHHTCS
T ss_pred             CCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HHhCCCCCCccc---------chHHHHHHHHHHcCC
Confidence            9999999999999999999985 67765444332211       122222222211         224688999999999


Q ss_pred             CCCCCCCHHHHHHHhcCc
Q 027675          162 DPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       162 ~p~~Rps~~~~l~~l~~~  179 (220)
                      ||++|||+++|++.|+..
T Consensus       275 ~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         275 NPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             SGGGSCCHHHHHHHHGGG
T ss_pred             ChhHCcCHHHHHHHHHHh
Confidence            999999999999999665

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=2.5e-33  Score=220.40  Aligned_cols=158  Identities=22%  Similarity=0.208  Sum_probs=120.5

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCC----CceecCccceeeecCCCCCcccceeecccCccChh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEM----NPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPE   77 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe   77 (220)
                      ..++.++.|++.||+|||+++   |+||||||+||+++.++    .+|++|||++........   .....+++.|+|||
T Consensus       113 ~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~APE  186 (293)
T d1jksa_         113 EEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPE  186 (293)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCB---CSCCCCCGGGCCHH
T ss_pred             hHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhhhhcCCCcc---ccccCCCCcccCHH
Confidence            357889999999999999999   99999999999998776    489999999876543221   22346788999999


Q ss_pred             hhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcc
Q 027675           78 YALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLL  157 (220)
Q Consensus        78 ~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  157 (220)
                      .+.+..++.++|||||||++|+|++|..||...+........      . .+..      .............+.++|.+
T Consensus       187 ~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i------~-~~~~------~~~~~~~~~~s~~~~~li~~  253 (293)
T d1jksa_         187 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------S-AVNY------EFEDEYFSNTSALAKDFIRR  253 (293)
T ss_dssp             HHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------H-TTCC------CCCHHHHTTSCHHHHHHHHT
T ss_pred             HHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHH------H-hcCC------CCCchhcCCCCHHHHHHHHH
Confidence            999988999999999999999999999999765543322111      1 1110      00000001123467899999


Q ss_pred             ccCCCCCCCCCHHHHHHHhcC
Q 027675          158 CVQEDPNDRPTMSDVVIMLGS  178 (220)
Q Consensus       158 cl~~~p~~Rps~~~~l~~l~~  178 (220)
                      ||+.||++|||++++++|-+-
T Consensus       254 ~L~~dP~~R~s~~eil~hp~~  274 (293)
T d1jksa_         254 LLVKDPKKRMTIQDSLQHPWI  274 (293)
T ss_dssp             TSCSSGGGSCCHHHHHHSTTT
T ss_pred             HccCChhHCcCHHHHhcCccc
Confidence            999999999999999987543

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.8e-33  Score=221.10  Aligned_cols=160  Identities=26%  Similarity=0.412  Sum_probs=124.1

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..+.+++.|++.||+|||+++   ++||||||+||+++.++.++++|||+++...............+++.|+|||.+.+
T Consensus       145 ~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  221 (311)
T d1t46a_         145 EDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN  221 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC
Confidence            357889999999999999999   99999999999999999999999999986554433344444677899999999999


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++|||||||++|||++ |.+||...+....      ..+....+......         ......+.++|.+||+
T Consensus       222 ~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~------~~~~i~~~~~~~~~---------~~~~~~l~~Li~~cl~  286 (311)
T d1t46a_         222 CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK------FYKMIKEGFRMLSP---------EHAPAEMYDIMKTCWD  286 (311)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH------HHHHHHHTCCCCCC---------TTSCHHHHHHHHHHTC
T ss_pred             CCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH------HHHHHhcCCCCCCc---------ccccHHHHHHHHHHcC
Confidence            889999999999999999998 5555544333221      11222222222111         1123468899999999


Q ss_pred             CCCCCCCCHHHHHHHhcCc
Q 027675          161 EDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~  179 (220)
                      .||++|||++++++.|++.
T Consensus       287 ~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         287 ADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             SSGGGSCCHHHHHHHHHHH
T ss_pred             CChhHCcCHHHHHHHHHHh
Confidence            9999999999999998654

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=4.8e-33  Score=215.22  Aligned_cols=154  Identities=27%  Similarity=0.356  Sum_probs=116.3

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +++++++.||+.||.|||+.+   ++||||||+||+++.++.++++|||++.......     ....++..|+|||.+.+
T Consensus       103 ~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-----~~~~~~~~y~aPE~l~~  174 (262)
T d1byga_         103 DCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALRE  174 (262)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHH
T ss_pred             HHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCCC-----ccccccccCCChHHHhC
Confidence            467899999999999999999   9999999999999999999999999987543221     22356789999999998


Q ss_pred             CCCcccCceeehhHHHHHHHh-cCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIIS-GKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++||||||+++|||++ |.+||...+.......       ...+.....+.         .....+.++|.+||.
T Consensus       175 ~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~-------i~~~~~~~~~~---------~~~~~~~~li~~cl~  238 (262)
T d1byga_         175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-------VEKGYKMDAPD---------GCPPAVYEVMKNCWH  238 (262)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH-------HTTTCCCCCCT---------TCCHHHHHHHHHHTC
T ss_pred             CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHH-------HHcCCCCCCCc---------cCCHHHHHHHHHHcc
Confidence            899999999999999999998 6887765544432211       11222222111         122467899999999


Q ss_pred             CCCCCCCCHHHHHHHhcCc
Q 027675          161 EDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~  179 (220)
                      .||++|||+.+++++|+..
T Consensus       239 ~dP~~Rps~~~l~~~L~~i  257 (262)
T d1byga_         239 LDAAMRPSFLQLREQLEHI  257 (262)
T ss_dssp             SSGGGSCCHHHHHHHHHHH
T ss_pred             cCHhHCcCHHHHHHHHHHH
Confidence            9999999999999998654

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.3e-33  Score=219.86  Aligned_cols=146  Identities=22%  Similarity=0.336  Sum_probs=114.6

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCC-CCCceecCccceeeecCCCCCcccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDH-EMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~   80 (220)
                      ++++.++.|+++||+|||+++   |+||||||+||+++. ++.++|+|||++.......    .....||+.|+|||.+.
T Consensus       110 ~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~~----~~~~~GT~~y~aPE~~~  182 (273)
T d1xwsa_         110 ELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIR  182 (273)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccceeccccc----ccccccCCCcCCHHHHc
Confidence            357889999999999999999   999999999999985 5789999999997644322    23356899999999998


Q ss_pred             cCCC-cccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           81 GGFF-SVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        81 ~~~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      +..+ +.++|||||||++|+|++|+.||...+..            . .+..    ...  .    ..+..+.++|.+||
T Consensus       183 ~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i------------~-~~~~----~~~--~----~~s~~~~~li~~~L  239 (273)
T d1xwsa_         183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------------I-RGQV----FFR--Q----RVSSECQHLIRWCL  239 (273)
T ss_dssp             HSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH------------H-HCCC----CCS--S----CCCHHHHHHHHHHT
T ss_pred             CCCCCCcccccccceeeehhHhhCCCCCCCchHH------------h-hccc----CCC--C----CCCHHHHHHHHHHc
Confidence            7665 67799999999999999999999642210            0 1110    000  1    11246789999999


Q ss_pred             CCCCCCCCCHHHHHHHhc
Q 027675          160 QEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~l~  177 (220)
                      +.||++|||++|++++-+
T Consensus       240 ~~dp~~R~s~~eil~hp~  257 (273)
T d1xwsa_         240 ALRPSDRPTFEEIQNHPW  257 (273)
T ss_dssp             CSSGGGSCCHHHHHTSGG
T ss_pred             cCCHhHCcCHHHHhcCHh
Confidence            999999999999998743

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.97  E-value=4.8e-33  Score=217.10  Aligned_cols=161  Identities=26%  Similarity=0.365  Sum_probs=116.1

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCC-CCcccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQ-TDGTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~y~aPe~~~   80 (220)
                      ++++.++.|+++||+|||++|   |+||||||+||+++.++.++++|||.+....... .........|++.|+|||++.
T Consensus       111 ~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~  187 (277)
T d1o6ya_         111 KRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR  187 (277)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHT
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHc
Confidence            467899999999999999999   9999999999999999999999999876543221 112223356899999999999


Q ss_pred             cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           81 GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      +..++.++|||||||++|+|++|..||...+.....      .+....+.....       ......+..+.++|.+||+
T Consensus       188 ~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~------~~~~~~~~~~~~-------~~~~~~s~~l~~li~~~L~  254 (277)
T d1o6ya_         188 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA------YQHVREDPIPPS-------ARHEGLSADLDAVVLKALA  254 (277)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHHCCCCCGG-------GTSSSCCHHHHHHHHHHTC
T ss_pred             CCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHH------HHHHhcCCCCCc-------hhccCCCHHHHHHHHHHcc
Confidence            988999999999999999999999999755443321      122222111110       0011123467899999999


Q ss_pred             CCCCCCC-CHHHHHHHhcC
Q 027675          161 EDPNDRP-TMSDVVIMLGS  178 (220)
Q Consensus       161 ~~p~~Rp-s~~~~l~~l~~  178 (220)
                      .||++|| |+++++..|..
T Consensus       255 ~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         255 KNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             SSGGGSCSSHHHHHHHHHH
T ss_pred             CCHhHCHhHHHHHHHHHHH
Confidence            9999999 89999887743

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.97  E-value=1.4e-32  Score=216.68  Aligned_cols=166  Identities=19%  Similarity=0.172  Sum_probs=119.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCC---CCCceecCccceeeecCCCC-----CcccceeecccCc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDH---EMNPKISDFGLTRIFEGKQT-----DGTTNRVVGTYGY   73 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~---~~~~~l~d~~~~~~~~~~~~-----~~~~~~~~~~~~y   73 (220)
                      .+++.++.|++.||+|||+++   |+||||||+||++..   +..++++|||++........     ........|++.|
T Consensus       103 ~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y  179 (299)
T d1ckia_         103 KTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY  179 (299)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSS
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccc
Confidence            467899999999999999999   999999999999864   44699999999987543221     1122335789999


Q ss_pred             cChhhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHH
Q 027675           74 MSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCIN  153 (220)
Q Consensus        74 ~aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (220)
                      +|||.+.+..++.++|||||||++|+|++|..||.............................         .....+.+
T Consensus       180 ~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~p~~~~~  250 (299)
T d1ckia_         180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK---------GYPSEFAT  250 (299)
T ss_dssp             CCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTT---------TSCHHHHH
T ss_pred             cCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhcc---------CCCHHHHH
Confidence            999999998899999999999999999999999976544433222111111110111111111         11236788


Q ss_pred             HhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          154 VGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       154 li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      +|..||+.||++||++.++.+.|+..
T Consensus       251 li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         251 YLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             HHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             HHHHHccCChhHCcCHHHHHHHHHHH
Confidence            99999999999999999888777554

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.4e-32  Score=216.53  Aligned_cols=171  Identities=22%  Similarity=0.217  Sum_probs=120.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||+|||++|   |+||||||+||+++.++.+||+|||++........  ......+++.|.|||.+..
T Consensus       102 ~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~apE~~~~  176 (298)
T d1gz8a_         102 PLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLG  176 (298)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB--CTTCCBCCCTTCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCcc--cceeecccceeeehhhhcc
Confidence            467899999999999999999   99999999999999999999999999875443221  2223468899999999877


Q ss_pred             CC-CcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhc---cccccccC---C-CCCcCc-----HHHH
Q 027675           82 GF-FSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEG---KALDMMDQ---K-PGAISK-----ANEI  148 (220)
Q Consensus        82 ~~-~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~---~-~~~~~~-----~~~~  148 (220)
                      .. .+.++|+|||||++|+|++|+.||...+................+.   ......+.   . ......     ...+
T Consensus       177 ~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  256 (298)
T d1gz8a_         177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD  256 (298)
T ss_dssp             CSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCC
T ss_pred             ccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCC
Confidence            65 4789999999999999999999997654433221110000000000   00000000   0 000000     1123


Q ss_pred             HHHHHHhccccCCCCCCCCCHHHHHHHhc
Q 027675          149 LKCINVGLLCVQEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       149 ~~~~~li~~cl~~~p~~Rps~~~~l~~l~  177 (220)
                      ..+.+++.+||+.||++|||++|+++|=+
T Consensus       257 ~~~~dll~~mL~~dP~~R~t~~ell~H~f  285 (298)
T d1gz8a_         257 EDGRSLLSQMLHYDPNKRISAKAALAHPF  285 (298)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhCCHh
Confidence            46789999999999999999999998743

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=99.97  E-value=1.3e-32  Score=214.47  Aligned_cols=156  Identities=24%  Similarity=0.322  Sum_probs=120.2

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ++++.++.||++||+|||++|   |+||||||+||+++.++.+||+|||++........   .....|++.|.|||.+.+
T Consensus       110 ~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~  183 (277)
T d1phka_         110 KETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIEC  183 (277)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchheeEccCCCc---eeeeeccCCCCCHHHhhc
Confidence            467899999999999999999   99999999999999999999999999987553222   233568899999999864


Q ss_pred             ------CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHh
Q 027675           82 ------GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVG  155 (220)
Q Consensus        82 ------~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  155 (220)
                            ..++.++||||+||++|+|++|+.||...+......      ... .+...      .........+..+.+++
T Consensus       184 ~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~------~i~-~~~~~------~~~~~~~~~s~~~~~li  250 (277)
T d1phka_         184 SMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR------MIM-SGNYQ------FGSPEWDDYSDTVKDLV  250 (277)
T ss_dssp             HHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHH-HTCCC------CCTTTGGGSCHHHHHHH
T ss_pred             cccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHH------HHH-hCCCC------CCCcccccCCHHHHHHH
Confidence                  245788999999999999999999997655433221      111 11110      11111122335788999


Q ss_pred             ccccCCCCCCCCCHHHHHHHh
Q 027675          156 LLCVQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       156 ~~cl~~~p~~Rps~~~~l~~l  176 (220)
                      .+||+.||++|||++++++|=
T Consensus       251 ~~~L~~~p~~R~s~~eil~h~  271 (277)
T d1phka_         251 SRFLVVQPQKRYTAEEALAHP  271 (277)
T ss_dssp             HHHCCSSGGGSCCHHHHTTSG
T ss_pred             HHHccCChhHCcCHHHHHcCH
Confidence            999999999999999999863

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3e-33  Score=222.31  Aligned_cols=152  Identities=25%  Similarity=0.318  Sum_probs=119.8

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +++..++.||+.||+|||+++   |+||||||+||+++.++.+||+|||++.......  .......|++.|+|||++.+
T Consensus       103 ~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~  177 (320)
T d1xjda_         103 SRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLG  177 (320)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccccc--ccccccCCCCCcCCHHHHcC
Confidence            367889999999999999999   9999999999999999999999999987544322  22333578999999999999


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccCC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQE  161 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  161 (220)
                      ..++.++|||||||++|+|++|+.||...+.......+       ..+..    . .+.     .....+.++|.+||+.
T Consensus       178 ~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i-------~~~~~----~-~p~-----~~s~~~~dli~~~L~~  240 (320)
T d1xjda_         178 QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI-------RMDNP----F-YPR-----WLEKEAKDLLVKLFVR  240 (320)
T ss_dssp             CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHCCC----C-CCT-----TSCHHHHHHHHHHSCS
T ss_pred             CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH-------HcCCC----C-CCc-----cCCHHHHHHHHHhccc
Confidence            99999999999999999999999999765544332111       11110    0 011     1234678999999999


Q ss_pred             CCCCCCCHH-HHHHH
Q 027675          162 DPNDRPTMS-DVVIM  175 (220)
Q Consensus       162 ~p~~Rps~~-~~l~~  175 (220)
                      ||++||++. ++++|
T Consensus       241 dP~~R~s~~~~l~~h  255 (320)
T d1xjda_         241 EPEKRLGVRGDIRQH  255 (320)
T ss_dssp             SGGGSBTTBSCGGGS
T ss_pred             CCCCCcCHHHHHHhC
Confidence            999999996 78754

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.6e-32  Score=217.32  Aligned_cols=161  Identities=24%  Similarity=0.305  Sum_probs=121.1

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCC--CcccceeecccCccChhhhh
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT--DGTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~y~aPe~~~   80 (220)
                      .+++++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.......  ........++..|.|||.+.
T Consensus       131 ~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  207 (311)
T d1r0pa_         131 DLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ  207 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHH
T ss_pred             HHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHh
Confidence            57889999999999999999   99999999999999999999999999976443221  11222346788999999999


Q ss_pred             cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           81 GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        81 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      +..++.++||||||+++|||++|..||......  ....    .....+.......         .....+.++|.+||.
T Consensus       208 ~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~----~~i~~g~~~~~p~---------~~~~~l~~li~~cl~  272 (311)
T d1r0pa_         208 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDIT----VYLLQGRRLLQPE---------YCPDPLYEVMLKCWH  272 (311)
T ss_dssp             HCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CH----HHHHTTCCCCCCT---------TCCHHHHHHHHHHTC
T ss_pred             cCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHH----HHHHcCCCCCCcc---------cCcHHHHHHHHHHcC
Confidence            989999999999999999999987776532211  1111    1112222221111         112367899999999


Q ss_pred             CCCCCCCCHHHHHHHhcCccc
Q 027675          161 EDPNDRPTMSDVVIMLGSEAV  181 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~~~  181 (220)
                      .||++||++.+|+++|+....
T Consensus       273 ~dP~~RPs~~ei~~~L~~i~~  293 (311)
T d1r0pa_         273 PKAEMRPSFSELVSRISAIFS  293 (311)
T ss_dssp             SSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCHhHCcCHHHHHHHHHHHHH
Confidence            999999999999999976643

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.7e-32  Score=219.45  Aligned_cols=169  Identities=21%  Similarity=0.251  Sum_probs=119.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCC-CceecCccceeeecCCCCCcccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEM-NPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~   80 (220)
                      +.+..+++||+.||+|||++|   |+||||||+||+++.++ .+||+|||++.........   ....++..|.|||.+.
T Consensus       122 ~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~  195 (350)
T d1q5ka_         122 IYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSYICSRYYRAPELIF  195 (350)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCC---CSCCSCTTSCCHHHHT
T ss_pred             HHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhccCCccc---ccccccccccChHHhh
Confidence            357889999999999999999   99999999999999775 7899999998765433222   2246788999999887


Q ss_pred             c-CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHH-----HHHHHh---c-cccc--cccCCC-CCcCcHHH
Q 027675           81 G-GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYA-----WKLWQE---G-KALD--MMDQKP-GAISKANE  147 (220)
Q Consensus        81 ~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~-----~~~~~~---~-~~~~--~~~~~~-~~~~~~~~  147 (220)
                      + ..++.++||||+||++|+|++|..||...+...........     ...+..   . ....  .....+ ........
T Consensus       196 ~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (350)
T d1q5ka_         196 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRT  275 (350)
T ss_dssp             TCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTS
T ss_pred             cccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCC
Confidence            5 46899999999999999999999999765544332221100     000000   0 0000  000000 00111123


Q ss_pred             HHHHHHHhccccCCCCCCCCCHHHHHHHh
Q 027675          148 ILKCINVGLLCVQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       148 ~~~~~~li~~cl~~~p~~Rps~~~~l~~l  176 (220)
                      ...+.++|.+||..||++|||+.|+++|=
T Consensus       276 s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp  304 (350)
T d1q5ka_         276 PPEAIALCSRLLEYTPTARLTPLEACAHS  304 (350)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence            34678999999999999999999999864

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.1e-32  Score=217.58  Aligned_cols=171  Identities=23%  Similarity=0.267  Sum_probs=121.0

Q ss_pred             chHHHHHHHHHHHHHHhhh--------CCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCC--Ccccceeeccc
Q 027675            2 EMLFNIILGVSRRLLYLHQ--------DSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT--DGTTNRVVGTY   71 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~--------~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~   71 (220)
                      +.+++++.+++.||.|||+        ++   |+||||||+||+++.++.+||+|||++........  ........|++
T Consensus       100 ~~~~~~~~~ia~gl~~lH~~~~~~~~~~~---IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~  176 (303)
T d1vjya_         100 EGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK  176 (303)
T ss_dssp             HHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCG
T ss_pred             HHHHHHHHHHHHHHHHHHHhhhhhccCCC---eeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceeccc
Confidence            4678999999999999997        46   99999999999999999999999999886643321  11223457899


Q ss_pred             CccChhhhhcCC------CcccCceeehhHHHHHHHhcCccCcccchhHHH--------hhHHHHHHHHHhccccccccC
Q 027675           72 GYMSPEYALGGF------FSVKSDVFSFGVVVLEIISGKRNTGFYNSELAL--------SLLGYAWKLWQEGKALDMMDQ  137 (220)
Q Consensus        72 ~y~aPe~~~~~~------~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~  137 (220)
                      .|+|||.+.+..      ++.++|||||||++|||++|..||.........        ............+..    .+
T Consensus       177 ~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~p  252 (303)
T d1vjya_         177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL----RP  252 (303)
T ss_dssp             GGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCC----CC
T ss_pred             CcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhcccc----CC
Confidence            999999987643      567899999999999999999887532211100        001111111111111    11


Q ss_pred             C-CCCcCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          138 K-PGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       138 ~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      . +...........+.+++.+||+.||++|||+.+|++.|+..
T Consensus       253 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i  295 (303)
T d1vjya_         253 NIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             CCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            1 11222334556788999999999999999999999998655

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=6.1e-32  Score=214.69  Aligned_cols=175  Identities=20%  Similarity=0.236  Sum_probs=121.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCC--CcccceeecccCccChhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQT--DGTTNRVVGTYGYMSPEYA   79 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~y~aPe~~   79 (220)
                      ..+..+++|++.||.|||+++   |+||||||+||+++.++.++++|||++........  ........+|+.|.|||.+
T Consensus       117 ~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~  193 (318)
T d3blha1         117 SEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELL  193 (318)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHH
T ss_pred             HHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHH
Confidence            357789999999999999999   99999999999999999999999999976542221  1122224678999999998


Q ss_pred             hcC-CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhc--------cccccccCCCCCcCcH-----
Q 027675           80 LGG-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEG--------KALDMMDQKPGAISKA-----  145 (220)
Q Consensus        80 ~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~-----  145 (220)
                      .+. .++.++||||+||++|+|++|+.||...+..................        ................     
T Consensus       194 ~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (318)
T d3blha1         194 LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLK  273 (318)
T ss_dssp             TTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHH
T ss_pred             cCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhc
Confidence            765 67899999999999999999999997655443332221110000000        0000000001111111     


Q ss_pred             --HHHHHHHHHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          146 --NEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       146 --~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                        .....++++|.+||+.||++|||++|+++|=+-.
T Consensus       274 ~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~  309 (318)
T d3blha1         274 AYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW  309 (318)
T ss_dssp             HHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGS
T ss_pred             cccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhc
Confidence              1123567899999999999999999999986543

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.3e-32  Score=217.86  Aligned_cols=157  Identities=26%  Similarity=0.335  Sum_probs=120.1

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..+++++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++.......   .....++..|.|||.+.+
T Consensus       127 ~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~  200 (309)
T d1fvra_         127 QQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNY  200 (309)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCceEEcccccccccccccc---ccceecCCcccchHHhcc
Confidence            357889999999999999999   99999999999999999999999999875432211   122457889999999999


Q ss_pred             CCCcccCceeehhHHHHHHHhcC-ccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGK-RNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                      ..++.++||||||+++|||++|. +||...+.......       ...+......         ......+.++|.+||+
T Consensus       201 ~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~-------i~~~~~~~~~---------~~~~~~~~~li~~cl~  264 (309)
T d1fvra_         201 SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-------LPQGYRLEKP---------LNCDDEVYDLMRQCWR  264 (309)
T ss_dssp             CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-------GGGTCCCCCC---------TTBCHHHHHHHHHHTC
T ss_pred             CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHH-------HHhcCCCCCC---------ccCCHHHHHHHHHHcC
Confidence            99999999999999999999976 46665443332211       1122221111         1123478899999999


Q ss_pred             CCCCCCCCHHHHHHHhcCcc
Q 027675          161 EDPNDRPTMSDVVIMLGSEA  180 (220)
Q Consensus       161 ~~p~~Rps~~~~l~~l~~~~  180 (220)
                      .||++|||+++|+++|+...
T Consensus       265 ~dP~~RPs~~eil~~L~~i~  284 (309)
T d1fvra_         265 EKPYERPSFAQILVSLNRML  284 (309)
T ss_dssp             SSGGGSCCHHHHHHHHHHHH
T ss_pred             CChhHCcCHHHHHHHHHHHH
Confidence            99999999999999987663

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.97  E-value=1.5e-32  Score=215.24  Aligned_cols=170  Identities=22%  Similarity=0.266  Sum_probs=116.5

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.||+.||+|||+.+   |+||||||+||+++.++.+|++|||.+........  ......+++.|.|||.+.+
T Consensus       100 ~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~~~~y~~pE~~~~  174 (286)
T d1ob3a_         100 VTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMG  174 (286)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTT
T ss_pred             hhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc--ccceecccchhhhHHHHhC
Confidence            467899999999999999999   99999999999999999999999999876443221  1222457889999999876


Q ss_pred             C-CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHH-----H---HHh-cc---ccccccCCCCCcCcHHHH
Q 027675           82 G-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWK-----L---WQE-GK---ALDMMDQKPGAISKANEI  148 (220)
Q Consensus        82 ~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~-----~---~~~-~~---~~~~~~~~~~~~~~~~~~  148 (220)
                      . .++.++|+|||||++|+|++|+.||...+.............     .   ... ..   ........+.........
T Consensus       175 ~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  254 (286)
T d1ob3a_         175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLD  254 (286)
T ss_dssp             CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCC
T ss_pred             CCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCC
Confidence            5 468999999999999999999999975544332211110000     0   000 00   000000000000011123


Q ss_pred             HHHHHHhccccCCCCCCCCCHHHHHHHh
Q 027675          149 LKCINVGLLCVQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       149 ~~~~~li~~cl~~~p~~Rps~~~~l~~l  176 (220)
                      ..+.++|.+||+.||++|||++|+++|=
T Consensus       255 ~~~~dli~~~L~~dP~~R~s~~ell~Hp  282 (286)
T d1ob3a_         255 ESGIDLLSKMLKLDPNQRITAKQALEHA  282 (286)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence            4678999999999999999999999763

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.97  E-value=1e-31  Score=211.13  Aligned_cols=168  Identities=15%  Similarity=0.128  Sum_probs=123.0

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCC-----CCCceecCccceeeecCCCCC-----cccceeeccc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDH-----EMNPKISDFGLTRIFEGKQTD-----GTTNRVVGTY   71 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~-----~~~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~   71 (220)
                      .++..++.|++.||+|||++|   |+||||||+||+++.     ++.++|+|||+++........     .......||+
T Consensus       101 ~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~  177 (293)
T d1csna_         101 KTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA  177 (293)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEch
Confidence            357889999999999999999   999999999999964     567999999999875432111     1223357899


Q ss_pred             CccChhhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHH
Q 027675           72 GYMSPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKC  151 (220)
Q Consensus        72 ~y~aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (220)
                      .|+|||.+.+..++.++|+||||+++|+|++|..||.........................+.....         ...+
T Consensus       178 ~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~---------p~~l  248 (293)
T d1csna_         178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGF---------PEEF  248 (293)
T ss_dssp             TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTS---------CHHH
T ss_pred             hhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCC---------CHHH
Confidence            9999999999999999999999999999999999997544433322221111111111111111111         1257


Q ss_pred             HHHhccccCCCCCCCCCHHHHHHHhcCccc
Q 027675          152 INVGLLCVQEDPNDRPTMSDVVIMLGSEAV  181 (220)
Q Consensus       152 ~~li~~cl~~~p~~Rps~~~~l~~l~~~~~  181 (220)
                      .+++..|++.+|++||+++.+.+.|.....
T Consensus       249 ~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~  278 (293)
T d1csna_         249 YKYMHYARNLAFDATPDYDYLQGLFSKVLE  278 (293)
T ss_dssp             HHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence            788888999999999999998887765433

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.2e-31  Score=215.37  Aligned_cols=167  Identities=25%  Similarity=0.284  Sum_probs=120.2

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.||+.||+|||++|   |+||||||+||+++.++.++++|||++.......     ....+++.|+|||.+.+
T Consensus       121 ~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~  192 (346)
T d1cm8a_         121 DRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEM-----TGYVVTRWYRAPEVILN  192 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSSC-----CSSCSCGGGCCTHHHHT
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceeccCCcc-----ccccccccccCHHHHcC
Confidence            467889999999999999999   9999999999999999999999999998654332     22467889999999876


Q ss_pred             C-CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHH-----HHHHh---------ccccccccCCCCCcCcHH
Q 027675           82 G-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAW-----KLWQE---------GKALDMMDQKPGAISKAN  146 (220)
Q Consensus        82 ~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-----~~~~~---------~~~~~~~~~~~~~~~~~~  146 (220)
                      . .++.++||||+||++|+|++|..||...+............     .....         ..................
T Consensus       193 ~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (346)
T d1cm8a_         193 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTN  272 (346)
T ss_dssp             TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTT
T ss_pred             CCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccC
Confidence            4 56899999999999999999999997655443322111100     00000         000000000000001112


Q ss_pred             HHHHHHHHhccccCCCCCCCCCHHHHHHHh
Q 027675          147 EILKCINVGLLCVQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       147 ~~~~~~~li~~cl~~~p~~Rps~~~~l~~l  176 (220)
                      ....+.++|.+||..||++|||++++++|=
T Consensus       273 ~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp  302 (346)
T d1cm8a_         273 ASPLAVNLLEKMLVLDAEQRVTAGEALAHP  302 (346)
T ss_dssp             CCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred             CCHHHHHHHHHHCcCChhHCcCHHHHhcCh
Confidence            234678999999999999999999999874

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=6.1e-32  Score=217.01  Aligned_cols=172  Identities=22%  Similarity=0.278  Sum_probs=119.6

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCC-CCCcccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGK-QTDGTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~y~aPe~~~   80 (220)
                      ..++.++.|++.||+|||++|   |+||||||+||+++.++.+||+|||++...... ..........+++.|.|||.+.
T Consensus       109 ~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  185 (345)
T d1pmea_         109 DHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML  185 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhh
Confidence            357889999999999999999   999999999999999999999999998764322 1122233456889999999985


Q ss_pred             -cCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHH-----Hh-------ccccccccCC--CCCcCcH
Q 027675           81 -GGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLW-----QE-------GKALDMMDQK--PGAISKA  145 (220)
Q Consensus        81 -~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-----~~-------~~~~~~~~~~--~~~~~~~  145 (220)
                       +..++.++||||+||++|+|++|..||...+...............     ..       ..........  +......
T Consensus       186 ~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (345)
T d1pmea_         186 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFP  265 (345)
T ss_dssp             TBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCT
T ss_pred             cCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCC
Confidence             4567889999999999999999999997544332222111110000     00       0000000000  0000000


Q ss_pred             HHHHHHHHHhccccCCCCCCCCCHHHHHHHh
Q 027675          146 NEILKCINVGLLCVQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       146 ~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l  176 (220)
                      .....+.+++.+||+.||++|||+++++++=
T Consensus       266 ~~s~~~~~li~~~L~~dP~~R~ta~e~L~hp  296 (345)
T d1pmea_         266 NADSKALDLLDKMLTFNPHKRIEVEQALAHP  296 (345)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence            1123678999999999999999999999873

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.6e-32  Score=216.17  Aligned_cols=155  Identities=17%  Similarity=0.235  Sum_probs=118.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCC--CCceecCccceeeecCCCCCcccceeecccCccChhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHE--MNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYA   79 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~--~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~   79 (220)
                      ++++.++.||+.||+|||++|   |+||||||+||+++.+  +.++++|||++......   .......+++.|.|||..
T Consensus       102 ~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~---~~~~~~~~t~~y~ape~~  175 (321)
T d1tkia_         102 REIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG---DNFRLLFTAPEYYAPEVH  175 (321)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT---CEEEEEESCGGGSCHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC---Ccccccccccccccchhc
Confidence            367889999999999999999   9999999999999854  47899999998765432   222335678899999999


Q ss_pred             hcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhcccc
Q 027675           80 LGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCV  159 (220)
Q Consensus        80 ~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  159 (220)
                      .+..++.++|||||||++|+|++|..||...+.......      ........       ...........+.++|.+||
T Consensus       176 ~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~------i~~~~~~~-------~~~~~~~~s~~~~~li~~~L  242 (321)
T d1tkia_         176 QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIEN------IMNAEYTF-------DEEAFKEISIEAMDFVDRLL  242 (321)
T ss_dssp             TTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH------HHHTCCCC-------CHHHHTTSCHHHHHHHHTTS
T ss_pred             cCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHH------HHhCCCCC-------ChhhccCCCHHHHHHHHHHc
Confidence            999999999999999999999999999976554432211      11111000       00000012346789999999


Q ss_pred             CCCCCCCCCHHHHHHH
Q 027675          160 QEDPNDRPTMSDVVIM  175 (220)
Q Consensus       160 ~~~p~~Rps~~~~l~~  175 (220)
                      ..||++|||++++++|
T Consensus       243 ~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         243 VKERKSRMTASEALQH  258 (321)
T ss_dssp             CSSGGGSCCHHHHHHS
T ss_pred             cCChhHCcCHHHHhcC
Confidence            9999999999999985

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.96  E-value=9e-31  Score=208.78  Aligned_cols=170  Identities=17%  Similarity=0.203  Sum_probs=118.1

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCC-CceecCccceeeecCCCCCcccceeecccCccChhhhh
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEM-NPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYAL   80 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~   80 (220)
                      ..+..+++||+.||+|||++|   |+||||||+|||++.++ .++|+|||++........   .....+++.|.|||.+.
T Consensus       129 ~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~  202 (328)
T d3bqca1         129 YDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLV  202 (328)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC---CCSCCSCGGGCCHHHHT
T ss_pred             HHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCCCc---ccccccCccccCccccc
Confidence            357889999999999999999   99999999999998655 589999999976543222   22346788999999988


Q ss_pred             cC-CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhH-HHH------HHHHHhcccc------cc--------ccCC
Q 027675           81 GG-FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLL-GYA------WKLWQEGKAL------DM--------MDQK  138 (220)
Q Consensus        81 ~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~-~~~------~~~~~~~~~~------~~--------~~~~  138 (220)
                      +. .++.++||||+||++|++++|..||............ ...      ..........      ..        ....
T Consensus       203 ~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (328)
T d3bqca1         203 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERF  282 (328)
T ss_dssp             TCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGG
T ss_pred             CCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhc
Confidence            75 4689999999999999999999998654433211110 000      0000000000      00        0000


Q ss_pred             CCCcCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHhc
Q 027675          139 PGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       139 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~  177 (220)
                      ............+.++|.+||..||++|||++|+++|=+
T Consensus       283 ~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~  321 (328)
T d3bqca1         283 VHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY  321 (328)
T ss_dssp             CCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             ccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence            111111122346789999999999999999999998643

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.3e-30  Score=204.45  Aligned_cols=170  Identities=18%  Similarity=0.185  Sum_probs=117.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      ..++.++.|++.||+|||+++   |+||||||+||+++.++.++++|||.+.........  .....++..|.|||.+.+
T Consensus       101 ~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~~~~~~~pe~~~~  175 (292)
T d1unla_         101 EIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFG  175 (292)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC--CCSCCSCGGGCCHHHHTT
T ss_pred             hHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCcc--ceeeccccchhhhhHhcc
Confidence            357889999999999999999   999999999999999999999999999865433221  222345778999999877


Q ss_pred             CC-CcccCceeehhHHHHHHHhcCccCcccch-hHHHhhHHHHHHHHHhcc------------ccccccCCCCCcCcHHH
Q 027675           82 GF-FSVKSDVFSFGVVVLEIISGKRNTGFYNS-ELALSLLGYAWKLWQEGK------------ALDMMDQKPGAISKANE  147 (220)
Q Consensus        82 ~~-~~~~~DiwslG~il~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~  147 (220)
                      .. ++.++|||||||++|+|++|+.||..... ..................            .................
T Consensus       176 ~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (292)
T d1unla_         176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKL  255 (292)
T ss_dssp             CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTC
T ss_pred             CCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccC
Confidence            65 58899999999999999999998643332 222211111100000000            00000000000111122


Q ss_pred             HHHHHHHhccccCCCCCCCCCHHHHHHHh
Q 027675          148 ILKCINVGLLCVQEDPNDRPTMSDVVIML  176 (220)
Q Consensus       148 ~~~~~~li~~cl~~~p~~Rps~~~~l~~l  176 (220)
                      ...+.+++.+||+.||++|||++|+++|=
T Consensus       256 s~~~~dll~~mL~~dP~~R~sa~e~L~Hp  284 (292)
T d1unla_         256 NATGRDLLQNLLKCNPVQRISAEEALQHP  284 (292)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCh
Confidence            34678899999999999999999999864

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.3e-30  Score=208.52  Aligned_cols=172  Identities=20%  Similarity=0.170  Sum_probs=118.7

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      +.++.+++||+.||+|||++|   |+||||||+||+++.++.++++|||+........   ......+++.|+|||.+.+
T Consensus       119 ~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~  192 (355)
T d2b1pa1         119 ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILG  192 (355)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------------------CCTTCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhcccccc---ccccccccccccChhhhcC
Confidence            467889999999999999999   9999999999999999999999999877544322   2233467899999999999


Q ss_pred             CCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHH----------------HHHHHHhccccc------c---cc
Q 027675           82 GFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGY----------------AWKLWQEGKALD------M---MD  136 (220)
Q Consensus        82 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~------~---~~  136 (220)
                      ..++.++||||+||++++|++|+.||...+..........                ............      .   ..
T Consensus       193 ~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (355)
T d2b1pa1         193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSL  272 (355)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGG
T ss_pred             CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCcccccccccccccccc
Confidence            9999999999999999999999999975543332221100                000111100000      0   00


Q ss_pred             CCCCCcCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHhcCc
Q 027675          137 QKPGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLGSE  179 (220)
Q Consensus       137 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~~~  179 (220)
                      ..............+.+||.+||..||++|||++|+|+|=+-.
T Consensus       273 ~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~  315 (355)
T d2b1pa1         273 FPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN  315 (355)
T ss_dssp             SCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTG
T ss_pred             ccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccC
Confidence            0111112234466789999999999999999999999885443

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=5.4e-30  Score=203.57  Aligned_cols=157  Identities=24%  Similarity=0.309  Sum_probs=116.3

Q ss_pred             hHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhcC
Q 027675            3 MLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALGG   82 (220)
Q Consensus         3 ~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~~   82 (220)
                      .++.++.||+.||+|||+++   ++||||||+||+++.++.++|+|||++.......... .....+++.|.+||.+.+.
T Consensus       130 ~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~-~~~~~g~~~~~~pe~~~~~  205 (322)
T d1vzoa_         130 EVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGTIEYMAPDIVRGG  205 (322)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGG-GCGGGSCCTTCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhhccccccc-ccccccccccchhHHhhcC
Confidence            56778999999999999999   9999999999999999999999999987654332222 2234678899999999764


Q ss_pred             --CCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHHHHHhccccccccCCCCCcCcHHHHHHHHHHhccccC
Q 027675           83 --FFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWKLWQEGKALDMMDQKPGAISKANEILKCINVGLLCVQ  160 (220)
Q Consensus        83 --~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  160 (220)
                        .++.++|||||||++|+|++|..||...+........   .+......        +.  ........+.++|.+||.
T Consensus       206 ~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i---~~~~~~~~--------~~--~~~~~s~~~~~li~~~l~  272 (322)
T d1vzoa_         206 DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI---SRRILKSE--------PP--YPQEMSALAKDLIQRLLM  272 (322)
T ss_dssp             C---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH---HHHHHHCC--------CC--CCTTSCHHHHHHHHHHTC
T ss_pred             CcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHhcccCC--------CC--CcccCCHHHHHHHHHHcc
Confidence              4678999999999999999999999654433221111   11111100        00  011233478899999999


Q ss_pred             CCCCCCC-----CHHHHHHHh
Q 027675          161 EDPNDRP-----TMSDVVIML  176 (220)
Q Consensus       161 ~~p~~Rp-----s~~~~l~~l  176 (220)
                      .||++||     |++|+++|-
T Consensus       273 ~dP~~R~s~~~~t~~eil~Hp  293 (322)
T d1vzoa_         273 KDPKKRLGCGPRDADEIKEHL  293 (322)
T ss_dssp             SSGGGSTTSSTTTHHHHHTSG
T ss_pred             cCHHHcCCCCcccHHHHHcCH
Confidence            9999999     589999764

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3.6e-30  Score=206.77  Aligned_cols=168  Identities=23%  Similarity=0.289  Sum_probs=115.0

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeeecCCCCCcccceeecccCccChhhhhc
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIFEGKQTDGTTNRVVGTYGYMSPEYALG   81 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~aPe~~~~   81 (220)
                      .++..++.||+.||+|||++|   |+||||||+||+++.++.++++|||++......     .....++..|.|||...+
T Consensus       121 ~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~-----~~~~~g~~~y~apE~~~~  192 (348)
T d2gfsa1         121 DHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLN  192 (348)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CCTGG-----GSSSCHHHHTSCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcccCcc-----cccccccccccCchhhcC
Confidence            467889999999999999999   999999999999999999999999998654322     222457889999998777


Q ss_pred             CC-CcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHHH-----HHHhc------cccccccCCCCCcC---cHH
Q 027675           82 GF-FSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAWK-----LWQEG------KALDMMDQKPGAIS---KAN  146 (220)
Q Consensus        82 ~~-~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~------~~~~~~~~~~~~~~---~~~  146 (220)
                      .. ++.++|||||||++|+|++|..||...+.............     .....      .........+....   ...
T Consensus       193 ~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (348)
T d2gfsa1         193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG  272 (348)
T ss_dssp             CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTT
T ss_pred             CccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCC
Confidence            54 58899999999999999999999975544333222111000     00000      00000000000000   011


Q ss_pred             HHHHHHHHhccccCCCCCCCCCHHHHHHHhc
Q 027675          147 EILKCINVGLLCVQEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       147 ~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~  177 (220)
                      ....+.++|.+||..||++|||++|+++|=+
T Consensus       273 ~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~  303 (348)
T d2gfsa1         273 ANPLAVDLLEKMLVLDSDKRITAAQALAHAY  303 (348)
T ss_dssp             CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             CCHHHHHHHHHHCcCChhhCcCHHHHhcCHh
Confidence            2346789999999999999999999998643

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.96  E-value=7.1e-29  Score=200.04  Aligned_cols=168  Identities=23%  Similarity=0.227  Sum_probs=116.6

Q ss_pred             chHHHHHHHHHHHHHHhhh-CCCCCeEeccCCCCceeeCCCCC------ceecCccceeeecCCCCCcccceeecccCcc
Q 027675            2 EMLFNIILGVSRRLLYLHQ-DSKLRIIHRDFKTSNILLDHEMN------PKISDFGLTRIFEGKQTDGTTNRVVGTYGYM   74 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~-~~~~~i~H~dlk~~nili~~~~~------~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~   74 (220)
                      ..+..+++|++.||.|||+ .|   |+||||||+||+++.++.      ++++|||.+......     .....+++.|+
T Consensus       125 ~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~  196 (362)
T d1q8ya_         125 IYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYR  196 (362)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGC
T ss_pred             HHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccceeeEeecccccccccc-----ccccccccccc
Confidence            3578899999999999997 88   999999999999976554      899999998754322     22346788999


Q ss_pred             ChhhhhcCCCcccCceeehhHHHHHHHhcCccCcccchhHHHhhHHHHH-----------HHHHhcc----------ccc
Q 027675           75 SPEYALGGFFSVKSDVFSFGVVVLEIISGKRNTGFYNSELALSLLGYAW-----------KLWQEGK----------ALD  133 (220)
Q Consensus        75 aPe~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-----------~~~~~~~----------~~~  133 (220)
                      |||.+.+..++.++|+||+||++++|++|+.||...+............           .....+.          ...
T Consensus       197 aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~  276 (362)
T d1q8ya_         197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLR  276 (362)
T ss_dssp             CHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBS
T ss_pred             ChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhh
Confidence            9999999899999999999999999999999986432211110000000           0000000          000


Q ss_pred             cccC-C---------CCCcCcHHHHHHHHHHhccccCCCCCCCCCHHHHHHHhc
Q 027675          134 MMDQ-K---------PGAISKANEILKCINVGLLCVQEDPNDRPTMSDVVIMLG  177 (220)
Q Consensus       134 ~~~~-~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~l~~l~  177 (220)
                      .... .         ............+.+++.+||+.||.+|||++|+|+|=+
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~  330 (362)
T d1q8ya_         277 NISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPW  330 (362)
T ss_dssp             SCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGG
T ss_pred             ccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence            0000 0         011122455678899999999999999999999998743

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.26  E-value=2.4e-12  Score=93.46  Aligned_cols=50  Identities=20%  Similarity=0.185  Sum_probs=44.4

Q ss_pred             chHHHHHHHHHHHHHHhhhCCCCCeEeccCCCCceeeCCCCCceecCccceeee
Q 027675            2 EMLFNIILGVSRRLLYLHQDSKLRIIHRDFKTSNILLDHEMNPKISDFGLTRIF   55 (220)
Q Consensus         2 ~~~~~i~~~l~~~l~~LH~~~~~~i~H~dlk~~nili~~~~~~~l~d~~~~~~~   55 (220)
                      +....++.|+++++.|||+.|   |+||||||+||++++++ ++|+|||.+...
T Consensus       103 ~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~liDFG~a~~~  152 (191)
T d1zara2         103 ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWIIDFPQSVEV  152 (191)
T ss_dssp             SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEECCCTTCEET
T ss_pred             HHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEEECCCcccC
Confidence            346789999999999999999   99999999999998654 889999988654

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.70  E-value=0.0089  Score=44.96  Aligned_cols=47  Identities=17%  Similarity=0.113  Sum_probs=32.4

Q ss_pred             HHHHHHHHHHHhhhCC-CCCeEeccCCCCceeeCCCCCceecCcccee
Q 027675            7 IILGVSRRLLYLHQDS-KLRIIHRDFKTSNILLDHEMNPKISDFGLTR   53 (220)
Q Consensus         7 i~~~l~~~l~~LH~~~-~~~i~H~dlk~~nili~~~~~~~l~d~~~~~   53 (220)
                      .+....+.+...+... ...++|+|+.++|++++.+....++||+.+.
T Consensus       165 ~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         165 EIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             HHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            3334444444444321 2249999999999999988767899999765

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=94.01  E-value=0.015  Score=42.29  Aligned_cols=29  Identities=24%  Similarity=0.326  Sum_probs=24.6

Q ss_pred             CeEeccCCCCceeeCCCCCceecCcccee
Q 027675           25 RIIHRDFKTSNILLDHEMNPKISDFGLTR   53 (220)
Q Consensus        25 ~i~H~dlk~~nili~~~~~~~l~d~~~~~   53 (220)
                      .++|+|+.+.||++++.+.+.++||+.+.
T Consensus       184 ~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         184 VFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             EEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             EEEEeeccCcceeecCCceEEEeechhcc
Confidence            48999999999999876656799998764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=92.87  E-value=0.014  Score=42.17  Aligned_cols=29  Identities=21%  Similarity=0.225  Sum_probs=24.9

Q ss_pred             CeEeccCCCCceeeCCCCCceecCcccee
Q 027675           25 RIIHRDFKTSNILLDHEMNPKISDFGLTR   53 (220)
Q Consensus        25 ~i~H~dlk~~nili~~~~~~~l~d~~~~~   53 (220)
                      .++|+|+.+.||+++.+..+.++||+.+.
T Consensus       176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         176 VVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             EEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             eEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence            48999999999999887667899998764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=92.67  E-value=0.051  Score=42.17  Aligned_cols=29  Identities=24%  Similarity=0.348  Sum_probs=25.2

Q ss_pred             CeEeccCCCCceeeCCCCCceecCccceee
Q 027675           25 RIIHRDFKTSNILLDHEMNPKISDFGLTRI   54 (220)
Q Consensus        25 ~i~H~dlk~~nili~~~~~~~l~d~~~~~~   54 (220)
                      .++|||+.+.||++++++ ++++|+..+..
T Consensus       224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~  252 (392)
T d2pula1         224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFY  252 (392)
T ss_dssp             EEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred             ceeccCCcCCceeEcCCc-eEEechhhccc
Confidence            499999999999998764 89999988764

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=90.24  E-value=0.14  Score=38.46  Aligned_cols=28  Identities=29%  Similarity=0.366  Sum_probs=22.7

Q ss_pred             CeEeccCCCCceeeCCCCCceecCccceee
Q 027675           25 RIIHRDFKTSNILLDHEMNPKISDFGLTRI   54 (220)
Q Consensus        25 ~i~H~dlk~~nili~~~~~~~l~d~~~~~~   54 (220)
                      .++|+|+.+.||++++.  ..++||+-+..
T Consensus       193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         193 LRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eeecCCCCcccEEEeCC--ceEEechhccc
Confidence            48999999999999743  56889987653

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=86.19  E-value=0.14  Score=39.59  Aligned_cols=16  Identities=38%  Similarity=0.630  Sum_probs=13.6

Q ss_pred             CeEeccCCCCceeeCC
Q 027675           25 RIIHRDFKTSNILLDH   40 (220)
Q Consensus        25 ~i~H~dlk~~nili~~   40 (220)
                      +++|+|+.+.||++.+
T Consensus       219 v~CHnDL~~~NiL~~~  234 (395)
T d1nw1a_         219 TFCHNDLQEGNILLPK  234 (395)
T ss_dssp             EEECSCCCGGGEEEEC
T ss_pred             eEEecCCCcccEeecc
Confidence            4789999999999843